PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Welscher, PT; Zuniga, A; Kuijper, S; Drenth, T; Goedemans, HJ; Meijlink, F; Zeller, R				Welscher, PT; Zuniga, A; Kuijper, S; Drenth, T; Goedemans, HJ; Meijlink, F; Zeller, R			Progression of vertebrate limb development through SHH-mediated counteraction of GLI3	SCIENCE			English	Article							CUBITUS INTERRUPTUS; POLARIZING ACTIVITY; MECHANISMS; ACTIVATION; MUTATIONS; MODEL; GENE	Distal limb development and specification of digit identities in tetrapods are under the control of a mesenchymal organizer called the polarizing region. Sonic Hedgehog (SHH) is the morphogenetic signal produced by the polarizing region in the posterior limb bud. Ectopic anterior SHH signaling induces digit duplications and has been suspected as a major cause underlying congenital malformations that result in digit polydactyly. Here, we report that the polydactyly of Gli3-deficient mice arises independently of SHH signaling. Disruption of one or both Gli3 alleles in mouse embryos lacking Shh progressively restores limb distal development and digit formation. Our genetic analysis indicates that SHH signaling counteracts GLI3-mediated repression of key regulator genes, cell survival, and distal progression of limb bud development.	Univ Utrecht, Fac Biol, Dept Dev Biol, NL-3584 CH Utrecht, Netherlands; Hubrecht Lab, NL-3584 CT Utrecht, Netherlands	Utrecht University; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Zeller, R (corresponding author), Univ Utrecht, Fac Biol, Dept Dev Biol, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	R.Zeller@bio.uu.nl	Zuniga, Aimée/AAG-7335-2020; Zeller, Rolf/C-2610-2013; Zuniga, Aimée/Q-2692-2018	Zuniga, Aimée/0000-0002-9953-3637; Zeller, Rolf/0000-0002-3186-7403; Zuniga, Aimée/0000-0002-9953-3637				Altaba ARI, 1999, DEVELOPMENT, V126, P3205; Biesecker LG, 1997, NAT GENET, V17, P259, DOI 10.1038/ng1197-259; Brewster R, 2000, DEVELOPMENT, V127, P4395; Capdevila J, 2001, ANNU REV CELL DEV BI, V17, P87, DOI 10.1146/annurev.cellbio.17.1.87; Caruccio NC, 1999, DEV BIOL, V212, P137, DOI 10.1006/dbio.1999.9321; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Chiang C, 2001, DEV BIOL, V236, P421, DOI 10.1006/dbio.2001.0346; Cohn MJ, 2000, NATURE, V406, P953, DOI 10.1038/35023216; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; DESCHAMPS J, 810680123 NETH RES O; Drossopoulou G, 2000, DEVELOPMENT, V127, P1337; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; JOHNSON RL, 1994, CURR OPIN GENET DEV, V4, P535, DOI 10.1016/0959-437X(94)90069-F; Johnson RL, 1997, CELL, V90, P979, DOI 10.1016/S0092-8674(00)80364-5; Kraus P, 2001, MECH DEVELOP, V100, P45, DOI 10.1016/S0925-4773(00)00492-5; MASUYA H, 1995, GENE DEV, V9, P1645, DOI 10.1101/gad.9.13.1645; Methot N, 2001, DEVELOPMENT, V128, P733; Qu SM, 1998, DEVELOPMENT, V125, P2711; Shin SH, 1999, P NATL ACAD SCI USA, V96, P2880, DOI 10.1073/pnas.96.6.2880; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Welscher PT, 2002, GENE DEV, V16, P421, DOI 10.1101/gad.219202; Ying LT, 2000, NAT NEUROSCI, V3, P979, DOI 10.1038/79916; Zakany J, 1999, CELL TISSUE RES, V296, P19, DOI 10.1007/s004410051262; Zuniga A, 1999, DEVELOPMENT, V126, P13; Zuniga A, 1999, NATURE, V401, P598, DOI 10.1038/44157	26	288	296	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 25	2002	298	5594					827	830		10.1126/science.1075620	http://dx.doi.org/10.1126/science.1075620			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607KR	12215652				2022-12-24	WOS:000178791200059
J	Kump, LR				Kump, LR			Reducing uncertainty about carbon dioxide as a climate driver	NATURE			English	Editorial Material							ATMOSPHERIC CO2; TEMPERATURES; HYPOTHESIS; ALBEDO; CORE; ICE	The lack of an adequate ancient analogue for future climates means that we ultimately must use and trust climate models, evaluated against modern observation and our best geologic records of warm and cold climates of the past. Armed with an elevated confidence in the models, we will then be able to make reliable predictions of the Earth's response to our risky experiment with the climate system.	Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; Penn State Univ, NASA, Astrobiol Inst, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Aeronautics & Space Administration (NASA); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Kump, LR (corresponding author), Penn State Univ, Dept Geosci, University Pk, PA 16802 USA.	lkump@psu.edu	Kump, Lee/H-8287-2012					Barron EJ, 1987, PALEOCEANOGRAPHY, V2, P729, DOI 10.1029/PA002i006p00729; Beerling DJ, 2002, P NATL ACAD SCI USA, V99, P7836, DOI 10.1073/pnas.122573099; BROCCOLI AJ, 1987, CLIM DYNAM, V1, P87; CHARLSON RJ, 1987, NATURE, V326, P655, DOI 10.1038/326655a0; Crowley TJ, 2001, SCIENCE, V292, P870, DOI 10.1126/science.1061664; Crowley TJ, 2000, WARM CLIMATES EARTH, P50, DOI DOI 10.1017/CBO9780511564512.004; DICKENS GR, 1995, PALEOCEANOGRAPHY, V10, P965, DOI 10.1029/95PA02087; Kump LR, 1999, PALAEOGEOGR PALAEOCL, V152, P173, DOI 10.1016/S0031-0182(99)00046-2; Montgomery DR, 2001, GEOLOGY, V29, P579, DOI 10.1130/0091-7613(2001)029<0579:CTATMO>2.0.CO;2; Pagani M, 1999, PALEOCEANOGRAPHY, V14, P273, DOI 10.1029/1999PA900006; Pearson PN, 2001, NATURE, V413, P481, DOI 10.1038/35097000; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Veizer J, 2000, NATURE, V408, P698, DOI 10.1038/35047044; Wilson PA, 2002, GEOLOGY, V30, P607, DOI 10.1130/0091-7613(2002)030<0607:TTCGHU>2.0.CO;2	14	52	59	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 12	2002	419	6903					188	190		10.1038/nature01087	http://dx.doi.org/10.1038/nature01087			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592HK	12226672				2022-12-24	WOS:000177931200047
J	Cortright, RD; Davda, RR; Dumesic, JA				Cortright, RD; Davda, RR; Dumesic, JA			Hydrogen from catalytic reforming of biomass-derived hydrocarbons in liquid water	NATURE			English	Article							GAS-SHIFT REACTION; METAL-CATALYSTS; KINETICS; GLUCOSE; CONVERSION; RUTHENIUM; FRUCTOSE; MODEL	Concerns about the depletion of fossil fuel reserves and the pollution caused by continuously increasing energy demands make hydrogen an attractive alternative energy source. Hydrogen is currently derived from nonrenewable natural gas and petroleum(1), but could in principle be generated from renewable resources such as biomass or water. However, efficient hydrogen production from water remains difficult and technologies for generating hydrogen from biomass, such as enzymatic decomposition of sugars(2-5), steam-reforming of bio-oils(6-8) and gasification(9), suffer from low hydrogen production rates and/or complex processing requirements. Here we demonstrate that hydrogen can be produced from sugars and alcohols at temperatures near 500 K in a single-reactor aqueous-phase reforming process using a platinum-based catalyst. We are able to convert glucose-which makes up the major energy reserves in plants and animals-to hydrogen and gaseous alkanes, with hydrogen constituting 50% of the products. We find that the selectivity for hydrogen production increases when we use molecules that are more reduced than sugars, with ethylene glycol and methanol being almost completely converted into hydrogen and carbon dioxide. These findings suggest that catalytic aqueous-phase reforming might prove useful for the generation of hydrogen-rich fuel gas from carbohydrates extracted from renewable biomass and biomass waste streams.	Univ Wisconsin, Dept Chem Engn, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Dumesic, JA (corresponding author), Univ Wisconsin, Dept Chem Engn, 1415 Johnson Dr, Madison, WI 53706 USA.							AMPHLETT JC, 1998, HYDROGEN ENERGY PROG, V3, P1681; AMPHLETT JC, 1998, P 33 INT EN CONV ENG, V269, P1; Bates SP, 1998, ADV CATAL, V42, P1, DOI 10.1016/S0360-0564(08)60627-6; Blanc B, 2000, GREEN CHEM, V2, P89, DOI 10.1039/a909131i; Collins P. C., 1995, MONOSACCHARIDES THEI; Eggleston G, 2000, J CARBOHYD CHEM, V19, P1305, DOI 10.1080/07328300008544153; Garcia L, 2000, APPL CATAL A-GEN, V201, P225, DOI 10.1016/S0926-860X(00)00440-3; Gates B.C., 1992, CATALYTIC CHEM; Greeley J, 2002, J AM CHEM SOC, V124, P7193, DOI 10.1021/ja017818k; GRENOBLE DC, 1981, J CATAL, V67, P90, DOI 10.1016/0021-9517(81)90263-3; Hilaire S, 2001, APPL CATAL A-GEN, V215, P271, DOI 10.1016/S0926-860X(01)00535-X; IGLESIA E, 1992, J CATAL, V137, P212, DOI 10.1016/0021-9517(92)90150-G; Kabyemela BM, 1999, IND ENG CHEM RES, V38, P2888, DOI 10.1021/ie9806390; KELLNER CS, 1981, J CATAL, V70, P418, DOI 10.1016/0021-9517(81)90354-7; Kumar N, 2000, PROCESS BIOCHEM, V35, P589, DOI 10.1016/S0032-9592(99)00109-0; LARMINIE J, 2000, FUEL CELL SYSTEMS EX, P189; Li HX, 2000, J CATAL, V191, P257, DOI 10.1006/jcat.1999.2792; Marquevich M, 1999, ENERG FUEL, V13, P1160, DOI 10.1021/ef990034w; MILNE TA, 2002, HYDROGEN BIOMASS STA, P1; NARAYAN R, 1984, BIOTECHNOL BIOENG S, V14, P563; Rostrup-Nielsen JR, 2001, PHYS CHEM CHEM PHYS, V3, P283, DOI 10.1039/b004660o; TRONCONI E, 1992, CHEM ENG SCI, V47, P2451, DOI 10.1016/0009-2509(92)87075-2; VANNICE MA, 1977, J CATAL, V50, P228, DOI 10.1016/0021-9517(77)90031-8; Woodward J, 2000, NATURE, V405, P1014, DOI 10.1038/35016633; Woodward J, 2000, ENERG FUEL, V14, P197, DOI 10.1021/ef990126l; Yokoi H, 2001, J BIOSCI BIOENG, V91, P58, DOI 10.1263/jbb.91.58	26	1682	1777	52	1466	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 29	2002	418	6901					964	967		10.1038/nature01009	http://dx.doi.org/10.1038/nature01009			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588AP	12198544				2022-12-24	WOS:000177677500041
J	Fisher, NC; Hanson, J; Phillips, A; Rao, JN; Swarbrick, ET				Fisher, NC; Hanson, J; Phillips, A; Rao, JN; Swarbrick, ET			Mortality from liver disease in the West Midlands, 1993-2000: observational study	BRITISH MEDICAL JOURNAL			English	Article									Russells Hall Hosp, Dudley Grp Hosp NHS Trust, Dept Gastroenterol, Dudley DY1 2HQ, W Midlands, England; Dudley Hlth Author, Dudley DY12 2DD, England; Wolverhampton Hlth Author, Wolverhampton WV13 0XE, England; Sandwell Hlth Author, Bromwich B70 9LD, England; Wolverhampton Univ, New Cross Hosp, Div Clin Sci, Wolverhampton WV10 0QP, England	Russells Hall Hospital; New Cross Hospital; University of Wolverhampton	Fisher, NC (corresponding author), Russells Hall Hosp, Dudley Grp Hosp NHS Trust, Dept Gastroenterol, Dudley DY1 2HQ, W Midlands, England.							Armitage P., 2001, STAT METHODS MED RES; Chick J, 1997, Health Bull (Edinb), V55, P134; *DEP HLTH, 1999, HLTH B DEP HLTH; NOBLE B, 1994, POPULATION TRENDS, V76, P1	4	23	23	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 10	2002	325	7359					312	313		10.1136/bmj.325.7359.312	http://dx.doi.org/10.1136/bmj.325.7359.312			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	584RQ	12169508	Bronze, Green Published			2022-12-24	WOS:000177482500019
J	Prasanth, SG; Prasanth, KV; Stillman, B				Prasanth, SG; Prasanth, KV; Stillman, B			Orc6 involved in DNA replication, chromosome segregation, and cytokinesis	SCIENCE			English	Article							ORIGIN RECOGNITION COMPLEX; CENTROMERE PROTEIN INCENP; CYCLE; CHECKPOINTS; METAPHASE; MITOSIS; KINASES; CELLS	Origin recognition complex (ORC) proteins serve as a landing pad for the assembly of a multiprotein prereplicative complex, which is required to initiate DNA replication. During mitosis, the smallest subunit of human ORC, Orc6, localizes to kinetochores and to a reticular-like structure around the cell periphery. As chromosomes segregate during anaphase, the reticular structures align along the plane of cell division and some Orc6 localizes to the midbody before cells separate. Silencing of Orc6 expression by small interfering RNA (siRNA) resulted in cells with multipolar spindles, aberrant mitosis, formation of multinucleated cells, and decreased DNA replication. Prolonged periods of Orc6 depletion caused a decrease in cell proliferation and increased cell death. These results implicate Orc6 as an essential gene that coordinates chromosome replication and segregation with cytokinesis.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Stillman, B (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.			Stillman, Bruce/0000-0002-9453-4091	NCI NIH HHS [CA13106, P01 CA013106] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adams RR, 2001, J CELL BIOL, V153, P865, DOI 10.1083/jcb.153.4.865; Bell SP, 2002, GENE DEV, V16, P659, DOI 10.1101/gad.969602; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Chesnokov I, 1999, GENE DEV, V13, P1289, DOI 10.1101/gad.13.10.1289; Chesnokov I, 2001, P NATL ACAD SCI USA, V98, P11997, DOI 10.1073/pnas.211342798; EARNSHAW WC, 1991, CHROMOSOMA, V100, P139, DOI 10.1007/BF00337241; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fortugno P, 2002, J CELL SCI, V115, P575; Gillespie PJ, 2001, BMC BIOCHEM, V2, DOI 10.1186/1472-2091-2-15; Glotzer M, 2001, ANNU REV CELL DEV BI, V17, P351, DOI 10.1146/annurev.cellbio.17.1.351; Harborth J, 2001, J CELL SCI, V114, P4557; Jablonski SA, 1998, CHROMOSOMA, V107, P386, DOI 10.1007/s004120050322; Kelly TJ, 2000, ANNU REV BIOCHEM, V69, P829, DOI 10.1146/annurev.biochem.69.1.829; Lee DG, 1997, MOL CELL BIOL, V17, P7159, DOI 10.1128/MCB.17.12.7159; Mendez J, 2002, MOL CELL, V9, P481, DOI 10.1016/S1097-2765(02)00467-7; MULLINS JM, 1982, J CELL BIOL, V94, P654, DOI 10.1083/jcb.94.3.654; Murakami H, 2000, BIOCHEM J, V349, P1, DOI 10.1042/0264-6021:3490001; Pflumm MF, 2001, DEVELOPMENT, V128, P1697; PRASANTH SG, UNPUB; Sibon OCM, 2000, NAT CELL BIOL, V2, P90, DOI 10.1038/35000041; Skoufias DA, 2001, P NATL ACAD SCI USA, V98, P4492, DOI 10.1073/pnas.081076898; Uren AG, 2000, CURR BIOL, V10, P1319, DOI 10.1016/S0960-9822(00)00769-7; Van Hooser AA, 1999, FASEB J, V13, pS216, DOI 10.1096/fasebj.13.9002.S216; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; Weinreich M, 2001, P NATL ACAD SCI USA, V98, P11211, DOI 10.1073/pnas.201387198; Zeitlin SG, 2001, CURR BIOL, V11, pR514, DOI 10.1016/S0960-9822(01)00307-4	26	165	171	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 9	2002	297	5583					1026	1031		10.1126/science.1072802	http://dx.doi.org/10.1126/science.1072802			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581ZN	12169736				2022-12-24	WOS:000177325400048
J	Garcia-Castro, MI; Marcelle, C; Bronner-Fraser, M				Garcia-Castro, MI; Marcelle, C; Bronner-Fraser, M			Ectodermal Wnt function as a neural crest inducer	SCIENCE			English	Article							BONE MORPHOGENETIC PROTEINS; WINGLESS PROTEIN; CELL PATTERN; INDUCTION; DORSAL; PLATE; EXPRESSION; TUBE; XENOPUS; FAMILY	Neural crest cells, which generate peripheral nervous system and facial skeleton, arise at the neural plate/ectodermal border via an inductive interaction between these tissues. Wnts and bone morphogenetic proteins (BMPs) play roles in neural crest induction in amphibians and zebrafish. Here, we show that, in avians, Wnt6 is localized in ectoderm and in vivo inhibition of Wnt signaling perturbs neural crest formation. Furthermore, Wnts induce neural crest from naive neural plates in vitro in a defined medium without added factors, whereas BMPs require additives. Our data suggest that Wnt molecules are necessary and sufficient to induce neural crest cells in avian embryos.	CALTECH, Div Biol 139 74, Pasadena, CA 91125 USA	California Institute of Technology	Garcia-Castro, MI (corresponding author), CALTECH, Div Biol 139 74, Wilson & Calif, Pasadena, CA 91125 USA.	mig1000@its.caltech.edu		Bronner, Marianne/0000-0003-4274-1862; Garcia-Castro, Martin I./0000-0001-5128-0004	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS036585, R01NS036585] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bang AG, 1999, DEV BIOL, V212, P366, DOI 10.1006/dbio.1999.9319; Basch ML, 2000, DEV NEUROSCI-BASEL, V22, P217, DOI 10.1159/000017444; BASLER K, 1993, CELL, V73, P687, DOI 10.1016/0092-8674(93)90249-P; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Cauthen CA, 2001, MECH DEVELOP, V104, P133, DOI 10.1016/S0925-4773(01)00369-0; CHAKRABARTI A, 1992, DEVELOPMENT, V115, P355; Chang CB, 1998, DEV BIOL, V194, P129, DOI 10.1006/dbio.1997.8820; Connolly DJ, 1997, INT J DEV BIOL, V41, P389; Cook D, 1996, EMBO J, V15, P4526, DOI 10.1002/j.1460-2075.1996.tb00830.x; Dale TC, 1998, BIOCHEM J, V329, P209; Deardorff MA, 2001, DEVELOPMENT, V128, P3655; DICKINSON ME, 1995, DEVELOPMENT, V121, P2099; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hammerschmidt M, 1996, DEVELOPMENT, V123, P95; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Hoppler S, 1996, GENE DEV, V10, P2805, DOI 10.1101/gad.10.21.2805; Hsieh JC, 1999, NATURE, V398, P431, DOI 10.1038/18899; Ikeya M, 1997, NATURE, V389, P966, DOI 10.1038/40146; LaBonne C, 1998, DEVELOPMENT, V125, P2403; Le Douarin NM, 1999, NEURAL CREST, V2; Lee KJ, 1999, ANNU REV NEUROSCI, V22, P261, DOI 10.1146/annurev.neuro.22.1.261; Liem KF, 1997, CELL, V91, P127, DOI 10.1016/S0092-8674(01)80015-5; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; McGrew LL, 1997, MECH DEVELOP, V69, P105, DOI 10.1016/S0925-4773(97)00160-3; McMahon JA, 1998, GENE DEV, V12, P1438, DOI 10.1101/gad.12.10.1438; Millar JBA, 2002, GENOME BIOL, V3; MonsoroBurq AH, 1996, DEVELOPMENT, V122, P3607; MOURY JD, 1989, DEV BIOL, V133, P44, DOI 10.1016/0012-1606(89)90295-9; Neave B, 1997, MECH DEVELOP, V62, P183, DOI 10.1016/S0925-4773(97)00659-X; Nguyen VH, 2000, DEVELOPMENT, V127, P1209; Nguyen VH, 1998, DEV BIOL, V199, P93, DOI 10.1006/dbio.1998.8927; NIETO MA, 1994, SCIENCE, V264, P835, DOI 10.1126/science.7513443; Pera E, 1999, DEVELOPMENT, V126, P63; RAMAKRISHNA NR, 1993, DEVELOPMENT, P95; ROLLHAUSERTERHORST J, 1979, ANAT EMBRYOL, V157, P113, DOI 10.1007/BF00315644; SaintJeannet JP, 1997, P NATL ACAD SCI USA, V94, P13713, DOI 10.1073/pnas.94.25.13713; Schultheiss TM, 1997, GENE DEV, V11, P451, DOI 10.1101/gad.11.4.451; Selleck MAJ, 1998, DEVELOPMENT, V125, P4919; SELLECK MAJ, 1995, DEVELOPMENT, V121, P525; Streit A, 1998, DEVELOPMENT, V125, P507; Tan C, 2001, DEVELOPMENT, V128, P3665; TUCKER GC, 1984, CELL DIFFER DEV, V14, P223, DOI 10.1016/0045-6039(84)90049-6; VANLEEUWEN F, 1994, NATURE, V368, P342, DOI 10.1038/368342a0; Watanabe Y, 1996, MECH DEVELOP, V57, P69, DOI 10.1016/0925-4773(96)00534-5; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Xu QH, 1998, DEVELOPMENT, V125, P4767; YAMADA T, 1993, CELL, V73, P673, DOI 10.1016/0092-8674(93)90248-O	47	390	396	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 2	2002	297	5582					848	851		10.1126/science.1070824	http://dx.doi.org/10.1126/science.1070824			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579RZ	12161657				2022-12-24	WOS:000177192800055
J	Levsky, JM; Shenoy, SM; Pezo, RC; Singer, RH				Levsky, JM; Shenoy, SM; Pezo, RC; Singer, RH			Single-cell gene expression profiling	SCIENCE			English	Article								A key goal of biology is to relate the expression of specific genes to a particular cellular phenotype. However, current assays for gene expression destroy the structural context. By combining advances in computational fluorescence microscopy with multiplex probe design, we devised technology in which the expression of many genes can be visualized simultaneously inside single cells with high spatial and temporal resolution. Analysis of 11 genes in serum-stimulated cultured cells revealed unique patterns of gene expression within individual cells. Using the nucleus as the substrate for parallel gene analysis, we provide a platform for the fusion of genomics and cell biology: "cellular genomics."	Yeshiva Univ Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Singer, RH (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Anat & Struct Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	rhsinger@aecom.yu.edu	shenoy, shailesh/AAD-4962-2020	Shenoy, Shailesh/0000-0002-5132-7236	NATIONAL CANCER INSTITUTE [R33CA083208] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288, T32GM007491] Funding Source: NIH RePORTER; NCI NIH HHS [R33CA83208] Funding Source: Medline; NIGMS NIH HHS [T32GM07288, T32GM07491, GM54887] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alwine J C, 1979, Methods Enzymol, V68, P220; BROWN J, 2001, NAT MED, V7, P4; DENDUNNEN JT, 1992, HUM MOL GENET, V1, P19; ERBA HP, 1988, MOL CELL BIOL, V8, P1775, DOI 10.1128/MCB.8.4.1775; FEMINO AM, 1998, SCIENCE, V280, P5363; HABETS GG, 2001, METHODS ENZYMOL, V332; HERSCHMAN HR, 1991, ANN REV BIOCH, V60; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; KISLAUSKIS EH, 1993, J CELL BIOL, V123, P165, DOI 10.1083/jcb.123.1.165; LANAHAN A, 1992, MOL CELL BIOL, V12, P3919, DOI 10.1128/MCB.12.9.3919; LAWRENCE JB, 1989, CELL, V57, P493, DOI 10.1016/0092-8674(89)90924-0; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; LOCKHART DJ, 1996, NAT BIOTECHNOL, V14, P13; NEDERLOF PM, 1992, CYTOMETRY, V13, P8; NG SY, 1998, NUCLEIC ACIDS RES, V17, P2; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Schrock E, 1996, SCIENCE, V273, P494, DOI 10.1126/science.273.5274.494; SCHWACHTGEN JL, 2000, DNA SEQUENCE, V10, P6; SPEICHER MR, 1996, NAT GENET, V12, P4; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484	20	384	441	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 2	2002	297	5582					836	840		10.1126/science.1072241	http://dx.doi.org/10.1126/science.1072241			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579RZ	12161654				2022-12-24	WOS:000177192800051
J	Ma, RLZ; Gao, JF; Meeker, ND; Fillmore, PD; Tung, HSK; Watanabe, T; Zachary, JF; Offner, H; Blankenhorn, EP; Teuscher, C				Ma, RLZ; Gao, JF; Meeker, ND; Fillmore, PD; Tung, HSK; Watanabe, T; Zachary, JF; Offner, H; Blankenhorn, EP; Teuscher, C			Identification of Bphs, an autoimmune disease locus, as histamine receptor H-1	SCIENCE			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; DELAYED-TYPE HYPERSENSITIVITY; WEIBEL-PALADE BODIES; BORDETELLA-PERTUSSIS; T-CELL; ENDOTHELIAL-CELLS; GENETIC-LOCI; MICE; SUSCEPTIBILITY; BRAIN	Bphs controls Bordetella pertussis toxin (PTX) induced vasoactive amine sensitization elicited by histamine (VAASH) and has an established role in autoimmunity. We report that congenic mapping links Bphs to the histamine H-1 receptor gene (Hrh1/H1R) and that H1R differs at three amino acid residues in VAASH-susceptible and -resistant mice. Hrh1(-/-) mice are protected from VAASH, which can be restored by genetic complementation with a susceptible Bphs/Hrh1 allele, and experimental allergic encephalomyelitis and autoimmune orchitis due to immune deviation. Thus, natural alleles of Hrh1 control both the autoimmune T cell and vascular responses regulated by histamine after PTX sensitization.	Univ Vermont, Dept Med, Burlington, VT 05405 USA; Chinese Acad Sci, Inst Genet, Lab Anim Ctr, Beijing 100101, Peoples R China; Univ Illinois, Dept Vet Pathobiol, Urbana, IL 61802 USA; Univ Virginia, Dept Pathol, Charlottesville, VA 22908 USA; Kyushu Univ, Med Inst Bioregulat, Fukuoka 812, Japan; Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Vet Affairs Med Ctr, Portland, OR 97201 USA; MCPHU, Dept Microbiol & Immunol, Philadelphia, PA 19129 USA	University of Vermont; Chinese Academy of Sciences; University of Illinois System; University of Illinois Urbana-Champaign; University of Virginia; Kyushu University; Oregon Health & Science University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Drexel University	Teuscher, C (corresponding author), Univ Vermont, Dept Med, Burlington, VT 05405 USA.				NIAID NIH HHS [AI4515, AI42376, AI41747, AI41236] Funding Source: Medline; NIAMS NIH HHS [AR45222] Funding Source: Medline; NINDS NIH HHS [NS23444, NS36526] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042376, R01AI041747, R01AI041236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR045222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023444, R01NS036526] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott NJ, 2000, CELL MOL NEUROBIOL, V20, P131, DOI 10.1023/A:1007074420772; Atkinson T, 1992, INFLAMMATION BASIC P, P193; Banu Y, 1999, J EXP MED, V189, P673, DOI 10.1084/jem.189.4.673; Blankenhorn EP, 2000, J IMMUNOL, V164, P3420, DOI 10.4049/jimmunol.164.6.3420; Bordet J., 1906, ANN LINSTITUT PASTEU, V20, P731; Butterfield RJ, 1998, J IMMUNOL, V161, P1860; Butterfield RJ, 2000, AM J PATHOL, V157, P637, DOI 10.1016/S0002-9440(10)64574-9; Dimitriadou V, 2000, INT J IMMUNOPHARMACO, V22, P673, DOI 10.1016/S0192-0561(00)00029-1; Fujimoto K, 1999, MOL PHARMACOL, V55, P735; HATTORI R, 1989, J BIOL CHEM, V264, P7768; Inoue I, 1996, P NATL ACAD SCI USA, V93, P13316, DOI 10.1073/pnas.93.23.13316; Jutel M, 2001, NATURE, V413, P420, DOI 10.1038/35096564; KASLOW HR, 1992, FASEB J, V6, P2684, DOI 10.1096/fasebj.6.9.1612292; Kobayashi T, 2000, J CLIN INVEST, V105, P1741, DOI 10.1172/JCI9441; LINTHICUM DS, 1982, CELL IMMUNOL, V73, P299, DOI 10.1016/0008-8749(82)90457-9; Matejuk A, 2002, J NEUROSCI RES, V67, P680, DOI 10.1002/jnr.10156; MUNOZ JJ, 1977, IMMUNOLOGY SERIES, V4; NEMETALLAH BR, 1985, ARCH ANDROLOGY, V15, P41, DOI 10.3109/01485018508986890; NEMETALLAH BR, 1985, ARCH ANDROLOGY, V15, P79, DOI 10.3109/01485018508986895; Offner H, 2000, J CLIN INVEST, V105, P1465, DOI 10.1172/JCI9213; ORR EL, 1989, J NEUROCHEM, V53, P111, DOI 10.1111/j.1471-4159.1989.tb07301.x; Pedotti R, 2001, NAT IMMUNOL, V2, P216, DOI 10.1038/85266; SEKURA RD, 1985, PERTUSSIS TOXIN; SEWELL WA, 1986, CELL IMMUNOL, V97, P238, DOI 10.1016/0008-8749(86)90394-1; SEWELL WA, 1983, J EXP MED, V157, P2087, DOI 10.1084/jem.157.6.2087; SEWELL WA, 1984, J IMMUNOL, V133, P1716; Smit MJ, 1999, CLIN EXP ALLERGY, V29, P19, DOI 10.1046/j.1365-2222.1999.00008.x; SUDWEEKS JD, 1993, P NATL ACAD SCI USA, V90, P3700, DOI 10.1073/pnas.90.8.3700; TEUSCHER C, 1985, IMMUNOGENETICS, V22, P417, DOI 10.1007/BF00418088; Teuscher C, 1998, J IMMUNOL, V160, P2751; Utgaard JO, 1998, J EXP MED, V188, P1751, DOI 10.1084/jem.188.9.1751; Vleeming W, 2000, BRIT J PHARMACOL, V129, P1801, DOI 10.1038/sj.bjp.0703263; WAXMAN FJ, 1984, CELL IMMUNOL, V85, P82, DOI 10.1016/0008-8749(84)90280-6; Wolff B, 1998, J EXP MED, V188, P1757, DOI 10.1084/jem.188.9.1757; [No title captured]	35	115	122	4	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 26	2002	297	5581					620	623		10.1126/science.1072810	http://dx.doi.org/10.1126/science.1072810			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577GY	12142541				2022-12-24	WOS:000177054200056
J	Zimmerman, SC; Wendland, MS; Rakow, NA; Zharov, I; Suslick, KS				Zimmerman, SC; Wendland, MS; Rakow, NA; Zharov, I; Suslick, KS			Synthetic hosts by monomolecular imprinting inside dendrimers	NATURE			English	Article							MOLECULAR RECOGNITION; CORED DENDRIMERS; POLYMERS; PORPHYRINS; ARCHITECTURE; METATHESIS; EVOLUTION; BINDING	Synthetic host systems capable of selectively binding guest molecules are of interest for applications ranging from separations and chemical or biological sensing to the development of biomedical materials. Such host systems can be efficiently prepared by 'imprinting' polymers or inorganic materials with template molecules, which, upon removal, leave behind spatially arranged functional groups that act as recognition sites(1-4). However, molecularly imprinted polymers have limitations, including incomplete template removal, broad guest affinities and selectivities, and slow mass transfer(5-8). An alternative strategy for moulding desired recognition sites uses combinatorial libraries of assemblies that are made of a relatively small number of molecules, interconverting in dynamic equilibrium; upon addition of a target molecule, the library equilibrium shifts towards the best hosts(9-11). Here we describe the dynamic imprinting of dendritic macromolecules with porphyrin templates to yield synthetic host molecules containing one binding site each. The process is based on our general strategy to prepare cored dendrimers(12,13), and involves covalent attachment of dendrons to a porphyrin core, cross-linking of the end-groups of the dendrons, and removal of the porphyrin template by hydrolysis. In contrast to more traditional polymer imprinting, our approach ensures nearly homogeneous binding sites and quantitative template removal. Moreover, the hosts are soluble in common organic solvents and amenable to the incorporation of other functional groups, which should facilitate further development of this system for novel applications.	Univ Illinois, Dept Chem, Urbana, IL 61801 USA; Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Zimmerman, SC (corresponding author), Univ Illinois, Dept Chem, 600 S Mathews Ave, Urbana, IL 61801 USA.		ZHAROV, ILYA/B-3166-2013; Suslick, Kenneth S/A-1841-2010; Zimmerman, Steven C. C/E-4244-2010	Suslick, Kenneth S/0000-0001-5422-0701; Zimmerman, Steven C. C/0000-0002-5333-3437; Wendland, Michael/0000-0002-3581-3349				ADLER AD, 1967, J ORG CHEM, V32, P476, DOI 10.1021/jo01288a053; ANDERSSON L, 1984, TETRAHEDRON LETT, V25, P5211, DOI 10.1016/S0040-4039(01)81566-5; Balzani V, 2001, COORDIN CHEM REV, V219, P545, DOI 10.1016/S0010-8545(01)00351-4; Bhyrappa P, 1996, J AM CHEM SOC, V118, P5708, DOI 10.1021/ja953474k; Coates GW, 1996, J AM CHEM SOC, V118, P229, DOI 10.1021/ja9532603; COLLMAN JP, 1978, J AM CHEM SOC, V100, P2761, DOI 10.1021/ja00477a031; Cousins GRL, 2000, CURR OPIN CHEM BIOL, V4, P270, DOI 10.1016/S1367-5931(00)00088-0; DANDLIKER PJ, 1996, ANGEW CHEM INT EDIT, V34, P2725; HAWKER CJ, 1990, J AM CHEM SOC, V112, P7638, DOI 10.1021/ja00177a027; Katz A, 1999, MACROMOLECULES, V32, P4113, DOI 10.1021/ma981445z; Katz A, 2000, NATURE, V403, P286, DOI 10.1038/35002032; Klekota B, 1999, TRENDS BIOTECHNOL, V17, P205, DOI 10.1016/S0167-7799(99)01305-0; Lehn JM, 2001, SCIENCE, V291, P2331, DOI 10.1126/science.1060066; Matsui J, 2000, J AM CHEM SOC, V122, P5218, DOI 10.1021/ja000064+; Newkome GR, 2001, DENDRIMERS DENDRONS; Ogoshi H, 1999, CURR OPIN CHEM BIOL, V3, P736, DOI 10.1016/S1367-5931(99)00033-2; Rakow NA, 2000, NATURE, V406, P710, DOI 10.1038/35021028; RHO TY, 1994, SYNTHETIC COMMUN, V24, P253, DOI 10.1080/00397919408013824; Sadamoto R, 1996, J AM CHEM SOC, V118, P3978, DOI 10.1021/ja952855v; SANDERS JKM, 1996, COMPREHENSIVE SUPRAM, V9, P131; Schultz LG, 2001, ANGEW CHEM INT EDIT, V40, P1962, DOI 10.1002/1521-3773(20010518)40:10<1962::AID-ANIE1962>3.0.CO;2-J; SELLERGREN B, 1993, J CHROMATOGR, V635, P39; SHEA KJ, 1994, TRENDS POLYM SCI, V2, P166; Trnka TM, 2001, ACCOUNTS CHEM RES, V34, P18, DOI 10.1021/ar000114f; VLATAKIS G, 1993, NATURE, V361, P645, DOI 10.1038/361645a0; Wendland MS, 1999, J AM CHEM SOC, V121, P1389, DOI 10.1021/ja983097m; WULFF G, 1972, ANGEW CHEM INT EDIT, V11, P341; WULFF G, 1995, ANGEW CHEM INT EDIT, V34, P1812, DOI 10.1002/anie.199518121	28	356	365	2	149	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 25	2002	418	6896					399	403		10.1038/nature00877	http://dx.doi.org/10.1038/nature00877			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576MU	12140553				2022-12-24	WOS:000177009700033
J	Yang, HI; Lu, SN; Liaw, YF; You, SL; Sun, CA; Wang, UY; Hsiao, CK; Chen, PJ; Chen, DS; Chen, CJ				Yang, HI; Lu, SN; Liaw, YF; You, SL; Sun, CA; Wang, UY; Hsiao, CK; Chen, PJ; Chen, DS; Chen, CJ		Taiwan Community Based Canc Scree	Hepatitis B e antigen and the risk of hepatocellular carcinoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VIRUS-INFECTION; TRANSGENIC MICE; SURFACE-ANTIGEN; TAIWAN; DNA; ANTIBODY; SAMPLE; ALPHA; GENE	Background The presence of hepatitis B e antigen (HBeAg) in serum indicates active viral replication in hepatocytes. HBeAg is thus a surrogate marker for the presence of hepatitis B virus DNA. We conducted a prospective study to determine the relation between positivity for hepatitis B surface antigen (HBsAg) and HBeAg and the development of hepatocellular carcinoma. Methods In 1991 and 1992,We enrolled 11,893 men without evidence of hepatocellular carcinoma (age range, 30 to 65 years) from seven townships in Taiwan. Serum samples obtained at the time of enrollment were tested for HBsAg and HBeAg by radioimmunoassay. The diagnosis of hepatocellular carcinoma was ascertained through data linkage with the computerized National Cancer Registry in Taiwan and with death certificates. We performed a multiple regression analysis to determine the relative risk of hepatocellular carcinoma among Men who were positive for HBsAg alone or for HBsAg and HBeAg, as compared with those who were negative for both. Results There were 111 cases of newly diagnosed hepatocellular carcinoma during 92,359 person-years of follow-up. The incidence rate of hepatocellular carcinoma was 1169 cases per 100,000 person-years among men who were positive for both HBsAg and HBeAg, 324 per 100,000 person-years for those who were positive for HBsAg only, and 39 per 100,000 person-years for those who were negative for both. After adjustment for age, sex, the presence or absence of antibodies against hepatitis C virus, cigarette-smoking status, and use or nonuse of alcohol, the relative risk of hepatocellular carcinoma was 9.6 (95 percent confidence interval, 6.0 to 15.2) among men who were positive for HBsAg alone and 60.2 (95 percent confidence interval, 35.5 to 1021) among those who were positive for both HBsAg and HBeAg, as compared with men who were negative for both. Conclusions Positivity for HBeAg is associated with an increased risk of hepatocellular carcinoma.	Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol, Taipei 10018, Taiwan; Kaohsiung Chang Gung Mem Hosp, Dept Gastroenterol, Kaohsiung, Taiwan; Chang Gung Mem Hosp, Tao Yuan, Taiwan; Chang Gung Univ, Tao Yuan, Taiwan; Natl Def Med Ctr, Dept Publ Hlth, Taipei, Taiwan; Tzu Chi Univ, Grad Inst Aboriginal Hlth, Hualien, Taiwan; Natl Taiwan Univ Hosp, Liver Res Unit, Taipei, Taiwan; Natl Taiwan Univ Hosp, Hepatitis Res Ctr, Taipei, Taiwan	National Taiwan University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; National Defense Medical Center; Tzu Chi University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Chen, CJ (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol, 1 Jen Ai Rd,Sect 1, Taipei 10018, Taiwan.		Chen, Chien-Jen/C-6976-2008; 王, 豊裕/C-1460-2010; Chen, Chien-Jen/N-4723-2019; Yang, Hwai-I/A-9470-2008; Ibrahim, Essam Hassan/G-1960-2018; Liaw, Yun-Fan/B-4305-2009	Yang, Hwai-I/0000-0002-3433-942X; Ibrahim, Essam Hassan/0000-0003-0130-2257; CHEN, DING-SHINN/0000-0001-7791-6154; hsiao, chuhsing kate/0000-0003-4905-8484; Chen, Pei-Jer/0000-0001-8316-3785				AALEN O, 1978, ANN STAT, V6, P701, DOI 10.1214/aos/1176344247; BEASLEY RP, 1981, LANCET, V2, P1129; BRESLOW N, 1974, ANN STAT, V2, P437, DOI 10.1214/aos/1176342705; CHEN CJ, 1991, HEPATOLOGY, V13, P398, DOI 10.1002/hep.1840130303; Chen CJ, 1997, J GASTROEN HEPATOL, V12, pS294, DOI 10.1111/j.1440-1746.1997.tb00513.x; CHEN DS, 1993, SCIENCE, V262, P369, DOI 10.1126/science.8211155; CHISARI FV, 1989, CELL, V59, P1145, DOI 10.1016/0092-8674(89)90770-8; CHU CM, 1983, HEPATOLOGY, V3, P947; Chu CM, 1997, J GASTROEN HEPATOL, V12, pS218, DOI 10.1111/j.1440-1746.1997.tb00503.x; Farrell G, 2000, J MED VIROL, V61, P374, DOI 10.1002/1096-9071(200007)61:3&lt;374::AID-JMV16&gt;3.0.CO;2-7; FEITELSON MA, 1993, ONCOGENE, V8, P1109; FREEMAN BA, 1982, LAB INVEST, V47, P412; Henkler F, 1996, J VIRAL HEPATITIS, V3, P109, DOI 10.1111/j.1365-2893.1996.tb00001.x; HEYWARD WL, 1982, LANCET, V2, P889; *IARC, 1994, IARC MON EV CARC RIS, V59; Kew MC, 1998, RES VIROLOGY, V149, P257, DOI 10.1016/S0923-2516(99)89003-7; KIM CM, 1991, NATURE, V351, P317, DOI 10.1038/351317a0; LIAW YF, 1984, J MED VIROL, V13, P385, DOI 10.1002/jmv.1890130410; Lin SM, 1999, HEPATOLOGY, V29, P971, DOI 10.1002/hep.510290312; LIN TM, 1991, ANTICANCER RES, V11, P2063; LU SN, 1988, CANCER-AM CANCER SOC, V62, P2051, DOI 10.1002/1097-0142(19881101)62:9<2051::AID-CNCR2820620930>3.0.CO;2-1; MATSUBARA K, 1990, MOL BIOL MED, V7, P243; Niederau C, 1996, NEW ENGL J MED, V334, P1422, DOI 10.1056/NEJM199605303342202; PATERLINI P, 1995, HEPATOLOGY, V21, P313, DOI 10.1002/hep.1840210208; PENA EA, 1993, J STAT PLAN INFER, V37, P193, DOI 10.1016/0378-3758(93)90088-N; POPPER H, 1987, P NATL ACAD SCI USA, V84, P866, DOI 10.1073/pnas.84.3.866; SHAFRITZ DA, 1981, HEPATOLOGY, V1, P1, DOI 10.1002/hep.1840010102; Tsai JF, 1996, BRIT J CANCER, V73, P1498, DOI 10.1038/bjc.1996.283; WANG JC, 1985, ANNU REV BIOCHEM, V54, P665, DOI 10.1146/annurev.biochem.54.1.665; WANG XW, 1995, CANCER RES, V55, P6012; YU MW, 1991, CANCER RES, V51, P5621	31	925	997	0	35	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 18	2002	347	3					168	174		10.1056/NEJMoa013215	http://dx.doi.org/10.1056/NEJMoa013215			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	574BR	12124405	Green Published			2022-12-24	WOS:000176869000003
J	Gomez, LD; Marshall, T; Tsai, PC; Shao, YS; Guo, YLL				Gomez, LD; Marshall, T; Tsai, PC; Shao, YS; Guo, YLL			Number of boys born to men exposed to polychlorinated byphenyls	LANCET			English	Article							SEX-RATIO; CHLORACNE; TAIWAN; COHORT; DIOXIN	We studied the sex of children born to individuals involved in the Yucheng oil disaster, Taiwan, who were exposed to polychlorinated byphenyls (PCBs) after an oil contamination accident in 1979. Men exposed to PCBs before age 20 years had a lower chance of having a baby boy than did age-matched and neighbourhood-matched controls (odds ratio 0.65, 95% CI 0.45-0.93). The male-to-female sex ratio of children born to men exposed to PCBs after age 20 years, however, approached that seen in controls (0.90, 0.59-1.35). We noted no significant difference in the birth ratio of infants born to exposed and unexposed mothers (0.93, 0.77-1.12). Our findings suggest that paternal exposure to PCBs before age 20 years affects the sex of a subsequently born child.	Natl Cheng Kung Univ, Coll Med, Tainan 70428, Taiwan; Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	National Cheng Kung University; University of London; London School of Hygiene & Tropical Medicine	Guo, YLL (corresponding author), Natl Cheng Kung Univ, Coll Med, Tainan 70428, Taiwan.		Guo, Yue-Liang Leon/ABF-2314-2020	Tsai, Pei-Chien/0000-0002-5044-6727; GUO, Yue Leon/0000-0002-8530-4809; Shao, Yu-Hsuan/0000-0002-0757-1901				Crisp TM, 1998, ENVIRON HEALTH PERSP, V106, P11, DOI 10.2307/3433911; Guo YLL, 1999, ENVIRON HEALTH PERSP, V107, P715, DOI 10.2307/3434656; Mocarelli P, 2000, LANCET, V355, P1858, DOI 10.1016/S0140-6736(00)02290-X; Moshammer H, 2000, LANCET, V356, P1271, DOI 10.1016/S0140-6736(05)73872-1; Rogan WJ, 1999, LANCET, V353, P206, DOI 10.1016/S0140-6736(05)77215-9	5	72	77	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 13	2002	360	9327					143	144		10.1016/S0140-6736(02)09386-8	http://dx.doi.org/10.1016/S0140-6736(02)09386-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573PB	12126828				2022-12-24	WOS:000176839100017
J	Jenkins, P				Jenkins, P			Doping in sport	LANCET			English	Editorial Material							GROWTH-HORMONE TREATMENT; ERYTHROPOIETIN; STRENGTH; ADULTS		St Bartholomews Hosp, Dept Endocrinol, London EC1A 7BE, England	University of London; Queen Mary University London	Jenkins, P (corresponding author), St Bartholomews Hosp, Dept Endocrinol, London EC1A 7BE, England.							CATLIN D, 2002, BMJ C DRUGS SPORT LO; CUNEO RC, 1991, J APPL PHYSIOL, V70, P688, DOI 10.1152/jappl.1991.70.2.688; DEYSSIG R, 1993, ACTA ENDOCRINOL-COP, V128, P313, DOI 10.1530/acta.0.1280313; Jenkins P, 1999, LANCET, V353, P1532, DOI 10.1016/S0140-6736(05)67231-5; Jenkins PJ, 1999, CLIN ENDOCRINOL, V50, P683, DOI 10.1046/j.1365-2265.1999.00784.x; Jenkins PJ, 2001, J CLIN ENDOCR METAB, V86, P2935, DOI 10.1210/jc.86.7.2935; Monson JP, 2000, CLIN ENDOCRINOL, V53, P281, DOI 10.1046/j.1365-2265.2000.01104.x; Skibeli V, 2001, BLOOD, V98, P3626, DOI 10.1182/blood.V98.13.3626; WIDE L, 1995, MED SCI SPORT EXER, V27, P1569; Wu Z, 1999, LANCET, V353, P895, DOI 10.1016/S0140-6736(99)00775-8; YARASHESKI KE, 1992, AM J PHYSIOL, V262, P261	11	13	13	1	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 13	2002	360	9327					99	100		10.1016/S0140-6736(02)09432-1	http://dx.doi.org/10.1016/S0140-6736(02)09432-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573PB	12126814				2022-12-24	WOS:000176839100003
J	van Woensel, JBM; van Aalderen, WMC				van Woensel, JBM; van Aalderen, WMC			Treatment for bronchiolitis: the story continues	LANCET			English	Editorial Material							RESPIRATORY SYNCYTIAL VIRUS; HOSPITALIZATIONS; CHILDREN		Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, NL-1105 AZ Amsterdam, Netherlands	Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	van Woensel, JBM (corresponding author), Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.b.vanwoensel@amc.uva.nl						Abul-Ainine A, 2002, ARCH DIS CHILD, V86, P276, DOI 10.1136/adc.86.4.276; Flores G, 1997, PEDIATRICS, V100, P233, DOI 10.1542/peds.100.2.233; Garrison MM, 2000, PEDIATRICS, V106, P184; Hall CB, 2001, NEW ENGL J MED, V344, P1917, DOI 10.1056/NEJM200106213442507; KELLNER JD, 1998, COCHRANE LIB; OPENSHAW PJM, 1995, SPRINGER SEMIN IMMUN, V17, P187; Ruuskanen O, 1993, Curr Probl Pediatr, V23, P50, DOI 10.1016/0045-9380(93)90003-U; Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440; van Woensel JBM, 2002, ARCH DIS CHILD, V86, P370, DOI 10.1136/adc.86.5.370; van Woensel JBM, 1997, THORAX, V52, P634, DOI 10.1136/thx.52.7.634	10	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 13	2002	360	9327					101	102		10.1016/S0140-6736(02)09433-3	http://dx.doi.org/10.1016/S0140-6736(02)09433-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573PB	12126816				2022-12-24	WOS:000176839100005
J	Yang, L; Huang, HW				Yang, L; Huang, HW			Observation of a membrane fusion intermediate structure	SCIENCE			English	Article							STALK MECHANISM; SYSTEMS; LIPIDS; PHASES; VIRUS	We report the observation of a phase of phospholipid that contains a structure similar to the commonly postulated interbilayer state that is crucial to membrane fusion. The widely accepted model for membrane fusion suggests that there is an intermediate state in which the two contacting monolayers become continuous via an hourglass-shaped structure called a stalk. Many efforts have been made to estimate the free energy for such a state in order to understand the functionality of membrane fusion proteins and to de ne key parameters in energy estimates. The observation of the stalk structure supports the stalk hypothesis for membrane fusion and enables the measurement of these parameters experimentally.	Brookhaven Natl Lab, Natl Synchrotron Light Source, Upton, NY 11973 USA; Rice Univ, Dept Phys & Astron, Houston, TX 77251 USA	State University of New York (SUNY) System; United States Department of Energy (DOE); Brookhaven National Laboratory; Rice University	Huang, HW (corresponding author), Brookhaven Natl Lab, Natl Synchrotron Light Source, Upton, NY 11973 USA.		Yang, Lin/D-5872-2013	Yang, Lin/0000-0003-1057-9194	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055203] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM55203] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BENTZ J, 1988, BIOPHYS J, V53, P593, DOI 10.1016/S0006-3495(88)83138-2; BLAUROCK AE, 1971, J MOL BIOL, V56, P35, DOI 10.1016/0022-2836(71)90082-9; Brunger AT, 2001, CURR OPIN STRUC BIOL, V11, P163, DOI 10.1016/S0959-440X(00)00186-X; CHERNOMORDIK L, 1995, J MEMBRANE BIOL, V146, P1; Chernomordik LV, 1997, J CELL BIOL, V136, P81, DOI 10.1083/jcb.136.1.81; Chizmadzhev YA, 1995, BIOPHYS J, V69, P2489, DOI 10.1016/S0006-3495(95)80119-0; DOMS RW, 1993, METHOD ENZYMOL, V221, P61, DOI 10.1016/0076-6879(93)21007-U; ELLENS H, 1989, BIOCHEMISTRY-US, V28, P3692, DOI 10.1021/bi00435a011; Gingell D., 1978, MEMBRANE FUSION, P791; Hui SW, 1999, COLLOID SURFACE B, V14, P213, DOI 10.1016/S0927-7765(99)00037-5; Hung WC, 2000, BBA-BIOMEMBRANES, V1467, P198, DOI 10.1016/S0005-2736(00)00221-2; Kanaseki T, 1997, J CELL BIOL, V137, P1041, DOI 10.1083/jcb.137.5.1041; Kozlovsky Y, 2002, BIOPHYS J, V82, P882, DOI 10.1016/S0006-3495(02)75450-7; Kuzmin PI, 2001, P NATL ACAD SCI USA, V98, P7235, DOI 10.1073/pnas.121191898; Lentz BR, 2000, CURR OPIN STRUC BIOL, V10, P607, DOI 10.1016/S0959-440X(00)00138-X; Lentz BR, 2002, BIOPHYS J, V82, P555, DOI 10.1016/S0006-3495(02)75420-9; Ludtke S, 1995, BIOCHEMISTRY-US, V34, P16764, DOI 10.1021/bi00051a026; Luzzati V., 1968, BIOL MEMBR, P71; MARIANI P, 1988, J MOL BIOL, V204, P165, DOI 10.1016/0022-2836(88)90607-9; MARKIN VS, 1984, GEN PHYSIOL BIOPHYS, V3, P361; Markin VS, 2002, BIOPHYS J, V82, P693, DOI 10.1016/S0006-3495(02)75432-5; PERUTZ MF, 1954, PROC R SOC LON SER-A, V225, P264, DOI 10.1098/rspa.1954.0202; SIEGEL DP, 1993, BIOPHYS J, V65, P2124, DOI 10.1016/S0006-3495(93)81256-6; Siegel DP, 1999, BIOPHYS J, V76, P291, DOI 10.1016/S0006-3495(99)77197-3; SOWERS AE, 1987, CELL FUSION; STEGMANN T, 1994, CURR BIOL, V4, P551, DOI 10.1016/S0960-9822(00)00123-8; TURNER DC, 1992, BIOCHEMISTRY-US, V31, P1340, DOI 10.1021/bi00120a009; WHITE JM, 1992, SCIENCE, V258, P917, DOI 10.1126/science.1439803; Yang L, 2000, BIOPHYS J, V79, P2002, DOI 10.1016/S0006-3495(00)76448-4; YANG L, IN PRESS	30	243	247	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 13	2002	297	5588					1877	1879		10.1126/science.1074354	http://dx.doi.org/10.1126/science.1074354			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592UJ	12228719				2022-12-24	WOS:000177955000046
J	Li, WKW				Li, WKW			Macroecological patterns of phytoplankton in the northwestern North Atlantic Ocean	NATURE			English	Article							SIZE; DIVERSITY; CHLOROPHYLL; ECOLOGY	Many issues in biological oceanography are regional or global in scope 1; however, there are not many data sets of extensive areal coverage for marine plankton. In microbial ecology, a fruitful approach to large-scale questions is comparative analysis(2,3) wherein statistical data patterns are sought from different ecosystems, frequently assembled from unrelated studies(4). A more recent approach termed macroecology characterizes phenomena emerging from large numbers of biological units by emphasizing the shapes and boundaries of statistical distributions, because these reflect the constraints on variation(5). Here, I use a set of flow cytometric measurements to provide macroecological perspectives on North Atlantic phytoplankton communities. Distinct trends of abundance in picophytoplankton and both small and large nanophytoplankton underlaid two patterns. First, total abundance of the three groups was related to assemblage mean-cell size according to the 3/4 power law of allometric scaling in biology(6,7). Second, cytometric diversity(8) (an ataxonomic measure of assemblage entropy) was maximal at intermediate levels of water column stratification(9). Here, intermediate disturbance shapes diversity through an equitable distribution of cells in size classes, from which arises a high overall biomass. By subsuming local fluctuations, macroecology reveals meaningful patterns of phytoplankton at large scales.	Fisheries & Oceans Canada, Bedford Inst Oceanog, Biol Oceanog Sect, Dartmouth, NS B2Y 4A2, Canada	Bedford Institute of Oceanography; Fisheries & Oceans Canada	Li, WKW (corresponding author), Fisheries & Oceans Canada, Bedford Inst Oceanog, Biol Oceanog Sect, POB 1006, Dartmouth, NS B2Y 4A2, Canada.	Lib@mar.dfo-mpo.gc.ca						AGUSTI S, 1989, LIMNOL OCEANOGR, V34, P1104, DOI 10.4319/lo.1989.34.6.1104; [Anonymous], 2012, NUMERICAL ECOLOGY; BELGRANO A, IN PRESS ECOL LETT; Brown J., 2000, SCALING BIOL; Brown JH, 1995, MACROECOLOGY; Cavender-Bares KK, 2001, LIMNOL OCEANOGR, V46, P778, DOI 10.4319/lo.2001.46.4.0778; CHISHOLM SW, 1992, ENVIR SCI R, V43, P213; Ciotti AM, 2002, LIMNOL OCEANOGR, V47, P404, DOI 10.4319/lo.2002.47.2.0404; Cole J. J., 1991, COMP ANAL ECOSYSTEMS; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Cullen John J., 2002, P297; Cyr H, 2000, SFI S SCI C, P267; Damuth JD, 1998, NATURE, V395, P115, DOI 10.1038/25843; Enquist BJ, 1998, NATURE, V395, P163, DOI 10.1038/25977; Gasol JM, 2000, FEMS MICROBIOL ECOL, V31, P99, DOI 10.1111/j.1574-6941.2000.tb00675.x; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; LAWS EA, 1981, MAR BIOL, V65, P13, DOI 10.1007/BF00397062; Li WKW, 1998, LIMNOL OCEANOGR, V43, P1746, DOI 10.4319/lo.1998.43.7.1746; LI WKW, 1995, MAR ECOL PROG SER, V122, P1, DOI 10.3354/meps122001; Li WKW, 2001, CYTOMETRY, V44, P236, DOI 10.1002/1097-0320(20010701)44:3<236::AID-CYTO1116>3.0.CO;2-5; Li WKW, 2001, DEEP-SEA RES PT II, V48, P2271, DOI 10.1016/S0967-0645(00)00180-6; Li WKW, 1997, LIMNOL OCEANOGR, V42, P874, DOI 10.4319/lo.1997.42.5.0874; Longhurst A., 2010, ECOLOGICAL GEOGRAPHY; MONTAGNES DJS, 1994, LIMNOL OCEANOGR, V39, P1044, DOI 10.4319/lo.1994.39.5.1044; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Reynolds C.S., 1997, VEGETATION PROCESSES, V9, DOI 10.1017/S0025315400036432; Rodriguez J, 2001, NATURE, V410, P360, DOI 10.1038/35066560; Rodriguez Jaime, 1994, Scientia Marina, V58, P1; SOMMER U, 1993, HYDROBIOLOGIA, V249, P1, DOI 10.1007/BF00008837; YENTSCH CS, 1989, LIMNOL OCEANOGR, V34, P1694, DOI 10.4319/lo.1989.34.8.1694	30	267	303	2	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 12	2002	419	6903					154	157		10.1038/nature00994	http://dx.doi.org/10.1038/nature00994			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592HK	12226662				2022-12-24	WOS:000177931200038
J	Zhou, ZL; Licklider, LJ; Gygi, SP; Reed, R				Zhou, ZL; Licklider, LJ; Gygi, SP; Reed, R			Comprehensive proteomic analysis of the human spliceosome	NATURE			English	Article							DOMINANT RETINITIS-PIGMENTOSA; RNA-POLYMERASE-II; SPLICING FACTORS; PROTEIN; DATABASE; COMPLEX; GENE	The precise excision of introns from pre-messenger RNA is performed by the spliceosome, a macromolecular machine containing five small nuclear RNAs and numerous proteins. Much has been learned about the protein components of the spliceosome from analysis of individual purified small nuclear ribonucleoproteins and salt-stable spliceosome 'core' particles. However, the complete set of proteins that constitutes intact functional spliceosomes has yet to be identified. Here we use maltose-binding protein affinity chromatography to isolate spliceosomes in highly purified and functional form. Using nanoscale microcapillary liquid chromatography tandem mass spectrometry, we identify similar to145 distinct spliceosomal proteins, making the spliceosome the most complex cellular machine so far characterized. Our spliceosomes comprise all previously known splicing factors and 58 newly identified components. The spliceosome contains at least 30 proteins with known or putative roles in gene expression steps other than splicing. This complexity may be required not only for splicing multi-intronic metazoan pre-messenger RNAs, but also for mediating the extensive coupling between splicing and other steps in gene expression.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Taplin Biol Mass Spectrometry Facil, Boston, MA 02115 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University	Reed, R (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.							Andersen JS, 2002, CURR BIOL, V12, P1, DOI 10.1016/S0960-9822(01)00650-9; BENNETT M, 1992, MOL CELL BIOL, V12, P3165, DOI 10.1128/MCB.12.7.3165; BENNETT M, 1992, GENE DEV, V6, P1986, DOI 10.1101/gad.6.10.1986; Bentley D, 1999, CURR OPIN CELL BIOL, V11, P347, DOI 10.1016/S0955-0674(99)80048-9; Burge CB, 1999, RNA WORLD, P525; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Chakarova CF, 2002, HUM MOL GENET, V11, P87, DOI 10.1093/hmg/11.1.87; Das R, 2000, MOL CELL, V5, P779, DOI 10.1016/S1097-2765(00)80318-4; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fong YW, 2001, NATURE, V414, P929, DOI 10.1038/414929a; FU XD, 1995, RNA, V1, P663; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; Hastings ML, 2001, CURR OPIN CELL BIOL, V13, P302, DOI 10.1016/S0955-0674(00)00212-X; Hirose Y, 2000, GENE DEV, V14, P1415; Horowitz DS, 2002, EMBO J, V21, P470, DOI 10.1093/emboj/21.3.470; Licklider LJ, 2002, ANAL CHEM, V74, P3076, DOI 10.1021/ac025529o; Little NA, 2000, HUM MOL GENET, V9, P2231, DOI 10.1093/oxfordjournals.hmg.a018914; Makarova OV, 2002, EMBO J, V21, P1148, DOI 10.1093/emboj/21.5.1148; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; McKie AB, 2001, HUM MOL GENET, V10, P1555, DOI 10.1093/hmg/10.15.1555; Neubauer G, 1998, NAT GENET, V20, P46, DOI 10.1038/1700; Reed R, 2002, CELL, V108, P523, DOI 10.1016/S0092-8674(02)00627-X; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Stevens SW, 2002, MOL CELL, V9, P31, DOI 10.1016/S1097-2765(02)00436-7; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Tacke R, 1999, CURR OPIN CELL BIOL, V11, P358, DOI 10.1016/S0955-0674(99)80050-7; Vithana EN, 2001, MOL CELL, V8, P375, DOI 10.1016/S1097-2765(01)00305-7; Will CL, 2001, CURR OPIN CELL BIOL, V13, P290, DOI 10.1016/S0955-0674(00)00211-8; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160; Zhou ZL, 1998, EMBO J, V17, P2095, DOI 10.1093/emboj/17.7.2095	30	697	713	2	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 12	2002	419	6903					182	185		10.1038/nature01031	http://dx.doi.org/10.1038/nature01031			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592HK	12226669				2022-12-24	WOS:000177931200045
J	Lohmann, I; McGinnis, N; Bodmer, M; McGinnis, W				Lohmann, I; McGinnis, N; Bodmer, M; McGinnis, W			The Drosophila Hox gene Deformed sculpts head morphology via direct regulation of the apoptosis activator reaper	CELL			English	Article							PROGRAMMED CELL-DEATH; FUSHI-TARAZU; BITHORAX COMPLEX; HOMEOTIC GENES; EMBRYONIC HEAD; EXPRESSION; ADHESION; ELEMENT; PROTEIN; TARGET	Hox proteins control morphological diversity along the anterior-posterior body axis of animals, but the cellular processes they directly regulate are poorly understood. We show that during early Drosophila development, the Hox protein Deformed (Dfd) maintains the boundary between the maxillary and mandibular head lobes by activating localized apoptosis. Dfd accomplishes this by directly activating the cell death promoting gene reaper (rpr). One other Hox gene,Abdominal-B (Abd-B), also regulates segment boundaries through the regional activation of apoptosis. Thus, one mechanism used by Drosophila Hox genes to modulate segmental morphology is to regulate programmed cell death, which literally sculpts segments into distinct shapes. This and other emerging evidence suggests that Hox proteins may often regulate the maintenance of segment boundaries.	Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	McGinnis, W (corresponding author), Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.							ABRAMS JM, 1993, DEVELOPMENT, V117, P29; Asano M, 1996, GENE DEV, V10, P1422, DOI 10.1101/gad.10.11.1422; Barolo S, 2000, BIOTECHNIQUES, V29, P726, DOI 10.2144/00294bm10; BERGSON C, 1990, EMBO J, V9, P4287, DOI 10.1002/j.1460-2075.1990.tb07877.x; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brodsky MH, 2000, CELL, V101, P103, DOI 10.1016/S0092-8674(00)80627-3; BROWN SJ, 1994, P NATL ACAD SCI USA, V91, P12922, DOI 10.1073/pnas.91.26.12922; Casso David, 2000, Mechanisms of Development, V91, P451, DOI 10.1016/S0925-4773(00)00248-3; Chen P, 1996, GENE DEV, V10, P1773, DOI 10.1101/gad.10.14.1773; Christich A, 2002, CURR BIOL, V12, P137, DOI 10.1016/S0960-9822(01)00658-3; DAWES R, 1994, DEVELOPMENT, V120, P1561; DELORENZI M, 1990, DEVELOPMENT, V108, P323; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; GARCIABELLIDO A, 1977, AM ZOOL, V17, P613; Gavalas A, 1997, DEVELOPMENT, V124, P3693; GOULD AP, 1992, DEVELOPMENT, V116, P1163; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; Graba Y, 1997, BIOESSAYS, V19, P379, DOI 10.1002/bies.950190505; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Handel K, 2000, DEV GENES EVOL, V210, P167, DOI 10.1007/s004270050301; Hay BA, 1995, CELL, V83, P1253, DOI 10.1016/0092-8674(95)90150-7; Hay BA, 1997, P NATL ACAD SCI USA, V94, P5195, DOI 10.1073/pnas.94.10.5195; HEUER JG, 1995, DEVELOPMENT, V121, P3861; HINZ U, 1992, DEVELOPMENT, V116, P543; Hu N, 1999, DEV BIOL, V214, P197, DOI 10.1006/dbio.1999.9391; Hughes CL, 2002, DEVELOPMENT, V129, P1225; Hurle JM, 1996, MICROSC RES TECHNIQ, V34, P236; Jiang CA, 2000, MOL CELL, V5, P445, DOI 10.1016/S1097-2765(00)80439-6; KIMMEL BE, 1990, GENE DEV, V4, P712, DOI 10.1101/gad.4.5.712; Kurada P, 1998, CELL, V95, P319, DOI 10.1016/S0092-8674(00)81764-X; Li KJ, 1996, CELL, V85, P585, DOI 10.1016/S0092-8674(00)81258-1; Li XL, 1999, EMBO J, V18, P198, DOI 10.1093/emboj/18.1.198; Lohr U, 2001, CURR BIOL, V11, P1403, DOI 10.1016/S0960-9822(01)00443-2; Mann RS, 1998, CURR OPIN GENET DEV, V8, P423, DOI 10.1016/S0959-437X(98)80113-5; Mann RS, 2000, ANNU REV CELL DEV BI, V16, P243, DOI 10.1146/annurev.cellbio.16.1.243; McGinnis W, 1990, Adv Genet, V27, P363; MEADOWS LA, 1994, J CELL SCI, V107, P321; Meier P, 2000, EMBO J, V19, P598, DOI 10.1093/emboj/19.4.598; Nassif C, 1998, DEV BIOL, V197, P170, DOI 10.1006/dbio.1998.8875; PATEL NH, 1994, DEVELOPMENT, P201; Peterson C, 2002, DEVELOPMENT, V129, P1467; Pradel J, 1998, INT J DEV BIOL, V42, P417; Raghavan S, 1997, NEURON, V18, P873, DOI 10.1016/S0896-6273(00)80327-X; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; SANCHEZHERRERO E, 1985, NATURE, V313, P108, DOI 10.1038/313108a0; Sanson B, 1996, NATURE, V383, P627, DOI 10.1038/383627a0; Saunders J., 1966, MAJOR PROBLEMS DEV B, P289; SCHMIDTOTT U, 1992, DEVELOPMENT, V116, P111; Srinivasula SM, 2002, CURR BIOL, V12, P125, DOI 10.1016/S0960-9822(01)00657-1; Stadler HS, 2001, DEVELOPMENT, V128, P4177; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; Telford MJ, 2000, CURR BIOL, V10, P349, DOI 10.1016/S0960-9822(00)00387-0; VACHON G, 1992, CELL, V71, P437, DOI 10.1016/0092-8674(92)90513-C; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319; WHITE K, 1995, TRENDS CELL BIOL, V5, P74, DOI 10.1016/S0962-8924(00)88950-3; Wing JP, 2002, CURR BIOL, V12, P131, DOI 10.1016/S0960-9822(01)00664-9; YOFFE KB, 1995, DEV BIOL, V170, P636, DOI 10.1006/dbio.1995.1243	59	161	164	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 23	2002	110	4					457	466		10.1016/S0092-8674(02)00871-1	http://dx.doi.org/10.1016/S0092-8674(02)00871-1			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	587QJ	12202035	Bronze			2022-12-24	WOS:000177653200007
J	Lin, J; Wu, H; Tarr, PT; Zhang, CY; Wu, ZD; Boss, O; Michael, LF; Puigserver, P; Isotani, E; Olson, EN; Lowell, BB; Bassel-Duby, R; Spiegelman, BM				Lin, J; Wu, H; Tarr, PT; Zhang, CY; Wu, ZD; Boss, O; Michael, LF; Puigserver, P; Isotani, E; Olson, EN; Lowell, BB; Bassel-Duby, R; Spiegelman, BM			Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres	NATURE			English	Article							SKELETAL-MUSCLE; FIBER-TYPE; MITOCHONDRIAL BIOGENESIS; COACTIVATOR PGC-1; CALCINEURIN; EXPRESSION; ELEMENTS; PATHWAY; MEF2; GENE	The biochemical basis for the regulation of fibre-type determination in skeletal muscle is not well understood. In addition to the expression of particular myofibrillar proteins, type I (slow-twitch) fibres are much higher in mitochondrial content and are more dependent on oxidative metabolism than type II (fast-twitch) fibres(1). We have previously identified a transcriptional co-activator, peroxisome-proliferator-activated receptor-gamma coactivator-1 (PGC-1alpha), which is expressed in several tissues including brown fat and skeletal muscle, and that activates mitochondrial biogenesis and oxidative metabolism(2-4).We show here that PGC-1alpha is expressed preferentially in muscle enriched in type I fibres. When PGC-1alpha is expressed at physiological levels in transgenic mice driven by a muscle creatine kinase (MCK) promoter, a fibre type conversion is observed: muscles normally rich in type II fibres are redder and activate genes of mitochondrial oxidative metabolism. Notably, putative type II muscles from PGC-1alpha transgenic mice also express proteins characteristic of type I fibres, such as troponin I (slow) and myoglobin, and show a much greater resistance to electrically stimulated fatigue. Using fibre-type-specific promoters, we show in cultured muscle cells that PGC-1alpha activates transcription in cooperation with Mef2 proteins and serves as a target for calcineurin signalling, which has been implicated in slow fibre gene expression. These data indicate that PGC-1alpha is a principal factor regulating muscle fibre type determination.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Endocrinol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Spiegelman, BM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.			Wu, Zhidan/0000-0001-7289-9420				Berchtold MW, 2000, PHYSIOL REV, V80, P1215, DOI 10.1152/physrev.2000.80.3.1215; Bigard X, 2000, J BIOL CHEM, V275, P19653, DOI 10.1074/jbc.M000430200; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; BOOTH FW, 1991, PHYSIOL REV, V71, P541, DOI 10.1152/physrev.1991.71.2.541; Calvo S, 1999, MOL CELL BIOL, V19, P515; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; Delling U, 2000, MOL CELL BIOL, V20, P6600, DOI 10.1128/MCB.20.17.6600-6611.2000; Esterbauer H, 1999, GENOMICS, V62, P98, DOI 10.1006/geno.1999.5977; GOLLNICK PD, 1972, J APPL PHYSIOL, V33, P312, DOI 10.1152/jappl.1972.33.3.312; Goto M, 2000, BIOCHEM BIOPH RES CO, V274, P350, DOI 10.1006/bbrc.2000.3134; Grange RW, 2001, AM J PHYSIOL-CELL PH, V281, pC1487, DOI 10.1152/ajpcell.2001.281.5.C1487; Hood DA, 2001, J APPL PHYSIOL, V90, P1137, DOI 10.1152/jappl.2001.90.3.1137; Jarvis JC, 1996, MUSCLE NERVE, V19, P1469, DOI 10.1002/(SICI)1097-4598(199611)19:11<1469::AID-MUS11>3.0.CO;2-O; JOHNSON JE, 1989, MOL CELL BIOL, V9, P3393, DOI 10.1128/MCB.9.8.3393; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200; Michael I, 1998, EUR MASS SPECTROM, V4, P1; Nakayama M, 1996, MOL CELL BIOL, V16, P2408; Naya FJ, 2000, J BIOL CHEM, V275, P4545, DOI 10.1074/jbc.275.7.4545; OGILVIE RW, 1990, STAIN TECHNOL, V65, P231, DOI 10.3109/10520299009105613; Olson EN, 2000, BIOESSAYS, V22, P510, DOI 10.1002/(SICI)1521-1878(200006)22:6<510::AID-BIES4>3.0.CO;2-1; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Wu H, 2001, EMBO J, V20, P6414, DOI 10.1093/emboj/20.22.6414; Wu H, 2000, EMBO J, V19, P1963, DOI 10.1093/emboj/19.9.1963; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	27	1928	2026	1	166	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 15	2002	418	6899					797	801		10.1038/nature00904	http://dx.doi.org/10.1038/nature00904			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UF	12181572				2022-12-24	WOS:000177428000044
J	Bailey, JA; Gu, ZP; Clark, RA; Reinert, K; Samonte, RV; Schwartz, S; Adams, MD; Myers, EW; Li, PW; Eichler, EE				Bailey, JA; Gu, ZP; Clark, RA; Reinert, K; Samonte, RV; Schwartz, S; Adams, MD; Myers, EW; Li, PW; Eichler, EE			Recent segmental duplications in the human genome	SCIENCE			English	Article							LOW-COPY REPEATS; DELETION SYNDROME; SEQUENCE; REARRANGEMENTS; ORGANIZATION; DISORDERS; EVOLUTION; GENES; SITES; MAP	Primate-specific segmental duplications are considered important in human disease and evolution. The inability to distinguish between allelic and duplication sequence overlap has hampered their characterization as well as assembly and annotation of our genome. We developed a method whereby each public sequence is analyzed at the clone level for overrepresentation within a whole-genome shotgun sequence. This test has the ability to detect duplications larger than 15 kilobases irrespective of copy number, location, or high sequence similarity. We mapped 169 large regions flanked by highly similar duplications. Twenty-four of these hot spots of genomic instability have been associated with genetic disease. Our analysis indicates a highly nonrandom chromosomal and genic distribution of recent segmental duplications, with a likely role in expanding protein diversity.	Case Western Reserve Univ, Sch Med, Ctr Computat Genom, Dept Genet, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Ctr Human Genet, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA; Celera Genom, Rockville, MD 20850 USA	Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland	Eichler, EE (corresponding author), Case Western Reserve Univ, Sch Med, Ctr Computat Genom, Dept Genet, Cleveland, OH 44106 USA.	eee@cwru.edu	Reinert, Knut/V-3327-2019	Reinert, Knut/0000-0003-3078-8129; Vallente, Rhea/0000-0002-1573-4782	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250, R01GM058815] Funding Source: NIH RePORTER; NCI NIH HHS [CA094816] Funding Source: Medline; NHGRI NIH HHS [HG002318] Funding Source: Medline; NIGMS NIH HHS [T32 GM007250, GM58815] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Apweiler R, 2000, BIOINFORMATICS, V16, P1145, DOI 10.1093/bioinformatics/16.12.1145; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bailey JA, 2002, AM J HUM GENET, V70, P83, DOI 10.1086/338458; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; Cheung VG, 2001, NATURE, V409, P953, DOI 10.1038/35057192; Christian SL, 1999, HUM MOL GENET, V8, P1025, DOI 10.1093/hmg/8.6.1025; Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; Edelmann L, 1999, AM J HUM GENET, V64, P1076, DOI 10.1086/302343; Eichler EE, 2001, TRENDS GENET, V17, P661, DOI 10.1016/S0168-9525(01)02492-1; Eichler EE, 2001, GENOME RES, V11, P653, DOI 10.1101/gr.188901; Guy J, 2000, HUM MOL GENET, V9, P2029, DOI 10.1093/hmg/9.13.2029; Jenne DE, 2001, AM J HUM GENET, V69, P516, DOI 10.1086/323043; Kawaguchi TK, 2001, NAT GENET, V29, P279, DOI 10.1038/ng757; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li W-H, 1997, MOL EVOLUTION; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Mazzarella R, 1998, GENOME RES, V8, P1007, DOI 10.1101/gr.8.10.1007; Mefford HC, 2002, NAT REV GENET, V3, P91, DOI 10.1038/nrg727; OHNO S, 1968, HEREDITAS-GENETISK A, V59, P169; Ohno S., 1970, EVOLUTION GENE DUPLI; Shaikh TH, 2000, HUM MOL GENET, V9, P489, DOI 10.1093/hmg/9.4.489; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040	25	969	1008	0	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 9	2002	297	5583					1003	1007		10.1126/science.1072047	http://dx.doi.org/10.1126/science.1072047			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581ZN	12169732				2022-12-24	WOS:000177325400042
J	Kivipelto, M; Helkala, EL; Laakso, MP; Hanninen, T; Hallikainen, M; Alhainen, K; Iivonen, S; Mannermaa, A; Tuomilehto, J; Nissinen, A; Soininen, H				Kivipelto, M; Helkala, EL; Laakso, MP; Hanninen, T; Hallikainen, M; Alhainen, K; Iivonen, S; Mannermaa, A; Tuomilehto, J; Nissinen, A; Soininen, H			Apolipoprotein E epsilon 4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease	ANNALS OF INTERNAL MEDICINE			English	Article							APOE GENOTYPE; COGNITIVE DECLINE; NORTH-KARELIA; DEMENTIA; POPULATION; ATHEROSCLEROSIS; ASSOCIATION; PREVALENCE; ROTTERDAM; AD	Background: Presence of the apolipoprotein E (apoE) epsilon4 allele, which is involved in cholesterol metabolism, is the most important genetic risk factor for Alzheimer disease. Elevated midlife values for total cholesterol level and blood pressure have been implicated recently as risk factors for Alzheimer disease. Objective: To study the relative importance and the putative relationship among the apoE epsilon4 allele, midlife total cholesterol level, and midlife blood pressure as risk factors for late-life Alzheimer disease. Design: Prospective population-based study. Setting: Kuopio and Joensuu, eastern Finland. Participants: Participants were derived from random population surveys from 1972, 1977, 1982, and 1987. A total of 1449 persons (73%), 65 to 79 years of age, participated in the reexamination in 1998 (mean follow-up, 21 years). Measurements: Midlife blood pressure and total cholesterol level, apoE genotype, and development of Alzheimer disease during follow-up. Results: The apoE epsilon4 allele was an independent risk factor for Alzheimer disease, even after adjustment for midlife vascular risk factors and other confounders (odds ratio, 2.1 [95% Cl, 1.1 to 4.1]). Similarly, elevated midlife values for serum total cholesterol level (odds ratio, 2.8 [Cl, 1.2 to 6.7]) and systolic blood pressure (odds ratio, 2.6 [Cl, 1.1 to 6.6]) were independent risk factors for Alzheimer disease, even after adjustment for apoE genotype and other confounding factors. Conclusions: The association between the apoE epsilon4 allele and Alzheimer disease does not seem to be mediated by vascular factors. The apoE epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for Alzheimer disease. The risk for Alzheimer disease from treatable factors-elevated total cholesterol level and blood pressure appears to be greater than that from the apoE epsilon4 allele.	Univ Kuopio, Dept Neurol & Neurosci, FIN-70211 Kuopio, Finland; Kuopio Univ Hosp, SF-70210 Kuopio, Finland; N Karelia Cent Hosp, Joensuu, Finland; Natl Publ Hlth Inst, Helsinki, Finland	University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Finland National Institute for Health & Welfare	Kivipelto, M (corresponding author), Univ Kuopio, Dept Neurol & Neurosci, POB 1627, FIN-70211 Kuopio, Finland.	miia.kivipelto@uku.fi	Laakso, Mikko/AHB-7022-2022; Kivipelto, Miia/AAS-3557-2021	Laakso, Mikko/0000-0003-1250-3425; Kivipelto, Miia/0000-0003-0992-3875				ALBERTS MJ, 1995, LANCET, V346, P575, DOI 10.1016/S0140-6736(95)91411-0; American Psychological Association, 1994, DIAGN STAT MAN MENT, V4th; Braak E, 1999, EUR ARCH PSY CLIN N, V249, P14; Brookmeyer R, 1998, AM J PUBLIC HEALTH, V88, P1337, DOI 10.2105/AJPH.88.9.1337; Carmelli D, 1998, NEUROLOGY, V50, P1580, DOI 10.1212/WNL.50.6.1580; Coca A, 1998, J HYPERTENS, V16, pS45; Frikke-Schmidt R, 2001, NEUROLOGY, V56, P194, DOI 10.1212/WNL.56.2.194; Haan MN, 1999, JAMA-J AM MED ASSOC, V282, P40, DOI 10.1001/jama.282.1.40; Hofman A, 1997, LANCET, V349, P151, DOI 10.1016/S0140-6736(96)09328-2; JARVIK GP, 1995, NEUROLOGY, V45, P1092, DOI 10.1212/WNL.45.6.1092; Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X; Kivipelto M, 2001, BMJ-BRIT MED J, V322, P1447, DOI 10.1136/bmj.322.7300.1447; Kivipelto M, 2001, NEUROLOGY, V56, P1683, DOI 10.1212/WNL.56.12.1683; Klungel OH, 2000, STROKE, V31, P420, DOI 10.1161/01.STR.31.2.420; Launer LJ, 2000, NEUROBIOL AGING, V21, P49, DOI 10.1016/S0197-4580(00)00096-8; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mitka W, 2001, JAMA-J AM MED ASSOC, V286, P2799; Notkola IL, 1998, NEUROEPIDEMIOLOGY, V17, P14, DOI 10.1159/000026149; PETERSEN RC, 1995, JAMA-J AM MED ASSOC, V273, P1274, DOI 10.1001/jama.273.16.1274; Prince M, 2000, NEUROLOGY, V54, P397, DOI 10.1212/WNL.54.2.397; PUSKA P, 1979, BRIT MED J, V2, P1173, DOI 10.1136/bmj.2.6199.1173; Romas SN, 1999, NEUROLOGY, V53, P517, DOI 10.1212/WNL.53.3.517; Skoog I, 1996, LANCET, V347, P1141, DOI 10.1016/S0140-6736(96)90608-X; Slooter AJC, 1999, NEUROLOGY, V53, P1593, DOI 10.1212/WNL.53.7.1593; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; TSUKAMOTO K, 1993, J LAB CLIN MED, V121, P598; VARTIAINEN E, 1994, INT J EPIDEMIOL, V23, P495, DOI 10.1093/ije/23.3.495; Wilson PWF, 1996, ARTERIOSCL THROM VAS, V16, P1250, DOI 10.1161/01.ATV.16.10.1250; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P1439, DOI 10.1001/archneur.57.10.1439	30	496	523	2	20	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 6	2002	137	3					149	155		10.7326/0003-4819-137-3-200208060-00006	http://dx.doi.org/10.7326/0003-4819-137-3-200208060-00006			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	580XP	12160362				2022-12-24	WOS:000177262300001
J	Johnstone, RA				Johnstone, RA			The evolution of inaccurate mimics	NATURE			English	Article							BATESIAN MIMICRY; MODEL; FREQUENCY	Instances of strikingly accurate Batesian mimicry (in which a palatable prey organism closely resembles an aversive model) are often cited to illustrate the power of natural selection(1). Less attention has been paid to those mimics, such as many hoverfly (Syrphidae) mimics of wasps or bees, that resemble their models only poorly(2-4). Attempts to provide an adaptive explanation for imperfect mimicry have suggested that what seems a crude resemblance to human observers may appear a close match to predators(2), or that inaccurate mimics may bear a general resemblance to several different model species(3,4). I show here, however, that truly inaccurate mimicry of a single model organism may be favoured over perfect resemblance, by kin selection. Signal detection theory predicts that predators will modify their level of discrimination adaptively in response to the relative frequencies and similarity of models and mimics(5-7). If models are rare and/or weakly aversive, greater local similarity of mimics can thus lead to greater attack rates. Where individual mimics are related to others in their vicinity, kin selection will then oppose the evolution of accurate mimicry.	Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Cambridge	Johnstone, RA (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.							BROWER JV, 1960, AM NAT, V94, P271, DOI 10.1086/282128; DITTRICH W, 1993, P ROY SOC B-BIOL SCI, V251, P195, DOI 10.1098/rspb.1993.0029; DUNCAN C. J., 1965, BEHAVIOUR, V24, P269, DOI 10.1163/156853965X00066; Edmunds M, 2000, BIOL J LINN SOC, V70, P459; Fisher R. A., 1930, GENETICAL THEORY NAT, DOI 10.5962/bhl.title.27468; Frank S. A., 1998, FDN SOCIAL EVOLUTION, DOI DOI 10.1515/9780691206820; GETTY T, 1985, AM NAT, V125, P239, DOI 10.1086/284339; GITTLEMAN JL, 1980, NATURE, V286, P149, DOI 10.1038/286149a0; GOODALE MA, 1977, ANIM BEHAV, V25, P660, DOI 10.1016/0003-3472(77)90117-8; GREENWOOD JJD, 1986, AM NAT, V128, P294, DOI 10.1086/284561; Guilford T, 1988, AM NAT, V131, P7; HARVEY PH, 1981, OIKOS, V37, P391, DOI 10.2307/3544135; HETZ M, 1988, OECOLOGIA, V76, P570, DOI 10.1007/BF00397872; HOWSE PE, 1994, P ROY SOC B-BIOL SCI, V257, P111, DOI 10.1098/rspb.1994.0102; LEA RG, 1972, BEHAVIOUR, V42, P131, DOI 10.1163/156853972X00149; Lindstrom L, 1997, P ROY SOC B-BIOL SCI, V264, P149, DOI 10.1098/rspb.1997.0022; Mappes J, 1997, EVOLUTION, V51, P2050, DOI 10.1111/j.1558-5646.1997.tb05129.x; Pfennig DW, 2001, NATURE, V410, P323, DOI 10.1038/35066628; PILECKI C, 1971, EVOLUTION, V25, P365, DOI 10.1111/j.1558-5646.1971.tb01890.x; Rodriguez-Girones MA, 1999, AM NAT, V153, P633, DOI 10.1086/303198; Wickler W., 1968, MIMICRY PLANTS ANIMA	21	70	71	2	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 1	2002	418	6897					524	526		10.1038/nature00845	http://dx.doi.org/10.1038/nature00845			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579EE	12152077				2022-12-24	WOS:000177162800038
J	Fegan, C				Fegan, C			Chronic lymphocytic leukaemia: one cell, two diseases?	LANCET			English	Editorial Material							LEUKEMIA; EXPRESSION; MUTATION; GENES; IDENTIFICATION; PHENOTYPE; BCL-6; CLL		Birmingham Heartlands & Solihull Natl Hlth Serv T, Dept Haematol, Birmingham B9 5SS, W Midlands, England		Fegan, C (corresponding author), Birmingham Heartlands & Solihull Natl Hlth Serv T, Dept Haematol, Birmingham B9 5SS, W Midlands, England.							Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; Dighiero G, 1996, LEUKEMIA LYMPHOMA, V22, P13, DOI 10.3109/10428199609102700; Fegan C, 1995, LEUKEMIA, V9, P2003; Gahn B, 1997, BLOOD, V89, P4275, DOI 10.1182/blood.V89.12.4275; Hamblin TJ, 2002, BLOOD, V99, P1023, DOI 10.1182/blood.V99.3.1023; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Jelinek DF, 2001, BRIT J HAEMATOL, V115, P854, DOI 10.1046/j.1365-2141.2001.03149.x; Klein U, 2001, J EXP MED, V194, P1625, DOI 10.1084/jem.194.11.1625; Kroeber A, 2000, BLOOD, V96, p835A; MOREAU EJ, 1997, AM J CLIN PATHOL, V108, P372; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Rosenwald A, 2001, J EXP MED, V194, P1639, DOI 10.1084/jem.194.11.1639; Sahota SS, 2000, BLOOD, V95, P3534, DOI 10.1182/blood.V95.11.3534.011k17_3534_3540; Stankovic T, 2002, BLOOD, V99, P300, DOI 10.1182/blood.V99.1.300; Stilgenbauer S, 2000, Rev Clin Exp Hematol, V4, P48, DOI 10.1046/j.1468-0734.2000.00003.x	16	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 20	2002	360	9328					184	186		10.1016/S0140-6736(02)09501-6	http://dx.doi.org/10.1016/S0140-6736(02)09501-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	576DX	12133650				2022-12-24	WOS:000176988500005
J	Hu, JP; Aguirre, M; Peto, C; Alonso, J; Ecker, J; Chory, J				Hu, JP; Aguirre, M; Peto, C; Alonso, J; Ecker, J; Chory, J			A role for peroxisomes in photomorphogenesis and development of Arabidopsis	SCIENCE			English	Article							GENE-EXPRESSION; LIGHT; MUTANT; PLANT; BIOGENESIS; DET1; TIME	The nuclear protein DET1 is a central repressor of photomorphogenesis in plants. We have identified the molecular lesion in ted3, a mutation that dominantly suppresses the phenotypes of det1-1. TED3 encodes a peroxisomal protein (AtPex2p) essential for Arabidopsis growth. Developmental defects and the abnormal expression of many genes in det1 are rescued by ted3. ted3 also partially suppresses another pleiotropic de-etiolated mutant cop1. Thus, peroxisomes, whose functions are still largely unexplored, play a key role in a photomorphogenetic pathway negatively regulated by the DET1 and COP proteins.	Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Neuronal Struct & Funct Lab, La Jolla, CA 92037 USA	Salk Institute; Howard Hughes Medical Institute; Salk Institute; Salk Institute	Chory, J (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA.	chory@salk.edu	Alonso, Jose M/K-6826-2014; Ecker, Joseph R/B-9144-2008	Alonso, Jose M/0000-0001-7087-1571; Ecker, Joseph R/0000-0001-5799-5895				Boudonck K, 1998, J CELL SCI, V111, P3687; CHORY J, 1989, CELL, V58, P991, DOI 10.1016/0092-8674(89)90950-1; Corpas FJ, 2001, TRENDS PLANT SCI, V6, P145, DOI 10.1016/S1360-1385(01)01898-2; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Hayashi M, 1998, PLANT CELL, V10, P183, DOI 10.1105/tpc.10.2.183; Hu J. L., UNPUB; Johnson TL, 2001, PLANT PHYSIOL, V127, P731, DOI 10.1104/pp.010262; KONIECZNY A, 1993, PLANT J, V4, P403, DOI 10.1046/j.1365-313X.1993.04020403.x; LI HM, 1995, PLANT CELL, V7, P1599, DOI 10.1105/tpc.7.10.1599; Lopez-Huertas E, 2000, EMBO J, V19, P6770, DOI 10.1093/emboj/19.24.6770; Mullineaux P, 2000, PHILOS T ROY SOC B, V355, P1531, DOI 10.1098/rstb.2000.0713; Neff MM, 2000, GENE DEV, V14, P257; PEPPER A, 1994, CELL, V78, P109, DOI 10.1016/0092-8674(94)90577-0; Pepper AE, 1997, GENETICS, V145, P1125; SCHROEDER D, IN PRESS CURR BIOL; Schwechheimer C, 2000, SEMIN CELL DEV BIOL, V11, P495, DOI 10.1006/scdb.2000.0203; Subramani S, 1998, PHYSIOL REV, V78, P171, DOI 10.1152/physrev.1998.78.1.171; Zolman BK, 2001, PLANT PHYSIOL, V127, P1266, DOI 10.1104/pp.010550	18	115	121	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 19	2002	297	5580					405	409		10.1126/science.1073633	http://dx.doi.org/10.1126/science.1073633			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574LV	12130786				2022-12-24	WOS:000176892600053
J	Kellner, AWA; Campos, DD				Kellner, AWA; Campos, DD			The function of the cranial crest and jaws of a unique pterosaur from the Early Cretaceous of Brazil	SCIENCE			English	Article								The discovery of a previously undescribed pterosaur, Thalassodromeus sethi, yields information on the function of cranial crests and the feeding strategy developed by these extinct flying reptiles. The material consists of a large skull ( length: 1420 millimeters, including the crest) with a huge bony crest that was well irrigated by blood vessels and may have been used for regulation of its body temperature. The rostrum consists of two bladelike laminae, the arrangement of which is analogous to the condition found in the bird Rynchops, which skims over the water to catch food, indicating that T. sethi also may have been a skimmer.	Univ Fed Rio de Janeiro, Museu Nacl, Dept Geol & Paleontol, Paleovertebrate Sector, BR-20940040 Rio De Janeiro, Brazil; Dept Nacl Prod Mineral, Museu Ciencias Terra, BR-22290240 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro	Kellner, AWA (corresponding author), Univ Fed Rio de Janeiro, Museu Nacl, Dept Geol & Paleontol, Paleovertebrate Sector, BR-20940040 Rio De Janeiro, Brazil.	kellner@mn.ufrj.br	Kellner, Alexander W/H-1023-2015; Kellner, Alexander/ABE-9591-2020	Kellner, Alexander W/0000-0001-7174-9447; Kellner, Alexander/0000-0001-7174-9447				Bennett S.C., 1992, Journal of Vertebrate Paleontology, V12, P422; Bennett S. C., 2001, PALAEONTOGR ABT A, V260, P1; BEURLEN K, 1971, AN ACAD BRAS CIENC, V43, P411; BRAMWELL CD, 1981, PHILOS T R SOC LON B, V267, P503; Buffetaut E, 2002, NATURWISSENSCHAFTEN, V89, P180, DOI 10.1007/s00114-002-0307-1; CAMPOS DD, 1985, AN ACAD BRAS CIENC, V57, P453; Campos Diogenes De A., 1997, Anais da Academia Brasileira de Ciencias, V69, P83; Eaton G. F., 1910, Memoirs of the Connecticut Academy of Arts and Sciences New Haven, V2; FARLOW JO, 1976, SCIENCE, V192, P1123, DOI 10.1126/science.192.4244.1123; Frey Eberhard, 1994, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V194, P379; Kellner A.W.A., 1989, Anais da Academia Brasileira de Ciencias, V61, P439; KELLNER A W A, 1988, Anais da Academia Brasileira de Ciencias, V60, P459; Kellner Alexander W. A., 1993, Journal of Vertebrate Paleontology, V13, p44A; Kellner Alexander Wilhelm Armin, 1994, Anais da Academia Brasileira de Ciencias, V66, P467; Kellner AWA, 1996, J VERTEBR PALEONTOL, V16, P222, DOI 10.1080/02724634.1996.10011310; Kellner AWA., 1994, ACTA GEOLOGICA LEOPO, V39, P175; Kellner AWA, 2000, NATL SCI MUSEUM MONO, V17, P1, DOI 10.1159/000061634; Kellner AWA, 1996, THESIS COLUMBIA U; KRIPP D, 1943, NOVA ACTA LEOPOLDINA, V12, P16; LANGSTON W, 1981, SCI AM, V244, P92; Maisey JG, 1991, SANTANA FOSSILS ILLU; PONS D, 1990, S BAC AR BAC INT NOR, P241; PRICE LI, 1971, AN ACAD BRAS CIENC, V43, P451; Sampson Scott D., 1997, P39; Sayao Juliana M., 2000, Boletim do Museu Nacional Nova Serie Geologia, V54, P1; Wellnhofer P., 1991, Mitteilungen der Bayerischen Staatssammlung fuer Palaeontologie und Historische Geologie, V31, P89; WELLNHOFER P, 1985, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V187, P105; Wellnhofer P., 1975, PALAONTOGRAPHICA A, V148, P1; Wellnhofer P, 1991, ILLUSTRATED ENCY PTE; Young CC, 1973, SPECIAL PUBLICATION, V11, P18; Zusi R. L., 1962, PUBL NUTTALL ORNITHO, V3, P1	31	81	88	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 19	2002	297	5580					389	392		10.1126/science.1073186	http://dx.doi.org/10.1126/science.1073186			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574LV	12130783				2022-12-24	WOS:000176892600048
J	Konner, M				Konner, M			Development: Weaving life's pattern	NATURE			English	Article									Emory Univ, Atlanta, GA 30322 USA	Emory University	Konner, M (corresponding author), Emory Univ, Atlanta, GA 30322 USA.							ANASTASI A, 1958, PSYCHOL REV, V65, P197, DOI 10.1037/h0044895; CHANGEUX JP, 1997, NEURONAL MAN BIOL MI; WOLPERT L, 1991, TRIUMP EMBRYO; [No title captured]	4	1	1	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 18	2002	418	6895					279	279		10.1038/418279a	http://dx.doi.org/10.1038/418279a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	574BF	12124603	Bronze			2022-12-24	WOS:000176868000022
J	Mukherjee, S; Brieba, LG; Sousa, R				Mukherjee, S; Brieba, LG; Sousa, R			Structural transitions mediating transcription initiation by T7 RNA polymerase	CELL			English	Article							LAC UV5 PROMOTER; TERNARY COMPLEXES; THUMB SUBDOMAIN; BACTERIOPHAGE-T7; DNA; ELONGATION; TERMINATION; STABILITY; MECHANISM; LYSOZYME	During transcription initiation, RNA polymerases appear to retain promoter interactions while transcribing short RNAs that are frequently released from the complex. Upon transition to elongation, the polymerase releases promoter and forms a stable elongation complex. Little is known about the changes in polymerase conformation or polymerase:DNA interactions that occur during this process. To characterize the transitions that occur in the T7 RNA polyrnerase transcription complex during initiation, we prepared enzymes with Fe-BABE conjugated at 11 different positions. Addition of H2O2 to transcription complexes prepared with these enzymes led to nucleic acid strand scission near the conjugate. Changes in the cleavage sites revealed a series of conformational changes and rearrangements of protein:nucleic acid contacts that mediate progression through the initiation reaction.	Univ Texas, Hlth Sci Ctr, Dept Biochem, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Sousa, R (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Biochem, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.		Brieba, Luis/I-8447-2016; Meares, Claude F/A-8345-2011	Brieba, Luis/0000-0002-6073-5207; Sousa, Rui/0000-0003-4314-121X	NIGMS NIH HHS [GM52522, R01 GM052522] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEESE LS, 1993, SCIENCE, V260, P352, DOI 10.1126/science.8469987; Brieba LG, 2001, BIOCHEMISTRY-US, V40, P3882, DOI 10.1021/bi002716c; Brieba LG, 2001, EMBO J, V20, P6826, DOI 10.1093/emboj/20.23.6826; Brieba LG, 2001, J BIOL CHEM, V276, P10306, DOI 10.1074/jbc.M009866200; CARPOUSIS AJ, 1980, BIOCHEMISTRY-US, V19, P3245, DOI 10.1021/bi00555a023; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; Cheetham GMT, 1999, NATURE, V399, P80, DOI 10.1038/19999; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Greiner DP, 1997, BIOCONJUGATE CHEM, V8, P44, DOI 10.1021/bc9600731; Gruber TM, 2001, MOL CELL, V8, P21, DOI 10.1016/S1097-2765(01)00292-1; HAN HY, 1994, P NATL ACAD SCI USA, V91, P4955, DOI 10.1073/pnas.91.11.4955; HANSEN UM, 1980, J BIOL CHEM, V255, P9564; Huang JB, 1999, J MOL BIOL, V293, P457, DOI 10.1006/jmbi.1999.3135; Huang JB, 2000, J MOL BIOL, V303, P347, DOI 10.1006/jmbi.2000.4150; IKEDA RA, 1986, P NATL ACAD SCI USA, V83, P3614, DOI 10.1073/pnas.83.11.3614; Jeruzalmi D, 1998, EMBO J, V17, P4101, DOI 10.1093/emboj/17.14.4101; Jia YP, 1997, BIOCHEMISTRY-US, V36, P4223, DOI 10.1021/bi9630467; KRUMMEL B, 1989, BIOCHEMISTRY-US, V28, P7829, DOI 10.1021/bi00445a045; Kuznedelov K, 2002, SCIENCE, V295, P855, DOI 10.1126/science.1066303; Landick R, 2001, CELL, V105, P567, DOI 10.1016/S0092-8674(01)00381-6; MACDONALD LE, 1993, J MOL BIOL, V232, P1030, DOI 10.1006/jmbi.1993.1458; MACDONALD LE, 1994, J MOL BIOL, V238, P145, DOI 10.1006/jmbi.1994.1277; MARTIN CT, 1988, BIOCHEMISTRY-US, V27, P3966, DOI 10.1021/bi00411a012; Mekler V, 2002, CELL, V108, P599, DOI 10.1016/S0092-8674(02)00667-0; Mentesana PE, 2000, J MOL BIOL, V302, P1049, DOI 10.1006/jmbi.2000.4114; Mukhopadhyay J, 2001, CELL, V106, P453, DOI 10.1016/S0092-8674(01)00464-0; Nudler E, 1999, J MOL BIOL, V288, P1, DOI 10.1006/jmbi.1999.2641; Palangat M, 2001, J MOL BIOL, V311, P265, DOI 10.1006/jmbi.2001.4842; Place C, 1999, BIOCHEMISTRY-US, V38, P4948, DOI 10.1021/bi982689e; SOUSA R, 1992, J MOL BIOL, V224, P319, DOI 10.1016/0022-2836(92)90997-X; SOUSA R, 1993, NATURE, V364, P593, DOI 10.1038/364593a0; SOUSA R, 1994, J MOL BIOL, V244, P6, DOI 10.1006/jmbi.1994.1699; STRANEY DC, 1987, J MOL BIOL, V193, P267, DOI 10.1016/0022-2836(87)90218-X; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Temiakov D, 2000, P NATL ACAD SCI USA, V97, P14109, DOI 10.1073/pnas.250473197; Ujvari A, 2000, J MOL BIOL, V295, P1173, DOI 10.1006/jmbi.1999.3418; Uptain SM, 1997, ANNU REV BIOCHEM, V66, P117, DOI 10.1146/annurev.biochem.66.1.117; Villemain J, 1998, J MOL BIOL, V281, P793, DOI 10.1006/jmbi.1998.1989; Villemain J, 1997, J MOL BIOL, V273, P958, DOI 10.1006/jmbi.1997.1358; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9; Zhang X, 1997, J MOL BIOL, V269, P10, DOI 10.1006/jmbi.1997.1016	41	40	45	4	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 12	2002	110	1					81	91		10.1016/S0092-8674(02)00815-2	http://dx.doi.org/10.1016/S0092-8674(02)00815-2			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	573PU	12150999	Bronze			2022-12-24	WOS:000176840700009
J	Ligoxygakis, P; Pelte, N; Hoffmann, JA; Reichhart, JM				Ligoxygakis, P; Pelte, N; Hoffmann, JA; Reichhart, JM			Activation of Drosophila Toll during fungal infection by a blood serine protease	SCIENCE			English	Article							HOST-DEFENSE; GENE; ANTIFUNGAL; BACTERIA; ENZYME	Drosophila host defense to fungal and Gram-positive bacterial infection is mediated by the Spaetzle/Toll/cactus gene cassette. It has been proposed that Toll does not function as a pattern recognition receptor per se but is activated through a cleaved form of the cytokine Spaetzle. The upstream events linking infection to the cleavage of Spaetzle have long remained elusive. Here we report the identification of a central component of the fungal activation of Toll. We show that ethylmethane sulfonate- induced mutations in the Persephone gene, which encodes a previously unknown serine protease, block induction of the Toll pathway by fungi and resistance to this type of infection.	Inst Biol Mol & Cellulaire, CNRS, UPR 9022, F-67084 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Reichhart, JM (corresponding author), Inst Biol Mol & Cellulaire, CNRS, UPR 9022, 15 Rue R Descartes, F-67084 Strasbourg, France.	jm.reichhart@ibmc.u-strasbg.fr						Barrett A. J., 1998, HDB PROTEOLYTIC ENZY; BRAND AH, 1993, DEVELOPMENT, V118, P401; Choe KM, 2002, SCIENCE, V296, P359, DOI 10.1126/science.1070216; Georgel P, 2001, DEV CELL, V1, P503, DOI 10.1016/S1534-5807(01)00059-4; Gottar M, 2002, NATURE, V416, P640, DOI 10.1038/nature734; Green C, 2000, GENETICS, V156, P1117; HASHIMOTO C, 1988, CELL, V52, P269, DOI 10.1016/0092-8674(88)90516-8; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Krem MM, 2002, TRENDS BIOCHEM SCI, V27, P67, DOI 10.1016/S0968-0004(01)02007-2; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; LEMAITRE B, 1995, P NATL ACAD SCI USA, V92, P9465, DOI 10.1073/pnas.92.21.9465; LeMosy EK, 1999, TRENDS CELL BIOL, V9, P102, DOI 10.1016/S0962-8924(98)01494-9; Levashina EA, 1999, SCIENCE, V285, P1917, DOI 10.1126/science.285.5435.1917; LIGOXYGAKIS P, UNPUB; LIGOXYGAKIS P, 2000, NATURE IMMUNOL, V1, P342; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; MORISATO D, 1994, CELL, V76, P677, DOI 10.1016/0092-8674(94)90507-X; Muta T, 1996, CURR OPIN IMMUNOL, V8, P41, DOI 10.1016/S0952-7915(96)80103-8; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Rutschmann S, 2000, NAT IMMUNOL, V1, P342, DOI 10.1038/79801; Rutschmann S, 2000, IMMUNITY, V12, P569, DOI 10.1016/S1074-7613(00)80208-3; Satoh D, 1999, J BIOL CHEM, V274, P7441, DOI 10.1074/jbc.274.11.7441; SMITH C, 1994, GENETICS, V136, P1355; Spradling A. C, 1986, DROSOPHILA PRACTICAL; Werner T, 2000, P NATL ACAD SCI USA, V97, P13772, DOI 10.1073/pnas.97.25.13772; Wright HT, 1996, BIOESSAYS, V18, P453, DOI 10.1002/bies.950180607	27	265	293	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 5	2002	297	5578					114	116		10.1126/science.1072391	http://dx.doi.org/10.1126/science.1072391			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	571HB	12098703				2022-12-24	WOS:000176711000047
J	Hoege, C; Pfander, B; Moldovan, GL; Pyrowolakis, G; Jentsch, S				Hoege, C; Pfander, B; Moldovan, GL; Pyrowolakis, G; Jentsch, S			RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO	NATURE			English	Article							CELL NUCLEAR ANTIGEN; CONJUGATING ENZYME COMPLEX; RING FINGER PROTEINS; SACCHAROMYCES-CEREVISIAE; POSTREPLICATION REPAIR; POLYUBIQUITIN CHAIN; CRYSTAL-STRUCTURE; SRS2 SUPPRESSOR; UV SENSITIVITY; YEAST SEPTINS	The RAD6 pathway is central to post-replicative DNA repair in eukaryotic cells; however, the machinery and its regulation remain poorly understood. Two principal elements of this pathway are the ubiquitin-conjugating enzymes RAD6 and the MMS2-UBC13 heterodimer, which are recruited to chromatin by the RING-finger proteins RAD18 and RAD5, respectively. Here we show that UBC9, a small ubiquitin-related modifier (SUMO)-conjugating enzyme, is also affiliated with this pathway and that proliferating cell nuclear antigen (PCNA)-a DNA-polymerase sliding clamp involved in DNA synthesis and repair-is a substrate. PCNA is monoubiquitinated through RAD6 and RAD18, modified by lysine-63-linked multi-ubiquitination-which additionally requires MMS2, UBC13 and RAD5-and is conjugated to SUMO by UBC9. All three modifications affect the same lysine residue of PCNA, suggesting that they label PCNA for alternative functions. We demonstrate that these modifications differentially affect resistance to DNA damage, and that damage-induced PCNA ubiquitination is elementary for DNA repair and occurs at the same conserved residue in yeast and humans.	Max Planck Inst Biochem, Dept Mol Cell Biol, D-82152 Martinsried, Germany	Max Planck Society	Jentsch, S (corresponding author), Max Planck Inst Biochem, Dept Mol Cell Biol, Klopferspitz 18A, D-82152 Martinsried, Germany.		Pfander, Boris/A-8703-2013	Pfander, Boris/0000-0003-2180-5054; George-Lucian, Moldovan/0000-0003-3825-149X				Amin NS, 1996, GENETICS, V144, P479; AYYAGARI R, 1995, MOL CELL BIOL, V15, P4420; BAILLY V, 1994, GENE DEV, V8, P811, DOI 10.1101/gad.8.7.811; BAUER GA, 1990, NUCLEIC ACIDS RES, V18, P261, DOI 10.1093/nar/18.2.261; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; BROODBAKKER JTW, 1983, OPHTHALMIC PAED GEN, V2, P95, DOI 10.3109/13816818309007797; Broomfield S, 2002, NUCLEIC ACIDS RES, V30, P732, DOI 10.1093/nar/30.3.732; Brusky J, 2000, CURR GENET, V37, P168, DOI 10.1007/s002940050515; Cejka P, 2001, GENETICS, V159, P953; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Eissenberg JC, 1997, MOL CELL BIOL, V17, P6367, DOI 10.1128/MCB.17.11.6367; Friedberg E.C., 2016, DNA REPAIR MUTAGENES, V33, P35; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; Hochstrasser M, 2002, MOL CELL, V9, P453, DOI 10.1016/S1097-2765(02)00486-0; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; JENTSCH S, 1987, NATURE, V329, P131, DOI 10.1038/329131a0; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; JOHNSON RE, 1992, MOL CELL BIOL, V12, P3807, DOI 10.1128/MCB.12.9.3807; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; KRISHNA TSR, 1994, J MOL BIOL, V241, P265, DOI 10.1006/jmbi.1994.1495; LAWRENCE CW, 1979, J BACTERIOL, V139, P866, DOI 10.1128/JB.139.3.866-876.1979; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Li ZQ, 2002, P NATL ACAD SCI USA, V99, P4459, DOI 10.1073/pnas.062047799; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; Moraes TF, 2001, NAT STRUCT BIOL, V8, P669, DOI 10.1038/90373; Muller S, 2000, J BIOL CHEM, V275, P13321, DOI 10.1074/jbc.275.18.13321; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; PRAKASH L, 1994, ANN NY ACAD SCI, V726, P267, DOI 10.1111/j.1749-6632.1994.tb52825.x; PRAKASH S, 1993, ANNU REV GENET, V27, P33, DOI 10.1146/annurev.ge.27.120193.000341; SCHIESTL RH, 1990, GENETICS, V124, P817; SEUFERT W, 1995, NATURE, V373, P78, DOI 10.1038/373078a0; SPENCE J, 1995, MOL CELL BIOL, V15, P1265; Spence J, 2000, CELL, V102, P67, DOI 10.1016/S0092-8674(00)00011-8; Tateishi S, 2000, P NATL ACAD SCI USA, V97, P7927, DOI 10.1073/pnas.97.14.7927; Torres-Ramos CA, 2002, MOL CELL BIOL, V22, P2419, DOI 10.1128/MCB.22.7.2419-2426.2002; TorresRamos CA, 1996, P NATL ACAD SCI USA, V93, P9676, DOI 10.1073/pnas.93.18.9676; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Tsurimoto T., 1999, FRONT BIOSCI, V4, P849; Ulrich HD, 2000, EMBO J, V19, P3388, DOI 10.1093/emboj/19.13.3388; Ulrich HD, 2002, EUKARYOT CELL, V1, P1, DOI 10.1128/EC.1.1.1-10.2002; Ulrich HD, 2001, NUCLEIC ACIDS RES, V29, P3487, DOI 10.1093/nar/29.17.3487; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Warbrick E, 2000, BIOESSAYS, V22, P997, DOI 10.1002/1521-1878(200011)22:11<997::AID-BIES6>3.3.CO;2-R; Xiao W, 2000, GENETICS, V155, P1633; Xiao W, 1999, MUTAT RES-DNA REPAIR, V435, P1, DOI 10.1016/S0921-8777(99)00034-8; Zhang ZG, 2000, NATURE, V408, P221, DOI 10.1038/35041601	52	1683	1752	75	556	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 12	2002	419	6903					135	141		10.1038/nature00991	http://dx.doi.org/10.1038/nature00991			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592HK	12226657				2022-12-24	WOS:000177931200033
J	Nestle, FO; Speidel, H; Speidel, MO				Nestle, FO; Speidel, H; Speidel, MO			Metallurgy - High nickel release from 1-and 2-euro coins	NATURE			English	Article							CONTACT-DERMATITIS		Univ Zurich Hosp, Dept Dermatol, CH-8901 Zurich, Switzerland; Swiss Fed Inst Technol, Dept Mat, Inst Met, CH-8092 Zurich, Switzerland	University of Zurich; University Zurich Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich	Nestle, FO (corresponding author), Univ Zurich Hosp, Dept Dermatol, CH-8901 Zurich, Switzerland.							ANDERSEN KE, 1995, TXB CONTACT DERMATIT, P418; *EUR STAND, 1999, 1811 EN EUR STAND; GOLLHAUSEN R, 1991, J AM ACAD DERMATOL, V25, P365, DOI 10.1016/0190-9622(91)70206-H; Liden C, 2001, CONTACT DERMATITIS, V44, P160, DOI 10.1034/j.1600-0536.2001.044003160.x; Nielsen NH, 1999, BRIT J DERMATOL, V141, P676; Speidel M.O., 1998, MAT MED, P191	6	85	88	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 12	2002	419	6903					132	132		10.1038/419132a	http://dx.doi.org/10.1038/419132a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592HK	12226655	Bronze			2022-12-24	WOS:000177931200030
J	Kuhlbrandt, W; Zeelen, J; Dietrich, J				Kuhlbrandt, W; Zeelen, J; Dietrich, J			Structure, mechanism, and regulation of the neurospora plasma membrane H+-ATPase	SCIENCE			English	Article							TRANSFORM INFRARED-SPECTROSCOPY; SARCOPLASMIC-RETICULUM; CALCIUM-PUMP; BACTERIORHODOPSIN; RESOLUTION; DOMAINS; MAPS	Proton pumps in the plasma membrane of plants and yeasts maintain the intracellular pH and membrane potential. To gain insight into the molecular mechanisms of proton pumping, we built an atomic homology model of the proton pump based on the 2.6 angstrom x-ray structure of the related Ca2+ pump from rabbit sarcoplasmic reticulum. The model, when fitted to an 8 angstrom map of the Neurospora proton pump determined by electron microscopy, reveals the likely path of the proton through the membrane and shows that the nucleotide-binding domain rotates by similar to70degrees to deliver adenosine triphosphate (ATP) to the phosphorylation site. A synthetic peptide corresponding to the carboxyl-terminal regulatory domain stimulates ATPase activity, suggesting a mechanism for proton transport regulation.	Max Planck Inst Biophys, D-60528 Frankfurt, Germany	Max Planck Society	Kuhlbrandt, W (corresponding author), Max Planck Inst Biophys, Heinrich Hoffmann Str 7, D-60528 Frankfurt, Germany.			Kuhlbrandt, Werner/0000-0002-2013-4810				Auer M, 1998, NATURE, V392, P840, DOI 10.1038/33967; BIGELOW DJ, 1992, BIOCHIM BIOPHYS ACTA, V1113, P323, DOI 10.1016/0304-4157(92)90005-U; CYRKLAFF M, 1995, EMBO J, V14, P1854, DOI 10.1002/j.1460-2075.1995.tb07177.x; GOORMAGHTIGH E, 1994, J BIOL CHEM, V269, P27409; Goossens A, 2000, MOL CELL BIOL, V20, P7654, DOI 10.1128/MCB.20.20.7654-7661.2000; HENNESSEY JP, 1988, J BIOL CHEM, V263, P3123; Hummer G, 2001, NATURE, V414, P188, DOI 10.1038/35102535; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KUBLER O, 1978, ULTRAMICROSCOPY, V3, P161, DOI 10.1016/S0304-3991(78)80022-9; KUHLBRANDT W, UNPUB; Lancaster CRD, 1997, STRUCTURE, V5, P1339, DOI 10.1016/S0969-2126(97)00285-2; Luecke H, 2000, BBA-BIOENERGETICS, V1460, P133, DOI 10.1016/S0005-2728(00)00135-3; Lutsenko S, 1997, J BIOL CHEM, V272, P18939, DOI 10.1074/jbc.272.30.18939; Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8; Morsomme P, 2000, BBA-REV BIOMEMBRANES, V1469, P133, DOI 10.1016/S0304-4157(00)00015-0; Ponamarev MV, 1998, BIOCHEMISTRY-US, V37, P17199, DOI 10.1021/bi981814j; PORTILLO F, 1991, FEBS LETT, V287, P71, DOI 10.1016/0014-5793(91)80018-X; PORTILLO F, 1999, BIOCHIM BIOPHYS ACTA, V1469, P31; Rhee KH, 2002, EMBO J, V21, P3582, DOI 10.1093/emboj/cdf385; Roseman AM, 2000, ACTA CRYSTALLOGR D, V56, P1332, DOI 10.1107/S0907444900010908; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SERRANO R, 1992, ACTA PHYSIOL SCAND, V146, P131; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TITTOR J, 1995, BIOPHYS CHEM, V56, P153, DOI 10.1016/0301-4622(95)00027-U; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Xu C, 2002, J MOL BIOL, V316, P201, DOI 10.1006/jmbi.2001.5330; Zhang PJ, 1998, NATURE, V392, P835, DOI 10.1038/33959; Zscherp C, 1999, P NATL ACAD SCI USA, V96, P5498, DOI 10.1073/pnas.96.10.5498	28	86	90	2	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2002	297	5587					1692	1696		10.1126/science.1072574	http://dx.doi.org/10.1126/science.1072574			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590JE	12169656				2022-12-24	WOS:000177819100047
J	Weller, GR; Kysela, B; Roy, R; Tonkin, LM; Scanlan, E; Della, M; Devine, SK; Day, JP; Wilkinson, A; di Fagagna, FD; Devine, KM; Bowater, RP; Jeggo, PA; Jackson, SP; Doherty, AJ				Weller, GR; Kysela, B; Roy, R; Tonkin, LM; Scanlan, E; Della, M; Devine, SK; Day, JP; Wilkinson, A; di Fagagna, FD; Devine, KM; Bowater, RP; Jeggo, PA; Jackson, SP; Doherty, AJ			Identification of a DNA nonhomologous end-joining complex in bacteria	SCIENCE			English	Article							DEPENDENT PROTEIN-KINASE; DOUBLE-STRAND BREAKS; KU PROTEIN; BACILLUS-SUBTILIS; REPAIR; BINDING; LIGASE; DOMAINS; CONSERVATION; HOMOLOGS	in eukaryotic cells, double-strand breaks (DSBs) in DNA are generally repaired by the pathway of homologous recombination or by DNA nonhomologous end joining (NHEJ). Both pathways have been highly conserved throughout eukaryotic evolution, but no equivalent NHEJ system has been identified in prokaryotes. The NHEJ pathway requires a DNA end-binding component called Ku. We have identified bacterial Ku homologs and show that these proteins retain the biochemical characteristics of the eukaryotic Ku heterodimer. Furthermore, we show that bacterial Ku specifically recruits DNA ligase to DNA ends and stimulates DNA ligation. Loss of these proteins leads to hypersensitivity to ionizing radiation in Bacillus subtilis. These data provide evidence that many bacteria possess a DNA DSB repair apparatus that shares many features with the NHEJ system of eukarya and suggest that this DNA repair pathway arose before the prokaryotic and eukaryotic lineages diverged.	Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 2XY, England; Univ Cambridge, Dept Haematol, Cambridge CB2 2XY, England; Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England; Univ Cambridge, Dept Zool, Cambridge CB2 1QR, England; Univ Cambridge, Wellcome Trust Canc Res UK, Inst Canc & Dev Biol, Cambridge CB2 1QR, England; Univ Dublin Trinity Coll, Smurfit Inst, Dept Genet, Dublin 2, Ireland; Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England	University of Cambridge; University of Cambridge; University of Sussex; University of Cambridge; Cancer Research UK; University of Cambridge; Trinity College Dublin; University of East Anglia	Doherty, AJ (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Hills Rd, Cambridge CB2 2XY, England.		Dry, Kate/I-2328-2014; d'Adda di Fagagna, Fabrizio/AAC-4683-2022; Bowater, Richard P/A-4227-2010; Jackson, Stephen Philip/R-4548-2019	d'Adda di Fagagna, Fabrizio/0000-0002-9603-5966; Bowater, Richard P/0000-0002-2745-7807; Jackson, Stephen Philip/0000-0001-9317-7937; DADDADIFAGAGNA, FABRIZIO/0000-0002-1976-3185; Doherty, Aidan/0000-0002-6370-1109				Aravind L, 2001, GENOME RES, V11, P1365, DOI 10.1101/gr.181001; Bliss TM, 1997, J BIOL CHEM, V272, P5765, DOI 10.1074/jbc.272.9.5765; Cary RB, 1997, P NATL ACAD SCI USA, V94, P4267, DOI 10.1073/pnas.94.9.4267; Chen L, 2000, J BIOL CHEM, V275, P26196, DOI 10.1074/jbc.M000491200; Critchlow SE, 1998, TRENDS BIOCHEM SCI, V23, P394, DOI 10.1016/S0968-0004(98)01284-5; Dandekar T, 1998, TRENDS BIOCHEM SCI, V23, P324, DOI 10.1016/S0968-0004(98)01274-2; DIFAGAGNA FD, UNPUB; Doherty AJ, 2000, NUCLEIC ACIDS RES, V28, P4051, DOI 10.1093/nar/28.21.4051; Doherty AJ, 2001, CURR BIOL, V11, pR920, DOI 10.1016/S0960-9822(01)00555-3; Doherty AJ, 2001, FEBS LETT, V500, P186, DOI 10.1016/S0014-5793(01)02589-3; DVIR A, 1992, P NATL ACAD SCI USA, V89, P11920, DOI 10.1073/pnas.89.24.11920; Dynan WS, 1998, NUCLEIC ACIDS RES, V26, P1551, DOI 10.1093/nar/26.7.1551; Featherstone C, 1999, MUTAT RES-DNA REPAIR, V434, P3, DOI 10.1016/S0921-8777(99)00006-3; Gell D, 1999, NUCLEIC ACIDS RES, V27, P3494, DOI 10.1093/nar/27.17.3494; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; KODAMA K, 1991, NUCLEIC ACIDS RES, V19, P6093, DOI 10.1093/nar/19.22.6093; McElhinny SAN, 2000, MOL CELL BIOL, V20, P2996, DOI 10.1128/MCB.20.9.2996-3003.2000; Osipovich O, 1997, J BIOL CHEM, V272, P27259, DOI 10.1074/jbc.272.43.27259; Osipovich O, 1999, BIOCHEM BIOPH RES CO, V261, P802, DOI 10.1006/bbrc.1999.1118; Pang DL, 1997, CANCER RES, V57, P1412; Petit JC, 2000, ACCREDIT QUAL ASSUR, V5, P28, DOI 10.1007/s007690050005; PFEIFFER P, 1994, MOL CELL BIOL, V14, P888, DOI 10.1128/MCB.14.2.888; Ramsden DA, 1998, EMBO J, V17, P609, DOI 10.1093/emboj/17.2.609; Sciochetti SA, 1999, J BACTERIOL, V181, P6053, DOI 10.1128/JB.181.19.6053-6062.1999; SHINOHARA A, 1995, TRENDS BIOCHEM SCI, V20, P387, DOI 10.1016/S0968-0004(00)89085-4; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; Sriskanda V, 1998, NUCLEIC ACIDS RES, V26, P4618, DOI 10.1093/nar/26.20.4618; Teo SH, 2000, CURR BIOL, V10, P165, DOI 10.1016/S0960-9822(00)00317-1; Vagner V, 1998, MICROBIOL-SGM, V144, P3097, DOI 10.1099/00221287-144-11-3097; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Wang JS, 1998, J BIOL CHEM, V273, P842, DOI 10.1074/jbc.273.2.842; Weller GR, 2001, FEBS LETT, V505, P340, DOI 10.1016/S0014-5793(01)02831-9; WELLER GR, UNPUB; Wu XT, 1996, MOL CELL BIOL, V16, P5186	34	250	267	3	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 6	2002	297	5587					1686	1689		10.1126/science.1074584	http://dx.doi.org/10.1126/science.1074584			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590JE	12215643				2022-12-24	WOS:000177819100045
J	Hahnloser, RHR; Kozhevnikov, AA; Fee, MS				Hahnloser, RHR; Kozhevnikov, AA; Fee, MS			An ultra-sparse code underlies the generation of neural sequences in a songbird	NATURE			English	Article							ZEBRA FINCH SONG; NUCLEUS ROBUSTUS-ARCHISTRIATALIS; IDENTIFICATION; BIRDSONG; VOCALIZATIONS; CONNECTIONS; PLASTICITY; BEHAVIOR; SYSTEM; SLEEP	Sequences of motor activity are encoded in many vertebrate brains by complex spatio-temporal patterns of neural activity; however, the neural circuit mechanisms underlying the generation of these pre-motor patterns are poorly understood. In songbirds, one prominent site of pre-motor activity is the forebrain robust nucleus of the archistriatum (RA), which generates stereotyped sequences of spike bursts during song(1) and recapitulates these sequences during sleep(2). We show that the stereotyped sequences in RA are driven from nucleus HVC (high vocal centre), the principal pre-motor input to RA(3,4). Recordings of identified HVC neurons in sleeping and singing birds show that individual HVC neurons projecting onto RA neurons produce bursts sparsely, at a single, precise time during the RA sequence. These HVC neurons burst sequentially with respect to one another. We suggest that at each time in the RA sequence, the ensemble of active RA neurons is driven by a subpopulation of RA-projecting HVC neurons that is active only at that time. As a population, these HVC neurons may form an explicit representation of time in the sequence. Such a sparse representation, a temporal analogue of the 'grandmother cell'(5) concept for object recognition, eliminates the problem of temporal interference during sequence generation and learning attributed to more distributed representations(6,7).	Bell Labs, Lucent Technol, Biol Computat Res Dept, Murray Hill, NJ 07974 USA; MIT, Howard Hughes Med Inst, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Alcatel-Lucent; Lucent Technologies; AT&T; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Fee, MS (corresponding author), Bell Labs, Lucent Technol, Biol Computat Res Dept, 600 Mt Ave, Murray Hill, NJ 07974 USA.		Kozhevnikov, Alexay/A-1092-2013	Kozhevnikov, Alexay/0000-0002-0033-9747; Hahnloser, Richard/0000-0002-4039-7773; Fee, Michale/0000-0001-7539-1745				AMARI SI, 1972, IEEE T COMPUT, P1197; Barlow Horace, 1995, P415; BOTTJER SW, 1989, J COMP NEUROL, V279, P312, DOI 10.1002/cne.902790211; Brainard MS, 2000, NATURE, V404, P762, DOI 10.1038/35008083; BRILLINGER DR, 1976, BIOL CYBERN, V22, P213, DOI 10.1007/BF00365087; Chi ZY, 2001, NEURON, V32, P899, DOI 10.1016/S0896-6273(01)00524-4; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; Doupe A J, 1993, Curr Opin Neurobiol, V3, P104, DOI 10.1016/0959-4388(93)90043-X; Doya K, 1998, CENTRAL AUDITORY PROCESSING AND NEURAL MODELING, P77; Dutar P, 1998, J NEUROPHYSIOL, V80, P1828, DOI 10.1152/jn.1998.80.4.1828; Fee MS, 1998, NATURE, V395, P67, DOI 10.1038/25725; Fee MS, 2001, J NEUROSCI METH, V112, P83, DOI 10.1016/S0165-0270(01)00426-5; Hermann M., 1995, NETWORK COMPUTATION, V6, P403; Immelmann K., 1969, P61; KLEIN MK, 1989, J AM VET MED ASSOC, V195, P246; KONISHI M, 1985, ANNU REV NEUROSCI, V8, P125, DOI 10.1146/annurev.ne.08.030185.001013; Konishi M., 1965, Zeitschrift fuer Tierpsychologie, V22, P770; MOONEY R, 1992, J NEUROSCI, V12, P2464; Mooney R, 2000, J NEUROSCI, V20, P5420, DOI 10.1523/JNEUROSCI.20-14-05420.2000; NOTTEBOHM F, 1982, J COMP NEUROL, V207, P344, DOI 10.1002/cne.902070406; Pearlmutter BA, 1989, NEURAL COMPUT, V1, P263, DOI 10.1162/neco.1989.1.2.263; PHILLIPS NH, 1992, NEUROSCI LETT, V145, P217, DOI 10.1016/0304-3940(92)90026-4; SCHARFF C, 1991, J NEUROSCI, V11, P2896; Swadlow HA, 1998, J NEUROSCI METH, V79, P131, DOI 10.1016/S0165-0270(97)00176-3; Troyer TW, 2000, J NEUROPHYSIOL, V84, P1224, DOI 10.1152/jn.2000.84.3.1224; VICARIO DS, 1991, J COMP NEUROL, V309, P486, DOI 10.1002/cne.903090405; VU ET, 1994, J NEUROSCI, V14, P6924; WILD JM, 1993, J COMP NEUROL, V338, P225, DOI 10.1002/cne.903380207; WILLSHAW DJ, 1969, NATURE, V222, P960, DOI 10.1038/222960a0; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871	30	691	702	2	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 5	2002	419	6902					65	70		10.1038/nature00974	http://dx.doi.org/10.1038/nature00974			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589YF	12214232				2022-12-24	WOS:000177788600037
J	Jain, T; Harlow, BL; Hornstein, MD				Jain, T; Harlow, BL; Hornstein, MD			Insurance coverage and outcomes of in vitro fertilization	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MULTIPLE-GESTATION; UNITED-STATES; 2 EMBRYOS; PREGNANCIES; TRIPLET; BIRTHS; RATES; COST; RISK; IVF	Background Although most insurance companies in the United States do not cover in vitro fertilization, a few states mandate such coverage. Methods We used 19913 data reported to the Centers for Disease Control and Prevention by 360 fertility clinics in the United States and 2000 U.S. Census data to determine utilization and outcomes of in vitro fertilization services according to the status of insurance coverage. Results Of the states in which in vitro fertilization services were available, 13 states (31 clinics) required complete insurance coverage, 5 states (27 clinics) required partial coverage, and 37 states plus Puerto Rico and the District of Columbia (302 clinics) required no coverage. Clinics in states that required complete coverage performed more in vitro fertilization cycles than clinics in states that required partial or no coverage (3.35 vs. 1.46 and 1.21 transfers per 1000 women of reproductive age, respectively; P < 0.001) and more transfers of frozen embryos (0.43 vs. 0.30 and 0.20 per 1000 women of reproductive age, respectively; P < 0.001). The percentage of cycles that resulted in live births was higher in states that did not require any coverage than in states that required partial or complete coverage (25.7 percent vs. 22.2 percent and 22.7 percent, respectively; P < 0.001), but the percentage of pregnancies with three or more fetuses was also higher (11.2 percent vs. 8.9 percent and 9.7 percent, respectively; P = 0.007). The number of fresh embryos transferred per cycle was lower in states that required complete coverage than in states that required partial or no coverage (P = 0.001 and P < 0.001, respectively). Conclusions State-mandated insurance coverage for in vitro fertilization services is associated with increased utilization of these services but with decreases in the number of embryos transferred per cycle, the percentage of cycles resulting in pregnancy, and the percentage of pregnancies with three or more fetuses.	Brigham & Womens Hosp, Dept Obstet & Gynecol, Boston, MA 02115 USA; Brigham & Womens Hosp, Obstet & Gynecol Epidemiol Ctr, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Hornstein, MD (corresponding author), Brigham & Womens Hosp, Dept Obstet & Gynecol, 75 Francis St, Boston, MA 02115 USA.		Jain, Tarun/ABF-7304-2020	Jain, Tarun/0000-0002-8889-084X; Harlow, Bernard/0000-0002-6735-8862				Albrecht JL, 1996, AM J OBSTET GYNECOL, V174, P1551, DOI 10.1016/S0002-9378(96)70605-1; *AM SOC REPR MED, 2000, MULT PREGN ASS INF T; [Anonymous], 2002, CENSUS 2000 SUMMARY; BALEN AH, 1993, HUM REPROD, V8, P1324, DOI 10.1093/oxfordjournals.humrep.a138250; CALLAHAN TL, 1994, NEW ENGL J MED, V331, P244, DOI 10.1056/NEJM199407283310407; *CDCP AM SOC REPR, 2000, RESOLVE 1998 ASS REP; COLLINS JA, 1994, NEW ENGL J MED, V331, P270, DOI 10.1056/NEJM199407283310412; COLLINS JA, 1995, FERTIL STERIL, V64, P538, DOI 10.1016/S0015-0282(16)57789-9; Elster N, 2000, FERTIL STERIL, V74, P617, DOI 10.1016/S0015-0282(00)00713-5; Faber K, 1997, HUM REPROD, V12, P1614; GABBE SG, 1996, OBSTET NORMAL PROBLE, P821; MOSHER WD, 1991, FERTIL STERIL, V56, P192; NEUMANN PJ, 1994, NEW ENGL J MED, V331, P239, DOI 10.1056/NEJM199407283310406; Neumann PJ, 1997, J HEALTH POLIT POLIC, V22, P1215, DOI 10.1215/03616878-22-5-1215; Roest J, 1997, FERTIL STERIL, V67, P290, DOI 10.1016/S0015-0282(97)81913-9; Schieve LA, 1999, JAMA-J AM MED ASSOC, V282, P1832, DOI 10.1001/jama.282.19.1832; SEOUD MAF, 1992, FERTIL STERIL, V57, P825; STAESSEN C, 1993, HUM REPROD, V8, P1650, DOI 10.1093/oxfordjournals.humrep.a137907; STEPTOE PC, 1978, LANCET, V2, P336; TALLO CP, 1995, J PEDIATR-US, V127, P794, DOI 10.1016/S0022-3476(95)70175-3; TASDEMIR M, 1995, HUM REPROD, V10, P2155; Templeton A, 1998, NEW ENGL J MED, V339, P573, DOI 10.1056/NEJM199808273390901; 2002, 1998 ASSISTED REPROD	23	206	208	0	7	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 29	2002	347	9					661	666		10.1056/NEJMsa013491	http://dx.doi.org/10.1056/NEJMsa013491			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587ZT	12200554				2022-12-24	WOS:000177675500006
J	Gu, ZZ; Kaul, M; Yan, BX; Kridel, SJ; Cui, JK; Strongin, A; Smith, JW; Liddington, RC; Lipton, SA				Gu, ZZ; Kaul, M; Yan, BX; Kridel, SJ; Cui, JK; Strongin, A; Smith, JW; Liddington, RC; Lipton, SA			S-nitrosylation of matrix metalloproteinases: Signaling pathway to neuronal cell death	SCIENCE			English	Article							FOCAL CEREBRAL-ISCHEMIA; NITRIC-OXIDE PRODUCTION; MATRIX-METALLOPROTEINASE-9; ACTIVATION; EXPRESSION; MECHANISM; REPERFUSION; INHIBITION; DEFICIENT; INCREASES	Matrix metalloproteinases (MMPs) are implicated in the pathogenesis of neurodegenerative diseases and stroke. However, the mechanism of MMP activation remains unclear. We report that MMP activation involves S-nitrosylation. During cerebral ischemia in vivo, MMP-9 colocalized with neuronal nitric oxide synthase. S-Nitrosylation activated MMP-9 in vitro and induced neuronal apoptosis. Mass spectrometry identified the active derivative of MMP-9, both in vitro and in vivo, as a stable sulfonic or sulfonic acid, whose formation was triggered by S-nitrosylation. These findings suggest a potential extracellular proteolysis pathway to neuronal cell death in which S-nitrosylation activates MMPs, and further oxidation results in a stable posttranslational modification with pathological activity.	Burnham Inst, Ctr Neurosci Aging, La Jolla, CA 92037 USA; Burnham Inst, Program Cell Adhes & Extracellular Matrix Biol, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute	Lipton, SA (corresponding author), Burnham Inst, Ctr Neurosci Aging, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	slipton@burnham.org	Strongin, Alex/R-6609-2019; Kaul, Marcus/AAS-8955-2020	Strongin, Alex/0000-0003-3765-3016; Lipton, Stuart/0000-0002-3490-1259	NCI NIH HHS [R01 CA 69306] Funding Source: Medline; NEI NIH HHS [R01 EY09024, R01 EY05477] Funding Source: Medline; NIAMS NIH HHS [AR08505, R01 AR42750] Funding Source: Medline; NIA NIH HHS [T32 AG00252] Funding Source: Medline; NICHD NIH HHS [P01 HD29587] Funding Source: Medline; NINDS NIH HHS [R01 NS41207] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD029587] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA069306] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY005477, R01EY009024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041207] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000252] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Asahi M, 2000, J CEREBR BLOOD F MET, V20, P1681, DOI 10.1097/00004647-200012000-00007; Asensio VC, 1999, TRENDS NEUROSCI, V22, P504, DOI 10.1016/S0166-2236(99)01453-8; Becker K, 1998, NAT STRUCT BIOL, V5, P267, DOI 10.1038/nsb0498-267; Cardone MH, 1997, CELL, V90, P315, DOI 10.1016/S0092-8674(00)80339-6; Choi YB, 2000, NAT NEUROSCI, V3, P15, DOI 10.1038/71090; DAWSON TM, 1994, J NEUROSCI, V14, P5147; Eberhardt W, 2000, KIDNEY INT, V57, P59, DOI 10.1046/j.1523-1755.2000.00808.x; Gasche Y, 1999, J CEREBR BLOOD F MET, V19, P1020, DOI 10.1097/00004647-199909000-00010; GU ZH, UNPUB; Huang DY, 2000, FASEB J, V14, P407, DOI 10.1096/fasebj.14.2.407; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Jia L, 1996, NATURE, V380, P221, DOI 10.1038/380221a0; Kridel SJ, 2001, J BIOL CHEM, V276, P20572, DOI 10.1074/jbc.M100900200; KUMURA E, 1994, J CEREBR BLOOD F MET, V14, P487, DOI 10.1038/jcbfm.1994.60; LEI SZ, 1992, NEURON, V8, P1087, DOI 10.1016/0896-6273(92)90130-6; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; Lukes A, 1999, MOL NEUROBIOL, V19, P267, DOI 10.1007/BF02821717; Matthews JR, 1996, NUCLEIC ACIDS RES, V24, P2236, DOI 10.1093/nar/24.12.2236; Melino G, 1997, NATURE, V388, P432, DOI 10.1038/41237; Montaner J, 2001, STROKE, V32, P1759, DOI 10.1161/01.STR.32.8.1759; Morgunova E, 1999, SCIENCE, V284, P1667, DOI 10.1126/science.284.5420.1667; Okamoto T, 1997, ARCH BIOCHEM BIOPHYS, V342, P261, DOI 10.1006/abbi.1997.0127; Romanic AM, 1998, STROKE, V29, P1020, DOI 10.1161/01.STR.29.5.1020; SATO S, 1994, BRAIN RES, V647, P91, DOI 10.1016/0006-8993(94)91402-8; Stamler JS, 1998, NAT STRUCT BIOL, V5, P247, DOI 10.1038/nsb0498-247; Stamler JS, 1997, NEURON, V18, P691, DOI 10.1016/S0896-6273(00)80310-4; STAMLER JS, 1994, CELL, V78, P931, DOI 10.1016/0092-8674(94)90269-0; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; Wang YMF, 1998, NAT MED, V4, P228, DOI 10.1038/nm0298-228; Wink DA, 1999, METHOD ENZYMOL, V301, P201; Yan BX, 2000, J BIOL CHEM, V275, P39964, DOI 10.1074/jbc.M007041200; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571; Zhang JW, 1997, J NEUROSCI METH, V76, P15, DOI 10.1016/S0165-0270(97)00065-4	34	786	825	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 16	2002	297	5584					1186	1190		10.1126/science.1073634	http://dx.doi.org/10.1126/science.1073634			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584BP	12183632				2022-12-24	WOS:000177447600052
J	Eden, S; Rohatgi, R; Podtelejnikov, AV; Mann, M; Kirschner, MW				Eden, S; Rohatgi, R; Podtelejnikov, AV; Mann, M; Kirschner, MW			Mechanism of regulation of WAVE1-induced actin nucleation by Rac1 and Nck	NATURE			English	Article							ALDRICH-SYNDROME PROTEIN; WASP-RELATED PROTEIN; ARP2/3 COMPLEX; N-WASP; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; MOLECULAR-CLONING; MASS-SPECTROMETRY; ACTIVATION; CDC42; WAVE	Rac signalling to actin-a pathway that is thought to be mediated by the protein Scar/WAVE (WASP (Wiskott-Aldrich syndrome protein)-family verprolin homologous protein)-has a principal role in cell motility. In an analogous pathway, direct interaction of Cdc42 with the related protein N-WASP stimulates actin polymerization(1). For the Rac-WAVE pathway, no such direct interaction has been identified. Here we report a mechanism by which Rac and the adapter protein Nck activate actin nucleation through WAVE1. WAVE1 exists in a heterotetrameric complex that includes orthologues of human PIR121 (p53-inducible messenger RNA with a relative molecular mass (M-r)of 140,000), Nap125 (NCK-associated protein with an M-r of 125,000) and HSPC300. Whereas recombinant WAVE1 is constitutively active, the WAVE1 complex is inactive. We therefore propose that Rac1 and Nck cause dissociation of the WAVE1 complex, which releases active WAVE1-HSPC300 and leads to actin nucleation.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Univ So Denmark Odense, Prot Interact Lab, DK-5230 Odense M, Denmark	Harvard University; Harvard Medical School	Kirschner, MW (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.		Podtelejnikov, Alexandre/B-6120-2017; Mann, Matthias/A-3454-2013	Podtelejnikov, Alexandre/0000-0002-8124-6584; Mann, Matthias/0000-0003-1292-4799				BAUMGARTNER S, 1995, J MOL BIOL, V251, P41, DOI 10.1006/jmbi.1995.0414; Bear JE, 1998, J CELL BIOL, V142, P1325, DOI 10.1083/jcb.142.5.1325; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; Hahne P, 2001, FEBS LETT, V492, P215, DOI 10.1016/S0014-5793(01)02239-6; Higgs HN, 2000, J CELL BIOL, V150, P1311, DOI 10.1083/jcb.150.6.1311; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Kitamura T, 1996, BIOCHEM BIOPH RES CO, V219, P509, DOI 10.1006/bbrc.1996.0264; Kitamura Y, 1997, BIOCHEM J, V322, P873, DOI 10.1042/bj3220873; Kobayashi K, 1998, J BIOL CHEM, V273, P291, DOI 10.1074/jbc.273.1.291; Ma L, 1998, P NATL ACAD SCI USA, V95, P15362, DOI 10.1073/pnas.95.26.15362; Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739; Miki H, 2000, NATURE, V408, P732, DOI 10.1038/35047107; Miki H, 1998, EMBO J, V17, P6932, DOI 10.1093/emboj/17.23.6932; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; Muller WA, 1996, TRENDS GENET, V12, P91, DOI 10.1016/0168-9525(96)81419-3; Nagase T, 1998, DNA Res, V5, P31, DOI 10.1093/dnares/5.1.31; Nagase T, 1996, DNA Res, V3, P17, DOI 10.1093/dnares/3.1.17; Nakagawa H, 2001, J CELL SCI, V114, P1555; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Rohatgi R, 2001, J BIOL CHEM, V276, P26448, DOI 10.1074/jbc.M103856200; Saller E, 1999, EMBO J, V18, P4424, DOI 10.1093/emboj/18.16.4424; Schenck A, 2001, P NATL ACAD SCI USA, V98, P8844, DOI 10.1073/pnas.151231598; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Suetsugu S, 1999, BIOCHEM BIOPH RES CO, V260, P296, DOI 10.1006/bbrc.1999.0894; Suzuki T, 2000, GENOMICS, V63, P246, DOI 10.1006/geno.1999.6053; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Witke W, 1998, EMBO J, V17, P967, DOI 10.1093/emboj/17.4.967; [No title captured]	30	613	636	3	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 15	2002	418	6899					790	793		10.1038/nature00859	http://dx.doi.org/10.1038/nature00859			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UF	12181570				2022-12-24	WOS:000177428000042
J	Cello, J; Paul, AV; Wimmer, E				Cello, J; Paul, AV; Wimmer, E			Chemical synthesis of poliovirus cDNA: Generation of infectious virus in the absence of natural template	SCIENCE			English	Article							NUCLEOTIDE-SEQUENCE; MOLECULAR-CLONING; RECEPTOR; RNA; TRANSLATION; EXPRESSION	Full-length poliovirus complementary DNA (cDNA) was synthesized by assembling oligonucleotides of plus and minus strand polarity. The synthetic poliovirus cDNA was transcribed by RNA polymerase into viral RNA, which translated and replicated in a cell-free extract, resulting in the de novo synthesis of infectious poliovirus. Experiments in tissue culture using neutralizing antibodies and CD155 receptor specific antibodies and neurovirulence tests in CD155 transgenic mice confirmed that the synthetic virus had biochemical and pathogenic characteristics of poliovirus. Our results show that it is possible to synthesize an infectious agent by in vitro chemical-biochemical means solely by following instructions from a written sequence.	SUNY Stony Brook, Sch Med, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Wimmer, E (corresponding author), SUNY Stony Brook, Sch Med, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA.							CAO X, 1993, J VIROL, V67, P3149; CELLO J, UNPUB; GROMEIER M, 1995, MICROB PATHOGENESIS, V18, P253, DOI 10.1016/S0882-4010(05)80002-6; HOGLE JM, 1985, SCIENCE, V229, P1358, DOI 10.1126/science.2994218; HORIE H, 1994, J VIROL, V68, P681, DOI 10.1128/JVI.68.2.681-688.1994; JANG SK, 1988, J VIROL, V62, P2636, DOI 10.1128/JVI.62.8.2636-2643.1988; KITAMURA N, 1981, NATURE, V291, P547, DOI 10.1038/291547a0; KOIKE S, 1990, EMBO J, V9, P3217, DOI 10.1002/j.1460-2075.1990.tb07520.x; KOIKE S, 1991, P NATL ACAD SCI USA, V88, P951, DOI 10.1073/pnas.88.3.951; MENDELSOHN CL, 1989, CELL, V56, P855, DOI 10.1016/0092-8674(89)90690-9; MIRZAYAN C, 1992, VIROLOGY, V189, P547, DOI 10.1016/0042-6822(92)90578-D; MOLLA A, 1991, SCIENCE, V254, P1647, DOI 10.1126/science.1661029; NOBIS P, 1985, J GEN VIROL, V66, P2563, DOI 10.1099/0022-1317-66-12-2563; Nomoto A, 2002, NAT IMMUNOL, V3, P205, DOI 10.1038/ni0302-205; Pan WQ, 1999, NUCLEIC ACIDS RES, V27, P1094, DOI 10.1093/nar/27.4.1094; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; Pfister T, 1999, ENCY VIROLOGY, P1330; RACANIELLO VR, 1981, P NATL ACAD SCI-BIOL, V78, P4887, DOI 10.1073/pnas.78.8.4887; REED L. J., 1938, AMER JOUR HYG, V27, P493; SCHAFFER FL, 1955, P NATL ACAD SCI USA, V41, P1020, DOI 10.1073/pnas.41.12.1020; VANDERWERF S, 1986, P NATL ACAD SCI USA, V83, P2330; WIMMER E, 1993, ANNU REV GENET, V27, P353, DOI 10.1146/annurev.ge.27.120193.002033; Wohler F., 1828, ANN PHYS CHEM, V88, P253, DOI DOI 10.1002/ANDP.18280880206; XIANG WK, 1995, J VIROL, V69, P3658, DOI 10.1128/JVI.69.6.3658-3667.1995; Xiang WK, 1997, SEMIN VIROL, V8, P256, DOI 10.1006/smvy.1997.0128	25	568	710	8	277	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 9	2002	297	5583					1016	1018		10.1126/science.1072266	http://dx.doi.org/10.1126/science.1072266			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581ZN	12114528				2022-12-24	WOS:000177325400045
J	Muranyi, W; Haas, J; Wagner, M; Krohne, G; Koszinowski, UH				Muranyi, W; Haas, J; Wagner, M; Krohne, G; Koszinowski, UH			Cytomegalovirus recruitment of cellular kinases to dissolve the nuclear lamina	SCIENCE			English	Article							PROTEIN; ENVELOPE; MEMBRANE; PHOSPHORYLATION; INFECTION; MITOSIS; VIRUS; AUTOINTEGRATION; PHASE; DNA	The passage of large-sized herpesviral capsids through the nuclear lamina and the inner nuclear membrane to leave the nucleus requires a dissolution of the nuclear lamina. Here, we report on the functions of M50/p35, a beta-herpesviral protein of murine cytomegalovirus. M50/p35 inserts into the inner nuclear membrane and is aggregated by a second viral protein, M53/p38, to form the capsid docking site. M50/p35 recruits the cellular protein kinase C for phosphorylation and dissolution of the nuclear lamina, suggesting that herpesviruses target a critical element of nuclear architecture.	Univ Munich, Genzentrum, D-80336 Munich, Germany; Univ Munich, Max Von Pettenkofer Inst, D-80336 Munich, Germany; Univ Wurzburg, Bioctr, Div Elect Microscopy, D-97074 Wurzburg, Germany	University of Munich; University of Munich; University of Wurzburg	Koszinowski, UH (corresponding author), Univ Munich, Genzentrum, D-80336 Munich, Germany.							Alcami A, 2000, IMMUNOL TODAY, V21, P447, DOI 10.1016/S0167-5699(00)01699-6; Buendia B, 2001, CELL MOL LIFE SCI, V58, P1781, DOI 10.1007/PL00000818; Chen HM, 1998, P NATL ACAD SCI USA, V95, P15270, DOI 10.1073/pnas.95.26.15270; CUDMORE S, 1995, NATURE, V378, P636, DOI 10.1038/378636a0; DELVAL M, 1989, CELL, V58, P305, DOI 10.1016/0092-8674(89)90845-3; DESSEV G, 1988, P NATL ACAD SCI USA, V85, P2994, DOI 10.1073/pnas.85.9.2994; FIELDS AP, 1988, J BIOL CHEM, V263, P8253; Furukawa K, 1999, J CELL SCI, V112, P2485; GERACE L, 1980, CELL, V19, P277, DOI 10.1016/0092-8674(80)90409-2; HOGER TH, 1991, EUR J CELL BIOL, V54, P150; JAULT FM, 1995, J VIROL, V69, P6697, DOI 10.1128/JVI.69.11.6697-6704.1995; Kolanus W, 1996, CELL, V86, P233, DOI 10.1016/S0092-8674(00)80095-1; Laguri C, 2001, STRUCTURE, V9, P503, DOI 10.1016/S0969-2126(01)00611-6; Lee MS, 1998, P NATL ACAD SCI USA, V95, P1528, DOI 10.1073/pnas.95.4.1528; Lu MS, 1996, J VIROL, V70, P8850, DOI 10.1128/JVI.70.12.8850-8857.1996; Mettenleiter TC, 2002, J VIROL, V76, P1537, DOI 10.1128/JVI.76.4.1537-1547.2002; Mocarski E, 1996, FIELDS VIROLOGY, P2447; OTTAVIANO Y, 1985, J BIOL CHEM, V260, P624; Otto H, 2001, EUR J BIOCHEM, V268, P420, DOI 10.1046/j.1432-1033.2001.01901.x; PETER M, 1990, CELL, V61, P591, DOI 10.1016/0092-8674(90)90471-P; RADSAK KD, 1991, EUR J CELL BIOL, V54, P299; Rawlinson WD, 1996, J VIROL, V70, P8833, DOI 10.1128/JVI.70.12.8833-8849.1996; Roller RJ, 2000, J VIROL, V74, P117, DOI 10.1128/JVI.74.1.117-129.2000; Scott ES, 2001, J VIROL, V75, P8818, DOI 10.1128/JVI.75.18.8818-8830.2001; Ye GJ, 2000, J VIROL, V74, P1355, DOI 10.1128/JVI.74.3.1355-1363.2000	25	224	230	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 2	2002	297	5582					854	857		10.1126/science.1071506	http://dx.doi.org/10.1126/science.1071506			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579RZ	12161659				2022-12-24	WOS:000177192800057
J	Poliakoff, M; Fitzpatrick, JM; Farren, TR; Anastas, PT				Poliakoff, M; Fitzpatrick, JM; Farren, TR; Anastas, PT			Green chemistry: Science and politics of change	SCIENCE			English	Article							SUPERCRITICAL FLUIDS	The chemical industry plays a key role in sustaining the world economy and underpinning future technologies, yet is under unprecedented pressure from the effects of globalization and change in many of its traditional markets. Against this background, what will be needed for the industry to embrace efforts to make it "greener"? We explore some of the issues raised by the development of green chemistry techniques and identify potential barriers to their implementation by industry.	Univ Nottingham, Sch Chem, Nottingham NG7 2RD, England; Rohm & Haas Co, Philadelphia, PA 19106 USA	University of Nottingham; Dow Chemical Company	Poliakoff, M (corresponding author), Univ Nottingham, Sch Chem, Nottingham NG7 2RD, England.		Anastas, Paul/L-3258-2013	Anastas, Paul/0000-0003-4777-5172				Adam D, 2000, NATURE, V407, P938, DOI 10.1038/35039717; Anastas P. T., 1998, GREEN CHEM THEORY PR; Cave GWV, 2001, CHEM COMMUN, P2159, DOI 10.1039/b106677n; Constable DJC, 2001, GREEN CHEM, V3, P7, DOI 10.1039/b007875l; Curzons AD, 2001, GREEN CHEM, V3, P1, DOI 10.1039/b007871i; Darr JA, 1999, CHEM REV, V99, P495, DOI 10.1021/cr970036i; DeSimone JM, 2002, SCIENCE, V297, P799, DOI 10.1126/science.1069622; Eissen M, 2002, ANGEW CHEM INT EDIT, V41, P414, DOI 10.1002/1521-3773(20020201)41:3<414::AID-ANIE414>3.0.CO;2-N; Freemantle M, 2001, CHEM ENG NEWS, V79, P30, DOI 10.1021/cen-v079n022.p030; Gray WK, 1999, J AM CHEM SOC, V121, P10711, DOI 10.1021/ja991562p; Gross RA, 2002, SCIENCE, V297, P803, DOI 10.1126/science.297.5582.803; HAMLEY PA, 2001, CHEM ENG, V72, P24; Hileman B, 2002, CHEM ENG NEWS, V80, P10; Hitzler MG, 1998, ORG PROCESS RES DEV, V2, P137, DOI 10.1021/op970056m; Hitzler MG, 1998, CHEM COMMUN, P359, DOI 10.1039/a707149c; Jessop PG, 1999, CHEM REV, V99, P475, DOI 10.1021/cr970037a; JESSOP PG, 1999, CHEM SYNTHESIS USING; Kazarian SG, 2000, CHEM COMMUN, P2047, DOI 10.1039/b005514j; MCGRAYNE SB, 2001, PROMETHEANS LAB CHEM; Oakes RS, 2001, J CHEM SOC PERK T 1, P917, DOI 10.1039/b101219n; Oakes RS, 1999, CHEM COMMUN, P247; Poliakoff M, 2001, NATURE, V413, P257, DOI 10.1038/35095133; Poliakoff M, 2001, NATURE, V412, P125, DOI 10.1038/35084292; Ritter SK, 2001, CHEM ENG NEWS, V79, P24, DOI 10.1021/cen-v079n027.p024; RITTER SK, 2001, CHEM ENG NEWS, V80, P26; Schmid A, 2001, NATURE, V409, P258, DOI 10.1038/35051736; SEDDON KR, 2002, GREEN CHEM, V4; Sheldon R. A., 1994, CHEMTECH, P38; SORRELL SR, REPORT BARRIERS PROJ; Talbot R. E., 1998, INT WATER C P, V59, P561; TAYLOR G, 2002, CHEM IND, V6, P12; WARHURST M, 2002, GREEN CHEM, V4, pG20; Watkins K, 2002, CHEM ENG NEWS, V80, P15, DOI 10.1021/cen-v080n016.p015; WILKINSON MP, 2002, GREEN CHEM, V4, pG34; WILLINGHAM GL, 1996, ACS SYM SER, V640, P226; WOODHOUSE EJ, 2003, CHEM STATES	36	686	702	10	273	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 2	2002	297	5582					807	810		10.1126/science.297.5582.807	http://dx.doi.org/10.1126/science.297.5582.807			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579RZ	12161647				2022-12-24	WOS:000177192800041
J	Hopfner, KP; Craig, L; Moncalian, G; Zinkel, RA; Usui, T; Owen, BAL; Karcher, A; Henderson, B; Bodmer, JL; McMurray, CT; Carney, JP; Petrini, JHJ; Tainer, JA				Hopfner, KP; Craig, L; Moncalian, G; Zinkel, RA; Usui, T; Owen, BAL; Karcher, A; Henderson, B; Bodmer, JL; McMurray, CT; Carney, JP; Petrini, JHJ; Tainer, JA			The Rad50 zinc-hook is a structure joining Mre11 complexes in DNA recombination and repair	NATURE			English	Article							STRAND BREAK REPAIR; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; PROTEIN COMPLEX; NUCLEASE; MAINTENANCE; YEAST; REQUIREMENT; CELLS	The Mre11 complex (Mre11-Rad50-Nbs1) is central to chromosomal maintenance and functions in homologous recombination, telomere maintenance and sister chromatid association(1-7). These functions all imply that the linked binding of two DNA substrates occurs, although the molecular basis for this process remains unknown. Here we present a 2.2 Angstrom crystal structure of the Rad50 coiled-coil region that reveals an unexpected dimer interface at the apex of the coiled coils in which pairs of conserved Cys-X-X-Cys motifs form interlocking hooks that bind one Zn2+ ion. Biochemical, X-ray and electron microscopy data indicate that these hooks can join oppositely protruding Rad50 coiled-coil domains to forma flexible bridge of up to 1,200 Angstrom. This suggests a function for the long insertion in the Rad50 ABC-ATPase domain(8). The Rad50 hook is functional, because mutations in this motif confer radiation sensitivity in yeast and disrupt binding at the distant Mre11 nuclease interface. These data support an architectural role for the Rad50 coiled coils in forming metal-mediated bridging complexes between two DNA-binding heads. The resulting assemblies have appropriate lengths and conformational properties to link sister chromatids in homologous recombination and DNA ends in non-homologous end-joining.	Scripps Res Inst, Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Univ Munich, Gene Ctr, D-81377 Munich, Germany; Univ Munich, Inst Biochem, D-81377 Munich, Germany; Univ Wisconsin, Genet Lab, Madison, WI 53706 USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Mayo Clin & Mayo Fdn, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA; Univ Maryland, Sch Med, Radiat Oncol Res Lab, Baltimore, MD 21201 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA	Scripps Research Institute; Scripps Research Institute; University of Munich; University of Munich; University of Wisconsin System; University of Wisconsin Madison; Memorial Sloan Kettering Cancer Center; Mayo Clinic; University System of Maryland; University of Maryland Baltimore; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Tainer, JA (corresponding author), Scripps Res Inst, Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA.		Hopfner, Karl-Peter/B-6864-2014; Tainer, John/GWQ-4878-2022; Moncalian, Gabriel/K-3493-2014; Owen, Barbara/AAD-2322-2021	Hopfner, Karl-Peter/0000-0002-4528-8357; Tainer, John/0000-0003-1659-2429; Moncalian, Gabriel/0000-0002-3007-6490; Petrini, John/0000-0001-5102-5679; Craig, Lisa/0000-0001-8515-9915				Anderson DE, 2001, J BIOL CHEM, V276, P37027, DOI 10.1074/jbc.M106179200; Bressan DA, 1998, GENETICS, V150, P591; Bressan DA, 1999, MOL CELL BIOL, V19, P7681; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen L, 2001, MOL CELL, V8, P1105, DOI 10.1016/S1097-2765(01)00388-4; Connelly JC, 1999, NUCLEIC ACIDS RES, V27, P1039, DOI 10.1093/nar/27.4.1039; Connelly JC, 1998, P NATL ACAD SCI USA, V95, P7969, DOI 10.1073/pnas.95.14.7969; de Jager M, 2001, MOL CELL, V8, P1129, DOI 10.1016/S1097-2765(01)00381-1; Furuse M, 1998, EMBO J, V17, P6412, DOI 10.1093/emboj/17.21.6412; Haber JE, 1998, CELL, V95, P583, DOI 10.1016/S0092-8674(00)81626-8; Hartsuiker E, 2001, EMBO J, V20, P6660, DOI 10.1093/emboj/20.23.6660; Hirano T, 1999, GENE DEV, V13, P11, DOI 10.1101/gad.13.1.11; Hopfner KP, 2000, J BACTERIOL, V182, P6036, DOI 10.1128/JB.182.21.6036-6041.2000; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; Huang JR, 2002, NUCLEIC ACIDS RES, V30, P667, DOI 10.1093/nar/30.3.667; Lobachev KS, 2002, CELL, V108, P183, DOI 10.1016/S0092-8674(02)00614-1; Luo GB, 1999, P NATL ACAD SCI USA, V96, P7376, DOI 10.1073/pnas.96.13.7376; Merino ST, 2000, P NATL ACAD SCI USA, V97, P10477, DOI 10.1073/pnas.190346097; Moreau S, 1999, MOL CELL BIOL, V19, P556; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Petrini JHJ, 2000, CURR OPIN CELL BIOL, V12, P293, DOI 10.1016/S0955-0674(00)00091-0; SHARPLES GJ, 1995, MOL MICROBIOL, V17, P1215, DOI 10.1111/j.1365-2958.1995.mmi_17061215_1.x; Trujillo KM, 2001, J BIOL CHEM, V276, P35458, DOI 10.1074/jbc.M105482200; Tsukamoto Y, 2001, CURR BIOL, V11, P1328, DOI 10.1016/S0960-9822(01)00372-4; Usui T, 2001, MOL CELL, V7, P1255, DOI 10.1016/S1097-2765(01)00270-2; Wu XL, 2001, J BIOL CHEM, V276, P1735, DOI 10.1074/jbc.M006727200; Xiao YH, 1997, NUCLEIC ACIDS RES, V25, P2985, DOI 10.1093/nar/25.15.2985; Yamaguchi-Iwai Y, 1999, EMBO J, V18, P6619, DOI 10.1093/emboj/18.23.6619; Zhu J, 2001, CURR BIOL, V11, P105, DOI 10.1016/S0960-9822(01)00019-7	30	409	418	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 1	2002	418	6897					562	566		10.1038/nature00922	http://dx.doi.org/10.1038/nature00922			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579EE	12152085				2022-12-24	WOS:000177162800047
J	Power, C; Manor, O; Li, L				Power, C; Manor, O; Li, L			Are inequalities in height underestimated by adult social position? Effects of changing social structure and height selection in a cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEALTH; MOBILITY; POLICY; MEN	Objectives To investigate whether changing social structure and social mobility related to height generate (inflate) inequalities in height. Design Longitudinal 1958. British birth cohort study. Setting England, Scotland, and Wales. Participants 10 176 people born 3-9 March 1958 for whom data were available at age 33 years. Main outcome measures Adult height and social class at age 33 years; class of origin (father's occupation when participant was 7 years old). Results Adult height showed a social gradient with class at age 7 years and age 33 years. The difference in mean height between extreme groups was greater for class of origin than for adult class, reducing from 2.21 cm to 1.62 cm for men and from 2.18 cm to 1.74 cm for women. This narrowing inequality was due mainly to a decrease in mean height in classes I and H. This was because of the pattern of height related social mobility in which, for example, men moving into classes I and H were taller (mean 177.2 cm) than men remaining in class Ell manual (mean 176.1 cm) yet shorter than men with class I and 11 origins (mean 178.3 cm) and the relatively large number of individuals moving into classes I and H. Changes in the structure of society, seen here with the general trend of upward social mobility, have acted to diminish inequalities in adult height. Conclusions The combination of changing social structure and height related mobility constrains, rather than inflates, inequalities in height and may lead to an underestimation of the role of childhood socioeconomic factors in the development of inequalities in adult disease.	Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London WC1N 1EH, England; Hebrew Univ Jerusalem, Sch Publ Hlth & Community Med, IL-91120 Jerusalem, Israel	University of London; University College London; Hebrew University of Jerusalem	Power, C (corresponding author), Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, 30 Guilford St, London WC1N 1EH, England.	cpower@ich.ucl.ac.uk						Bartley M, 1997, J HEALTH SOC BEHAV, V38, P376, DOI 10.2307/2955432; *CTR LONG STUD I E, 1994, 3148 SN CTR LONG STU; *DEP HLTH, 1995, VAR HLTH WHAT CAN DE; Elstad JI, 2001, EUR J PUBLIC HEALTH, V11, P135, DOI 10.1093/eurpub/11.2.135; FERRI E, 1993, LIFE 33 5 FOLLOW UP; LEON DA, 1995, J EPIDEMIOL COMMUN H, V49, P5, DOI 10.1136/jech.49.1.5; Macintyre S, 2001, BRIT MED J, V322, P222, DOI 10.1136/bmj.322.7280.222; MARMOT MG, 1984, LANCET, V1, P1003; SMITH GD, 1990, BMJ-BRIT MED J, V301, P373, DOI 10.1136/bmj.301.6748.373; Smith GD, 2001, BRIT MED J, V322, P184, DOI 10.1136/bmj.322.7280.184; Sorkin JD, 1999, EPIDEMIOL REV, V21, P247, DOI 10.1093/oxfordjournals.epirev.a018000; Townsend P., 1988, INEQUALITIES HLTH BL; WAALER HT, 1984, ACTA MED SCAND, P1; WALKER M, 1988, J EPIDEMIOL COMMUN H, V42, P299, DOI 10.1136/jech.42.3.299; YARNELL JWG, 1992, EUR HEART J, V13, P1602, DOI 10.1093/oxfordjournals.eurheartj.a060111	15	46	48	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 20	2002	325	7356					131	134		10.1136/bmj.325.7356.131	http://dx.doi.org/10.1136/bmj.325.7356.131			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	577PG	12130607	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000177069900018
J	Lu, TT; Cyster, JG				Lu, TT; Cyster, JG			Integrin-mediated long-term B cell retention in the splenic marginal zone	SCIENCE			English	Article							LYMPHOTOXIN-BETA-RECEPTOR; LYMPHOCYTE MIGRATION; MICE; ADHESION; RESPONSIVENESS; POPULATION; FOLLICLES; TISSUES; SUBSETS; SPLEEN	The mechanisms that control localization of marginal zone (MZ) B cells are poorly understood. Here we show that MZ B cells express elevated levels of the integrins LFA-1 (alphaLbeta2) and alpha4beta1 and that they bind to the ligands ICAM-1 and VCAM-1. These ligands are expressed within the MZ in a lymphotoxin-dependent manner. Combined inhibition of LFA-1 and alpha4beta1 causes a rapid and selective release of B cells from the MZ. Furthermore, lipopolysaccharide-triggered MZ B cell relocalization involves down-regulation of integrin-mediated adhesion. These studies identify key requirements for MZ B cell localization and establish a role for integrins in peripheral lymphoid tissue compartmentalization.	Univ Calif San Francisco, Dept Microbiol & Immunol, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Div Pediat Immunol & Rheumatol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Cyster, JG (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, Howard Hughes Med Inst, 513 Parnassus Ave, San Francisco, CA 94143 USA.			Lu, Theresa/0000-0002-5707-8744	NIAID NIH HHS [AI-40098] Funding Source: Medline; NICHD NIH HHS [K12-HD00850] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040098, R37AI040098] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Ansel KM, 2002, IMMUNITY, V16, P67, DOI 10.1016/S1074-7613(01)00257-6; Berlin-Rufenach C, 1999, J EXP MED, V189, P1467, DOI 10.1084/jem.189.9.1467; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; Cariappa A, 2001, IMMUNITY, V14, P603, DOI 10.1016/S1074-7613(01)00135-2; Cyster JG, 1995, IMMUNITY, V3, P691, DOI 10.1016/1074-7613(95)90059-4; DUNNWALTERS DK, 1995, J EXP MED, V182, P559, DOI 10.1084/jem.182.2.559; Ettinger R, 2001, J EXP MED, V193, P1333, DOI 10.1084/jem.193.11.1333; Fu YX, 1999, ANNU REV IMMUNOL, V17, P399, DOI 10.1146/annurev.immunol.17.1.399; Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591; Girkontaite I, 2001, NAT IMMUNOL, V2, P855, DOI 10.1038/ni0901-855; Grimaldi CM, 2001, J IMMUNOL, V167, P1886, DOI 10.4049/jimmunol.167.4.1886; Guinamard R, 2000, NAT IMMUNOL, V1, P31, DOI 10.1038/76882; Hargreaves DC, 2001, J EXP MED, V194, P45, DOI 10.1084/jem.194.1.45; KRAAL G, 1992, INT REV CYTOL, V132, P31, DOI 10.1016/S0074-7696(08)62453-5; Li YJ, 2002, J EXP MED, V195, P181, DOI 10.1084/jem.20011453; LU TB, UNPUB; Mackay F, 1997, EUR J IMMUNOL, V27, P2033, DOI 10.1002/eji.1830270830; MACLENNAN ICM, 1982, IMMUNOL TODAY, V3, P305, DOI 10.1016/0167-5699(82)90032-9; Makowska A, 1999, EUR J IMMUNOL, V29, P3285, DOI 10.1002/(SICI)1521-4141(199910)29:10<3285::AID-IMMU3285>3.3.CO;2-G; Martin F, 2000, IMMUNOL REV, V175, P70, DOI 10.1034/j.1600-065X.2000.017515.x; Martin F, 2001, CURR OPIN IMMUNOL, V13, P195, DOI 10.1016/S0952-7915(00)00204-1; McDonald JT, 2000, IMMUNOL INVEST, V29, P71; Mebius RE, 1998, J IMMUNOL, V161, P3836; Murphy M, 1998, CELL DEATH DIFFER, V5, P497, DOI 10.1038/sj.cdd.4400374; Papayannopoulou T, 2001, BLOOD, V97, P1282, DOI 10.1182/blood.V97.5.1282; PIALI L, 1995, J CELL BIOL, V130, P451, DOI 10.1083/jcb.130.2.451; Rose DM, 2001, J IMMUNOL, V167, P2824, DOI 10.4049/jimmunol.167.5.2824; Scharffetter-Kochanek K, 1998, J EXP MED, V188, P119, DOI 10.1084/jem.188.1.119; SCHMIDT EE, 1993, SCANNING MICROSCOPY, V7, P613; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Wagner N, 1996, NATURE, V382, P366, DOI 10.1038/382366a0; Wellmann U, 2001, EUR J IMMUNOL, V31, P2800, DOI 10.1002/1521-4141(200109)31:9<2800::AID-IMMU2800>3.0.CO;2-E; XU H, 1994, J EXP MED, V180, P95, DOI 10.1084/jem.180.1.95	34	303	307	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 19	2002	297	5580					409	412		10.1126/science.1071632	http://dx.doi.org/10.1126/science.1071632			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574LV	12130787				2022-12-24	WOS:000176892600054
J	Hughes, P; Turton, P; Hopper, E; Evans, CDH				Hughes, P; Turton, P; Hopper, E; Evans, CDH			Assessment of guidelines for good practice in psychosocial care of mothers after stillbirth: a cohort study	LANCET			English	Article							DISORGANIZED ATTACHMENT; CONFIDENCE-INTERVALS; PREGNANCY; SATISFACTION; DEPRESSION; SUBSEQUENT; MANAGEMENT; CHILDHOOD; BEHAVIOR; GRIEF	Background Most maternity units have good practice protocols, advising that after stillbirth parents should be encouraged to see and hold their dead infant. Our aim was to assess whether adherence to these protocols is associated with measurably beneficial effects on the psychological health of mother and next-born child. This study forms part of a wider case-control study of the psychological effects of stillbirth. Methods We identified 65 women in the pregnancy after stillbirth, and enrolled matched controls for 60 of them. Outcome measures included depression, anxiety, and posttraumatic-stress disorder (PTSD) in pregnancy and 1 year after the next birth, and disorganised attachment behaviour in the next-born infant. Comparison variables included seeing and holding the stillborn infant, having a funeral, and keeping mementoes. Findings Behaviours that promote contact with the stillborn infant were associated with worse outcome. Women who had held their stillborn infant were more depressed than those who only saw the infant, while those who did not see the infant were least likely to be depressed (13 of 33, 39%, vs three of 14, 21%, vs one of 17, 6%; p=0.03). Women who had seen their stillborn infant had greater anxiety (p=0.02) and higher symptoms of PTSD than those who had not (p=0.02), and their next-born infants were more likely to show disorganised attachment behaviour (18 of 43, 42%, vs one of 12, 8%, p=0.04). Having a funeral and keeping mementoes were not associated with further adverse outcomes, but small numbers limited interpretation. Interpretation Our findings do not support good-practice guidelines, which state that failure to see and hold the dead child could have adverse effects on parents' mourning.	St George Hosp, Sch Med, Dept Psychiat, London SW17 0RE, England; Rampton Hosp, London, England; Tavistock Clin, Tavistock & Portman NHS Trust, London, England	St Georges University London	Hughes, P (corresponding author), St George Hosp, Sch Med, Dept Psychiat, London SW17 0RE, England.		Evans, Chris/E-7526-2011	Evans, Chris/0000-0002-4197-4202				Ainsworth M. D. S., 1978, PATTERNS ATTACHMENT; Allen NB, 1998, DEV PSYCHOPATHOL, V10, P513, DOI 10.1017/S0954579498001722; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BOURNE S, 1984, BRIT MED J, V289, P147, DOI 10.1136/bmj.289.6438.147; CAIN AC, 1964, J CHILD PSYCHOL PSYC, V3, P443, DOI 10.1016/S0002-7138(09)60158-8; Carter Jemmy, 1986, CHILD BIRTH AGES; COOPER JD, 1980, BRIT J SOC WORK, V10, P55; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; CUISINIER MCJ, 1993, EUR J OBSTET GYN R B, V52, P163, DOI 10.1016/0028-2243(93)90066-L; FORREST CG, 1982, BRIT MED J, V285, P1475; GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746; Hughes P, 2001, J CHILD PSYCHOL PSYC, V42, P791; Hughes PM, 1999, BRIT MED J, V318, P1721, DOI 10.1136/bmj.318.7200.1721; JOLLY H, 1976, P ROY SOC MED, V69, P835, DOI 10.1177/003591577606901124; LASKER JN, 1994, DEATH STUD, V18, P41, DOI 10.1080/07481189408252642; LEWIS E, 1976, LANCET, V2, P619; LEWIS E, 1979, ARCH DIS CHILD, V54, P303, DOI 10.1136/adc.54.4.303; LEWIS E, 1978, BRIT J MED PSYCHOL, V51, P237, DOI 10.1111/j.2044-8341.1978.tb02468.x; Main M, 1990, ATTACHMENT PRESCHOOL, P121; May WL, 1997, STAT MED, V16, P2127, DOI 10.1002/(SICI)1097-0258(19970930)16:18<2127::AID-SIM633>3.0.CO;2-W; METCALFE M, 1965, BRIT J PSYCHIAT, V111, P240, DOI 10.1192/bjp.111.472.240; Murray D, 1990, J REPROD INFANT PSYC, V8, P99, DOI DOI 10.1080/02646839008403615; Oakley A., 1984, THE CAPTURED WOMB; POZNANSKI EO, 1972, J PEDIATR-US, V81, P1190; Radestad I, 1996, BRIT MED J, V312, P1505, DOI 10.1136/bmj.312.7045.1505; Rand CSW, 1998, J PSYCHOSOM OBST GYN, V19, P44, DOI 10.3109/01674829809044220; *ROYAL COLL OBST G, 1985, REP RCOG WORK PART M; SPIELBERGER CD, 1970, TEST STATE TRAIT ANX; Turton P, 2001, BRIT J PSYCHIAT, V178, P556, DOI 10.1192/bjp.178.6.556; van Ijzendoorn MH, 1999, DEV PSYCHOPATHOL, V11, P225, DOI 10.1017/S0954579499002035; WATSON CG, 1991, J CLIN PSYCHOL, V47, P179, DOI 10.1002/1097-4679(199103)47:2<179::AID-JCLP2270470202>3.0.CO;2-P	32	163	166	0	22	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 13	2002	360	9327					114	118		10.1016/S0140-6736(02)09410-2	http://dx.doi.org/10.1016/S0140-6736(02)09410-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	573PB	12126820				2022-12-24	WOS:000176839100009
J	Vasan, RS; Benjamin, EJ; Larson, MG; Leip, EP; Wang, TJ; Wilson, PWF; Levy, D				Vasan, RS; Benjamin, EJ; Larson, MG; Leip, EP; Wang, TJ; Wilson, PWF; Levy, D			Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction - The Framingham Heart study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MYOCARDIAL-INFARCTION; DIAGNOSTIC-TEST; PRIMARY-CARE; ECHOCARDIOGRAPHY; POPULATION; ACCURACY; FAILURE; MARKER; MORTALITY; SURVIVAL	Context Several reports have suggested the usefulness of plasma brain natriuretic peptide (BNP) as a screening test for left ventricular hypertrophy (LVH) and systolic dysfunction (LVSD). Prior studies were limited by small sample sizes and selection bias and none compared the diagnostic performance of these peptides in men and women. Objectives To examine the usefulness of natriuretic peptides for screening for elevated LV mass and LVSD in the community. Design, Setting, and Participants Community-based prospective cohort study of 3177 participants (1707 women) from the Framingham Study who attended a routine examination in 1995-1998. Main Outcome Measures Receiver operating characteristic (ROC) curves, test sensitivity, specificity, positive and negative predictive values, and likelihood ratios for identifying elevated LV mass (sex-specific 90th percentile or higher of LV mass/[height](2)), LVSD (ejection fraction less than or equal to 50% and/or fractional shortening <29%), and moderate to severe LVSD (ejection fraction less than or equal to40% and/or fractional shortening <22%) at different discrimination limits of plasma BNP and N-terminal proatrial natriuretic peptide (NT-ANP), with echocardiography as the criterion standard. Results The areas under the ROC curves for elevated LV mass or LVSD were at or below 0.75 for both peptides, were higher for men compared with women, and were similar for BNP and NT-ANP. The diagnostic performance of natriuretic peptides for LVSD improved in women but not in men when select high-risk subgroups were targeted. Discrimination limits based on high specificity (0.95) yielded better positive predictive values and likelihood ratios compared with age- and sex-specific reference limits yet only identified less than one third of participants who had elevated LV mass or LVSD. Conclusion In our large community-based sample, the performance of BNP and NT-ANP for detection of elevated LV mass and LVSD was suboptimal, suggesting limited usefulness of natriuretic peptides as mass screening tools.	NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; Boston Univ, Sch Med, Dept Med, Cardiol Sect, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Med, Prevent Med & Epidemiol Sect, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Med, Div Endocrinol, Boston, MA 02118 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Med,Cardiol Div, Boston, MA USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Cardiol, Boston, MA USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Clin Epidemiol, Boston, MA USA; NHLBI, Bethesda, MD 20892 USA	Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Boston University; Boston University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Vasan, RS (corresponding author), NHLBI, Framingham Heart Study, 73 Mt Wayte Ave,Suite 2, Framingham, MA 01702 USA.		Ramachandran, Vasan/Y-2527-2019; Levy, Daniel/ABF-6873-2021; Levy, Daniel/ABB-2752-2021; Benjamin, Emelia/E-7103-2011	Ramachandran, Vasan/0000-0001-7357-5970; Levy, Daniel/0000-0003-1843-8724; Larson, Martin/0000-0002-9631-1254; Benjamin, Emelia/0000-0003-4076-2336	NHLBI NIH HHS [N01-HC-25195, 1R01HL67288-01, K24 HL 04334-01A1] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067288, K24HL004334] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Black HR, 1997, ARCH INTERN MED, V157, P2413; BOYKO EJ, 1994, MED DECIS MAKING, V14, P175, DOI 10.1177/0272989X9401400210; Cowie MR, 1997, LANCET, V350, P1349, DOI 10.1016/S0140-6736(97)06031-5; Davidson NC, 1996, AM J CARDIOL, V77, P828, DOI 10.1016/S0002-9149(97)89176-X; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; FAHEY MT, 1995, AM J EPIDEMIOL, V141, P680, DOI 10.1093/oxfordjournals.aje.a117485; FOUAD FM, 1984, J AM COLL CARDIOL, V3, P1500, DOI 10.1016/S0735-1097(84)80289-2; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hosmer D.W., 2004, APPL LOGISTIC REGRES, VSecond; Jacobsen SJ, 1996, ARCH INTERN MED, V156, P2462, DOI 10.1001/archinte.156.21.2462; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Kannel WB, 1987, FRAMINGHAM HEART STU; LERMAN A, 1993, LANCET, V341, P1105, DOI 10.1016/0140-6736(93)93125-K; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Luchner A, 2002, CARDIOVASC RES, V53, P720, DOI 10.1016/S0008-6363(01)00510-7; Luchner A, 2000, J HYPERTENS, V18, P1121, DOI 10.1097/00004872-200018080-00018; Maisel AS, 2001, AM HEART J, V141, P367, DOI 10.1067/mhj.2001.113215; McClure SJ, 1998, BRIT MED J, V317, P516; McDonagh TA, 1997, LANCET, V350, P829, DOI 10.1016/S0140-6736(97)03033-X; McDonagh TA, 1998, LANCET, V351, P9, DOI 10.1016/S0140-6736(97)03034-1; McMurray JV, 1998, EUR HEART J, V19, P842, DOI 10.1093/eurheartj/19.6.842; NICKLAS JM, 1992, NEW ENGL J MED, V327, P685; Omland T, 1996, CIRCULATION, V93, P1963, DOI 10.1161/01.CIR.93.11.1963; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; QUINONES MA, 1978, CHEST, V74, P59, DOI 10.1378/chest.74.1.59; Remaley AT, 1999, CLIN CHEM, V45, P934; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Schirmer H, 1999, EUR HEART J, V20, P755, DOI 10.1053/euhj.1998.1396; Sheps SG, 1997, HYPERTENSION, V29, P560, DOI 10.1161/01.HYP.29.2.560; Smith H, 2000, BMJ-BRIT MED J, V320, P906, DOI 10.1136/bmj.320.7239.906; Suzuki T, 2000, JPN HEART J, V41, P205, DOI 10.1536/jhj.41.205; SWETS JA, 1991, MED DECIS MAKING, V11, P9, DOI 10.1177/0272989X9101100102; Wald NJ, 1999, BMJ-BRIT MED J, V319, P1562, DOI 10.1136/bmj.319.7224.1562; Wang TJ, 2002, AM J CARDIOL, V90, P254, DOI 10.1016/S0002-9149(02)02464-5; Watanabe J, 2001, CIRCULATION, V104, P1911, DOI 10.1161/circ.104.16.1911; Willenheimer RB, 1997, SCAND CARDIOVASC J, V31, P9, DOI 10.3109/14017439709058063; Yamamoto K, 1996, HYPERTENSION, V28, P988, DOI 10.1161/01.HYP.28.6.988; Yamamoto K, 2000, J CARD FAIL, V6, P194, DOI 10.1054/jcaf.2000.9676; YOUDEN WJ, 2001, CANCER, V3, P32	42	365	381	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 11	2002	288	10					1252	1259		10.1001/jama.288.10.1252	http://dx.doi.org/10.1001/jama.288.10.1252			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592BW	12215132				2022-12-24	WOS:000177917700024
J	Zansky, S; Wallace, B; Schoonmaker-Bopp, D; Smith, P; Ramsey, F; Painter, J; Gupta, A; Kalluri, P; Noviello, S				Zansky, S; Wallace, B; Schoonmaker-Bopp, D; Smith, P; Ramsey, F; Painter, J; Gupta, A; Kalluri, P; Noviello, S		CDC	Outbreak of multidrug-resistant Salmonella Newport - United States, January-April 2002 (Reprinted from MMWR, vol 51, pg 545-548, 2002)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint									Wadsworth Ctr, Albany, CA USA; New York State Dept Hlth, Albany, NY 12237 USA; US Food Safety & Inspect Serv, USDA, Washington, DC 20250 USA; CDC, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA	State University of New York (SUNY) System; United States Department of Agriculture (USDA); Centers for Disease Control & Prevention - USA								Altekruse SF, 1996, J FOOD PROTECT, V59, P287, DOI 10.4315/0362-028X-59.3.287; [Anonymous], PUBL HLTH ACT PLAN C; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P545; GUPTA A, 2001, INF DIS SOC AM; Helms M, 2002, EMERG INFECT DIS, V8, P490, DOI 10.3201/eid0805.010267; MCCARTHY T, 2002, INT C EM INF DIS; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; RANKIN SC, 2002, 3 INT C EM INF DIS; SPIKA JS, 1987, NEW ENGL J MED, V316, P565, DOI 10.1056/NEJM198703053161001; *USDA, PROGR REP SALM TEST; VARMA JK, 2002, NARMS 1996 2000 INT	11	41	43	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 28	2002	288	8					951	953						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587RM	12201274				2022-12-24	WOS:000177656400007
J	Splawski, I; Timothy, KW; Tateyama, M; Clancy, CE; Malhotra, A; Beggs, AH; Cappuccio, FP; Sagnella, GA; Kass, RS; Keating, MT				Splawski, I; Timothy, KW; Tateyama, M; Clancy, CE; Malhotra, A; Beggs, AH; Cappuccio, FP; Sagnella, GA; Kass, RS; Keating, MT			Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia	SCIENCE			English	Article							LONG-QT SYNDROME; TORSADES-DE-POINTES; MOLECULAR MECHANISM; MUTATIONS; REPOLARIZATION; POPULATION; DURATION; THERAPY; DEATH	Every year, similar to450,000 individuals in the United States die suddenly of cardiac arrhythmia. We identified a variant of the cardiac sodium channel gene SCN5A that is associated with arrhythmia in African Americans ( P = 0.000028) and linked with arrhythmia risk in an African-American family (P = 0.005). In transfected cells, the variant allele (Y1102) accelerated channel activation, increasing the likelihood of abnormal cardiac repolarization and arrhythmia. About 13.2% of African Americans carry the Y1102 allele. Because Y1102 has a subtle effect on risk, most carriers will never have an arrhythmia. However, Y1102 may be a useful molecular marker for the prediction of arrhythmia susceptibility in the context of additional acquired risk factors such as the use of certain medications.	Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA; Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; Columbia Univ Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA; Childrens Hosp, Div Genet, Boston, MA 02115 USA; Univ London St Georges Hosp, Sch Med, Dept Gen Practice & Primary Care, London SW17 0RE, England; Univ London St Georges Hosp, Sch Med, Dept Med Physiol, London SW17 0RE, England	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Columbia University; Harvard University; Boston Children's Hospital; St Georges University London; St Georges University London	Keating, MT (corresponding author), Childrens Hosp, Dept Cardiol, 300 Longwood Ave, Boston, MA 02115 USA.		Cappuccio, Francesco/D-3028-2009; Clancy, Colleen/B-2528-2010; Cappuccio, Francesco Paolo/ABF-1094-2020	Cappuccio, Francesco Paolo/0000-0002-7842-5493; Beggs, Alan/0000-0001-8818-0568	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL053773, R01HL056810, P01HL067849] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL 67849, HL53773, R01 HL 56810, R01 HL48074] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		An RH, 1998, CIRC RES, V83, P141, DOI 10.1161/01.RES.83.2.141; BENNETT PB, 1995, NATURE, V376, P683, DOI 10.1038/376683a0; Cappuccio FP, 1997, HEART, V78, P555, DOI 10.1136/hrt.78.6.555; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; Clancy CE, 2002, CIRCULATION, V105, P1208, DOI 10.1161/hc1002.105183; Clancy CE, 2001, CARDIOVASC RES, V50, P301, DOI 10.1016/S0008-6363(00)00293-5; Clancy CE, 1999, NATURE, V400, P566, DOI 10.1038/23034; Compton SJ, 1996, CIRCULATION, V94, P1018, DOI 10.1161/01.CIR.94.5.1018; GELLENS ME, 1992, P NATL ACAD SCI USA, V89, P554, DOI 10.1073/pnas.89.2.554; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HASSTEDT SJ, 1993, PEDIGREE ANAL PACKAG; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Kilborn MJ, 2001, BRIT MED J, V322, P672; MARTIN AB, 1995, AM J CARDIOL, V75, P950, DOI 10.1016/S0002-9149(99)80697-3; Moss AJ, 2000, CIRCULATION, V101, P616, DOI 10.1161/01.CIR.101.6.616; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Roden DM, 2001, CARDIOVASC RES, V50, P224, DOI 10.1016/S0008-6363(00)00302-3; RODEN DM, 1993, EUR HEART J, V14, P56, DOI 10.1093/eurheartj/14.suppl_H.56; Sagnella GA, 1999, J HYPERTENS, V17, P657, DOI 10.1097/00004872-199917050-00009; Schott JJ, 1999, NAT GENET, V23, P20, DOI 10.1038/12618; Splawski I, 1997, NAT GENET, V17, P338, DOI 10.1038/ng1197-338; Tan HL, 2001, NATURE, V409, P1043, DOI 10.1038/35059090; Viswanathan PC, 1999, CIRCULATION, V99, P2466, DOI 10.1161/01.CIR.99.18.2466; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Wang Q, 1996, GENOMICS, V34, P9, DOI 10.1006/geno.1996.0236; Yap YG, 2000, BRIT MED J, V320, P1158, DOI 10.1136/bmj.320.7243.1158; Zheng ZJ, 2001, CIRCULATION, V104, P2158, DOI 10.1161/hc4301.098254	27	377	401	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 23	2002	297	5585					1333	1336		10.1126/science.1073569	http://dx.doi.org/10.1126/science.1073569			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FL	12193783				2022-12-24	WOS:000177573900043
J	Crump, JA; Sulka, AC; Langer, AJ; Schaben, C; Crielly, AS; Gage, R; Baysinger, M; Moll, M; Withers, G; Toney, DM; Hunter, SB; Hoekstra, RM; Wong, SK; Griffin, PM; Van Gilder, TJ				Crump, JA; Sulka, AC; Langer, AJ; Schaben, C; Crielly, AS; Gage, R; Baysinger, M; Moll, M; Withers, G; Toney, DM; Hunter, SB; Hoekstra, RM; Wong, SK; Griffin, PM; Van Gilder, TJ			An outbreak of Escherichia coli O157 : H7 infections among visitors to a dairy farm	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEMOLYTIC-UREMIC SYNDROME; UNITED-STATES; CATTLE; ENVIRONMENT; FAMILIES	Background Outbreaks of Escherichia coli O157: H7 infections have involved direct transmission from animals and their environment to humans. We describe an outbreak among visitors to a Pennsylvania dairy and petting farm that provides public access to animals. Methods We conducted both a case-control study among visitors to a farm to identify risk factors for infection and a household survey to determine the rates of diarrheal illness among these visitors. We performed an extensive environmental study to identify sources of E. coli O157:117 on the farm. Results Fifty-one patients with confirmed or suspected E. coli O157:H7 infection were enrolled in the case-control study. The median age of the patients was four years, and the hemolytic-uremic syndrome developed in eight. Contact with calves and their environment was associated with an increased risk of infection, whereas hand washing was protective. The household survey indicated that visitors to the farm during the outbreak had higher than expected rates of diarrhea. Environmental studies showed that 28 of the 216 cattle on the farm (13 percent) were colonized with E. coli O157:H7 that had the same distinct pattern on pulsed-field gel electrophoresis that was found in isolates from the patients. This organism was also recovered from surfaces that were accessible to the public. Conclusions In a large outbreak of E. coli O157:H7 infections among visitors to a dairy farm, predominantly children, high rates of carriage of E. coli O157: H7 among calves and young cattle most likely resulted in contamination of both the animals' hides and the environment.	CDCP, Foodborne & Diarrheal Dis Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; CDCP, Epidem Intelligence Serv, Div Appl Publ Hlth Training, Epidemiol Program Off, Atlanta, GA 30333 USA; CDCP, Biostat & Informat Management Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Montgomery Cty Hlth Dept, Norristown, PA USA; Penn Dept Hlth, Harrisburg, PA 17108 USA; Penn Dept Hlth, Bur Labs, Lionville, PA USA; Virginia Dept Consolidated Lab Serv, Richmond, VA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Crump, JA (corresponding author), CDCP, Foodborne & Diarrheal Dis Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, MS A-38,1600 Clifton Rd, Atlanta, GA 30333 USA.		Crump, John A./AAZ-6412-2020; Langer, Adam Justin/P-1188-2019	Crump, John A./0000-0002-4529-102X; Langer, Adam Justin/0000-0001-5980-3359; Hoekstra, Robert Michael/0000-0002-0340-8015				BOYCE TG, 1995, NEW ENGL J MED, V333, P364, DOI 10.1056/NEJM199508103330608; *CDCP, 2000, STAND MOL SUBT FOODB; *CDCP, 1997, FOODB DIS ACT SURV N; *CDCP, 1999, FOODB DIS ACT SURV N; Chapman PA, 1997, EPIDEMIOL INFECT, V119, P245, DOI 10.1017/S0950268897007826; Hancock D., 1998, ESCHERICHIA COLI, V157, P85, DOI [10.3168/jds.S0022-0302(05)73131-3., DOI 10.3168/JDS.S0022-0302(05)73131-3]; Hancock DD, 1998, PREV VET MED, V35, P11, DOI 10.1016/S0167-5877(98)00050-6; Hancock DD, 1997, J FOOD PROTECT, V60, P462, DOI 10.4315/0362-028X-60.5.462; Hancock DD, 1997, EPIDEMIOL INFECT, V118, P193, DOI 10.1017/S0950268896007212; KASSENBORG H, 1998, INT C EM INF DIS ATL; Kernland KH, 1997, SCHWEIZ MED WSCHR, V127, P1229; MARTIN ML, 1986, LANCET, V2, P1043; Maule A, 2000, J APPL MICROBIOL, V88, p71S, DOI 10.1111/j.1365-2672.2000.tb05334.x; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Milne L M, 1999, Commun Dis Public Health, V2, P22; O'Brien SJ, 2001, EMERG INFECT DIS, V7, P1049, DOI 10.3201/eid0706.010626; OLSVIK O, 1991, MOL CELL PROBE, V5, P429, DOI 10.1016/S0890-8508(05)80014-3; PARRY SM, 1995, LANCET, V346, P572, DOI 10.1016/S0140-6736(95)91407-2; Rahn K, 1997, EPIDEMIOL INFECT, V119, P251, DOI 10.1017/S0950268897007929; Rahn K, 1998, J INFECT DIS, V177, P1139, DOI 10.1086/517394; Randall L P, 1999, Vet Rec, V145, P500; Reymond D, 1996, J CLIN MICROBIOL, V34, P2053, DOI 10.1128/JCM.34.9.2053-2057.1996; Shukla R, 1995, Commun Dis Rep CDR Rev, V5, pR86; Swaminathan B, 2001, EMERG INFECT DIS, V7, P382; Trevena W B, 1999, Commun Dis Public Health, V2, P263; Warshawsky Bryna, 2002, Can J Infect Dis, V13, P175; Wilson JB, 1996, J INFECT DIS, V174, P1021, DOI 10.1093/infdis/174.5.1021; 2001, MMWR MORB MORTAL WKL, V50, P293	28	123	139	0	7	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 22	2002	347	8					555	560		10.1056/NEJMoa020524	http://dx.doi.org/10.1056/NEJMoa020524			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587ZR	12192014				2022-12-24	WOS:000177675400003
J	Williams, BAP; Hirt, RP; Lucocq, JM; Embley, TM				Williams, BAP; Hirt, RP; Lucocq, JM; Embley, TM			A mitochondrial remnant in the microsporidian Trachipleistophora hominis	NATURE			English	Article							PARASITE ENTAMOEBA-HISTOLYTICA; MOLECULAR EVIDENCE; NOSEMA-LOCUSTAE; GENE; EUKARYOTES; EVOLUTION; SEQUENCE; GENOME; HSP70; FUNGI	Microsporidia are obligate intracellular parasites of several eukaryotes. They have a highly complex and unique infection apparatus but otherwise appear structurally simple(1). Microsporidia are thought to lack typical eukaryotic organelles, such as mitochondria and peroxisomes. This has been interpreted as support for the hypothesis that these peculiar eukaryotes diverged before the mitochondrial endosymbiosis, which would make them one of the earliest offshoots in eukaryotic evolution(2,3). But microsporidial nuclear genes that encode orthologues of typical mitochondrial heatshock Hsp70 proteins have been detected, which provides evidence for secondary loss of the organelle or endosymbiont(4-6). In addition, gene trees and more sophisticated phylogenetic analyses have recovered microsporidia as the relatives of fungi, rather than as basal eukaryotes(7-9). Here we show that a highly specific antibody raised against a Trachipleistophora hominis Hsp70 protein detects the presence, under light and electron microscopy, of numerous tiny (similar to50 x 90 nm) organelles with double membranes in this human microsporidial parasite. The finding of relictual mitochondria in microsporidia provides further evidence of the reluctance of eukaryotes to lose the mitochondrial organelle, even when its canonical function of aerobic respiration has been apparently lost.	Nat Hist Museum, Dept Zool, London SW7 5BD, England; Univ Dundee, Sch Life Sci, Dundee DD1 5EH, Scotland	Natural History Museum London; University of Dundee	Embley, TM (corresponding author), Nat Hist Museum, Dept Zool, Cromwell Rd, London SW7 5BD, England.		Hirt, Robert/R-5429-2017	Hirt, Robert/0000-0002-3760-9958; lucocq, john/0000-0002-5191-0093; Embley, Thomas Martin/0000-0002-1484-340X; Williams, Bryony/0000-0003-1123-2176				Akhmanova A, 1998, NATURE, V396, P527, DOI 10.1038/25023; Arisue N, 2002, PARASITOL INT, V51, P9, DOI 10.1016/S1383-5769(01)00093-9; BUCHBERGER A, 1997, GUIDEBOOK MOL CHAPER, P22; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Canning E.U., 1990, P53; CAVALIERSMITH T, 1987, NATURE, V326, P332, DOI 10.1038/326332a0; Cheney SA, 2001, PARASITE, V8, P91, DOI 10.1051/parasite/2001082091; Dyall SD, 2000, CURR OPIN MICROBIOL, V3, P404, DOI 10.1016/S1369-5274(00)00112-0; Fast NM, 2001, MOL BIOCHEM PARASIT, V117, P201, DOI 10.1016/S0166-6851(01)00356-5; Germot A, 1997, MOL BIOCHEM PARASIT, V87, P159, DOI 10.1016/S0166-6851(97)00064-9; Hirt RP, 1999, P NATL ACAD SCI USA, V96, P580, DOI 10.1073/pnas.96.2.580; Hirt RP, 1997, CURR BIOL, V7, P995, DOI 10.1016/S0960-9822(06)00420-9; Hollister WS, 1996, PARASITOLOGY, V112, P143, DOI 10.1017/S0031182000065185; Huynen MA, 2001, HUM MOL GENET, V10, P2463, DOI 10.1093/hmg/10.21.2463; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; Keeling PJ, 2000, MOL BIOL EVOL, V17, P23, DOI 10.1093/oxfordjournals.molbev.a026235; Lill R, 2000, TRENDS BIOCHEM SCI, V25, P352, DOI 10.1016/S0968-0004(00)01589-9; LOCKHART PJ, 1994, MOL BIOL EVOL, V11, P605; Mai ZM, 1999, MOL CELL BIOL, V19, P2198; Peyretaillade E, 1998, MOL BIOL EVOL, V15, P683, DOI 10.1093/oxfordjournals.molbev.a025971; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; Roger AJ, 1998, P NATL ACAD SCI USA, V95, P229, DOI 10.1073/pnas.95.1.229; Tovar J, 1999, MOL MICROBIOL, V32, P1013, DOI 10.1046/j.1365-2958.1999.01414.x; Van de Peer Y, 2000, GENE, V246, P1, DOI 10.1016/S0378-1119(00)00063-9; van der Giezen M, 2002, EMBO J, V21, P572, DOI 10.1093/emboj/21.4.572; Vavra Jiri, 1999, P7; VOSSBRINCK CR, 1987, NATURE, V326, P411, DOI 10.1038/326411a0; WILBANKS S, 1997, GUIDEBOOK MOL CHAPER, P13; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	29	295	325	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 22	2002	418	6900					865	869		10.1038/nature00949	http://dx.doi.org/10.1038/nature00949			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585YR	12192407				2022-12-24	WOS:000177555600035
J	Ahlert, J; Shepard, E; Lomovskaya, N; Zazopoulos, E; Staffa, A; Bachmann, BO; Huang, KX; Fonstein, L; Czisny, A; Whitwam, RE; Farnet, CM; Thorson, JS				Ahlert, J; Shepard, E; Lomovskaya, N; Zazopoulos, E; Staffa, A; Bachmann, BO; Huang, KX; Fonstein, L; Czisny, A; Whitwam, RE; Farnet, CM; Thorson, JS			The calicheamicin gene cluster and its iterative type I enediyne PKS	SCIENCE			English	Article							FATTY-ACIDS; BIOSYNTHESIS; DNA; CHEMISTRY; CLONING	The enediynes exemplify nature's ingenuity. We have cloned and characterized the biosynthetic locus coding for perhaps the most notorious member of the nonchromoprotein enediyne family, calicheamicin. This gene cluster contains an unusual polyketide synthase (PKS) that is demonstrated to be essential for enediyne biosynthesis. Comparison of the calicheamicin locus with the locus encoding the chromoprotein enediyne C-1027 reveals that the enediyne PKS is highly conserved among these distinct enediyne families. Contrary to previous hypotheses, this suggests that the chromoprotein and nonchromoprotein enediynes are generated by similar biosynthetic pathways.	Ecopia Biosci Inc, Montreal, PQ H4S 2A1, Canada; Univ Wisconsin, Sch Pharm, Pharmaceut Sci Div, Lab Biosynthet Chem, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison	Farnet, CM (corresponding author), Ecopia Biosci Inc, 7290 Frederick Banting, Montreal, PQ H4S 2A1, Canada.	farnet@ecopiabio.com; jthorson@pharmacy.wisc.edu	Farnet, Chris/ABE-5463-2021; Thorson, Jon S/L-3696-2013	Thorson, Jon S/0000-0002-7148-0721; Bachmann, Brian/0000-0001-5815-1176; Farnet, Chris/0000-0003-4927-198X	NCI NIH HHS [CA08748, CA84374] Funding Source: Medline; NIGMS NIH HHS [GM58196] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA008748, R01CA084374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058196] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AHLERT J, UNPUB; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; Biggins JB, 2000, P NATL ACAD SCI USA, V97, P13537, DOI 10.1073/pnas.240460997; BIGGINS JB, UNPUB; Danishefsky SJ, 1996, J ORG CHEM, V61, P16, DOI 10.1021/jo951560x; Decker H, 1996, FEMS MICROBIOL LETT, V141, P195, DOI 10.1016/0378-1097(96)00221-2; DEVOSS JJ, 1990, J AM CHEM SOC, V112, P4554, DOI 10.1021/ja00167a069; FANTINI AA, 1995, ENEDIYNE ANTIBIOTICS, P39; GREENSTEIN M, 1986, ANTIMICROB AGENTS CH, V29, P861, DOI 10.1128/AAC.29.5.861; HENSENS OD, 1989, J AM CHEM SOC, V111, P3295, DOI 10.1021/ja00191a028; Kieser T., 2000, PRACTICAL STREPTOMYC; LAM KS, 1993, J AM CHEM SOC, V115, P12340, DOI 10.1021/ja00079a014; Liu W, 2002, SCIENCE, V297, P1170, DOI 10.1126/science.1072110; LOVE SF, 1992, APPL ENVIRON MICROB, V58, P1376, DOI 10.1128/AEM.58.4.1376-1378.1992; Metz JG, 2001, SCIENCE, V293, P290, DOI 10.1126/science.1059593; Morita N, 2000, BIOCHEM SOC T, V28, P943, DOI 10.1042/BST0280943; MYERS AG, 1994, J AM CHEM SOC, V116, P1255, DOI 10.1021/ja00083a012; Sievers EL, 2001, CURR OPIN ONCOL, V13, P522, DOI 10.1097/00001622-200111000-00016; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Takeyama H, 1997, MICROBIOL-UK, V143, P2725, DOI 10.1099/00221287-143-8-2725; Thorson JS, 2000, CURR PHARM DESIGN, V6, P1841, DOI 10.2174/1381612003398564; Watanabe CMH, 2002, CHEM BIOL, V9, P245, DOI 10.1016/S1074-5521(02)00103-5; Weitnauer G, 2001, CHEM BIOL, V8, P569, DOI 10.1016/S1074-5521(01)00040-0; Whitwam RE, 2000, J AM CHEM SOC, V122, P1556, DOI 10.1021/ja993612w; ZEIN N, 1988, SCIENCE, V240, P1198, DOI 10.1126/science.3240341	25	233	251	2	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 16	2002	297	5584					1173	1176		10.1126/science.1072105	http://dx.doi.org/10.1126/science.1072105			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584BP	12183629				2022-12-24	WOS:000177447600048
J	Lindskog, M; Svenningsson, P; Pozzi, L; Kim, Y; Fienberg, AA; Bibb, JA; Fredholm, BB; Nairn, AC; Greengard, P; Fisone, G				Lindskog, M; Svenningsson, P; Pozzi, L; Kim, Y; Fienberg, AA; Bibb, JA; Fredholm, BB; Nairn, AC; Greengard, P; Fisone, G			Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine	NATURE			English	Article							ADENOSINE A(2A) RECEPTORS; RAT STRIATUM; REGULATED PHOSPHOPROTEIN; GENE-EXPRESSION; DOPAMINE; NEURONS; CLONING; BRAIN; MICE	Caffeine has been imbibed since ancient times in tea and coffee, and more recently in colas. Caffeine owes its psychostimulant action to a blockade of adenosine A(2A) receptors(1), but little is known about its intracellular mechanism of action. Here we show that the stimulatory effect of caffeine on motor activity in mice was greatly reduced following genetic deletion of DARPP-32 (dopamine- and cyclic AMP-regulated phosphoprotein of relative molecular mass 32,000)(2). Results virtually identical to those seen with caffeine were obtained with the selective A(2A) antagonist SCH 58261. The depressant effect of the A(2A) receptor agonist, CGS 21680, on motor activity was also greatly attenuated in DARPP-32 knockout mice. In support of a role for DARPP-32 in the action of caffeine, we found that, in striata of intact mice, caffeine increased the state of phosphorylation of DARPP-32 at Thr 75. Caffeine increased Thr 75 phosphorylation through inhibition of PP-2A-catalysed dephosphorylation, rather than through stimulation of cyclin-dependent kinase 5 (Cdk5)-catalysed phosphorylation, of this residue. Together, these studies demonstrate the involvement of DARPP-32 and its phosphorylation/dephosphorylation in the stimulant action of caffeine.	Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden; Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA; Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden	Karolinska Institutet; Rockefeller University; Karolinska Institutet	Fisone, G (corresponding author), Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden.	gilberto.fisone@neuro.ki.se	Lindskog, Maria/F-1729-2011; Svenningsson, Per JL/K-5210-2014; Pozzi, Laura/F-8687-2011	Lindskog, Maria/0000-0002-4178-2825; Pozzi, Laura/0000-0001-7662-2904; Kim, Yong/0000-0002-1387-2962; Fisone, Gilberto/0000-0002-0719-8000; Nairn, Angus/0000-0002-7075-0195	NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044] Funding Source: NIH RePORTER; NIDA NIH HHS [P01 DA010044] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Bibb JA, 1999, NATURE, V402, P669, DOI 10.1038/45251; EHRLICH ME, 1990, J MOL NEUROSCI, V2, P1, DOI 10.1007/BF02896920; El Yacoubi M, 2000, BRIT J PHARMACOL, V129, P1465, DOI 10.1038/sj.bjp.0703170; Fienberg AA, 1998, SCIENCE, V281, P838, DOI 10.1126/science.281.5378.838; FINK JS, 1992, MOL BRAIN RES, V14, P186, DOI 10.1016/0169-328X(92)90173-9; Fredholm BB, 1999, PHARMACOL REV, V51, P83; FREDHOLM BB, 1977, MED BIOL, V55, P262; GERFEN CR, 1992, ANNU REV NEUROSCI, V15, P285, DOI 10.1146/annurev.ne.15.030192.001441; HEMMINGS HC, 1986, J NEUROSCI, V6, P1469; Kafka SH, 1996, EUR J PHARMACOL, V295, P147, DOI 10.1016/0014-2999(95)00668-0; Kull B, 2000, MOL PHARMACOL, V58, P771, DOI 10.1124/mol.58.4.771; Ledent C, 1997, NATURE, V388, P674, DOI 10.1038/41771; LEMOINE C, 1995, J COMP NEUROL, V355, P418, DOI 10.1002/cne.903550308; Liu L, 1998, J IRON STEEL RES INT, V5, P1; Nishi A, 2000, P NATL ACAD SCI USA, V97, P12840, DOI 10.1073/pnas.220410397; Nishi A, 1999, J NEUROCHEM, V72, P2015, DOI 10.1046/j.1471-4159.1999.0722015.x; OGREN SO, 1979, DOPAMINERGIC ERGOT D, P225; Ongini E, 1997, DRUG DEVELOP RES, V42, P63; Ouimet CC, 1998, BRAIN RES, V808, P8, DOI 10.1016/S0006-8993(98)00724-0; Rimondini R, 1998, EUR J PHARMACOL, V347, P153, DOI 10.1016/S0014-2999(98)00107-1; SCHIFFMANN SN, 1993, J NEUROSCI, V13, P1080; SNYDER SH, 1981, P NATL ACAD SCI-BIOL, V78, P3260, DOI 10.1073/pnas.78.5.3260; Svenningsson P, 2000, P NATL ACAD SCI USA, V97, P1856, DOI 10.1073/pnas.97.4.1856; Svenningsson P, 2000, J NEUROCHEM, V75, P248, DOI 10.1046/j.1471-4159.2000.0750248.x; WALAAS SI, 1983, NATURE, V301, P69	25	131	135	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 15	2002	418	6899					774	778		10.1038/nature00817	http://dx.doi.org/10.1038/nature00817			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UF	12181566				2022-12-24	WOS:000177428000038
J	Schofield, L; Hewitt, MC; Evans, K; Siomos, MA; Seeberger, PH				Schofield, L; Hewitt, MC; Evans, K; Siomos, MA; Seeberger, PH			Synthetic GPI as a candidate anti-toxic vaccine in a model of malaria	NATURE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; VASCULAR ENDOTHELIAL-CELLS; TUMOR-NECROSIS-FACTOR; PROTEIN-KINASE-C; GLYCOSYLPHOSPHATIDYLINOSITOL TOXIN; PLASMODIUM-FALCIPARUM; INTRAERYTHROCYTIC STAGE; MONOCLONAL-ANTIBODY; SIGNAL-TRANSDUCTION; CEREBRAL MALARIA	The malaria parasite Plasmodium falciparum infects 5-10% of the world's population and kills two million people annually(1). Fatalities are thought to result in part from pathological reactions initiated by a malarial toxin. Glycosylphosphatidylinositol (GPI) originating from the parasite has the properties predicted of a toxin(2-6); however, a requirement for toxins in general and GPI in particular in malarial pathogenesis and fatality remains unproven. As anti-toxic vaccines can be highly effective public health tools, we sought to determine whether anti-GPI vaccination could prevent pathology and fatalities in the Plasmodium berghei/rodent model of severe malaria. The P. falciparum GPI glycan of the sequence NH2-CH2-CH2-PO4-( Manalpha1-2) 6Manalpha1-2Manalpha1-6Manalpha1-4GlcNH(2)alpha1-6myo-inositol- 1,2-cyclic-phosphate was chemically synthesized, conjugated to carriers, and used to immunize mice. Recipients were substantially protected against malarial acidosis, pulmonary oedema, cerebral syndrome and fatality. Anti-GPI antibodies neutralized pro-inflammatory activity by P. falciparum in vitro. Thus, we show that GPI is a significant pro-inflammatory endotoxin of parasitic origin, and that several disease parameters in malarious mice are toxin-dependent. GPI may contribute to pathogenesis and fatalities in humans. Synthetic GPI is therefore a prototype carbohydrate anti-toxic vaccine against malaria.	Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; MIT, Dept Chem, Cambridge, MA 02139 USA	Royal Melbourne Hospital; Walter & Eliza Hall Institute; Massachusetts Institute of Technology (MIT)	Schofield, L (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia.	schofield@wehi.edu.au; seeberg@mit.edu						Almeida IC, 2000, EMBO J, V19, P1476, DOI 10.1093/emboj/19.7.1476; Berhe S, 1999, MOL BIOCHEM PARASIT, V103, P273, DOI 10.1016/S0166-6851(99)00125-5; Chang WL, 2001, INFECT IMMUN, V69, P7341, DOI 10.1128/IAI.69.12.7341-7348.2001; CHRISTOPHERS S. R., 1924, Indian Journal of Medical Research, V12, P273; de Souza JB, 2002, MICROBES INFECT, V4, P291, DOI 10.1016/S1286-4579(02)01541-1; DIECKMANNSCHUPPERT A, 1992, EUR J BIOCHEM, V205, P815, DOI 10.1111/j.1432-1033.1992.tb16846.x; DIECKMANNSCHUPPERT A, 1993, EUR J BIOCHEM, V216, P779, DOI 10.1111/j.1432-1033.1993.tb18198.x; GEROLD P, 1994, J BIOL CHEM, V269, P2597; Golgi C, 1886, ARCHIVO SCI MEDICHE, V10, P109; Gowda DC, 1997, J BIOL CHEM, V272, P6428, DOI 10.1074/jbc.272.10.6428; GRAU GE, 1991, EUR J IMMUNOL, V21, P2265, DOI 10.1002/eji.1830210939; GRAU GE, 1989, NEW ENGL J MED, V320, P1586, DOI 10.1056/NEJM198906153202404; GRAU GE, 1989, P NATL ACAD SCI USA, V86, P5572, DOI 10.1073/pnas.86.14.5572; GRAU GE, 1987, SCIENCE, V237, P1210, DOI 10.1126/science.3306918; Jennings VM, 1997, INFECT IMMUN, V65, P4883, DOI 10.1128/IAI.65.11.4883-4887.1997; Magez S, 1998, J IMMUNOL, V160, P1949; MCCONVILLE MJ, 1993, BIOCHEM J, V294, P305, DOI 10.1042/bj2940305; MCGREGOR IA, 1956, BRIT MED J, V2, P686, DOI 10.1136/bmj.2.4994.686; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Naik RS, 2000, J EXP MED, V192, P1563, DOI 10.1084/jem.192.11.1563; SCHOFIELD F, 1986, REV INFECT DIS, V8, P144; Schofield L, 1996, J IMMUNOL, V156, P1886; SCHOFIELD L, 1993, J EXP MED, V177, P145, DOI 10.1084/jem.177.1.145; SINTON J. A., 1939, JOUR MALARIA INST INDIA, V2, P71; TACHADO SD, 1994, BIOCHEM BIOPH RES CO, V205, P984, DOI 10.1006/bbrc.1994.2763; Tachado SD, 1996, J IMMUNOL, V156, P1897; Tachado SD, 1997, P NATL ACAD SCI USA, V94, P4022, DOI 10.1073/pnas.94.8.4022; TURNER GDH, 1994, AM J PATHOL, V145, P1057; WHITE NJ, 1992, ADV PARASIT, V31, P83, DOI 10.1016/S0065-308X(08)60021-4; *WHO, 1992, WORLD HLTH STAT Q, V45, P257	30	377	400	0	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 15	2002	418	6899					785	789		10.1038/nature00937	http://dx.doi.org/10.1038/nature00937			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UF	12181569				2022-12-24	WOS:000177428000041
J	Zhu, M; Yu, XB				Zhu, M; Yu, XB			A primitive fish close to the common ancestor of tetrapods and lungfish	NATURE			English	Article							PSAROLEPIS; AUSTRALIA	The relationship of the three living groups of sarcopterygians or lobe-finned fish (tetrapods, lungfish and coelacanths) has been a matter of debate(1-5). Although opinions still differ, most recent phylogenies suggest that tetrapods are more closely related to lungfish than to coelacanths(6-10). However, no previously known fossil taxon exhibits a concrete character combination approximating the condition expected in the last common ancestor of tetrapods and lungfish-and it is still poorly understood how early sarcopterygians diverged into the tetrapod lineage (Tetrapodomorpha)(7) and the lungfish lineage (Dipnomorpha)(7). Here we describe a fossil sarcopterygian fish, Styloichthys changae gen. et sp. nov., that possesses an eyestalk and which exhibits the character combination expected in a stem group close to the last common ancestor of tetrapods and lungfish. Styloichthys from the Lower Devonian of China bridges the morphological gap between stem-group sarcopterygians (Psarolepis and Achoania)(10) and basal tetrapodomorphs/basal dipnomorphs. It provides information that will help in the study of the relationship of early sarcopterygians, and which will also help to resolve the tetrapod-lungfish divergence into a documented sequence of character acquisition.	Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; Kean Univ, Dept Biol Sci, Union, NJ 07083 USA	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Zhu, M (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, POB 643, Beijing 100044, Peoples R China.	zhumin@ht.rol.cn.net	Zhu, Min/E-8728-2012; Yu, Xiaobo/G-7160-2011; min, zhu/AAL-6712-2021	Zhu, Min/0000-0002-4786-0898; Yu, Xiaobo/0000-0001-9600-7888; 				Ahlberg PE, 1998, NATURE, V395, P792, DOI 10.1038/27421; AHLBERG PE, 1991, ZOOL J LINN SOC-LOND, V103, P241, DOI 10.1111/j.1096-3642.1991.tb00905.x; Basden AM, 2000, NATURE, V403, P185, DOI 10.1038/35003183; Basden AM, 2001, J VERTEBR PALEONTOL, V21, P754, DOI 10.1671/0272-4634(2001)021[0754:APANFT]2.0.CO;2; CHAN V, 1993, PEDIATR PULM, V15, P183, DOI 10.1002/ppul.1950150310; Chang M.-M., 1982, THESIS STOCKHOLM U; Chang Mee-Mann, 1997, American Museum Novitates, V3189, P1; CHANG MM, 1991, VERTEBRATES RELATED, P355; Cloutier Richard, 1996, P227; Husken T.-C., 1997, Acta Universitatis Carolinae Geologica, V40, P445, DOI 10.1016/B978-012670950-6/50018-7; Forey PL., 1998, HIST COELACANTH FISH; Fox Richard C., 1995, Memoirs of the Queensland Museum, V38, P97; Gardiner B.G., 1984, Bulletin of the British Museum (Natural History) Geology, V37, P173; Janvier P., 1996, EARLY VERTEBRATES; JESSEN H L, 1980, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V167, P180; Johanson Z, 1998, NATURE, V394, P569, DOI 10.1038/29058; Long J.A., 1989, Journal of Vertebrate Paleontology, V9, P1; Long JA, 2001, J VERTEBR PALEONTOL, V21, P815, DOI 10.1671/0272-4634(2001)021[0815:OTROPA]2.0.CO;2; MAISEY J G, 1986, Cladistics, V2, P201, DOI 10.1111/j.1096-0031.1986.tb00462.x; MEYER A, 1995, TRENDS ECOL EVOL, V35, P93; ROSEN D E, 1981, Bulletin of the American Museum of Natural History, V167, P159; SCHULTZE HP, 1994, SYST BIOL, V43, P155, DOI 10.2307/2413459; SCHULTZE HP, 1987, J MORPH S, V1, P39; Swofford D., 1998, PAUP PHYLOGENETIC AN; Yu XB, 1998, J VERTEBR PALEONTOL, V18, P261, DOI 10.1080/02724634.1998.10011055; Zardoya R, 1998, MOL BIOL EVOL, V15, P506, DOI 10.1093/oxfordjournals.molbev.a025950; Zhu M, 2001, SYST ASSOC SPEC VOL, V61, P289; Zhu M, 1999, NATURE, V397, P607, DOI 10.1038/17594; Zhu M, 2001, NATURE, V410, P81, DOI 10.1038/35065078; [No title captured]	30	96	110	2	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 15	2002	418	6899					767	770		10.1038/nature00871	http://dx.doi.org/10.1038/nature00871			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UF	12181564				2022-12-24	WOS:000177428000036
J	Crawford, LM				Crawford, LM			Proposed reporting guidance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									US FDA, Off Commissioner Food & Drugs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Crawford, LM (corresponding author), US FDA, Off Commissioner Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 14	2002	288	6					688	688		10.1001/jama.288.6.688	http://dx.doi.org/10.1001/jama.288.6.688			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	583KY	12169049				2022-12-24	WOS:000177408100007
J	Rappuoli, R; Miller, HI; Falkow, S				Rappuoli, R; Miller, HI; Falkow, S			Medicine - The intangible value of vaccination	SCIENCE			English	Editorial Material									Chiron SpA, IRIS, I-53100 Siena, Italy; Stanford Univ, Hoover Inst, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Novartis; Stanford University; Stanford University	Rappuoli, R (corresponding author), Chiron SpA, IRIS, Via Fiorentina 1, I-53100 Siena, Italy.	rino_rappuoli@chiron.it						BARKSRUGGLES E, 2002, SAN FRANCISCO C 0106, pD6; Bloom DE, 2000, SCIENCE, V287, P1207, DOI 10.1126/science.287.5456.1207; Brugha R, 2002, LANCET, V359, P435, DOI 10.1016/S0140-6736(02)07607-9; *CDC, 2002, MMWR-MORBID MORTAL W, V51, P190; *CDC, 2002, MMWR-MORBID MORTAL W, V50, P1159; *CDC, 1999, OUNC PREV WHAT AR RE; *CDC, 2000, CALL SHOTS IMM FIN P, P1; CDC, 1999, MMWR MORB MORTAL WKL, V48, P243; *CDC, 2001, MMWR-MORBID MORTAL W, V50, P1144; *CDC, 2002, MMWR-MORBID MORTAL W, V51, P234; Fenner F., 1988, HIST INT PUBLIC HLTH; Greco M, 2001, VACCINE, V20, pS101, DOI 10.1016/S0264-410X(01)00293-6; Hotez PJ, 2001, EMBO REP, V2, P862, DOI 10.1093/embo-reports/kve215; Hull HF, 1997, SCIENCE, V275, P40, DOI 10.1126/science.275.5296.40; ORENSTEIN WA, 1999, VACCINES, P1024; SACHS J, 2002, SAN FRANCISCO C 0106, pD6; Stratton KR, 2000, VACC 21 CENT TOOL DE, P460; VISCUSI WK, 1996, ADV MED INNOVATION H	18	105	111	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 9	2002	297	5583					937	+		10.1126/science.1075173	http://dx.doi.org/10.1126/science.1075173			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581ZN	12169712				2022-12-24	WOS:000177325400018
J	Jackson, RB; Banner, JL; Jobbagy, EG; Pockman, WT; Wall, DH				Jackson, RB; Banner, JL; Jobbagy, EG; Pockman, WT; Wall, DH			Ecosystem carbon loss with woody plant invasion of grasslands	NATURE			English	Article							SOIL ORGANIC-CARBON; VEGETATION CHANGE; CLIMATE; RESPONSES; BUDGET	The invasion of woody vegetation into deserts, grasslands and savannas is generally thought to lead to an increase in the amount of carbon stored in those ecosystems. For this reason, shrub and forest expansion (for example, into grasslands) is also suggested to be a substantial, if uncertain, component of the terrestrial carbon sink(1-14). Here we investigate woody plant invasion along a precipitation gradient (200 to 1,100 mm yr(-1)) by comparing carbon and nitrogen budgets and soil delta(13)C profiles between six pairs of adjacent grasslands, in which one of each pair was invaded by woody species 30 to 100 years ago. We found a clear negative relationship between precipitation and changes in soil organic carbon and nitrogen content when grasslands were invaded by woody vegetation, with drier sites gaining, and wetter sites losing, soil organic carbon. Losses of soil organic carbon at the wetter sites were substantial enough to offset increases in plant biomass carbon, suggesting that current land-based assessments may overestimate carbon sinks. Assessments relying on carbon stored from woody plant invasions to balance emissions may therefore be incorrect.	Duke Univ, Dept Biol, Durham, NC 27708 USA; Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC 27708 USA; Univ Texas, Dept Geol Sci, Austin, TX 78712 USA; Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA	Duke University; Duke University; University of Texas System; University of Texas Austin; Colorado State University	Jackson, RB (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	jackson@duke.edu	Banner, Jay L/C-8676-2011; Wall, Diana H/F-5491-2011; Pockman, William T/D-4086-2014; Jobbágy, Esteban Gabriel/A-6293-2010	Pockman, William T/0000-0002-3286-0457; Jobbágy, Esteban Gabriel/0000-0002-4214-6011; Jackson, Robert/0000-0001-8846-7147				Allen CD, 1998, P NATL ACAD SCI USA, V95, P14839, DOI 10.1073/pnas.95.25.14839; Amundson R, 2001, ANNU REV EARTH PL SC, V29, P535, DOI 10.1146/annurev.earth.29.1.535; Archer S., 2001, GLOBAL BIOGEOCHEM CY, P115; Batjes NH, 2014, EUR J SOIL SCI, V65, P10, DOI 10.1111/ejss.12114_2; Boutton TW, 1998, GEODERMA, V82, P5, DOI 10.1016/S0016-7061(97)00095-5; Brown JH, 1997, P NATL ACAD SCI USA, V94, P9729, DOI 10.1073/pnas.94.18.9729; BURKE IC, 1989, SOIL SCI SOC AM J, V53, P800, DOI 10.2136/sssaj1989.03615995005300030029x; Casper BB, 1997, ANNU REV ECOL SYST, V28, P545, DOI 10.1146/annurev.ecolsys.28.1.545; Conant RT, 2001, ECOL APPL, V11, P343, DOI 10.1890/1051-0761(2001)011[0343:GMACIG]2.0.CO;2; Fang JY, 2001, SCIENCE, V292, P2320, DOI 10.1126/science.1058629; Gill RA, 2002, NATURE, V417, P279, DOI 10.1038/417279a; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Houghton RA, 1999, SCIENCE, V285, P574, DOI 10.1126/science.285.5427.574; Jackson RB, 2000, ECOL APPL, V10, P470, DOI 10.1890/1051-0761(2000)010[0470:BCOVCA]2.0.CO;2; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.2307/2641104; Neill C, 2000, ADV SOIL SCI-SER, P197; NEPSTAD DC, 1994, NATURE, V372, P666, DOI 10.1038/372666a0; Pacala SW, 2001, SCIENCE, V292, P2316, DOI 10.1126/science.1057320; POST WM, 1982, NATURE, V298, P156, DOI 10.1038/298156a0; Schimel DS, 2001, NATURE, V414, P169, DOI 10.1038/35102500; SCHLESINGER WH, 1990, SCIENCE, V247, P1043, DOI 10.1126/science.247.4946.1043; Scholes RJ, 1997, ANNU REV ECOL SYST, V28, P517, DOI 10.1146/annurev.ecolsys.28.1.517; Tilman D, 2000, ECOLOGY, V81, P2680, DOI 10.1890/0012-9658(2000)081[2680:FSAECS]2.0.CO;2; Trumbore SE, 1997, P NATL ACAD SCI USA, V94, P8284, DOI 10.1073/pnas.94.16.8284; TUCKER CJ, 1991, SCIENCE, V253, P299, DOI 10.1126/science.253.5017.299; Turner B., 1990, EARTH TRANSFORMED HU; Van Auken OW, 2000, ANNU REV ECOL SYST, V31, P197, DOI 10.1146/annurev.ecolsys.31.1.197; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Vitousek PM, 1999, OECOLOGIA, V121, P255, DOI 10.1007/s004420050927; Wall DH, 2001, ECOL STU AN, V152, P47	30	727	794	12	415	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 8	2002	418	6898					623	626		10.1038/nature00910	http://dx.doi.org/10.1038/nature00910			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581RA	12167857				2022-12-24	WOS:000177305600038
J	Froehlich, AC; Liu, Y; Loros, JJ; Dunlap, JC				Froehlich, AC; Liu, Y; Loros, JJ; Dunlap, JC			White collar-1, a circadian blue light photoreceptor, binding to the frequency promoter	SCIENCE			English	Article							CLOCK GENE-FREQUENCY; NEUROSPORA-CRASSA; SIGNAL-TRANSDUCTION; FEEDBACK LOOP; PROTEIN; PHOTORESPONSES; RHYTHMS; PAS; EXPRESSION; PLANTS	In the fungus Neurospora crassa, the blue light photoreceptor(s) and signaling pathway( s) have not been identified. We examined light signaling by exploiting the light sensitivity of the Neurospora biological clock, specifically the rapid induction by light of the clock component frequency (frq). Light induction of frq is transcriptionally controlled and requires two cis-acting elements (LREs) in the frq promoter. Both LREs are bound by a White Collar-1 (WC-1)/White Collar-2 (WC-2) containing complex (WCC), and light causes decreased mobility of the WCC bound to the LREs. The use of in vitro translated WC-1 and WC-2 confirmed that WC-1, with flavin adenine dinucleotide as a cofactor, is the blue light photoreceptor that mediates light input to the circadian system through direct binding( with WC-2) to the frq promoter.	Dartmouth Coll, Sch Med, Dept Genet, Hanover, NH 03755 USA; Dartmouth Coll, Sch Med, Dept Biochem, Hanover, NH 03755 USA	Dartmouth College; Dartmouth College	Loros, JJ (corresponding author), Dartmouth Coll, Sch Med, Dept Genet, Hanover, NH 03755 USA.		Dunlap, Jay/L-6232-2013; Loros, Jennifer/B-6293-2014	Dunlap, Jay/0000-0003-1577-0457; 	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH044651] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37GM34985] Funding Source: Medline; NIMH NIH HHS [MH44651] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; Ballario P, 1998, MOL MICROBIOL, V29, P719, DOI 10.1046/j.1365-2958.1998.00955.x; Ballario P, 1996, EMBO J, V15, P1650, DOI 10.1002/j.1460-2075.1996.tb00510.x; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; BILWES AM, UNPUB; Briggs WR, 1999, ANNU REV CELL DEV BI, V15, P33, DOI 10.1146/annurev.cellbio.15.1.33; CARATTOLI A, 1994, MOL MICROBIOL, V13, P787, DOI 10.1111/j.1365-2958.1994.tb00471.x; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Cheng P, 2001, EMBO J, V20, P101, DOI 10.1093/emboj/20.1.101; Collett MA, 2002, GENETICS, V160, P149; Crosson S, 2001, P NATL ACAD SCI USA, V98, P2995, DOI 10.1073/pnas.051520298; CROSTHWAITE SK, 1995, CELL, V81, P1003, DOI 10.1016/S0092-8674(05)80005-4; Crosthwaite SK, 1997, SCIENCE, V276, P763, DOI 10.1126/science.276.5313.763; Denault DL, 2001, EMBO J, V20, P109, DOI 10.1093/emboj/20.1.109; DHARMANANDA S, 1980, THESIS U CALIFORNIA; FRANCIS CD, 1979, PLANT PHYSIOL, V64, P1000, DOI 10.1104/pp.64.6.1000; FROEHLICH AC, UNPUB; Garceau NY, 1997, CELL, V89, P469, DOI 10.1016/S0092-8674(00)80227-5; Harmer SL, 2001, ANNU REV CELL DEV BI, V17, P215, DOI 10.1146/annurev.cellbio.17.1.215; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; He QY, 2002, SCIENCE, V297, P840, DOI 10.1126/science.1072795; Heintzen C, 2001, CELL, V104, P453, DOI 10.1016/S0092-8674(01)00232-X; Iseki M, 2002, NATURE, V415, P1047, DOI 10.1038/4151047a; Lee K, 2000, SCIENCE, V289, P107, DOI 10.1126/science.289.5476.107; Lee K. T., UNPUB; Linden H, 1997, FUNGAL GENET BIOL, V22, P141, DOI 10.1006/fgbi.1997.1013; Linden H, 1997, EMBO J, V16, P98, DOI 10.1093/emboj/16.1.98; Linden H, 1997, MOL GEN GENET, V254, P111, DOI 10.1007/s004380050398; Liu Y, 1998, SCIENCE, V281, P825, DOI 10.1126/science.281.5378.825; LOROS JJ, 1989, SCIENCE, V243, P385, DOI 10.1126/science.2563175; Loros JJ, 2001, ANNU REV PHYSIOL, V63, P757, DOI 10.1146/annurev.physiol.63.1.757; Luo CH, 1998, EMBO J, V17, P1228, DOI 10.1093/emboj/17.5.1228; Margolin BS, 1997, FUNGAL GENET NEWSLET, V44, P34, DOI [10.4148/1941-4765.1281, DOI 10.1128/EC.00244-07]; MCCLUNG CR, 1989, NATURE, V339, P558, DOI 10.1038/339558a0; Merrow M, 2001, EMBO J, V20, P307, DOI 10.1093/emboj/20.3.307; PAIETTA J, 1981, P NATL ACAD SCI-BIOL, V78, P5573, DOI 10.1073/pnas.78.9.5573; PAIETTA J, 1983, PLANT PHYSIOL, V72, P764, DOI 10.1104/pp.72.3.764; Payen A. de, 1843, ANN CHIM PHYS, V9, P5; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Roenneberg T, 2000, METHOD ENZYMOL, V305, P104; SARGENT ML, 1967, PLANT PHYSIOL, V42, P1504, DOI 10.1104/pp.42.11.1504; SCHMITZ O, 2000, SCIENCE, V289; Staben C, 1989, FUNGAL GENET NEWSL, V36, P79, DOI DOI 10.4148/1941-4765.1519; Thresher RJ, 1998, SCIENCE, V282, P1490, DOI 10.1126/science.282.5393.1490	44	393	414	2	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 2	2002	297	5582					815	819		10.1126/science.1073681	http://dx.doi.org/10.1126/science.1073681			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579RZ	12098706				2022-12-24	WOS:000177192800044
J	Baeyens, L; Vermeersch, E; Bourgeois, P				Baeyens, L; Vermeersch, E; Bourgeois, P			Bicyclist's vulva: observational study	BRITISH MEDICAL JOURNAL			English	Article									Free Univ Brussels, Hop Univ Brugmann, Sports Gynaecol Unit, B-1020 Brussels, Belgium; Inst Jules Bordet, Dept Radioisotopes, B-1000 Brussels, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Institut Jules Bordet	Baeyens, L (corresponding author), Free Univ Brussels, Hop Univ Brugmann, Sports Gynaecol Unit, Pl Van Gehuchten, B-1020 Brussels, Belgium.							Abraham P, 1997, SPORTS MED, V24, P221, DOI 10.2165/00007256-199724040-00001; Bourgeois P., 1997, EUR J LYMPHOL, V6, P10; MELLION MB, 1991, SPORTS MED, V11, P52, DOI 10.2165/00007256-199111010-00004; POWELL B, 1983, JAMA-J AM MED ASSOC, V249, P2457, DOI 10.1001/jama.1983.03330420019014; RUBIN JR, 1993, J VASC SURG, V17, P896, DOI 10.1016/0741-5214(93)90039-O	5	21	21	1	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 20	2002	325	7356					138	138		10.1136/bmj.325.7356.138	http://dx.doi.org/10.1136/bmj.325.7356.138			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	577PG	12130610	Green Published, Bronze			2022-12-24	WOS:000177069900021
J	Waalen, J; Felitti, V; Beutler, E				Waalen, J; Felitti, V; Beutler, E			Haemoglobin and ferritin concentrations in men and women: cross sectional study	BRITISH MEDICAL JOURNAL			English	Article									Scripps Res Inst, Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; Kaiser Permanente, Dept Prevent Med, San Diego, CA 92111 USA	Scripps Research Institute; Kaiser Permanente	Waalen, J (corresponding author), Scripps Res Inst, Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA.				NCRR NIH HHS [RR00833, M01 RR000833] Funding Source: Medline; NIDDK NIH HHS [DK 07022-20, R01 DK053505, DK53505-04, T32 DK007022] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053505, T32DK007022] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Beutler E, 2002, LANCET, V359, P211, DOI 10.1016/S0140-6736(02)07447-0; BEUTLER E, 1960, ANN INTERN MED, V52, P378, DOI 10.7326/0003-4819-52-2-378; GARDNER FH, 1968, BRIT J HAEMATOL, V14, P611, DOI 10.1111/j.1365-2141.1968.tb00367.x; GIULIETTI M, 1991, LAB ANIM SCI, V41, P606; Rushton DH, 2001, BMJ-BRIT MED J, V322, P1355, DOI 10.1136/bmj.322.7298.1355	5	23	23	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 20	2002	325	7356					137	137		10.1136/bmj.325.7356.137	http://dx.doi.org/10.1136/bmj.325.7356.137			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	577PG	12130609	Green Published, Bronze			2022-12-24	WOS:000177069900020
J	Millar, CB; Guy, J; Sansom, OJ; Selfridge, J; MacDougall, E; Hendrich, B; Keightley, PD; Bishop, SM; Clarke, AR; Bird, A				Millar, CB; Guy, J; Sansom, OJ; Selfridge, J; MacDougall, E; Hendrich, B; Keightley, PD; Bishop, SM; Clarke, AR; Bird, A			Enhanced CpG mutability and tumorigenesis in MBD4-deficient mice	SCIENCE			English	Article							DNA N-GLYCOSYLASE; GENETIC INSTABILITY; TRANSGENIC MICE; MED1 MBD4; MIN MICE; MUTATIONS; 5-METHYLCYTOSINE; DEAMINATION; CARCINOMAS; SPECTRUM	The mammalian protein MBD4 contains a methyl-CpG binding domain and can enzymatically remove thymine (T) or uracil (U) from a mismatched CpG site in vitro. These properties suggest that MBD4 might function in vivo to minimize the mutability of 5-methylcytosine by removing its deamination product from DNA. We tested this hypothesis by analyzing Mbd4(-/-) mice and found that the frequency of of C 3 T transitions at CpG sites was increased by a factor of three. On a cancer-susceptible Apc(Min/+) background, Mbd4(-/-) mice showed accelerated tumor formation with CpG --> TpG mutations in the Apc gene. Thus MBD4 suppresses CpG mutability and tumorigenesis in vivo.	Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3US, S Glam, Wales; Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JT, Midlothian, Scotland	University of Edinburgh; Cardiff University; University of Edinburgh	Bird, A (corresponding author), Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Kings Bldg, Edinburgh EH9 3JR, Midlothian, Scotland.		Hendrich, Brian/AAG-5898-2020; Clarke, Alan R/A-6256-2008; clarke, alan r/P-2820-2014	Hendrich, Brian/0000-0002-0231-3073; SELFRIDGE, JIM/0000-0003-2473-4386; Clarke, Alan/0000-0002-4281-426X; Sansom, Owen J./0000-0001-9540-3010; Millar, Catherine/0000-0002-8649-5408; Guy, Jacky/0000-0002-8440-5667; Bird, Adrian/0000-0002-8600-0372				Bader S, 2000, BRIT J CANCER, V83, P1646, DOI 10.1054/bjoc.2000.1482; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; GUY J, UNPUB; Harbach PR, 1999, ENVIRON MOL MUTAGEN, V33, P132, DOI 10.1002/(SICI)1098-2280(1999)33:2<132::AID-EM5>3.0.CO;2-2; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Hendrich B, 1999, NATURE, V401, P301, DOI 10.1038/45843; Hendrich B, 1999, MAMM GENOME, V10, P906, DOI 10.1007/s003359901112; Jakubczak JL, 1996, P NATL ACAD SCI USA, V93, P9073, DOI 10.1073/pnas.93.17.9073; KOHLER SW, 1991, P NATL ACAD SCI USA, V88, P7958, DOI 10.1073/pnas.88.18.7958; Krawczak M, 1998, AM J HUM GENET, V63, P474, DOI 10.1086/301965; Kuraguchi M, 2000, ONCOGENE, V19, P5755, DOI 10.1038/sj.onc.1203962; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; LEROY JL, 1988, J MOL BIOL, V200, P223, DOI 10.1016/0022-2836(88)90236-7; LUONGO C, 1994, CANCER RES, V54, P5947; MILLAR CH, UNPUB; NEDDERMANN P, 1993, J BIOL CHEM, V268, P21218; Petronzelli F, 2000, J BIOL CHEM, V275, P32422, DOI 10.1074/jbc.M004535200; Petronzelli F, 2000, J CELL PHYSIOL, V185, P473, DOI 10.1002/1097-4652(200012)185:3<473::AID-JCP19>3.0.CO;2-#; Poole A, 2001, NAT REV MOL CELL BIO, V2, P147, DOI 10.1038/35052091; Riccio A, 1999, NAT GENET, V23, P266, DOI 10.1038/15443; SHEN JC, 1994, NUCLEIC ACIDS RES, V22, P972, DOI 10.1093/nar/22.6.972; Shoemaker AR, 1997, CANCER RES, V57, P1999; SKARNES WC, 1995, P NATL ACAD SCI USA, V92, P6592, DOI 10.1073/pnas.92.14.6592; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; WIEBAUER K, 1989, NATURE, V339, P234, DOI 10.1038/339234a0	25	242	254	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 19	2002	297	5580					403	405		10.1126/science.1073354	http://dx.doi.org/10.1126/science.1073354			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574LV	12130785	Green Submitted			2022-12-24	WOS:000176892600052
J	Baek, SH; Ohgi, KA; Rose, DW; Koo, EH; Glass, CK; Rosenfeld, MG				Baek, SH; Ohgi, KA; Rose, DW; Koo, EH; Glass, CK; Rosenfeld, MG			Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-kappa B and beta-amyloid precursor protein	CELL			English	Article							NUCLEAR RECEPTOR-COREPRESSOR; SIGNAL-TRANSDUCTION PATHWAY; INTRACELLULAR DOMAIN; HISTONE DEACETYLASE; METASTASIS SUPPRESSOR; ALZHEIMER-DISEASE; TAK1 MAPKKK; REPRESSION; RELEASE; GAMMA	Defining the molecular mechanisms that integrate diverse signaling pathways at the level of gene transcription remains a central issue in biology. Here, we demonstrate that interleukin-1beta (IL-1beta) causes nuclear export of a specific N-CoR corepressor complex, resulting in derepression of a specific subset of NF-kappaB-regulated genes, exemplified by the tetraspanin KA/1 that regulates membrane receptor function. Nuclear export of the N-CoR/TAB2/HDAC3 complex by IL-1beta is temporally linked to selective recruitment of a Tip60 coactivator complex. Surprisingly, KA/1 is also directly activated by a ternary complex, dependent on the acetyltransferase activity of Tip60, consisting of the presenilin-dependent C-terminal cleavage product of the amyloid beta precursor protein (APP), Fe65, and Tip60, identifying a specific in vivo gene target of an APP-dependent transcription complex in the brain.	Univ Calif San Diego, Howard Hughes Med Inst, Dept Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cellular & Mol Med, Sch Med, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Rosenfeld, MG (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Dept Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.		Glass, Christopher/AAI-3933-2021	Glass, Christopher/0000-0003-4344-3592				Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Borg JP, 1996, MOL CELL BIOL, V16, P6229; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Dechend R, 1999, ONCOGENE, V18, P3316, DOI 10.1038/sj.onc.1202717; DONG JT, 1995, SCIENCE, V268, P884, DOI 10.1126/science.7754374; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; FUJITA T, 1993, GENE DEV, V7, P1354, DOI 10.1101/gad.7.7b.1354; Glass CK, 2000, GENE DEV, V14, P121; Guenther MG, 2000, GENE DEV, V14, P1048; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; Kao HY, 1998, GENE DEV, V12, P2269, DOI 10.1101/gad.12.15.2269; Kimberly WT, 2001, J BIOL CHEM, V276, P40288, DOI 10.1074/jbc.C100447200; KOO EH, 1994, J BIOL CHEM, V269, P17386; Lavinsky RM, 1998, P NATL ACAD SCI USA, V95, P2920, DOI 10.1073/pnas.95.6.2920; Lee FS, 1997, CELL, V88, P213, DOI 10.1016/S0092-8674(00)81842-5; Li J, 2001, J BIOL CHEM, V276, P18579, DOI 10.1074/jbc.M100846200; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Lim GP, 2000, J NEUROSCI, V20, P5709, DOI 10.1523/JNEUROSCI.20-15-05709.2000; Maecker HT, 1997, FASEB J, V11, P428, DOI 10.1096/fasebj.11.6.9194523; Mattson MP, 2001, J CLIN INVEST, V107, P247, DOI 10.1172/JCI11916; McKay LI, 1999, ENDOCR REV, V20, P435, DOI 10.1210/er.20.4.435; Mrak RE, 2000, J NEUROPATH EXP NEUR, V59, P471, DOI 10.1093/jnen/59.6.471; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Odintsova E, 2000, CURR BIOL, V10, P1009, DOI 10.1016/S0960-9822(00)00652-7; Passer Brent, 2000, Journal of Alzheimer's Disease, V2, P289; Perissi V, 1999, GENE DEV, V13, P3198, DOI 10.1101/gad.13.24.3198; Pinnix I, 2001, J BIOL CHEM, V276, P481, DOI 10.1074/jbc.M005968200; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Smith CL, 1997, MOL ENDOCRINOL, V11, P657, DOI 10.1210/me.11.6.657; Steiner H, 2001, J MOL NEUROSCI, V17, P193, DOI 10.1385/JMN:17:2:193; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Underhill C, 2000, J BIOL CHEM, V275, P40463, DOI 10.1074/jbc.M007864200; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Wen YD, 2000, P NATL ACAD SCI USA, V97, P7202, DOI 10.1073/pnas.97.13.7202; Wyss-Coray T, 2000, NAT MED, V6, P973, DOI 10.1038/79661; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9	45	471	504	1	16	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 12	2002	110	1					55	67		10.1016/S0092-8674(02)00809-7	http://dx.doi.org/10.1016/S0092-8674(02)00809-7			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	573PU	12150997	Bronze			2022-12-24	WOS:000176840700007
J	Clack, JA				Clack, JA			An early tetrapod from 'Romer's Gap'	NATURE			English	Article							ACANTHOSTEGA GUNNARI JARVIK; CARBONIFEROUS TETRAPOD; EVOLUTION; SKELETON; ANATOMY	The fossil record of early tetrapods has been increased recently by new finds from the Devonian period(1) and mid-late Early Carboniferous period(2). Despite this, understanding of tetrapod evolution has been hampered by a 20-million-year gap ('Romer's Gap'(3)) that covers the crucial, early period when many key features of terrestrial tetrapods were acquired. Here I describe the only articulated skeleton of a tetrapod, Pederpes, yet found from the Tournaisian epoch (354-344 million years ago (Myr)). The new taxon includes a pes with five robust digits, but a very small, possibly supernumerary digit preserved on the manus suggests the presence of polydactyly. Polydactylous early tetrapods may have survived beyond the end of the Devonian and pentadactyly cannot be assumed for the pes. However, the pes has characteristics that distinguish it from the paddle-like feet of the Devonian forms and resembles the feet of later, more terrestrially adapted Carboniferous forms. Pederpes is the earliest-known tetrapod to show the beginnings of terrestrial locomotion and was at least functionally pentadactyl. With its later American sister-genus, Whatcheeria(4,5), it represents the next most primitive tetrapod clade after those of the Late Devonian, bridging the temporal, morphological and phylogenetic gaps that have hitherto separated Late Devonian and mid-Carboniferous tetrapod faunas.	Univ Cambridge, Museum Zool, Cambridge CB2 3EJ, England	University of Cambridge	Clack, JA (corresponding author), Univ Cambridge, Museum Zool, Downing St, Cambridge CB2 3EJ, England.	j.a.clack@zoo.cam.ac.uk	TATSUTA, HARUKI/F-2997-2010					Anderson JS, 2001, SYST BIOL, V50, P170; Bolt John R., 2000, P1044; CAMERON IB, 1985, BRIT GEOLOGICAL SURV; CARROLL RL, 1995, STUDIES EARLY VERTEB, P389; CLACK JA, 1994, T ROY SOC EDIN-EARTH, V84, P369; Clack JA, 1998, ZOOL J LINN SOC-LOND, V122, P61, DOI 10.1006/zjls.1997.0114; CLACK JA, 1994, NATURE, V369, P392, DOI 10.1038/369392a0; Clack JA, 1998, NATURE, V394, P66, DOI 10.1038/27895; Clack Jennifer A., 2000, Amphibian Biology, V4, P1030; Clack Jennifer A., 2000, Amphibian Biology, V4, P979; Coates MI, 1996, T ROY SOC EDIN-EARTH, V87, P363, DOI 10.1017/S0263593300006787; COATES MI, 1990, NATURE, V347, P66, DOI 10.1038/347066a0; COATES MI, 1995, STUDIES EARLY VERTEB, P373; GODFREY SJ, 1989, PHILOS T ROY SOC B, V323, P75, DOI 10.1098/rstb.1989.0002; HOLMES R, 1984, PHILOS T ROY SOC B, V306, P431, DOI 10.1098/rstb.1984.0103; Laurin Michel, 1997, P9, DOI 10.1016/B978-012676460-4/50003-2; LEBEDEV OA, 1995, ZOOL J LINN SOC-LOND, V114, P307, DOI 10.1006/zjls.1995.0027; LOMBARD RE, 1995, PALAEONTOLOGY, V38, P471; MADDISON WP, 1992, MACCLADE VERSION 3 0; Milner AC, 1998, ZOOL J LINN SOC-LOND, V122, P211, DOI 10.1111/j.1096-3642.1998.tb02530.x; PANCHEN AL, 1985, PHILOS T ROY SOC B, V309, P505, DOI 10.1098/rstb.1985.0095; PATERSON IB, 1990, BRIT GEOLOGICAL SURV; Paton RL, 1999, NATURE, V398, P508, DOI 10.1038/19071; SWOFFORD DL, 1993, PAUP PHYLOGENETIC EN	24	104	109	2	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 4	2002	418	6893					72	76		10.1038/nature00824	http://dx.doi.org/10.1038/nature00824			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569JL	12097908				2022-12-24	WOS:000176599200040
J	Starr, DA; Han, M				Starr, DA; Han, M			Role of ANC-1 in tethering nuclei to the actin cytoskeleton	SCIENCE			English	Article							PROTEIN; MIGRATION; NEMATODE; MEMBRANE; ENVELOPE; UNC-84; FAMILY; CELLS; GENE	Mutations in anc-1 (nuclear anchorage defective) disrupt the positioning of nuclei and mitochondria in Caenorhabditis elegans. ANC-1 is shown to consist of mostly coiled regions with a nuclear envelope localization domain (called the KASH domain) and an actin-binding domain; this structure was conserved with the Drosophila protein Msp-300 and the mammalian Syne proteins. Antibodies against ANC-1 localized cytoplasmically and were enriched at the nuclear periphery in an UNC-84 dependent manner. Overexpression of the KASH domain or the actin-binding domain caused a dominant negative anchorage defect. Thus, ANC-1 may connect nuclei to the cytoskeleton by interacting with UNC-84 at the nuclear envelope and with actin in the cytoplasm.	Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA; Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Han, M (corresponding author), Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA.	mhan@colorado.edu		Starr, Daniel/0000-0001-7339-6606	NIGMS NIH HHS [F32 GM020127] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM020127] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Apel ED, 2000, J BIOL CHEM, V275, P31986, DOI 10.1074/jbc.M004775200; Burton EA, 2002, CELL, V108, P5, DOI 10.1016/S0092-8674(01)00626-2; Chytilova E, 2000, MOL BIOL CELL, V11, P2733, DOI 10.1091/mbc.11.8.2733; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gimona M, 2002, FEBS LETT, V513, P98, DOI 10.1016/S0014-5793(01)03240-9; Guild GM, 1997, J CELL BIOL, V138, P783, DOI 10.1083/jcb.138.4.783; HEDGECOCK EM, 1982, CELL, V30, P321, DOI 10.1016/0092-8674(82)90038-1; HORVITZ HR, 1980, GENETICS, V96, P435; Lee KK, 2002, MOL BIOL CELL, V13, P892, DOI 10.1091/mbc.01-06-0294; Malone CJ, 1999, DEVELOPMENT, V126, P3171; Mislow JMK, 2002, J CELL SCI, V115, P61; Morris NR, 2000, J CELL BIOL, V148, P1097, DOI 10.1083/jcb.148.6.1097; Mosley-Bishop KL, 1999, CURR BIOL, V9, P1211, DOI 10.1016/S0960-9822(99)80501-6; Ono S, 1999, J CELL BIOL, V145, P491, DOI 10.1083/jcb.145.3.491; Reinsch S, 1998, J CELL SCI, V111, P2283; RosenbergHasson Y, 1996, MECH DEVELOP, V60, P83, DOI 10.1016/S0925-4773(96)00602-8; Starr DA, 2001, DEVELOPMENT, V128, P5039; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; VOLK T, 1992, DEVELOPMENT, V116, P721; Welte MA, 1998, CELL, V92, P547, DOI 10.1016/S0092-8674(00)80947-2; YAN Y, 1993, SCIENCE, V262, P2027, DOI 10.1126/science.8266097; Zhang QP, 2001, J CELL SCI, V114, P4485; Zhen YY, 2002, J CELL SCI, V115, P3207	23	302	317	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 11	2002	298	5592					406	409		10.1126/science.1075119	http://dx.doi.org/10.1126/science.1075119			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	602NB	12169658				2022-12-24	WOS:000178510400046
J	Pukkala, E; Aspholm, R; Auvinen, A; Eliasch, H; Gundestrup, M; Haldorsen, T; Hammar, N; Hrafnkelsson, J; Kyyronen, P; Linnersjo, A; Raffnsson, V; Storm, H; Tveten, U				Pukkala, E; Aspholm, R; Auvinen, A; Eliasch, H; Gundestrup, M; Haldorsen, T; Hammar, N; Hrafnkelsson, J; Kyyronen, P; Linnersjo, A; Raffnsson, V; Storm, H; Tveten, U			Incidence of cancer among Nordic airline pilots over five decades: occupational cohort study	BRITISH MEDICAL JOURNAL			English	Article							CABIN ATTENDANTS; BREAST-CANCER; MORTALITY; RADIATION; FLIGHT; LEUKEMIA; EXPOSURE; RISK	Objective To assess the incidence of cancer among male airline pilots in the Nordic countries, with special reference to risk related to cosmic radiation. Design Retrospective cohort study, with follow up of cancer incidence through the national cancer registries. Setting Denmark, Finland, Iceland, Norway, and Sweden. Participants 10 032 male airline pilots, with an average follow up of 17 years. Main outcome measures Standardised incidence ratios, with expected numbers based on national cancer incidence rates; dose-response analysis using Poisson regression. Results 466 cases of cancer were diagnosed compared with 456 expected. The only significantly increased standardised incidence ratios were for skin cancer: melanoma 2.3 (95% confidence interval 1.7 to 3.0), non-melanoma 2.1 (1.7 to 2.8), basal cell carcinoma 2.5 (1.9 to 3.2). The relative risk of skin cancers increased with the estimated radiation dose. The relative risk of prostate cancer increased with increasing number of flight hours in long distance aircraft. Conclusions This study does not indicate a marked increase in cancer risk attributable to cosmic radiation, although some influence of cosmic radiation on skin cancer cannot be entirely excluded. The suggestion of an association between number of long distance flights (possibly related to circadian hormonal disturbances) and prostate cancer needs to be confirmed.	Finnish Canc Registry, Inst Stat & Epidemiol Canc Res, FIN-00170 Helsinki, Finland; Pilots Assoc, Finnish Airline, FIN-01530 Vantaa, Finland; STUK, Radiat & Nucl Safety Author, FIN-00881 Helsinki, Finland; Swedish SAS, S-19587 Stockholm, Sweden; Univ Hosp, Natl Clin Aviat Med, Ctr Heart, DK-2220 Copenhagen N, Denmark; Kreftregisteret, Inst Populat Based Canc Res, N-0310 Oslo, Norway; Karolinska Inst, Inst Environm Med, S-17177 Stockholm, Sweden; Stockholm Ctr Publ Hlth, Dept Epidemiol, S-17176 Stockholm, Sweden; Landspitalinn, Dept Oncol, IS-105 Reykjavik, Iceland; Univ Iceland, Dept Prevent Med, IS-105 Reykjavik, Iceland; Danish Canc Soc, Canc Prevent & Documentat, DK-2100 Copenhagen O, Denmark; Inst Energy Technol, N-2007 Kjeller, Norway	Finnish Cancer Registry; Radiation & Nuclear Safety Authority (STUK); Karolinska Institutet; University of Iceland; Danish Cancer Society; Institute for Energy Technology (IFE)	Pukkala, E (corresponding author), Finnish Canc Registry, Inst Stat & Epidemiol Canc Res, Liisankatu 21 B, FIN-00170 Helsinki, Finland.		Auvinen, Anssi/AAD-9311-2020; Auvinen, Anssi/AAL-2111-2020	Auvinen, Anssi/0000-0003-1125-4818; Storm, Hans/0000-0001-7223-8198				ANDERSEN A, 1999, SCAND J WORK ENV S2, V25; Armstrong BK, 1996, CANC EPIDEMIOLOGY PR, P1282; Ballard T, 2000, AVIAT SPACE ENVIR MD, V71, P216; BAND PR, 1990, AVIAT SPACE ENVIR MD, V61, P299; Band PR, 1996, AM J EPIDEMIOL, V143, P137; CARDIS E, 1995, RADIAT RES, V142, P117, DOI 10.2307/3579020; DIFFEY BL, 1990, AVIAT SPACE ENVIR MD, V61, P1032; Gundestrup M, 1999, LANCET, V354, P2029, DOI 10.1016/S0140-6736(99)05093-X; Haldorsen T, 2001, INT J EPIDEMIOL, V30, P825, DOI 10.1093/ije/30.4.825; Haldorsen T, 2000, SCAND J WORK ENV HEA, V26, P106, DOI 10.5271/sjweh.519; Hammar N, 2002, AVIAT SPACE ENVIR MD, V73, P2; ICRP, 1991, ANN ICRP, V21, P1; Irvine D, 1999, AVIAT SPACE ENVIR MD, V70, P548; KAJI M, 1993, AVIAT SPACE ENVIR MD, V64, P748; PUKKALA E, 1995, BRIT MED J, V311, P649, DOI 10.1136/bmj.311.7006.649; Pukkala E, 1995, CONTRIBUTIONS EPIDEM, V7; Rafnsson V, 2000, OCCUP ENVIRON MED, V57, P175, DOI 10.1136/oem.57.3.175; Rafnsson V, 2001, CANCER CAUSE CONTROL, V12, P95, DOI 10.1023/A:1008983416836; Stevens RG, 1996, ENVIRON HEALTH PERSP, V104, P135, DOI 10.2307/3432703; Tveten U, 2000, RADIAT PROT DOSIM, V87, P157, DOI 10.1093/oxfordjournals.rpd.a032992	20	109	116	0	17	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 14	2002	325	7364					567	569		10.1136/bmj.325.7364.567	http://dx.doi.org/10.1136/bmj.325.7364.567			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	595JJ	12228131	Bronze, Green Published			2022-12-24	WOS:000178105200015
J	Manheimer, E; Anderson, D				Manheimer, E; Anderson, D			Survey of public information about ongoing clinical trials funded by industry: evaluation of completeness and accessibility	BRITISH MEDICAL JOURNAL			English	Article							ACCESS	Objective To evaluate the completeness and accessibility of public information about US clinical trials of drugs in development. Design Review of online registers of clinical trials. Data sources Drugs in phase Ell trials were identified using three drug industry sources: PhRMA Survey, What's in the Pipeline, and the NDA Pipeline. Drug trials were then searched for on the following publicly accessible registers of clinical trials: CancerNet.gov, CenterWatch.com, ClinicalTrials.gov, and registers associated with the 37 "Comprehensive Cancer Centers" designated by the National Cancer Institute. Main outcome measure Extent of availability of public information on phase III trials of drugs in development for treating either prostate or colon cancer. Results Search of industry sources identified 12 drugs for prostate cancer and 20 for colon cancer undergoing phase III trials. The most comprehensive publicly available register, ClinicalTrials.gov, contained trial listings for only seven of the prostate cancer drugs and 10 of the colon cancer drugs. Trials of three prostate cancer and three colon cancer drugs were listed on only one register each. A substantial proportion of trials of prostate cancer drugs (3/12) and colon cancer drugs (8/20) were not associated with trial listings in any registers. Conclusions Existing trials registers are unlikely to be meeting user needs since many ongoing drug trials are not listed. There is a clear need for a comprehensive clinical trials register encompassing all ongoing trials, including industry sponsored trials.	Brown Univ, Ctr Clin Trials & Evidence Based Healthcare, Providence, RI 02912 USA	Brown University	Manheimer, E (corresponding author), Brown Univ, Ctr Clin Trials & Evidence Based Healthcare, 169 Angell St, Providence, RI 02912 USA.							*AM SOC CLIN ONC, ASCO SURV PHARM IND; Anderson D., 2001, CONTROL CLIN TRIALS, V22, p40S; Chalmers I., 2001, SYSTEMATIC REV HLTH, P429, DOI DOI 10.1002/9780470693926.CH24; *DEP HLTH RES DEV, RES GOV FRAM; Dickersin K, 1998, CLIN OBSTET GYNECOL, V41, P315, DOI 10.1097/00003081-199806000-00012; Dickersin K, 2002, EVAL HEALTH PROF, V25, P38, DOI 10.1177/0163278702025001004; Egger M., 2008, SYSTEMATIC REV HLTH; HETHERINGTON J, 1989, PEDIATRICS, V84, P374; Horton R, 1999, BRIT MED J, V319, P865, DOI 10.1136/bmj.319.7214.865; McCray AT, 2000, ANN INTERN MED, V133, P609, DOI 10.7326/0003-4819-133-8-200010170-00013; METZ JM, 2001, P AN M AM SOC CLIN, V20, pA395; *PHRMA, PHRMA 1999 SURV NEW; Rennie D, 1999, JAMA-J AM MED ASSOC, V282, P1766, DOI 10.1001/jama.282.18.1766; SCHERER RW, 1994, JAMA-J AM MED ASSOC, V272, P158, DOI 10.1001/jama.272.2.158; Shepperd S, 1999, BMJ-BRIT MED J, V319, P764, DOI 10.1136/bmj.319.7212.764; Sykes R, 1998, BRIT MED J, V317, P1172, DOI 10.1136/bmj.317.7167.1172; *US NAT LIB MED, UN MED LANG SYST UML; VALE CL, 2001, P 9 ANN COCHR C, P78; 2000, R DIRECTIONS, P6; 1999, R DIRECTIONS, P5	20	35	35	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 7	2002	325	7363					528	531		10.1136/bmj.325.7363.528	http://dx.doi.org/10.1136/bmj.325.7363.528			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	593NJ	12217994	Bronze, Green Published			2022-12-24	WOS:000177997800020
J	Gutfreund, Y; Zheng, WM; Knudsen, EI				Gutfreund, Y; Zheng, WM; Knudsen, EI			Gated visual input to the central auditory system	SCIENCE			English	Article							OPTIC TECTUM; SPACE MAP; BARN OWL; INFERIOR COLLICULUS; REPRESENTATION; CALIBRATION; EXPERIENCE; PLASTICITY; ADJUSTMENT; MIDBRAIN	The central auditory system translates sound localization cues into a map of space guided, in part, by visual experience. In barn owls, this process takes place in the external nucleus of the inferior colliculus (ICX). However, to date, no trace of visual activity has been observed in this auditory nucleus. Here we show that strong visual responses, which are appropriate to guide auditory plasticity, appear in the ICX when inhibition is blocked in the optic tectum. Thus, visual spatial information is gated into the auditory system by an inhibitory mechanism that operates at a higher level in the brain.	Stanford Univ, Dept Neurobiol, Sch Med, Stanford, CA 94305 USA	Stanford University	Gutfreund, Y (corresponding author), Stanford Univ, Dept Neurobiol, Sch Med, Stanford, CA 94305 USA.				NIDCD NIH HHS [DC 00155-2] Funding Source: Medline	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BRAINARD MS, 1993, J NEUROSCI, V13, P4589; Feldman DE, 1997, J NEUROSCI, V17, P6820; FELIX D, 1994, NEUROSCI LETT, V169, P212, DOI 10.1016/0304-3940(94)90394-8; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; Hyde PS, 2000, J COMP NEUROL, V421, P146, DOI 10.1002/(SICI)1096-9861(20000529)421:2<146::AID-CNE2>3.0.CO;2-5; Hyde PS, 2002, NATURE, V415, P73, DOI 10.1038/415073a; Hyde PS, 2001, J NEUROSCI, V21, P8586, DOI 10.1523/JNEUROSCI.21-21-08586.2001; Kim JJ, 1998, SCIENCE, V279, P570, DOI 10.1126/science.279.5350.570; KING AJ, 1993, EXP BRAIN RES, V94, P444; King AJ, 1999, BIOESSAYS, V21, P900, DOI 10.1002/(SICI)1521-1878(199911)21:11<900::AID-BIES2>3.0.CO;2-6; KNUDSEN EI, 1982, J NEUROSCI, V2, P1177; KNUDSEN EI, 1991, J NEUROSCI, V11, P1727; KNUDSEN EI, 1991, SCIENCE, V253, P85, DOI 10.1126/science.2063209; Luksch H, 2000, J NEUROSCI, V20; OLSEN JF, 1989, J NEUROSCI, V9, P2591; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; VEENMAN CL, 1994, J COMP NEUROL, V344, P161, DOI 10.1002/cne.903440202; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; Zheng WM, 2001, J NEUROSCI, V21, P4356, DOI 10.1523/JNEUROSCI.21-12-04356.2001	19	73	75	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 30	2002	297	5586					1556	1559		10.1126/science.1073712	http://dx.doi.org/10.1126/science.1073712			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588JA	12202831				2022-12-24	WOS:000177697300058
J	Jetz, W; Rahbek, C				Jetz, W; Rahbek, C			Geographic range size and determinants of avian species richness	SCIENCE			English	Article							HABITAT HETEROGENEITY; GEOMETRIC CONSTRAINTS; LATITUDINAL GRADIENTS; PATTERNS; ENERGY; DIVERSITY; MODEL	Geographic patterns in species richness are mainly based on wide-ranging species because their larger number of distribution records has a disproportionate contribution to the species richness counts. Here we demonstrate how this effect strongly influences our understanding of what determines species richness. Using both conventional and spatial regression models, we show that for sub-Saharan African birds, the apparent role of productivity diminishes with decreasing range size, whereas the significance of topographic heterogeneity increases. The relative importance of geometric constraints from the continental edge is moderate. Our findings highlight the failure of traditional species richness models to account for narrow-ranging species that frequently are also threatened.	Univ Oxford, Dept Zool, Oxford OX1 3PS, England; Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; Univ Copenhagen, Zool Museum, DK-2100 Copenhagen O, Denmark	University of Oxford; University of New Mexico; University of Copenhagen	Jetz, W (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	walter.jetz@zoo.ox.ac.uk	Jetz, Walter/ABF-1517-2020; Rahbek, Carsten/L-1129-2013; Rahbek, Carsten/D-9372-2013	Rahbek, Carsten/0000-0003-4585-0300; Jetz, Walter/0000-0002-1971-7277				Ahn C-H, 1994, J JAPANESE SOC PHOTO, V33, P12, DOI DOI 10.4287/JSPRS.33.2_12; Anderson S., 1985, AM MUS NOVIT, V2833, P1; [Anonymous], 1994, RARITY; Balmford A, 2001, SCIENCE, V291, P2616, DOI 10.1126/science.291.5513.2616; Brown JH, 1995, MACROECOLOGY; Burgess N. D., 1998, SPECIES, V30, P16; Cliff A. D., 1981, SPATIAL PROCESSES MO; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; COLWELL RK, 1994, AM NAT, V144, P570, DOI 10.1086/285695; CONNOR EF, 1979, AM NAT, V113, P791, DOI 10.1086/283438; Cressie Noel., 2015, STAT SPATIO TEMPORAL; CROWE TM, 1982, J ZOOL, V198, P417, DOI 10.1111/jzo.1982.198.4.417; CURRIE DJ, 1991, AM NAT, V137, P27, DOI 10.1086/285144; CURRIE DJ, 1987, NATURE, V329, P326, DOI 10.1038/329326a0; Elenga H, 2000, J BIOGEOGR, V27, P621, DOI 10.1046/j.1365-2699.2000.00430.x; GRAVES GR, 1985, AUK, V102, P556, DOI 10.1093/auk/102.3.556; Guegan JF, 1998, NATURE, V391, P382, DOI 10.1038/34899; Hansson L., 1995, MOSAIC LANDSCAPES EC; Jetz W, 2001, P NATL ACAD SCI USA, V98, P5661, DOI 10.1073/pnas.091100998; JETZ W, GEOMETRIC EFFECTS SP; Kerr JT, 1997, NATURE, V385, P252, DOI 10.1038/385252a0; Koleff P, 2001, ECOGRAPHY, V24, P341, DOI 10.1034/j.1600-0587.2001.240312.x; Lees DC, 1999, BIOL J LINN SOC, V67, P529, DOI 10.1111/j.1095-8312.1999.tb01945.x; Lennon JJ, 2000, ECOGRAPHY, V23, P101, DOI 10.1034/j.1600-0587.2000.230111.x; Lennon JJ, 2000, J ANIM ECOL, V69, P581, DOI 10.1046/j.1365-2656.2000.00418.x; New M, 1999, J CLIMATE, V12, P829, DOI 10.1175/1520-0442(1999)012<0829:RTCSTC>2.0.CO;2; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; PAGEL MD, 1991, AM NAT, V137, P791, DOI 10.1086/285194; POMEROY D, 1993, CONSERV BIOL, V7, P901, DOI 10.1046/j.1523-1739.1993.740901.x; Rahbek C, 2001, P NATL ACAD SCI USA, V98, P4534, DOI 10.1073/pnas.071034898; Ricklefs Robert E., 1993, P350; Rosenzweig Michael L., 1993, P52; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Stattersfield A J, 2000, THREATENED BIRDS WOR, P205; TURNER JRG, 1988, NATURE, V335, P539, DOI 10.1038/335539a0; *USGS USAID AFR DA, AVHRR NDVI; Willig MR, 1998, OIKOS, V81, P93, DOI 10.2307/3546471; WOODWARD FI, 1995, GLOBAL BIOGEOCHEM CY, V9, P471, DOI 10.1029/95GB02432	38	503	547	9	183	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2002	297	5586					1548	1551		10.1126/science.1072779	http://dx.doi.org/10.1126/science.1072779			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588JA	12202829				2022-12-24	WOS:000177697300056
J	Wettey, FR; Hawkins, SFC; Stewart, A; Luzio, JP; Howard, JC; Jackson, AP				Wettey, FR; Hawkins, SFC; Stewart, A; Luzio, JP; Howard, JC; Jackson, AP			Controlled elimination of clathrin heavy-chain expression in DT40 lymphocytes	SCIENCE			English	Article							PROTEIN-KINASE-B; SIGNAL-TRANSDUCTION; LYSOSOMAL-ENZYMES; PLASMA-MEMBRANE; RECEPTOR; TRAFFICKING; CELLS; TRANSFECTION; TRANSFERRIN; ENDOCYTOSIS	We exploited the high rate of homologous recombination shown by the chicken B cell line DT40 to inactivate the endogenous alleles for clathrin heavy chain and replace them with human clathrin complementary DNA under the control of a tetracycline-regulatable promoter. Clathrin repression perturbed the activities of Akt-mediated and mitogen-activated protein kinase mediated signaling pathways and induced apoptosis; this finding suggests that in DT40 cells clathrin helps to maintain the integrity of antiapoptotic survival pathways. We also describe a variant cell line in which these signaling pathways were unaffected by clathrin down-regulation. This variant cell line did not undergo apoptosis in the absence of clathrin and was used to examine the effects of clathrin depletion on membrane-trafficking pathways. Receptor-mediated and fluid-phase endocytosis were both substantially inhibited, and transferrin-receptor recycling was modestly inhibited. Surprisingly, clathrin removal did not affect the morphology or biochemical composition of lysosomes.	Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; Univ Cologne, Inst Genet, D-50674 Cologne, Germany; Addenbrookes Hosp, Dept Clin Biochem, Cambridge CB2 2XY, England; Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge CB2 2XY, England	University of Cambridge; University of Cologne; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Jackson, AP (corresponding author), Univ Cambridge, Dept Biochem, Bldg O,Downing Site,Tennis Court Rd, Cambridge CB2 1QW, England.	a.p.jackson@bioc.cam.ac.uk		Jackson, Antony Philip/0000-0002-2895-7387				ACTON SL, 1993, MOL BIOL CELL, V4, P647, DOI 10.1091/mbc.4.6.647; BAASS PC, 1995, TRENDS CELL BIOL, V5, P465, DOI 10.1016/S0962-8924(00)89116-3; BABA TW, 1985, VIROLOGY, V144, P139, DOI 10.1016/0042-6822(85)90312-5; Babst M, 2000, TRAFFIC, V1, P248, DOI 10.1034/j.1600-0854.2000.010307.x; Balbis A, 2000, ENDOCRINOLOGY, V141, P4041, DOI 10.1210/en.141.11.4041; Benmerah A, 1998, J CELL BIOL, V140, P1055, DOI 10.1083/jcb.140.5.1055; Bennett EM, 2001, MOL BIOL CELL, V12, P2790, DOI 10.1091/mbc.12.9.2790; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Bright NA, 1997, J CELL SCI, V110, P2027; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; Carpenter G, 2000, BIOESSAYS, V22, P697, DOI 10.1002/1521-1878(200008)22:8<697::AID-BIES3>3.3.CO;2-T; Ceresa BP, 2000, CURR OPIN CELL BIOL, V12, P204, DOI 10.1016/S0955-0674(99)00077-0; CHANG MP, 1993, EMBO J, V12, P2169, DOI 10.1002/j.1460-2075.1993.tb05865.x; Copier J, 1998, IMMUNOLOGY, V93, P505; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Dittmer F, 1999, J CELL SCI, V112, P1591; DOXSEY SJ, 1987, CELL, V50, P453, DOI 10.1016/0092-8674(87)90499-5; Evan G, 1998, SCIENCE, V281, P1317, DOI 10.1126/science.281.5381.1317; GABEL CA, 1984, J CELL BIOL, V99, P296, DOI 10.1083/jcb.99.1.296; Gold MR, 1999, J IMMUNOL, V163, P1894; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GRAHAM J, 1993, METHODS MOLEC BIOL, V19; Hueber AO, 1998, TRENDS GENET, V14, P364, DOI 10.1016/S0168-9525(98)01520-0; Jin J, 2001, DEV CELL, V1, P817, DOI 10.1016/S1534-5807(01)00090-9; KARIN M, 1981, J BIOL CHEM, V256, P3245; Lahti JM, 1999, METHODS, V17, P305, DOI 10.1006/meth.1999.0744; LEMMON SK, 1987, SCIENCE, V238, P504, DOI 10.1126/science.3116672; LIPPINCOTTSCHWARTZ J, 1987, CELL, V49, P669, DOI 10.1016/0092-8674(87)90543-5; Luzio JP, 2000, J CELL SCI, V113, P1515; Moore DD, 1995, GLOB MOB SURV; PAYNE GS, 1987, MOL CELL BIOL, V7, P3888, DOI 10.1128/MCB.7.11.3888; Peden AA, 2002, J CELL BIOL, V156, P327, DOI 10.1083/jcb.200107140; RUSCETTI T, 1994, J CELL BIOL, V126, P343, DOI 10.1083/jcb.126.2.343; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; SEEGER M, 1992, EMBO J, V11, P2811, DOI 10.1002/j.1460-2075.1992.tb05348.x; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; Traub LM, 1996, J CELL BIOL, V135, P1801, DOI 10.1083/jcb.135.6.1801; van Dam EM, 2002, MOL BIOL CELL, V13, P169, DOI 10.1091/mbc.01-07-0380; WETTEY FR, UNPUB; Winding P, 2001, J IMMUNOL METHODS, V249, P1, DOI 10.1016/S0022-1759(00)00333-1; Xue LZ, 1999, MOL CELL NEUROSCI, V14, P180, DOI 10.1006/mcne.1999.0780	43	57	58	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2002	297	5586					1521	1525		10.1126/science.1074222	http://dx.doi.org/10.1126/science.1074222			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588JA	12202821				2022-12-24	WOS:000177697300048
J	Chow, A; Toomre, D; Garrett, W; Mellman, I				Chow, A; Toomre, D; Garrett, W; Mellman, I			Dendritic cell maturation triggers retrograde MHC class II transport from lysosomes to the plasma membrane	NATURE			English	Article							EVANESCENT-WAVE MICROSCOPY; DEVELOPMENTAL REGULATION; ENDOCYTIC COMPARTMENTS; INFLAMMATORY STIMULI; DOWN-REGULATION; SURFACE; MACROPINOCYTOSIS; EXOCYTOSIS; COMPLEXES; IMMUNITY	Central to the initiation of immune responses is recognition of peptide antigen by T lymphocytes. The cell biology of dendritic cells makes them ideally suited for the essential process of antigen presentation(1). Their life cycle includes several stages characterized by distinct functions and mechanisms of regulation(2). Immature dendritic cells synthesize large amounts of major histocompatibility complex class II molecules (MHC II), but the alphabeta-dimers are targeted to late endosomes and lysosomes (often referred to as MHC class II compartments) where they reside unproductively with internalized antigens. After exposure to microbial products or inflammatory mediators, endocytosis is downregulated, the expression of co-stimulatory molecules is enhanced, and newly formed immunogenic MHC II-peptide complexes are transported to the cell surface(3-10). That these MHC II molecules reach the surface is surprising, as the lysosomes comprise the terminal degradative compartment of the endocytic pathway from which exogenous components generally cannot be recovered intact(11). Here we have visualized this pathway in live dendritic cells by video microscopy, using cells expressing MHC II tagged with green fluorescent protein (GFP). We show that on stimulation, dendritic cells generate tubules from lysosomal compartments that go on to fuse directly with the plasma membrane.	Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Immunobiol Sect, Ludwig Inst Canc Res, New Haven, CT 06520 USA	Yale University; Ludwig Institute for Cancer Research; Yale University	Mellman, I (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, 333 Cedar St,POB 208002, New Haven, CT 06520 USA.		Mellman, Ira/ABG-5896-2020	Garrett, Wendy/0000-0002-5092-0150				Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; COLE NB, 1995, CURR OPIN CELL BIOL, V7, P55, DOI 10.1016/0955-0674(95)80045-X; De Veerman M, 1999, J IMMUNOL, V162, P144; Garrett WS, 2000, CELL, V102, P325, DOI 10.1016/S0092-8674(00)00038-6; Inaba K, 2000, J EXP MED, V191, P927, DOI 10.1084/jem.191.6.927; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Kleijmeer M, 2001, J CELL BIOL, V155, P53, DOI 10.1083/jcb.200103071; Kleijmeer MJ, 1997, J CELL BIOL, V139, P639, DOI 10.1083/jcb.139.3.639; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; Lankar D, 2002, J EXP MED, V195, P461, DOI 10.1084/jem.20011543; MATHIS DJ, 1983, P NATL ACAD SCI-BIOL, V80, P273, DOI 10.1073/pnas.80.1.273; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; OZATO K, 1980, J IMMUNOL, V124, P533; Pierre P, 1996, IMMUNITY, V4, P229, DOI 10.1016/S1074-7613(00)80431-8; Pierre P, 1998, CELL, V93, P1135, DOI 10.1016/S0092-8674(00)81458-0; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; RACOOSIN EL, 1993, J CELL BIOL, V121, P1011, DOI 10.1083/jcb.121.5.1011; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Schmoranzer J, 2000, J CELL BIOL, V149, P23, DOI 10.1083/jcb.149.1.23; Steyer JA, 2001, NAT REV MOL CELL BIO, V2, P268, DOI 10.1038/35067069; Stinchcombe JC, 1999, J CELL BIOL, V147, P1, DOI 10.1083/jcb.147.1.1; Toomre D, 2000, J CELL BIOL, V149, P33, DOI 10.1083/jcb.149.1.33; Toomre D, 2001, TRENDS CELL BIOL, V11, P298, DOI 10.1016/S0962-8924(01)02027-X; Turley SJ, 2000, SCIENCE, V288, P522, DOI 10.1126/science.288.5465.522; West MA, 2000, CURR BIOL, V10, P839, DOI 10.1016/S0960-9822(00)00595-9; Wubbolts R, 1996, J CELL BIOL, V135, P611, DOI 10.1083/jcb.135.3.611; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500	30	334	347	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 29	2002	418	6901					988	994		10.1038/nature01006	http://dx.doi.org/10.1038/nature01006			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588AP	12198549				2022-12-24	WOS:000177677500047
J	Genoux, D; Haditsch, U; Knobloch, M; Michalon, A; Storm, D; Mansuy, IM				Genoux, D; Haditsch, U; Knobloch, M; Michalon, A; Storm, D; Mansuy, IM			Protein phosphatase 1 is a molecular constraint on learning and memory	NATURE			English	Article							GENE-EXPRESSION; CREB; TERM; PHOSPHORYLATION; CALCINEURIN; INDUCTION; CAMKII; RATS; LTP	Repetition in learning is a prerequisite for the formation of accurate and long-lasting memory. Practice is most effective when widely distributed over time, rather than when closely spaced or massed. But even after efficient learning, most memories dissipate with time unless frequently used(1,2). The molecular mechanisms of these time-dependent constraints on learning and memory are unknown. Here we show that protein phosphatase 1 (PP1) determines the efficacy of learning and memory by limiting acquisition and favouring memory decline. When PP1 is genetically inhibited during learning, short intervals between training episodes are sufficient for optimal performance. The enhanced learning correlates with increased phosphorylation of cyclic AMP-dependent response element binding (CREB) protein, of Ca2+/calmodulin-dependent protein kinase II (CaMKII) and of the GluR1 subunit of the AMPA receptor; it also correlates with CREB-dependent gene expression that, in control mice, occurs only with widely distributed training. Inhibition of PP1 prolongs memory when induced after learning, suggesting that PP1 also promotes forgetting. This property may account for ageing-related cognitive decay, as old mutant animals had preserved memory. Our findings emphasize the physiological importance of PP1 as a suppressor of learning and memory, and as a potential mediator of cognitive decline during ageing.	ETH Honggerberg, Dept Biol, Swiss Fed Inst Technol, Inst Cell Biol, CH-8093 Zurich, Switzerland; Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Washington; University of Washington Seattle	Mansuy, IM (corresponding author), ETH Honggerberg, Dept Biol, Swiss Fed Inst Technol, Inst Cell Biol, CH-8093 Zurich, Switzerland.	isabelle.mansuy@cell.biol.ethz.ch	Knobloch, Marlen/A-9565-2015; Mansuy, Isabelle M/N-3042-2015	Knobloch, Marlen/0000-0002-7490-0285; Mansuy, Isabelle M/0000-0001-7785-5371; Michalon, Aubin/0000-0002-5246-4881				Abel T, 1998, SCIENCE, V279, P338, DOI 10.1126/science.279.5349.338; ALBERTS AS, 1994, MOL CELL BIOL, V14, P4398, DOI 10.1128/MCB.14.7.4398; Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; Connor JH, 1998, METH MOL B, V93, P41; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Foster TC, 2001, J NEUROSCI, V21, P4066, DOI 10.1523/JNEUROSCI.21-11-04066.2001; Gallagher M, 1997, ANNU REV PSYCHOL, V48, P339, DOI 10.1146/annurev.psych.48.1.339; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; HAGIWARA M, 1992, CELL, V70, P105, DOI 10.1016/0092-8674(92)90537-M; HUANG FL, 1976, EUR J BIOCHEM, V70, P419, DOI 10.1111/j.1432-1033.1976.tb11032.x; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; Lisman J, 1997, SCIENCE, V276, P2001, DOI 10.1126/science.276.5321.2001; Lisman JE, 2001, NEURON, V31, P191, DOI 10.1016/S0896-6273(01)00364-6; Malleret G, 2001, CELL, V104, P675, DOI 10.1016/S0092-8674(01)00264-1; Mansuy IM, 1998, NEURON, V21, P257, DOI 10.1016/S0896-6273(00)80533-4; Mansuy IM, 1998, CELL, V92, P39, DOI 10.1016/S0092-8674(00)80897-1; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Morishita W, 2001, NEURON, V32, P1133, DOI 10.1016/S0896-6273(01)00554-2; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Norris CM, 1998, J NEUROPHYSIOL, V80, P1567, DOI 10.1152/jn.1998.80.3.1567; Sara SJ, 2000, LEARN MEMORY, V7, P73, DOI 10.1101/lm.7.2.73; SAVE E, 1992, BEHAV NEUROSCI, V106, P447, DOI 10.1037/0735-7044.106.3.447; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Spear N.E., 1994, MEMORY PHENOMENA PRI; Spear NE, 1978, PROCESSING MEMORIES; Strack S, 1997, J NEUROCHEM, V68, P2119; Sweatt JD, 2001, CURR BIOL, V11, pR391, DOI 10.1016/S0960-9822(01)00216-0; Villarreal DM, 2002, NAT NEUROSCI, V5, P48, DOI 10.1038/nn776	30	343	360	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 29	2002	418	6901					970	975		10.1038/nature00928	http://dx.doi.org/10.1038/nature00928			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	588AP	12198546				2022-12-24	WOS:000177677500043
J	Pradhan, AD; Manson, JE; Rossouw, JE; Siscovick, DS; Mouton, CP; Rifai, N; Wallace, RB; Jackson, RD; Pettinger, MB; Ridker, PM				Pradhan, AD; Manson, JE; Rossouw, JE; Siscovick, DS; Mouton, CP; Rifai, N; Wallace, RB; Jackson, RD; Pettinger, MB; Ridker, PM			Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease - Prospective analysis from the Women's Health Initiative observational study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; POSTMENOPAUSAL WOMEN; PLASMA-CONCENTRATION; UNSTABLE ANGINA; INSULIN-RESISTANCE; ADIPOSE-TISSUE; RISK; INTERLEUKIN-6; OBESITY	Context Postmenopausal hormone replacement therapy (HRT) has been shown to elevate C-reactive protein (CRP) levels. Several inflammatory biomarkers, including CRP, are associated with increased cardiovascular risk. However, whether the,effect of HRT on CRP represents a clinical hazard is unknown. Objectives To assess the association between baseline levels of CRP and interleukin 6 (IL-6) and incident coronary heart disease (CHD) and to examine the relationship between baseline use of HRT, CRP, and IL-6 levels as they relate to subsequent vascular risk. Design, Setting, and Participants Prospective, nested case-control study of postmenopausal women, forming part of the Women's Health Initiative, a large, nationwide, observational study. Among 75343 women with no history of cardiovascular disease or cancer, 304 women who developed incident CHD were defined as cases and matched by age, smoking status, ethnicity, and follow-up time with 304 study participants who remained event free during a median observation period of 2.9 years. Main Outcome Measure Incidence of first myocardial infarction or death from CHD. Results Median baseline levels of CRP (0.33 vs 0.25 mg/dL; interquartile range [IQR], 0.14-0.71 vs 0.10-0.47; P < 001) and IL-6 (1.81 vs 1.47 pg/mL; IQR, 1.30-2.75 vs 1.05-2.15; P < .001) were significantly higher among cases compared with controls. In matched analyses, the odds ratio (OR) for incident CHD in the highest vs lowest quartile was 2.3 for CRP (95% confidence interval [CI], 1.4-3.7; P for trend = .002) and 3.3 for IL-6 (95% 10, 2.0-5.5; P for trend <.001), After additional adjustment for lipid and nonlipid risk factors, both inflammatory markers were significantly associated with a 2-fold increase in odds for CHD events. As anticipated, current use of HRT was associated with significantly elevated median CRP levels. However, there was no association between HRT and IL-6. In analyses comparing individuals with comparable baseline levels of either CRP or IL-6, those taking or not taking HRT had similar CHD ORs. In analyses stratified by HRT, we observed a positively graded relationship between plasma CRP levels and the OR for CHD among both users and nonusers of HRT across the full spectrum of baseline CRP. Conclusions These prospective findings indicate that CRP and IL-6 independently predict vascular events among apparently healthy postmenopausal women and that HRT increases CRP. However, use or nonuse of HRT had less importance as a predictor of cardiovascular risk than did baseline levels of either CRP or IL-6.	Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Div Prevent Med, Boston, MA 02215 USA; Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Div Cardiol, Boston, MA 02215 USA; Brigham & Womens Hosp, Leducq Ctr Mol & Genet Epidemiol Cardiovasc Disor, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA; NHLBI, Bethesda, MD 20892 USA; Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA USA; Univ Texas, Hlth Sci Ctr, Dept Family & Community Med, Div Community Geriatr, San Antonio, TX USA; Childrens Hosp, Med Ctr, Dept Pathol, Boston, MA 02115 USA; Univ Iowa, Coll Med, Dept Epidemiol, Iowa City, IA USA; Ohio State Univ, Div Endocrinol Diabet & Metab, Columbus, OH 43210 USA; Fred Hutchinson Canc Res Ctr, Womens Hlth Initiat Clin Coordinating Ctr, Seattle, WA 98104 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Texas System; University of Texas Health San Antonio; Harvard University; Boston Children's Hospital; University of Iowa; University System of Ohio; Ohio State University; Fred Hutchinson Cancer Center	Ridker, PM (corresponding author), Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Div Prevent Med, 900 Commonwealth Ave E, Boston, MA 02215 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063293] Funding Source: NIH RePORTER; WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH [N01WH032109] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 63293, HL 07575] Funding Source: Medline; WHI NIH HHS [N01-WH-3-2109] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); WHI NIH HHS		Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Barinas-Mitchell E, 2001, AM J EPIDEMIOL, V153, P1094, DOI 10.1093/aje/153.11.1094; Biasucci LM, 1999, CIRCULATION, V99, P855, DOI 10.1161/01.CIR.99.7.855; Cushman M, 1999, ARTERIOSCL THROM VAS, V19, P893, DOI 10.1161/01.ATV.19.4.893; Cushman M, 1999, CIRCULATION, V100, P717, DOI 10.1161/01.CIR.100.7.717; Danesh J, 2000, BMJ-BRIT MED J, V321, P199, DOI 10.1136/bmj.321.7255.199; Hak AE, 1999, ARTERIOSCL THROM VAS, V19, P1986, DOI 10.1161/01.ATV.19.8.1986; Harris TB, 1999, AM J MED, V106, P506, DOI 10.1016/S0002-9343(99)00066-2; Hastie TJ., 1990, GEN ADDITIVE MODELS; Haverkate F, 1997, LANCET, V349, P462, DOI 10.1016/S0140-6736(96)07591-5; Hemminki E, 1997, BRIT MED J, V315, P149, DOI 10.1136/bmj.315.7101.149; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Koenig W, 1999, CIRCULATION, V99, P237, DOI 10.1161/01.CIR.99.2.237; Kuller LH, 1996, AM J EPIDEMIOL, V144, P537, DOI 10.1093/oxfordjournals.aje.a008963; Lindahl B, 2000, NEW ENGL J MED, V343, P1139, DOI 10.1056/NEJM200010193431602; LIUZZO G, 1994, NEW ENGL J MED, V331, P417, DOI 10.1056/NEJM199408183310701; Lowe GDO, 2001, THROMB HAEMOSTASIS, V86, P550; MILLER VT, 1995, JAMA-J AM MED ASSOC, V273, P199, DOI 10.1001/jama.1995.03520270033028; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; Morrow DA, 1998, J AM COLL CARDIOL, V31, P1460, DOI 10.1016/S0735-1097(98)00136-3; Nakagomi A, 2000, CIRCULATION, V101, P1785, DOI 10.1161/01.CIR.101.15.1785; Ockene IS, 2001, CLIN CHEM, V47, P444; Rexrode KM, 1996, CURR OPIN CARDIOL, V11, P490, DOI 10.1097/00001573-199609000-00007; Ridker PM, 1999, CIRCULATION, V100, P713, DOI 10.1161/01.CIR.100.7.713; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Ridker PM, 2001, NEW ENGL J MED, V344, P1959, DOI 10.1056/NEJM200106283442601; Ridker PM, 1999, CIRCULATION, V100, P230, DOI 10.1161/01.CIR.100.3.230; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ridker PM, 2001, JAMA-J AM MED ASSOC, V285, P2481, DOI 10.1001/jama.285.19.2481; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Sattar N, 1999, LANCET, V354, P487, DOI 10.1016/S0140-6736(99)02079-6; Straub RH, 2000, J CLIN ENDOCR METAB, V85, P1340, DOI 10.1210/jc.85.3.1340; Tracy RP, 1997, ARTERIOSCL THROM VAS, V17, P1121, DOI 10.1161/01.ATV.17.6.1121; van Baal WM, 1999, THROMB HAEMOSTASIS, V81, P925, DOI 10.1055/s-0037-1614600; Walsh BW, 2000, J CLIN ENDOCR METAB, V85, P214, DOI 10.1210/jc.85.1.214; Weinhold B, 1997, BIOCHEM J, V327, P425, DOI 10.1042/bj3270425; Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972	38	525	536	1	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 28	2002	288	8					980	987		10.1001/jama.288.8.980	http://dx.doi.org/10.1001/jama.288.8.980			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587RM	12190368	Bronze			2022-12-24	WOS:000177656400023
J	Mehlmann, LM; Jones, TLZ; Jaffe, LA				Mehlmann, LM; Jones, TLZ; Jaffe, LA			Meiotic arrest in the mouse follicle maintained by a G(s) protein in the oocyte	SCIENCE			English	Article							BETA-GAMMA-SUBUNITS; PLATELET MEMBRANES; ADENYLYL-CYCLASE; MOLECULAR-BASIS; XENOPUS-LAEVIS; RELEASE; MATURATION; INHIBITION; INVITRO; FLUID	The mammalian ovarian follicle consists of a multilayered complex of somatic cells that surround the oocyte. A signal from the follicle cells keeps the oocyte cell cycle arrested at prophase of meiosis I until luteinizing hormone from the pituitary acts on the follicle cells to release the arrest, causing meiosis to continue. Here we show that meiotic arrest can be released in mice by microinjecting the oocyte within the follicle with an antibody that inhibits the stimulatory heterotrimeric GTP-binding protein G(s). This indicates that G(s) activity in the oocyte is required to maintain meiotic arrest within the ovarian follicle and suggests that the follicle may keep the cell cycle arrested by activating G(s).	Univ Connecticut, Ctr Hlth, Dept Physiol, Farmington, CT 06032 USA; NIDDKD, Metab Dis Branch, NIH, Bethesda, MD 20892 USA	University of Connecticut; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Mehlmann, LM (corresponding author), Univ Connecticut, Ctr Hlth, Dept Physiol, Farmington, CT 06032 USA.		Holt, Janet E/B-2415-2013		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK043013] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Albertini DF, 2001, REPRODUCTION, V121, P647, DOI 10.1530/rep.0.1210647; ANDERSON E, 1976, J CELL BIOL, V71, P680, DOI 10.1083/jcb.71.2.680; ANTONELLI M, 1994, FEBS LETT, V340, P249, DOI 10.1016/0014-5793(94)80148-7; Araque A, 2000, J NEUROSCI, V20, P666, DOI 10.1523/JNEUROSCI.20-02-00666.2000; Bruzzone R, 1996, EUR J BIOCHEM, V238, P1, DOI 10.1111/j.1432-1033.1996.0001q.x; CHIDIAC P, 1994, MOL PHARMACOL, V45, P490; de Ligt RAF, 2000, BRIT J PHARMACOL, V130, P1, DOI 10.1038/sj.bjp.0703311; DOWNS SM, 1992, J EXP ZOOL, V262, P391, DOI 10.1002/jez.1402620405; Eppig J. J., 1993, OVARY, P185; EPPIG JJ, 1991, BIOL REPROD, V45, P824, DOI 10.1095/biolreprod45.6.824; EPPIG JJ, 1985, BIOL REPROD, V33, P1041, DOI 10.1095/biolreprod33.5.1041; GALLO CJ, 1995, J CELL BIOL, V130, P275, DOI 10.1083/jcb.130.2.275; GILULA NB, 1978, J CELL BIOL, V78, P58, DOI 10.1083/jcb.78.1.58; HAND AR, UNPUB; IIRI T, 1994, NATURE, V371, P164, DOI 10.1038/371164a0; KIEHART DP, 1982, METHOD CELL BIOL, V25, P13, DOI 10.1016/S0091-679X(08)61418-1; Lutz LB, 2000, J BIOL CHEM, V275, P41512, DOI 10.1074/jbc.M006757200; MEHLMANN LM, 1994, BIOL REPROD, V51, P1088, DOI 10.1095/biolreprod51.6.1088; Mehlmann LM, 1998, DEV BIOL, V203, P221, DOI 10.1006/dbio.1998.9051; RACOWSKY C, 1989, DEV BIOL, V134, P297, DOI 10.1016/0012-1606(89)90102-4; ROBISHAW JD, 1986, J BIOL CHEM, V261, P9587; Sheng YL, 2001, CURR BIOL, V11, P405, DOI 10.1016/S0960-9822(01)00123-3; Simon AM, 1997, NATURE, V385, P525, DOI 10.1038/385525a0; SIMONDS WF, 1989, P NATL ACAD SCI USA, V86, P7809, DOI 10.1073/pnas.86.20.7809; SIMONDS WF, 1989, FEBS LETT, V249, P189, DOI 10.1016/0014-5793(89)80622-2; TSAFRIRI A, 1975, ENDOCRINOLOGY, V96, P922, DOI 10.1210/endo-96-4-922; WILEY HS, 1981, J BIOL CHEM, V256, P8626; [No title captured]	28	171	178	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 23	2002	297	5585					1343	1345		10.1126/science.1073978	http://dx.doi.org/10.1126/science.1073978			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FL	12193786				2022-12-24	WOS:000177573900046
J	Schroder, ARW; Shinn, P; Chen, HM; Berry, C; Ecker, JR; Bushman, F				Schroder, ARW; Shinn, P; Chen, HM; Berry, C; Ecker, JR; Bushman, F			HIV-1 integration in the human genome favors active genes and local hotspots	CELL			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; I-HYPERSENSITIVE SITES; RETROVIRUS INTEGRATION; DNA INTEGRATION; DIRECTS INTEGRATION; PREFERRED TARGETS; SEQUENCE; VITRO; VIVO; INFECTION	A defining feature of HIV replication is integration of the proviral cDNA into human DNA. The selection of chromosomal targets for integration is crucial for efficient viral replication, but the mechanism is poorly understood. Here we describe mapping of 524 sites of HIV cDNA integration on the human genome sequence. Genes were found to be strongly favored as integration acceptor sites. Global analysis of cellular transcription indicated that active genes were preferential integration targets, particularly genes that were activated in cells after infection by HIV-1. Regional hotspots for integration were also found, including a 2.4 kb region containing I % of sites. These data document unexpectedly strong biases in integration site selection and suggest how selective targeting promotes aggressive HIV replication.	Salk Inst Biol Studies, Infect Dis Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Genom Anal Lab, La Jolla, CA 92037 USA; Univ Calif San Diego, Sch Med, Dept Family Prevent Med, La Jolla, CA 92093 USA	Salk Institute; Salk Institute; University of California System; University of California San Diego	Bushman, F (corresponding author), Salk Inst Biol Studies, Infect Dis Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	bushman@salk.edu	Wilson, Matthew H/K-3193-2013; Ecker, Joseph R/B-9144-2008	Ecker, Joseph R/0000-0001-5799-5895; Chen, Huaming/0000-0001-5289-7882	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052845, R01AI034786] Funding Source: NIH RePORTER; NIAID NIH HHS [AI52845, AI34786, R01 AI052845] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arendt CW, 2001, GENOME BIOL, V2; Boeke JD, 1998, CELL, V93, P1087, DOI 10.1016/S0092-8674(00)81450-6; BROWN PO, 1987, CELL, V49, P347, DOI 10.1016/0092-8674(87)90287-X; BUKRINSKY MI, 1993, P NATL ACAD SCI USA, V90, P6125, DOI 10.1073/pnas.90.13.6125; BURKE WD, 1993, MOL BIOL EVOL, V10, P163; BUSHMAN FD, 1994, P NATL ACAD SCI USA, V91, P9233, DOI 10.1073/pnas.91.20.9233; BUSHMAN FD, 1992, P NATL ACAD SCI USA, V89, P3458, DOI 10.1073/pnas.89.8.3458; Bushman FD, 2001, LATERAL DNA TRANSFER; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Carteau S, 1998, J VIROL, V72, P4005, DOI 10.1128/JVI.72.5.4005-4014.1998; Coffin J.M., 1997, RETROVIRUSES; Corbeil A, 2001, GENOME RES, V11, P1198, DOI 10.1101/gr.GR-1802R; Davis CB, 1997, J EXP MED, V186, P1793, DOI 10.1084/jem.186.10.1793; ELLISON V, 1990, J VIROL, V64, P2711, DOI 10.1128/JVI.64.6.2711-2715.1990; Farnet C, 1997, CELL, V88, P1; FARNET CM, 1990, P NATL ACAD SCI USA, V87, P4164, DOI 10.1073/pnas.87.11.4164; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; Gaiano N, 1996, NATURE, V383, P829, DOI 10.1038/383829a0; GALLAY P, 1995, CELL, V83, P569, DOI 10.1016/0092-8674(95)90097-7; Geiss GK, 2000, VIROLOGY, V266, P8, DOI 10.1006/viro.1999.0044; Hansen MST, 1999, NAT BIOTECHNOL, V17, P578, DOI 10.1038/9886; HARTUNG S, 1986, NATURE, V320, P365, DOI 10.1038/320365a0; JI H, 1993, CELL, V73, P1007, DOI 10.1016/0092-8674(93)90278-X; Jordan A, 2001, EMBO J, V20, P1726, DOI 10.1093/emboj/20.7.1726; Kafri T, 1999, J VIROL, V73, P576, DOI 10.1128/JVI.73.1.576-584.1999; Katz RA, 1998, J BIOL CHEM, V273, P24190, DOI 10.1074/jbc.273.37.24190; Katz RA, 2001, J BIOL CHEM, V276, P34213, DOI 10.1074/jbc.M104632200; KIRCHNER J, 1995, SCIENCE, V267, P1488, DOI 10.1126/science.7878467; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leclercq I, 2000, J VIROL, V74, P2305, DOI 10.1128/JVI.74.5.2305-2312.2000; Li L, 2001, EMBO J, V20, P3272, DOI 10.1093/emboj/20.12.3272; Miller MD, 1997, J VIROL, V71, P5382, DOI 10.1128/JVI.71.7.5382-5390.1997; MOOSLEHNER K, 1990, J VIROL, V64, P3056, DOI 10.1128/JVI.64.6.3056-3058.1990; PANET A, 1977, CELL, V11, P933, DOI 10.1016/0092-8674(77)90304-X; Popik W, 2000, VIROLOGY, V276, P1, DOI 10.1006/viro.2000.0581; PRUSS D, 1994, J BIOL CHEM, V269, P25031; PRUSS D, 1994, P NATL ACAD SCI USA, V91, P5913, DOI 10.1073/pnas.91.13.5913; PRYCIAK PM, 1992, P NATL ACAD SCI USA, V89, P9237, DOI 10.1073/pnas.89.19.9237; PRYCIAK PM, 1992, CELL, V69, P769, DOI 10.1016/0092-8674(92)90289-O; ROHDEWOHLD H, 1987, J VIROL, V61, P336, DOI 10.1128/JVI.61.2.336-343.1987; SCHERDIN U, 1990, J VIROL, V64, P907, DOI 10.1128/JVI.64.2.907-912.1990; Scottoline BP, 1997, GENE DEV, V11, P371, DOI 10.1101/gad.11.3.371; SHIH CC, 1988, CELL, V53, P531, DOI 10.1016/0092-8674(88)90569-7; Simmons A, 2001, IMMUNITY, V14, P763, DOI 10.1016/S1074-7613(01)00158-3; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; Stevens SW, 1996, J VIROL, V70, P6459, DOI 10.1128/JVI.70.9.6459-6462.1996; STEVENS SW, 1994, P NATL ACAD SCI USA, V91, P5557, DOI 10.1073/pnas.91.12.5557; Swingler S, 1997, J VIROL, V71, P4372, DOI 10.1128/JVI.71.6.4372-4377.1997; TEMIN HM, 1980, COLD SPRING HARB SYM, V44, P773, DOI 10.1101/SQB.1980.044.01.083; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; VIJAYA S, 1986, J VIROL, V60, P683, DOI 10.1128/JVI.60.2.683-692.1986; Weidhaas JB, 2000, J VIROL, V74, P8382, DOI 10.1128/JVI.74.18.8382-8389.2000; WITHERSWARD ES, 1994, GENE DEV, V8, P1473, DOI 10.1101/gad.8.12.1473; ZIJLSTRA M, 1989, NATURE, V342, P435, DOI 10.1038/342435a0	54	1305	1373	1	62	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 23	2002	110	4					521	529		10.1016/S0092-8674(02)00864-4	http://dx.doi.org/10.1016/S0092-8674(02)00864-4			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	587QJ	12202041	Bronze			2022-12-24	WOS:000177653200013
J	Zhang, CL; McKinsey, TA; Chang, SR; Antos, CL; Hill, JA; Olson, EN				Zhang, CL; McKinsey, TA; Chang, SR; Antos, CL; Hill, JA; Olson, EN			Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy	CELL			English	Article							MEF2 TRANSCRIPTION FACTOR; DEPENDENT PROTEIN-KINASE; IN-VIVO; CALCINEURIN; MITR; ASSOCIATION; MYOGENESIS; ACTIVATION; BINDING; P300	The heart responds to stress signals by growth, which is accompanied by activation of MEF2 transcription factor and reprogramming of diac gene expression. We show here that class 11 tone deacetylases (HDACs), which repress MEF2 activity, are substrates for a stress-responsive specific for conserved serines that regulate HDAC interactions. Signal-resistant HDAC lacking these phosphorylation sites are refractory hypertrophic signaling and inhibit cardiomyocyte pertrophy. Conversely, mutant mice lacking the class HDAC, HDAC9, are sensitized to hypertrophic and exhibit stress-dependent cardiomegaly. class 11 HDACs act as signal-responsive of the transcriptional program governing cardiac pertrophy and heart failure.	Univ Texas, SW Med Ctr, Dept Biol Mol, Dallas, TX 75390 USA; Vet Affairs Med Ctr, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Div Cardiovasc, Iowa City, IA 52242 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa	Olson, EN (corresponding author), Univ Texas, SW Med Ctr, Dept Biol Mol, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.		Antos, Christopher L/E-8171-2010		NHLBI NIH HHS [R37 HL053351, R01 HL053351] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053351, R37HL053351] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Chien KR, 1999, CELL, V98, P555, DOI 10.1016/S0092-8674(00)80043-4; Frey N, 2000, NAT MED, V6, P1221, DOI 10.1038/81321; Grozinger CM, 2002, CHEM BIOL, V9, P3, DOI 10.1016/S1074-5521(02)00092-3; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Hill JA, 2000, CIRCULATION, V101, P2863, DOI 10.1161/01.CIR.101.24.2863; Impey S, 2002, NEURON, V34, P235, DOI 10.1016/S0896-6273(02)00654-2; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Johnson CA, 1999, SEMIN CELL DEV BIOL, V10, P179, DOI 10.1006/scdb.1999.0299; Kato T, 2000, CIRC RES, V87, P937, DOI 10.1161/01.RES.87.10.937; Kirchhefer U, 1999, CARDIOVASC RES, V42, P254, DOI 10.1016/S0008-6363(98)00296-X; Liang QR, 2001, J BIOL CHEM, V276, P30245, DOI 10.1074/jbc.M102174200; Lowes BD, 2002, NEW ENGL J MED, V346, P1357, DOI 10.1056/NEJMoa012630; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; Lu JR, 2000, P NATL ACAD SCI USA, V97, P4070, DOI 10.1073/pnas.080064097; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Morin S, 2000, EMBO J, V19, P2046, DOI 10.1093/emboj/19.9.2046; Naya FJ, 1999, DEVELOPMENT, V126, P2045; Passier R, 2000, J CLIN INVEST, V105, P1395, DOI 10.1172/JCI8551; Sartorelli V, 1997, MOL CELL BIOL, V17, P1010, DOI 10.1128/MCB.17.2.1010; Sparrow DB, 1999, EMBO J, V18, P5085, DOI 10.1093/emboj/18.18.5085; Youn HD, 2000, EMBO J, V19, P4323, DOI 10.1093/emboj/19.16.4323; Zhang CL, 2001, P NATL ACAD SCI USA, V98, P7354, DOI 10.1073/pnas.131198498; Zhang CL, 2001, J BIOL CHEM, V276, P35, DOI 10.1074/jbc.M007364200; Zhang T, 2002, J BIOL CHEM, V277, P1261, DOI 10.1074/jbc.M108525200; Zhou XB, 2001, P NATL ACAD SCI USA, V98, P10572, DOI 10.1073/pnas.191375098	29	767	802	1	45	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 23	2002	110	4					479	488		10.1016/S0092-8674(02)00861-9	http://dx.doi.org/10.1016/S0092-8674(02)00861-9			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	587QJ	12202037	Green Accepted, Bronze			2022-12-24	WOS:000177653200009
J	Wilder-Smith, A; Barkham, TMS; Earnest, A; Paton, NI				Wilder-Smith, A; Barkham, TMS; Earnest, A; Paton, NI			Acquisition of W135 meningococcal carriage in Hajj pilgrims and transmission to household contacts: prospective study	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Tan Tock Seng Hosp, Travellers Hlth & Vaccinat Ctr, Singapore 308433, Singapore; Tan Tock Seng Hosp, Dept Pathol & Lab Med, Singapore 308433, Singapore; Tan Tock Seng Hosp, Clin Epidemiol Unit, Singapore 308433, Singapore; Tan Tock Seng Hosp, Dept Infect Dis, Singapore 308433, Singapore	Tan Tock Seng Hospital; Tan Tock Seng Hospital; Tan Tock Seng Hospital; Tan Tock Seng Hospital	Wilder-Smith, A (corresponding author), Tan Tock Seng Hosp, Travellers Hlth & Vaccinat Ctr, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore.	epvws@pacific.net.sg	Earnest, Arul/L-4747-2013; Wilder-Smith, Annelies/F-8751-2015	Earnest, Arul/0000-0003-2693-5034; Wilder-Smith, Annelies/0000-0003-0362-5375				[Anonymous], 2001, Wkly Epidemiol Rec, V76, P141; Popovic T, 2000, EMERG INFECT DIS, V6, P428, DOI 10.3201/eid0604.000423; Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807; Taha MK, 2000, LANCET, V356, P2159, DOI 10.1016/S0140-6736(00)03502-9	4	48	50	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 17	2002	325	7360					365	366		10.1136/bmj.325.7360.365	http://dx.doi.org/10.1136/bmj.325.7360.365			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587DV	12183308	Green Published, Bronze			2022-12-24	WOS:000177626000019
J	Polishchuk, LV				Polishchuk, LV			Ecology: Conservation priorities for Russian mammals	SCIENCE			English	Editorial Material							BIODIVERSITY		Moscow MV Lomonosov State Univ, Dept Gen Ecol, Moscow 119899, Russia; Netherlands Inst Ecol, Dept Food Web Studies, Ctr Limnol, NL-3631 AC Nieuwersluis, Netherlands	Lomonosov Moscow State University; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Polishchuk, LV (corresponding author), Moscow MV Lomonosov State Univ, Dept Gen Ecol, Moscow 119899, Russia.	LV@Polishchuk.msk.ru	Polishchuk, Leonard/I-9342-2012					BANNIKOV AG, 1984, RED BOOK USSR RARE 1, V1; Brook BW, 2000, NATURE, V404, P385, DOI 10.1038/35006050; Coulson T, 2001, TRENDS ECOL EVOL, V16, P219, DOI 10.1016/S0169-5347(01)02137-1; *MIN NAT RES RUSS, 2001, EC NAT RES RUSS 2002; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Pimm S. L., 1991, BALANCE NATURE ECOLO; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Polishchuk LV, 2001, ZH OBSHCH BIOL, V62, P3; *RUSS CONS MON CTR, 1997, 1 RUSS CONS MON CTR; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Southwood T.R.E., 1976, P26	11	14	14	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 16	2002	297	5584					1123	1123		10.1126/science.1072836	http://dx.doi.org/10.1126/science.1072836			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584BP	12183611				2022-12-24	WOS:000177447600024
J	Yan, H; Yuan, WS; Velculescu, VE; Vogelstein, B; Kinzler, KW				Yan, H; Yuan, WS; Velculescu, VE; Vogelstein, B; Kinzler, KW			Allelic variation in human gene expression	SCIENCE			English	Article									Johns Hopkins Med Inst, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; Johns Hopkins Med Inst, Howard Hughes Med Inst, Baltimore, MD 21231 USA; Johns Hopkins Univ, Dept Math Sci, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Kinzler, KW (corresponding author), Johns Hopkins Med Inst, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA.		Velculescu, Victor/ABF-4846-2020	Velculescu, Victor/0000-0003-1195-438X; Edsall, Lee Elizabeth/0000-0002-0326-2829	NATIONAL CANCER INSTITUTE [R01CA057345, R37CA057345, P50CA062924, R01CA043460, R37CA043460] Funding Source: NIH RePORTER; NCI NIH HHS [CA57345, CA43460, CA 62924] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Johnson NA, 2000, J THEOR BIOL, V205, P527, DOI 10.1006/jtbi.2000.2070; Levine M, 2002, NATURE, V415, P848, DOI 10.1038/415848a; Matyas G, 2002, HUM MUTAT, V19, P58, DOI 10.1002/humu.10013; Yan H, 2002, NAT GENET, V30, P25, DOI 10.1038/ng799	4	587	610	2	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 16	2002	297	5584					1143	1143		10.1126/science.1072545	http://dx.doi.org/10.1126/science.1072545			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584BP	12183620				2022-12-24	WOS:000177447600037
J	Dobson, CM				Dobson, CM			Protein-misfolding diseases: Getting out of shape	NATURE			English	Editorial Material									Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of Cambridge	Dobson, CM (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.							BLIS RJ, 2002, NATURE, V416, P483; Dobson CM, 2001, PHILOS T ROY SOC B, V356, P129, DOI 10.1098/rstb.2000.0757; Ferguson NM, 2002, NATURE, V415, P420, DOI 10.1038/nature709; Iversen L, 2002, NATURE, V417, P231, DOI 10.1038/417231a; OSERMELY P, 2001, TRENDS GENOM, V17, P701; SOLOMON B, 2001, CONFORMATIONAL DIS C	6	284	293	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 15	2002	418	6899					729	730		10.1038/418729a	http://dx.doi.org/10.1038/418729a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UF	12181546				2022-12-24	WOS:000177428000018
J	Lindsay, ME; Plafker, K; Smith, AE; Clurman, BE; Macara, IG				Lindsay, ME; Plafker, K; Smith, AE; Clurman, BE; Macara, IG			Npap60/Nup50 is a tri-stable switch that stimulates importin-alpha :beta-mediated nuclear protein import	CELL			English	Article							PORE COMPLEX; LOCALIZATION SEQUENCES; YEAST NUCLEOPORIN; STRUCTURAL BASIS; EXPORT; TRANSPORT; NUP2P; BINDING; IDENTIFICATION; RANGTP	Many nuclear-targeted proteins are transported through the nuclear pore complex (NPC) by the importin-alpha:beta receptor. We now show that Npap60 (also called Nup50), a protein previously believed to be a structural component of the NPC, is a Ran binding protein and a cofactor for importin-alpha:beta-mediated import. Npap60 is a tri-stable switch that alternates between binding modes. The C terminus binds importin-P through RanGTP. The N terminus binds the C terminus of importin-alpha, while a central domain binds importin-beta. Npap60:importin-alpha:beta binds cargo and can stimulate nuclear import. Endogenous Npap60 can shuttle and is accessible from the cytoplasmic side of the nuclear envelope. These results identify Npap60 as a cofactor for importin-alpha:beta nuclear import and as a previously unidentified subunit of the importin complex.	Univ Virginia, Sch Med, Ctr Cell Signaling, Charlottesville, VA 22908 USA; Univ Virginia, Sch Med, Dept Microbiol, Charlottesville, VA 22908 USA; Univ Virginia, Sch Med, Dept Pharmacol, Charlottesville, VA 22908 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA	University of Virginia; University of Virginia; University of Virginia; Fred Hutchinson Cancer Center	Macara, IG (corresponding author), Univ Virginia, Sch Med, Ctr Cell Signaling, Charlottesville, VA 22908 USA.		Clurman, Bruce/AAV-3854-2021		NCI NIH HHS [CA84069] Funding Source: Medline; NIGMS NIH HHS [GM50526] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA084069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050526] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAM SA, 1991, CELL, V66, P837, DOI 10.1016/0092-8674(91)90431-W; Aitchison JD, 1996, SCIENCE, V274, P624, DOI 10.1126/science.274.5287.624; Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3; Bayliss R, 1999, J MOL BIOL, V293, P579, DOI 10.1006/jmbi.1999.3166; BELANGER KD, 1994, J CELL BIOL, V126, P619, DOI 10.1083/jcb.126.3.619; Bischoff FR, 1997, FEBS LETT, V419, P249, DOI 10.1016/S0014-5793(97)01467-1; Black BE, 1999, MOL CELL BIOL, V19, P8616; Booth JW, 1999, J BIOL CHEM, V274, P32360, DOI 10.1074/jbc.274.45.32360; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Denning D, 2001, J CELL BIOL, V154, P937, DOI 10.1083/jcb.200101007; Dilworth DJ, 2001, J CELL BIOL, V153, P1465, DOI 10.1083/jcb.153.7.1465; Englmeier L, 2001, EMBO REP, V2, P926, DOI 10.1093/embo-reports/kve200; Fan F, 1997, GENOMICS, V40, P444, DOI 10.1006/geno.1996.4557; Floer M, 1997, J BIOL CHEM, V272, P19538, DOI 10.1074/jbc.272.31.19538; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; GORLICH D, 1995, NATURE, V377, P246, DOI 10.1038/377246a0; GORLICH D, 1994, CELL, V79, P767, DOI 10.1016/0092-8674(94)90067-1; Gorlich D, 1996, EMBO J, V15, P1810, DOI 10.1002/j.1460-2075.1996.tb00530.x; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; Guan TL, 2000, MOL CELL BIOL, V20, P5619, DOI 10.1128/MCB.20.15.5619-5630.2000; Herold A, 1998, J CELL BIOL, V143, P309, DOI 10.1083/jcb.143.2.309; Hood JK, 2000, J CELL SCI, V113, P1471; IMAMOTO N, 1995, EMBO J, V14, P3617, DOI 10.1002/j.1460-2075.1995.tb00031.x; Kutay U, 1997, CELL, V90, P1061, DOI 10.1016/S0092-8674(00)80372-4; Lindsay ME, 2001, J CELL BIOL, V153, P1391, DOI 10.1083/jcb.153.7.1391; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; Pemberton LF, 1998, CURR OPIN CELL BIOL, V10, P392, DOI 10.1016/S0955-0674(98)80016-1; Plafker K, 2000, MOL CELL BIOL, V20, P3510, DOI 10.1128/MCB.20.10.3510-3521.2000; Plafker SM, 2000, EMBO J, V19, P5502, DOI 10.1093/emboj/19.20.5502; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Rout MP, 1997, CELL, V89, P715, DOI 10.1016/S0092-8674(00)80254-8; Ryan KJ, 2000, CURR OPIN CELL BIOL, V12, P361, DOI 10.1016/S0955-0674(00)00101-0; Smitherman M, 2000, MOL CELL BIOL, V20, P5631, DOI 10.1128/MCB.20.15.5631-5642.2000; Solsbacher J, 2000, MOL CELL BIOL, V20, P8468, DOI 10.1128/MCB.20.22.8468-8479.2000; Taura T, 1998, P NATL ACAD SCI USA, V95, P7427, DOI 10.1073/pnas.95.13.7427; WEIS K, 1995, SCIENCE, V268, P1049, DOI 10.1126/science.7754385; Welch K, 1999, MOL CELL BIOL, V19, P8400	39	92	94	1	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 9	2002	110	3					349	360		10.1016/S0092-8674(02)00836-X	http://dx.doi.org/10.1016/S0092-8674(02)00836-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	583MN	12176322	Bronze			2022-12-24	WOS:000177411800011
J	Miller, MG; Johnson, AD				Miller, MG; Johnson, AD			White-opaque switching in Candida albicans is controlled by mating-type locus homeodomain proteins and allows efficient mating	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; SIGNAL-TRANSDUCTION; GENE; TRANSITION; PHASE; PHENOTYPE; MISEXPRESSION; CONSTRUCTION; VIRULENCE; HOMOLOG	Discovered over a decade ago, white-opaque switching in the human fungal pathogen Candida albicans is an alternation between two quasistable, heritable transcriptional states. Here, we show that white-opaque switching and sexual mating are both controlled by mating type locus homeodomain proteins and that opaque cells mate approximately 10(6) times more efficiently than do white cells. These results show that opaque cells are a mating-competent form of C. albicans and that this pathogen undergoes a white-to-opaque switch as a critical step in the mating process. As white cells are generally more robust in a mammalian host than are opaque cells, this strategy allows the organism to survive the rigors of life within a mammalian host, yet generate mating-competent cells.	Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Johnson, AD (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049187] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI49187] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDERSON J, 1989, INFECT IMMUN, V57, P458, DOI 10.1128/IAI.57.2.458-467.1989; ANDERSON J, 1990, J BACTERIOL, V172, P224, DOI 10.1128/JB.172.1.224-235.1990; ANDERSON JM, 1987, J BACTERIOL, V169, P5579, DOI 10.1128/jb.169.12.5579-5588.1987; Casselton LA, 1998, MICROBIOL MOL BIOL R, V62, P55, DOI 10.1128/MMBR.62.1.55-70.1998; CHU WS, 1992, J BACTERIOL, V174, P2951, DOI 10.1128/JB.174.9.2951-2957.1992; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COLLART MA, 1993, CURRENT PROTOCOL S23, V2; Coppin E, 1997, MICROBIOL MOL BIOL R, V61, P411, DOI 10.1128/.61.4.411-428.1997; Diener AC, 1996, GENETICS, V143, P769; Edmond MB, 1999, CLIN INFECT DIS, V29, P239, DOI 10.1086/520192; FONZI WA, 1993, GENETICS, V134, P717; Galitski T, 1999, SCIENCE, V285, P251, DOI 10.1126/science.285.5425.251; HERSKOWITZ I, 1981, MOL BIOL YEAST SACCH, P181; HERSKOWITZ I, 1992, MOL CELLULAR BIOL YE, V2, P583; Hoyer LL, 2001, TRENDS MICROBIOL, V9, P176, DOI 10.1016/S0966-842X(01)01984-9; Hull CM, 2000, SCIENCE, V289, P307, DOI 10.1126/science.289.5477.307; Hull CM, 1999, SCIENCE, V285, P1271, DOI 10.1126/science.285.5431.1271; Janbon G, 1999, GENETICS, V153, P653; Janbon G, 1998, P NATL ACAD SCI USA, V95, P5150, DOI 10.1073/pnas.95.9.5150; JOHNSON AD, 1995, CURR OPIN GENET DEV, V5, P552, DOI 10.1016/0959-437X(95)80022-0; Klar AJS, 2001, GENETICS, V158, P919; KOLOTILA MP, 1990, INFECT IMMUN, V58, P1174, DOI 10.1128/IAI.58.5.1174-1179.1990; Kronstad JW, 1997, ANNU REV GENET, V31, P245, DOI 10.1146/annurev.genet.31.1.245; Kvaal C, 1999, INFECT IMMUN, V67, P6652; Kvaal CA, 1997, INFECT IMMUN, V65, P4468, DOI 10.1128/IAI.65.11.4468-4475.1997; Leberer E, 1996, P NATL ACAD SCI USA, V93, P13217, DOI 10.1073/pnas.93.23.13217; Mackay Vivian L., 1993, P273; Magee BB, 2000, SCIENCE, V289, P310, DOI 10.1126/science.289.5477.310; MORROW B, 1989, J GEN MICROBIOL, V135, P1201; MORROW B, 1992, MOL CELL BIOL, V12, P2997, DOI 10.1128/MCB.12.7.2997; MORROW B, 1993, INFECT IMMUN, V61, P1823, DOI 10.1128/IAI.61.5.1823-1828.1993; Raymond M, 1998, MOL MICROBIOL, V27, P587, DOI 10.1046/j.1365-2958.1998.00704.x; RUSTCHENKOBULGAC EP, 1991, J BACTERIOL, V173, P6586, DOI 10.1128/jb.173.20.6586-6596.1991; SADHU C, 1992, MOL CELL BIOL, V12, P1977, DOI 10.1128/MCB.12.5.1977; SLUTSKY B, 1987, J BACTERIOL, V169, P189, DOI 10.1128/JB.169.1.189-197.1987; SOLL DR, 1993, TRENDS GENET, V9, P61, DOI 10.1016/0168-9525(93)90189-O; Soll DR, 1997, MICROBIOL-UK, V143, P279, DOI 10.1099/00221287-143-2-279; Sonneborn A, 1999, INFECT IMMUN, V67, P4655, DOI 10.1128/IAI.67.9.4655-4660.1999; SPRAGUE G F JR, 1991, P77; Srikantha T, 2000, J BACTERIOL, V182, P1580, DOI 10.1128/JB.182.6.1580-1591.2000; Srikantha T, 2001, J BACTERIOL, V183, P4614, DOI 10.1128/JB.183.15.4614-4625.2001; SRIKANTHA T, 1993, GENE, V131, P53, DOI 10.1016/0378-1119(93)90668-S; Tibayrenc M, 1997, TRENDS MICROBIOL, V5, P253, DOI 10.1016/S0966-842X(97)01068-8; TSUBOI R, 1994, J MED VET MYCOL, V32, P91; Tzung KW, 2001, P NATL ACAD SCI USA, V98, P3249, DOI 10.1073/pnas.061628798; Vilgalys R, 1997, TRENDS MICROBIOL, V5, P254, DOI 10.1016/S0966-842X(97)01076-7; WHITE TC, 1993, J BACTERIOL, V175, P6126, DOI 10.1128/JB.175.19.6126-6133.1993; Yesland K, 2000, MICROBIOL-SGM, V146, P2097, DOI 10.1099/00221287-146-9-2097	48	404	433	0	23	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 9	2002	110	3					293	302		10.1016/S0092-8674(02)00837-1	http://dx.doi.org/10.1016/S0092-8674(02)00837-1			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	583MN	12176317	Bronze			2022-12-24	WOS:000177411800006
J	Kumar, R; Wang, RA; Mazumdar, A; Talukder, AH; Mandal, M; Yang, ZB; Bagheri-Yarmand, R; Sahin, A; Hortobagyi, G; Adam, L; Barnes, CJ; Vadlamudi, RK				Kumar, R; Wang, RA; Mazumdar, A; Talukder, AH; Mandal, M; Yang, ZB; Bagheri-Yarmand, R; Sahin, A; Hortobagyi, G; Adam, L; Barnes, CJ; Vadlamudi, RK			A naturally occurring MTA1 variant sequesters oestrogen receptor-alpha in the cytoplasm	NATURE			English	Article							ESTROGEN-RECEPTOR; BREAST-CANCER; MCF-7 CELLS; GENE; SEQUENCE; EXPRESSION; GROWTH	Oestrogen receptor (ER) is a good prognostic marker for the treatment of breast cancers. Upregulation of metastatic tumour antigen 1 (MTA1) is associated with the invasiveness and metastatic potential of several human cancers(1,2) and acts as a corepressor of nuclear ER-alpha(3). Here we identify a naturally occurring short form of MTA1 (MTA1s) that contains a previously unknown sequence of 33 amino acids with an ER-binding motif, Leu-Arg-Ile-Leu-Leu (LRILL). MTA1s localizes in the cytoplasm, sequesters ER in the cytoplasm, and enhances non-genomic responses of ER. Deleting the LRILL motif in MTA1s abolishes its co-repressor function and its interaction with ER, and restores nuclear localization of ER. Dysregulation of human epidermal growth factor receptor-2 in breast cancer cells enhances the expression of MTA1s and the cytoplasmic sequestration of ER. Expression of MTA1s in breast cancer cells prevents ligand-induced nuclear translocation of ER and stimulates malignant phenotypes. MTA1s expression is increased in human breast tumours with no or low nuclear ER. The regulation of the cellular localization of ER by MTA1s represents a mechanism for redirecting nuclear receptor signalling by nuclear exclusion.	Univ Texas, MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Kumar, R (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.		Wang, Brian/HGA-9535-2022; Mandal, Mahitosh/GMW-6195-2022	Mandal, Mahitosh/0000-0003-3861-3323; Bagheri-Yarmand, Rozita/0000-0001-5139-6381; Wang, Rui-An/0000-0003-2320-1211				BENZ CC, 1992, BREAST CANCER RES TR, V24, P85, DOI 10.1007/BF01961241; BERRY M, 1989, P NATL ACAD SCI USA, V86, P1218, DOI 10.1073/pnas.86.4.1218; CATORIA G, 1999, EMBO J, V18, P2500; Crawford J, 1999, GENOMICS, V56, P90, DOI 10.1006/geno.1998.5676; Henttu PMA, 1997, MOL CELL BIOL, V17, P1832, DOI 10.1128/MCB.17.4.1832; Kumar R, 1996, CLIN CANCER RES, V2, P1215; KUMAR V, 1987, CELL, V51, P941, DOI 10.1016/0092-8674(87)90581-2; Mandal M, 2001, J BIOL CHEM, V276, P9699, DOI 10.1074/jbc.M008514200; Mazumdar A, 2001, NAT CELL BIOL, V3, P30, DOI 10.1038/35050532; Migliaccio A, 1996, EMBO J, V15, P1292, DOI 10.1002/j.1460-2075.1996.tb00471.x; Nawa A, 2000, J CELL BIOCHEM, V79, P202, DOI 10.1002/1097-4644(20001101)79:2<202::AID-JCB40>3.0.CO;2-L; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; Song RXD, 2002, MOL ENDOCRINOL, V16, P116, DOI 10.1210/me.16.1.116; TOH Y, 1994, J BIOL CHEM, V269, P229; Vadlamudi RK, 2001, J BIOL CHEM, V276, P38272	15	189	199	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 8	2002	418	6898					654	657		10.1038/nature00889	http://dx.doi.org/10.1038/nature00889			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581RA	12167865				2022-12-24	WOS:000177305600046
J	Little, SJ; Holte, S; Routy, JP; Daar, ES; Markowitz, M; Collier, AC; Koup, RA; Mellors, JW; Connick, E; Conway, B; Kilby, M; Wang, L; Whitcomb, JM; Hellmann, NS; Richman, DD				Little, SJ; Holte, S; Routy, JP; Daar, ES; Markowitz, M; Collier, AC; Koup, RA; Mellors, JW; Connick, E; Conway, B; Kilby, M; Wang, L; Whitcomb, JM; Hellmann, NS; Richman, DD			Antiretroviral-drug resistance among patients recently infected with HIV	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SOCIETY-USA PANEL; ZIDOVUDINE-RESISTANCE; REVERSE-TRANSCRIPTASE; VERTICAL TRANSMISSION; GENOTYPIC RESISTANCE; THERAPY; MUTATIONS; AIDS; SUSCEPTIBILITY	Background Among persons in North America who are newly infected With the human immunodeficiency virus (HIV), the prevalence of transmitted resistance to antiretroviral drugs has been estimated at 1 to 11 percent. Methods We performed a retrospective analysis of susceptibility to antiretroviral drugs before treatment and drug-resistance mutations in HIV in plasma samples from 377 subjects with primary HIV infection who had not yet received treatment and who were identified between May 1995 and June 2000 in 10 North American cities. Responses to treatment could be evaluated in 202 subjects. Results Over the five-year period, the frequency of transmitted drug resistance increased significantly. The frequency of high-level resistance to one or more drugs (indicated by a value of more than 10 for the ratio of the 50 percent inhibitory concentration [IC50] for the subject's virus to the IC50 for a drug-sensitive reference virus) increased from 3.4 percent during the period from 1995 to 1998 to 12.4 percent during the period from 1999 to 2000 (P = 0.002), and the frequency of multidrug resistance increased from 1.1 percent to 6.2 percent (P = 0.01). The frequency of resistance mutations detected by sequence analysis increased from 8.0 percent to 22.7 percent (P < 0.001), and the frequency of multidrug resistance detected by sequence analysis increased from 3.8 percent to 10.2 percent (P = 0.05). Among subjects infected with drug-resistant virus, the time to viral suppression after the initiation of antiretroviral therapy was longer (P = 0.05), and the time to virologic failure was shorter (P = 0.05). Conclusions The proportion of new HIV infections that involve drug-resistant virus is increasing in North America. Initial antiretroviral therapy is more likely to fail in patients who are infected with drug-resistant virus. Testing for resistance to drugs before therapy begins is now indicated even for recently infected patients.	Univ Calif San Diego, Antiviral Res Ctr, Dept Med, San Diego, CA 92103 USA; Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA; Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, Seattle, WA 98104 USA; Univ Washington, Dept Med, Seattle, WA USA; McGill Univ, Dept Med, Ctr Hlth, Montreal, PQ, Canada; Univ Calif Los Angeles, Harbor Med Ctr, Dept Med, Torrance, CA 90509 USA; Aaron Diamond AIDS Res Ctr, New York, NY USA; NIH, Vaccine Res Ctr, Bethesda, MD 20892 USA; Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA; Univ British Columbia, Dept Pharmacol & Med Therapeut, Vancouver, BC V5Z 1M9, Canada; Univ Alabama, Dept Med, Birmingham, AL 35294 USA; Virologic, San Francisco, CA USA; Vet Affairs San Diego Healthcare Syst, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; McGill University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; National Institutes of Health (NIH) - USA; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of British Columbia; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Little, SJ (corresponding author), Univ Calif San Diego, Antiviral Res Ctr, Dept Med, 150 W Washington St,Ste 100, San Diego, CA 92103 USA.		FRCPI, Mark D Kilby MB BS DSc MD FRCOG/AAW-9704-2020; Little, Susan/AAA-6116-2019	FRCPI, Mark D Kilby MB BS DSc MD FRCOG/0000-0001-9987-4223; 	NCRR NIH HHS [M01-RR0002, M01-RR00425, M01-RR00102] Funding Source: Medline; NIAID NIH HHS [AI 36214, AI 38858, AI 41532, AI 43638, AI 47033, AI 29164, AI 43271-01, AI 41536, AI 41535, AI 467376-03, AI 27670] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000425, M01RR000102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI041535, P30AI036214, ZIAAI005014, R37AI029164, R01AI029164, R01AI047033, U01AI041532, Z01AI005014, U01AI027670, U01AI038858, U01AI043638, R01AI043271, U01AI041536] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 1999, MMWR MORB MORTAL WKL, V48, P45; Autran B, 1997, SCIENCE, V277, P112, DOI 10.1126/science.277.5322.112; Balotta C, 2000, ANTIVIR THER, V5, P7; Boden D, 1999, JAMA-J AM MED ASSOC, V282, P1135, DOI 10.1001/jama.282.12.1135; Bozzette SA, 1998, NEW ENGL J MED, V339, P1897, DOI 10.1056/NEJM199812243392606; Brodine SK, 1999, ANN INTERN MED, V131, P502, DOI 10.7326/0003-4819-131-7-199910050-00004; Brown AJL, 2000, J VIROL, V74, P10269, DOI 10.1128/JVI.74.22.10269-10273.2000; BROWN AJL, 2002, 9 C RETR OPP INF SEA; Carpenter CCJ, 2000, JAMA-J AM MED ASSOC, V283, P381, DOI 10.1001/jama.283.3.381; Colgrove RC, 1998, AIDS, V12, P2281, DOI 10.1097/00002030-199817000-00009; CONLON CP, 1994, J INFECT DIS, V169, P411, DOI 10.1093/infdis/169.2.411; Conway B, 1999, CLIN INFECT DIS, V28, P910, DOI 10.1086/515225; DAQUILA RT, 1995, ANN INTERN MED, V122, P401, DOI 10.7326/0003-4819-122-6-199503150-00001; deRonde A, 1996, AIDS, V10, P231, DOI 10.1097/00002030-199602000-00017; ERICE A, 1993, NEW ENGL J MED, V328, P1163, DOI 10.1056/NEJM199304223281605; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; FITZGIBBON JE, 1993, NEW ENGL J MED, V329, P1835, DOI 10.1056/NEJM199312163292502; Garcia-Lerma JG, 2001, P NATL ACAD SCI USA, V98, P13907, DOI 10.1073/pnas.241300698; Hecht FM, 1998, NEW ENGL J MED, V339, P307, DOI 10.1056/NEJM199807303390504; Hirsch MS, 2000, JAMA-J AM MED ASSOC, V283, P2417, DOI 10.1001/jama.283.18.2417; Imrie A, 1997, J INFECT DIS, V175, P1502, DOI 10.1086/516487; Jacobson M A, 1998, AIDS, V12 Suppl A, pS157; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Janssen RS, 1999, JAMA-J AM MED ASSOC, V281, P1893; Johnson VA, 2001, J INFECT DIS, V183, P1688, DOI 10.1086/320697; Kamkamidze G, 2001, J CLIN VIROL, V22, P143, DOI 10.1016/S1386-6532(01)00178-0; Kellogg T, 1999, AIDS, V13, P2303, DOI 10.1097/00002030-199911120-00013; Lederman MM, 1998, J INFECT DIS, V178, P70, DOI 10.1086/515591; Little SJ, 1999, JAMA-J AM MED ASSOC, V282, P1142, DOI 10.1001/jama.282.12.1142; LITTLE SJ, 2002, 9 C RETR OPP INF SEA; LITTLE SJ, 2001, ANTIVIR THER S, V6, P21; Lorenzi P, 1999, AIDS, V13, pF17, DOI 10.1097/00002030-199902040-00001; Masquelier B, 2001, J ACQ IMMUN DEF SYND, V27, P99, DOI 10.1097/00126334-200106010-00001; MAYERS DL, 1995, AIDS RES HUM RETROV, V11, pS162; Murphy EL, 2001, ANN INTERN MED, V135, P17, DOI 10.7326/0003-4819-135-1-200107030-00005; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Petropoulos CJ, 2000, ANTIMICROB AGENTS CH, V44, P920, DOI 10.1128/AAC.44.4.920-928.2000; Porter K, 2001, BRIT MED J, V322, P1087, DOI 10.1136/bmj.322.7294.1087; Quigg M, 1997, AIDS, V11, P835; RICHMAN DD, 2001, 41 INT C ANT AG CHEM; Rubio A, 1997, AIDS, V11, P1184, DOI 10.1097/00002030-199709000-00016; Salomon H, 2000, AIDS, V14, pF17, DOI 10.1097/00002030-200001280-00003; *STAT CTR HIV AIDS, 2002, AC HIV INF EARL DIS; VEENSTRA J, 1995, CLIN INFECT DIS, V21, P556, DOI 10.1093/clinids/21.3.556; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Yerly S, 2001, AIDS, V15, P2287, DOI 10.1097/00002030-200111230-00010; Yerly S, 1999, LANCET, V354, P729, DOI 10.1016/S0140-6736(98)12262-6; Zolopa AR, 1999, ANN INTERN MED, V131, P813, DOI 10.7326/0003-4819-131-11-199912070-00003; 2001, MMWR MORB MORTAL WKL, V50, P117; 2001, MMWR MORB MORTAL WKL, V50, P440	50	925	987	2	52	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 8	2002	347	6					385	394		10.1056/NEJMoa013552	http://dx.doi.org/10.1056/NEJMoa013552			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587YR	12167680				2022-12-24	WOS:000177672400002
J	Buchholz, U; Mermin, J; Rios, R; Casagrande, TL; Galey, F; Lee, M; Quattrone, A; Farrar, J; Nagelkerke, N; Werner, SB				Buchholz, U; Mermin, J; Rios, R; Casagrande, TL; Galey, F; Lee, M; Quattrone, A; Farrar, J; Nagelkerke, N; Werner, SB			An outbreak of food-borne illness associated with methomyl-contaminated salt	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Context On January 5, 1999, the California Department of Health Services was notified of the repeated occurrence (December 21, 1998, and January 2, 1999) of gastrointestinal tract illness among patrons at a Thai restaurant in central California. Objective To identify the source of the outbreak. Design Case-control study; microbiological and toxicological laboratory testing of samples of food, stool, and vomitus. Setting Thai food restaurant in central California. Participants Patrons of the restaurant. A case (n=107) was defined as dizziness, nausea, or vomiting occurring in a person who ate at the restaurant between December 20, 1998, and January 2, 1999, with onset of symptoms within 2 hours of eating. A control (n = 169) was a person who ate at the restaurant during the same period but reported no symptoms. Main Outcome Measures Odds ratios (ORs) of illness associated with food exposures; ORs of shifts during which illness occurred associated with certain cooks; laboratory results. Results The median latency period was 40 minutes from beginning eating to first symptom and was 2 hours to onset of diarrhea. The median duration of symptoms was 6 hours. Twenty-six persons (24%) visited the emergency department or were treated by a physician; no person required hospitalization. Patients reported nausea (95%), dizziness (72%), abdominal cramps (58%), headache (52%), vomiting (51%), chills (48%), and diarrhea (46%). Fifty-one cases (48%) included dizziness, lightheadedness, or a feeling of disequilibrium as the initial symptom. Illness was statistically associated with several foods and ingredients, but no single dish or ingredient explained a substantial number of cases. The analysis of food exposures included salt added by cooks, as estimated by using the amount of salt in the recipe for each dish and the amount of each dish eaten by respondents. This association was stronger with increasing levels of salt: ORs for illness among persons who consumed more than 0.42 to 0.84, more than 0.84 to 1.25, and more than 1.25 tsp of salt added to foods in the kitchen were 1.9 (95% confidence interval [CI], 0.6-5.7), 3.0 (95% Cl, 1.0-8.8), and 4.0 (95% Cl, 1.3-13.5) compared with persons who consumed less than 0.42 tsp (P value for trend=.004). Methomyl, a highly toxic carbamate pesticide, was identified in a sample of vomitus (20 ppm) and in salt taken from containers in the storeroom (mean, 5600 ppm) and the stovetop (mean, 1425 ppm). The oral toxic dose causing illness in 50% of those exposed to methomyl was estimated to be 0.15 mg/kg of body weight (estimated range, 0.09-0.31 mg/kg of body weight). The presence of cook A was associated with shifts during which cases of illness occurred (OR, 10.4; 95% Cl, 1.2-157.4). Conclusion This outbreak of gastrointestinal illness was associated with the consumption of food seasoned with methomyl-contaminated salt. To allow rapid assessment for further investigational and control measures by health officials, physicians should report suspected outbreaks of illness to public health departments, however trivial the symptoms or cause may seem.	Ctr Dis Control & Prevent, Epidem Intelligence Serv, Epidemiol Program Off, Atlanta, GA USA; Fresno Cty Dept Community Hlth, Fresno, CA USA; Univ Calif Davis, Davis, CA 95616 USA; Calif Dept Food & Agr, Sacramento, CA 95814 USA; Calif Dept Hlth Serv, Berkeley, CA USA; Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands	Centers for Disease Control & Prevention - USA; University of California System; University of California Davis; California Department of Food & Agriculture; California Department of Health Care Services; Netherlands National Institute for Public Health & the Environment	Buchholz, U (corresponding author), Robert Koch Inst, Zentrum Infekt Epidemiol, Seestr 10, D-13353 Berlin, Germany.		Mermin, Jonathan/J-9847-2012; QUATTRONE, Aldo/A-6734-2016	QUATTRONE, Aldo/0000-0003-2001-957X				KIDD H, 1991, AGROCHEMICALS HDB, V3, P11; LIDDLE JA, 1979, CLIN TOXICOL, V15, P159, DOI 10.3109/15563657908989861; SWADDIWUDHIPONG W, 1989, Southeast Asian Journal of Tropical Medicine and Public Health, V20, P125	3	19	20	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 7	2002	288	5					604	610		10.1001/jama.288.5.604	http://dx.doi.org/10.1001/jama.288.5.604			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	581FJ	12150672				2022-12-24	WOS:000177280200019
J	Obata, Y; Kono, T; Hatada, I				Obata, Y; Kono, T; Hatada, I			Oogenesis: Maturation of mouse fetal germ cells in vitro - Even immature oocytes can eventually be fertilized after some skilful manipulation.	NATURE			English	Article							EPIGENETIC MODIFICATIONS; IN-VITRO; GROWTH; EXPRESSION; MICE; FOLLICLES		Gunma Univ, Ctr Gene Res, Maebashi, Gumma 3718511, Japan; Tokyo Univ Agr, Dept Biosci, Setagaya Ku, Tokyo 1568502, Japan	Gunma University; Tokyo University of Agriculture	Obata, Y (corresponding author), Gunma Univ, Ctr Gene Res, 3-39-22 Showa Machi, Maebashi, Gumma 3718511, Japan.	ihatada@showa.gunma-u.ac.jp						Bao SQ, 2000, BIOL REPROD, V62, P616, DOI 10.1095/biolreprod62.3.616; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; BUEHR M, 1985, GAMETE RES, V11, P271, DOI 10.1002/mrd.1120110306; Cortvrindt R, 1996, HUM REPROD, V11, P2656; Eppig JJ, 1996, BIOL REPROD, V54, P197, DOI 10.1095/biolreprod54.1.197; Kono T, 1996, NAT GENET, V13, P91, DOI 10.1038/ng0596-91; Lucifero D, 2002, GENOMICS, V79, P530, DOI 10.1006/geno.2002.6732; Obata Y, 2002, J BIOL CHEM, V277, P5285, DOI 10.1074/jbc.M108586200; Obata Y, 1998, DEVELOPMENT, V125, P1553; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Wutz A, 1997, NATURE, V389, P745, DOI 10.1038/39631	11	77	79	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 1	2002	418	6897					497	498		10.1038/418497a	http://dx.doi.org/10.1038/418497a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579EE	12152066	Bronze			2022-12-24	WOS:000177162800027
J	Crawford, SC; Davis, JA; Siddiqui, NA; de Caestecker, L; Gillis, CR; Hole, D				Crawford, SC; Davis, JA; Siddiqui, NA; de Caestecker, L; Gillis, CR; Hole, D			The waiting time paradox: population based retrospective study of treatment delay and survival of women with endometrial cancer in Scotland	BRITISH MEDICAL JOURNAL			English	Article							CARCINOMA		Stobhill Gen Hosp, Dept Gynaecol Oncol, Glasgow G21 3UW, Lanark, Scotland; Greater Glasgow Hlth Board, Dept Publ Hlth, Glasgow G3 8YT, Lanark, Scotland; Univ Glasgow, Dept Publ Hlth, W Scotland Canc Surveillance Unit, Glasgow G12 8RZ, Lanark, Scotland; Aberdeen Matern Hosp, Scottish Programme Clin Effectiveness Reprod Hlth, Aberdeen, Scotland	University of Glasgow; University of Aberdeen	Crawford, SC (corresponding author), Stobhill Gen Hosp, Dept Gynaecol Oncol, Glasgow G21 3UW, Lanark, Scotland.							Creutzberg CL, 2000, LANCET, V355, P1404, DOI 10.1016/S0140-6736(00)02139-5; Fruchter R G, 1981, Cancer Detect Prev, V4, P481; MENCZER J, 1995, AM J OBSTET GYNECOL, V173, P774, DOI 10.1016/0002-9378(95)90340-2; *NHS EX, 1999, GUID COMM CANC SERV, P25; SHEPHERD JH, 1989, BRIT J OBSTET GYNAEC, V96, P889, DOI 10.1111/j.1471-0528.1989.tb03341.x	5	78	79	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 27	2002	325	7357					196	196		10.1136/bmj.325.7357.196	http://dx.doi.org/10.1136/bmj.325.7357.196			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	580PX	12142308	Bronze, Green Published, Green Accepted			2022-12-24	WOS:000177243900021
J	Stoodley, N				Stoodley, N			Non-accidental head injury in children: gathering the evidence	LANCET			English	Editorial Material							TRAUMATIC BRAIN INJURY; YOUNG-CHILDREN; IMAGING FINDINGS; INFANTS; NEUROPATHOLOGY; ABUSE		Univ Wales Hosp, Cardiff CF14 4XW, S Glam, Wales	Cardiff University	Stoodley, N (corresponding author), Univ Wales Hosp, Heath Pk, Cardiff CF14 4XW, S Glam, Wales.							Barlow KM, 1999, ACTA PAEDIATR, V88, P734; Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; Biousse V, 2002, AM J OPHTHALMOL, V133, P249, DOI 10.1016/S0002-9394(01)01366-6; Chabrol B, 1999, CHILD ABUSE NEGLECT, V23, P217, DOI 10.1016/S0145-2134(98)00128-8; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; Haviland J, 1997, ARCH DIS CHILD, V77, P504, DOI 10.1136/adc.77.6.504; Jayawant S, 1998, BMJ-BRIT MED J, V317, P1558, DOI 10.1136/bmj.317.7172.1558; Kemp AM, 2002, ARCH DIS CHILD, V86, P98, DOI 10.1136/adc.86.2.98; Liu AY, 1999, AM J NEURORADIOL, V20, P1636; Prasad MR, 2002, PEDIATR NEUROSURG, V36, P64, DOI 10.1159/000048355; Sane SM, 2000, PEDIATRICS, V105, P1345; SATO Y, 1989, RADIOLOGY, V173, P653, DOI 10.1148/radiology.173.3.2813768; Suh DY, 2001, NEUROSURGERY, V49, P309, DOI 10.1097/00006123-200108000-00011	17	13	13	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 27	2002	360	9329					271	272		10.1016/S0140-6736(02)09563-6	http://dx.doi.org/10.1016/S0140-6736(02)09563-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	578DT	12147367				2022-12-24	WOS:000177102700005
J	Cha, RS; Kleckner, N				Cha, RS; Kleckner, N			ATR homolog Mec1 promotes fork progression, thus averting breaks in replication slow zones	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE CHROMOSOME; MEIOTIC DNA-REPLICATION; SITES; PAUSE; MAP; LOCALIZATION; COMPLETION; COHESION; ORIGINS; GROWTH	Budding yeast Mec1, homolog of mammalian ATR, is an essential protein that mediates S-phase checkpoint responses and meiotic recombination. Elimination of Mec1 function leads to genomewide fork stalling followed by chromosome breakage. Breaks do not result from stochastic collapse of stalled forks or other incidental lesions; instead, they occur in specific regions of the genome during a G(2) chromosomal transition. Break regions are found to be genetically encoded replication slow zones (RSZs), a newly discovered yeast chromosomal determinant. Thus, Mec1 has important functions in normal S phase and the genome instability of mec1 (and, analogously, ATR(-/-)) mutants stems from defects in these basic roles.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Kleckner, N (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	kleckner@fas.harvard.edu		Cha, Rita/0000-0001-8223-1520	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM025326, R01GM025326] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM25326, R01 GM025326] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; BAKER BS, 1972, GENETICS, V71, P255; Baudat F, 1997, P NATL ACAD SCI USA, V94, P5213, DOI 10.1073/pnas.94.10.5213; Blat Y, 1999, CELL, V98, P249, DOI 10.1016/S0092-8674(00)81019-3; Borde V, 2000, SCIENCE, V290, P806, DOI 10.1126/science.290.5492.806; Borde V, 1999, MOL CELL BIOL, V19, P4832; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; Brown EJ, 2000, GENE DEV, V14, P397; Cha RS, 2000, GENE DEV, V14, P493; Desany BA, 1998, GENE DEV, V12, P2956, DOI 10.1101/gad.12.18.2956; Deshpande AM, 1996, SCIENCE, V272, P1030, DOI 10.1126/science.272.5264.1030; Dujon B, 1996, TRENDS GENET, V12, P263, DOI 10.1016/0168-9525(96)10027-5; GREENFEDER SA, 1992, MOL CELL BIOL, V12, P4056, DOI 10.1128/MCB.12.9.4056; GREENFEDER SA, 1992, MOL BIOL CELL, V3, P999, DOI 10.1091/mbc.3.9.999; Grushcow JM, 1999, GENETICS, V153, P607; GUTHRIE C, 1991, GUIDE YEAST GENET MO, V194; HENNESSY KM, 1991, GENE DEV, V5, P958, DOI 10.1101/gad.5.6.958; HILL TM, 1996, ESCHERICHIA COLI SAL, P1602; LAIRD CD, 1993, COLD SPRING HARB SYM, V58, P633, DOI 10.1101/SQB.1993.058.01.070; Le SY, 1997, YEAST, V13, P1029, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1029::AID-YEA160>3.0.CO;2-1; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; MATHEWS CK, 1993, PROG NUCLEIC ACID RE, V44, P167, DOI 10.1016/S0079-6603(08)60220-2; NEWLON CS, 1991, GENETICS, V129, P343; NGHIEM P, 2001, P NATL ACAD SCI USA, P9029; Poloumienko A, 2001, MOL BIOL CELL, V12, P3317, DOI 10.1091/mbc.12.11.3317; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; REDDY GPV, 1983, NATURE, V304, P658; SCHLEGEL R, 1986, SCIENCE, V232, P1264, DOI 10.1126/science.2422760; SHARP PM, 1993, NUCLEIC ACIDS RES, V21, P179, DOI 10.1093/nar/21.2.179; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; Shirahige K, 1998, NATURE, V395, P618, DOI 10.1038/27007; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Sutherland G, 1985, FRAGILE SITES HUMAN; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; THEIS J, 2001, MOL CELL BIOL, V21, P2970; Thrower DA, 2001, MOL BIOL CELL, V12, P2800, DOI 10.1091/mbc.12.9.2800; Toth A, 1999, GENE DEV, V13, P320, DOI 10.1101/gad.13.3.320; Waizenegger IC, 2000, CELL, V103, P399, DOI 10.1016/S0092-8674(00)00132-X; Wang YZ, 2001, MOL CELL BIOL, V21, P4938, DOI 10.1128/MCB.21.15.4938-4948.2001; Xu Y, 1996, GENE DEV, V10, P2401, DOI 10.1101/gad.10.19.2401; Yang DQ, 2000, NAT CELL BIOL, V2, P893, DOI 10.1038/35046542; Zhao XL, 2001, EMBO J, V20, P3544, DOI 10.1093/emboj/20.13.3544; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; ZHU JG, 1992, MOL CELL BIOL, V12, P4733, DOI 10.1128/MCB.12.10.4733	44	366	378	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 26	2002	297	5581					602	606		10.1126/science.1071398	http://dx.doi.org/10.1126/science.1071398			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577GY	12142538				2022-12-24	WOS:000177054200051
J	Mahdavi, J; Sonden, B; Hurtig, M; Olfat, FO; Forsberg, L; Roche, N; Angstrom, J; Larsson, T; Teneberg, S; Karlsson, KA; Altraia, S; Wadstrom, T; Kersulyte, D; Berg, DE; Dubois, A; Petersson, C; Magnusson, KE; Norberg, T; Lindh, F; Lundskog, BB; Arnqvist, A; Hammarstrom, L; Boren, T				Mahdavi, J; Sonden, B; Hurtig, M; Olfat, FO; Forsberg, L; Roche, N; Angstrom, J; Larsson, T; Teneberg, S; Karlsson, KA; Altraia, S; Wadstrom, T; Kersulyte, D; Berg, DE; Dubois, A; Petersson, C; Magnusson, KE; Norberg, T; Lindh, F; Lundskog, BB; Arnqvist, A; Hammarstrom, L; Boren, T			Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation	SCIENCE			English	Article							BLOOD-GROUP ANTIGENS; HUMAN GASTRIC EPITHELIUM; SIALYL-LEWIS-A; PATHOGENICITY ISLAND; MONOCLONAL-ANTIBODY; CELL LINEAGE; CARCINOMA; EXPRESSION; GLYCOSYLATION; SPECIFICITY	Helicobacter pylori adherence in the human gastric mucosa involves specific bacterial adhesins and cognate host receptors. Here, we identify sialyl-dimeric-Lewis x glycosphingolipid as a receptor for H. pylori and show that H. pylori infection induced formation of sialyl-Lewis x antigens in gastric epithelium in humans and in a Rhesus monkey. The corresponding sialic acid binding adhesin (SabA) was isolated with the retagging method, and the underlying sabA gene (JHP662/HP0725) was identified. The ability of many H. pylori strains to adhere to sialylated glycoconjugates expressed during chronic inflammation might thus contribute to virulence and the extraordinary chronicity of H. pylori infection.	Umea Univ, Dept Odontol Oral Microbiol, SE-90187 Umea, Sweden; Swedish Inst Infect Dis Control, SE-17182 Solna, Sweden; Univ Gothenburg, Inst Med Biochem, SE-40530 Gothenburg, Sweden; Univ Tartu, Inst Mol & Cell Biol, EE-51010 Tartu, Estonia; Lund Univ, Dept Infect Dis & Med Microbiol, SE-22362 Lund, Sweden; Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; Uniformed Serv Univ Hlth Sci, Dept Med, Gastrointestinal & Liver Studies Lab, Bethesda, MD 20814 USA; Linkoping Univ, Dept Mol & Clin Med, Div Med Microbiol, SE-58185 Linkoping, Sweden; Swedish Univ Agr Sci, Dept Chem, SE-75007 Uppsala, Sweden; IsoSep AB, SE-14636 Tullinge, Sweden; Umea Univ, Dept Med Biosci Clin Cytol, SE-90187 Umea, Sweden; Umea Univ, Dept Biol Mol, SE-90187 Umea, Sweden; Karolinska Inst, Novum, Ctr Biotechnol, SE-14157 Huddinge, Sweden	Umea University; Swedish Institute for Infectious Disease Control; University of Gothenburg; University of Tartu; Lund University; Washington University (WUSTL); Uniformed Services University of the Health Sciences - USA; Linkoping University; Swedish University of Agricultural Sciences; Umea University; Umea University; Karolinska Institutet	Boren, T (corresponding author), Umea Univ, Dept Odontol Oral Microbiol, SE-90187 Umea, Sweden.	Thomas.Boren@odont.umu.se	Aspholm, Marina/ABB-5298-2020	Aspholm, Marina/0000-0003-3175-6022; Magnusson, Karl-Eric/0000-0002-7809-8437	NATIONAL CANCER INSTITUTE [R01CA082312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038166, R03AI049161] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574, R01DK053727] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA082312, R01 CA082312-08] Funding Source: Medline; NIAID NIH HHS [R03 AI49161, R01 AI38166] Funding Source: Medline; NIDDK NIH HHS [P30 DK052574, R01 DK53727, P30 DK52574] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akopyants NS, 1998, MOL MICROBIOL, V28, P37, DOI 10.1046/j.1365-2958.1998.00770.x; Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Alper J, 2001, SCIENCE, V291, P2338, DOI 10.1126/science.291.5512.2338; Amado M, 1998, GASTROENTEROLOGY, V114, P462, DOI 10.1016/S0016-5085(98)70529-3; Angstrom J, 1998, GLYCOBIOLOGY, V8, P297, DOI 10.1093/glycob/8.4.297; ARNQVIST A, UNPUB; Barstrom M, 2000, CARBOHYD RES, V328, P525, DOI 10.1016/S0008-6215(00)00128-2; BLASZCZYKTHURIN M, 1987, J BIOL CHEM, V262, P372; BOREN T, 1993, SCIENCE, V262, P1892, DOI 10.1126/science.8018146; BOREN T, 1994, SCIENCE, V264, P1387, DOI 10.1126/science.264.5164.1387; Censini S, 1996, P NATL ACAD SCI USA, V93, P14648, DOI 10.1073/pnas.93.25.14648; CLAUSEN H, 1989, VOX SANG, V56, P1, DOI 10.1111/j.1423-0410.1989.tb03040.x; Cover T. L., 2001, PRINCIPLES BACTERIAL, P509; Dubois A, 1999, GASTROENTEROLOGY, V116, P90, DOI 10.1016/S0016-5085(99)70232-5; FALK P, 1993, P NATL ACAD SCI USA, V90, P2035, DOI 10.1073/pnas.90.5.2035; FALK PG, 1995, P NATL ACAD SCI USA, V92, P1515, DOI 10.1073/pnas.92.5.1515; Gerhard M, 1999, P NATL ACAD SCI USA, V96, P12778, DOI 10.1073/pnas.96.22.12778; GERHARD M, 2001, MOL CELL BIOL, pCH12; Guruge JL, 1998, P NATL ACAD SCI USA, V95, P3925, DOI 10.1073/pnas.95.7.3925; HAKOMORI S, 1989, GANGLIOSIDES CANCER, P58; HAKOMORI SI, 1989, ADV CANCER RES, V52, P257; Herron MJ, 2000, SCIENCE, V288, P1653, DOI 10.1126/science.288.5471.1653; HURTIG M, UNPUB; Ilver D, 1998, SCIENCE, V279, P373, DOI 10.1126/science.279.5349.373; KARLSSON KA, 1987, METHOD ENZYMOL, V138, P212; Karlsson KA, 1998, MOL MICROBIOL, V29, P1, DOI 10.1046/j.1365-2958.1998.00854.x; Larsson T, 2000, FEBS LETT, V469, P155, DOI 10.1016/S0014-5793(00)01270-9; LEVERY SB, 1986, CARBOHYD RES, V151, P311, DOI 10.1016/S0008-6215(00)90351-3; MADRID JF, 1990, HISTOCHEMISTRY, V95, P179; MAGNANI JL, 1981, SCIENCE, V212, P55, DOI 10.1126/science.7209516; NORREGAARDJENSEN O, 1999, METHODS MOLEC BIOL, P571; Ota H, 1998, VIRCHOWS ARCH, V433, P419, DOI 10.1007/s004280050269; SAKAMOTO J, 1989, CANCER RES, V49, P745; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; Segal ED, 1999, P NATL ACAD SCI USA, V96, P14559, DOI 10.1073/pnas.96.25.14559; SIPPONEN P, 1986, ACTA PATH MICRO IM A, V94, P305; SIPPONEN P, 1989, SCAND J GASTROENTERO, V24, P581, DOI 10.3109/00365528909093093; SUERBAUM S, 1993, J BACTERIOL, V175, P3278, DOI 10.1128/jb.175.11.3278-3288.1993; Syder AJ, 1999, MOL CELL, V3, P263, DOI 10.1016/S1097-2765(00)80454-2; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483	40	639	691	1	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 26	2002	297	5581					573	578		10.1126/science.1069076	http://dx.doi.org/10.1126/science.1069076			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577GY	12142529	Green Submitted, Green Accepted			2022-12-24	WOS:000177054200042
J	Golding, NL; Staff, NP; Spruston, N				Golding, NL; Staff, NP; Spruston, N			Dendritic spikes as a mechanism for cooperative long-term potentiation	NATURE			English	Article							CA1 PYRAMIDAL NEURONS; HIPPOCAMPAL-NEURONS; SYNAPTIC POTENTIALS; CALCIUM INFLUX; IN-VIVO; PROPAGATION; INITIATION; PLASTICITY; AFFERENTS; INDUCTION	Strengthening of synaptic connections following coincident pre- and postsynaptic activity was proposed by Hebb as a cellular mechanism for learning(1). Contemporary models assume that multiple synapses must act cooperatively to induce the postsynaptic activity required for hebbian synaptic plasticity(2-5). One mechanism for the implementation of this cooperation is action potential firing, which begins in the axon, but which can influence synaptic potentiation following active backpropagation into dendrites(6). Backpropagation is limited, however, and action potentials often fail to invade the most distal dendrites(7-10). Here we show that long-term potentiation of synapses on the distal dendrites of hippocampal CA1 pyramidal neurons does require cooperative synaptic inputs, but does not require axonal action potential firing and backpropagation. Rather, locally generated and spatially restricted regenerative potentials (dendritic spikes) contribute to the postsynaptic depolarization and calcium entry necessary to trigger potentiation of distal synapses. We find that this mechanism can also function at proximal synapses, suggesting that dendritic spikes participate generally in a form of synaptic potentiation that does not require postsynaptic action potential firing in the axon.	Northwestern Univ, Inst Neurosci, Dept Neurobiol & Physiol, Evanston, IL 60208 USA	Northwestern University	Spruston, N (corresponding author), Northwestern Univ, Inst Neurosci, Dept Neurobiol & Physiol, 2153 N Campus Dr, Evanston, IL 60208 USA.		Staff, Nathan/M-2583-2019	Staff, Nathan/0000-0001-6760-3859; Spruston, Nelson/0000-0003-3118-1636				Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; CALLAWAY JC, 1995, J NEUROPHYSIOL, V74, P1395, DOI 10.1152/jn.1995.74.4.1395; COLBERT CM, 1993, BRAIN RES, V606, P87, DOI 10.1016/0006-8993(93)91573-B; Golding NL, 1999, J NEUROSCI, V19, P8789, DOI 10.1523/JNEUROSCI.19-20-08789.1999; Golding NL, 2001, J NEUROPHYSIOL, V86, P2998, DOI 10.1152/jn.2001.86.6.2998; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; GUSTAFSSON B, 1987, J NEUROSCI, V7, P774; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Hebb D.O., 1949, ORG BEHAV; Helmchen F, 1999, NAT NEUROSCI, V2, P989, DOI 10.1038/14788; Kamondi A, 1998, HIPPOCAMPUS, V8, P244, DOI 10.1002/(SICI)1098-1063(1998)8:3<244::AID-HIPO7>3.0.CO;2-J; Kamondi A, 1998, J NEUROSCI, V18, P3919; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; LEE KS, 1983, J NEUROSCI, V3, P1369; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MCNAUGHTON BL, 1978, BRAIN RES, V157, P277, DOI 10.1016/0006-8993(78)90030-6; MEL BW, 1993, J NEUROPHYSIOL, V70, P1086, DOI 10.1152/jn.1993.70.3.1086; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; Pike FG, 1999, J PHYSIOL-LONDON, V518, P571, DOI 10.1111/j.1469-7793.1999.0571p.x; Poirazi P, 2001, NEURON, V29, P779, DOI 10.1016/S0896-6273(01)00252-5; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Schiller J, 1998, NAT NEUROSCI, V1, P114, DOI 10.1038/363; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; Segev I, 1998, TRENDS NEUROSCI, V21, P453, DOI 10.1016/S0166-2236(98)01327-7; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/s0896-6273(01)00542-6; SPRUSTON N, 1994, TRENDS NEUROSCI, V17, P161, DOI 10.1016/0166-2236(94)90094-9; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; Wei DS, 2001, SCIENCE, V293, P2272, DOI 10.1126/science.1061198	30	451	461	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 18	2002	418	6895					326	331		10.1038/nature00854	http://dx.doi.org/10.1038/nature00854			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574BF	12124625				2022-12-24	WOS:000176868000043
J	Humphries, MM; Thomas, DW; Speakman, JR				Humphries, MM; Thomas, DW; Speakman, JR			Climate-mediated energetic constraints on the distribution of hibernating mammals	NATURE			English	Article							BATS MYOTIS-LUCIFUGUS; LIMITS	To predict the consequences of human-induced global climate change, we need to understand how climate is linked to biogeography(1). Energetic constraints are commonly invoked to explain animal distributions, and physiological parameters are known to vary along distributional gradients(2). But the causal nature of the links between climate and animal biogeography remain largely obscure(2,3). Here we develop a bioenergetic model that predicts the feasibility of mammalian hibernation under different climatic conditions. As an example, we use the well-quantified hibernation energetics of the little brown bat (Myotis lucifugus) to parameterize the model(4). Our model predicts pronounced effects of ambient temperature on total winter energy requirements, and a relatively narrow combination of hibernaculum temperatures and winter lengths permitting successful hibernation. Microhabitat and northern distribution limits of M. lucifugus are consistent with model predictions, suggesting that the thermal dependence of hibernation energetics constrains the biogeography of this species. Integrating projections of climate change into our model predicts a pronounced northward range expansion of hibernating bats within the next 80 years. Bioenergetics can provide the simple link between climate and biogeography needed to predict the consequences of climate change.	Univ Aberdeen, Dept Zool, Aberdeen AB24 3TZ, Scotland; Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; Univ Sherbrooke, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada; Rowett Res Inst, Aberdeen AB21 9BS, Scotland	University of Aberdeen; University of Alberta; University of Sherbrooke; University of Aberdeen	Humphries, MM (corresponding author), Univ Aberdeen, Dept Zool, Aberdeen AB24 3TZ, Scotland.	murray_humphries@hotmail.com	Speakman, John R./A-9494-2008	Speakman, John R./0000-0002-2457-1823				BELL GP, 1986, J COMP PHYSIOL B, V156, P441, DOI 10.1007/BF01101107; BRACK V, 1985, CAN J ZOOL, V63, P2952, DOI 10.1139/z85-442; Canterbury G, 2002, ECOLOGY, V83, P946, DOI 10.2307/3071904; Chown SL, 1999, BIOL REV, V74, P87, DOI 10.1017/S000632319800526X; Davis W. H., 1964, Journal of Mammalogy, V45, P475, DOI 10.2307/1377426; DWYER P D, 1971, Mammalia, V35, P424, DOI 10.1515/mamm.1971.35.3.424; FENTON MB, 1980, MAMMALIAN SPECIES, V142, P1, DOI DOI 10.2307/3503792; GATES DM, 1993, CLIMATE CHANGE ITS B, P162; HENSHAW RE, 1966, PHYSIOL ZOOL, V39, P223, DOI 10.1086/physzool.39.3.30152849; Johns TC, 1997, CLIM DYNAM, V13, P103, DOI 10.1007/s003820050155; Johnston I.A., 1996, ANIMALS TEMPERATURE; Kunz TH, 1998, ECOSCIENCE, V5, P8, DOI 10.1080/11956860.1998.11682443; MCMANUS JJ, 1974, J MAMMAL, V55, P844, DOI 10.2307/1379416; MENAKER M, 1962, J CELL COMPAR PHYSL, V59, P163, DOI 10.1002/jcp.1030590209; Nagorsen David W., 1994, Northwestern Naturalist, V74, P61, DOI 10.2307/3536599; NAGORSEN DW, 1980, CAN FIELD NAT, V94, P83; Parker DI, 1997, ARCTIC, V50, P256; Pearson E. W., 1962, Journal of Mammalogy, V43, P27, DOI 10.2307/1376877; RAESLY RL, 1987, AM MIDL NAT, V118, P15, DOI 10.2307/2425624; RAINEY RC, 1976, INSECT FLIGHT, P75; ROOT T, 1988, J BIOGEOGR, V15, P489, DOI 10.2307/2845278; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; SCHOWALTER DB, 1980, J MAMMAL, V61, P350, DOI 10.2307/1380065; SPEAKMAN JR, IN PRESS BAT BIOL; Thomas DW, 1995, SYM ZOOL S, P233; Twente J. W., 1960, Proceedings of the Utah Academy, V37, P67; Webb PI, 1996, CAN J ZOOL, V74, P761, DOI 10.1139/z96-087; WEINER J, 1992, TRENDS ECOL EVOL, V7, P384, DOI 10.1016/0169-5347(92)90009-Z; WHITAKER JO, 1992, AM MIDL NAT, V127, P52, DOI 10.2307/2426321; [No title captured]	30	254	267	3	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 18	2002	418	6895					313	316		10.1038/nature00828	http://dx.doi.org/10.1038/nature00828			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574BF	12124621				2022-12-24	WOS:000176868000039
J	Saitou, M; Barton, SC; Surani, MA				Saitou, M; Barton, SC; Surani, MA			A molecular programme for the specification of germ cell fate in mice	NATURE			English	Article							MOUSE EMBRYO; MESODERM FORMATION; GENE-EXPRESSION; STEM-CELLS; HOMOLOG; PROTEIN; GENERATION; FAMILY; TISSUE; LINE	Germ cell fate in mice is induced in proximal epiblast cells by the extra-embryonic ectoderm, and is not acquired through the inheritance of any preformed germ plasm. To determine precisely how germ cells are specified, we performed a genetic screen between single nascent germ cells and their somatic neighbours that share common ancestry. Here we show that fragilis, an interferon-inducible transmembrane protein, marks the onset of germ cell competence, and we propose that through homotypic association, it demarcates germ cells from somatic neighbours. Using single-cell gene expression profiles, we also show that only those cells with the highest expression of fragilis subsequently express stella, a gene that we detected exclusively in lineage-restricted germ cells. The stella positive nascent germ cells exhibit repression of homeobox genes, which may explain their escape from a somatic cell fate and the retention of pluripotency.	Univ Cambridge, Wellcome Trust Canc Res UK Inst Canc & Dev Biol, Cambridge CB2 1QR, England	University of Cambridge	Surani, MA (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Inst Canc & Dev Biol, Tennis Court Rd, Cambridge CB2 1QR, England.			Surani, Azim/0000-0002-8640-4318				Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; BARLOW DP, 1984, DIFFERENTIATION, V27, P229, DOI 10.1111/j.1432-0436.1984.tb01433.x; BARNES JD, 1994, DEV BIOL, V161, P168, DOI 10.1006/dbio.1994.1018; BASTIAN H, 1990, EMBO J, V9, P1839, DOI 10.1002/j.1460-2075.1990.tb08309.x; BRADY G, 1993, METHOD ENZYMOL, V225, P611; CHIQUOINE AD, 1954, ANAT REC, V118, P135, DOI 10.1002/ar.1091180202; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; DEBLANDRE GA, 1995, J BIOL CHEM, V270, P23860, DOI 10.1074/jbc.270.40.23860; DOWNS KM, 1993, DEVELOPMENT, V118, P1255; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; EDDY EM, 1975, INT REV CYTOL, V43, P229; EVANS SS, 1993, J IMMUNOL, V150, P736; EVANS SS, 1990, BLOOD, V76, P2583; FRIEDMAN RL, 1984, CELL, V38, P745, DOI 10.1016/0092-8674(84)90270-8; FROHMAN MA, 1990, DEVELOPMENT, V110, P589; FUJII T, 1994, DEV DYNAM, V199, P73, DOI 10.1002/aja.1001990108; FUJIWARA Y, 1994, P NATL ACAD SCI USA, V91, P12258, DOI 10.1073/pnas.91.25.12258; GINSBURG M, 1990, DEVELOPMENT, V110, P521; GOMPERTS M, 1994, DEVELOPMENT, V120, P135; GURDON JB, 1993, CURR OPIN GENET DEV, V3, P662, DOI 10.1016/0959-437X(93)90104-W; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; HERRMANN BG, 1991, DEVELOPMENT, V113, P913; HERRMANN BG, 1990, NATURE, V343, P617, DOI 10.1038/343617a0; Johnson AD, 2001, DEV BIOL, V234, P402, DOI 10.1006/dbio.2001.0264; JOHNSON AD, 2000, GERM CELLS COLD SPRI, P61; Kita Masakazu, 1994, Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales, V188, P593; Kuramochi-Miyagawa S, 2001, MECH DEVELOP, V108, P121, DOI 10.1016/S0925-4773(01)00499-3; LAWSON KA, 1994, CIBA F SYMP, V182, P68; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; MACGREGOR GR, 1995, DEVELOPMENT, V121, P1487; McLaren A, 1999, GENE DEV, V13, P373, DOI 10.1101/gad.13.4.373; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Pesce M, 1998, BIOESSAYS, V20, P722, DOI 10.1002/(SICI)1521-1878(199809)20:9&lt;722::AID-BIES5&gt;3.0.CO;2-I; REID LE, 1989, P NATL ACAD SCI USA, V86, P840, DOI 10.1073/pnas.86.3.840; Saitou M, 1998, J CELL BIOL, V141, P397, DOI 10.1083/jcb.141.2.397; Sato M, 2002, MECH DEVELOP, V113, P91, DOI 10.1016/S0925-4773(02)00002-3; Seydoux G, 1999, DEVELOPMENT, V126, P3275; Sutasurya L. A., 1979, PRIMORDIAL GERM CELL; Tam PPL, 1996, DEV BIOL, V178, P124, DOI 10.1006/dbio.1996.0203; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; Toyooka Y, 2000, MECH DEVELOP, V93, P139, DOI 10.1016/S0925-4773(00)00283-5; Weismann A., 1892, KEIMPLASMA THEORIE V; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Wylie C, 1999, CELL, V96, P165, DOI 10.1016/S0092-8674(00)80557-7; Yeom YI, 1996, DEVELOPMENT, V122, P881; Ying Y, 2000, MOL ENDOCRINOL, V14, P1053, DOI 10.1210/me.14.7.1053; Ying Y, 2001, DEV BIOL, V232, P484, DOI 10.1006/dbio.2001.0173; Ying Y, 2001, P NATL ACAD SCI USA, V98, P7858, DOI 10.1073/pnas.151242798; Yoshimizu T, 2001, DEVELOPMENT, V128, P481	50	645	694	1	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 18	2002	418	6895					293	300		10.1038/nature00927	http://dx.doi.org/10.1038/nature00927			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574BF	12124616				2022-12-24	WOS:000176868000034
J	Choi, YH; Gehring, M; Johnson, L; Hannon, M; Harada, JJ; Goldberg, RB; Jacobsen, SE; Fischer, RL				Choi, YH; Gehring, M; Johnson, L; Hannon, M; Harada, JJ; Goldberg, RB; Jacobsen, SE; Fischer, RL			DEMETER, a DNA glycosylase domain protein, is required for endosperm gene imprinting and seed viability in Arabidopsis	CELL			English	Article							POLYCOMB GROUP GENE; MEDEA; FIE; FERTILIZATION; MUTATIONS; PLANTS; ORIGIN; MECHANISMS; EXPRESSION; THALIANA	We isolated mutations in Arabidopsis to understand how the female gametophyte controls embryo and endosperm development. For the DEMETER (DME) gene, seed viability depends only on the maternal allele. DME encodes a large protein with DNA glycosylase and nuclear localization domains. DME is expressed primarily in the central cell of the female gametophyte, the progenitor of the endosperm. DME is required for maternal allele expression of the imprinted MEDEA (MEA) Polycomb gene in the central cell and endosperm. Ectopic DME expression in endosperm activates expression of the normally silenced paternal MEA allele. In leaf, ectopic DME expression induces MEA and nicks the MEA promoter. Thus, a DNA glycosylase activates maternal expression of an imprinted gene in the central cell.	Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; Univ Calif Davis, Plant Biol Sect, Div Biol Sci, Davis, CA 95616 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Berkeley; University of California System; University of California Los Angeles; University of California System; University of California Davis; University of California System; University of California Los Angeles	Fischer, RL (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.		Choi, Yeonhee/AAF-5906-2020		NIGMS NIH HHS [GM 60398] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM060398, R01GM060398] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Birve A, 2001, DEVELOPMENT, V128, P3371; BOWMAN JL, 1994, ARABIDOPSIS ATLAS MO, P135; Brown RC, 1999, SEX PLANT REPROD, V12, P32, DOI 10.1007/s004970050169; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; CAVROIS M, 1995, RES VIROLOGY, V146, P179, DOI 10.1016/0923-2516(96)80578-4; Drews GN, 1998, PLANT CELL, V10, P5, DOI 10.1105/tpc.10.1.5; Francis NJ, 2001, NAT REV MOL CELL BIO, V2, P409, DOI 10.1038/35073039; Garcia-Ortiz MV, 2001, PLANT MOL BIOL, V47, P795, DOI 10.1023/A:1013644026132; Grossniklaus U, 1998, SCIENCE, V280, P446, DOI 10.1126/science.280.5362.446; Holding DR, 2002, PLANTA, V214, P373, DOI 10.1007/s00425-001-0686-0; IRISH VF, 1992, DEVELOPMENT, V115, P745; Jacobsen SE, 2000, CURR BIOL, V10, P179, DOI 10.1016/S0960-9822(00)00324-9; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jiricny J, 2002, NATURE, V415, P593, DOI 10.1038/415593a; Jost JP, 2001, NUCLEIC ACIDS RES, V29, P4452, DOI 10.1093/nar/29.21.4452; Kakutani T, 1996, P NATL ACAD SCI USA, V93, P12406, DOI 10.1073/pnas.93.22.12406; Kasinsky HE, 2001, FASEB J, V15, P34, DOI 10.1096/fj.00-0237rev; Kinoshita T, 1999, PLANT CELL, V11, P1945, DOI 10.1105/tpc.11.10.1945; Kiyosue T, 1999, P NATL ACAD SCI USA, V96, P4186, DOI 10.1073/pnas.96.7.4186; Krokan HE, 1997, BIOCHEM J, V325, P1; Langst G, 2001, MOL CELL, V8, P1085, DOI 10.1016/S1097-2765(01)00397-5; Luo M, 2000, P NATL ACAD SCI USA, V97, P10637, DOI 10.1073/pnas.170292997; Luo M, 1999, P NATL ACAD SCI USA, V96, P296, DOI 10.1073/pnas.96.1.296; MEYEROWITZ EM, 1994, ARABIDOPSIS, P435; Niwa Y, 1999, PLANT J, V18, P455, DOI 10.1046/j.1365-313X.1999.00464.x; Ohad N, 1999, PLANT CELL, V11, P407, DOI 10.1105/tpc.11.3.407; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; ROGERS SG, 1987, METHOD ENZYMOL, V153, P253; Scharer OD, 2001, BIOESSAYS, V23, P270, DOI 10.1002/1521-1878(200103)23:3<270::AID-BIES1037>3.0.CO;2-J; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; Tini M, 2002, MOL CELL, V9, P265, DOI 10.1016/S1097-2765(02)00453-7; Vielle-Calzada JP, 1999, GENE DEV, V13, P2971, DOI 10.1101/gad.13.22.2971; Vinkenoog R, 2000, PLANT CELL, V12, P2271, DOI 10.1105/tpc.12.11.2271; Yadegari R, 2000, PLANT CELL, V12, P2367, DOI 10.1105/tpc.12.12.2367	34	554	600	9	79	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 12	2002	110	1					33	42		10.1016/S0092-8674(02)00807-3	http://dx.doi.org/10.1016/S0092-8674(02)00807-3			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	573PU	12150995	Bronze			2022-12-24	WOS:000176840700005
J	Hobbs, NK; Bondareva, AA; Barnett, S; Capecchi, MR; Schmidt, EE				Hobbs, NK; Bondareva, AA; Barnett, S; Capecchi, MR; Schmidt, EE			Removing the vertebrate-specific TBP N terminus disrupts placental beta 2m-dependent interactions with the maternal immune system	CELL			English	Article							TATA-BINDING PROTEIN; MHC CLASS-I; TFIID-TAU; T-CELLS; MOUSE; MICE; GENE; TRANSCRIPTION; PREGNANCY; IMPLANTATION	Mammalian TBP consists of a 180 amino acid core that is common to all eukaryotes, fused to a vertebrate-specific N-terminal domain. We generated mice having a modified tbp allele, tbp(DeltaN), that produces a version of TBP lacking 111 of the 135 vertebrate-specific amino acids. Most tbp(DeltaN/DeltaN) fetuses (>90%) died in mid-gestation from an apparent defect in the placenta. tbp(DeltaN/DeltaN) fetuses could be rescued by supplying them with a wild-type tetraploid placenta. Mutants also could be rescued by rearing them in immunocompromised mothers. In immune-competent mothers, survival of tbp(DeltaN/DeltaN) fetuses increased when fetal/placental beta2m expression was genetically disrupted. These results suggest that the TBP N terminus functions in transcriptional regulation of a placental beta2m-dependent process that favors maternal immunotolerance of pregnancy.	Montana State Univ, Vet Mol Biol Marsh Labs, Bozeman, MT 59717 USA; Univ Utah, Howard Hughes Med Inst, Eccles Inst Human Genet, Salt Lake City, UT 84112 USA	Montana State University System; Montana State University Bozeman; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	Schmidt, EE (corresponding author), Montana State Univ, Vet Mol Biol Marsh Labs, Bozeman, MT 59717 USA.	eschmidt@montana.edu			NICHD NIH HHS [R03 HD035824-02, R03 HD039242-01, R03 HD039242-02] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD039242, R03HD035824] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Albright SR, 2000, GENE, V242, P1, DOI 10.1016/S0378-1119(99)00495-3; Auchinloss H.J, 1999, FUNDAMENTAL IMMUNOLO, P1175; CROSS JC, 1994, SCIENCE, V266, P1508, DOI 10.1126/science.7985020; Dang Y, 2001, J IMMUNOL, V166, P3641, DOI 10.4049/jimmunol.166.6.3641; Du Pasquier L., 1999, FUNDAMENTAL IMMUNOLO, P605; DYNLACHT BD, 1991, CELL, V66, P563, DOI 10.1016/0092-8674(81)90019-2; Erlebacher A, 2001, CURR OPIN IMMUNOL, V13, P590, DOI 10.1016/S0952-7915(00)00264-8; Freiman RN, 2001, SCIENCE, V293, P2084, DOI 10.1126/science.1061935; Fuzzi B, 2002, EUR J IMMUNOL, V32, P311, DOI 10.1002/1521-4141(200202)32:2<311::AID-IMMU311>3.3.CO;2-#; GUILLEMOT F, 1994, NATURE, V371, P333, DOI 10.1038/371333a0; HALLAK M, 1994, J SOC GYNECOL INVEST, V1, P25, DOI 10.1177/107155769400100106; HASHIMOTO S, 1992, NUCLEIC ACIDS RES, V20, P3788, DOI 10.1093/nar/20.14.3788; Hausner W, 2001, J BACTERIOL, V183, P3025, DOI 10.1128/JB.183.10.3025-3031.2001; HERNANDEZ N, 1993, GENE DEV, V7, P1291, DOI 10.1101/gad.7.7b.1291; Hiller MA, 2001, GENE DEV, V15, P1021, DOI 10.1101/gad.869101; Hogan B, 1994, MANIPULATING MOUSE E; HUNZIKER RD, 1986, CRC CR REV IMMUNOL, V6, P245; Hutter H, 1998, Dev Immunol, V6, P197, DOI 10.1155/1998/65065; JAFFE L, 1992, P NATL ACAD SCI USA, V89, P5927, DOI 10.1073/pnas.89.13.5927; JAFFE L, 1991, J IMMUNOL, V147, P2740; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; Kraut N, 1998, EMBO J, V17, P6276, DOI 10.1093/emboj/17.21.6276; LI XP, 1993, TRANSPLANTATION, V55, P940, DOI 10.1097/00007890-199304000-00046; Littlefield O, 1999, P NATL ACAD SCI USA, V96, P13668, DOI 10.1073/pnas.96.24.13668; Loke YW, 2000, J REPROD FERTIL, P83; MARGULIES DH, 1999, FUNDAMENTAL IMMUNOLO, P263; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; NAGY A, 1990, DEVELOPMENT, V110, P815; Ohbayashi T, 1996, BIOCHEM BIOPH RES CO, V225, P275, DOI 10.1006/bbrc.1996.1166; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; Pfeiffer KA, 2001, MOL HUM REPROD, V7, P373, DOI 10.1093/molehr/7.4.373; Qureshi SA, 1997, EMBO J, V16, P2927, DOI 10.1093/emboj/16.10.2927; Rinkenberger JL, 1997, DEV GENET, V21, P6, DOI 10.1002/(SICI)1520-6408(1997)21:1&lt;6::AID-DVG2&gt;3.0.CO;2-B; Riteau B, 2001, TRANSPLANT P, V33, P2360, DOI 10.1016/S0041-1345(01)02021-8; ROSSANT J, 1998, MECH DEVELOP, V73, P133; Schmidt EE, 1997, J BIOL CHEM, V272, P5326, DOI 10.1074/jbc.272.8.5326; SCHREIBER H, 1999, FUNDAMENTAL IMMUNOLO, P1237; SHEVACH EM, 1999, FUNDAMENTAL IMMUNOLO, P1089; SUMITA K, 1993, NUCLEIC ACIDS RES, V21, P2769, DOI 10.1093/nar/21.11.2769; TAFURI A, 1995, SCIENCE, V270, P630, DOI 10.1126/science.270.5236.630; TAKADA R, 1992, P NATL ACAD SCI USA, V89, P11809, DOI 10.1073/pnas.89.24.11809; Tanaka M, 1997, DEV BIOL, V190, P55, DOI 10.1006/dbio.1997.8685; van Kampen CA, 2001, HUM IMMUNOL, V62, P201, DOI 10.1016/S0198-8859(01)00209-9; VANVLASSELAER P, 1984, CELL IMMUNOL, V83, P422, DOI 10.1016/0008-8749(84)90322-8; Varshavsky A, 1997, GENES CELLS, V2, P13, DOI 10.1046/j.1365-2443.1997.1020301.x; WEGMANN TG, 1980, CAN MED ASSOC J, V123, P991; WEGMANN TG, 1979, P NATL ACAD SCI USA, V76, P2410, DOI 10.1073/pnas.76.5.2410; Xu CG, 2000, SCIENCE, V287, P498, DOI 10.1126/science.287.5452.498; Yamamoto H, 1998, GENE DEV, V12, P1315, DOI 10.1101/gad.12.9.1315; Yamasaki M, 2001, J IMMUNOL, V166, P7244, DOI 10.4049/jimmunol.166.12.7244; Zhang D, 2001, SCIENCE, V292, P1153, DOI 10.1126/science.1059188	54	32	36	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 12	2002	110	1					43	54		10.1016/S0092-8674(02)00806-1	http://dx.doi.org/10.1016/S0092-8674(02)00806-1			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	573PU	12150996	Green Accepted, Bronze			2022-12-24	WOS:000176840700006
J	Gong, YY; Cardwell, K; Hounsa, A; Egal, S; Turner, PC; Hall, AJ; Wild, CP				Gong, YY; Cardwell, K; Hounsa, A; Egal, S; Turner, PC; Hall, AJ; Wild, CP			Dietary aflatoxin exposure and impaired growth in young children from Benin and Togo: cross sectional study	BRITISH MEDICAL JOURNAL			English	Article							HEPATOCELLULAR-CARCINOMA		Univ Leeds, Sch Med, Mol Epidemiol Unit, Leeds LS2 9JT, W Yorkshire, England; Int Inst Trop Agr, Cotonou, Benin; Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	University of Leeds; University of London; London School of Hygiene & Tropical Medicine	Wild, CP (corresponding author), Univ Leeds, Sch Med, Mol Epidemiol Unit, Leeds LS2 9JT, W Yorkshire, England.		Gong, Yun Yun/C-8412-2018; Wild, Christopher/ABC-6260-2020; Turner, Paul C/B-8131-2013; Turner, Paul C/A-6152-2011; Gong, Yun Yun/L-7094-2016	Gong, Yun Yun/0000-0003-4927-5526; Wild, Christopher/0000-0003-0249-8669; Gong, Yun Yun/0000-0003-4927-5526	NIEHS NIH HHS [P01 ES006052] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES006052] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		HALL AJ, 1994, HUMAN HLTH VET AGR S, P233; Montesano R, 1997, JNCI-J NATL CANCER I, V89, P1844, DOI 10.1093/jnci/89.24.1844; Terry MB, 2001, INT J EPIDEMIOL, V30, P95, DOI 10.1093/ije/30.1.95; Turner PC, 2000, TROP MED INT HEALTH, V5, P837, DOI 10.1046/j.1365-3156.2000.00664.x; Wild CP, 2000, MUTAT RES-REV MUTAT, V462, P381, DOI 10.1016/S1383-5742(00)00027-2	5	318	327	1	44	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 6	2002	325	7354					20	21		10.1136/bmj.325.7354.20	http://dx.doi.org/10.1136/bmj.325.7354.20			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573BC	12098724	Green Accepted, Green Published, Bronze			2022-12-24	WOS:000176808600017
J	Drasdo, N; Chiti, Z; Owens, DR; North, RV				Drasdo, N; Chiti, Z; Owens, DR; North, RV			Effect of darkness on inner retinal hypoxia in diabetes	LANCET			English	Article							RETINOPATHY	It has been postulated that diabetic retinopathy might be initiated by hypoxia during the hours of darkness. Oscillatory potentials, which reflect inner retinal function, are reduced in diabetic patients. We tested the effect of oxygen inhalation on the amplitude of these oscillatory potentials after dark adaptation in seven patients with type 2 diabetes and eight controls. We found that the decreased oscillatory potentials induced by dark adaptation in the diabetic patients increased during oxygen inhalation to an amplitude that was not significantly different from that of the controls before oxygen. Oscillatory potentials in the controls were unaffected by oxygen. This finding strengthens support for the suggestion that diabetic patients might benefit from sleeping with night-time illumination.	Cardiff Univ, Dept Optometry & Vis Sci, Cardiff CF10 3NB, S Glam, Wales; Univ Wales Coll Med, Cardiff CF4 4XN, S Glam, Wales	Cardiff University; Cardiff University	Drasdo, N (corresponding author), Cardiff Univ, Dept Optometry & Vis Sci, Redwood Bldg,King Edward VII Ave,Cathays Pk, Cardiff CF10 3NB, S Glam, Wales.			North, Rachel Valerie/0000-0002-6657-5099				AIELLO LP, 1997, INVST OPHTHALMOL VIS, V38, P1847; Arden GB, 2001, BRIT J OPHTHALMOL, V85, P366, DOI 10.1136/bjo.85.3.366; Arden GB, 1998, VISION RES, V38, P1723, DOI 10.1016/S0042-6989(98)00004-2; Drasdo N, 2001, INVEST OPHTH VIS SCI, V42, P1266; RIVA CE, 1983, INVEST OPHTH VIS SCI, V24, P47	5	46	49	1	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 29	2002	359	9325					2251	2253		10.1016/S0140-6736(02)09265-6	http://dx.doi.org/10.1016/S0140-6736(02)09265-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	567YJ	12103292				2022-12-24	WOS:000176514500014
J	Hanratty, B; Hibbert, D; Mair, F; May, C; Ward, C; Capewell, S; Litva, A; Corcoran, G				Hanratty, B; Hibbert, D; Mair, F; May, C; Ward, C; Capewell, S; Litva, A; Corcoran, G			Doctors' perceptions of palliative care for heart failure: focus group study	BRITISH MEDICAL JOURNAL			English	Article							OF-LIFE; DISEASE; END; COMMUNICATION; FAMILY; CANCER	Objectives To identify doctors' perceptions of the need for palliative care for heart failure and barriers to change. Design Qualitative study with focus groups. Setting North west England. Participants General practitioners and consultants in cardiology, geriatrics, palliative care, and general medicine. Results Doctors supported the development of palliative care for patients with heart failure with the general practitioner as a central figure. They were reluctant to endorse expansion of specialist palliative care services. Barriers to developing approaches to palliative care in heart failure related to three main areas: the organisation of health care, the unpredictable course of heart failure, and the doctors' understanding of roles. The health system was thought to work against provision of holistic care, exacerbated by issues of professional rivalry and control. The priorities identified for the future were developing the role of the nurse, better community support for primary care, and enhanced communication between all the health professionals involved in the care of patients with heart failure. Conclusions Greater consideration should be given to the care of patients dying with heart failure, clarifying the roles of doctors and nurses in different specialties, and reshaping the services provided for them. Many of the organisational and professional issues are not peculiar to patients dying with heart failure, and addressing such concerns as the lack of coordination and continuity in medical care would benefit all patients.	Univ Liverpool, Dept Publ Hlth, Liverpool L69 3GB, Merseyside, England; Univ Liverpool, Dept Primary Care, Liverpool L69 3GB, Merseyside, England; Univ Newcastle Upon Tyne, Ctr Hlth Serv Res, Newcastle Upon Tyne NE3 1SX, Tyne & Wear, England; Wythenshawe Hosp, Dept Cardiol, Manchester M23 9LT, Lancs, England; Univ Hosp Aintree, Dept Palliat Care, Liverpool L9 7AL, Merseyside, England	University of Liverpool; University of Liverpool; Newcastle University - UK; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital	Hanratty, B (corresponding author), Univ Liverpool, Dept Publ Hlth, Liverpool L69 3GB, Merseyside, England.		Hanratty, Barbara/AAH-1801-2019; May, Carl/A-8502-2011	May, Carl/0000-0002-0451-2690; Hanratty, Barbara/0000-0002-3122-7190; Mair, Frances/0000-0001-9780-1135				ADDINGTONHALL J, 1995, STROKE, V26, P2242, DOI 10.1161/01.STR.26.12.2242; Anderson H, 2001, PALLIATIVE MED, V15, P279, DOI 10.1191/026921601678320269; Blue L, 2001, BRIT MED J, V323, P715, DOI 10.1136/bmj.323.7315.715; Davis RC, 2000, BRIT MED J, V320, P39, DOI 10.1136/bmj.320.7226.39; *DEP HLTH, 2000, NAT SERV FRAM COR HE; FRASER D, 1999, QSR NVIVO REFERENCE; Gibbs LME, 1998, BRIT MED J, V317, P961, DOI 10.1136/bmj.317.7164.961; Gore JM, 2000, THORAX, V55, P1000, DOI 10.1136/thorax.55.12.1000; Hanson LC, 1997, J AM GERIATR SOC, V45, P1339, DOI 10.1111/j.1532-5415.1997.tb02933.x; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; Lloyd-Williams M, 2002, FAM PRACT, V19, P219, DOI 10.1093/fampra/19.3.219; McCarthy M, 1996, J ROY COLL PHYS LOND, V30, P325; *NAT COUNC HOSP SP, 1998, 14 NCHSPC; Rich MW, 1995, NEW ENGL J MED, V333, P1213; Rogers AE, 2000, BMJ-BRIT MED J, V321, P605, DOI 10.1136/bmj.321.7261.605; Silverman D., 1985, QUALITATIVE METHODOL; Skilbeck J, 1998, PALLIATIVE MED, V12, P245, DOI 10.1191/026921698677124622; Sloan RH, 2002, BRIT MED J, V324, P1035, DOI 10.1136/bmj.324.7344.1035; Stewart S, 2001, EUR J HEART FAIL, V3, P315, DOI 10.1016/S1388-9842(00)00141-0; Tobin Terry, 2002, Health Serv J, V112, P22; Ward C, 2002, HEART, V87, P294, DOI 10.1136/heart.87.3.294; 2001, 52001 BRIT HEART FDN	22	126	127	0	10	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 14	2002	325	7364					581	585		10.1136/bmj.325.7364.581	http://dx.doi.org/10.1136/bmj.325.7364.581			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	595JJ	12228136	Bronze, Green Published			2022-12-24	WOS:000178105200023
J	Farkas, I; Helbing, D; Vicsek, T				Farkas, I; Helbing, D; Vicsek, T			Social behaviour: Mexican waves in an excitable medium - The stimulation of this concerted motion among expectant spectators is explained.	NATURE			English	Article									Eotvos Lorand Univ, Dept Biol Phys, H-1117 Budapest, Hungary; Tech Univ Dresden, Inst Econ & Traff, D-01062 Dresden, Germany	Eotvos Lorand University; Technische Universitat Dresden	Farkas, I (corresponding author), Eotvos Lorand Univ, Dept Biol Phys, H-1117 Budapest, Hungary.	vicsek@angel.elte.hu	Helbing, Dirk/C-6114-2008; Vicsek, Tamas/A-3305-2009; Farkas, Illes/C-1504-2008	Farkas, Illes/0000-0001-5341-5582				Bub G, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.058101; GREENBERG JM, 1978, SIAM J APPL MATH, V34, P515, DOI 10.1137/0134040; WIENER N, 1946, Arch Inst Cardiol Mex, V16, P205	3	108	111	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 12	2002	419	6903					131	132		10.1038/419131a	http://dx.doi.org/10.1038/419131a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592HK	12226653	Green Submitted			2022-12-24	WOS:000177931200029
J	Kramer, G; Rauch, T; Rist, W; Vorderwulbecke, S; Patzelt, H; Schulze-Specking, A; Ban, N; Deuerling, E; Bukau, B				Kramer, G; Rauch, T; Rist, W; Vorderwulbecke, S; Patzelt, H; Schulze-Specking, A; Ban, N; Deuerling, E; Bukau, B			L23 protein functions as a chaperone docking site on the ribosome	NATURE			English	Article							COLI TRIGGER FACTOR; BINDING; HSP70	During translation, the first encounter of nascent polypeptides is with the ribosome-associated chaperones that assist the folding process-a principle that seems to be conserved in evolution(1-3).In Escherichia coli, the ribosome-bound Trigger Factor chaperones the folding of cytosolic proteins by interacting with nascent polypeptides(4,5). Here we identify a ribosome-binding motif in the amino-terminal domain of Trigger Factor. We also show the formation of crosslinked products between Trigger Factor and two adjacent ribosomal proteins, L23 and L29, which are located at the exit of the peptide tunnel in the ribosome. L23 is essential for the growth of E. coli and the association of Trigger Factor with the ribosome, whereas L29 is dispensable in both processes. Mutation of an exposed glutamate in L23 prevents Trigger Factor from interacting with ribosomes and nascent chains, and causes protein aggregation and conditional lethality in cells that lack the protein repair function of the DnaK chaperone. Purified L23 also interacts specifically with Trigger Factor in vitro. We conclude that essential L23 provides a chaperone docking site on ribosomes that directly links protein biosynthesis with chaperone-assisted protein folding.	Heidelberg Univ, Zentrum Mol Biol ZMBH, D-69120 Heidelberg, Germany; Univ Freiburg, Inst Mol Biol & Biochem, D-79104 Freiburg, Germany; ETH Honggerberg, Swiss Fed Inst Technol, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	Ruprecht Karls University Heidelberg; University of Freiburg; Swiss Federal Institutes of Technology Domain; ETH Zurich	Bukau, B (corresponding author), Heidelberg Univ, Zentrum Mol Biol ZMBH, INF282, D-69120 Heidelberg, Germany.	E.Deuerling@zmbh.uni-heidelberg.de; bukau@zmbh.uni-heidelberg.de		Rist, Wolfgang/0000-0002-0626-3544; Bukau, Bernd/0000-0003-0521-7199; Kramer, Gunter/0000-0001-7552-8393				AMANN E, 1988, GENE, V69, P301, DOI 10.1016/0378-1119(88)90440-4; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bukau B, 2000, CELL, V101, P119, DOI 10.1016/S0092-8674(00)80806-5; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deuerling E, 1999, NATURE, V400, P693, DOI 10.1038/23301; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hesterkamp T, 1997, J BIOL CHEM, V272, P21865, DOI 10.1074/jbc.272.35.21865; Hesterkamp T, 1996, P NATL ACAD SCI USA, V93, P4437, DOI 10.1073/pnas.93.9.4437; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Patzelt H, 2001, P NATL ACAD SCI USA, V98, P14244, DOI 10.1073/pnas.261432298; Schaffitzel E, 2001, BIOL CHEM, V382, P1235, DOI 10.1515/BC.2001.154; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Teter SA, 1999, CELL, V97, P755, DOI 10.1016/S0092-8674(00)80787-4; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomoyasu T, 2001, MOL MICROBIOL, V40, P397, DOI 10.1046/j.1365-2958.2001.02383.x; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0	20	262	267	4	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 12	2002	419	6903					171	174		10.1038/nature01047	http://dx.doi.org/10.1038/nature01047			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592HK	12226666	Green Published			2022-12-24	WOS:000177931200042
J	Spangler, JG; George, G; Foley, KL; Crandall, SJ				Spangler, JG; George, G; Foley, KL; Crandall, SJ			Tobacco intervention training - Current efforts and gaps in US medical schools	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							PATIENT-CENTERED APPROACH; SMOKING-CESSATION; CARDIOVASCULAR-DISEASE; DEPENDENCE CURRICULA; OVERCOMING BARRIERS; STUDENTS; PHYSICIAN; ATTITUDES; NICOTINE; SKILLS	Context Research has documented that US medical schools inadequately teach tobacco intervention skills. Objective To examine effective training methods for tobacco intervention in undergraduate medical education. Data Sources Using indexing terms related to tobacco intervention and medical education, we searched MEDLINE (1966-June 2002) and the Cochrane Database of Systematic Reviews (through issue 2, 2002). Reference lists of relevant articles were also read to identify additional articles. Because of their importance to tobacco intervention, we also reviewed Ockene and colleagues' tobacco education research and the tobacco treatment guidelines of the United States Public Health Service and the United States Preventive Services Task Force. Study Selection All study designs that incorporated process or outcome evaluation of tobacco intervention educational methods for medical students were included in this review. Of an initial 1241 articles retrieved, 82 included medical students. Reviewing abstracts and references of these articles identified 13 pertinent studies. Data Extraction Quality criteria for inclusion consisted of explicit evaluation of the educational methods used. Data extraction identified all evaluations and any problems in program implementation. Data Synthesis Enhanced instructional methods (eg, the use of patient-centered counseling, standardized patient instructors, role playing, or a combination of these) are more effective for teaching tobacco intervention than are traditional didactic methods alone and can be effectively inserted into medical school curricula. Conclusions Various educational methods have been used to train medical students in tobacco intervention. Nonetheless, gaps still exist within undergraduate medical education, including a lack of integration of tobacco dependence information throughout all 4 years of medical school curricula, specific training in smokeless tobacco intervention, tobacco intervention training that addresses cultural issues, and long-term studies showing that such training is retained.	Wake Forest Univ, Sch Med, Dept Family & Community Med, Winston Salem, NC 27157 USA; Wake Forest Univ, Sch Med, Dept Publ Hlth Sci, Winston Salem, NC 27157 USA; Univ Texas, MD Anderson Canc Ctr, Dept Behav Sci, Houston, TX 77030 USA	Wake Forest University; Wake Forest University; University of Texas System; UTMD Anderson Cancer Center	Spangler, JG (corresponding author), Wake Forest Univ, Sch Med, Dept Family & Community Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.	jspangle@wfubmc.edu	Crandall, Sonia/A-1613-2019		PHS HHS [1 D12 HP 00007-01] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Ahluwalia CS, 1998, J GEN INTERN MED, V13, P1, DOI 10.1046/j.1525-1497.1998.00001.x; ALLEN SS, 1990, AM J PREV MED, V6, P28, DOI 10.1016/S0749-3797(18)31041-9; [Anonymous], 1998, MMWR-MORBID MORTAL W, V47, P229; Bland E, 2001, AM J DRUG ALCOHOL AB, V27, P483, DOI 10.1081/ADA-100104513; Boehlecke B, 1996, MED EDUC, V30, P283, DOI 10.1111/j.1365-2923.1996.tb00830.x; Campinha-Bacote J, 1999, J NURS EDUC, V38, P203; CANTOR JC, 1993, JAMA-J AM MED ASSOC, V270, P1035, DOI 10.1001/jama.270.9.1035; Centers for Disease Control and Prevention (CDC), 1993, MMWR Morb Mortal Wkly Rep, V42, P854; Chin JL, 2000, PUBLIC HEALTH REP, V115, P25, DOI 10.1093/phr/115.1.25; Chung TWH, 1996, MED EDUC, V30, P290, DOI 10.1111/j.1365-2923.1996.tb00831.x; COULTAS DB, 1994, ACAD MED, V69, pS48, DOI 10.1097/00001888-199410000-00039; ERAKER SA, 1985, AM J MED, V78, P817, DOI 10.1016/0002-9343(85)90289-X; Eyler AE, 1997, AM J PREV MED, V13, P153, DOI 10.1016/S0749-3797(18)30187-9; Ferry LH, 1999, JAMA-J AM MED ASSOC, V282, P825, DOI 10.1001/jama.282.9.825; Ferry LH, 1999, PRIMARY CARE, V26, P707, DOI 10.1016/S0095-4543(05)70125-1; FIORE MC, 1994, JAMA-J AM MED ASSOC, V271, P624, DOI 10.1001/jama.271.8.624; FIORE MC, 2000, TREATING TOBACCO USE; Geller AC, 2000, J CANCER EDUC, V15, P196; GILPIN E, 1992, TOBACCO CONTROL, V0001; Hatsukami D K, 1999, Nicotine Tob Res, V1, P21, DOI 10.1080/14622299050011131; HATZIANDREU EJ, 1990, J NATL CANCER I, V82, P1402, DOI 10.1093/jnci/82.17.1402; Iribarren C, 1999, NEW ENGL J MED, V340, P1773, DOI 10.1056/NEJM199906103402301; Johnson KM, 1997, ADDICT BEHAV, V22, P207, DOI 10.1016/S0306-4603(96)00015-9; Kristeller J L, 1996, Indiana Med, V89, P199; Leischow SJ, 1996, AM J HEALTH BEHAV, V20, P304; Levenkron J C, 1990, Am J Prev Med, V6, P29; LEVENKRON JC, 1987, J MED EDUC, V62, P665; LEVENKRON JC, 1987, AM J PREV MED, V3, P152; Lipkus I M, 1999, Nicotine Tob Res, V1, P77, DOI 10.1080/14622299050011181; London RF, 1999, JAMA-J AM MED ASSOC, V282, P875, DOI 10.1001/jama.282.9.875; MACMAHON B, 1988, BIOMED PHARMACOTHER, V42, P93; Munoz RF, 1997, AM J COMMUN PSYCHOL, V25, P325, DOI 10.1023/A:1024676626955; *NCI, 1999, NAT AM OUTR REP AM I; *NCI, 1998, SMOK TOB MON, V9; Nunez AE, 2000, ACAD MED, V75, P1071, DOI 10.1097/00001888-200011000-00011; OCKENE JK, 1987, PREV MED, V16, P723, DOI 10.1016/0091-7435(87)90054-5; OCKENE JK, 1988, ARCH INTERN MED, V148, P1039, DOI 10.1001/archinte.148.5.1039; OCKENE JK, 1987, AM J PUBLIC HEALTH, V77, P782, DOI 10.2105/AJPH.77.7.782; OCKENE JK, 1991, J GEN INTERN MED, V6, P1, DOI 10.1007/BF02599381; OCKENE JK, 1992, PREVENTION CORONARY; Office of Evaluations and Inspections, 1992, DHHS PUBL, V92-00500; ORLEANS CT, 1985, ANNU REV MED, V36, P51; Papadakis MA, 1997, ACAD MED, V72, P725, DOI 10.1097/00001888-199708000-00021; Roche AM, 1996, PREV MED, V25, P251, DOI 10.1006/pmed.1996.0054; ROYCE JM, 1995, J NATL MED ASSOC, V87, P291; Schorling JB, 1997, PREV MED, V26, P92, DOI 10.1006/pmed.1996.9988; SEIM HC, 1995, MED EDUC, V29, P139, DOI 10.1111/j.1365-2923.1995.tb02817.x; SEVERSON H, 1994, ENOUGH SNUFF GUIDE Q, P50; SHERIN K, 1982, POSTGRAD MED, V72, P99, DOI 10.1080/00325481.1982.11716185; Short GJ, 1999, ACAD MED, V74, P1158, DOI 10.1097/00001888-199911000-00007; SILAGY C, 2001, PHYSICIAN ADVICE SMO; Smith SS, 1999, PRIMARY CARE, V26, P433, DOI 10.1016/S0095-4543(05)70112-3; Spangler JG, 2001, ACAD MED, V76, P521, DOI 10.1097/00001888-200105000-00055; STEVENS VJ, 1995, AM J PUBLIC HEALTH, V85, P231, DOI 10.2105/AJPH.85.2.231; STILLMAN PL, 1983, J MED EDUC, V58, P941; U.S. Department of Health and Human Services, 2001, WOM SMOK REP SURG GE; *US DEP HHS, 1992, SMOK TOB HLTH INT PE, P219; US Department of Health and Human Services, 1998, TOB US US RAC ETHN M; *US PREV SERV TASK, 1996, COUNS PREV TOB US; Usatine RP, 1996, ACAD MED, V71, pS96, DOI 10.1097/00001888-199601000-00055; Wadland W, 2000, JAMA-J AM MED ASSOC, V283, P1426, DOI 10.1001/jama.283.11.1426; WELCH M, 2002, CONCEPT PAPERS COMMI; WELLS KB, 1984, MED CARE, V22, P360, DOI 10.1097/00005650-198404000-00007; WELTY TK, 1995, AM J EPIDEMIOL, V142, P269, DOI 10.1093/oxfordjournals.aje.a117633; Winn D M, 1997, Adv Dent Res, V11, P313; 1993, MMWR MORB MORTAL WKL, V42, P645; 1997, MMWR MORB MORTAL WKL, V46, P1217; 1993, MMWR MORB MORTAL WKL, V42, P263	68	98	104	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 4	2002	288	9					1102	1109		10.1001/jama.288.9.1102	http://dx.doi.org/10.1001/jama.288.9.1102			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	589NA	12204079				2022-12-24	WOS:000177764600013
J	Partridge, L; Gems, D				Partridge, L; Gems, D			Ageing: A lethal side-effect	NATURE			English	Editorial Material									UCL, Dept Biol, London WC1E 6BT, England	University of London; University College London	Partridge, L (corresponding author), UCL, Dept Biol, Darwin Bldg,Gower St, London WC1E 6BT, England.		Partridge, Linda/E-7342-2015; Partridge, Linda/A-5501-2010	Partridge, Linda/0000-0001-9615-0094; Gems, David/0000-0002-6653-4676	Biotechnology and Biological Sciences Research Council [SF19106] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Austad S. N., 1997, WHY WE AGE; Partridge L, 2002, NAT REV GENET, V3, P165, DOI 10.1038/nrg753; [No title captured]	3	17	18	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 29	2002	418	6901					921	921		10.1038/418921a	http://dx.doi.org/10.1038/418921a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588AP	12198525				2022-12-24	WOS:000177677500023
J	Phillips, OL; Martinez, RV; Arroyo, L; Baker, TR; Killeen, T; Lewis, SL; Malhi, Y; Mendoza, AM; Neill, D; Vargas, PN; Alexiades, M; Ceron, C; Di Fiore, A; Erwin, T; Jardim, A; Palacios, W; Saldias, M; Vinceti, B				Phillips, OL; Martinez, RV; Arroyo, L; Baker, TR; Killeen, T; Lewis, SL; Malhi, Y; Mendoza, AM; Neill, D; Vargas, PN; Alexiades, M; Ceron, C; Di Fiore, A; Erwin, T; Jardim, A; Palacios, W; Saldias, M; Vinceti, B			Increasing dominance of large lianas in Amazonian forests	NATURE			English	Article							ATMOSPHERIC CARBON-DIOXIDE; TROPICAL FORESTS; RAIN-FOREST; PATTERNS; BIOMASS; SINK	Ecological orthodoxy suggests that old-growth forests should be close to dynamic equilibrium, but this view has been challenged by recent findings that neotropical forests are accumulating carbon(1,2) and biomass(3,4), possibly in response to the increasing atmospheric concentrations of carbon dioxide(5,6). However, it is unclear whether the recent increase in tree biomass has been accompanied by a shift in community composition. Such changes could reduce or enhance the carbon storage potential of old-growth forests in the long term. Here we show that non-fragmented Amazon forests are experiencing a concerted increase in the density, basal area and mean size of woody climbing plants (lianas). Over the last two decades of the twentieth century the dominance of large lianas relative to trees has increased by 1.7-4.6% a year. Lianas enhance tree mortality and suppress tree growth(7), so their rapid increase implies that the tropical terrestrial carbon sink may shut down sooner than current models suggest(8-10). Predictions of future tropical carbon fluxes will need to account for the changing composition and dynamics of supposedly undisturbed forests.	Univ Leeds, Sch Geog, Ctr Biodivers & Conservat, Leeds LS2 9JT, W Yorkshire, England; Jardin Bot Missouri, Jaen, Peru; Missouri Bot Garden, St Louis, MO 63166 USA; Museo Hist Nat Moel Kempff Mercado, Santa Cruz, Bolivia; Conservat Int, Washington, DC 20036 USA; Univ Edinburgh, Sch Earth Environm & Geog Sci, Edinburgh EH9 3JU, Midlothian, Scotland; Univ San Antonio Abad Cusco, Herbario Vargas, Cuzco, Peru; Fdn Jatun Sacha, Quito, Ecuador; Univ Cent Ecuador, Escuela Biol, Herbario QAP, Quito, Ecuador; New York Bot Garden, Bronx, NY 10458 USA; NYU, Dept Anthropol, New York, NY 10003 USA; Smithsonian Inst, Museum Nat Hist, Washington, DC 20560 USA	University of Leeds; Missouri Botanical Gardens; Conservation International; University of Edinburgh; Universidad Nacional de San Antonio Abad del Cusco; Universidad Central del Ecuador; New York Botanical Garden; New York University; Smithsonian Institution; Smithsonian National Museum of Natural History	Phillips, OL (corresponding author), Univ Leeds, Sch Geog, Ctr Biodivers & Conservat, Leeds LS2 9JT, W Yorkshire, England.	o.phillips@geog.leeds.ac.uk	Phillips, Oliver/A-1523-2011	Phillips, Oliver/0000-0002-8993-6168; Neill, David Alan/0000-0002-5143-9430; Lewis, Simon/0000-0002-8066-6851				Brown S., 1997, FAO Forestry Paper; Chambers JQ, 2001, NATURE, V410, P429, DOI 10.1038/35068624; Condit R, 1996, J VEG SCI, V7, P405, DOI 10.2307/3236284; CONDON MA, 1992, FUNCT ECOL, V6, P680, DOI 10.2307/2389964; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Gentry A.H., 1991, BIOL VINES, P3; Gerwing JJ, 2000, J TROP ECOL, V16, P327, DOI 10.1017/S0266467400001437; GRACE J, 1995, SCIENCE, V270, P778, DOI 10.1126/science.270.5237.778; GRANADOS J, IN PRESS GLOB CHANGE; Hegarty E.E., 1991, BIOL VINES, P313; Korner C, 2000, ECOL APPL, V10, P1590, DOI 10.2307/2641226; Laurance WF, 2001, ECOLOGY, V82, P105, DOI 10.1890/0012-9658(2001)082[0105:RFFATS]2.0.CO;2; Malhi Y, 1998, J GEOPHYS RES-ATMOS, V103, P31593, DOI 10.1029/98JD02647; Malhi Y, 2000, TRENDS ECOL EVOL, V15, P332, DOI 10.1016/S0169-5347(00)01906-6; MALHI Y, IN PRESS J VEGN SCI; Perez-Salicrup DR, 2001, BIOTROPICA, V33, P34, DOI 10.1111/j.1744-7429.2001.tb00155.x; PHILLIPS O, 1993, ECON BOT, V47, P33, DOI [10.1007/BF02862203, 10.1007/BF02862204]; Phillips OL, 1998, SCIENCE, V282, P439, DOI 10.1126/science.282.5388.439; Phillips OL, 2002, ECOL APPL, V12, P576, DOI 10.1890/1051-0761(2002)012[0576:CIGOTF]2.0.CO;2; PHILLIPS OL, 1994, SCIENCE, V263, P954, DOI 10.1126/science.263.5149.954; Phillips OL, 1997, BIODIVERS CONSERV, V6, P291, DOI 10.1023/A:1018352405482; PHILLIPS OL, IN PRESS GLOBAL PATT; PRENTICE IC, 2001, IN PRESS CLIMATE CHA, pCH3; PUTZ FE, 1983, BIOTROPICA, V15, P185, DOI 10.2307/2387827; Retallack GJ, 2001, NATURE, V411, P287, DOI 10.1038/35077041; Schnitzer SA, 2002, TRENDS ECOL EVOL, V17, P223, DOI 10.1016/S0169-5347(02)02491-6; Sombroek W, 2001, AMBIO, V30, P388, DOI 10.1639/0044-7447(2001)030[0388:SATPOA]2.0.CO;2; van Reeuwijk L.P, 1995, PROCEDURES SOIL ANAL; White A, 2000, GLOBAL CHANGE BIOL, V6, P817, DOI 10.1046/j.1365-2486.2000.00358.x	29	405	442	3	106	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 15	2002	418	6899					770	774		10.1038/nature00926	http://dx.doi.org/10.1038/nature00926			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UF	12181565	Green Accepted			2022-12-24	WOS:000177428000037
J	Roth, GS; Lane, MA; Ingram, DK; Mattison, JA; Elahi, D; Tobin, JD; Muller, D; Metter, EJ				Roth, GS; Lane, MA; Ingram, DK; Mattison, JA; Elahi, D; Tobin, JD; Muller, D; Metter, EJ			Biomarkers of caloric restriction may predict longevity in humans	SCIENCE			English	Article							RHESUS-MONKEYS		NIA, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Roth, GS (corresponding author), NIA, 5600 Nathan Shock Dr, Baltimore, MD 21224 USA.				NATIONAL INSTITUTE ON AGING [Z01AG000302, ZIAAG000302, ZIAAG000015, Z01AG000304, Z01AG000015] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		KALIMI M, 1999, DEHYDROEPIANDROSTERO; LANE MA, 1995, AM J PHYSIOL-ENDOC M, V268, pE941, DOI 10.1152/ajpendo.1995.268.5.E941; Lane MA, 1998, J ANTI-AGING MED, V1, P315, DOI DOI 10.1089/rej.1.1998.1.315; Roth GS, 2001, J CLIN ENDOCR METAB, V86, P3292, DOI 10.1210/jc.86.7.3292; Shock N.W., 1984, NORMAL HUMAN AGING B; WEINDRUCH R, 1988, RETARDATION AGING DI; Zainal TA, 2000, FASEB J, V14, P1825, DOI 10.1096/fj.99-0881com	7	292	301	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 2	2002	297	5582					811	811		10.1126/science.1071851	http://dx.doi.org/10.1126/science.1071851			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579RZ	12161648				2022-12-24	WOS:000177192800042
J	Pelletier, L; Stern, CA; Pypaert, M; Sheff, D; Ngo, HM; Roper, N; He, CY; Hu, K; Toomre, D; Coppens, I; Roos, DS; Joiner, KA; Warren, G				Pelletier, L; Stern, CA; Pypaert, M; Sheff, D; Ngo, HM; Roper, N; He, CY; Hu, K; Toomre, D; Coppens, I; Roos, DS; Joiner, KA; Warren, G			Golgi biogenesis in Toxoplasma gondii	NATURE			English	Article							CELL-CYCLE; APPARATUS; COMPLEX; ER; MAINTENANCE; DYNAMICS; MITOSIS; STAGE; EXIT	Two models have been put forward to explain the growth of new Golgi during the cell cycle. The first suggests that a new Golgi grows out of the endoplasmic reticulum by de novo synthesis(1). The second suggests that a pre-existing Golgi is needed for the growth of a new one, that is, the Golgi is an autonomously replicating organelle(2). To resolve this issue, we have exploited the simplicity of the apicomplexan parasite Toxoplasma gondii(3), which has only a single Golgi stack(4). Here we show, by using video fluorescence microscopy and three-dimensional reconstructions of serial thin sections, that the Golgi grows by a process of lateral extension followed by medial fission. Further fission leads to the inheritance by each daughter of a pair of Golgi structures, which then coalesce to re-form a single Golgi. Our results indicate that new Golgi grow by autonomous duplication and raise the possibility that the Golgi is a paired structure that is analogous to centrioles(5).	Yale Univ, Sch Med, Ludwig Inst Canc Res, Dept Cell Biol, New Haven, CT 06520 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06520 USA; Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	Ludwig Institute for Cancer Research; Yale University; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Yale University; University of Pennsylvania	Warren, G (corresponding author), Yale Univ, Sch Med, Ludwig Inst Canc Res, Dept Cell Biol, 333 Cedar St, New Haven, CT 06520 USA.		Sheff, David/A-1269-2007; Pelletier, Laurence/F-8858-2013; He, Cynthia/H-9789-2012; Joiner, Keith/AAH-1059-2021	Joiner, Keith/0000-0003-3062-823X; Roos, David Siker/0000-0001-6725-4089				Bracker CE, 1996, PROTOPLASMA, V194, P250, DOI 10.1007/BF01882032; Cole NB, 1996, MOL BIOL CELL, V7, P631, DOI 10.1091/mbc.7.4.631; Dubremetz JF, 1998, INT J PARASITOL, V28, P1007, DOI 10.1016/S0020-7519(98)00076-9; Field H, 2000, MOL BIOCHEM PARASIT, V107, P329, DOI 10.1016/S0166-6851(00)00224-3; Hager KM, 1999, J CELL SCI, V112, P2631; Hu K, 2002, MOL BIOL CELL, V13, P593, DOI 10.1091/mbc.01-06-0309; Joiner KA, 2002, J CELL BIOL, V157, P557, DOI 10.1083/jcb.200112144; Kelly TJ, 2000, ANNU REV BIOCHEM, V69, P829, DOI 10.1146/annurev.biochem.69.1.829; Lippincott-Schwartz J, 2000, HISTOCHEM CELL BIOL, V114, P93; LUJAN HD, 1995, J BIOL CHEM, V270, P4612, DOI 10.1074/jbc.270.9.4612; Marshall WF, 2001, CURR BIOL, V11, pR487, DOI 10.1016/S0960-9822(01)00289-5; ODENTHALSCHNITTLER M, 1993, BIOCHEM J, V291, P713, DOI 10.1042/bj2910713; Pelletier L, 2000, NAT CELL BIOL, V2, P840, DOI 10.1038/35041089; Piel M, 2001, SCIENCE, V291, P1550, DOI 10.1126/science.1057330; Presley JF, 1998, MOL BIOL CELL, V9, P1617, DOI 10.1091/mbc.9.7.1617; PREUSS D, 1992, MOL BIOL CELL, V3, P789, DOI 10.1091/mbc.3.7.789; Radke JR, 2001, MOL BIOCHEM PARASIT, V115, P165, DOI 10.1016/S0166-6851(01)00284-5; Roos David S., 1999, Novartis Foundation Symposium, V226, P176; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Rossanese OW, 1999, J CELL BIOL, V145, P69, DOI 10.1083/jcb.145.1.69; Seemann J, 2000, NATURE, V407, P1022, DOI 10.1038/35039538; SHEFFIELD HG, 1968, J PARASITOL, V54, P209, DOI 10.2307/3276925; Shima DT, 1997, J CELL BIOL, V137, P1211, DOI 10.1083/jcb.137.6.1211; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045; WARREN G, 1993, ANNU REV BIOCHEM, V62, P323, DOI 10.1146/annurev.bi.62.070193.001543; Whaley W.B., 1975, GOLGI APPARATUS; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945; Wooding S, 1998, MOL BIOL CELL, V9, P2667, DOI 10.1091/mbc.9.9.2667; Zaal KJM, 1999, CELL, V99, P589, DOI 10.1016/S0092-8674(00)81548-2	29	143	153	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 1	2002	418	6897					548	552		10.1038/nature00946	http://dx.doi.org/10.1038/nature00946			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579EE	12152082				2022-12-24	WOS:000177162800044
J	Nam, KH; Li, JM				Nam, KH; Li, JM			BRI1/BAK1, a receptor kinase pair mediating brassinosteroid signaling	CELL			English	Article							LEUCINE-RICH REPEAT; CYTOPLASMIC DOMAINS; ARABIDOPSIS; GENE; GROWTH; ACTIVATION; BRI1; CYTOCHROME-P450; CLAVATA3; LIGAND	The Arabidopsis BAK1 (BRI1 Associated receptor Kinase 1) was identified by a yeast two-hybrid screen as a specific interactor for BRI1, a critical component of a membrane brassinosteroid (BR) receptor. In yeast, BAK1/BRI1 interaction activates their kinase activities through transphosphorylation. BAK1 and BRI1 share similar gene expression and subcellular localization patterns and physically associate with each other in plants. Overexpression of the BAK1 gene leads to a phenotype reminiscent of BRI1-overexpression transgenic plants and rescues a weak bri1 mutant. In contrast, a bak1 knockout mutation gives rise to a weak bri1-like phenotype and enhances a weak bri1 mutation. We propose that BAK1 and BRI1 function together to mediate plant steroid signaling.	Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Li, JM (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.	jian@umich.edu	Li, Jianming/O-1772-2014	Li, Jianming/0000-0003-3231-0778	NIGMS NIH HHS [R01 GM060519, R01 GM060519-02, GM60519] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060519] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bishop GJ, 2002, PLANT CELL, V14, pS97, DOI 10.1105/tpc.001461; CHEN RH, 1995, J BIOL CHEM, V270, P12235, DOI 10.1074/jbc.270.20.12235; Clark SE, 2001, NAT REV MOL CELL BIO, V2, P276, DOI 10.1038/35067079; CLIFFORD R, 1994, GENETICS, V137, P531; Clouse SD, 1996, PLANT PHYSIOL, V111, P671, DOI 10.1104/pp.111.3.671; Clouse SD, 1998, ANNU REV PLANT PHYS, V49, P427, DOI 10.1146/annurev.arplant.49.1.427; Fankhauser C, 1999, SCIENCE, V284, P1539, DOI 10.1126/science.284.5419.1539; Feng XH, 1996, J BIOL CHEM, V271, P13123, DOI 10.1074/jbc.271.22.13123; Friedrichsen D, 2001, BIOESSAYS, V23, P1028, DOI 10.1002/bies.1148; Friedrichsen DM, 2000, PLANT PHYSIOL, V123, P1247, DOI 10.1104/pp.123.4.1247; Giranton JL, 2000, P NATL ACAD SCI USA, V97, P3759, DOI 10.1073/pnas.070025097; He ZH, 2000, SCIENCE, V288, P2360, DOI 10.1126/science.288.5475.2360; Hecht V, 2001, PLANT PHYSIOL, V127, P803, DOI 10.1104/pp.010324; Jeong S, 1999, PLANT CELL, V11, P1925, DOI 10.1105/tpc.11.10.1925; Kauschmann A, 1996, PLANT J, V9, P701, DOI 10.1046/j.1365-313X.1996.9050701.x; Kim J, 1997, P NATL ACAD SCI USA, V94, P11786, DOI 10.1073/pnas.94.22.11786; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Li J, 2001, P NATL ACAD SCI USA, V98, P5916, DOI 10.1073/pnas.091065998; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Li JM, 2002, SCIENCE, V295, P1299; Li JM, 2001, PLANT PHYSIOL, V127, P14, DOI 10.1104/pp.127.1.14; Mathur J, 1998, PLANT J, V14, P593, DOI 10.1046/j.1365-313X.1998.00158.x; Noguchi T, 1999, PLANT PHYSIOL, V121, P743, DOI 10.1104/pp.121.3.743; Oh MH, 2000, PLANT PHYSIOL, V124, P751, DOI 10.1104/pp.124.2.751; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schmidt EDL, 1997, DEVELOPMENT, V124, P2049; Shah H, 2001, J MOL BIOL, V309, P641, DOI 10.1006/jmbi.2001.4706; Shah K, 2001, J BIOL CHEM, V276, P41263, DOI 10.1074/jbc.M102381200; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Simin K, 1998, GENETICS, V148, P801; Torii KU, 2000, CURR OPIN PLANT BIOL, V3, P361, DOI 10.1016/S1369-5266(00)00097-2; Trotochaud AE, 2000, SCIENCE, V289, P613, DOI 10.1126/science.289.5479.613; Trotochaud AE, 1999, PLANT CELL, V11, P393, DOI 10.1105/tpc.11.3.393; von Arnim AG, 1998, GENE, V221, P35, DOI 10.1016/S0378-1119(98)00433-8; Wang ZY, 2001, NATURE, V410, P380, DOI 10.1038/35066597; WANG ZY, 2000, PLANT BIOL; Winkler RG, 1998, PLANT PHYSIOL, V118, P743, DOI 10.1104/pp.118.3.743; Yamamuro C, 2000, PLANT CELL, V12, P1591, DOI 10.1105/tpc.12.9.1591	39	817	885	12	161	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 26	2002	110	2					203	212		10.1016/S0092-8674(02)00814-0	http://dx.doi.org/10.1016/S0092-8674(02)00814-0			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	578EV	12150928	Bronze			2022-12-24	WOS:000177105200008
J	Lin, SJ; Kaeberlein, M; Andalis, AA; Sturtz, LA; Defossez, PA; Culotta, VC; Fink, GR; Guarente, L				Lin, SJ; Kaeberlein, M; Andalis, AA; Sturtz, LA; Defossez, PA; Culotta, VC; Fink, GR; Guarente, L			Calorie restriction extends Saccharomyces cerevisiae lifespan by increasing respiration	NATURE			English	Article							SUPEROXIDE-DISMUTASE; PROTEIN SIR2; METABOLISM; EXTENSION; LONGEVITY; OVEREXPRESSION; CATALASE; STRESS; NAD	Calorie restriction (CR) extends lifespan in a wide spectrum of organisms and is the only regimen known to lengthen the lifespan of mammals(1-4). We established a model of CR in budding yeast Saccharomyces cerevisiae. In this system, lifespan can be extended by limiting glucose or by reducing the activity of the glucose-sensing cyclic-AMP-dependent kinase (PKA)(5). Lifespan extension in a mutant with reduced PKA activity requires Sir2 and NAD (nicotinamide adenine dinucleotide)(5). In this study we explore how CR activates Sir2 to extend lifespan. Here we show that the shunting of carbon metabolism toward the mitochondrial tricarboxylic acid cycle and the concomitant increase in respiration play a central part in this process. We discuss how this metabolic strategy may apply to CR in animals.	MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Johns Hopkins Univ, Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Johns Hopkins University	Guarente, L (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	leng@mit.edu		Kaeberlein, Matt/0000-0002-1311-3421; Defossez, Pierre-Antoine/0000-0002-6463-9263				Bakker BM, 2001, FEMS MICROBIOL REV, V25, P15, DOI 10.1016/S0168-6445(00)00039-5; Blom J, 2000, APPL ENVIRON MICROB, V66, P1970, DOI 10.1128/AEM.66.5.1970-1973.2000; DEWINDE JH, 1993, PROG NUCLEIC ACID RE, V46, P51, DOI 10.1016/S0079-6603(08)61018-1; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; FORSBURG SL, 1989, GENE DEV, V3, P1166, DOI 10.1101/gad.3.8.1166; Guarente L, 2000, GENE DEV, V14, P1021; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Hegde P, 2000, BIOTECHNIQUES, V29, P548, DOI 10.2144/00293bi01; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Longo VD, 1996, J BIOL CHEM, V271, P12275, DOI 10.1074/jbc.271.21.12275; Melov S, 2000, SCIENCE, V289, P1567, DOI 10.1126/science.289.5484.1567; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; Pronk JT, 1996, YEAST, V12, P1607, DOI 10.1002/(SICI)1097-0061(199612)12:16<1607::AID-YEA70>3.0.CO;2-4; Roth GS, 1999, J AM GERIATR SOC, V47, P896, DOI 10.1111/j.1532-5415.1999.tb03851.x; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; STRYER I, 1995, BIOCHEMISTRY; Taub J, 1999, NATURE, V399, P162, DOI 10.1038/20208; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; WEINDRUCH W, 1998, RETARDATION AGING DI; YU BP, 1994, MODULATION AGING PRO	28	811	847	3	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 18	2002	418	6895					344	348		10.1038/nature00829	http://dx.doi.org/10.1038/nature00829			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574BF	12124627				2022-12-24	WOS:000176868000047
J	Johnston, S				Johnston, S			All that glitters is not gold	LANCET			English	Editorial Material									Belfast City Hosp, Dept Gastroenterol, Belfast BT9 7AB, Antrim, North Ireland	Belfast City Hospital	Johnston, S (corresponding author), Belfast City Hosp, Dept Gastroenterol, Lisburn Rd, Belfast BT9 7AB, Antrim, North Ireland.								0	0	0	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 13	2002	360	9327					137	137		10.1016/S0140-6736(02)09414-X	http://dx.doi.org/10.1016/S0140-6736(02)09414-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573PB	12126824				2022-12-24	WOS:000176839100013
J	Pando, MP; Morse, D; Cermakian, N; Sassone-Corsi, P				Pando, MP; Morse, D; Cermakian, N; Sassone-Corsi, P			Phenotypic rescue of a peripheral clock genetic defect via SCN hierarchical dominance	CELL			English	Article							MAMMALIAN PERIOD GENES; SUPRACHIASMATIC NUCLEUS; CIRCADIAN CLOCK; MESSENGER-RNA; DIFFERENTIAL REGULATION; RHYTHMIC EXPRESSION; LOCOMOTOR-ACTIVITY; PHOTIC INDUCTION; LIGHT; TISSUES	The mammalian circadian system contains both central and peripheral oscillators. To understand the communication pathways between them, we have studied the rhythmic behavior of mouse embryo fibroblasts (MEFs) surgically implanted in mice of different genotypes. MEFs from Perl(-/-) mice have a much shorter period in culture than do tissues in the intact animal. When implanted back into mice, however, the Perl(-/-) MEF take on the rhythmic characteristics of the host. A functioning clock is required for oscillations in the target tissues, as arrhythmic clock(c/c) MEFs remain arrhythmic in implants. These results demonstrate that SON hierarchical dominance can compensate for severe intrinsic genetic defects in peripheral clocks, but cannot induce rhythmicity in clock-defective tissues.	ULP, CNRS, INSERM, Inst Genet & Biol Mol & Cellulaire, F-67404 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Sassone-Corsi, P (corresponding author), ULP, CNRS, INSERM, Inst Genet & Biol Mol & Cellulaire, 1 Rue Laurent Fries, F-67404 Strasbourg, France.	paolosc@igbmc.u-strasbg.fr	Sassone-Corsi, Paolo/H-6182-2011	Morse, David/0000-0003-4131-4367; Cermakian, Nicolas/0000-0003-4517-9131				Abe M, 2002, J NEUROSCI, V22, P350, DOI 10.1523/JNEUROSCI.22-01-00350.2002; Abrahamson EE, 2001, NEUROREPORT, V12, P435, DOI 10.1097/00001756-200102120-00048; Allen G, 2001, J NEUROSCI, V21, P7937, DOI 10.1523/JNEUROSCI.21-20-07937.2001; Aston-Jones G, 2001, NAT NEUROSCI, V4, P732, DOI 10.1038/89522; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Brown SA, 1999, CURR OPIN GENET DEV, V9, P588, DOI 10.1016/S0959-437X(99)00009-X; Buijs RM, 2001, NAT REV NEUROSCI, V2, P521, DOI 10.1038/35081582; Cermakian N, 2000, P NATL ACAD SCI USA, V97, P4339, DOI 10.1073/pnas.97.8.4339; Cermakian N, 2001, EMBO J, V20, P3967, DOI 10.1093/emboj/20.15.3967; Cermakian N, 2000, NAT REV MOL CELL BIO, V1, P59, DOI 10.1038/35036078; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Giebultowicz JM, 2000, CURR BIOL, V10, P107, DOI 10.1016/S0960-9822(00)00299-2; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Herzog ED, 1998, NAT NEUROSCI, V1, P708, DOI 10.1038/3708; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Klein D.C., 1991, SUPRACHIASMATIC NUCL; Kramer A, 2001, SCIENCE, V294, P2511, DOI 10.1126/science.1067716; KRIEGER DT, 1977, SCIENCE, V197, P398, DOI 10.1126/science.877566; Krishnan B, 1999, NATURE, V400, P375, DOI 10.1038/22566; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Le Minh N, 2001, EMBO J, V20, P7128, DOI 10.1093/emboj/20.24.7128; LeSauter J, 1998, CHRONOBIOL INT, V15, P535, DOI 10.3109/07420529808998706; Maywood ES, 1999, P NATL ACAD SCI USA, V96, P15211, DOI 10.1073/pnas.96.26.15211; McNamara P, 2001, CELL, V105, P877, DOI 10.1016/S0092-8674(01)00401-9; Mrosovsky N, 1996, BIOL REV, V71, P343, DOI 10.1111/j.1469-185X.1996.tb01278.x; Oishi K, 1998, BIOCHEM BIOPH RES CO, V253, P199, DOI 10.1006/bbrc.1998.9779; Oishi K, 2000, BIOCHEM BIOPH RES CO, V268, P164, DOI 10.1006/bbrc.1999.2054; Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531; PALMER TD, 1989, BLOOD, V73, P438; PITTENDRIGH CS, 1993, ANNU REV PHYSIOL, V55, P16; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Redlin U, 1999, J COMP PHYSIOL A, V184, P439, DOI 10.1007/s003590050343; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Ripperger JA, 2000, GENE DEV, V14, P679; Sakamoto K, 1998, J BIOL CHEM, V273, P27039, DOI 10.1074/jbc.273.42.27039; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Shearman LP, 1999, NEUROREPORT, V10, P613, DOI 10.1097/00001756-199902250-00031; Silver R, 1996, NATURE, V382, P810, DOI 10.1038/382810a0; STLOUIS D, 1988, P NATL ACAD SCI USA, V85, P3150; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Tosini G, 1996, SCIENCE, V272, P419, DOI 10.1126/science.272.5260.419; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; Ueyama T, 1999, NAT NEUROSCI, V2, P1051, DOI 10.1038/15973; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Whitmore D, 1998, NAT NEUROSCI, V1, P701, DOI 10.1038/3703; Whitmore D, 2000, NATURE, V404, P87, DOI 10.1038/35003589; Yagita K, 2000, GENE DEV, V14, P1353; Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	63	141	146	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 12	2002	110	1					107	117		10.1016/S0092-8674(02)00803-6	http://dx.doi.org/10.1016/S0092-8674(02)00803-6			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	573PU	12151001	Bronze			2022-12-24	WOS:000176840700011
J	Davison, PA; Hunter, CN; Horton, P				Davison, PA; Hunter, CN; Horton, P			Overexpression of beta-carotene hydroxylase enhances stress tolerance in Arabidopsis	NATURE			English	Article							CHLOROPHYLL FLUORESCENCE; TRANSGENIC PLANTS; BIOSYNTHESIS; PHOTOPROTECTION; ACCUMULATION; ZEAXANTHIN; THALIANA; MUTANTS; PHOTOINHIBITION; METABOLISM	Plant stress caused by extreme environmental conditions is already a principal reason for yield reduction in crops(1). The threat of global environment change makes it increasingly important to generate crop plants that will withstand such conditions. Stress, particularly stress caused by increased sunlight, leads to the production of reactive oxygen species that cause photo-oxidative cell damage(2). Carotenoids, which are present in the membranes of all photosynthetic organisms, help protect against such light-dependent oxidative damage(3). In plants, the xanthophyll cycle (the reversible interconversion of two carotenoids, violaxanthin and zeaxanthin(4)) has a key photoprotective role(5) and is therefore a promising target for genetic engineering to enhance stress tolerance. Here we show that in Arabidopsis thaliana overexpression of the chyB gene that encodes beta-carotene hydroxylase-an enzyme in the zeaxanthin biosynthetic pathway(6)-causes a specific twofold increase in the size of the xanthophyll cycle pool. The plants are more tolerant to conditions of high light and high temperature, as shown by reduced leaf necrosis, reduced production of the stress indicator anthocyanin and reduced lipid peroxidation. Stress protection is probably due to the function of zeaxanthin in preventing oxidative damage of membranes.	Univ Sheffield, Dept Mol Biol & Biotechnol, Robert Hill Inst, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Horton, P (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Robert Hill Inst, Sheffield S10 2TN, S Yorkshire, England.		Horton, Peter/A-3958-2012	Horton, Peter/0000-0002-6095-1460				COGDELL RJ, 1987, BIOCHIM BIOPHYS ACTA, V895, P63, DOI 10.1016/S0304-4173(87)80008-3; Cunningham FX, 1998, ANNU REV PLANT PHYS, V49, P557, DOI 10.1146/annurev.arplant.49.1.557; DEMMIGADAMS B, 1992, ANNU REV PLANT PHYS, V43, P599, DOI 10.1146/annurev.pp.43.060192.003123; DIXON RA, 1995, PLANT CELL, V7, P1085, DOI 10.1105/tpc.7.7.1085; Havaux M, 1999, P NATL ACAD SCI USA, V96, P8762, DOI 10.1073/pnas.96.15.8762; Havaux M, 1996, PLANT CELL ENVIRON, V19, P1359, DOI 10.1111/j.1365-3040.1996.tb00014.x; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; Hurry V, 1997, PLANT PHYSIOL, V113, P639, DOI 10.1104/pp.113.2.639; Khush G., 2001, NOVART FDN SYMP, V236, P11; Laby RJ, 2000, PLANT J, V23, P587, DOI 10.1046/j.1365-313x.2000.00833.x; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; MISAWA N, 1994, PLANT J, V6, P481, DOI 10.1046/j.1365-313X.1994.6040481.x; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; NOCTOR G, 1991, BIOCHIM BIOPHYS ACTA, V1057, P320, DOI 10.1016/S0005-2728(05)80143-4; Pogson BJ, 1998, P NATL ACAD SCI USA, V95, P13324, DOI 10.1073/pnas.95.22.13324; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Rissler HM, 2001, PHOTOSYNTH RES, V67, P127, DOI 10.1023/A:1010669404183; ROCK CD, 1991, P NATL ACAD SCI USA, V88, P7496, DOI 10.1073/pnas.88.17.7496; Romer S, 2000, NAT BIOTECHNOL, V18, P666, DOI 10.1038/76523; Ruban AV, 1999, J BIOL CHEM, V274, P10458, DOI 10.1074/jbc.274.15.10458; Sandmann G, 2001, TRENDS PLANT SCI, V6, P14, DOI 10.1016/S1360-1385(00)01817-3; Sun ZR, 1996, J BIOL CHEM, V271, P24349, DOI 10.1074/jbc.271.40.24349; VALVEKENS D, 1988, P NATL ACAD SCI USA, V85, P5536, DOI 10.1073/pnas.85.15.5536; Verhoeven AS, 2001, PHOTOSYNTH RES, V67, P27, DOI 10.1023/A:1010684327864; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Xiang CB, 2001, PLANT PHYSIOL, V126, P564, DOI 10.1104/pp.126.2.564; YAMAMOTO HY, 1962, ARCH BIOCHEM BIOPHYS, V97, P168, DOI 10.1016/0003-9861(62)90060-7; Ye XD, 2000, SCIENCE, V287, P303, DOI 10.1126/science.287.5451.303; Young AJ, 2001, ARCH BIOCHEM BIOPHYS, V385, P20, DOI 10.1006/abbi.2000.2149	30	278	310	4	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 11	2002	418	6894					203	206		10.1038/nature00861	http://dx.doi.org/10.1038/nature00861			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	571GV	12110893				2022-12-24	WOS:000176710400045
J	Park, JM; Greten, FR; Li, ZW; Karin, M				Park, JM; Greten, FR; Li, ZW; Karin, M			Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition	SCIENCE			English	Article							ACTIVATED PROTEIN-KINASE; BACILLUS-ANTHRACIS; KAPPA-B; TOXIN; SUSCEPTIBILITY; TRANSCRIPTION	The bacterium Bacillus anthracis causes the death of macrophages, which may allow it to avoid detection by the innate immune system. We found that B. anthracis lethal factor (LF) selectively induces apoptosis of activated macrophages by cleaving the amino-terminal extension of mitogen-activated protein kinase (MAPK) kinases (MKKs) that activate p38 MAPKs. Because macrophages that are deficient in transcription factor nuclear factor kappaB (NF-kappaB) are also sensitive to activation-induced death and p38 is required for expression of certain NF-kappaB target genes, p38 is probably essential for synergistic induction of those NF-kappaB target genes that prevent apoptosis of activated macrophages. This dismantling of the p38 MAPK module represents a strategy used by B. anthracis to paralyze host innate immunity.	Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Karin, M (corresponding author), Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, 9500 Gilman Dr, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu	Greten, Florian R/AAF-5196-2020	Greten, Florian R/0000-0002-3928-6080	NIAID NIH HHS [AI43477] Funding Source: Medline; NIEHS NIH HHS [ES04151, ES06376, ES10337] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES004151, R01ES006376, P42ES010337, R37ES004151] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen KD, 2000, J CELL BIOCHEM, V76, P585, DOI 10.1002/(SICI)1097-4644(20000315)76:4<585::AID-JCB7>3.0.CO;2-U; Chu WM, 2000, CELL, V103, P909, DOI 10.1016/S0092-8674(00)00194-X; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Duesbery NS, 2001, P NATL ACAD SCI USA, V98, P4089, DOI 10.1073/pnas.061031898; Erwin JL, 2001, INFECT IMMUN, V69, P1175, DOI 10.1128/IAI.69.2.1175-1177.2001; Grinberg LM, 2001, MODERN PATHOL, V14, P482, DOI 10.1038/modpathol.3880337; Hanna PC, 1999, TRENDS MICROBIOL, V7, P180, DOI 10.1016/S0966-842X(99)01507-3; Hirayoshi K, 1999, METHOD ENZYMOL, V304, P351; KEPPIE J, 1963, BRIT J EXP PATHOL, V44, P446; KLIMPEL KR, 1992, P NATL ACAD SCI USA, V89, P10277, DOI 10.1073/pnas.89.21.10277; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Lin CG, 1996, CURR MICROBIOL, V33, P224, DOI 10.1007/s002849900104; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Pannifer AD, 2001, NATURE, V414, P229, DOI 10.1038/n35101998; Roberts JE, 1998, MOL MICROBIOL, V29, P581, DOI 10.1046/j.1365-2958.1998.00953.x; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; SINGH Y, 1989, J BIOL CHEM, V264, P11099; Vitale G, 2000, BIOCHEM J, V352, P739, DOI 10.1042/0264-6021:3520739; Weinrauch Y, 1999, ANNU REV MICROBIOL, V53, P155, DOI 10.1146/annurev.micro.53.1.155; WELKOS SL, 1986, INFECT IMMUN, V51, P795, DOI 10.1128/IAI.51.3.795-800.1986; Xia Y, 1998, GENE DEV, V12, P3369, DOI 10.1101/gad.12.21.3369	30	403	427	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 20	2002	297	5589					2048	2051		10.1126/science.1073163	http://dx.doi.org/10.1126/science.1073163			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594XV	12202685	Green Submitted			2022-12-24	WOS:000178078500045
J	Suzuki, Y; Kelly, SD; Kemner, KM; Banfield, JF				Suzuki, Y; Kelly, SD; Kemner, KM; Banfield, JF			Radionuclide contamination - Nanometre-size products of uranium bioreduction	NATURE			English	Article									Argonne Natl Lab, Div Environm Res, Argonne, IL 60439 USA; Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; Univ Wisconsin, Dept Geol & Geophys, Madison, WI 53706 USA	United States Department of Energy (DOE); Argonne National Laboratory; University of California System; University of California Berkeley; University of Wisconsin System; University of Wisconsin Madison	Suzuki, Y (corresponding author), Japan Marine Sci & Technol Ctr, Yokosuka, Kanagawa 237006, Japan.	jill@seismo.berkeley.edu	Suzuki, Yohey/G-4980-2014	Banfield, Jill/0000-0001-8203-8771				Bond PL, 2000, APPL ENVIRON MICROB, V66, P3842, DOI 10.1128/AEM.66.9.3842-3849.2000; Grenthe I., 1992, CHEM THERMODYNAMICS; Lovely D.R., 1991, NATURE, V350, P413; RAI D, 1990, INORG CHEM, V29, P260, DOI 10.1021/ic00327a022	4	292	309	0	120	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 12	2002	419	6903					134	134		10.1038/419134a	http://dx.doi.org/10.1038/419134a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592HK	12226656	Bronze			2022-12-24	WOS:000177931200032
J	Einsle, O; Tezcan, FA; Andrade, SLA; Schmid, B; Yoshida, M; Howard, JB; Rees, DC				Einsle, O; Tezcan, FA; Andrade, SLA; Schmid, B; Yoshida, M; Howard, JB; Rees, DC			Nitrogenase MoFe-protein at 1.16 angstrom resolution: A central ligand in the FeMo-cofactor	SCIENCE			English	Article							MOLYBDENUM IRON PROTEIN; CRYSTAL-STRUCTURE; CLUSTERS; MODELS; SYSTEM	A high-resolution crystallographic analysis of the nitrogenase MoFe-protein reveals a previously unrecognized ligand coordinated to six iron atoms in the center of the catalytically essential FeMo-cofactor. The electron density for this ligand is masked in structures with resolutions lower than 1.55 angstroms, owing to Fourier series termination ripples from the surrounding iron and sulfur atoms in the cofactor. The central atom completes an approximate tetrahedral coordination for the six iron atoms, instead of the trigonal coordination proposed on the basis of lower resolution structures. The crystallographic refinement at 1.16 angstrom resolution is consistent with this newly detected component being a light element, most plausibly nitrogen. The presence of a nitrogen atom in the cofactor would have important implications for the mechanism of dinitrogen reduction by nitrogenase.	CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; Univ Minnesota, Dept Biochem, Minneapolis, MN 55455 USA	California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology; University of Minnesota System; University of Minnesota Twin Cities	Rees, DC (corresponding author), CALTECH, Howard Hughes Med Inst, Mail Code 147-75CH, Pasadena, CA 91125 USA.	dcrees@caltech.edu	Andrade, Susana L. A./D-5119-2012	Andrade, Susana L. A./0000-0003-2267-8499; Einsle, Oliver/0000-0001-8722-2893				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BOLIN JT, 1993, ACS SYM SER, V535, P186; Bragg WL, 1930, PHILOS MAG, V10, P823; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burgess BK, 1996, CHEM REV, V96, P2983, DOI 10.1021/cr950055x; CHAN MK, 1993, SCIENCE, V260, P792, DOI 10.1126/science.8484118; Christiansen J, 2001, ANNU REV PLANT PHYS, V52, P269, DOI 10.1146/annurev.arplant.52.1.269; COCHRAN W, 1966, DETERMINATION CRYSTA; Cruickshank DWJ, 1999, ACTA CRYSTALLOGR D, V55, P583, DOI 10.1107/S0907444998012645; DENG HB, 1993, ANGEW CHEM INT EDIT, V32, P1062, DOI 10.1002/anie.199310621; EINSLE O, UNPUB; Ertl G., 1997, HDB HETEROGENEOUS CA, V4; Howard JB, 1996, CHEM REV, V96, P2965, DOI 10.1021/cr9500545; JAMES RW, 1948, ACTA CRYSTALLOGR, V1, P132, DOI 10.1107/S0365110X48000351; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KIM J, 1993, BIOCHEMISTRY-US, V32, P7104, DOI 10.1021/bi00079a006; KIM JS, 1992, SCIENCE, V257, P1677, DOI 10.1126/science.1529354; KIM JS, 1992, NATURE, V360, P553, DOI 10.1038/360553a0; Lee HI, 1998, BIOCHEMISTRY-US, V37, P13370, DOI 10.1021/bi980956a; Logadottir A, 2001, SURF SCI, V489, P135, DOI 10.1016/S0039-6028(01)01171-2; MARTINENGO S, 1979, J AM CHEM SOC, V101, P7095, DOI 10.1021/ja00517a067; Mayer SM, 1999, J MOL BIOL, V292, P871, DOI 10.1006/jmbi.1999.3107; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peters JW, 1997, BIOCHEMISTRY-US, V36, P1181, DOI 10.1021/bi9626665; Rees DC, 2000, CURR OPIN CHEM BIOL, V4, P559, DOI 10.1016/S1367-5931(00)00132-0; Siegbahn PEM, 1998, J PHYS CHEM B, V102, P1615, DOI 10.1021/jp972207t; Smith BE, 1999, ADV INORG CHEM, V47, P159, DOI 10.1016/S0898-8838(08)60078-1; Stavrev KK, 1996, CHEM-EUR J, V2, P83, DOI 10.1002/chem.19960020115; THOMANN H, 1987, J AM CHEM SOC, V109, P7913, DOI 10.1021/ja00259a067; Thorneley R.N.F., 1985, MOLYBDENUM ENZYMES, V1, P221; TRUE AE, 1990, J AM CHEM SOC, V112, P651, DOI 10.1021/ja00158a024; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; WOLLE D, 1992, J BIOL CHEM, V267, P3667	34	845	862	11	288	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2002	297	5587					1696	1700		10.1126/science.1073877	http://dx.doi.org/10.1126/science.1073877			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590JE	12215645				2022-12-24	WOS:000177819100048
J	Gao, GX; Guo, XM; Goff, SP				Gao, GX; Guo, XM; Goff, SP			Inhibition of retroviral RNA production by ZAP, a CCCH-type zinc finger protein	SCIENCE			English	Article							HUMAN MXA PROTEIN; AU-RICH ELEMENTS; MESSENGER-RNA; GENE-TRANSFER; TRISTETRAPROLIN; CELLS; DESTABILIZATION; DEADENYLATION; TRANSDUCTION; DEGRADATION	Cells have evolved multiple mechanisms to inhibit viral replication. To identify previously unknown antiviral activities, we screened mammalian complementary DNA (cDNA) libraries for genes that prevent infection by a genetically marked retrovirus. Virus-resistant cells were selected from pools of transduced clones, and an active antiviral cDNA was recovered. The gene encodes a CCCH-type zinc finger protein designated ZAP. Expression of the gene caused a profound and specific loss of viral messenger RNAs (mRNAs) from the cytoplasm without affecting the levels of nuclear mRNAs. The finding suggests the existence of a previously unknown machinery for the inhibition of virus replication, targeting a step in viral gene expression.	Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Chinese Acad Sci, Inst Microbiol, Beijing 100080, Peoples R China	Columbia University; Howard Hughes Medical Institute; Chinese Academy of Sciences; Institute of Microbiology, CAS	Goff, SP (corresponding author), Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, 701 W 168th St, New York, NY 10032 USA.		Goff, Stephen P/K-6337-2014	Goff, Stephen P/0000-0003-0693-5547	NATIONAL CANCER INSTITUTE [R01CA030488, R37CA030488] Funding Source: NIH RePORTER; NCI NIH HHS [CA 30488] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		An DS, 1997, J VIROL, V71, P1397, DOI 10.1128/JVI.71.2.1397-1404.1997; Bothe GWM, 2000, GENESIS, V26, P165, DOI 10.1002/(SICI)1526-968X(200002)26:2<165::AID-GENE22>3.0.CO;2-F; Carballo E, 2000, BLOOD, V95, P1891, DOI 10.1182/blood.V95.6.1891; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Der SD, 1997, P NATL ACAD SCI USA, V94, P3279, DOI 10.1073/pnas.94.7.3279; Frese M, 1996, J VIROL, V70, P915, DOI 10.1128/JVI.70.2.915-923.1996; GAO G, UNPUB; Gao GX, 1999, MOL BIOL CELL, V10, P1705, DOI 10.1091/mbc.10.6.1705; Haller O, 1998, REV SCI TECH OIE, V17, P220, DOI 10.20506/rst.17.1.1084; KERR IM, 1978, P NATL ACAD SCI USA, V75, P256, DOI 10.1073/pnas.75.1.256; Lai WS, 2001, J BIOL CHEM, V276, P23144, DOI 10.1074/jbc.M100680200; Lai WS, 2000, J BIOL CHEM, V275, P17827, DOI 10.1074/jbc.M001696200; Lai WS, 1999, MOL CELL BIOL, V19, P4311; LANDOLFO S, 1995, PHARMACOL THERAPEUT, V65, P415, DOI 10.1016/0163-7258(95)98599-L; Levy DE, 2001, CYTOKINE GROWTH F R, V12, P143, DOI 10.1016/S1359-6101(00)00027-7; MACDONALD ME, COMMUNICATION; MARKOWITZ D, 1988, J VIROL, V62, P1120, DOI 10.1128/JVI.62.4.1120-1124.1988; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; PAVLOVIC J, 1995, J VIROL, V69, P4506, DOI 10.1128/JVI.69.7.4506-4510.1995; Player MR, 1998, PHARMACOL THERAPEUT, V78, P55, DOI 10.1016/S0163-7258(97)00167-8; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; Williams BRG, 1999, ONCOGENE, V18, P6112, DOI 10.1038/sj.onc.1203127; Zhou AM, 1999, VIROLOGY, V258, P435, DOI 10.1006/viro.1999.9738	24	341	356	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 6	2002	297	5587					1703	1706		10.1126/science.1074276	http://dx.doi.org/10.1126/science.1074276			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590JE	12215647				2022-12-24	WOS:000177819100050
J	Monnin, T; Ratnieks, FLW; Jones, GR; Beard, R				Monnin, T; Ratnieks, FLW; Jones, GR; Beard, R			Pretender punishment induced by chemical signalling in a queenless ant	NATURE			English	Article							CUTICULAR HYDROCARBONS; SOCIAL INSECTS; FERTILITY; DOMINANCE; WORKERS	Animal societies are stages for both conflict and cooperation. Reproduction is often monopolized by one or a few individuals who behave aggressively to prevent subordinates from reproducing (for example, naked mole-rats(1), wasps(2) and ants(3)). Here we report an unusual mechanism by which the dominant individual maintains reproductive control. In the queenless ant Dinoponera quadriceps, only the alpha female reproduces. If the alpha is challenged by another female she chemically marks the pretender who is then punished(4) by low-ranking females. This cooperation between alpha and low-rankers allows the alpha to inflict punishment indirectly, thereby maintaining her reproductive primacy without having to fight.	Univ Sheffield, Dept Anim & Plant Sci, Lab Apiculture & Social Insects, Sheffield S10 2TN, S Yorkshire, England; Univ Keele, Sch Chem & Phys, Chem Ecol Grp, Keele ST5 5BG, Staffs, England	University of Sheffield; Keele University	Monnin, T (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Lab Apiculture & Social Insects, Sheffield S10 2TN, S Yorkshire, England.	Thibaud.Monnin@snv.jussieu.fr	Monnin, Thibaud/J-9409-2012	Monnin, Thibaud/0000-0003-3762-942X				ALLIES AB, 1986, J CHEM ECOL, V12, P1285, DOI 10.1007/BF01012348; Barron AB, 2001, BEHAV ECOL SOCIOBIOL, V50, P199, DOI 10.1007/s002650100362; Billen Johan, 1998, P3; Clarke FM, 1997, P ROY SOC B-BIOL SCI, V264, P993, DOI 10.1098/rspb.1997.0137; CLUTTONBROCK TH, 1995, NATURE, V373, P209, DOI 10.1038/373209a0; Cuvillier-Hot V, 2001, J INSECT PHYSIOL, V47, P485, DOI 10.1016/S0022-1910(00)00137-2; Foster KR, 2000, NATURE, V407, P692, DOI 10.1038/35037665; Foster KR, 2001, P ROY SOC B-BIOL SCI, V268, P169, DOI 10.1098/rspb.2000.1346; Gobin B, 1999, ANIM BEHAV, V58, P1117, DOI 10.1006/anbe.1999.1245; HEINZE J, 1994, NATURWISSENSCHAFTEN, V81, P489, DOI 10.1007/s001140050114; Heinze J, 1998, CHEMOECOLOGY, V8, P169, DOI 10.1007/s000490050022; HOLLDOBLER B, 1990, NATS; KELLER L, 1993, ANIM BEHAV, V45, P787, DOI 10.1006/anbe.1993.1092; Liebig J, 1999, P ROY SOC B-BIOL SCI, V266, P1865, DOI 10.1098/rspb.1999.0858; Liebig J, 2000, P NATL ACAD SCI USA, V97, P4124, DOI 10.1073/pnas.97.8.4124; Monnin T, 2001, BEHAV ECOL SOCIOBIOL, V50, P97, DOI 10.1007/s002650100351; Monnin T, 1999, BEHAV ECOL, V10, P323, DOI 10.1093/beheco/10.3.323; Monnin T, 1997, NATURWISSENSCHAFTEN, V84, P499, DOI 10.1007/s001140050433; Monnin T, 1998, ANIM BEHAV, V55, P299, DOI 10.1006/anbe.1997.0601; Ortius D, 1999, BEHAV ECOL SOCIOBIOL, V45, P151, DOI 10.1007/s002650050548; Peeters C, 1999, P ROY SOC B-BIOL SCI, V266, P1323, DOI 10.1098/rspb.1999.0782; Peeters Christian, 1993, P234; RATNIEKS FLW, 1988, AM NAT, V132, P217, DOI 10.1086/284846; RATNIEKS FLW, 1989, NATURE, V342, P796, DOI 10.1038/342796a0; REGNIER FE, 1971, SCIENCE, V172, P267, DOI 10.1126/science.172.3980.267; Roseler P.-F., 1991, P309; Solomon N. G., 1997, COOPERATIVE BREEDING; Stacey P.B., 1990, COOPERATIVE BREEDING; Wilson EO., 1971, INSECT SOC	30	108	111	0	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 5	2002	419	6902					61	65		10.1038/nature00932	http://dx.doi.org/10.1038/nature00932			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589YF	12214231	Green Accepted			2022-12-24	WOS:000177788600036
J	D'Aunno, T; Pollack, HA				D'Aunno, T; Pollack, HA			Changes in methadone treatment practices - Results from a national panel study, 1988-2000	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SUBSTANCE-ABUSE TREATMENT; DRUG-USERS; MANAGED CARE; HIV	Context Results from several studies conducted in the early 1990s showed that the majority of US methadone maintenance programs did not use treatment practices that met established standards for the care of heroin users. Effective treatment for heroin users is critical given the upsurge in heroin use and the continued role of injection drug use in the human immunodeficiency virus and hepatitis C epidemics. Objectives To examine the extent to which US methadone maintenance treatment programs have made changes in the past 12 years to provide adequate methadone doses and to identify factors associated with variation in program performance. Design, Setting, and Participants Program directors and clinical supervisors of nationally representative methadone treatment programs that varied by ownership (for-profit, public, or private not-for-profit) and setting (eg, free-standing, hospital-based) were surveyed in 1988 (n=172), 1990 (n=140), 1995 (n=116), and 2000 (n=150). Main Outcome Measures Percentage of patients in each treatment program receiving methadone dosages of less than 40, 60, and 80 mg/d. Results The percentage of patients receiving methadone dosage levels less than the recommended 60 mg/d has decreased from 79.5% in 1988 to 35.5% in 2000. Results also show that programs with a greater percentage of African American patients are especially likely to dispense low dosages, while programs with Joint Commission on Accreditation of Healthcare Organizations accreditation are more likely to provide adequate methadone doses. Conclusions Efforts to improve methadone treatment practices appear to be making progress, but many patients are still receiving substandard care.	Univ Chicago, Sch Social Serv Adm, Chicago, IL 60637 USA; Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; Univ Michigan, Sch Publ Hlth, Dept Hlth Policy & Management, Ann Arbor, MI 48109 USA	University of Chicago; University of Chicago; University of Michigan System; University of Michigan	D'Aunno, T (corresponding author), INSEAD, Blvd Constance, F-77305 Fontainebleau, France.		D'Aunno, Thomas/V-8107-2019; Pollack, Harold A/A-1166-2007; D'Aunno, Thomas/P-9320-2019		NATIONAL INSTITUTE ON DRUG ABUSE [R01DA003272] Funding Source: NIH RePORTER; NIDA NIH HHS [DA03272] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		[Anonymous], 1995, FEDERAL REGULATION M; Bach PB, 1999, AM J PUBLIC HEALTH, V89, P662, DOI 10.2105/AJPH.89.5.662; BALL JC, 1991, EFFECTIVENESS METHOD; BATTON HL, 1992, DRUG SERVICES RES SU; COOPER JR, 1992, JAMA-J AM MED ASSOC, V267, P281; CZECHOWICZ D, 1997, J MAINT ADDICT, V1, P11; D'Aunno T, 1999, AM J DRUG ALCOHOL AB, V25, P681, DOI 10.1081/ADA-100101886; DAUNNO T, 1992, JAMA-J AM MED ASSOC, V267, P253, DOI 10.1001/jama.267.2.253; DAUNNO T, 1995, TREATING DRUG ABUSE; Diggle PJ, 2002, ANAL LONGITUDINAL DA; *GEN ACC OFF, 1990, GAOHRD90104 GEN ACC; GROVES R, 1988, TELEPHONE SURVEY MET; Hagan H, 2000, MT SINAI J MED, V67, P423; Holmberg SD, 1996, AM J PUBLIC HEALTH, V86, P642, DOI 10.2105/AJPH.86.5.642; *I MED, 2000, NO TIM LOS MAK MOST; Joseph H, 2000, MT SINAI J MED, V67, P347; Leavitt SB, 2000, MT SINAI J MED, V67, P404; Lemak CH, 2001, J BEHAV HEALTH SER R, V28, P12, DOI 10.1007/BF02287231; Lemak CH, 2001, MED CARE RES REV, V58, P455, DOI 10.1177/107755870105800405; Little R. J. A., 1987, STAT ANAL MISSING DA; LITTLE RJA, 1995, J AM STAT ASSOC, V90, P1112, DOI 10.2307/2291350; MCCANN MJ, 1994, CSAT TECHNICAL ASSIS, V7; METZGER DS, 1993, J ACQ IMMUN DEF SYND, V6, P1049; *NIH CONS STAT 108, EFF MED TREATM OP AD; *OFF NAT DRUG CONT, 1988, WHAT AM US SPEND ILL; PARRINO MW, 1993, TREATMENT IMPROVEMEN; PLAUT JJ, 1998, HEROIN AGE CRACK COC, P160; Pollack HA, 2001, MED DECIS MAKING, V21, P357, DOI 10.1177/02729890122062659; SIMPSON DD, 1997, TREATING DRUG ABUSER, P41; Strain EC, 1999, JAMA-J AM MED ASSOC, V281, P1000, DOI 10.1001/jama.281.11.1000; *US DEP HHS OFF AP, DRUG ALC SERV INF; VAUGHN TE, 1993, THESIS U MICHIGAN AN; West SL, 2000, J SUBST ABUSE, V12, P405, DOI 10.1016/S0899-3289(01)00054-2; 1991, MONITORING FUTURE 20	34	106	106	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 21	2002	288	7					850	856		10.1001/jama.288.7.850	http://dx.doi.org/10.1001/jama.288.7.850			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585FC	12186602	Bronze			2022-12-24	WOS:000177513100027
J	Huizinga, EG; Tsuji, S; Romijn, RAP; Schiphorst, ME; de Groot, PG; Sixma, JJ; Gros, P				Huizinga, EG; Tsuji, S; Romijn, RAP; Schiphorst, ME; de Groot, PG; Sixma, JJ; Gros, P			Structures of glycoprotein Ib alpha and its complex with von Willebrand factor A1 domain	SCIENCE			English	Article							ALANINE SCANNING MUTAGENESIS; VONWILLEBRAND DISEASE; CRYSTAL-STRUCTURE; FACTOR-BINDING; MUTATIONS; RECOGNITION; IX	Transient interactions of platelet-receptor glycoprotein Ibalpha (GpIbalpha) and the plasma protein von Willebrand factor (VWF) reduce platelet velocity at sites of vascular damage and play a role in haemostasis and thrombosis. Here we present structures of the GpIbalpha amino-terminal domain and its complex with the VWF domain A1. In the complex, GpIbalpha wraps around one side of A1, providing two contact areas bridged by an area of solvated charge interaction. The structures explain the effects of gain-of-function mutations related to bleeding disorders and provide a model for shear-induced activation. These detailed insights into the initial interactions in platelet adhesion are relevant to the development of antithrombotic drugs.	Univ Utrecht, Bijvoet Ctr Biomol Res, Dept Crystal & Struct Chem, NL-3584 CH Utrecht, Netherlands; Univ Med Ctr Utrecht, Inst Biomembranes, Dept Haematol, Thrombosis & Haemostasis Lab, Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University Medical Center	Huizinga, EG (corresponding author), Univ Utrecht, Bijvoet Ctr Biomol Res, Dept Crystal & Struct Chem, Padualaan 8, NL-3584 CH Utrecht, Netherlands.		Gros, Piet/AAD-6452-2019; Gros, Piet/I-5569-2016	Gros, Piet/0000-0002-7782-2585; Gros, Piet/0000-0002-7782-2585				Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Berndt MC, 2001, THROMB HAEMOSTASIS, V86, P178; Blanco F, 1998, CURR OPIN STRUC BIOL, V8, P107, DOI 10.1016/S0959-440X(98)80017-1; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Celikel R, 2000, NAT STRUCT BIOL, V7, P881; Celikel R, 1998, NAT STRUCT BIOL, V5, P189, DOI 10.1038/nsb0398-189; Cruz MA, 2000, J BIOL CHEM, V275, P19098, DOI 10.1074/jbc.M002292200; Dong JF, 2000, J BIOL CHEM, V275, P27663; Dong JF, 2001, J BIOL CHEM, V276, P16690, DOI 10.1074/jbc.M101035200; Emsley J, 1998, J BIOL CHEM, V273, P10396, DOI 10.1074/jbc.273.17.10396; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; GINSBURG D, 1993, THROMB HAEMOSTASIS, V69, P177; Goto S, 2001, Clin Lab, V47, P327; GOTO S, 1995, J BIOL CHEM, V270, P23352, DOI 10.1074/jbc.270.40.23352; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Lankhof H, 1996, THROMB HAEMOSTASIS, V75, P950; Matsushita T, 2000, J BIOL CHEM, V275, P11044, DOI 10.1074/jbc.275.15.11044; MATSUSHITA T, 1995, J BIOL CHEM, V270, P13406, DOI 10.1074/jbc.270.22.13406; MILLER JL, 1991, P NATL ACAD SCI USA, V88, P4761, DOI 10.1073/pnas.88.11.4761; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; RUSSELL SD, 1993, BLOOD, V81, P1787; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Savage B, 1996, CELL, V84, P289, DOI 10.1016/S0092-8674(00)80983-6; Sheinerman FB, 2000, CURR OPIN STRUC BIOL, V10, P153, DOI 10.1016/S0959-440X(00)00065-8; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Tait AS, 2001, BLOOD, V98, P1812, DOI 10.1182/blood.V98.6.1812; Vasudevan S, 2000, J BIOL CHEM, V275, P12763, DOI 10.1074/jbc.275.17.12763	29	459	491	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 16	2002	297	5584					1176	1179		10.1126/science.107355	http://dx.doi.org/10.1126/science.107355			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584BP	12183630	Green Submitted			2022-12-24	WOS:000177447600049
J	Li, JX; Kinoshita, T; Pandey, S; Ng, CKY; Gygi, SP; Shimazaki, K; Assmann, SM				Li, JX; Kinoshita, T; Pandey, S; Ng, CKY; Gygi, SP; Shimazaki, K; Assmann, SM			Modulation of an RNA-binding protein by abscisic-acid-activated protein kinase	NATURE			English	Article							MESSENGER-RNA; GUARD-CELLS; ARABIDOPSIS; GENE; EXPRESSION; ENCODES; RESPONSES; PLANTS	Protein kinases are involved in stress signalling in both plant and animal systems. The hormone abscisic acid mediates the responses of plants to stresses such as drought, salinity and cold. Abscisic-acid-activated protein kinase (AAPK)-found in guard cells, which control stomatal pores-has been shown to regulate plasma membrane ion channels(1). Here we show that AAPK-interacting protein 1 (AKIP1), with sequence homology to heterogeneous nuclear RNA-binding protein A/B, is a substrate of AAPK. AAPK-dependent phosphorylation is required for the interaction of AKIP1 with messenger RNA that encodes dehydrin, a protein implicated in cell protection under stress conditions. AAPK and AKIP1 are present in the guard-cell nucleus, and in vivo treatment of such cells with abscisic acid enhances the partitioning of AKIP1 into subnuclear foci which are reminiscent of nuclear speckles. These results show that phosphorylation-regulated RNA target discrimination by heterogeneous nuclear RNA-binding proteins(2) may be a general phenomenon in eukaryotes, and implicate a plant hormone in the regulation of protein dynamics during rapid subnuclear reorganization.	Penn State Univ, Dept Biol, Mueller Lab 208, University Pk, PA 16802 USA; Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 8108560, Japan; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Kyushu University; Harvard University; Harvard Medical School	Li, JX (corresponding author), Penn State Univ, Dept Biol, Mueller Lab 208, University Pk, PA 16802 USA.		Pandey, Sona/M-2847-2013; Ng, Carl K/B-4626-2013; Kinoshita, Toshinori/C-2891-2012	Pandey, Sona/0000-0002-5570-3120; Kinoshita, Toshinori/0000-0001-7621-1259; Ng, Carl/0000-0001-5832-3265				Assmann SM, 2001, CURR OPIN PLANT BIOL, V4, P421, DOI 10.1016/S1369-5266(00)00195-3; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Busk PK, 1998, PLANT MOL BIOL, V37, P425, DOI 10.1023/A:1006058700720; Dixon AK, 1998, NUCLEIC ACIDS RES, V26, P4426, DOI 10.1093/nar/26.19.4426; Dunn MA, 1996, PLANT MOL BIOL, V30, P947, DOI 10.1007/BF00020806; Freire MA, 1995, PLANT MOL BIOL, V29, P797, DOI 10.1007/BF00041169; GOMEZ J, 1988, NATURE, V334, P262, DOI 10.1038/334262a0; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hugouvieux V, 2001, CELL, V106, P477, DOI 10.1016/S0092-8674(01)00460-3; KHAN FA, 1991, FEBS LETT, V290, P159, DOI 10.1016/0014-5793(91)81249-8; Kinoshita T, 1999, EMBO J, V18, P5548, DOI 10.1093/emboj/18.20.5548; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; Lambermon MHL, 2000, EMBO J, V19, P1638, DOI 10.1093/emboj/19.7.1638; Li JX, 1996, PLANT CELL, V8, P2359, DOI 10.1105/tpc.8.12.2359; Li JX, 2000, SCIENCE, V287, P300, DOI 10.1126/science.287.5451.300; Li JX, 1998, PLANT PHYSIOL, V116, P785, DOI 10.1104/pp.116.2.785; Lorkovic ZJ, 2000, TRENDS PLANT SCI, V5, P160, DOI 10.1016/S1360-1385(00)01595-8; Lorkovic ZJ, 2002, NUCLEIC ACIDS RES, V30, P623, DOI 10.1093/nar/30.3.623; Lu C, 2000, PLANT CELL, V12, P2351, DOI 10.1105/tpc.12.12.2351; Macknight R, 1997, CELL, V89, P737, DOI 10.1016/S0092-8674(00)80256-1; Melcak I, 2001, MOL BIOL CELL, V12, P393, DOI 10.1091/mbc.12.2.393; Misteli T, 2001, SCIENCE, V291, P843, DOI 10.1126/science.291.5505.843; Moriyama Y, 1997, ANGIOLOGY, V48, P839, DOI 10.1177/000331979704800912; Moz Y, 1999, J BIOL CHEM, V274, P25266, DOI 10.1074/jbc.274.36.25266; Ostrowski J, 2001, P NATL ACAD SCI USA, V98, P9044, DOI 10.1073/pnas.161284098; Schomburg FM, 2001, PLANT CELL, V13, P1427, DOI 10.1105/tpc.13.6.1427; Schroeder JI, 2001, NATURE, V410, P327, DOI 10.1038/35066500; SHEN LM, 1995, PHYSIOL PLANTARUM, V95, P99, DOI 10.1111/j.1399-3054.1995.tb00814.x; STONE JM, 1994, SCIENCE, V266, P793, DOI 10.1126/science.7973632; Xiong LM, 2001, DEV CELL, V1, P771, DOI 10.1016/S1534-5807(01)00087-9	30	136	141	2	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 15	2002	418	6899					793	797		10.1038/nature00936	http://dx.doi.org/10.1038/nature00936			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UF	12181571				2022-12-24	WOS:000177428000043
J	Taggart, AKP; Teng, SC; Zakian, VA				Taggart, AKP; Teng, SC; Zakian, VA			Est1p as a cell cycle-regulated activator of telomere-bound telomerase	SCIENCE			English	Article							DNA-POLYMERASE-ALPHA; SACCHAROMYCES-CEREVISIAE; CHROMOSOME STABILITY; BINDING PROTEIN; IN-VIVO; YEAST; CDC13; REPLICATION; IDENTIFICATION; MAINTENANCE	In Saccharomyces cerevisiae, the telomerase components Est2p, TLC1 RNA, Est1p, and Est3p are thought to form a complex that acts late during chromosome replication ( S phase) upon recruitment by Cdc13p, a telomeric DNA binding protein. Consistent with this model, we show that Est1p, Est2p, and Cdc13p are telomere-associated at this time. However, Est2p, but not Est1p, also binds telomeres before late S phase. The cdc13-2 allele has been proposed to be defective in recruitment, yet Est1p and Est2p telomere association persists in cdc13-2 cells. These findings suggest a model in which Est1p binds telomeres late in S phase and interacts with Cdc13p to convert inactive, telomere-bound Est2p to an active form.	Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Zakian, VA (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.			TENG, SHU-CHUN/0000-0002-6492-2560	NCI NIH HHS [T32 CA09528-16] Funding Source: Medline; NIGMS NIH HHS [GM43265] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043265] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; Bourns BD, 1998, MOL CELL BIOL, V18, P5600, DOI 10.1128/MCB.18.9.5600; Chandra A, 2001, GENE DEV, V15, P404, DOI 10.1101/gad.861001; CONRAD MN, 1990, CELL, V63, P739, DOI 10.1016/0092-8674(90)90140-A; Diede SJ, 1999, CELL, V99, P723, DOI 10.1016/S0092-8674(00)81670-0; Evans SK, 1999, SCIENCE, V286, P117, DOI 10.1126/science.286.5437.117; Hughes TR, 2000, P NATL ACAD SCI USA, V97, P6457, DOI 10.1073/pnas.97.12.6457; Marcand S, 2000, CURR BIOL, V10, P487, DOI 10.1016/S0960-9822(00)00450-4; Nugent CI, 1998, GENE DEV, V12, P1073, DOI 10.1101/gad.12.8.1073; Nugent CI, 1996, SCIENCE, V274, P249, DOI 10.1126/science.274.5285.249; Pennock E, 2001, CELL, V104, P387, DOI 10.1016/S0092-8674(01)00226-4; Prescott J, 1997, GENE DEV, V11, P2790, DOI 10.1101/gad.11.21.2790; Qi HY, 2000, GENE DEV, V14, P1777; SANDELL LL, 1994, P NATL ACAD SCI USA, V91, P12061, DOI 10.1073/pnas.91.25.12061; SIKORSKI RS, 1989, GENETICS, V122, P19; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; TAGGART AKP, UNPUB; Tsukamoto Y, 2001, CURR BIOL, V11, P1328, DOI 10.1016/S0960-9822(01)00372-4; Wellinger RJ, 1996, CELL, V85, P423, DOI 10.1016/S0092-8674(00)81120-4; WRIGHT JH, 1992, GENE DEV, V6, P197, DOI 10.1101/gad.6.2.197; ZAKIAN VA, 1995, SCIENCE, V270, P1601, DOI 10.1126/science.270.5242.1601	22	294	301	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 9	2002	297	5583					1023	1026		10.1126/science.1074968	http://dx.doi.org/10.1126/science.1074968			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581ZN	12169735				2022-12-24	WOS:000177325400047
J	Herbst, J; Heyne, K; Diller, R				Herbst, J; Heyne, K; Diller, R			Femtosecond infrared spectroscopy of bacteriorhodopsin chromophore isomerization	SCIENCE			English	Article							PROTONATED SCHIFF-BASE; RESONANCE RAMAN-SPECTRA; VIBRATIONAL ANALYSIS; QUANTUM YIELD; PHOTOCYCLE; PHOTOISOMERIZATION; INTERMEDIATE; RELAXATION; TRANSITION; DYNAMICS	The vibrational dynamics of the retinal chromophore all-trans-to-13-cis photoisomerization in bacteriorhodopsin has been studied with mid-infrared absorption spectroscopy at high time resolution ( about 200 femtoseconds). After photoexcitation of light-adapted bacteriorhodopsin, the transient infrared absorption was probed in a broad spectral region, including vibrations with dominant C-C, C=C and C=NH stretching mode amplitude. All photoproduct modes, especially those around 1190 reciprocal-centimeters that are indicative for a 13-cis configuration of the chromophore, rise with a time constant of similar to0.5 picosecond. The results presented give direct vibrational-spectroscopic evidence for the isomerization taking place within 0.5 picosecond, as has been suggested by previous optical femtosecond time-resolved experiments but questioned recently by picosecond time-resolved vibrational spectroscopy experiments.	Free Univ Berlin, Inst Expt Phys, D-14195 Berlin, Germany	Free University of Berlin	Diller, R (corresponding author), Free Univ Berlin, Inst Expt Phys, Arnimallee 14, D-14195 Berlin, Germany.	diller@physik.fu-berlin.de	Diller, Rolf/P-8470-2018	Diller, Rolf/0000-0002-3629-8334				Aharoni A, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1210, DOI 10.1023/A:1013175000873; Atkinson GH, 2000, J PHYS CHEM A, V104, P4130, DOI 10.1021/jp9918306; BRACK TL, 1991, J PHYS CHEM-US, V95, P2351, DOI 10.1021/j100159a043; BRAIMAN M, 1982, P NATL ACAD SCI-BIOL, V79, P403, DOI 10.1073/pnas.79.2.403; Curry B., 1985, ADV INFRARED RAMAN S, V12, P115; Diller R, 1998, CHEM PHYS LETT, V295, P47, DOI 10.1016/S0009-2614(98)00932-4; DILLER R, 1995, CHEM PHYS LETT, V241, P109, DOI 10.1016/0009-2614(95)00598-X; DOBLER J, 1988, CHEM PHYS LETT, V144, P215, DOI 10.1016/0009-2614(88)87120-3; DOIG SJ, 1991, J PHYS CHEM-US, V95, P6372, DOI 10.1021/j100169a054; Dziewior R, 1996, BER BUNSEN PHYS CHEM, V100, P2103, DOI 10.1002/bbpc.19961001231; Gai F, 1998, SCIENCE, V279, P1886, DOI 10.1126/science.279.5358.1886; Garavelli M, 1999, J AM CHEM SOC, V121, P1023, DOI 10.1021/ja981719y; Hamm P, 1996, CHEM PHYS LETT, V263, P613, DOI 10.1016/S0009-2614(96)01269-9; Hamm P, 1997, CHEM PHYS LETT, V268, P180, DOI 10.1016/S0009-2614(97)00142-5; HAMM P, 1995, CHEM PHYS, V200, P415, DOI 10.1016/0301-0104(95)00262-6; HERBST J, UNPUB; Kobayashi T, 2001, NATURE, V414, P531, DOI 10.1038/35107042; LOHRMANN R, 1991, J PHYS CHEM-US, V95, P1993, DOI 10.1021/j100158a020; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; MATHIES RA, 1988, SCIENCE, V240, P777, DOI 10.1126/science.3363359; POLLAND HJ, 1986, BIOPHYS J, V49, P651, DOI 10.1016/S0006-3495(86)83692-X; RIMAI L, 1973, J AM CHEM SOC, V95, P4493, DOI 10.1021/ja00795a005; SCHNEIDER G, 1989, CHEM PHYS, V131, P17, DOI 10.1016/0301-0104(89)87078-8; SIEBERT F, 1999, BIOPHYS J, V76, P2687; SMITH SO, 1987, J PHYS CHEM-US, V91, P804, DOI 10.1021/j100288a011; SMITH SO, 1987, J AM CHEM SOC, V109, P3108, DOI 10.1021/ja00244a038; Song L, 1998, J AM CHEM SOC, V120, P8889, DOI 10.1021/ja980390d; TITTOR J, 1990, FEBS LETT, V263, P269, DOI 10.1016/0014-5793(90)81390-A; VANDENBERG R, 1990, BIOPHYS J, V58, P135, DOI 10.1016/S0006-3495(90)82359-6; Zinth W, 2001, SPRINGER SERIES CHEM, V66, P680; 1995, ISR J CHEM, V35	31	187	193	4	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 2	2002	297	5582					822	825		10.1126/science.1072144	http://dx.doi.org/10.1126/science.1072144			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579RZ	12161649				2022-12-24	WOS:000177192800046
J	Swerdlow, AJ; Higgins, CD; Adlard, P; Preece, MA				Swerdlow, AJ; Higgins, CD; Adlard, P; Preece, MA			Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959-85: a cohort study	LANCET			English	Article							EPITHELIAL-CELL PROLIFERATION; IGF-BINDING-PROTEINS; FACTOR-I; FACTOR (IGF)-I; COLORECTAL NEOPLASIA; ACROMEGALIC PATIENTS; PREMATURE MORTALITY; LEUKEMIA; ADULTS; WOMEN	Background Growth hormone raises serum concentrations of insulin-like growth factor IGFI, which is mitogenic and antiapoptotic. There is evidence that raised endogenous levels of growth hormone and IGFI might be associated with increased risk of certain solid cancers, but there have been no data on long-term risks of solid cancers after growth hormone treatment. Methods We did a cohort study to investigate cancer incidence and mortality in 1848 patients in the UK who were treated during childhood and early adulthood with human pituitary growth hormone during the period from 1959 to 1985. Patients were followed up for cancer incidence to December, 1995 and for mortality to December, 2000. Risk of cancer in the cohort was compared with that in the general population, controlling for age, sex, and calendar period. Findings Patients treated with human pituitary growth hormone had significantly raised risks of mortality from cancer overall (standardised mortality ratio 2.8, 95% CI 1.3-5.1; ten cases), colorectal cancer (10.8, 1.3-38.8; two cases), and Hodgkin's disease (11.4, 1.4-41.3; two cases). Incidence of colorectal cancer was also greatly raised (7.9, 1.0-28.7). After exclusion of patients whose original diagnosis rendered them at high risk of cancer, the significance and size of the risks of colorectal cancer incidence and mortality, and of Hodgkin's disease mortality were increased. Interpretation Although based on small numbers, the risk of colorectal cancer is of some concern and further investigation in other cohorts is needed. We have no evidence as to whether growth hormone in modern dosage regimens is associated with an increased risk of colorectal cancer.	Inst Canc Res, Epidemiol Sect, Sutton SM2 5NG, Surrey, England; London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London, England; Inst Child Hlth, Biochem Endocrinol & Metab Unit, London, England	University of London; Institute of Cancer Research - UK; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London	Swerdlow, AJ (corresponding author), Inst Canc Res, Epidemiol Sect, Sutton SM2 5NG, Surrey, England.			Swerdlow, Anthony/0000-0001-5550-4159				Allen DB, 1997, J PEDIATR-US, V131, pS32, DOI 10.1016/S0022-3476(97)70008-8; Beentjes JAM, 2000, CLIN ENDOCRINOL, V52, P457, DOI 10.1046/j.1365-2265.2000.00993.x; Blethen SL, 1996, J CLIN ENDOCR METAB, V81, P1704, DOI 10.1210/jc.81.5.1704; BRESLOW NE, 1987, IARC SCI PUBLICATION, V82; BUCHANAN CR, 1991, BRIT MED J, V302, P824, DOI 10.1136/bmj.302.6780.824; Cats A, 1996, CANCER RES, V56, P523; Chan JM, 1998, SCIENCE, V279, P563, DOI 10.1126/science.279.5350.563; Christiansen JS, 2001, J CLIN ENDOCR METAB, V86, P1868; FRADKIN JE, 1993, JAMA-J AM MED ASSOC, V270, P2829, DOI 10.1001/jama.270.23.2829; Ghigo E, 1999, AM J PHYSIOL-ENDOC M, V276, pE1009, DOI 10.1152/ajpendo.1999.276.6.E1009; Giovannucci E, 2000, CANCER EPIDEM BIOMAR, V9, P345; Hankinson SE, 1998, LANCET, V351, P1393, DOI 10.1016/S0140-6736(97)10384-1; Jenkins PJ, 1997, CLIN ENDOCRINOL, V47, P17, DOI 10.1046/j.1365-2265.1997.1911029.x; JUUL A, 1994, CLIN ENDOCRINOL, V41, P85, DOI 10.1111/j.1365-2265.1994.tb03788.x; JUUL A, 1994, EUR J ENDOCRINOL, V131, P41, DOI 10.1530/eje.0.1310041; Kaaks R, 2000, JNCI-J NATL CANCER I, V92, P1592, DOI 10.1093/jnci/92.19.1592; LAHM H, 1994, INT J CANCER, V58, P452, DOI 10.1002/ijc.2910580325; Ma J, 1999, J NATL CANCER I, V91, P620, DOI 10.1093/jnci/91.7.620; Ng ST, 1997, NAT MED, V3, P1141, DOI 10.1038/nm1097-1141; Nishi Y, 1999, J CLIN ENDOCR METAB, V84, P1961, DOI 10.1210/jc.84.6.1961; OgilvyStuart AL, 1995, HORM RES, V44, P73, DOI 10.1159/000184677; Orme SM, 1998, J CLIN ENDOCR METAB, V83, P2730, DOI 10.1210/jc.83.8.2730; PINES A, 1985, AM J GASTROENTEROL, V80, P266; Probst-Hensch NM, 2001, BRIT J CANCER, V85, P1695, DOI 10.1054/bjoc.2001.2172; RABEN MS, 1958, J CLIN ENDOCR METAB, V18, P901, DOI 10.1210/jcem-18-8-901; Renehan AG, 2000, GUT, V46, P440, DOI 10.1136/gut.46.3.440; Renehan AG, 2001, BRIT J SURG, V88, P107, DOI 10.1046/j.1365-2168.2001.01645.x; RON E, 1991, CANCER, V68, P1673, DOI 10.1002/1097-0142(19911015)68:8<1673::AID-CNCR2820680802>3.0.CO;2-0; ROSEN T, 1990, LANCET, V336, P285, DOI 10.1016/0140-6736(90)91812-O; Swerdlow AJ, 2001, CANC INCIDENCE MORTA; Tomlinson JW, 2001, LANCET, V357, P425, DOI 10.1016/S0140-6736(00)04006-X; TUFFLI GA, 1995, J CLIN ENDOCR METAB, V80, P1416, DOI 10.1210/jc.80.4.1416; WHO (World Health Organization), 1977, MAN INT STAT CLASS D	33	204	211	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 27	2002	360	9329					273	277		10.1016/S0140-6736(02)09519-3	http://dx.doi.org/10.1016/S0140-6736(02)09519-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	578DT	12147369				2022-12-24	WOS:000177102700007
J	Walker, N; Schwartlander, B; Bryce, J				Walker, N; Schwartlander, B; Bryce, J			Meeting international goals in child survival and HIV/AIDS	LANCET			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PERINATAL HIV-1 TRANSMISSION; INFANT TRANSMISSION; ORAL ZIDOVUDINE; COTE-DIVOIRE; PREVENTION; INFECTION; MORTALITY; IMPACT; AIDS	Background After a decade of focused efforts to reduce under-5 mortality results have been mixed, with the HIV/AIDS epidemic often used to explain reversing trends. We investigated this assumption by estimating HIV-attributable under-5 mortality in 39 countries in sub-Saharan Africa and comparing it to total mortality in children younger than 5 years between 1990 and 1999. Methods Annual HIV-attributable under-5 mortality was estimated in a four-step process with previously obtained data from antenatal clinics in 39 countries based on HIV seroprevalence among pregnant women. This process produced estimates of: the number of children born to HIV-infected women; the number of children infected via mother-to-child-transmission of HIV; the number of HIV-infected children who died before age 5 years; and the number of HIV-infected children who died before age 5 years adjusted for competing causes of mortality. Findings An estimated 330 000 children younger than age 5 years died in sub-Saharan Africa in 1999 with HIV infection. When corrected for competing causes of mortality, HIV infection caused 7.7% of under-5 deaths in 1999, a significant rise from 2% in 1990. Five countries (Botswana, Namibia, Swaziland, Zambia, and Zimbabwe) have rates of HIN-attributable under-5 mortality of above 30 per 1000. An additional 16 countries have HIV-specific under-5 mortality rates between 10 and 25 per 1000. The remaining 18 countries have rates under 10 per 1000. Interpretation HIV/AIDS is an increasingly important cause of under-5 mortality in Africa. However, in many African countries, slowing or reversal of trends in child mortality cannot be explained by HIV alone. To meet international goals for reductions in child mortality, efforts must continue to focus on HIV/AIDS, but must also strengthen health systems that can deliver available interventions for the other major killer diseases of children in the developing world.	Joint UN Programme HIV AIDS, CH-1211 Geneva, Switzerland; WHO, CH-1211 Geneva, Switzerland	World Health Organization	Walker, N (corresponding author), Joint UN Programme HIV AIDS, 20 Ave Appia, CH-1211 Geneva, Switzerland.	walkern@unaids.org						Ahmad OB, 2000, B WORLD HEALTH ORGAN, V78, P1175; Bobat R, 1999, SAMJ, V89, P46; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Cooper ER, 2000, J ACQ IMMUN DEF SYND, V24, P45; Dabis F, 1999, LANCET, V353, P786, DOI 10.1016/S0140-6736(98)11046-2; De Cock KM, 2000, JAMA-J AM MED ASSOC, V283, P1175, DOI 10.1001/jama.283.9.1175; Gray RH, 1998, LANCET, V351, P98, DOI 10.1016/S0140-6736(97)09381-1; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Hill K, 1999, TRENDS CHILD MORTALI; KAMELANTANO Y, 2000, 13 INT AIDS C JUL 9; Kind C, 1998, AIDS, V12, P205, DOI 10.1097/00002030-199802000-00011; MANASEKIHOLLAND S, 2000, GLOBAL BREASTFEEDING; Mandelbrot L, 1998, JAMA-J AM MED ASSOC, V280, P55, DOI 10.1001/jama.280.1.55; NICOLL A, 1994, AIDS, V8, P995, DOI 10.1097/00002030-199407000-00019; OBERLE MW, 1980, INT J EPIDEMIOL, V9, P341, DOI 10.1093/ije/9.4.341; Ota MOC, 2000, AIDS, V14, P435, DOI 10.1097/00002030-200003100-00018; SAZAWAL S, 1992, LANCET, V340, P528, DOI 10.1016/0140-6736(92)91720-S; Schellenberg JRMA, 2001, LANCET, V357, P1241, DOI 10.1016/S0140-6736(00)04404-4; Schwartlander B, 2001, SCIENCE, V292, P2434, DOI 10.1126/science.1062876; Schwartlander B, 1999, AIDS, V13, P2445, DOI 10.1097/00002030-199912030-00017; Shaffer N, 1999, LANCET, V353, P773, DOI 10.1016/S0140-6736(98)10411-7; Spira R, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.5.e56; Taha T E, 2000, Pediatrics, V106, pE77, DOI 10.1542/peds.106.6.e77; *UN, WE CHILDR END DEC RE; *UN JOINT PROGR HI, 1998, REP GLOB HIV AIDS EP; *UN JOINT PROGR HI, 2000, REP GLOB HIV AIDS EP; *UN SECR DEP EC SO, 1999, DEM IMP HIV AIDS REP; *UN SECR DEP EC SO, 1999, AG PATT FERT 1995 20; Urassa M, 2001, AIDS, V15, P2017, DOI 10.1097/00002030-200110190-00015; *US BUR CENS, 2000, INT DAT BAS UNP TABL; *US BUR CENS, 2000, HIV AIDS SURV DAT BA; VANBALEN H, 1981, LANCET, V1, P764; Walker N, 2001, AIDS, V15, P1545, DOI 10.1097/00002030-200108170-00012; Wiktor SZ, 1999, LANCET, V353, P781, DOI 10.1016/S0140-6736(98)10412-9	34	94	95	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 27	2002	360	9329					284	289		10.1016/S0140-6736(02)09550-8	http://dx.doi.org/10.1016/S0140-6736(02)09550-8			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	578DT	12147371				2022-12-24	WOS:000177102700009
J	Lauwereyns, J; Watanabe, K; Coe, B; Hikosaka, O				Lauwereyns, J; Watanabe, K; Coe, B; Hikosaka, O			A neural correlate of response bias in monkey caudate nucleus	NATURE			English	Article							SACCADIC EYE-MOVEMENTS; NEURONAL-ACTIVITY; FUNCTIONAL-PROPERTIES; BASAL GANGLIA; REWARD; EXPECTATION; CORTEX; SIGNALS; TARGET	Primates are equipped with neural circuits in the prefrontal cortex(1-6), the parietal cortex(7) and the basal ganglia(6,8-11) that predict the availability of reward during the performance of behavioural tasks. It is not known, however, how reward value is incorporated in the control of action. Here we identify neurons in the monkey caudate nucleus that create a spatially selective response bias depending on the expected gain. In behavioural tasks, the monkey had to make a visually guided eye movement in every trial, but was rewarded for a correct response in only half of the trials. Reward availability was predictable on the basis of the spatial position of the visual target. We found that caudate neurons change their discharge rate systematically, even before the appearance of the visual target, and usually fire more when the contralateral position is associated with reward. Strong anticipatory activity of neurons with a contralateral preference is associated with decreased latency for eye movements in the contralateral direction. We conclude that this neuronal mechanism creates an advance bias that favours a spatial response when it is associated with a high reward value.	NEI, Sensorimotor Res Lab, NIH, Bethesda, MD 20892 USA; Juntendo Univ, Dept Physiol, Bunkyo Ku, Tokyo 1130033, Japan	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Juntendo University	Hikosaka, O (corresponding author), NEI, Sensorimotor Res Lab, NIH, Bldg 49,Room 2A50, Bethesda, MD 20892 USA.			Watanabe, Katsumi/0000-0003-1282-9994; Coe, Brian/0000-0002-3985-0163; Lauwereyns, Jan/0000-0003-0551-2550	NATIONAL EYE INSTITUTE [Z01EY000415, ZIAEY000415] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Amador N, 2000, J NEUROPHYSIOL, V84, P2166, DOI 10.1152/jn.2000.84.4.2166; APICELLA P, 1992, J NEUROPHYSIOL, V68, P945, DOI 10.1152/jn.1992.68.3.945; Basso MA, 1997, NATURE, V389, P66, DOI 10.1038/37975; BINDRA D, 1968, PSYCHOL REV, V75, P1, DOI 10.1037/h0025306; DICKINSON A, 1994, ANIM LEARN BEHAV, V22, P1, DOI 10.3758/BF03199951; Dorris MC, 1998, J NEUROSCI, V18, P7015; FISHER RS, 1986, BRAIN RES, V398, P148, DOI 10.1016/0006-8993(86)91260-6; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; HIKOSAKA O, 1983, J NEUROPHYSIOL, V49, P1268; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P780, DOI 10.1152/jn.1989.61.4.780; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P814, DOI 10.1152/jn.1989.61.4.814; IKEDA T, 2001, SOC NEUR ABSTR, V27; Kawagoe R, 1998, NAT NEUROSCI, V1, P411, DOI 10.1038/1625; KAWAGUCHI Y, 1990, J NEUROSCI, V10, P3421; Kobayashi S, 2002, J NEUROPHYSIOL, V87, P1488, DOI 10.1152/jn.00472.2001; Lauwereyns J, 2002, NEURON, V33, P463, DOI 10.1016/S0896-6273(02)00571-8; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Rescorla RA, 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; ROLLS ET, 1983, BEHAV BRAIN RES, V7, P179, DOI 10.1016/0166-4328(83)90191-2; ROLLS ET, 1999, BRAIN EMOTION; Sato M, 2002, J NEUROSCI, V22, P2363, DOI 10.1523/JNEUROSCI.22-06-02363.2002; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SCHULTZ W, 1992, J NEUROSCI, V12, P4595, DOI 10.1523/jneurosci.12-12-04595.1992; Takikawa Y, 2002, J NEUROPHYSIOL, V87, P508, DOI 10.1152/jn.00288.2001; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Watanabe M, 2001, EXP BRAIN RES, V140, P511, DOI 10.1007/s002210100856; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0	28	315	321	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 25	2002	418	6896					413	417		10.1038/nature00892	http://dx.doi.org/10.1038/nature00892			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576MU	12140557				2022-12-24	WOS:000177009700037
J	Lorincz, AT; Castle, PE; Sherman, ME; Scott, DR; Glass, AG; Wacholder, S; Rush, BB; Gravitt, PE; Schussler, JE; Schiffman, M				Lorincz, AT; Castle, PE; Sherman, ME; Scott, DR; Glass, AG; Wacholder, S; Rush, BB; Gravitt, PE; Schussler, JE; Schiffman, M			Viral load of human papillomavirus and risk of CIN3 or cervical cancer	LANCET			English	Article							INTRAEPITHELIAL NEOPLASIA	Carcinogenic human papillomaviruses (HPV) are thought to be necessary for development of cervical cancer. We assessed whether higher viral loads of such viruses predicted future risk of CIN3 or cancer (CIN3+) in a cohort of 20 810 women followed up for 10 years with cytological screening. We measured the viral load for 13 types of carcinogenic HPV (relative light units normalised to 1 pg/mL HPV 16 positive controls [RLU/PC]) using Hybrid Capture 2 testing of cervicovaginal lavages obtained at enrolment. Results were stratified into four groups (RLU/PC 1 to <10, 10 to <100, 100 to <1000, &GE;1000). Although presence of HPV strongly Increased risk of CIN3+, high viral load did not further predict risk of CIN3+.	Digene Corp, Gaithersburg, MD 20878 USA; NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; Kaiser Permanente, Portland, OR USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; Informat Management Serv Inc, Silver Spring, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Kaiser Permanente; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Information Management Services, Inc.	Lorincz, AT (corresponding author), Digene Corp, 1201 Clopper Rd, Gaithersburg, MD 20878 USA.		Schiffman, Mark/B-9766-2015; Castle, Philip/AAP-6395-2020	Castle, Philip/0000-0003-1082-6554				OSTOR AG, 1993, INT J GYNECOL PATHOL, V12, P186; Schiffman M, 2000, JAMA-J AM MED ASSOC, V283, P87, DOI 10.1001/jama.283.1.87; SCHIFFMAN MH, 1993, JNCI-J NATL CANCER I, V85, P958, DOI 10.1093/jnci/85.12.958; Scott DR, 2002, CANCER CYTOPATHOL, V96, P14, DOI 10.1002/cncr.10317; Ylitalo N, 2000, LANCET, V355, P2194, DOI 10.1016/S0140-6736(00)02402-8	5	174	212	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 20	2002	360	9328					228	229		10.1016/S0140-6736(02)09463-1	http://dx.doi.org/10.1016/S0140-6736(02)09463-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	576DX	12133661				2022-12-24	WOS:000176988500016
J	Galindo, MI; Bishop, SA; Greig, S; Couso, JP				Galindo, MI; Bishop, SA; Greig, S; Couso, JP			Leg patterning driven by proximal-distal interactions and EGFR signaling	SCIENCE			English	Article							DROSOPHILA LEG; DPP EXPRESSION; WINGLESS; AXIS; SPECIFICATION; APPENDAGE; PATHWAY; GENES; LIMBS; MUTATIONS	wingless and decapentaplegic signaling establishes the proximal-distal axis of Drosophila legs by activating the expression of genes such as Distalless and dachshund in broad proximal-distal domains during early leg development. However, here we show that wingless and decapentaplegic are not required throughout all of proximal-distal development. The tarsus, which has been proposed to be an ancestral structure, is instead defined by the activity of Distalless, dachshund, and a distal gradient of epidermal growth factor receptor ( EGFR) Ras signaling. Our results uncover a mechanism for appendage patterning directed by genes expressed in proximal-distal domains and possibly conserved in other arthropods and vertebrates.	Univ Sussex, Sch Biol Sci, Brighton BN1 9QG, E Sussex, England	University of Sussex	Couso, JP (corresponding author), Univ Sussex, Sch Biol Sci, Brighton BN1 9QG, E Sussex, England.		Galindo, Máximo Ibo/A-5299-2010; Couso, Juan Pablo/ABH-5860-2020	Galindo, Máximo Ibo/0000-0001-8448-9760; 				Abu-Shaar M, 1998, DEVELOPMENT, V125, P3821; Abzhanov A, 2000, DEV BIOL, V227, P673, DOI 10.1006/dbio.2000.9904; ASHBURNER M, 1989, DROSOPHILA LAB HDB, P140; BEJSOVEC A, 1991, DEVELOPMENT, V113, P471; Bodenstein D, 1994, BIOL DROSOPHILA, P275; BRYANT SV, 1981, SCIENCE, V212, P993, DOI 10.1126/science.212.4498.993; CAMPBELL G, 1993, CELL, V74, P1113, DOI 10.1016/0092-8674(93)90732-6; Casares F, 2001, SCIENCE, V293, P1477, DOI 10.1126/science.1062542; CASTELLIGAIR J, 1995, DEVELOPMENT, V121, P2973; Chu J, 2002, DEVELOPMENT, V129, P695; Couso JP, 1998, INT J DEV BIOL, V42, P345; COUSO JP, 1993, SCIENCE, V259, P484, DOI 10.1126/science.8424170; COUSO JP, 1994, DEVELOPMENT, V120, P621; COUSO JP, UNPUB; Davis RJ, 1999, DEV GENES EVOL, V209, P526, DOI 10.1007/s004270050285; DIAZBENJUMEA FJ, 1994, NATURE, V372, P175, DOI 10.1038/372175a0; Gelbart WM, 1999, NUCLEIC ACIDS RES, V27, P85, DOI 10.1093/nar/27.1.85; GODT D, 1993, DEVELOPMENT, V119, P799; Gonzalez-Crespo S, 1998, NATURE, V394, P196, DOI 10.1038/28197; Goto S, 1999, DEVELOPMENT, V126, P3407; Jiang J, 1996, CELL, V86, P401, DOI 10.1016/S0092-8674(00)80113-0; Jockusch EL, 2000, DEVELOPMENT, V127, P1617; Kojima T, 2000, DEVELOPMENT, V127, P769; Lecuit T, 1997, NATURE, V388, P139, DOI 10.1038/40563; Mercader N, 1999, NATURE, V402, P425, DOI 10.1038/46580; Niwa N, 2000, DEVELOPMENT, V127, P4373; Pueyo JI, 2000, DEVELOPMENT, V127, P5391; Qu SM, 1998, DEVELOPMENT, V125, P2711; Robledo RF, 2002, GENE DEV, V16, P1089, DOI 10.1101/gad.988402; Schnepp B, 1996, GENE DEV, V10, P2302, DOI 10.1101/gad.10.18.2302; Schweitzer R, 1997, TRENDS GENET, V13, P191, DOI 10.1016/S0168-9525(97)01091-3; St Pierre SE, 2002, DEVELOPMENT, V129, P1273; VANDENHEUVEL M, 1993, EMBO J, V12, P5293, DOI 10.1002/j.1460-2075.1993.tb06225.x	33	132	134	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 12	2002	297	5579					256	259		10.1126/science.1072311	http://dx.doi.org/10.1126/science.1072311			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	571UT	12114628				2022-12-24	WOS:000176738100043
J	Whittle, H; Jaffar, S; Wansbrough, M; Mendy, M; Dumpis, U; Collinson, A; Hall, A				Whittle, H; Jaffar, S; Wansbrough, M; Mendy, M; Dumpis, U; Collinson, A; Hall, A			Observational study of vaccine efficacy 14 years after trial of hepatitis B vaccination in Gambian children	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LONG-TERM EFFICACY; 12-YEAR FOLLOW-UP; VIRUS-INFECTION	Objective To determine the duration of protection from hepatitis B vaccine given in-infancy and early childhood. Design Cross sectional serological study of hepatitis B virus infection in children of various ages 14 years after the start of a trial of vaccination regimens. Setting Two villages in the Gambia. Participants Children and adolescents given hepatitis B vaccine in infancy or early childhood: 232 were aged 1-5 years, 225 aged 5-9 years, 220 aged 10-14 years, and 175 aged 15-19 years. Main outcome measures Vaccine efficacy against infection and against chronic infection in the different age groups. Results Vaccine efficacy against chronic hepatitis B virus carriage was 94% (95% confidence interval 89% to 97%) which did not vary significantly between the age groups. Efficacy against infection was 80% (76% to 84%). This, was significantly lower in the oldest age group (65%, 56 to 73). Of the uninfected participants in this age group, 36% had no detectable hepatitis B virus surface antibody. Time since vaccination and a low peak antibody response were the most powerful risk factors for breakthrough infection (P < 0.001 in each case). Low peak antibody response was also a risk factor for chronic carriage (odds ratio 95, 19 to 466). Conclusions Children vaccinated in infancy are at increased risk of hepatitis B virus infection in the late teens. The risk of chronic carriage after sexual exposure needs further assessment to determine if booster vaccines are necessary.	MRC Labs, Banjul, Gambia; Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	MRC Laboratory Molecular Biology; University of London; London School of Hygiene & Tropical Medicine	Whittle, H (corresponding author), MRC Labs, POB 273, Banjul, Gambia.	hwhittle@mrc.gm	Mendy, Maimuna/ABD-5038-2021	Dumpis, Uga/0000-0001-6778-9411; Jaffar, Shabbar/0000-0002-9615-1588				[Anonymous], 1987, CANCER RES, V47, P5782; Banatvala J, 2000, LANCET, V355, P561, DOI 10.1016/S0140-6736(99)07239-6; Chen HL, 1996, JAMA-J AM MED ASSOC, V276, P906, DOI 10.1001/jama.276.11.906; COURSAGET P, 1994, J HEPATOL, V21, P250, DOI 10.1016/S0168-8278(05)80404-0; *GAMB HEP INV STUD, 1996, ANN REP 1996, P12; GROSSKURTH H, 1995, LANCET, V346, P530, DOI 10.1016/S0140-6736(95)91380-7; Jack AD, 1999, J INFECT DIS, V179, P489, DOI 10.1086/314578; KANE MA, 1993, DIS CONTROL PRIORITI, P321; Liao SS, 1999, VACCINE, V17, P2661, DOI 10.1016/S0264-410X(99)00031-6; MAYANS MV, 1990, LANCET, V336, P1107, DOI 10.1016/0140-6736(90)92580-B; Ratcliffe AA, 2000, B WORLD HEALTH ORGAN, V78, P570; WHITTLE H, 1990, J INFECT DIS, V161, P1112, DOI 10.1093/infdis/161.6.1112; WHITTLE HC, 1987, ANN TROP PAEDIATR, V7, P6, DOI 10.1080/02724936.1987.11748464; WHITTLE HC, 1991, LANCET, V337, P747, DOI 10.1016/0140-6736(91)91367-4; WHITTLE HC, 1995, LANCET, V345, P1089, DOI 10.1016/S0140-6736(95)90822-6; WHITTLE HC, 1983, LANCET, V1, P1203; *WHO SCI GROUP PRE, 1983, LANCET, V1, P463; Yuen MF, 1999, HEPATOLOGY, V29, P924, DOI 10.1002/hep.510290327	18	103	112	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 14	2002	325	7364					569	572		10.1136/bmj.325.7364.569	http://dx.doi.org/10.1136/bmj.325.7364.569			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	595JJ	12228132	Green Published, Bronze, Green Accepted			2022-12-24	WOS:000178105200016
J	Lee, DM; Friend, DS; Gurish, MF; Benoist, C; Mathis, D; Brenner, MB				Lee, DM; Friend, DS; Gurish, MF; Benoist, C; Mathis, D; Brenner, MB			Mast cells: A cellular link between autoantibodies and inflammatory arthritis	SCIENCE			English	Article							FC-GAMMA-RIII; C-KIT LIGAND; RHEUMATOID-ARTHRITIS; DIFFERENTIAL EXPRESSION; ARTHUS REACTION; TNF-ALPHA; T-CELL; RECEPTOR; MOUSE; DISEASE	Previous studies have revealed that autoantibodies, complement components, and Fc receptors each participate in the pathogenesis of erosive arthritis in K/BxN mice. However, it is not known which cellular populations are responsive to these inflammatory signals. We find that two strains of mice deficient in mast cells, W/W-v and Sl/Sl(d) were resistant to development of joint inflammation and that susceptibility was restored in the W/W-v strain by mast cell engraftment. Thus, mast cells may function as a cellular link between autoantibodies, soluble mediators, and other effector populations in inflammatory arthritis.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Immunol & Immunogenet, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Brenner, MB (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA.				NIAMS NIH HHS [1R01 AR/AI46580-01] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046580] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALBER G, 1992, J IMMUNOL, V149, P2428; Baumann U, 2000, J IMMUNOL, V164, P1065, DOI 10.4049/jimmunol.164.2.1065; Baumann U, 2001, J IMMUNOL, V167, P1022, DOI 10.4049/jimmunol.167.2.1022; Bendele A, 1999, ARTHRITIS RHEUM, V42, P498, DOI 10.1002/1529-0131(199904)42:3<498::AID-ANR15>3.0.CO;2-A; BRANNAN CI, 1991, P NATL ACAD SCI USA, V88, P4671, DOI 10.1073/pnas.88.11.4671; BRODER I, 1972, MED CLIN N AM, V56, P529, DOI 10.1016/S0025-7125(16)32412-9; BURD PR, 1989, J EXP MED, V170, P245, DOI 10.1084/jem.170.1.245; Dombrowicz D, 1997, J CLIN INVEST, V99, P915, DOI 10.1172/JCI119256; Echtenacher B, 1996, NATURE, V381, P75, DOI 10.1038/381075a0; FUREDER W, 1995, J IMMUNOL, V155, P3152; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; GORDON JR, 1990, NATURE, V346, P274, DOI 10.1038/346274a0; GURISH MF, 1992, J EXP MED, V175, P1003, DOI 10.1084/jem.175.4.1003; Huang CF, 1998, J IMMUNOL, V160, P1910; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Ji H, 2002, J EXP MED, V196, P77, DOI 10.1084/jem.20020439; JONES VE, 1982, CLIN EXP IMMUNOL, V49, P31; KATZ HR, 1992, J IMMUNOL, V148, P868; Kiener HP, 1998, ARTHRITIS RHEUM-US, V41, P233, DOI 10.1002/1529-0131(199802)41:2<233::AID-ART7>3.0.CO;2-V; KITAMURA Y, 1978, BLOOD, V52, P447; KITAMURA Y, 1979, J EXP MED, V150, P482, DOI 10.1084/jem.150.3.482; Korganow AS, 1999, IMMUNITY, V10, P451, DOI 10.1016/S1074-7613(00)80045-X; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; LEE DS, UNPUB; Malaviya R, 1996, NATURE, V381, P77, DOI 10.1038/381077a0; Matsumoto I, 1999, SCIENCE, V286, P1732, DOI 10.1126/science.286.5445.1732; Matsumoto I, 2002, NAT IMMUNOL, V3, P360, DOI 10.1038/ni772; NAKANO T, 1985, J EXP MED, V162, P1025, DOI 10.1084/jem.162.3.1025; NOCKA K, 1990, EMBO J, V9, P1805, DOI 10.1002/j.1460-2075.1990.tb08305.x; Schaller M, 2001, NAT IMMUNOL, V2, P746, DOI 10.1038/90696; SUZUKI K, 1995, BIOCHEM J, V305, P301, DOI 10.1042/bj3050301; Sylvestre DL, 1996, IMMUNITY, V5, P387, DOI 10.1016/S1074-7613(00)80264-2; Wipke BT, 2001, J IMMUNOL, V167, P1601, DOI 10.4049/jimmunol.167.3.1601; ZSEBO KM, 1990, CELL, V63, P213, DOI 10.1016/0092-8674(90)90302-U	34	613	660	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 6	2002	297	5587					1689	1692		10.1126/science.1073176	http://dx.doi.org/10.1126/science.1073176			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590JE	12215644				2022-12-24	WOS:000177819100046
J	Poulet, JFA; Hedwig, B				Poulet, JFA; Hedwig, B			A corollary discharge maintains auditory sensitivity during sound production	NATURE			English	Article							ECHOLOCATING BATS; NEURAL ATTENUATION; CRICKET; RESPONSES; NEURONS; INHIBITION; SYSTEM; INPUT	Speaking and singing present the auditory system of the caller with two fundamental problems: discriminating between self-generated and external auditory signals and preventing desensitization. In humans(1) and many other vertebrates(2-7), auditory neurons in the brain are inhibited during vocalization but little is known about the nature of the inhibition. Here we show, using intracellular recordings of auditory neurons in the singing cricket, that presynaptic inhibition of auditory afferents and postsynaptic inhibition of an identified auditory interneuron occur in phase with the song pattern. Presynaptic and postsynaptic inhibition persist in a fictively singing, isolated cricket central nervous system and are therefore the result of a corollary discharge from the singing motor network. Mimicking inhibition in the interneuron by injecting hyperpolarizing current suppresses its spiking response to a 100-dB sound pressure level (SPL) acoustic stimulus and maintains its response to subsequent, quieter stimuli. Inhibition by the corollary discharge reduces the neural response to self-generated sound and protects the cricket's auditory pathway from self-induced desensitization.	Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Cambridge	Poulet, JFA (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.			Poulet, James/0000-0003-0296-5415				BELL CC, 1981, SCIENCE, V214, P450, DOI 10.1126/science.7291985; BELL CC, 1984, COMP PHYSL SENSORY S, P636; BORG E, 1989, SCI AM, V261, P62; Clarac F, 1996, EXP BRAIN RES, V112, P163; CREUTZFELDT O, 1989, EXP BRAIN RES, V77, P476, DOI 10.1007/BF00249601; Givois V, 2000, J EXP BIOL, V203, P2529; GUTHRIE BL, 1983, SCIENCE, V221, P1193, DOI 10.1126/science.6612334; Hardt M, 1999, J COMP NEUROL, V403, P281, DOI 10.1002/(SICI)1096-9861(19990118)403:3<281::AID-CNE1>3.0.CO;2-0; Hedwig B, 2000, J NEUROPHYSIOL, V83, P712, DOI 10.1152/jn.2000.83.2.712; HENNIG RM, 1994, J EXP BIOL, V187, P45; JONES MDR, 1973, J COMP PHYSIOL, V87, P89, DOI 10.1007/BF00699298; Knepper M, 1997, COMPUT METH PROG BIO, V52, P75, DOI 10.1016/S0169-2607(96)01781-6; MCCASLAND JS, 1981, P NATL ACAD SCI-BIOL, V78, P7815, DOI 10.1073/pnas.78.12.7815; METZNER W, 1989, NATURE, V341, P529, DOI 10.1038/341529a0; MICHEL K, 1974, Z MORPHOL TIERE, V77, P285, DOI 10.1007/BF00298805; MULLERPREUSS P, 1981, BRAIN RES, V215, P61, DOI 10.1016/0006-8993(81)90491-1; NARINS PM, 1992, J ACOUST SOC AM, V91, P3551, DOI 10.1121/1.402844; NOCKE H, 1972, J COMP PHYSIOL, V80, P141, DOI 10.1007/BF00696487; POLLACK GS, 1988, J NEUROSCI, V8, P2635; Poulet JFA, 2001, J EXP BIOL, V204, P1281; Schildberger K., 1989, P423; SCHULLER G, 1979, J COMP PHYSIOL, V132, P39, DOI 10.1007/BF00617730; SILLAR KT, 1988, NATURE, V331, P262, DOI 10.1038/331262a0; SOBEL EC, 1994, SCIENCE, V263, P823, DOI 10.1126/science.263.5148.823; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; SUGA N, 1972, SCIENCE, V177, P82, DOI 10.1126/science.177.4043.82; SUGA N, 1975, J EXP BIOL, V62, P277; SUGA N, 1974, SCIENCE, V183, P1211, DOI 10.1126/science.183.4130.1211; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503; ZARETSKY M, 1979, NATURE, V280, P583, DOI 10.1038/280583a0	30	107	108	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 22	2002	418	6900					872	876		10.1038/nature00919	http://dx.doi.org/10.1038/nature00919			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585YR	12192409				2022-12-24	WOS:000177555600037
J	Lee, EY; Marcucci, M; Daniell, L; Pypaert, M; Weisz, OA; Ochoa, GC; Farsad, K; Wenk, MR; De Camilli, P				Lee, EY; Marcucci, M; Daniell, L; Pypaert, M; Weisz, OA; Ochoa, GC; Farsad, K; Wenk, MR; De Camilli, P			Amphiphysin 2 (Bin1) and T-tubule biogenesis in muscle	SCIENCE			English	Article							SYNAPTIC VESICLE ENDOCYTOSIS; MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; CAVEOLIN-3; CLATHRIN; DYNAMIN; TISSUE; DIFFERENTIATION; IDENTIFICATION; CHOLESTEROL	In striated muscle, the plasma membrane forms tubular invaginations (transverse tubules or T-tubules) that function in depolarization-contraction coupling. Caveolin-3 and amphiphysin were implicated in their biogenesis. Amphiphysin isoforms have a putative role in membrane deformation at endocytic sites. An isoform of amphiphysin 2 concentrated at T-tubules induced tubular plasma membrane invaginations when expressed in nonmuscle cells. This property required exon 10, a phosphoinositide-binding module. In developing myotubes, amphiphysin 2 and caveolin-3 segregated in tubular and vesicular portions of the T-tubule system, respectively. These findings support a role of the bilayer-deforming properties of amphiphysin at T-tubules and, more generally, a physiological role of amphiphysin in membrane deformation.	Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; Univ Pittsburgh, Renal Electrolyte Div, Pittsburgh, PA 15261 USA	Yale University; Howard Hughes Medical Institute; Yale University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	De Camilli, P (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, 295 Congress Ave, New Haven, CT 06510 USA.		Wenk, Markus Rene/D-1441-2014		NCI NIH HHS [CA46128] Funding Source: Medline; NINDS NIH HHS [NS36251] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA046128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS036251, R01NS036251] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bird I M, 1998, Methods Mol Biol, V105, P1; Butler MH, 1997, J CELL BIOL, V137, P1355, DOI 10.1083/jcb.137.6.1355; Carozzi AJ, 2000, TRAFFIC, V1, P326, DOI 10.1034/j.1600-0854.2000.010406.x; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Galbiati F, 2001, J BIOL CHEM, V276, P21425, DOI 10.1074/jbc.M100828200; Galbiati F, 2001, TRENDS MOL MED, V7, P435, DOI 10.1016/S1471-4914(01)02105-0; HILGEMANN DW, 2001, SCI STKE; ISHIKAWA H, 1968, J CELL BIOL, V38, P51, DOI 10.1083/jcb.38.1.51; Lee E, 2002, P NATL ACAD SCI USA, V99, P161, DOI 10.1073/pnas.012607799; Lee E, UNPUB; Martin TFJ, 1998, ANNU REV CELL DEV BI, V14, P231, DOI 10.1146/annurev.cellbio.14.1.231; McMahon HT, 1997, FEBS LETT, V413, P319, DOI 10.1016/S0014-5793(97)00928-9; McNally EM, 1998, HUM MOL GENET, V7, P871, DOI 10.1093/hmg/7.5.871; Neufeld EB, 1996, J BIOL CHEM, V271, P21604, DOI 10.1074/jbc.271.35.21604; Parton RG, 1997, J CELL BIOL, V136, P137, DOI 10.1083/jcb.136.1.137; Ramjaun AR, 1997, J BIOL CHEM, V272, P16700, DOI 10.1074/jbc.272.26.16700; Razzaq A, 2001, GENE DEV, V15, P2967, DOI 10.1101/gad.207801; Scherer PE, 1997, J BIOL CHEM, V272, P29337, DOI 10.1074/jbc.272.46.29337; SCHIAFFINO S, 1977, TISSUE CELL, V9, P437, DOI 10.1016/0040-8166(77)90004-0; SHARP AH, 1987, J BIOL CHEM, V262, P12309; Slepnev VI, 2000, J BIOL CHEM, V275, P17583, DOI 10.1074/jbc.M910430199; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Wechsler-Reya RJ, 1998, MOL CELL BIOL, V18, P566, DOI 10.1128/MCB.18.1.566; WechslerReya R, 1997, J BIOL CHEM, V272, P31453, DOI 10.1074/jbc.272.50.31453; Wenk MR, 2001, NEURON, V32, P79, DOI 10.1016/S0896-6273(01)00456-1	29	300	308	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 16	2002	297	5584					1193	1196		10.1126/science.1071362	http://dx.doi.org/10.1126/science.1071362			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584BP	12183633				2022-12-24	WOS:000177447600054
J	Fang, J; McCutchan, TF				Fang, J; McCutchan, TF			Malaria: Thermoregulation in a parasite's life cycle	NATURE			English	Article							SUBUNIT RIBOSOMAL-RNA; PLASMODIUM-FALCIPARUM; DISTINCT; GENES		NIAID, Growth & Dev Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Fang, J (corresponding author), NIAID, Growth & Dev Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000208, ZIAAI000208] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		GUNDERSON JH, 1987, SCIENCE, V238, P933, DOI 10.1126/science.3672135; LI J, 1994, MOL BIOCHEM PARASIT, V65, P283, DOI 10.1016/0166-6851(94)90079-5; MCCUTCHAN TF, 1988, MOL BIOCHEM PARASIT, V28, P63, DOI 10.1016/0166-6851(88)90181-8; Noden BH, 1995, PARASITOLOGY, V111, P539, DOI 10.1017/S0031182000077003; Rogers MJ, 1996, RNA, V2, P134; ROSALINA ML, 1999, MOL BIOCHEM PARASIT, V99, P193; Velichutina IV, 1998, RNA, V4, P594, DOI 10.1017/S1355838298980049; Waters AP, 1997, J BIOL CHEM, V272, P3583, DOI 10.1074/jbc.272.6.3583; WATERS AP, 1988, NATURE, V333, P74	9	36	38	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 15	2002	418	6899					742	742		10.1038/418742a	http://dx.doi.org/10.1038/418742a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UF	12181557	Bronze			2022-12-24	WOS:000177428000029
J	van Zuilen, MA; Lepland, A; Arrhenius, G				van Zuilen, MA; Lepland, A; Arrhenius, G			Reassessing the evidence for the earliest traces of life	NATURE			English	Article							ISUA SUPRACRUSTAL BELT; WEST-GREENLAND; GREENSTONE-BELT; ISOTOPIC COMPOSITION; SEDIMENTARY-ROCKS; IRON-FORMATION; CARBON; ORIGIN; METAMORPHISM; EARTH	The isotopic composition of graphite is commonly used as a biomarker in the oldest (> 3.5 Gyr ago) highly metamorphosed terrestrial rocks. Earlier studies on isotopic characteristics of graphite occurring in rocks of the approximately 3.8-Gyr-old Isua supracrustal belt (ISB) in southern West Greenland have suggested the presence of a vast microbial ecosystem in the early Archean(1-4). This interpretation, however, has to be approached with extreme care(5). Here we show that graphite occurs abundantly in secondary carbonate veins in the ISB that are formed at depth in the crust by injection of hot fluids reacting with older crustal rocks (metasomatism). During these reactions, graphite forms from the disproportionation of Fe(II)-bearing carbonates at high temperature. These metasomatic rocks, which clearly lack biological relevance, were earlier thought to be of sedimentary origin and their graphite association provided the basis for inferences about early life(1-4). The new observations thus call for a reassessment of previously presented evidence for ancient traces of life in the highly metamorphosed Early Archaean rock record.	Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; Geol Survey Norway, N-7491 Trondheim, Norway; Tallinn Univ Technol, Inst Geol, Tallinn, Estonia	University of California System; University of California San Diego; Scripps Institution of Oceanography; Geological Survey of Norway; Tallinn University of Technology	van Zuilen, MA (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	mvanzuil@ucsd.edu		Lepland, Aivo/0000-0002-0248-1405				ABED AM, 1990, GEOL SOC SPEC PUBL, V52, P193, DOI 10.1144/GSL.SP.1990.052.01.14; Appel PWU, 1998, TERRA NOVA, V10, P57; APPEL PWU, 1980, PRECAMBRIAN RES, V11, P73; BOAK JL, 1982, EARTH PLANET SC LETT, V59, P155, DOI 10.1016/0012-821X(82)90123-6; CHACKO T, 1991, GEOCHIM COSMOCHIM AC, V55, P2867, DOI 10.1016/0016-7037(91)90452-B; Dimroth E., 1982, SEDIMENT GEOL, P16; DYMEK RF, 1988, PRECAMBRIAN RES, V39, P247, DOI 10.1016/0301-9268(88)90022-8; Fedo CM, 2002, SCIENCE, V296, P1448, DOI 10.1126/science.1070336; Fedo CM, 2001, SEDIMENT GEOL, V141, P61, DOI 10.1016/S0037-0738(01)00068-9; FRENCH BM, 1971, AM J SCI, V271, P37, DOI 10.2475/ajs.271.1.37; Hayes J. M., 1983, EARTHS EARLIEST BIOS, P93; Hayes JM, 1996, NATURE, V384, P21, DOI 10.1038/384021a0; LEPLAND A, IN PRESS PRECAMBRIAN; Macpherson CG, 1999, GEOCHIM COSMOCHIM AC, V63, P1805, DOI 10.1016/S0016-7037(99)00124-6; Mojzsis SJ, 1996, NATURE, V384, P55, DOI 10.1038/384055a0; Myers JS, 2001, PRECAMBRIAN RES, V105, P129, DOI 10.1016/S0301-9268(00)00108-X; NAGY B, 1970, GEOCHIM COSMOCHIM AC, V34, P525, DOI 10.1016/0016-7037(70)90144-4; NUTMAN AP, 1984, PRECAMBRIAN RES, V25, P365, DOI 10.1016/0301-9268(84)90010-X; OEHLER DZ, 1977, PRECAMBRIAN RES, V5, P221, DOI 10.1016/0301-9268(77)90029-8; PERRY EC, 1977, EARTH PLANET SC LETT, V36, P280, DOI 10.1016/0012-821X(77)90210-2; Rose NM, 1996, AM J SCI, V296, P1004, DOI 10.2475/ajs.296.9.1004; Rosing MT, 1999, SCIENCE, V283, P674, DOI 10.1126/science.283.5402.674; Rosing MT, 1996, GEOLOGY, V24, P43, DOI 10.1130/0091-7613(1996)024<0043:EPOESS>2.3.CO;2; ROSING MT, 1993, CHEM GEOL, V108, P187, DOI 10.1016/0009-2541(93)90324-C; SCHIDLOWSKI M, 1979, GEOCHIM COSMOCHIM AC, V43, P189, DOI 10.1016/0016-7037(79)90238-2; Schidlowski M, 2001, PRECAMBRIAN RES, V106, P117, DOI 10.1016/S0301-9268(00)00128-5; SCHIDLOWSKI M, 1988, NATURE, V333, P313, DOI 10.1038/333313a0; Ueno Y, 2002, GEOCHIM COSMOCHIM AC, V66, P1257, DOI 10.1016/S0016-7037(01)00840-7; VANZUILEN MA, UNPUB PRECAMBR RES	29	226	235	1	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 8	2002	418	6898					627	630		10.1038/nature00934	http://dx.doi.org/10.1038/nature00934			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581RA	12167858				2022-12-24	WOS:000177305600039
J	Barker, S; Elderfield, H				Barker, S; Elderfield, H			Foraminiferal calcification response to glacial-interglacial changes in atmospheric CO2	SCIENCE			English	Article							CARBON-DIOXIDE; NORTH-ATLANTIC; TEMPERATURE; SEAWATER; PRECIPITATION; PALEOSALINITY; DELTA-O-18; CALCITE	A record of foraminiferal shell weight across glacial-interglacial Termination I shows a response related to seawater carbonate ion concentration and allows reconstruction of a record of carbon dioxide in surface seawater that matches the atmospheric record. The results support suggestions that higher atmospheric carbon dioxide directly affects marine calcification, an effect that may be of global importance to past and future changes in atmospheric CO2. The process provides negative feedback to the influence of marine calcification on atmospheric carbon dioxide and is of practical importance to the application of paleoceanographic proxies.	Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England	University of Cambridge	Barker, S (corresponding author), Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England.	sbar98@esc.cam.ac.uk	Stephen, Barker/C-2770-2009	Stephen, Barker/0000-0001-7870-6431				BERTRAM CJ, 1995, PALEOCEANOGRAPHY, V10, P563, DOI 10.1029/94PA03058; BIANCHI GG, 1999, THESIS U CAMBRIDGE; Bijma J., 1999, USE PROXIES PALEOCEA, DOI DOI 10.1007/978-3-642-58646-0_20; Broecker W, 2001, PALEOCEANOGRAPHY, V16, P531, DOI 10.1029/2000PA000600; Broecker W, 2001, GEOCHEM GEOPHY GEOSY, V2, part. no.; Broecker WS, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000231; BROECKER WS, 1979, SCIENCE, V206, P409, DOI 10.1126/science.206.4417.409; Broecker WS, 1982, TRACERS SEA; BROECKER WS, COMMUNICATION; de Villiers S, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000169; Elderfield H, 2000, NATURE, V405, P442, DOI 10.1038/35013033; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Langdon C, 2000, GLOBAL BIOGEOCHEM CY, V14, P639, DOI 10.1029/1999GB001195; Lea DW, 1999, GEOCHIM COSMOCHIM AC, V63, P2369, DOI 10.1016/S0016-7037(99)00197-0; Levitus S., 1994, WORLD OCEAN ATLAS 19, V4; Lewis E., 1998, ORNLCDIAC105; Marubini F, 2001, MAR ECOL PROG SER, V220, P153, DOI 10.3354/meps220153; Mashiotta TA, 1999, EARTH PLANET SC LETT, V170, P417, DOI 10.1016/S0012-821X(99)00116-8; MILLERO FJ, 1995, GEOCHIM COSMOCHIM AC, V59, P661, DOI 10.1016/0016-7037(94)00354-O; OPPO DW, 1993, SCIENCE, V259, P1148, DOI 10.1126/science.259.5098.1148; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; Rohling EJ, 1998, J GEOPHYS RES-OCEANS, V103, P1307, DOI 10.1029/97JC01047; Schmidt GA, 1999, PALEOCEANOGRAPHY, V14, P422, DOI 10.1029/1999PA900008; Shackleton NJ, 2000, SCIENCE, V289, P1897, DOI 10.1126/science.289.5486.1897; Spero HJ, 1997, NATURE, V390, P497, DOI 10.1038/37333; Weaver PPE, 1999, PALEOCEANOGRAPHY, V14, P336, DOI 10.1029/1999PA900009; Wolf-Gladrow DA, 1999, TELLUS B, V51, P461, DOI 10.1034/j.1600-0889.1999.00023.x; Zeebe R.E., 2001, ELSEV OCEANOGR SERIE; ZHONG SJ, 1989, CHEM GEOL, V78, P283, DOI 10.1016/0009-2541(89)90064-8; Zondervan I, 2001, GLOBAL BIOGEOCHEM CY, V15, P507, DOI 10.1029/2000GB001321; Zuddas P, 1998, GEOCHIM COSMOCHIM AC, V62, P757, DOI 10.1016/S0016-7037(98)00026-X	31	272	284	2	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 2	2002	297	5582					833	836		10.1126/science.1072815	http://dx.doi.org/10.1126/science.1072815			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579RZ	12161653				2022-12-24	WOS:000177192800050
J	Rolain, JM; Foucault, C; Guieu, R; La Scola, B; Brouqui, P; Raoult, D				Rolain, JM; Foucault, C; Guieu, R; La Scola, B; Brouqui, P; Raoult, D			Bartonella quintana in human erythrocytes	LANCET			English	Article								Bartonella quintana Is transmitted by body lice among homeless people. Infection with this organism leads to chronic bacteraemia with few symptoms. We looked for B quintana In erythrocytes In a population of homeless people In Marseille, France. In this report we show the Intraerythrocytic presence of B quintana In people with symptomless bacteraemia, by use of a specific monoclonal antibody and laser confocal microscopy. Presence of at least 5x10(4) colony-forming units per mL was predictive of Intracelluar Infection. However, such Infection was not associated with evidence of haemolysis. Colonisation of erythrocytes could allow efficient transmission of B quintana by body lice.	Hop CHU Nord, Serv Malad Infect & Trop, Marseille, France; Univ Mediterranee, Fac Med, Unite Rickettsies, CNRS,UPRESA 6020, F-13385 Marseille 05, France; Hop La Timone, Lab Biochim Pr Rochat, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Raoult, D (corresponding author), Hop CHU Nord, Serv Malad Infect & Trop, Marseille, France.		Brouqui, Philippe/P-5771-2016; Rolain, Jean-Marc/Y-3788-2019; RAOULT, Didier/A-8434-2008; LA SCOLA, Bernard/P-6477-2016	Rolain, Jean-Marc/0000-0002-2402-4467; RAOULT, Didier/0000-0002-0633-5974; LA SCOLA, Bernard/0000-0001-8006-7704				Jacomo V, 2002, CLIN DIAGN LAB IMMUN, V9, P8, DOI 10.1128/CDLI.9.1.8-18.2002; KORDICK DL, 1995, J CLIN MICROBIOL, V33, P1655, DOI 10.1128/JCM.33.6.1655-1656.1995; Liang ZX, 2001, CLIN DIAGN LAB IMMUN, V8, P847, DOI 10.1128/CDLI.8.4.847-849.2001; Raoult D, 2001, Lancet Infect Dis, V1, P77, DOI 10.1016/S1473-3099(01)00062-7; ROUX V, 1995, GENE, V156, P107, DOI 10.1016/0378-1119(94)00919-J	5	60	62	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 20	2002	360	9328					226	228		10.1016/S0140-6736(02)09462-X	http://dx.doi.org/10.1016/S0140-6736(02)09462-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	576DX	12133660				2022-12-24	WOS:000176988500015
J	Perez-Orive, J; Mazor, O; Turner, GC; Cassenaer, S; Wilson, RI; Laurent, G				Perez-Orive, J; Mazor, O; Turner, GC; Cassenaer, S; Wilson, RI; Laurent, G			Oscillations and sparsening of odor representations in the mushroom body	SCIENCE			English	Article							VISUAL-CORTEX; PATTERN-RECOGNITION; CORTICAL NEURON; ANTENNAL LOBE; SYNCHRONIZATION; RESPONSES; BRAIN; INFORMATION; INTEGRATOR; CELLS	In the insect olfactory system, oscillatory synchronization is functionally relevant and reflects the coherent activation of dynamic neural assemblies. We examined the role of such oscillatory synchronization in information transfer between networks in this system. The antennal lobe is the obligatory relay for olfactory afferent signals and generates oscillatory output. The mushroom body is responsible for formation and retrieval of olfactory and other memories. The format of odor representations differs significantly across these structures. Whereas representations are dense, dynamic, and seemingly redundant in the antennal lobe, they are sparse and carried by more selective neurons in the mushroom body. This transformation relies on a combination of oscillatory dynamics and intrinsic and circuit properties that act together to selectively filter and synthesize the output from the antennal lobe. These results provide direct support for the functional relevance of correlation codes and shed some light on the role of oscillatory synchronization in sensory networks.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Laurent, G (corresponding author), CALTECH, Div Biol, 139-74, Pasadena, CA 91125 USA.	laurentg@caltech.edu	Laurent, Gilles/A-4583-2012; Wilson, Rachel/E-2227-2012	Laurent, Gilles/0000-0002-2296-114X; Perez-Orive, Javier/0000-0002-4799-0326; Mazor, Ofer/0000-0002-6860-7242; Turner, Glenn/0000-0002-5341-2784; Wilson, Rachel/0000-0001-8573-9266	NCRR NIH HHS [P41-RR09754] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR009754] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; ABELES M, 1982, ISRAEL J MED SCI, V18, P83; ABELES M, 1993, J NEUROPHYSIOL, V70, P1629, DOI 10.1152/jn.1993.70.4.1629; Adrian ED, 1942, J PHYSIOL-LONDON, V100, P459, DOI 10.1113/jphysiol.1942.sp003955; BARLOW HB, 1969, ANN NY ACAD SCI, V156, P872, DOI 10.1111/j.1749-6632.1969.tb14019.x; BRAGIN A, 1995, J NEUROSCI, V15, P47; Cain WS, 1996, CHEM SENSES, V21, P35, DOI 10.1093/chemse/21.1.35; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Contreras D, 1997, J NEUROPHYSIOL, V78, P335, DOI 10.1152/jn.1997.78.1.335; Csibra G, 2000, SCIENCE, V290, P1582, DOI 10.1126/science.290.5496.1582; Diesmann M, 1999, NATURE, V402, P529, DOI 10.1038/990101; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; DuchampViret P, 1996, NEUROSCIENCE, V74, P885, DOI 10.1016/0306-4522(96)00194-7; ECKHORN R, 1988, BIOL CYBERN, V60, P121, DOI 10.1007/BF00202899; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Fricker D, 2000, NEURON, V28, P559, DOI 10.1016/S0896-6273(00)00133-1; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Galarreta M, 2001, SCIENCE, V292, P2295, DOI 10.1126/science.1061395; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; GELPERIN A, 1990, NATURE, V345, P437, DOI 10.1038/345437a0; Gray C M, 1994, J Comput Neurosci, V1, P11, DOI 10.1007/BF00962716; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Haberly L.B., 1990, Cerebral Cortex, V8B, P137; Hansson BS, 2000, ANNU REV ENTOMOL, V45, P203, DOI 10.1146/annurev.ento.45.1.203; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; HOPFIELD JJ, 1995, NATURE, V376, P33, DOI 10.1038/376033a0; Kenyon F., 1896, J COMP NEUROL, V6, P133, DOI DOI 10.1002/CNE.910060302; Konig P, 1996, TRENDS NEUROSCI, V19, P130, DOI 10.1016/S0166-2236(96)80019-1; Lam YW, 2000, J NEUROSCI, V20, P749, DOI 10.1523/JNEUROSCI.20-02-00749.2000; LAURENT G, 1994, J NEUROSCI, V14, P2993; LAURENT G, 1994, SCIENCE, V265, P1872, DOI 10.1126/science.265.5180.1872; Laurent G, 1996, J NEUROSCI, V16, P3837; Leitch B, 1996, J COMP NEUROL, V372, P487; Linster C, 1999, PHYSIOL BEHAV, V66, P701, DOI 10.1016/S0031-9384(99)00007-4; Livermore A, 1996, J EXP PSYCHOL HUMAN, V22, P267, DOI 10.1037/0096-1523.22.2.267; MacLeod K, 1996, SCIENCE, V274, P976, DOI 10.1126/science.274.5289.976; MacLeod K, 1998, NATURE, V395, P693, DOI 10.1038/27201; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; NEMITZ JW, 1983, J NEUROPHYSIOL, V49, P188, DOI 10.1152/jn.1983.49.1.188; Patel AD, 2000, NATURE, V404, P80, DOI 10.1038/35003577; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; POUZAT C, IN PRESS MODEL BASED; POWER DV, 1997, NEUROTRANSMITTER MET; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; ROLLS ET, 1995, J NEUROPHYSIOL, V73, P713, DOI 10.1152/jn.1995.73.2.713; RUEHLE A, 1997, SCIENCE, V281, P34; SCHAFER S, 1994, J NEUROSCI, V14, P4600; Shadlen MN, 1999, NEURON, V24, P67, DOI 10.1016/S0896-6273(00)80822-3; Steriade M, 1996, J NEUROSCI, V16, P392, DOI 10.1523/jneurosci.16-01-00392.1996; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; TANABE T, 1975, J NEUROPHYSIOL, V38, P1284, DOI 10.1152/jn.1975.38.5.1284; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; VONDERMALSBURG C, 1986, BIOL CYBERN, V54, P29, DOI 10.1007/BF00337113; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Wehr M, 1996, NATURE, V384, P162, DOI 10.1038/384162a0; Wicklein M, 2000, J COMP NEUROL, V424, P356; Willmore B, 2001, NETWORK-COMP NEURAL, V12, P255, DOI 10.1088/0954-898X/12/3/302; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672; Zou ZH, 2001, NATURE, V414, P173, DOI 10.1038/35102506	60	560	565	2	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 19	2002	297	5580					359	365		10.1126/science.1070502	http://dx.doi.org/10.1126/science.1070502			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574LV	12130775				2022-12-24	WOS:000176892600040
J	Rikkinen, J; Oksanen, I; Lohtander, K				Rikkinen, J; Oksanen, I; Lohtander, K			Lichen guilds share related cyanobacterial symbionts	SCIENCE			English	Article							SPECIFICITY		Univ Helsinki, Dept Appl Biol, FIN-00014 Helsinki, Finland; Univ Helsinki, Dept Appl Chem & Microbiol, FIN-00014 Helsinki, Finland; Univ Helsinki, Dept Systemat & Ecol, FIN-00014 Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki	Rikkinen, J (corresponding author), Univ Helsinki, Dept Appl Biol, POB 27, FIN-00014 Helsinki, Finland.		Rikkinen, Jouko/AAM-8732-2021					Lohtander K, 2000, MYCOLOGIA, V92, P728, DOI 10.2307/3761429; Paulsrud P, 1998, APPL ENVIRON MICROB, V64, P310; Paulsrud P, 2001, NEW PHYTOL, V152, P117, DOI 10.1046/j.0028-646x.2001.00234.x; Paulsrud P, 2001, THESIS UPPSALA U UPP; RIKKINEN J, IN PRESS CYANOBACTER; RIKKINEN J, 1995, BRYOBROTHERA, V4, P170; SWOFFORD DL, 2000, PHYLOGENET ANAL US P; WILMOTTE A, 1993, FEBS LETT, V317, P96, DOI 10.1016/0014-5793(93)81499-P	8	140	142	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 19	2002	297	5580					357	357		10.1126/science.1072961	http://dx.doi.org/10.1126/science.1072961			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574LV	12130774				2022-12-24	WOS:000176892600039
J	Lashuel, HA; Hartley, D; Petre, BM; Walz, T; Lansbury, PT				Lashuel, HA; Hartley, D; Petre, BM; Walz, T; Lansbury, PT			Neurodegenerative disease - Amyloid pores from pathogenic mutations	NATURE			English	Article							ALZHEIMERS-DISEASE; TOXICITY		Brigham & Womens Hosp, Ctr Neurol Dis, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dept Neurol, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard University; Harvard Medical School	Lansbury, PT (corresponding author), Brigham & Womens Hosp, Ctr Neurol Dis, 65 Landsdowne St, Cambridge, MA 02139 USA.		Lashuel, Hilal/M-3500-2017	Walz, Thomas/0000-0003-2606-2835				Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Goldberg MS, 2000, NAT CELL BIOL, V2, pE115, DOI 10.1038/35017124; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Hotze EM, 2002, J BIOL CHEM, V277, P11597, DOI 10.1074/jbc.M111039200; Janson J, 1999, DIABETES, V48, P491, DOI 10.2337/diabetes.48.3.491; Kagan BL, 2001, BRAIN RES BULL, V56, P281, DOI 10.1016/S0361-9230(01)00654-2; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lansbury PT, 1999, P NATL ACAD SCI USA, V96, P3342, DOI 10.1073/pnas.96.7.3342; Lin H, 2001, FASEB J, V15, P2433, DOI 10.1096/fj.01-0377com; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Sousa MM, 2001, AM J PATHOL, V159, P1993; Volles MJ, 2002, BIOCHEMISTRY-US, V41, P4595, DOI 10.1021/bi0121353; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a	13	1071	1108	3	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 18	2002	418	6895					291	291		10.1038/418291a	http://dx.doi.org/10.1038/418291a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574BF	12124613	Green Published, Bronze			2022-12-24	WOS:000176868000031
J	Calman, KC				Calman, KC			Communication of risk: choice, consent, and trust	LANCET			English	Editorial Material							MMR; INFORMATION		Univ Durham, Durham DH1 3HP, England	Durham University	Calman, KC (corresponding author), Univ Durham, Old Elvet, Durham DH1 3HP, England.	Kenneth.calman@durham.ac.uk						Bennett P., 1999, RISK COMMUNICATION P; Berry CL, 2000, J ROY COLL PHYS LOND, V34, P486; Calman K, 2001, PUBLIC ADMIN, V79, P185, DOI 10.1111/1467-9299.00252; Calman KC, 1996, BRIT MED J, V313, P799; Calman KC, 2001, TRANSFUSION, V41, P1326, DOI 10.1046/j.1537-2995.2001.41111326.x; Calman KC, 2001, BRIT J GEN PRACT, V51, P47; Edwards A, 2001, BRIT J GEN PRACT, V51, P259; Elliman DAC, 2001, ARCH DIS CHILD, V85, P271, DOI 10.1136/adc.85.4.271; GUTTELING JM, 1996, EXPLORING RISK COMMU; Heller D, 2001, BMJ-BRIT MED J, V323, P839; Heller T, 2001, BRIT MED J, V323, P838, DOI 10.1136/bmj.323.7317.838; Hupcey JE, 2001, J ADV NURS, V36, P282, DOI 10.1046/j.1365-2648.2001.01970.x; Jewell D, 2001, BRIT J GEN PRACT, V51, P875; Misselbrook D, 2001, BRIT J GEN PRACT, V51, P276; Richard MA, 1999, BRIT J DERMATOL, V140, P909, DOI 10.1046/j.1365-2133.1999.02824.x	15	60	60	1	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 13	2002	360	9327					166	168		10.1016/S0140-6736(02)09421-7	http://dx.doi.org/10.1016/S0140-6736(02)09421-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573PB	12126841				2022-12-24	WOS:000176839100029
J	Keleman, K; Rajagopalan, S; Cleppien, D; Teis, D; Paiha, K; Huber, LA; Technau, GM; Dickson, BJ				Keleman, K; Rajagopalan, S; Cleppien, D; Teis, D; Paiha, K; Huber, LA; Technau, GM; Dickson, BJ			Comm sorts Robo to control axon guidance at the Drosophila midline	CELL			English	Article							GROWTH CONE GUIDANCE; CNS MIDLINE; MEMBRANE-PROTEIN; NERVOUS-SYSTEM; RECEPTORS; PATHWAY; MELANOGASTER; NEUROBLASTS; ROUNDABOUT; SUBFAMILY	Axon growth across the Drosophila midline requires Comm to downregulate Robo, the receptor for the midline repellent Slit. We show here that comm is required in neurons, not in midline cells as previously thought, and that it is expressed specifically and transiently in commissural neurons. Comm acts as a sorting receptor for Robo, diverting it from the synthetic to the late endocytic pathway. A conserved cytoplasmic LPSY motif is required for endosomal sorting of Comm in vitro and for Comm to downregulate Robo and promote midline crossing in vivo. Axon traffic at the CNS midline is thus controlled by the intracellular trafficking of the Robo guidance receptor, which in turn depends on the precisely regulated expression of the Comm sorting receptor.	Res Inst Mol Pathol, A-1030 Vienna, Austria; Univ Mainz, Inst Genet, D-55128 Mainz, Germany	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Johannes Gutenberg University of Mainz	Dickson, BJ (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.		Dickson, Barry/AAE-7632-2019; Huber, Lukas Alfons/AAM-3499-2021	Dickson, Barry/0000-0003-0715-892X; Teis, David/0000-0002-8181-0253; Huber, Lukas Alfons/0000-0003-1116-2120				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Bonkowsky JL, 1999, MECH DEVELOP, V82, P181, DOI 10.1016/S0925-4773(99)00007-6; Bonkowsky JL, 1999, NATURE, V402, P540, DOI 10.1038/990122; Bossing T, 1996, DEV BIOL, V179, P41, DOI 10.1006/dbio.1996.0240; Dittrich R, 1997, DEVELOPMENT, V124, P2515; Georgiou M, 2002, DEVELOPMENT, V129, P2947; GRIFFITHS G, 1988, CELL, V52, P329, DOI 10.1016/S0092-8674(88)80026-6; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; Helliwell SB, 2001, J CELL BIOL, V153, P649, DOI 10.1083/jcb.153.4.649; Higashijima S, 1996, DEVELOPMENT, V122, P527; HOLT RA, 2002, IN PRESS SCIENCE; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kidd T, 1998, NEURON, V20, P25, DOI 10.1016/S0896-6273(00)80431-6; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; LINSTEDT AD, 1993, MOL BIOL CELL, V4, P679, DOI 10.1091/mbc.4.7.679; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Nagaso H, 2001, J HISTOCHEM CYTOCHEM, V49, P1177, DOI 10.1177/002215540104900911; O'Keefe DD, 1998, DEVELOPMENT, V125, P3915; Overly CC, 1996, J NEUROSCI, V16, P6056; Prokop Andreas, 1993, P33; Rajagopalan S, 2000, CELL, V103, P1033, DOI 10.1016/S0092-8674(00)00207-5; Rajagopalan S, 2000, NEURON, V28, P767, DOI 10.1016/S0896-6273(00)00152-5; Roberg KJ, 1997, J CELL BIOL, V137, P1469, DOI 10.1083/jcb.137.7.1469; Rubino M, 2000, J BIOL CHEM, V275, P3745, DOI 10.1074/jbc.275.6.3745; Schmid A, 1999, DEVELOPMENT, V126, P4653; Schmidt JG, 1997, J NEUROL REHABIL, V11, P189; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Simpson JH, 2000, NEURON, V28, P753, DOI 10.1016/S0896-6273(00)00151-3; Tear G, 1996, NEURON, V16, P501, DOI 10.1016/S0896-6273(00)80070-7; Thor S, 1999, NATURE, V397, P76, DOI 10.1038/16275; Wolf B, 1998, DEVELOPMENT, V125, P3853	32	236	242	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 23	2002	110	4					415	427		10.1016/S0092-8674(02)00901-7	http://dx.doi.org/10.1016/S0092-8674(02)00901-7			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	587QJ	12202032	Bronze			2022-12-24	WOS:000177653200004
J	Winnett, M				Winnett, M			Cries and whiskers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 21	2002	288	7					806	806		10.1001/jama.288.7.806	http://dx.doi.org/10.1001/jama.288.7.806			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585FC	12186579				2022-12-24	WOS:000177513100001
J	Chuck, AL; Turner, SM; Liss, PS				Chuck, AL; Turner, SM; Liss, PS			Direct evidence for a marine source of C-1 and C-2 alkyl nitrates	SCIENCE			English	Article							PACIFIC; TEMPERATURE; TROPOSPHERE; CHEMISTRY; NITROGEN; AIR	Alkyl nitrates are a significant component of the odd nitrogen reservoir and play an important role in regulating tropospheric ozone levels in remote marine regions. Measurements of methyl and ethyl nitrate in seawater and air samples along two Atlantic Ocean transects provide the first direct evidence for an oceanic source of these compounds. Equatorial surface waters were highly supersaturated (up to 800%) in both species, with the waters in the temperate regions generally being closer to equilibrium. A simple box model calculation suggests that the equatorial source could be a major component of the local atmospheric alkyl nitrate budget.	Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	Chuck, AL (corresponding author), Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England.		LISS, Peter S./A-8219-2013					Aiken J, 2000, PROG OCEANOGR, V45, P257, DOI 10.1016/S0079-6611(00)00005-7; ATKINSON R, 1987, J ATMOS CHEM, V5, P91; ATLAS E, 1993, J GEOPHYS RES-ATMOS, V98, P16933, DOI 10.1029/93JD01005; ATLAS E, 1988, NATURE, V331, P426, DOI 10.1038/331426a0; Blake NJ, 1999, J GEOPHYS RES-ATMOS, V104, P21803, DOI 10.1029/1999JD900238; Clemitshaw KC, 1997, J PHOTOCH PHOTOBIO A, V102, P117, DOI 10.1016/S1010-6030(96)04458-9; DAY DA, 2002, J GEOPHYS RES, P107; Jones AE, 1999, J GEOPHYS RES-ATMOS, V104, P21355, DOI 10.1029/1999JD900362; KAMES J, 1992, J ATMOS CHEM, V15, P79, DOI 10.1007/BF00053611; Liss P.S., 1986, ROLE AIR SEA EXCHANG, P113, DOI [10.1007/978-94-009-4738-2_5, DOI 10.1007/978-94-009-4738-2_5]; LUTJEHARMS JRE, 1987, S AFR J MARINE SCI, V5, P35, DOI 10.2989/025776187784522612; MCAULLIF C, 1971, CHEM TECHNOL, P46; McIntyre H.P., 2001, THESIS U E ANGLIA NO; Nightingale PD, 2000, GLOBAL BIOGEOCHEM CY, V14, P373, DOI 10.1029/1999GB900091; ROBERTS JM, 1990, ATMOS ENVIRON A-GEN, V24, P243, DOI 10.1016/0960-1686(90)90108-Y; Schneider M, 1999, CHEMOSPHERE, V38, P233, DOI 10.1016/S0045-6535(98)00173-8; Singh H, 2001, NATURE, V410, P1078, DOI 10.1038/35074067; Talbot RW, 2000, J GEOPHYS RES-ATMOS, V105, P6681, DOI 10.1029/1999JD901114; TURBERG MP, 1990, J PHOTOCH PHOTOBIO A, V51, P281, DOI 10.1016/1010-6030(90)87063-H; WANNINKHOF R, 1992, J GEOPHYS RES-OCEANS, V97, P7373, DOI 10.1029/92JC00188; Wayne, 1991, CHEM ATMOSPHERES INT; WILLIAMS J, 1994, THESIS U E ANGLIA NO	22	81	82	4	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 16	2002	297	5584					1151	1154		10.1126/science.1073896	http://dx.doi.org/10.1126/science.1073896			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584BP	12183621				2022-12-24	WOS:000177447600040
J	Breyton, C; Haase, W; Rapoport, TA; Kuhlbrandt, W; Collinson, I				Breyton, C; Haase, W; Rapoport, TA; Kuhlbrandt, W; Collinson, I			Three-dimensional structure of the bacterial protein-translocation complex SecYEG	NATURE			English	Article							ESCHERICHIA-COLI; PREPROTEIN TRANSLOCATION; MEMBRANE; SECA; CHANNEL; RECONSTITUTION; TOPOLOGY; SEC61P	Transport and membrane integration of polypeptides is carried out by specific protein complexes in the membranes of all living cells. The Sec transport path provides an essential and ubiquitous route for protein translocation(1). In the bacterial cytoplasmic membrane, the channel is formed by oligomers of a heterotrimeric membrane protein complex consisting of subunits SecY, SecE and SecG(2,3). In the endoplasmic reticulum membrane, the channel is formed from the related Sec61 complex(4). Here we report the structure of the Escherichia coli SecYEG assembly at an in-plane resolution of 8 Angstrom. The three-dimensional map, calculated from two-dimensional SecYEG crystals, reveals a sandwich of two membranes interacting through the extensive cytoplasmic domains. Each membrane is composed of dimers of SecYEG. The monomeric complex contains 15 transmembrane helices. In the centre of the dimer we observe a 16 x 25 Angstrom cavity closed on the periplasmic side by two highly tilted transmembrane helices. This may represent the closed state of the protein-conducting channel.	Max Planck Inst Biophys, Abt Strukturbiol, D-60528 Frankfurt, Germany; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; IBPC, CNRS, UMR 7099, F-75005 Paris, France	Max Planck Society; Harvard University; Harvard Medical School; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Breyton, C (corresponding author), Max Planck Inst Biophys, Abt Strukturbiol, Hoffmann Str 7, D-60528 Frankfurt, Germany.	Cecile.Breyton@ibpc.fr; Ian.Collinson@mpibp-frankfurt.mpg.de		Collinson, Ian/0000-0002-3931-0503; Kuhlbrandt, Werner/0000-0002-2013-4810				AKIMARU J, 1991, P NATL ACAD SCI USA, V88, P6545, DOI 10.1073/pnas.88.15.6545; AKIYAMA Y, 1987, EMBO J, V6, P3465, DOI 10.1002/j.1460-2075.1987.tb02670.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; Bessonneau P, 2002, EMBO J, V21, P995, DOI 10.1093/emboj/21.5.995; BRUNDAGE L, 1990, CELL, V62, P649, DOI 10.1016/0092-8674(90)90111-Q; Collinson I, 2001, EMBO J, V20, P2462, DOI 10.1093/emboj/20.10.2462; Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003; Duong F, 1997, EMBO J, V16, P2756, DOI 10.1093/emboj/16.10.2756; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; Eichler J, 1997, EMBO J, V16, P2188, DOI 10.1093/emboj/16.9.2188; FLOWER AM, 1995, EMBO J, V14, P884, DOI 10.1002/j.1460-2075.1995.tb07070.x; Fujimoto K, 1997, HISTOCHEM CELL BIOL, V107, P87, DOI 10.1007/s004180050092; GORLICH D, 1992, CELL, V71, P489, DOI 10.1016/0092-8674(92)90517-G; Grigorieff N, 1996, J MOL BIOL, V259, P393, DOI 10.1006/jmbi.1996.0328; Hanein D, 1996, CELL, V87, P721, DOI 10.1016/S0092-8674(00)81391-4; HENDERSON R, 1986, ULTRAMICROSCOPY, V19, P147, DOI 10.1016/0304-3991(86)90203-2; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kaufmann A, 1999, BIOCHEMISTRY-US, V38, P9115, DOI 10.1021/bi990539d; KLEYMANN G, 1995, J HISTOCHEM CYTOCHEM, V43, P607, DOI 10.1177/43.6.7769231; Manting EH, 2000, EMBO J, V19, P852, DOI 10.1093/emboj/19.5.852; Matlack KES, 1998, CELL, V92, P381, DOI 10.1016/S0092-8674(00)80930-7; Menetret JF, 2000, MOL CELL, V6, P1219, DOI 10.1016/S1097-2765(00)00118-0; NISHIYAMA K, 1994, EMBO J, V13, P3272, DOI 10.1002/j.1460-2075.1994.tb06628.x; Nishiyama KI, 1996, CELL, V85, P71, DOI 10.1016/S0092-8674(00)81083-1; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; Shilton B, 1998, FEBS LETT, V436, P277, DOI 10.1016/S0014-5793(98)01141-7; Unger VM, 2000, ACTA CRYSTALLOGR D, V56, P1259, DOI 10.1107/S0907444900011252; van der Wolk JPW, 1997, EMBO J, V16, P7297, DOI 10.1093/emboj/16.24.7297; Veenendaal AKJ, 2001, J BIOL CHEM, V276, P32559, DOI 10.1074/jbc.M103912200	30	207	210	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 8	2002	418	6898					662	665		10.1038/nature00827	http://dx.doi.org/10.1038/nature00827			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581RA	12167867				2022-12-24	WOS:000177305600048
J	Travis, DJ; Carleton, AM; Lauritsen, RG				Travis, DJ; Carleton, AM; Lauritsen, RG			Climatology: Contrails reduce daily temperature range - A brief interval when the skies were clear of jets unmasked an effect on climate.	NATURE			English	Article							TRENDS; CLOUD		Univ Wisconsin, Dept Geog & Geol, Whitewater, WI 53190 USA; Penn State Univ, Dept Geog, University Pk, PA 16801 USA	University of Wisconsin System; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Travis, DJ (corresponding author), Univ Wisconsin, Dept Geog & Geol, Whitewater, WI 53190 USA.							CHANGNON SA, 1981, J APPL METEOROL, V20, P496, DOI 10.1175/1520-0450(1981)020<0496:MCSATT>2.0.CO;2; DeGrand JQ, 2000, J APPL METEOROL, V39, P1434, DOI 10.1175/1520-0450(2000)039<1434:ASBCDO>2.0.CO;2; Duda DP, 2001, J GEOPHYS RES-ATMOS, V106, P4927, DOI 10.1029/2000JD900393; KARL TR, 1993, B AM METEOROL SOC, V74, P1007, DOI 10.1175/1520-0477(1993)074<1007:ANPORG>2.0.CO;2; Liebmann B, 1996, B AM METEOROL SOC, V77, P1275; Meerkotter R, 1999, ANN GEOPHYS-ATM HYDR, V17, P1080, DOI 10.1007/s00585-999-1080-7; Sassen K, 1997, B AM METEOROL SOC, V78, P1885, DOI 10.1175/1520-0477(1997)078<1885:CCATPF>2.0.CO;2; Travis D. J., 1997, J WEATHER MODIFICAT, V29, P74	8	97	101	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 8	2002	418	6898					601	601		10.1038/418601a	http://dx.doi.org/10.1038/418601a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581RA	12167846				2022-12-24	WOS:000177305600027
J	Heisler, LK; Cowley, MA; Tecott, LH; Fan, W; Low, MJ; Smart, JL; Rubinstein, M; Tatro, JB; Marcus, JN; Holstege, H; Lee, CE; Cone, RD; Elmquist, JK				Heisler, LK; Cowley, MA; Tecott, LH; Fan, W; Low, MJ; Smart, JL; Rubinstein, M; Tatro, JB; Marcus, JN; Holstege, H; Lee, CE; Cone, RD; Elmquist, JK			Activation of central melanocortin pathways by fenfluramine	SCIENCE			English	Article							RECEPTOR SUBTYPE; ARCUATE NUCLEUS; POMC NEURONS; BODY-WEIGHT; RAT-BRAIN; OBESITY; LEPTIN; SEROTONIN; MOUSE; MICE	D-fenfluramine (d-FEN) was once widely prescribed and was among the most effective weight loss drugs, but was withdrawn from clinical use because of reports of cardiac complications in a subset of patients. Discerning the neurobiology underlying the anorexic action of d-FEN may facilitate the development of new drugs to prevent and treat obesity. Through a combination of functional neuroanatomy, feeding, and electrophysiology studies in rodents, we show that d-FEN induced anorexia requires activation of central nervous system melanocortin pathways. These results provide a mechanistic explanation of d-FEN's anorexic actions and indicate that drugs targeting these downstream melanocortin pathways may prove to be effective and more selective anti-obesity treatments.	Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02215 USA; Oregon Hlth & Sci Univ, Oregon natl Primate Res Ctr, Div Neurosci, Beaverton, OR 97006 USA; Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; Univ San Francisco, Dept Psychiat, San Francisco, CA 94117 USA; Univ San Francisco, Ctr Neurobiol & Psychiat, San Francisco, CA 94117 USA; Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Biol Sci, RA-1053 Buenos Aires, DF, Argentina; Univ Buenos Aires, Inst Invest Ingn Genet & Biol Mol, CONICET, RA-1053 Buenos Aires, DF, Argentina; Tufts Univ, Sch Med, Dept Neurosci & Pharmacol & Expt Therapeut, Boston, MA 02111 USA; Tufts Univ, Sch Med, Tufts New England Med Ctr, Div Endocrinol Diabet Metab & Mol Med, Boston, MA 02111 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; University of San Francisco; University of San Francisco; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Tufts University; Tufts Medical Center; Tufts University	Elmquist, JK (corresponding author), Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA.		Cowley, Michael A/B-9428-2008	Cowley, Michael A/0000-0001-7811-134X; Heisler, Lora/0000-0002-7731-1419; Holstege, Henne/0000-0002-7688-3087; Low, Malcolm/0000-0002-9900-3708	FOGARTY INTERNATIONAL CENTER [R03TW001233] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F31HG000201] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK055819, P01DK056116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061624, R01MH044694, R01MH061583] Funding Source: NIH RePORTER; FIC NIH HHS [R03TW01233] Funding Source: Medline; NHGRI NIH HHS [F31HG00201] Funding Source: Medline; NIDDK NIH HHS [P01DK55819, P01DK056116] Funding Source: Medline; NIMH NIH HHS [R01MH061583, R01MH44694, R01MH61624] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Barsh GS, 2000, NATURE, V404, P644, DOI 10.1038/35007519; BULTMAN SJ, 1992, CELL, V71, P1195, DOI 10.1016/S0092-8674(05)80067-4; Butler AA, 2000, ENDOCRINOLOGY, V141, P3518, DOI 10.1210/en.141.9.3518; Chen AS, 2000, NAT GENET, V26, P97, DOI 10.1038/79254; Connolly HM, 1997, NEW ENGL J MED, V337, P581, DOI 10.1056/NEJM199708283370901; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Elias CF, 1998, NEURON, V21, P1375, DOI 10.1016/S0896-6273(00)80656-X; Elias CF, 1999, NEURON, V23, P775, DOI 10.1016/S0896-6273(01)80035-0; Elias CF, 2000, J COMP NEUROL, V423, P261; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Fan T, 2000, ENDOCRINOLOGY, V141, P3072; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; GUYGRAND B, 1989, LANCET, V2, P1142; GuyGrand B, 1995, OBES RES, V3, pS491, DOI 10.1002/j.1550-8528.1995.tb00217.x; Heal DJ, 1998, BRIT J PHARMACOL, V125, P301, DOI 10.1038/sj.bjp.0702067; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; KISS J, 1984, NEUROSCI LETT, V44, P119, DOI 10.1016/0304-3940(84)90068-5; LI BH, 1993, BRAIN RES BULL, V31, P43, DOI 10.1016/0361-9230(93)90009-Z; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; MOLINEAUX SM, 1989, P NATL ACAD SCI USA, V86, P6793, DOI 10.1073/pnas.86.17.6793; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Scammell TE, 1996, J NEUROSCI, V16, P6246; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; Vickers SP, 1999, PSYCHOPHARMACOLOGY, V143, P309, DOI 10.1007/s002130050952; WRIGHT DE, 1995, J COMP NEUROL, V351, P357, DOI 10.1002/cne.903510304; Yeo GSH, 1998, NAT GENET, V20, P111, DOI 10.1038/2404	27	381	399	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 26	2002	297	5581					609	611		10.1126/science.1072327	http://dx.doi.org/10.1126/science.1072327			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577GY	12142539				2022-12-24	WOS:000177054200053
J	Preitner, N; Damiola, F; Molina, LL; Zakany, J; Duboule, D; Albrecht, U; Schibler, U				Preitner, N; Damiola, F; Molina, LL; Zakany, J; Duboule, D; Albrecht, U; Schibler, U			The orphan nuclear receptor REV-ERB alpha controls circadian transcription within the positive limb of the mammalian circadian oscillator	CELL			English	Article							SUPRACHIASMATIC NUCLEUS; RHYTHMIC EXPRESSION; FEEDBACK LOOPS; MESSENGER-RNA; ROR-BETA; CLOCK; GENE; IDENTIFICATION; SUPERFAMILY; REPRESSION	Mammalian circadian rhythms are generated by a feedback loop in which BMAL1 and CLOCK, players of the positive limb, activate transcription of the cryptochrome and period genes, components of the negative limb. Bmal1 and Per transcription cycles display nearly opposite phases and are thus governed by different mechanisms. Here, we identify the orphan nuclear receptor REV-ERBalpha as the major regulator of cyclic Bmal1 transcription. Circadian Rev-erbalpha expression is controlled by components of the general feedback loop. Thus, REV-ERBalpha constitutes a molecular link through which components of the negative limb drive antiphasic expression of components of the positive limb. While REV-ERBalpha influences the period length and affects the phase-shifting properties of the clock, it is not required for circadian rhythm generation.	Univ Geneva, Dept Mol Biol Sci 2, CH-1211 Geneva 4, Switzerland; Univ Geneva, Dept Anim Biol Sci 3, CH-1211 Geneva 4, Switzerland; Univ Fribourg, Dept Med, Div Biochem, CH-1700 Fribourg, Switzerland	University of Geneva; University of Geneva; University of Fribourg	Schibler, U (corresponding author), Univ Geneva, Dept Mol Biol Sci 2, 30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.	ueli.schibler@molbio.unige.ch	Albrecht, Urs/A-9831-2011	Albrecht, Urs/0000-0002-0663-8676; Damiola, Francesca/0000-0002-0238-1252; Lopez-Molina, Luis/0000-0003-0463-1187; duboule, denis/0000-0001-9961-2960				Adelmant G, 1996, P NATL ACAD SCI USA, V93, P3553, DOI 10.1073/pnas.93.8.3553; Albrecht U, 2002, J APPL PHYSIOL, V92, P1348, DOI 10.1152/japplphysiol.00759.2001; Allada R, 2001, ANNU REV NEUROSCI, V24, P1091, DOI 10.1146/annurev.neuro.24.1.1091; Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Cermakian N, 2000, P NATL ACAD SCI USA, V97, P4339, DOI 10.1073/pnas.97.8.4339; Chomez P, 2000, DEVELOPMENT, V127, P1489; Delaunay F, 2000, SCIENCE, V289, P297, DOI 10.1126/science.289.5477.297; DUMAS B, 1994, MOL ENDOCRINOL, V8, P996, DOI 10.1210/me.8.8.996; Fonjallaz P, 1996, EMBO J, V15, P351, DOI 10.1002/j.1460-2075.1996.tb00365.x; FORMAN BM, 1994, MOL ENDOCRINOL, V8, P1253, DOI 10.1210/me.8.9.1253; GIGUERE V, 1994, GENE DEV, V8, P538, DOI 10.1101/gad.8.5.538; Glossop NRJ, 1999, SCIENCE, V286, P766, DOI 10.1126/science.286.5440.766; HARDING HP, 1993, MOL CELL BIOL, V13, P3113, DOI 10.1128/MCB.13.5.3113; HARDING HP, 1995, MOL CELL BIOL, V15, P4791; Harmer SL, 2001, ANNU REV CELL DEV BI, V17, P215, DOI 10.1146/annurev.cellbio.17.1.215; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Joyner AL, 1993, GENE TARGETING PRACT; LAVERY DJ, 1993, GENE DEV, V7, P1871, DOI 10.1101/gad.7.10.1871; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; LopezMolina L, 1997, EMBO J, V16, P6762, DOI 10.1093/emboj/16.22.6762; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Medvedev A, 1996, GENE, V181, P199, DOI 10.1016/S0378-1119(96)00504-5; MIYAJIMA N, 1989, CELL, V57, P31, DOI 10.1016/0092-8674(89)90169-4; Nef S, 1996, MECH DEVELOP, V55, P65, DOI 10.1016/0925-4773(95)00491-2; Park HT, 1996, NEUROSCI LETT, V217, P17, DOI 10.1016/S0304-3940(96)13060-3; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; RETNAKARAN R, 1994, MOL ENDOCRINOL, V8, P1234, DOI 10.1210/me.8.9.1234; Ripperger JA, 2000, GENE DEV, V14, P679; RUSAK B, 1979, PHYSIOL REV, V59, P449, DOI 10.1152/physrev.1979.59.3.449; Schaeren-Wiemers N, 1997, EUR J NEUROSCI, V9, P2687, DOI 10.1111/j.1460-9568.1997.tb01698.x; Schibler U, 1999, DEV GENETICS EPIGENE, P487; Shearman LP, 2000, MOL CELL BIOL, V20, P6269, DOI 10.1128/MCB.20.17.6269-6275.2000; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Sumi Y, 2002, NEUROSCI LETT, V320, P13, DOI 10.1016/S0304-3940(02)00011-3; Whitmore D, 1998, NAT NEUROSCI, V1, P701, DOI 10.1038/3703; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yu WJ, 2002, BIOCHEM BIOPH RES CO, V290, P933, DOI 10.1006/bbrc.2001.6300; Zamir I, 1997, GENE DEV, V11, P835, DOI 10.1101/gad.11.7.835; Zamir I, 1996, MOL CELL BIOL, V16, P5458; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118	45	1557	1629	5	128	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 26	2002	110	2					251	260		10.1016/S0092-8674(02)00825-5	http://dx.doi.org/10.1016/S0092-8674(02)00825-5			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	578EV	12150932	Bronze			2022-12-24	WOS:000177105200012
J	Giaever, G; Chu, AM; Ni, L; Connelly, C; Riles, L; Veronneau, S; Dow, S; Lucau-Danila, A; Anderson, K; Andre, B; Arkin, AP; Astromoff, A; El Bakkoury, M; Bangham, R; Benito, R; Brachat, S; Campanaro, S; Curtiss, M; Davis, K; Deutschbauer, A; Entian, KD; Flaherty, P; Foury, F; Garfinkel, DJ; Gerstein, M; Gotte, D; Guldener, U; Hegemann, JH; Hempel, S; Herman, Z; Jaramillo, DF; Kelly, DE; Kelly, SL; Kotter, P; LaBonte, D; Lamb, DC; Lan, N; Liang, H; Liao, H; Liu, L; Luo, CY; Lussier, M; Mao, R; Menard, P; Ooi, SL; Revuelta, JL; Roberts, CJ; Rose, M; Ross-Macdonald, P; Scherens, B; Schimmack, G; Shafer, B; Shoemaker, DD; Sookhai-Mahadeo, S; Storms, RK; Strathern, JN; Valle, G; Voet, M; Volckaert, G; Wang, CY; Ward, TR; Wilhelmy, J; Winzeler, EA; Yang, YH; Yen, G; Youngman, E; Yu, KX; Bussey, H; Boeke, JD; Snyder, M; Philippsen, P; Davis, RW; Johnston, M				Giaever, G; Chu, AM; Ni, L; Connelly, C; Riles, L; Veronneau, S; Dow, S; Lucau-Danila, A; Anderson, K; Andre, B; Arkin, AP; Astromoff, A; El Bakkoury, M; Bangham, R; Benito, R; Brachat, S; Campanaro, S; Curtiss, M; Davis, K; Deutschbauer, A; Entian, KD; Flaherty, P; Foury, F; Garfinkel, DJ; Gerstein, M; Gotte, D; Guldener, U; Hegemann, JH; Hempel, S; Herman, Z; Jaramillo, DF; Kelly, DE; Kelly, SL; Kotter, P; LaBonte, D; Lamb, DC; Lan, N; Liang, H; Liao, H; Liu, L; Luo, CY; Lussier, M; Mao, R; Menard, P; Ooi, SL; Revuelta, JL; Roberts, CJ; Rose, M; Ross-Macdonald, P; Scherens, B; Schimmack, G; Shafer, B; Shoemaker, DD; Sookhai-Mahadeo, S; Storms, RK; Strathern, JN; Valle, G; Voet, M; Volckaert, G; Wang, CY; Ward, TR; Wilhelmy, J; Winzeler, EA; Yang, YH; Yen, G; Youngman, E; Yu, KX; Bussey, H; Boeke, JD; Snyder, M; Philippsen, P; Davis, RW; Johnston, M			Functional profiling of the Saccharomyces cerevisiae genome	NATURE			English	Article							YEAST GENOME; EXPRESSION; DELETION; GENES	Determining the effect of gene deletion is a fundamental approach to understanding gene function. Conventional genetic screens exhibit biases, and genes contributing to a phenotype are often missed. We systematically constructed a nearly complete collection of gene-deletion mutants (96% of annotated open reading frames, or ORFs) of the yeast Saccharomyces cerevisiae. DNA sequences dubbed 'molecular bar codes' uniquely identify each strain, enabling their growth to be analysed in parallel and the fitness contribution of each gene to be quantitatively assessed by hybridization to high-density oligonucleotide arrays. We show that previously known and new genes are necessary for optimal growth under six well-studied conditions: high salt, sorbitol, galactose, pH 8, minimal medium and nystatin treatment. Less than 7% of genes that exhibit a significant increase in messenger RNA expression are also required for optimal growth in four of the tested conditions. Our results validate the yeast gene-deletion collection as a valuable resource for functional genomics.	Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA; Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; Rosetta Inpharmat Inc, Kirkland, WA 98034 USA; Catholic Univ Louvain, FYSA, B-1348 Louvain, Belgium; Free Univ Brussels, Lab Physiol Cellulaire, Gosselies, Belgium; Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Free Univ Brussels, IRMW, B-1070 Brussels, Belgium; Univ Salamanca, CSIC, Inst Microbiol & Bioquim, Dept Genet & Microbiol, E-37007 Salamanca, Spain; Univ Basel, Biozentrum, Dept Mol Microbiol, CH-4056 Basel, Switzerland; Univ Padua, Dept Biol, I-35121 Padua, Italy; Goethe Univ Frankfurt, Inst Microbiol, EUROSCARF, D-60439 Frankfurt, Germany; Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA; NCI, Ctr Canc Res, Gene Regulat & Chromosome Biol Lab, Frederick, MD 21702 USA; Univ Dusseldorf, Inst Mikrobiol, D-40225 Dusseldorf, Germany; Univ Wales, Inst Biol Sci, Aberystwyth SY23 3DA, Dyfed, Wales; Concordia Univ, Dept Biol, Montreal, PQ H3G 1M8, Canada; Katholieke Univ Leuven, Lab Gene Technol, B-3001 Heverlee, Belgium	Stanford University; Stanford University; Yale University; Yale University; Johns Hopkins University; Washington University (WUSTL); McGill University; Universite Catholique Louvain; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca; University of Basel; University of Padua; Goethe University Frankfurt; University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Heinrich Heine University Dusseldorf; Aberystwyth University; Concordia University - Canada; KU Leuven	Davis, RW (corresponding author), Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA.	dbowe@cmgm.stanford.edu	Storms, Reginald/B-2405-2013; BENITO, ROCIO/B-4271-2017; Lucau-Danila, Anca/AAE-7674-2021; Arkin, Adam P/A-6751-2008; Winzeler, Elizabeth/AAP-6752-2020; Campanaro, Stefano/I-5657-2019; Flaherty, Patrick/A-1720-2011; Revuelta, Jose L/C-2324-2012; Johnston, Mark/K-3543-2019; Entian, Karl-Dieter/D-3080-2011; Johnston, Mark/R-6156-2019; Revuelta, Jose Luis/ABG-1502-2020; Youngman, Elaine/O-7449-2019; Arkin, Adam/M-9941-2019; André, Bruno/D-1725-2010; Güldener, Ulrich/G-5227-2012	BENITO, ROCIO/0000-0001-9781-4198; Arkin, Adam P/0000-0002-4999-2931; Winzeler, Elizabeth/0000-0002-4049-2113; Revuelta, Jose L/0000-0001-7838-5308; Johnston, Mark/0000-0002-4932-7229; Revuelta, Jose Luis/0000-0001-7838-5308; Arkin, Adam/0000-0002-4999-2931; Güldener, Ulrich/0000-0001-5052-8610; Boeke, Jef/0000-0001-5322-4946; Lemire-Brachat, Sophie/0000-0002-3398-8225; LUCAU-DANILA, Anca/0000-0002-9379-6241; CAMPANARO, STEFANO/0000-0002-9431-1648; VALLE, GIORGIO/0000-0003-4377-5685; Snyder, Michael/0000-0003-0784-7987; Menard, Patrice/0000-0001-8844-3727				BENZER S, 1961, P NATL ACAD SCI USA, V47, P403, DOI 10.1073/pnas.47.3.403; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; GUTHRIE C, 1991, GUIDE YEAST GENETICS, P12; Hamer L, 2001, P NATL ACAD SCI USA, V98, P5110, DOI 10.1073/pnas.091094198; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Jones E. W., 1982, MOL BIOL YEAST SACCH, P181; Liu LX, 1999, GENOME RES, V9, P859, DOI 10.1101/gr.9.9.859; Mewes HW, 2000, NUCLEIC ACIDS RES, V28, P37, DOI 10.1093/nar/28.1.37; Ni L, 2001, MOL BIOL CELL, V12, P2147, DOI 10.1091/mbc.12.7.2147; Piano F, 2000, CURR BIOL, V10, P1619, DOI 10.1016/S0960-9822(00)00869-1; Poon PP, 1996, P NATL ACAD SCI USA, V93, P10074, DOI 10.1073/pnas.93.19.10074; Posas F, 1996, CELL, V86, P865, DOI 10.1016/S0092-8674(00)80162-2; Ross-Macdonald P, 1999, NATURE, V402, P413, DOI 10.1038/46558; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; Sherman F., 1986, METHODS YEAST GENETI, P145; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; WACH A, 1996, EUROFAN; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yale J, 2001, J BIOL CHEM, V276, P15996, DOI 10.1074/jbc.M008209200; Zambrowicz BP, 1998, NATURE, V392, P608, DOI 10.1038/33423	22	3071	4284	7	330	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 25	2002	418	6896					387	391		10.1038/nature00935	http://dx.doi.org/10.1038/nature00935			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576MU	12140549				2022-12-24	WOS:000177009700029
J	Nowlan, W				Nowlan, W			Human genetics: A rational view of insurance and genetic discrimination	SCIENCE			English	Editorial Material							INFORMATION; LAWS		Natl Life Insurance Co, Montpelier, VT 05604 USA		Nowlan, W (corresponding author), Natl Life Insurance Co, Montpelier, VT 05604 USA.							*AM COUNC LIF INS, 2000, LIF INS FACT BOOK 20; Annas GJ, 2001, NEW ENGL J MED, V345, P385, DOI 10.1056/NEJM200108023450523; ENGMAN M, 1998, AM AC INS MED ANN M; Greely HT, 2001, U PENN LAW REV, V149, P1483, DOI 10.2307/3312966; Hall MA, 2000, AM J HUM GENET, V66, P293, DOI 10.1086/302714; HALL MA, 2000, NY TIMES        0219, pD7; Holtzman NA, 2000, NEW ENGL J MED, V343, P141, DOI 10.1056/NEJM200007133430213; HUDSON KL, 1995, SCIENCE, V270, P391, DOI 10.1126/science.270.5235.391; Lapham EV, 1996, SCIENCE, V274, P621, DOI 10.1126/science.274.5287.621; LEE AM, 1939, FINE ART PROPAGANDA; NOWLAN WJ, 1999, NATL UNDERWRITER, V15, P39; Stephenson J, 1999, JAMA-J AM MED ASSOC, V282, P2197, DOI 10.1001/jama.282.23.2197; Welch HG, 1998, JAMA-J AM MED ASSOC, V280, P1525, DOI 10.1001/jama.280.17.1525	13	35	35	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 12	2002	297	5579					195	196		10.1126/science.1070987	http://dx.doi.org/10.1126/science.1070987			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	571UT	12114609				2022-12-24	WOS:000176738100020
J	Mbulaiteye, SM; Mahe, C; Whitworth, JAG; Ruberantwari, A; Nakiyingi, JS; Ojwiya, A; Kamali, A				Mbulaiteye, SM; Mahe, C; Whitworth, JAG; Ruberantwari, A; Nakiyingi, JS; Ojwiya, A; Kamali, A			Declining HIV-1 incidence and associated prevalence over 10 years in a rural population in south-west Uganda: a cohort study	LANCET			English	Article							SEXUALLY-TRANSMITTED DISEASES; CONDOM PROMOTION; INFECTION-RATES; TANZANIA; BEHAVIOR; TRENDS; SEROPREVALENCE; PROSTITUTES; MORTALITY; EPIDEMIC	Background In Uganda, there have been encouraging reports of reductions in HIV-1 prevalence but not in incidence, which is the most reliable measure of epidemic trends. We describe HIV-1 incidence and prevalence trends in a rural population-based cohort between 1989 and 1999. Methods We surveyed the adult population of 15 neighbouring villages for HIV-1 infection using annual censuses, questionnaires, and serological surveys. We report crude annual incidence rates by calendar year and prevalence by survey round. Findings 6566 HIV-1 seronegative adults were bled two or more times between January, 1990, and December, 1999, contributing 31984 person years at risk (PYAR) and 190 seroconversions. HIV-1 incidence fell from 8.0 to 5.2 per 1000 PYAR between 1990 and 1999 (p=0.002, chi(2) for trend). Significant sex-specific and age-group-specific reductions in incidence were evident. Incidence was 37% lower for 1995-99 than for 1990-94 (p=0.002, t-test). On average, 4642 adult residents had a definite HIV-1 serostatus at each yearly survey round. HIV-1 prevalence fell significantly between the first and tenth annual survey rounds (p=0.03, chi(2) for trend), especially among men aged 20-24 years (6.5% to 2.2%) and 25-29 years (15.2% to 10.9%) and women aged 13-19 years (2.8% to 0.9%) and 20-24 years (19.3% to 10.1%) (all p<0-001, &chi;(2) for trend). Interpretation Our findings of a significant drop in adult HIV-1 incidence in rural Ugandans give hope to AIDS control programmes elsewhere in sub-Saharan Africa where rates of HIV-1 infection remain high.	Uganda Virus Res Inst, MRC, Program AIDS Uganda, Entebbe, Uganda	Uganda Virus Research Institute	Whitworth, JAG (corresponding author), Uganda Virus Res Inst, MRC, Program AIDS Uganda, POB 49, Entebbe, Uganda.		Mbulaiteye, Sam/O-3056-2019	Mbulaiteye, Sam/0000-0002-8273-9831				ALLEN S, 1992, JAMA-J AM MED ASSOC, V268, P3338, DOI 10.1001/jama.268.23.3338; ASIMWEOKIROR G, 1997, AIDS, V11, P1757; Baeten JM, 2000, J ACQ IMMUN DEF SYND, V24, P458, DOI 10.1097/00126334-200008150-00011; Fylkesnes K, 2001, AIDS, V15, P907, DOI 10.1097/00002030-200105040-00011; GROSSKURTH H, 1995, LANCET, V346, P530, DOI 10.1016/S0140-6736(95)91380-7; Joint Select Committee on Victims Compensation, 2000, REP GLOB HIV AIDS EP, P9; *JOINT UN PROGR HI, 1998, MEAS SUCC UG; Kamali A, 2000, AIDS, V14, P427, DOI 10.1097/00002030-200003100-00017; Kamali A, 1999, SEX TRANSM INFECT, V75, P98, DOI 10.1136/sti.75.2.98; KAMENGA M, 1991, AIDS, V5, P61, DOI 10.1097/00002030-199101000-00009; Kilian AHD, 1999, AIDS, V13, P391, DOI 10.1097/00002030-199902250-00012; LAGA M, 1994, LANCET, V344, P246, DOI 10.1016/S0140-6736(94)93005-8; Meda N, 1999, AIDS, V13, P1397, DOI 10.1097/00002030-199907300-00018; MULDER D, 1995, BRIT MED J, V311, P833, DOI 10.1136/bmj.311.7009.833; Ngweshemi JZL, 1996, AIDS, V10, P1415, DOI 10.1097/00002030-199610000-00015; Nunn AJ, 1997, BRIT MED J, V315, P767, DOI 10.1136/bmj.315.7111.767; NUNN AJ, 1993, AIDS, V7, P1057, DOI 10.1097/00002030-199308000-00005; Nunn AJ, 1996, LANCET, V348, P833, DOI 10.1016/S0140-6736(05)65261-0; NUNN AJ, 1995, AIDS, V9, P503, DOI 10.1097/00002030-199509050-00013; NUNN AJ, 1994, METHOD INFORM MED, V33, P253; Orroth KK, 2000, AIDS, V14, P1429, DOI 10.1097/00002030-200007070-00017; PIOT P, 2000, REPORT GLOBAL HIV AI; SEELEY J, 1991, AIDS Care, V3, P207, DOI 10.1080/09540129108253064; Senkoro KP, 2000, J ACQ IMMUN DEF SYND, V23, P194; Strickler Howard, 1995, Annals of Epidemiology, V5, P447, DOI 10.1016/1047-2797(95)00070-4; Tarantola D, 1997, AIDS, V11 Suppl B, pS5; Wawer MJ, 1997, AIDS, V11, P1023, DOI 10.1097/00002030-199708000-00011; WILLERFORD DM, 1993, J INFECT DIS, V167, P1414, DOI 10.1093/infdis/167.6.1414	28	113	114	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 6	2002	360	9326					41	46		10.1016/S0140-6736(02)09331-5	http://dx.doi.org/10.1016/S0140-6736(02)09331-5			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	569JR	12114040				2022-12-24	WOS:000176599700010
J	Wienholds, E; Schulte-Merker, S; Walderich, B; Plasterk, RHA				Wienholds, E; Schulte-Merker, S; Walderich, B; Plasterk, RHA			Target-selected inactivation of the zebrafish rag1 gene	SCIENCE			English	Article							RADIATION HYBRID MAP; CAENORHABDITIS-ELEGANS; RECOMBINATION; MUTAGENESIS; EXPRESSION; MUTATIONS; REGION; GENOME	The zebrafish has become a favorite organism for genetic analysis of vertebrate development, but methods for generating mutants by reverse genetic approaches have been lacking. We report a method to obtain stable mutants of a gene based on knowledge of the gene sequence only. Parental fish were mutagenized with N-ethyl-N-nitrosourea; in 2679 F-1 fish, the rag1 gene was analyzed for heterozygous mutations by resequencing. In total, we found 15 mutations: 9 resulted in amino acid substitutions and 1 resulted in a premature stop codon. This truncation mutant was found to be homozygous viable and defective in V( D) J joining. Although presumably immune deficient, these homozygous rag1 mutant fish are able to reach adulthood and are fertile. As sperm samples from all 2679 F-1 fish were collected and cryopreserved, we have in principle generated a mutant library from which mutants of most zebrafish genes can be isolated.	Netherlands Inst Dev Biol, Hubrecht Lab, Ctr Biomed Genet, NL-3584 CT Utrecht, Netherlands; ARTEMIS Pharmaceut GmbH, Exelixis Deutschland, D-72076 Tubingen, Germany	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Plasterk, RHA (corresponding author), Netherlands Inst Dev Biol, Hubrecht Lab, Ctr Biomed Genet, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	plasterk@niob.knaw.nl						BALLINGER DG, 1989, P NATL ACAD SCI USA, V86, P9402, DOI 10.1073/pnas.86.23.9402; Beier DR, 2000, MAMM GENOME, V11, P594, DOI 10.1007/s003350010113; Bentley A, 2000, GENETICS, V156, P1169; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; COGHILL EL, 2002, NAT GENET, V19, P19; Danilova N, 2000, IMMUNOGENETICS, V52, P81, DOI 10.1007/s002510000255; DANILOVA N, COMMUNICATION; Driever W, 1996, DEVELOPMENT, V123, P37; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Geisler R, 1999, NAT GENET, V23, P86, DOI 10.1038/12692; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gordon D, 2001, GENOME RES, V11, P614, DOI 10.1101/gr.171401; Haffter P, 1996, DEVELOPMENT, V123, P1; Hukriede N, 2001, GENOME RES, V11, P2127, DOI 10.1101/gr.210601; Jansen G, 1997, NAT GENET, V17, P119, DOI 10.1038/ng0997-119; Jansen G, 1999, NAT GENET, V21, P414, DOI 10.1038/7753; KAISER K, 1990, P NATL ACAD SCI USA, V87, P1686, DOI 10.1073/pnas.87.5.1686; KULKOSKY J, 1992, MOL CELL BIOL, V12, P2331, DOI 10.1128/MCB.12.5.2331; Liu LX, 1999, GENOME RES, V9, P859, DOI 10.1101/gr.9.9.859; Ma CG, 2001, P NATL ACAD SCI USA, V98, P2461, DOI 10.1073/pnas.041449398; McCallum CM, 2000, NAT BIOTECHNOL, V18, P455, DOI 10.1038/74542; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Notarangelo LD, 1999, CURR OPIN IMMUNOL, V11, P435, DOI 10.1016/S0952-7915(99)80073-9; Parinov S, 2000, CURR OPIN BIOTECH, V11, P157, DOI 10.1016/S0958-1669(00)00075-6; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; THOMPSON S, 1989, CELL, V56, P313, DOI 10.1016/0092-8674(89)90905-7; van Eeden FJM, 1999, METHOD CELL BIOL, V60, P21; Willett CE, 1997, DEV BIOL, V182, P331, DOI 10.1006/dbio.1996.8446; Willett CE, 1997, IMMUNOGENETICS, V45, P394, DOI 10.1007/s002510050221; Woods IG, 2000, GENOME RES, V10, P1903, DOI 10.1101/gr.10.12.1903; ZWAAL RR, 1993, P NATL ACAD SCI USA, V90, P7431, DOI 10.1073/pnas.90.16.7431	32	316	346	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 5	2002	297	5578					99	102		10.1126/science.1071762	http://dx.doi.org/10.1126/science.1071762			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	571HB	12098699				2022-12-24	WOS:000176711000042
J	Glockner, G; Eichinger, L; Szafranski, K; Pachebat, JA; Bankier, AT; Dear, PH; Lehmann, D; Baumgart, C; Parra, G; Abril, JF; Guigo, R; Kumpf, K; Tunggal, B; Cox, E; Quail, MA; Platzer, M; Rosenthal, A; Noegel, AA				Glockner, G; Eichinger, L; Szafranski, K; Pachebat, JA; Bankier, AT; Dear, PH; Lehmann, D; Baumgart, C; Parra, G; Abril, JF; Guigo, R; Kumpf, K; Tunggal, B; Cox, E; Quail, MA; Platzer, M; Rosenthal, A; Noegel, AA		Dictyostelium Genome Sequencing	Sequence and analysis of chromosome 2 of Dictyostelium discoideum	NATURE			English	Article							GENOME SEQUENCE; MODEL	The genome of the lower eukaryote Dictyostelium discoideum comprises six chromosomes. Here we report the sequence of the largest, chromosome 2, which at 8 megabases (Mb) represents about 25% of the genome. Despite an A+T content of nearly 80%, the chromosome codes for 2,799 predicted protein coding genes and 73 transfer RNA genes. This gene density, about 1 gene per 2.6 kilobases (kb), is surpassed only by Saccharomyces cerevisiae (one per 2 kb) and is similar to that of Schizosaccharomyces pombe (one per 2.5 kb)(1,2). If we assume that the other chromosomes have a similar gene density, we can expect around 11,000 genes in the D. discoideum genome. A significant number of the genes show higher similarities to genes of vertebrates than to those of other fully sequenced eukaryotes(1-6). This analysis strengthens the view that the evolutionary position of D. discoideum is located before the branching of metazoa and fungi but after the divergence of the plant kingdom(7), placing it close to the base of metazoan evolution.	Univ Cologne, Fac Med, Ctr Biochem, D-50931 Cologne, Germany; IMB Jena, Dept Genome Anal, D-07745 Jena, Germany; Univ Cambridge, MRC Ctr, Mol Biol Lab, Cambridge CB2 2QH, England; Univ Pompeu Fabra, Inst Municipal Invest Med, Grp Recerca Informat Biomed, Ctr Regulacio Genom, Barcelona 08003, Spain; Princeton Univ, Princeton, NJ 08544 USA; Sanger Inst, Hinxton CB10 1SA, Cambs, England; Univ Jena, D-07743 Jena, Germany	University of Cologne; MRC Laboratory Molecular Biology; University of Cambridge; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Princeton University; Wellcome Trust Sanger Institute; Friedrich Schiller University of Jena	Glockner, G (corresponding author), Univ Cologne, Fac Med, Ctr Biochem, Joseph Stelzmann Str 52, D-50931 Cologne, Germany.	gernot@imb-jena.de; noegel@uni-koeln.de	Glöckner, Gernot/A-7800-2010; Quail, michael/ABE-6131-2020; Guigo, Roderic/D-1303-2010; Ferrando, Josep F Abril/B-3877-2014; Dear, Paul H/A-1162-2012; Eichinger, Ludwig/AAJ-8895-2021; Gasull, Martina/J-4076-2019	Glöckner, Gernot/0000-0002-9061-1061; Guigo, Roderic/0000-0002-5738-4477; Ferrando, Josep F Abril/0000-0001-7793-589X; Eichinger, Ludwig/0000-0003-1594-6117; Pachebat, Justin/0000-0003-3369-3205; Parra, Genis/0000-0002-0575-2936				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Apweiler R, 2000, BIOINFORMATICS, V16, P1145, DOI 10.1093/bioinformatics/16.12.1145; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baldauf SL, 2000, SCIENCE, V290, P972, DOI 10.1126/science.290.5493.972; Bowman S, 1999, NATURE, V400, P532, DOI 10.1038/22964; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; COX EC, 1990, P NATL ACAD SCI USA, V87, P8247, DOI 10.1073/pnas.87.21.8247; Dear P.H., 1997, GENOME MAPPING PRACT, P95; Eichinger L, 1999, MICROSC RES TECHNIQ, V47, P124, DOI 10.1002/(SICI)1097-0029(19991015)47:2<124::AID-JEMT5>3.0.CO;2-8; Firtel RA, 2000, CURR OPIN GENET DEV, V10, P421, DOI 10.1016/S0959-437X(00)00107-6; Fortini ME, 2000, J CELL BIOL, V150, pF23, DOI 10.1083/jcb.150.2.F23; Gardner MJ, 1998, SCIENCE, V282, P1126, DOI 10.1126/science.282.5391.1126; Glockner G, 2001, GENOME RES, V11, P585, DOI 10.1101/gr.GR-1622RR; GLOCKNER G, 2000, CURR GENOMICS, V1, P289; GOEBL MG, 1986, CELL, V46, P983, DOI 10.1016/0092-8674(86)90697-5; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Kay RR, 1999, TRENDS GENET, V15, P294, DOI 10.1016/S0168-9525(99)01770-9; Konfortov BA, 2000, GENOME RES, V10, P1737, DOI 10.1101/gr.141700; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lim LP, 2001, P NATL ACAD SCI USA, V98, P11193, DOI 10.1073/pnas.201407298; Loomis WF, 1996, MICROBIOL REV, V60, P135, DOI 10.1128/MMBR.60.1.135-150.1996; LOOMIS WF, 1997, DICTYOSTELIUM MODEL, P15; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Morio T, 1998, DNA Res, V5, P335, DOI 10.1093/dnares/5.6.335; Noegel AA, 2000, J CELL SCI, V113, P759; PAN WC, 1981, CELL, V23, P459, DOI 10.1016/0092-8674(81)90141-0; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Parra G, 2000, GENOME RES, V10, P511, DOI 10.1101/gr.10.4.511; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724	30	143	1053	2	18	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 4	2002	418	6893					79	85		10.1038/nature00847	http://dx.doi.org/10.1038/nature00847			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569JL	12097910				2022-12-24	WOS:000176599200042
J	Verma, R; Aravind, L; Oania, R; McDonald, WH; Yates, JR; Koonin, EV; Deshaies, RJ				Verma, R; Aravind, L; Oania, R; McDonald, WH; Yates, JR; Koonin, EV; Deshaies, RJ			Role of Rpn11 metalloprotease in deubiquitination and degradation by the 26S proteasome	SCIENCE			English	Article							UBIQUITIN; YEAST; GENE; TRANSCRIPTION; RECOGNITION; ACTIVATION; INHIBITOR; CLEAVAGE; SUBUNIT; ENZYMES	The 26 S proteasome mediates degradation of ubiquitin-conjugated proteins. Although ubiquitin is recycled from proteasome substrates, the molecular basis of deubiquitination at the proteasome and its relation to substrate degradation remain unknown. The Rpn11 subunit of the proteasome lid subcomplex contains a highly conserved Jab1/MPN domain associated metalloisopeptidase (JAMM) motif EXnHXHX10D. Mutation of the predicted active-site histidines to alanine (rpn11AXA) was lethal and stabilized ubiquitin pathway substrates in yeast. Rpn11(AXA) mutant proteasomes assembled normally but failed to either deubiquitinate or degrade ubiquitinated Sic1 in vitro. Our findings reveal an unexpected coupling between substrate deubiquitination and degradation and suggest a unifying rationale for the presence of the lid in eukaryotic proteasomes.	CALTECH, Dept Biol, Pasadena, CA 91125 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA; Scripps Res Inst, Dept Cell Biol, San Diego, CA 92037 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Scripps Research Institute	Deshaies, RJ (corresponding author), CALTECH, Dept Biol, Pasadena, CA 91125 USA.	deshaies@caltech.edu	McDonald, W. Hayes/B-4109-2016; Deshaies, Raymond/B-8354-2014	McDonald, W. Hayes/0000-0002-3510-426X; Deshaies, Raymond/0000-0002-3671-9354; Aravind, L/0000-0003-0771-253X	NCRR NIH HHS [RR11823-05-01] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		AMON A, 1994, CELL, V77, P1037, DOI 10.1016/0092-8674(94)90443-X; Borodovsky A, 2001, EMBO J, V20, P5187, DOI 10.1093/emboj/20.18.5187; Chung CH, 1999, BIOCHEM BIOPH RES CO, V266, P633, DOI 10.1006/bbrc.1999.1880; Conaway RC, 2002, SCIENCE, V296, P1254, DOI 10.1126/science.1067466; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; EYTAN E, 1993, J BIOL CHEM, V268, P4668; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; JOHNSON ES, 1992, EMBO J, V11, P497, DOI 10.1002/j.1460-2075.1992.tb05080.x; Lam YA, 2002, NATURE, V416, P763, DOI 10.1038/416763a; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; PAPA FR, 1993, NATURE, V366, P313, DOI 10.1038/366313a0; Ponting CP, 1999, J MOL BIOL, V289, P729, DOI 10.1006/jmbi.1999.2827; Rinaldi T, 1998, MOL BIOL CELL, V9, P2917, DOI 10.1091/mbc.9.10.2917; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; SEUFERT W, 1992, EMBO J, V11, P3077, DOI 10.1002/j.1460-2075.1992.tb05379.x; SHIMANUKI M, 1995, J CELL SCI, V108, P569; Smith CK, 1999, P NATL ACAD SCI USA, V96, P6678, DOI 10.1073/pnas.96.12.6678; Stitzel ML, 2001, GENE DEV, V15, P128, DOI 10.1101/gad.863801; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; Verma R, 2000, CELL, V101, P341, DOI 10.1016/S0092-8674(00)80843-0; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Verma R, 2001, MOL CELL, V8, P439, DOI 10.1016/S1097-2765(01)00308-2; Verma R. P., UNPUB; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Wilkinson KD, 1998, UBIQUITIN BIOL CELL, P99	31	775	811	1	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 18	2002	298	5593					611	615		10.1126/science.1075898	http://dx.doi.org/10.1126/science.1075898			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604RL	12183636				2022-12-24	WOS:000178634800044
J	Hutvagner, G; Zamore, PD				Hutvagner, G; Zamore, PD			A microRNA in a multiple-turnover RNAi enzyme complex	SCIENCE			English	Article							C-ELEGANS; REGULATORY RNA; INTERFERENCE; GENE; EXPRESSION; RDE-1; TRANSCRIPTION; INITIATION; PATHWAY; LIN-14	In animals, the double-stranded RNA-specific endonuclease Dicer produces two classes of functionally distinct, tiny RNAs: microRNAs ( miRNAs) and small interfering RNAs (siRNAs). miRNAs regulate mRNA translation, whereas siRNAs direct RNA destruction via the RNA interference (RNAi) pathway. Here we show that, in human cell extracts, the miRNA let-7 naturally enters the RNAi pathway, which suggests that only the degree of complementarity between a miRNA and its RNA target determines its function. Human let-7 is a component of a previously identified, miRNA-containing ribonucleoprotein particle, which we show is an RNAi enzyme complex. Each let-7 containing complex directs multiple rounds of RNA cleavage, which explains the remarkable efficiency of the RNAi pathway in human cells.	Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Zamore, PD (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Lazare Res Bldg,Room 825,364 Plantat St, Worcester, MA 01605 USA.	phillip.zamore@umassmed.edu	Zamore, Phillip D/A-8941-2013	Zamore, Phillip/0000-0002-4505-9618; Hutvagner, Gyorgy/0000-0002-7231-9446	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062862, R37GM062862] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM62862-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Billy E, 2001, P NATL ACAD SCI USA, V98, P14428, DOI 10.1073/pnas.261562698; Catalanotto C, 2000, NATURE, V404, P245, DOI 10.1038/35005169; Catalanotto C, 2002, GENE DEV, V16, P790, DOI 10.1101/gad.222402; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; HUTVAGNER G, UNPUB; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lipardi C, 2001, CELL, V107, P297, DOI 10.1016/S0092-8674(01)00537-2; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Morel JB, 2002, PLANT CELL, V14, P629, DOI 10.1105/tpc.010358; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Plasterk RHA, 2002, SCIENCE, V296, P1263, DOI 10.1126/science.1072148; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; SCHWARZ D, IN PRESS MOL CELL; SCHWARZ D, UNPUB; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Williams RW, 2002, P NATL ACAD SCI USA, V99, P6889, DOI 10.1073/pnas.072190799; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5	37	1537	1855	4	202	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 20	2002	297	5589					2056	2060		10.1126/science.1073827	http://dx.doi.org/10.1126/science.1073827			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594XV	12154197				2022-12-24	WOS:000178078500048
J	Rusconi, CP; Scardino, E; Layzer, J; Pitoc, GA; Ortel, TL; Monroe, D; Sullenger, BA				Rusconi, CP; Scardino, E; Layzer, J; Pitoc, GA; Ortel, TL; Monroe, D; Sullenger, BA			RNA aptamers as reversible antagonists of coagulation factor IXa	NATURE			English	Article							HEPARIN-INDUCED THROMBOCYTOPENIA; ANTICOAGULANT-THERAPY; BIND; INHIBITION; GENERATION; MOLECULES; SELECTION	Many therapeutic agents are associated with adverse effects in patients. Anticoagulants can engender acute complications such as significant bleeding that increases patient morbidity and mortality(1). Antidote control provides the safest means to regulate drug action. For this reason, despite its known limitations and toxicities, heparin use remains high because it is the only anticoagulant that can be controlled by an antidote, the polypeptide protamine(2-4). To date, no generalizable strategy for developing drug-antidote pairs has been described. We investigated whether drug-antidote pairs could be rationally designed by taking advantage of properties inherent to nucleic acids to make antidote-controlled anticoagulant agents. Here we show that protein-binding oligonucleotides (aptamers) against coagulation factor IXa are potent anticoagulants. We also show that oligonucleotides complementary to these aptamers can act as antidotes capable of efficiently reversing the activity of these new anticoagulants in plasma from healthy volunteers and from patients who cannot tolerate heparin(5). This generalizable strategy for rationally designing a drug-antidote pair thus opens up the way for developing safer regulatable therapeutics.	Duke Univ, Med Ctr, Dept Surg, Program Combinatorial Therapeut, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pathol & Med, Durham, NC 27710 USA; Univ N Carolina, Sch Med, Ctr Thrombosis & Hemostasis, Chapel Hill, NC 27599 USA	Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Rusconi, CP (corresponding author), Duke Univ, Med Ctr, Dept Surg, Program Combinatorial Therapeut, Durham, NC 27710 USA.	c.rusconi@cgct.duke.edu; b.sullenger@cgct.duke.edu		Monroe, Dougald/0000-0002-0493-2943				BOCK LC, 1992, NATURE, V355, P564, DOI 10.1038/355564a0; Campbell K R, 2000, J Invasive Cardiol, V12 Suppl F, p14F; Carr JA, 1999, J CARDIOVASC SURG, V40, P659; Choudhri TF, 1999, J EXP MED, V190, P91, DOI 10.1084/jem.190.1.91; Davis JP, 1996, METHOD ENZYMOL, V267, P302; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Feuerstein GZ, 1999, THROMB HAEMOSTASIS, V82, P1443; Fitzwater T, 1996, METHOD ENZYMOL, V267, P275; Greinacher A, 1999, CIRCULATION, V99, P73, DOI 10.1161/01.CIR.99.1.73; Hicke BJ, 2000, J CLIN INVEST, V106, P923, DOI 10.1172/JCI11324; Hirsh J, 2001, CIRCULATION, V103, P2994, DOI 10.1161/01.CIR.103.24.2994; HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8; Johnson K, 1998, CORONARY ARTERY DIS, V9, P83, DOI 10.1097/00019501-199809020-00004; KA High, 1995, MOL BASIS THROMBOSIS, P215; Levine MN, 2001, CHEST, V119, p108S, DOI 10.1378/chest.119.1_suppl.108S; Lewis BE, 2001, CIRCULATION, V103, P1838; PIEKEN WA, 1991, SCIENCE, V253, P314, DOI 10.1126/science.1857967; PIFARRE R, 1997, NEW ANTICOAGULANTS C, P1; Rusconi CP, 2000, THROMB HAEMOSTASIS, V84, P841; Silverman SK, 1999, BIOCHEMISTRY-US, V38, P8691, DOI 10.1021/bi9906118; Spanier TB, 1998, J THORAC CARDIOV SUR, V116, P860, DOI 10.1016/S0022-5223(98)00437-1; Tasset DM, 1997, J MOL BIOL, V272, P688, DOI 10.1006/jmbi.1997.1275; Tucker CE, 1999, J CHROMATOGR B, V732, P203, DOI 10.1016/S0378-4347(99)00285-6; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; van Dijk MA, 2001, CURR OPIN CHEM BIOL, V5, P368, DOI 10.1016/S1367-5931(00)00216-7; Warkentin TE, 1998, THROMB HAEMOSTASIS, V79, P1; Watson SR, 2000, ANTISENSE NUCLEIC A, V10, P63, DOI 10.1089/oli.1.2000.10.63; White R, 2001, MOL THER, V4, P567, DOI 10.1006/mthe.2001.0495; White RR, 2000, J CLIN INVEST, V106, P929, DOI 10.1172/JCI11325	29	408	457	5	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 5	2002	419	6902					90	94		10.1038/nature00963	http://dx.doi.org/10.1038/nature00963			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589YF	12214238				2022-12-24	WOS:000177788600043
J	Hakimi, MA; Bochar, DA; Schmiesing, JA; Dong, YS; Barak, OG; Speicher, DW; Yokomori, K; Shiekhattar, R				Hakimi, MA; Bochar, DA; Schmiesing, JA; Dong, YS; Barak, OG; Speicher, DW; Yokomori, K; Shiekhattar, R			A chromatin remodelling complex that loads cohesin onto human chromosomes	NATURE			English	Article							SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; RAD21; TRANSCRIPTION; METHYLATION; NUCLEOSOME; ANAPHASE; PROTEIN; FAMILY; GENE	Nucleosomal DNA is arranged in a higher-order structure that presents a barrier to most cellular processes involving protein DNA interactions(1). The cellular machinery involved in sister chromatid cohesion, the cohesin complex, also requires access to the nucleosomal DNA to perform its function in chromosome segregation(2-10). The machineries that provide this accessibility are termed chromatin remodelling factors(11). Here, we report the isolation of a human ISWI (SNF2h)-containing chromatin remodelling complex that encompasses components of the cohesin and NuRD complexes. We show that the hRAD21 subunit of the cohesin complex directly interacts with the ATPase subunit SNF2h. Mapping of hRAD21, SNF2h and Mi2 binding sites by chromatin immunoprecipitation experiments reveals the specific association of these three proteins with human DNA elements containing Alu sequences. We find a correlation between modification of histone tails and association of the SNF2h/cohesin complex with chromatin. Moreover, we show that the association of the cohesin complex with chromatin can be regulated by the state of DNA methylation. Finally, we present evidence pointing to a role for the ATPase activity of SNF2h in the loading of hRAD21 on chromatin.	Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA	The Wistar Institute; University of California System; University of California Irvine	Shiekhattar, R (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.		Bochar, Daniel A/A-9224-2009; HAKIMI, Mohamed-ali/Q-6475-2019; HAKIMI, Mohamed-Ali/F-9806-2014; HAKIMI, Mohamed-ali/GYJ-0879-2022	HAKIMI, Mohamed-ali/0000-0002-2547-8233; HAKIMI, Mohamed-Ali/0000-0002-2547-8233; 				BIRKENBIHL RP, 1992, NUCLEIC ACIDS RES, V20, P6605, DOI 10.1093/nar/20.24.6605; BIRKENBIHL RP, 1995, J BIOL CHEM, V270, P7703, DOI 10.1074/jbc.270.13.7703; Bochar DA, 2000, CELL, V102, P257, DOI 10.1016/S0092-8674(00)00030-1; Bochar DA, 2000, P NATL ACAD SCI USA, V97, P1038, DOI 10.1073/pnas.97.3.1038; Broday L, 1999, MOL CELL BIOL, V19, P3198; Fyodorov DV, 2001, CELL, V106, P523, DOI 10.1016/S0092-8674(01)00478-0; Gelbart ME, 2001, MOL CELL BIOL, V21, P2098, DOI 10.1128/MCB.21.6.2098-2106.2001; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Hakimi MA, 2002, P NATL ACAD SCI USA, V99, P7420, DOI 10.1073/pnas.112008599; HELLMANNBLUMBERG U, 1993, MOL CELL BIOL, V13, P4523, DOI 10.1128/MCB.13.8.4523; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; LAI JS, 1992, P NATL ACAD SCI USA, V89, P6958, DOI 10.1073/pnas.89.15.6958; LARIONOV VL, 1985, CURR GENET, V10, P15, DOI 10.1007/BF00418488; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Mighell AJ, 1997, FEBS LETT, V417, P1, DOI 10.1016/S0014-5793(97)01259-3; Schmid CW, 1998, NUCLEIC ACIDS RES, V26, P4541, DOI 10.1093/nar/26.20.4541; Schmiesing JA, 1998, P NATL ACAD SCI USA, V95, P12906, DOI 10.1073/pnas.95.22.12906; STOGER R, 1993, CELL, V73, P61, DOI 10.1016/0092-8674(93)90160-R; STRUNNIKOV AV, 1993, J CELL BIOL, V123, P1635, DOI 10.1083/jcb.123.6.1635; Tatebayashi K, 1998, GENETICS, V148, P49; Tomonaga T, 2000, GENE DEV, V14, P2757, DOI 10.1101/gad.832000; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Waizenegger IC, 2000, CELL, V103, P399, DOI 10.1016/S0092-8674(00)00132-X; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4	27	218	222	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 29	2002	418	6901					994	998		10.1038/nature01024	http://dx.doi.org/10.1038/nature01024			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588AP	12198550				2022-12-24	WOS:000177677500048
J	Vogelbein, WK; Lovko, VJ; Shields, JD; Reece, KS; Mason, PL; Haas, LW; Walker, CC				Vogelbein, WK; Lovko, VJ; Shields, JD; Reece, KS; Mason, PL; Haas, LW; Walker, CC			Pfiesteria shumwayae kills fish by micropredation not exotoxin secretion	NATURE			English	Article							TOXIC PFIESTERIA; ESTUARINE FISH; HUMAN HEALTH; LIFE-CYCLE; DINOFLAGELLATE; PISCICIDA; DINOPHYCEAE; MENHADEN; BEHAVIOR; RECEPTOR	Pfiesteria piscicida and P. shumwayae reportedly secrete potent exotoxins thought to cause fish lesion events, acute fish kills and human disease in mid-Atlantic USA estuaries(1-7). However, Pfiesteria toxins have never been isolated or characterized(8). We investigated mechanisms by which P. shumwayae kills fish using three different approaches. Here we show that larval fish bioassays conducted in tissue culture plates fitted with polycarbonate membrane inserts exhibited mortality (100%) only in treatments where fish and dinospores were in physical contact. No mortalities occurred in treatments where the membrane prevented contact between dinospores and fish. Using differential centrifugation and filtration of water from a fish-killing culture, we produced 'dinoflagellate', 'bacteria' and 'cell-free' fractions. Larval fish bioassays of these fractions resulted in mortalities (60-100% in less than 24 h) only in fractions containing live dinospores ('whole water', 'dinoflagellate'), with no mortalities in 'cell-free' or 'bacteria'-enriched fractions. Videomicrography and electron microscopy show dinospores swarming toward and attaching to skin, actively feeding, and rapidly denuding fish of epidermis. We show here that our cultures of actively fish-killing P. shumwayae do not secrete potent exotoxins; rather, fish mortality results from micropredatory feeding.	Coll William & Mary, Virginia Inst Marine Sci, Gloucester Point, VA 23062 USA; US EPA, Natl Hlth & Environm Effects Res Lab, Gulf Ecol Div, Gulf Breeze, FL 32561 USA	William & Mary; Virginia Institute of Marine Science; United States Environmental Protection Agency	Vogelbein, WK (corresponding author), Coll William & Mary, Virginia Inst Marine Sci, Gloucester Point, VA 23062 USA.							BERRY JP, IN PRESS P NATL ACAD; Blazer VS, 1999, J AQUAT ANIM HEALTH, V11, P340, DOI 10.1577/1548-8667(1999)011&lt;0340:AAACOU&gt;2.0.CO;2; Blazer VS, 2002, J AQUAT ANIM HEALTH, V14, P1, DOI 10.1577/1548-8667(2002)014&lt;0001:AIIAMA&gt;2.0.CO;2; Burkholder JM, 2001, PHYCOLOGIA, V40, P186, DOI 10.2216/i0031-8884-40-3-186.1; Burkholder JM, 2001, ENVIRON HEALTH PERSP, V109, P745, DOI 10.2307/3454922; BURKHOLDER JM, 1995, MAR ECOL PROG SER, V124, P43, DOI 10.3354/meps124043; BURKHOLDER JM, 1992, NATURE, V358, P407, DOI 10.1038/358407a0; Burkholder JM, 1997, LIMNOL OCEANOGR, V42, P1052, DOI 10.4319/lo.1997.42.5_part_2.1052; CALLINAN RB, 1994, P ODA REG SEM EP ULC, P248; DYKSTRA MJ, 1989, J FISH DIS, V12, P175, DOI 10.1111/j.1365-2761.1989.tb00289.x; El-Nabawi A, 2000, TOXICOL APPL PHARM, V169, P84, DOI 10.1006/taap.2000.9042; ELNABAWI A, 2000, J EXP MAR BIOL ECOL, V255, P65; Glasgow HB, 2001, PHYCOLOGIA, V40, P234, DOI 10.2216/i0031-8884-40-3-234.1; Glasgow HB, 2001, ENVIRON HEALTH PERSP, V109, P715, DOI 10.2307/3454919; GLASGOW HB, 1995, J TOXICOL ENV HEALTH, V46, P501, DOI 10.1080/15287399509532051; Grattan LM, 1998, LANCET, V352, P532, DOI 10.1016/S0140-6736(98)02132-1; Grattan LM, 2001, BIOSCIENCE, V51, P853, DOI 10.1641/0006-3568(2001)051[0853:HHROET]2.0.CO;2; Kiryu Y, 2002, J AQUAT ANIM HEALTH, V14, P11, DOI 10.1577/1548-8667(2002)014&lt;0011:IOSUIA&gt;2.0.CO;2; Litaker RW, 2002, J PHYCOL, V38, P442, DOI 10.1046/j.1529-8817.2002.t01-1-01242.x; Melo AC, 2001, ENVIRON HEALTH PERSP, V109, P731, DOI 10.2307/3454920; Moeller PDR, 2001, ENVIRON HEALTH PERSP, V109, P739, DOI 10.2307/3454921; NOGA EJ, 1988, DIS AQUAT ORGAN, V4, P189, DOI 10.3354/dao004189; Noga EJ, 1996, MAR POLLUT BULL, V32, P219, DOI 10.1016/0025-326X(95)00114-3; SCHNEPF E, 1984, NATURWISSENSCHAFTEN, V71, P218, DOI 10.1007/BF00490442; SCHNEPF E, 1992, EUR J PROTISTOL, V28, P3, DOI 10.1016/S0932-4739(11)80315-9; SHUMWAY S, 2000, AG S HARMF MAR ALG U, P64; SPERO HJ, 1981, J PHYCOL, V17, P43, DOI 10.1111/j.0022-3646.1981.00043.x; Steidinger KA, 1996, J PHYCOL, V32, P157, DOI 10.1111/j.0022-3646.1996.00157.x; Vogelbein WK, 2001, ENVIRON HEALTH PERSP, V109, P687, DOI 10.2307/3454914; VOGELBEIN WK, 2000, AG S HARMF MAR ALG U, P81	30	64	69	0	218	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 29	2002	418	6901					967	970		10.1038/nature01008	http://dx.doi.org/10.1038/nature01008			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588AP	12198545				2022-12-24	WOS:000177677500042
J	Ownby, DR; Johnson, CC; Peterson, EL				Ownby, DR; Johnson, CC; Peterson, EL			Exposure to dogs and cats in the first year of life and risk of allergic sensitization at 6 to 7 years of age	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HOUSE-DUST ENDOTOXIN; CORD BLOOD-IGE; SERUM IGE; RESPIRATORY SYMPTOMS; BRONCHIAL RESPONSIVENESS; ASTHMATIC-CHILDREN; PARENTAL SMOKING; HAY-FEVER; POPULATION; PREVALENCE	Context Childhood asthma is strongly associated with allergic sensitization. Studies have suggested that animal exposure during infancy reduces subsequent allergic sensitization. Objective To evaluate the relationship between dog and cat exposure in the first year of life and allergic sensitization at 6 to 7 years of age. Design, Setting, and Subjects Prospective birth cohort study of healthy, fullterm infants enrolled in a health maintenance organization in suburban Detroit, Mich, who were born between April 15,1987, and August 31,1989, and followed up yearly to a mean age of 6.7 years. Of 835 children initially in the study at birth, 474 (57%) completed follow-up evaluations at age 6 to 7 years. Main Outcome Measures Atopy, defined as any skin prick test positivity to 6 common aeroallergens (dust mites [Dermatophagoides farinae, D pteronyssinus], dog, cat, short ragweed [Ambrosia artemisiifolia], and blue grass [Poa pratensis]); seroatopy, defined as any positive allergen-specific IgE test result for the same 6 allergens or for Alternaria species. Results The prevalence of any skin prick test positivity (atopy) at age 6 to 7 years was 33.6% with no dog or cat exposure in the first year of life, 34.3% with exposure to 1 dog or cat, and 15.4% with exposure to 2 or more dogs or cats (P = .005). The prevalence of any positive allergen-specific IgE test result (seroatopy) was 38.5% with no dog or cat exposure, 41.2% with exposure to 1 dog or cat, and 17.9% with exposure to 2 or more dogs or cats (P = .003). After adjustment for cord serum IgE concentration, sex, older siblings, parental smoking, parental asthma, bedroom dust mite allergen levels at 2 years, and current dog and cat ownership, exposure to 2 or more dogs or cats in the first year of life was associated with a significantly lower risk of atopy (adjusted odds ratio, 0.23; 95% confidence interval, 0.09-0.60) and seroatopy (adjusted odds ratio, 0.33; 95% confidence interval, 0.13-0.83). Conclusion Exposure to 2 or more dogs or cats in the first year of life may reduce subsequent risk of allergic sensitization to multiple allergens during childhood.	Med Coll Georgia, Dept Pediat, Sect Allergy & Immunol, Augusta, GA 30912 USA; Henry Ford Hlth Syst, Dept Biostat & Res Epidemiol, Detroit, MI USA; Wayne State Univ, Natl Inst Environm Hlth Sci Ctr Mol & Cellular To, Detroit, MI USA	University System of Georgia; Augusta University; Henry Ford Health System; Henry Ford Hospital; Wayne State University	Ownby, DR (corresponding author), Med Coll Georgia, Dept Pediat, Sect Allergy & Immunol, BG-1019, Augusta, GA 30912 USA.	downby@mail.mcg.edu		Johnson, Christine Cole/0000-0002-6864-6604	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006639] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Apelberg BJ, 2001, J ALLERGY CLIN IMMUN, V107, P455, DOI 10.1067/mai.2001.113240; AVITAL A, 1991, AM REV RESPIR DIS, V144, P36, DOI 10.1164/ajrccm/144.1.36; BACKER V, 1992, ALLERGY, V47, P484, DOI 10.1111/j.1398-9995.1992.tb00669.x; Ball TM, 2000, NEW ENGL J MED, V343, P538, DOI 10.1056/NEJM200008243430803; Bergmann RL, 1997, CLIN EXP ALLERGY, V27, P752, DOI 10.1046/j.1365-2222.1997.310899.x; Braback Lennart, 1995, Archives of Disease in Childhood, V72, P487; Burr ML, 1997, CLIN EXP ALLERGY, V27, P1247; Cohen J., 1988, STAT POWER ANAL BEHA; Custovic A, 2001, J ALLERGY CLIN IMMUN, V108, P537, DOI 10.1067/mai.2001.118599; Ernst P, 2000, AM J RESP CRIT CARE, V161, P1563, DOI 10.1164/ajrccm.161.5.9908119; Everitt B.S., 1977, ANAL CONTINGENCY TAB; GALDESSEBALDT M, 1985, J PEDIATR-US, V107, P526, DOI 10.1016/S0022-3476(85)80009-3; Gereda JE, 2000, LANCET, V355, P1680, DOI 10.1016/S0140-6736(00)02239-X; Gold DR, 1999, AM J RESP CRIT CARE, V160, P227, DOI 10.1164/ajrccm.160.1.9807104; Hesselmar B, 1999, CLIN EXP ALLERGY, V29, P611; HORWOOD LJ, 1985, PEDIATRICS, V75, P859; Hosmer D.W., 2004, APPL LOGISTIC REGRES, VSecond; Johnson CC, 1998, AM J EPIDEMIOL, V147, P1145; Johnson CC, 1996, CLIN EXP ALLERGY, V26, P624, DOI 10.1111/j.1365-2222.1996.tb00588.x; Joseph CLM, 2000, CHEST, V117, P1336, DOI 10.1378/chest.117.5.1336; KJELLMAN NIM, 1984, ANN ALLERGY, V53, P167; Lindfors A, 1999, J ALLERGY CLIN IMMUN, V104, P755, DOI 10.1016/S0091-6749(99)70284-8; Litonjua AA, 1997, AM J RESP CRIT CARE, V156, P23, DOI 10.1164/ajrccm.156.1.9608072; MARTINEZ FD, 1988, AM REV RESPIR DIS, V138, P518, DOI 10.1164/ajrccm/138.3.518; Nafstad P, 2001, ALLERGY, V56, P307, DOI 10.1034/j.1398-9995.2001.00881.x; NETER J, 1990, APPL STAT MODELS REG; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Osborne ML, 1998, AM J RESP CRIT CARE, V157, P123, DOI 10.1164/ajrccm.157.1.9612063; OWNBY DR, 1991, J ALLERGY CLIN IMMUN, V88, P555, DOI 10.1016/0091-6749(91)90148-H; Ownby DR, 2000, AM J RESP CRIT CARE, V161, P1578, DOI 10.1164/ajrccm.161.5.9812156; Ownby DR, 1996, PEDIATR ALLERGY IMMU, V7, P125, DOI 10.1111/j.1399-3038.1996.tb00119.x; Ownby DR, 1996, ANN ALLERG ASTHMA IM, V77, P304, DOI 10.1016/S1081-1206(10)63325-X; Ownby DR, 2000, ARCH PEDIAT ADOL MED, V154, P1237, DOI 10.1001/archpedi.154.12.1237; Park JH, 2001, AM J RESP CRIT CARE, V163, P322, DOI 10.1164/ajrccm.163.2.2002088; PEAT JK, 1987, CLIN ALLERGY, V17, P291, DOI 10.1111/j.1365-2222.1987.tb02017.x; PEAT JK, 1989, CLIN EXP ALLERGY, V19, P299, DOI 10.1111/j.1365-2222.1989.tb02387.x; Peterson EL, 1999, J ALLERGY CLIN IMMUN, V104, P348, DOI 10.1016/S0091-6749(99)70378-7; Peterson EL, 1997, J CLIN EPIDEMIOL, V50, P917, DOI 10.1016/S0895-4356(97)00095-4; Platts-Mills T, 2001, LANCET, V357, P752, DOI 10.1016/S0140-6736(00)04168-4; Platts-Mills TAE, 1997, J ALLERGY CLIN IMMUN, V100, pS2, DOI 10.1016/S0091-6749(97)70292-6; POPP W, 1990, ALLERGY, V45, P75, DOI 10.1111/j.1398-9995.1990.tb01087.x; Reijonen TM, 2000, PEDIATRICS, V106, P1406, DOI 10.1542/peds.106.6.1406; Remes ST, 2001, J ALLERGY CLIN IMMUN, V108, P509, DOI 10.1067/mai.2001.117797; Riedler J, 2000, CLIN EXP ALLERGY, V30, P194, DOI 10.1046/j.1365-2222.2000.00799.x; Roost HP, 1999, J ALLERGY CLIN IMMUN, V104, P941, DOI 10.1016/S0091-6749(99)70072-2; Rosenstreich DL, 1997, NEW ENGL J MED, V336, P1356, DOI 10.1056/NEJM199705083361904; SAS Institute Inc, 1999, SAS STAT US GUID; SEARS MR, 1993, CLIN EXP ALLERGY, V23, P941, DOI 10.1111/j.1365-2222.1993.tb00279.x; SKOBELOFF EM, 1992, JAMA-J AM MED ASSOC, V268, P3437, DOI 10.1001/jama.268.24.3437; SPORIK R, 1995, AM J RESP CRIT CARE, V151, P1388, DOI 10.1164/ajrccm.151.5.7735590; SPORIK R, 1990, NEW ENGL J MED, V323, P502, DOI 10.1056/NEJM199008233230802; Steerenberg PA, 1999, CLIN EXP ALLERGY, V29, P1304, DOI 10.1046/j.1365-2222.1999.00658.x; STODDARD JJ, 1995, AM J EPIDEMIOL, V141, P96, DOI 10.1093/oxfordjournals.aje.a117418; SUONIEMI I, 1981, ALLERGY, V36, P263, DOI 10.1111/j.1398-9995.1981.tb01573.x; TAKEDA K, 1993, CLIN EXP ALLERGY, V23, P450, DOI 10.1111/j.1365-2222.1993.tb00353.x; VANTO T, 1983, ACTA PAEDIATR SCAND, V72, P571, DOI 10.1111/j.1651-2227.1983.tb09773.x; von Mutius E, 2000, J ALLERGY CLIN IMMUN, V105, P9, DOI 10.1016/S0091-6749(00)90171-4; Withers NJ, 1998, AM J RESP CRIT CARE, V158, P352, DOI 10.1164/ajrccm.158.2.9705079; WRIGHT AL, 1994, PEDIATRICS, V94, P895; YUNGINGER JW, 1992, AM REV RESPIR DIS, V146, P888, DOI 10.1164/ajrccm/146.4.888	60	512	529	1	44	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 28	2002	288	8					963	972		10.1001/jama.288.8.963	http://dx.doi.org/10.1001/jama.288.8.963			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587RM	12190366	Bronze			2022-12-24	WOS:000177656400021
J	Kane, B				Kane, B			Chronic HIV infection: Can anyone afford a drug holiday?	ANNALS OF INTERNAL MEDICINE			English	News Item																		Lisziewicz J, 1999, NEW ENGL J MED, V340, P1683, DOI 10.1056/NEJM199905273402114; Yeni PG, 2002, JAMA-J AM MED ASSOC, V288, P222, DOI 10.1001/jama.288.2.222; 2001, AIDS, V15, P2251; 2002, MMWR MORB MORTAL WKL, V17, P55; 2001, JAMA, V286, P2568; 2001, N ENGL J MED, V344, P472; 1997, AIDS, V11, P477	7	2	2	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 20	2002	137	4					301	304		10.7326/0003-4819-137-4-200208200-00031	http://dx.doi.org/10.7326/0003-4819-137-4-200208200-00031			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585BB	12186535				2022-12-24	WOS:000177502300023
J	Oddie, S; Embleton, ND				Oddie, S; Embleton, ND		No Neonatal Network	Risk factors for early onset neonatal group B streptococcal sepsis: case-control study	BRITISH MEDICAL JOURNAL			English	Article							INTRAPARTUM AMPICILLIN; INFECTION; PROPHYLAXIS; PREVENTION; DISEASE	Objectives To quantify risk factors for and the prevalence of early onset group B streptococcal sepsis in neonates in a geographically defined population. Design Cases were collected prospectively for two years from April 1998 and compared with four controls each, matched for time and place of delivery. Setting The former Northern health region of the United Kingdom. Participants Infants infected with group B streptococcus in the first week of life. Results The prevalence of early onset group B streptococcal sepsis was 0.57 per 1000 live births. Premature infants comprised 38% of all cases and 83% of die deaths. Prematurity (odds ratio 10.4,95% confidence interval 3.9 to 27.6), rupture of the membranes more than 18 hours before delivery (25.8, 10.2 to 64.8), rupture of the membranes before the onset of labour (11.1, 4.8 to 25.9), and intrapartum fever (10.0, 2.4 to 40.8) were significant risk factors for infection. Had the interim recommendations on best practice issued by the Group B Streptococcus Working Group of the Public Health Laboratory Service been uniformly applied to the fetuses alive at the onset of labour, 29 of 37 (78%) might have been given antibiotic prophylaxis during labour. At least 23 of these 29 (79%) could have had antibiotics for four hours or more before delivery. To achieve this, 16% of all women would have been given antibiotics during labour. Conclusions Early onset group B streptococcal sepsis remains an important problem in the United Kingdom. Prevention based on risk factors might reduce the prevalence at the cost of treating many women with risk factors. Using rupture of the membranes before the onset of labour as a risk factor might be expected to improve the success of guidelines for prophylaxis.	Royal Victoria Infirm, Dept Child Hlth, Newcastle Neonatal Serv, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England	Newcastle University - UK	Oddie, S (corresponding author), Royal Victoria Infirm, Dept Child Hlth, Newcastle Neonatal Serv, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.		Embleton, Nicholas/D-4905-2011	Embleton, Nicholas/0000-0003-3750-5566				American College of Obstetrics and Gynecologists. ACOG Committee opinion, 1996, INT J GYNECOL OBSTET, V54, P197; BAKER CJ, 2001, INFECT DIS FETUS NEW, P1091; Beardsall K, 2000, ARCH DIS CHILD-FETAL, V82, pF205, DOI 10.1136/fn.82.3.F205; Benitz WE, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.6.e77; BENITZ WE, 1999, PEDIATRICS, V103, pE79; BIGNARDI GE, 1999, COMMUN DIS PUBLIC HL, V2, P264; DAGAPEYEFF K, 2001, ARCH DIS CHILD S, V84, pA30; De Cueto M, 1998, OBSTET GYNECOL, V91, P112, DOI 10.1016/S0029-7844(97)00587-5; Embleton N, 1999, ARCH DIS CHILD-FETAL, V80, pF139, DOI 10.1136/fn.80.2.F139; FEY R, 1999, ARCH DIS CHILD FE S1, V80, pG202; FEY RJ, 1999, ARCH DIS CHILD S, V80, pA70; Halsey NA, 1997, PEDIATRICS, V99, P489, DOI 10.1542/peds.99.3.489; HEATH PT, 2001, ARCH DIS CHILD S, V84, pA8; HEY EN, 1984, BRIT MED J, V288, P1717; Isaacs D, 1998, ARCH DIS CHILD-FETAL, V79, pF81, DOI 10.1136/fn.79.2.F81; Jeffery HE, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.1.e2; Joseph TA, 1998, ARCH PEDIAT ADOL MED, V152, P35; Kenyon SL, 2001, LANCET, V357, P979, DOI 10.1016/S0140-6736(00)04233-1; *MAT CHILD HLTH CO, 2000, 7 MAT CHILD HLTH CON; McCartney C, 2001, LANCET, V357, P395, DOI 10.1016/S0140-6736(05)71530-0; Moses LM, 1998, ARCH DIS CHILD-FETAL, V79, pF148, DOI 10.1136/fn.79.2.F148; *PHLS GROUP B STRE, 2000, INT BEST PRACT REC P; PYLIPOW M, 1994, PEDIATRICS, V93, P631; Schrag SJ, 2000, NEW ENGL J MED, V342, P15, DOI 10.1056/NEJM200001063420103; WEBBER S, 1990, ARCH DIS CHILD, V65, P207, DOI 10.1136/adc.65.2.207	25	100	110	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 10	2002	325	7359					308	311		10.1136/bmj.325.7359.308	http://dx.doi.org/10.1136/bmj.325.7359.308			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	584RQ	12169506	Bronze, Green Published			2022-12-24	WOS:000177482500017
J	Groman, JD; Meyer, ME; Wilmott, RW; Zeitlin, PL; Cutting, GR				Groman, JD; Meyer, ME; Wilmott, RW; Zeitlin, PL; Cutting, GR			Variant cystic fibrosis phenotypes in the absence of CFTR mutations	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENE-MUTATIONS; 5T ALLELE; DISEASE; SWEAT; PANCREAS; MARKERS	Background Cystic fibrosis is a life-limiting autosomal recessive disorder with a highly variable clinical presentation. The classic form involves characteristic findings in the respiratory tract, gastrointestinal tract, male reproductive tract, and sweat glands and is caused by loss-of-function mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Nonclassic forms Of cystic fibrosis have been associated with mutations that reduce but do not eliminate the function of the CFTR protein. We assessed whether alteration in CFTR function is responsible for the entire spectrum of variant cystic fibrosis phenotypes. Methods Extensive genetic analysis of the CFTR gene was performed in 74 patients with nonclassic cystic fibrosis who had been referred by 34 medical centers. We evaluated two families that each included a proband without identified mutations and a sibling with nonclassic cystic fibrosis to determine whether there was linkage to the CFTR locus and to measure the extent of CFTR function in the sweat gland and nasal epithelium. Results Of the 74 patients studied, 29 had two mutations in the CFTR gene, 15 had one mutation, and 30 had no mutations. A final genotype of two mutations was more common among patients who had been referred after screening for common cystic fibrosis-causing mutations identified one mutation than among those who had been referred after screening had identified no such mutations (26 of 34 patients vs. 3 of 40 patients, P < 0.001). Comparison of clinical features and sweat chloride concentrations revealed no significant differences among patients with two, one, or no CFTR mutations. Haplotype analysis in the two families revealed no linkage to CFTR. Although each of the affected siblings had elevated sweat chloride concentrations, measurements of cyclic AMP-mediated ion and fluid transport in the sweat gland and nasal epithelium demonstrated the presence of functional CFTR. Conclusions Factors other than mutations in the CFTR gene can produce phenotypes clinically indistinguishable from nonclassic cystic fibrosis caused by CFTR dysfunction.	Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Cyst Fibrosis Fdn Genotyping Ctr, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Predoctoral Training Program Human Genet, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; St Louis Univ, Sch Med, Dept Pediat, St Louis, MO 63104 USA	Johns Hopkins University; Cystic Fibrosis Foundation; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Saint Louis University	Cutting, GR (corresponding author), Childrens Med Surg Ctr, 9-125,600 N Wolfe St, Baltimore, MD 21287 USA.	gcutting@jhmi.edu		Zeitlin, Pamela/0000-0002-2719-1834	NCRR NIH HHS [RR00052] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Andersen DH, 1938, AM J DIS CHILD, V56, P344, DOI 10.1001/archpedi.1938.01980140114013; Boehm CD, 1999, MOL GENET METAB, V66, P128, DOI 10.1006/mgme.1998.2779; Bronsveld I, 1999, THORAX, V54, P278, DOI 10.1136/thx.54.3.278; Callen A, 2000, J PEDIATR-US, V137, P849, DOI 10.1067/mpd.2000.109198; Choi JY, 2001, NATURE, V410, P94, DOI 10.1038/35065099; Cohn JA, 1998, NEW ENGL J MED, V339, P653, DOI 10.1056/NEJM199809033391002; CUTTING GR, 1997, EMERY RIMOINS PRINCI, V2, P2685; *CYST FIBR FDN, 2000, CYST FIBR FDN PAT RE; DISANTAGNESE PA, 1953, PEDIATRICS, V12, P549; Dreesen JCFM, 2000, MOL HUM REPROD, V6, P391, DOI 10.1093/molehr/6.5.391; GAN KH, 1995, NEW ENGL J MED, V333, P95, DOI 10.1056/NEJM199507133330204; GIBSON LE, 1959, PEDIATRICS, V23, P545; Guggino WB, 1999, CELL, V96, P607, DOI 10.1016/S0092-8674(00)80570-X; HIGHSMITH WE, 1994, NEW ENGL J MED, V331, P974, DOI 10.1056/NEJM199410133311503; *HOSP SICK CHILDR, 2001, CYST FIBR MUT DAT BA; KEREM BS, 1989, AM J HUM GENET, V44, P827; KNOWLES MR, 1995, HUM GENE THER, V6, P445, DOI 10.1089/hum.1995.6.4-445; KRISTIDIS P, 1992, AM J HUM GENET, V50, P1178; Mak V, 1999, JAMA-J AM MED ASSOC, V281, P2217, DOI 10.1001/jama.281.23.2217; Marchand E, 2001, CHEST, V119, P762, DOI 10.1378/chest.119.3.762; MCCONKIEROSELL A, 1989, ANN INTERN MED, V111, P797, DOI 10.7326/0003-4819-111-10-797; Mekus F, 1998, HUM GENET, V102, P582, DOI 10.1007/s004390050744; Miller PW, 1996, AM J HUM GENET, V59, P45; Noone PG, 2000, AM J RESP CRIT CARE, V162, P1919, DOI 10.1164/ajrccm.162.5.2003160; RIORDAN JR, 1989, SCIENCE, V245, P1437; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rubenstein RC, 1998, AM J RESP CRIT CARE, V157, P484, DOI 10.1164/ajrccm.157.2.9706088; TSUI LC, 1988, AM J HUM GENET, V42, P184; TSUI LC, 1985, SCIENCE, V230, P1054, DOI 10.1126/science.2997931; Wang XJ, 2000, JAMA-J AM MED ASSOC, V284, P1814, DOI 10.1001/jama.284.14.1814; Welsh MJ, 2001, METABOLIC MOL BASES, P5121; Wine JJ, 1999, J CLIN INVEST, V103, P309, DOI 10.1172/JCI6222; Zielenski J, 2000, RESPIRATION, V67, P117, DOI 10.1159/000029497	33	121	126	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 8	2002	347	6					401	407		10.1056/NEJMoa011899	http://dx.doi.org/10.1056/NEJMoa011899			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587YR	12167682	Bronze			2022-12-24	WOS:000177672400004
J	Toyoshima, C; Nomura, H				Toyoshima, C; Nomura, H			Structural changes in the calcium pump accompanying the dissociation of calcium	NATURE			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; CA2+ TRANSPORT ATPASE; ION-TRANSPORT; ALPHA-SUBUNIT; PHOSPHORYLATION; THAPSIGARGIN; STABILIZATION; DOMAINS; BINDING; ORGANIZATION	In skeletal muscle, calcium ions are transported (pumped) against a concentration gradient from the cytoplasm into the sarcoplasmic reticulum, an intracellular organelle. This causes muscle cells to relax after cytosolic calcium increases during excitation. The Ca2+ ATPase that carries out this pumping is a representative P-type ion-transporting ATPase. Here we describe the structure of this ion pump at 3.1 Angstrom resolution in a Ca2+-free (E2) state, and compare it with that determined previously for the Ca2+-bound (E1Ca(2+)) state. The structure of the enzyme stabilized by thapsigargin, a potent inhibitor, shows large conformation differences from that in E1Ca(2+). Three cytoplasmic domains gather to form a single headpiece, and six of the ten transmembrane helices exhibit large-scale rearrangements. These rearrangements ensure the release of calcium ions into the lumen of sarcoplasmic reticulum and, on the cytoplasmic side, create a pathway for entry of new calcium ions.	Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan	University of Tokyo	Toyoshima, C (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan.	ct@iam.u-tokyo.ac.jp	Toyoshima, Chikashi/R-4153-2019	Toyoshima, Chikashi/0000-0001-9640-0778				ALBERS RW, 1967, ANNU REV BIOCHEM, V36, P727, DOI 10.1146/annurev.bi.36.070167.003455; ANDERSEN JP, 1994, J BIOL CHEM, V269, P15931; ANDERSEN JP, 1992, J BIOL CHEM, V267, P2767; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P127, DOI 10.1016/S0968-0004(98)01189-X; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BRUNGER AT, 1990, ACTA CRYSTALLOGR A, V46, P46, DOI 10.1107/S0108767389009633; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHRISTENSEN SB, 1982, J ORG CHEM, V47, P649; Christensen SB, 1997, PROG CH ORG NAT PROD, V71, P129; COLL RJ, 1984, J BIOL CHEM, V259, P4249; Danko S, 2001, FEBS LETT, V505, P129, DOI 10.1016/S0014-5793(01)02801-0; Danko S, 2001, FEBS LETT, V489, P277, DOI 10.1016/S0014-5793(01)02111-1; DEMEIS L, 1979, ANNU REV BIOCHEM, V48, P275; Gatto C, 1999, J BIOL CHEM, V274, P13737, DOI 10.1074/jbc.274.20.13737; GLUSKER JP, 1991, ADV PROTEIN CHEM, V42, P1; Hayward S, 1999, PROTEINS, V36, P425, DOI 10.1002/(SICI)1097-0134(19990901)36:4<425::AID-PROT6>3.3.CO;2-J; Hua SM, 1997, BIOCHEMISTRY-US, V36, P11865, DOI 10.1021/bi970105n; JAMES P, 1989, NATURE, V342, P90, DOI 10.1038/342090a0; Johnson LN, 2001, CHEM REV, V101, P2209, DOI 10.1021/cr000225s; JORGENSEN PL, 1986, BIOCHIM BIOPHYS ACTA, V860, P570, DOI 10.1016/0005-2736(86)90555-9; Juul B, 2000, INT CONGR SER, V1207, P233; JUUL B, 1995, J BIOL CHEM, V270, P20123, DOI 10.1074/jbc.270.34.20123; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KUTSCHABSKY L, 1986, CRYST RES TECHNOL, V21, P627, DOI 10.1002/crat.2170210513; Lee AG, 2001, BIOCHEM J, V356, P665, DOI 10.1042/0264-6021:3560665; LUTSENKO S, 1995, P NATL ACAD SCI USA, V92, P7936, DOI 10.1073/pnas.92.17.7936; MACLENNAN DH, 1985, NATURE, V316, P696, DOI 10.1038/316696a0; MacLennan DH, 1997, J BIOL CHEM, V272, P28815, DOI 10.1074/jbc.272.46.28815; MEDDA P, 1987, EUR J BIOCHEM, V165, P251, DOI 10.1111/j.1432-1033.1987.tb11435.x; Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PIKULA S, 1988, J BIOL CHEM, V263, P5277; POST RL, 1972, J BIOL CHEM, V247, P6530; SAGARA Y, 1991, J BIOL CHEM, V266, P13503; STOKES DL, 1990, BIOPHYS J, V57, P1, DOI 10.1016/S0006-3495(90)82501-7; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Xu C, 2002, J MOL BIOL, V316, P201, DOI 10.1006/jmbi.2001.5330; Yu MH, 1998, J BIOL CHEM, V273, P3542, DOI 10.1074/jbc.273.6.3542; YU X, 1993, BIOPHYS J, V64, P1232, DOI 10.1016/S0006-3495(93)81489-9; Zhang PJ, 1998, NATURE, V392, P835, DOI 10.1038/33959; ZHANG Z, 1995, J BIOL CHEM, V270, P16283; Zhang ZS, 2000, BIOCHEMISTRY-US, V39, P8758, DOI 10.1021/bi000185m; Zhang ZS, 2001, J BIOL CHEM, V276, P15232, DOI 10.1074/jbc.M010813200	44	765	791	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 8	2002	418	6898					605	611		10.1038/nature00944	http://dx.doi.org/10.1038/nature00944			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581RA	12167852				2022-12-24	WOS:000177305600033
J	Briggs, SD; Xiao, TJ; Sun, ZW; Caldwell, JA; Shabanowitz, J; Hunt, DF; Allis, CD; Strahl, BD				Briggs, SD; Xiao, TJ; Sun, ZW; Caldwell, JA; Shabanowitz, J; Hunt, DF; Allis, CD; Strahl, BD			Gene silencing - Trans-histone regulatory pathway in chromatin	NATURE			English	Article									Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Univ Virginia, Dept Chem, Charlottesville, VA 22908 USA; Univ Virginia, Dept Pathol, Charlottesville, VA 22908 USA	University of Virginia; University of North Carolina; University of North Carolina Chapel Hill; University of Virginia; University of Virginia	Briggs, SD (corresponding author), Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.		Hunt, Donald F/I-6936-2012; Strahl, Brian/C-7601-2012	Hunt, Donald F/0000-0003-2815-6368; Strahl, Brian/0000-0002-4947-6259; Briggs, Scott D/0000-0003-2852-3594				Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Bryk M, 2002, CURR BIOL, V12, P165, DOI 10.1016/S0960-9822(01)00652-2; Dlakic M, 2001, TRENDS BIOCHEM SCI, V26, P405, DOI 10.1016/S0968-0004(01)01856-4; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6	11	376	391	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 1	2002	418	6897					498	498		10.1038/nature00970	http://dx.doi.org/10.1038/nature00970			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579EE	12152067	Bronze			2022-12-24	WOS:000177162800028
J	Moore, SA; Saito, F; Chen, JG; Michele, DE; Henry, MD; Messing, A; Cohn, RD; Ross-Barta, SE; Westra, S; Williamson, RA; Hoshi, T; Campbell, KP				Moore, SA; Saito, F; Chen, JG; Michele, DE; Henry, MD; Messing, A; Cohn, RD; Ross-Barta, SE; Westra, S; Williamson, RA; Hoshi, T; Campbell, KP			Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy	NATURE			English	Article							FUKUYAMA-TYPE; LAMININ; DISRUPTION; DEFICIENCY; MUTATIONS; INTEGRINS; MEMBRANE; COMPLEX; ROLES; MICE	Fukuyama congenital muscular dystrophy (FCMD), muscle-eye-brain disease (MEB), and Walker-Warburg syndrome are congenital muscular dystrophies (CMDs) with associated developmental brain defects(1-4). Mutations reported in genes of FCMD2 and MEB5 patients suggest that the genes may be involved in protein glycosylation. Dystroglycan is a highly glycosylated component of the muscle dystrophin-glycoprotein complex(6) that is also expressed in brain, where its function is unknown(7). Here we show that brain-selective deletion of dystroglycan in mice is sufficient to cause CMD-like brain malformations, including disarray of cerebral cortical layering, fusion of cerebral hemispheres and cerebellar folia, and aberrant migration of granule cells. Dystroglycan-null brain loses its high-affinity binding to the extracellular matrix protein laminin, and shows discontinuities in the pial surface basal lamina (glia limitans) that probably underlie the neuronal migration errors. Furthermore, mutant mice have severely blunted hippocampal long-term potentiation with electrophysiologic characterization indicating that dystroglycan might have a postsynaptic role in learning and memory. Our data strongly support the hypothesis that defects in dystroglycan are central to the pathogenesis of structural and functional brain abnormalities seen in CMD.	Univ Iowa, Howard Hughes Med Inst, Dept Physiol & Biophys, Iowa City, IA 52242 USA; Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA; Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA; Univ Iowa, Dept Obstet & Gynecol, Iowa City, IA 52242 USA; Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53705 USA	Howard Hughes Medical Institute; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Campbell, KP (corresponding author), Univ Iowa, Howard Hughes Med Inst, Dept Physiol & Biophys, Iowa City, IA 52242 USA.	kevin-campbell@uiowa.edu	Cohn, Ronald/AAC-5835-2021	Campbell, Kevin/0000-0003-2066-5889; Moore, Steven/0000-0002-6353-7900; Henry, Michael/0000-0002-7871-245X				Aravind L, 1999, CURR BIOL, V9, pR836, DOI 10.1016/S0960-9822(00)80039-1; Arikawa-Hirasawa E, 1999, NAT GENET, V23, P354, DOI 10.1038/15537; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Brockington M, 2001, AM J HUM GENET, V69, P1198, DOI 10.1086/324412; CHOI BH, 1994, MICROSC RES TECHNIQ, V28, P193, DOI 10.1002/jemt.1070280304; Cohn RD, 2000, MUSCLE NERVE, V23, P1456, DOI 10.1002/1097-4598(200010)23:10<1456::AID-MUS2>3.0.CO;2-T; Cormand B, 2001, NEUROLOGY, V56, P1059, DOI 10.1212/WNL.56.8.1059; De Arcangelis A, 1999, DEVELOPMENT, V126, P3957; Duclos F, 1998, J CELL BIOL, V142, P1461, DOI 10.1083/jcb.142.6.1461; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; FUKUYAMA Y, 1981, BRAIN DEV-JPN, V3, P1; Grady RM, 2000, NEURON, V25, P279, DOI 10.1016/S0896-6273(00)80894-6; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; GREWAL PK, 1908, NAT GENET, V28, P151; Haltia M, 1997, ANN NEUROL, V41, P173, DOI 10.1002/ana.410410208; Hayashi YK, 2001, NEUROLOGY, V57, P115, DOI 10.1212/WNL.57.1.115; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Henry MD, 1999, CURR OPIN CELL BIOL, V11, P602, DOI 10.1016/S0955-0674(99)00024-1; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; MALENKA RC, 1991, NEURON, V6, P53, DOI 10.1016/0896-6273(91)90121-F; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Miner JH, 1998, J CELL BIOL, V143, P1713, DOI 10.1083/jcb.143.6.1713; Potocnik AJ, 2000, IMMUNITY, V12, P653, DOI 10.1016/S1074-7613(00)80216-2; Ross ME, 2001, ANNU REV NEUROSCI, V24, P1041, DOI 10.1146/annurev.neuro.24.1.1041; SCHULZ PE, 1994, J NEUROSCI, V14, P5325; Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003; Williamson RA, 1997, HUM MOL GENET, V6, P831, DOI 10.1093/hmg/6.6.831; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3; Zaccaria ML, 2001, NEUROSCIENCE, V104, P311, DOI 10.1016/S0306-4522(01)00092-6; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	30	439	446	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 25	2002	418	6896					422	425		10.1038/nature00838	http://dx.doi.org/10.1038/nature00838			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576MU	12140559				2022-12-24	WOS:000177009700039
J	Bledsoe, RK; Montana, VG; Stanley, TB; Delves, CJ; Apolito, CJ; McKee, DD; Consler, TG; Parks, DJ; Stewart, EL; Willson, TM; Lambert, MH; Moore, JT; Pearce, KH; Xu, HE				Bledsoe, RK; Montana, VG; Stanley, TB; Delves, CJ; Apolito, CJ; McKee, DD; Consler, TG; Parks, DJ; Stewart, EL; Willson, TM; Lambert, MH; Moore, JT; Pearce, KH; Xu, HE			Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition	CELL			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; THYROID-HORMONE RECEPTOR; HEAT-SHOCK-PROTEIN; NUCLEAR RECEPTOR; STEROID-RECEPTOR; MOLECULAR-BASIS; ESTROGEN-RECEPTOR; ANDROGEN RECEPTOR; CO-REPRESSOR; HSP90	Transcriptional regulation by the glucocorticoid receptor (GR) is mediated by hormone binding, receptor dimerization, and coactivator recruitment. Here, we report the crystal structure of the human GR ligand binding domain (LBD) bound to dexamethasone and a coactivator motif derived from the transcriptional intermediary factor 2. Despite structural similarity to other steroid receptors, the GR LBD adopts a surprising dimer configuration involving formation of an intermolecular P sheet. Functional studies demonstrate that the novel dimer interface is important for GR-mediated activation. The structure also reveals an additional charge clamp that determines the binding selectivity of a coactivator and a distinct ligand binding pocket that explains its selectivity for endogenous steroid hormones. These results establish a framework for understanding the roles of protein-hormone and protein-protein interactions in GR signaling pathways.	GlaxoSmithKline, Computat Analyt & Strust Sci, Discovery Res, Res Triangle Pk, NC 27709 USA; GlaxoSmithKline, Nucl Receptor Syst Res, Discovery Res, Res Triangle Pk, NC 27709 USA; GlaxoSmithKline, High Throughput Chem, Discovery Res, Res Triangle Pk, NC 27709 USA; GlaxoSmithKline, High Throughput Biol, Discovery Res, Res Triangle Pk, NC 27709 USA; GlaxoSmithKline, Gene Express & Prot Biochem, Discovery Res, Stevenage SG1 2NY, Herts, England; GlaxoSmithKline, Gene Express & Prot Biochem, Discovery Res, Res Triangle Pk, NC 27709 USA	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Pearce, KH (corresponding author), Van Andel Res Inst, Lab Struct Sci, 333 Bostowick NE, Grand Rapids, MI 49503 USA.	kenneth.h.pearce@gsk.com; eric.xu@vai.org	Xu, H. Eric/ABD-7487-2021; feinstein, doug/M-9414-2019; ID, IMCACAT/D-5867-2014	Xu, H. Eric/0000-0002-6829-8144				Auwerx J, 1999, CELL, V97, P161; Barnes PJ, 1998, AM J RESP CRIT CARE, V157, pS1, DOI 10.1164/ajrccm.157.3.157315; BOURGUET W, 1995, NATURE, V375, P377, DOI 10.1038/375377a0; BRESNICK EH, 1989, J BIOL CHEM, V264, P4992; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Caamano CA, 1998, J BIOL CHEM, V273, P20473, DOI 10.1074/jbc.273.32.20473; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Cohn E. J., 1943, PROTEINS AMINO ACIDS; CONNOLLY ML, 1983, SCIENCE, V221, P709, DOI 10.1126/science.6879170; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; Ding XF, 1998, MOL ENDOCRINOL, V12, P302, DOI 10.1210/me.12.2.302; DURCHSCHLAG H, 1986, THERMODYNAMIC DATA B, P45; Escriva H, 2000, BIOESSAYS, V22, P717; Freeman BC, 2000, GENE DEV, V14, P422; Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7; GARABEDIAN MJ, 1992, MOL BIOL CELL, V3, P1245, DOI 10.1091/mbc.3.11.1245; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; LAMBERT MH, 1997, PRACTICAL APPL COMPU, P243; LeDouarin B, 1996, EMBO J, V15, P6701, DOI 10.1002/j.1460-2075.1996.tb01060.x; List HJ, 1999, EXP CELL RES, V250, P414, DOI 10.1006/excr.1999.4517; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; Matias PM, 2000, J BIOL CHEM, V275, P26164, DOI 10.1074/jbc.M004571200; McKay LI, 1999, ENDOCR REV, V20, P435, DOI 10.1210/er.20.4.435; Moore LB, 2000, J BIOL CHEM, V275, P15122, DOI 10.1074/jbc.M001215200; Morishima Y, 2000, J BIOL CHEM, V275, P18054, DOI 10.1074/jbc.M000434200; NAVAZA J, 1992, MOL REPLACEMENT, P87; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; ONATE SA, 1995, SCIENCE, V270, P1354; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PICARD D, 1990, NATURE, V348, P166, DOI 10.1038/348166a0; Ping DS, 1999, J IMMUNOL, V162, P727; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; Reichardt HM, 2000, ADV PHARMACOL, V47, P1; RENAUD JP, 1995, NATURE, V378, P681, DOI 10.1038/378681a0; Sack JS, 2001, P NATL ACAD SCI USA, V98, P4904, DOI 10.1073/pnas.081565498; Savory JGA, 2001, MOL CELL BIOL, V21, P781, DOI 10.1128/MCB.21.3.781-793.2001; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Valentine JE, 2000, J BIOL CHEM, V275, P25322, DOI 10.1074/jbc.M002497200; Voegel JJ, 1998, EMBO J, V17, P507, DOI 10.1093/emboj/17.2.507; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; WAGNER RL, 1995, NATURE, V378, P690, DOI 10.1038/378690a0; Werner S, 1996, STEROIDS, V61, P216, DOI 10.1016/0039-128X(96)00017-7; Williams SP, 1998, NATURE, V393, P392, DOI 10.1038/30775; Willson TM, 1996, J MED CHEM, V39, P665, DOI 10.1021/jm950395a; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; Xu HE, 2001, P NATL ACAD SCI USA, V98, P13919, DOI 10.1073/pnas.241410198; Xu HE, 2002, NATURE, V415, P813, DOI 10.1038/415813a; Zhang SM, 1996, MOL ENDOCRINOL, V10, P24, DOI 10.1210/me.10.1.24	51	626	659	0	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 12	2002	110	1					93	105		10.1016/S0092-8674(02)00817-6	http://dx.doi.org/10.1016/S0092-8674(02)00817-6			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	573PU	12151000	Bronze			2022-12-24	WOS:000176840700010
J	Chen, CR; Kang, YB; Siegel, PM; Massague, J				Chen, CR; Kang, YB; Siegel, PM; Massague, J			E2F4/5 and p107 as Smad cofactors linking the TGF beta receptor to c-myc repression	CELL			English	Article							GROWTH-FACTOR-BETA; CELL-CYCLE ARREST; TRANSCRIPTION FACTORS; STRUCTURAL BASIS; DNA-BINDING; FUNCTIONAL INTERACTION; TARGETED DISRUPTION; MICE LACKING; CANCER CELLS; IN-VIVO	Smad3 is a direct mediator of transcriptional activation by the TGFbeta receptor. Its target genes in epithelial cells include cyclin-dependent kinase inhibitors that generate a cytostatic reponse. We defined how, in the same context, Smad3 can also mediate transcriptional repression of the growth-promoting gene c-myc. A complex containing Smad3, the transcription factors E2F4/5 and DP1, and the corepressor p107 preexists in the cytoplasm. In response to TGFbeta, this complex moves into the nucleus and associates with Smad4, recognizing a composite Smad-E2F site on c-myc for repression. Previously known as the ultimate recipients of cdk regulatory signals, E2F4/5 and p107 act here as transducers of TGFbeta receptor signals upstream of cdk. Smad proteins therefore mediate transcriptional activation or repression depending on their associated partners.	Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, Cell Biol Program, New York, NY 10021 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Massague, J (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, Cell Biol Program, 1275 York Ave, New York, NY 10021 USA.			Massague, Joan/0000-0001-9324-8408; Kang, Yibin/0000-0002-1626-6730				ALEXANDROW MG, 1995, CANCER RES, V55, P1452; Ashcroft GS, 1999, NAT CELL BIOL, V1, P260, DOI 10.1038/12971; Bai RY, 2002, NAT CELL BIOL, V4, P181, DOI 10.1038/ncb753; Bonni S, 2001, NAT CELL BIOL, V3, P587, DOI 10.1038/35078562; Bottinger EP, 1997, KIDNEY INT, V51, P1355, DOI 10.1038/ki.1997.185; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; BUCKLES R, 1995, J URBAN TECHNOL, V2, P31, DOI 10.1080/10630739508724497; Calonge MJ, 1999, J BIOL CHEM, V274, P33637, DOI 10.1074/jbc.274.47.33637; Chen CR, 2001, P NATL ACAD SCI USA, V98, P992, DOI 10.1073/pnas.98.3.992; Chen X, 1997, NATURE, V389, P85, DOI 10.1038/38008; Chen YG, 1998, GENE DEV, V12, P2144, DOI 10.1101/gad.12.14.2144; Claassen GF, 2000, P NATL ACAD SCI USA, V97, P9498, DOI 10.1073/pnas.150006697; Classon M, 2001, EXP CELL RES, V264, P135, DOI 10.1006/excr.2000.5135; Cobrinik D, 1996, GENE DEV, V10, P1633, DOI 10.1101/gad.10.13.1633; Depoortere F, 2000, MOL BIOL CELL, V11, P1061, DOI 10.1091/mbc.11.3.1061; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; Eisenman RN, 2001, GENE DEV, V15, P2023, DOI 10.1101/gad928101; Feng XH, 1998, GENE DEV, V12, P2153, DOI 10.1101/gad.12.14.2153; Gaubatz S, 2000, MOL CELL, V6, P729, DOI 10.1016/S1097-2765(00)00071-X; Germain S, 2000, GENE DEV, V14, P435; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Hata A, 2000, CELL, V100, P229, DOI 10.1016/S0092-8674(00)81561-5; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Huse M, 2001, MOL CELL, V8, P671, DOI 10.1016/S1097-2765(01)00332-X; Iavarone A, 1999, MOL CELL BIOL, V19, P916; Janknecht R, 1998, GENE DEV, V12, P2114, DOI 10.1101/gad.12.14.2114; Jayaraman L, 2000, J BIOL CHEM, V275, P40710, DOI 10.1074/jbc.M005799200; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Labbe E, 1998, MOL CELL, V2, P109, DOI 10.1016/S1097-2765(00)80119-7; LeCouter JE, 1998, MOL CELL BIOL, V18, P7455, DOI 10.1128/MCB.18.12.7455; Lee MH, 1996, GENE DEV, V10, P1621, DOI 10.1101/gad.10.13.1621; LEES JA, 1993, MOL CELL BIOL, V13, P7813, DOI 10.1128/MCB.13.12.7813; Lo RS, 1998, EMBO J, V17, P996, DOI 10.1093/emboj/17.4.996; Luo KX, 1999, GENE DEV, V13, P2196, DOI 10.1101/gad.13.17.2196; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Moberg K, 1996, MOL CELL BIOL, V16, P1436; Mulligan G, 1998, TRENDS GENET, V14, P223, DOI 10.1016/S0168-9525(98)01470-X; Pouponnot C, 1998, J BIOL CHEM, V273, P22865, DOI 10.1074/jbc.273.36.22865; Qin BY, 2001, MOL CELL, V8, P1303, DOI 10.1016/S1097-2765(01)00417-8; Randall RA, 2002, EMBO J, V21, P145, DOI 10.1093/emboj/21.1.145; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; REYNISDOTTIR I, 1995, GENE DEV, V9, P1831, DOI 10.1101/gad.9.15.1831; Reynisdottir I, 1997, GENE DEV, V11, P492, DOI 10.1101/gad.11.4.492; ROBERTS AB, 1986, P NATL ACAD SCI USA, V83, P4167, DOI 10.1073/pnas.83.12.4167; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; SANCHEZ A, 1995, J CELL PHYSIOL, V165, P398, DOI 10.1002/jcp.1041650221; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Shen X, 1998, MOL BIOL CELL, V9, P3309, DOI 10.1091/mbc.9.12.3309; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Shi YG, 1997, NATURE, V388, P87, DOI 10.1038/40431; Sun Y, 1999, MOL CELL, V4, P499, DOI 10.1016/S1097-2765(00)80201-4; Takahashi Y, 2000, GENE DEV, V14, P804; Tommasi S, 1997, J BIOL CHEM, V272, P30483, DOI 10.1074/jbc.272.48.30483; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Truant R, 1999, J BIOL CHEM, V274, P32167, DOI 10.1074/jbc.274.45.32167; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; VAIRO G, 1995, GENE DEV, V9, P869, DOI 10.1101/gad.9.7.869; Warner BJ, 1999, MOL CELL BIOL, V19, P5913; Whitman M, 1998, GENE DEV, V12, P2445, DOI 10.1101/gad.12.16.2445; Wotton D, 1999, CELL, V97, P29, DOI 10.1016/S0092-8674(00)80712-6; Wu G, 2000, SCIENCE, V287, P92, DOI 10.1126/science.287.5450.92; Wu JW, 2001, MOL CELL, V8, P1277, DOI 10.1016/S1097-2765(01)00421-X; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593; Yagi K, 2002, J BIOL CHEM, V277, P854, DOI 10.1074/jbc.M104170200; Zavadil J, 2001, P NATL ACAD SCI USA, V98, P6686, DOI 10.1073/pnas.111614398; ZHANG YH, 1995, ONCOGENE, V10, P2085; Zheng N, 1999, GENE DEV, V13, P666, DOI 10.1101/gad.13.6.666; Zhu YA, 1998, CELL, V94, P703, DOI 10.1016/S0092-8674(00)81730-4; Zwicker J, 1996, SCIENCE, V271, P1595, DOI 10.1126/science.271.5255.1595	73	358	382	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 12	2002	110	1					19	32		10.1016/S0092-8674(02)00801-2	http://dx.doi.org/10.1016/S0092-8674(02)00801-2			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	573PU	12150994	Bronze			2022-12-24	WOS:000176840700004
J	Martin, BR				Martin, BR			Medical marijuana - moving beyond the smoke	LANCET			English	Editorial Material							SYMPTOMS		Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA	Virginia Commonwealth University	Martin, BR (corresponding author), Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Med Coll Virginia Campus, Richmond, VA 23298 USA.							*AM MED ASS, 1998, SUBJ MED MAR; Benson J.A., 1999, MARIJUANA MED; British Medical Association, 1997, THER US CANN; Cabral GA, 1998, J NEUROIMMUNOL, V83, P116, DOI 10.1016/S0165-5728(97)00227-0; Haney M, 1999, PSYCHOPHARMACOLOGY, V141, P395, DOI 10.1007/s002130050849; *HLTH COUNC NETH S, 1996, MAR MED; Martin BR, 1998, NEUROBIOL DIS, V5, P447, DOI 10.1006/nbdi.1998.0218; MARTIN BR, 2002, NEUROPSYCHOPHARMACOL, P1519; *NIH, 1997, WORKSH MED UT MAR BE; Solowij N, 2002, JAMA-J AM MED ASSOC, V287, P1123, DOI 10.1001/jama.287.9.1123; TASHKIN DP, 1987, AM REV RESPIR DIS, V135, P209; World Health Organization, 1997, CANN HLTH PERSP RES	12	6	6	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 6	2002	360	9326					4	5		10.1016/S0140-6736(02)09360-1	http://dx.doi.org/10.1016/S0140-6736(02)09360-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	569JR	12114033				2022-12-24	WOS:000176599700004
J	Terman, JR; Mao, TY; Pasterkamp, RJ; Yu, HH; Kolodkin, AL				Terman, JR; Mao, TY; Pasterkamp, RJ; Yu, HH; Kolodkin, AL			MICALs, a family of conserved flavoprotein oxidoreductases, function in plexin-mediated axonal repulsion	CELL			English	Article							FAD-BINDING; ESCHERICHIA-COLI; SEMAPHORIN-III; GUIDANCE; TRANSMEMBRANE; PROJECTIONS; DROSOPHILA; MECHANISM; PROTEINS; DOMAIN	Members of the semaphorin family of secreted and transmembrane proteins utilize plexins as neuronal receptors to signal repulsive axon guidance. It remains unknown how plexin proteins are directly linked to the regulation of cytoskeletal dynamics. Here, we show that Drosophila MICAL, a large, multidomain, cytosolic protein expressed in axons, interacts with the neuronal plexin A (PlexA) receptor and is required for Semaphorin 1a (Sema-1a)-PlexA-mediated repulsive axon guidance. In addition to containing several domains known to interact with cytoskeletal components, MICAL has a flavoprotein monooxygenase domain, the integrity of which is required for Sema-1a-PlexA repulsive axon guidance. Vertebrate orthologs of Drosophila MICAL are neuronally expressed and also interact with vertebrate plexins, and monooxygenase inhibitors abrogate semaphorin-mediated axonal repulsion. These results suggest a novel role for oxidoreductases in repulsive neuronal guidance.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University	Kolodkin, AL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.		Yu, Hung-Hsiang/AGP-0497-2022	Yu, Hung-Hsiang/0000-0002-2430-9251; Mao, Tianyi/0000-0002-3532-8319; Pasterkamp, Jeroen/0000-0003-1631-6440				Abe I, 2000, BIOCHEM BIOPH RES CO, V268, P767, DOI 10.1006/bbrc.2000.2217; Abe I, 2000, FEBS LETT, V483, P131, DOI 10.1016/S0014-5793(00)02100-1; Bach I, 2000, MECH DEVELOP, V91, P5, DOI 10.1016/S0925-4773(99)00314-7; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bretscher A, 2000, ANNU REV CELL DEV BI, V16, P113, DOI 10.1146/annurev.cellbio.16.1.113; Cheng HJ, 2001, NEURON, V32, P249, DOI 10.1016/S0896-6273(01)00478-0; Dalle-Donne I, 2001, FREE RADICAL BIO MED, V31, P1624, DOI 10.1016/S0891-5849(01)00749-3; Dalle-Donne I, 2001, FREE RADICAL BIO MED, V31, P1075, DOI 10.1016/S0891-5849(01)00690-6; Dym O, 2001, PROTEIN SCI, V10, P1712, DOI 10.1110/ps.12801; EGGINK G, 1990, J MOL BIOL, V212, P135, DOI 10.1016/0022-2836(90)90310-I; Eppink MHM, 1997, PROTEIN SCI, V6, P2454; FAN JH, 1993, J CELL BIOL, V121, P867, DOI 10.1083/jcb.121.4.867; Finkel T, 1998, CURR OPIN CELL BIOL, V10, P248, DOI 10.1016/S0955-0674(98)80147-6; Gimona M, 2002, FEBS LETT, V513, P98, DOI 10.1016/S0014-5793(01)03240-9; GOLEMIS EA, 1994, CURRENT PROTOCOLS MO; Goodman CS, 1999, CELL, V97, P551, DOI 10.1016/S0092-8674(00)80766-7; Harris BZ, 2001, J CELL SCI, V114, P3219; HE Z, 2002, SCI STKE, V119; HOSOKAWA K, 1966, J BIOL CHEM, V241, P2453; Juurlink B H, 1998, J Spinal Cord Med, V21, P309; Kim SO, 2002, CELL, V109, P383, DOI 10.1016/S0092-8674(02)00723-7; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Kubo A, 1997, ARCH BIOCHEM BIOPHYS, V345, P271, DOI 10.1006/abbi.1997.0242; Landgraf M, 1997, J NEUROSCI, V17, P9642; LAWTON MP, 1993, J BIOL CHEM, V268, P5728; Lindsay H, 2000, J BIOL CHEM, V275, P36665, DOI 10.1074/jbc.M004777200; Liu BP, 2001, CURR OPIN CELL BIOL, V13, P619, DOI 10.1016/S0955-0674(00)00260-X; Macheroux P, 1999, METH MOL B, V131, P1; MASSEY V, 1994, J BIOL CHEM, V269, P22459; MASSEY V, 1995, FASEB J, V9, P473, DOI 10.1096/fasebj.9.7.7737454; MATTHES DJ, 1995, CELL, V81, P631, DOI 10.1016/0092-8674(95)90084-5; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; Milzani A, 1997, ARCH BIOCHEM BIOPHYS, V339, P267, DOI 10.1006/abbi.1996.9847; O'Neill GM, 2000, TRENDS CELL BIOL, V10, P111, DOI 10.1016/S0962-8924(99)01714-6; Pasterkamp RJ, 1998, J NEUROSCI, V18, P9962; Raper JA, 2000, CURR OPIN NEUROBIOL, V10, P88, DOI 10.1016/S0959-4388(99)00057-4; Rhee S. G., 2000, SCI STKE, V53; SCHULZ GE, 1992, CURR OPIN STRUC BIOL, V2, P61; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; Suzuki T, 2002, J BIOL CHEM, V277, P14933, DOI 10.1074/jbc.M111842200; Takahashi T, 2001, NEURON, V29, P429, DOI 10.1016/S0896-6273(01)00216-1; Tamagnone L, 2000, TRENDS CELL BIOL, V10, P377, DOI 10.1016/S0962-8924(00)01816-X; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Vallon O, 2000, PROTEINS, V38, P95, DOI 10.1002/(SICI)1097-0134(20000101)38:1<95::AID-PROT10>3.0.CO;2-A; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; White DJ, 2001, MOL MICROBIOL, V42, P503, DOI 10.1046/j.1365-2958.2001.02659.x; Whitford KL, 2001, NEURON, V32, P1, DOI 10.1016/S0896-6273(01)00459-7; WIERENGA RK, 1986, J MOL BIOL, V187, P101, DOI 10.1016/0022-2836(86)90409-2; Winberg ML, 1998, CELL, V93, P581, DOI 10.1016/S0092-8674(00)81187-3; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8; Xu XM, 2000, J NEUROSCI, V20, P2638; Yu HH, 1998, NEURON, V20, P207, DOI 10.1016/S0896-6273(00)80450-X	53	273	285	1	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 28	2002	109	7					887	900		10.1016/S0092-8674(02)00794-8	http://dx.doi.org/10.1016/S0092-8674(02)00794-8			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	570KJ	12110185	Bronze			2022-12-24	WOS:000176657200011
J	Prezant, DJ; Weiden, M; Banauch, GI; McGuinness, G; Rom, WN; Aldrich, TK; Kelly, KJ				Prezant, DJ; Weiden, M; Banauch, GI; McGuinness, G; Rom, WN; Aldrich, TK; Kelly, KJ			Cough and bronchial responsiveness in firefighters at the World Trade Center site	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HIGH-RESOLUTION CT; AIRWAY RESPONSIVENESS; RESPIRATORY SYMPTOMS; CHRYSOTILE ASBESTOS; PERSISTENT ASTHMA; METHACHOLINE; EXPOSURE; HYPERREACTIVITY; ISOCYANATES; CHALLENGE	Background: Workers from the Fire Department of New York City were exposed to a variety of inhaled materials during and after the collapse of the World Trade Center. We evaluated clinical features in a series of 332 firefighters in whom severe cough developed after exposure and the prevalence and severity of bronchial hyperreactivity in firefighters without severe cough classified according to the level of exposure. Methods: ``World Trade Center cough'' was defined as a persistent cough that developed after exposure to the site and was accompanied by respiratory symptoms severe enough to require medical leave for at least four weeks. Evaluation of exposed firefighters included completion of a standard questionnaire, spirometry, airway-responsiveness testing, and chest imaging. Results: In the first six months after September 11, 2001, World Trade Center cough occurred in 128 of 1636 firefighters with a high level of exposure (8 percent), 187 of 6958 with a moderate level of exposure (3 percent), and 17 of 1320 with a low level of exposure (1 percent). In addition, 95 percent had symptoms of dyspnea, 87 percent had gastroesophageal reflux disease, and 54 percent had nasal congestion. Of those tested before treatment of World Trade Center cough, 63 percent of firefighters (149 of 237) had a response to a bronchodilator and 24 percent (9 of 37) had bronchial hyperreactivity. Chest radiographs were unchanged from precollapse findings in 319 of the 332 with World Trade Center cough. Among the cohort without severe cough, bronchial hyperreactivity was present in 77 firefighters with a high level of exposure (23 percent) and 26 with a moderate level of exposure (8 percent). Conclusions: Intense, short-term exposure to materials generated during the collapse of the World Trade Center was associated with bronchial responsiveness and the development of cough. Clinical and physiological severity was related to the intensity of exposure.	Fire Dept New York City, Bur Hlth Serv, New York, NY USA; Albert Einstein Coll Med, Bronx, NY 10467 USA; Montefiore Med Ctr, Dept Med, Div Pulm Med, Bronx, NY 10467 USA; NYU, Sch Med, Dept Med, Div Pulm & Crit Care Med, New York, NY USA; NYU, Sch Med, Dept Environm Med, New York, NY USA; NYU, Sch Med, Dept Radiol, New York, NY USA	Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; New York University; New York University; New York University	Prezant, DJ (corresponding author), Montefiore Med Ctr, Div Pulm, Centennial 423, Bronx, NY 10467 USA.	prezand@fdny.nyc.gov		Rom, William/0000-0002-8793-7028; McGuinness, Georgeann/0000-0002-5326-9180	PHS HHS [M010096] Funding Source: Medline; ODCDC CDC HHS [U1Q/CCU221158-01] Funding Source: Medline; NIOSH CDC HHS [R01-OH07350] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); ODCDC CDC HHS; NIOSH CDC HHS		[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; [Anonymous], 2001, MMWR-MORBID MORTAL W, V51, P453; Arakawa H, 1998, AM J ROENTGENOL, V170, P1349, DOI 10.2214/ajr.170.5.9574614; BROOKS SM, 1985, CHEST, V88, P376, DOI 10.1378/chest.88.3.376; CHIA KS, 1990, BRIT J IND MED, V47, P524; Crapo RO, 2000, AM J RESP CRIT CARE, V161, P309; EBER CD, 1993, J COMPUT ASSIST TOMO, V17, P853, DOI 10.1097/00004728-199311000-00003; ERNST P, 1989, THORAX, V44, P116, DOI 10.1136/thx.44.2.116; Field SK, 2002, CHEST, V121, P1024, DOI 10.1378/chest.121.4.1024; HARGREAVE FE, 1985, AIRWAY RESPONSIVENES, P94; HARLESS KW, 1978, ENVIRON RES, V16, P360, DOI 10.1016/0013-9351(78)90169-X; HERVE P, 1986, AM REV RESPIR DIS, V134, P986, DOI 10.1164/arrd.1986.134.5.986; HUDGEL DW, 1988, J LAB CLIN MED, V111, P684; Irwin RS, 1997, ARCH INTERN MED, V157, P1981, DOI 10.1001/archinte.157.17.1981; Irwin RS, 2000, NEW ENGL J MED, V343, P1715, DOI 10.1056/NEJM200012073432308; IRWIN RS, 1990, AM REV RESPIR DIS, V141, P640, DOI 10.1164/ajrccm/141.3.640; JACK CIA, 1995, THORAX, V50, P201, DOI 10.1136/thx.50.2.201; KINSELLA J, 1991, LANCET, V337, P595, DOI 10.1016/0140-6736(91)91650-J; KNUDSON RJ, 1983, AM REV RESPIR DIS, V127, P725; KORN RJ, 1987, AM REV RESPIR DIS, V136, P298, DOI 10.1164/ajrccm/136.2.298; KOUFMAN JA, 1998, OTOLARYNGOLOGY HEAD; Lemiere C, 1996, MED CLIN N AM, V80, P749, DOI 10.1016/S0025-7125(05)70466-1; MAPP CE, 1988, AM REV RESPIR DIS, V137, P1326, DOI 10.1164/ajrccm/137.6.1326; Petran M, 2000, OCCUP MED-OXFORD, V50, P103, DOI 10.1093/occmed/50.2.103; PRATTER MR, 1993, ANN INTERN MED, V119, P977, DOI 10.7326/0003-4819-119-10-199311150-00003; RIJCKEN B, 1987, AM REV RESPIR DIS, V136, P62, DOI 10.1164/ajrccm/136.1.62; RIJCKEN B, 1993, AM REV RESPIR DIS, V147, P1447, DOI 10.1164/ajrccm/147.6_Pt_1.1447; RODRIGUEZROISIN R, 1986, B EUR PHYSIOPATH RES, V22, P225; SAETTA M, 1995, AM J RESP CRIT CARE, V151, P489, DOI 10.1164/ajrccm.151.2.7842211; SHERMAN CB, 1989, AM REV RESPIR DIS, V140, P185, DOI 10.1164/ajrccm/140.1.185; Tarlo SM, 2000, OCCUP MED, V15, P471; Townsend MC, 2000, J OCCUP ENVIRON MED, V42, P228, DOI 10.1097/00043764-200003000-00003; VANGANSE WF, 1972, AM REV RESPIR DIS, V105, P30; Verlato G, 1996, EUR RESPIR J, V9, P506, DOI 10.1183/09031936.96.09030506; Vijayan VK, 1996, EUR RESPIR J, V9, P1977, DOI 10.1183/09031936.96.09101977; WRIGHT RA, 1990, GASTROENTEROLOGY, V99, P71, DOI 10.1016/0016-5085(90)91231-T; Zuskin E, 1998, J OCCUP ENVIRON MED, V40, P814, DOI 10.1097/00043764-199809000-00011	37	322	324	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 12	2002	347	11					806	815		10.1056/NEJMoa021300	http://dx.doi.org/10.1056/NEJMoa021300			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592DK	12226151	Bronze			2022-12-24	WOS:000177921300005
J	Seifritz, E; Esposito, F; Hennel, F; Mustovic, H; Neuhoff, JG; Bilecen, D; Tedeschi, G; Scheffler, K; Di Salle, F				Seifritz, E; Esposito, F; Hennel, F; Mustovic, H; Neuhoff, JG; Bilecen, D; Tedeschi, G; Scheffler, K; Di Salle, F			Spatiotemporal pattern of neural processing in the human auditory cortex	SCIENCE			English	Article							INDEPENDENT COMPONENT ANALYSIS; BLIND SEPARATION; CORTICAL-NEURONS; FUNCTIONAL MRI; FMRI DATA; SOUNDS; BRAIN; TONES; NOISE	The principles that the auditory cortex uses to decipher a stream of acoustic information have remained elusive. Neural responses in the animal auditory cortex can be broadly classified into transient and sustained activity. We examined the existence of similar principles in the human brain. Sound-evoked, blood oxygen level-dependent signal response was decomposed temporally into independent transient and sustained constituents, which predominated in different portions-core and belt-of the auditory cortex. Converging with unit recordings, our data suggest that this spatiotemporal pattern in the auditory cortex may represent a fundamental principle of analyzing sound information.	Univ Basel, Dept Psychiat, CH-4025 Basel, Switzerland; Univ Naples 2, Div Neurol 2, I-80138 Naples, Italy; Ctr Hosp, Fdn Rech Appl Psychiat, Magnet Resonance Dept, F-68250 Rouffach, France; Coll Wooster, Dept Psychol, Wooster, OH 44691 USA; Univ Basel, Dept Radiol, CH-4031 Basel, Switzerland; Univ Freiburg, Dept Radiol, Sect Med Phys, D-79106 Freiburg, Germany; Univ Naples Federico II, Dept Neurol Sci, Div Neuroradiol, I-80127 Naples, Italy	University of Basel; Universita della Campania Vanvitelli; College of Wooster; University of Basel; University of Freiburg; University of Naples Federico II	Seifritz, E (corresponding author), Univ Basel, Dept Psychiat, CH-4025 Basel, Switzerland.		Neuhoff, John G/A-2955-2016; Esposito, Fabrizio/M-8555-2015	Esposito, Fabrizio/0000-0002-5099-9786; Hennel, Franciszek/0000-0003-0043-9921; Di Salle, Francesco/0000-0002-0226-8460; Scheffler, Klaus/0000-0001-6316-8773				Atzori M, 2001, NAT NEUROSCI, V4, P1230, DOI 10.1038/nn760; Bandettini PA, 1998, MAGNET RESON MED, V39, P410, DOI 10.1002/mrm.1910390311; Belin P, 1999, NEUROIMAGE, V10, P417, DOI 10.1006/nimg.1999.0480; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Biswal BB, 1999, J COMPUT ASSIST TOMO, V23, P265, DOI 10.1097/00004728-199903000-00016; Brown GD, 2001, TRENDS NEUROSCI, V24, P54, DOI 10.1016/S0166-2236(00)01683-0; Calhoun VD, 2001, HUM BRAIN MAPP, V13, P43, DOI 10.1002/hbm.1024; Duann JR, 2002, NEUROIMAGE, V15, P823, DOI 10.1006/nimg.2001.1049; Eggermont JJ, 2002, J NEUROPHYSIOL, V87, P305, DOI 10.1152/jn.00490.2001; EHRET G, 1997, CENTRAL AUDITORY SYS; Friston K.J., 1994, HUMAN BRAIN MAPPING, V2, P211, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Giraud AL, 2000, J NEUROPHYSIOL, V84, P1588, DOI 10.1152/jn.2000.84.3.1588; Hackett TA, 2001, J COMP NEUROL, V441, P197, DOI 10.1002/cne.1407; HENNEL F, 1998, MAGMA S, V6, P87; Kilgard MP, 1998, NAT NEUROSCI, V1, P727, DOI 10.1038/3729; Lu T, 2001, NAT NEUROSCI, V4, P1131, DOI 10.1038/nn737; Makeig S, 2002, SCIENCE, V295, P690, DOI 10.1126/science.1066168; McKeown MJ, 1998, HUM BRAIN MAPP, V6, P160, DOI 10.1002/(SICI)1097-0193(1998)6:3<160::AID-HBM5>3.3.CO;2-R; MIDDLEBROOKS JC, 1994, SCIENCE, V264, P842, DOI 10.1126/science.8171339; Miller LM, 2001, NEURON, V32, P151, DOI 10.1016/S0896-6273(01)00445-7; Nagarajan SS, 2002, J NEUROPHYSIOL, V87, P1723, DOI 10.1152/jn.00632.2001; PANTEV C, 1991, P NATL ACAD SCI USA, V88, P8996, DOI 10.1073/pnas.88.20.8996; Penhune VB, 1996, CEREB CORTEX, V6, P661, DOI 10.1093/cercor/6.5.661; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; Recanzone GH, 2000, HEARING RES, V150, P104, DOI 10.1016/S0378-5955(00)00194-5; Robson MD, 1998, NEUROIMAGE, V7, P185, DOI 10.1006/nimg.1998.0322; Tian B, 2001, SCIENCE, V292, P290, DOI 10.1126/science.1058911; Wessinger CM, 2001, J COGNITIVE NEUROSCI, V13, P1, DOI 10.1162/089892901564108; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7	31	166	171	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 6	2002	297	5587					1706	1708		10.1126/science.1074355	http://dx.doi.org/10.1126/science.1074355			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590JE	12215648				2022-12-24	WOS:000177819100051
J	Doyle, MR; Davis, SJ; Bastow, RM; McWatters, HG; Kozma-Bognar, L; Nagy, F; Millar, AJ; Amasino, RM				Doyle, MR; Davis, SJ; Bastow, RM; McWatters, HG; Kozma-Bognar, L; Nagy, F; Millar, AJ; Amasino, RM			The ELF4 gene controls circadian rhythms and flowering time in Arabidopsis thaliana	NATURE			English	Article							HYPOCOTYL ELONGATION; CLOCK; PROTEIN; ENCODES; PHOTOMORPHOGENESIS; DYSFUNCTION; MUTAGENESIS; EXPRESSION; PHYB; TOC1	Many plants use day length as an environmental cue to ensure proper timing of the switch from vegetative to reproductive growth. Day-length sensing involves an interaction between the relative length of day and night, and endogenous rhythms that are controlled by the plant circadian clock(1). Thus, plants with defects in circadian regulation cannot properly regulate the timing of the floral transition(2). Here we describe the gene EARLY FLOWERING 4 (ELF4), which is involved in photoperiod perception and circadian regulation. ELF4 promotes clock accuracy and is required for sustained rhythms in the absence of daily light/dark cycles. elf4 mutants show attenuated expression of CIRCADIAN CLOCK ASSOCIATED 1 (CCA1), a gene that is thought to function as a central oscillator component(3,4). In addition, elf4 plants transiently show output rhythms with highly variable period lengths before becoming arrhythmic. Mutations in elf4 result in early flowering in non-inductive photoperiods, which is probably caused by elevated amounts of CONSTANS (CO), a gene that promotes floral induction(5).	Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Univ Wisconsin, Mol & Cellular Biol Program, Madison, WI 53706 USA; Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; Biol Res Ctr, Inst Plant Biol, H-6726 Szeged, Hungary	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Warwick; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	Amasino, RM (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.	Andrew.Millar@warwick.ac.uk; amasino@biochemwisc.edu	Nagy, Ferenc/D-3532-2015; Millar, Andrew J/G-2423-2012; Kozma-Bognar, Laszlo/L-8384-2018	Nagy, Ferenc/0000-0002-6157-9269; Millar, Andrew J/0000-0003-1756-3654; Kozma-Bognar, Laszlo/0000-0002-8289-193X				Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; ARONSON BD, 1994, P NATL ACAD SCI USA, V91, P7683, DOI 10.1073/pnas.91.16.7683; Bell-Pedersen D, 2001, PHILOS T ROY SOC B, V356, P1697, DOI 10.1098/rstb.2001.0968; Bognar LK, 1999, P NATL ACAD SCI USA, V96, P14652, DOI 10.1073/pnas.96.25.14652; Carre IA, 1995, PLANT CELL, V7, P2039, DOI 10.2307/3870149; Carre IA, 2001, J BIOL RHYTHM, V16, P415, DOI 10.1177/074873001129002006; Covington MF, 2001, PLANT CELL, V13, P1305, DOI 10.1105/tpc.13.6.1305; Davis SJ, 2001, PLANT PHYSIOL, V126, P656, DOI 10.1104/pp.126.2.656; Dowson-Day MJ, 1999, PLANT J, V17, P63, DOI 10.1046/j.1365-313X.1999.00353.x; FELDMANN KA, 1991, PLANT J, V1, P71, DOI 10.1111/j.1365-313X.1991.00071.x; Hicks KA, 1996, SCIENCE, V274, P790, DOI 10.1126/science.274.5288.790; Hicks KA, 2001, PLANT CELL, V13, P1281, DOI 10.1105/tpc.13.6.1281; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; Liu XL, 2001, PLANT CELL, V13, P1293, DOI 10.1105/tpc.13.6.1293; McWatters HG, 2000, NATURE, V408, P716, DOI 10.1038/35047079; Onouchi H, 2000, PLANT CELL, V12, P885, DOI 10.1105/tpc.12.6.885; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; Reed JW, 2000, PLANT PHYSIOL, V122, P1149, DOI 10.1104/pp.122.4.1149; Samach A, 2000, BIOESSAYS, V22, P38, DOI 10.1002/(SICI)1521-1878(200001)22:1&lt;38::AID-BIES8&gt;3.0.CO;2-L; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Thomas B., 1997, PHOTOPERIODISM PLANT; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Zagotta MT, 1996, PLANT J, V10, P691, DOI 10.1046/j.1365-313X.1996.10040691.x	25	357	383	6	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 5	2002	419	6902					74	77		10.1038/nature00954	http://dx.doi.org/10.1038/nature00954			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589YF	12214234				2022-12-24	WOS:000177788600039
J	Allen, AP; Brown, JH; Gillooly, JF				Allen, AP; Brown, JH; Gillooly, JF			Global biodiversity, biochemical kinetics, and the energetic-equivalence rule	SCIENCE			English	Article							SPECIES-DIVERSITY; SCALE PATTERNS; TEMPERATURE; GRADIENTS; RICHNESS; SIZE	The latitudinal gradient of increasing biodiversity from poles to equator is one of the most prominent but least understood features of life on Earth. Here we show that species diversity can be predicted from the biochemical kinetics of metabolism. We first demonstrate that the average energy flux of populations is temperature invariant. We then derive a model that quantitatively predicts how species diversity increases with environmental temperature. Predictions are supported by data for terrestrial, freshwater, and marine taxa along latitudinal and elevational gradients. These results establish a thermodynamic basis for the regulation of species diversity and the organization of ecological communities.	Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA	University of New Mexico	Allen, AP (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.	drewa@unm.edu	Allen, Andrew/B-8045-2011	Allen, Andrew/0000-0003-0304-7544				Brown J.H., 1998, BIOGEOGRAPHY; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; CURRIE DJ, 1991, AM NAT, V137, P27, DOI 10.1086/285144; DAMUTH J, 1987, BIOL J LINN SOC, V31, P193, DOI 10.1111/j.1095-8312.1987.tb01990.x; DUELLMAN WE, 1988, ANN MO BOT GARD, V75, P79, DOI 10.2307/2399467; Enquist BJ, 2001, NATURE, V410, P655, DOI 10.1038/35070500; Enquist BJ, 1998, NATURE, V395, P163, DOI 10.1038/25977; Enquist BJ, 2002, SCIENCE, V295, P1517, DOI 10.1126/science.1066360; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; GENTRY AH, 1988, ANN MO BOT GARD, V75, P1, DOI 10.2307/2399464; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Gillooly JF, 2002, NATURE, V417, P70, DOI 10.1038/417070a; GILLOOLY JF, UNPUB; Hubbell Stephen P., 2001, V32, pi; ISOBE T, 1990, ASTROPHYS J, V364, P104, DOI 10.1086/169390; LEGATES DR, 1990, THEOR APPL CLIMATOL, V41, P11, DOI 10.1007/BF00866198; Lieberman D, 1996, J ECOL, V84, P137, DOI 10.2307/2261350; Oberdorff T, 1995, ECOGRAPHY, V18, P345, DOI 10.1111/j.1600-0587.1995.tb00137.x; Ritchie ME, 1999, NATURE, V400, P557, DOI 10.1038/23010; Rohde K, 1998, INT J PARASITOL, V28, P461, DOI 10.1016/S0020-7519(97)00209-9; ROHDE K, 1992, OIKOS, V65, P514, DOI 10.2307/3545569; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Roy K, 1998, P NATL ACAD SCI USA, V95, P3699, DOI 10.1073/pnas.95.7.3699; WRIGHT DH, 1983, OIKOS, V41, P496, DOI 10.2307/3544109	24	603	636	8	235	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2002	297	5586					1545	1548		10.1126/science.1072380	http://dx.doi.org/10.1126/science.1072380			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588JA	12202828				2022-12-24	WOS:000177697300055
J	Biederer, T; Sara, Y; Mozhayeva, M; Atasoy, D; Liu, XR; Kavalali, ET; Sudhof, TC				Biederer, T; Sara, Y; Mozhayeva, M; Atasoy, D; Liu, XR; Kavalali, ET; Sudhof, TC			SynCAM, a synaptic adhesion molecule that drives synapse assembly	SCIENCE			English	Article							CELL-ADHESION; FASCICLIN II; EPH RECEPTORS; PDZ PROTEIN; NEUREXINS; BINDING; CALMODULIN; MODULATION; EXOCYTOSIS; SEQUENCES	Synapses, the junctions between nerve cells through which they communicate, are formed by the coordinated assembly and tight attachment of pre- and postsynaptic specializations. We now show that SynCAM is a brain-specific, immunoglobulin domain containing protein that binds to intracellular PDZ-domain proteins and functions as a homophilic cell adhesion molecule at the synapse. Expression of the isolated cytoplasmic tail of SynCAM in neurons inhibited synapse assembly. Conversely, expression of full-length SynCAM in nonneuronal cells induced synapse formation by cocultured hippocampal neurons with normal release properties. Glutamatergic synaptic transmission was reconstituted in these nonneuronal cells by coexpressing glutamate receptors with SynCAM, which suggests that a single type of adhesion molecule and glutamate receptor are sufficient for a functional postsynaptic response.	Univ Texas, Ctr Basic Neurosci, SW Med Ctr, Dallas, TX 75390 USA; Univ Texas, Dept Mol Genet, SW Med Ctr, Dallas, TX 75390 USA; Univ Texas, Dept Physiol, SW Med Ctr, Dallas, TX 75390 USA; Univ Texas, Howard Hughes Med Inst, SW Med Ctr, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Sudhof, TC (corresponding author), Univ Texas, Ctr Basic Neurosci, SW Med Ctr, Dallas, TX 75390 USA.	Thomas.Biederer@UTSouthwestern.edu; Thomas.Sudhof@UTSouthwestern.edu	Atasoy, Deniz/B-3414-2018; Biederer, Thomas/AAZ-6133-2021; Atasoy, Deniz/AAR-7917-2020	Biederer, Thomas/0000-0003-0912-1514; Atasoy, Deniz/0000-0002-3325-8820; Sara, Yildirim/0000-0003-1079-0782				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAILEY CH, 1992, SCIENCE, V256, P645, DOI 10.1126/science.1585177; Banker G., 1998, CULTURING NERVE CELL; Betz WJ, 1996, CURR OPIN NEUROBIOL, V6, P365, DOI 10.1016/S0959-4388(96)80121-8; Biederer T, 2001, J BIOL CHEM, V276, P47869, DOI 10.1074/jbc.M105287200; Butz S, 1999, J BIOL CHEM, V274, P18290, DOI 10.1074/jbc.274.26.18290; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; Davis GW, 1997, NEURON, V19, P561, DOI 10.1016/S0896-6273(00)80372-4; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; Feng GP, 2000, NEURON, V25, P295, DOI 10.1016/S0896-6273(00)80895-8; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; Gomyo H, 1999, GENOMICS, V62, P139, DOI 10.1006/geno.1999.6001; GORMAN C, 1985, DNA CLONING PRACTICA, V2, P143; Grootjans JJ, 1997, P NATL ACAD SCI USA, V94, P13683, DOI 10.1073/pnas.94.25.13683; Hata Y, 1996, J NEUROSCI, V16, P2488; Hsueh YP, 1998, J CELL BIOL, V142, P139, DOI 10.1083/jcb.142.1.139; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Kavalali ET, 1999, P NATL ACAD SCI USA, V96, P12893, DOI 10.1073/pnas.96.22.12893; Klein R, 2001, CURR OPIN CELL BIOL, V13, P196, DOI 10.1016/S0955-0674(00)00197-6; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; LISMAN JE, 1993, TRENDS NEUROSCI, V16, P141, DOI 10.1016/0166-2236(93)90122-3; MAYFORD M, 1992, SCIENCE, V256, P638, DOI 10.1126/science.1585176; Mozhayeva MG, 2002, J NEUROSCI, V22, P654, DOI 10.1523/JNEUROSCI.22-03-00654.2002; Nguyen T, 1997, J BIOL CHEM, V272, P26032, DOI 10.1074/jbc.272.41.26032; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; PHELAN P, 1997, NEUROCHEMISTRY PRACT, P1; Sanes JR, 1999, CURR OPIN NEUROBIOL, V9, P79, DOI 10.1016/S0959-4388(99)80010-5; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Schmitz F, 2000, NEURON, V28, P857, DOI 10.1016/S0896-6273(00)00159-8; Sheng M, 2000, ANNU REV PHYSIOL, V62, P755, DOI 10.1146/annurev.physiol.62.1.755; SNOW PM, 1989, CELL, V59, P313, DOI 10.1016/0092-8674(89)90293-6; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Sudhof TC, 2001, SYNAPSES, P275; Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003; Sugita S, 2000, BIOCHEMISTRY-US, V39, P2940, DOI 10.1021/bi9920984; Sugita S, 2002, NEUROSCIENCE, V112, P51, DOI 10.1016/S0306-4522(02)00063-5; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; THIERY JP, 1977, J BIOL CHEM, V252, P6841; Thomas U, 1997, NEURON, V19, P787, DOI 10.1016/S0896-6273(00)80961-7; Tomita S, 2001, J CELL BIOL, V153, pF19, DOI 10.1083/jcb.153.5.F19; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; USHKARYOV YA, 1994, J BIOL CHEM, V269, P11987; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Zito K, 1997, NEURON, V19, P1007, DOI 10.1016/S0896-6273(00)80393-1	47	581	608	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2002	297	5586					1525	1531		10.1126/science.1072356	http://dx.doi.org/10.1126/science.1072356			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588JA	12202822				2022-12-24	WOS:000177697300049
J	Mazal, PR; Schaufler, R; Altenhuber-Muller, R; Haitel, A; Watschinger, B; Kratzik, C; Krupitza, G; Regele, H; Meisl, FT; Zechner, O; Kerjaschki, D; Susani, M				Mazal, PR; Schaufler, R; Altenhuber-Muller, R; Haitel, A; Watschinger, B; Kratzik, C; Krupitza, G; Regele, H; Meisl, FT; Zechner, O; Kerjaschki, D; Susani, M			Derivation of nephrogenic adenomas from renal tubular cells in kidney-transplant recipients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CALMETTE-GUERIN TREATMENT; URINARY-TRACT; AQUAPORIN FAMILY; WATER CHANNELS; BLADDER; LESION; ADENOCARCINOMA; HISTOGENESIS; METAPLASIA; UROTHELIUM	Background Nephrogenic adenomas are benign, tumor-like lesions within the urothelial mucosa of the urinary tract that are not uncommon in renal-transplant recipients. We investigated the origin of nephrogenic adenomas in renal-transplant recipients. Methods Tissue sections were analyzed by fluorescence in situ hybridization with the use of probes for the X and Y chromosomes, by immunohistochemical methods with the use of antibodies to renal tubular antigens, and by lectin histochemical methods. Forty-six nephrogenic adenomas from 29 patients were analyzed. Results All nephrogenic adenomas in 14 female recipients of transplants from male donors and 10 male recipients of transplants from female donors showed the same sex-chromosome status as the donor kidney, but not the same sex-chromosome status as the recipient's surrounding bladder tissue. The nephrogenic adenomas from all 6 female recipients of transplants from female donors showed female chromosomes, and those from the 16 male recipients of transplants from male donors showed male chromosomes. The presence of aquaporin 1, PAX2, and lectin-binding capacity for peanut agglutinin, Lotus tetragonolobus agglutinin, and Sophora Japonica agglutinin in nephrogenic adenomas indicated an origin from renal tubular cells. Conclusions Nephrogenic adenomas in renal-transplant recipients are derived from tubular cells of the renal transplants and are riot metaplastic proliferations of the recipient's bladder urothelium.	Univ Vienna, Dept Clin Pathol, Gen Hosp, A-1090 Vienna, Austria; Univ Vienna, Ctr Excellence Clin & Expt Oncol, A-1090 Vienna, Austria; Univ Vienna, Dept Internal Med 3, A-1090 Vienna, Austria; Univ Vienna, Dept Urol, A-1090 Vienna, Austria; Wilhelminen Hosp, Dept Nephrol, Vienna, Austria; Wilhelminen Hosp, Dept Urol, Vienna, Austria	University of Vienna; University of Vienna; University of Vienna; University of Vienna; Wilhelminenspital; Wilhelminenspital	Susani, M (corresponding author), Univ Vienna, Dept Clin Pathol, Gen Hosp, Wahringer Guertel 18-20, A-1090 Vienna, Austria.			Mazal, Peter/0000-0002-9586-6231; Krupitza, Georg/0000-0003-2949-7906				Agre P, 1996, NEPHROLOGIE, V17, P409; Banyai-Falger S, 1998, TRANSPLANTATION, V65, P511, DOI 10.1097/00007890-199802270-00010; BEAUDRY C, 1983, J UROLOGY, V130, P1183, DOI 10.1016/S0022-5347(17)51746-2; BEHESTI M, 1982, UROLOGY, V20, P298, DOI 10.1016/0090-4295(82)90645-8; Dahl E, 1997, BIOESSAYS, V19, P755, DOI 10.1002/bies.950190905; DAVIS T A, 1949, Northwest Med, V48, P182; DEVINE P, 1984, AM J CLIN PATHOL, V81, P728, DOI 10.1093/ajcp/81.6.728; Dorrenhaus A, 2000, ARCH TOXICOL, V74, P618, DOI 10.1007/s002040000173; FORD TF, 1985, BRIT J UROL, V57, P427, DOI 10.1111/j.1464-410X.1985.tb06303.x; Fournier G, 1996, J UROLOGY, V156, P41, DOI 10.1016/S0022-5347(01)65932-9; FRIEDMAN NB, 1950, J UROLOGY, V64, P657, DOI 10.1016/S0022-5347(17)68693-2; Gilcrease MZ, 1998, HUM PATHOL, V29, P1451, DOI 10.1016/S0046-8177(98)90015-6; GONZALEZ JA, 1988, J UROLOGY, V139, P45, DOI 10.1016/S0022-5347(17)42285-3; Gordon H L, 1975, Urology, V5, P275, DOI 10.1016/0090-4295(75)90031-X; Grupp C, 2001, AM J KIDNEY DIS, V37, P84, DOI 10.1053/ajkd.2001.20592; IMAHORI SC, 1980, UROLOGY, V16, P310, DOI 10.1016/0090-4295(80)90055-2; JAKSE G, 1983, EUR UROL, V9, P60; JOHANNES A, 1988, UROLOGE A, V27, P204; KAVER I, 1985, UROLOGY, V26, P506, DOI 10.1016/0090-4295(85)90169-4; Kilciler M, 2000, UROL INT, V64, P229, DOI 10.1159/000030538; KUNZE E, 1993, PATHOL RES PRACT, V189, P217, DOI 10.1016/S0344-0338(11)80097-X; MALPICA A, 1994, HUM PATHOL, V25, P390, DOI 10.1016/0046-8177(94)90148-1; MAREK J, 1985, PATHOL RES PRACT, V180, P569, DOI 10.1016/S0344-0338(85)80028-5; MARTINEZ ER, 1998, ARCH ESP UROL, V51, P284; MCINTIRE TL, 1987, UROLOGY, V29, P237, DOI 10.1016/0090-4295(87)90060-4; MIETTINEN HHA, 1983, LAB INVEST, V49, P317; NIELSEN S, 1995, KIDNEY INT, V48, P1057, DOI 10.1038/ki.1995.389; OLIVA E, 1995, MODERN PATHOL, V8, P722; OSHEA PA, 1981, J UROLOGY, V125, P249, DOI 10.1016/S0022-5347(17)54990-3; Oyama N, 1998, Int J Urol, V5, P185, DOI 10.1111/j.1442-2042.1998.tb00275.x; Peeker R, 1997, BRIT J UROL, V80, P539, DOI 10.1046/j.1464-410X.1997.00418.x; Piper NY, 1999, J UROLOGY, V161, P605, DOI 10.1016/S0022-5347(01)61964-5; Pycha A, 1998, UROLOGY, V52, P756, DOI 10.1016/S0090-4295(98)00371-9; RACUSEN LC, 1991, LAB INVEST, V64, P546; Racusen LC, 1998, CLIN EXP PHARMACOL P, V25, P273, DOI 10.1111/j.1440-1681.1998.t01-3-.x; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; RACUSEN LC, 1995, KIDNEY INT, V48, P536, DOI 10.1038/ki.1995.324; Satoh F, 2000, PATHOL INT, V50, P458, DOI 10.1046/j.1440-1827.2000.01070.x; SCHAAFSMA HE, 1990, AM J PATHOL, V136, P329; SILVA FG, 1993, ARCH PATHOL LAB MED, V117, P1233; STILMANT MM, 1986, J UROLOGY, V135, P359, DOI 10.1016/S0022-5347(17)45639-4; STRAND WR, 1987, J UROLOGY, V137, P491, DOI 10.1016/S0022-5347(17)44083-3; Tse V, 1997, UROLOGY, V50, P690, DOI 10.1016/S0090-4295(97)00334-8; ULRICH W, 1985, HISTOPATHOLOGY, V9, P1037; vanderLinden PJQ, 1996, HUM REPROD, V11, P53, DOI 10.1093/humrep/11.suppl_3.53; VORREUTHER R, 1994, UROL INT, V53, P227, DOI 10.1159/000282678; Weingartner K, 1997, J UROLOGY, V158, P1175, DOI 10.1016/S0022-5347(01)64416-1; WOOD DP, 1988, J UROLOGY, V139, P130, DOI 10.1016/S0022-5347(17)42319-6; YOUNG RH, 1986, AM J SURG PATHOL, V10, P268, DOI 10.1097/00000478-198604000-00005; ZEIDAN BS, 1992, TRANSPLANT P, V24, P752	50	98	107	0	4	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 29	2002	347	9					653	659		10.1056/NEJMoa013413	http://dx.doi.org/10.1056/NEJMoa013413			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587ZT	12200552	Bronze			2022-12-24	WOS:000177675500004
J	Koops, L; Lindley, RI				Koops, L; Lindley, RI			Thrombolysis for acute ischaemic stroke: consumer involvement in design of new randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article							ACUTE ISCHEMIC STROKE; RECRUITMENT	Objectives To determine whether consumer involvement would help to solve some of the ethical problems associated with research into thrombolysis for acute ischaemic stroke, with its inherent risk of fatal intracranial haemorrhage. Design Quantitative and qualitative research. Setting and participants Consultation phase: three meetings were held to discuss the planned research, and participants completed a questionnaire. Qualitative work: focus group meetings explored the issues raised during the consultation phase. Design of information leaflets for patients and relatives: trial materials were drafted during the consultation phase and revised in the light of feedback from the focus group meetings and review by patients and caters on a stroke rehabilitation unit. Results 54 people attended the consultation meetings. Four (9%) participants considered the risks of thrombolysis too great, but most (89%) were prepared to accept the treatment in a clinical trial. Nearly all would accept treatment if it was shown to be effective. Most (85%) would give their consent to enter the planned trial. The focus group meetings and feedback from patients and carers led to significant changes in the information leaflets. The revised trial materials were considered ethical by a national multicentre research ethics committee. Conclusions Consumers generally supported a planned trial, and their involvement helped to refine trial consent procedures and led to an ethically acceptable trial design.	Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	Lindley, RI (corresponding author), Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland.		Lindley, Richard/B-8148-2013	Lindley, Richard/0000-0002-0104-5679				APPLEBY P, 1994, LANCET, V343, P311, DOI 10.1016/S0140-6736(94)91161-4; BAUM M, 1993, LANCET, V341, P812, DOI 10.1016/0140-6736(93)90573-Y; Entwistle VA, 1998, BRIT MED J, V316, P463, DOI 10.1136/bmj.316.7129.463; Gage BF, 1996, ARCH INTERN MED, V156, P1829, DOI 10.1001/archinte.156.16.1829; Hanley B, 2001, BRIT MED J, V322, P519, DOI 10.1136/bmj.322.7285.519; Lindley RI, 1998, BRIT MED J, V316, P1005, DOI 10.1136/bmj.316.7136.1005; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; SOLOMON NA, 1994, STROKE, V25, P1721, DOI 10.1161/01.STR.25.9.1721; THORNTON H, 1993, LANCET, V341, P795, DOI 10.1016/0140-6736(93)90568-2; Wardlaw JM, 1997, LANCET, V350, P607, DOI 10.1016/S0140-6736(97)03022-5; Wichman A, 1997, NEUROLOGY, V48, P1151, DOI 10.1212/WNL.48.5.1151	11	80	81	0	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 24	2002	325	7361					415	+		10.1136/bmj.325.7361.415	http://dx.doi.org/10.1136/bmj.325.7361.415			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	588RY	12193356	Green Published, Bronze			2022-12-24	WOS:000177715500018
J	Steinbrook, R				Steinbrook, R			Beyond Barcelona - The global response to HIV	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																			0	5	6	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 22	2002	347	8					553	554		10.1056/NEJMp020094	http://dx.doi.org/10.1056/NEJMp020094			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587ZR	12192013				2022-12-24	WOS:000177675400002
J	Rockoff, A				Rockoff, A			Vanity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 14	2002	288	6					677	677		10.1001/jama.288.6.677	http://dx.doi.org/10.1001/jama.288.6.677			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	583KY	12169046				2022-12-24	WOS:000177408100001
J	DeSimone, JM				DeSimone, JM			Practical approaches to green solvents	SCIENCE			English	Article							SUPERCRITICAL CARBON-DIOXIDE; ORGANIC-COMPOUNDS; SEPARATION; WATER; HYDROFORMYLATION; POLYMERIZATIONS; FLUOROPOLYMERS; PRECIPITATION; HYDROGENATION; COMPLEXES	Solvents are widely used in commercial manufacturing and service industries. Despite abundant precaution, they inevitably contaminate our air, land, and water because they are difficult to contain and recycle. Researchers have therefore focused on reducing solvent use through the development of solvent-free processes and more efficient recycling protocols. However, these approaches have their limitations, necessitating a pollution prevention approach and the search for environmentally benign solvent alternatives. This report highlights opportunities for the practical implementation of such green solvents.	Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; N Carolina State Univ, Dept Chem Engn, Raleigh, NC 27695 USA; Micell Technol, Raleigh, NC 27613 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; North Carolina State University	DeSimone, JM (corresponding author), Univ N Carolina, Dept Chem, CB 3290, Chapel Hill, NC 27599 USA.							Abdul-Sada AK, 1995, World Pat., Patent No. [WO 95 21806, 9521806]; Anastas P. T., 1998, GREEN CHEM THEORY PR; ANASTAS PT, 1994, ACS SYM SER, V677, P2; BAGALA JM, 2001, Patent No. 6325846; Balbuena PB, 1998, J PHYS CHEM B, V102, P3806, DOI 10.1021/jp972870h; Balema VP, 2002, J AM CHEM SOC, V124, P6244, DOI 10.1021/ja017908p; Behles JA, 2001, PURE APPL CHEM, V73, P1281, DOI 10.1351/pac200173081281; BERNDT WR, 2000, Patent No. 6056789; Blanchard L. A., 1999, NATURE, V28, P399; Breslow R, 1998, GREEN CHEMISTRY, P225; Butler R, 2001, ADV MATER, V13, P1459, DOI 10.1002/1521-4095(200110)13:19<1459::AID-ADMA1459>3.0.CO;2-K; Carlson R.L., 1962, SILENT SPRING; Charpentier PA, 1999, MACROMOLECULES, V32, P5973, DOI 10.1021/ma990377t; CHAUVIN Y, 1996, ANGEW CHEM INT EDIT, V34, P2698; Curran DP, 2001, SYNLETT, P1488; Curran DP, 2000, PURE APPL CHEM, V72, P1649, DOI 10.1351/pac200072091649; Curran DP, 1998, ANGEW CHEM INT EDIT, V37, P1175, DOI 10.1002/(SICI)1521-3773(19980518)37:9<1174::AID-ANIE1174>3.0.CO;2-P; DESIMONE JM, 1992, SCIENCE, V257, P945, DOI 10.1126/science.257.5072.945; DESIMONE JM, 1999, Patent No. 5944996; DESIMONE JM, 2001, Patent No. 6001418; DeSimone L.D., 2000, ECOEFFICIENCY BUSINE; DeVito SC, 1996, ACS SYM SER, V640, P16; DIXON DJ, 1993, AICHE J, V39, P127, DOI 10.1002/aic.690390113; Dolman SJ, 2002, J AM CHEM SOC, V124, P6991, DOI 10.1021/ja012534l; *EPA MAN, 1996, RPA625R96004 US EPA; *EPA NAT EMM STAND, 1993, 1993 EC IMP AN HAL S; FOX DW, 1964, Patent No. 3153008; Hitzler MG, 1997, CHEM COMMUN, P1667, DOI 10.1039/a704371f; HORVATH IT, 1994, SCIENCE, V266, P72, DOI 10.1126/science.266.5182.72; Horvath IT, 1998, ACCOUNTS CHEM RES, V31, P641, DOI 10.1021/ar970342i; JESSOP PG, 1994, J AM CHEM SOC, V116, P8851, DOI 10.1021/ja00098a072; JESSOP PG, 1999, CHEM SYNTHESIS USING; Kendall JL, 1999, CHEM REV, V99, P543, DOI 10.1021/cr9700336; Krocher O, 1997, CHEM COMMUN, P453, DOI 10.1039/a608150i; LI CJ, 1993, CHEM REV, V93, P2023, DOI 10.1021/cr00022a004; Lo WJ, 2000, J BIOMED MATER RES, V50, P536, DOI 10.1002/(SICI)1097-4636(20000615)50:4<536::AID-JBM9>3.3.CO;2-L; Luo ZY, 2001, SCIENCE, V291, P1766, DOI 10.1126/science.1057567; MACHALABA D, 1999, WALL STREET J   0203; MCHUGH MA, 1996, SUPERCRITICAL FLUID; MEIXNER J, 2001, Patent No. 6232360; MOORE S, 1994, CHEM ENG-NEW YORK, V101, P32; Namatsu H, 2000, J VAC SCI TECHNOL B, V18, P780, DOI 10.1116/1.591276; NIELSEN KA, 1996, Patent No. 5509959; OSTERYOUNG RA, 1987, NATO ASI SER, V202, P329; PARKINSON G, 1999, CHEM ENG, V106, P17; Reichardt C., 1988, SOLVENTS SOLVENT EFF; ROBINSON J, 1979, J AM CHEM SOC, V101, P323, DOI 10.1021/ja00496a008; ROMACK TJ, 1995, MACROMOLECULES, V28, P8429, DOI 10.1021/ma00128a065; Salzer A, 2002, CHEM ENG NEWS, V80, P4; *SEIM IND ASS SIA, 1997, NAT TECHN ROADM SEM; *SEM IND ASS SIA, 1999, NAT TECHN ROADM SEM; STEINER R, 1993, CHEM ENG-NEW YORK, V100, P114; Subramaniam B, 1997, J PHARM SCI-US, V86, P885, DOI 10.1021/js9700661; TANAKA T, 1993, JPN J APPL PHYS, V12, P5831; TESTER JW, 1993, ACS SYM SER, V518, pCH3; THOMASON TB, 1984, HAZARD WASTE HAZARD, V1, P453, DOI 10.1089/hzw.1984.1.453; TSAI SP, 1995, Patent No. 5464760; VOSS D, 2002, TECHNOL REV      JAN, P27; Walsh KA, 1996, CHEM WEEK, V158, P38; Wells S.L, 2001, ANGEW CHEM INT EDIT, V40, P518, DOI [10.1002/1521-3773(20010202)40:33.0.CO;2-4, DOI 10.1002/1521-3773(20010202)40:33.0.CO;2-4]; WILKES JS, 1982, INORG CHEM, V21, P1263, DOI 10.1021/ic00133a078	61	829	851	7	188	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 2	2002	297	5582					799	803		10.1126/science.1069622	http://dx.doi.org/10.1126/science.1069622			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579RZ	12161645				2022-12-24	WOS:000177192800039
J	Sun, X; Mariani, FV; Martin, GR				Sun, X; Mariani, FV; Martin, GR			Functions of FGF signalling from the apical ectodermal ridge in limb development	NATURE			English	Article							CHICK LIMB; PATTERN-FORMATION; BUD DEVELOPMENT; CELL-MIGRATION; GROWTH; OUTGROWTH; AER; MORPHOGENESIS; INDUCTION; MUTANT	To determine the role of fibroblast growth factor (FGF) signalling from the apical ectodermal ridge (AER), we inactivated Fgf4 and Fgf8 in AER cells or their precursors at different stages of mouse limb development. We show that FGF4 and FGF8 regulate cell number in the nascent limb bud and are required for survival of cells located far from the AER. On the basis of the skeletal phenotypes observed, we conclude that these functions are essential to ensure that sufficient progenitor cells are available to form the normal complement of skeletal elements, and perhaps other limb tissues. In the complete absence of both FGF4 and FGF8 activities, limb development fails. We present a model to explain how the mutant phenotypes arise from FGF-mediated effects on limb bud size and cell survival.	Univ Calif San Francisco, Sch Med, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Program Dev Biol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Martin, GR (corresponding author), Univ Calif San Francisco, Sch Med, Dept Anat, San Francisco, CA 94143 USA.	gmartin@itsa.ucsf.edu		Mariani, Francesca/0000-0003-1619-8763	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD008696] Funding Source: NIH RePORTER; NICHD NIH HHS [F32 HD008696] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALBERCH P, 1983, J EMBRYOL EXP MORPH, V76, P177; BALDWIN HS, 1994, DEVELOPMENT, V120, P2539; BOBER E, 1994, DEVELOPMENT, V120, P603; Capdevila J, 1999, MOL CELL, V4, P839, DOI 10.1016/S1097-2765(00)80393-7; CARTER TC, 1954, J GENET, V52, P1, DOI 10.1007/BF02981488; Chiang C, 2001, DEV BIOL, V236, P421, DOI 10.1006/dbio.2001.0346; Colvin JS, 2001, CELL, V104, P875, DOI 10.1016/S0092-8674(01)00284-7; Dahn RD, 2000, SCIENCE, V289, P438, DOI 10.1126/science.289.5478.438; Dudley AT, 2002, NATURE, V418, P539, DOI 10.1038/nature00945; FALLON JF, 1994, SCIENCE, V264, P104, DOI 10.1126/science.7908145; FELDMAN B, 1995, SCIENCE, V267, P246, DOI 10.1126/science.7809630; GURLEY LR, 1978, EUR J BIOCHEM, V84, P1, DOI 10.1111/j.1432-1033.1978.tb12135.x; Hinchliffe J. R., 1980, DEV VERTEBRATE LIMB; HORNBRUCH A, 1970, NATURE, V226, P764, DOI 10.1038/226764a0; Johnson RL, 1997, CELL, V90, P979, DOI 10.1016/S0092-8674(00)80364-5; Kingsley D M, 2001, Novartis Found Symp, V232, P213; Kraus P, 2001, MECH DEVELOP, V100, P45, DOI 10.1016/S0925-4773(00)00492-5; Lewandoski M, 2000, NAT GENET, V26, P460, DOI 10.1038/82609; Li SG, 1999, DEV BIOL, V211, P335, DOI 10.1006/dbio.1999.9317; MAINI PK, 1991, INT REV CYTOL, V129, P91; Martin GR, 1998, GENE DEV, V12, P1571, DOI 10.1101/gad.12.11.1571; Mercader N, 2000, DEVELOPMENT, V127, P3961; Mercader N, 1999, NATURE, V402, P425, DOI 10.1038/46580; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Min Q, 1998, TEACH LEARN MED, V10, P12, DOI 10.1207/S15328015TLM1001_3; Moon AM, 2000, NAT GENET, V26, P455, DOI 10.1038/82601; Moon AM, 2000, DEVELOPMENT, V127, P989; MUNEOKA K, 1989, J EXP ZOOL, V249, P50, DOI 10.1002/jez.1402490110; NISWANDER L, 1993, CELL, V75, P579, DOI 10.1016/0092-8674(93)90391-3; Ornitz DM, 2001, GENOME BIOL, V2; PRAHLAD KV, 1979, J EXP ZOOL, V209, P427, DOI 10.1002/jez.1402090308; Revest JM, 2001, DEV BIOL, V231, P47, DOI 10.1006/dbio.2000.0144; ROWE DA, 1982, J EMBRYOL EXP MORPH, V68, P1; ROWE DA, 1982, DEV BIOL, V93, P83, DOI 10.1016/0012-1606(82)90241-X; RUBIN L, 1972, DEV BIOL, V28, P94, DOI 10.1016/0012-1606(72)90129-7; SAUNDERS JW, 1948, J EXP ZOOL, V108, P363, DOI 10.1002/jez.1401080304; Saxton TM, 2000, NAT GENET, V24, P420, DOI 10.1038/74279; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; STARK RJ, 1974, DEV BIOL, V38, P51, DOI 10.1016/0012-1606(74)90258-9; SUMMERBELL D, 1974, J EMBRYOL EXP MORPH, V32, P651; SUMMERBELL D, 1973, NATURE, V244, P492, DOI 10.1038/244492a0; Sun X, 2000, NAT GENET, V25, P83, DOI 10.1038/75644; Sun X, 1999, GENE DEV, V13, P1834, DOI 10.1101/gad.13.14.1834; Takahashi M, 1998, DEVELOPMENT, V125, P4417; Vargesson N, 1997, DEVELOPMENT, V124, P1909; WOLPERT L, 1979, J EMBRYOL EXP MORPH, V50, P175; WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15; Xu JS, 2000, DEVELOPMENT, V127, P1833	48	423	437	2	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 1	2002	418	6897					501	508		10.1038/nature00902	http://dx.doi.org/10.1038/nature00902			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579EE	12152071				2022-12-24	WOS:000177162800032
J	Ye, H; Arron, JR; Lamothe, B; Cirilli, M; Kobayashi, T; Shevde, NK; Segal, D; Dzivenu, OK; Vologodskaia, M; Yim, M; Du, K; Singh, S; Pike, JW; Darnay, BG; Choi, Y; Wu, H				Ye, H; Arron, JR; Lamothe, B; Cirilli, M; Kobayashi, T; Shevde, NK; Segal, D; Dzivenu, OK; Vologodskaia, M; Yim, M; Du, K; Singh, S; Pike, JW; Darnay, BG; Choi, Y; Wu, H			Distinct molecular mechanism for initiating TRAF6 signalling	NATURE			English	Article							NF-KAPPA-B; DEFECTIVE INTERLEUKIN-1; STRUCTURAL BASIS; RECEPTOR; KINASE; ACTIVATION; CD40; RECOGNITION; FAMILY; IRAK	Tumour-necrosis factor (TNF) receptor-associated factor 6 (TRAF6) is the only TRAF family member that participates in signal transduction of both the TNF receptor (TNFR) superfamily and the interleukin-1 receptor (IL-1R)/Toll-like receptor (TLR) superfamily(1-5); it is important for adaptive immunity, innate immunity and bone homeostasis. Here we report crystal structures of TRAF6, alone and in complex with TRAF6-binding peptides from CD40 and TRANCE-R (also known as RANK), members of the TNFR superfamily, to gain insight into the mechanism by which TRAF6 mediates several signalling cascades. A 408 difference in the directions of the bound peptides in TRAF6 and TRAF2 shows that there are marked structural differences between receptor recognition by TRAF6 and other TRAFs. The structural determinant of the petide-TRAF6 interaction reveals a Pro-X-Glu-X-X-(aromatic/acidic residue) TRAF6-binding motif, which is present not only in CD40 and TRANCE-R but also in the three IRAK adapter kinases for IL-1R/TLR signalling. Cell-permeable peptides with the TRAF6-binding motif inhibit TRAF6 signalling, which indicates their potential as therapeutic modulators. Our studies identify a universal mechanism by which TRAF6 regulates several signalling cascades in adaptive immunity, innate immunity and bone homeostasis.	Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA; Rockefeller Univ, Tri Inst MD PhD Program, New York, NY 10021 USA; Rockefeller Univ, Immunol Lab, New York, NY 10021 USA; Univ Penn, Sch Med, Dept Pathol & Lab Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Univ Texas, MD Anderson Canc Ctr, Dept Bioimmunotherapy, Houston, TX 77030 USA; CNR, Ist Strutturist Chim Giordano Giacomello, Monterotondo Staz, Italy; Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Imgenex Corp, San Diego, CA 92121 USA	Cornell University; Rockefeller University; Rockefeller University; University of Pennsylvania; Pennsylvania Medicine; University of Texas System; UTMD Anderson Cancer Center; Consiglio Nazionale delle Ricerche (CNR); University of Wisconsin System; University of Wisconsin Madison	Wu, H (corresponding author), Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA.			Arron, Joseph/0000-0001-7677-9979				Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Arron JR, 2000, NATURE, V408, P535, DOI 10.1038/35046196; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUNDEL DR, 1987, METHOD ENZYMOL, V247, P288; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; Chung JY, 2002, J CELL SCI, V115, P679; Darnay BG, 1999, J BIOL CHEM, V274, P7724, DOI 10.1074/jbc.274.12.7724; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Haridas V, 1998, J IMMUNOL, V160, P3152; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Liu XY, 2000, J BIOL CHEM, V275, P16774; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; McCarthy JV, 1998, J BIOL CHEM, V273, P16968, DOI 10.1074/jbc.273.27.16968; McWhirter SM, 1999, P NATL ACAD SCI USA, V96, P8408, DOI 10.1073/pnas.96.15.8408; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park YC, 1999, NATURE, V398, P533, DOI 10.1038/19110; Pullen SS, 1999, J BIOL CHEM, V274, P14246, DOI 10.1074/jbc.274.20.14246; Pullen SS, 1998, BIOCHEMISTRY-US, V37, P11836, DOI 10.1021/bi981067q; Shevde NK, 2000, P NATL ACAD SCI USA, V97, P7829, DOI 10.1073/pnas.130200197; TONG L, 1993, J APPL CRYSTALLOGR, V26, P748, DOI 10.1107/S0021889893005631; Wesche H, 1999, J BIOL CHEM, V274, P19403, DOI 10.1074/jbc.274.27.19403; Wong BR, 1998, J BIOL CHEM, V273, P28355, DOI 10.1074/jbc.273.43.28355; Ye H, 1999, MOL CELL, V4, P321, DOI 10.1016/S1097-2765(00)80334-2; Zhang FX, 1999, J BIOL CHEM, V274, P7611, DOI 10.1074/jbc.274.12.7611	30	504	529	4	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 25	2002	418	6896					443	447		10.1038/nature00888	http://dx.doi.org/10.1038/nature00888			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576MU	12140561				2022-12-24	WOS:000177009700044
J	Robinson, IM; Ranjan, R; Schwarz, TL				Robinson, IM; Ranjan, R; Schwarz, TL			Synaptotagmins I and IV promote transmitter release independently of Ca2+ binding in the C(2)A domain	NATURE			English	Article							NEUROTRANSMITTER RELEASE; SYNAPTIC TRANSMISSION; REGULATED EXOCYTOSIS; CALCIUM-DEPENDENCE; MUTANTS; DROSOPHILA; VESICLES; ABSENCE; SENSORS; ELEGANS	At nerve terminals, a focal and transient increase in intracellular Ca2+ triggers the fusion of neurotransmitter-filled vesicles with the plasma membrane. The most extensively studied candidate for the Ca2+-sensing trigger is synaptotagmin I, whose Ca2+-dependent interactions with acidic phospholipids and syntaxin(1) have largely been ascribed to its C(2)A domain(2-6), although the C2B domain also binds Ca2+ (refs 7, 8). Genetic tests of synaptotagmin I have been equivocal as to whether it is the Ca2+-sensing trigger of fusion(6,9-15). Synaptotagmin IV, a related isoform that does not bind Ca2+ in the C(2)A domain, might be an inhibitor of release(16,17). We mutated an essential aspartate of the Ca2+ binding site of the synaptotagmin I C(2)A domain and expressed it in Drosophila lacking synaptotagmin I. Here we show that, despite the disruption of the binding site, the Ca2+-dependent properties of transmission were not altered. Similarly, we found that synaptotagmin IV could substitute for synaptotagmin I. We conclude that the C(2)A domain of synaptotagmin is not required for Ca2+-dependent synaptic transmission, and that synaptotagmin IV promotes rather than inhibits transmission.	Childrens Hosp, Div Neurosci, Boston, MA 02115 USA; Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; University of Cambridge; Harvard University; Harvard Medical School	Schwarz, TL (corresponding author), Childrens Hosp, Div Neurosci, 300 Longwood Ave, Boston, MA 02115 USA.							BROADIE K, 1994, P NATL ACAD SCI USA, V91, P10727, DOI 10.1073/pnas.91.22.10727; Burgoyne RD, 1998, CELL CALCIUM, V24, P367, DOI 10.1016/S0143-4160(98)90060-4; CHAPMAN ER, 1994, J BIOL CHEM, V269, P5735; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667; DAMER CK, 1994, J BIOL CHEM, V269, P31115; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; Desai RC, 2000, J CELL BIOL, V150, P1125, DOI 10.1083/jcb.150.5.1125; DIANTONIO A, 1994, NEURON, V12, P909, DOI 10.1016/0896-6273(94)90342-5; DIANTONIO A, 1993, CELL, V73, P1281, DOI 10.1016/0092-8674(93)90356-U; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Haucke V, 1999, SCIENCE, V285, P1268, DOI 10.1126/science.285.5431.1268; JORGENSEN EM, 1995, NATURE, V378, P196, DOI 10.1038/378196a0; Kee Y, 1996, J NEUROSCI, V16, P1975; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; LI C, 1995, J BIOL CHEM, V270, P24898, DOI 10.1074/jbc.270.42.24898; LITTLETON JT, 1994, P NATL ACAD SCI USA, V91, P10888, DOI 10.1073/pnas.91.23.10888; Littleton JT, 1999, NATURE, V400, P757, DOI 10.1038/23462; Loewen CA, 2001, GENESIS, V31, P30, DOI 10.1002/gene.10002; MACKLER JM, 2002, NATURE          0707; MARTIN AR, 1955, J PHYSIOL-LONDON, V130, P114, DOI 10.1113/jphysiol.1955.sp005397; NEHER E, 1994, NATURE, V372, P316, DOI 10.1038/372316a0; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; Reist NE, 1998, J NEUROSCI, V18, P7662; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Ubach J, 1998, EMBO J, V17, P3921, DOI 10.1093/emboj/17.14.3921; Voets T, 2001, P NATL ACAD SCI USA, V98, P11680, DOI 10.1073/pnas.201398798; vonPoser C, 1997, J BIOL CHEM, V272, P14314, DOI 10.1074/jbc.272.22.14314; Wang CT, 2001, SCIENCE, V294, P1111, DOI 10.1126/science.1064002; ZHANG JZ, 1994, CELL, V78, P751, DOI 10.1016/S0092-8674(94)90442-1; Zhang XY, 1998, BIOCHEMISTRY-US, V37, P12395, DOI 10.1021/bi9807512	31	179	188	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 18	2002	418	6895					336	340		10.1038/nature00915	http://dx.doi.org/10.1038/nature00915			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574BF	12110845				2022-12-24	WOS:000176868000045
J	Moreno, JC; Bikker, H; Kempers, MJE; van Trotsenburg, P; Baas, F; de Vijlder, JJM; Vulsma, T; Ris-Stalpers, C				Moreno, JC; Bikker, H; Kempers, MJE; van Trotsenburg, P; Baas, F; de Vijlder, JJM; Vulsma, T; Ris-Stalpers, C			Inactivating mutations in the gene for thyroid oxidase 2 (THOX2) and congenital hypothyroidism	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FACTOR-I TTF-1; NADPH OXIDASE; TRANSIENT HYPOTHYROIDISM; FREE-THYROXINE; GOITER; INFANTS; NEWBORN; CLONING; THYROGLOBULIN; CHILDHOOD	Background Several genetic defects are associated with permanent congenital hypothyroidism. Immunologic, environmental, and iatrogenic (but not genetic) factors are known to induce transient congenital hypothyroidism, which spontaneously resolves within the first months of life. We hypothesized that molecular defects in the thyroid oxidase system, which is composed of at least two proteins, might be involved in the pathogenesis of permanent or transient congenital hypothyroidism in babies with defects in iodide organification, for which the oxidase system is required. Methods Nine patients were recruited who had idiopathic congenital hypothyroidism (one with permanent and eight With transient hypothyroidism) and an iodide-organification defect and who had been identified by the screening program for congenital hypothyroidism. The DNA of the patients and their relatives was analyzed for mutations in the genes for thyroid oxidase 1 (THOX1) and 2 (THOX2). Results The one patient with permanent and severe thyroid hormone deficiency and a complete iodide-organification defect had a homozygous nonsense mutation in the THOX2 gene that eliminates all functional domains of the protein. Three of the eight patients with mild transient congenital hypothyroidism and a partial iodide-organification defect had heterozygous mutations in the THOX2 gene that prematurely truncate the protein, thus abolishing its functional domains. Conclusions Biallelic inactivating mutations in the THOX2 gene result in complete disruption of thyroid-hormone synthesis and are associated with severe and permanent congenital hypothyroidism. Monoallelic mutations are associated with milder, transient hypothyroidism caused by insufficient thyroidal production of hydrogen peroxide, which prevents the synthesis of sufficient quantities of thyroid hormones to meet the large requirement for thyroid hormones at the beginning of life.	Emma Childrens Hosp, Dept Pediat Endocrinol, Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Neurozintuigen Lab, NL-1105 AZ Amsterdam, Netherlands	Emma Children's Hospital; University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Moreno, JC (corresponding author), POB 22700, NL-1100 DE Amsterdam, Netherlands.	j.c.moreno@amc.uva.nl	Baas, Frank/F-9574-2010; van Trotsenburg, Paul/ABC-2379-2020	Baas, Frank/0000-0003-3912-5428; van Trotsenburg, Paul/0000-0002-9677-7441				Bakker B, 2000, J CLIN ENDOCR METAB, V85, P3708, DOI 10.1210/jc.85.10.3708; Bakker B, 1999, J ENDOCRINOL, V161, P115, DOI 10.1677/joe.0.1610115; CALACIURA F, 1995, CLIN ENDOCRINOL, V43, P473, DOI 10.1111/j.1365-2265.1995.tb02620.x; Clifton-Bligh RJ, 1998, NAT GENET, V19, P399, DOI 10.1038/1294; COAKLEY JC, 1989, AUST PAEDIATR J, V25, P25; CORVILAIN B, 1991, ENDOCRINOLOGY, V128, P779, DOI 10.1210/endo-128-2-779; De Deken X, 2000, J BIOL CHEM, V275, P23227, DOI 10.1074/jbc.M000916200; De Deken X, 2002, EXP CELL RES, V273, P187, DOI 10.1006/excr.2001.5444; DELANGE F, 1978, J PEDIATR-US, V92, P974, DOI 10.1016/S0022-3476(78)80380-1; DEVIJLDER JJM, 2000, WERNER INGBARS THYRO, P733; Devriendt K, 1998, NEW ENGL J MED, V338, P1317, DOI 10.1056/NEJM199804303381817; Dupuy C, 1999, J BIOL CHEM, V274, P37265, DOI 10.1074/jbc.274.52.37265; Everett LA, 1997, NAT GENET, V17, P411, DOI 10.1038/ng1297-411; Figueiredo MDL, 2001, J CLIN ENDOCR METAB, V86, P4843, DOI 10.1210/jc.86.10.4843; FISHER DA, 1981, NEW ENGL J MED, V304, P702, DOI 10.1056/NEJM198103193041205; FISHER DA, 1979, J PEDIATR-US, V94, P700, DOI 10.1016/S0022-3476(79)80133-X; FISHER DA, 1991, J CLIN ENDOCR METAB, V72, P523, DOI 10.1210/jcem-72-3-523; Frank JE, 1996, J PEDIATR-US, V128, P548, DOI 10.1016/S0022-3476(96)70368-2; Haddow JE, 1999, NEW ENGL J MED, V341, P549, DOI 10.1056/NEJM199908193410801; Hishinuma A, 1999, J CLIN ENDOCR METAB, V84, P1438, DOI 10.1210/jc.84.4.1438; Jones AC, 1999, CLIN CHEM, V45, P1133; Keller T, 1998, PLANT CELL, V10, P255, DOI 10.1105/tpc.10.2.255; KUSAKABE T, 1975, METABOLISM, V24, P1103, DOI 10.1016/0026-0495(75)90147-X; LALLEMAND D, 1983, J PEDIATR-US, V102, P935, DOI 10.1016/S0022-3476(83)80028-6; Lapi P, 1997, THYROID, V7, P383, DOI 10.1089/thy.1997.7.383; LEGER J, 1988, ARCH FR PEDIATR, V45, P783; Macchia PE, 1998, NAT GENET, V19, P83, DOI 10.1038/ng0598-83; MATSUURA N, 1980, NEW ENGL J MED, V303, P738, DOI 10.1056/NEJM198009253031306; MCDOUGALL IR, 2000, WERNER INGBARS THYRO, P355; Moreno JC, 2001, GENOMICS, V75, P70, DOI 10.1006/geno.2001.6586; NELSON JC, 1993, J PEDIATR-US, V123, P899, DOI 10.1016/S0022-3476(05)80385-3; *NEW ENGL CONG HYP, 1981, LANCET, V14, P1095; NIEPOMNISZCZE H, 1987, J CLIN ENDOCR METAB, V65, P344, DOI 10.1210/jcem-65-2-344; NOSE O, 1986, J PEDIATR-US, V108, P573, DOI 10.1016/S0022-3476(86)80838-1; Perna MG, 1997, THYROID, V7, P377, DOI 10.1089/thy.1997.7.377; Pop VJ, 1999, CLIN ENDOCRINOL, V50, P149, DOI 10.1046/j.1365-2265.1999.00639.x; SAVA L, 1984, J CLIN ENDOCR METAB, V59, P90, DOI 10.1210/jcem-59-1-90; STUBBE P, 1980, EUR J PEDIATR, V135, P97, DOI 10.1007/BF00445902; TRIMARCHI F, 1983, ACTA PAEDIATR SCAND, V72, P145, DOI 10.1111/j.1651-2227.1983.tb09684.x; van de Graaf SAR, 1999, BIOCHIMIE, V81, P425, DOI 10.1016/S0300-9084(99)80091-1; Van Hauwe P, 1998, HUM MOL GENET, V7, P1099, DOI 10.1093/hmg/7.7.1099; vanWassenaer AG, 1997, NEW ENGL J MED, V336, P21, DOI 10.1056/NEJM199701023360104; VULSMA T, 1989, NEW ENGL J MED, V321, P13, DOI 10.1056/NEJM198907063210103; VULSMA T, 1991, THESIS U AMSTERDAM A; Xiao WZ, 2001, HUM MUTAT, V17, P439, DOI 10.1002/humu.1130.abs; Yu LX, 1999, BLOOD, V94, P2497, DOI 10.1182/blood.V94.7.2497.419k11_2497_2504	46	345	371	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 11	2002	347	2					95	102		10.1056/NEJMoa012752	http://dx.doi.org/10.1056/NEJMoa012752			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	572HC	12110737	Green Published			2022-12-24	WOS:000176767300004
J	Hettiaratchy, S; Butler, PEM				Hettiaratchy, S; Butler, PEM			Face transplantation - fantasy or the future?	LANCET			English	Editorial Material							INDUCTION; TOLERANCE		Royal Free Hosp, Dept Plast Surg, London NW3 20G, England; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Transplantat Biol Res Ctr, Boston, MA USA	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital	Butler, PEM (corresponding author), Royal Free Hosp, Dept Plast Surg, London NW3 20G, England.			Butler, Peter/0000-0001-7419-1493				Boyd JG, 2002, EUR J NEUROSCI, V15, P613, DOI 10.1046/j.1460-9568.2002.01891.x; Doolabh VB, 1999, PLAST RECONSTR SURG, V103, P1928, DOI 10.1097/00006534-199906000-00018; Francois CG, 2000, MICROSURG, V20, P360, DOI 10.1002/1098-2752(2000)20:8<360::AID-MICR4>3.3.CO;2-5; LEE WPA, 1991, PLAS RECONSTR SURG, V87, P400; Rossini AA, 1999, PHYSIOL REV, V79, P99, DOI 10.1152/physrev.1999.79.1.99; Spitzer TR, 1999, TRANSPLANTATION, V68, P480, DOI 10.1097/00007890-199908270-00006	6	58	62	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 6	2002	360	9326					5	6		10.1016/S0140-6736(02)09361-3	http://dx.doi.org/10.1016/S0140-6736(02)09361-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	569JR	12114034				2022-12-24	WOS:000176599700005
J	Parkhurst, JO				Parkhurst, JO			The Ugandan success story? Evidence and claims of HIV-1 prevention	LANCET			English	Editorial Material							PREVALENCE; INFECTION; BEHAVIOR; WOMEN		Univ London London Sch Hyg & Trop Med, Hlth Policy Unit, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Parkhurst, JO (corresponding author), Univ London London Sch Hyg & Trop Med, Hlth Policy Unit, Keppel St, London WC1E 7HT, England.	justin.parkhurst@lshtm.ac.uk	Parkhurst, Justin/AAP-3615-2021					AsiimweOkiror G, 1997, AIDS, V11, P1757, DOI 10.1097/00002030-199714000-00013; Browne S., 1999, AID PATRONAGE PARTNE; BURNELL PJ, 1991, AID FATIGUE CONCEPT; FISHER I, 2001, NY TIMES        0303; Garnett GP, 1998, AIDS PATIENT CARE ST, V12, P435, DOI 10.1089/apc.1998.12.435; *GOV UG, NAT STRAT FRAM HIV A; Gray RH, 1998, LANCET, V351, P98, DOI 10.1016/S0140-6736(97)09381-1; Karim QA, 1997, AIDS SB, V11, P143; Kilian AHD, 1999, AIDS, V13, P391, DOI 10.1097/00002030-199902250-00012; Macintyre K, 2001, AIDS EDUC PREV, V13, P160, DOI 10.1521/aeap.13.2.160.19736; MBULAITEYE S, 2000, 13 INT AIDS C JUL 9; Parkhurst Justin O., 2001, INT RELAT, V15, P69, DOI DOI 10.1177/004711701015006006; Stoneburner RL, 1996, AM J EPIDEMIOL, V144, P682, DOI 10.1093/oxfordjournals.aje.a008981; *UG AIDS COMM, 1994, ANN REP 1993; *UG MIN HLTH AIDS, 1999, HIV AIDS SURV REP; *UG MIN HLTH COND, 1999, DRAFT OV COND SIT UG; *UNAIDS, 2000, UG EP FACT SHEET HIV; *UNAIDS, 1998, REACH REG CONS IMPR; Williams B, 2001, STAT MED, V20, P2003, DOI 10.1002/sim.840; Zaba BW, 2000, AIDS, V14, P2741, DOI 10.1097/00002030-200012010-00014	20	66	67	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 6	2002	360	9326					78	80		10.1016/S0140-6736(02)09340-6	http://dx.doi.org/10.1016/S0140-6736(02)09340-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	569JR	12114061				2022-12-24	WOS:000176599700030
J	Cope, GA; Suh, GSB; Aravind, L; Schwarz, SE; Zipursky, SL; Koonin, EV; Deshaies, RJ				Cope, GA; Suh, GSB; Aravind, L; Schwarz, SE; Zipursky, SL; Koonin, EV; Deshaies, RJ			Role of predicted metalloprotease motif of Jab1/Csn5 in cleavage of Nedd8 from Cul1	SCIENCE			English	Article							MODULATE AP-1 ACTIVITY; SCF UBIQUITIN-LIGASE; COP9 SIGNALOSOME; FISSION YEAST; COMPLEX; JAB1; ZINC; TRANSCRIPTION; PURIFICATION; P27(KIP1)	COP9 signalosome (CSN) cleaves the ubiquitin-like protein Nedd8 from the Cul1 subunit of SCF ubiquitin ligases. The Jab1/MPN domain metalloenzyme (JAMM) motif in the Jab1/Csn5 subunit was found to underlie CSN's Nedd8 isopeptidase activity. JAMM is found in proteins from archaea, bacteria, and eukaryotes, including the Rpn11 subunit of the 26 S proteasome. Metal chelators and point mutations within JAMM abolished CSN-dependent cleavage of Nedd8 from Cul1, yet had little effect on CSN complex assembly. Optimal SCF activity in yeast and both viability and proper photoreceptor cell ( R cell) development in Drosophila melanogaster required an intact Csn5 JAMM domain. We propose that JAMM isopeptidases play important roles in a variety of physiological pathways.	CALTECH, Dept Biol, Pasadena, CA 91125 USA; Univ Calif Los Angeles, Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA	California Institute of Technology; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Deshaies, RJ (corresponding author), CALTECH, Dept Biol, Pasadena, CA 91125 USA.		Deshaies, Raymond/B-8354-2014	Deshaies, Raymond/0000-0002-3671-9354; Suh, Greg/0000-0003-4381-658X; Zipursky, Stephen/0000-0001-5630-7181; Aravind, L/0000-0003-0771-253X	NATIONAL LIBRARY OF MEDICINE [Z01LM000061, ZIALM000061] Funding Source: NIH RePORTER	NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aravind L, 1998, PROTEIN SCI, V7, P1250, DOI 10.1002/pro.5560070521; Bianchi E, 2000, NATURE, V404, P617, DOI 10.1038/35007098; Claret FX, 1996, NATURE, V383, P453, DOI 10.1038/383453a0; COPE G, UNPUB; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Freilich S, 1999, CURR BIOL, V9, P1187, DOI 10.1016/S0960-9822(00)80023-8; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; GomezOrtiz M, 1997, FEBS LETT, V400, P336, DOI 10.1016/S0014-5793(96)01412-3; HOLLAND DR, 1995, PROTEIN SCI, V4, P1955, DOI 10.1002/pro.5560041001; Kawakami T, 2001, EMBO J, V20, P4003, DOI 10.1093/emboj/20.15.4003; Kleemann R, 2000, NATURE, V408, P211, DOI 10.1038/35041591; Lammer D, 1998, GENE DEV, V12, P914, DOI 10.1101/gad.12.7.914; Liakopoulos D, 1998, EMBO J, V17, P2208, DOI 10.1093/emboj/17.8.2208; LOEWY AG, 1993, J BIOL CHEM, V268, P9071; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Mundt KE, 1999, CURR BIOL, V9, P1427, DOI 10.1016/S0960-9822(00)80091-3; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Osaka F, 2000, EMBO J, V19, P3475, DOI 10.1093/emboj/19.13.3475; Podust VN, 2000, P NATL ACAD SCI USA, V97, P4579, DOI 10.1073/pnas.090465597; Ponting CP, 1999, J MOL BIOL, V289, P729, DOI 10.1006/jmbi.1999.2827; RAWLINGS ND, 1995, METHOD ENZYMOL, V248, P183; ROST B, 1994, COMPUT APPL BIOSCI, V10, P53; Schwechheimer C, 2001, SCIENCE, V292, P1379, DOI 10.1126/science.1059776; Seeger M, 2001, CURR BIOL, V11, pR643, DOI 10.1016/S0960-9822(01)00382-7; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Suh GSB, 2002, NEURON, V33, P35, DOI 10.1016/S0896-6273(01)00576-1; Tomoda K, 1999, NATURE, V398, P160, DOI 10.1038/18230; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Wei N, 1998, PHOTOCHEM PHOTOBIOL, V68, P237; Wei N, 1999, TRENDS GENET, V15, P98, DOI 10.1016/S0168-9525(98)01670-9; ZHOU C, 2001, BMC BIOCH	33	557	582	2	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 18	2002	298	5593					608	611		10.1126/science.1075901	http://dx.doi.org/10.1126/science.1075901			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604RL	12183637				2022-12-24	WOS:000178634800043
J	Depew, MJ; Lufkin, T; Rubenstein, JLR				Depew, MJ; Lufkin, T; Rubenstein, JLR			Specification of jaw subdivisions by Dix genes	SCIENCE			English	Article							HOMEOBOX GENES; NEURAL CREST; DISTAL-LESS; BRANCHIAL ARCH; DLX GENES; HOMEOTIC TRANSFORMATION; MORPHOGENESIS; FOREBRAIN; DIFFERENTIATION; DROSOPHILA	The success of vertebrates was due in part to the acquisition and modi cation of jaws. Jaws are principally derived from the branchial arches, embryonic structures that exhibit proximodistal polarity. To investigate the mechanisms that specify the identity of skeletal elements within the arches, we examined mice lacking expression of Dlx5 and Dlx6, linked homeobox genes expressed distally but not proximally within the arches. Dlx5/6(-/-) mutants exhibit homeotic transformation of lower jaws to upper jaws. We suggest that nested Dlx expression in the arches patterns their proximodistal axes. Evolutionary acquisition and subsequent refinement of jaws may have been dependent on modi cation of Dlx expression.	Univ Calif San Francisco, Ctr Neurobiol & Psychiat, Dept Oral Biol, Nina Ireland Lab Dev Neurobiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Neurobiol & Psychiat, Dept Psychiat, San Francisco, CA 94143 USA; Mt Sinai Sch Med, Brookdale Ctr Dev & Mol Biol, New York, NY 10029 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Icahn School of Medicine at Mount Sinai	Rubenstein, JLR (corresponding author), Univ Calif San Francisco, Ctr Neurobiol & Psychiat, Dept Oral Biol, Nina Ireland Lab Dev Neurobiol, 401 Parnassus Ave, San Francisco, CA 94143 USA.		Lufkin, Thomas/AAG-7476-2019; Lufkin, Thomas/B-5352-2011	Lufkin, Thomas/0000-0002-7902-4771; Lufkin, Thomas/0000-0002-7902-4771	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007204] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH001046] Funding Source: NIH RePORTER; NIDCR NIH HHS [T32DE07204] Funding Source: Medline; NIMH NIH HHS [K02MH01046-01] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Acampora D, 1999, DEVELOPMENT, V126, P3795; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Barghusen H.R., 1979, P265; Campbell G, 1998, DEVELOPMENT, V125, P4483; Cecconi F, 1997, DEV DYNAM, V210, P184, DOI 10.1002/(SICI)1097-0177(199710)210:2<184::AID-AJA10>3.0.CO;2-E; Charite J, 2001, GENE DEV, V15, P3039, DOI 10.1101/gad.931701; Cohn MJ, 2002, NATURE, V416, P386, DOI 10.1038/416386a; DEBEER G, 1985, DEV VERTEBRATE SKULL; Depew M.J., 2002, MOUSE DEV PATTERNING, P421; Depew MJ, 1999, DEVELOPMENT, V126, P3831; GANS C, 1983, SCIENCE, V220, P268, DOI 10.1126/science.220.4594.268; GENDRONMAGUIRE M, 1993, CELL, V75, P1317, DOI 10.1016/0092-8674(93)90619-2; HARDY MH, 1992, TRENDS GENET, V8, P55, DOI 10.1016/0168-9525(92)90350-D; HARDY MH, 1968, J EMBRYOL EXP MORPH, V19, P157; Kimmel CB, 2001, J ANAT, V199, P105, DOI 10.1046/j.1469-7580.2001.19910105.x; Kojima T, 2000, DEVELOPMENT, V127, P769; Lanctot C, 1999, DEVELOPMENT, V126, P1805; LANGILLE RM, 1989, BIOL REV, V64, P73, DOI 10.1111/j.1469-185X.1989.tb00672.x; Lee SH, 2001, NATURE, V414, P909, DOI 10.1038/414909a; Lu MF, 1999, DEVELOPMENT, V126, P495; Mallatt J, 1997, ZOOL-ANAL COMPLEX SY, V100, P128; MARTIN JF, 1995, GENE DEV, V9, P1237, DOI 10.1101/gad.9.10.1237; MATSUO I, 1995, GENE DEV, V9, P2646, DOI 10.1101/gad.9.21.2646; Moore W.J., 1981, MAMMALIAN SKULL; Neidert AH, 2001, P NATL ACAD SCI USA, V98, P1665, DOI 10.1073/pnas.98.4.1665; Panganiban G, 2000, DEV DYNAM, V218, P554, DOI 10.1002/1097-0177(200008)218:4<554::AID-DVDY1023>3.0.CO;2-#; QIU MS, 1995, GENE DEV, V9, P2523, DOI 10.1101/gad.9.20.2523; Qiu MS, 1997, DEV BIOL, V185, P165, DOI 10.1006/dbio.1997.8556; Qu SM, 1999, DEVELOPMENT, V126, P359; RIJLI FM, 1993, CELL, V75, P1333, DOI 10.1016/0092-8674(93)90620-6; ROBINSON GW, 1994, MECH DEVELOP, V48, P199, DOI 10.1016/0925-4773(94)90060-4; Robledo RF, 2002, GENE DEV, V16, P1089, DOI 10.1101/gad.988402; SAKAMOTO MK, 1989, ANAT REC, V223, P299, DOI 10.1002/ar.1092230309; SATOKATA I, 1994, NAT GENET, V6, P348, DOI 10.1038/ng0494-348; Satokata I, 2000, NAT GENET, V24, P391, DOI 10.1038/74231; Selleri L, 2001, DEVELOPMENT, V128, P3543; Shigetani Y, 2002, SCIENCE, V296, P1316, DOI 10.1126/science.1068310; Shimeld SM, 2000, P NATL ACAD SCI USA, V97, P4449, DOI 10.1073/pnas.97.9.4449; Srivastava D, 1997, NAT GENET, V16, P154, DOI 10.1038/ng0697-154; Stock DW, 1996, P NATL ACAD SCI USA, V93, P10858, DOI 10.1073/pnas.93.20.10858; Sumiyama K, 2002, P NATL ACAD SCI USA, V99, P780, DOI 10.1073/pnas.012584999; Szeto DP, 1999, GENE DEV, V13, P484, DOI 10.1101/gad.13.4.484; Trumpp A, 1999, GENE DEV, V13, P3136, DOI 10.1101/gad.13.23.3136; Tucker AS, 1998, SCIENCE, V282, P1136, DOI 10.1126/science.282.5391.1136; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Zerucha T, 2000, J NEUROSCI, V20, P709, DOI 10.1523/JNEUROSCI.20-02-00709.2000	46	353	362	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 11	2002	298	5592					381	385		10.1126/science.1075703	http://dx.doi.org/10.1126/science.1075703			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	602NB	12193642				2022-12-24	WOS:000178510400039
J	Nieder, A; Freedman, DJ; Miller, EK				Nieder, A; Freedman, DJ; Miller, EK			Representation of the quantity of visual items in the primate prefrontal cortex	SCIENCE			English	Article							NUMERICAL ASSESSMENT; ACTIVATION; THINKING; MONKEYS; NUMBER; MODEL; BRAIN; AREAS	Deriving the quantity of items is an abstract form of categorization. To explore it, monkeys were trained to judge whether successive visual displays contained the same quantity of items. Many neurons in the lateral prefrontal cortex were tuned for quantity irrespective of the exact physical appearance of the displays. Their tuning curves formed overlapping filters, which may explain why behavioral discrimination improves with increasing numerical distance and why discrimination of two quantities with equal numerical distance worsens as their numerical size increases. A mechanism that extracts the quantity of visual field items could contribute to general numerical ability.	MIT, RIKEN, Picower Ctr Learning & Memory, Neurosci Res Ctr, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); RIKEN; Massachusetts Institute of Technology (MIT)	Nieder, A (corresponding author), MIT, RIKEN, Picower Ctr Learning & Memory, Neurosci Res Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA.		Miller, Earl K./AAE-8187-2019	Miller, Earl K./0000-0002-0582-6958				Boysen S. T., 1993, DEV NUMERICAL COMPET; Brannon EM, 1998, SCIENCE, V282, P746, DOI 10.1126/science.282.5389.746; BURBAUD P, 1995, J NEUROPHYSIOL, V74, P2194, DOI 10.1152/jn.1995.74.5.2194; DAVIS H, 1988, BEHAV BRAIN SCI, V11, P561, DOI 10.1017/S0140525X00053437; Dehaene S, 1999, SCIENCE, V284, P970, DOI 10.1126/science.284.5416.970; DEHAENE S, 1993, J COGNITIVE NEUROSCI, V5, P390, DOI 10.1162/jocn.1993.5.4.390; Dehaene S, 2001, PSYCHOL SCI, V12, P244, DOI 10.1111/1467-9280.00343; Dehaene S, 1998, TRENDS NEUROSCI, V21, P355, DOI 10.1016/S0166-2236(98)01263-6; ELGAR MA, 1989, BIOL REV, V64, P13, DOI 10.1111/j.1469-185X.1989.tb00636.x; EMMERTON J, 2001, AVIAN VISUAL COGNITI; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Freedman DJ, 2002, J NEUROPHYSIOL, V88, P929, DOI 10.1152/jn.2002.88.2.929; Hauser MD, 2000, P ROY SOC B-BIOL SCI, V267, P829, DOI 10.1098/rspb.2000.1078; Hauser MD, 1996, P NATL ACAD SCI USA, V93, P1514, DOI 10.1073/pnas.93.4.1514; LUCCHELLI F, 1993, J NEUROL NEUROSUR PS, V56, P304, DOI 10.1136/jnnp.56.3.304; MANDLER G, 1982, J EXP PSYCHOL GEN, V111, P1, DOI 10.1037/0096-3445.111.1.1; MCCOMB K, 1994, ANIM BEHAV, V47, P379, DOI 10.1006/anbe.1994.1052; ROLAND PE, 1985, J NEUROPHYSIOL, V53, P1219, DOI 10.1152/jn.1985.53.5.1219; Sakurai Y, 1996, J NEUROL SCI, V139, P89, DOI 10.1016/0022-510X(96)00039-1; Sawamura H, 2002, NATURE, V415, P918, DOI 10.1038/415918a; VANOEFFELEN MP, 1982, PERCEPT PSYCHOPHYS, V32, P163, DOI 10.3758/BF03204275; WASHBURN DA, 1991, PSYCHOL SCI, V2, P190, DOI 10.1111/j.1467-9280.1991.tb00130.x; Wilson ML, 2001, ANIM BEHAV, V61, P1203, DOI 10.1006/anbe.2000.1706	23	461	474	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 6	2002	297	5587					1708	1711		10.1126/science.1072493	http://dx.doi.org/10.1126/science.1072493			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590JE	12215649				2022-12-24	WOS:000177819100052
J	Bourne, HR; Weiner, O				Bourne, HR; Weiner, O			A chemical compass	NATURE			English	Editorial Material									Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Harvard Medical School	Bourne, HR (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.		Weiner, Orion D/F-2576-2011	Weiner, Orion D/0000-0002-1778-6543				CORNER FI, 2002, CELL, V109, P541; Verkhovsky AB, 1999, CURR BIOL, V9, P11, DOI 10.1016/S0960-9822(99)80042-6; Weiner OD, 2002, CURR OPIN CELL BIOL, V14, P196, DOI 10.1016/S0955-0674(02)00310-1; ZIGMOND SH, 1977, J CELL BIOL, V75, P606, DOI 10.1083/jcb.75.2.606	4	102	103	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 5	2002	419	6902					21	21		10.1038/419021a	http://dx.doi.org/10.1038/419021a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589YF	12214215				2022-12-24	WOS:000177788600021
J	Du, HS; Rosbash, M				Du, HS; Rosbash, M			The U1 snRNP protein U1C recognizes the 5 ' splice site in the absence of base pairing	NATURE			English	Article							PRE-MESSENGER-RNA; 5' SPLICE-SITE; COMPLEX-FORMATION; SR PROTEINS; YEAST; IDENTIFICATION; SELECTION; CLEAVAGE	Splicing of precursor messenger RNA takes place in the spliceosome, a large RNA/protein macromolecular machine(1). Spliceosome assembly occurs in an ordered pathway in vitro and is conserved between yeast and mammalian systems. The earliest step is commitment complex formation in yeast or E complex formation in mammals, which engages the pre-mRNA in the splicing pathway and involves interactions between U1 small nuclear ribonucleoprotein (snRNP) and the pre-mRNA 5' splice site(2,3). Complex formation depends on highly conserved base pairing between the 5' splice site and the 5' end of U1 snRNA, both in vivo and in vitro(4-7). U1 snRNP proteins also contribute to U1 snRNP activity(8-10). Here we show that U1 snRNP lacking the 5' end of its snRNA retains 5'-splice-site sequence specificity. We also show that recombinant yeast U1C protein, a U1 snRNP protein, selects a 5'-splice-site-like sequence in which the first four nucleotides, GUAU, are identical to the first four nucleotides of the yeast 5'-splice-site consensus sequence. We propose that a U1C 5'-splice-site interaction precedes pre-mRNA/U1 snRNA base pairing and is the earliest step in the splicing pathway.	Brandeis Univ, Dept Biol, Howard Hughes Med Inst, Waltham, MA 02454 USA	Brandeis University; Howard Hughes Medical Institute	Rosbash, M (corresponding author), Brandeis Univ, Dept Biol, Howard Hughes Med Inst, MS008,415 South St, Waltham, MA 02454 USA.	rosbash@brandeis.edu						Abovich N, 1997, CELL, V89, P403, DOI 10.1016/S0092-8674(00)80221-4; Berglund JA, 1997, CELL, V89, P781, DOI 10.1016/S0092-8674(00)80261-5; Burge CB, 1999, RNA WORLD, P525; Chen JYF, 2001, MOL CELL, V7, P227, DOI 10.1016/S1097-2765(01)00170-8; CRISPINO JD, 1995, GENE DEV, V9, P2314, DOI 10.1101/gad.9.18.2314; CRISPINO JD, 1994, SCIENCE, V265, P1866, DOI 10.1126/science.8091213; Crispino JD, 1996, RNA, V2, P664; Du H, 2001, RNA, V7, P133, DOI 10.1017/S1355838201001844; HEINRICHS V, 1990, SCIENCE, V247, P69, DOI 10.1126/science.2136774; HERSCHLAG D, 1991, P NATL ACAD SCI USA, V88, P6921, DOI 10.1073/pnas.88.16.6921; JAMISON SF, 1995, NUCLEIC ACIDS RES, V23, P3260, DOI 10.1093/nar/23.16.3260; Johnson TL, 2001, GENE DEV, V15, P1957, DOI 10.1101/gad.895601; KONFORTI BB, 1995, RNA, V1, P815; LERNER MR, 1980, NATURE, V283, P220, DOI 10.1038/283220a0; Lund M, 2002, RNA, V8, P166, DOI 10.1017/S1355838202010786; Maroney PA, 2000, MOL CELL, V6, P317, DOI 10.1016/S1097-2765(00)00032-0; MICHAUD S, 1991, GENE DEV, V5, P2534, DOI 10.1101/gad.5.12b.2534; Puig O, 1999, GENE DEV, V13, P569, DOI 10.1101/gad.13.5.569; Reyes J, 1996, RNA, V2, P213; Rossi F, 1996, J BIOL CHEM, V271, P23985, DOI 10.1074/jbc.271.39.23985; SERAPHIN B, 1989, CELL, V59, P349, DOI 10.1016/0092-8674(89)90296-1; SERAPHIN B, 1988, EMBO J, V7, P2533, DOI 10.1002/j.1460-2075.1988.tb03101.x; SILICIANO PG, 1988, GENE DEV, V2, P1258, DOI 10.1101/gad.2.10.1258; Tang J, 1997, EMBO J, V16, P4082, DOI 10.1093/emboj/16.13.4082; TARN WY, 1994, GENE DEV, V8, P2704, DOI 10.1101/gad.8.22.2704; TRAUB P, 1969, J MOL BIOL, V40, P391, DOI 10.1016/0022-2836(69)90161-2; Valcarcel J, 1996, SCIENCE, V273, P1706, DOI 10.1126/science.273.5282.1706; Zhang D, 1999, GENE DEV, V13, P581, DOI 10.1101/gad.13.5.581; ZHUANG Y, 1986, CELL, V46, P827, DOI 10.1016/0092-8674(86)90064-4	29	121	123	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 5	2002	419	6902					86	90		10.1038/nature00947	http://dx.doi.org/10.1038/nature00947			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589YF	12214237				2022-12-24	WOS:000177788600042
J	Henry, MR; Cho, MK; Weaver, MA; Merz, JF				Henry, MR; Cho, MK; Weaver, MA; Merz, JF			Genetics: DNA patenting and licensing	SCIENCE			English	Editorial Material									Univ Penn, Ctr Bioeth, Philadelphia, PA 19104 USA; Stanford Univ, Ctr Biomed Eth, Palo Alto, CA 94304 USA	University of Pennsylvania; Pennsylvania Medicine; Stanford University	Merz, JF (corresponding author), Univ Penn, Ctr Bioeth, Philadelphia, PA 19104 USA.			Merz, Jon/0000-0002-0612-7104	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002034] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG002034-03, R01 HG002034-01A1, R01HG02034, R01 HG002034-02, R01 HG002034, R01 HG002034-01A1S1, R01 HG002034-01A1S2] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Heller MA, 1998, SCIENCE, V281, P517; Mowery DC, 2001, RES POLICY, V30, P99, DOI 10.1016/S0048-7333(99)00100-6; PRESSMAN L, 2000, AUTM LICENSING SURVE; ROUMEL TJ, COMMUNICATION; Schissel A, 1999, NATURE, V402, P118, DOI 10.1038/45907; Thomas SM, 1996, NATURE, V380, P387, DOI 10.1038/380387a0; Thomas SM, 1997, NATURE, V388, P709, DOI 10.1038/41853; WALSH J, 2001, C OP PAT SYST INS NE; 4237224	9	22	22	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 23	2002	297	5585					1279	1279		10.1126/science.1070899	http://dx.doi.org/10.1126/science.1070899			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FL	12193770	Green Accepted			2022-12-24	WOS:000177573900022
J	West, PM; Packer, C				West, PM; Packer, C			Sexual selection, temperature, and the lion's mane	SCIENCE			English	Article							NATURAL-SELECTION; CLIMATE; COOPERATION; POPULATION; INDUCE; COSTS; GOATS; CELLS; COLOR	The mane of the African lion ( Panthera leo) is a highly variable trait that reflects male condition and ambient temperature. We examined the consequences of this variation in a long-term study of lions in the Serengeti National Park, Tanzania. Mane darkness indicates nutrition and testosterone and influences both female choice and male-male competition. Mane length signals fighting success and only appears to influence male-male assessment. Dark-maned males enjoy longer reproductive life-spans and higher offspring survival, but they suffer higher surface temperatures, abnormal sperm, and lower food intake during hot months of the year. Maned males are hotter than females, and males have lighter and/or shorter manes in hotter seasons, years, and habitats. This phenotypic plasticity suggests that the mane will respond to forecasted increases in ambient temperature.	Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	West, PM (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, 1987 Upper Buford Circle, St Paul, MN 55108 USA.	west0302@umn.edu						ACHARYA RM, 1995, SMALL RUMINANT RES, V18, P245, DOI 10.1016/0921-4488(95)00703-6; Andersson Malte, 1994; Buchanan KL, 2001, P ROY SOC B-BIOL SCI, V268, P1337, DOI 10.1098/rspb.2001.1669; COOK RB, 1994, THERIOGENOLOGY, V41, P653, DOI 10.1016/0093-691X(94)90175-I; Darwin C., 1871, P423; Emlen DJ, 2001, SCIENCE, V291, P1534, DOI 10.1126/science.1056607; ENDLER JA, 1980, EVOLUTION, V34, P76, DOI 10.1111/j.1558-5646.1980.tb04790.x; Forchhammer MC, 2001, J ANIM ECOL, V70, P721, DOI 10.1046/j.0021-8790.2001.00532.x; Funston PJ, 1998, ANIM BEHAV, V56, P1333, DOI 10.1006/anbe.1998.0884; Griffith SC, 1999, NATURE, V400, P358, DOI 10.1038/22536; HEINSOHN R, 1995, SCIENCE, V269, P1260, DOI 10.1126/science.7652573; HEMMER H, 1974, Veroeffentlichungen der Zoologischen Staatssammlung (Muenchen), V17, P167; HILL GE, 1993, BIOL J LINN SOC, V49, P63, DOI 10.1006/bijl.1993.1023; HILSBERG S, 2000, ASPEKTE KLINISCHEN A; Hulme M, 2001, CLIM RES, V17, P145, DOI 10.3354/cr017145; Kalas JA, 1997, J BIOGEOGR, V24, P213, DOI 10.1046/j.1365-2699.1997.00093.x; MARLER CA, 1988, BEHAV ECOL SOCIOBIOL, V23, P21, DOI 10.1007/BF00303053; Moen RA, 1999, EVOL ECOL RES, V1, P235; Moller AP., 1994, SEXUAL SELECTION BAR; PACKER C, 1983, AM NAT, V121, P716, DOI 10.1086/284097; PACKER C, 1982, NATURE, V296, P740, DOI 10.1038/296740a0; Packer C, 2000, AM ANTHROPOL, V102, P829, DOI 10.1525/aa.2000.102.4.829; PACKER C, 1991, NATURE, V351, P562, DOI 10.1038/351562a0; PANT KP, 1985, PESQUI AGROPECU BRAS, V20, P717; Pocock RI, 1931, J BOMBAY NAT HIST SO, V34, P638; Robbins C. T., 1993, WILDLIFE FEEDING NUT; Schaller G. B., 1972, SERENGETI LION; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; Selous F. C., 1908, AFRICAN NATURE NOTES; Tear TH, 1997, J WILDLIFE MANAGE, V61, P1142, DOI 10.2307/3802112; Thornton MJ, 2001, J ENDOCRINOL, V168, P401, DOI 10.1677/joe.0.1680401; WALSBERG GE, 1990, PHYSIOL ZOOL, V63, P1025, DOI 10.1086/physzool.63.5.30152627; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wiens JJ, 2001, TRENDS ECOL EVOL, V16, P517, DOI 10.1016/S0169-5347(01)02217-0; WILDT DE, 1987, NATURE, V329, P328, DOI 10.1038/329328a0; WILLIAMS CK, 1989, J ANIM ECOL, V58, P495, DOI 10.2307/4844; WILSON MJ, 1983, ENDOCRINOLOGY, V112, P321, DOI 10.1210/endo-112-1-321; ZAHAVI A, 1977, J THEOR BIOL, V67, P603, DOI 10.1016/0022-5193(77)90061-3	38	206	212	6	267	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2002	297	5585					1339	1343		10.1126/science.1073257	http://dx.doi.org/10.1126/science.1073257			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FL	12193785				2022-12-24	WOS:000177573900045
J	Lawlor, DA; Ebrahim, S; Smith, GD				Lawlor, DA; Ebrahim, S; Smith, GD			Role of endogenous oestrogen in aetiology of coronary heart disease: analysis of age related trends in coronary heart disease and breast cancer in England and Wales and Japan	BRITISH MEDICAL JOURNAL			English	Article							MENOPAUSE; PARADOX; MYTH		Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England	University of Bristol	Lawlor, DA (corresponding author), Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England.		Davey Smith, George/A-7407-2013	Davey Smith, George/0000-0002-1407-8314; Lawlor, Debbie A/0000-0002-6793-2262				Lawlor DA, 2001, BRIT MED J, V323, P541, DOI 10.1136/bmj.323.7312.541; Meilahn E, 1999, HEALTH AND DISEASE AMONG WOMEN: BIOLOGICAL AND ENVIRONMENTAL INFLUENCES, P155; TRACY RE, 1966, J CHRON DIS, V19, P1245, DOI 10.1016/0021-9681(66)90022-1; Tunstall-Pedoe H, 1998, LANCET, V351, P1425, DOI 10.1016/S0140-6736(97)11321-6; Witteman JCM, 1998, LANCET, V352, P407, DOI 10.1016/S0140-6736(05)60507-7	5	21	22	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 10	2002	325	7359					311	312		10.1136/bmj.325.7359.311	http://dx.doi.org/10.1136/bmj.325.7359.311			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	584RQ	12169507	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000177482500018
J	Gilbert, N; Lutz-Prigge, S; Moran, JV				Gilbert, N; Lutz-Prigge, S; Moran, JV			Genomic deletions created upon LINE-1 retrotransposition	CELL			English	Article							HUMAN L1 RETROTRANSPOSITION; HUMAN TRANSPOSABLE ELEMENT; REVERSE TRANSCRIPTION; ESCHERICHIA-COLI; GENE; RNA; CELLS; RECOMBINATION; ENDONUCLEASE; MECHANISM	LINE-1 (L1) retrotransposition continues to impact the human genome, yet little is known about how L1 integrates into DNA. Here, we developed a plasmid-based rescue system and have used it to recover 37 new Ll retrotransposition events from cultured human cells. Sequencing of the insertions revealed the usual Ll structural hallmarks; however, in four instances, retrotransposition generated large target site deletions. Remarkably, three of those resulted in the formation of chimeric Lls, containing the 5' end of an endogenous L1 fused precisely to our engineered L1. Thus, our data demonstrate multiple pathways for Ll integration in cultured cells, and show that L1 is not simply an insertional mutagen, but that its retrotransposition can result in significant deletions of genomic sequence.	Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Gilbert, N (corresponding author), Univ Michigan, Sch Med, Dept Human Genet, 1241 E Catherine St, Ann Arbor, MI 48109 USA.	gilbertn@umich.edu; moranj@umich.edu	Gilbert, Nicolas/M-9568-2018	Gilbert, Nicolas/0000-0003-3311-7494; Lutz, Sheila/0000-0002-6729-4598	NIGMS NIH HHS [GM60518] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060518] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Boeke JD, 1997, NAT GENET, V16, P6, DOI 10.1038/ng0597-6; Carroll ML, 2001, J MOL BIOL, V311, P17, DOI 10.1006/jmbi.2001.4847; Chaboissier MC, 2000, NUCLEIC ACIDS RES, V28, P2467, DOI 10.1093/nar/28.13.2467; Cost GJ, 1998, BIOCHEMISTRY-US, V37, P18081, DOI 10.1021/bi981858s; DOMBROSKI BA, 1991, SCIENCE, V254, P1805, DOI 10.1126/science.1662412; Esnault C, 2000, NAT GENET, V24, P363, DOI 10.1038/74184; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; Garvey SM, 2002, GENOMICS, V79, P146, DOI 10.1006/geno.2002.6685; Hayakawa T, 2001, P NATL ACAD SCI USA, V98, P11399, DOI 10.1073/pnas.191268198; Hayward BE, 1997, GENETICS, V146, P641; Hohjoh H, 1997, EMBO J, V16, P6034, DOI 10.1093/emboj/16.19.6034; Hohjoh H, 1996, EMBO J, V15, P630, DOI 10.1002/j.1460-2075.1996.tb00395.x; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; KASS DH, 1995, MOL CELL BIOL, V15, P19, DOI 10.1128/MCB.15.1.19; Kojima T, 2000, MOL BRAIN RES, V75, P121, DOI 10.1016/S0169-328X(99)00313-7; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Liao DQ, 1998, J MOL EVOL, V46, P649, DOI 10.1007/PL00006345; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; LUAN DD, 1995, MOL CELL BIOL, V15, P3882; MARTIN SL, 1991, MOL CELL BIOL, V11, P4804, DOI 10.1128/MCB.11.9.4804; MATHIAS SL, 1991, SCIENCE, V254, P1808, DOI 10.1126/science.1722352; Moran J.V., 2002, MOBILE DNA, P836; Moran JV, 1999, SCIENCE, V283, P1530, DOI 10.1126/science.283.5407.1530; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Morrish TA, 2002, NAT GENET, V31, P159, DOI 10.1038/ng898; Ostertag EM, 2001, GENOME RES, V11, P2059, DOI 10.1101/gr.205701; Ovchinnikov I, 2001, GENOME RES, V11, P2050, DOI 10.1101/gr.194701; Sassaman DM, 1997, NAT GENET, V16, P37, DOI 10.1038/ng0597-37; Saxton JA, 1998, J MOL BIOL, V280, P611, DOI 10.1006/jmbi.1998.1899; Segal Y, 1999, AM J HUM GENET, V64, P62, DOI 10.1086/302213; Sheen FM, 2000, GENOME RES, V10, P1496, DOI 10.1101/gr.149400; Su LK, 2000, HUM GENET, V106, P101, DOI 10.1007/s004390051016; SWERGOLD GD, 1990, MOL CELL BIOL, V10, P6718, DOI 10.1128/MCB.10.12.6718; Symer DE, 2002, CELL, V110, P327, DOI 10.1016/S0092-8674(02)00839-5; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; TANG XR, 1994, NUCLEIC ACIDS RES, V22, P2857, DOI 10.1093/nar/22.14.2857; Wang T, 2001, GENE CHROMOSOME CANC, V31, P91, DOI 10.1002/gcc.1110; Wei W, 2000, ANAL BIOCHEM, V284, P435, DOI 10.1006/abio.2000.4675; Wei W, 2001, MOL CELL BIOL, V21, P1429, DOI 10.1128/MCB.21.4.1429-1439.2001	39	359	367	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 9	2002	110	3					315	325		10.1016/S0092-8674(02)00828-0	http://dx.doi.org/10.1016/S0092-8674(02)00828-0			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	583MN	12176319	Bronze			2022-12-24	WOS:000177411800008
J	Miller, MB; Skorupski, K; Lenz, DH; Taylor, RK; Bassler, BL				Miller, MB; Skorupski, K; Lenz, DH; Taylor, RK; Bassler, BL			Parallel quorum sensing systems converge to regulate virulence in Vibrio cholerae	CELL			English	Article							ACYLHOMOSERINE LACTONE SYNTHASE; LOCUS CONTROLLING EXPRESSION; TOXIN-COREGULATED PILUS; GRAM-NEGATIVE BACTERIA; AUTOINDUCER SYNTHESIS; S-ADENOSYLMETHIONINE; NUCLEOTIDE-SEQUENCE; HOMOSERINE LACTONES; GENETIC-ANALYSIS; EL-TOR	The marine bacterium Vibrio harveyi possesses two quorum sensing systems (System I and System 2) that regulate bioluminescence. Although the Vibrio cholerae genome sequence reveals that a V. harveyi-like System 2 exists, it does not predict the existence of a V. harveyi-like System 1 or any obvious quorum sensing-controlled target genes. In this report we identify and characterize the genes encoding an additional V. cholerae autoinducer synthase and its cognate sensor. Analysis of double mutants indicates that a third as yet unidentified sensory circuit exists in V. cholerae. This quorum sensing apparatus is unusually complex, as it is composed of at least three parallel signaling channels. We show that in V. cholerae these communication systems converge to control virulence.	Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Dartmouth Coll Sch Med, Dept Microbiol & Immunol, Hanover, NH 03755 USA	Princeton University; Dartmouth College	Bassler, BL (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.			Bassler, Bonnie/0000-0002-0043-746X	NIAID NIH HHS [AI39654, AI41558] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041558, R29AI041558, R01AI039654] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BASSLER BL, 1993, MOL MICROBIOL, V9, P773, DOI 10.1111/j.1365-2958.1993.tb01737.x; BASSLER BL, 1994, MOL MICROBIOL, V12, P403, DOI 10.1111/j.1365-2958.1994.tb01029.x; BASSLER BL, 1994, MOL MICROBIOL, V13, P273, DOI 10.1111/j.1365-2958.1994.tb00422.x; Bassler BL, 1997, J BACTERIOL, V179, P4043, DOI 10.1128/jb.179.12.4043-4045.1997; CAO JG, 1989, J BIOL CHEM, V264, P21670; Chen X, 2002, NATURE, V415, P545, DOI 10.1038/415545a; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; de Kievit TR, 2000, INFECT IMMUN, V68, P4839, DOI 10.1128/IAI.68.9.4839-4849.2000; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; DERITA VJ, 1991, P NATL ACAD SCI USA, V88, P5403; ENGEBRECHT J, 1987, NUCLEIC ACIDS RES, V15, P10455, DOI 10.1093/nar/15.24.10455; ENGEBRECHT J, 1984, P NATL ACAD SCI-BIOL, V81, P4154, DOI 10.1073/pnas.81.13.4154; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; Freeman JA, 1999, J BACTERIOL, V181, P899, DOI 10.1128/JB.181.3.899-906.1999; Freeman JA, 1999, MOL MICROBIOL, V31, P665, DOI 10.1046/j.1365-2958.1999.01208.x; Freeman JA, 2000, MOL MICROBIOL, V35, P139, DOI 10.1046/j.1365-2958.2000.01684.x; GARDEL CL, 1994, METHOD ENZYMOL, V235, P517; GILSON L, 1995, J BACTERIOL, V177, P6946, DOI 10.1128/jb.177.23.6946-6951.1995; Hanzelka BL, 1996, J BACTERIOL, V178, P5291, DOI 10.1128/jb.178.17.5291-5294.1996; Hanzelka BL, 1999, J BACTERIOL, V181, P5766, DOI 10.1128/JB.181.18.5766-5770.1999; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; IWANAGA M, 1986, MICROBIOL IMMUNOL, V30, P1075, DOI 10.1111/j.1348-0421.1986.tb03037.x; Jobling MG, 1997, MOL MICROBIOL, V26, P1023, DOI 10.1046/j.1365-2958.1997.6402011.x; Kalogeraki VS, 1997, GENE, V188, P69, DOI 10.1016/S0378-1119(96)00778-0; Kleerebezem M, 1997, MOL MICROBIOL, V24, P895, DOI 10.1046/j.1365-2958.1997.4251782.x; Klose KE, 1998, J BACTERIOL, V180, P5256, DOI 10.1128/JB.180.19.5256-5259.1998; Laue RE, 2000, MICROBIOL-UK, V146, P2469, DOI 10.1099/00221287-146-10-2469; Lazazzera BA, 1998, TRENDS MICROBIOL, V6, P288, DOI 10.1016/S0966-842X(98)01313-4; Lilley BN, 2000, MOL MICROBIOL, V36, P940, DOI 10.1046/j.1365-2958.2000.01913.x; Liu PC, 1996, CURR MICROBIOL, V33, P129, DOI 10.1007/s002849900087; Manefield M, 2000, APPL ENVIRON MICROB, V66, P2079, DOI 10.1128/AEM.66.5.2079-2084.2000; MARTIN M, 1989, J BACTERIOL, V171, P2406, DOI 10.1128/jb.171.5.2406-2414.1989; McClean KH, 1997, MICROBIOL-UK, V143, P3703, DOI 10.1099/00221287-143-12-3703; Metcalf WW, 1996, PLASMID, V35, P1, DOI 10.1006/plas.1996.0001; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; More MI, 1996, SCIENCE, V272, P1655, DOI 10.1126/science.272.5268.1655; PALMER LM, 1991, APPL ENVIRON MICROB, V57, P1286, DOI 10.1128/AEM.57.5.1286-1293.1991; Parsek MR, 1999, P NATL ACAD SCI USA, V96, P4360, DOI 10.1073/pnas.96.8.4360; PIPER KR, 1993, NATURE, V362, P448, DOI 10.1038/362448a0; Ravn L, 2001, J MICROBIOL METH, V44, P239, DOI 10.1016/S0167-7012(01)00217-2; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Schaefer AL, 2000, METHOD ENZYMOL, V305, P288; Schaefer AL, 2001, METHOD ENZYMOL, V336, P41, DOI 10.1016/S0076-6879(01)36576-X; Schauder S, 2001, MOL MICROBIOL, V41, P463, DOI 10.1046/j.1365-2958.2001.02532.x; Schauder S, 2001, GENE DEV, V15, P1468, DOI 10.1101/gad.899601; Shaw PD, 1997, P NATL ACAD SCI USA, V94, P6036, DOI 10.1073/pnas.94.12.6036; SHOWALTER RE, 1990, J BACTERIOL, V172, P2946, DOI 10.1128/jb.172.6.2946-2954.1990; Skorupski K, 1996, GENE, V169, P47, DOI 10.1016/0378-1119(95)00793-8; Skorupski K, 1997, MOL MICROBIOL, V25, P1003, DOI 10.1046/j.1365-2958.1997.5481909.x; SLAUCH JM, 1991, J BACTERIOL, V173, P4039, DOI 10.1128/jb.173.13.4039-4048.1991; SUN D, 1991, INFECT IMMUN, V59, P114, DOI 10.1128/IAI.59.1.114-118.1991; Surette MG, 1999, P NATL ACAD SCI USA, V96, P1639, DOI 10.1073/pnas.96.4.1639; TAYLOR RK, 1987, P NATL ACAD SCI USA, V84, P2833, DOI 10.1073/pnas.84.9.2833; Thelin KH, 1996, INFECT IMMUN, V64, P2853, DOI 10.1128/IAI.64.7.2853-2856.1996; Val DL, 1998, J BACTERIOL, V180, P2644, DOI 10.1128/JB.180.10.2644-2651.1998; ZHANG LH, 1993, NATURE, V362, P446, DOI 10.1038/362446a0; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	57	479	518	3	81	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 9	2002	110	3					303	314		10.1016/S0092-8674(02)00829-2	http://dx.doi.org/10.1016/S0092-8674(02)00829-2			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	583MN	12176318	Bronze			2022-12-24	WOS:000177411800007
J	Corma, A; Diaz-Cabanas, M; Martinez-Triguero, J; Rey, F; Rius, J				Corma, A; Diaz-Cabanas, M; Martinez-Triguero, J; Rey, F; Rius, J			A large-cavity zeolite with wide pore windows and potential as an oil refining catalyst	NATURE			English	Article							HIGH-SILICA; METHYLCYCLOHEXANE; CRACKING; ITQ-7; UNITS; BETA; GE	Crude oil is an important feedstock for the petrochemical industry and the dominant energy source driving the world economy, but known oil reserves will cover demand for no more than 50 years at the current rate of consumption(1). This situation calls for more efficient strategies for converting crude oil into fuel and petrochemical products. At present, more than 40% of oil conversion is achieved using catalysts based on faujasite; this zeolite requires extensive post-synthesis treatment to produce an ultrastable form 2,3, and has a large cavity accessible through four 0.74-nm-wide windows and thus limits the access of oil molecules to the catalytically active sites. The use of zeolites with better accessibility to their active sites should result in improved catalyst efficiency. To date, two zeolites with effective pore diameters exceeding that of faujasite have been reported(4,5), but their one-dimensional pore topology excludes use in oil refining. Similarly, zeolites with large pores and a three-dimensional pore topology have been reported(6-8), but in all these materials the pore openings are smaller than in faujasite. Here we report the synthesis of ITQ-21, a zeolite with a three-dimensional pore network containing 1.18-nm-wide cavities, each of which is accessible through six circular and 0.74-nm-wide windows. As expected for a zeolite with this structure, ITQ-21 exhibits high catalytic activity and selectivity for valuable products in preliminary oil refining tests.	Univ Politecn Valencia, CSIC, Inst Tecnol Quim, Valencia 46022, Spain; Inst Ciencia Mat Barcelona, CSIC, Bellaterra, Catalunya, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Tecnologia Quimica (ITQ); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia de Materiales de Barcelona (ICMAB)	Corma, A (corresponding author), Univ Politecn Valencia, CSIC, Inst Tecnol Quim, Avda Naranjos S-N, Valencia 46022, Spain.	acorma@itq.upv.es	Rey, Fernando/C-6778-2011; Martinez-Triguero, Joaquin/H-4269-2015; CANOS, AVELINO CORMA/A-3040-2013	Rey, Fernando/0000-0003-3227-5669; Martinez-Triguero, Joaquin/0000-0003-4590-724X; CANOS, AVELINO CORMA/0000-0002-2232-3527; RIUS, JORDI/0000-0002-8376-8634				BAERLOCHER C, 2000, ATLAS ZEOLITE FRAMEW; BISWAS J, 1990, APPL CATAL, V63, P197, DOI 10.1016/S0166-9834(00)81716-9; Blasco T, 2002, J PHYS CHEM B, V106, P2634, DOI 10.1021/jp013302b; Camblor MA, 2001, MICROPOR MESOPOR MAT, V48, P11, DOI 10.1016/S1387-1811(01)00325-0; Cerqueira HS, 2001, IND ENG CHEM RES, V40, P1032, DOI 10.1021/ie000730f; Corma A, 2001, ANGEW CHEM INT EDIT, V40, P2277, DOI 10.1002/1521-3773(20010618)40:12<2277::AID-ANIE2277>3.0.CO;2-O; CORMA A, 1991, APPL CATAL, V67, P307; Corma A, 1997, J CATAL, V165, P102, DOI 10.1006/jcat.1997.1474; Corma A, 2001, CHEM COMMUN, P1486, DOI 10.1039/b104114m; Corma A, 2001, J CATAL, V197, P151, DOI 10.1006/jcat.2000.3065; Corma V, 2000, ANGEW CHEM INT EDIT, V39, P2346; Freyhardt CC, 1996, NATURE, V381, P295, DOI 10.1038/381295a0; KLINOWSKI J, 1984, PROG NUCL MAG RES SP, V16, P237, DOI 10.1016/0079-6565(84)80007-2; LACOMBE S, 2001, STUD SURF SCI CATAL, V135, P4272; MARCILLY C, 2001, STUD SURF SCI CATAL, V135, P37, DOI DOI 10.1016/S0167-2991(01)81185-X; MARTINO G, 2000, STUD SURF SCI CATAL, V130, P83; O'Keeffe M, 1999, CHEM-EUR J, V5, P2796, DOI 10.1002/(SICI)1521-3765(19991001)5:10<2796::AID-CHEM2796>3.3.CO;2-Y; Rius J, 1999, POWDER DIFFR, V14, P267, DOI 10.1017/S0885715600010654; RUIS J, 1999, PROGRAM LSP7 PROGRAM; TREACY MMJ, 1988, NATURE, V332, P249, DOI 10.1038/332249a0; Yoshikawa M, 1998, J PHYS CHEM B, V102, P7139, DOI 10.1021/jp982169t	21	450	474	7	341	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 1	2002	418	6897					514	517		10.1038/nature00924	http://dx.doi.org/10.1038/nature00924			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579EE	12152074				2022-12-24	WOS:000177162800035
J	Ford, N				Ford, N			Slow response to Angola's food crisis	LANCET			English	Editorial Material									Med Sans Frontieres, London EC1R 5DJ, England	Doctors Without Borders	Ford, N (corresponding author), Med Sans Frontieres, 124-32 Clerkenwell Rd, London EC1R 5DJ, England.							Ford N, 2001, LANCET, V358, P1543, DOI 10.1016/S0140-6736(01)06588-6; Stokes C, 2000, LANCET, V356, P2093, DOI 10.1016/S0140-6736(00)03415-2; 2002, LANCET, V359, P2125	3	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 27	2002	360	9329					334	334		10.1016/S0140-6736(02)09559-4	http://dx.doi.org/10.1016/S0140-6736(02)09559-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	578DT	12147391				2022-12-24	WOS:000177102700029
J	Marshall, T; Rouse, A				Marshall, T; Rouse, A			Resource implications and health benefits of primary prevention strategies for cardiovascular disease in people aged 30 to 74: mathematical modelling study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY HEART-DISEASE; RISK PROFILE; CHOLESTEROL; METAANALYSIS; STROKE; STATINS	Objective To develop a model to determine the resource costs and health benefits of implementing guidelines for the prevention of cardiovascular disease in primary care, Design Modelling of data from six strategies for prevention of cardiovascular disease. Strategies incorporated two ways of identifying patients for assessment: traditional (assessment of all adults) and novel (preselection of patients For assessment using a prior estimate of their risk of cardiovascular disease). Three treatment strategies were modelled in conjunction with each identification strategy. Setting England. Subjects Patients aged 30 to 74 eligible for primary prevention strategies for cardiovascular disease who were selected from a hypothetical population of 2000. Main outcome measures Resource costs of assessing eligible adults, providing treatment and follow up and number of cardiovascular events this should prevent. Results Novel strategies prevented more cardiovascular disease, at lower cost, than traditional strategies. Some treatment strategies prevent more cardiovascular disease with fewer resources than others. The findings were robust across a range of different assumptions about workload. Conclusion Preselecting patients for assessment makes better use of staff time than assessing all adults. Treating many patients with low cost drugs is more efficient than prescribing a few patients intensive antihypertensives and statins. Authors of guidelines should model workload implications and health benefits of following their recommendations.	Univ Birmingham, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Marshall, T (corresponding author), Univ Birmingham, Birmingham B15 2TT, W Midlands, England.	T.P.Marshall@bham.ac.uk		Marshall, Tom/0000-0001-9277-5214				ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; Bakx JC, 1999, HUISARTS WETENSCHAP, V42, P53; Blauw GJ, 1997, STROKE, V28, P946, DOI 10.1161/01.STR.28.5.946; *BRIT MED ASS, 2000, BRIT NAT FORM; *BRIT MED ASS ROYA, 2000, BRIT NAT FORM; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; *DEP HLTH, 2002, DOH B; *DEP HLTH, 2000, PREV COR HEART DIS H, P2; *DEP HLTH, 2000, HLTH SURV ENGL 98; *DEP HLTH PRESCR P, DRUG TAR JAN 2002; Gueyffier F, 1997, ANN INTERN MED, V126, P761, DOI 10.7326/0003-4819-126-10-199705150-00002; Hebert PR, 1997, JAMA-J AM MED ASSOC, V278, P313, DOI 10.1001/jama.278.4.313; JACKSON R, 1993, BRIT MED J, V307, P107, DOI 10.1136/bmj.307.6896.107; LaRosa JC, 1999, JAMA-J AM MED ASSOC, V282, P2340, DOI 10.1001/jama.282.24.2340; *LOND SCH HYG TROP, LOC STAND COSTS PATH; *LOND SCH HYG TROP, UNPUB LOC STAND COST; MARCOVINA SM, 1994, CLIN CHEM, V40, P574; Marshall T, 2001, BRIT J GEN PRACT, V51, P571; *MED RES COUNC GEN, 1998, LANCET, V351, P23; Neal B, 2000, LANCET, V356, P1955; Netten A.P., 2000, UNIT COSTS HLTH SOCI; Pedersen TR, 1996, CIRCULATION, V93, P1796, DOI 10.1161/01.CIR.93.10.1796; RODERICK PJ, 1993, BRIT J CLIN PHARMACO, V35, P219, DOI 10.1111/j.1365-2125.1993.tb05689.x; Roncaglioni MC, 2001, LANCET, V357, P1706, DOI 10.1016/S0140-6736(00)04836-4; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Wood D, 1998, HEART S2, V80	27	40	40	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 27	2002	325	7357					197	199		10.1136/bmj.325.7357.197	http://dx.doi.org/10.1136/bmj.325.7357.197			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	580PX	12142309	Bronze, Green Published			2022-12-24	WOS:000177243900022
J	Van Eerdewegh, P; Little, RD; Dupuis, J; Del Mastro, RG; Falls, K; Simon, J; Torrey, D; Pandit, S; McKenny, J; Braunschweiger, K; Walsh, A; Liu, ZY; Hayward, B; Folz, C; Manning, SP; Bawa, A; Saracino, L; Thackston, M; Benchekroun, Y; Capparell, N; Wang, M; Adair, R; Feng, Y; Dubois, J; FitzGerald, MG; Huang, H; Gibson, R; Allen, KM; Pedan, A; Danzig, MR; Umland, SP; Egan, RW; Cuss, FM; Rorke, S; Clough, JB; Holloway, JW; Holgate, ST; Keith, TP				Van Eerdewegh, P; Little, RD; Dupuis, J; Del Mastro, RG; Falls, K; Simon, J; Torrey, D; Pandit, S; McKenny, J; Braunschweiger, K; Walsh, A; Liu, ZY; Hayward, B; Folz, C; Manning, SP; Bawa, A; Saracino, L; Thackston, M; Benchekroun, Y; Capparell, N; Wang, M; Adair, R; Feng, Y; Dubois, J; FitzGerald, MG; Huang, H; Gibson, R; Allen, KM; Pedan, A; Danzig, MR; Umland, SP; Egan, RW; Cuss, FM; Rorke, S; Clough, JB; Holloway, JW; Holgate, ST; Keith, TP			Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness	NATURE			English	Article							LINKAGE DISEQUILIBRIUM; PROTEASE; PROTEINS; MARKERS; MUTATION; DOMAIN; FAMILY	Asthma is a common respiratory disorder characterized by recurrent episodes of coughing, wheezing and breathlessness. Although environmental factors such as allergen exposure are risk factors in the development of asthma, both twin and family studies point to a strong genetic component(1,2). To date, linkage studies have identified more than a dozen genomic regions linked to asthma(3). In this study, we performed a genome-wide scan on 460 Caucasian families and identified a locus on chromosome 20p13 that was linked to asthma (log(10) of the likelihood ratio (LOD), 2.94) and bronchial hyperresponsiveness (LOD, 3.93). A survey of 135 polymorphisms in 23 genes identified the ADAM33 gene 4 as being significantly associated with asthma using case-control, transmission disequilibrium and haplotype analyses (P=0.04-0.000003). ADAM proteins are membrane-anchored metalloproteases with diverse functions, which include the shedding of cell-surface proteins such as cytokines and cytokine receptors(5). The identification and characterization of ADAM33, a putative asthma susceptibility gene identified by positional cloning in an outbred population, should provide insights into the pathogenesis and natural history of this common disease.	Genome Therapeut Corp, Waltham, MA 02453 USA; Schering Plough Corp, Res Inst, Kenilworth, NJ 07033 USA; Univ Southampton, Sch Med, Resp Cell & Mol Biol Infect Inflammat & Repair Re, Southampton Gen Hosp, Southampton, Hants, England	Merck & Company; Schering Plough Corporation; University of Southampton	Keith, TP (corresponding author), Genome Therapeut Corp, 100 Beaver St, Waltham, MA 02453 USA.		Little, Randall/O-7172-2014; Holloway, John W/B-5424-2009	Holloway, John W/0000-0001-9998-0464; Dupuis, Josee/0000-0003-2871-3603; Hayward, Brooke/0000-0002-1234-7445				Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Black RA, 1998, CURR OPIN CELL BIOL, V10, P654, DOI 10.1016/S0955-0674(98)80042-2; BOEHNKE M, 1991, AM J HUM GENET, V48, P22; Burney P, 1997, AM J RESP CRIT CARE, V156, P1773; Das M, 2001, PHYSIOL GENOMICS, V6, P57, DOI 10.1152/physiolgenomics.2001.6.2.57; Del Mastro R G, 1997, Methods Mol Biol, V68, P183; DESANCTIS GT, 1995, NAT GENET, V11, P150, DOI 10.1038/ng1095-150; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; Dupuis J, 1999, GENETICS, V151, P373; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Ghosh S, 1997, GENOME RES, V7, P165, DOI 10.1101/gr.7.2.165; Holgate ST, 2000, J ALLERGY CLIN IMMUN, V105, P193, DOI 10.1016/S0091-6749(00)90066-6; Howard L, 2000, BIOCHEM J, V348, P21, DOI 10.1042/0264-6021:3480021; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; Loechel F, 1999, J BIOL CHEM, V274, P13427, DOI 10.1074/jbc.274.19.13427; Los H, 2001, Twin Res, V4, P81, DOI 10.1375/1369052012191; Maquat LE, 2001, NAT GENET, V27, P5, DOI 10.1038/83759; MATISE TC, 1994, NAT GENET, V6, P384, DOI 10.1038/ng0494-384; Mullberg J, 2000, EUR CYTOKINE NETW, V11, P27; Primakoff P, 2000, TRENDS GENET, V16, P83, DOI 10.1016/S0168-9525(99)01926-5; Richter A, 2001, AM J RESP CELL MOL, V25, P385, DOI 10.1165/ajrcmb.25.3.4437; Soares M. B., 1994, AUTOMATED DNA SEQUEN, P110; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Stone AL, 1999, J PROTEIN CHEM, V18, P447, DOI 10.1023/A:1020692710029; Wilkinson J, 1998, GENOMICS, V53, P251, DOI 10.1006/geno.1998.5485; Wjst M, 1998, BIOINFORMATICS, V14, P827, DOI 10.1093/bioinformatics/14.9.827; YAGAMIHIROMASA T, 1995, NATURE, V377, P652, DOI 10.1038/377652a0; Yoshinaka T, 2002, GENE, V282, P227, DOI 10.1016/S0378-1119(01)00818-6	30	816	855	0	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 25	2002	418	6896					426	430		10.1038/nature00878	http://dx.doi.org/10.1038/nature00878			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576MU	12110844				2022-12-24	WOS:000177009700040
J	Geiderman, JM; Larkin, GL				Geiderman, JM; Larkin, GL			Commercial filming of patient care activities in hospitals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INFORMED CONSENT; CARDIOPULMONARY-RESUSCITATION; DOMESTIC VIOLENCE; NEWS MEDIA; EMERGENCY; TELEVISION; HEALTH; MEDICINE; CONFIDENTIALITY; PUBLICATION	Commercial filming of patient care activities is common in hospital settings. This article reviews common circumstances in which patients are commercially filmed, explores the potential positive and negative aspects of filming, and considers the ethical and legal issues associated with commercial filming of patients in hospital settings. We examine the competing goals of commercial filming and the duties of journalists vs the rights of patients to privacy. Current standards and recommendations for commercial filming of patient care activities are reviewed and additional recommendations are offered.	Cedars Sinai Med Ctr, Burns & Allen Res Inst, Ruth & Harry Roman Emergency Dept, Los Angeles, CA 90048 USA; Cedars Sinai Med Ctr, Burns & Allen Res Inst, Dept Emergency Med, Los Angeles, CA 90048 USA; Cedars Sinai Med Ctr, Burns & Allen Res Inst, Cedars Sinai Ctr Hlth Care Eth, Los Angeles, CA 90048 USA; Univ Texas SW, Parkland Mem Hosp, Dept Surg Emergency Med, Dallas, TX USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of Texas System; University of Texas Southwestern Medical Center Dallas	Geiderman, JM (corresponding author), Cedars Sinai Med Ctr, Burns & Allen Res Inst, Ruth & Harry Roman Emergency Dept, 8700 Beverly Blvd,Room 1110, Los Angeles, CA 90048 USA.			LARKIN, GREGORY LUKE/0000-0002-8655-7824				Adomat R, 1999, Nurs Stand, V14, P37; ALBERTS MJ, 1992, STROKE, V23, P352, DOI 10.1161/01.STR.23.3.352; ALDERMAN E, 1995, RIGHT PRIVACY, pR13; *AM MED ASS COUNC, 3101 CEJA AM MED ASS; [Anonymous], THEORY JUSTICE; Bauer HM, 1999, WESTERN J MED, V171, P118; Beauchamp T., 1994, PRINCIPLES BIOMEDICA, P120; BLOCK MR, 1985, J FAM PRACTICE, V21, P467; BOROW W, 1993, JAMA-J AM MED ASSOC, V270, P1601, DOI 10.1001/jama.270.13.1601; Clever LH, 1997, JAMA-J AM MED ASSOC, V278, P628, DOI 10.1001/jama.278.8.628; Cohn V, 1996, JAMA-J AM MED ASSOC, V276, P1917; Cohn V, 2001, STAT MED, V20, P1341, DOI 10.1002/sim.671; Collins S, 2001, WESTERN J MED, V175, P384, DOI 10.1136/ewjm.175.6.384; DANIELS N, 1985, JUST HLTH CARE, P36; De Amici D, 2000, ANESTH ANALG, V90, P739, DOI 10.1097/00000539-200003000-00042; DEJONG W, 1990, HEALTH AFFAIR, V9, P30, DOI 10.1377/hlthaff.9.2.30; deSemir V, 1996, LANCET, V347, P1163, DOI 10.1016/S0140-6736(96)90614-5; Diem SJ, 1996, NEW ENGL J MED, V334, P1578, DOI 10.1056/NEJM199606133342406; DIKEMA DS, 1996, AM J EMERG MED, V14, P226; Eitel DR, 1998, J FAM PRACTICE, V46, P251; EPPLER E, 1994, ANN EMERG MED, V24, P202, DOI 10.1016/S0196-0644(94)70131-8; Fontanarosa PB, 1997, JAMA-J AM MED ASSOC, V278, P682, DOI 10.1001/jama.278.8.682; FOUBISTER V, 2000, AM MED NEWS     0327, P43; FRANKEL DH, 1995, LANCET, V345, P1105, DOI 10.1016/S0140-6736(95)90836-6; Frankena W. K., 1973, ETHICS, P47; Freed GL, 1996, JAMA-J AM MED ASSOC, V276, P1869, DOI 10.1001/jama.276.23.1869; Geiderman J, 2000, ANN EMERG MED, V35, P403, DOI 10.1016/S0196-0644(00)70063-1; Geiderman JM, 2001, ANN EMERG MED, V37, P217, DOI 10.1067/mem.2001.113559; GERBNER G, 1981, NEW ENGL J MED, V305, P901, DOI 10.1056/NEJM198110083051530; Holden JD, 2001, J EVAL CLIN PRACT, V7, P65, DOI 10.1046/j.1365-2753.2001.00280.x; Hood CA, 1998, BRIT MED J, V316, P1009, DOI 10.1136/bmj.316.7136.1009; HOYT DB, 1988, J TRAUMA, V28, P435, DOI 10.1097/00005373-198804000-00003; HYMAN A, 1995, JAMA-J AM MED ASSOC, V273, P1781, DOI 10.1001/jama.273.22.1781; ISERSON KI, 1995, ETHICS EMERGENCY MED, P427; Iserson KV, 2001, ANN EMERG MED, V37, P220, DOI 10.1067/mem.2001.113560; JENCKS SF, 1994, JOINT COMM J QUAL IM, V20, P359; Jones RB, 1999, J MED ETHICS, V25, P379, DOI 10.1136/jme.25.5.379; KASSIRER JP, 2000, BOSTON GLOBE    0911, pA17; Knopp RK, 1999, EMERG MED CLIN N AM, V17, P385, DOI 10.1016/S0733-8627(05)70066-3; MANN FA, 1994, J TRAUMA, V36, P226, DOI 10.1097/00005373-199402000-00015; MARTIN H, 2002, LOS ANGELES TIM 0115, pA1; MASON MS, 2000, CHRISTIAN SCI M 0602; McArthur DL, 2001, WESTERN J MED, V175, P380, DOI 10.1136/ewjm.175.6.380; MEAD GE, 1995, J MED ETHICS, V21, P39, DOI 10.1136/jme.21.1.39; Mlinek EJ, 1997, ACAD EMERG MED, V4, P1142, DOI 10.1111/j.1553-2712.1997.tb03697.x; Moreno J, 1998, JAMA-J AM MED ASSOC, V280, P1951, DOI 10.1001/jama.280.22.1951; Moynihan R, 2000, NEW ENGL J MED, V342, P1645, DOI 10.1056/NEJM200006013422206; Nelkin D, 1996, LANCET, V347, P1600, DOI 10.1016/S0140-6736(96)91081-8; Nelkin D, 2001, PERSPECT BIOL MED, V44, P199, DOI 10.1353/pbm.2001.0032; NELKIN D, 1991, MILBANK Q, V69, P293, DOI 10.2307/3350206; PARSONS HM, 1974, SCIENCE, V183, P922, DOI 10.1126/science.183.4128.922; POMPLIO N, 2001, AM J REV         JUL, P14; PROSSER WL, 1960, CALIF LAW REV, V48, P383, DOI 10.2307/3478805; Protection of Human Subjects, 1996, FED REGISTER, V61, P51497; Rodriguez MA, 1998, WESTERN J MED, V169, P337; Rodriguez RM, 2001, ACAD EMERG MED, V8, P740, DOI 10.1111/j.1553-2712.2001.tb00195.x; Rogers G, 1999, INT J QUAL HEALTH C, V11, P251, DOI 10.1093/intqhc/11.3.251; *ROYAL SOC MED, 1985, PUBL UND SCI REP ROY; Santora TA, 1996, AM J EMERG MED, V14, P564, DOI 10.1016/S0735-6757(96)90100-X; SCHUMACHER WC, 2000, EMERGENCY PHYSIC DEC, P7; SHUCHMAN M, 1997, ANN INTERN MED, V126, P967; Simon RI, 1997, J FORENSIC SCI, V42, P884; SMITH MS, 1988, NEW ENGL J MED, V319, P1421, DOI 10.1056/NEJM198811243192119; Smithline HA, 1999, ACAD EMERG MED, V6, P776, DOI 10.1111/j.1553-2712.1999.tb01205.x; Snider DE, 1997, JAMA-J AM MED ASSOC, V278, P624, DOI 10.1001/jama.278.8.624; Turney J, 1996, LANCET, V347, P1087, DOI 10.1016/S0140-6736(96)90283-4; TUROW J, 1985, J COMMUN, V35, P36, DOI 10.1111/j.1460-2466.1985.tb02971.x; TUROW J, 1996, LANCET, V347, P1382; Warren SD., 1890, HARVARD LAW REV, V4, P193, DOI DOI 10.2307/1321160; Weil TP, 2001, AM J MED QUAL, V16, P23, DOI 10.1177/106286060101600105; WEISS BD, 1982, JAMA-J AM MED ASSOC, V247, P2695, DOI 10.1001/jama.247.19.2695; WINSTEN JA, 1985, HLTH AFF MILLWOOD, V5, P5; Wolfe S, 1999, Clin Perform Qual Health Care, V7, P38; 2000, HLTH CARE PR MA 0914, P18; 2000, HLTH CARE PR MA 0914, P19	75	16	16	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 17	2002	288	3					373	379		10.1001/jama.288.3.373	http://dx.doi.org/10.1001/jama.288.3.373			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	573AK	12117405	Bronze			2022-12-24	WOS:000176807000032
J	Yu, SW; Wang, HM; Poitras, MF; Coombs, C; Bowers, WJ; Federoff, HJ; Poirier, GG; Dawson, TM; Dawson, VL				Yu, SW; Wang, HM; Poitras, MF; Coombs, C; Bowers, WJ; Federoff, HJ; Poirier, GG; Dawson, TM; Dawson, VL			Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor	SCIENCE			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; GENOMIC STABILITY; GENE DISRUPTION; POLYMERASE; ACTIVATION; PARP; SYNTHETASE; NEUROTOXICITY; REPERFUSION; INHIBITION	Poly(ADP-ribose) polymerase-1 (PARP-1) protects the genome by functioning in the DNA damage surveillance network. PARP-1 is also a mediator of cell death after ischemia-reperfusion injury, glutamate excitotoxicity, and various inflammatory processes. We show that PARP-1 activation is required for translocation of apoptosis-inducing factor (AIF) from the mitochondria to the nucleus and that AIF is necessary for PARP-1 dependent cell death. N-methyl-N'-nitro-N-nitrosoguanidine, H2O2, and N-methyl-D-aspartate induce AIF translocation and cell death, which is prevented by PARP inhibitors or genetic knockout of PARP-1, but is caspase independent. Microinjection of an antibody to AIF protects against PARP-1 dependent cytotoxicity. These data support a model in which PARP-1 activation signals AIF release from mitochondria, resulting in a caspase-independent pathway of programmed cell death.	Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21287 USA; Univ Rochester, Ctr Aging & Dev Biol, Dept Neurol, Rochester, NY 14642 USA; Univ Laval, Med Res Ctr, CHUQ, Hlth & Environm Unit, Ste Foy, PQ G1V 4G2, Canada	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Rochester; Laval University	Dawson, VL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21287 USA.	vdawson@jhmi.edu	Dawson, Valina/Y-9757-2019	Dawson, Valina/0000-0002-2915-3970; Poirier, Guy/0000-0002-4869-1424				Cosi C, 1999, ANN NY ACAD SCI, V890, P227, DOI 10.1111/j.1749-6632.1999.tb07998.x; DEMURCIA G, 1994, MOL CELL BIOCHEM, V138, P15, DOI 10.1007/BF00928438; Di Lisa F, 2001, J BIOL CHEM, V276, P2571, DOI 10.1074/jbc.M006825200; Eliasson MJL, 1997, NAT MED, V3, P1089, DOI 10.1038/nm1097-1089; ENDRES M, 1997, BLOOD FLOW METAB, V17, P1143; Ferri KF, 2000, J EXP MED, V192, P1081, DOI 10.1084/jem.192.8.1081; Filipovic DM, 1999, AM J PHYSIOL-RENAL, V277, pF428, DOI 10.1152/ajprenal.1999.277.3.F428; Ha HC, 1999, P NATL ACAD SCI USA, V96, P13978, DOI 10.1073/pnas.96.24.13978; Herceg Z, 1999, MOL CELL BIOL, V19, P5124; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; LAUTIER D, 1993, MOL CELL BIOCHEM, V122, P171, DOI 10.1007/BF01076101; Lee Y, 1999, J BIOL CHEM, V274, P19792, DOI 10.1074/jbc.274.28.19792; Mandir AS, 2000, J NEUROSCI, V20, P8005; Mandir AS, 1999, P NATL ACAD SCI USA, V96, P5774, DOI 10.1073/pnas.96.10.5774; MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A; Petronilli V, 2001, J BIOL CHEM, V276, P12030, DOI 10.1074/jbc.M010604200; Pieper AA, 2000, MOL MED, V6, P271, DOI 10.1007/BF03401936; Rath PC, 1999, J CLIN IMMUNOL, V19, P350, DOI 10.1023/A:1020546615229; Shall S, 2000, MUTAT RES-DNA REPAIR, V460, P1, DOI 10.1016/S0921-8777(00)00016-1; Smulson ME, 2000, ADV ENZYME REGUL, V40, P183, DOI 10.1016/S0065-2571(99)00024-2; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Szabo C, 1998, TRENDS PHARMACOL SCI, V19, P287, DOI 10.1016/S0165-6147(98)01193-6; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Virag L, 1998, J IMMUNOL, V161, P3753; Walisser JA, 1999, EXP CELL RES, V251, P401, DOI 10.1006/excr.1999.4589; Wang ZQ, 1997, GENE DEV, V11, P2347, DOI 10.1101/gad.11.18.2347; ZHANG J, 1994, SCIENCE, V263, P687, DOI 10.1126/science.8080500	28	1473	1528	3	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 12	2002	297	5579					259	263		10.1126/science.1072221	http://dx.doi.org/10.1126/science.1072221			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	571UT	12114629				2022-12-24	WOS:000176738100044
J	Maguire, JD; Sumawinata, IW; Masbar, S; Laksana, B; Prodjodipuro, P; Susanti, I; Sismadi, P; Mahmud, N; Bangs, MJ; Baird, JK				Maguire, JD; Sumawinata, IW; Masbar, S; Laksana, B; Prodjodipuro, P; Susanti, I; Sismadi, P; Mahmud, N; Bangs, MJ; Baird, JK			Chloroquine-resistant Plasmodium malariae in south Sumatra, Indonesia	LANCET			English	Article								Oral chloroquine is the treatment of choice for uncomplicated Plasmodium malariae Infections worldwide. We did a prospective 28-day In-vivo assessment of the efficacy of chloroquine for treatment of P malariae on Legundl Island In Lampung Bay, Sumatra, Indonesia. Of 28 patients, one had recurrent parasitaemia an day 28, and two had persistent parasitaemia to day 8. Whole-blood chloroquine and desethylchloroquine concentrations were at ordinarily effective levels (greater than or equal to100 mug/L) on day 8 In both cases of persistent parasitaemia. These findings suggest that clinical resistance to chloroquine by P malariae occurs In the Indonesian archipelago of southeast Asia.	USN, Med Res Unit 2, Jakarta, Indonesia; Indonesian Minist Hlth, Inst Hlth Res & Dev, Jakarta, Indonesia; Dist Hlth Serv, Lampung Selatan, Sumatra, Indonesia	University of 19 November Kolaka; Ministry of Health - Indonesia	Maguire, JD (corresponding author), US Embassy Jakarta, Unit 8132, NAMRU TWO, FPO, AP 96520 USA.							COLLINS WE, 1973, AM J TROP MED HYG, V22, P685, DOI 10.4269/ajtmh.1973.22.685; Kimura Masatsugu, 1997, Parasitology International, V46, P91, DOI 10.1016/S1383-5769(97)00013-5; Mason DP, 1999, J THEOR BIOL, V198, P549, DOI 10.1006/jtbi.1999.0932; ROMBO L, 1986, T ROY SOC TROP MED H, V80, P763, DOI 10.1016/0035-9203(86)90380-9; Tan-Ariya Peerapan, 1994, Southeast Asian Journal of Tropical Medicine and Public Health, V25, P784	5	67	69	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 6	2002	360	9326					58	60		10.1016/S0140-6736(02)09336-4	http://dx.doi.org/10.1016/S0140-6736(02)09336-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	569JR	12114045	Green Submitted			2022-12-24	WOS:000176599700015
J	McCaffrey, AP; Meuse, L; Pham, TTT; Conklin, DS; Hannon, GJ; Kay, MA				McCaffrey, AP; Meuse, L; Pham, TTT; Conklin, DS; Hannon, GJ; Kay, MA			Gene expression - RNA interference in adult mice	NATURE			English	Article							PLASMID DNA; HEPATOCYTES		Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Stanford University; Stanford University; Cold Spring Harbor Laboratory	McCaffrey, AP (corresponding author), Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA.		Eckhardt, Erik/G-1567-2010; Hannon, Gregory/AAB-3568-2019	Conklin, Douglas/0000-0003-4922-4307; Kay, Mark/0000-0002-2799-2615				Bitko V, 2001, BMC Microbiol, V1, P34, DOI 10.1186/1471-2180-1-34; Chang JH, 2001, J VIROL, V75, P3469, DOI 10.1128/JVI.75.7.3469-3473.2001; Contag CH, 1997, PHOTOCHEM PHOTOBIOL, V66, P523, DOI 10.1111/j.1751-1097.1997.tb03184.x; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Tuschl T, 2002, NAT BIOTECHNOL, V20, P446, DOI 10.1038/nbt0502-446; Yant SR, 2000, NAT GENET, V25, P35, DOI 10.1038/75568; Zhang GF, 1999, HUM GENE THER, V10, P1735, DOI 10.1089/10430349950017734	9	854	1143	0	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 4	2002	418	6893					38	39		10.1038/418038a	http://dx.doi.org/10.1038/418038a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569JL	12097900				2022-12-24	WOS:000176599200030
J	Zhang, YX; Yu, ZL; Fu, XR; Liang, C				Zhang, YX; Yu, ZL; Fu, XR; Liang, C			Noc3p, a bHLH protein, plays an integral role in the initiation of DNA replication in budding yeast	CELL			English	Article							ORIGIN RECOGNITION COMPLEX; CYCLIN-DEPENDENT KINASES; LOOP-HELIX PROTEINS; SACCHAROMYCES-CEREVISIAE; MCM PROTEINS; S-PHASE; CELL-CYCLE; CHROMOSOMAL REPLICATION; LICENSING SYSTEM; RE-REPLICATION	Initiation of eukaryotic DNA replication requires many proteins that interact with one another and with replicators. Using a yeast genetic screen, we have identified Noc3p (nucleolar complex-associated protein) as a novel replication-initiation protein. Noc3p interacts with MCM proteins and ORC and binds to chromatin and replicators throughout the cell cycle. It functions as a critical link between ORC and other initiation proteins to effect chromatin association of Cdc6p and MCM proteins for the establishment and maintenance of prereplication complexes. Noc3p is highly conserved in eukaryotes and is the first identified bHLH (basic helix-loop-helix) protein required for replication initiation. As Noc3p is also required for pre-rRNA processing, Noc3p is a multifunctional protein that plays essential roles in two vital cellular processes.	Hong Kong Univ Sci & Technol, Dept Biochem, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology	Liang, C (corresponding author), Hong Kong Univ Sci & Technol, Dept Biochem, Clear Water Bay, Kowloon, Hong Kong, Peoples R China.			Zhang, Yuexuan/0000-0002-5227-0809				Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; BELL SP, 1993, SCIENCE, V262, P1844, DOI 10.1126/science.8266072; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; BUENO A, 1992, EMBO J, V11, P2167, DOI 10.1002/j.1460-2075.1992.tb05276.x; Calzada A, 2001, NATURE, V412, P355, DOI 10.1038/35085610; CHONG JPJ, 1995, NATURE, V375, P418, DOI 10.1038/375418a0; Cocker JH, 1996, NATURE, V379, P180, DOI 10.1038/379180a0; Coleman TR, 1996, CELL, V87, P53, DOI 10.1016/S0092-8674(00)81322-7; DAHMANN C, 1995, CURR BIOL, V5, P1257, DOI 10.1016/S0960-9822(95)00252-1; Dalton S, 1997, MOL CELL BIOL, V17, P5867, DOI 10.1128/MCB.17.10.5867; DIFFLEY JFX, 1994, CELL, V78, P303, DOI 10.1016/0092-8674(94)90299-2; DOHMEN RJ, 1994, SCIENCE, V263, P1273, DOI 10.1126/science.8122109; Donovan S, 1997, P NATL ACAD SCI USA, V94, P5611, DOI 10.1073/pnas.94.11.5611; Drury LS, 2000, CURR BIOL, V10, P231, DOI 10.1016/S0960-9822(00)00355-9; FOSS M, 1993, SCIENCE, V262, P1838, DOI 10.1126/science.8266071; FOX CA, 1995, GENE DEV, V9, P911, DOI 10.1101/gad.9.8.911; GAVIN KA, 1995, SCIENCE, V270, P1667, DOI 10.1126/science.270.5242.1667; Gopalakrishnan V, 2001, P NATL ACAD SCI USA, V98, P13114, DOI 10.1073/pnas.221467598; HENNESSY KM, 1991, GENE DEV, V5, P958, DOI 10.1101/gad.5.6.958; HOGAN E, 1992, P NATL ACAD SCI USA, V89, P3098, DOI 10.1073/pnas.89.7.3098; Homesley L, 2000, GENE DEV, V14, P913; Jallepalli PV, 1996, GENE DEV, V10, P541, DOI 10.1101/gad.10.5.541; Lei M, 1996, MOL CELL BIOL, V16, P5081; LIANG C, 1995, CELL, V81, P667, DOI 10.1016/0092-8674(95)90528-6; Liang C, 1997, GENE DEV, V11, P3375, DOI 10.1101/gad.11.24.3375; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; LOO S, 1995, MOL BIOL CELL, V6, P741, DOI 10.1091/mbc.6.6.741; MADINE MA, 1995, NATURE, V375, P421, DOI 10.1038/375421a0; Maiorano D, 2000, NATURE, V404, P622, DOI 10.1038/35007104; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Merchant AM, 1997, MOL CELL BIOL, V17, P3261, DOI 10.1128/MCB.17.6.3261; Milkereit P, 2001, CELL, V105, P499, DOI 10.1016/S0092-8674(01)00358-0; MuziFalconi M, 1995, P NATL ACAD SCI USA, V92, P12475, DOI 10.1073/pnas.92.26.12475; Nguyen VQ, 2001, NATURE, V411, P1068, DOI 10.1038/35082600; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; Nishitani H, 2001, J BIOL CHEM, V276, P44905, DOI 10.1074/jbc.M105406200; Owens JC, 1997, P NATL ACAD SCI USA, V94, P12521, DOI 10.1073/pnas.94.23.12521; Robinson KA, 2000, NUCLEIC ACIDS RES, V28, P1499, DOI 10.1093/nar/28.7.1499; Saha P, 1998, J BIOL CHEM, V273, P18205, DOI 10.1074/jbc.273.29.18205; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Tanaka S, 2002, NAT CELL BIOL, V4, P198, DOI 10.1038/ncb757; Tanaka TU, 1997, CELL, V90, P649, DOI 10.1016/S0092-8674(00)80526-7; Thommes P, 1997, EMBO J, V16, P3312, DOI 10.1093/emboj/16.11.3312; Weinreich M, 1999, EMBO J, V18, P5334, DOI 10.1093/emboj/18.19.5334; Weinreich M, 1999, P NATL ACAD SCI USA, V96, P441, DOI 10.1073/pnas.96.2.441; Weinreich M, 2001, P NATL ACAD SCI USA, V98, P11211, DOI 10.1073/pnas.201387198; Whittaker AJ, 2000, GENE DEV, V14, P1765; Williams RS, 1997, P NATL ACAD SCI USA, V94, P142, DOI 10.1073/pnas.94.1.142; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; YAN H, 1991, GENE DEV, V5, P944, DOI 10.1101/gad.5.6.944; YAN H, 1993, GENE DEV, V7, P2149, DOI 10.1101/gad.7.11.2149; Yan Z, 1998, P NATL ACAD SCI USA, V95, P3603, DOI 10.1073/pnas.95.7.3603; Yankulov K, 1999, MOL CELL BIOL, V19, P6154; Zou L, 1998, SCIENCE, V280, P593, DOI 10.1126/science.280.5363.593; Zou L, 1997, MOL CELL BIOL, V17, P553, DOI 10.1128/MCB.17.2.553	55	90	91	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 28	2002	109	7					849	860		10.1016/S0092-8674(02)00805-X	http://dx.doi.org/10.1016/S0092-8674(02)00805-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	570KJ	12110182	Bronze			2022-12-24	WOS:000176657200008
J	Zhu, CM; Mills, KD; Ferguson, DO; Lee, C; Manins, J; Fleming, J; Gao, YJ; Morton, CC; Alt, FW				Zhu, CM; Mills, KD; Ferguson, DO; Lee, C; Manins, J; Fleming, J; Gao, YJ; Morton, CC; Alt, FW			Unrepaired DNA breaks in p53-deficient cells lead to oncogenic gene amplification subsequent to translocations	CELL			English	Article							DIHYDROFOLATE-REDUCTASE GENE; WILD-TYPE P53; V(D)J RECOMBINATION; FRAGILE SITES; EMBRYONIC LETHALITY; CHROMOSOME BREAKAGE; MAMMALIAN-CELLS; HAMSTER CELLS; LIGASE-IV; REPAIR	Amplification of large genomic regions associated with complex translocations (complicons) is a basis for tumor progression and drug resistance. We show that pro-B lymphomas in mice deficient for both p53 and nonhomologous end-joining (NHEJ) contain complicons that coamplify c-myc (chromosome 15) and IgH (chromosome 12) sequences. While all carry a translocated (12;15) chromosome, coamplified sequences are located within a separate complicon that often involves a third chromosome. Complicon formation is initiated by recombination of RAGI1/2-catalyzed IgH locus double-strand breaks with sequences downstream of c-myc, generating a dicentric (15;12) chromosome as an amplification intermediate. This recombination event employs a microhomology-based end-joining repair pathway, as opposed to classic NHEJ or homologous recombination. These findings suggest a general model for oncogenic complicon formation.	Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Ctr Blood Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Alt, FW (corresponding author), Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA.				NATIONAL CANCER INSTITUTE [P01CA092625] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL067580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI035714] Funding Source: NIH RePORTER; NCI NIH HHS [CA92625] Funding Source: Medline; NHLBI NIH HHS [K08 HL67580-02] Funding Source: Medline; NIAID NIH HHS [AI35714] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALT FW, 1978, J BIOL CHEM, V253, P1357; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Baumann P, 1998, P NATL ACAD SCI USA, V95, P14066, DOI 10.1073/pnas.95.24.14066; Bogue MA, 1997, IMMUNITY, V7, P37, DOI 10.1016/S1074-7613(00)80508-7; Boulton SJ, 1996, NUCLEIC ACIDS RES, V24, P4639, DOI 10.1093/nar/24.23.4639; Boulton SJ, 1996, EMBO J, V15, P5093, DOI 10.1002/j.1460-2075.1996.tb00890.x; Carson DR, 2001, P NATL ACAD SCI USA, V98, P8270, DOI 10.1073/pnas.131022798; Coene ED, 1997, VIRCHOWS ARCH, V430, P365, DOI 10.1007/s004280050045; Coquelle A, 1997, CELL, V89, P215, DOI 10.1016/S0092-8674(00)80201-9; CORY S, 1985, EMBO J, V4, P675, DOI 10.1002/j.1460-2075.1985.tb03682.x; Debatisse M, 1998, RECENT RES CANCER, V154, P216; Difilippantonio MJ, 2000, NATURE, V404, P510, DOI 10.1038/35006670; DJALALI M, 1987, HUM GENET, V77, P157, DOI 10.1007/BF00272384; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Essers J, 1997, CELL, V89, P195, DOI 10.1016/S0092-8674(00)80199-3; FEDERSPIEL NA, 1984, J BIOL CHEM, V259, P9127; Ferguson DO, 2001, ONCOGENE, V20, P5572, DOI 10.1038/sj.onc.1204767; Frank KM, 1998, NATURE, V396, P173, DOI 10.1038/24172; Frank KM, 2000, MOL CELL, V5, P993, DOI 10.1016/S1097-2765(00)80264-6; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; Gao YJ, 2000, NATURE, V404, P897, DOI 10.1038/35009138; Gao YJ, 1998, CELL, V95, P891, DOI 10.1016/S0092-8674(00)81714-6; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Gu YS, 1997, IMMUNITY, V7, P653, DOI 10.1016/S1074-7613(00)80386-6; Kabotyanski EB, 1998, NUCLEIC ACIDS RES, V26, P5333, DOI 10.1093/nar/26.23.5333; Kline GH, 2001, J IMMUNOL, V167, P5136, DOI 10.4049/jimmunol.167.9.5136; Kuehl WM, 2002, NAT REV CANCER, V2, P175, DOI 10.1038/nrc746; KUO MT, 1994, MOL CELL BIOL, V14, P5202, DOI 10.1128/MCB.14.8.5202; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Lee J, 1999, IMMUNITY, V11, P771, DOI 10.1016/S1074-7613(00)80151-X; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Li ZY, 1995, CELL, V83, P1079, DOI 10.1016/0092-8674(95)90135-3; Lim DS, 2000, MOL CELL BIOL, V20, P3772, DOI 10.1128/MCB.20.11.3772-3780.2000; LIVINGSTONE LR, 1992, CELL, V70, P923, DOI 10.1016/0092-8674(92)90243-6; Liyanage M, 1996, NAT GENET, V14, P312, DOI 10.1038/ng1196-312; MA C, 1993, GENE DEV, V7, P605, DOI 10.1101/gad.7.4.605; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; McClintock B, 1941, GENETICS, V26, P234; Megonigal MD, 1998, P NATL ACAD SCI USA, V95, P6413, DOI 10.1073/pnas.95.11.6413; Padilla-Nash HM, 2001, GENE CHROMOSOME CANC, V30, P349, DOI 10.1002/gcc.1101; Paulson TG, 1998, MOL CELL BIOL, V18, P3089, DOI 10.1128/MCB.18.5.3089; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Pipiras E, 1998, EMBO J, V17, P325, DOI 10.1093/emboj/17.1.325; Richardson C, 2000, NATURE, V405, P697, DOI 10.1038/35015097; Richardson C, 2000, MOL CELL BIOL, V20, P9068, DOI 10.1128/MCB.20.23.9068-9075.2000; ROTH DB, 1986, MOL CELL BIOL, V6, P4295, DOI 10.1128/MCB.6.12.4295; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Schwab M, 1999, SEMIN CANCER BIOL, V9, P319, DOI 10.1006/scbi.1999.0126; Sharpless NE, 2001, MOL CELL, V8, P1187, DOI 10.1016/S1097-2765(01)00425-7; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Skok JA, 2001, NAT IMMUNOL, V2, P848, DOI 10.1038/ni0901-848; SMITH KA, 1990, CELL, V63, P1219, DOI 10.1016/0092-8674(90)90417-D; STARK GR, 1993, ADV CANCER RES, V61, P87, DOI 10.1016/S0065-230X(08)60956-2; TACCIOLI GE, 1993, SCIENCE, V260, P207, DOI 10.1126/science.8469973; TOLEDO F, 1992, EMBO J, V11, P2665, DOI 10.1002/j.1460-2075.1992.tb05332.x; Vanasse GJ, 1999, J CLIN INVEST, V103, P1669, DOI 10.1172/JCI6658; Verkaik NS, 2002, EUR J IMMUNOL, V32, P701, DOI 10.1002/1521-4141(200203)32:3<701::AID-IMMU701>3.0.CO;2-T; WINDLE B, 1991, GENE DEV, V5, P160, DOI 10.1101/gad.5.2.160; YIN YX, 1992, CELL, V70, P937, DOI 10.1016/0092-8674(92)90244-7; ZIMMERMAN K, 1990, Critical Reviews in Oncogenesis, V2, P75	60	344	351	1	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 28	2002	109	7					811	821		10.1016/S0092-8674(02)00770-5	http://dx.doi.org/10.1016/S0092-8674(02)00770-5			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	570KJ	12110179	Bronze			2022-12-24	WOS:000176657200005
J	Potter, JE				Potter, JE			Do ask, do tell	ANNALS OF INTERNAL MEDICINE			English	Editorial Material								As a consequence of bias and ignorance within the medical profession, lesbians and gay men frequently receive suboptimal health care. Knowledge of each patient's sexual orientation and behaviors is critical for the development of a productive therapeutic relationship, accurate risk assessment, and the provision of pertinent preventive counseling. However, clinicians often forget to ask about this information, and many lesbians and gay men are reticent to reveal the truth. I present vignettes from my personal experiences as a lesbian patient and doctor to illustrate the importance of creating an environment in which such disclosure can occur and to portray the challenges and rewards of coming out as a gay physician.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Potter, JE (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, 330 Brookline Ave, Boston, MA 02215 USA.	jpotter@caregroup.harvard.edu						Dean L., 2000, J GAY LESBIAN MED AS, V4, P102, DOI DOI 10.1023/A:1009573800168; Diamant A. L., 2000, J GAY LESBIAN MED AS, V4, P41, DOI DOI 10.1023/A:1009513623365; Miller Neil, 1995, OUT PAST GAY LESBIAN	3	10	10	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 3	2002	137	5	1				341	343		10.7326/0003-4819-137-5_Part_1-200209030-00010	http://dx.doi.org/10.7326/0003-4819-137-5_Part_1-200209030-00010			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	591DZ	12204018				2022-12-24	WOS:000177865600005
J	Benoff, B; Yang, HW; Lawson, CL; Parkinson, G; Liu, JS; Blatter, E; Ebright, YW; Berman, HM; Ebright, RH				Benoff, B; Yang, HW; Lawson, CL; Parkinson, G; Liu, JS; Blatter, E; Ebright, YW; Berman, HM; Ebright, RH			Structural basis of transcription activation: the CAP-alpha CTD-DNA complex	SCIENCE			English	Article							AMP RECEPTOR PROTEIN; COLI RNA-POLYMERASE; C-TERMINAL DOMAIN; LAC OPERON TRANSCRIPTION; PROMOTER OPEN COMPLEX; ESCHERICHIA-COLI; DEPENDENT PROMOTERS; FUNCTIONAL SUBUNIT; MINOR-GROOVE; CLASS-I	The Escherichia coli catabolite activator protein (CAP) activates transcription at P-lac, P-gal, and other promoters through interactions with the RNA polymerase alpha subunit carboxyl-terminal domain (alphaCTD). We determined the crystal structure of the CAP-alphaCTD-DNA complex at a resolution of 3.1 angstroms. CAP makes direct protein-protein interactions with alphaCTD, and alphaCTD makes direct protein-DNA interactions with the DNA segment adjacent to the DNA site for CAP. There are no large-scale conformational changes in CAP and alphaCTD, and the interface between CAP and alphaCTD is small. These findings are consistent with the proposal that activation involves a simple "recruitment" mechanism.	Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA; Rutgers State Univ, Dept Chem, Piscataway, NJ 08854 USA; Rutgers State Univ, Howard Hughes Med Inst, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Howard Hughes Medical Institute; Rutgers State University New Brunswick	Berman, HM (corresponding author), Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA.		Ebright, Richard/O-3321-2019	Ebright, Richard/0000-0001-8915-7140; Berman, Helen/0000-0002-3337-0660; Lawson, Catherine/0000-0002-3261-7035	NIGMS NIH HHS [GM21589, GM41376, GM64375] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021589, R01GM041376, P20GM064375] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BELL A, 1990, NUCLEIC ACIDS RES, V18, P7243, DOI 10.1093/nar/18.24.7243; BERMAN HM, 1999, OXFORD HDB NUCL ACID, P295; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; Chen H. M., UNPUB; Czarniecki D, 1997, J BACTERIOL, V179, P423, DOI 10.1128/jb.179.2.423-429.1997; Dove SL, 1997, NATURE, V386, P627, DOI 10.1038/386627a0; ESCHENLAUER AC, 1991, J BACTERIOL, V173, P5024, DOI 10.1128/jb.173.16.5024-5029.1991; Flatow U, 1996, J BACTERIOL, V178, P2436, DOI 10.1128/jb.178.8.2436-2439.1996; Gaal T, 1996, GENE DEV, V10, P16, DOI 10.1101/gad.10.1.16; Gourse RL, 2000, MOL MICROBIOL, V37, P687, DOI 10.1046/j.1365-2958.2000.01972.x; JEON YH, 1995, SCIENCE, V270, P1495, DOI 10.1126/science.270.5241.1495; KATAHIRA M, 1990, NUCLEIC ACIDS RES, V18, P613, DOI 10.1093/nar/18.3.613; KOLB A, 1993, NUCLEIC ACIDS RES, V21, P319, DOI 10.1093/nar/21.2.319; KOPKA ML, 1983, J MOL BIOL, V163, P129, DOI 10.1016/0022-2836(83)90033-5; Law EC, 1999, BIOCHEM J, V337, P415, DOI 10.1042/0264-6021:3370415; Lu XJ, 2000, J MOL BIOL, V300, P819, DOI 10.1006/jmbi.2000.3690; MacDonald D, 2001, J MOL BIOL, V306, P1081, DOI 10.1006/jmbi.2001.4447; MALAN TP, 1984, J MOL BIOL, V180, P881, DOI 10.1016/0022-2836(84)90262-6; Murakami K, 1996, EMBO J, V15, P4358, DOI 10.1002/j.1460-2075.1996.tb00809.x; Naryshkin N, 2000, CELL, V101, P601, DOI 10.1016/S0092-8674(00)80872-7; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NIU W, 1994, J MOL BIOL, V243, P595, DOI 10.1016/0022-2836(94)90034-5; Niu W, 1996, CELL, V87, P1123, DOI 10.1016/S0092-8674(00)81806-1; Noel RJ, 1998, J MOL BIOL, V282, P495, DOI 10.1006/jmbi.1998.2040; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parkinson G, 1996, J MOL BIOL, V260, P395, DOI 10.1006/jmbi.1996.0409; Parkinson G, 1996, NAT STRUCT BIOL, V3, P837, DOI 10.1038/nsb1096-837; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Ptashne M., 2002, GENES SIGNALS; REN YL, 1988, P NATL ACAD SCI USA, V85, P4138, DOI 10.1073/pnas.85.12.4138; Ross W, 2001, GENE DEV, V15, P491, DOI 10.1101/gad.870001; RYU S, 1994, P NATL ACAD SCI USA, V91, P8582, DOI 10.1073/pnas.91.18.8582; Savery NJ, 1998, EMBO J, V17, P3439, DOI 10.1093/emboj/17.12.3439; Savery NJ, 2002, J BACTERIOL, V184, P2273, DOI 10.1128/JB.184.8.2273-2280.2002; SAVERY NJ, 1995, BIOCHEM J, V309, P77, DOI 10.1042/bj3090077; SCHNEIDER B, 1993, BIOPHYS J, V65, P2291, DOI 10.1016/S0006-3495(93)81306-7; SCHNEIDER BL, UNPUB; SCHULTZ SC, 1991, SCIENCE, V253, P1001, DOI 10.1126/science.1653449; STRANEY DC, 1989, J MOL BIOL, V206, P41, DOI 10.1016/0022-2836(89)90522-6; TANG H, 1994, GENE DEV, V8, P3058, DOI 10.1101/gad.8.24.3058; Wang SL, 2000, J BIOL CHEM, V275, P33457, DOI 10.1074/jbc.M004877200; YANG ZH, 1991, FASEB J, V5, pA814; Yasuno K, 2001, J MOL BIOL, V306, P213, DOI 10.1006/jmbi.2000.4369; ZHOU YH, 1994, J MOL BIOL, V243, P603, DOI 10.1016/0022-2836(94)90035-3; ZHOU YH, 1994, EMBO J, V13, P4549, DOI 10.1002/j.1460-2075.1994.tb06776.x; ZHOU YH, 1993, P NATL ACAD SCI USA, V90, P6081, DOI 10.1073/pnas.90.13.6081; ZHOU YH, 1993, CELL, V73, P375, DOI 10.1016/0092-8674(93)90236-J; ZOU C, 1992, MOL MICROBIOL, V6, P2599, DOI 10.1111/j.1365-2958.1992.tb01437.x	49	183	192	2	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 30	2002	297	5586					1562	1566		10.1126/science.1076376	http://dx.doi.org/10.1126/science.1076376			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588JA	12202833				2022-12-24	WOS:000177697300060
J	Berman, DM; Karhadkar, SS; Hallahan, AR; Pritchard, JI; Eberhart, CG; Watkins, DN; Chen, JK; Cooper, MK; Taipale, J; Olson, JM; Beachy, PA				Berman, DM; Karhadkar, SS; Hallahan, AR; Pritchard, JI; Eberhart, CG; Watkins, DN; Chen, JK; Cooper, MK; Taipale, J; Olson, JM; Beachy, PA			Medulloblastoma growth inhibition by Hedgehog pathway blockade	SCIENCE			English	Article							PRIMITIVE NEUROECTODERMAL TUMORS; CENTRAL-NERVOUS-SYSTEM; BASAL-CELL CARCINOMAS; SONIC HEDGEHOG; CEREBELLUM; MICE; PROLIFERATION; MUTATIONS; EXPRESSION; NETWORK	Constitutive Hedgehog (Hh) pathway activity is associated with initiation of neoplasia, but its role in the continued growth of established tumors is unclear. Here, we investigate the therapeutic efficacy of the Hh pathway antagonist cyclopamine in preclinical models of medulloblastoma, the most common malignant brain tumor in children. Cyclopamine treatment of murine medulloblastoma cells blocked proliferation in vitro and induced changes in gene expression consistent with initiation of neuronal differentiation and loss of neuronal stem cell like character. This compound also caused regression of murine tumor allografts in vivo and induced rapid death of cells from freshly resected human medulloblastomas, but not from other brain tumors, thus establishing a specific role for Hh pathway activity in medulloblastoma growth.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Univ Washington, Childrens Hosp, Div Clin Res, Fred Hutchinson Canc Res Ctr, Seattle, WA 98105 USA; Univ Washington, Childrens Hosp, Div Pediat Oncol, Seattle, WA 98105 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Fred Hutchinson Cancer Center; Seattle Children's Hospital; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle	Olson, JM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.		Hallahan, Andrew R/F-1757-2010; Karhadkar, Sunil/Y-9235-2019; Chen, James/G-9972-2011; Watkins, David N/I-6113-2013	Karhadkar, Sunil/0000-0001-7943-0203; Chen, James/0000-0002-9220-8436; berman, david/0000-0001-5985-3698				Almqvist PM, 2002, J HISTOCHEM CYTOCHEM, V50, P147, DOI 10.1177/002215540205000203; BenArie N, 1996, HUM MOL GENET, V5, P1207, DOI 10.1093/hmg/5.9.1207; Berman D.S., UNPUB; Bhardwaj G, 2001, NAT IMMUNOL, V2, P172, DOI 10.1038/84282; Burger PC, 1994, TUMORS CENTRAL NERVO; Cogen PH, 1996, J NEURO-ONCOL, V29, P103, DOI 10.1007/BF00165523; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Kalderon D, 2000, CELL, V103, P371, DOI 10.1016/S0092-8674(00)00129-X; KEELER RF, 1968, TERATOLOGY, V1, P5, DOI 10.1002/tera.1420010103; Kenney AM, 2000, MOL CELL BIOL, V20, P9055, DOI 10.1128/MCB.20.23.9055-9067.2000; Miyata T, 1999, GENE DEV, V13, P1647, DOI 10.1101/gad.13.13.1647; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Reifenberger J, 1998, CANCER RES, V58, P1798; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Taylor MD, 2002, NAT GENET, V31, P306, DOI 10.1038/ng916; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wallace VA, 1999, CURR BIOL, V9, P445, DOI 10.1016/S0960-9822(99)80195-X; Wechsler-Reya R, 2001, ANNU REV NEUROSCI, V24, P385, DOI 10.1146/annurev.neuro.24.1.385; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Wetmore C, 2000, CANCER RES, V60, P2239; Wetmore C, 2001, CANCER RES, V61, P513; Wolter M, 1997, CANCER RES, V57, P2581; Xie JW, 1997, CANCER RES, V57, P2369; Zurawel RH, 2000, GENE CHROMOSOME CANC, V28, P77, DOI 10.1002/(SICI)1098-2264(200005)28:1<77::AID-GCC9>3.0.CO;2-Y	30	652	728	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 30	2002	297	5586					1559	1561		10.1126/science.1073733	http://dx.doi.org/10.1126/science.1073733			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588JA	12202832				2022-12-24	WOS:000177697300059
J	Nakatomi, H; Kuriu, T; Okabe, S; Yamamoto, S; Hatano, O; Kawahara, N; Tamura, A; Kirino, T; Nakafuku, M				Nakatomi, H; Kuriu, T; Okabe, S; Yamamoto, S; Hatano, O; Kawahara, N; Tamura, A; Kirino, T; Nakafuku, M			Regeneration of hippocampal pyramidal neurons after ischemic brain injury by recruitment of endogenous neural progenitors	CELL			English	Article							FIBROBLAST-GROWTH-FACTOR; CENTRAL-NERVOUS-SYSTEM; TRANSIENT FOREBRAIN ISCHEMIA; ADULT MAMMALIAN BRAIN; RAT SPINAL-CORD; STEM-CELLS; SUBVENTRICULAR ZONE; SYNAPTIC PLASTICITY; NEUROTROPHIC FACTOR; GERBIL HIPPOCAMPUS	The adult brain is extremely vulnerable to. various insults. The recent discovery of neural progenitors in adult mammals, however, raises the possibility of repairing damaged tissue by recruiting their latent regenerative potential. Here we show that activation of endogenous progenitors leads to massive regeneration of hippocampal pyramidal neurons after ischemic brain injury. Endogenous progenitors proliferate in response to ischemia and subsequently migrate into the hippocampus to regenerate new neurons. Intraventricular infusion of growth factors markedly augments these responses, thereby increasing the number of newborn neurons. Our studies suggest that regenerated neurons are integrated into the existing brain circuitry and contribute to ameliorating neurological deficits. These results expand the possibility of novel neuronal cell regeneration therapies for stroke and other neurological diseases.	Univ Tokyo, Grad Sch Med, Dept Neurobiol, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Grad Sch Med, Dept Neurosurg, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Grad Sch Med, Dept Orthoped Surg, Bunkyo Ku, Tokyo 1130033, Japan; Tokyo Med & Dent Univ, Dept Anat & Cell Biol, Bunkyo Ku, Tokyo 1138519, Japan; Japan Sci & Technol Cooperat, CREST, Minato Ku, Tokyo 1050011, Japan; Nara Med Univ, Dept Anat, Nara 6348521, Japan; Teikyo Univ, Sch Med, Dept Neurosurg, Itabashi Ku, Tokyo 1738605, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST); Nara Medical University; Teikyo University	Nakafuku, M (corresponding author), Univ Tokyo, Grad Sch Med, Dept Neurobiol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.		Nakafuku, Masato/J-3068-2013	Okabe, Shigeo/0000-0003-1216-8890; Nakafuku, Masato/0000-0001-7783-9005				Aberg MAI, 2000, J NEUROSCI, V20, P2896; Bethel A, 1997, STROKE, V28, P609, DOI 10.1161/01.STR.28.3.609; Bjorklund A, 2000, NAT NEUROSCI, V3, P537, DOI 10.1038/75705; Colbourne F, 1999, STROKE, V30, P662, DOI 10.1161/01.STR.30.3.662; Colbourne F, 1999, J NEUROSCI, V19, P4200; Craig CG, 1996, J NEUROSCI, V16, P2649; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Fallon J, 2000, P NATL ACAD SCI USA, V97, P14686, DOI 10.1073/pnas.97.26.14686; Gould E, 1997, NEUROSCIENCE, V80, P427, DOI 10.1016/S0306-4522(97)00127-9; Gould E, 2002, J NEUROSCI, V22, P619, DOI 10.1523/JNEUROSCI.22-03-00619.2002; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Kiprianova I, 1999, EXP NEUROL, V159, P511, DOI 10.1006/exnr.1999.7109; KIRINO T, 1984, ACTA NEUROPATHOL, V62, P209, DOI 10.1007/BF00691854; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Liu JL, 1998, J NEUROSCI, V18, P7768; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; Okabe S, 1998, J NEUROSCI, V18, P4177; Palmer TD, 1999, J NEUROSCI, V19, P8487; Pencea V, 2001, J NEUROSCI, V21, P6706, DOI 10.1523/JNEUROSCI.21-17-06706.2001; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; Rietze R, 2000, J COMP NEUROL, V424, P397; Scharff C, 2000, NEURON, V25, P481, DOI 10.1016/S0896-6273(00)80910-1; SMITH KA, 1984, ANNU REV IMMUNOL, V2, P319, DOI 10.1146/annurev.immunol.2.1.319; Suda Y, 2001, DEVELOPMENT, V128, P2433; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wagner JP, 1999, J NEUROSCI, V19, P6006, DOI 10.1523/JNEUROSCI.19-14-06006.1999; Weiss S, 1996, J NEUROSCI, V16, P7599; Yamamoto S, 2001, EXP NEUROL, V172, P115, DOI 10.1006/exnr.2001.7798; Yamamoto S, 2001, J NEUROSCI, V21, P9814, DOI 10.1523/JNEUROSCI.21-24-09814.2001; Yonemori F, 1999, J CEREBR BLOOD F MET, V19, P483, DOI 10.1097/00004647-199905000-00002; Yoshimura S, 2001, P NATL ACAD SCI USA, V98, P5874, DOI 10.1073/pnas.101034998; Zhang WD, 2000, HIPPOCAMPUS, V10, P512, DOI 10.1002/1098-1063(2000)10:5<512::AID-HIPO2>3.0.CO;2-M	38	1178	1283	4	110	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 23	2002	110	4					429	441		10.1016/S0092-8674(02)00862-0	http://dx.doi.org/10.1016/S0092-8674(02)00862-0			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	587QJ	12202033	Bronze			2022-12-24	WOS:000177653200005
J	Hails, RS				Hails, RS			Assessing the risks associated with new agricultural practices	NATURE			English	Article							GENETICALLY-MODIFIED CROPS; FARMLAND BIRDS; GRANIVOROUS BIRDS; SURVIVAL RATES; BIODIVERSITY; ABUNDANCE; DIVERSITY; ECOLOGY; GREEN; INTENSIFICATION	One key challenge for the twenty-first century is how to produce the food we need, yet ensure the landscape we want. Genetically modified crops have focused our attention on how to answer this question for one part of agriculture. The same principles could be applied to assess environmental impacts of future land-use change in a much broader context.	NERC, Ctr Ecol & Hydrol, Oxford OX1 3SR, England	UK Centre for Ecology & Hydrology (UKCEH); UK Research & Innovation (UKRI); Natural Environment Research Council (NERC)	Hails, RS (corresponding author), NERC, Ctr Ecol & Hydrol, Mansfield Rd, Oxford OX1 3SR, England.	rha@ceh.ac.uk	Hails, Rosemary S/E-9478-2010	Hails, Rosemary S/0000-0002-6975-1318				*ADV COMM REL ENV, 2001, GUID ASS IMP WID BIO; Agricultural & Environmental Biotechnology Commission, 2001, CROPS TRIAL; Bakker JP, 1999, TRENDS ECOL EVOL, V14, P63, DOI 10.1016/S0169-5347(98)01544-4; Beringer J, 2001, OUTLOOK AGR, V30, P7, DOI 10.5367/000000001101293391; Bobbink R., 1996, MANUAL METHODOLOGIES, P71; Campbell L.H., 1997, 227 JNCC; Chamberlain DE, 2000, J APPL ECOL, V37, P771, DOI 10.1046/j.1365-2664.2000.00548.x; Chamberlain DE, 1999, J APPL ECOL, V36, P856, DOI 10.1046/j.1365-2664.1999.00453.x; Chamberlain DE, 2000, AGR ECOSYST ENVIRON, V78, P1, DOI 10.1016/S0167-8809(99)00105-X; Conway G, 1999, NATURE, V402, pC55, DOI [10.1038/35011545, 10.1038/990141]; COOPER JI, 1997, COMMERCIALISATION TR, P115; CRAWLEY MJ, 1993, NATURE, V363, P620, DOI 10.1038/363620a0; Crawley MJ, 1999, NATURE, V400, P501, DOI 10.1038/22869; Crawley MJ, 2001, NATURE, V409, P682, DOI 10.1038/35055621; Daily GC, 2000, SCIENCE, V289, P395, DOI 10.1126/science.289.5478.395; *DEP ENV FOOD RUR, DIG ENV STAT; Donald PF, 2001, P ROY SOC B-BIOL SCI, V268, P25, DOI 10.1098/rspb.2000.1325; Falconer K, 2000, LAND USE POLICY, V17, P269, DOI 10.1016/S0264-8377(00)00036-3; Firbank Les, 2002, Aspects of Applied Biology, V67, P165; Firbank LG, 1999, NATURE, V399, P727, DOI 10.1038/21516; Firbank LG, 2000, SCIENCE, V289, P1481, DOI 10.1126/science.289.5484.1481; Gates S, 2000, J APPL ECOL, V37, P806, DOI 10.1046/j.1365-2664.2000.00549.x; Hails RS, 2000, TRENDS ECOL EVOL, V15, P14, DOI 10.1016/S0169-5347(99)01751-6; Haines-Young RH., 2000, ACCOUNTING NATURE AS; Hald AB, 1999, J APPL ECOL, V36, P24, DOI 10.1046/j.1365-2664.1999.00364.x; Kleijn D, 2001, NATURE, V413, P723, DOI 10.1038/35099540; Krebs JR, 1999, NATURE, V400, P611, DOI 10.1038/23127; Lawton JH, 2000, COMMUNITY ECOLOGY CH, P227; Marsh J., 2000, INTEGRATED FARM MANA; Peach WJ, 2001, BIOL CONSERV, V101, P361, DOI 10.1016/S0006-3207(01)00083-0; Perfecto I, 1996, BIOSCIENCE, V46, P598, DOI 10.2307/1312989; Phipps RH, 2002, J ANIM FEED SCI, V11, P1; Pidgeon JD, 2001, BCPC CONFERENCE - WEEDS 2001, VOLS 1 AND 2, P373; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Policy Commission on the Future of Farming and Food, 2002, FARM FOOD SUST FUT; Pretty JN, 2000, AGR SYST, V65, P113, DOI 10.1016/S0308-521X(00)00031-7; Robinson RA, 2002, J APPL ECOL, V39, P157, DOI 10.1046/j.1365-2664.2002.00695.x; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Siriwardena GM, 1998, BIRD STUDY, V45, P276, DOI 10.1080/00063659809461099; Siriwardena GM, 1999, IBIS, V141, P621, DOI 10.1111/j.1474-919X.1999.tb07370.x; Smart SM, 2000, J APPL ECOL, V37, P398, DOI 10.1046/j.1365-2664.2000.00508.x; Sutherland WJ, 2002, TRENDS ECOL EVOL, V17, P148, DOI 10.1016/S0169-5347(01)02421-1; Tilman D, 1998, NATURE, V396, P211, DOI 10.1038/24254; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; TREWAVAS AJ, 2001, EMBO REP, V2, P1; VESTERBY M, 2001, ERS STAT B, V973; Watkinson AR, 2000, SCIENCE, V289, P1554, DOI 10.1126/science.289.5484.1554; Whitfield J, 2001, NATURE, V413, P659, DOI 10.1038/35099698; Wilson JD, 1999, AGR ECOSYST ENVIRON, V75, P13, DOI 10.1016/S0167-8809(99)00064-X; Wilson P. J., 1994, BR CROP PR, V58, P253	51	90	96	1	65	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 8	2002	418	6898					685	688		10.1038/nature01016	http://dx.doi.org/10.1038/nature01016			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581RA	12167875				2022-12-24	WOS:000177305600055
J	Sheehy, AM; Gaddis, NC; Choi, JD; Malim, MH				Sheehy, AM; Gaddis, NC; Choi, JD; Malim, MH			Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein	NATURE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TYPE-1 VIF; DNA-SYNTHESIS; SOR GENE; RNA; CELLS; GAG; RESTRICTION; REPLICATION; EFFICIENT	Viruses have developed diverse non-immune strategies to counteract host-mediated mechanisms that confer resistance to infection. The Vif (virion infectivity factor) proteins are encoded by primate immunodeficiency viruses, most notably human immunodeficiency virus-1 (HIV-1). These proteins are potent regulators of virus infection and replication and are consequently essential for pathogenic infections in vivo(1-6). HIV-1 Vif seems to be required during the late stages of virus production(3,6) for the suppression of an innate antiviral phenotype that resides in human T lymphocytes(7,8). Thus, in the absence of Vif, expression of this phenotype renders progeny virions non-infectious. Here, we describe a unique cellular gene, CEM15, whose transient or stable expression in cells that do not normally express CEM15 recreates this phenotype, but whose antiviral action is overcome by the presence of Vif. Because the Vif: CEM15 regulatory circuit is critical for HIV-1 replication, perturbing the circuit may be a promising target for future HIV/AIDS therapies.	Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; Univ Penn, Childrens Hosp Philadelphia, Sch Med, Div Human Genet, Philadelphia, PA 19104 USA; Kings Coll London, Guys Kings & St Thomas Sch Med, Dept Infect Dis, London SE1 9RT, England	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of London; King's College London	Malim, MH (corresponding author), Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA.	michael.malim@kcl.ac.uk	Liu, FL/D-1795-2009; Gaddis, Nathan/GXG-6395-2022; Gaddis, Nathan/GXG-6447-2022	Gaddis, Nathan/0000-0001-5205-7138; Malim, Michael/0000-0002-7699-2064				BHATTACHARYA S, 1994, TRENDS BIOCHEM SCI, V19, P105, DOI 10.1016/0968-0004(94)90200-3; Camaur D, 1996, J VIROL, V70, P6106, DOI 10.1128/JVI.70.9.6106-6111.1996; COURCOUL M, 1995, J VIROL, V69, P2068, DOI 10.1128/JVI.69.4.2068-2074.1995; Desrosiers RC, 1998, J VIROL, V72, P1431, DOI 10.1128/JVI.72.2.1431-1437.1998; Dettenhofer M, 2000, J VIROL, V74, P8938, DOI 10.1128/JVI.74.19.8938-8945.2000; FISHER AG, 1987, SCIENCE, V237, P888, DOI 10.1126/science.3497453; FOLEY GE, 1965, CANCER RES, V25, P1254; Fouchier RAM, 1996, J VIROL, V70, P8263, DOI 10.1128/JVI.70.12.8263-8269.1996; Fouchier RAM, 1997, EMBO J, V16, P4531, DOI 10.1093/emboj/16.15.4531; GABUZDA DH, 1992, J VIROL, V66, P6489, DOI 10.1128/JVI.66.11.6489-6495.1992; Hassaine G, 2001, J BIOL CHEM, V276, P16885, DOI 10.1074/jbc.M009076200; Khan MA, 2001, J VIROL, V75, P7252, DOI 10.1128/JVI.75.16.7252-7265.2001; LIU HM, 1995, J VIROL, V69, P7630, DOI 10.1128/JVI.69.12.7630-7638.1995; MACGINNITIE AJ, 1995, J BIOL CHEM, V270, P14768, DOI 10.1074/jbc.270.24.14768; Madani N, 1998, J VIROL, V72, P10251, DOI 10.1128/JVI.72.12.10251-10255.1998; Madsen P, 1999, J INVEST DERMATOL, V113, P162, DOI 10.1046/j.1523-1747.1999.00682.x; NARA PL, 1988, NATURE, V332, P469, DOI 10.1038/332469a0; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; PRYCIAK PM, 1992, J VIROL, V66, P5959, DOI 10.1128/JVI.66.10.5959-5966.1992; Simon JHM, 1997, J VIROL, V71, P5259, DOI 10.1128/JVI.71.7.5259-5267.1997; Simon JHM, 1998, NAT MED, V4, P1397, DOI 10.1038/3987; Simon JHM, 1996, J VIROL, V70, P5297, DOI 10.1128/JVI.70.8.5297-5305.1996; Simon JHM, 1998, EMBO J, V17, P1259, DOI 10.1093/emboj/17.5.1259; SMITH AA, 1994, BIOCHEMISTRY-US, V33, P6468, DOI 10.1021/bi00187a012; SOVA P, 1993, J VIROL, V67, P6322, DOI 10.1128/JVI.67.10.6322-6326.1993; STREBEL K, 1987, NATURE, V328, P728, DOI 10.1038/328728a0; TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591; Towers G, 2000, P NATL ACAD SCI USA, V97, P12295, DOI 10.1073/pnas.200286297; VONSCHWEDLER U, 1993, J VIROL, V67, P4945, DOI 10.1128/JVI.67.8.4945-4955.1993; Zhang H, 2000, J VIROL, V74, P8252, DOI 10.1128/JVI.74.18.8252-8261.2000	30	1839	1933	1	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 8	2002	418	6898					646	650		10.1038/nature00939	http://dx.doi.org/10.1038/nature00939			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581RA	12167863				2022-12-24	WOS:000177305600044
J	Ueda, HR; Chen, WB; Adachi, A; Wakamatsu, H; Hayashi, S; Takasugi, T; Nagano, M; Nakahama, K; Suzuki, Y; Sugano, S; Iino, M; Shigeyoshi, Y; Hashimoto, S				Ueda, HR; Chen, WB; Adachi, A; Wakamatsu, H; Hayashi, S; Takasugi, T; Nagano, M; Nakahama, K; Suzuki, Y; Sugano, S; Iino, M; Shigeyoshi, Y; Hashimoto, S			A transcription factor response element for gene expression during circadian night	NATURE			English	Article							CLOCK; DROSOPHILA; MECHANISM; CLONING	Mammalian circadian clocks consist of complex integrated feedback loops(1-10) that cannot be elucidated without comprehensive measurement of system dynamics and determination of network structures(11). To dissect such a complicated system, we took a systems-biological approach based on genomic, molecular and cell biological techniques. We profiled suprachiasmatic nuclei and liver genome-wide expression patterns under light/dark cycles and constant darkness. We determined transcription start sites of human orthologues for newly identified cycling genes and then performed bioinformatical searches for relationships between time-of-day specific expression and transcription factor response elements around transcription start sites. Here we demonstrate the role of the Rev-ErbA/ROR response element in gene expression during circadian night, which is in phase with Bmal1 and in antiphase to Per2 oscillations. This role was verified using an in vitro validation system, in which cultured fibroblasts transiently transfected with clock-controlled reporter vectors exhibited robust circadian bioluminescence(12).	Yamanouchi Pharmaceut Co Ltd, Inst Drug Discovery Res, Mol Med Labs, Tsukuba, Ibaraki 3058585, Japan; Univ Tokyo, Grad Sch Med, Dept Pharmacol, Bunkyo Ku, Tokyo 1130033, Japan; Kinki Univ, Sch Med, Dept Anat & Neurobiol, Osakasayama, Osaka 5898511, Japan; Univ Tokyo, Inst Med Sci, Ctr Human Genome, Minato Ku, Tokyo 1088639, Japan	Astellas Pharmaceuticals; University of Tokyo; Kindai University (Kinki University); University of Tokyo	Ueda, HR (corresponding author), Yamanouchi Pharmaceut Co Ltd, Inst Drug Discovery Res, Mol Med Labs, 21 Miyukigaoka, Tsukuba, Ibaraki 3058585, Japan.		Jansen, Heiko T./A-5770-2008; Wakamatsu, Hisanori/AAV-9782-2021; Ueda, Hiroki R/C-5037-2014	Jansen, Heiko T./0000-0003-0178-396X; Ueda, Hiroki R/0000-0001-8342-9176				Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; CHEN W, UNPUB CURR BIOL; Cho RJ, 2001, NAT GENET, V27, P48, DOI 10.1038/83751; Claridge-Chang A, 2001, NEURON, V32, P657, DOI 10.1016/S0896-6273(01)00515-3; Clayton JD, 2001, NATURE, V409, P829, DOI 10.1038/35057006; Duffield GE, 2002, CURR BIOL, V12, P551, DOI 10.1016/S0960-9822(02)00765-0; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Grundschober C, 2001, J BIOL CHEM, V276, P46751, DOI 10.1074/jbc.M107499200; HARDING HP, 1993, MOL CELL BIOL, V13, P3113, DOI 10.1128/MCB.13.5.3113; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Hida A, 2000, GENOMICS, V65, P224, DOI 10.1006/geno.2000.6166; Jetten AM, 2001, PROG NUCLEIC ACID RE, V69, P205, DOI 10.1016/S0079-6603(01)69048-2; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; MARUYAMA K, 1994, GENE, V138, P171; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Obrietan K, 1999, J BIOL CHEM, V274, P17748, DOI 10.1074/jbc.274.25.17748; PACAUCCARALERTK.S, 1994, TAX MOL CELL BIOL, V14, P456; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; UEDA HR, 2000, J BIOL CHEM, V277, P14018; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Yu WJ, 2002, BIOCHEM BIOPH RES CO, V290, P933, DOI 10.1006/bbrc.2001.6300; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4	30	652	677	1	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 1	2002	418	6897					534	539		10.1038/nature00906	http://dx.doi.org/10.1038/nature00906			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579EE	12152080				2022-12-24	WOS:000177162800041
J	Kim, DH; Feinbaum, R; Alloing, G; Emerson, FE; Garsin, DA; Inoue, H; Tanaka-Hino, M; Hisamoto, N; Matsumoto, K; Tan, MW; Ausubel, FM				Kim, DH; Feinbaum, R; Alloing, G; Emerson, FE; Garsin, DA; Inoue, H; Tanaka-Hino, M; Hisamoto, N; Matsumoto, K; Tan, MW; Ausubel, FM			A conserved p38 MAP kinase pathway in Caenorhabditis elegans innate immunity	SCIENCE			English	Article							C-ELEGANS; MUTATIONS; RNA	A genetic screen for Caenorhabditis elegans mutants with enhanced susceptibility to killing by Pseudomonas aeruginosa led to the identification of two genes required for pathogen resistance: sek-1, which encodes a mitogen-activated protein (MAP) kinase kinase, and nsy-1, which encodes a MAP kinase kinase kinase. RNA interference assays and biochemical analysis established that a p38 ortholog, pmk-1, functions as the downstream MAP kinase required for pathogen defense. These data suggest that this MAP kinase signaling cassette represents an ancient feature of innate immune responses in evolutionarily diverse species.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Japan Sci & Technol Corp, CREST, Chikusa Ku, Nagoya, Aichi 4648602, Japan; Nagoya Univ, Grad Sch Sci, Dept Mol Biol, Nagoya, Aichi 4648602, Japan	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Japan Science & Technology Agency (JST); Nagoya University	Ausubel, FM (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA.	ausubel@molbio.mgh.harvard.edu		Inoue, Hideki/0000-0002-4301-1936	NIGMS NIH HHS [GM48707] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM048707, R01GM048707] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aballay A, 2001, P NATL ACAD SCI USA, V98, P2735, DOI 10.1073/pnas.041613098; ABALLAY A, UNPUB; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; BEANAN MJ, 1992, DEVELOPMENT, V116, P755; Berman Kevin, 2001, Molecular Cell Biology Research Communications, V4, P337, DOI 10.1006/mcbr.2001.0300; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; Han ZQS, 1998, MOL CELL BIOL, V18, P3527, DOI 10.1128/MCB.18.6.3527; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Ihle JN, 2000, CELL, V102, P131, DOI 10.1016/S0092-8674(00)00017-9; KIM D, UNPUB; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Reiner DJ, 1999, NATURE, V402, P199, DOI 10.1038/46072; Sagasti A, 2001, CELL, V105, P221, DOI 10.1016/S0092-8674(01)00313-0; Sluss HK, 1996, GENE DEV, V10, P2745, DOI 10.1101/gad.10.21.2745; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Tanaka-Hino M, 2002, EMBO REP, V3, P56, DOI 10.1093/embo-reports/kvf001; Troemel ER, 1999, CELL, V99, P387, DOI 10.1016/S0092-8674(00)81525-1; Vidal S, 2001, GENE DEV, V15, P1900, DOI 10.1101/gad.203301; Villanueva A, 2001, EMBO J, V20, P5114, DOI 10.1093/emboj/20.18.5114; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147	24	573	614	2	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 26	2002	297	5581					623	626		10.1126/science.1073759	http://dx.doi.org/10.1126/science.1073759			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577GY	12142542				2022-12-24	WOS:000177054200057
J	Zhang, Y; Ma, C; Delohery, T; Nasipak, B; Foat, BC; Bounoutas, A; Bussemaker, HJ; Kim, SK; Chalfie, M				Zhang, Y; Ma, C; Delohery, T; Nasipak, B; Foat, BC; Bounoutas, A; Bussemaker, HJ; Kim, SK; Chalfie, M			Identification of genes expressed in C-elegans touch receptor neurons	NATURE			English	Article							CAENORHABDITIS-ELEGANS; HOMEOPROTEINS UNC-86; MEC-3; DIFFERENTIATION; MICROTUBULES; SENSITIVITY; SEQUENCES; GENOMICS; ENCODES	The extent of gene regulation in cell differentiation is poorly understood. We previously used saturation mutagenesis to identify 18 genes that are needed for the development and function of a single type of sensory neuron-the touch receptor neuron for gentle touch in Caenorhabditis elegans(1,2). One of these genes, mec-3, encodes a transcription factor that controls touch receptor differentiation(3,4). By culturing and isolating wild-type and mec-3 mutant cells from embryos and applying their amplified RNA to DNA microarrays, here we have identified genes that are known to be expressed in touch receptors, a previously uncloned gene (mec-17) that is needed for maintaining touch receptor differentiation(2,5), and more than 50 previously unknown mec-3-dependent genes. These genes are randomly distributed in the genome and under-represented both for genes that are co-expressed in operons and for multiple members of gene families. Using regions 5' of the start codon of the first 20 genes, we have also identified an over-represented heptanucleotide, AATGCAT, that is needed for the expression of touch receptor genes(6).	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Stanford Univ, Med Ctr, Dept Genet & Dev Biol, Stanford, CA 94305 USA	Columbia University; Memorial Sloan Kettering Cancer Center; Stanford University	Chalfie, M (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.				NIGMS NIH HHS [R37 GM030997] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030997] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILEY TL, 1994, ISMB, V2, P28; Barnes TM, 1996, J NEUROCHEM, V67, P46; Blumenthal T, 2002, NATURE, V417, P851, DOI 10.1038/nature00831; CHALFIE M, 1982, J CELL BIOL, V93, P15, DOI 10.1083/jcb.93.1.15; CHALFIE M, 1981, DEV BIOL, V82, P358, DOI 10.1016/0012-1606(81)90459-0; CHALFIE M, 1989, SCIENCE, V243, P1027, DOI 10.1126/science.2646709; Duggan A, 1998, DEVELOPMENT, V125, P4107; EBERWINE J, 1992, P NATL ACAD SCI USA, V89, P3010, DOI 10.1073/pnas.89.7.3010; Fukushige T, 1999, J CELL SCI, V112, P395; Gu GQ, 1996, P NATL ACAD SCI USA, V93, P6577, DOI 10.1073/pnas.93.13.6577; HAN M, 1991, GENE DEV, V5, P2188, DOI 10.1101/gad.5.12a.2188; Hill AA, 2000, SCIENCE, V290, P809, DOI 10.1126/science.290.5492.809; HUANG LS, 1994, MOL BIOL CELL, V5, P395, DOI 10.1091/mbc.5.4.395; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; Jiang M, 2001, P NATL ACAD SCI USA, V98, P218, DOI 10.1073/pnas.011520898; Liang P, 1997, J CELL SCI, V110, P1431; Lockhart DJ, 2000, NATURE, V405, P827, DOI 10.1038/35015701; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; MITANI S, 1993, DEVELOPMENT, V119, P773; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; SAVAGE C, 1989, GENE DEV, V3, P870, DOI 10.1101/gad.3.6.870; Treinin M, 1998, P NATL ACAD SCI USA, V95, P15492, DOI 10.1073/pnas.95.26.15492; TREININ M, 1995, NEURON, V14, P871, DOI 10.1016/0896-6273(95)90231-7; Van Helden J, 2000, YEAST, V16, P177, DOI 10.1002/(SICI)1097-0061(20000130)16:2<177::AID-YEA516>3.0.CO;2-9; WAY JC, 1989, GENE DEV, V3, P1823, DOI 10.1101/gad.3.12a.1823; WAY JC, 1988, CELL, V54, P5, DOI 10.1016/0092-8674(88)90174-2; XUE D, 1992, EMBO J, V11, P4969, DOI 10.1002/j.1460-2075.1992.tb05604.x; XUE D, 1993, SCIENCE, V261, P1324, DOI 10.1126/science.8103239	30	173	208	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 18	2002	418	6895					331	335		10.1038/nature00891	http://dx.doi.org/10.1038/nature00891			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574BF	12124626				2022-12-24	WOS:000176868000044
J	Reilly, BM; Evans, AT; Schaider, JJ; Das, K; Calvin, JE; Moran, LA; Roberts, RR; Martinez, E				Reilly, BM; Evans, AT; Schaider, JJ; Das, K; Calvin, JE; Moran, LA; Roberts, RR; Martinez, E			Impact of a clinical decision rule on hospital triage of patients with suspected acute cardiac ischemia in the emergency department	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE CORONARY SYNDROMES; ACUTE CHEST PAIN; ELEVATION MYOCARDIAL-INFARCTION; RISK STRATIFICATION; UNSTABLE ANGINA; PREDICTIVE INSTRUMENT; MISSED DIAGNOSES; POTENTIAL IMPACT; OBSERVATION UNIT; TROPONIN-I	Context Emergency department (ED) physicians often are uncertain about wherein the hospital to triage patients with suspected acute cardiac ischemia, Many patients are triaged unnecessarily to intensive or intermediate cardiac care units. Objective To determine whether use of a clinical decision rule improves physicians' hospital triage decisions for patients with suspected acute cardiac ischemia. Design and Setting Prospective before-after impact analysis conducted at a large, urban, US public hospital. Participants Consecutive patients admitted from the ED with suspected acute cardiac ischemia during 2 periods: preintervention group (n=207 patients enrolled in March 1997) and intervention group (n = 1008 patients enrolled in August-November 1999). Intervention An adaptation of a previously validated clinical decision rule was adopted as the standard of care in the ED after a 3-month period of pilot testing and training. The rule predicts major cardiac complications within 72 hours after evaluation in the ED and stratifies patients' risk of major complications into 4 groups-high, moderate, low, and very low-according to electrocardiographic findings and presence or absence of 3 clinical predictors in the ED, Main Outcome Measures Safety of physicians' triage decisions, defined as the proportion of patients with major cardiac complications who were admitted to inpatient cardiac care beds (coronary care unit or inpatient telemetry unit); efficiency of decisions, defined as the proportion of patients without major complications who were triaged to an ED observation unit or an unmonitored ward. Results By intention-to-treat analysis, efficiency was higher in the intervention group (36%) than the preintervention group (21%) (difference, 15%; 95% confidence interval [CI], 8%-21%; P<.001). Safety was not significantly different (94% in the intervention group vs 89%; difference, 5%; 95% Cl, -11 % to 39%; P=.57). Subgroup analysis of intervention-group patients showed higher efficiency when physicians actually used the decision rule (38% vs 27%; difference, 11 %; 95% Cl, 3%-18%; P=.01). Improved efficiency was explained solely by different triage decisions for very low-risk patients. Most surveyed physicians (16/19 [84%]) believed that the decision rule improved patient care. Conclusions Use of the clinical decision rule had a favorable impact on physicians' hospital triage decisions. Efficiency improved without compromising safety.	Cook Cty Hosp, Dept Med, Chicago, IL 60612 USA; Cook Cty Hosp, Dept Emergency Med, Chicago, IL 60612 USA; Rush Med Coll, Chicago, IL 60612 USA	John H Stroger Junior Hospital Cook County; John H Stroger Junior Hospital Cook County; Rush University	Reilly, BM (corresponding author), Cook Cty Hosp, Dept Med, Room 2129,1835 W Harrison St, Chicago, IL 60612 USA.							Antman EM, 2000, JAMA-J AM MED ASSOC, V284, P835, DOI 10.1001/jama.284.7.835; Antman EM, 1996, NEW ENGL J MED, V335, P1342, DOI 10.1056/NEJM199610313351802; Bayes-Genis A, 2001, NEW ENGL J MED, V345, P1022, DOI 10.1056/NEJMoa003147; Braunwald E, 2000, CIRCULATION, V102, P1193, DOI 10.1161/01.CIR.102.10.1193; CALVIN JE, 1995, JAMA-J AM MED ASSOC, V273, P136; Canto JG, 2000, JAMA-J AM MED ASSOC, V283, P3223, DOI 10.1001/jama.283.24.3223; de Lemos JA, 2001, NEW ENGL J MED, V345, P1014, DOI 10.1056/NEJMoa011053; DIAMOND GA, 1979, NEW ENGL J MED, V300, P1350, DOI 10.1056/NEJM197906143002402; Durairaj L, 2001, AM J MED, V110, P7, DOI 10.1016/S0002-9343(00)00640-9; Farkouh ME, 1998, NEW ENGL J MED, V339, P1882, DOI 10.1056/NEJM199812243392603; Goldman L, 2001, AM J MED, V110, P67, DOI 10.1016/S0002-9343(00)00679-3; GOLDMAN L, 1988, NEW ENGL J MED, V318, P797, DOI 10.1056/NEJM198803313181301; Goldman L, 1996, NEW ENGL J MED, V334, P1498, DOI 10.1056/NEJM199606063342303; Goodacre SW, 2000, J ACCID EMERG MED, V17, P1; Hamm CW, 1997, NEW ENGL J MED, V337, P1648, DOI 10.1056/NEJM199712043372302; LEE TH, 1995, ANN INTERN MED, V122, P434, DOI 10.7326/0003-4819-122-6-199503150-00006; LEE TH, 1987, AM J CARDIOL, V60, P219, DOI 10.1016/0002-9149(87)90217-7; Mace SE, 2002, ACAD EMERG MED, V9, P169, DOI 10.1197/aemj.9.2.169; Martinez E, 2001, AM J MED, V110, P274, DOI 10.1016/S0002-9343(00)00710-5; MCCARTHY BD, 1993, ANN EMERG MED, V22, P579, DOI 10.1016/S0196-0644(05)81945-6; McGinn TG, 2000, JAMA-J AM MED ASSOC, V284, P79, DOI 10.1001/jama.284.1.79; Mehta RH, 2000, NEW ENGL J MED, V342, P1207, DOI 10.1056/NEJM200004203421610; MIETTINEN O, 1985, STAT MED, V4, P213, DOI 10.1002/sim.4780040211; Nichol G, 1997, ANN INTERN MED, V127, P996, DOI 10.7326/0003-4819-127-11-199712010-00009; O'Rourke RA, 2001, ARCH INTERN MED, V161, P674, DOI 10.1001/archinte.161.5.674; Ohman EM, 1996, NEW ENGL J MED, V335, P1333, DOI 10.1056/NEJM199610313351801; Ohman EM, 2000, JAMA-J AM MED ASSOC, V284, P876, DOI 10.1001/jama.284.7.876; Panju AA, 1998, JAMA-J AM MED ASSOC, V280, P1256, DOI 10.1001/jama.280.14.1256; Pope JH, 2000, NEW ENGL J MED, V342, P1163, DOI 10.1056/NEJM200004203421603; POZEN MW, 1984, NEW ENGL J MED, V310, P1273, DOI 10.1056/NEJM198405173102001; Reilly B, 1999, AM J MED, V106, P285, DOI 10.1016/S0002-9343(99)00024-8; Reilly BM, 2002, AM J MED, V112, P95, DOI 10.1016/S0002-9343(01)01054-3; RUSNAK RA, 1989, ANN EMERG MED, V18, P1021; SCHOR S, 1976, JAMA-J AM MED ASSOC, V236, P941; Selker HP, 1997, ANN EMERG MED, V29, P1, DOI 10.1016/S0196-0644(97)70297-X; Selker HP, 1998, ANN INTERN MED, V129, P845, DOI 10.7326/0003-4819-129-11_Part_1-199812010-00002; Selker HP, 1997, ANN INTERN MED, V127, P538, DOI 10.7326/0003-4819-127-7-199710010-00006; Tatum JL, 1997, ANN EMERG MED, V29, P116, DOI 10.1016/S0196-0644(97)70317-2; Zalenski RJ, 1998, AM J CARDIOL, V81, P1305, DOI 10.1016/S0002-9149(98)00159-3; Zalenski RJ, 1997, ARCH INTERN MED, V157, P1085, DOI 10.1001/archinte.157.10.1085	40	82	84	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 17	2002	288	3					342	350		10.1001/jama.288.3.342	http://dx.doi.org/10.1001/jama.288.3.342			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573AK	12117399	Bronze			2022-12-24	WOS:000176807000026
J	Levy, YY; Mesnage, S; Mylne, JS; Gendall, AR; Dean, C				Levy, YY; Mesnage, S; Mylne, JS; Gendall, AR; Dean, C			Multiple roles of Arabidopsis VRN1 in vernalization and flowering time control	SCIENCE			English	Article							MADS DOMAIN PROTEIN; EXPRESSION; THALIANA; GENES; REPRESSOR; ENCODES; VECTORS; GENOME	Arabidopsis VRN genes mediate vernalization, the process by which a long period of cold induces a mitotically stable state that leads to accelerated flowering during later development. VRN1 encodes a protein that binds DNA in vitro in a non sequence-specific manner and functions in stable repression of the major target of the vernalization pathway, the oral repressor FLC. Overexpression of VRN1 reveals a vernalization-independent function for VRN1, mediated predominantly through the oral pathway integrator FT, and demonstrates that VRN1 requires vernalization-specific factors to target FLC.	John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Dean, C (corresponding author), John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Colney Lane, Norwich NR4 7UH, Norfolk, England.		Mylne, Josh/GMX-4544-2022; Mylne, Joshua S/A-5581-2009; MESNAGE, Stephane/H-7156-2019	Mylne, Josh/0000-0003-4957-6388; Mylne, Joshua S/0000-0003-4957-6388; MESNAGE, Stephane/0000-0003-1648-4890; Gendall, Anthony/0000-0002-2255-3939				Bent E, 1998, PLANT J, V13, P849, DOI 10.1046/j.1365-313X.1998.00082.x; Blazquez M, 2001, EMBO REP, V2, P1078, DOI 10.1093/embo-reports/kve254; Chandler J, 1996, PLANT J, V10, P637, DOI 10.1046/j.1365-313X.1996.10040637.x; CLARKE JH, 1995, MOL GEN GENET, V248, P278, DOI 10.1007/BF02191594; Gendall AR, 2001, CELL, V107, P525, DOI 10.1016/S0092-8674(01)00573-6; Kanaya E, 2002, J BIOL CHEM, V277, P11957, DOI 10.1074/jbc.M108889200; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; Lee H, 2000, GENE DEV, V14, P2366, DOI 10.1101/gad.813600; Macknight R, 1997, CELL, V89, P737, DOI 10.1016/S0092-8674(00)80256-1; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Mozo T, 1998, PLANT J, V16, P377, DOI 10.1046/j.1365-313x.1998.00299.x; Mylne J, 1998, PLANT MOL BIOL REP, V16, P257, DOI 10.1023/A:1007520410190; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/0968-0004(96)10031-1; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Sheldon CC, 2000, P NATL ACAD SCI USA, V97, P3753, DOI 10.1073/pnas.060023597; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Simon JA, 2002, CURR OPIN GENET DEV, V12, P210, DOI 10.1016/S0959-437X(02)00288-5; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Suzuki M, 1997, PLANT CELL, V9, P799, DOI 10.1105/tpc.9.5.799; TRIEZENBERG SJ, 1995, CURR OPIN GENET DEV, V5, P190, DOI 10.1016/0959-437X(95)80007-7; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; VARAGONA MJ, 1992, PLANT CELL, V4, P1213, DOI 10.1105/tpc.4.10.1213; von Arnim AG, 1998, GENE, V221, P35, DOI 10.1016/S0378-1119(98)00433-8	25	318	368	6	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 12	2002	297	5579					243	246		10.1126/science.1072147	http://dx.doi.org/10.1126/science.1072147			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	571UT	12114624				2022-12-24	WOS:000176738100039
J	Patel, MG; Wright, DJ; Gill, PS; Jerwood, D; Silcock, J; Chrystyn, H				Patel, MG; Wright, DJ; Gill, PS; Jerwood, D; Silcock, J; Chrystyn, H			Prescribing of lipid lowering drugs to South Asian patients: ecological study	BRITISH MEDICAL JOURNAL			English	Article							ORIGIN		Univ Bradford, Sch Pharm, Bradford BD7 1DP, W Yorkshire, England; Univ Bradford, Sch Comp & Math, Bradford BD7 1DP, W Yorkshire, England; Univ Birmingham, Dept Primary Care & Gen Practice, Hlth Inequalities Res Grp, Birmingham B15 2TT, W Midlands, England	University of Bradford; University of Bradford; University of Birmingham	Patel, MG (corresponding author), Univ Bradford, Sch Pharm, Bradford BD7 1DP, W Yorkshire, England.		Silcock, Jonathan/AAB-1856-2020; Silcock, Jonathan/AAZ-2124-2021	Silcock, Jonathan/0000-0002-4920-9249; Patel, Mahendra/0000-0001-6703-3542				Bhopal R, 1999, BRIT MED J, V319, P215, DOI 10.1136/bmj.319.7204.215; Cummins C, 1999, J PUBLIC HEALTH MED, V21, P401, DOI 10.1093/pubmed/21.4.401; *DEP HLTH, 2000, NAT SERV FRAM COR HE; Primatesta P, 2000, BMJ-BRIT MED J, V321, P1322, DOI 10.1136/bmj.321.7272.1322; Wild S, 1997, BRIT MED J, V314, P705, DOI 10.1136/bmj.314.7082.705	5	21	21	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 6	2002	325	7354					25	26		10.1136/bmj.325.7354.25	http://dx.doi.org/10.1136/bmj.325.7354.25			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573BC	12098726	Bronze, Green Published			2022-12-24	WOS:000176808600020
J	Kulheim, C; Agren, J; Jansson, S				Kulheim, C; Agren, J; Jansson, S			Rapid regulation of light harvesting and plant fitness in the field	SCIENCE			English	Article							CHLOROPHYLL FLUORESCENCE; ARABIDOPSIS-THALIANA; XANTHOPHYLL CYCLE; GREEN PLANTS; MUTANTS; ENERGY	We used Arabidopsis thaliana mutants to examine how a photosynthetic regulatory process, the qE-type or DeltapH-dependent nonphotochemical quenching, hereafter named feedback de-excitation, influences plant fitness in different light environments. We show that the feedback de-excitation is important for plant fitness in the field and in fluctuating light in a controlled environment but that it does not affect plant performance under constant light conditions. Our findings demonstrate that the feedback de-excitation confers a strong fitness advantage under field conditions and suggest that this advantage is due to the increase in plant tolerance to variation in light intensity rather than tolerance to high-intensity light itself.	Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, SE-90187 Umea, Sweden; Uppsala Univ, Dept Plant Ecol, Evolutionary Biol Ctr, SE-75236 Uppsala, Sweden	Umea University; Uppsala University	Jansson, S (corresponding author), Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, SE-90187 Umea, Sweden.	stefan.jansson@plantphys.umu.se	Kulheim, Carsten/F-4720-2010; Jansson, Stefan/A-1119-2009; Ågren, Jon/E-6093-2011	Jansson, Stefan/0000-0002-7906-6891; Ågren, Jon/0000-0001-9573-2463; Kulheim, Carsten/0000-0002-0798-3324				DemmigAdams B, 1996, TRENDS PLANT SCI, V1, P21, DOI 10.1016/S1360-1385(96)80019-7; Havaux M, 1999, P NATL ACAD SCI USA, V96, P8762, DOI 10.1073/pnas.96.15.8762; Havaux M, 2001, PLANTA, V213, P953, DOI 10.1007/s004250100572; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; HORTON P, 1994, PLANT PHYSIOL, V106, P415, DOI 10.1104/pp.106.2.415; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Mitchell-Olds T, 2001, TRENDS ECOL EVOL, V16, P693, DOI 10.1016/S0169-5347(01)02291-1; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Niyogi KK, 1998, PLANT CELL, V10, P1121, DOI 10.1105/tpc.10.7.1121; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; OQUIST G, 1988, PHYSIOL PLANTARUM, V73, P211, DOI 10.1111/j.1399-3054.1988.tb00588.x; SCHMITT J, 1995, AM NAT, V146, P9347	13	433	454	0	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 5	2002	297	5578					91	93		10.1126/science.1072359	http://dx.doi.org/10.1126/science.1072359			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	571HB	12098696				2022-12-24	WOS:000176711000039
J	Vekua, A; Lordkipanidze, D; Rightmire, GP; Agusti, J; Ferring, R; Maisuradze, G; Mouskhelishvili, A; Nioradze, M; de Leon, MP; Tappen, M; Tvalchrelidze, M; Zollikofer, C				Vekua, A; Lordkipanidze, D; Rightmire, GP; Agusti, J; Ferring, R; Maisuradze, G; Mouskhelishvili, A; Nioradze, M; de Leon, MP; Tappen, M; Tvalchrelidze, M; Zollikofer, C			A new skull of early homo from Dmanisi, Georgia	SCIENCE			English	Article							TAXONOMY; REMAINS; ERECTUS	Another hominid skull has been recovered at Dmanisi ( Republic of Georgia) from the same strata in which hominid remains have been reported previously. The Dmanisi site dated to similar to1.75 million years ago has now produced craniofacial portions of several hominid individuals, along with many well-preserved animal fossils and quantities of stone artifacts. Although there are certain anatomical differences among the Dmanisi specimens, the hominids do not clearly represent more than one taxon. We assign the new skull provisionally to Homo erectus (=ergaster). The Dmanisi specimens are the most primitive and small-brained fossils to be grouped with this species or any taxon linked unequivocally with genus Homo and also the ones most similar to the presumed habilis-like stem. We suggest that the ancestors of the Dmanisi population dispersed from Africa before the emergence of humans identified broadly with the H. erectus grade.	Georgian Acad Sci, Georgian State Museum, GE-380007 Tbilisi, Georgia; Georgian Acad Sci, Inst Paleobiol, GE-380004 Tbilisi, Georgia; SUNY Binghamton, Dept Anthropol, Binghamton, NY 13902 USA; Inst Paleontol M Crusafont, Sabadell 08201, Spain; Univ N Texas, Dept Geog, Denton, TX 76203 USA; Georgian Acad Sci, Inst Geog, GE-380093 Tbilisi, Georgia; Georgian Acad Sci, Archeol Ctr, GE-380002 Tbilisi, Georgia; Univ Zurich Irchel, Inst Anthropol, CH-8057 Zurich, Switzerland; Univ Zurich Irchel, MultiMedia Lab, CH-8057 Zurich, Switzerland; Univ Minnesota, Dept Anthropol, Minneapolis, MN 55455 USA; Georgian Acad Sci, Inst Geol, GE-380093 Tbilisi, Georgia	National Academy of Sciences of Georgia; National Academy of Sciences of Georgia; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; University of North Texas System; University of North Texas Denton; National Academy of Sciences of Georgia; National Academy of Sciences of Georgia; University of Zurich; University of Zurich; University of Minnesota System; University of Minnesota Twin Cities; National Academy of Sciences of Georgia	Lordkipanidze, D (corresponding author), Georgian Acad Sci, Georgian State Museum, 3 Purtseladze St, GE-380007 Tbilisi, Georgia.	geonathist@ip.osgf.ge	Lordkipanidze, David/AAH-6472-2020					Asfaw B, 2002, NATURE, V416, P317, DOI 10.1038/416317a; BEHRENSMEYER AK, 1978, PALEOBIOLOGY, V4, P150, DOI 10.1017/S0094837300005820; Dean C, 2001, NATURE, V414, P628, DOI 10.1038/414628a; GABOUNIA L, 1995, ANTHROPOLOGIE, V99, P29; Gabunia L, 2000, SCIENCE, V288, P1019, DOI 10.1126/science.288.5468.1019; Gabunia L, 2000, SCIENCE, V289, P55; Gabunia L, 2001, EVOL ANTHROPOL, V10, P158, DOI 10.1002/evan.1030; Gabunia L, 2000, J HUM EVOL, V38, P785, DOI 10.1006/jhev.1999.0383; GABUNIA L, 2001, EURASIA, V2, P128; GABUNIA L, 1992, JAHR RGZM, V39, P185; Gabunia L., 2000, ERAUL, V92, P13; GABUNIA L, 1993, DMANISI MAN ACCOMPAN, P1; Gabunia L.K., 1999, ARCHAOL KORRESPONDEN, V29, P451; GABUNIA LL, UNPUB C R ACAD SCI; JUSTUS A, 2001, MITT BERL GESEL ANTH, V21, P61; Kimbel WH, 1996, J HUM EVOL, V31, P549, DOI 10.1006/jhev.1996.0079; Lordkipanidze D, 2002, J HUM EVOL, V42, pA20; MCCOLLUM MA, 1993, J HUM EVOL, V24, P87, DOI 10.1006/jhev.1993.1009; Rightmire GP, 1998, AM J PHYS ANTHROPOL, V106, P61, DOI 10.1002/(SICI)1096-8644(199805)106:1<61::AID-AJPA5>3.3.CO;2-U; RIGHTMIRE GP, 1990, COMP ANATOMICAL STUD, P1; ROBINSON JT, 1965, NATURE, V205, P121, DOI 10.1038/205121a0; Tappen Martha, 2002, P161; TESAKOV AS, 1998, TNO, V60, P71; Tobias P.V, 1991, OLDUVAI GORGE, V4, P1; Walker A, 1993, NARIOKOTOME HOMO ERE, P1; WALKER A, 1976, EARLIEST MAN ENV LAK, P484; Weidenreich F., 1943, Palaeontologia Sinica, VD 10, P1; Wolpoff M. H., 1999, PALEOANTHROPOLOGY; Wood B, 1999, SCIENCE, V284, P65, DOI 10.1126/science.284.5411.65; WOOD B, 1992, NATURE, V355, P783, DOI 10.1038/355783a0; Wood B., 1991, HOMINID CRANIAL REMA, V4; ZAGWIJN WH, 1998, TNO, V60, P19	32	255	267	2	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 5	2002	297	5578					85	89		10.1126/science.1072953	http://dx.doi.org/10.1126/science.1072953			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	571HB	12098694				2022-12-24	WOS:000176711000037
J	Nonaka, S; Shiratori, H; Saijoh, Y; Hamada, H				Nonaka, S; Shiratori, H; Saijoh, Y; Hamada, H			Determination of left-right patterning of the mouse embryo by artificial nodal flow	NATURE			English	Article							LEFT-RIGHT ASYMMETRY; SITUS-INVERSUS; EXPRESSION; MICE; CILIA	Substantial insight has recently been achieved into the mechanisms responsible for the generation of left-right (L-R) asymmetry in the vertebrate body plan(1-4). However, the mechanism that underlies the initial breaking of symmetry has remained unclear. In the mouse, a leftward fluid flow on the ventral side of the node caused by the vortical motion of cilia (referred to as nodal flow) is implicated in symmetry breaking(5), but direct evidence for the role of this flow has been lacking. Here we describe the development of a system in which mouse embryos are cultured under an artificial fluid flow and with which we have examined how flow affects L-R patterning. An artificial rightward flow that was sufficiently rapid to reverse the intrinsic leftward nodal flow resulted in reversal of situs in wild-type embryos. The artificial flow was also able to direct the situs of mutant mouse embryos with immotile cilia. These results provide the first direct evidence for the role of mechanical fluid flow in L-R patterning.	Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; Japan Sci & Technol Corp, CREST, Tokyo, Japan	Osaka University; Japan Science & Technology Agency (JST)	Nonaka, S (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, 1-3 Yamada Oka, Suita, Osaka 5650871, Japan.		Hamada, Hiroshi/N-6374-2015; Nonaka, Shigenori/I-2132-2013	Hamada, Hiroshi/0000-0002-7196-5948; Nonaka, Shigenori/0000-0002-8093-0325; Saijoh, Yukio/0000-0002-7548-4789				Beddington RSP, 1999, CELL, V96, P195, DOI 10.1016/S0092-8674(00)80560-7; Capdevila J, 2000, CELL, V101, P9, DOI 10.1016/S0092-8674(00)80619-4; Collignon J, 1996, NATURE, V381, P155, DOI 10.1038/381155a0; DOWNS KM, 1993, DEVELOPMENT, V118, P1255; FUJINAGA M, 1991, TERATOLOGY, V44, P453, DOI 10.1002/tera.1420440411; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; Hogan B, 1994, MANIPULATING MOUSE E; Lowe LA, 1996, NATURE, V381, P158, DOI 10.1038/381158a0; Meno C, 1997, GENES CELLS, V2, P513, DOI 10.1046/j.1365-2443.1997.1400338.x; Meno C, 1996, NATURE, V381, P151, DOI 10.1038/381151a0; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Okada Y, 1999, MOL CELL, V4, P459, DOI 10.1016/S1097-2765(00)80197-5; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Shiratori H, 2001, MOL CELL, V7, P137, DOI 10.1016/S1097-2765(01)00162-9; SULIK K, 1994, DEV DYNAM, V201, P260, DOI 10.1002/aja.1002010309; Supp DM, 1999, DEVELOPMENT, V126, P5495; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; Wright C V, 2001, Dev Cell, V1, P179, DOI 10.1016/S1534-5807(01)00036-3	18	481	504	2	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 4	2002	418	6893					96	99		10.1038/nature00849	http://dx.doi.org/10.1038/nature00849			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569JL	12097914				2022-12-24	WOS:000176599200046
J	Otto, A; White, JD; Simoneit, BRT				Otto, A; White, JD; Simoneit, BRT			Natural product terpenoids in Eocene and Miocene conifer fossils	SCIENCE			English	Article							CUPRESSACEAE; GERMANY; BASIN	Numerous saturated and aromatic hydrocarbons, but not polar compounds, originating from plants and microorganisms (biomarkers) have been reported in sediments, coals, and petroleum. Here we describe natural product terpenoids found in two fossil conifers, Taxodium balticum (Eocene) and Glyptostrobus oregonensis (Miocene). A similar terpenoid pattern is also observed in extant Taxodium distichum. The preservation of characteristic terpenoids (unaltered natural products) in the fossil conifers supports their systematic assignment to the Cypress family (Cupressaceae sensu lato). The results also show that fossil conifers can contain polar terpenoids, which are valuable markers for (paleo) chemosystematics and phylogeny.	Oregon State Univ, Environm & Petr Geochem Grp, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA; Oregon State Univ, Dept Chem, Corvallis, OR 97331 USA	Oregon State University; Oregon State University	Otto, A (corresponding author), Univ Frankfurt, Inst Mineral Umweltanalyt, Georg Voigt Str 14, D-60054 Frankfurt, Germany.		SIMONEIT, BERND R. T./A-2008-2013					Baset ZH, 1980, ADV ORG GEOCHEM, P619; BRUNSFELD SJ, 1994, SYST BOT, V19, P253, DOI 10.2307/2419600; ENZELL CR, 1967, ARK KEMI, V26, P425; ERDTMAN H, 1966, PROGR CHEM ORGANIC N, V24, P207; ERDTMAN H, 1968, RECENT ADV PHYTOCHEM, V1, P1; Gadek PA, 2000, AM J BOT, V87, P1044, DOI 10.2307/2657004; HEGNAUER R., 1986, CHEMOTAXONOMIE PFLAN, V7; HEGNAUER R., 1962, CHEMOTAXONOMIE PFLAN, V1; HIROSE Y, 1983, TETRAHEDRON LETT, V24, P1535, DOI 10.1016/S0040-4039(00)81702-5; KUPCHAN SM, 1969, J ORG CHEM, V34, P3912, DOI 10.1021/jo01264a036; Mai D. H., 1985, ABHANDLUNGEN STAATLI, V38, P1; Otto A, 1997, ORG GEOCHEM, V26, P105, DOI 10.1016/S0146-6380(96)00133-7; Otto A, 2001, GEOCHIM COSMOCHIM AC, V65, P3505, DOI 10.1016/S0016-7037(01)00693-7; Otto A, 2001, BOT REV, V67, P141, DOI 10.1007/BF02858076; OTTO A, UNPUB; Peters K.E., 1993, BIOMARKER GUIDE INTE; SHIBUYA T, 1992, PHYTOCHEMISTRY, V31, P4289, DOI 10.1016/0031-9422(92)80460-V; Simoneit B.R.T., 1998, HDB ENV CHEM, V3, P175; Simoneit BRT, 1999, ENVIRON SCI POLLUT R, V6, P159, DOI 10.1007/BF02987621; Simoneit BRT, 1986, BIOL MARKERS SEDIMEN, V24, P43; Smiley C. J., 1985, LATE CENOZOIC HIST P, P95; STREIBL M, 1969, ORGANIC GEOCHEMISTRY, P401; SU WC, 1993, PHYTOCHEMISTRY, V34, P779, DOI 10.1016/0031-9422(93)85358-X; TEGELAAR EW, 1989, GEOCHIM COSMOCHIM AC, V53, P3103, DOI 10.1016/0016-7037(89)90191-9; Tissot B.P., 1984, PETROLEUM FORMATION, DOI 10.1007/978-3-642-96446-6; WANG TG, 1990, FUEL, V69, P12, DOI 10.1016/0016-2361(90)90252-L	26	70	74	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 30	2002	297	5586					1543	1545		10.1126/science.1074225	http://dx.doi.org/10.1126/science.1074225			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588JA	12202827				2022-12-24	WOS:000177697300054
J	Burtis, KC				Burtis, KC			Development: Doublesex in the middle	SCIENCE			English	Editorial Material							DROSOPHILA; EVOLUTION; PROTEINS; WINGLESS; DISC		Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA	University of California System; University of California Davis	Burtis, KC (corresponding author), Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA.			Burtis, Kenneth/0000-0002-9644-3265				Ahmad SM, 2002, CELL, V109, P651, DOI 10.1016/S0092-8674(02)00744-4; BURTIS KC, 1991, EMBO J, V10, P2577, DOI 10.1002/j.1460-2075.1991.tb07798.x; Cline TW, 1996, ANNU REV GENET, V30, P637, DOI 10.1146/annurev.genet.30.1.637; ERDMAN SE, 1993, EMBO J, V12, P527, DOI 10.1002/j.1460-2075.1993.tb05684.x; Keisman EL, 2001, DEVELOPMENT, V128, P1643; Keisman EL, 2001, DEV CELL, V1, P215, DOI 10.1016/S1534-5807(01)00027-2; Kopp A, 2000, NATURE, V408, P553, DOI 10.1038/35046017; Matsuda M, 2002, NATURE, V417, P559, DOI 10.1038/nature751; Sanchez L, 2001, DEVELOPMENT, V128, P1033; Schutt C, 2000, DEVELOPMENT, V127, P667; Sefton L, 2000, NATURE, V405, P970, DOI 10.1038/35016119; Sutherland D, 1996, CELL, V87, P1091, DOI 10.1016/S0092-8674(00)81803-6; Zhu LY, 2000, GENE DEV, V14, P1750	13	8	8	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 16	2002	297	5584					1135	1136		10.1126/science.1074492	http://dx.doi.org/10.1126/science.1074492			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584BP	12183618				2022-12-24	WOS:000177447600035
J	Li, X; Perissi, V; Liu, F; Rose, DW; Rosenfeld, MG				Li, X; Perissi, V; Liu, F; Rose, DW; Rosenfeld, MG			Tissue-specific regulation of retinal and pituitary precursor cell proliferation	SCIENCE			English	Article							HISTONE DEACETYLASE COMPLEX; TUMOR-SUPPRESSOR; HOMEOBOX GENE; MICE LACKING; EYES; PROTEINS; DIFFERENTIATION; HYPERPLASIA; COMPONENT; HOMOLOGS	Mammalian organogenesis requires the expansion of pluripotent precursor cells before the subsequent determination of specific cell types, but the tissue-specific molecular mechanisms that regulate the initial expansion of primordial cells remain poorly defined. We have genetically established that Six6 homeodomain factor, acting as a strong tissue-specific repressor, regulates early progenitor cell proliferation during mammalian retinogenesis and pituitary development. Six6, in association with Dach corepressors, regulates proliferation by directly repressing cyclin-dependent kinase inhibitors, including the p27Kip1 promoter. These data reveal a molecular mechanism by which a tissue-specific transcriptional repressor-corepressor complex can provide an organ-specific strategy for physiological expansion of precursor populations.	Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, Dept Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Endocrinol & Metab, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Rosenfeld, MG (corresponding author), Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, Dept Mol Med, 9500 Gilman Dr,Room 345, La Jolla, CA 92093 USA.	mrosenfeld@ucsd.edu		Perissi, Valentina/0000-0002-3716-0003	NIDDK NIH HHS [5F32DK09814] Funding Source: Medline; Telethon [484/B] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK009814] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Telethon(Fondazione Telethon); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BONINI NM, 1993, CELL, V72, P379, DOI 10.1016/0092-8674(93)90115-7; Cepko CL, 1999, CURR OPIN NEUROBIOL, V9, P37, DOI 10.1016/S0959-4388(99)80005-1; Chen R, 1997, CELL, V91, P893, DOI 10.1016/S0092-8674(00)80481-X; CHEYETTE BNR, 1994, NEURON, V12, P977, DOI 10.1016/0896-6273(94)90308-5; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Gallardo ME, 1999, GENOMICS, V61, P82, DOI 10.1006/geno.1999.5916; Hazbun TR, 1997, BIOCHEMISTRY-US, V36, P3680, DOI 10.1021/bi9625206; Heanue TA, 1999, GENE DEV, V13, P3231, DOI 10.1101/gad.13.24.3231; Jean D, 1999, MECH DEVELOP, V84, P31, DOI 10.1016/S0925-4773(99)00068-4; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Kwon TK, 1996, GENE, V180, P113, DOI 10.1016/S0378-1119(96)00416-7; Levine EM, 2000, DEV BIOL, V219, P299, DOI 10.1006/dbio.2000.9622; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Nomura T, 1999, GENE DEV, V13, P412, DOI 10.1101/gad.13.4.412; Oliver G, 1995, DEVELOPMENT, V121, P4045; Perron M, 2000, CELL MOL LIFE SCI, V57, P215, DOI 10.1007/PL00000685; Pignoni F, 1997, CELL, V91, P881, DOI 10.1016/S0092-8674(00)80480-8; QUELLE DE, 1995, CELL, V83, P993; Shinagawa T, 2000, EMBO J, V19, P2280, DOI 10.1093/emboj/19.10.2280; Sidman RL, 1961, STRUCTURE EYE, P487; Xu PX, 1997, P NATL ACAD SCI USA, V94, P11974, DOI 10.1073/pnas.94.22.11974; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215; Zimmerman JE, 1997, GENOME RES, V7, P128, DOI 10.1101/gr.7.2.128; Zuber ME, 1999, CELL, V98, P341, DOI 10.1016/S0092-8674(00)81963-7	25	219	230	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 16	2002	297	5584					1180	1183						4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584BP	12130660				2022-12-24	WOS:000177447600050
J	Sethi, S; Evans, N; Grant, BJB; Murphy, TF				Sethi, S; Evans, N; Grant, BJB; Murphy, TF			New strains of bacteria and exacerbations of chronic obstructive pulmonary disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NONTYPABLE HAEMOPHILUS-INFLUENZAE; RESPIRATORY-TRACT COLONIZATION; CHRONIC-BRONCHITIS; BRANHAMELLA-CATARRHALIS; PSEUDOMONAS-AERUGINOSA; AIRWAY INFLAMMATION; IMMUNE-RESPONSE; INFECTION; ETIOLOGY	Background The role of bacterial pathogens in acute exacerbations of chronic obstructive pulmonary disease is controversial. In older studies, the rates of isolation of bacterial pathogens from sputum were the same during acute exacerbations and during stable disease. However, these studies did not differentiate among strains within a bacterial species and therefore could not detect changes in strains over time. We hypothesized that the acquisition of a new strain of a pathogenic bacterial species is associated with exacerbation of chronic obstructive pulmonary disease. Methods We conducted a prospective study in which clinical information and sputum samples for culture were collected monthly and during exacerbations from 81 outpatients with chronic obstructive pulmonary disease. Molecular typing of sputum isolates of nonencapsulated Haemophilus influenzae, Moraxella catarrhalis, Streptococcus pneumoniae, and Pseudomonas aeruginosa was performed. Results Over a period of 56 months, the 81 patients made a total of 1975 clinic visits, 374 of which were made during exacerbations (mean, 2.1 per patient per year). On the basis of molecular typing, an exacerbation was diagnosed at 33.0 percent of the clinic visits that involved isolation of a new strain of a bacterial pathogen, as compared with 15.4 percent of visits at which no new strain was isolated (P < 0.001; relative risk of an exacerbation, 2.15; 95 percent confidence interval, 1.83 to 2.53). Isolation of a new strain of H. influenzae, M. catarrhalis, or S. pneumoniae was associated with a significantly increased risk of an exacerbation. Conclusions The association between an exacerbation and the isolation of a new strain of a bacterial pathogen supports the causative role of bacteria in exacerbations of chronic obstructive pulmonary disease.	Vet Affairs Western New York Healthcare Syst 151, Buffalo, NY 14215 USA; SUNY Buffalo, Div Pulm & Crit Care Med, Dept Med, Buffalo, NY 14260 USA; SUNY Buffalo, Div Infect Dis, Dept Med, Buffalo, NY 14260 USA; SUNY Buffalo, Dept Microbiol, Buffalo, NY 14260 USA; SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14260 USA; SUNY Buffalo, Dept Social & Prevent Med, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Sethi, S (corresponding author), Vet Affairs Western New York Healthcare Syst 151, 3495 Bailey Ave, Buffalo, NY 14215 USA.	ssethi@buffalo.edu		Murphy, Timothy/0000-0002-3496-2641				Bresser P, 1997, EUR RESPIR J, V10, P2319, DOI 10.1183/09031936.97.10102319; BURROWS B, 1969, NEW ENGL J MED, V280, P397, DOI 10.1056/NEJM196902202800801; CELLI BR, 1995, AM J RESP CRIT CARE, V152, pS77; CHAPMAN AJ, 1985, J INFECT DIS, V151, P878, DOI 10.1093/infdis/151.5.878; Connors AF, 1996, AM J RESP CRIT CARE, V154, P959, DOI 10.1164/ajrccm.154.4.8887592; Connors AF, 1997, AM J RESP CRIT CARE, V155, P386; DUIM B, 1994, MOL MICROBIOL, V11, P1181, DOI 10.1111/j.1365-2958.1994.tb00394.x; Eller J, 1998, CHEST, V113, P1542, DOI 10.1378/chest.113.6.1542; FADEN H, 1989, J INFECT DIS, V160, P999, DOI 10.1093/infdis/160.6.999; Fagon J Y, 1996, Semin Respir Infect, V11, P109; FAGON JY, 1990, AM REV RESPIR DIS, V142, P1004, DOI 10.1164/ajrccm/142.5.1004; GROTHUES D, 1988, J CLIN MICROBIOL, V26, P1973, DOI 10.1128/JCM.26.10.1973-1977.1988; GUMP DW, 1976, AM REV RESPIR DIS, V113, P465; Hill AT, 1999, AM J RESP CRIT CARE, V160, P1968, DOI 10.1164/ajrccm.160.6.9904097; Hirschmann JV, 2000, CHEST, V118, P193, DOI 10.1378/chest.118.1.193; KLINGMAN KL, 1995, AM J RESP CRIT CARE, V152, P1072, DOI 10.1164/ajrccm.152.3.7663786; LEFEVRE JC, 1993, J CLIN MICROBIOL, V31, P2724, DOI 10.1128/JCM.31.10.2724-2728.1993; MASLOW JN, 1993, CLIN INFECT DIS, V17, P153, DOI 10.1093/clinids/17.2.153; MCHARDY VU, 1980, BRIT J DIS CHEST, V74, P228, DOI 10.1016/0007-0971(80)90048-0; Miravitlles M, 1999, CHEST, V116, P40, DOI 10.1378/chest.116.1.40; MONSO E, 1995, AM J RESP CRIT CARE, V152, P1316, DOI 10.1164/ajrccm.152.4.7551388; Murphy TF, 2000, CHEST, V118, P204, DOI 10.1378/chest.118.1.204; MURPHY TF, 1992, AM REV RESPIR DIS, V146, P1067, DOI 10.1164/ajrccm/146.4.1067; MURPHY TF, 1983, J INFECT DIS, V147, P838, DOI 10.1093/infdis/147.5.838; Murphy TF, 1999, J INFECT DIS, V180, P404, DOI 10.1086/314870; Obaji A, 2001, DRUG AGING, V18, P1, DOI 10.2165/00002512-200118010-00001; Seemungal TAR, 2000, AM J RESP CRIT CARE, V161, P1608, DOI 10.1164/ajrccm.161.5.9908022; SENEFF MG, 1995, JAMA-J AM MED ASSOC, V274, P1852, DOI 10.1001/jama.274.23.1852; Sethi S, 2000, CHEST, V118, P1557, DOI 10.1378/chest.118.6.1557; Sethi S, 2000, CHEST, V117, p380S, DOI 10.1378/chest.117.5_suppl_2.380S; SMITH CB, 1976, J INFECT DIS, V134, P552, DOI 10.1093/infdis/134.6.552; Soler N, 1999, EUR RESPIR J, V14, P1015, DOI 10.1183/09031936.99.14510159; Speijer H, 1999, J CLIN MICROBIOL, V37, P3654, DOI 10.1128/JCM.37.11.3654-3661.1999; TAGER I, 1975, NEW ENGL J MED, V292, P563, DOI 10.1056/NEJM197503132921105; WACHOLDER S, 1986, AM J EPIDEMIOL, V123, P174, DOI 10.1093/oxfordjournals.aje.a114212; Yi KC, 1997, J INFECT DIS, V176, P1247, DOI 10.1086/514119; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	37	715	761	1	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 15	2002	347	7					465	471		10.1056/NEJMoa012561	http://dx.doi.org/10.1056/NEJMoa012561			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587ZM	12181400				2022-12-24	WOS:000177674400002
J	Kohli, RM; Walsh, CT; Burkart, MD				Kohli, RM; Walsh, CT; Burkart, MD			Biomimetic synthesis and optimization of cyclic peptide antibiotics	NATURE			English	Article							THIOESTERASE; BIOSYNTHESIS; SYNTHETASES; BACTERIAL; DOMAINS	Molecules in nature are often brought to a bioactive conformation by ring formation (macrocyclization)(1). A recurrent theme in the enzymatic synthesis of macrocyclic compounds by non-ribosomal and polyketide synthetases is the tethering of activated linear intermediates through thioester linkages to carrier proteins, in a natural analogy to solid-phase synthesis(2). A terminal thioesterase domain of the synthetase catalyses release from the tether and cyclization(3,4). Here we show that an isolated thioesterase can catalyse the cyclization of linear peptides immobilized on a solid-phase support modified with a biomimetic linker, offering the possibility of merging natural-product biosynthesis with combinatorial solid-phase chemistry. Starting from the cyclic decapeptide antibiotic tyrocidine A, this chemo-enzymatic approach allows us to diversify the linear peptide both to probe the enzymology of the macrocyclizing enzyme, TycC thioesterase, and to create a library of cyclic peptide antibiotic products. We have used this method to reveal natural-product analogues of potential therapeutic utility; these compounds have an increased preference for bacterial over eukaryotic membranes and an improved spectrum of activity against some common bacterial pathogens.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Walsh, CT (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA.			Kohli, Rahul/0000-0002-7689-5678				Cane DE, 1998, SCIENCE, V282, P63, DOI 10.1126/science.282.5386.63; Hancock REW, 1998, TRENDS BIOTECHNOL, V16, P82, DOI 10.1016/S0167-7799(97)01156-6; HULL SE, 1978, NATURE, V275, P206, DOI 10.1038/275206a0; Izumiya N., 1979, SYNTHETIC ASPECTS BI; Keating TA, 2001, CHEMBIOCHEM, V2, P99, DOI 10.1002/1439-7633(20010202)2:2<99::AID-CBIC99>3.0.CO;2-3; Kohli RM, 2001, BIOCHEMISTRY-US, V40, P7099, DOI 10.1021/bi010036j; Kondejewski LH, 1999, J BIOL CHEM, V274, P13181, DOI 10.1074/jbc.274.19.13181; KUO MC, 1980, BIOPHYS J, V32, P807, DOI 10.1016/S0006-3495(80)85018-1; Lambalot RH, 1996, CHEM BIOL, V3, P923, DOI 10.1016/S1074-5521(96)90181-7; Li J, 1996, BIOCHEMISTRY-US, V35, P9967, DOI 10.1021/bi9605292; Marahiel MA, 1997, CHEM REV, V97, P2651, DOI 10.1021/cr960029e; Matsuzaki K, 1999, BBA-BIOMEMBRANES, V1462, P1, DOI 10.1016/S0005-2736(99)00197-2; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; OVCHINNIKOV YA, 1982, PROTEINS, V5, P391; RIZO J, 1992, ANNU REV BIOCHEM, V61, P387, DOI 10.1146/annurev.bi.61.070192.002131; Scott CP, 2001, CHEM BIOL, V8, P801, DOI 10.1016/S1074-5521(01)00052-7; STACHELHAUS T, 1995, SCIENCE, V269, P69, DOI 10.1126/science.7604280; Trauger JW, 2000, NATURE, V407, P215, DOI 10.1038/35025116; YOUNG JDE, 1986, ANAL BIOCHEM, V154, P649, DOI 10.1016/0003-2697(86)90042-4; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	20	242	261	0	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 8	2002	418	6898					658	661		10.1038/nature00907	http://dx.doi.org/10.1038/nature00907			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581RA	12167866				2022-12-24	WOS:000177305600047
J	Pandur, P; Lasche, M; Eisenberg, LM; Kuhl, M				Pandur, P; Lasche, M; Eisenberg, LM; Kuhl, M			Wnt-11 activation of a non-canonical Wnt signalling pathway is required for cardiogenesis	NATURE			English	Article							CONVERGENT EXTENSION MOVEMENTS; PROTEIN-KINASE-C; XENOPUS-LAEVIS; TRANSCRIPTION FACTOR; CARDIAC DEVELOPMENT; SIGNALING PATHWAYS; FRIZZLED HOMOLOGS; WNT/BETA-CATENIN; EXPRESSION; MESODERM	Formation of the vertebrate heart requires a complex interplay of several temporally regulated signalling cascades(1). In Xenopus laevis, cardiac specification occurs during gastrulation and requires signals from the dorsal lip and underlying endoderm(2). Among known Xenopus Wnt genes, only Wnt-11 shows a spatiotemporal pattern of expression that correlates with cardiac specification, which indicates that Wnt-11 may be involved in heart development(3,4). Here we show, through loss- and gain-of-function experiments, that XWnt-11 is required for heart formation in Xenopus embryos and is sufficient to induce a contractile phenotype in embryonic explants. Treating the mouse embryonic carcinoma stem cell line P19 with murine Wnt-11 conditioned medium triggers cardiogenesis, which indicates that the function of Wnt-11 in heart development has been conserved in higher vertebrates. XWnt-11 mediates this effect by non-canonical Wnt signalling, which is independent of beta-catenin and involves protein kinase C and Jun amino-terminal kinase. Our results indicate that the cardiac developmental program requires non-canonical Wnt signal transduction.	Univ Gottingen, Abt Entwicklungsbiochem, Jr Grp SFB 271, D-37073 Gottingen, Germany; Univ Ulm, Biochem Abt, D-89081 Ulm, Germany; Med Univ S Carolina, Dept Cell Biol & Anat, Charleston, SC 29425 USA	University of Gottingen; Ulm University; Medical University of South Carolina	Kuhl, M (corresponding author), Univ Gottingen, Abt Entwicklungsbiochem, Jr Grp SFB 271, Humboldtallee 23, D-37073 Gottingen, Germany.	wnt_signaling@web.de						BADER D, 1982, J CELL BIOL, V95, P763, DOI 10.1083/jcb.95.3.763; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Boutros M, 1999, MECH DEVELOP, V83, P27, DOI 10.1016/S0925-4773(99)00046-5; De Windt LJ, 2000, J BIOL CHEM, V275, P13571, DOI 10.1074/jbc.275.18.13571; Djiane A, 2000, DEVELOPMENT, V127, P3091; DRYSDALE TA, 1994, DEV BIOL, V165, P432, DOI 10.1006/dbio.1994.1265; Eisenberg CA, 1999, DEV DYNAM, V216, P45, DOI 10.1002/(SICI)1097-0177(199909)216:1<45::AID-DVDY7>3.0.CO;2-L; Eisenberg CA, 1997, DEVELOPMENT, V124, P525; Grepin C, 1997, DEVELOPMENT, V124, P2387; GRUNZ H, 1983, ROUX ARCH DEV BIOL, V192, P130, DOI 10.1007/BF00848681; Kispert A, 1996, DEVELOPMENT, V122, P3627; KU M, 1993, DEVELOPMENT, V119, P1161; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701; Kuhl M, 2001, MECH DEVELOP, V106, P61, DOI 10.1016/S0925-4773(01)00416-6; Marvin MJ, 2001, GENE DEV, V15, P316, DOI 10.1101/gad.855501; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; NASCONE N, 1995, DEVELOPMENT, V121, P515; Nishitoh H, 1998, MOL CELL, V2, P389, DOI 10.1016/S1097-2765(00)80283-X; Pera EM, 2000, MECH DEVELOP, V96, P183, DOI 10.1016/S0925-4773(00)00394-4; Runnicki M.A., 1987, TERATOCARCINOMAS EMB, P19; Schneider VA, 2001, GENE DEV, V15, P304, DOI 10.1101/gad.855601; Schroeder KE, 1999, DEV BIOL, V214, P288, DOI 10.1006/dbio.1999.9426; Sheldahl LC, 1999, CURR BIOL, V9, P695, DOI 10.1016/S0960-9822(99)80310-8; Sucov HM, 1998, ANNU REV PHYSIOL, V60, P287, DOI 10.1146/annurev.physiol.60.1.287; Tada M, 2000, DEVELOPMENT, V127, P2227; TONISSEN KF, 1994, DEV BIOL, V162, P325, DOI 10.1006/dbio.1994.1089; Torres MA, 1996, J CELL BIOL, V133, P1123, DOI 10.1083/jcb.133.5.1123; Yamanaka H, 2002, EMBO REP, V3, P69, DOI 10.1093/embo-reports/kvf008	29	422	448	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 8	2002	418	6898					636	641		10.1038/nature00921	http://dx.doi.org/10.1038/nature00921			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581RA	12167861				2022-12-24	WOS:000177305600042
J	Rappe, MS; Connon, SA; Vergin, KL; Giovannoni, SJ				Rappe, MS; Connon, SA; Vergin, KL; Giovannoni, SJ			Cultivation of the ubiquitous SAR11 marine bacterioplankton clade	NATURE			English	Article							PHYLOGENETIC DIVERSITY; BACTERIAL DIVERSITY; DILUTION CULTURE; IDENTIFICATION; PICOPLANKTON; PROKARYOTES; SEQUENCES; CLUSTER; ARCHAEA; PROBES	The alpha-proteobacterial lineage that contains SAR11 and related ribosomal RNA gene clones was among the first groups of organisms to be identified when cultivation-independent approaches based on rRNA gene cloning and sequencing were applied to survey microbial diversity in natural ecosystems(1). This group accounts for 26% of all ribosomal RNA genes that have been identified in sea water and has been found in nearly every pelagic marine bacterioplankton community studied by these methods(2). The SAR11 clade represents a pervasive problem in microbiology: despite its ubiquity, it has defied cultivation efforts. Genetic evidence suggests that diverse uncultivated microbial taxa dominate most natural ecosystems(3-5), which has prompted widespread efforts to elucidate the geochemical activities of these organisms without the benefit of cultures for study(6,7). Here we report the isolation of representatives of the SAR11 clade. Eighteen cultures were initially obtained by means of high-throughput procedures for isolating cell cultures through the dilution of natural microbial communities into very low nutrient media. Eleven of these cultures have been successfully passaged and cryopreserved for future study. The volume of these cells, about 0.01 mum(3), places them among the smallest free-living cells in culture.	Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA	Oregon State University	Giovannoni, SJ (corresponding author), Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA.		Connon, Stephanie A/K-1959-2012	VERGIN, KEVIN/0000-0002-8972-2813				AMANN RI, 1990, J BACTERIOL, V172, P762, DOI 10.1128/jb.172.2.762-770.1990; Bahr M, 1996, AQUAT MICROB ECOL, V11, P271, DOI 10.3354/ame011271; Bano N, 2002, APPL ENVIRON MICROB, V68, P505, DOI 10.1128/AEM.68.2.505-518.2002; Beja O, 2001, NATURE, V411, P786, DOI 10.1038/35081051; BUTTON DK, 1993, APPL ENVIRON MICROB, V59, P881, DOI 10.1128/AEM.59.3.881-891.1993; Davis H. C., 1958, Fishery Bulletin United States, V58, P293; DELONG EF, 1993, LIMNOL OCEANOGR, V38, P924, DOI 10.4319/lo.1993.38.5.0924; Ducklow H., 2000, MICROBIAL ECOLOGY OC, P85, DOI DOI 10.1002/9780470281840; Fuhrman JA, 1997, MAR ECOL PROG SER, V150, P275, DOI 10.3354/meps150275; Garcia-Martinez J, 2000, MOL ECOL, V9, P935, DOI 10.1046/j.1365-294x.2000.00953.x; Giovannoni S., 2000, P47; GIOVANNONI SJ, 1990, NATURE, V345, P60, DOI 10.1038/345060a0; GIOVANNONI SJ, 1990, APPL ENVIRON MICROB, V56, P2572, DOI 10.1128/AEM.56.8.2572-2575.1990; GIOVANNONI SJ, 1988, J BACTERIOL, V170, P720, DOI 10.1128/jb.170.2.720-726.1988; Glockner FO, 1996, SYST APPL MICROBIOL, V19, P403; HICKS RE, 1992, APPL ENVIRON MICROB, V58, P2158, DOI 10.1128/AEM.58.7.2158-2163.1992; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; Ludwig W, 1998, ELECTROPHORESIS, V19, P554, DOI 10.1002/elps.1150190416; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; Rappe MS, 1997, LIMNOL OCEANOGR, V42, P811, DOI 10.4319/lo.1997.42.5.0811; Rochelle P. A., 1995, NUCL ACIDS ENV, P219, DOI DOI 10.1007/978-3-642-79050-8_11; SCHUT F, 1993, APPL ENVIRON MICROB, V59, P2150, DOI 10.1128/AEM.59.7.2150-2160.1993; Stein JL, 1996, J BACTERIOL, V178, P591, DOI 10.1128/jb.178.3.591-599.1996; SWOFFORD D, 2000, PAUL ASTERISQUE 4 0; WARD DM, 1992, ADV MICROB ECOL, V12, P219; Yager PL, 2001, LIMNOL OCEANOGR, V46, P790, DOI 10.4319/lo.2001.46.4.0790	27	662	714	14	196	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 8	2002	418	6898					630	633		10.1038/nature00917	http://dx.doi.org/10.1038/nature00917			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581RA	12167859				2022-12-24	WOS:000177305600040
J	Brittis, PA; Lu, Q; Flanagan, JG				Brittis, PA; Lu, Q; Flanagan, JG			Axonal protein synthesis provides a mechanism for localized regulation at an intermediate target	CELL			English	Article							ALKALINE-PHOSPHATASE FUSIONS; TYROSINE KINASE; ROBO RECEPTORS; MESSENGER-RNA; GROWTH CONES; GUIDANCE; MIDLINE; SLIT; EXPRESSION; TRANSLATION	As axons grow past intermediate targets, they change their responsiveness to guidance cues. Local upregulation of receptor expression is involved, but the mechanisms for this are not clear. Here protein synthesis is traced within individual axons by introducing RNAs encoding visualizable reporters. Individual severed axons and growth cones can translate proteins and also export them to the cell surface. As axons reach the spinal cord midline, EphA2 is among the receptors upregulated on at least some distal axon segments. Midline reporter upregulation is recapitulated by part of the EphA2 mRNA 3' untranslated region, which is highly conserved and includes known translational control sequences. These results show axons contain all the machinery for protein translation and cell surface expression, and they reveal a potentially general and flexible RNA-based mechanism for regulation localized within a subregion of the axon.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Flanagan, JG (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	flanagan@hms.harvard.edu	Flanagan, John/AAM-2995-2020					Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Alvarez J, 2000, PROG NEUROBIOL, V62, P1, DOI 10.1016/S0301-0082(99)00062-3; Bassell GJ, 1998, J NEUROSCI, V18, P251; BASTIANI MJ, 1987, CELL, V48, P745, DOI 10.1016/0092-8674(87)90072-9; Bergemann AD, 1998, ONCOGENE, V16, P471, DOI 10.1038/sj.onc.1201557; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; BRITTIS PA, 1995, EXP NEUROL, V134, P1, DOI 10.1006/exnr.1995.1031; BRITTIS PA, 1995, MOL CELL NEUROSCI, V6, P433, DOI 10.1006/mcne.1995.1032; Brose K, 2000, CURR OPIN NEUROBIOL, V10, P95, DOI 10.1016/S0959-4388(99)00066-5; Burstyn-Cohen T, 1999, NEURON, V23, P233, DOI 10.1016/S0896-6273(00)80776-X; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Davies SJA, 1997, NATURE, V390, P680, DOI 10.1038/37776; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; Eng H, 1999, J NEUROSCI, V19, P1; Flanagan JG, 1998, CELL, V92, P429, DOI 10.1016/S0092-8674(00)80935-6; Flanagan JG, 2000, METHOD ENZYMOL, V327, P19, DOI 10.1016/S0076-6879(00)27264-9; Gale NW, 1996, NEURON, V17, P9, DOI 10.1016/S0896-6273(00)80276-7; GILARDIHEBENSTREIT P, 1992, ONCOGENE, V7, P2499; Imondi R, 2001, DEVELOPMENT, V128, P4859; Job C, 2001, NAT REV NEUROSCI, V2, P889, DOI 10.1038/35104069; Kaprielian Z, 2001, DEV DYNAM, V221, P154, DOI 10.1002/dvdy.1143; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; KOENIG E, 1967, J NEUROCHEM, V14, P437, DOI 10.1111/j.1471-4159.1967.tb09542.x; Koenig E, 2000, J NEUROSCI, V20, P8390, DOI 10.1523/JNEUROSCI.20-22-08390.2000; Kullander K, 2001, NEURON, V29, P73, DOI 10.1016/S0896-6273(01)00181-7; LINDBERG RA, 1990, MOL CELL BIOL, V10, P6316, DOI 10.1128/MCB.10.12.6316; Lodish H, 2000, MOL CELL BIOL, V4; Lu Q, 2001, CELL, V105, P69, DOI 10.1016/S0092-8674(01)00297-5; Magal E, 1996, J NEUROSCI RES, V43, P735, DOI 10.1002/(SICI)1097-4547(19960315)43:6<735::AID-JNR10>3.0.CO;2-X; MANOIL C, 1990, J BACTERIOL, V172, P515, DOI 10.1128/jb.172.2.515-518.1990; Martin KC, 2000, CURR OPIN NEUROBIOL, V10, P587, DOI 10.1016/S0959-4388(00)00128-8; Mendez R, 2000, NATURE, V404, P302, DOI 10.1038/35005126; Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745; Rajagopalan S, 2000, CELL, V103, P1033, DOI 10.1016/S0092-8674(00)00207-5; Richter JD, 1999, MICROBIOL MOL BIOL R, V63, P446, DOI 10.1128/MMBR.63.2.446-456.1999; SCHWARTZ JH, 2000, PRINCIPLES NEURAL SC, P88; SHAW G, 1977, EXP CELL RES, V104, P55, DOI 10.1016/0014-4827(77)90068-4; SILOSSANTIAGO I, 1992, J COMP NEUROL, V325, P514, DOI 10.1002/cne.903250405; Simpson JH, 2000, CELL, V103, P1019, DOI 10.1016/S0092-8674(00)00206-3; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Spencer GE, 2000, J NEUROBIOL, V44, P72, DOI 10.1002/1097-4695(200007)44:1<72::AID-NEU7>3.0.CO;2-#; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; STOECKLI ET, 1995, NEURON, V14, P1165, DOI 10.1016/0896-6273(95)90264-3; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; TANAKA E, 1995, CELL, V83, P171, DOI 10.1016/0092-8674(95)90158-2; Terskikh A, 2000, SCIENCE, V290, P1585, DOI 10.1126/science.290.5496.1585; Teruel MN, 1999, J NEUROSCI METH, V93, P37, DOI 10.1016/S0165-0270(99)00112-0; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wells DG, 2000, CURR OPIN NEUROBIOL, V10, P132, DOI 10.1016/S0959-4388(99)00050-1; Wickens M, 2000, COLD SPRING HARBOR M, V39, P295; Yokoyama N, 2001, NEURON, V29, P85, DOI 10.1016/S0896-6273(01)00182-9; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	55	323	332	2	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 26	2002	110	2					223	235		10.1016/S0092-8674(02)00813-9	http://dx.doi.org/10.1016/S0092-8674(02)00813-9			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	578EV	12150930	Bronze			2022-12-24	WOS:000177105200010
J	Stracker, TH; Carson, CT; Weitzman, MD				Stracker, TH; Carson, CT; Weitzman, MD			Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex	NATURE			English	Article							NIJMEGEN BREAKAGE SYNDROME; LATE GENE-EXPRESSION; EARLY REGION-4; PROTEIN COMPLEX; DAMAGE RESPONSE; REPLICATION; MRE11; TELOMERES; PHOSPHORYLATION; DELETION	In mammalian cells, a conserved multiprotein complex of Mre11, Rad50 and NBS1 (also known as nibrin and p95) is important for double-strand break repair, meiotic recombination and telomere maintenance(1-4). This complex forms nuclear foci and may be a sensor of double-strand breaks. In the absence of the early region E4, the double-stranded DNA genome of adenovirus is joined into concatemers too large to be packaged(5,6). We have investigated the cellular proteins involved in this concatemer formation and how they are inactivated by E4 products during a wild-type infection. Here we show that concatemerization requires functional Mre11 and NBS1, and that these proteins are found at foci adjacent to viral replication centres. Infection with wild-type virus results in both reorganization and degradation of members of the Mre11-Rad50-NBS1 complex. These activities are mediated by three viral oncoproteins that prevent concatemerization. This targeting of cellular proteins involved in genomic stability suggests a mechanism for 'hit-and-run' transformation observed for these viral oncoproteins(7).	Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; Univ Calif San Diego, Dept Biol, Grad Program, San Diego, CA 92093 USA	Salk Institute; University of California System; University of California San Diego	Weitzman, MD (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Stracker, Travis H/I-2815-2015	Stracker, Travis H/0000-0002-8650-2081				Boyer J, 1999, VIROLOGY, V263, P307, DOI 10.1006/viro.1999.9866; Bressan DA, 1998, GENETICS, V150, P591; BRIDGE E, 1989, J VIROL, V63, P631, DOI 10.1128/JVI.63.2.631-638.1989; BRIDGE E, 1990, VIROLOGY, V174; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Cathomen T, 2000, J VIROL, V74, P11407, DOI 10.1128/JVI.74.23.11407-11412.2000; DEVRIES E, 1989, J MOL BIOL, V208, P65, DOI 10.1016/0022-2836(89)90088-0; Doucas V, 1996, GENE DEV, V10, P196, DOI 10.1101/gad.10.2.196; Gatei M, 2000, NAT GENET, V25, P115, DOI 10.1038/75508; Haber JE, 1998, CELL, V95, P583, DOI 10.1016/S0092-8674(00)81626-8; Haber JE, 1997, CELL, V89, P163, DOI 10.1016/S0092-8674(00)80194-4; HALBERT DN, 1985, J VIROL, V56, P250, DOI 10.1128/JVI.56.1.250-257.1985; Lombard DB, 2000, CANCER RES, V60, P2331; Maser RS, 2001, MOL CELL BIOL, V21, P6006, DOI 10.1128/MCB.21.17.6006-6016.2001; Moreau S, 1999, MOL CELL BIOL, V19, P556; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Nelms BE, 1998, SCIENCE, V280, P590, DOI 10.1126/science.280.5363.590; Nevels M, 2001, J VIROL, V75, P3089, DOI 10.1128/JVI.75.7.3089-3094.2001; Petrini JHJ, 1999, AM J HUM GENET, V64, P1264, DOI 10.1086/302391; Querido E, 2001, GENE DEV, V15, P3104, DOI 10.1101/gad.926401; Riballo E, 1999, CURR BIOL, V9, P699, DOI 10.1016/S0960-9822(99)80311-X; WEIDEN MD, 1994, P NATL ACAD SCI USA, V91, P153, DOI 10.1073/pnas.91.1.153; WEINBERG DH, 1986, J VIROL, V57, P833, DOI 10.1128/JVI.57.3.833-838.1986; WEINBERG DH, 1983, P NATL ACAD SCI-BIOL, V80, P5383, DOI 10.1073/pnas.80.17.5383; Weitzman MD, 1996, J VIROL, V70, P1845, DOI 10.1128/JVI.70.3.1845-1854.1996; Wu GK, 2000, J BIOL CHEM, V275, P30618, DOI 10.1074/jbc.C000390200; Wu XH, 2000, NATURE, V405, P477, DOI 10.1038/35013089; Zhao S, 2000, NATURE, V405, P473, DOI 10.1038/35013083; Zhu XD, 2000, NAT GENET, V25, P347, DOI 10.1038/77139	29	416	422	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 18	2002	418	6895					348	352		10.1038/nature00863	http://dx.doi.org/10.1038/nature00863			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574BF	12124628				2022-12-24	WOS:000176868000048
J	Gagnon, E; Duclos, S; Rondeau, C; Chevet, E; Cameron, PH; Steele-Mortimer, O; Paiement, J; Bergeron, JJM; Desjardins, M				Gagnon, E; Duclos, S; Rondeau, C; Chevet, E; Cameron, PH; Steele-Mortimer, O; Paiement, J; Bergeron, JJM; Desjardins, M			Endoplasmic reticulum-mediated phagocytosis is a mechanism of entry into macrophages	CELL			English	Article							ISOLATED RAT HEPATOCYTES; LEGIONELLA-PNEUMOPHILA; PHOSPHATIDYLINOSITOL 3-KINASE; MATURING PHAGOSOMES; CONTAINING VACUOLES; IN-VITRO; MATURATION; FUSION; CALRETICULIN; CELLS	Phagocytosis is a key aspect of our innate ability to fight infectious diseases. In this study, we have found that fusion of the endoplasmic reticulum (ER) with the macrophage plasmalemma, underneath phagocytic cups, is a source of membrane for phagosome formation in macrophages. Successive waves of ER become associated with maturing phagosomes during phagolysosome biogenesis. Thus, the ER appears to possess unexpectedly pluripotent fusion properties. ER-mediated phagocytosis is regulated in part by phosphatidylinositol 3-kinase and used for the internalization of inert particles and intracellular pathogens, regardless of their final trafficking in the host. In neutrophils, where pathogens are rapidly killed, the ER is not used as a major source of membrane for phagocytosis. We propose that intracellular pathogens have evolved to adapt and exploit ER-mediated phagocytosis to avoid destruction in host cells.	Univ Montreal, Dept Pathol & Biol Cellulaire, Montreal, PQ H3C 3J7, Canada; McGill Univ, Dept Surg, Montreal, PQ H3A 2T5, Canada; McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2T5, Canada; NIAID, Rocky Mt Labs, Intracellular Parasites Lab, Hamilton, MT 59840 USA; Caprion Pharmaceut Inc, Montreal, PQ, Canada	Universite de Montreal; McGill University; McGill University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Desjardins, M (corresponding author), Univ Montreal, Dept Pathol & Biol Cellulaire, Montreal, PQ H3C 3J7, Canada.		Bergeron, John/AAW-1893-2021; chevet, eric/E-4992-2016	chevet, eric/0000-0001-5855-4522; Desjardins, Michel/0000-0002-5684-5980	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000918] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; ANDERSON TD, 1986, AM J PATHOL, V124, P226; BIDANI A, 1995, J LEUKOCYTE BIOL, V57, P275, DOI 10.1002/jlb.57.2.275; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Botelho RJ, 2000, J CELL BIOL, V151, P1353, DOI 10.1083/jcb.151.7.1353; CANNON GJ, 1992, J CELL SCI, V101, P907; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; Cougoule C, 2002, INFECT IMMUN, V70, P1591, DOI 10.1128/IAI.70.3.1591-1598.2002; Cox D, 1999, J BIOL CHEM, V274, P1240, DOI 10.1074/jbc.274.3.1240; Dermine JF, 2001, J BIOL CHEM, V276, P18507, DOI 10.1074/jbc.M101113200; Desjardins M, 1997, J CELL SCI, V110, P2303; DESJARDINS M, 1995, TRENDS CELL BIOL, V5, P183, DOI 10.1016/S0962-8924(00)88989-8; DESJARDINS M, 1994, J BIOL CHEM, V269, P32194; DESJARDINS M, 1994, J CELL BIOL, V124, P677, DOI 10.1083/jcb.124.5.677; Diakonova M, 2002, MOL BIOL CELL, V13, P402, DOI 10.1091/mbc.01-05-0273; Duclos S, 2000, J CELL SCI, V113, P3531; Garin J, 2001, J CELL BIOL, V152, P165, DOI 10.1083/jcb.152.1.165; Gold ES, 2000, IMMUNITY, V12, P285, DOI 10.1016/S1074-7613(00)80181-8; GRIFFITHS G, 1983, J CELL BIOL, V96, P835, DOI 10.1083/jcb.96.3.835; Hackam DJ, 1998, P NATL ACAD SCI USA, V95, P11691, DOI 10.1073/pnas.95.20.11691; HEINE JW, 1971, J CELL BIOL, V48, P703, DOI 10.1083/jcb.48.3.703; HORWITZ MA, 1983, J EXP MED, V158, P1319, DOI 10.1084/jem.158.4.1319; Jahraus A, 1998, J BIOL CHEM, V273, P30379, DOI 10.1074/jbc.273.46.30379; Johnson S, 2001, TRENDS CELL BIOL, V11, P122, DOI 10.1016/S0962-8924(01)01926-2; Kakimura J, 2001, BIOCHEM BIOPH RES CO, V281, P6, DOI 10.1006/bbrc.2001.4299; KATZ SM, 1982, LAB INVEST, V46, P24; Kleijmeer MJ, 2001, TRAFFIC, V2, P124, DOI 10.1034/j.1600-0854.2001.020207.x; Lafont F, 1999, P NATL ACAD SCI USA, V96, P3734, DOI 10.1073/pnas.96.7.3734; Laufs H, 2002, INFECT IMMUN, V70, P826, DOI 10.1128/IAI.70.2.826-835.2002; Lavoie C, 2000, P NATL ACAD SCI USA, V97, P13637, DOI 10.1073/pnas.240278097; Massol P, 1998, EMBO J, V17, P6219, DOI 10.1093/emboj/17.21.6219; May RC, 2001, J CELL SCI, V114, P1061; Meresse S, 1997, ELECTROPHORESIS, V18, P2682, DOI 10.1002/elps.1150181425; Meresse S, 1999, NAT CELL BIOL, V1, pE183, DOI 10.1038/15620; Merhi Y, 1999, ARTERIOSCL THROM VAS, V19, P372, DOI 10.1161/01.ATV.19.2.372; Muller-Taubenberger A, 2001, EMBO J, V20, P6772, DOI 10.1093/emboj/20.23.6772; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Okazaki Y, 2000, J BIOL CHEM, V275, P35751, DOI 10.1074/jbc.M007476200; OLAFSON RW, 1990, J BIOL CHEM, V265, P12240; OU WJ, 1993, NATURE, V364, P771, DOI 10.1038/364771a0; PAIEMENT J, 1983, J CELL BIOL, V96, P1791, DOI 10.1083/jcb.96.6.1791; PAIEMENT J, 1988, J HISTOCHEM CYTOCHEM, V36, P441, DOI 10.1177/36.4.2450122; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; PITT A, 1992, J CLIN INVEST, V90, P1978, DOI 10.1172/JCI116077; Pizarro-Cerda J, 1998, INFECT IMMUN, V66, P5711; ROKEACH LA, 1991, PROTEIN ENG, V4, P981, DOI 10.1093/protein/4.8.981; Scianimanico S, 1999, CELL MICROBIOL, V1, P19, DOI 10.1046/j.1462-5822.1999.00002.x; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Steele-Mortimer O, 1999, CELL MICROBIOL, V1, P33, DOI 10.1046/j.1462-5822.1999.00003.x; SWANSON MS, 1995, INFECT IMMUN, V63, P3609, DOI 10.1128/IAI.63.9.3609-3620.1995; TARDIEUX I, 1992, CELL, V71, P1117, DOI 10.1016/S0092-8674(05)80061-3; Tilney LG, 2001, J CELL SCI, V114, P4637; VICKER MG, 1977, EXP CELL RES, V109, P127, DOI 10.1016/0014-4827(77)90052-0; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; Whatmore J, 1999, BIOCHEM J, V341, P435, DOI 10.1042/0264-6021:3410435; Zapun A, 1999, STRUCT FOLD DES, V7, pR173, DOI 10.1016/S0969-2126(99)80112-9	56	536	553	2	27	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 12	2002	110	1					119	131		10.1016/S0092-8674(02)00797-3	http://dx.doi.org/10.1016/S0092-8674(02)00797-3			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	573PU	12151002	Bronze			2022-12-24	WOS:000176840700012
J	Jensen, T; van de Bildt, M; Dietz, HH; Andersen, TH; Hammer, AS; Kuiken, T; Osterhaus, A				Jensen, T; van de Bildt, M; Dietz, HH; Andersen, TH; Hammer, AS; Kuiken, T; Osterhaus, A			Another phocine distemper outbreak in Europe	SCIENCE			English	Article							VIRUS		Seal Rehabil & Res Ctr, NL-9968 AG Pieterburen, Netherlands; Danish Vet Inst, DK-8200 Aarhus N, Denmark; Erasmus MC, Inst Virol, NL-3015 GE Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Jensen, T (corresponding author), Seal Rehabil & Res Ctr, Hoofdstr 94A, NL-9968 AG Pieterburen, Netherlands.			Osterhaus, Albert/0000-0002-6074-1172				BARRETT T, 1993, VIROLOGY, V193, P1010, DOI 10.1006/viro.1993.1217; COSBY SL, 1988, NATURE, V336, P115, DOI 10.1038/336115b0; DIETZ R, 1989, AMBIO, V18, P258; GRENFELL BT, 1992, SCI TOTAL ENVIRON, V115, P15, DOI 10.1016/0048-9697(92)90029-R; OSTERHAUS ADME, 1988, NATURE, V335, P20, DOI 10.1038/335020a0; OSTERHAUS ADME, 1989, NATURE, V337, P21, DOI 10.1038/337021a0; REINEKING B, 2002, COMMON WADDEN S 0619; TOUGAARD S, 2000, WADDEN SEA NEWSL, P29	8	119	126	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 12	2002	297	5579					209	209		10.1126/science.1075343	http://dx.doi.org/10.1126/science.1075343			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	571UT	12114617	Green Submitted			2022-12-24	WOS:000176738100030
J	Kerr, B; Riley, MA; Feldman, MW; Bohannan, BJM				Kerr, B; Riley, MA; Feldman, MW; Bohannan, BJM			Local dispersal promotes biodiversity in a real-life game of rock-paper-scissors	NATURE			English	Article							ESCHERICHIA-COLI; BACTERIA; ALLELOPATHY; POPULATIONS; COMPETITION; EVOLUTION; DYNAMICS; RESISTANCE; DIVERSITY; PLANKTON	One of the central aims of ecology is to identify mechanisms that maintain biodiversity(1,2). Numerous theoretical models have shown that competing species can coexist if ecological processes such as dispersal, movement, and interaction occur over small spatial scales(1-10). In particular, this may be the case for nontransitive communities, that is, those without strict competitive hierarchies(3,6,8,11). The classic non-transitive system involves a community of three competing species satisfying a relationship similar to the children's game rock-paper-scissors, where rock crushes scissors, scissors cuts paper, and paper covers rock. Such relationships have been demonstrated in several natural systems(12-14). Some models predict that local interaction and dispersal are sufficient to ensure coexistence of all three species in such a community, whereas diversity is lost when ecological processes occur over larger scales(6,8). Here, we test these predictions empirically using a non-transitive model community containing three populations of Escherichia coli. We find that diversity is rapidly lost in our experimental community when dispersal and interaction occur over relatively large spatial scales, whereas all populations coexist when ecological processes are localized.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06511 USA	Stanford University; Yale University	Kerr, B (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.		Bohannan, Brendan J. M./R-1582-2017; Riley, Margaret Ann/AAB-9743-2022	Bohannan, Brendan J. M./0000-0003-2907-1016; 				ADAMS J, 1979, GENETICS, V91, P627; Bohannan BJM, 2000, ECOL LETT, V3, P362, DOI 10.1046/j.1461-0248.2000.00161.x; BUSS LW, 1979, AM NAT, V113, P223, DOI 10.1086/283381; CHAO L, 1981, P NATL ACAD SCI-BIOL, V78, P6324, DOI 10.1073/pnas.78.10.6324; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Czaran TL, 2002, P NATL ACAD SCI USA, V99, P786, DOI 10.1073/pnas.012399899; Dieckmann U., 2000, GEOMETRY ECOLOGICAL; DURRETT R, 1994, THEOR POPUL BIOL, V46, P363, DOI 10.1006/tpbi.1994.1032; Durrett R, 1997, J THEOR BIOL, V185, P165, DOI 10.1006/jtbi.1996.0292; Feldgarden M, 1998, EVOLUTION, V52, P1270, DOI 10.1111/j.1558-5646.1998.tb02008.x; Feldgarden M, 1999, EVOLUTION, V53, P1019, DOI 10.1111/j.1558-5646.1999.tb04517.x; FRANK SA, 1994, EVOL ECOL, V8, P369, DOI 10.1007/BF01238189; Frean M, 2001, P ROY SOC B-BIOL SCI, V268, P1323, DOI 10.1098/rspb.2001.1670; Gordon DM, 1999, MICROBIOL-SGM, V145, P655, DOI 10.1099/13500872-145-3-655; HASSELL MP, 1994, NATURE, V370, P290, DOI 10.1038/370290a0; Huisman J, 1999, NATURE, V402, P407, DOI 10.1038/46540; Huisman J, 2001, ECOL LETT, V4, P408, DOI 10.1046/j.1461-0248.2001.00256.x; Iwasa Y, 1998, EVOL ECOL, V12, P785, DOI 10.1023/A:1006590431483; James R, 1996, MICROBIOL-SGM, V142, P1569, DOI 10.1099/13500872-142-7-1569; KORONA R, 1994, P NATL ACAD SCI USA, V91, P9037, DOI 10.1073/pnas.91.19.9037; Nakamaru M, 2000, THEOR POPUL BIOL, V57, P131, DOI 10.1006/tpbi.1999.1448; Pagie L, 1999, J THEOR BIOL, V196, P251, DOI 10.1006/jtbi.1998.0838; PAQUIN CE, 1983, NATURE, V306, P368, DOI 10.1038/306368a0; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Rice EL, 1984, ALLELOPATHY; Riley MA, 1999, TRENDS MICROBIOL, V7, P129, DOI 10.1016/S0966-842X(99)01459-6; Rohani P, 1997, TRENDS ECOL EVOL, V12, P70, DOI 10.1016/S0169-5347(96)20103-X; Sinervo B, 1996, NATURE, V380, P240, DOI 10.1038/380240a0; Tilman D., 1997, SPATIAL ECOLOGY ROLE; Tilman David, 1993, P13	30	1075	1092	5	297	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 11	2002	418	6894					171	174		10.1038/nature00823	http://dx.doi.org/10.1038/nature00823			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	571GV	12110887				2022-12-24	WOS:000176710400037
J	Du, YCN; Stillman, B				Du, YCN; Stillman, B			Yph1p, an ORC-interacting protein: Potential links between cell proliferation control, DNA replication, and ribosome biogenesis	CELL			English	Article							ORIGIN RECOGNITION COMPLEX; SACCHAROMYCES-CEREVISIAE; PHOSPHATASE YVH1P; GENE-EXPRESSION; YEAST GENE; INITIATION; CYCLE; TRANSLATION; PESCADILLO; GROWTH	Immunoprecipitation of the origin recognition complex (ORC) from yeast extracts identified Yph1p, an essential protein containing a BRCT domain. Two Yph1p complexes were characterized. Besides ORC, MCM proteins, cell-cycle regulatory proteins, checkpoint proteins, 60S ribosomal proteins, and preribosome particle proteins were found to be associated with Yph1p. Yph1p is predominantly nucleolar and is required for 60S ribosomal subunit biogenesis and possibly for translation on polysomes. Proliferating cells depleted of Yph1p arrest in G(1) or G(2), with no cells in S phase, or significantly delay S phase progression after release from a hydroxyurea arrest. Yph1p levels decline as cells commit to exit the cell cycle, and levels vary depending on energy source. Yph1p may link cell proliferation control to DNA replication, ribosome biogenesis, and translation on polysomes.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Stillman, B (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	stiliman@cshl.org		Stillman, Bruce/0000-0002-9453-4091	NIGMS NIH HHS [R01 GM045436, GM45436] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045436] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams CC, 2002, RNA, V8, P150, DOI 10.1017/S1355838202010026; Allende ML, 1996, GENE DEV, V10, P3141, DOI 10.1101/gad.10.24.3141; AMBERG DC, 1995, YEAST, V11, P1275, DOI 10.1002/yea.320111307; BAIM SB, 1985, MOL CELL BIOL, V5, P1839, DOI 10.1128/MCB.5.8.1839; Bassler J, 2001, MOL CELL, V8, P517, DOI 10.1016/S1097-2765(01)00342-2; Basu U, 2001, MOL CELL BIOL, V21, P1453, DOI 10.1128/MCB.21.5.1453-1462.2001; Beeser AE, 2000, J BACTERIOL, V182, P3517, DOI 10.1128/JB.182.12.3517-3528.2000; BELL SP, 1993, SCIENCE, V262, P1844, DOI 10.1126/science.8266072; BELL SP, 1995, CELL, V83, P563, DOI 10.1016/0092-8674(95)90096-9; Charpentier AH, 2000, CANCER RES, V60, P5977; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Dillin A, 1998, SCIENCE, V279, P1733, DOI 10.1126/science.279.5357.1733; Dutta A, 1997, ANNU REV CELL DEV BI, V13, P293, DOI 10.1146/annurev.cellbio.13.1.293; ENGBERG J, 1985, EUR J CELL BIOL, V36, P133; Haber JE, 1998, ANNU REV GENET, V32, P561, DOI 10.1146/annurev.genet.32.1.561; Harnpicharnchai P, 2001, MOL CELL, V8, P505, DOI 10.1016/S1097-2765(01)00344-6; Hodges PE, 1999, NUCLEIC ACIDS RES, V27, P69, DOI 10.1093/nar/27.1.69; Jager S, 2001, EMBO J, V20, P4423, DOI 10.1093/emboj/20.16.4423; Kelly TJ, 2000, ANNU REV BIOCHEM, V69, P829, DOI 10.1146/annurev.biochem.69.1.829; KEM SE, 1991, SCIENCE, V252, P1708; Kennedy BK, 2000, GENE DEV, V14, P2855, DOI 10.1101/gad.842600; Kinoshita Y, 2001, J BIOL CHEM, V276, P6656, DOI 10.1074/jbc.M008536200; Kobayashi T, 1996, GENES CELLS, V1, P465, DOI 10.1046/j.1365-2443.1996.d01-256.x; Kondoh H, 2000, GENES CELLS, V5, P525, DOI 10.1046/j.1365-2443.2000.00344.x; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Liang C, 1997, GENE DEV, V11, P3375, DOI 10.1101/gad.11.24.3375; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; MARECHAL V, 1994, MOL CELL BIOL, V14, P7414, DOI 10.1128/MCB.14.11.7414; MILLER SD, 1995, MOL CELL BIOL, V15, P6554; NORBURY C, 1992, ANNU REV BIOCHEM, V61, P441, DOI 10.1146/annurev.bi.61.070192.002301; Olson MOJ, 2000, TRENDS CELL BIOL, V10, P189, DOI 10.1016/S0962-8924(00)01738-4; Pak DTS, 1997, CELL, V91, P311, DOI 10.1016/S0092-8674(00)80415-8; Pestov DG, 2001, MOL CELL BIOL, V21, P4246, DOI 10.1128/MCB.21.13.4246-4255.2001; Pestov DG, 2001, NUCLEIC ACIDS RES, V29, P3621, DOI 10.1093/nar/29.17.3621; Racevskis J, 1996, CELL GROWTH DIFFER, V7, P271; RIVIN CJ, 1980, J CELL BIOL, V85, P96, DOI 10.1083/jcb.85.1.96; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; SAFFER LD, 1986, MOL CELL BIOL, V6, P1148, DOI 10.1128/MCB.6.4.1148; Sakumoto N, 2001, BIOCHEM BIOPH RES CO, V289, P608, DOI 10.1006/bbrc.2001.6021; Saveanu C, 2001, EMBO J, V20, P6475, DOI 10.1093/emboj/20.22.6475; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Senger B, 2001, MOL CELL, V8, P1363, DOI 10.1016/S1097-2765(01)00403-8; STARK GR, 1984, ANNU REV BIOCHEM, V53, P447, DOI 10.1146/annurev.bi.53.070184.002311; Strezoska Z, 2000, MOL CELL BIOL, V20, P5516, DOI 10.1128/MCB.20.15.5516-5528.2000; Tao WK, 1999, P NATL ACAD SCI USA, V96, P6937, DOI 10.1073/pnas.96.12.6937; TOLLERVEY D, 1993, CELL, V72, P443, DOI 10.1016/0092-8674(93)90120-F; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Wade C, 2001, MOL CELL BIOL, V21, P8638, DOI 10.1128/MCB.21.24.8638-8650.2001; WARD MP, 1994, MOL CELL BIOL, V14, P5619, DOI 10.1128/MCB.14.9.5619; Warner JR, 2001, CELL, V107, P133, DOI 10.1016/S0092-8674(01)00531-1; Weinberger M, 1999, J BIOL CHEM, V274, P35975, DOI 10.1074/jbc.274.50.35975; Wood LC, 1999, J BIOL CHEM, V274, P11653, DOI 10.1074/jbc.274.17.11653	53	151	155	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 28	2002	109	7					835	848		10.1016/S0092-8674(02)00773-0	http://dx.doi.org/10.1016/S0092-8674(02)00773-0			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	570KJ	12110181	Bronze			2022-12-24	WOS:000176657200007
J	Crawford, LM				Crawford, LM			Drug for colorectal cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commissioner Food & Drugs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Crawford, LM (corresponding author), US FDA, Off Commissioner Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 11	2002	288	10					1225	1225		10.1001/jama.288.10.1225	http://dx.doi.org/10.1001/jama.288.10.1225			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592BW	12215114				2022-12-24	WOS:000177917700005
J	Baker, DN				Baker, DN			How to cope with space weather	SCIENCE			English	Editorial Material									Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Baker, DN (corresponding author), Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80309 USA.							Baker DN, 1998, ADV SPACE RES, V22, P7, DOI 10.1016/S0273-1177(97)01095-8; BAKER DN, 1998, EOS T AGU, V79, P477, DOI [10.1029/98EO00359, DOI 10.1029/98E000359]; BROOKS J, 1959, NEW YORKER MAGA 0207, P39; Carlowicz M.J., 2002, STORMS SUN; Kappenman J. G., 2001, NATO ASI BOOK SPACE, V38, P335; Lanzerotti LJ, 2001, GEOPHYS MONOGR SER, V125, P11; *NOAA, 1995, NAT SPAC WEATH PROGR; Robinson RM, 2001, GEOPH MONOG SERIES, V125, P1; Singer HJ, 2001, GEOPH MONOG SERIES, V125, P23; Turner R, 2000, IEEE T PLASMA SCI, V28, P2103, DOI 10.1109/27.902237; Withbroe GL, 2001, GEOPH MONOG SERIES, V125, P45	11	150	160	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 30	2002	297	5586					1486	1487		10.1126/science.1074956	http://dx.doi.org/10.1126/science.1074956			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588JA	12202809				2022-12-24	WOS:000177697300035
J	Takahashi, N; Kishimoto, T; Nemoto, T; Kadowaki, T; Kasai, H				Takahashi, N; Kishimoto, T; Nemoto, T; Kadowaki, T; Kasai, H			Fusion pore dynamics and insulin granule exocytosis in the pancreatic islet	SCIENCE			English	Article							MOTOR-NERVE TERMINALS; MEMBRANE-FUSION; SECRETORY GRANULE; BETA-CELLS; FLUORESCENCE MICROSCOPY; MAST-CELLS; VESICLE; RELEASE; PROTEIN	Insulin secretion from intact mouse pancreatic islets was investigated with two-photon excitation imaging. Insulin granule exocytosis occurred mainly toward the interstitial space, away from blood vessels. The fusion pore was unusually stable with a lifetime of 1.8 seconds. Opening of the 1.4-nanometer-diameter pore was preceded by unrestricted lateral diffusion of lipids along the inner wall of the pore, supporting the idea that this structure is composed of membrane lipids. When the pore dilated to 12 nanometers, the granules rapidly flattened and discharged their contents. Thus, our methodology reveals fusion pore dynamics in intact tissues at nanometer resolution.	Natl Inst Physiol Sci, Dept Cell Physiol, Okazaki, Aichi 4448585, Japan; Grad Univ Adv Studies, Okazaki, Aichi 4448585, Japan; Univ Tokyo, Grad Sch Med, Dept Metab Dis, Bunkyo Ku, Tokyo 1138655, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan; University of Tokyo	Kasai, H (corresponding author), Natl Inst Physiol Sci, Dept Cell Physiol, Okazaki, Aichi 4448585, Japan.		Nemoto, Tomomi/B-4412-2012	Nemoto, Tomomi/0000-0001-6102-1495; Kasai, Haruo/0000-0003-2327-9027				Barg S, 2002, NEURON, V33, P287, DOI 10.1016/S0896-6273(02)00563-9; Bennett M V, 1992, Semin Cell Biol, V3, P29; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; BONNERWEIR S, 1988, DIABETES, V37, P616, DOI 10.2337/diabetes.37.5.616; BRECKENRIDGE LJ, 1987, NATURE, V328, P814, DOI 10.1038/328814a0; CHANDLER DE, 1980, J CELL BIOL, V86, P666, DOI 10.1083/jcb.86.2.666; Chanturiya A, 1997, P NATL ACAD SCI USA, V94, P14423, DOI 10.1073/pnas.94.26.14423; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; DETOLEDO GA, 1993, NATURE, V363, P554, DOI 10.1038/363554a0; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; Eto K, 1999, SCIENCE, V283, P981, DOI 10.1126/science.283.5404.981; Fujiwara T, 2002, J CELL BIOL, V157, P1071, DOI 10.1083/jcb.200202050; Henkel AW, 1996, P NATL ACAD SCI USA, V93, P1918, DOI 10.1073/pnas.93.5.1918; HUTTON JC, 1989, DIABETOLOGIA, V32, P271, DOI 10.1007/BF00265542; INTVELD PA, 1984, DIABETES, V33, P101, DOI 10.2337/diabetes.33.1.101; Ioan CE, 2000, MACROMOLECULES, V33, P5730, DOI 10.1021/ma000282n; Kahn CR, 1994, JOSLINS DIABETES MEL; Kanaseki T, 1997, J CELL BIOL, V137, P1041, DOI 10.1083/jcb.137.5.1041; MONCK JR, 1990, P NATL ACAD SCI USA, V87, P7804, DOI 10.1073/pnas.87.20.7804; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Nemoto T, 2001, NAT CELL BIOL, V3, P253, DOI 10.1038/35060042; ORCI L, 1987, NATURE, V326, P77, DOI 10.1038/326077a0; ORCI L, 1973, SCIENCE, V179, P82, DOI 10.1126/science.179.4068.82; PIPELEERS DG, 1992, DIABETES, V41, P777, DOI 10.2337/diabetes.41.7.777; Plattner H, 1997, J CELL BIOL, V139, P1709, DOI 10.1083/jcb.139.7.1709; Qian WJ, 2000, ANAL CHEM, V72, P711, DOI 10.1021/ac991085t; Takahashi N, 1999, P NATL ACAD SCI USA, V96, P760, DOI 10.1073/pnas.96.2.760; Takahashi N, 1997, J CELL BIOL, V138, P55, DOI 10.1083/jcb.138.1.55; Takahashi N, 2002, DIABETES, V51, pS25, DOI 10.2337/diabetes.51.2007.S25; TSE FW, 1993, J CELL BIOL, V121, P543, DOI 10.1083/jcb.121.3.543; Zhou Z, 1996, BIOPHYS J, V70, P1543, DOI 10.1016/S0006-3495(96)79718-7; Zimmerberg J, 2001, TRENDS CELL BIOL, V11, P233, DOI 10.1016/S0962-8924(01)02003-7; ZIMMERBERG J, 1987, P NATL ACAD SCI USA, V84, P1585, DOI 10.1073/pnas.84.6.1585	34	220	226	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 23	2002	297	5585					1349	1352		10.1126/science.1073806	http://dx.doi.org/10.1126/science.1073806			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FL	12193788				2022-12-24	WOS:000177573900048
J	Shao, ZZ; Vollrath, F				Shao, ZZ; Vollrath, F			Materials: Surprising strength of silkworm silk	NATURE			English	Article									Fudan Univ, Dept Macromol Sci, Shanghai 200433, Peoples R China; Fudan Univ, Key Lab Polymer Engn Educ Minist, Shanghai 200433, Peoples R China; Univ Oxford, Dept Zool, Oxford OX1 PX3, England	Fudan University; Fudan University; University of Oxford	Shao, ZZ (corresponding author), Fudan Univ, Dept Macromol Sci, Shanghai 200433, Peoples R China.			Vollrath, Fritz/0000-0003-3484-9005				Kaplan D.L., 1994, SILK POLYM MAT SCI B; Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780; Miura Mikihiko, 1998, Journal of Sericultural Science of Japan, V67, P51; Monti P, 1998, J RAMAN SPECTROSC, V29, P297, DOI 10.1002/(SICI)1097-4555(199804)29:4<297::AID-JRS240>3.0.CO;2-G; Perez-Rigueiro J, 2000, POLYMER, V41, P8433, DOI 10.1016/S0032-3861(00)00179-8; Perez-Rigueiro J, 2001, J APPL POLYM SCI, V82, P1928, DOI 10.1002/app.2038; Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000; VOLLRATH F, 2001, Z P R SOC LOND B, V268, P2339; Wiedbrauck J., 1955, Zeitschrift fuer Tierpsychologie Berlin, V12, P176; Wilding M.A., 1996, POLYM MAT ENCY, V11, P8307	10	725	769	30	547	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 15	2002	418	6899					741	741		10.1038/418741a	http://dx.doi.org/10.1038/418741a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UF	12181556				2022-12-24	WOS:000177428000028
J	Kochel, TJ; Watts, DM; Halstead, SB; Hayes, CG; Espinoza, A; Felices, V; Caceda, R; Bautista, CT; Montoya, Y; Douglas, S; Russe, KL				Kochel, TJ; Watts, DM; Halstead, SB; Hayes, CG; Espinoza, A; Felices, V; Caceda, R; Bautista, CT; Montoya, Y; Douglas, S; Russe, KL			Effect of dengue-1 antibodies on American dengue-2 viral infection and dengue haemorrhagic fever	LANCET			English	Article							VIRUSES	In Iquitos, Peru, no cases of dengue haemorrhagic fever have been recorded in individuals infected with dengue-1 virus followed by American genotype dengue-2 (American dengue-2) virus. We assayed serum samples collected in Iquitos that tested positive for antibodies of monotype dengue-1 and monotype dengue-2 using a plaque reduction neutralisation test to determine their ability to neutralise the infectivity of two dengue-1 viruses, two American dengue-2 viruses, and two Asian dengue-2 viruses. Sera positive for the dengue-1 antibody neutralised dengue-1 viruses and American dengue-2 viruses much more effectively than Asian dengue-2 viruses. Neutralisation of American dengue-2 virus by sera positive for dengue-1 antibodies may account for the absence of dengue haemorrhagic fever in individuals infected with dengue-1 in 1990-91 followed by American dengue-2 virus in 1995 in Iquitos, Peru.	Naval Med Res Ctr Detachment, Dept Virol, Lima, Peru; Naval Med Res Ctr, Silver Spring, MD USA; Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; Peruvian Natl Inst Hlth, Lima, Peru	Naval Medical Research Center (NMRC); Uniformed Services University of the Health Sciences - USA; Instituto Nacional de Salud - Peru	Kochel, TJ (corresponding author), Amer Embassy Peru, NMRCD, Unit 3800, APO, AA 34031 USA.		Felices, Vidal/AAL-1717-2020; Bautista, Christian/B-2812-2011	Felices, Vidal/0000-0001-5336-7293; Bautista, Christian/0000-0002-1228-0754				LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Leitmeyer KC, 1999, J VIROL, V73, P4738, DOI 10.1128/JVI.73.6.4738-4747.1999; MORENS DM, 1985, J CLIN MICROBIOL, V22, P250, DOI 10.1128/JCM.22.2.250-254.1985; VORNDAM V, 1994, J VIROL METHODS, V48, P237, DOI 10.1016/0166-0934(94)90122-8; Watts DM, 1999, LANCET, V354, P1431, DOI 10.1016/S0140-6736(99)04015-5	5	118	128	1	17	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 27	2002	360	9329					310	312		10.1016/S0140-6736(02)09522-3	http://dx.doi.org/10.1016/S0140-6736(02)09522-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	578DT	12147378				2022-12-24	WOS:000177102700016
J	Chi, TH; Wan, M; Zhao, KJ; Taniuchi, I; Chen, L; Littman, DR; Crabtree, GR				Chi, TH; Wan, M; Zhao, KJ; Taniuchi, I; Chen, L; Littman, DR; Crabtree, GR			Reciprocal regulation of CD4/CD8 expression by SWI/SNF-like BAF complexes	NATURE			English	Article							CD4 GENE-EXPRESSION; T-CELL DEVELOPMENT; STOCHASTIC MECHANISM; CHROMATIN; LINEAGE; PROMOTER; SUBSETS; BRAHMA; YEAST	Thymic development produces two sub-lineages of T cells expressing either CD4 or CD8 co-receptors that assist antibody production and mediate cell killing, respectively. The mechanisms for mutually exclusive co-receptor expression remain poorly defined(1,2). We find that mutations in the high mobility group (HMG) domain of BAF57-a DNA-binding subunit of the mammalian SWI/SNF-like chromatin-remodelling BAF complexesor in the BAF complex ATPase subunit Brg, impair both CD4 silencing and CD8 activation. Brg is haploinsufficient for CD8 activation, but not for CD4 silencing, whereas BAF57 mutations preferentially impair CD4 silencing, pointing to target- and subunit-specific mechanisms of chromatin remodelling. BAF complexes directly bind the CD4 silencer, but the BAF57 HMG domain is dispensable for tethering BAF complexes to the CD4 silencer or other chromatin loci in vivo, or for remodelling reconstituted templates in vitro(3,4), suggesting that chromatin remodelling in vivo requires HMG-dependent DNA bending. These results indicate that BAF complexes contribute to lineage bifurcation by reciprocally regulating lineage-specific genes, reminiscent of the role of the yeast SWI/SNF complex in mediating mating-type switching(5,6)	Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Pathol & Dev Biol, Stanford, CA 94305 USA; NHLBI, Mol Immunol Lab, NIH, Bethesda, MD 20892 USA; NYU, Sch Med, Skirball Inst Biomol Med, Mol Pathogenesis Program, New York, NY 10016 USA; NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA	Howard Hughes Medical Institute; Stanford University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); New York University; Howard Hughes Medical Institute; New York University	Crabtree, GR (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Pathol & Dev Biol, Stanford, CA 94305 USA.		Taniuchi, Ichiro/N-6399-2015	Taniuchi, Ichiro/0000-0002-9853-9068				Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; DAVIS CB, 1993, CELL, V73, P237, DOI 10.1016/0092-8674(93)90226-G; Ellmeier W, 1999, ANNU REV IMMUNOL, V17, P523, DOI 10.1146/annurev.immunol.17.1.523; FUNGLEUNG WP, 1991, CELL, V65, P443, DOI 10.1016/0092-8674(91)90462-8; GODFREY DI, 1993, J IMMUNOL, V150, P4244; Klochendler-Yeivin A, 2000, EMBO REP, V1, P500, DOI 10.1093/embo-reports/kvd129; Leung RKM, 2001, NAT IMMUNOL, V2, P1167, DOI 10.1038/ni733; Liu R, 2001, CELL, V106, P309, DOI 10.1016/S0092-8674(01)00446-9; NAKAYAMA T, 1990, SCIENCE, V249, P1558, DOI 10.1126/science.2120773; Nie ZQ, 2000, MOL CELL BIOL, V20, P8879, DOI 10.1128/MCB.20.23.8879-8888.2000; Phelan ML, 1999, MOL CELL, V3, P247, DOI 10.1016/S1097-2765(00)80315-9; Reyes JC, 1998, EMBO J, V17, P6979, DOI 10.1093/emboj/17.23.6979; Robertson HG, 1997, AFR ENTOMOL, V5, P1; Sarafova SD, 1999, BRAZ J MED BIOL RES, V32, P785, DOI 10.1590/S0100-879X1999000700001; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; STERN M, 1984, J MOL BIOL, V178, P853, DOI 10.1016/0022-2836(84)90315-2; Sudarsanam P, 2000, TRENDS GENET, V16, P345, DOI 10.1016/S0168-9525(00)02060-6; TAMKUN JW, 1992, CELL, V68, P561, DOI 10.1016/0092-8674(92)90191-E; TEH HS, 1991, NATURE, V349, P241, DOI 10.1038/349241a0; Wang WD, 1998, P NATL ACAD SCI USA, V95, P492, DOI 10.1073/pnas.95.2.492; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5; Zou YR, 2001, NAT GENET, V29, P332, DOI 10.1038/ng750	23	199	205	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 11	2002	418	6894					195	199		10.1038/nature00876	http://dx.doi.org/10.1038/nature00876			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	571GV	12110891				2022-12-24	WOS:000176710400043
J	Lee, SK; Yu, SL; Prakash, L; Prakash, S				Lee, SK; Yu, SL; Prakash, L; Prakash, S			Requirement of yeast RAD2, a homolog of human XPG gene, for efficient RNA polymerase II transcription: Implications for Cockayne syndrome	CELL			English	Article							NUCLEOTIDE EXCISION-REPAIR; XERODERMA-PIGMENTOSUM PATIENTS; SACCHAROMYCES-CEREVISIAE; DNA-REPAIR; COUPLED REPAIR; 6-AZAURACIL SENSITIVITY; NUCLEASE ACTIVITY; ABASIC SITES; IN-VITRO; B GENE	In addition to xeroderma pigmentosum, mutations in the human XPG gene cause early onset Cockayne syndrome (CS). Here, we provide evidence for the involvement of RAD2, the S. cerevisiae counterpart of XPG, in promoting efficient RNA polymerase II transcription. Inactivation of RAD26, the S. cerevisiae counterpart of the human CSB gene, also causes a deficiency in transcription, and a synergistic decline in transcription occurs in the absence of both the RAD2 and RAD26 genes. Growth is also retarded in the rad2Delta and rad26Delta single mutant strains, and a very severe growth inhibition is seen in the rad2Delta rad26Delta double mutant. From these and other observations presented here, we suggest that transcriptional defects are the underlying cause of CS.	Univ Texas, Med Branch, Sealy Ctr Mol Sci, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Prakash, S (corresponding author), Univ Texas, Med Branch, Sealy Ctr Mol Sci, 6-104 Blocker Med Res Bldg,11th & Mech St, Galveston, TX 77555 USA.		Prakash, Satya/C-6420-2013	Prakash, Louise/0000-0001-9143-6261; Prakash, Satya/0000-0001-7228-1444	NATIONAL CANCER INSTITUTE [R01CA041261, R01CA035035, R37CA041261, R37CA035035] Funding Source: NIH RePORTER; NCI NIH HHS [CA35035, CA41261] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALANI E, 1987, GENETICS, V116, P541, DOI 10.1534/genetics.112.541.test; Bambara RA, 1997, J BIOL CHEM, V272, P4647, DOI 10.1074/jbc.272.8.4647; BOOTSMA D, 1993, NATURE, V363, P114, DOI 10.1038/363114a0; CHRISTIE KR, 1994, J BIOL CHEM, V269, P936; Coin F, 1999, EMBO J, V18, P1357, DOI 10.1093/emboj/18.5.1357; Constantinou A, 1999, J BIOL CHEM, V274, P5637, DOI 10.1074/jbc.274.9.5637; Cooper PK, 1997, SCIENCE, V275, P990, DOI 10.1126/science.275.5302.990; EXINGER F, 1992, CURR GENET, V22, P9, DOI 10.1007/BF00351735; GUZDER SN, 1994, NATURE, V369, P578, DOI 10.1038/369578a0; Guzder SN, 1996, J BIOL CHEM, V271, P18314, DOI 10.1074/jbc.271.31.18314; GUZDER SN, 1994, NATURE, V367, P91, DOI 10.1038/367091a0; HABRAKEN Y, 1995, J BIOL CHEM, V270, P30194; Hanawalt PC, 2000, NATURE, V405, P415, DOI 10.1038/35013197; Harada YN, 1999, MOL CELL BIOL, V19, P2366, DOI 10.1128/mcb.19.3.2366; HARRINGTON JJ, 1994, GENE DEV, V8, P1344, DOI 10.1101/gad.8.11.1344; HENNING KA, 1995, CELL, V82, P555, DOI 10.1016/0092-8674(95)90028-4; HIGGINS DR, 1984, GENE, V30, P121, DOI 10.1016/0378-1119(84)90112-4; HUANG JC, 1994, P NATL ACAD SCI USA, V91, P12213, DOI 10.1073/pnas.91.25.12213; Le Page F, 2000, CELL, V101, P159, DOI 10.1016/S0092-8674(00)80827-2; Lee SK, 2001, MOL CELL BIOL, V21, P8651, DOI 10.1128/MCB.21.24.8651-8656.2001; Lennon JC, 1998, MOL CELL BIOL, V18, P5771, DOI 10.1128/MCB.18.10.5771; LYAMICHEV V, 1993, SCIENCE, V260, P778, DOI 10.1126/science.7683443; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; NAKANISHI T, 1995, J BIOL CHEM, V270, P8991, DOI 10.1074/jbc.270.15.8991; NANCE MA, 1992, AM J MED GENET, V42, P68, DOI 10.1002/ajmg.1320420115; Nouspikel T, 1997, P NATL ACAD SCI USA, V94, P3116, DOI 10.1073/pnas.94.7.3116; ODONOVAN A, 1994, NATURE, V371, P432, DOI 10.1038/371432a0; Powell W, 1996, J BIOL CHEM, V271, P6866, DOI 10.1074/jbc.271.12.6866; Prakash S, 2000, MUTAT RES-FUND MOL M, V451, P13, DOI 10.1016/S0027-5107(00)00037-3; QIU HF, 1993, GENE DEV, V7, P2161, DOI 10.1101/gad.7.11.2161; Reardon JT, 1997, P NATL ACAD SCI USA, V94, P9463, DOI 10.1073/pnas.94.17.9463; REINES D, 1994, TRANSCRIPTION MECHAN, P263; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; Selby CP, 1997, P NATL ACAD SCI USA, V94, P11205, DOI 10.1073/pnas.94.21.11205; Selby CP, 1997, J BIOL CHEM, V272, P1885, DOI 10.1074/jbc.272.3.1885; SELBY CP, 1993, SCIENCE, V260, P53, DOI 10.1126/science.8465200; Shaw RJ, 2000, MOL CELL BIOL, V20, P7427, DOI 10.1128/MCB.20.20.7427-7437.2000; Torres-Ramos CA, 2000, MOL CELL BIOL, V20, P3522, DOI 10.1128/MCB.20.10.3522-3528.2000; TRECO DA, 1993, CURRENT PROTOCOLS MO, V2; vanderHorst GTJ, 1997, CELL, V89, P425, DOI 10.1016/S0092-8674(00)80223-8; VANGOOL AJ, 1994, EMBO J, V13, P5361, DOI 10.1002/j.1460-2075.1994.tb06871.x; VANHOFFEN A, 1993, NUCLEIC ACIDS RES, V21, P5890, DOI 10.1093/nar/21.25.5890; VENEMA J, 1990, P NATL ACAD SCI USA, V87, P4707, DOI 10.1073/pnas.87.12.4707	43	70	71	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 28	2002	109	7					823	834		10.1016/S0092-8674(02)00795-X	http://dx.doi.org/10.1016/S0092-8674(02)00795-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	570KJ	12110180	Bronze			2022-12-24	WOS:000176657200006
J	Weil, E; Wachterman, M; McCarthy, EP; Davis, RB; O'Day, B; Iezzoni, LI; Wee, CC				Weil, E; Wachterman, M; McCarthy, EP; Davis, RB; O'Day, B; Iezzoni, LI; Wee, CC			Obesity among adults with disabling conditions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS INDEX; DISABILITY; OVERWEIGHT; WEIGHT; PEOPLE; WOMEN; RISK; LIFE	Context Obesity, a leading cause of preventable death and chronic disease, is associated with disability. Little is known about obesity among adults with specific disabilities. Objectives To determine the prevalence of obesity in adults with physical and sensory limitations and serious mental illness. Design, Setting, and Participants The 1994-1995 National Health Interview Survey of 145007 US community-dwelling respondents, 25626 of whom had 1 or more disabilities. Main Outcome Measures Likelihood of being obese, attempting weight loss, and receiving exercise counseling among adults with and without disabilities. Results Among adults with disabilities, 24.9% were obese vs 15.1 % of those without disabilities. After adjusting for sociodemographic factors, adults with a disability were more likely to be obese, with an adjusted odds ratio (AOR) of 1.9 (95% confidence interval [01, 1.8-2.0). The highest risk occurred among adults with some (AOR, 2.4; 95% Cl, 2.3-2.5) or severe (AOR, 2.5; 95% Cl, 2.3-2.7) lower extremity mobility difficulties. After further adjustment for comorbid conditions, adults with disabilities were as likely to attempt weight loss as those without disabilities, except for adults with severe lower extremity mobility difficulties, who were less likely (AOR, 0.7; 95% Cl, 0.5-0.9]), and adults with mental illness, who were more likely (AOR, 1.4; 95% Cl, 1.2-1.8). Physician exercise counseling was reported less often among adults with severe lower extremity (AOR, 0.5; 95% Cl, 0.4-0.7) and upper extremity (AOR, 0.7; 95% Cl, 0.5-1.0) mobility difficulties. Conclusion Obesity appears to be more prevalent in adults with sensory, physical, and mental health conditions. Health care practitioners should address weight control and exercise among adults with disabilities.	Beth Israel Deaconess Med Ctr, Dept Med, Div Gen Med & Primary Care, Boston, MA 02215 USA; Cherry Engn Support Serv Inc, Mclean, VA USA	Harvard University; Beth Israel Deaconess Medical Center	Wee, CC (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Gen Med & Primary Care, 330 Brookline Ave, Boston, MA 02215 USA.	cweekuo@caregroup.harvard.edu			AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS010223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK002962] Funding Source: NIH RePORTER; AHRQ HHS [R01 HS10223-03] Funding Source: Medline; NIDDK NIH HHS [1K23 DK02962] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ades PA, 2001, NEW ENGL J MED, V345, P892, DOI 10.1056/NEJMra001529; Altman RD, 2000, ARTHRITIS RHEUM-US, V43, P1905; [Anonymous], 1998, CLIN GUID ID EV TREA; [Anonymous], HLTH PEOPL 2010 UND; Brown S, 1999, PSYCHOL MED, V29, P697, DOI 10.1017/S0033291798008186; Brownson RC, 2001, AM J PUBLIC HEALTH, V91, P1995, DOI 10.2105/AJPH.91.12.1995; CDC, BEH RISK FACT SURV S; Davidson S, 2001, AUST NZ J PSYCHIAT, V35, P196, DOI 10.1046/j.1440-1614.2001.00877.x; Devlin MJ, 2000, AM J PSYCHIAT, V157, P854, DOI 10.1176/appi.ajp.157.6.854; Ferraro KF, 2002, AM J PUBLIC HEALTH, V92, P834, DOI 10.2105/AJPH.92.5.834; Galuska DA, 1999, JAMA-J AM MED ASSOC, V282, P1576, DOI 10.1001/jama.282.16.1576; Han TS, 1998, AM J PUBLIC HEALTH, V88, P1814, DOI 10.2105/AJPH.88.12.1814; Heath G W, 1997, Exerc Sport Sci Rev, V25, P195; Iezzoni LI, 2001, AM J MED QUAL, V16, P135; KOCH GG, 1975, INT STAT REV, V43, P59, DOI 10.2307/1402660; LAUNER LJ, 1994, JAMA-J AM MED ASSOC, V271, P1093, DOI 10.1001/jama.271.14.1093; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; *RES TRIANGL I, 1992, SUDAAN US MAN REL 5; ROWLAND ML, 1990, AM J CLIN NUTR, V52, P1125, DOI 10.1093/ajcn/52.6.1125; *US PREV SERV TASK, 1996, GUID CLIN PREV SERV, P61; Wee CC, 1999, JAMA-J AM MED ASSOC, V282, P1583, DOI 10.1001/jama.282.16.1583	21	182	185	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 11	2002	288	10					1265	1268		10.1001/jama.288.10.1265	http://dx.doi.org/10.1001/jama.288.10.1265			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	592BW	12215134	Bronze			2022-12-24	WOS:000177917700026
J	Rosenfeld, D; Lahav, R; Khain, A; Pinsky, M				Rosenfeld, D; Lahav, R; Khain, A; Pinsky, M			The role of sea spray in cleansing air pollution over ocean via cloud processes	SCIENCE			English	Article							CONDENSATION NUCLEI; CONVECTIVE CLOUDS; AEROSOL; PRECIPITATION; RAIN; MICROPHYSICS; ATMOSPHERE; SULFATE	Particulate air pollution has been shown to strongly suppress precipitation from convective clouds over land. New observations show that precipitation from similar polluted clouds over oceans is much less affected, because large sea salt nuclei override the precipitation suppression effect of the large number of small pollution nuclei. Raindrops initiated by the sea salt grow by collecting small cloud droplets that form on the pollution particles, thereby cleansing the air. Therefore, sea salt helps cleanse the atmosphere of the air pollution via cloud processes. This implies that over oceans, the climatic aerosol indirect effects are significantly smaller than current estimates.	Hebrew Univ Jerusalem, Inst Earth Sci, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Rosenfeld, D (corresponding author), Hebrew Univ Jerusalem, Inst Earth Sci, IL-91904 Jerusalem, Israel.		Rosenfeld, Daniel/F-6077-2016; Rosenfeld, Daniel/AAJ-4617-2021	Rosenfeld, Daniel/0000-0002-0784-7656; Rosenfeld, Daniel/0000-0002-0784-7656				ACKERMAN AS, 1993, SCIENCE, V262, P226, DOI 10.1126/science.262.5131.226; ALBRECHT BA, 1989, SCIENCE, V245, P1227, DOI 10.1126/science.245.4923.1227; Breon FM, 2002, SCIENCE, V295, P834, DOI 10.1126/science.1066434; Cooper WA, 1997, J APPL METEOROL, V36, P1449, DOI 10.1175/1520-0450(1997)036<1449:CPTHSW>2.0.CO;2; Feingold G, 1999, J ATMOS SCI, V56, P4100, DOI 10.1175/1520-0469(1999)056<4100:TIOGCC>2.0.CO;2; Hegg DA, 1998, J GEOPHYS RES-ATMOS, V103, P5671, DOI 10.1029/97JD03652; Heymsfield AJ, 2001, J GEOPHYS RES-ATMOS, V106, P28653, DOI 10.1029/2000JD900776; Khain A, 2000, ATMOS RES, V55, P159, DOI 10.1016/S0169-8095(00)00064-8; Khain AP, 2001, GEOPHYS RES LETT, V28, P3887, DOI 10.1029/2000GL012662; Lelieveld J, 2001, SCIENCE, V291, P1031, DOI 10.1126/science.1057103; Levin Z, 1996, J APPL METEOROL, V35, P1511, DOI 10.1175/1520-0450(1996)035<1511:TEODPC>2.0.CO;2; LUCAS C, 1994, J ATMOS SCI, V51, P3183, DOI 10.1175/1520-0469(1994)051<3183:VVIOCO>2.0.CO;2; O'Dowd CD, 1999, Q J ROY METEOR SOC, V125, P1295, DOI 10.1256/smsqj.55609; Ramanathan V, 2001, SCIENCE, V294, P2119, DOI 10.1126/science.1064034; Rosenfeld D, 1999, GEOPHYS RES LETT, V26, P3105, DOI 10.1029/1999GL006066; Rosenfeld D, 1998, B AM METEOROL SOC, V79, P2457, DOI 10.1175/1520-0477(1998)079<2457:SBIIPF>2.0.CO;2; Rosenfeld D, 2000, SCIENCE, V287, P1793, DOI 10.1126/science.287.5459.1793; Rosenfeld D, 2001, P NATL ACAD SCI USA, V98, P5975, DOI 10.1073/pnas.101122798; ROSENFELD D, IN PRESS METEOROL MO; Rosenfeld D, 1994, ATMOS RES, V34, P259, DOI 10.1016/0169-8095(94)90096-5; RUDICH Y, IN PRESS NATURE; Satheesh SK, 2000, NATURE, V405, P60, DOI 10.1038/35011039; Sugimoto N, 2000, J MAR METEOROL SOC, V76, P93; TWOMEY S, 1977, J ATMOS SCI, V34, P1149, DOI 10.1175/1520-0469(1977)034<1149:TIOPOT>2.0.CO;2; WOODCOCK AH, 1953, J METEOROL, V10, P362, DOI 10.1175/1520-0469(1953)010<0366:SNIMAA>2.0.CO;2; Yin Y, 2000, ATMOS RES, V53, P91, DOI 10.1016/S0169-8095(99)00046-0; ZIPSER EJ, 1980, J ATMOS SCI, V37, P2458, DOI 10.1175/1520-0469(1980)037<2458:CVVEIG>2.0.CO;2	27	152	166	0	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2002	297	5587					1667	1670		10.1126/science.1073869	http://dx.doi.org/10.1126/science.1073869			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590JE	12183635				2022-12-24	WOS:000177819100039
J	Gianopoulos, I; Stephens, D; Davis, A				Gianopoulos, I; Stephens, D; Davis, A			Follow up of people fitted with hearing aids after adult hearing screening: the need for support after fitting	BRITISH MEDICAL JOURNAL			English	Article							DISABILITY		Univ Wales Hosp, Welsh Hearing Inst, Cardiff CF14 4XW, S Glam, Wales; Univ Nottingham, MRC, Inst Hearing Res, Nottingham NG7 2RD, England	Cardiff University; University of Nottingham	Stephens, D (corresponding author), Univ Wales Hosp, Welsh Hearing Inst, Cardiff CF14 4XW, S Glam, Wales.		Davis, Adrian C/E-6022-2015; Gianopoulos, I/F-1211-2013	Davis, Adrian C/0000-0001-7134-7528; 				DAVIES ER, 1992, SIGNAL PROCESS, V26, P1, DOI 10.1016/0165-1684(92)90051-W; DAVIS A, 1997, ADULT AUDIOLOGY; NOBLE WG, 1970, J AUD RES, V10, P229; Rosen J K, 1979, Scand Audiol, V8, P111, DOI 10.3109/01050397909076309; STEPHENS SDG, 1990, BRIT MED J, V300, P508, DOI 10.1136/bmj.300.6723.508	5	31	32	0	12	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 31	2002	325	7362					471	471		10.1136/bmj.325.7362.471	http://dx.doi.org/10.1136/bmj.325.7362.471			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592EZ	12202328	Bronze, Green Published			2022-12-24	WOS:000177924900020
J	Castro, RF; Jackson, KA; Goodell, MA; Robertson, CS; Liu, H; Shine, HD				Castro, RF; Jackson, KA; Goodell, MA; Robertson, CS; Liu, H; Shine, HD			Failure of bone marrow cells to transdifferentiate into neural cells in vivo	SCIENCE			English	Article							HEMATOPOIETIC STEM-CELLS; IN-VIVO; EXPRESSION; BRAIN		Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Shine, HD (corresponding author), Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA.			Goodell, Margaret A./0000-0003-1111-2932				Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; Liu H, 2002, J NEUROTRAUM, V19, P327, DOI 10.1089/089771502753594891; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789	7	346	423	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 23	2002	297	5585					1299	1299		10.1126/science.297.5585.1299	http://dx.doi.org/10.1126/science.297.5585.1299			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FL	12193778				2022-12-24	WOS:000177573900033
J	Bernards, R; Weinberg, RA				Bernards, R; Weinberg, RA			Metastasis genes: A progression puzzle	NATURE			English	Editorial Material									Netherlands Canc Inst, Div Mol Carcinogenesis, Amsterdam, Netherlands; Netherlands Canc Inst, Ctr Biomed Genet, Amsterdam, Netherlands; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA	Netherlands Cancer Institute; Netherlands Cancer Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Bernards, R (corresponding author), Netherlands Canc Inst, Div Mol Carcinogenesis, Plesmanlaan 121, Amsterdam, Netherlands.			Bernards, Rene/0000-0001-8677-3423				Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; POZZATTI R, 1986, SCIENCE, V232, P223, DOI 10.1126/science.3456644; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Yokota J, 2000, CARCINOGENESIS, V21, P497, DOI 10.1093/carcin/21.3.497	4	651	682	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 22	2002	418	6900					823	823		10.1038/418823a	http://dx.doi.org/10.1038/418823a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585YR	12192390	Green Submitted, Bronze			2022-12-24	WOS:000177555600018
J	Shi, JY; Krishnamoorthy, G; Yang, YW; Hu, L; Chaturvedi, N; Harilal, D; Qin, J; Cui, JM				Shi, JY; Krishnamoorthy, G; Yang, YW; Hu, L; Chaturvedi, N; Harilal, D; Qin, J; Cui, JM			Mechanism of magnesium activation of calcium-activated potassium channels	NATURE			English	Article							CA2+-ACTIVATED K+ CHANNELS; BK CHANNEL; CA2+-DEPENDENT ACTIVATION; PROTEINS; VOLTAGE; DOMAIN; CONDUCTANCE; SENSITIVITY; SUBUNIT; MSLO	Large-conductance (BK type) Ca2+-dependent K+ channels are essential for modulating muscle contraction and neuronal activities such as synaptic transmission and hearing(1-5). BK channels are activated by membrane depolarization and intracellular Ca2+ and Mg2+ (refs 6-10). The energy provided by voltage, Ca2+ and Mg2+ binding are additive in activating the channel, suggesting that these signals open the activation gate through independent pathways(9,11). Here we report a molecular investigation of a Mg2+ dependent activation mechanism. Using a combined site-directed mutagenesis and structural analysis, we demonstrate that a structurally new Mg2+-binding site in the RCK/Rossman fold domain-an intracellular structural motif that immediately follows the activation gate S6 helix(12-15)-is responsible for Mg2+ dependent activation. Mutations that impair or abolish Mg2+ sensitivity do not affect Ca2+ sensitivity, and vice versa. These results indicate distinct structural pathways for Mg2+ - and Ca2+ dependent activation and suggest a possible mechanism for the coupling between Mg2+ binding and channel opening.	Case Western Reserve Univ, Cardiac Bioelect Res & Training Ctr, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; Cleveland Clin Fdn, Lerner Res Inst, Struct Biol Program, Cleveland, OH 44195 USA	Case Western Reserve University; Case Western Reserve University; Cleveland Clinic Foundation	Cui, JM (corresponding author), Case Western Reserve Univ, Cardiac Bioelect Res & Training Ctr, Cleveland, OH 44106 USA.		Hu, Lei/B-1455-2009	Natarajan, Gayathri/0000-0001-7654-5013; Qin, Jun/0000-0002-2647-9270; Krishnamoorthy, Gayathri/0000-0002-2208-3244	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070393] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL070393] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADELMAN JP, 1992, NEURON, V9, P209, DOI 10.1016/0896-6273(92)90160-F; Bian S, 2001, P NATL ACAD SCI USA, V98, P4776, DOI 10.1073/pnas.081072398; BRANDEN CI, 1980, Q REV BIOPHYS, V13, P317, DOI 10.1017/S0033583500001712; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; Cui J, 1997, J GEN PHYSIOL, V109, P647, DOI 10.1085/jgp.109.5.647; Cui JM, 2000, BIOCHEMISTRY-US, V39, P15612, DOI 10.1021/bi001509+; Fettiplace R, 1999, ANNU REV PHYSIOL, V61, P809, DOI 10.1146/annurev.physiol.61.1.809; FLATMAN PW, 1991, ANNU REV PHYSIOL, V53, P259, DOI 10.1146/annurev.ph.53.030191.001355; HOROVITZ A, 1990, J MOL BIOL, V214, P613, DOI 10.1016/0022-2836(90)90275-Q; Isaacson JS, 2001, NEURON, V31, P1027, DOI 10.1016/S0896-6273(01)00428-7; Jiang YX, 2001, NEURON, V29, P593, DOI 10.1016/S0896-6273(01)00236-7; Johnson JP, 2001, NATURE, V412, P917, DOI 10.1038/35091089; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; MARTY A, 1981, NATURE, V291, P497, DOI 10.1038/291497a0; MILKMAN R, 1994, P NATL ACAD SCI USA, V91, P3510, DOI 10.1073/pnas.91.9.3510; NEEDHAM JV, 1993, BIOCHEMISTRY-US, V32, P3363, DOI 10.1021/bi00064a020; PALLOTTA BS, 1981, NATURE, V293, P471, DOI 10.1038/293471a0; Perozo E, 1999, SCIENCE, V285, P73, DOI 10.1126/science.285.5424.73; ROBITAILLE R, 1993, NEURON, V11, P645, DOI 10.1016/0896-6273(93)90076-4; Rosenblatt KP, 1997, NEURON, V19, P1061, DOI 10.1016/S0896-6273(00)80397-9; Schreiber M, 1999, NAT NEUROSCI, V2, P416, DOI 10.1038/8077; Schreiber M, 1998, J BIOL CHEM, V273, P3509, DOI 10.1074/jbc.273.6.3509; Shi JY, 2001, J GEN PHYSIOL, V118, P589, DOI 10.1085/jgp.118.5.589; STOCK JB, 1992, J BIOL CHEM, V267, P19753; WEI A, 1994, NEURON, V13, P671, DOI 10.1016/0896-6273(94)90034-5; Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448; Zhang X, 2001, J GEN PHYSIOL, V118, P607, DOI 10.1085/jgp.118.5.607	29	168	175	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 22	2002	418	6900					876	880		10.1038/nature00941	http://dx.doi.org/10.1038/nature00941			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585YR	12192410				2022-12-24	WOS:000177555600038
J	Weir, AAS; Chappell, J; Kacelnik, A				Weir, AAS; Chappell, J; Kacelnik, A			Shaping of hooks in new Caledonian crows	SCIENCE			English	Article							CEBUS-APELLA; TOOL-USE; MANUFACTURE		Dept Zool, Oxford OX1 3PS, England		Kacelnik, A (corresponding author), Dept Zool, S Parks Rd, Oxford OX1 3PS, England.		Chappell, Jackie/W-6772-2019; Weir, Alex/B-4664-2008	Chappell, Jackie/0000-0001-7338-9449; 				ANDERSON JR, 1994, MAMMALIA, V58, P351, DOI 10.1515/mamm.1994.58.3.351; Chappell J, 2002, ANIM COGN, V5, P71, DOI 10.1007/s10071-002-0130-2; CHEVALIERSKOLNIKOFF S, 1989, BEHAV BRAIN SCI, V12, P561, DOI 10.1017/S0140525X00057678; Hunt GR, 2000, P ROY SOC B-BIOL SCI, V267, P403, DOI 10.1098/rspb.2000.1015; Hunt GR, 1996, NATURE, V379, P249, DOI 10.1038/379249a0; Pepperberg IM., 1999, ALEX STUDIES COGNITI; POVINELLI DJ, 2000, FOLK PHYSICS APES; Tomasello M, 1997, PRIMATE COGNITION; Visalberghi E, 1997, INT J PRIMATOL, V18, P811, DOI 10.1023/A:1026399930727	9	381	394	3	199	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 9	2002	297	5583					981	981		10.1126/science.1073433	http://dx.doi.org/10.1126/science.1073433			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581ZN	12169726				2022-12-24	WOS:000177325400035
J	Dudley, AT; Ros, MA; Tabin, CJ				Dudley, AT; Ros, MA; Tabin, CJ			A re-examination of proximodistal patterning during vertebrate limb development	NATURE			English	Article							APICAL ECTODERMAL RIDGE; CELL-DIVISION; MORPHOGENESIS; GROWTH; BUD; MISEXPRESSION; EXPRESSION; MESODERM; GENES; DEATH	The 'progress zone' model provides a framework for understanding progressive development of the vertebrate limb(1). This model holds that undifferentiated cells in a zone of fixed size at the distal tip of the limb bud (the progress zone) undergo a progressive change in positional information such that their specification is altered from more proximal to more distal fates. This positional change is thought to be driven by an internal clock that is kept active as long as the cells remain in the progress zone. However, owing to cell division, the most proximal of these cells are continually pushed outside the confines of the zone. As they exit, clock function ceases and cells become fixed with the positional value last attained while within the zone. In contrast to this model, our data suggest that the various limb segments are 'specified' early in limb development as distinct domains, with subsequent development involving expansion of these progenitor populations before differentiation. We also find, however, that the distal limb mesenchyme becomes progressively 'determined', that is, irreversibly fixed, to a progressively limited range of potential proximodistal fates.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Univ Cantabria, Fac Med, Dept Anat & Biol Celular, Santander 39011, Spain	Harvard University; Harvard Medical School; Universidad de Cantabria	Tabin, CJ (corresponding author), Harvard Univ, Sch Med, Dept Genet, 200 Longwood Ave, Boston, MA 02115 USA.	tabin@rascal.med.harvard.edu	Ros, Maria A./K-8160-2014	Ros, Maria A./0000-0002-1224-7671				Chapman DL, 1996, DEV DYNAM, V206, P379, DOI 10.1002/(SICI)1097-0177(199608)206:4<379::AID-AJA4>3.0.CO;2-F; CROSBY GM, 1975, DEV BIOL, V46, P28, DOI 10.1016/0012-1606(75)90084-6; FALLON JF, 1994, SCIENCE, V264, P104, DOI 10.1126/science.7908145; FREDERICK JM, 1982, J EMBRYOL EXP MORPH, V67, P13; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GibsonBrown JJ, 1996, MECH DEVELOP, V56, P93, DOI 10.1016/0925-4773(96)00514-X; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hardy A, 1995, DEVELOPMENT, V121, P4329; HORNBRUCH A, 1970, NATURE, V226, P764, DOI 10.1038/226764a0; KIENY M, 1977, ROUX ARCH DEV BIOL, V183, P177, DOI 10.1007/BF00867319; LEWIS JH, 1975, J EMBRYOL EXP MORPH, V33, P419; Logan M, 1998, METHODS, V14, P407, DOI 10.1006/meth.1998.0595; NISWANDER L, 1993, CELL; Piedra ME, 2000, MECH DEVELOP, V90, P167, DOI 10.1016/S0925-4773(99)00247-6; ROS MA, 1994, DEV BIOL, V166, P59, DOI 10.1006/dbio.1994.1296; ROWE DA, 1982, DEV BIOL, V93, P83, DOI 10.1016/0012-1606(82)90241-X; RUBIN L, 1972, DEV BIOL, V28, P94, DOI 10.1016/0012-1606(72)90129-7; SAUNDERS JW, 1948, J EXP ZOOL, V108, P363, DOI 10.1002/jez.1401080304; SUMMERBELL D, 1974, J EMBRYOL EXP MORPH, V32, P651; SUMMERBELL D, 1973, NATURE, V244, P492, DOI 10.1038/244492a0; Sun X, 2002, NATURE, V418, P501, DOI 10.1038/nature00902; Vargesson N, 1997, DEVELOPMENT, V124, P1909; WADA N, 1993, DEV GROWTH DIFFER, V35, P421; WOLPERT L, 1979, J EMBRYOL EXP MORPH, V50, P175; YOKOUCHI Y, 1995, GENE DEV, V9, P2509, DOI 10.1101/gad.9.20.2509	25	218	222	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 1	2002	418	6897					539	544		10.1038/nature00945	http://dx.doi.org/10.1038/nature00945			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579EE	12152081				2022-12-24	WOS:000177162800042
J	Kenchaiah, S; Evans, JC; Levy, D; Wilson, PWF; Benjamin, EJ; Larson, MG; Kannel, WB; Vasan, RS				Kenchaiah, S; Evans, JC; Levy, D; Wilson, PWF; Benjamin, EJ; Larson, MG; Kannel, WB; Vasan, RS			Obesity and the risk of heart failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LEFT-VENTRICULAR MASS; ARTERIAL-HYPERTENSION; GENERAL-POPULATION; WEIGHT-GAIN; FRAMINGHAM; DISEASE; MEN; PROGNOSIS; WOMEN	Background Extreme obesity is recognized to be a risk factor for heart failure. It is unclear whether overweight and lesser degrees of obesity also pose a risk. Methods We investigated the relation between the body-mass index (the weight in kilograms divided by the square of the height in meters) and the incidence of heart failure among 5881 participants in the Framingham Heart Study (mean age, 55 years; 54 percent women). With the use of Cox proportional-hazards models, the body-mass index was evaluated both as a continuous variable and as a categorical variable (normal, 18.5 to 24.9; overweight, 25.0 to 29.9; and obese, 30.0 or more). Results During follow-up (mean, 14 years), heart failure developed in 496 subjects (258 women and 238 men). After adjustment for established risk factors, there was an increase in the risk of heart failure of 5 percent for men and 7 percent for women for each increment of 1 in body-mass index. As compared with subjects with a normal body-mass index, obese subjects had a doubling of the risk of heart failure. For women, the hazard ratio was 2.12 (95 percent confidence interval, 1.51 to 2.97); for men, the hazard ratio was 1.90 (95 percent confidence interval, 1.30 to 2.79). A graded increase in the risk of heart failure was observed across categories of body-mass index. The hazard ratios per increase in category were 1.46 in women (95 percent confidence interval, 1.23 to 1.72) and 1.37 in men (95 percent confidence interval, 1.13 to 1.67). Conclusions In our large, community-based sample, increased body-mass index was associated with an increased risk of heart failure. Given the high prevalence of obesity in the United States, strategies to promote optimal body weight may reduce the population burden of heart failure.	Framingham Heart Dis Epidemiol Study, Framingham, MA 01702 USA; Boston Univ, Sch Med, Sect Prevent Med, Boston, MA 02118 USA; Boston Univ, Sch Med, Cardiol Sect, Boston, MA 02118 USA; Beth Israel Deaconess Med Ctr, Div Cardiol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA; NHLBI, Bethesda, MD 20892 USA	Framingham Heart Study; Boston University; Boston University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Vasan, RS (corresponding author), Framingham Heart Dis Epidemiol Study, 73 Mt Wayte Ave,Suite 2, Framingham, MA 01702 USA.		Ramachandran, Vasan/Y-2527-2019; Levy, Daniel/ABB-2752-2021; Kenchaiah, Satish/A-1519-2016; Wilson, Peter W.F./J-2455-2016; Levy, Daniel/ABF-6873-2021; Benjamin, Emelia/E-7103-2011	Ramachandran, Vasan/0000-0001-7357-5970; Kenchaiah, Satish/0000-0002-8731-8702; Levy, Daniel/0000-0003-1843-8724; Benjamin, Emelia/0000-0003-4076-2336; Larson, Martin/0000-0002-9631-1254	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL004334] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HC-25195, 1K24 HL04334] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALEXANDER J K, 1962, Cardiovasc Res Cent Bull, V1, P39; ALPERT MA, 1995, AM HEART J, V130, P1068, DOI 10.1016/0002-8703(95)90210-4; Alpert MA, 2001, AM J MED SCI, V321, P225, DOI 10.1097/00000441-200104000-00003; *AM HEART ASS, 2001, 2002 HEART STROK STA; Anker SD, 1999, CURR OPIN CARDIOL, V14, P211, DOI 10.1097/00001573-199905000-00004; [Anonymous], 2000, WHO TECH REP SER, V894, P1; Caruana L, 2000, BRIT MED J, V321, P215, DOI 10.1136/bmj.321.7255.215; CHAN JM, 1994, DIABETES CARE, V17, P961, DOI 10.2337/diacare.17.9.961; Chen YT, 1999, AM J MED, V106, P605, DOI 10.1016/S0002-9343(99)00126-6; COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001; COX DR, 1972, J R STAT SOC B, V34, P187; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Engeli S, 2001, J MOL MED, V79, P21, DOI 10.1007/s001090000144; Gardin JM, 2001, AM J CARDIOL, V87, P1051, DOI 10.1016/S0002-9149(01)01460-6; HAMMOND IW, 1988, J AM COLL CARDIOL, V12, P996, DOI 10.1016/0735-1097(88)90467-6; He J, 2001, ARCH INTERN MED, V161, P996, DOI 10.1001/archinte.161.7.996; Hunt SA, 2001, J AM COLL CARDIOL, V38, P2101, DOI 10.1016/S0735-1097(01)01683-7; Kannel W B, 1979, Diabetes Care, V2, P120, DOI 10.2337/diacare.2.2.120; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; KANNEL WB, 1987, NIH PUBLICATION NAT; Kannell WB, 1999, ARCH INTERN MED, V159, P1197, DOI 10.1001/archinte.159.11.1197; LAUER MS, 1991, JAMA-J AM MED ASSOC, V266, P231, DOI 10.1001/jama.266.2.231; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; MANSON JAE, 1990, NEW ENGL J MED, V322, P882, DOI 10.1056/NEJM199003293221303; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; MESSERLI FH, 1983, ANN INTERN MED, V99, P757, DOI 10.7326/0003-4819-99-6-757; MESSERLI FH, 1983, AM J MED, V74, P808, DOI 10.1016/0002-9343(83)91071-9; Mosterd A, 2001, EUR HEART J, V22, P1318, DOI 10.1053/euhj.2000.2533; *NAT HEART LUNG BL, 1998, NIH PUBL NAT HEART L; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; *SAS I INC, 1997, SAS STAT SOFTW CHANG, P871; Stamler J, 1991, Ann Epidemiol, V1, P347, DOI 10.1016/1047-2797(91)90045-E; Vasan RS, 1997, NEW ENGL J MED, V336, P1350, DOI 10.1056/NEJM199705083361903; Vasan RS, 2000, CIRCULATION, V101, P2118, DOI 10.1161/01.CIR.101.17.2118; Vincent HK, 1999, INT J OBESITY, V23, P67, DOI 10.1038/sj.ijo.0800761; Wilhelmsen L, 2001, J INTERN MED, V249, P253, DOI 10.1046/j.1365-2796.2001.00801.x; Zhou YT, 2000, P NATL ACAD SCI USA, V97, P1784, DOI 10.1073/pnas.97.4.1784	37	1887	1978	1	55	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 1	2002	347	5					305	313		10.1056/NEJMoa020245	http://dx.doi.org/10.1056/NEJMoa020245			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587WC	12151467				2022-12-24	WOS:000177665900002
J	Selvachandran, SN; Hodder, RJ; Ballal, MS; Jones, P; Cade, D				Selvachandran, SN; Hodder, RJ; Ballal, MS; Jones, P; Cade, D			Prediction of colorectal cancer by a patient consultation questionnaire and scoring system: a prospective study	LANCET			English	Article							DIAGNOSIS; SYMPTOMS; DURATION; DELAY; CARCINOMA	Background Current NHS guidelines for referral of patients with colorectal symptoms classify many as high risk but fail to identify a significant number of cancers in the low-risk group. We describe a practical scoring method to predict colorectal cancers. Methods From October, 1999, 2268 patients with distal colonic symptoms, referred by general practitioners, completed a patient consultation questionnaire linked to a computerised record. Referrals Were prioritised with a malignancy risk score by a senior colorectal surgeon separately from the general practitioner's letter and from the questionnaire. A weighted numerical score was derived from weighting of primary symptoms and symptom complexes and was calculated automatically when the questionnaire data were entered into the computer program. Analysis by receiver-operating characteristics assessed the scoring systems. Sensitivities and specificities of scoring systems were compared with McNemar's test. Findings Of the 2268 patients, 95 had colorectal cancer. The average weighted numerical score was significantly higher for patients with cancer than for non-cancer patients (mean 76.5 [95% CI 72.2-80.9] vs 44.5 [43.6-45.4]; p<0.0001). At similar cancer detection rates, the malignancy risk score derived from the patient consultation questionnaire and the weighted numerical score graded lower proportions of referrals as urgent than did the current NHS guidelines (43.1% and 39.8% vs 49.8%; p<0.0001). Interpretation The patient consultation questionnaire depends on history alone and is easily reproducible. In conjunction with the weighted numerical score, which removes operator bias, it can be used as an accurate system for prediction of symptomatic colorectal cancer.	Leighton Hosp, Mid Cheshire Hosp Trust, Dept Surg, Crewe CW1 4QJ, Cheshire, England; Keele Univ, Dept Math, Keele, Staffs, England	Keele University	Cade, D (corresponding author), Leighton Hosp, Mid Cheshire Hosp Trust, Dept Surg, Middlewich Rd, Crewe CW1 4QJ, Cheshire, England.							COHEN JR, 1983, AUST NZ J SURG, V53, P113, DOI 10.1111/j.1445-2197.1983.tb02409.x; CONI L, 2001, COLORECT DIS S1, V3, P33; Copeland G P, 1991, Br J Surg, V78, P355, DOI 10.1002/bjs.1800780327; *DEP HLTH, 2000, NHS EX GUID URG REF; DIXON AR, 1990, BRIT MED J, V301, P152, DOI 10.1136/bmj.301.6744.152; Dodds S, 1999, GUT, V44, pA99; ECCERSLEY AJP, 2001, COLORECT DIS S1, V3, P34; FIJTEN GH, 1995, FAM PRACT, V12, P279, DOI 10.1093/fampra/12.3.279; FLASHMAN K, 2001, COLORECT DIS S1, V3; GOODMAN D, 1993, BRIT J SURG, V80, P1327, DOI 10.1002/bjs.1800801037; HAGGER R, 2001, COLORECT DIS S1, V3; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; HARINATH G, 2001, COLORECT DIS, V3; HERIOT AG, 2001, COLORECT DIS S1, V3; HOLLIDAY HW, 1979, LANCET, V1, P309; HURST NG, 2001, COLORECT DIS S1, V3; Jones R, 2001, BRIT MED J, V322, P1555, DOI 10.1136/bmj.322.7302.1555; KEDDIE N, 1968, LANCET, V2, P749; KELLY MJ, 2001, COLORECT DIS S1, V3, P33; KEMPPAINEN M, 1993, AGE AGEING, V22, P260, DOI 10.1093/ageing/22.4.260; KYLE SM, 1991, AUST NZ J SURG, V61, P137, DOI 10.1111/j.1445-2197.1991.tb00190.x; LYDEARD S, 1991, FAM PRACT, V8, P84, DOI 10.1093/fampra/8.1.84; Majumdar SR, 1999, AM J GASTROENTEROL, V94, P3039, DOI 10.1111/j.1572-0241.1999.01454.x; MIHSSIN N, 2001, COLORECT DIS S1, V3, P33; *NHS EX, 1997, IMPR OUTC COL CANC; ROBINSON E, 1986, EUR J CANCER CLIN ON, V22, P157, DOI 10.1016/0277-5379(86)90025-8; ROWEJONES DC, 1965, LANCET, V2, P973, DOI 10.1016/S0140-6736(65)92839-4; Royal College of Physicians of London, 1996, GUID MAN COL CANC, P3; SHEKOUH AR, 2001, COLORECT DIS S1, V3; STUBBS RS, 1986, EUR J SURG ONCOL, V12, P127	30	114	117	1	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 27	2002	360	9329					278	283		10.1016/S0140-6736(02)09549-1	http://dx.doi.org/10.1016/S0140-6736(02)09549-1			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	578DT	12147370				2022-12-24	WOS:000177102700008
J	Li, J; Wen, JQ; Lease, KA; Doke, JT; Tax, FE; Walker, JC				Li, J; Wen, JQ; Lease, KA; Doke, JT; Tax, FE; Walker, JC			BAK1, an Arabidopsis LRR receptor-like protein kinase, interacts with BRI1 and modulates brassinosteroid signaling	CELL			English	Article							LEUCINE-RICH REPEAT; THALIANA; GENE; BIOSYNTHESIS; GROWTH; TRANSDUCTION; ENCODES; EMBRYOS; MUTANT; FORM	Brassinosteroids regulate plant growth and development through a protein complex that includes the leucine-rich repeat receptor-like protein kinase (LRR-RLK) brassinosteroid-insensitive 1 (BRI1). Activation tagging was used to identify a dominant genetic suppressor of bri1, bak1-1D (bri1-associated receptor kinase 1-1Dominant), which encodes an LRR-RLK, distinct from BRI1. Overexpression of BAK1 results in elongated organ phenotypes, while a null allele of BAK1 displays a semidwarfed phenotype and has reduced sensitivity to brassinosteroids (BRs). BAK1 is a serine/threonine protein kinase, and BRI1 and BAK1 interact in vitro and in vivo. Expression of a dominant-negative mutant allele of BAK1 causes a severe dwarf phenotype, resembling the phenotype of null bri1 alleles. These results indicate BAK1 is a component of BR signaling.	Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA	University of Missouri System; University of Missouri Columbia; University of Arizona	Walker, JC (corresponding author), Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA.	walkerj@missouri.edu		Tax, Frans/0000-0002-1386-3310; Wen, Jiangqi/0000-0001-5113-7750; Walker, John/0000-0002-2050-1641				Asami T, 2000, PLANT PHYSIOL, V123, P93, DOI 10.1104/pp.123.1.93; BECKER D, 1992, PLANT MOL BIOL, V20, P1195, DOI 10.1007/BF00028908; Braun DM, 1997, PLANT J, V12, P83, DOI 10.1046/j.1365-313X.1997.12010083.x; Choe S, 2001, PLANT J, V26, P573, DOI 10.1046/j.1365-313x.2001.01055.x; Choe SW, 1998, PLANT CELL, V10, P231, DOI 10.1105/tpc.10.2.231; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Clouse SD, 1996, PLANT PHYSIOL, V111, P671, DOI 10.1104/pp.111.3.671; Friedrichsen DM, 2000, PLANT PHYSIOL, V123, P1247, DOI 10.1104/pp.123.4.1247; Fujioka S, 1997, PLANT CELL, V9, P1951, DOI 10.1105/tpc.9.11.1951; He ZH, 2000, SCIENCE, V288, P2360, DOI 10.1126/science.288.5475.2360; Hecht V, 2001, PLANT PHYSIOL, V127, P803, DOI 10.1104/pp.010324; HORN MA, 1994, BBA-PROTEIN STRUCT M, V1208, P65, DOI 10.1016/0167-4838(94)90160-0; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kauschmann A, 1996, PLANT J, V9, P701, DOI 10.1046/j.1365-313X.1996.9050701.x; Li J, 2001, P NATL ACAD SCI USA, V98, P5916, DOI 10.1073/pnas.091065998; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Li JM, 2002, SCIENCE, V295, P1299; Li JM, 2001, PLANT PHYSIOL, V127, P14, DOI 10.1104/pp.127.1.14; Li JM, 1996, SCIENCE, V272, P398, DOI 10.1126/science.272.5260.398; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Noguchi T, 1999, PLANT PHYSIOL, V121, P743, DOI 10.1104/pp.121.3.743; Perez-Perez JM, 2002, DEV BIOL, V242, P161, DOI 10.1006/dbio.2001.0543; Schmidt EDL, 1997, DEVELOPMENT, V124, P2049; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Wang ZY, 2002, DEV CELL, V2, P505, DOI 10.1016/S1534-5807(02)00153-3; Wang ZY, 2001, NATURE, V410, P380, DOI 10.1038/35066597; Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003; Yin YH, 2002, CELL, V109, P181, DOI 10.1016/S0092-8674(02)00721-3	30	967	1055	14	219	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 26	2002	110	2					213	222		10.1016/S0092-8674(02)00812-7	http://dx.doi.org/10.1016/S0092-8674(02)00812-7			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	578EV	12150929	Bronze			2022-12-24	WOS:000177105200009
J	Thaler, JP; Lee, SK; Jurata, LW; Gill, GN; Pfaff, SL				Thaler, JP; Lee, SK; Jurata, LW; Gill, GN; Pfaff, SL			LIM factor Lhx3 contributes to the specification of motor neuron and interneuron identity through cell-type-specific protein-protein interactions	CELL			English	Article							ACTIVITY IN-VIVO; HOMEODOMAIN PROTEINS; HOMEOBOX GENES; TRANSCRIPTION FACTORS; SPINAL-CORD; EXPRESSION; CHIP; DROSOPHILA; FATE; CODE	LIM homeodomain codes regulate the development of many cell types, though it is poorly understood how these factors control gene expression in a cell-specific manner. Lhx3 is involved in the generation of two adjacent, but distinct, cell types for locomotion, motor neurons and V2 interneurons. Using in vivo function and protein interaction assays, we found that Lhx3 binds directly to the LIM cofactor NLI to trigger V2 interneuron differentiation. In motor neurons, however, IsI1 is available to compete for binding to NLI, displacing Lhx3 to a high-affinity binding site on the C-terminal region of IsI1 and thereby transforming Lhx3 from an interneuron-promoting factor to a motor neuron-promoting factor. This switching mechanism enables specific LIM complexes to form in each cell type and ensures that neuronal fates are tightly segregated.	Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	Salk Institute; University of California System; University of California San Diego	Pfaff, SL (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.				NIDDK NIH HHS [DK13149] Funding Source: Medline; NINDS NIH HHS [R01NS37116] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK013149, R01DK013149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037116] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Agulnick AD, 1996, NATURE, V384, P270, DOI 10.1038/384270a0; Appel B, 1995, DEVELOPMENT, V121, P4117; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Bach I, 1997, GENE DEV, V11, P1370, DOI 10.1101/gad.11.11.1370; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Dasen JS, 1999, CURR OPIN GENET DEV, V9, P566, DOI 10.1016/S0959-437X(99)00015-5; Dawid IB, 1998, TRENDS GENET, V14, P156, DOI 10.1016/S0168-9525(98)01424-3; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; ERICSON J, 1992, SCIENCE, V256, P1555, DOI 10.1126/science.1350865; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hobert O, 2000, TRENDS GENET, V16, P75, DOI 10.1016/S0168-9525(99)01883-1; Howard PW, 2000, J BIOL CHEM, V275, P13336, DOI 10.1074/jbc.275.18.13336; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Johnson JD, 1997, MOL CELL BIOL, V17, P3488, DOI 10.1128/MCB.17.7.3488; Jurata LW, 2000, CURR OPIN NEUROBIOL, V10, P72, DOI 10.1016/S0959-4388(99)00053-7; Jurata LW, 1998, J BIOL CHEM, V273, P3152, DOI 10.1074/jbc.273.6.3152; Jurata LW, 1996, P NATL ACAD SCI USA, V93, P11693, DOI 10.1073/pnas.93.21.11693; Jurata LW, 1997, MOL CELL BIOL, V17, P5688, DOI 10.1128/MCB.17.10.5688; Kenny DA, 1998, P NATL ACAD SCI USA, V95, P11257, DOI 10.1073/pnas.95.19.11257; Kessaris N, 2001, NEURON, V31, P677, DOI 10.1016/S0896-6273(01)00430-5; Lee SK, 2001, NAT NEUROSCI, V4, P1183, DOI 10.1038/nn750; Marin O, 2000, J NEUROSCI, V20, P6063; Marquardt T, 2001, CELL, V106, P651, DOI 10.1016/S0092-8674(01)00499-8; Milan M, 1999, MOL CELL, V4, P267, DOI 10.1016/S1097-2765(00)80374-3; Milan M, 1998, GENE DEV, V12, P2912, DOI 10.1101/gad.12.18.2912; Moran-Rivard L, 2001, NEURON, V29, P385, DOI 10.1016/S0896-6273(01)00213-6; Morcillo P, 1997, GENE DEV, V11, P2729, DOI 10.1101/gad.11.20.2729; Muhr J, 2001, CELL, V104, P861, DOI 10.1016/S0092-8674(01)00283-5; Nakagawa Y, 2001, J NEUROSCI, V21, P2711, DOI 10.1523/JNEUROSCI.21-08-02711.2001; Nakamura H, 2001, METHODS, V24, P43, DOI 10.1006/meth.2001.1155; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Ramain P, 2000, MOL CELL, V6, P781, DOI 10.1016/S1097-2765(05)00079-1; Sander M, 2000, GENE DEV, V14, P2134, DOI 10.1101/gad.820400; Sharma K, 2000, NATURE, V406, P515, DOI 10.1038/35020078; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Sheng HZ, 1996, SCIENCE, V272, P1004, DOI 10.1126/science.272.5264.1004; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1; THOR S, 1991, NEURON, V7, P881, DOI 10.1016/0896-6273(91)90334-V; Thor S, 1999, NATURE, V397, P76, DOI 10.1038/16275; Torigoi E, 2000, P NATL ACAD SCI USA, V97, P2686, DOI 10.1073/pnas.050586397; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Vallstedt A, 2001, NEURON, V31, P743, DOI 10.1016/S0896-6273(01)00412-3; van Meyel DJ, 2000, DEVELOPMENT, V127, P1823; van Meyel DJ, 1999, MOL CELL, V4, P259, DOI 10.1016/S1097-2765(00)80373-1; VarelaEchavarria A, 1996, MOL CELL NEUROSCI, V8, P242, DOI 10.1006/mcne.1996.0061	47	272	281	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 26	2002	110	2					237	249		10.1016/S0092-8674(02)00823-1	http://dx.doi.org/10.1016/S0092-8674(02)00823-1			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	578EV	12150931	Bronze			2022-12-24	WOS:000177105200011
J	Tonello, F; Seveso, M; Marin, O; Mock, M; Montecucco, C				Tonello, F; Seveso, M; Marin, O; Mock, M; Montecucco, C			Pharmacology - Screening inhibitors of anthrax lethal factor	NATURE			English	Article							KINASE-KINASE; MACROPHAGES		Univ Padua, CNR, Ist Neurosci, Dipartimento Sci Biomed, I-35121 Padua, Italy; Univ Padua, Ist Veneto Med Mol, I-35121 Padua, Italy; Univ Padua, Dipartimento Chim Biol, I-35121 Padua, Italy; Univ Padua, CRIBI, I-35121 Padua, Italy; Inst Pasteur, Lab Genet Mol Toxines, CNRS, URA 557, F-75724 Paris 15, France	Consiglio Nazionale delle Ricerche (CNR); University of Padua; University of Padua; Veneto Institute Molecular Medicine; University of Padua; University of Padua; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Tonello, F (corresponding author), Univ Padua, CNR, Ist Neurosci, Dipartimento Sci Biomed, Via G Colombo 3, I-35121 Padua, Italy.		Tonello, Fiorella/AAM-6737-2021; Tonello, Fiorella/G-8957-2013	Tonello, Fiorella/0000-0001-8935-8938; Tonello, Fiorella/0000-0001-8935-8938				Chaudry GJ, 2002, TRENDS MICROBIOL, V10, P58, DOI 10.1016/S0966-842X(01)02294-6; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; FRIEDLANDER AM, 1986, J BIOL CHEM, V261, P7123; Friedlander AM, 2001, NATURE, V414, P160, DOI 10.1038/35102660; Hanna P, 1998, CURR TOP MICROBIOL, V225, P13; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Pannifer AD, 2001, NATURE, V414, P229, DOI 10.1038/n35101998; Roques BP, 2000, TRENDS PHARMACOL SCI, V21, P475, DOI 10.1016/S0165-6147(00)01571-6; Schwarze SR, 2000, TRENDS CELL BIOL, V10, P290, DOI 10.1016/S0962-8924(00)01771-2; Vitale G, 1998, BIOCHEM BIOPH RES CO, V248, P706, DOI 10.1006/bbrc.1998.9040; Vitale G, 2000, BIOCHEM J, V352, P739, DOI 10.1042/0264-6021:3520739	11	101	105	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 25	2002	418	6896					386	386		10.1038/418386a	http://dx.doi.org/10.1038/418386a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576MU	12140548	Green Submitted, Bronze			2022-12-24	WOS:000177009700028
J	Hobbs, R				Hobbs, R			Checks and balances	LANCET			English	Editorial Material									Univ Birmingham, Dept Gen Practice, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Hobbs, R (corresponding author), Univ Birmingham, Dept Gen Practice, Birmingham B15 2TT, W Midlands, England.			hobbs, richard/0000-0001-7976-7172					0	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 20	2002	360	9328					254	254		10.1016/S0140-6736(02)09467-9	http://dx.doi.org/10.1016/S0140-6736(02)09467-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	576DX	12133676				2022-12-24	WOS:000176988500031
J	Scaffidi, P; Misteli, T; Bianchi, ME				Scaffidi, P; Misteli, T; Bianchi, ME			Release of chromatin protein HMGB1 by necrotic cells triggers inflammation	NATURE			English	Article							LINKER HISTONES B4; HIGH-MOBILITY; DNA; BINDING; H1; APOPTOSIS; MEDIATOR; HMG-1	High mobility group 1 (HMGB1) protein is both a nuclear factor and a secreted protein. In the cell nucleus it acts as an architectural chromatin-binding factor that bends DNA and promotes protein assembly on specific DNA targets(1,2). Outside the cell, it binds with high affinity to RAGE (the receptor for advanced glycation end products) 3 and is a potent mediator of inflammation(4-6). HMGB1 is secreted by activated monocytes and macrophages(4), and is passively released by necrotic or damaged cells(7-9). Here we report that Hmgb1(-/-) necrotic cells have a greatly reduced ability to promote inflammation, which proves that the release of HMGB1 can signal the demise of a cell to its neighbours. Apoptotic cells do not release HMGB1 even after undergoing secondary necrosis and partial autolysis, and thus fail to promote inflammation even if not cleared promptly by phagocytic cells. In apoptotic cells, HMGB1 is bound firmly to chromatin because of generalized underacetylation of histone and is released in the extracellular medium (promoting inflammation) if chromatin deacetylation is prevented. Thus, cells undergoing apoptosis are programmed to withhold the signal that is broadcast by cells that have been damaged or killed by trauma.	Univ Vita Salute San Raffaele, I-20132 Milan, Italy; Ist Sci San Raffaele, DIBIT, I-20132 Milan, Italy; NCI, NIH, Bethesda, MD 20892 USA	Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Bianchi, ME (corresponding author), Univ Vita Salute San Raffaele, I-20132 Milan, Italy.	bianchi.marco@hsr.it	Bianchi, Marco Emilio/K-3417-2018; Scaffidi, Paola/GRS-9019-2022	Bianchi, Marco Emilio/0000-0002-5329-6445; Scaffidi, Paola/0000-0002-3642-4193				Abraham E, 2000, J IMMUNOL, V165, P2950, DOI 10.4049/jimmunol.165.6.2950; Andersson L1992A, SCRIPTA BOT BELG, V1, P1; Bianchi ME, 2000, EMBO REP, V1, P109, DOI 10.1093/embo-reports/kvd030; Bustin M, 2001, TRENDS BIOCHEM SCI, V26, P152, DOI 10.1016/S0968-0004(00)01777-1; Bustin M, 1999, MOL CELL BIOL, V19, P5237; Calogero S, 1999, NAT GENET, V22, P276, DOI 10.1038/10338; Degryse B, 2001, J CELL BIOL, V152, P1197, DOI 10.1083/jcb.152.6.1197; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Fadok VA, 2001, J IMMUNOL, V166, P6847, DOI 10.4049/jimmunol.166.11.6847; Falciola L, 1997, J CELL BIOL, V137, P19, DOI 10.1083/jcb.137.1.19; Herrmann M, 1998, ARTHRITIS RHEUM-US, V41, P1241, DOI 10.1002/1529-0131(199807)41:7<1241::AID-ART15>3.0.CO;2-H; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Kato A, 2000, AM J PATHOL, V157, P297, DOI 10.1016/S0002-9440(10)64540-3; Lawson JA, 2000, TOXICOL SCI, V54, P509, DOI 10.1093/toxsci/54.2.509; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; Muller S, 2001, EMBO J, V20, P4337, DOI 10.1093/emboj/20.16.4337; Nightingale K, 1996, EMBO J, V15, P548, DOI 10.1002/j.1460-2075.1996.tb00387.x; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Ren Y, 1998, CELL DEATH DIFFER, V5, P563, DOI 10.1038/sj.cdd.4400407; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; THOMAS SHL, 1993, PHARMACOL THERAPEUT, V60, P91, DOI 10.1016/0163-7258(93)90023-7; Ura K, 1996, EMBO J, V15, P4959, DOI 10.1002/j.1460-2075.1996.tb00876.x; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Zappavigna V, 1996, EMBO J, V15, P4981, DOI 10.1002/j.1460-2075.1996.tb00878.x	24	3166	3363	11	215	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 11	2002	418	6894					191	195		10.1038/nature00858	http://dx.doi.org/10.1038/nature00858			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	571GV	12110890				2022-12-24	WOS:000176710400042
J	Raguram, R; Venkateswaran, A; Ramakrishna, J; Weiss, MG				Raguram, R; Venkateswaran, A; Ramakrishna, J; Weiss, MG			Traditional community resources for mental health: a report of temple healing from India	BRITISH MEDICAL JOURNAL			English	Article							ALTERNATIVE MEDICINE; COMPLEMENTARY	The use of complementary medicine and the traditional medicine of other cultures has been increasing in Europe and North America.(3) Although less well documented, the use of complementary medicines and consultations with traditional healers is widely acknowledged in low income countries, such as India. Here too the limited availability of health services motivates the use of a wide range of alternative systems of care for various ailments, including mental illnesses(4).	Natl Inst Mental Hlth & Neurosci, Bangalore 560029, Karnataka, India; Swiss Trop Inst, Dept Epidemiol & Publ Hlth, CH-4002 Basel, Switzerland	National Institute of Mental Health & Neurosciences - India; University of Basel; Swiss Tropical & Public Health Institute	Raguram, R (corresponding author), Natl Inst Mental Hlth & Neurosci, Bangalore 560029, Karnataka, India.							[Anonymous], 1982, NAT MENT HLTH PROGR; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Ernst E, 2000, BMJ-BRIT MED J, V321, P1133, DOI 10.1136/bmj.321.7269.1133; FISHER P, 1994, BRIT MED J, V309, P107, DOI 10.1136/bmj.309.6947.107; Jablensky A, 2000, EUR ARCH PSY CLIN N, V250, P274, DOI 10.1007/s004060070002; KAPUR RL, 1975, BRIT J PSYCHIAT, V127, P286, DOI 10.1192/bjp.127.3.286; KAPUR RL, 1979, SOC SCI MED-MED ANTH, V13, P27, DOI 10.1016/0160-7987(79)90015-2; OVERALL JE, 1962, PSYCHOL REP, V10, P799; PAKASLAHTI A, 1998, CHANGING PATTERNS FA; RAGHU TM, 1999, CULTURAL ASPECTS SCH; Umbricht D, 1995, SCHIZOPHRENIA BULL, V21, P593, DOI 10.1093/schbul/21.4.593; VENKATESWARAN V, 2001, THESIS NATL I MENTAL; Weiss M.G., 2001, ANTHROPOL MED, V8, P5, DOI [10.1080/13648470120070980, DOI 10.1080/13648470120070980]; WHO, 2012, ICD 10 CLASS MENT BE	14	95	97	0	9	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 6	2002	325	7354					38	40		10.1136/bmj.325.7354.38	http://dx.doi.org/10.1136/bmj.325.7354.38			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	573BC	12098731	Green Published, Green Submitted			2022-12-24	WOS:000176808600025
J	Tabara, H; Yigit, E; Siomi, H; Mello, CC				Tabara, H; Yigit, E; Siomi, H; Mello, CC			The dsRNA binding protein RDE-4 interacts with RDE-1, DCR-1, and a DExX-box helicase to direct RNAi in C-elegans	CELL			English	Article							GERM-LINE DEVELOPMENT; DOUBLE-STRANDED-RNA; GENE; INTERFERENCE; TRANSGENE; ENCODES; DEFENSE; IDENTIFICATION; TRANSCRIPTION; REQUIREMENTS	Double-stranded(ds) RNA induces potent gene silencing, termed RNA interference (RNAi). At an early step in RNAi, an RNaseIII-related enzyme, Dicer (DCR-1), processes long-trigger dsRNA into small interfering RNAs (siRNAs). DCR-1 is also required for processing endogenous regulatory RNAs called miRNAs, but how DCR-1 recognizes its endogenous and foreign substrates is not yet understood. Here we show that the C. elegans RNAi pathway gene, rde-4, encodes a dsRNA binding protein that interacts during RNAi with RNA identical to the trigger dsRNA. RDE-4 protein also interacts in vivo with DCR-1, RDE-1, and a conserved DExH-box helicase. Our findings suggest a model in which RDE-4 and RDE-1 function together to detect and retain foreign dsRNA and to present this dsRNA to DCR-1 for processing.	Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; Univ Tokushima, Inst Genome Res, Tokushima 7708503, Japan; Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; Tokushima University; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Mello, CC (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	craig.mello@umassmed.edu	Siomi, Haruhiko/A-7020-2015	Siomi, Haruhiko/0000-0001-8690-3822	NIGMS NIH HHS [GM58800] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058800] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baulcombe D, 2002, CURR BIOL, V12, pR82, DOI 10.1016/S0960-9822(02)00665-6; Benfey PN, 1999, CURR BIOL, V9, pR171, DOI 10.1016/S0960-9822(99)80105-5; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; BLUMENTHAL T, 1995, TRENDS GENET, V11, P132, DOI 10.1016/S0168-9525(00)89026-5; Catalanotto C, 2000, NATURE, V404, P245, DOI 10.1038/35005169; Catalanotto C, 2002, GENE DEV, V16, P790, DOI 10.1101/gad.222402; Clauser KR, 1999, ANAL CHEM, V71, P2871, DOI 10.1021/ac9810516; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Cogoni C, 2000, CURR OPIN GENET DEV, V10, P638, DOI 10.1016/S0959-437X(00)00134-9; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Dalmay T, 2001, EMBO J, V20, P2069, DOI 10.1093/emboj/20.8.2069; Dernburg AF, 2000, GENE DEV, V14, P1578; Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597; Fierro-Monti I, 2000, TRENDS BIOCHEM SCI, V25, P241, DOI 10.1016/S0968-0004(00)01580-2; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Grishok A, 2000, SCIENCE, V287, P2494, DOI 10.1126/science.287.5462.2494; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Ketting RF, 2000, NATURE, V404, P296, DOI 10.1038/35005113; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lipardi C, 2001, CELL, V107, P297, DOI 10.1016/S0092-8674(01)00537-2; Mello C, 1995, METHOD CELL BIOL, V48, P451; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Plasterk RHA, 2000, CURR OPIN GENET DEV, V10, P562, DOI 10.1016/S0959-437X(00)00128-3; PROUD CG, 1995, TRENDS BIOCHEM SCI, V20, P241, DOI 10.1016/S0968-0004(00)89025-8; Ratcliff F, 1997, SCIENCE, V276, P1558, DOI 10.1126/science.276.5318.1558; Reinscheid RK, 2000, PEPTIDES, V21, P901, DOI 10.1016/S0196-9781(00)00226-6; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; Ryter JM, 1998, EMBO J, V17, P7505, DOI 10.1093/emboj/17.24.7505; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tabara H, 1999, DEVELOPMENT, V126, P1; Tijsterman M, 2002, SCIENCE, V295, P694, DOI 10.1126/science.1067534; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Vance V, 2001, SCIENCE, V292, P2277, DOI 10.1126/science.1061334; Waterhouse PM, 2001, NATURE, V411, P834, DOI 10.1038/35081168; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wu-Scharf D, 2000, SCIENCE, V290, P1159, DOI 10.1126/science.290.5494.1159; Zhang XX, 2000, MICROB PATHOGENESIS, V28, P267, DOI 10.1006/mpat.1999.0349	49	369	439	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 28	2002	109	7					861	871		10.1016/S0092-8674(02)00793-6	http://dx.doi.org/10.1016/S0092-8674(02)00793-6			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	570KJ	12110183	Bronze			2022-12-24	WOS:000176657200009
J	Gong, F; Yanofsky, C				Gong, F; Yanofsky, C			Instruction of translating ribosome by nascent peptide	SCIENCE			English	Article							ESCHERICHIA-COLI K-12; TRYPTOPHANASE OPERON EXPRESSION; OPEN READING FRAMES; ERYTHROMYCIN RESISTANCE; ANGSTROM RESOLUTION; SUBUNIT; RNA; RECOGNITION; INDUCTION; CLEAVAGE	Expression of the tryptophanase operon of Escherichia coli is regulated by catabolite repression and tryptophan-induced transcription antitermination. An induction site activated by L-tryptophan is created in the translating ribosome during synthesis of TnaC, the 24-residue leader peptide. Replacing the tnaC stop codon with a tryptophan codon allows tryptophan-charged tryptophan transfer RNA to substitute for tryptophan as inducer. This suggests that the ribosomal A site occupied by the tryptophanyl moiety of the charged transfer RNA is the site of induction. The location of tryptophan-12 of nascent TnaC in the peptide exit tunnel was crucial for induction. These results show that a nascent peptide sequence can influence translation continuation and termination within a translating ribosome.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University	Yanofsky, C (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.							Alderete JP, 2001, J VIROL, V75, P7188, DOI 10.1128/JVI.75.15.7188-7192.2001; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; BOTSFORD JL, 1971, J BACTERIOL, V105, P303, DOI 10.1128/JB.105.1.303-312.1971; DEELEY MC, 1981, J BACTERIOL, V147, P787, DOI 10.1128/JB.147.3.787-796.1981; Freistroffer DV, 2000, P NATL ACAD SCI USA, V97, P2046, DOI 10.1073/pnas.030541097; Gaba A, 2001, EMBO J, V20, P6453, DOI 10.1093/emboj/20.22.6453; Gabashvili IS, 2001, MOL CELL, V8, P181, DOI 10.1016/S1097-2765(01)00293-3; GOLLNICK P, 1990, J BACTERIOL, V172, P3100, DOI 10.1128/jb.172.6.3100-3107.1990; Gong F, 2002, J BIOL CHEM, V277, P17095, DOI 10.1074/jbc.M201213200; Gong F, 2001, J BIOL CHEM, V276, P1974, DOI 10.1074/jbc.M008892200; Gong F, 2001, P NATL ACAD SCI USA, V98, P8997, DOI 10.1073/pnas.171299298; KAZARINOFF MN, 1977, J BIOL CHEM, V252, P7598; Kramer G, 2001, INT J BIOCHEM CELL B, V33, P541, DOI 10.1016/S1357-2725(01)00044-9; Lovett PS, 1996, MICROBIOL REV, V60, P366, DOI 10.1128/MMBR.60.2.366-385.1996; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; PHILLIPS RS, 1985, J BIOL CHEM, V260, P4665; Raney A, 2002, J BIOL CHEM, V277, P5988, DOI 10.1074/jbc.M108375200; Simonson AB, 2002, NATURE, V416, P281, DOI 10.1038/416281a; STEWART V, 1986, J BACTERIOL, V166, P217, DOI 10.1128/jb.166.1.217-223.1986; STEWART V, 1986, J BACTERIOL, V167, P383, DOI 10.1128/jb.167.1.383-386.1986; Tenson T, 2002, CELL, V108, P591, DOI 10.1016/S0092-8674(02)00669-4; WEISBLUM B, 1995, ANTIMICROB AGENTS CH, V39, P577, DOI 10.1128/AAC.39.3.577; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; YONATH A, 1987, SCIENCE, V236, P813, DOI 10.1126/science.3576200; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	27	186	191	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 13	2002	297	5588					1864	1867		10.1126/science.1073997	http://dx.doi.org/10.1126/science.1073997			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592UJ	12228716				2022-12-24	WOS:000177955000042
J	Milligan, AJ; Morel, FMM				Milligan, AJ; Morel, FMM			A proton buffering role for silica in diatoms	SCIENCE			English	Article							CARBONIC-ANHYDRASE ACTIVITY; MARINE DIATOMS; GROWTH; CYCLE; MECHANISMS; LIMITATION; TRANSPORT; FAMILY; ENZYME; ALGAE	For 40 million years, diatoms have dominated the reverse weathering of silica on Earth. These photosynthetic protists take up dissolved silicic acid from the water and precipitate opaline silica to form their cell wall. We show that the biosilica of diatoms is an effective pH buffer, enabling the enzymatic conversion of bicarbonate to CO2, an important step in inorganic carbon acquisition by these organisms. Because diatoms are responsible for one-quarter of global primary production and for a large fraction of the carbon exported to the deep sea, the global cycles of Si and C may be linked mechanistically.	Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA	Princeton University	Morel, FMM (corresponding author), Princeton Univ, Dept Geosci, Guyot Hall, Princeton, NJ 08544 USA.		Morel, Francois M M/A-8107-2008					AIZAWA K, 1986, FEMS MICROBIOL LETT, V39, P215, DOI 10.1016/0378-1097(86)90447-7; Badger MR, 1998, CAN J BOT, V76, P1052, DOI 10.1139/b98-074; Burkhardt S, 2001, LIMNOL OCEANOGR, V46, P1378, DOI 10.4319/lo.2001.46.6.1378; CARLISLE EM, 1986, CIBA F SYMP, V121, P123; Cox EH, 2000, BIOCHEMISTRY-US, V39, P12128, DOI 10.1021/bi001416s; DAVIDSON AT, 1994, MAR BIOL, V119, P507, DOI 10.1007/BF00354312; Dixit S, 2002, GEOCHIM COSMOCHIM AC, V66, P2559, DOI 10.1016/S0016-7037(02)00854-2; Dugdale RC, 1998, NATURE, V391, P270, DOI 10.1038/34630; Epstein E, 1999, ANNU REV PLANT PHYS, V50, P641, DOI 10.1146/annurev.arplant.50.1.641; Hayes JM, 1999, CHEM GEOL, V161, P103, DOI 10.1016/S0009-2541(99)00083-2; Hildebrand M, 1997, NATURE, V385, P688, DOI 10.1038/385688b0; Kroger N, 1999, SCIENCE, V286, P1129, DOI 10.1126/science.286.5442.1129; KROGER N, 1994, EMBO J, V13, P4676, DOI 10.1002/j.1460-2075.1994.tb06791.x; MALVIA RG, 1989, PALAIOS, V4, P519; Martin-Jezequel V, 2000, J PHYCOL, V36, P821, DOI 10.1046/j.1529-8817.2000.00019.x; Nimer NA, 1999, J PHYCOL, V35, P1200, DOI 10.1046/j.1529-8817.1999.3561200.x; PAASCHE E, 1980, LIMNOL OCEANOGR, V25, P474, DOI 10.4319/lo.1980.25.3.0474; PALMQVIST K, 1994, PHYSIOL PLANTARUM, V90, P537; Pearson PN, 2000, NATURE, V406, P695, DOI 10.1038/35021000; Pocker Y, 2000, CELL MOL LIFE SCI, V57, P1008, DOI 10.1007/PL00000741; PRICE N M, 1988, Biological Oceanography, V6, P443; Ragueneau O, 2000, GLOBAL PLANET CHANGE, V26, P317, DOI 10.1016/S0921-8181(00)00052-7; RAVEN JA, 1983, BIOL REV, V58, P179, DOI 10.1111/j.1469-185X.1983.tb00385.x; RIEBESELL U, 1993, NATURE, V361, P249, DOI 10.1038/361249a0; Roberts SB, 1997, J PHYCOL, V33, P845, DOI 10.1111/j.0022-3646.1997.00845.x; Schindler P., 1968, HELV CHIM ACTA, V51, P1781, DOI DOI 10.1002/HLCA.19680510738; SILVERMAN DN, 1982, METHOD ENZYMOL, V87, P732; Smetacek V, 1999, PROTIST, V150, P25, DOI 10.1016/S1434-4610(99)70006-4; Sultemeyer D, 1998, CAN J BOT, V76, P962; Tripp BC, 2000, BIOCHEMISTRY-US, V39, P9232, DOI 10.1021/bi0001877; Tu C, 2001, J AM CHEM SOC, V123, P5861, DOI 10.1021/ja010301o; VILLAREAL TA, 1988, DEEP-SEA RES, V35, P1037, DOI 10.1016/0198-0149(88)90075-1	32	135	142	2	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 13	2002	297	5588					1848	1850		10.1126/science.1074958	http://dx.doi.org/10.1126/science.1074958			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592UJ	12228711				2022-12-24	WOS:000177955000036
J	Munn, DH; Sharma, MD; Lee, JR; Jhaver, KG; Johnson, TS; Keskin, DB; Marshall, B; Chandler, P; Antonia, SJ; Burgess, R; Slingluff, CL; Mellor, AL				Munn, DH; Sharma, MD; Lee, JR; Jhaver, KG; Johnson, TS; Keskin, DB; Marshall, B; Chandler, P; Antonia, SJ; Burgess, R; Slingluff, CL; Mellor, AL			Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase	SCIENCE			English	Article							NECROSIS-FACTOR-ALPHA; TRYPTOPHAN CATABOLISM; HUMAN MACROPHAGES; PERIPHERAL-BLOOD; FETAL REJECTION; LYMPH-NODES; IFN-GAMMA; INTERFERON; ANTIGEN; PROLIFERATION	Antigen-presenting cells (APCs) can induce tolerance or immunity. We describe a subset of human APCs that express indoleamine 2,3-dioxygenase (IDO) and inhibit T cell proliferation in vitro. IDO-positive APCs constituted a discrete subset identified by coexpression of the cell-surface markers CD123 and CCR6. In the dendritic cell (DC) lineage, IDO-mediated suppressor activity was present in fully mature as well as immature CD123(+) DCs. IDO+ DCs could also be readily detected in vivo, which suggests that these cells may represent a regulatory subset of APCs in humans.	Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30912 USA; Med Coll Georgia, Dept Pediat, Augusta, GA 30912 USA; Vet Affairs Med Ctr, Augusta, GA 30912 USA; Med Coll Georgia, Dept Pathol, Augusta, GA 30912 USA; H Lee Moffitt Canc Ctr & Res Inst, Interdisciplinary Oncol Program, Tampa, FL 33612 USA; Med Coll Georgia, Dept Med, Augusta, GA 30912 USA; Univ Virginia, Dept Surg, Charlottesville, VA 22908 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; US Department of Veterans Affairs; Veterans Health Administration (VHA); University System of Georgia; Augusta University; H Lee Moffitt Cancer Center & Research Institute; University System of Georgia; Augusta University; University of Virginia	Munn, DH (corresponding author), Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30912 USA.	dmunn@mail.mcg.edu		Munn, David/0000-0002-7711-2858	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI044759, R01AI044219] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL60137] Funding Source: Medline; NIAID NIH HHS [AI44759, AI44219] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alexander AM, 2002, DIABETES, V51, P356, DOI 10.2337/diabetes.51.2.356; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; Chambers CA, 2001, TRENDS IMMUNOL, V22, P217, DOI 10.1016/S1471-4906(01)01868-3; Chen BG, 1998, BLOOD, V91, P4652, DOI 10.1182/blood.V91.12.4652.412a03_4652_4661; Cochran AJ, 2001, MODERN PATHOL, V14, P604, DOI 10.1038/modpathol.3880358; Curelli S, 2001, J INTERF CYTOK RES, V21, P431, DOI 10.1089/107999001750277916; DAI W, 1990, BIOCHEM BIOPH RES CO, V168, P1, DOI 10.1016/0006-291X(90)91666-G; Dzionek A, 2000, J IMMUNOL, V165, P6037, DOI 10.4049/jimmunol.165.11.6037; Fallarino F, 2002, INT IMMUNOL, V14, P65, DOI 10.1093/intimm/14.1.65; Grant RS, 2000, J VIROL, V74, P4110, DOI 10.1128/JVI.74.9.4110-4115.2000; Grohmann U, 2001, J IMMUNOL, V167, P708, DOI 10.4049/jimmunol.167.2.708; Grohmann U, 2001, J IMMUNOL, V166, P277, DOI 10.4049/jimmunol.166.1.277; Hwu P, 2000, J IMMUNOL, V164, P3596, DOI 10.4049/jimmunol.164.7.3596; Jonuleit H, 1997, EUR J IMMUNOL, V27, P3135, DOI 10.1002/eji.1830271209; KAMIMURA S, 1991, ACTA MED OKAYAMA, V45, P135; Konieczny BT, 1998, J IMMUNOL, V160, P2059; Kudo Y, 2000, BBA-MOL BASIS DIS, V1500, P119, DOI 10.1016/S0925-4439(99)00096-4; Mellor AL, 2002, J IMMUNOL, V168, P3771, DOI 10.4049/jimmunol.168.8.3771; MELLROY D, 2001, BLOOD, V97, P3470; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Munn DH, 1999, J EXP MED, V189, P1363, DOI 10.1084/jem.189.9.1363; Munn DH, 1996, J IMMUNOL, V156, P523; MUNN DH, UNPUB; Orenstein JM, 1999, ULTRASTRUCT PATHOL, V23, P79, DOI 10.1080/019131299281734; Reddy A, 1997, BLOOD, V90, P3640, DOI 10.1182/blood.V90.9.3640; Romani N, 1996, J IMMUNOL METHODS, V196, P137, DOI 10.1016/0022-1759(96)00078-6; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Shortman K, 2001, NAT IMMUNOL, V2, P988, DOI 10.1038/ni1101-988; Steinbrink K, 1997, J IMMUNOL, V159, P4772; Steinman RM, 2002, P NATL ACAD SCI USA, V99, P351, DOI 10.1073/pnas.231606698; Summers KL, 2001, AM J PATHOL, V159, P285, DOI 10.1016/S0002-9440(10)61694-X; THOMAS SR, 1994, J BIOL CHEM, V269, P14457; Thomas SR, 2001, J IMMUNOL, V166, P6332, DOI 10.4049/jimmunol.166.10.6332; Yang D, 1999, J IMMUNOL, V163, P1737	34	822	897	0	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2002	297	5588					1867	1870		10.1126/science.1073514	http://dx.doi.org/10.1126/science.1073514			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592UJ	12228717				2022-12-24	WOS:000177955000043
J	Pell, JP; Sirel, JM; Marsden, AK; Ford, I; Walker, NL; Cobbe, SM				Pell, JP; Sirel, JM; Marsden, AK; Ford, I; Walker, NL; Cobbe, SM			Potential impact of public access defibrillators on survival after out of hospital cardiopulmonary arrest: retrospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							AMERICAN-HEART-ASSOCIATION; CARDIAC-ARREST; AIRLINE	Objective To estimate the potential impact of public access defibrillators on overall survival after out of hospital cardiac arrest. Design Retrospective cohort study using data from an electronic register. A statistical model was used to estimate the effect on survival of placing public access defibrillators at suitable or possibly suitable sites. Setting Scottish Ambulance Service. Subjects Records of all out of hospital cardiac arrests due to heart disease in Scotland in 1991-8. Main outcome measures Observed and predicted survival to discharge from hospital. Results Of 15 189 arrests, 12 004 (79.0%) occurred in sites not suitable for the location of public access defibrillators, 453 (3.0%) in sites where they may be suitable, and 2732 (18.0%) in suitable sites. Defibrillation was given in 67.9% of arrests that occurred in possibly suitable sites for locating defibrillators and in 72.9% of arrests that occurred in suitable sites. Compared with an actual overall survival of 744 (5.0%), the predicted survival with public access defibrillators ranged from 942 (6.3%) to 959 (6.5%), depending on the assumptions made regarding defibrillator coverage. Conclusions The predicted increase in survival from targeted provision of public access defibrillators is less than the increase achievable through expansion of first responder defibrillation to non-ambulance personnel, such as police or firefighters, or of bystander cardiopulmonary resuscitation. Additional resources for wide scale coverage of public access defibrillators are probably not justified by the marginal improvement in survival.	Univ Glasgow, Dept Med Cardiol, Glasgow G31 2ER, Lanark, Scotland; Scottish Ambulance Serv Headquarters, Edinburgh EH10 5UU, Midlothian, Scotland; Univ Glasgow, Robertson Ctr Biostat, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow; University of Glasgow	Cobbe, SM (corresponding author), Univ Glasgow, Dept Med Cardiol, Glasgow G31 2ER, Lanark, Scotland.		Ford, Ian/ABE-6145-2020	Pell, Jill/0000-0002-8898-7035				CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; Nichol G, 1998, CIRCULATION, V97, P1309, DOI 10.1161/01.CIR.97.13.1309; Nichol G, 1998, CIRCULATION, V97, P1315, DOI 10.1161/01.CIR.97.13.1315; ORourke MF, 1997, CIRCULATION, V96, P2849, DOI 10.1161/01.CIR.96.9.2849; Page RL, 2000, NEW ENGL J MED, V343, P1210, DOI 10.1056/NEJM200010263431702; Pell JP, 2001, BRIT MED J, V322, P1385, DOI 10.1136/bmj.322.7299.1385; *SECR STAT HLTH, 1999, SAV LIV OUR HLTH NAT; SEDGWICK ML, 1994, RESUSCITATION, V27, P55, DOI 10.1016/0300-9572(94)90022-1; Valenzuela TD, 2000, NEW ENGL J MED, V343, P1206, DOI 10.1056/NEJM200010263431701; WEAVER WD, 1988, NEW ENGL J MED, V319, P661, DOI 10.1056/NEJM198809153191101; WILCOXGOK VL, 1991, MED CARE, V29, P104, DOI 10.1097/00005650-199102000-00003	11	58	61	0	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 7	2002	325	7363					515	517		10.1136/bmj.325.7363.515	http://dx.doi.org/10.1136/bmj.325.7363.515			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	593NJ	12217989	Bronze, Green Accepted, Green Published			2022-12-24	WOS:000177997800015
J	Di Noia, J; Neuberger, MS				Di Noia, J; Neuberger, MS			Altering the pathway of immunoglobulin hypermutation by inhibiting uracil-DNA glycosylase	NATURE			English	Article							SOMATIC HYPERMUTATION; DEAMINATED CYTOSINE; ESCHERICHIA-COLI; GENE CONVERSION; N-GLYCOSIDASE; HUMAN-CELLS; EXCISION; BACTERIOPHAGE-PBS2; INSTABILITY; EXPRESSION	A functional immune system depends on the production of a wide range of immunoglobulin molecules. Immunoglobulin variable region (IgV) genes are diversified after gene rearrangement by hypermutation. In the DNA deamination model, we have proposed that deamination of dC residues to dU by activation-induced deaminase (AID) triggers this diversification. In hypermutating chicken DT40 B cells, most IgV mutations are dC --> dG/dA or dG --> dC/dT transversions, which are proposed to result from replication over sites of base loss produced by the excision activity of uracil-DNA glycosylase. Blocking the activity of uracil-DNA glycosylase should instead lead to replication over the dU lesion, resulting in dC --> dT (and dG --> dA) transitions. Here we show that expression in DT40 cells of a bacteriophage-encoded protein that inhibits uracil-DNA glycosylase shifts the pattern of IgV gene mutations from transversion dominance to transition dominance. This is good evidence that antibody diversification involves dC --> dU deamination within the immunoglobulin locus itself.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Neuberger, MS (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.		Di Noia, Javier Marcelo/D-2285-2012	Di Noia, Javier Marcelo/0000-0003-2896-0321				BABA TW, 1985, VIROLOGY, V144, P139, DOI 10.1016/0042-6822(85)90312-5; BUERSTEDDE JM, 1990, EMBO J, V9, P921, DOI 10.1002/j.1460-2075.1990.tb08190.x; FRIEDBERG EC, 1975, J VIROL, V16, P315, DOI 10.1128/JVI.16.2.315-321.1975; Handa P, 2001, J BIOL CHEM, V276, P17324, DOI 10.1074/jbc.M011166200; Harris RS, 2001, J VIROL, V75, P10488, DOI 10.1128/JVI.75.21.10488-10492.2001; Harris RS, 2002, CURR BIOL, V12, P435, DOI 10.1016/S0960-9822(02)00717-0; Haushalter KA, 1999, CURR BIOL, V9, P174, DOI 10.1016/S0960-9822(99)80087-6; KARRAN P, 1981, BIOCHEMISTRY-US, V20, P6092, DOI 10.1021/bi00524a027; LINDAHL T, 1974, P NATL ACAD SCI USA, V71, P3649, DOI 10.1073/pnas.71.9.3649; Lindahl T, 2000, MUTAT RES-REV MUTAT, V462, P129, DOI 10.1016/S1383-5742(00)00024-7; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; MOL CD, 1995, CELL, V82, P701, DOI 10.1016/0092-8674(95)90467-0; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Nilsen H, 2000, MOL CELL, V5, P1059, DOI 10.1016/S1097-2765(00)80271-3; Nilsen H, 2001, EMBO J, V20, P4278, DOI 10.1093/emboj/20.15.4278; Pearl LH, 2000, MUTAT RES-DNA REPAIR, V460, P165, DOI 10.1016/S0921-8777(00)00025-2; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Radany EH, 2000, MUTAT RES-DNA REPAIR, V461, P41, DOI 10.1016/S0921-8777(00)00040-9; Sale JE, 2001, NATURE, V412, P921, DOI 10.1038/35091100; Takata M, 2001, MOL CELL BIOL, V21, P2858, DOI 10.1128/MCB.21.8.2858-2866.2001; WANG ZG, 1988, J BACTERIOL, V170, P1082, DOI 10.1128/jb.170.3.1082-1091.1988	21	429	439	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 5	2002	419	6902					43	48		10.1038/nature00981	http://dx.doi.org/10.1038/nature00981			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589YF	12214226				2022-12-24	WOS:000177788600031
J	Ravasz, E; Somera, AL; Mongru, DA; Oltvai, ZN; Barabasi, AL				Ravasz, E; Somera, AL; Mongru, DA; Oltvai, ZN; Barabasi, AL			Hierarchical organization of modularity in metabolic networks	SCIENCE			English	Article							SCALE-FREE NETWORKS; REGULATORY NETWORKS; SMALL-WORLD; BIOLOGY; PATHWAYS; DEFINITION; MOTIFS	Spatially or chemically isolated functional modules composed of several cellular components and carrying discrete functions are considered fundamental building blocks of cellular organization, but their presence in highly integrated biochemical networks lacks quantitative support. Here, we show that the metabolic networks of 43 distinct organisms are organized into many small, highly connected topologic modules that combine in a hierarchical manner into larger, less cohesive units, with their number and degree of clustering following a power law. Within Escherichia coli, the uncovered hierarchical modularity closely overlaps with known metabolic functions. The identified network architecture may be generic to system-level cellular organization.	Northwestern Univ, Dept Pathol, Chicago, IL 60611 USA; Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA	Northwestern University; University of Notre Dame	Oltvai, ZN (corresponding author), Northwestern Univ, Dept Pathol, Chicago, IL 60611 USA.	zno008@northwestern.edu; alb@nd.edu	Barabasi, Albert-Laszlo/S-6474-2017; Regan, Erzsébet Ravasz/AAG-8989-2019	Regan, Erzsébet Ravasz/0000-0002-8663-3153; Barabasi, Albert/0000-0002-4028-3522				Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barabasi AL, 2001, PHYSICA A, V299, P559, DOI 10.1016/S0378-4371(01)00369-7; Bollobas B., 2001, RANDOM GRAPHS, V2nd edn; Dorogovtsev SN, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.066122; DOROGOVTSEV SN, 2001, CONDMAT0112143; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Featherstone DE, 2002, BIOESSAYS, V24, P267, DOI 10.1002/bies.10054; Flake GW, 2002, COMPUTER, V35, P66, DOI 10.1109/2.989932; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; GIRVAN M, 2001, CONDMAT0112110; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hasty J, 2001, NAT REV GENET, V2, P268, DOI 10.1038/35066056; Holter NS, 2001, P NATL ACAD SCI USA, V98, P1693, DOI 10.1073/pnas.98.4.1693; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Karp PD, 2002, NUCLEIC ACIDS RES, V30, P56, DOI 10.1093/nar/30.1.56; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Lauffenburger DA, 2000, P NATL ACAD SCI USA, V97, P5031, DOI 10.1073/pnas.97.10.5031; Overbeek R, 2000, NUCLEIC ACIDS RES, V28, P123, DOI 10.1093/nar/28.1.123; Rao CV, 2001, ANNU REV BIOMED ENG, V3, P391, DOI 10.1146/annurev.bioeng.3.1.391; Schilling CH, 2000, J THEOR BIOL, V203, P229, DOI 10.1006/jtbi.2000.1073; Schuster S, 2000, NAT BIOTECHNOL, V18, P326, DOI 10.1038/73786; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Smith E D, 2002, ADV COMPLEX SYST, V5, P43, DOI DOI 10.1142/S021952590200047X; SOKAL J, 1973, NUMERICAL TAXONOMY; Vazquez A, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.066130; VAZQUEZ AM, IN PRESS; Wagner A, 2001, P ROY SOC B-BIOL SCI, V268, P1803, DOI 10.1098/rspb.2001.1711; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wolf YI, 2002, BIOESSAYS, V24, P105, DOI 10.1002/bies.10059; Wuchty S, 2001, MOL BIOL EVOL, V18, P1694, DOI 10.1093/oxfordjournals.molbev.a003957	32	2817	2957	6	361	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2002	297	5586					1551	1555		10.1126/science.1073374	http://dx.doi.org/10.1126/science.1073374			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588JA	12202830	Green Submitted			2022-12-24	WOS:000177697300057
J	Cho, HS; Leahy, DJ				Cho, HS; Leahy, DJ			Structure of the extracellular region of HER3 reveals an interdomain tether	SCIENCE			English	Article							EPIDERMAL GROWTH-FACTOR; LIGAND-BINDING SPECIFICITY; FACTOR RECEPTOR; EGF RECEPTOR; PROTEIN STRUCTURES; SIGNALING NETWORK; DOMAIN; EXPRESSION; AFFINITY; MODEL	We have determined the 2.6 angstrom crystal structure of the entire extracellular region of human HER3 ( ErbB3), a member of the epidermal growth factor receptor ( EGFR) family. The structure consists of four domains with structural homology to domains found in the type I insulin-like growth factor receptor. The HER3 structure reveals contact between domains II and IV that constrains the relative orientations of ligand-binding domains and provides structural basis for understanding both multiple-affinity forms of EGFRs and conformational changes induced in the receptor by ligand binding during signaling. These results also suggest new therapeutic approaches to modulating the behavior of members of the EGFR family.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University	Leahy, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Biophys & Biophys Chem, 725 N Wolfe St, Baltimore, MD 21205 USA.							BARGMANN CI, 1986, NATURE, V319, P226, DOI 10.1038/319226a0; BROWN PM, 1994, EUR J BIOCHEM, V225, P223, DOI 10.1111/j.1432-1033.1994.00223.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARSON M, 1997, RIBBONS, V277; COHEN S, 1987, IN VITRO CELL DEV B, V23, P239; Domagala T, 2000, GROWTH FACTORS, V18, P11, DOI 10.3109/08977190009003231; Elleman TC, 2001, BIOCHEMISTRY-US, V40, P8930, DOI 10.1021/bi010037b; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; GADELLA TWJ, 1995, J CELL BIOL, V129, P1543, DOI 10.1083/jcb.129.6.1543; Garrett TPJ, 1998, NATURE, V394, P395, DOI 10.1038/28668; GRASBERGER B, 1986, P NATL ACAD SCI USA, V83, P6258, DOI 10.1073/pnas.83.17.6258; GREENFIELD C, 1989, EMBO J, V8, P4115, DOI 10.1002/j.1460-2075.1989.tb08596.x; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KOHDA D, 1993, J BIOL CHEM, V268, P1976; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KRAUS MH, 1989, P NATL ACAD SCI USA, V86, P9193, DOI 10.1073/pnas.86.23.9193; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; LAX I, 1991, CELL REGUL, V2, P337, DOI 10.1091/mbc.2.5.337; LAX I, 1991, J BIOL CHEM, V266, P13828; Leahy DJ, 2000, PROTEIN EXPRES PURIF, V20, P500, DOI 10.1006/prep.2000.1331; Lemmon MA, 1997, EMBO J, V16, P281, DOI 10.1093/emboj/16.2.281; Mendrola JM, 2002, J BIOL CHEM, V277, P4704, DOI 10.1074/jbc.M108681200; MONTELIONE GT, 1992, BIOCHEMISTRY-US, V31, P236, DOI 10.1021/bi00116a033; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; PLOWMAN GD, 1990, P NATL ACAD SCI USA, V87, P4905, DOI 10.1073/pnas.87.13.4905; Riese DJ, 1998, BIOESSAYS, V20, P41, DOI 10.1002/(SICI)1521-1878(199801)20:1<41::AID-BIES7>3.0.CO;2-V; SCHECHTER Y, 1979, NATURE, V278, P835, DOI 10.1038/278835a0; SCHLESSINGER J, 1983, CRC CR REV BIOCH MOL, V14, P93, DOI 10.3109/10409238309102791; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shak S, 1999, SEMIN ONCOL, V26, P71; SLIWKOWSKI MX, 1994, J BIOL CHEM, V269, P14661; STANLEY P, 1975, CELL, V6, P121, DOI 10.1016/0092-8674(75)90002-1; Tang CK, 1998, HORMONES SIGNALING, P113; Tanner KG, 1999, J BIOL CHEM, V274, P35985, DOI 10.1074/jbc.274.50.35985; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; WOLTJER RL, 1992, P NATL ACAD SCI USA, V89, P7801, DOI 10.1073/pnas.89.16.7801; WU DG, 1990, P NATL ACAD SCI USA, V87, P3151, DOI 10.1073/pnas.87.8.3151; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1443, DOI 10.1021/bi00379a035; ZHANG KYJ, 1990, ACTA CRYSTALLOGR A, V46, P377, DOI 10.1107/S0108767389012158	43	329	371	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 23	2002	297	5585					1330	1333		10.1126/science.1074611	http://dx.doi.org/10.1126/science.1074611			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FL	12154198				2022-12-24	WOS:000177573900042
J	Tapon, N; Harvey, KF; Bell, DW; Wahrer, DCR; Schiripo, TA; Haber, DA; Hariharan, IK				Tapon, N; Harvey, KF; Bell, DW; Wahrer, DCR; Schiripo, TA; Haber, DA; Hariharan, IK			salvador promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines	CELL			English	Article							DEPENDENT KINASE INHIBITOR; REAPER; HID; DEGRADATION; PROTEINS; SURVIVAL; GROWTH; DIAP1; GRIM; HOMOLOGS	The number of cells in an organism is determined by regulating both cell proliferation and cell death. Relatively few mechanisms have been identified that can modulate both of these processes. In a screen for Drosophila mutations that result in tissue overgrowth, we identified salvador (sav), a gene that promotes both cell cycle exit and cell death. Elevated Cyclin E and DIAP1 levels are found in mutant cells, resulting in delayed cell cycle exit and impaired apoptosis. Salvador contains two WW domains and binds to the Warts (or LATS) protein kinase. The human ortholog of salvador(hWW45) is mutated in three cancer cell lines. Thus, salvador restricts cell numbers in vivo by functioning as a dual regulator of cell proliferation and apoptosis.	Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Hariharan, IK (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Bldg 149,13th St, Charlestown, MA 02129 USA.	hariharan@helix.mgh.harvard.edu	Harvey, Kieran/AAD-5268-2022	Harvey, Kieran/0000-0001-7845-369X; Tapon, Nicolas/0000-0001-5267-6510	NATIONAL CANCER INSTITUTE [R21CA087691] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061672] Funding Source: NIH RePORTER; NCI NIH HHS [CA87691] Funding Source: Medline; NEI NIH HHS [EY11632] Funding Source: Medline; NIGMS NIH HHS [GM61672] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bergmann A, 1998, CELL, V95, P331, DOI 10.1016/S0092-8674(00)81765-1; BRYANT PJ, 1993, DEVELOPMENT, P239; deNooij JC, 1996, CELL, V87, P1237, DOI 10.1016/S0092-8674(00)81819-X; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; Hay BA, 1995, CELL, V83, P1253, DOI 10.1016/0092-8674(95)90150-7; Hays R, 2002, NAT CELL BIOL, V4, P425, DOI 10.1038/ncb794; Holley CL, 2002, NAT CELL BIOL, V4, P439, DOI 10.1038/ncb798; Jones L, 2000, DEVELOPMENT, V127, P4619; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kato Y, 2002, J BIOL CHEM, V277, P10173, DOI 10.1074/jbc.M110490200; KNOBLICH JA, 1994, CELL, V77, P107, DOI 10.1016/0092-8674(94)90239-9; Kurada P, 1998, CELL, V95, P319, DOI 10.1016/S0092-8674(00)81764-X; Lane ME, 1996, CELL, V87, P1225, DOI 10.1016/S0092-8674(00)81818-8; Lisi S, 2000, GENETICS, V154, P669; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; Newsome TP, 2000, DEVELOPMENT, V127, P851; Prober DA, 2000, CELL, V100, P435, DOI 10.1016/S0092-8674(00)80679-0; Ryoo HD, 2002, NAT CELL BIOL, V4, P432, DOI 10.1038/ncb795; St John MAR, 1999, NAT GENET, V21, P182, DOI 10.1038/5965; Tao WF, 1999, NAT GENET, V21, P177, DOI 10.1038/5960; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; Valverde P, 2000, BIOCHEM BIOPH RES CO, V276, P990, DOI 10.1006/bbrc.2000.3582; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; Wilson R, 2002, NAT CELL BIOL, V4, P445, DOI 10.1038/ncb799; Wing JP, 2002, NAT CELL BIOL, V4, P451, DOI 10.1038/ncb800; Wolff Tanya, 1993, P1277; XU TA, 1995, DEVELOPMENT, V121, P1053; Yoo SJ, 2002, NAT CELL BIOL, V4, P416, DOI 10.1038/ncb793	29	653	686	2	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 23	2002	110	4					467	478		10.1016/S0092-8674(02)00824-3	http://dx.doi.org/10.1016/S0092-8674(02)00824-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	587QJ	12202036	Bronze			2022-12-24	WOS:000177653200008
J	Symer, DE; Connelly, C; Szak, ST; Caputo, EM; Cost, GJ; Parmigiani, G; Boeke, JD				Symer, DE; Connelly, C; Szak, ST; Caputo, EM; Cost, GJ; Parmigiani, G; Boeke, JD			Human L1 retrotransposition is associated with genetic instability in vivo	CELL			English	Article							HUMAN TRANSPOSABLE ELEMENT; LINE-1 RETROTRANSPOSITION; MAMMALIAN-CELLS; DNA; ENDONUCLEASE; REARRANGEMENTS; RECOMBINATION; INTEGRATION; MECHANISM; EVOLUTION	Retrotransposons have shaped eukaryotic genomes for millions of years. To analyze the consequences of human Ll retrotransposition, we developed a genetic system to recover many new L1 insertions in somatic cells. Forty-two de novo integrants were recovered that faithfully mimic many aspects of L1s that accumulated since the primate radiation. Their structures experimentally demonstrate an association between Ll retrotransposition and various forms of genetic instability. Numerous L1 element inversions, extra nucleotide insertions, exon deletions, a chromosomal inversion, and flanking sequence comobilization (called 5' transduction) were identified. In a striking number of integrants, short identical sequences were shared between the donor and the target site's 3' end, suggesting a mechanistic model that helps explain the structure of Ll insertions.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; Johns Hoipkins, Sidney Kimmel Comprehens Canc Ctr, Dept Med Oncol, Baltimore, MD 21231 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA; Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Boeke, JD (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, 725 N Wolfe St, Baltimore, MD 21205 USA.	jboeke@jhmi.edu	Symer, David E./E-4173-2011	Boeke, Jef/0000-0001-5322-4946; Cost, Gregory/0000-0002-8509-4653	NATIONAL CANCER INSTITUTE [P01CA016519] Funding Source: NIH RePORTER; NCI NIH HHS [CA16519] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Agresti A., 1990, CATEGORICAL DATA ANA, pXV; Boissinot S, 2000, MOL BIOL EVOL, V17, P915, DOI 10.1093/oxfordjournals.molbev.a026372; Boissinot S, 2001, MOL BIOL EVOL, V18, P926, DOI 10.1093/oxfordjournals.molbev.a003893; Cost GJ, 1998, BIOCHEMISTRY-US, V37, P18081, DOI 10.1021/bi981858s; DOMBROSKI BA, 1991, SCIENCE, V254, P1805, DOI 10.1126/science.1662412; Esnault C, 2000, NAT GENET, V24, P363, DOI 10.1038/74184; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; Gilbert N, 2002, CELL, V110, P315, DOI 10.1016/S0092-8674(02)00828-0; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hughes JF, 2001, NAT GENET, V29, P487, DOI 10.1038/ng775; JENSEN S, 1995, BIOCHEM BIOPH RES CO, V15, P111; Jurka J, 1997, P NATL ACAD SCI USA, V94, P1872, DOI 10.1073/pnas.94.5.1872; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; MATHIAS SL, 1991, SCIENCE, V254, P1808, DOI 10.1126/science.1722352; Moore JK, 1996, NATURE, V383, P644, DOI 10.1038/383644a0; Moran JV, 1999, SCIENCE, V283, P1530, DOI 10.1126/science.283.5407.1530; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Morrish TA, 2002, NAT GENET, V31, P159, DOI 10.1038/ng898; NEVERS P, 1977, NATURE, V268, P109, DOI 10.1038/268109a0; Ostertag EM, 2001, ANNU REV GENET, V35, P501, DOI 10.1146/annurev.genet.35.102401.091032; Ostertag EM, 2001, GENOME RES, V11, P2059, DOI 10.1101/gr.205701; Ovchinnikov I, 2001, GENOME RES, V11, P2050, DOI 10.1101/gr.194701; REVIE D, 1988, NUCLEIC ACIDS RES, V16, P10301, DOI 10.1093/nar/16.21.10301; ROTH DB, 1985, MOL CELL BIOL, V5, P2599, DOI 10.1128/MCB.5.10.2599; Santos FR, 2000, HUM MOL GENET, V9, P421, DOI 10.1093/hmg/9.3.421; Sassaman DM, 1997, NAT GENET, V16, P37, DOI 10.1038/ng0597-37; Saxton JA, 1998, J MOL BIOL, V280, P611, DOI 10.1006/jmbi.1998.1899; SMIT AF, 2001, REPEATMASKER; SMIT AFA, 1995, J MOL BIOL, V246, P401, DOI 10.1006/jmbi.1994.0095; SZAK ST, 2002, IN PRESS GENOME BIOL; Teng SC, 1996, NATURE, V383, P641, DOI 10.1038/383641a0; Wei W, 2000, ANAL BIOCHEM, V284, P435, DOI 10.1006/abio.2000.4675; Wei W, 2001, MOL CELL BIOL, V21, P1429, DOI 10.1128/MCB.21.4.1429-1439.2001	35	341	349	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 9	2002	110	3					327	338		10.1016/S0092-8674(02)00839-5	http://dx.doi.org/10.1016/S0092-8674(02)00839-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	583MN	12176320	Bronze			2022-12-24	WOS:000177411800009
J	Wichterle, H; Lieberam, I; Porter, JA; Jessell, TM				Wichterle, H; Lieberam, I; Porter, JA; Jessell, TM			Directed differentiation of embryonic stem cells into motor neurons	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; VENTRAL NEURAL-TUBE; LIM HOMEOBOX GENES; CHICK-EMBRYO; IN-VITRO; HOMEODOMAIN PROTEIN; INDUCTIVE SIGNALS; SPINAL-CORD; ES CELLS; SPECIFICATION	Inductive signals and transcription factors involved in motor neuron generation have been identified, raising the question of whether these developmental insights can be used to direct stem cells to a motor neuron fate. We show that developmentally relevant signaling factors can induce mouse embryonic stem (ES) cells to differentiate into spinal progenitor cells, and subsequently into motor neurons, through a pathway recapitulating that used in vivo. ES cell-derived motor neurons can populate the embryonic spinal cord, extend axons, and form synapses with target muscles. Thus, inductive signals involved in normal pathways of neurogenesis can direct ES cells to form specific classes of CNS neurons.	Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Curis Inc, Cambridge, MA 02138 USA	Columbia University; Howard Hughes Medical Institute	Jessell, TM (corresponding author), Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA.		Lieberam, Ivo/C-5324-2009	Lieberam, Ivo/0000-0003-3539-3054				ABBONDANZO SJ, 1993, METHOD ENZYMOL, V225, P803; Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; Belting HG, 1998, J EXP ZOOL, V282, P196, DOI 10.1002/(SICI)1097-010X(199809/10)282:1/2&lt;196::AID-JEZ22&gt;3.0.CO;2-R; BLOCHGALLEGO E, 1991, DEVELOPMENT, V111, P221; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Byrd N, 2002, DEVELOPMENT, V129, P361; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; CHOI T, 1991, MOL CELL BIOL, V11, P3070, DOI 10.1128/MCB.11.6.3070; DAVIS CA, 1988, GENE DEV, V2, P1736, DOI 10.1101/gad.2.12b.1736; Durston AJ, 1998, CURR TOP DEV BIOL, V40, P111, DOI 10.1016/S0070-2153(08)60366-X; Dyer MA, 2001, DEVELOPMENT, V128, P1717; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gratsch TE, 2002, DEV BIOL, V245, P83, DOI 10.1006/dbio.2002.0629; HOLLYDAY M, 1977, BRAIN RES, V132, P197, DOI 10.1016/0006-8993(77)90416-4; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Lee KJ, 1999, ANNU REV NEUROSCI, V22, P261, DOI 10.1146/annurev.neuro.22.1.261; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; Lee SK, 2001, NAT NEUROSCI, V4, P1183, DOI 10.1038/nn750; Li M, 1998, CURR BIOL, V8, P971, DOI 10.1016/S0960-9822(98)70399-9; Liu JP, 2001, NEURON, V32, P997, DOI 10.1016/S0896-6273(01)00544-X; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Mallamaci A, 1996, MECH DEVELOP, V58, P165, DOI 10.1016/S0925-4773(96)00571-0; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; Muhr J, 1999, NEURON, V23, P689, DOI 10.1016/S0896-6273(01)80028-3; Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; OBRIEN MK, 1990, J NEUROBIOL, V21, P313, DOI 10.1002/neu.480210207; Pattyn A, 2000, DEVELOPMENT, V127, P1349; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Rathjen J, 2002, DEVELOPMENT, V129, P2649; Renoncourt Y, 1998, MECH DEVELOP, V79, P185, DOI 10.1016/S0925-4773(98)00189-0; Reubinoff BE, 2001, NAT BIOTECHNOL, V19, P1134, DOI 10.1038/nbt1201-1134; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; Sander M, 2000, GENE DEV, V14, P2134, DOI 10.1101/gad.820400; Sharma K, 2000, NATURE, V406, P515, DOI 10.1038/35020078; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Streit A, 2000, NATURE, V406, P74, DOI 10.1038/35017617; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1; Tropepe V, 2001, NEURON, V30, P65, DOI 10.1016/S0896-6273(01)00263-X; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Vallstedt A, 2001, NEURON, V31, P743, DOI 10.1016/S0896-6273(01)00412-3; Wilson SI, 2000, CURR BIOL, V10, P421, DOI 10.1016/S0960-9822(00)00431-0; Wilson SI, 2001, NAT NEUROSCI, V4, P1161, DOI 10.1038/nn747; Wilson SI, 2001, NATURE, V411, P325, DOI 10.1038/35077115; Wood HB, 1999, MECH DEVELOP, V86, P197, DOI 10.1016/S0925-4773(99)00116-1; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	61	1293	1401	2	123	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 9	2002	110	3					385	397		10.1016/S0092-8674(02)00835-8	http://dx.doi.org/10.1016/S0092-8674(02)00835-8			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	583MN	12176325	Bronze			2022-12-24	WOS:000177411800014
J	Gross, RA; Kalra, B				Gross, RA; Kalra, B			Biodegradable polymers for the environment	SCIENCE			English	Article							BLEND MISCIBILITY; CELLULOSE-ACETATE	Biodegradable polymers are designed to degrade upon disposal by the action of living organisms. Extraordinary progress has been made in the development of practical processes and products from polymers such as starch, cellulose, and lactic acid. The need to create alternative biodegradable water-soluble polymers for down-the-drain products such as detergents and cosmetics has taken on increasing importance. Consumers have, however, thus far attached little or no added value to the property of biodegradability, forcing industry to compete head-to-head on a cost-performance basis with existing familiar products. In addition, no suitable infrastructure for the disposal of biodegradable materials exists as yet.	Polytech Univ, Natl Sci Fdn, Ctr Biocatalysis & Bioproc Macromol, Brooklyn, NY 11201 USA	National Science Foundation (NSF); New York University; Polytechnic University Puerto Rico	Gross, RA (corresponding author), Polytech Univ, Natl Sci Fdn, Ctr Biocatalysis & Bioproc Macromol, 6 Metrotech Ctr, Brooklyn, NY 11201 USA.							[Anonymous], 1971, LACTIC ACID PROPERTI; Bastioli C, 1998, MACROMOL SYMP, V135, P193, DOI 10.1002/masy.19981350122; Bastioli C, 1998, POLYM DEGRAD STABIL, V59, P263, DOI 10.1016/S0141-3910(97)00156-0; BASTOLI C, 2001, ACT C BIRM UK 29 30; Buchanan CM, 1997, J ENVIRON POLYM DEGR, V5, P209; Buchanan CM, 1996, J ENVIRON POLYM DEGR, V4, P179, DOI 10.1007/BF02067452; COOK WJ, 1981, J POLYM SCI POL LETT, V19, P159, DOI 10.1002/pol.1981.130190402; DOI Y, 1994, P 3 INT SCI WORKSH B; Doi Y., 1990, MICROBIAL POLYESTERS; Grigat E, 1998, POLYM DEGRAD STABIL, V59, P223, DOI 10.1016/S0141-3910(97)00174-2; GROSS RA, 1995, J MACROMOL SCI PURE, VA32, P613, DOI 10.1080/10601329508010275; Guillet J., 1973, POLYM SCI TECHNOL, V3, P61; Kaplan D. L., 1993, BIODEGRADABLE POLYM, P1; Lowe C. E., 1954, [No title captured], Patent No. [2,668,162, 2668162, US2668162A]; Lunt J, 1998, POLYM DEGRAD STABIL, V59, P145, DOI 10.1016/S0141-3910(97)00148-1; Moore GF, 1997, ADV BIODEGRADABLE PO, V9; Steinbuchel A., 1991, BIOMATERIALS, P123, DOI DOI 10.1007/978-1-349-11167-1_3; TOKIWA Y, 1976, J FERMENT TECHNOL, V54, P603; WOODINGS C, 2001, NF NEW FIBRES; 2001, FRANKFURTER ALLGEMEI, P19	20	1340	1425	24	702	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 2	2002	297	5582					803	807		10.1126/science.297.5582.803	http://dx.doi.org/10.1126/science.297.5582.803			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579RZ	12161646	Green Submitted			2022-12-24	WOS:000177192800040
J	Matthews, FE; Dening, T				Matthews, FE; Dening, T		UK Med Res Council Cognitive Funct	Prevalence of dementia in institutional care	LANCET			English	Article								Information about dementia prevalence In residential and nursing care homes helps these institutions to meet residents' needs. We combined residential characteristics ascertained at a screening Interview in 1991-93 with dementia diagnoses from assessment interviews In the UK Medical Research Council Cognitive Function and Ageing Study, a population-based study of 13 004 elderly people. Almost 5% of people aged 65 years or older lived in institution-34% (95% Cl 30-39) of individuals with dementia. Within institutions, dementia prevalence was 62% (52-71), and was slightly higher in women than in men, with no increase by age. That most residents have dementia has Implications for the type of care that institutions provide.	Univ Forvie Site, Inst Publ Hlth, MRC, Biostat Unit, Cambridge CB2 2SR, England; Fulbourne Hosp, Addenbrooks NHS Trust, Cambridge CB1 5EF, England	MRC Biostatistics Unit; University of Cambridge	Matthews, FE (corresponding author), Univ Forvie Site, Inst Publ Hlth, MRC, Biostat Unit, Cambridge CB2 2SR, England.		Matthews, Fiona/O-6932-2015; Dening, Tom/E-1335-2013	Matthews, Fiona/0000-0002-1728-2388; Dening, Tom/0000-0003-3387-4241				Brayne C, 1998, PSYCHOL MED, V28, P319; COPELAND JRM, 1986, PSYCHOL MED, V16, P89, DOI 10.1017/S0033291700057779; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Macdonald AJD, 2002, AGE AGEING, V31, P58, DOI 10.1093/ageing/31.1.58; *OFF POP CENS SURV, 1994, REV 1991 POP EST SUP	5	126	126	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 20	2002	360	9328					225	226		10.1016/S0140-6736(02)09461-8	http://dx.doi.org/10.1016/S0140-6736(02)09461-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	576DX	12133659				2022-12-24	WOS:000176988500014
J	Tirlapur, UK; Konig, K				Tirlapur, UK; Konig, K			Cell biology - Targeted transfection by femtosecond laser	NATURE			English	Article							MICROSCOPY; MEMBRANE		Univ Jena, Inst Anat 2, Laser Microscopy Div, D-07743 Jena, Germany	Friedrich Schiller University of Jena	Tirlapur, UK (corresponding author), Univ Jena, Inst Anat 2, Laser Microscopy Div, Teichgraben 7, D-07743 Jena, Germany.							Bildirici L, 2000, NATURE, V405, P298, DOI 10.1038/35012701; Knoblauch M, 1999, NAT BIOTECHNOL, V17, P906, DOI 10.1038/12902; Konig K, 2000, J MICROSC-OXFORD, V200, P83, DOI 10.1046/j.1365-2818.2000.00738.x; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Luo D, 2000, NAT BIOTECHNOL, V18, P33, DOI 10.1038/71889; Pepperkok R, 1999, CURR BIOL, V9, P269, DOI 10.1016/S0960-9822(99)80117-1; SO PTC, 1995, BIOIMAGING, V3, P1; Squirrell JM, 1999, NAT BIOTECHNOL, V17, P763, DOI 10.1038/11698; Stephens DJ, 2001, P NATL ACAD SCI USA, V98, P4295, DOI 10.1073/pnas.081065198; TAO W, 1987, P NATL ACAD SCI USA, V84, P4180, DOI 10.1073/pnas.84.12.4180	10	520	572	2	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 18	2002	418	6895					290	291		10.1038/418290a	http://dx.doi.org/10.1038/418290a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574BF	12124612				2022-12-24	WOS:000176868000030
J	Abouheif, E; Wray, GA				Abouheif, E; Wray, GA			Evolution of the gene network underlying wing polyphenism in ants	SCIENCE			English	Article							ULTRABITHORAX; HYMENOPTERA; LOCALIZATION; FORMICIDAE; EXPRESSION; PATTERN; CASTE	Wing polyphenism in ants evolved once, 125 million years ago, and has been a key to their amazing evolutionary success. We characterized the expression of several genes within the network underlying the wing primordia of reproductive ( winged) and sterile ( wingless) ant castes. We show that the expression of several genes within the network is conserved in the winged castes of four ant species, whereas points of interruption within the network in the wingless castes are evolutionarily labile. The simultaneous evolutionary lability and conservation of the network underlying wing development in ants may have played an important role in the morphological diversification of this group and may be a general feature of polyphenic development and evolution in plants and animals.	Duke Univ, Dept Biol, Durham, NC 27708 USA	Duke University	Abouheif, E (corresponding author), Duke Univ, Dept Biol, POB 90338, Durham, NC 27708 USA.	abouheif@duke.edu	Abouheif, Ehab/H-2507-2011	Abouheif, Ehab/0000-0001-7651-1737				Aspland SE, 1997, DEVELOPMENT, V124, P741; Brakefield PM, 1996, NATURE, V384, P236, DOI 10.1038/384236a0; Brook WJ, 1996, ANNU REV CELL DEV BI, V12, P161, DOI 10.1146/annurev.cellbio.12.1.161; Carroll S. B., 2001, DNA DIVERSITY MOL GE; CARROLL SB, 1994, SCIENCE, V265, P109, DOI 10.1126/science.7912449; COHEN B, 1993, DEVELOPMENT, V117, P597; Cohen S. M., 1993, DEV DROSOPHILA MELAN, P747; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Grimaldi D, 2000, P NATL ACAD SCI USA, V97, P13678, DOI 10.1073/pnas.240452097; Holldobler B., 1990, pi; Holldobler B, 1994, JOURNEY ANTS; KELSH R, 1994, DEV GENET, V15, P19, DOI 10.1002/dvg.1020150104; Labandeira CC, 1998, ANNU REV EARTH PL SC, V26, P329, DOI 10.1146/annurev.earth.26.1.329; Nijhout H.F., 1994, INSECT HORMONES; Nijhout HF, 1999, BIOSCIENCE, V49, P181, DOI 10.2307/1313508; PANGANIBAN G, 1995, SCIENCE, V270, P1363, DOI 10.1126/science.270.5240.1363; PASSERA L, 1979, INSECT SOC, V26, P343, DOI 10.1007/BF02223553; PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9; PATEL NH, 1989, CELL, V58, P955, DOI 10.1016/0092-8674(89)90947-1; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schlichting CD, 1998, PHENOTYPIC EVOLUTION; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Weatherbee SD, 1998, GENE DEV, V12, P1474, DOI 10.1101/gad.12.10.1474; Weatherbee SD, 1999, CURR BIOL, V9, P109, DOI 10.1016/S0960-9822(99)80064-5; WHEELER DE, 1983, J INSECT PHYSIOL, V29, P847, DOI 10.1016/0022-1910(83)90151-8; WHEELER DE, 1981, INT J INSECT MORPHOL, V10, P131, DOI 10.1016/S0020-7322(81)80018-9; WHEELER GEORGE C., 1938, PSYCHE, V45, P139, DOI 10.1155/1938/53417; WILSON EO, 1953, Q REV BIOL, V28, P136, DOI 10.1086/399512; WILSON EO, 1987, PALEOBIOLOGY, V13, P44	31	314	320	1	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 12	2002	297	5579					249	252		10.1126/science.1071468	http://dx.doi.org/10.1126/science.1071468			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	571UT	12114626				2022-12-24	WOS:000176738100041
J	Clutton-Brock, TH; Russell, AF; Sharpe, LL; Young, AJ; Balmforth, Z; McIlrath, GM				Clutton-Brock, TH; Russell, AF; Sharpe, LL; Young, AJ; Balmforth, Z; McIlrath, GM			Evolution and development of sex differences in cooperative behavior in meerkats	SCIENCE			English	Article							SURICATA-SURICATTA; HELPING-BEHAVIOR; MONGOOSE; HELPERS; BIRDS	In cooperatively breeding birds, where helpers of both sexes assist with the provisioning and upbringing of offspring who are not their own, males tend to contribute more than females to rearing young. This sex difference has been attributed to paternity uncertainty, but could also occur because males contribute more where they are likely to remain and breed in their group of origin. In contrast to most birds, female meerkats (Suricata suricatta) are more likely to breed in their natal group than males. We show that female meerkat helpers contribute more to rearing young than males and that female helpers feed female pups more frequently than males. Our results suggest that sex differences in cooperative behavior are generated by sex differences in philopatry and occur because females derive greater direct benefits than males from raising recruits to their natal group. These findings support the view that direct, mutualistic benefits are important in the evolution of specialized cooperative behavior.	Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; Univ Stellenbosch, Dept Zool, ZA-7602 Matieland, South Africa; Univ Pretoria, Mammal Res Inst, ZA-0002 Pretoria, South Africa	University of Cambridge; Stellenbosch University; University of Pretoria	Clutton-Brock, TH (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.							BARNARD JA, 2000, THESIS CAMBRIDGE U; Brotherton PNM, 2001, BEHAV ECOL, V12, P590, DOI 10.1093/beheco/12.5.590; CLARKE MF, 1984, BEHAV ECOL SOCIOBIOL, V14, P137, DOI 10.1007/BF00291904; Clutton-Brock T, 2002, SCIENCE, V296, P69, DOI 10.1126/science.296.5565.69; Clutton-Brock TH, 2000, P ROY SOC B-BIOL SCI, V267, P301, DOI 10.1098/rspb.2000.1000; Clutton-Brock TH, 1998, P ROY SOC B-BIOL SCI, V265, P2291, DOI 10.1098/rspb.1998.0573; Clutton-Brock TH, 2001, SCIENCE, V291, P478, DOI 10.1126/science.291.5503.478; Clutton-Brock TH, 2001, ANIM BEHAV, V61, P705, DOI 10.1006/anbe.2000.1631; Clutton-Brock TH, 1999, J ANIM ECOL, V68, P672, DOI 10.1046/j.1365-2656.1999.00317.x; Clutton-Brock TH, 2001, SCIENCE, V293, P2446, DOI 10.1126/science.1061274; Cockburn A, 1998, ANNU REV ECOL SYST, V29, P141, DOI 10.1146/annurev.ecolsys.29.1.141; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; GRIFFIN AS, 1999, THESIS EDINBURGH U; KOMDEUR J, 1994, P ROY SOC B-BIOL SCI, V256, P47, DOI 10.1098/rspb.1994.0047; LACEY EA, 1990, ECOLOGY NAKED MOLE R, P275; MALCOLM JR, 1982, BEHAV ECOL SOCIOBIOL, V10, P1, DOI 10.1007/BF00296390; MCGOWAN KJ, 1989, ANIM BEHAV, V37, P1000, DOI 10.1016/0003-3472(89)90144-9; O'Riain MJ, 2000, BEHAV ECOL SOCIOBIOL, V48, P471, DOI 10.1007/s002650000249; OWENS DD, 1984, NATURE, V308, P843, DOI 10.1038/308843a0; ROOD JP, 1983, ADV STUDY MAMMALIAN, P454; Stacey P.B., 1990, COOPERATIVE BREEDING; Strahl S.D., 1990, P131, DOI 10.1017/CBO9780511752452.006; Zahavi A., 1990, P103, DOI 10.1017/CBO9780511752452.005	23	182	184	2	108	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 12	2002	297	5579					253	256		10.1126/science.1071412	http://dx.doi.org/10.1126/science.1071412			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	571UT	12114627				2022-12-24	WOS:000176738100042
J	Yang, XY; Zhang, FX; Kudlow, JE				Yang, XY; Zhang, FX; Kudlow, JE			Recruitment of O-GlcNAc transferase to promoters by corepressor mSin3A: Coupling protein O-GlcNAcylation to transcriptional repression	CELL			English	Article							PROTEASOME-DEPENDENT DEGRADATION; HISTONE DEACETYLASE ACTIVITY; RNA-POLYMERASE-II; TETRATRICOPEPTIDE REPEATS; TERMINAL DOMAIN; N-COR; ORDERED RECRUITMENT; MEDIATED REPRESSION; IN-VITRO; CHROMATIN	Transcription factors and RNA polymerase II can be modified by O-linked N-acetylglucosamine (O-GlcNAc) monosaccharides at serine or threonine residues, yet the precise functional roles of this modification are largely unknown. Here, we show that O-GlcNAc transferase (OGT), the enzyme that catalyzes this post-translational modification, interacts with a histone deacetylase complex by binding to the corepressor mSin3A. Functionally, OGT and mSin3A cooperatively repress transcription in parallel with histone deacetylation. We propose that mSin3A targets OGT to promoters to inactivate transcription factors and RNA polymerase II by O-GlcNAc modification, which acts in concert with histone deacetylation to promote gene silencing in an efficient and specific manner.	Univ Alabama, Dept Med, Div Endocrinol & Metab, Dept Cell Biol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Kudlow, JE (corresponding author), Univ Alabama, Dept Med, Div Endocrinol & Metab, Dept Cell Biol, Birmingham, AL 35294 USA.							Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Ahringer J, 2000, TRENDS GENET, V16, P351, DOI 10.1016/S0168-9525(00)02066-7; Alland L, 1997, NATURE, V387, P49, DOI 10.1038/387049a0; AYER DE, 1995, CELL, V80, P767, DOI 10.1016/0092-8674(95)90355-0; Berger SL, 2001, SCIENCE, V292, P64; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; Burke LJ, 2000, FASEB J, V14, P1876, DOI 10.1096/fj.99-0943rev; Chen HW, 1999, CELL, V98, P675, DOI 10.1016/S0092-8674(00)80054-9; Chen HW, 2001, CURR OPIN CELL BIOL, V13, P218, DOI 10.1016/S0955-0674(00)00200-3; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Dahmus ME, 1996, J BIOL CHEM, V271, P19009, DOI 10.1074/jbc.271.32.19009; Fuks F, 2001, EMBO J, V20, P2536, DOI 10.1093/emboj/20.10.2536; Glass CK, 2000, GENE DEV, V14, P121; Gregory PD, 2001, EXP CELL RES, V265, P195, DOI 10.1006/excr.2001.5187; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Hart GW, 1997, ANNU REV BIOCHEM, V66, P315, DOI 10.1146/annurev.biochem.66.1.315; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; HERSCHBACH BM, 1994, NATURE, V370, P309, DOI 10.1038/370309a0; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; JACKSON SP, 1988, CELL, V55, P125, DOI 10.1016/0092-8674(88)90015-3; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kadosh D, 1998, GENE DEV, V12, P797, DOI 10.1101/gad.12.6.797; Kao HY, 2002, J BIOL CHEM, V277, P187, DOI 10.1074/jbc.M108931200; Kao HY, 2000, GENE DEV, V14, P55; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; KELLY WG, 1989, CELL, V57, P243, DOI 10.1016/0092-8674(89)90962-8; KELLY WG, 1993, J BIOL CHEM, V268, P10416; Kouzarides T, 1999, CURR OPIN GENET DEV, V9, P40, DOI 10.1016/S0959-437X(99)80006-9; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Kuchin S, 1998, MOL CELL BIOL, V18, P1163, DOI 10.1128/MCB.18.3.1163; Kuzmichev A, 2001, CURR TOP MICROBIOL, V254, P35; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Laherty CD, 1998, MOL CELL, V2, P33, DOI 10.1016/S1097-2765(00)80111-2; LAMB JR, 1995, TRENDS BIOCHEM SCI, V20, P257, DOI 10.1016/S0968-0004(00)89037-4; Lubas WA, 2000, J BIOL CHEM, V275, P10983, DOI 10.1074/jbc.275.15.10983; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Moazed D, 2001, CURR OPIN CELL BIOL, V13, P232, DOI 10.1016/S0955-0674(00)00202-7; Mowen KA, 2001, CELL, V104, P731, DOI 10.1016/S0092-8674(02)08085-6; Muller C, 2001, CURR OPIN GENET DEV, V11, P167, DOI 10.1016/S0959-437X(00)00175-1; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Ng HH, 2000, TRENDS BIOCHEM SCI, V25, P121; Ng HH, 1999, NAT GENET, V23, P58, DOI 10.1038/12659; Pham AD, 2000, SCIENCE, V289, P2357, DOI 10.1126/science.289.5488.2357; Redd MJ, 1996, MOL CELL BIOL, V16, P2865; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Roos MD, 1997, MOL CELL BIOL, V17, P6472, DOI 10.1128/MCB.17.11.6472; Roose J, 2000, NAT IMMUNOL, V1, P275, DOI 10.1038/79713; Sekinger EA, 2001, CELL, V105, P403, DOI 10.1016/S0092-8674(01)00329-4; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Sif S, 2001, GENE DEV, V15, P603, DOI 10.1101/gad.872801; Smith RL, 2000, TRENDS BIOCHEM SCI, V25, P325, DOI 10.1016/S0968-0004(00)01592-9; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Su KH, 1999, J BIOL CHEM, V274, P15194, DOI 10.1074/jbc.274.21.15194; Su KH, 2000, BIOCHEM J, V348, P281, DOI 10.1042/0264-6021:3480281; TZAMARIAS D, 1995, GENE DEV, V9, P821, DOI 10.1101/gad.9.7.821; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Watson AD, 2000, GENE DEV, V14, P2737, DOI 10.1101/gad.829100; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Wolffe AP, 2000, BIOCHEM SOC T, V28, P379, DOI 10.1042/0300-5127:0280379; Wong CW, 1998, MOL CELL BIOL, V18, P5500, DOI 10.1128/MCB.18.9.5500; Wu JS, 2001, MOL CELL, V7, P117, DOI 10.1016/S1097-2765(01)00160-5; Yang WM, 1996, P NATL ACAD SCI USA, V93, P12845, DOI 10.1073/pnas.93.23.12845; Yang XY, 2001, P NATL ACAD SCI USA, V98, P6611, DOI 10.1073/pnas.111099998; Zhang Y, 1997, CELL, V89, P357, DOI 10.1016/S0092-8674(00)80216-0	69	319	332	1	32	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 12	2002	110	1					69	80		10.1016/S0092-8674(02)00810-3	http://dx.doi.org/10.1016/S0092-8674(02)00810-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	573PU	12150998	Bronze			2022-12-24	WOS:000176840700008
J	Ludwig, M; Sabatier, N; Bull, PM; Landgraf, R; Dayanithi, G; Leng, G				Ludwig, M; Sabatier, N; Bull, PM; Landgraf, R; Dayanithi, G; Leng, G			Intracellular calcium stores regulate activity-dependent neuropeptide release from dendrites	NATURE			English	Article							MILK-EJECTION REFLEX; RAT SUPRAOPTIC NEURONS; IN-VITRO; SUBSTANTIA-NIGRA; OXYTOCIN NEURONS; SUCKLED RATS; GABA RELEASE; CELLS; VASOPRESSIN; NUCLEUS	Information in neurons flows from synapses, through the dendrites and cell body (soma), and, finally, along the axon as spikes of electrical activity that will ultimately release neurotransmitters from the nerve terminals. However, the dendrites of many neurons also have a secretory role, transmitting information back to afferent nerve terminals(1-4). In some central nervous system neurons, spikes that originate at the soma can travel along dendrites as well as axons, and may thus elicit secretion from both compartments(1). Here, we show that in hypothalamic oxytocin neurons, agents that mobilize intracellular Ca2+ induce oxytocin release from dendrites without increasing the electrical activity of the cell body, and without inducing secretion from the nerve terminals. Conversely, electrical activity in the cell bodies can cause the secretion of oxytocin from nerve terminals with little or no release from the dendrites. Finally, mobilization of intracellular Ca2+ can also prime the releasable pool of oxytocin in the dendrites. This priming action makes dendritic oxytocin available for release in response to subsequent spike activity. Priming persists for a prolonged period, changing the nature of interactions between oxytocin neurons and their neighbours.	Univ Edinburgh, Sch Med, Dept Biomed Sci, Edinburgh EH8 9XD, Midlothian, Scotland; Max Planck Inst Psychiat, Inst Clin, D-80804 Munich, Germany; Univ Montpellier 2, INSERM 432, Dept Neurobiol, F-34094 Montpellier, France	University of Edinburgh; Max Planck Society; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Ludwig, M (corresponding author), Univ Edinburgh, Sch Med, Dept Biomed Sci, George Sq, Edinburgh EH8 9XD, Midlothian, Scotland.		Dayanithi, Govindan/F-6068-2016; Leng, Gareth/C-6688-2011; Dayanithi, Govindan/H-3131-2014	Dayanithi, Govindan/0000-0002-1009-7809; Leng, Gareth/0000-0002-2388-8466; Dayanithi, Govindan/0000-0002-1009-7809				BELIN V, 1986, J PHYSIOL-LONDON, V377, P369, DOI 10.1113/jphysiol.1986.sp016192; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Blochl A, 1996, MOL CELL NEUROSCI, V7, P173, DOI 10.1006/mcne.1996.0014; Brown D, 1997, J PHYSIOL-LONDON, V503, P625, DOI 10.1111/j.1469-7793.1997.625bg.x; CHERAMY A, 1981, NATURE, V289, P537, DOI 10.1038/289537a0; Chevaleyre V, 2000, J NEUROSCI, V20, P5813, DOI 10.1523/JNEUROSCI.20-15-05813.2000; DYBALL REJ, 1986, J PHYSIOL-LONDON, V380, P239, DOI 10.1113/jphysiol.1986.sp016283; HAUSSER M, 1995, NEURON, V15, P637, DOI 10.1016/0896-6273(95)90152-3; Isaacson JS, 2001, P NATL ACAD SCI USA, V98, P337, DOI 10.1073/pnas.021445798; Isaacson JS, 1998, NEURON, V20, P749, DOI 10.1016/S0896-6273(00)81013-2; Jourdain P, 1998, J NEUROSCI, V18, P6641; Kirkpatrick K, 1996, J PHYSIOL-LONDON, V494, P389, DOI 10.1113/jphysiol.1996.sp021500; Kombian SB, 1997, NEURON, V19, P903, DOI 10.1016/S0896-6273(00)80971-X; LAMBERT RC, 1994, J PHYSIOL-LONDON, V478, P275, DOI 10.1113/jphysiol.1994.sp020249; LAMBERT RC, 1993, NEUROSCIENCE, V57, P1027, DOI 10.1016/0306-4522(93)90046-I; LENG G, 1981, EXP BRAIN RES, V41, P135; Leng G, 1999, PROG NEUROBIOL, V57, P625, DOI 10.1016/S0301-0082(98)00072-0; LENG G, 1991, NEUROENDOCRINE RES M, P769; LINCOLN DW, 1974, J PHYSIOL-LONDON, V242, P533, DOI 10.1113/jphysiol.1974.sp010722; LINCOLN DW, 1972, J ANAT, V111, P327; Ludwig M, 1998, J NEUROENDOCRINOL, V10, P881; Ludwig M, 1997, EUR J NEUROSCI, V9, P2532, DOI 10.1111/j.1460-9568.1997.tb01682.x; MOOS F, 1989, EXP BRAIN RES, V76, P593, DOI 10.1007/BF00248916; MOOS F, 1984, J ENDOCRINOL, V102, P63, DOI 10.1677/joe.0.1020063; POW DV, 1989, NEUROSCIENCE, V32, P435, DOI 10.1016/0306-4522(89)90091-2; Treiman M, 1998, TRENDS PHARMACOL SCI, V19, P131, DOI 10.1016/S0165-6147(98)01184-5; Zilberter Y, 1999, NEURON, V24, P979, DOI 10.1016/S0896-6273(00)81044-2	27	252	256	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 4	2002	418	6893					85	89		10.1038/nature00822	http://dx.doi.org/10.1038/nature00822			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569JL	12097911	Green Published			2022-12-24	WOS:000176599200043
J	Volpe, TA; Kidner, C; Hall, IM; Teng, G; Grewal, SIS; Martienssen, RA				Volpe, TA; Kidner, C; Hall, IM; Teng, G; Grewal, SIS; Martienssen, RA			Regulation of heterochromatic silencing and histone H3 lysine-9 methylation by RNAi	SCIENCE			English	Article							YEAST SCHIZOSACCHAROMYCES-POMBE; DISRUPT CHROMOSOME SEGREGATION; FISSION YEAST; DNA METHYLATION; DROSOPHILA-MELANOGASTER; TRANSPOSABLE ELEMENTS; NEUROSPORA-CRASSA; MESSENGER-RNA; C-ELEGANS; GENE	Eukaryotic heterochromatin is characterized by a high density of repeats and transposons, as well as by modified histones, and influences both gene expression and chromosome segregation. In the fission yeast Schizosaccharomyces pombe, we deleted the argonaute, dicer, and RNA-dependent RNA polymerase gene homologs, which encode part of the machinery responsible for RNA interference (RNAi). Deletion results in the aberrant accumulation of complementary transcripts from centromeric heterochromatic repeats. This is accompanied by transcriptional de-repression of transgenes integrated at the centromere, loss of histone H3 lysine-9 methylation, and impairment of centromere function. We propose that double-stranded RNA arising from centromeric repeats targets formation and maintenance of heterochromatin through RNAi.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory	Martienssen, RA (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.			Kidner, Catherine/0000-0001-6426-3000	NIGMS NIH HHS [GM59772] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059772] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akhtar A, 2000, NATURE, V407, P405, DOI 10.1038/35030169; ALLSHIRE R, COMMUNICATION; ALLSHIRE RC, 1994, CELL, V76, P157, DOI 10.1016/0092-8674(94)90180-5; ALLSHIRE RC, 1995, GENE DEV, V9, P218, DOI 10.1101/gad.9.2.218; Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Aravind L, 2000, P NATL ACAD SCI USA, V97, P11319, DOI 10.1073/pnas.200346997; Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; Ayoub N, 2000, GENETICS, V156, P983; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Baum M, 2000, MOL CELL BIOL, V20, P2852, DOI 10.1128/MCB.20.8.2852-2864.2000; BAUM M, 1994, MOL BIOL CELL, V5, P747, DOI 10.1091/mbc.5.7.747; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Catalanotto C, 2002, GENE DEV, V16, P790, DOI 10.1101/gad.222402; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Cogoni C, 1996, EMBO J, V15, P3153, DOI 10.1002/j.1460-2075.1996.tb00678.x; Dalmay T, 2000, PLANT CELL, V12, P369, DOI 10.1105/tpc.12.3.369; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Ekwall K, 1999, GENETICS, V153, P1153; Ekwall K, 1996, J CELL SCI, V109, P2637; Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597; FISHEL B, 1988, MOL CELL BIOL, V8, P754, DOI 10.1128/MCB.8.2.754; Gendrel AV, 2002, SCIENCE, V297, P1871, DOI 10.1126/science.1074950; Grewal SIS, 2002, CURR OPIN GENET DEV, V12, P178, DOI 10.1016/S0959-437X(02)00284-8; Grewal SIS, 1997, GENETICS, V146, P1221; HALL IH, UNPUB; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Heard E, 2001, CELL, V107, P727, DOI 10.1016/S0092-8674(01)00598-0; Henikoff S, 1992, CURR OPIN GENET DEV, V2, P907, DOI 10.1016/S0959-437X(05)80114-5; HOCHSTENBACH F, 1999, FISSION YEAST HDB; Jensen S, 1999, NAT GENET, V21, P209, DOI 10.1038/5997; Jones L, 1999, PLANT CELL, V11, P2291, DOI 10.1105/tpc.11.12.2291; JORGENSEN R, 1990, TRENDS BIOTECHNOL, V8, P340, DOI 10.1016/0167-7799(90)90220-R; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; KIDNER C, UNPUB; KLAR AJS, 1993, COLD SPRING HARB SYM, V58, P457, DOI 10.1101/SQB.1993.058.01.052; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Lipardi C, 2001, CELL, V107, P297, DOI 10.1016/S0092-8674(01)00537-2; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Lynn K, 1999, DEVELOPMENT, V126, P469; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Martienssen RA, 2001, SCIENCE, V293, P1070, DOI 10.1126/science.293.5532.1070; Matzke MA, 2001, CURR OPIN GENET DEV, V11, P221, DOI 10.1016/S0959-437X(00)00183-0; Montgomery MK, 1998, P NATL ACAD SCI USA, V95, P15502, DOI 10.1073/pnas.95.26.15502; Nabeshima K, 1998, MOL BIOL CELL, V9, P3211, DOI 10.1091/mbc.9.11.3211; Nakagawa H, 2002, GENE DEV, V16, P1766, DOI 10.1101/gad.997702; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Partridge JF, 2000, GENE DEV, V14, P783; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; REINHART B, 1831, SCIENCE, V297, DOI DOI 10.1126/SCIENCE.1077183; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Schmidt A, 1999, GENETICS, V151, P749; Shiu PKT, 2001, CELL, V107, P905, DOI 10.1016/S0092-8674(01)00609-2; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; STEINER NC, 1993, MOL CELL BIOL, V13, P4578, DOI 10.1128/MCB.13.8.4578; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; TAKAHASHI K, 1991, J MOL BIOL, V218, P13, DOI 10.1016/0022-2836(91)90867-6; Takahashi K, 2000, SCIENCE, V288, P2215, DOI 10.1126/science.288.5474.2215; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; TYERS M, 1992, EMBO J, V11, P1773, DOI 10.1002/j.1460-2075.1992.tb05229.x; Vaistij FE, 2002, PLANT CELL, V14, P857, DOI 10.1105/tpc.010480; VOLPE T, UNPUB; Wallrath L, 1998, CURR OPIN GENET DEV, V8, P147, DOI 10.1016/S0959-437X(98)80135-4; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724	72	1564	1752	6	129	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 13	2002	297	5588					1833	1837		10.1126/science.1074973	http://dx.doi.org/10.1126/science.1074973			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592UJ	12193640				2022-12-24	WOS:000177955000034
J	Main, CJ; Williams, ACD				Main, CJ; Williams, ACD			ABC of psychological medicine - Musculoskeletal pain	BMJ-BRITISH MEDICAL JOURNAL			English	Review									Hope Hosp, Dept Behav Med, Salford M6 8HD, Lancs, England; Univ London, Guys Kings & St Thomass Sch Med, London WC1E 7HU, England	University of London; King's College London	Main, CJ (corresponding author), Hope Hosp, Dept Behav Med, Salford M6 8HD, Lancs, England.		de C Williams, Amanda C/C-7816-2009	Williams, Amanda/0000-0003-3761-8704				Accident Compensation Corporation Ministry of Health Health Quality & Safety Commission New Zealand New Zealand Government, 2022, LIV STRONG LONG PREV; *CLIN STAND ADV GR, 1994, CLIN STAND ADV GROUP; ROLAND M, 2002, BACK BOOK; *ROYAL COLL GEN PR, 1996, CLIN GUID MAN AC LOW; Waddell G, 2000, OCCUPATIONAL HLTH GU	5	73	75	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 7	2002	325	7363					534	537		10.1136/bmj.325.7363.534	http://dx.doi.org/10.1136/bmj.325.7363.534			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	593NJ	12217996	Green Published			2022-12-24	WOS:000177997800022
J	Truitt, WA; Coolen, LM				Truitt, WA; Coolen, LM			Identification of a potential ejaculation generator in the spinal cord	SCIENCE			English	Article							SEXUAL FUNCTION; RAT; FEMALE; BRAIN; STIMULATION; MEN	We tested the significance of a population of lumbar spinothalamic cells for male sexual behavior in rats. These cells are positioned to relay ejaculation-related signals from reproductive organs to the brain, and they express neurokinin-1 receptors. Ablation of these neurons by the selective toxin SSP-saporin resulted in a complete disruption of ejaculatory behavior. In contrast, other components of sexual behavior remained intact. These results suggest that this population of spinothalamic cells plays a pivotal role in generation of ejaculatory behavior and may be part of a spinal ejaculation generator.	Univ Cincinnati, Coll Med, Dept Cell Biol Neurobiol & Anat, Cincinnati, OH 45267 USA; Univ Cincinnati, Coll Med, Grad Program Neurosci, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Coolen, LM (corresponding author), Univ Cincinnati, Coll Med, Dept Cell Biol Neurobiol & Anat, POB 670521, Cincinnati, OH 45267 USA.	Lique.Coolen@uc.edu		Coolen, Lique/0000-0003-2920-1116	NIMH NIH HHS [MH60781] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Brackett NL, 1998, J UROLOGY, V159, P1931, DOI 10.1016/S0022-5347(01)63200-2; GILVERNET JM, 1994, BRIT J UROL, V73, P442, DOI 10.1111/j.1464-410X.1994.tb07612.x; HOLMES GM, 1991, PHYSIOL BEHAV, V49, P1235, DOI 10.1016/0031-9384(91)90357-T; JU G, 1987, NEUROSCIENCE, V20, P439, DOI 10.1016/0306-4522(87)90103-5; McKenna K., 1999, ENCY REPROD, P1002; MCKENNA KE, 1991, AM J PHYSIOL, V261, pR1276, DOI 10.1152/ajpregu.1991.261.5.R1276; MCKENNA KE, 1997, AUT NER SYS, V11, P151; Meisel Robert L., 1994, P3; NEWMAN HF, 1982, UROLOGY, V19, P341, DOI 10.1016/0090-4295(82)90186-8; Nicholas AP, 1999, NEUROSCI LETT, V270, P9, DOI 10.1016/S0304-3940(99)00446-2; Ohl DA, 1997, MALE INFERTILITY SEX, P219; PESCATORI ES, 1993, J UROLOGY, V149, P627, DOI 10.1016/S0022-5347(17)36168-2; Pfaus JG, 1997, BRAIN RES BULL, V44, P397, DOI 10.1016/S0361-9230(97)00219-0; TRUITT W, UNPUB; Truitt W. A., 2001, Hormones and Behavior, V39, P352; Veening JG, 1998, BEHAV BRAIN RES, V92, P181, DOI 10.1016/S0166-4328(97)00190-3; Wiley RG, 1999, NEUROSCI LETT, V277, P1, DOI 10.1016/S0304-3940(99)00846-0	17	236	242	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2002	297	5586					1566	1569		10.1126/science.1073885	http://dx.doi.org/10.1126/science.1073885			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588JA	12202834				2022-12-24	WOS:000177697300061
J	Kwon, HJ; Smith, WC; Scharon, AJ; Hwang, SH; Kurth, MJ; Shen, B				Kwon, HJ; Smith, WC; Scharon, AJ; Hwang, SH; Kurth, MJ; Shen, B			C-O bond formation by polyketide synthases	SCIENCE			English	Article							ACYL CARRIER PROTEIN; MALONYL-COENZYME-A; DIRECTED MUTAGENESIS; ESCHERICHIA-COLI; BIOSYNTHESIS; STREPTOMYCES; PATHWAY; CLONING; STRAIN; ACID	Polyketide synthases (PKSs) assemble the polyketide carbon backbone by sequential decarboxylative condensation of acyl coenzyme A (CoA) precursors, and the C-C bond-forming step in this process is catalyzed by the beta-ketoacyl synthase (KS) domain or subunit. Genetic and biochemical characterization of the nonactin biosynthesis gene cluster from Streptomyces griseus revealed two KSs, NonJ and NonK, that are highly homologous to known KSs but catalyze sequential condensation of the acyl CoA substrates by forming C-O rather than C-C bonds. This chemistry can be used in PKS engineering to increase the scope and diversity of polyketide biosynthesis.	Univ Wisconsin, Div Pharmaceut Sci, Madison, WI 53705 USA; Univ Wisconsin, Dept Chem, Madison, WI 53705 USA; Univ Calif Davis, Dept Chem, Davis, CA 95616 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Davis	Shen, B (corresponding author), Univ Wisconsin, Div Pharmaceut Sci, Madison, WI 53705 USA.				NIAID NIH HHS [AI51689] Funding Source: Medline; NIGMS NIH HHS [T32 GM08505] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K02AI051689] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008505] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahlert J, 2002, SCIENCE, V297, P1173, DOI 10.1126/science.1072105; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; Bisang C, 1999, NATURE, V401, P502, DOI 10.1038/46829; Cane DE, 1998, SCIENCE, V282, P63, DOI 10.1126/science.282.5386.63; Eckermann S, 1998, NATURE, V396, P387, DOI 10.1038/24652; Fleck WF, 1996, J BASIC MICROB, V36, P235, DOI 10.1002/jobm.3620360405; Funa N, 1999, NATURE, V400, P897, DOI 10.1038/23748; Gokhale RS, 1999, SCIENCE, V284, P482, DOI 10.1126/science.284.5413.482; He M, 2000, J BACTERIOL, V182, P2619, DOI 10.1128/JB.182.9.2619-2623.2000; Hopwood DA, 1997, CHEM REV, V97, P2465, DOI 10.1021/cr960034i; Jez JM, 2000, CHEM BIOL, V7, P919, DOI 10.1016/S1074-5521(00)00041-7; Jez JM, 2000, BIOCHEMISTRY-US, V39, P890, DOI 10.1021/bi991489f; KAO CM, 1995, J AM CHEM SOC, V117, P9105, DOI 10.1021/ja00140a043; Kennedy J, 1999, SCIENCE, V284, P1368, DOI 10.1126/science.284.5418.1368; Kwon HJ, 2001, J AM CHEM SOC, V123, P3385, DOI 10.1021/ja0100827; Liu W, 2002, SCIENCE, V297, P1170, DOI 10.1126/science.1072110; MARSDEN AFA, 1994, SCIENCE, V263, P378, DOI 10.1126/science.8278811; MCDANIEL R, 1993, SCIENCE, V262, P1546, DOI 10.1126/science.8248802; MCDANIEL R, 1995, NATURE, V375, P549, DOI 10.1038/375549a0; Metz JG, 2001, SCIENCE, V293, P290, DOI 10.1126/science.1059593; Nelson ME, 2002, J AM CHEM SOC, V124, P2894, DOI 10.1021/ja016965f; Olsen JG, 1999, FEBS LETT, V460, P46, DOI 10.1016/S0014-5793(99)01303-4; Pfeifer BA, 2001, SCIENCE, V291, P1790, DOI 10.1126/science.1058092; PIEPER R, 1995, NATURE, V378, P263, DOI 10.1038/378263a0; Rajgarhia VB, 1997, J BACTERIOL, V179, P2690, DOI 10.1128/jb.179.8.2690-2696.1997; Schroder J., 1999, COMPREHENSIVE NATURA, V1, P749, DOI DOI 10.1016/b978-0-08-091283-7.00029-1; SHEN B, 1993, SCIENCE, V262, P1535, DOI 10.1126/science.8248801; Shen B, 2000, TOP CURR CHEM, V209, P1; Smith WC, 2000, ANTIMICROB AGENTS CH, V44, P1809, DOI 10.1128/AAC.44.7.1809-1817.2000; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; VARA J, 1989, J BACTERIOL, V171, P5872, DOI 10.1128/jb.171.11.5872-5881.1989	31	62	69	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 23	2002	297	5585					1327	1330		10.1126/science.1073175	http://dx.doi.org/10.1126/science.1073175			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FL	12193782				2022-12-24	WOS:000177573900041
J	Moore, AW; Jan, LY; Jan, YN				Moore, AW; Jan, LY; Jan, YN			hamlet, a binary genetic switch between single- and multiple-dendrite neuron morphology	SCIENCE			English	Article							ZINC-FINGER PROTEIN; PR-DOMAIN FAMILY; MYELOID-LEUKEMIA; DROSOPHILA; EXPRESSION; OUTGROWTH; GENOME	The dendritic morphology of neurons determines the number and type of inputs they receive. In the Drosophila peripheral nervous system ( PNS), the external sensory (ES) neurons have a single nonbranched dendrite, whereas the lineally related multidendritic ( MD) neurons have extensively branched dendritic arbors. We report that hamlet is a binary genetic switch between these contrasting morphological types. In hamlet mutants, ES neurons are converted to an MD fate, whereas ectopic hamlet expression in MD precursors results in transformation of MD neurons into ES neurons. Moreover, hamlet expression induced in MD neurons undergoing dendrite outgrowth drastically reduces arbor branching.	Univ Calif San Francisco, Dept Physiol, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem, Howard Hughes Med Inst, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Jan, YN (corresponding author), Univ Calif San Francisco, Dept Physiol, Howard Hughes Med Inst, Box 0444, San Francisco, CA 94143 USA.		Moore, Adrian Walton/AAN-5656-2021; Moore, Adrian W/A-3339-2013	Moore, Adrian Walton/0000-0002-8242-301X; Moore, Adrian W/0000-0002-8242-301X; Jan, Yuh Nung/0000-0003-1367-6299; Jan, Lily/0000-0003-3938-8498	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040929] Funding Source: NIH RePORTER; NINDS NIH HHS [R01NS40929] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; BIER E, 1989, GENE DEV, V3, P1273, DOI 10.1101/gad.3.9.1273; BLOCHLINGER K, 1990, GENE DEV, V4, P1322, DOI 10.1101/gad.4.8.1322; DESAI C, 1988, NATURE, V336, P638, DOI 10.1038/336638a0; Fears S, 1996, P NATL ACAD SCI USA, V93, P1642, DOI 10.1073/pnas.93.4.1642; Gao FB, 1999, GENE DEV, V13, P2549, DOI 10.1101/gad.13.19.2549; GARRIGA G, 1993, GENE DEV, V7, P2097, DOI 10.1101/gad.7.11.2097; Hoyt PR, 1997, MECH DEVELOP, V65, P55, DOI 10.1016/S0925-4773(97)00057-9; Huang S, 1998, J BIOL CHEM, V273, P15933, DOI 10.1074/jbc.273.26.15933; HUANG S, 1994, CELL, V78, P9, DOI 10.1016/0092-8674(94)90565-7; Jiang GL, 2000, HISTOL HISTOPATHOL, V15, P109, DOI 10.14670/HH-15.109; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; MISQUITTA L, 2000, PROTOCOLS, P361; MORISHITA K, 1988, CELL, V54, P831, DOI 10.1016/S0092-8674(88)91175-0; Orgogozo V, 2001, DEVELOPMENT, V128, P631; Soderholm J, 1997, LEUKEMIA, V11, P352, DOI 10.1038/sj.leu.2400584; VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8; VANROESSEL P, 2000, PROTOCOLS, P439	18	100	102	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 23	2002	297	5585					1355	1358		10.1126/science.1072387	http://dx.doi.org/10.1126/science.1072387			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FL	12193790				2022-12-24	WOS:000177573900050
J	Yang, T; Espenshade, PJ; Wright, ME; Yabe, D; Gong, Y; Aebersold, R; Goldstein, JL; Brown, MS				Yang, T; Espenshade, PJ; Wright, ME; Yabe, D; Gong, Y; Aebersold, R; Goldstein, JL; Brown, MS			Crucial step in cholesterol homeostasis: Sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER	CELL			English	Article							CLEAVAGE-ACTIVATING PROTEIN; GROWTH-RESPONSE; CELLS; IDENTIFICATION; MUTANTS; GENES; PROTEOLYSIS; EXPRESSION; COMPLEXES; DOMAIN	Using coimmunoprecipitation and tandem mass spectrometry, we identify INSIG-1 as an ER protein that binds the sterol-sensing domain of SREBP cleavage-activating protein (SCAP) and facilitates retention of the SCAP/SREBP complex in the ER. In steroldepleted cells, SCAP escorts SREBPs from ER to Golgi for proteolytic processing, thereby allowing SREBPs to stimulate cholesterol synthesis. Sterols induce binding of SCAP to INSIG-11, as determined by blue native-PAGE, and this is correlated with the inhibition of SCAP exit from the ER. Overexpression of INSIG-1 increases the sensitivity of cells to sterol-mediated inhibition of SREBP processing. Mutant SCAP(Y298C) fails to bind INSIG-11 and is resistant to sterol-mediated inhibition of ER exit. By facilitating sterol -dependent ER retention of SCAP, INSIG-11 plays a central role in cholesterol homeostasis.	Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA; Inst Syst Biol, Seattle, WA 98105 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Institute for Systems Biology (ISB)	Goldstein, JL (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA.	joe.goldstein@utsouthwestern.edu; mike.brown@utsouthwestern.edu	Yabe, Daisuke/J-6682-2014; Gong, Yi/AAQ-7515-2020	Yabe, Daisuke/0000-0002-5334-7687; Wright, Michael/0000-0002-4243-2931	NATIONAL CANCER INSTITUTE [R33CA084698] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NCI NIH HHS [1R33CA-84698] Funding Source: Medline; NHLBI NIH HHS [HL-20948] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BERGMANN JE, 1989, METHOD CELL BIOL, V32, P85; BROWN AJ, 2002, IN PRESS MOL CELL; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; DeBose-Boyd RA, 1999, CELL, V99, P703, DOI 10.1016/S0092-8674(00)81668-2; DIAMOND RH, 1993, J BIOL CHEM, V268, P15185; Goldstein JL, 2002, ARCH BIOCHEM BIOPHYS, V397, P139, DOI 10.1006/abbi.2001.2615; Hua XX, 1996, J BIOL CHEM, V271, P10379, DOI 10.1074/jbc.271.17.10379; Hua XX, 1996, CELL, V87, P415, DOI 10.1016/S0092-8674(00)81362-8; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; LUONG A, 2000, THESIS U TEXAS SW ME, P1; METHERALL JE, 1989, J BIOL CHEM, V264, P15634; MOHN KL, 1991, MOL CELL BIOL, V11, P381, DOI 10.1128/MCB.11.1.381; Nohturfft A, 2000, CELL, V102, P315, DOI 10.1016/S0092-8674(00)00037-4; Nohturfft A, 1998, P NATL ACAD SCI USA, V95, P12848, DOI 10.1073/pnas.95.22.12848; Nohturfft A, 1998, J BIOL CHEM, V273, P17243, DOI 10.1074/jbc.273.27.17243; Peng Y, 1997, GENOMICS, V43, P278, DOI 10.1006/geno.1997.4821; Rawson RB, 1999, J BIOL CHEM, V274, P28549, DOI 10.1074/jbc.274.40.28549; Reeves PJ, 1996, P NATL ACAD SCI USA, V93, P11487, DOI 10.1073/pnas.93.21.11487; Sakai J, 1998, J BIOL CHEM, V273, P5785, DOI 10.1074/jbc.273.10.5785; Sakai J, 1997, J BIOL CHEM, V272, P20213, DOI 10.1074/jbc.272.32.20213; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; TOLLESHAUG H, 1982, CELL, V30, P715, DOI 10.1016/0092-8674(82)90276-8; Yang T, 2000, J BIOL CHEM, V275, P29881, DOI 10.1074/jbc.M005439200; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	27	742	780	2	79	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 23	2002	110	4					489	500		10.1016/S0092-8674(02)00872-3	http://dx.doi.org/10.1016/S0092-8674(02)00872-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	587QJ	12202038	Bronze			2022-12-24	WOS:000177653200010
J	Xia, XM; Zeng, XH; Lingle, CJ				Xia, XM; Zeng, XH; Lingle, CJ			Multiple regulatory sites in large-conductance calcium-activated potassium channels	NATURE			English	Article							CA2+-ACTIVATED K+ CHANNEL; BK CHANNELS; SKELETAL-MUSCLE; CA2+-DEPENDENT ACTIVATION; GATING KINETICS; RAT MUSCLE; VOLTAGE; CA2+; DOMAIN; SENSITIVITY	Large conductance, Ca2+- and voltage-activated K+ channels (BK) respond to two distinct physiological signals-membrane voltage and cytosolic Ca2+ (refs 1, 2). Channel opening is regulated by changes in Ca2+ concentration spanning 0.5 muM to 50 mM (refs 2-5), a range of Ca2+ sensitivity unusual among Ca2+ -regulated proteins. Although voltage regulation arises from mechanisms shared with other voltage-gated channels(6-8), the mechanisms of Ca2+ regulation remain largely unknown. One potential Ca2+-regulatory site, termed the 'Ca2+ bowl', has been located to the large cytosolic carboxy terminus(9-11). Here we show that a second region of the C terminus, the RCK domain (regulator of conductance for K+ (ref. 12)), contains residues that define two additional regulatory effects of divalent cations. One site, together with the Ca2+ bowl, accounts for all physiological regulation of BK channels by Ca2+; the other site contributes to effects of millimolar divalent cations that may mediate physiological regulation by cytosolic Mg2+ (refs 5, 13). Independent regulation by multiple sites explains the large concentration range over which BK channels are regulated by Ca2+. This allows BK channels to serve a variety of physiological roles contingent on the Ca2+ concentration to which the channels are exposed(14,15).	Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Lingle, CJ (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, Box 8054, St Louis, MO 63110 USA.			Lingle, Christopher/0000-0002-9916-3795				ADELMAN JP, 1992, NEURON, V9, P209, DOI 10.1016/0896-6273(92)90160-F; BARRETT JN, 1982, J PHYSIOL-LONDON, V331, P211, DOI 10.1113/jphysiol.1982.sp014370; Bellamacina CR, 1996, FASEB J, V10, P1257, DOI 10.1096/fasebj.10.11.8836039; Bian S, 2001, P NATL ACAD SCI USA, V98, P4776, DOI 10.1073/pnas.081072398; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; Cox DH, 2000, J GEN PHYSIOL, V116, P411, DOI 10.1085/jgp.116.3.411; Cox DH, 1997, J GEN PHYSIOL, V110, P257, DOI 10.1085/jgp.110.3.257; Cui J, 1997, J GEN PHYSIOL, V109, P647, DOI 10.1085/jgp.109.5.647; Cui JM, 2000, BIOCHEMISTRY-US, V39, P15612, DOI 10.1021/bi001509+; FERGUSON WB, 1991, J GEN PHYSIOL, V98, P163, DOI 10.1085/jgp.98.1.163; GOLOWASCH J, 1986, J EXP BIOL, V124, P5; Horrigan FT, 1999, J GEN PHYSIOL, V114, P277, DOI 10.1085/jgp.114.2.277; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2001, NEURON, V29, P593, DOI 10.1016/S0896-6273(01)00236-7; Jones EMC, 1999, J PHYSIOL-LONDON, V518, P653, DOI 10.1111/j.1469-7793.1999.0653p.x; Lingle CJ, 2001, J GEN PHYSIOL, V117, P583, DOI 10.1085/jgp.117.6.583; Meera P, 1997, P NATL ACAD SCI USA, V94, P14066, DOI 10.1073/pnas.94.25.14066; MOCZYDLOWSKI E, 1983, J GEN PHYSIOL, V82, P511, DOI 10.1085/jgp.82.4.511; Moss BL, 2001, J GEN PHYSIOL, V118, P711, DOI 10.1085/jgp.118.6.711; OBERHAUSER A, 1988, J GEN PHYSIOL, V92, P67, DOI 10.1085/jgp.92.1.67; Rothberg BS, 1999, J GEN PHYSIOL, V114, P93, DOI 10.1085/jgp.114.1.93; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; Schreiber M, 1999, NAT NEUROSCI, V2, P416, DOI 10.1038/8077; Schreiber M, 1998, J BIOL CHEM, V273, P3509, DOI 10.1074/jbc.273.6.3509; Shao LR, 1999, J PHYSIOL-LONDON, V521, P135, DOI 10.1111/j.1469-7793.1999.00135.x; SHEN KZ, 1994, PFLUG ARCH EUR J PHY, V426, P440, DOI 10.1007/BF00388308; Shi JY, 2001, J GEN PHYSIOL, V118, P589, DOI 10.1085/jgp.118.5.589; WEI A, 1994, NEURON, V13, P671, DOI 10.1016/0896-6273(94)90034-5; Xia XM, 1999, J NEUROSCI, V19, P5255, DOI 10.1523/jneurosci.19-13-05255.1999; Zhang X, 2001, J GEN PHYSIOL, V118, P607, DOI 10.1085/jgp.118.5.607	30	286	299	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 22	2002	418	6900					880	884		10.1038/nature00956	http://dx.doi.org/10.1038/nature00956			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585YR	12192411				2022-12-24	WOS:000177555600039
J	Elowitz, MB; Levine, AJ; Siggia, ED; Swain, PS				Elowitz, MB; Levine, AJ; Siggia, ED; Swain, PS			Stochastic gene expression in a single cell	SCIENCE			English	Article							ESCHERICHIA-COLI; BACTERIOPHAGE-LAMBDA; CHEMOTAXIS; PROMOTERS; NETWORKS; SYSTEM; NOISE	Clonal populations of cells exhibit substantial phenotypic variation. Such heterogeneity can be essential for many biological processes and is conjectured to arise from stochasticity, or noise, in gene expression. We constructed strains of Escherichia coli that enable detection of noise and discrimination between the two mechanisms by which it is generated. Both stochasticity inherent in the biochemical process of gene expression (intrinsic noise) and fluctuations in other cellular components (extrinsic noise) contribute substantially to overall variation. Transcription rate, regulatory dynamics, and genetic factors control the amplitude of noise. These results establish a quantitative foundation for modeling noise in genetic networks and reveal how low intracellular copy numbers of molecules can fundamentally limit the precision of gene regulation.	Rockefeller Univ, Canc Biol Lab, New York, NY 10021 USA; Rockefeller Univ, Ctr Studies Phys & Biol, New York, NY 10021 USA	Rockefeller University; Rockefeller University	Elowitz, MB (corresponding author), Rockefeller Univ, Canc Biol Lab, 1230 York Ave, New York, NY 10021 USA.		Swain, Peter S/AAW-3265-2020	Swain, Peter/0000-0001-7489-8587	NIGMS NIH HHS [GM59018] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059018] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Boyd D, 2000, J BACTERIOL, V182, P842, DOI 10.1128/JB.182.3.842-847.2000; Capaldo F N, 1975, Basic Life Sci, V5A, P405; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; DEUSCHLE U, 1986, EMBO J, V5, P2987, DOI 10.1002/j.1460-2075.1986.tb04596.x; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Fiering S, 2000, BIOESSAYS, V22, P381, DOI 10.1002/(SICI)1521-1878(200004)22:4<381::AID-BIES8>3.0.CO;2-E; GUPTASARMA P, 1995, BIOESSAYS, V17, P987, DOI 10.1002/bies.950171112; HEITZLER P, 1991, CELL, V64, P1083, DOI 10.1016/0092-8674(91)90263-X; KO MSH, 1992, BIOESSAYS, V14, P341, DOI 10.1002/bies.950140510; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; MALONEY PC, 1973, J MOL BIOL, V73, P77, DOI 10.1016/0022-2836(73)90160-5; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; MEYER BJ, 1980, J MOL BIOL, V139, P163, DOI 10.1016/0022-2836(80)90303-4; Miller J.H., 1992, SHORT COURSE BACTERI, P150; PARKINSON JS, 1982, J BACTERIOL, V151, P106, DOI 10.1128/JB.151.1.106-113.1982; Paulsson J, 2001, Q REV BIOPHYS, V34, P1, DOI 10.1017/S0033583501003663; SPUDICH JL, 1976, NATURE, V262, P467, DOI 10.1038/262467a0; SWAIN PS, IN PRESS P NATL ACAD; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597	24	3579	3663	14	545	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 16	2002	297	5584					1183	1186		10.1126/science.1070919	http://dx.doi.org/10.1126/science.1070919			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584BP	12183631				2022-12-24	WOS:000177447600051
J	Marsh, JL; Hutton, JL; Binks, K				Marsh, JL; Hutton, JL; Binks, K			Removal of radiation dose response effects: an example of over-matching	BRITISH MEDICAL JOURNAL			English	Article							BRITISH-NUCLEAR-FUELS; SELLAFIELD PLANT; CANCER MORTALITY; WORKERS; MORBIDITY		Westlakes Sci Consulting, Occupat Hlth & Med Stat, Moor Row CA24 3LN, Cumbria, England; Univ Newcastle Upon Tyne, Dept Stat, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK	Marsh, JL (corresponding author), Univ Warwick, Dept Stat, Coventry CV4 7AL, W Midlands, England.							BRESLOW NE, 1980, IARC SCI PUBL, V1, P94; *COMM BIOL EFF ION, 1990, HLTH EFF EXP LOW LEV; DOUGLAS AJ, 1994, BRIT J CANCER, V70, P1232, DOI 10.1038/bjc.1994.479; Omar RZ, 1999, BRIT J CANCER, V79, P1288, DOI 10.1038/sj.bjc.6690207; *SAS I, 2000, SAS STAT US GUID VER, P2569; SMITH PG, 1986, BRIT MED J, V293, P845, DOI 10.1136/bmj.293.6551.845	6	23	24	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 10	2002	325	7359					327	330		10.1136/bmj.325.7359.327	http://dx.doi.org/10.1136/bmj.325.7359.327			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	584RQ	12169512	Green Published			2022-12-24	WOS:000177482500023
J	Spitzer, D				Spitzer, D			Uphill falling	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 7	2002	288	5					548	548		10.1001/jama.288.5.548	http://dx.doi.org/10.1001/jama.288.5.548			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	581FJ	12150653				2022-12-24	WOS:000177280200001
J	Marsicano, G; Wotjak, CT; Azad, SC; Bisogno, T; Rammes, G; Cascio, MG; Hermann, H; Tang, JR; Hofmann, C; Zieglgansberger, W; Di Marzo, V; Lutz, B				Marsicano, G; Wotjak, CT; Azad, SC; Bisogno, T; Rammes, G; Cascio, MG; Hermann, H; Tang, JR; Hofmann, C; Zieglgansberger, W; Di Marzo, V; Lutz, B			The endogenous cannabinoid system controls extinction of aversive memories	NATURE			English	Article							BASOLATERAL AMYGDALA; PREFRONTAL CORTEX; MOUSE-BRAIN; RECEPTOR; MICE; FEAR; CB1; TRANSMISSION; ENHANCEMENT; ANTAGONIST	Acquisition and storage of aversive memories is one of the basic principles of central nervous systems throughout the animal kingdom(1). In the absence of reinforcement, the resulting behavioural response will gradually diminish to be finally extinct. Despite the importance of extinction(2), its cellular mechanisms are largely unknown. The cannabinoid receptor 1 (CB1)(3) and endocannabinoids(4) are present in memory-related brain areas(5,6) and modulate memory(7,8). Here we show that the endogenous cannabinoid system has a central function in extinction of aversive memories. CB1-deficient mice showed strongly impaired short-term and long-term extinction in auditory fear-conditioning tests, with unaffected memory acquisition and consolidation. Treatment of wild-type mice with the CB1 antagonist SR141716A mimicked the phenotype of CB1-deficient mice, revealing that CB1 is required at the moment of memory extinction. Consistently, tone presentation during extinction trials resulted in elevated levels of endocannabinoids in the basolateral amygdala complex,a region known to control extinction of aversive memories(9). In the basolateral amygdala, endocannabinoids and CB1 were crucially involved in long-term depression of GABA (gamma-aminobutyric acid)-mediated inhibitory currents. We propose that endocannabinoids facilitate extinction of aversive memories through their selective inhibitory effects on local inhibitory networks in the amygdala.	Max Planck Inst Psychiat, Mol Genet Behav Grp, D-80804 Munich, Germany; Max Planck Inst Psychiat, Neuronal Plast Mouse Behav Grp, D-80804 Munich, Germany; Max Planck Inst Psychiat, Neuropharmacol Grp, D-80804 Munich, Germany; Univ Munich, Klinikum Grosshadern, Clin Anaesthesiol, D-81377 Munich, Germany; CNR, Inst Biomol Chem, Endocannabinoid Res Grp, I-80078 Naples, Italy; GSF, Natl Res Ctr Environm & Hlth, Inst Mammalian Genet, D-85764 Neuherberg, Germany	Max Planck Society; Max Planck Society; Max Planck Society; University of Munich; Consiglio Nazionale delle Ricerche (CNR); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Lutz, B (corresponding author), Max Planck Inst Psychiat, Mol Genet Behav Grp, Kraepelinstr 2-10, D-80804 Munich, Germany.		Di Marzo, Vincenzo/AAD-7742-2019; Wotjak, Carsten T./S-3200-2019; Lutz, Beat/AFK-6229-2022; Bisogno, Tiziana/B-7891-2015; Lutz, Beat/AAG-4538-2022	Di Marzo, Vincenzo/0000-0002-1490-3070; Marsicano, Giovanni/0000-0003-3804-1951				Collins DR, 1999, J NEUROSCI, V19, P836; Davis M., 2000, CONT ISSUES MODELING, P113, DOI [DOI 10.1007/978-1-4757-4860-4_8, 10.1007/978-1-4757-4860-4_8]; de Fonseca FR, 1998, NEUROBIOL DIS, V5, P483, DOI 10.1006/nbdi.1998.0217; Di Marzo V, 2000, J NEUROCHEM, V75, P2434, DOI 10.1046/j.1471-4159.2000.0752434.x; Di Marzo V, 1998, TRENDS NEUROSCI, V21, P521, DOI 10.1016/S0166-2236(98)01283-1; El-Ghundi M, 2001, BRAIN RES, V892, P86, DOI 10.1016/S0006-8993(00)03234-0; FALLS WA, 1992, J NEUROSCI, V12, P854; FRANKLIN KBJ, 1997, MOUSE BRAIN; Hampson RE, 1998, NEUROBIOL DIS, V5, P474, DOI 10.1006/nbdi.1998.0223; Harris JA, 1998, PSYCHOPHARMACOLOGY, V140, P105, DOI 10.1007/s002130050745; Katona I, 2001, J NEUROSCI, V21, P9506, DOI 10.1523/JNEUROSCI.21-23-09506.2001; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lu KT, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0005.2001; Marsicano G, 1999, EUR J NEUROSCI, V11, P4213, DOI 10.1046/j.1460-9568.1999.00847.x; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; MCGAUGH JL, 1990, BEHAV NEUROSCI, V104, P264, DOI 10.1037/0735-7044.104.2.264; Medina JF, 2002, NAT REV NEUROSCI, V3, P122, DOI 10.1038/nrn728; MORGAN MA, 1993, NEUROSCI LETT, V163, P109, DOI 10.1016/0304-3940(93)90241-C; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Pertwee RG, 2001, PROG NEUROBIOL, V63, P569, DOI 10.1016/S0301-0082(00)00031-9; Petitet F, 1999, EUR J PHARMACOL, V374, P417, DOI 10.1016/S0014-2999(99)00189-2; Quirk GJ, 2000, J NEUROSCI, V20, P6225, DOI 10.1523/JNEUROSCI.20-16-06225.2000; Rammes G, 2000, EUR J NEUROSCI, V12, P2534, DOI 10.1046/j.1460-9568.2000.00108.x; Rammes G, 2001, NEUROSCIENCE, V107, P85, DOI 10.1016/S0306-4522(01)00336-0; Reibaud M, 1999, EUR J PHARMACOL, V379, pR1, DOI 10.1016/S0014-2999(99)00496-3; RINALDICARMONA M, 1994, FEBS LETT, V350, P240, DOI 10.1016/0014-5793(94)00773-X; Royer S, 1999, J NEUROSCI, V19, P10575; Santini E, 2001, J NEUROSCI, V21, P9009, DOI 10.1523/JNEUROSCI.21-22-09009.2001; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076	30	1302	1338	1	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 1	2002	418	6897					530	534		10.1038/nature00839	http://dx.doi.org/10.1038/nature00839			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579EE	12152079				2022-12-24	WOS:000177162800040
J	Hunt, KK; Vorburger, SA				Hunt, KK; Vorburger, SA			Hurdles and hopes for cancer treatment	SCIENCE			English	Editorial Material							DIRECTED GENE-THERAPY		Univ Texas, MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Hunt, KK (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Surg Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.							BLAESE RM, 1995, SCIENCE, V270, P475, DOI 10.1126/science.270.5235.475; Hacein-Bey-Abina S, 2002, NEW ENGL J MED, V346, P1185, DOI 10.1056/NEJMoa012616; Haviv YS, 2001, ADV DRUG DELIVER REV, V53, P135, DOI 10.1016/S0169-409X(01)00225-3; MILLER DG, 1990, MOL CELL BIOL, V10, P4239, DOI 10.1128/MCB.10.8.4239; Rainov NG, 2000, HUM GENE THER, V11, P2389, DOI 10.1089/104303400750038499; SINKOVICS J, 1993, INTERVIROLOGY, V36, P193, DOI 10.1159/000150339; SMITH RR, 1956, CANCER, V9, P1211, DOI 10.1002/1097-0142(195611/12)9:6<1211::AID-CNCR2820090624>3.0.CO;2-7; Swisher SG, 1999, J NATL CANCER I, V91, P763, DOI 10.1093/jnci/91.9.763; VANIN EF, 1994, J VIROL, V68, P4241, DOI 10.1128/JVI.68.7.4241-4250.1994; YANG YP, 1995, J VIROL, V69, P2004, DOI 10.1128/JVI.69.4.2004-2015.1995	10	75	85	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 19	2002	297	5580					415	416		10.1126/science.297.5580.415	http://dx.doi.org/10.1126/science.297.5580.415			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574LV	12130788				2022-12-24	WOS:000176892600055
J	Walter, JH; White, FJ; Hall, SK; MacDonald, A; Rylance, G; Boneh, A; Francis, DE; Shortland, GJ; Schmidt, M; Vail, A				Walter, JH; White, FJ; Hall, SK; MacDonald, A; Rylance, G; Boneh, A; Francis, DE; Shortland, GJ; Schmidt, M; Vail, A			How practical are recommendations for dietary control in phenylketonuria?	LANCET			English	Article								In patients with phenylketonuria, blood phenylalanine concentration during childhood is the major determinant of cognitive outcome. Guidelines provide age-related recommendations for treatment. To ascertain the extent to which these alms are achievable, we audited results from four centres for the years 1994-2000. The median proportion of samples with phenylalanine concentrations above those recommended was less than 30% for those younger than age 10 years but almost 80% for those aged 15 years and older. Similarly, the median frequency of blood sampling, expressed as a proportion of that recommended, was more than 80% for patients younger than 10 years but less than 50% by age 15 years. Our results indicate the difficulty of maintaining control In phenylketonuria, especially in older rather than younger children.	Royal Manchester Childrens Hosp, Willink Biochem Genet Unit, Manchester M27 4HA, Lancs, England; Birmingham Childrens Hosp, Birmingham, W Midlands, England; Royal Melbourne Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; Univ Wales Hosp, Dept Child Hlth, Cardiff CF4 4XW, S Glam, Wales; Univ Manchester, Biostat Grp, Manchester, Lancs, England	Royal Manchester Children's Hospital; University of Birmingham; Murdoch Children's Research Institute; Cardiff University; University of Manchester	Walter, JH (corresponding author), Royal Manchester Childrens Hosp, Willink Biochem Genet Unit, Manchester M27 4HA, Lancs, England.		White, Fiona/F-5251-2018; White, Fiona/P-5220-2019	White, Fiona/0000-0003-4936-1029; White, Fiona/0000-0003-4936-1029; Vail, Andy/0000-0001-8274-2726				ASPLIN D, 1999, MANAGEMENT PKU; BEASLEY MG, 1994, Q J MED, V87, P155; Schweitzer-Krantz S, 2000, EUR J PEDIATR, V159, pS70, DOI 10.1007/PL00014385; SMITH I, 1993, ARCH DIS CHILD, V68, P426; WAISBREN SE, 1987, PEDIATRICS, V79, P351	5	233	240	0	22	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 6	2002	360	9326					55	57		10.1016/S0140-6736(02)09334-0	http://dx.doi.org/10.1016/S0140-6736(02)09334-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	569JR	12114043				2022-12-24	WOS:000176599700013
J	Keren, K; Krueger, M; Gilad, R; Ben-Yoseph, G; Sivan, U; Braun, E				Keren, K; Krueger, M; Gilad, R; Ben-Yoseph, G; Sivan, U; Braun, E			Sequence-specific molecular lithography on single DNA molecules	SCIENCE			English	Article							RECA PROTEIN; CIRCUITS; CLEAVAGE	Recent advances in the realization of individual molecular-scale electronic devices emphasize the need for novel tools and concepts capable of assembling such devices into large-scale functional circuits. We demonstrated sequence-specific molecular lithography on substrate DNA molecules by harnessing homologous recombination by RecA protein. In a sequence-specific manner, we patterned the coating of DNA with metal, localized labeled molecular objects and grew metal islands on specific sites along the DNA substrate, and generated molecularly accurate stable DNA junctions for patterning the DNA substrate connectivity. In our molecular lithography, the information encoded in the DNA molecules replaces the masks used in conventional microelectronics, and the RecA protein serves as the resist. The molecular lithography works with high resolution over a broad range of length scales from nanometers to many micrometers.	Technion Israel Inst Technol, Dept Phys, IL-32000 Haifa, Israel; Technion Israel Inst Technol, Inst Solid State, IL-32000 Haifa, Israel	Technion Israel Institute of Technology; Technion Israel Institute of Technology	Braun, E (corresponding author), Technion Israel Inst Technol, Dept Phys, IL-32000 Haifa, Israel.	erez@physics.technion.ac.il	Krueger, Michael/A-4099-2011	Krueger, Michael/0000-0002-2476-5505; Keren, Kinneret/0000-0002-2962-6977				Bachtold A, 2001, SCIENCE, V294, P1317, DOI 10.1126/science.1065824; BENSIMON D, 1995, PHYS REV LETT, V74, P4754, DOI 10.1103/PhysRevLett.74.4754; Braun E, 1998, NATURE, V391, P775, DOI 10.1038/35826; Cox MM, 2000, PROG NUCLEIC ACID RE, V63, P311, DOI 10.1016/S0079-6603(08)60726-6; Eichen Y, 1998, ACTA POLYM, V49, P663, DOI 10.1002/(SICI)1521-4044(199810)49:10/11<663::AID-APOL663>3.0.CO;2-4; EICHEN Y, 1999, Patent No. 0025136; FERRIN LJ, 1991, SCIENCE, V254, P1494, DOI 10.1126/science.1962209; HONIGBERG SM, 1986, P NATL ACAD SCI USA, V83, P9586, DOI 10.1073/pnas.83.24.9586; Huang Y, 2001, SCIENCE, V294, P1313, DOI 10.1126/science.1066192; Joachim C, 2000, NATURE, V408, P541, DOI 10.1038/35046000; Lieber CM, 2001, SCI AM, V285, P58, DOI 10.1038/scientificamerican0901-58; Mao CD, 1999, J AM CHEM SOC, V121, P5437, DOI 10.1021/ja9900398; MULLER B, 1992, EMBO J, V11, P2685, DOI 10.1002/j.1460-2075.1992.tb05334.x; Niemeyer CM, 2000, CURR OPIN CHEM BIOL, V4, P609, DOI 10.1016/S1367-5931(00)00140-X; Richter J, 2000, ADV MATER, V12, P507, DOI 10.1002/(SICI)1521-4095(200004)12:7<507::AID-ADMA507>3.0.CO;2-G; Sato T, 1997, J APPL PHYS, V82, P696, DOI 10.1063/1.365600; Storhoff JJ, 1999, CHEM REV, V99, P1849, DOI 10.1021/cr970071p; Szybalski W, 1997, CURR OPIN BIOTECH, V8, P75, DOI 10.1016/S0958-1669(97)80161-9; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998	19	532	545	0	119	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 5	2002	297	5578					72	75		10.1126/science.1071247	http://dx.doi.org/10.1126/science.1071247			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	571HB	12098693				2022-12-24	WOS:000176711000033
J	Klyachko, VA; Jackson, MB				Klyachko, VA; Jackson, MB			Capacitance steps and fusion pores of small and large-dense-core vesicles in nerve terminals	NATURE			English	Article							MEMBRANE CAPACITANCE; EXOCYTOSIS; RELEASE; NEUROTRANSMITTER; ENDOCYTOSIS; RECORDINGS; DIFFUSION; DISCHARGE; GRANULES; EVENTS	The vesicles that package neurotransmitters fall into two distinct classes, large dense-core vesicles (LDCVs) and small synaptic vesicles, the coexistence of which is widespread in nerve terminals(1). High resolution capacitance recording reveals unitary steps proportional to vesicle size. Measurements of capacitance steps during LDCV and secretory granule fusion in endocrine and immune cells have provided important insights into exocytosis(2-4); however, extending these measurements to small synaptic vesicles has proven difficult. Here we report single vesicle capacitance steps in posterior pituitary nerve terminals. These nerve terminals contain neuropeptide-laden LDCVs, as well as microvesicles. Microvesicles are similar to synaptic vesicles in size, morphology 5 and molecular composition(6-8), but their contents are unknown. Capacitance steps of two characteristic sizes, corresponding with microvesicles and LDCVs, were detected in patches of nerve terminal membrane. Both types of vesicles fuse in response to depolarization-induced Ca2+ entry. Both undergo a reversible fusion process commonly referred to as 'kiss-and-run', but only rarely. Fusion pores seen during microvesicle kiss-and-run have a conductance of 19 pS, 11 times smaller than LDCV fusion pores. Thus, LDCVs and microvesicles use structurally different intermediates during exocytosis.	Univ Wisconsin, Dept Physiol, Madison, WI 53706 USA; Univ Wisconsin, Biophys Grad Program, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Jackson, MB (corresponding author), Univ Wisconsin, Dept Physiol, 1300 Univ Ave, Madison, WI 53706 USA.	mjackson@physiology.wisc.edu	Klyachko, Vitaly/E-9431-2012					Ales E, 1999, NAT CELL BIOL, V1, P40, DOI 10.1038/9012; ALMERS W, 1991, ANN NY ACAD SCI, V635, P318, DOI 10.1111/j.1749-6632.1991.tb36502.x; BRECKENRIDGE LJ, 1987, NATURE, V328, P814, DOI 10.1038/328814a0; BRUNS D, 1995, NATURE, V377, P62, DOI 10.1038/377062a0; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; Debus K, 2000, BIOPHYS J, V78, P2983, DOI 10.1016/S0006-3495(00)76837-8; DECAMILLI P, 1990, ANNU REV PHYSIOL, V52, P625, DOI 10.1146/annurev.ph.52.030190.003205; FERNANDEZ JM, 1984, NATURE, V312, P453, DOI 10.1038/312453a0; Fesce Riccardo, 1994, Trends in Cell Biology, V4, P1, DOI 10.1016/0962-8924(94)90025-6; Gentet LJ, 2000, BIOPHYS J, V79, P314, DOI 10.1016/S0006-3495(00)76293-X; Hsu SF, 1996, J PHYSIOL-LONDON, V494, P539, DOI 10.1113/jphysiol.1996.sp021512; Khanin R, 1997, BIOPHYS J, V72, P507, DOI 10.1016/S0006-3495(97)78691-0; KHANIN R, 1994, BIOPHYS J, V67, P966, DOI 10.1016/S0006-3495(94)80562-4; LINDAU M, 1995, CURR OPIN CELL BIOL, V7, P509, DOI 10.1016/0955-0674(95)80007-7; LOLLIKE K, 1995, J CELL BIOL, V129, P99, DOI 10.1083/jcb.129.1.99; MORRIS JF, 1980, NEUROSCIENCE, V5, P639, DOI 10.1016/0306-4522(80)90061-5; MORRISON DL, 1995, INT J REHABIL RES, V18, P1, DOI 10.1097/00004356-199501000-00001; NAGASAWA J, 1971, NATURE, V232, P341, DOI 10.1038/232341a0; NANAVATI C, 1993, SCIENCE, V259, P963, DOI 10.1126/science.8438154; NAVONE F, 1989, J CELL BIOL, V109, P3425, DOI 10.1083/jcb.109.6.3425; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; Pupier S, 1997, J NEUROSCI, V17, P2722; RAE JL, 1992, PFLUG ARCH EUR J PHY, V420, P618, DOI 10.1007/BF00374642; ROSENBOOM H, 1994, P NATL ACAD SCI USA, V91, P5267, DOI 10.1073/pnas.91.12.5267; SPRUCE AE, 1990, NEURON, V4, P643, DOI 10.1016/0896-6273(90)90192-I; Stiles JR, 1996, P NATL ACAD SCI USA, V93, P5747, DOI 10.1073/pnas.93.12.5747; TSE FW, 1993, J CELL BIOL, V121, P543, DOI 10.1083/jcb.121.3.543; VERHAGE M, 1991, NEURON, V6, P517, DOI 10.1016/0896-6273(91)90054-4; WALCHSOLIMENA C, 1993, J NEUROSCI, V13, P3895; ZIMMERBERG J, 1994, J CELL BIOL, V127, P1885, DOI 10.1083/jcb.127.6.1885	30	227	235	0	21	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 4	2002	418	6893					89	92		10.1038/nature00852	http://dx.doi.org/10.1038/nature00852			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569JL	12097912				2022-12-24	WOS:000176599200044
J	Fukushima, K; Yamanobe, T; Shinmei, Y; Fukushima, J; Kurkin, S; Peterson, BW				Fukushima, K; Yamanobe, T; Shinmei, Y; Fukushima, J; Kurkin, S; Peterson, BW			Coding of smooth eye movements in three-dimensional space by frontal cortex	NATURE			English	Article							DISPARITY SENSITIVITY; PREMOTOR CORTEX; CORTICAL AREA; PURSUIT; NEURONS; MONKEY; RESPONSES; DIRECTION; MACAQUE; SIGNALS	Through the development of a high-acuity fovea, primates with frontal eyes have acquired the ability to use binocular eye movements to track small objects moving in space(1). The smooth-pursuit system moves both eyes in the same direction to track movement in the frontal plane (frontal pursuit), whereas the vergence system moves left and right eyes in opposite directions to track targets moving towards or away from the observer (vergence tracking). In the cerebral cortex and brainstem, signals related to vergence eye movements-and the retinal disparity and blur signals that elicit them-are coded independently of signals related to frontal pursuit(2-6). Here we show that these types of signal are represented in a completely different way in the smooth-pursuit region of the frontal eye fields(7-11). Neurons of the frontal eye field modulate strongly during both frontal pursuit and vergence tracking, which results in three-dimensional cartesian representations of eye movements. We propose that the brain creates this distinctly different intermediate representation to allow these neurons to function as part of a system that enables primates to track and manipulate objects moving in three-dimensional space.	Hokkaido Univ, Sch Med, Dept Physiol, Sapporo, Hokkaido 0608638, Japan; Northwestern Univ, Sch Med, Chicago, IL 60611 USA	Hokkaido University; Northwestern University	Fukushima, K (corresponding author), Hokkaido Univ, Sch Med, Dept Physiol, West 7,North 15, Sapporo, Hokkaido 0608638, Japan.	kikuro@med.hokudai.ac.jp	Kurkin, Sergei/F-3268-2011; /G-2241-2012					COLBY CL, 1993, J NEUROPHYSIOL, V69, P902, DOI 10.1152/jn.1993.69.3.902; CUMMING BG, 1994, VISUAL DETECTION MOT, P333; Eifuku S, 1999, J NEUROPHYSIOL, V82, P2462, DOI 10.1152/jn.1999.82.5.2462; Ferraina S, 2000, J NEUROPHYSIOL, V83, P625, DOI 10.1152/jn.2000.83.1.625; FERRERA VP, 2000, SOC NEUR ABSTR, V26, P669; FOGASSI L, 1992, EXP BRAIN RES, V89, P686, DOI 10.1007/BF00229894; Fogassi L, 1996, J NEUROPHYSIOL, V76, P141, DOI 10.1152/jn.1996.76.1.141; Fukushima K, 2000, J NEUROPHYSIOL, V83, P563, DOI 10.1152/jn.2000.83.1.563; Fukushima K, 1999, ANN NY ACAD SCI, V871, P248, DOI 10.1111/j.1749-6632.1999.tb09189.x; Fukushima K, 2002, EXP BRAIN RES, V145, P104, DOI 10.1007/s00221-002-1088-7; Gamlin PD, 2000, NATURE, V407, P1003, DOI 10.1038/35039506; Gamlin PDR, 1999, OPHTHAL PHYSL OPT, V19, P81, DOI 10.1046/j.1475-1313.1999.00434.x; GOTTLIEB JP, 1994, J NEUROPHYSIOL, V72, P1634, DOI 10.1152/jn.1994.72.4.1634; Graziano MSA, 1997, J NEUROPHYSIOL, V77, P2268, DOI 10.1152/jn.1997.77.5.2268; JUDGE SJ, 1986, J NEUROPHYSIOL, V55, P915, DOI 10.1152/jn.1986.55.5.915; Kakei S, 2001, NAT NEUROSCI, V4, P1020, DOI 10.1038/nn726; Krauzlis RJ, 1996, EXP BRAIN RES, V109, P289; MacAvoy MG, 1991, CEREB CORTEX, V1, P95, DOI 10.1093/cercor/1.1.95; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1148, DOI 10.1152/jn.1983.49.5.1148; Mays LE, 1995, CURR OPIN NEUROBIOL, V5, P763, DOI 10.1016/0959-4388(95)80104-9; MAYS LE, 1986, J NEUROPHYSIOL, V56, P1007, DOI 10.1152/jn.1986.56.4.1007; Mushiake H, 1997, J NEUROPHYSIOL, V78, P567, DOI 10.1152/jn.1997.78.1.567; ROY JP, 1992, J NEUROSCI, V12, P2478; Semmlow JL, 1998, VISION RES, V38, P1145, DOI 10.1016/S0042-6989(97)00251-4; Shi DX, 1998, J NEUROPHYSIOL, V80, P458, DOI 10.1152/jn.1998.80.1.458; Takemura A, 2001, J NEUROPHYSIOL, V85, P2245, DOI 10.1152/jn.2001.85.5.2245; Tanaka M, 1998, J NEUROPHYSIOL, V80, P28, DOI 10.1152/jn.1998.80.1.28; Tian JR, 1996, J NEUROPHYSIOL, V76, P2740, DOI 10.1152/jn.1996.76.4.2740; Zee DS., 1999, NEUROLOGY EYE MOVEME; Zhou W, 1998, NATURE, V393, P692, DOI 10.1038/31489	30	78	78	2	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 12	2002	419	6903					157	162		10.1038/nature00953	http://dx.doi.org/10.1038/nature00953			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592HK	12226663				2022-12-24	WOS:000177931200039
J	Litingtung, Y; Dahn, RD; Li, YN; Fallon, JF; Chiang, C				Litingtung, Y; Dahn, RD; Li, YN; Fallon, JF; Chiang, C			Shh and Gli3 are dispensable for limb skeleton formation but regulate digit number and identity	NATURE			English	Article							CUBITUS-INTERRUPTUS PROTEIN; SONIC HEDGEHOG; POLARIZING ACTIVITY; ACTIVATION; REPRESSOR; MUTATIONS; GENE; MICE; ZPA	Most current models propose Sonic hedgehog (Shh) as the primary determinant of anteroposterior development of amniote limbs(1). Shh protein is said to be required to direct the formation of skeletal elements and to specify digit identity through dose-dependent activation of target gene expression. However, the identity of genes targeted by Shh, and the regulatory mechanisms controlling their expression, remain poorly understood. Gli3 (the gene implicated in human Greig cephalopolysyndactyly syndrome) is proposed to negatively regulate Shh by restricting its expression and influence to the posterior mesoderm(2-4). Here we report genetic analyses in mice showing that Shh and Gli3 are dispensable for formation of limb skeletal elements: Shh(-/-) Gli3(-/-) limbs are distally complete and polydactylous, but completely lack wild-type digit identities. We show that the effects of Shh signalling on skeletal patterning and ridge maintenance are necessarily mediated through Gli3. We propose that the function of Shh and Gli3 in limb skeletal patterning is limited to refining autopodial morphology, imposing pentadactyl constraint on the limb's polydactyl potential, and organizing digit identity specification, by regulating the relative balance of Gli3 transcriptional activator and repressor activities.	Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37232 USA; Univ Wisconsin, Dept Anat, Madison, WI 53706 USA	Vanderbilt University; University of Wisconsin System; University of Wisconsin Madison	Fallon, JF (corresponding author), Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37232 USA.	jfallon@facstaff.wisc.edu; chin.chiang@vanderbilt.edu						AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; Brewster R, 2000, DEVELOPMENT, V127, P4395; Brewster R, 1998, NATURE, V393, P579, DOI 10.1038/31242; Buscher D, 1997, MECH DEVELOP, V62, P175, DOI 10.1016/S0925-4773(97)00656-4; Caruccio NC, 1999, DEV BIOL, V212, P137, DOI 10.1006/dbio.1999.9321; Castilla EE, 1996, AM J MED GENET, V65, P295, DOI 10.1002/(SICI)1096-8628(19961111)65:4<295::AID-AJMG10>3.0.CO;2-P; Chiang C, 2001, DEV BIOL, V236, P421, DOI 10.1006/dbio.2001.0346; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Fraidenraich D, 1998, DEV BIOL, V204, P197, DOI 10.1006/dbio.1998.9053; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Kraus P, 2001, MECH DEVELOP, V100, P45, DOI 10.1016/S0925-4773(00)00492-5; Lewis PM, 2001, CELL, V105, P599, DOI 10.1016/S0092-8674(01)00369-5; Martin GR, 1998, GENE DEV, V12, P1571, DOI 10.1101/gad.12.11.1571; MASUYA H, 1995, GENE DEV, V9, P1645, DOI 10.1101/gad.9.13.1645; Methot N, 1999, CELL, V96, P819, DOI 10.1016/S0092-8674(00)80592-9; Methot N, 2001, DEVELOPMENT, V128, P733; Pearse RV, 1998, J EXP ZOOL, V282, P677, DOI 10.1002/(SICI)1097-010X(19981215)282:6<677::AID-JEZ4>3.0.CO;2-F; Qu SM, 1997, DEVELOPMENT, V124, P3999; Radhakrishna U, 1999, AM J HUM GENET, V65, P645, DOI 10.1086/302557; Sanz-Ezquerro JJ, 2001, DIFFERENTIATION, V69, P91, DOI 10.1046/j.1432-0436.2001.690203.x; Sasaki H, 1999, DEVELOPMENT, V126, P3915; Shin SH, 1999, P NATL ACAD SCI USA, V96, P2880, DOI 10.1073/pnas.96.6.2880; Sun X, 2000, NAT GENET, V25, P83, DOI 10.1038/75644; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Welscher PT, 2002, GENE DEV, V16, P421, DOI 10.1101/gad.219202; Yang Y, 1997, DEVELOPMENT, V124, P4393; Ying LT, 2000, NAT NEUROSCI, V3, P979, DOI 10.1038/79916; Zuniga A, 1999, DEVELOPMENT, V126, P13; Zuniga A, 1999, NATURE, V401, P598, DOI 10.1038/44157	30	445	462	2	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 29	2002	418	6901					979	983		10.1038/nature01033	http://dx.doi.org/10.1038/nature01033			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588AP	12198547				2022-12-24	WOS:000177677500045
J	Paci, E; Duffy, SW; Giorgi, D; Zappa, M; Crocetti, E; Vezzosi, V; Bianchi, S; Cataliotti, L; del Turco, MR				Paci, E; Duffy, SW; Giorgi, D; Zappa, M; Crocetti, E; Vezzosi, V; Bianchi, S; Cataliotti, L; del Turco, MR			Are breast cancer screening programmes increasing rates of mastectomy? Observational study	BRITISH MEDICAL JOURNAL			English	Article									Ctr Study & Prevent Canc CSPO, Epidemiol Unit, I-50135 Florence, Italy; Ctr Study & Prevent Canc CSPO, Screening Unit, I-50135 Florence, Italy; Imperial Canc Res Fund, Dept Math Stat & Epidemiol, London WC2A 3PX, England; Azienda Sanitaria Locale 2, Epidemiol Unit, I-55100 Lucca, Italy; Univ Florence, Dept Pathol, I-50134 Florence, Italy; Univ Florence, Dept Surg, I-50134 Florence, Italy	Cancer Research UK; University of Florence; University of Florence	Paci, E (corresponding author), Ctr Study & Prevent Canc CSPO, Epidemiol Unit, Via S Salvi 12, I-50135 Florence, Italy.		Cataliotti, Luigi/ABD-2131-2021					Day NE, 1984, BIOMETRICS, V43, P1; Olsen O, 2001, LANCET, V358, P1340, DOI 10.1016/S0140-6736(01)06449-2; PACI E, 2001, QUANTITATIVE METHODS; Wingo PA, 2000, CANCER CAUSE CONTROL, V11, P497, DOI 10.1023/A:1008944209648	4	40	40	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 24	2002	325	7361					418	418		10.1136/bmj.325.7361.418	http://dx.doi.org/10.1136/bmj.325.7361.418			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	588RY	12193357	Bronze, Green Published			2022-12-24	WOS:000177715500019
J	Taddio, A; Shah, V; Gilbert-MacLeod, C; Katz, J				Taddio, A; Shah, V; Gilbert-MacLeod, C; Katz, J			Conditioning and hyperalgesia in newborns exposed to repeated heel lances	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEONATAL CIRCUMCISION; PAIN; INFANTS; DETERMINANTS; CRY; VACCINATION; REACTIVITY; CHILDREN	Context Hospitalized infants undergo repeated invasive procedures. It is unknown whether cumulative experiences with pain lead to anticipatory pain behaviors and hyperalgesia. Objectives To determine whether newborns who are born to mothers with diabetes and undergo repeated pain learn to anticipate pain and exhibit more pain during a painful procedure than normal infants. Design, Setting, and Participants Prospective cohort study of 21 full-term newborns born to mothers with diabetes and 21 born to mothers with uneventful pregnancies, at a university teaching hospital between August 1999 and October 2000. Infants of diabetic mothers underwent repeated heel lances in the first 24 to 36 hours of life for monitoring of blood glucose concentrations. Pain responses of all infants undergoing a venipuncture on the dorsum of the hand to obtain blood for the newborn screening test after the first day of life were compared. In addition, from September through November 2001, 12 infants of diabetic mothers and 12 normal infants were compared for pain reactions to intramuscular vitamin K injection after birth. Main Outcome Measures Percentages of time observed grimacing and crying and visual analog scale WAS) scores. Results Raters were blinded to exposure group. Median baseline scores for grimacing, crying time, and VAS did not differ significantly between groups (P=.27, P=.32, and P=.32, respectively). Median scores (interquartile range) for grimacing during skin cleansing were higher in infants of diabetic mothers (22.2% [77.5%] vs 0% [15%]; P=.03). The VAS scores for both groups were zero, but the distribution of the scores was significantly different (86% of normal infants vs 52% of infants of diabetic mothers had scores of zero) (P=.04). During venipuncture, infants of diabetic mothers had higher median scores for grimacing (81.7% [32.5%] vs 40% [73.4%]; P=.01), VAS (69% [27.5%] vs 5% [60.5%]; P=.002), and crying (40.2% [77%] vs 0% [54.8%]; P=.03) compared with normal infants. There were no differences between groups on any pain measure in response to intramuscular injection. Conclusions Newborns who had diabetic mothers and were exposed to repeated heel lances in the first 24 to 36 hours of life learned to anticipate pain and exhibited more intense pain responses during venipuncture than normal infants.	Univ Toronto, Hosp Sick Children, Dept Pharm, Grad Dept Pharmaceut Sci, Toronto, ON M5G 1X8, Canada; Mt Sinai Hosp, Dept Paediat, Toronto, ON M5G 1X5, Canada; Univ Toronto, Toronto Gen Hosp, Dept Anesthesia & Pain Management, Toronto, ON, Canada; Univ Toronto, Mt Sinai Hosp, Dept Publ Hlth Sci, Toronto, ON, Canada; Univ Toronto, Mt Sinai Hosp, Dept Anesthesia, Toronto, ON, Canada; IWK Grace Hlth Ctr, Halifax, NS, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Dalhousie University	Taddio, A (corresponding author), Univ Toronto, Hosp Sick Children, Dept Pharm, Grad Dept Pharmaceut Sci, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	anna.taddio@sickkids.on.ca	Katz, Joel/HDO-1635-2022; Shah, Vibhuti/P-5853-2015; Katz, Joel/J-7015-2014	Katz, Joel/0000-0002-8686-447X				Abu-Saad HH, 1998, SEMIN PERINATOL, V22, P402, DOI 10.1016/S0146-0005(98)80056-6; CRAIG KD, 1988, CAN J BEHAV SCI, V20, P442, DOI 10.1037/h0079934; FITZGERALD M, 1989, PAIN, V39, P31, DOI 10.1016/0304-3959(89)90172-3; Franck LS, 2000, PEDIATR CLIN N AM, V47, P487, DOI 10.1016/S0031-3955(05)70222-4; Grunau RE, 2000, CLIN J PAIN, V16, P37, DOI 10.1097/00002508-200003000-00007; Grunau RE, 2001, PEDIATRICS, V107, P105, DOI 10.1542/peds.107.1.105; GRUNAU RVE, 1987, PAIN, V28, P395, DOI 10.1016/0304-3959(87)90073-X; GUNNAR MR, 1992, PEDIATRICS, V90, P491; HADJISTAVROPOULOS HD, 1994, J PEDIATR PSYCHOL, V19, P485, DOI 10.1093/jpepsy/19.4.485; Health Canada, 2000, PER HLTH IND CAN RES; Hepper PG, 1996, ACTA PAEDIATR, V85, P16, DOI 10.1111/j.1651-2227.1996.tb14272.x; Oberlander TF, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.1.e6; OWENS ME, 1984, PAIN, V20, P77, DOI 10.1016/0304-3959(84)90813-3; PORTER FL, PEDIATRICS; Shah V, 1998, ARCH DIS CHILD-FETAL, V79, pF209, DOI 10.1136/fn.79.3.F209; Shah VS, 1997, ARCH DIS CHILD-FETAL, V77, pF143, DOI 10.1136/fn.77.2.F143; Stevens B, 1996, CLIN J PAIN, V12, P13, DOI 10.1097/00002508-199603000-00004; Stevens B, 1997, ACTA PAEDIATR, V86, P837, DOI 10.1111/j.1651-2227.1997.tb08607.x; TADDIO A, 1995, LANCET, V345, P291, DOI 10.1016/S0140-6736(95)90278-3; Taddio A, 1997, LANCET, V349, P599, DOI 10.1016/S0140-6736(96)10316-0; Taddio A, 1999, PROG PAIN RES MANAG, V13, P57; Williams AF, 1997, B WORLD HEALTH ORGAN, V75, P261	22	233	239	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 21	2002	288	7					857	861		10.1001/jama.288.7.857	http://dx.doi.org/10.1001/jama.288.7.857			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585FC	12186603	Bronze, Green Submitted			2022-12-24	WOS:000177513100028
J	Kirk, O; Reiss, P; Uberti-Foppa, C; Bickel, M; Gerstoft, J; Pradier, C; Wit, FW; Ledergerber, B; Lundgren, JD; Furrer, H; Seven European HIV Cohorts				Kirk, O; Reiss, P; Uberti-Foppa, C; Bickel, M; Gerstoft, J; Pradier, C; Wit, FW; Ledergerber, B; Lundgren, JD; Furrer, H; Seven European HIV Cohorts			Safe interruption of maintenance therapy against previous infection with four common HIV-associated opportunistic pathogens during potent antiretroviral therapy	ANNALS OF INTERNAL MEDICINE			English	Article							PNEUMOCYSTIS-CARINII-PNEUMONIA; PLACEBO-CONTROLLED TRIAL; ACQUIRED-IMMUNODEFICIENCY-SYNDROME; AVIUM COMPLEX BACTEREMIA; MYCOBACTERIUM-AVIUM; CYTOMEGALOVIRUS RETINITIS; PRIMARY PROPHYLAXIS; SECONDARY PROPHYLAXIS; HIV-1-INFECTED PATIENTS; TOXOPLASMA ENCEPHALITIS	Background: The safety of interrupting maintenance therapy for previous opportunistic infections other than Pneumocystis carinii pneumonia among patients with HIV infection who respond to potent antiretroviral therapy has not been well documented. Objective: To assess the safety of interrupting maintenance therapy for cytomegalovirus (CMV) end-organ disease, disseminated Mycobacterium avium complex (MAC) infection, cerebral toxoplasmosis, and extrapulmonary cryptococcosis in patients receiving antiretroviral therapy. Design: Observational study. Setting: Seven European HIV cohorts. Patients: 358 patients taking potent antiretroviral therapy (greater than or equal to3 drugs) who interrupted maintenance therapy at a CD4 lymphocyte count greater than 50 x 10(6) cells/L. Measurements: Recurrence of opportunistic infection after interruption of maintenance therapy. Results: 379 interruptions of maintenance therapy were identified: 162 for CMV disease, 103 for MAC infection, 75 for toxoplasmosis, and 39 for cryptococcosis. During 781 person-years of follow-up, five patients had relapse. Two relapses (one of CMV disease and one of MAC infection) were diagnosed after maintenance therapy was interrupted when the CD4 lymphocyte count was less than 100 x 106 cells/L or when only one recent measurement exceeded this value. Two relapses (one of CMV disease and one of MAC infection) were diagnosed after maintenance therapy was interrupted once CD4 counts were greater than 100 x 106 cells/L for 10 and 8 months, respectively. One relapse (toxoplasmosis) was diagnosed after maintenance therapy interruption at a CD4 lymphocyte count greater than 200 x 106 cells/L for 15 months. The overall incidences of recurrent CMV disease, MAC infection, toxoplasmosis, and cryptococcosis were 0.54 per 100 person-years (95% Cl, 0.07 to 1.95 per 100 person-years), 0.90 per 100 person-years (Cl, 0.11 to 3.25 per 100 person-years), 0.84 per 100 person-years (Cl, 0.02 to 4.68 per 100 person-years), and 0.00 per 100 person-years (Cl, 0.00 to 5.27 per 100 person-years), respectively. Conclusion: Maintenance therapy against previous infection with CMV, MAC, Toxoplasma gondii, or Cryptococcus neoformans in patients with HIV infection can be interrupted after sustained CD4 count increases to greater than 200 (or possibly 100 to 200) x 106 cells/L for at least 6 months after the start of potent antiretroviral therapy.	Univ Copenhagen, Hvidovre Hosp, Coordinating Ctr EuroSIDA, Dept Infect Dis, DK-2650 Hvidovre, Denmark; Rigshosp, DK-2100 Copenhagen, Denmark; Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; Hosp San Raffaele, I-20132 Milan, Italy; JW Goethe Univ Clin, Frankfurt, Germany; Hop Archet, Nice, France; Univ Zurich Hosp, CH-8091 Zurich, Switzerland; Univ Hosp Bern, CH-3010 Bern, Switzerland	University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Amsterdam; Academic Medical Center Amsterdam; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Goethe University Frankfurt; Goethe University Frankfurt Hospital; CHU Nice; University of Zurich; University Zurich Hospital; University of Bern; University Hospital of Bern	Kirk, O (corresponding author), Univ Copenhagen, Hvidovre Hosp, Coordinating Ctr EuroSIDA, Dept Infect Dis, Kettegaard Alle, DK-2650 Hvidovre, Denmark.	oki@cphiv.dk	VALLET, Yannick/F-9979-2011; Foppa, Caterina Uberti/ABH-3089-2020; Pradier, Christian/AAE-9669-2022; Furrer, Hansjakob/G-6768-2013; Wit, Ferdinand/AAC-3803-2019; Pradier, Christian/AFE-8255-2022; kirk, ole/ABB-4746-2021; Lundgren, Jens/AAE-6876-2019; Ledergerber, Bruno/B-5656-2009	Foppa, Caterina Uberti/0000-0001-5271-9138; Furrer, Hansjakob/0000-0002-1375-3146; Ledergerber, Bruno/0000-0002-6881-4401; Lundgren, Jens/0000-0001-8901-7850				*1999 USPHS IDSA, 1999, MMWR-MORBID MORTAL W, V48, P1; *2001 USPHS IDSA, 2001, UIG PREV OPP INF PER; Aberg JA, 1998, J INFECT DIS, V178, P1446, DOI 10.1086/314469; Autran B, 1997, SCIENCE, V277, P112, DOI 10.1126/science.277.5322.112; BOZZETTE SA, 1991, NEW ENGL J MED, V324, P580, DOI 10.1056/NEJM199102283240902; Brodt HR, 1997, AIDS, V11, P1731, DOI 10.1097/00002030-199714000-00010; Carr A, 1998, LANCET, V351, P256, DOI 10.1016/S0140-6736(97)07529-6; Curi ALL, 2001, BRIT J OPHTHALMOL, V85, P471, DOI 10.1136/bjo.85.4.471; Currier JS, 2000, ANN INTERN MED, V133, P493, DOI 10.7326/0003-4819-133-7-200010030-00008; de Quiros JCLB, 2001, NEW ENGL J MED, V344, P159, DOI 10.1056/NEJM200101183440301; Dube MP, 1997, J INFECT DIS, V176, P1225, DOI 10.1086/514116; El-Sadr WM, 2000, NEW ENGL J MED, V342, P1085, DOI 10.1056/NEJM200004133421503; FEINSTEIN A, 1984, STAT MED, V3, P341, DOI 10.1002/sim.4780030409; Foudraine NA, 1998, AIDS, V12, P35, DOI 10.1097/00002030-199801000-00005; Furrer H, 2000, LANCET, V355, P2217, DOI 10.1016/S0140-6736(00)02407-7; Furrer H, 1999, NEW ENGL J MED, V340, P1301, DOI 10.1056/NEJM199904293401701; Furrer H, 2001, AIDS, V15, P501, DOI 10.1097/00002030-200103090-00009; Furrer H, 2000, AIDS, V14, P1409, DOI 10.1097/00002030-200007070-00014; Hadad DJ, 1998, CLIN INFECT DIS, V26, P758, DOI 10.1086/514577; HAVERKOS HW, 1987, AM J MED, V82, P907, DOI 10.1016/0002-9343(87)90151-3; JACOBSON MA, 1993, J INFECT DIS, V168, P112, DOI 10.1093/infdis/168.1.112; JACOBSON MA, 1988, J MED VIROL, V25, P339, DOI 10.1002/jmv.1890250311; Jouan M, 2001, AIDS, V15, P23, DOI 10.1097/00002030-200101050-00006; Katlama C, 1996, CLIN INFECT DIS, V22, P268, DOI 10.1093/clinids/22.2.268; Kirk O, 1999, AIDS, V13, P1647, DOI 10.1097/00002030-199909100-00007; Komanduri KV, 2001, J INFECT DIS, V183, P1285, DOI 10.1086/319683; Komanduri KV, 1998, NAT MED, V4, P953, DOI 10.1038/nm0898-953; Ledergerber B, 2001, NEW ENGL J MED, V344, P168, DOI 10.1056/NEJM200101183440302; Li TS, 1998, LANCET, V351, P1682, DOI 10.1016/S0140-6736(97)10291-4; Lundgren JD, 1997, J ACQ IMMUN DEF SYND, V16, P153, DOI 10.1097/00042560-199711010-00003; Macdonald JC, 1998, J INFECT DIS, V177, P1182, DOI 10.1086/515281; Martinez E, 2000, AIDS, V14, P2615, DOI 10.1097/00002030-200011100-00029; Martinez E, 1999, AIDS, V13, P147; Murphy M, 1997, AIDS, V11, P261; Mussini C, 2000, J INFECT DIS, V181, P1635, DOI 10.1086/315471; Nieuwkerk PT, 2001, ARCH INTERN MED, V161, P1962, DOI 10.1001/archinte.161.16.1962; Nwokolo NC, 2001, AIDS, V15, P1438, DOI 10.1097/00002030-200107270-00015; PALESTINE AG, 1991, ANN INTERN MED, V115, P665, DOI 10.7326/0003-4819-115-9-665; Pocock SJ, 2000, NEW ENGL J MED, V342, P1907, DOI 10.1056/NEJM200006223422511; Pradier C, 1997, AIDS, V11, P832; RENOLD C, 1992, MEDICINE, V71, P224, DOI 10.1097/00005792-199207000-00005; Rizzardi GP, 1996, J INFECTION, V32, P123, DOI 10.1016/S0163-4453(96)91312-2; Schneider MME, 1999, LANCET, V353, P201, DOI 10.1016/S0140-6736(98)07204-3; Soriano V, 2000, AIDS, V14, P383, DOI 10.1097/00002030-200003100-00011; Sudre P, 2000, SCHWEIZ MED WSCHR, V130, P1493; Tural C, 1998, J INFECT DIS, V177, P1080, DOI 10.1086/517399; Vrabec TR, 1998, OPHTHALMOLOGY, V105, P1259, DOI 10.1016/S0161-6420(98)97031-2; Weverling GJ, 1999, LANCET, V353, P1293, DOI 10.1016/S0140-6736(99)03287-0; Whitcup SM, 1999, JAMA-J AM MED ASSOC, V282, P1633, DOI 10.1001/jama.282.17.1633; Whitcup SM, 1997, JAMA-J AM MED ASSOC, V277, P1519, DOI 10.1001/jama.277.19.1519; Yangco BG, 2000, ANN INTERN MED, V132, P201, DOI 10.7326/0003-4819-132-3-200002010-00005	51	93	98	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 20	2002	137	4					239	250		10.7326/0003-4819-137-4-200208200-00008	http://dx.doi.org/10.7326/0003-4819-137-4-200208200-00008			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585BB	12186514				2022-12-24	WOS:000177502300004
J	Dohlman, HG				Dohlman, HG			Desensitization: Diminishing returns	NATURE			English	Editorial Material							PROTEIN		Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Dohlman, HG (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Campus Box 7260, Chapel Hill, NC 27599 USA.			Dohlman, Henrik/0000-0003-2443-0729				Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Wang YQ, 2002, J BIOL CHEM, V277, P15766, DOI 10.1074/jbc.M111733200	4	10	10	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 8	2002	418	6898					591	591		10.1038/418591a	http://dx.doi.org/10.1038/418591a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581RA	12167838	Bronze			2022-12-24	WOS:000177305600020
J	Kreiss, K; Gomaa, A; Kullman, G; Fedan, K; Simoes, EJ; Enright, PL				Kreiss, K; Gomaa, A; Kullman, G; Fedan, K; Simoes, EJ; Enright, PL			Clinical bronchiolitis obliterans in workers at a microwave-popcorn plant	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VALUES; SAMPLE	Background In May 2000, eight persons who had formerly worked at a microwave-popcorn production plant were reported to have severe bronchiolitis obliterans. No recognized cause was identified in the plant. Therefore, we medically evaluated current employees and assessed their occupational exposures. Methods Questionnaire responses and spirometric findings in participating workers were compared with data from the third National Health and Nutrition Examination Survey, after adjustment for age and smoking status. We evaluated the relation between exposures and health-related outcomes by analyzing the rates of symptoms and abnormalities according to current and cumulative exposure to diacetyl, the predominant ketone in artificial butter flavoring and in the air at the plant. Results Of the 135 current workers at the plant, 117 (87 percent) completed the questionnaire. These 117 workers had 2.6 times the expected rates of chronic cough and shortness of breath, according to comparisons with the national data, and twice the expected rates of physician-diagnosed asthma and chronic bronchitis. Overall, the workers had 3.3 times the expected rate of airway obstruction; those who had never smoked had 10.8 times the expected rate. Workers directly involved in the production of microwave popcorn had higher rates of shortness of breath on exertion and skin problems that had developed since they started work than workers in other parts of the plant. There was a strong relation between the quartile of estimated cumulative exposure to diacetyl and the frequency and extent of airway obstruction. Conclusions The excess rates of lung disease and lung-function abnormalities and the relation between exposure and outcomes in this working population indicate that they probably had occupational bronchiolitis obliterans caused by the inhalation of volatile butter-flavoring ingredients.	NIOSH, Div Resp Dis Studies, Morgantown, WV 26505 USA; Missouri Dept Hlth & Senior Serv, Off Epidemiol, Jefferson City, MO USA	Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH)	Kreiss, K (corresponding author), NIOSH, Div Resp Dis Studies, H2800,1095 Willowdale Rd, Morgantown, WV 26505 USA.	kkreiss@cdc.gov	Simoes, Eduardo J/H-4546-2018	Simoes, Eduardo J/0000-0003-4371-4305				AKPINARELCI M, 2002, AM J RESP CRIT CARE, V165, pA526; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; [Anonymous], 1991, AM REV RESPIR DIS, V144, P1202, DOI 10.1164/ajrccm/144.5.1202; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P2185; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P345; Eller P., 1994, DHHS NIOSH PUBLICATI, V94-113; FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; HUBBS AF, 2002, TOXICOL SCI S, V66, P194; *INT BAK SERV INC, 1986, DHHS NIOSH PUBL; *INT LAB OFF, 1980, OCC SAF HLTH SER, V22; King T. E., 1998, FISHMANS PULMONARY D, P825; Lockey J., 2002, AM J RESP CRIT CARE, V165, pA461; MILLER A, 1983, AM REV RESPIR DIS, V127, P270; MONSON RR, 1990, OCCUPATIONAL EPIDEMI, P114; MORGAN RH, 1979, AM J ROENTGENOL, V132, P803, DOI 10.2214/ajr.132.5.803; National Center for Health Statistics, 1996, 3 NAT HLTH NUTR EX S; Parmet AJ, 2002, J OCCUP ENVIRON MED, V44, P216, DOI 10.1097/00043764-200203000-00002; SAS Institute, 1990, SAS STAT US GUID VER	19	316	323	1	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 1	2002	347	5					330	338		10.1056/NEJMoa020300	http://dx.doi.org/10.1056/NEJMoa020300			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587WC	12151470	Bronze			2022-12-24	WOS:000177665900005
J	Edgar, M				Edgar, M			A new classification of adolescent idiopathic scoliosis	LANCET			English	Editorial Material							FUSION LEVELS		Middlesex Hosp, Dept Orthopaed Surg, London W1N 8AA, England; Univ Coll Hosp Trust, London W1N 8AA, England	University of London; University College London	Edgar, M (corresponding author), Middlesex Hosp, Dept Orthopaed Surg, London W1N 8AA, England.							BURSTEIN AH, 1993, J BONE JOINT SURG AM, V75A, P1743, DOI 10.2106/00004623-199312000-00001; Cummings RJ, 1998, J BONE JOINT SURG AM, V80A, P1107; D'Andrea LP, 2000, SPINE, V25, P1795, DOI 10.1097/00007632-200007150-00010; KING HA, 1983, J BONE JOINT SURG AM, V65, P1302, DOI 10.2106/00004623-198365090-00012; Lenke LG, 2001, J BONE JOINT SURG AM, V83A, P1169, DOI 10.2106/00004623-200108000-00006; Lenke LG, 2001, SPINE, V26, P2347, DOI 10.1097/00007632-200111010-00011; McCance SE, 1998, SPINE, V23, P2063, DOI 10.1097/00007632-199810010-00005; NASH CL, 1969, J BONE JOINT SURG AM, VA 51, P223, DOI 10.2106/00004623-196951020-00002; Poncet P, 2001, SPINE, V26, P2235, DOI 10.1097/00007632-200110150-00015; PONSETI IV, 1950, J BONE JOINT SURG AM, V32-A, P381, DOI 10.2106/00004623-195032020-00017	10	2	2	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 27	2002	360	9329					270	271		10.1016/S0140-6736(02)09562-4	http://dx.doi.org/10.1016/S0140-6736(02)09562-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	578DT	12147366				2022-12-24	WOS:000177102700004
J	Sogo, JM; Lopes, M; Foiani, M				Sogo, JM; Lopes, M; Foiani, M			Fork reversal and ssDNA accumulation at stalled replication forks owing to checkpoint defects	SCIENCE			English	Article							DNA-REPLICATION; DAMAGE; PHOSPHORYLATION; ACTIVATION; ORIGINS; KINASE; MEC1	Checkpoint-mediated control of replicating chromosomes is essential for preventing cancer. In yeast, Rad53 kinase protects stalled replication forks from pathological rearrangements. To characterize the mechanisms controlling fork integrity, we analyzed replication intermediates formed in response to replication blocks using electron microscopy. At the forks, wild-type cells accumulate short single-stranded regions, which likely causes checkpoint activation, whereas rad53 mutants exhibit extensive single-stranded gaps and hemi-replicated intermediates, consistent with a lagging-strand synthesis defect. Further, rad53 cells accumulate Holliday junctions through fork reversal. We speculate that, in checkpoint mutants, abnormal replication intermediates begin to form because of uncoordinated replication and are further processed by unscheduled recombination pathways, causing genome instability.	Ist FIRC Oncol Mol, I-20141 Milan, Italy; ETH Honggerberg, Inst Cell Biol, CH-8093 Zurich, Switzerland; Univ Milan, Dipartimento Genet & Biol Microrganismi, I-20133 Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Milan	Foiani, M (corresponding author), Ist FIRC Oncol Mol, Via Adamello 16, I-20141 Milan, Italy.	foiani@ifom-firc.it	Lopes, Massimo/G-4300-2013; Foiani, Marco/M-8234-2014	Foiani, Marco/0000-0003-4795-834X				Allers T, 2000, Nucleic Acids Res, V28, pe6, DOI 10.1093/nar/28.2.e6; Bashkirov VI, 2000, MOL CELL BIOL, V20, P4393, DOI 10.1128/MCB.20.12.4393-4404.2000; Boddy MN, 2001, CURR BIOL, V11, pR953, DOI 10.1016/S0960-9822(01)00572-3; Brush GS, 1996, P NATL ACAD SCI USA, V93, P15075, DOI 10.1073/pnas.93.26.15075; Desany BA, 1998, GENE DEV, V12, P2956, DOI 10.1101/gad.12.18.2956; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; Gasser R, 1996, J MOL BIOL, V258, P224, DOI 10.1006/jmbi.1996.0245; Gruber M, 2000, MOL CELL BIOL, V20, P5777, DOI 10.1128/MCB.20.15.5777-5787.2000; Haber JE, 2001, CELL, V107, P551, DOI 10.1016/S0092-8674(01)00593-1; INMAN RB, 1984, BIOCHIM BIOPHYS ACTA, V783, P205, DOI 10.1016/0167-4781(84)90030-7; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Liberi G, 2000, EMBO J, V19, P5027, DOI 10.1093/emboj/19.18.5027; Lindsay HD, 1998, GENE DEV, V12, P382, DOI 10.1101/gad.12.3.382; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Lowndes NF, 2000, CURR OPIN GENET DEV, V10, P17, DOI 10.1016/S0959-437X(99)00050-7; LUCCHINI R, 1995, NATURE, V374, P276, DOI 10.1038/374276a0; Marini F, 1997, EMBO J, V16, P639, DOI 10.1093/emboj/16.3.639; Myung KJ, 2001, CELL, V104, P397, DOI 10.1016/S0092-8674(01)00227-6; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Seigneur M, 1998, CELL, V95, P419, DOI 10.1016/S0092-8674(00)81772-9; Shirahige K, 1998, NATURE, V395, P618, DOI 10.1038/27007; Singleton MR, 2001, CELL, V107, P79, DOI 10.1016/S0092-8674(01)00501-3; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; VAZE MB, UNPUB; Weinert T, 1997, CANCER SURV, V29, P109	27	653	666	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 26	2002	297	5581					599	602		10.1126/science.1074023	http://dx.doi.org/10.1126/science.1074023			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577GY	12142537				2022-12-24	WOS:000177054200050
J	Wootton, JC; Feng, XR; Ferdig, MT; Cooper, RA; Mu, JB; Baruch, DI; Magill, AJ; Su, XZ				Wootton, JC; Feng, XR; Ferdig, MT; Cooper, RA; Mu, JB; Baruch, DI; Magill, AJ; Su, XZ			Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum	NATURE			English	Article							HUMAN MALARIA; PARASITE POPULATIONS; RECENT ORIGIN; RESISTANCE; PROTEIN; POLYMORPHISMS; PFCRT	Widespread use of antimalarial agents can profoundly influence the evolution of the human malaria parasite Plasmodium falciparum. Recent selective sweeps for drug-resistant genotypes may have restricted the genetic diversity of this parasite, resembling effects attributed in current debates(1-4) to a historic population bottleneck. Chloroquine-resistant (CQR) parasites were initially reported about 45 years ago from two foci in southeast Asia and South America(5), but the number of CQR founder mutations and the impact of chlorquine on parasite genomes worldwide have been difficult to evaluate. Using 342 highly polymorphic microsatellite markers from a genetic map(6), here we show that the level of genetic diversity varies substantially among different regions of the parasite genome, revealing extensive linkage disequilibrium surrounding the key CQR gene pfcrt(7) and at least four CQR founder events. This disequilibrium and its decay rate in the pfcrt-flanking region are consistent with strong directional selective sweeps occurring over only similar to20-80 sexual generations, especially a single resistant pfcrt haplotype spreading to very high frequencies throughout most of Asia and Africa. The presence of linkage disequilibrium provides a basis for mapping genes under drug selection in P. falciparum.	NIAID, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA; NIH, Computat Biol Branch, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA; Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; Walter Reed Army Med Ctr, Walter Reed Army Inst Res, Div Communicable Dis & Immunol, Washington, DC 20307 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); University of Notre Dame; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Walter Reed National Military Medical Center	Su, XZ (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.		feng, xiaorong/G-4811-2010; Ferdig, Michael/C-6627-2016	feng, xiaorong/0000-0001-8410-3020; Su, Xinzhuan/0000-0003-3246-3248	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000892, Z01AI000892] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM000026, Z01LM000026] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Conway DJ, 1999, P NATL ACAD SCI USA, V96, P4506, DOI 10.1073/pnas.96.8.4506; Conway DJ, 2000, MOL BIOCHEM PARASIT, V111, P163, DOI 10.1016/S0166-6851(00)00313-3; Djimde A, 2001, NEW ENGL J MED, V344, P257, DOI 10.1056/NEJM200101253440403; Dorsey G, 2001, J INFECT DIS, V183, P1417, DOI 10.1086/319865; Dye C, 1997, P ROY SOC B-BIOL SCI, V264, P61, DOI 10.1098/rspb.1997.0009; ESCALANTE AA, 1995, MOL BIOL EVOL, V12, P616; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; Hey J, 1999, CURR BIOL, V9, pR565, DOI 10.1016/S0960-9822(99)80356-X; HILL WG, 1995, GENET RES, V65, P53, DOI 10.1017/S0016672300033000; Hughes AL, 2001, P ROY SOC B-BIOL SCI, V268, P1855, DOI 10.1098/rspb.2001.1759; Nomura T, 2001, J INFECT DIS, V183, P1653, DOI 10.1086/320707; PAUL REL, 1995, SCIENCE, V269, P1709, DOI 10.1126/science.7569897; PAYNE D, 1987, PARASITOL TODAY, V3, P241, DOI 10.1016/0169-4758(87)90147-5; Rich SM, 1998, GENETICS, V150, P515; Su XZ, 1999, SCIENCE, V286, P1351, DOI 10.1126/science.286.5443.1351; Su XZ, 1997, CELL, V91, P593, DOI 10.1016/S0092-8674(00)80447-X; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Volkman SK, 2001, SCIENCE, V293, P482, DOI 10.1126/science.1059878; Walliker David, 1998, P235	20	566	579	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 18	2002	418	6895					320	323		10.1038/nature00813	http://dx.doi.org/10.1038/nature00813			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574BF	12124623				2022-12-24	WOS:000176868000041
J	Vignaud, P; Duringer, P; Mackaye, HT; Likius, A; Blondel, C; Boisserie, JR; de Bonis, L; Eisenmann, V; Etienne, ME; Geraads, D; Guy, F; Lehmann, T; Lihoreau, F; Lopez-Martinez, N; Mourer-Chauvire, C; Otero, O; Rage, JC; Schuster, M; Viriot, L; Zazzo, A; Brunet, M				Vignaud, P; Duringer, P; Mackaye, HT; Likius, A; Blondel, C; Boisserie, JR; de Bonis, L; Eisenmann, V; Etienne, ME; Geraads, D; Guy, F; Lehmann, T; Lihoreau, F; Lopez-Martinez, N; Mourer-Chauvire, C; Otero, O; Rage, JC; Schuster, M; Viriot, L; Zazzo, A; Brunet, M			Geology and palaeontology of the Upper Miocene Toros-Menalla hominid locality, Chad	NATURE			English	Article							MANONGA VALLEY; EARLY PLIOCENE; DISCOVERY; RIFT; TANZANIA; LOTHAGAM; ETHIOPIA; FAUNA	All six known specimens of the early hominid Sahelanthropus tchadensis come from Toros-Menalla site 266 (TM 266), a single locality in the Djurab Desert, northern Chad, central Africa. Here we present a preliminary analysis of the palaeontological and palaeoecological context of these finds. The rich fauna from TM 266 includes a significant aquatic component such as fish, crocodiles and amphibious mammals, alongside animals associated with gallery forest and savannah, such as primates, rodents, elephants, equids and bovids. The fauna suggests a biochronological age between 6 and 7 million years. Taken together with the sedimentological evidence, the fauna suggests that S. tchadensis lived close to a lake, but not far from a sandy desert, perhaps the oldest record of desert conditions in the Neogene of northern central Africa.	Univ Poitiers, Fac Sci, F-86022 Poitiers, France; Univ Poitiers, CNRS, UMR 6046, F-86022 Poitiers, France; Univ Strasbourg 1, Ctr Geochim Surface, CNRS, UMR 7517, F-67084 Strasbourg, France; Univ NDjamena, Ndjamena, Chad; Museum Natl Hist Nat, F-75005 Paris, France; CNRS, UMR 8569, F-75005 Paris, France; CNRS, UPR 2147, F-75014 Paris, France; Harvard Univ, Peabody Museum, Cambridge, MA 02138 USA; Univ Complutense, Dept Paleontol, E-28040 Madrid, Spain; Univ Lyon 1, Ctr Sci Terre, CNRS, UMR 5125, F-69622 Villeurbanne, France; Univ Paris 06, CNRS, UMR 162, F-75252 Paris 05, France; Univ Paris 06, Inst Natl Rech Agron, F-75252 Paris 05, France	Universite de Poitiers; Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Harvard University; Complutense University of Madrid; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; INRAE; UDICE-French Research Universities; Sorbonne Universite	Vignaud, P (corresponding author), Univ Poitiers, Fac Sci, 40 Ave Recteur Pineau, F-86022 Poitiers, France.		Lund, Laura/H-7335-2012; Geraads, Denis/AAY-6051-2020; GERAADS, Denis/AAC-7241-2021; Blondel, cecile/AEY-9166-2022; zazzo, Antoine/H-1697-2011; Otero, Olga/T-5467-2018; Lopez-Martinez, Nieves/A-6718-2008; Lihoreau, Fabrice/C-6671-2015; Blondel, cecile/AAH-2618-2022	GERAADS, Denis/0000-0003-2475-8011; Blondel, cecile/0000-0002-7022-6959; zazzo, Antoine/0000-0001-7608-2207; Otero, Olga/0000-0002-8129-2054; Lihoreau, Fabrice/0000-0002-4327-5341; Schuster, Mathieu/0000-0002-4412-8685; Viriot, Laurent/0000-0003-2092-588X; GUY, Franck/0000-0001-7032-7963				BRUNET M, 1995, NATURE, V378, P273, DOI 10.1038/378273a0; Brunet M, 1998, CR ACAD SCI II A, V326, P153, DOI 10.1016/S1251-8050(97)87460-5; Brunet M, 2002, NATURE, V418, P145, DOI 10.1038/nature00879; Brunet M, 1996, CR ACAD SCI II A, V322, P907; Brunet M, 2000, J VERTEBR PALEONTOL, V20, P205, DOI 10.1671/0272-4634(2000)020[0205:CDOAVF]2.0.CO;2; CORYDON SC, 1977, P K NED AKAD B PHYS, V80, P61; de Bonis Louis, 1994, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V194, P343; Deino AL, 2002, J HUM EVOL, V42, P117, DOI 10.1006/jhev.2001.0521; Duringer P, 2000, LETHAIA, V33, P277; Eisenmann V, 1999, FOSSIL VERTEBRATES OF ARABIA, P234; Gaziry Abdel Wahid, 1987, P287; GENTRY A W, 1980, Annals of the South African Museum, V79, P213; Gentry Alan W., 1997, Topics in Geobiology, V14, P107; GERAADS D, 1989, GEOBIOS-LYON, V22, P777, DOI 10.1016/S0016-6995(89)80072-5; Ghienne JF, 2002, QUATERN INT, V87, P81, DOI 10.1016/S1040-6182(01)00063-5; Harris J.M., 1979, Transactions of the American Philosophical Society, V69, P1, DOI 10.2307/1006288; HUNTER RE, 1986, J SEDIMENT PETROL, V56, P387, DOI 10.1306/212F8922-2B24-11D7-8648000102C1865D; HUNTER RE, 1977, SEDIMENTOLOGY, V24, P361, DOI 10.1111/j.1365-3091.1977.tb00128.x; LEAKEY MD, 1987, LAETOLI PLIOCENE SIT, P524; Leakey MG, 1996, J VERTEBR PALEONTOL, V16, P556, DOI 10.1080/02724634.1996.10011339; Lehmann Ulrich, 1987, P323; McDougall I, 1999, J GEOL SOC LONDON, V156, P731, DOI 10.1144/gsjgs.156.4.0731; Pickford M, 2001, CR ACAD SCI II A, V332, P145, DOI 10.1016/S1251-8050(01)01528-2; Schuster M, 2000, CR ACAD SCI II A, V331, P15, DOI 10.1016/S1251-8050(00)01377-X; SEIGNOBOS C, 1993, SERIE C SEMINAIRES O, P165; Stewart Kathlyn M., 1997, Topics in Geobiology, V14, P333; TASSY P, 1994, CIFEB OCCAS PUBL, P217; Tassy P., 1994, GEOLOGY PALAEOBIOLOG, VII, P217; Tassy P., 1986, CAHIERS PALEONTOLOGI; Thomas H, 1977, P 8 PAN C PREH, P82; WOLDEGABRIEL G, 1994, NATURE, V371, P330, DOI 10.1038/371330a0; WoldeGabriel G, 2001, NATURE, V412, P175, DOI 10.1038/35084058	32	271	282	1	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 11	2002	418	6894					152	155		10.1038/nature00880	http://dx.doi.org/10.1038/nature00880			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	571GV	12110881				2022-12-24	WOS:000176710400031
J	Kwon, YT; Kashina, AS; Davydov, IV; Hu, RG; An, JY; Seo, JW; Du, F; Varshavsky, A				Kwon, YT; Kashina, AS; Davydov, IV; Hu, RG; An, JY; Seo, JW; Du, F; Varshavsky, A			An essential role of N-terminal arginylation in cardiovascular development	SCIENCE			English	Article							END RULE PATHWAY; RNA-PROTEIN TRANSFERASE; METHIONINE AMINOPEPTIDASE; UBIQUITIN; DEGRADATION; COMPONENT; ASPARTATE; LACKING; CELLS; MOUSE	The enzymatic conjugation of arginine to the N-termini of proteins is a part of the ubiquitin-dependent N-end rule pathway of protein degradation. In mammals, three N-terminal residues aspartate, glutamate, and cysteine are substrates for arginylation. The mouse ATE1 gene encodes a family of Arg-tRNA-protein transferases (R-transferases) that mediate N-terminal arginylation. We constructed ATE1-lacking mouse strains and found that ATE1(-/-) embryos die with defects in heart development and in angiogenic remodeling of the early vascular plexus. Through biochemical analyses, we show that N-terminal cysteine, in contrast to N-terminal aspartate and glutamate, is oxidized before its arginylation by R-transferase, suggesting that the arginylation branch of the N-end rule pathway functions as an oxygen sensor.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Varshavsky, A (corresponding author), CALTECH, Div Biol, 147-75,1200 E Calif Blvd, Pasadena, CA 91125 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031530] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM31530] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AUSUBEL FM, 2001, CURRENT PROTOCOLS MO; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Creazzo TL, 1998, ANNU REV PHYSIOL, V60, P267, DOI 10.1146/annurev.physiol.60.1.267; Davydov IV, 2000, J BIOL CHEM, V275, P22931, DOI 10.1074/jbc.M001605200; GONDA DK, 1989, J BIOL CHEM, V264, P16700; Griffith EC, 1997, CHEM BIOL, V4, P461, DOI 10.1016/S1074-5521(97)90198-8; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; KAIJI H, 1963, BIOCHIM BIOPHYS ACTA, V76, P474; Kwon YT, 1998, P NATL ACAD SCI USA, V95, P7898, DOI 10.1073/pnas.95.14.7898; Kwon YT, 2000, MOL CELL BIOL, V20, P4135, DOI 10.1128/MCB.20.11.4135-4148.2000; Kwon YT, 1999, MOL CELL BIOL, V19, P182; Kwon YT, 2001, MOL CELL BIOL, V21, P8007, DOI 10.1128/MCB.21.23.8007-8021.2001; Levy F, 1996, P NATL ACAD SCI USA, V93, P4907, DOI 10.1073/pnas.93.10.4907; LI J, 1995, BIOCHEMISTRY-US, V34, P15829, DOI 10.1021/bi00048a028; Rao H, 2001, NATURE, V410, P955, DOI 10.1038/35073627; Sin N, 1997, P NATL ACAD SCI USA, V94, P6099, DOI 10.1073/pnas.94.12.6099; Srivastava D, 2001, ANNU REV PHYSIOL, V63, P451, DOI 10.1146/annurev.physiol.63.1.451; Suzuki T, 1999, EMBO J, V18, P6017, DOI 10.1093/emboj/18.21.6017; Takao K, 1999, BIOL PHARM BULL, V22, P1007; TETAZ T, 1990, BIOCHEM INT, V22, P561; Turner GC, 2000, SCIENCE, V289, P2117, DOI 10.1126/science.289.5487.2117; Turner GC, 2000, NATURE, V405, P579, DOI 10.1038/35014629; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Varshavsky A, 2000, METHOD ENZYMOL, V327, P578, DOI 10.1016/S0076-6879(00)27303-5; YAGI T, 1979, BIOCHEM BIOPH RES CO, V90, P447, DOI 10.1016/0006-291X(79)91255-5	28	246	260	2	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 5	2002	297	5578					96	99		10.1126/science.1069531	http://dx.doi.org/10.1126/science.1069531			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	571HB	12098698				2022-12-24	WOS:000176711000041
J	Grimes, DA				Grimes, DA			Switching emergency contraception to over-the-counter status	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ADVANCE PROVISION; NICOTINE PATCH; SAFETY; LABEL		Family Hlth Int, Res Triangle Pk, NC 27713 USA		Grimes, DA (corresponding author), Family Hlth Int, Res Triangle Pk, NC 27713 USA.							AUBENY E, 2000, EUR J CONTRACEPT  S1, V5, P41; Davidson M, 1998, ARCH FAM MED, V7, P569, DOI 10.1001/archfami.7.6.569; EC Hughes, 1972, OBSTETRIC GYNECOLOGI, P327; Ellertson C, 1998, J Am Med Womens Assoc (1972), V53, P226; Ellertson C, 2001, OBSTET GYNECOL, V98, P570, DOI 10.1016/S0029-7844(01)01506-X; ELLERTSON C, 1998, J AM MED WOM ASS S2, V53, P232; Glasier A, 1998, NEW ENGL J MED, V339, P1, DOI 10.1056/NEJM199807023390101; Grimes D, 1998, LANCET, V352, P428; Grimes DA, 1997, NEW ENGL J MED, V337, P1078, DOI 10.1056/NEJM199710093371510; Grimes DA, 2001, OBSTET GYNECOL, V98, P151, DOI 10.1016/S0029-7844(01)01412-0; Grimes DA, 2001, WOMEN HEALTH ISS, V11, P397, DOI 10.1016/S1049-3867(01)00126-8; GRIMES DA, 1992, NEW ENGL J MED, V327, P1088, DOI 10.1056/NEJM199210083271509; GRIMES DA, 1992, AM J OBSTET GYNECOL, V166, P1950, DOI 10.1016/0002-9378(92)91394-P; Grimes DA, 2000, LANCET, V356, P1013, DOI 10.1016/S0140-6736(00)02699-4; Hays JT, 1999, AM J PUBLIC HEALTH, V89, P1701, DOI 10.2105/AJPH.89.11.1701; Henshaw SK, 1998, FAM PLANN PERSPECT, V30, P24, DOI 10.2307/2991522; *HJ KAIS FAM FDN, 2000, EM CONTR PRESCR COUN, P1; Lovvorn A, 2000, CONTRACEPTION, V61, P287, DOI 10.1016/S0010-7824(00)00107-4; Matheson CI, 1998, FAM PRACT, V15, P38, DOI 10.1093/fampra/15.1.38; Mullen WH, 1997, ANN EMERG MED, V29, P255, DOI 10.1016/S0196-0644(97)70277-4; Piaggio G, 1999, LANCET, V353, P721, DOI 10.1016/S0140-6736(98)05718-3; Raine T, 2000, OBSTET GYNECOL, V96, P1, DOI 10.1016/S0029-7844(00)00830-9; RAMANWILMS L, 1995, OBSTET GYNECOL, V85, P141, DOI 10.1016/0029-7844(94)00341-A; Raymond EG, 2002, OBSTET GYNECOL, V100, P342, DOI 10.1016/S0029-7844(02)02086-0; ROWLANDS S, 1991, BR J FAM PLANN, V17, P23; Soller RW, 1999, DRUG INF J, V33, P799, DOI 10.1177/009286159903300320; Trussell J, 2000, OBSTET GYNECOL, V95, P267, DOI 10.1016/S0029-7844(99)00518-9; U.S. Preventive Services Task Force, 1996, GUID CLIN PREV SERV; Ventura S J, 1999, Natl Vital Stat Rep, V47, P1; von Hertzen H, 2000, CONTRACEPTION, V61, P303, DOI 10.1016/S0010-7824(00)00116-5; Wearn AM, 1999, J CLIN PHARM THER, V24, P313, DOI 10.1046/j.1365-2710.1999.00234.x; WEBB A, 1994, BRIT MED J, V308, P135, DOI 10.1136/bmj.308.6921.135; *WHO, 2000, IMPR ACC QUAL CAR FA; WILLS SE, 2002, NATL REV         MAR; 2002, COUNTER MED WHATS RI; 1987, WHO TECH REP SER, V753, P7; 2002, TAKING EC COUNTER	37	35	35	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 12	2002	347	11					846	849		10.1056/NEJMsb020913	http://dx.doi.org/10.1056/NEJMsb020913			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592DK	12226159				2022-12-24	WOS:000177921300013
J	Kideys, AE				Kideys, AE			Fall and rise of the Black Sea ecosystem	SCIENCE			English	Editorial Material							CTENOPHORE MNEMIOPSIS; CASPIAN SEA; LARVAE; EGGS		Middle E Tech Univ, Inst Marine Sci, TR-33731 Erdemli, Turkey	Middle East Technical University	Kideys, AE (corresponding author), Middle E Tech Univ, Inst Marine Sci, TR-33731 Erdemli, Turkey.	kideys@ims.metu.edu.tr	KIDEYS, Ahmet E/Q-1824-2015	KIDEYS, AHMET ERKAN/0000-0002-1113-2434				[Anonymous], 2000, BIOL INVASIONS; DUMONT H, 1995, NATURE, V377, P673, DOI 10.1038/377673a0; Dumont HJ, 1998, LIMNOL OCEANOGR, V43, P44, DOI 10.4319/lo.1998.43.1.0044; Eker E, 1999, ICES J MAR SCI, V56, P15, DOI 10.1006/jmsc.1999.0604; Finenko GA, 2001, HYDROBIOLOGIA, V451, P177, DOI 10.1023/A:1011819819448; FINENKO GA, 2001, MNEM ADV GROUP 1 WOR; Humborg C, 1997, NATURE, V386, P385, DOI 10.1038/386385a0; Kideys AE, 2001, MAR BIOL, V139, P535; Kideys AE, 2000, J MARINE SYST, V24, P355, DOI 10.1016/S0924-7963(99)00095-0; KIDEYS AE, 1994, J MARINE SYST, V5, P171, DOI 10.1016/0924-7963(94)90030-2; Kideys AE, 1999, ICES J MAR SCI, V56, P58, DOI 10.1006/jmsc.1999.0605; KIDEYS AE, 2001, STRATEGY COMBATTING; KIDEYS AE, UNPUB; KOPELEVICH OV, IN PRESS J MAR SYS; KOVALEV AV, 1998, NATO TU BLACK SEA PR, P221; Leppakoski E, 1996, AMBIO, V25, P380; MEE LD, 1992, AMBIO, V21, P278; Moncheva S.V., 2001, P 9 INT C HARMF ALG, P177; NIERMANN U, 1994, ICES J MAR SCI, V51, P395, DOI 10.1006/jmsc.1994.1041; Shiganova TA, 2001, OCEANOLOGY+, V41, P517; Shiganova TA, 2000, ICES J MAR SCI, V57, P641, DOI 10.1006/jmsc.2000.0736; Shtereva G, 1999, WATER SCI TECHNOL, V39, P37, DOI 10.1016/S0273-1223(99)00205-X; SHUSHKINA EA, 1990, OCEANOLOGY, V30, P521; SOROKIN YS, 2002, BLACK SEA ECOLOGY OC; TSIKHONLUKASHIN.YA, 1991, OCEANOLOGY, V31, P196; VINOGRADOV ME, 1989, OKEANOLOGIYA+, V29, P293; Vladimirov VL, 1997, NATO ASI 2, V27, P33; Yunev OA, 2002, MAR ECOL PROG SER, V230, P11, DOI 10.3354/meps230011; Zaitsev Yu.P., 1992, Fisheries Oceanography, V1, P180, DOI 10.1111/j.1365-2419.1992.tb00036.x; Zenkevitch L., 1963, BIOL SEAS USSR	30	256	280	0	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 30	2002	297	5586					1482	1484		10.1126/science.1073002	http://dx.doi.org/10.1126/science.1073002			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588JA	12202806				2022-12-24	WOS:000177697300032
J	Perozo, E; Cortes, DM; Sompornpisut, P; Kloda, A; Martinac, B				Perozo, E; Cortes, DM; Sompornpisut, P; Kloda, A; Martinac, B			Open channel structure of MscL and the gating mechanism of mechanosensitive channels	NATURE			English	Article							ESCHERICHIA-COLI; ION-CHANNEL; CONFORMATIONAL-CHANGES; PROTEIN STRUCTURES; K+ CHANNEL; ARCHITECTURE; ACTIVATION; PRESSURE; INSIGHTS; MODELS	Mechanosensitive channels act as membrane-embedded mechano-electrical switches, opening a large water-filled pore in response to lipid bilayer deformations. This process is critical to the response of living organisms to direct physical stimulation, such as in touch, hearing and osmoregulation. Here, we have determined the structural rearrangements that underlie these events in the large prokaryotic mechanosensitive channel (MscL) using electron paramagnetic resonance spectroscopy and site-directed spin labelling. MscL was trapped in both the open and in an intermediate closed state by modulating bilayer morphology. Transition to the intermediate state is characterized by small movements in the first transmembrane helix (TM1). Subsequent transitions to the open state are accompanied by massive rearrangements in both TM1 and TM2, as shown by large increases in probe dynamics, solvent accessibility and the elimination of all intersubunit spin-spin interactions. The open state is highly dynamic, supporting a water-filled pore of at least 25 Angstrom, lined mostly by TM1. These structures suggest a plausible molecular mechanism of gating in mechanosensitive channels.	Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22906 USA; Univ Virginia, Ctr Struct Biol, Charlottesville, VA 22906 USA; Univ Western Australia, Queen Elizabeth II Med Ctr, Dept Pharmacol, Crawley, WA 6009, Australia; Chulalongkorn Univ, Fac Sci, Dept Chem, Bangkok 10330, Thailand	University of Virginia; University of Virginia; University of Western Australia; Chulalongkorn University	Perozo, E (corresponding author), Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22906 USA.		Martinac, Boris/A-7178-2018	Martinac, Boris/0000-0001-8422-7082				ALTENBACH C, 1990, SCIENCE, V248, P1088, DOI 10.1126/science.2160734; Batiza AF, 1999, STRUCTURE, V7, pR99, DOI 10.1016/S0969-2126(99)80061-6; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Cortes DM, 2001, J GEN PHYSIOL, V117, P165, DOI 10.1085/jgp.117.2.165; Cruickshank CC, 1997, BIOPHYS J, V73, P1925, DOI 10.1016/S0006-3495(97)78223-7; Gullingsrud J, 2001, BIOPHYS J, V80, P2074, DOI 10.1016/S0006-3495(01)76181-4; Hamill OP, 2001, PHYSIOL REV, V81, P685, DOI 10.1152/physrev.2001.81.2.685; Hubbell WL, 2000, NAT STRUCT BIOL, V7, P735, DOI 10.1038/78956; Hubbell WL, 1998, CURR OPIN STRUC BIOL, V8, P649, DOI 10.1016/S0959-440X(98)80158-9; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Levina N, 1999, EMBO J, V18, P1730, DOI 10.1093/emboj/18.7.1730; Liu YS, 2001, NAT STRUCT BIOL, V8, P883, DOI 10.1038/nsb1001-883; Maingret F, 2000, J BIOL CHEM, V275, P10128, DOI 10.1074/jbc.275.14.10128; MARTINAC B, 1990, NATURE, V348, P261, DOI 10.1038/348261a0; MARTINAC B, 1987, P NATL ACAD SCI USA, V84, P2297, DOI 10.1073/pnas.84.8.2297; Martinac B, 2001, CELL PHYSIOL BIOCHEM, V11, P61, DOI 10.1159/000047793; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Ou XR, 1998, P NATL ACAD SCI USA, V95, P11471, DOI 10.1073/pnas.95.19.11471; Patel AJ, 1998, EMBO J, V17, P4283, DOI 10.1093/emboj/17.15.4283; Perozo E, 1998, NAT STRUCT BIOL, V5, P459, DOI 10.1038/nsb0698-459; Perozo E, 2002, NAT STRUCT BIOL, V9, P696, DOI 10.1038/nsb827; Perozo E, 2001, J GEN PHYSIOL, V118, P193, DOI 10.1085/jgp.118.2.193; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Sompornpisut P, 2001, BIOPHYS J, V81, P2530, DOI 10.1016/S0006-3495(01)75898-5; Sompornpisut Pornthep, 2002, Biophysical Journal, V82, p474a; Spencer RH, 1999, CURR OPIN STRUC BIOL, V9, P650, DOI 10.1016/S0959-440X(99)00022-6; Spencer RH, 1999, CURR OPIN STRUC BIOL, V9, P448, DOI 10.1016/S0959-440X(99)80063-3; Sukharev S, 2001, BIOPHYS J, V81, P917, DOI 10.1016/S0006-3495(01)75751-7; Sukharev S, 2001, NATURE, V409, P720, DOI 10.1038/35055559; Sukharev SI, 1999, J GEN PHYSIOL, V113, P525, DOI 10.1085/jgp.113.4.525; SUKHAREV SI, 1994, NATURE, V368, P265, DOI 10.1038/368265a0; Sukharev SI, 1997, ANNU REV PHYSIOL, V59, P633, DOI 10.1146/annurev.physiol.59.1.633; Wood JM, 1999, MICROBIOL MOL BIOL R, V63, P230, DOI 10.1128/MMBR.63.1.230-262.1999; Yoshimura K, 1999, BIOPHYS J, V77, P1960, DOI 10.1016/S0006-3495(99)77037-2; Yoshimura K, 2001, BIOPHYS J, V80, P2198, DOI 10.1016/S0006-3495(01)76192-9; [No title captured]	37	465	489	5	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 29	2002	418	6901					942	948		10.1038/nature00992	http://dx.doi.org/10.1038/nature00992			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588AP	12198539				2022-12-24	WOS:000177677500036
J	Tsai, HH; Frost, E; To, V; Robinson, S; ffrench-Constant, C; Geertman, R; Ransohoff, RM; Miller, RH				Tsai, HH; Frost, E; To, V; Robinson, S; ffrench-Constant, C; Geertman, R; Ransohoff, RM; Miller, RH			The chemokine receptor CXCR2 controls positioning of oligodendrocyte precursors in developing spinal cord by arresting their migration	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; GROWTH-FACTOR; LINEAGE; CELL; INTERLEUKIN-8; ORIGIN; GENE; DIFFERENTIATION; PROLIFERATION; EXPRESSION	Spinal cord oligodendrocytes originate in the ventricular zone and subsequently migrate to white matter, stop, proliferate, and differentiate. Here we demonstrate a role for the chemokine CXCL1 and its receptor CXCR2 in patterning the developing spinal cord. Signaling through CXCR2, CXCL1 inhibited oligodendrocyte precursor migration. The migrational arrest was rapid, reversible, concentration dependent, and reflected enhanced cell/substrate interactions. White matter expression of CXCL1 was temporo-spatially regulated. Developing CXCR2 null spinal cords contained reduced oligodendrocytes, abnormally concentrated at the periphery. In slice preparations, CXCL1 inhibited embryonic oligodendrocyte precursor migration, and widespread dispersal of postnatal precursors occurred in the absence of CXCR2 signaling. These data suggest that population of presumptive white matter by oligodendrocyte precursors is dependent on localized expression of CXCL1.	Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA; Uniformed Serv Univ Hlth Sci, Dept Anat & Cell Biol, Bethesda, MD 20814 USA; Univ Hosp Cleveland, Res Inst, Dept Neurosurg, Cleveland, OH 44106 USA; Cambridge Ctr Brain Repair, Cambridge CB2 2PY, England; Cleveland Clin Fdn, Lerner Res Inst, Dept Neurol & Neurosci, Cleveland, OH 44195 USA	Case Western Reserve University; Uniformed Services University of the Health Sciences - USA; University Hospitals of Cleveland; University of Cambridge; Cleveland Clinic Foundation	Miller, RH (corresponding author), Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA.		Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036674, R37NS036674] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 36674] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANISOWICZ A, 1987, P NATL ACAD SCI USA, V84, P7188, DOI 10.1073/pnas.84.20.7188; ARMSTRONG GR, 1991, CYTOPATHOLOGY, V2, P52; BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97; BAGGIOLINI M, 1992, INT ARCH ALLERGY IMM, V99, P196, DOI 10.1159/000236247; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; BARRES BA, 1994, NATURE, V367, P371, DOI 10.1038/367371a0; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; BUNGE RP, 1968, PHYSIOL REV, V48, P197, DOI 10.1152/physrev.1968.48.1.197; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; Chisholm A, 1999, CURR OPIN NEUROBIOL, V9, P603, DOI 10.1016/S0959-4388(99)00021-5; COCHRAN BH, 1983, CELL, V33, P939, DOI 10.1016/0092-8674(83)90037-5; Dreyfus CF, 1999, J NEUROSCI RES, V56, P1, DOI 10.1002/(SICI)1097-4547(19990401)56:1<1::AID-JNR1>3.0.CO;2-3; Frost E, 1996, DEV NEUROSCI-BASEL, V18, P266, DOI 10.1159/000111416; Frost EE, 2000, METH MOL B, V139, P265; Glabinski AR, 1997, AM J PATHOL, V150, P617; HUBER AR, 1991, SCIENCE, V254, P99, DOI 10.1126/science.1718038; HUO Y, 2001, J CLIN INVEST, V108, P1269; Lu Q, 2001, CELL, V105, P69, DOI 10.1016/S0092-8674(01)00297-5; Ma Q, 1999, IMMUNITY, V10, P463, DOI 10.1016/S1074-7613(00)80046-1; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Martins-Green M., 1997, Cytokine and Growth Factor Reviews, V8, P221, DOI 10.1016/S1359-6101(97)00016-6; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; Miller RH, 1997, J NEUROSCI RES, V50, P157; MILNER R, 1994, DEVELOPMENT, V120, P3497; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; NOLL E, 1993, DEVELOPMENT, V118, P563; ONO K, 1995, DEVELOPMENT, V121, P1743; OQUENDO P, 1989, J BIOL CHEM, V264, P4133; Orentas DM, 1996, DEV BIOL, V177, P43, DOI 10.1006/dbio.1996.0143; Pringle NP, 1996, DEV BIOL, V177, P30, DOI 10.1006/dbio.1996.0142; PRINGLE NP, 1993, DEVELOPMENT, V117, P525; RICHARDSON WD, 1988, CELL, V53, P309, DOI 10.1016/0092-8674(88)90392-3; RICHMOND A, 1988, J CELL BIOCHEM, V36, P185, DOI 10.1002/jcb.240360209; Robinson S, 1998, J NEUROSCI, V18, P10457; TANI M, 1994, BRAIN PATHOL, V4, P135, DOI 10.1111/j.1750-3639.1994.tb00824.x; TSAI HH, 2001, SOC NEUR ABSTR, V897, P11; WARF BC, 1991, J NEUROSCI, V11, P2477; WARRINGTON AE, 1993, J NEUROSCI RES, V34, P1, DOI 10.1002/jnr.490340102; Weber KSC, 1999, EUR J IMMUNOL, V29, P700, DOI 10.1002/(SICI)1521-4141(199902)29:02<700::AID-IMMU700>3.0.CO;2-1; Wu Q, 2000, J NEUROSCI, V20, P2609; Zhang H, 1996, J NEUROSCI, V16, P6886; ZHOU L, 1995, J NEUROSCI RES, V42, P504, DOI 10.1002/jnr.490420409; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	45	275	287	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 9	2002	110	3					373	383		10.1016/S0092-8674(02)00838-3	http://dx.doi.org/10.1016/S0092-8674(02)00838-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	583MN	12176324	Bronze			2022-12-24	WOS:000177411800013
J	Batterham, RL; Cowley, MA; Small, CJ; Herzog, H; Cohen, MA; Dakin, CL; Wren, AM; Brynes, AE; Low, MJ; Ghatei, MA; Cone, RD; Bloom, SR				Batterham, RL; Cowley, MA; Small, CJ; Herzog, H; Cohen, MA; Dakin, CL; Wren, AM; Brynes, AE; Low, MJ; Ghatei, MA; Cone, RD; Bloom, SR			Gut hormone PYY3-36 physiologically inhibits food intake	NATURE			English	Article							NEUROPEPTIDE-Y RECEPTOR; PEPTIDE-YY; ARCUATE NUCLEUS; BODY-WEIGHT; NEURONS; SYSTEM; RELEASE; LEPTIN; ANALOG; RAT	Food intake is regulated by the hypothalamus, including the melanocortin and neuropeptide Y (NPY) systems in the arcuate nucleus(1). The NPY Y2 receptor (Y2R), a putative inhibitory presynaptic receptor, is highly expressed on NPY neurons(2) in the arcuate nucleus, which is accessible to peripheral hormones(3). Peptide YY3-36 (PYY3-36), a Y2R agonist(4), is released from the gastrointestinal tract postprandially in proportion to the calorie content of a meal(5-7). Here we show that peripheral injection of PYY3-36 in rats inhibits food intake and reduces weight gain. PYY3-36 also inhibits food intake in mice but not in Y2r-null mice, which suggests that the anorectic effect requires the Y2R. Peripheral administration of PYY3-36 increases c-Fos immunoreactivity in the arcuate nucleus and decreases hypothalamic Npy messenger RNA. Intra-arcuate injection of PYY3-36 inhibits food intake. PYY3-36 also inhibits electrical activity of NPY nerve terminals, thus activating adjacent pro-opiomelanocortin (POMC) neurons(8). In humans, infusion of normal postprandial concentrations of PYY3-36 significantly decreases appetite and reduces food intake by 33% over 24 h. Thus, postprandial elevation of PYY3-36 may act through the arcuate nucleus Y2R to inhibit feeding in a gut-hypothalamic pathway.	Imperial Coll Fac Med, London W12 0NN, England; Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA; Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; Garvan Inst Med Res, Neurobiol Program, Sydney, NSW 2010, Australia	Imperial College London; Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Garvan Institute of Medical Research	Bloom, SR (corresponding author), Imperial Coll Fac Med, Hammersmith Campus,Du Cane Rd, London W12 0NN, England.		Cowley, Michael A/B-9428-2008; Herzog, Herbert/B-8294-2008	Cowley, Michael A/0000-0001-7811-134X; Batterham, Rachel/0000-0002-5477-8585; Low, Malcolm/0000-0002-9900-3708				ADRIAN TE, 1985, GASTROENTEROLOGY, V89, P1070, DOI 10.1016/0016-5085(85)90211-2; Barrachina MD, 1997, AM J PHYSIOL-REG I, V272, pR1007, DOI 10.1152/ajpregu.1997.272.3.R1007; Barsh GS, 2000, NATURE, V404, P644, DOI 10.1038/35007519; Broberger C, 1997, NEUROENDOCRINOLOGY, V66, P393, DOI 10.1159/000127265; Butler AA, 2001, NAT NEUROSCI, V4, P605, DOI 10.1038/88423; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Edwards CMB, 2001, AM J PHYSIOL-ENDOC M, V281, pE155, DOI 10.1152/ajpendo.2001.281.1.E155; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; GRANDT D, 1994, REGUL PEPTIDES, V51, P151, DOI 10.1016/0167-0115(94)90204-6; Grove KL, 2000, NEUROSCIENCE, V100, P731, DOI 10.1016/S0306-4522(00)00308-0; HOFFMAN GE, 1993, FRONT NEUROENDOCRIN, V14, P173, DOI 10.1006/frne.1993.1006; Kalra SP, 1999, ENDOCR REV, V20, P68, DOI 10.1210/er.20.1.68; Keire DA, 2000, AM J PHYSIOL-GASTR L, V279, pG126, DOI 10.1152/ajpgi.2000.279.1.G126; Kim MS, 2000, DIABETES, V49, P177, DOI 10.2337/diabetes.49.2.177; Kim MS, 2000, J CLIN INVEST, V105, P1005, DOI 10.1172/JCI8857; Moran TH, 2000, NUTRITION, V16, P858, DOI 10.1016/S0899-9007(00)00419-6; PedersenBjergaard U, 1996, SCAND J CLIN LAB INV, V56, P497, DOI 10.3109/00365519609088805; POTTER EK, 1994, EUR J PHARM-MOLEC PH, V267, P253, DOI 10.1016/0922-4106(94)90148-1; RABEN A, 1995, BRIT J NUTR, V73, P517, DOI 10.1079/BJN19950056; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Small CJ, 1997, P NATL ACAD SCI USA, V94, P11686, DOI 10.1073/pnas.94.21.11686; Soderberg C, 2000, J NEUROCHEM, V75, P908, DOI 10.1046/j.1471-4159.2000.0750908.x; Tarling MM, 1997, INTENS CARE MED, V23, P256, DOI 10.1007/s001340050325	23	1654	1800	4	129	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 8	2002	418	6898					650	654		10.1038/nature00887	http://dx.doi.org/10.1038/nature00887			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581RA	12167864				2022-12-24	WOS:000177305600045
J	Bickford, D				Bickford, D			Animal behaviour - Male parenting of New Guinea froglets	NATURE			English	Article							CARE		Univ Miami, Coral Gables, FL 33124 USA; Wildlife Conservat Soc, Papua New Guinea Program, Goroka, Papua N Guinea	University of Miami	Bickford, D (corresponding author), Univ Miami, POB 249118, Coral Gables, FL 33124 USA.		Bickford, David P/A-5306-2011	Bickford, David P/0000-0003-1478-3387				BICKFORD DP, 2001, THESIS U MIAMI; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C, DOI DOI 10.104641420-9101.1992.5040719.X; COGGER HG, 1996, REPTILES AMPHIBIANS, P159; Crump Martha L., 1996, Advances in the Study of Behavior, V25, P109; DIESEL R, 1995, COPEIA, P354; SIMON MP, 1983, BEHAV ECOL SOCIOBIOL, V14, P61, DOI 10.1007/BF00366657; Wright DD, 1997, BIOTROPICA, V29, P250, DOI 10.1111/j.1744-7429.1997.tb00426.x; Zweifel R.G., 1972, Bulletin Am Mus nat Hist, V148, P411	8	22	24	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 8	2002	418	6898					601	602		10.1038/418601b	http://dx.doi.org/10.1038/418601b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581RA	12167847				2022-12-24	WOS:000177305600028
J	Bisson, LF; Waterhouse, AL; Ebeler, SE; Walker, MA; Lapsley, JT				Bisson, LF; Waterhouse, AL; Ebeler, SE; Walker, MA; Lapsley, JT			The present and future of the international wine industry	NATURE			English	Article							CHARACTER IMPACT ODORANTS; XYLELLA-FASTIDIOSA; ALCOHOL; IDENTIFICATION; MECHANISMS; MORTALITY; DISEASE	Wine production is both art and science, a blend of individual creativity and innovative technology. But wine production is also business, with economic factors driving manufacturing practices. To be successful in the modern marketplace, a winemaker must integrate the artistic and economic aspects of wine production, and possess a solid understanding of the intrinsic and extrinsic factors that underlie purchase motivation.	Univ Calif Davis, Dept Viticulture & Enol, Davis, CA 95616 USA; Univ Calif Davis, UC Davis Extens, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Bisson, LF (corresponding author), Univ Calif Davis, Dept Viticulture & Enol, 1 Shields Ave, Davis, CA 95616 USA.		Waterhouse, Andrew/F-6719-2011	Waterhouse, Andrew/0000-0002-5088-7442; Ebeler, Susan/0000-0002-8394-6736				Acree TE, 1997, ANAL CHEM, V69, pA170, DOI 10.1021/ac971560s; Aigrain P., 2001, Bulletin de l'OIV, V74, P209; [Anonymous], 1998, CHEM WINE FLAVOR; Brand G, 2001, NEUROSCI BIOBEHAV R, V25, P159, DOI 10.1016/S0149-7634(01)00005-7; de Lorimier AA, 2000, AM J SURG, V180, P357, DOI 10.1016/S0002-9610(00)00486-4; Donald TM, 2002, THEOR APPL GENET, V104, P610, DOI 10.1007/s00122-001-0768-1; Dufour C, 1999, J AGR FOOD CHEM, V47, P678, DOI 10.1021/jf980314u; Ebeler SE, 1999, FLAVOR CHEMISTRY, P409; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; GERMAN BG, 1997, WINE NUTR THERAPEUTI, P196; Granett J, 2001, ANNU REV ENTOMOL, V46, P387, DOI 10.1146/annurev.ento.46.1.387; Gronbaek M, 2000, ANN INTERN MED, V133, P411, DOI 10.7326/0003-4819-133-6-200009190-00008; Guth H, 1997, J AGR FOOD CHEM, V45, P3022, DOI 10.1021/jf9608433; Guth H, 1997, J AGR FOOD CHEM, V45, P3027, DOI 10.1021/jf970280a; GUTH H, 1998, CHEM WINE FLAVOR, P39; HOPKINS DL, 1989, ANNU REV PHYTOPATHOL, V27, P271, DOI 10.1146/annurev.py.27.090189.001415; Ishibashi Tokuo, 1999, Japanese Journal of Alcohol Studies and Drug Dependence, V34, P117; Jung DM, 2000, J AGR FOOD CHEM, V48, P407, DOI 10.1021/jf9906883; KINSELLA JE, 1993, FOOD TECHNOL-CHICAGO, V47, P85; LAVILLE P, 1990, B OIV, V217, P709; LODHI MA, 1995, GENOME, V38, P786, DOI 10.1139/g95-100; Lucia SP, 1963, HIST WINE THERAPY; MARMOT MG, 1981, LANCET, V1, P580; Nijveldt RJ, 2001, AM J CLIN NUTR, V74, P418; NOBLE AC, 1980, J AGR FOOD CHEM, V28, P346, DOI 10.1021/jf60228a030; Ohmart C. P., 2000, LODI WINEGROWERS WOR; Pauquet J, 2001, THEOR APPL GENET, V103, P1201, DOI 10.1007/s001220100664; PROTIN R, 1971, B OIV, V44, P110; Purcell AH, 1999, PLANT DIS, V83, P825, DOI 10.1094/PDIS.1999.83.9.825; RENAUD S, 1992, LANCET, V339, P1523, DOI 10.1016/0140-6736(92)91277-F; Rouquier S, 2000, P NATL ACAD SCI USA, V97, P2870, DOI 10.1073/pnas.040580197; Sosinsky A, 2000, GENOMICS, V70, P49, DOI 10.1006/geno.2000.6363; STEINBERG D, 1993, J INTERN MED, V233, P227, DOI 10.1111/j.1365-2796.1993.tb00980.x; STEVENSON RL, 1923, AMATEUR EMIGRANT SIL; YEGGE J, 2000, P ASEV 50 ANN ANN M; 2000, B OIV S, P20	36	152	168	4	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 8	2002	418	6898					696	699		10.1038/nature01018	http://dx.doi.org/10.1038/nature01018			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581RA	12167877				2022-12-24	WOS:000177305600057
J	Nathan, R; Katul, GG; Horn, HS; Thomas, SM; Oren, R; Avissar, R; Pacala, SW; Levin, SA				Nathan, R; Katul, GG; Horn, HS; Thomas, SM; Oren, R; Avissar, R; Pacala, SW; Levin, SA			Mechanisms of long-distance dispersal of seeds by wind	NATURE			English	Article							PLANT MIGRATION; TURBULENCE; MODEL	Long-distance dispersal (LDD) is central to species expansion following climate change, re-colonization of disturbed areas and control of pests(1-8). The current paradigm is that the frequency and spatial extent of LDD events are extremely difficult to predict(9-12). Here we show that mechanistic models coupling seed release and aerodynamics with turbulent transport processes provide accurate probabilistic descriptions of LDD of seeds by wind. The proposed model reliably predicts the vertical distribution of dispersed seeds of five tree species observed along a 45-m high tower in an eastern US deciduous forest. Simulations show that uplifting above the forest canopy is necessary and sufficient for LDD, hence, they provide the means to define LDD quantitatively rather than arbitrarily. Seed uplifting probability thus sets an upper bound on the probability of long-distance colonization. Uplifted yellow poplar seeds are on average lighter than seeds at the forest floor, but also include the heaviest seeds. Because uplifting probabilities are appreciable (as much as 15%), and tree seed crops are commonly massive, some LDD events will establish individuals that can critically affect plant dynamics on large scales.	Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC 27708 USA; Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; Duke Univ, Dept Civil & Environm Engn, Durham, NC 27708 USA	Ben Gurion University; Duke University; Princeton University; Duke University	Nathan, R (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	rnathan@bgumail.bgu.ac.il	Levin, Simon A/J-1218-2014; Oren, Ram/AAC-5326-2019; Nathan, Ran/A-9380-2008; Katul, Gabriel G/A-7210-2008	Levin, Simon A/0000-0002-8216-5639; Oren, Ram/0000-0002-5654-1733; Nathan, Ran/0000-0002-5733-6715; Katul, Gabriel G/0000-0001-9768-3693				Bullock JM, 2000, OECOLOGIA, V124, P506, DOI 10.1007/PL00008876; Burns R.M., 1990, AGR HDB USDA, V654; Cain ML, 2000, AM J BOT, V87, P1217, DOI 10.2307/2656714; Clark JS, 1998, BIOSCIENCE, V48, P13, DOI 10.2307/1313224; Clark JS, 1998, ECOL MONOGR, V68, P213, DOI 10.1890/0012-9615(1998)068[0213:SASSOR]2.0.CO;2; Clark JS, 2001, AM NAT, V157, P537, DOI 10.1086/319934; DESTEVEN D, 1991, ECOLOGY, V72, P1076, DOI 10.2307/1940607; Finnigan J, 2000, ANNU REV FLUID MECH, V32, P519, DOI 10.1146/annurev.fluid.32.1.519; GREENE DF, 1995, CAN J BOT, V73, P1036, DOI 10.1139/b95-113; Gregory P.H., 1973, MICROBIOLOGY ATMOSPH, V2nd; Higgins SI, 1999, AM NAT, V153, P464, DOI 10.1086/303193; HIGGINS SI, UNPUB ECOLOGY; Horn HS, 2001, ECOL RES, V16, P877, DOI 10.1046/j.1440-1703.2001.00456.x; Hsieh CI, 1997, WATER RESOUR RES, V33, P427, DOI 10.1029/96WR03136; Katul GG, 1998, BOUND-LAY METEOROL, V89, P47, DOI 10.1023/A:1001509106381; Katul GG, 1998, J APPL METEOROL, V37, P1533, DOI 10.1175/1520-0450(1998)037<1533:ATASTN>2.0.CO;2; Leonard KJ, 1986, PLANT DIS EPIDEMIOLO; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; MONIN AS, 1971, STAT FLUID MECH, V1, P209; Nathan R, 2001, ECOLOGY, V82, P374, DOI 10.1890/0012-9658(2001)082[0374:FVASAO]2.0.CO;2; Nathan R, 2000, TRENDS ECOL EVOL, V15, P278, DOI 10.1016/S0169-5347(00)01874-7; NATHAN R, 2001, ENCY BIODIVERSITY, V2, P127; Nathan Ran, 2001, Trends in Ecology and Evolution, V16, P481, DOI 10.1016/S0169-5347(01)02272-8; OKUBO A, 1989, ECOLOGY, V70, P329, DOI 10.2307/1937537; Pasquill F., 1983, ATMOSPHERIC DIFFUSIO, V3rd; Ridley H., 1930, J ECOL, DOI DOI 10.2307/2255951; Ridley HN, 1905, ANN BOT-LONDON, V19, P351, DOI 10.1093/oxfordjournals.aob.a089006; Van der Pijl L, 1982, PRINCIPLES DISPERSAL, V214; Webber M. L., 1934, MALAYAN FORESTER, V3, P18; WILLSON MF, 1993, VEGETATIO, V108, P261	30	465	491	1	188	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 25	2002	418	6896					409	413		10.1038/nature00844	http://dx.doi.org/10.1038/nature00844			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576MU	12140556				2022-12-24	WOS:000177009700036
J	Lohmann, C; Myhr, KL; Wong, ROL				Lohmann, C; Myhr, KL; Wong, ROL			Transmitter-evoked local calcium release stabilizes developing dendrites	NATURE			English	Article							DEVELOPING CHICK RETINA; HIPPOCAMPAL-NEURONS; NERVOUS-SYSTEM; SYNAPTIC CA2+; STORES; SYNAPTOGENESIS; SPINES; CELLS; SPECIFICITY; TRANSIENTS	In the central nervous system, dendritic arborizations of neurons undergo dynamic structural remodelling during development. Processes are elaborated, maintained or eliminated to attain the adult pattern of synaptic connections(1-3). Although neuronal activity influences this remodelling(4-6), it is not known how activity exerts its effects. Here we show that neurotransmission- evoked calcium (Ca2+) release from intracellular stores stabilizes dendrites during the period of synapse formation. Using a ballistic labelling method to load cells with Ca2+ indicator dyes 7, we simultaneously monitored dendritic activity and structure in the intact retina. Two distinct patterns of spontaneous Ca2+ increases occurred in developing retinal ganglion cells-global increases throughout the arborization, and local 'flashes' of activity restricted to small dendritic segments. Blockade of local, but not global, activity caused rapid retraction of dendrites. This retraction was prevented locally by focal uncaging of caged Ca2+ that triggered Ca2+ release from internal stores. Thus, local Ca2+ release is a mechanism by which afferent activity can selectively and differentially regulate dendritic structure across the developing arborization.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Wong, ROL (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, 660 S Euclid, St Louis, MO 63110 USA.		Lohmann, Christian/B-8003-2012	Lohmann, Christian/0000-0002-1780-2419				Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Catsicas M, 1998, CURR BIOL, V8, P283, DOI 10.1016/S0960-9822(98)70110-1; Chang KT, 2001, NEURON, V32, P855, DOI 10.1016/S0896-6273(01)00516-5; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; EILERS J, 1995, NATURE, V373, P155, DOI 10.1038/373155a0; Gan WB, 2000, NEURON, V27, P219, DOI 10.1016/S0896-6273(00)00031-3; Hering H, 1996, J COMP NEUROL, V375, P393, DOI 10.1002/(SICI)1096-9861(19961118)375:3<393::AID-CNE4>3.0.CO;2-Y; HUGHES WF, 1974, ANAT REC, V179, P297, DOI 10.1002/ar.1091790302; KETTUNEN P, IN PRESS J NEUROSCI; Koizumi S, 1999, NEURON, V22, P125, DOI 10.1016/S0896-6273(00)80684-4; Korkotian E, 1999, P NATL ACAD SCI USA, V96, P12068, DOI 10.1073/pnas.96.21.12068; Li Z, 2000, NAT NEUROSCI, V3, P217, DOI 10.1038/72920; McAllister AK, 2000, CEREB CORTEX, V10, P963, DOI 10.1093/cercor/10.10.963; MILLAR TJ, 1987, NEUROSCIENCE, V21, P725, DOI 10.1016/0306-4522(87)90033-9; Myhr KL, 2001, J NEUROSCI, V21, P8664, DOI 10.1523/JNEUROSCI.21-21-08664.2001; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; Rose CR, 2001, NEURON, V31, P519, DOI 10.1016/S0896-6273(01)00402-0; Sernagor E, 2000, J NEUROSCI, V20, part. no.; Spitzer NC, 2000, BIOESSAYS, V22, P811; Svoboda K, 1999, NEURON, V22, P427, DOI 10.1016/S0896-6273(00)80698-4; VAUGHN JE, 1989, SYNAPSE, V3, P255, DOI 10.1002/syn.890030312; WONG ROL, 1991, J NEUROBIOL, V22, P685, DOI 10.1002/neu.480220704; Wong WT, 2001, NAT NEUROSCI, V4, P351, DOI 10.1038/85987; Wong WT, 2000, J NEUROSCI, V20, P5024; Wong WT, 2000, CURR OPIN NEUROBIOL, V10, P118, DOI 10.1016/S0959-4388(99)00059-8; Wong WT, 1998, J NEUROSCI, V18, P8839; Yuste R, 2000, NAT NEUROSCI, V3, P653, DOI 10.1038/76609; Yuste R, 1996, NEURON, V16, P701, DOI 10.1016/S0896-6273(00)80091-4	28	181	182	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 11	2002	418	6894					177	181		10.1038/nature00850	http://dx.doi.org/10.1038/nature00850			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	571GV	12110889				2022-12-24	WOS:000176710400039
J	Essner, JJ; Vogan, KJ; Wagner, MK; Tabin, CJ; Yost, HJ; Brueckner, M				Essner, JJ; Vogan, KJ; Wagner, MK; Tabin, CJ; Yost, HJ; Brueckner, M			Conserved function for embryonic nodal cilia	NATURE			English	Article							LEFT-RIGHT ASYMMETRY; MICE; INVERSUS; FLOW		Univ Utah, Ctr Children, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Pediat & Cardiol, New Haven, CT 06520 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Harvard University; Harvard Medical School; Yale University	Essner, JJ (corresponding author), Univ Utah, Ctr Children, Huntsman Canc Inst, Salt Lake City, UT 84112 USA.			Vogan, Kyle/0000-0001-9565-9665; Essner, Jeffrey/0000-0001-8816-3848				Capdevila J, 2000, CELL, V101, P9, DOI 10.1016/S0092-8674(00)80619-4; Cooper MS, 1996, DEV BIOL, V180, P184, DOI 10.1006/dbio.1996.0294; Manner J, 2001, ANAT EMBRYOL, V203, P481, DOI 10.1007/s004290100183; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Okada Y, 1999, MOL CELL, V4, P459, DOI 10.1016/S1097-2765(00)80197-5; Olbrich H, 2002, NAT GENET, V30, P143, DOI 10.1038/ng817; Supp DM, 1999, DEVELOPMENT, V126, P5495; Supp DM, 1997, NATURE, V389, P963, DOI 10.1038/40140; Wright C V, 2001, Dev Cell, V1, P179, DOI 10.1016/S1534-5807(01)00036-3	9	280	291	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 4	2002	418	6893					37	38		10.1038/418037a	http://dx.doi.org/10.1038/418037a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569JL	12097899				2022-12-24	WOS:000176599200029
J	Johnson, JR; Manges, AR; O'Bryan, TT; Riley, LW				Johnson, JR; Manges, AR; O'Bryan, TT; Riley, LW			A disseminated multidrug-resistant clonal group of uropathogenic Escherichia coli in pyelonephritis	LANCET			English	Article							URINARY-TRACT INFECTIONS	In acute pyelonephritis, bacterial resistance to cotrimoxazole predicts treatment failure, but the clonal basis of such resistance is undefined. We did molecular and serological analyses of 170 Escherichia coli urine isolates obtained in 1994-96 from women with acute pyelonephritis. 12 (7%) of the pyelonephritis isolates were in clonal group A (CGA; responsible for 38-51% of co-trimoxazole resistance in acute cystitis), including ten (34%) of 29 isolates that were resistant to co-trimoxazole. CGA isolates were obtained from diverse locations across the USA and were related to the 015:K52:H1 clone of the 1986-87 outbreak in London, UK. Thus, CGA is broadly disseminated and contributes to cotrimoxazole resistance in pyelonephritis as well as in cystitis.	Vet Affairs Med Ctr, Med Serv, Minneapolis, MN 55417 USA; Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol & Publ Hlth Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Immun, Berkeley, CA 94720 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Johnson, JR (corresponding author), Vet Affairs Med Ctr, Med Serv, Minneapolis, MN 55417 USA.				NIDDK NIH HHS [DK-47504] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047504] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Gupta K, 2001, ANN INTERN MED, V135, P41, DOI 10.7326/0003-4819-135-1-200107030-00012; JOHNSON JR, 1999, 99 GEN M AM SOC MICR, P31; Manges AR, 2001, NEW ENGL J MED, V345, P1007, DOI 10.1056/NEJMoa011265; ONEILL PM, 1990, J MED MICROBIOL, V33, P23, DOI 10.1099/00222615-33-1-23; Talan DA, 2000, JAMA-J AM MED ASSOC, V283, P1583, DOI 10.1001/jama.283.12.1583	5	89	90	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 29	2002	359	9325					2249	2251		10.1016/S0140-6736(02)09264-4	http://dx.doi.org/10.1016/S0140-6736(02)09264-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	567YJ	12103291				2022-12-24	WOS:000176514500013
J	Pena, M; Bonatti, LL; Nespor, M; Mehler, J				Pena, M; Bonatti, LL; Nespor, M; Mehler, J			Signal-driven computations in speech processing	SCIENCE			English	Article							LANGUAGE-ACQUISITION; INFANTS; CUES	Learning a language requires both statistical computations to identify words in speech and algebraic-like computations to discover higher level ( grammatical) structure. Here we show that these computations can be influenced by subtle cues in the speech signal. After a short familiarization to a continuous speech stream, adult listeners are able to segment it using powerful statistics, but they fail to extract the structural regularities included in the stream even when the familiarization is greatly extended. With the introduction of subliminal segmentation cues, however, these regularities can be rapidly captured.	Scuola Int Super Studi Avanzati, Trieste, Italy; Univ Paris 08, St Denis, France; Univ Ferrara, I-44100 Ferrara, Italy; CNRS, Lab Sci Cognit & Psycholinguist, Paris, France; EHESS, Paris, France	International School for Advanced Studies (SISSA); Universite Paris-VIII; University of Ferrara; Centre National de la Recherche Scientifique (CNRS)	Mehler, J (corresponding author), Scuola Int Super Studi Avanzati, Trieste, Italy.		Bonatti, Luca Lorenzo/AAA-2410-2019	Bonatti, Luca Lorenzo/0000-0001-8624-9007				Aslin RN, 1996, SIGNAL TO SYNTAX: BOOTSTRAPPING FROM SPEECH TO GRAMMAR IN EARLY ACQUISITION, P117; Chomsky N., 2002, JANUA LINGUARUM; CHRISTOPHE A, 1994, J ACOUST SOC AM, V95, P1570, DOI 10.1121/1.408544; Fiser J, 2002, J EXP PSYCHOL LEARN, V28, P458, DOI 10.1037//0278-7393.28.3.458; Fiser J, 2001, PSYCHOL SCI, V12, P499, DOI 10.1111/1467-9280.00392; Gleitman L., 1982, LANG ACQUIS, P3; Hayes J.R., 1970, COGNITION DEV LANGUA, P221; Kirkham NZ, 2002, COGNITION, V83, pB35, DOI 10.1016/S0010-0277(02)00004-5; Marcus G., 2001, ALGEBRAIC MIND INTEG; Marcus GF, 1999, SCIENCE, V283, P77, DOI 10.1126/science.283.5398.77; MORGAN JL, 1987, COGNITIVE PSYCHOL, V19, P498, DOI 10.1016/0010-0285(87)90017-X; MORGAN JL, 1989, J MEM LANG, V28, P360, DOI 10.1016/0749-596X(89)90039-9; MORGAN JL, 1981, J VERB LEARN VERB BE, V20, P67, DOI 10.1016/S0022-5371(81)90312-1; MORTON J, 1976, PSYCHOL REV, V83, P405, DOI 10.1037/0033-295X.83.5.405; Newport EL, 2000, PROC ANN BUCLD, P1; PINKER S, 1991, SCIENCE, V253, P530, DOI 10.1126/science.1857983; Saffran JR, 1996, J MEM LANG, V35, P606, DOI 10.1006/jmla.1996.0032; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Saffran JR, 1999, COGNITION, V70, P27, DOI 10.1016/S0010-0277(98)00075-4; Seidenberg MS, 1997, SCIENCE, V275, P1599, DOI 10.1126/science.275.5306.1599	20	270	273	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 18	2002	298	5593					604	607		10.1126/science.1072901	http://dx.doi.org/10.1126/science.1072901			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	604RL	12202684				2022-12-24	WOS:000178634800042
J	Bardeesy, N; Sinha, M; Hezel, AF; Signoretti, S; Hathaway, NA; Sharpless, NE; Loda, M; Carrasco, DR; DePinho, RA				Bardeesy, N; Sinha, M; Hezel, AF; Signoretti, S; Hathaway, NA; Sharpless, NE; Loda, M; Carrasco, DR; DePinho, RA			Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation	NATURE			English	Article							PEUTZ-JEGHERS-SYNDROME; SOMATIC MUTATIONS; G(1) CONTROL; INK4A LOCUS; GROWTH; EXPRESSION; MICE; IMMORTALIZATION; ACTIVATION; SENESCENCE	Germline mutations in LKB1 (also known as STK11) are associated with Peutz-Jeghers syndrome (PJS), a disorder with predisposition to gastrointestinal polyposis and cancer(1). PJS polyps are unusual neoplasms characterized by marked epithelial and stromal overgrowth but have limited malignant potential(2). Here we show that Lkb1(+/-) mice develop intestinal polyps identical to those seen in individuals affected with PJS. Consistent with this in vivo tumour suppressor function, Lkb1 deficiency prevents culture-induced senescence without loss of Ink4a/Arf or p53. Despite compromised mortality, Lkb1(-/-) mouse embryonic fibroblasts show resistance to transformation by activated Ha-Ras either alone or with immortalizing oncogenes. This phenotype is in agreement with the paucity of mutations in Ras seen in PJS polyps(3,4) and suggests that loss of Lkb1 function as an early neoplastic event renders cells resistant to subsequent oncogene-induced transformation. In addition, the Lkb1 transcriptome shows modulation of factors linked to angiogenesis, extracellular matrix remodelling, cell adhesion and inhibition of Ras transformation. Together, our data rationalize several features of PJS polyposis-notably its peculiar histopathological presentation and limited malignant potential-and place Lkb1 in a distinct class of tumour suppressors.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	DePinho, RA (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Adult Oncol, 44 Binney St, Boston, MA 02115 USA.			DePinho, Ronald/0000-0002-5625-577X; Sharpless, Norman/0000-0001-7078-9455				Avizienyte E, 1998, CANCER RES, V58, P2087; Avizienyte E, 1999, AM J PATHOL, V154, P677, DOI 10.1016/S0002-9440(10)65314-X; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; CARRASCO D, 1994, DEVELOPMENT, V120, P2991; COOPER HS, 1998, PATHOLOGY GASTROINTE, P819; Dannenberg JH, 2000, GENE DEV, V14, P3051, DOI 10.1101/gad.847700; Entius MM, 2001, J CLIN PATHOL, V54, P126, DOI 10.1136/jcp.54.2.126; Esteller M, 2000, ONCOGENE, V19, P164, DOI 10.1038/sj.onc.1203227; Giardiello FM, 2000, GASTROENTEROLOGY, V119, P1447, DOI 10.1053/gast.2000.20228; Gruber SB, 1998, CANCER RES, V58, P5267; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Hemminki A, 1997, NAT GENET, V15, P87, DOI 10.1038/ng0197-87; Jishage K, 2002, P NATL ACAD SCI USA, V99, P8903, DOI 10.1073/pnas.122254599; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Miyoshi H, 2002, CANCER RES, V62, P2261; Qing J, 1997, ONCOGENE, V15, P2159, DOI 10.1038/sj.onc.1201385; Ramirez RD, 2001, GENE DEV, V15, P398, DOI 10.1101/gad.859201; REEVE JG, 1995, J BIOL CHEM, V270, P135, DOI 10.1074/jbc.270.1.135; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Silver DP, 2001, MOL CELL, V8, P233, DOI 10.1016/S1097-2765(01)00295-7; Vasseur S, 2002, EMBO REP, V3, P165, DOI 10.1093/embo-reports/kvf023; Whitehead LP, 1999, MOL CELL BIOL, V19, P7759; Ylikorkala A, 2001, SCIENCE, V293, P1323, DOI 10.1126/science.1062074; Yoshioka N, 2000, J VIROL, V74, P1008, DOI 10.1128/JVI.74.2.1008-1013.2000	30	341	352	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 12	2002	419	6903					162	167		10.1038/nature01045	http://dx.doi.org/10.1038/nature01045			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592HK	12226664				2022-12-24	WOS:000177931200040
J	Crawford, LM				Crawford, LM			First drug for women with constipation-predominant IBS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commissioner Food & Drugs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Crawford, LM (corresponding author), US FDA, Off Commissioner Food & Drugs, HF-1,Room 14-71,5600 Fisshers Ln, Rockville, MD 20857 USA.								0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 11	2002	288	10					1225	1225		10.1001/jama.288.10.1225	http://dx.doi.org/10.1001/jama.288.10.1225			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592BW	12215114				2022-12-24	WOS:000177917700007
J	Verissimo, A; Cochrane, MA; Souza, C				Verissimo, A; Cochrane, MA; Souza, C			Ecology - National forests in the Amazon	SCIENCE			English	Editorial Material									Inst Homem & Meio Ambiente Amazonia IMAZON, Belem, Para, Brazil; Michigan State Univ, Ctr Climate & Earth Observat, E Lansing, MI 48823 USA	Michigan State University	Cochrane, MA (corresponding author), Inst Homem & Meio Ambiente Amazonia IMAZON, Belem, Para, Brazil.	cochrane@globalchange.msu.edu	Cochrane, Mark A/A-1735-2018; Souza, CARLOS/AAK-8207-2021	Cochrane, Mark A/0000-0002-4573-568X; Souza, CARLOS/0000-0002-0205-6134				Barreto P, 1998, FOREST ECOL MANAG, V108, P9, DOI 10.1016/S0378-1127(97)00251-X; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; CAPOBIANCO JP, 2001, BIODIVERSIDADE AMAZO, P540; *GOV BRAS MIN MEIO, 2000, PROGR NAC FLOR, P49; *GOV EST ACR, 2002, PROGR DES SUST EST A; Laurance WF, 2001, SCIENCE, V291, P438, DOI 10.1126/science.291.5503.438; Nepstad D, 2002, SCIENCE, V295, P629, DOI 10.1126/science.1067053; Verissimo A, 2002, CONSERV ECOL, V6; VERISSIMO A, 2000, IDENTIFICACAO AREAS; VERISSIMO A, 2001, IDENTIFICACAO AREAS; VINCENT JR, 1992, SCIENCE, V256, P1651, DOI 10.1126/science.256.5064.1651	11	52	56	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2002	297	5586					1478	1478						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588JA	12202804				2022-12-24	WOS:000177697300028
J	Roy, PJ; Stuart, JM; Lund, J; Kim, SK				Roy, PJ; Stuart, JM; Lund, J; Kim, SK			Chromosomal clustering of muscle-expressed genes in Caenorhabditis elegans	NATURE			English	Article							POLYCISTRONIC TRANSCRIPTION; GENOME; DOMAINS; PROTEIN; MAP	Chromosomes are divided into domains of open chromatin, where genes have the potential to be expressed, and domains of closed chromatin, where genes are not expressed(1). Classic examples of open chromatin domains include 'puffs' on polytene chromosomes in Drosophila and extended loops from lampbrush chromosomes(2,3). If multiple genes were typically expressed together from a single open chromatin domain, the position of co-expressed genes along the chromosomes would appear clustered. To investigate whether co-expressed genes are clustered, we examined the chromosomal positions of the genes expressed in muscle of Caenorhabditis elegans at the first larval stage. Here we show that co-expressed genes in C. elegans are clustered in groups of 2-5 along the chromosomes, suggesting that expression from a chromatin domain can extend over several genes. These observations reveal a higher-order organization of the structure of the genome, in which the order of genes along the chromosome is correlated with their expression in specific tissues.	Stanford Univ, Med Ctr, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Med Ctr, Dept Genet, Stanford, CA 94305 USA; Stanford Med Informat, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Kim, SK (corresponding author), Stanford Univ, Med Ctr, Dept Dev Biol, Stanford, CA 94305 USA.		; Roy, Peter/G-5357-2014	Stuart, Joshua/0000-0002-2171-565X; Roy, Peter/0000-0003-2959-2276				BEERMANN W, 1964, J EXP ZOOL, V157, P49, DOI 10.1002/jez.1401570110; BLUMENTHAL T, 1995, TRENDS GENET, V11, P132, DOI 10.1016/S0168-9525(00)89026-5; Blumenthal T, 1998, BIOESSAYS, V20, P480, DOI 10.1002/(SICI)1521-1878(199806)20:6&lt;480::AID-BIES6&gt;3.0.CO;2-Q; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; FUKAMIKOBAYASHI K, 1993, FEBS LETT, V335, P289, DOI 10.1016/0014-5793(93)80749-K; GALL JG, 1962, P NATL ACAD SCI USA, V48, P562, DOI 10.1073/pnas.48.4.562; Goodenough JB, 2000, INT J INORG MATER, V2, P3, DOI 10.1016/S1466-6049(99)00069-0; GORLACH M, 1994, EXP CELL RES, V211, P400, DOI 10.1006/excr.1994.1104; HEBBES TR, 1994, EMBO J, V13, P1823, DOI 10.1002/j.1460-2075.1994.tb06451.x; Jiang M, 2001, P NATL ACAD SCI USA, V98, P218, DOI 10.1073/pnas.011520898; Jones AR, 1996, DEV BIOL, V180, P165, DOI 10.1006/dbio.1996.0293; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; OKKEMA PG, 1993, GENETICS, V135, P385; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; STALDER J, 1980, CELL, V20, P451, DOI 10.1016/0092-8674(80)90631-5; Stein L, 2001, NUCLEIC ACIDS RES, V29, P82, DOI 10.1093/nar/29.1.82; Tenenbaum SA, 2000, P NATL ACAD SCI USA, V97, P14085, DOI 10.1073/pnas.97.26.14085; Wang E, 2000, NAT BIOTECHNOL, V18, P457, DOI 10.1038/74546; WEINTRAUB H, 1984, HARVEY LECT, V79, P217	20	331	342	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 29	2002	418	6901					975	979		10.1038/nature01012	http://dx.doi.org/10.1038/nature01012			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588AP	12214599				2022-12-24	WOS:000177677500044
J	Rhoades, MW; Reinhart, BJ; Lim, LP; Burge, CB; Bartel, B; Bartel, DP				Rhoades, MW; Reinhart, BJ; Lim, LP; Burge, CB; Bartel, B; Bartel, DP			Prediction of plant microRNA targets	CELL			English	Article							RNA-INTERFERENCE; C-ELEGANS; CAENORHABDITIS-ELEGANS; OVULE DEVELOPMENT; REGULATORY RNA; CELL-DIVISION; DNA-BINDING; GENE; ARABIDOPSIS; LIN-14	We predict regulatory targets for 14 Arabidopsis microRNAs (miRNAs) by identifying mRNAs with near complementarity. Complementary sites within predicted targets are conserved in rice. Of the 49 predicted targets, 34 are members of transcription factor gene families involved in developmental patterning or cell differentiation. The near-perfect complementarity between plant miRNAs and their targets suggests that many plant miRNAs act similarly to small interfering RNAs and direct mRNA cleavage. The targeting of developmental transcription factors suggests that many plant miRNAs function during cellular differentiation to clear key regulatory transcripts from daughter cell lineages.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Rice University	Bartel, B (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	bartel@rice.edu; dbartel@wi.mit.edu	Burge, Christopher B./AAH-2177-2020; Chan, Edward K. L./B-5671-2009; Bartel, Bonnie/D-3550-2011; Bartel, Bonnie/O-8119-2019	Chan, Edward K. L./0000-0003-3938-9503; Bartel, Bonnie/0000-0002-6367-346X; Bartel, Bonnie/0000-0002-6367-346X	NHGRI NIH HHS [R01 HG02439] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002439] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Aida M, 1997, PLANT CELL, V9, P841, DOI 10.1105/tpc.9.6.841; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; BEMSTEIN E, 2001, RNA, V7, P1509; Bohmert K, 1998, EMBO J, V17, P170, DOI 10.1093/emboj/17.1.170; Bolle C, 2000, GENE DEV, V14, P1269; Cui YH, 1999, PLANT CELL, V11, P2217, DOI 10.1105/tpc.11.11.2217; DiLaurenzio L, 1996, CELL, V86, P423, DOI 10.1016/S0092-8674(00)80115-4; Dsouza M, 1997, TRENDS GENET, V13, P497, DOI 10.1016/S0168-9525(97)01347-4; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Gocal GFW, 2001, PLANT PHYSIOL, V127, P1682, DOI 10.1104/pp.010442; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Ha I, 1996, GENE DEV, V10, P3041, DOI 10.1101/gad.10.23.3041; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Helariutta Y, 2000, CELL, V101, P555, DOI 10.1016/S0092-8674(00)80865-X; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Hutvagner G, 2002, CURR OPIN GENET DEV, V12, P225, DOI 10.1016/S0959-437X(02)00290-3; Jacobsen SE, 1999, DEVELOPMENT, V126, P5231; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Kiss T, 2002, CELL, V109, P145, DOI 10.1016/S0092-8674(02)00718-3; Klein J, 1996, MOL GEN GENET, V250, P7, DOI 10.1007/BF02191820; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Liscum E, 2002, PLANT MOL BIOL, V49, P387, DOI 10.1023/A:1015255030047; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Matzke MA, 2001, CURR OPIN GENET DEV, V11, P221, DOI 10.1016/S0959-437X(00)00183-0; McConnell JR, 2001, NATURE, V411, P709, DOI 10.1038/35079635; McManus MT, 2002, RNA, V8, P842, DOI 10.1017/S1355838202024032; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Peng JR, 1997, GENE DEV, V11, P3194, DOI 10.1101/gad.11.23.3194; Ray A, 1996, DEVELOPMENT, V122, P2631; Ray S, 1996, DEV BIOL, V180, P365, DOI 10.1006/dbio.1996.0309; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Reinscheid RK, 2000, PEPTIDES, V21, P901, DOI 10.1016/S0196-9781(00)00226-6; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; ROBINSONBEERS K, 1992, PLANT CELL, V4, P1237, DOI 10.1105/tpc.4.10.1237; Rogg LE, 2001, DEV CELL, V1, P595, DOI 10.1016/S1534-5807(01)00077-6; Silverstone AL, 1998, PLANT CELL, V10, P155, DOI 10.1105/tpc.10.2.155; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; Ulmasov T, 1999, PLANT J, V19, P309, DOI 10.1046/j.1365-313X.1999.00538.x; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Yeh RF, 2001, GENOME RES, V11, P803, DOI 10.1101/gr.175701; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037	49	1648	1950	3	252	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 23	2002	110	4					513	520		10.1016/S0092-8674(02)00863-2	http://dx.doi.org/10.1016/S0092-8674(02)00863-2			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	587QJ	12202040	Green Published, Bronze			2022-12-24	WOS:000177653200012
J	Schuch, R; Nelson, D; Fischetti, VA				Schuch, R; Nelson, D; Fischetti, VA			A bacteriolytic agent that detects and kills Bacillus anthracis	NATURE			English	Article							CEREUS SPORES; LYTIC ENZYME; THURINGIENSIS; EXPRESSION; INFECTIONS; GENES	The dormant and durable spore form of Bacillus anthracis is an ideal biological weapon of mass destruction(1,2). Once inhaled, spores are transported by alveolar macrophages to lymph nodes surrounding the lungs, where they germinate; subsequent vegetative expansion causes an overwhelming flood of bacteria and toxins into the blood, killing up to 99% of untreated victims. Natural and genetically engineered antibiotic- resistant bacilli amplify the threat of spores being used as weapons, and heighten the need for improved treatments and spore-detection methods after an intentional release. We exploited the inherent binding specificity and lytic action of bacteriophage enzymes called lysins for the rapid detection and killing of B. anthracis. Here we show that the PlyG lysin, isolated from the gamma phage of B. anthracis, specifically kills B. anthracis isolates and other members of the B. anthracis 'cluster' of bacilli in vitro and in vivo. Both vegetative cells and germinating spores are susceptible. The lytic specificity of PlyG was also exploited as part of a rapid method for the identification of B. anthracis. We conclude that PlyG is a tool for the treatment and detection of B. anthracis.	Rockefeller Univ, Lab Bacterial Pathogenesis & Immunol, New York, NY 10021 USA	Rockefeller University	Fischetti, VA (corresponding author), Rockefeller Univ, Lab Bacterial Pathogenesis & Immunol, 1230 York Ave, New York, NY 10021 USA.		Nelson, Daniel C./I-2198-2012	Nelson, Daniel C./0000-0003-3248-4831				BROWN ER, 1955, J INFECT DIS, V96, P34, DOI 10.1093/infdis/96.1.34; Brussow H, 2002, CELL, V108, P13, DOI 10.1016/S0092-8674(01)00637-7; BURDON KL, 1967, J INFECT DIS, V117, P307, DOI 10.1093/infdis/117.4.307; CORRAN J, 1968, MOL GEN GENET, V103, P42, DOI 10.1007/BF00271156; Fischetti VA, 2001, NAT BIOTECHNOL, V19, P734, DOI 10.1038/90777; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Helgason E, 2000, J CLIN MICROBIOL, V38, P1615, DOI 10.1128/JCM.38.4.1615-1622.2000; Helgason E, 2000, APPL ENVIRON MICROB, V66, P2627, DOI 10.1128/AEM.66.6.2627-2630.2000; Henriques AO, 2000, METHODS, V20, P95, DOI 10.1006/meth.1999.0909; Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236; Jackson PJ, 1997, APPL ENVIRON MICROB, V63, P1400, DOI 10.1128/AEM.63.4.1400-1405.1997; JENKINSON HF, 1980, J BACTERIOL, V141, P793, DOI 10.1128/JB.141.2.793-805.1980; Keim P, 2000, J BACTERIOL, V182, P2928, DOI 10.1128/JB.182.10.2928-2936.2000; LAMANNA C, 1963, J BACTERIOL, V85, P532, DOI 10.1128/JB.85.3.532-535.1963; Loeffler JM, 2001, SCIENCE, V294, P2170, DOI 10.1126/science.1066869; Loessner MJ, 2002, MOL MICROBIOL, V44, P335, DOI 10.1046/j.1365-2958.2002.02889.x; LOESSNER MJ, 1995, MOL MICROBIOL, V16, P1231, DOI 10.1111/j.1365-2958.1995.tb02345.x; Lopez R, 1997, MICROB DRUG RESIST, V3, P199, DOI 10.1089/mdr.1997.3.199; MAKINO S, 1994, MICROBIOL-SGM, V140, P1403, DOI 10.1099/00221287-140-6-1403; Mazas M, 1999, INT J FOOD MICROBIOL, V53, P61, DOI 10.1016/S0168-1605(99)00145-2; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Nelson D, 2001, P NATL ACAD SCI USA, V98, P4107, DOI 10.1073/pnas.061038398; Pannucci J, 2002, J BACTERIOL, V184, P134, DOI 10.1128/JB.184.1.134-141.2002; Redmond C., 1996, SALISBURY MED B SP S, V87, P60; SANTO LY, 1974, J BACTERIOL, V120, P475, DOI 10.1128/JB.120.1.475-481.1974; Schmitt CK, 2001, INFECT IMMUN, V69, P5619, DOI 10.1128/IAI.69.9.5619-5625.2001; Stopa PJ, 1999, FIELD ANAL CHEM TECH, V3, P283, DOI 10.1002/(SICI)1520-6521(1999)3:4/5<283::AID-FACT7>3.0.CO;2-9; Ticknor LO, 2001, APPL ENVIRON MICROB, V67, P4863, DOI 10.1128/AEM.67.10.4863-4873.2001; Turnbull PCB, 1999, J APPL MICROBIOL, V87, P237, DOI 10.1046/j.1365-2672.1999.00876.x; Wang IN, 2000, ANNU REV MICROBIOL, V54, P799, DOI 10.1146/annurev.micro.54.1.799	30	469	547	3	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 22	2002	418	6900					884	889		10.1038/nature01026	http://dx.doi.org/10.1038/nature01026			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585YR	12192412				2022-12-24	WOS:000177555600040
J	Taipale, J; Cooper, MK; Maiti, T; Beachy, PA				Taipale, J; Cooper, MK; Maiti, T; Beachy, PA			Patched acts catalytically to suppress the activity of Smoothened	NATURE			English	Article							STEROL-SENSING DOMAIN; BASAL-CELL CARCINOMAS; PICK C1 PROTEIN; SONIC HEDGEHOG; SUBCELLULAR-LOCALIZATION; VESICULAR TRAFFICKING; MUTATIONS; GENE; IDENTIFICATION; PATHWAY	Mutations affecting the transmembrane proteins Patched (Ptc) or Smoothened (Smo) that trigger ligand-independent activity of the Hedgehog (Hh) signalling pathway are associated with human tumours such as basal cell carcinoma (BCC) and medulloblastoma(1-3). Despite extensive genetic studies demonstrating the importance of these receptor components in embryonic patterning and cancer, the mechanism by which Ptc regulates Smo is not understood(4). Here we report that Ptc and Smo are not significantly associated within Hh-responsive cells. Furthermore, we show that free Ptc (unbound by Hh) acts sub-stoichiometrically to suppress Smo activity and thus is critical in specifying the level of pathway activity. Patched is a twelve-transmembrane protein with homology to bacterial proton-driven transmembrane molecular transporters; we demonstrate that the function of Ptc is impaired by alterations of residues that are conserved in and required for function of these bacterial transporters. These results suggest that the Ptc tumour suppressor functions normally as a transmembrane molecular transporter, which acts indirectly to inhibit Smo activity, possibly through changes in distribution or concentration of a small molecule.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University	Beachy, PA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Howard Hughes Med Inst, Baltimore, MD 21205 USA.							Alcedo J, 2000, MOL CELL, V6, P457, DOI 10.1016/S1097-2765(00)00044-7; Aszterbaum M, 1998, J INVEST DERMATOL, V110, P885, DOI 10.1046/j.1523-1747.1998.00222.x; Bale AE, 2001, HUM MOL GENET, V10, P757, DOI 10.1093/hmg/10.7.757; Briscoe J, 2001, MOL CELL, V7, P1279, DOI 10.1016/S1097-2765(01)00271-4; Burke R, 1999, CELL, V99, P803, DOI 10.1016/S0092-8674(00)81677-3; CAPDEVILA J, 1994, DEVELOPMENT, V120, P987; Chidambaram A, 1996, CANCER RES, V56, P4599; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; Davies JP, 2000, SCIENCE, V290, P2295, DOI 10.1126/science.290.5500.2295; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; Fuse N, 1999, P NATL ACAD SCI USA, V96, P10992, DOI 10.1073/pnas.96.20.10992; Goldberg M, 1999, J BIOL CHEM, V274, P26065, DOI 10.1074/jbc.274.37.26065; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Guan L, 2001, J BACTERIOL, V183, P1734, DOI 10.1128/JB.183.5.1734-1739.2001; Ingham PW, 2000, CURR BIOL, V10, P1315, DOI 10.1016/S0960-9822(00)00755-7; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; INGHAM PW, 1991, NATURE, V353, P184, DOI 10.1038/353184a0; Kalderon D, 2000, CELL, V103, P371, DOI 10.1016/S0092-8674(00)00129-X; Ko DC, 2001, MOL BIOL CELL, V12, P601, DOI 10.1091/mbc.12.3.601; Martin V, 2001, CURR BIOL, V11, P601, DOI 10.1016/S0960-9822(01)00178-6; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Strutt H, 2001, CURR BIOL, V11, P608, DOI 10.1016/S0960-9822(01)00179-8; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Tseng Tsai-Tien, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P107; Wechsler-Reya R, 2001, ANNU REV NEUROSCI, V24, P385, DOI 10.1146/annurev.neuro.24.1.385; Wicking C, 1997, AM J HUM GENET, V60, P21; Williams KP, 1999, J CELL SCI, V112, P4405; Zeng X, 2001, NATURE, V411, P716, DOI 10.1038/35079648	30	598	630	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 22	2002	418	6900					892	897		10.1038/nature00989	http://dx.doi.org/10.1038/nature00989			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585YR	12192414				2022-12-24	WOS:000177555600042
J	Shamasunder, B; Bero, L				Shamasunder, B; Bero, L			Financial ties and conflicts of interest between pharmaceutical and tobacco companies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INDUSTRY	Corporate diversification allows for well-hidden financial ties between pharmaceutical and tobacco companies, which can cause a conflict of interest in the development and marketing of pharmaceutical products. In our investigation of tobacco company documents released and posted on the Internet as a result of the Master Settlement Agreement, we have found that these financial ties have fostered both competition and collaboration between the tobacco and pharmaceutical industries. We present 3 case studies. One shows how tobacco companies pressured pharmaceutical companies to scale back their smoking cessation educational materials that accompanied Nicorette. The second shows how they restricted to whom the pharmaceutical company could market its transdermal nicotine patch. In the third case, we show how subsidiary tobacco and pharmaceutical companies of a parent company collaborated in the production of a nicotine-release gum. Thus, because tobacco cessation product marketing has been altered as a result of these financial conflicts, disclosure would serve the interest of public health.	Univ Calif San Francisco, Inst Hlth Policy Studies, Dept Clin Pharm, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Bero, L (corresponding author), 3333 Calif St,Suite 265, San Francisco, CA 94143 USA.							BALLIN SD, 1989, TOB US AM C REP DALL; BLUM A, 1985, NY STATE J MED, P328; BUDICH KM, 1991, Q A TOBACCO REGULATI; CHARLES JL, 1982, CGA41065 CIBA GEIG P; *CIBA, 1943, CIBA S TOB, V4, P1426; *COAL SMOK OR HLTH, 1993, HIST OV CIG NIC REG; COTIGNOLA F, 1992, NICOTINE PATCH IND V; ELLIOT D, 1992, COMMUNICATION   0311; *FDC, 1992, FDC REP, V54, P8; FREUDENHEIM M, 1992, NY TIMES        0819; Garner B. A, 1999, BLACKS LAW DICT; JENKINS RW, 1980, COMMUNICATION   0116; JENKINS RW, 1977, COMMUNICATION   1122; Joossens L, 1996, Tob Control, V5, P177, DOI 10.1136/tc.5.3.177; KANIPE RW, 1987, MASTERPIECE TOBACS C; KAY A, 1984, COMMUNICATION   1217; Krantz A, 1998, NAT BIOTECHNOL, V16, P1294, DOI 10.1038/4243; Landman A, 2000, TOB CONTROL, V9, P339, DOI 10.1136/tc.9.3.339; LATSHAW RD, 1985, COMMUNICATION   0122; LATSHAW RD, 1984, COMMUNICATION   0507; LATSHAW RD, 1982, M DOW PHARM M JUL 13; LATSHAW RD, 1984, COMMUNICATION   1023; LATSHAW RD, 1985, COMMUNICATION   0118; LATSHAW RD, 1985, DOW ICORETTE SITUAT; LINDSAY D, 1982, 1170 TD CIBA GEIG RI; LUDOLF A, 1993, NICOTINE PATCH SUMMA; *M DOW PHARM, 1984, IF YOU WANT QUIT GOO; Markides CC, 1997, HARVARD BUS REV, V75, P93; MCDONALD CE, 1991, WORLDWIDE PRODUCERS; *MM DOW PHARM INC, 1981, SMOK CESS NEWSL; Muggli ME, 2001, AM J PUBLIC HEALTH, V91, P1419, DOI 10.2105/AJPH.91.9.1419; OSDENE TS, 1979, M CIBA GEIG PERS; OSDENE TS, 1982, COMMUNICATION   0104; *P MORR, 1991, SMOK CESS NIC DEL DE; *P MORR, 1993, RIS FALL RIS NIC PAT; *P MORR, 1992, PATCH ADV; *P MORR, SMOK CESS NIC DEL DE; *P MORR, 1992, NIC PATCH QUAL RES I; *P MORR, 1992, NIC PATCH ADV WEEKL; *P MORR, 1992, NIC PATCH CONS RES; PADOAN A, 1992, NICOTINE SKIN PATCH; RESNIK F, 1985, COMMUNICATION   0920; REUTER B, 2001, COMPETITIVE ANAL; RYAN N, 1992, NICOTINE PATCH ADV; SEIDENSTICKER R, 1991, COMMUNICATION   0523; Stern D, 1992, NICOTINE PATCH TRACK; SYKES L, 1992, COMMUNICATION   0313; SYKES L, 1992, COMMUNICATION   0128; TAYLOR JM, 1987, MASTERPIECE TOBACS; TIGHE L, 1992, COMMUNICATION   0722	50	25	25	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 14	2002	288	6					738	744		10.1001/jama.288.6.738	http://dx.doi.org/10.1001/jama.288.6.738			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	583KY	12169078				2022-12-24	WOS:000177408100035
J	Jefferis, BJMH; Power, C; Hertzman, C				Jefferis, BJMH; Power, C; Hertzman, C			Birth weight, childhood socioeconomic environment, and cognitive development in the 1958 British birth cohort study	BRITISH MEDICAL JOURNAL			English	Article							FOR-GESTATIONAL-AGE; ADULT LIFE; FOLLOW-UP; HEALTH; BORN	Objectives To examine the combined effect of social class and weight at birth on cognitive trajectories during school age and the associations between birth weight and educational outcomes through to 33 years. Design Longitudinal, population based, birth cohort study. Participants 10 845 males and females born during 3-9 March 1958 with information on birth weight, social class, and cognitive tests. Main outcome measures Reading, maths, draw a man, copying designs, verbal and non-verbal ability tests at ages 7, 11, and 16, highest qualifications achieved by 33, and trajectories of maths standardised scores at 7-16 years. Results The outcome of all childhood cognitive tests and educational achievements improved significantly with increasing birth weight. Analysis of maths scores at 7 and of highest qualifications achieved by 33 showed that the relations were robust to adjustment for potential confounding factors. For each kilogram increase in birth weight, maths z score increased by 0.17 (adjusted estimate 0.15, 95% confidence interval 0.10 to 0.21) for males and 0.21 (0.20,0.14 to 0.25) for females. Trajectories of maths z scores between 7 and 16 years diverged for different social class groups: participants from classes I and II increased their relative position on the score with increasing age, whereas classes IV and V showed a relative decline with increasing age. Birth weight explained much less of the variation in cognition than did social class (range 0.5-1.5% v 2.9-12.5%). Conclusions The postnatal environment has an overwhelming influence on cognitive function through to early adulthood, but these strong effects do not explain the weaker but independent association with birth weight.	Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London WC1N 1EH, England; Univ British Columbia, Fac Med, Dept Hlth Care & Epidemiol, Vancouver, BC V6T 1Z3, Canada	University of London; University College London; University of British Columbia	Power, C (corresponding author), Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, 30 Guilford St, London WC1N 1EH, England.		Jefferis, Barbara/AAE-5186-2020; Jefferis, Barbara JMH/C-1786-2008	Jefferis, Barbara/0000-0002-0850-3177; Jefferis, Barbara JMH/0000-0002-0850-3177				Butler NR, 1969, 2 REPORT BRIT PERINA; DAVIE R, 1972, BIRTH 7 FULL STAT AP; Douglas James W.B, 1964, HOME SCH; DRILLIEN CM, 1969, ARCH DIS CHILD, V44, P562, DOI 10.1136/adc.44.237.562; FERRI E, 1993, LIFE 33 5 FOLLOW UP; FOGELMAN K, 1978, EDUC STUD, V4, P121, DOI 10.1080/0305569780040205; GOLDSTEIN H, 1976, BIOL HUMAN FETAL GRO, P81; Goldstein H, 1995, MULTILEVEL STAT MODE, DOI 10.1002/9780470973394; GOLDSTEIN H, 1983, GROWING UP GREAT BRI, P9; Goodenough FL., 1926, MEASUREMENT INTELLIG; Kaplan GA, 2001, INT J EPIDEMIOL, V30, P256, DOI 10.1093/ije/30.2.256; Martyn CN, 1996, BRIT MED J, V312, P1393; Matte TD, 2001, BRIT MED J, V323, P310, DOI 10.1136/bmj.323.7308.310; OUNSTED MK, 1983, EARLY HUM DEV, V8, P243, DOI 10.1016/0378-3782(83)90007-5; PHAROAH POD, 1994, ARCH DIS CHILD, V70, P264, DOI 10.1136/adc.70.4.264; Power C, 1997, LANCET, V350, P1584, DOI 10.1016/S0140-6736(97)07474-6; Power C, 2000, BRIT MED J, V320, P840, DOI 10.1136/bmj.320.7238.840; Richards M, 2001, BRIT MED J, V322, P199, DOI 10.1136/bmj.322.7280.199; SEIDMAN DS, 1992, OBSTET GYNECOL, V79, P543; Shenkin SD, 2001, ARCH DIS CHILD, V85, P189, DOI 10.1136/adc.85.3.189; Sommerfelt K, 2000, ARCH DIS CHILD, V83, P25, DOI 10.1136/adc.83.1.25; Sorensen HT, 1997, BRIT MED J, V315, P401, DOI 10.1136/bmj.315.7105.401; Southgate V, 1962, SOUTHGATE GROUP READ; Strauss RS, 2000, JAMA-J AM MED ASSOC, V283, P625, DOI 10.1001/jama.283.5.625; WEIR W, 1992, ARCH DIS CHILD, V67, P675; WERNER EE, 1986, RISK INTELLECTUAL PS	26	182	191	0	21	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 10	2002	325	7359					305	308		10.1136/bmj.325.7359.305	http://dx.doi.org/10.1136/bmj.325.7359.305			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	584RQ	12169505	Bronze, Green Published			2022-12-24	WOS:000177482500016
J	Russell, TP				Russell, TP			Surface-responsive materials	SCIENCE			English	Article							DIBLOCK COPOLYMERS; PROCESSING AID; POLYMER; METHACRYLATE); POLYETHYLENE; RESISTANT; BLENDS		Univ Massachusetts, Dept Polymer Sci & Engn, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Russell, TP (corresponding author), Univ Massachusetts, Dept Polymer Sci & Engn, Amherst, MA 01003 USA.		Russell, Thomas Paul/ADL-3689-2022	Russell, Thomas Paul/0000-0001-6384-5826				ANASTASIADIS SH, 1990, J CHEM PHYS, V92, P5677, DOI 10.1063/1.458499; Banerjee P, 2000, J BIOMED MATER RES, V50, P331, DOI 10.1002/(SICI)1097-4636(20000605)50:3<331::AID-JBM6>3.3.CO;2-K; CHAUDHURY MK, 1992, SCIENCE, V256, P1539, DOI 10.1126/science.256.5063.1539; COULON G, 1989, MACROMOLECULES, V22, P2581, DOI 10.1021/ma00196a006; Crevoisier GB, 1999, SCIENCE, V285, P1246, DOI 10.1126/science.285.5431.1246; Falsafi A, 2000, LANGMUIR, V16, P1816, DOI 10.1021/la990345z; Genzer J, 2000, SCIENCE, V290, P2130, DOI 10.1126/science.290.5499.2130; HENKEE CS, 1988, J MATER SCI, V23, P1685, DOI 10.1007/BF01115708; Hester JF, 1999, MACROMOLECULES, V32, P1643, DOI 10.1021/ma980707u; Hong Y, 1999, J RHEOL, V43, P781, DOI 10.1122/1.550999; Hong Y, 2000, POLYMER, V41, P7705, DOI 10.1016/S0032-3861(00)00130-0; Ichimura K, 2000, SCIENCE, V288, P1624, DOI 10.1126/science.288.5471.1624; Irvine DJ, 2001, BIOMACROMOLECULES, V2, P545, DOI 10.1021/bm015510f; Khongtong S, 2002, J AM CHEM SOC, V124, P7254, DOI 10.1021/ja017396e; MORI H, 1994, MACROMOLECULES, V27, P4093, DOI 10.1021/ma00093a010; PENELLE JP, 2002, MACROMOLECULES, V35, P329; Pollard M, 1998, MACROMOLECULES, V31, P6493, DOI 10.1021/ma980316f; RUSSELL TP, 1994, NATURE, V368, P729, DOI 10.1038/368729a0; RUZETTE AV, 1990, J CHEM PHYS, V41, P525; Ruzette AVG, 1998, MACROMOLECULES, V31, P8509, DOI 10.1021/ma981055c; Senshu K, 1999, LANGMUIR, V15, P1754, DOI 10.1021/la980815+; Thanawala SK, 2000, LANGMUIR, V16, P1256, DOI 10.1021/la9906626; THEODOROU DN, 1988, MACROMOLECULES, V21, P1422, DOI 10.1021/ma00183a038; Vaidya A, 2002, J COLLOID INTERF SCI, V249, P235, DOI 10.1006/jcis.2002.8262; Walton DG, 1997, MACROMOLECULES, V30, P6947, DOI 10.1021/ma970698+	25	446	460	7	163	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 9	2002	297	5583					964	967		10.1126/science.1075997	http://dx.doi.org/10.1126/science.1075997			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581ZN	12169722				2022-12-24	WOS:000177325400031
J	Nanchahal, K; Duncan, JR; Durrington, PN; Jackson, RT				Nanchahal, K; Duncan, JR; Durrington, PN; Jackson, RT			Analysis of predicted coronary heart disease risk in England based on Framingham study risk appraisal models published in 1991 and 2000	BRITISH MEDICAL JOURNAL			English	Article									Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Hlth Promot Res Unit, London WC1E 7HT, England; GlaxoSmithKline, Harlow CM19 5AW, Essex, England; Univ Manchester, Manchester Royal Infirm, Med Unit, Clin Res Div 2, Manchester M13 9WL, Lancs, England; Univ Auckland, Fac Med & Hlth Sci, Auckland 1, New Zealand	University of London; London School of Hygiene & Tropical Medicine; GlaxoSmithKline; University of Manchester; University of Auckland	Nanchahal, K (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Hlth Promot Res Unit, London WC1E 7HT, England.			Nanchahal, Kiran/0000-0001-8812-7628; Jackson, Rod/0000-0001-5914-6934				ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; D'Agostino RB, 2000, AM HEART J, V139, P272, DOI 10.1016/S0002-8703(00)90236-9; Erens B., 2000, HLTH SURVEY ENGLAND; Ramsay LE, 1999, BMJ-BRIT MED J, V319, P630, DOI 10.1136/bmj.319.7210.630; Taggart DP, 1998, HEART, V80, P1	5	5	5	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 27	2002	325	7357					194	195		10.1136/bmj.325.7357.194	http://dx.doi.org/10.1136/bmj.325.7357.194			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	580PX	12142307	Green Published, Bronze, Green Accepted			2022-12-24	WOS:000177243900018
J	Glatzel, M; Rogivue, C; Ghani, A; Streffer, JR; Amsler, L; Aguzzi, A				Glatzel, M; Rogivue, C; Ghani, A; Streffer, JR; Amsler, L; Aguzzi, A			Incidence of Creutzfeldt-Jakob disease in Switzerland	LANCET			English	Article							PRION	The incidence of Creutzfeldt-Jakob disease (CJD) in Switzerland increased two-fold in 2001, and figures from the first quarter of 2002 indicate that it continues to rise. Neither age at onset nor duration of disease were different from previous years. Genetic analysis of the 27 reported cases revealed only one disease-associated mutation in the prion gene. None of the recognised risk factors for acquired CJD were reported on the offical notification forms. Glycotype profiling, histopathology, and immunohistochemistry indicate that none of the cases fulfilled the definition of variant CJD, which is thought to be caused by bovine prions. Several scenarios could account for the increase in CJD, including improved reporting, iatrogenic transmission, and transmission of a prion zoonosis.	Inst Neuropathol, CH-8091 Zurich, Switzerland; Natl Reference Ctr Prion Dis, CH-8091 Zurich, Switzerland; Fed Off Publ Hlth, Div Epidemiol & Infect Dis, Bern, Switzerland; Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis Epidemiol, London, England; Univ Zurich, Div Psychiat Res, Zurich, Switzerland	Imperial College London; University of Zurich	Aguzzi, A (corresponding author), Inst Neuropathol, Schmelzbergstr 12, CH-8091 Zurich, Switzerland.		Glatzel, Markus/V-8844-2019; Glatzel, Markus/G-3356-2011; Ghani, Azra/B-8560-2009; Aguzzi, Adriano/A-3351-2008	Glatzel, Markus/0000-0002-7720-8817; Glatzel, Markus/0000-0002-7720-8817; Rolf Streffer, Johannes/0000-0002-9387-5951; Ghani, Azra/0000-0002-0007-4910; Aguzzi, Adriano/0000-0002-0344-6708				Aguzzi A, 1997, NATURE, V389, P795, DOI 10.1038/39758; Collins S, 1999, LANCET, V353, P693, DOI 10.1016/S0140-6736(98)08138-0; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Will RG, 2000, ANN NEUROL, V47, P575; Windl O, 1999, HUM GENET, V105, P244, DOI 10.1007/s004390051096	5	71	73	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 13	2002	360	9327					139	141		10.1016/S0140-6736(02)09384-4	http://dx.doi.org/10.1016/S0140-6736(02)09384-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573PB	12126826				2022-12-24	WOS:000176839100015
J	Moore, H; Dvorakova, K; Jenkins, N; Breed, W				Moore, H; Dvorakova, K; Jenkins, N; Breed, W			Exceptional sperm cooperation in the wood mouse	NATURE			English	Article							EXPRESSION; MICE; CELLS	Spermatozoa from a single male will compete for fertilization of ova with spermatozoa from another male when present in the female reproductive tract at the same time(1). Close genetic relatedness predisposes individuals towards altruism, and as haploid germ cells of an ejaculate will have genotypic similarity of 50%, it is predicted that spermatozoa may display cooperation and altruism to gain an advantage when intermale sperm competition is intense(2). We report here the probable altruistic behaviour of spermatozoa in an eutherian mammal. Spermatozoa of the common wood mouse, Apodemus sylvaticus, displayed a unique morphological transformation resulting in cooperation in distinctive aggregations or 'trains' of hundreds or thousands of cells, which significantly increased sperm progressive motility. Eventual dispersal of sperm trains was associated with most of the spermatozoa undergoing a premature acrosome reaction. Cells undergoing an acrosome reaction in aggregations remote from the egg are altruistic in that they help sperm transport to the egg but compromise their own fertilizing ability.	Univ Sheffield, Sect Reprod & Dev Med, Sheffield S10 2UH, S Yorkshire, England; Charles Univ, Dept Dev Biol, CR-12844 Prague, Czech Republic; Univ Adelaide, Dept Anat Sci, Adelaide, SA 5005, Australia	University of Sheffield; Charles University Prague; University of Adelaide	Moore, H (corresponding author), Univ Sheffield, Sect Reprod & Dev Med, Sheffield S10 2UH, S Yorkshire, England.		Komrsková, Kateřina/P-7920-2019; Dvorakova-Hortova, Katerina/A-8705-2010	Komrsková, Kateřina/0000-0002-6837-2148; Dvorakova-Hortova, Katerina/0000-0002-6837-2148; Breed, William/0000-0003-1739-6593				Baker R.R., 1995, HUMAN SPERM COMPETIT; BAKER RR, 1988, ANIM BEHAV, V36, P936, DOI 10.1016/S0003-3472(88)80178-7; Bedford J. M., 1979, The spermatozoon. Maturation, motility, surface properties and comparative aspects. Proceedings of the Third International Symposium on the Spermatozoon, held at the American Academy of Arts and Sciences, Boston, and the Swope Conference Center, Marine Biological Laboratories, Woods Hole, Massachusetts, May 2-5, 1978., P7; BIRKHEAD TR, 1996, SPERM COMPETITION SE; BIRKHEAD TR, 1999, P R SOC LOND B, V266, P1; Breed WG, 2000, J MAMMAL, V81, P758, DOI 10.1644/1545-1542(2000)081&lt;0758:BMTMAS&gt;2.3.CO;2; Dawkins R, 1976, SELFISH GENE; De Kretser D. M., 1994, P1177; FRASER LR, 1975, BIOL REPROD, V13, P513, DOI 10.1095/biolreprod13.5.513; Friend GF, 1936, Q J MICROSC SCI, V78, P419; Haig D, 1996, P NATL ACAD SCI USA, V93, P6547, DOI 10.1073/pnas.93.13.6547; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; HANAK V, 1979, MAMMALS; HARCOURT AH, 1981, NATURE, V293, P55, DOI 10.1038/293055a0; Hayashi F, 1996, J INSECT PHYSIOL, V42, P859, DOI 10.1016/0022-1910(96)00037-6; Holt C, 1997, J ANDROL, V18, P312; KIM E, 1989, MOL CELL BIOL, V9, P1875, DOI 10.1128/MCB.9.5.1875; Kleene KC, 2001, MECH DEVELOP, V106, P3, DOI 10.1016/S0925-4773(01)00413-0; MOORE HD, 1999, P R SOC LOND B, V266, P2243; Moore HDM, 1996, J ANDROL, V17, P50; Moore HDM, 1996, REPROD FERT DEVELOP, V8, P605, DOI 10.1071/RD9960605; MOORE HDM, 1985, EXP CLIN IMMUNOGENET, V2, P84; SHEPHERD BA, 1979, ARCH ANDROLOGY, V2, P53, DOI 10.3109/01485017908987292; SIVINSKI J, 1984, SPERM COMPETITION EV, P223; TEW TE, 1994, BEHAV ECOL SOCIOBIOL, V34, P337, DOI 10.1007/BF01209780; Trivers R., 1985, SOCIAL EVOLUTION; Wassarman PM, 2001, NAT CELL BIOL, V3, pE59, DOI 10.1038/35055178; Xu X, 1999, NAT GENET, V23, P118, DOI 10.1038/12729; Yanagimachi R., 1994, P189	29	183	187	3	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 11	2002	418	6894					174	177		10.1038/nature00832	http://dx.doi.org/10.1038/nature00832			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	571GV	12110888	Green Accepted			2022-12-24	WOS:000176710400038
J	Wang, J; Hamilton, JI; Carter, MS; Li, S; Wilkinson, MF				Wang, J; Hamilton, JI; Carter, MS; Li, S; Wilkinson, MF			Alternatively spliced TCR mRNA induced by disruption of reading frame	SCIENCE			English	Article							PREMATURE TERMINATION CODON; MESSENGER-RNA LEVELS; NONSENSE CODONS; REGULATORY MECHANISM; PROTEIN-SYNTHESIS; DEPENDENT MANNER; SITE SELECTION; IN-VITRO; TRANSLATION; MUTATIONS	Nonsense codons that prematurely terminate translation generate potentially deleterious truncated proteins. Here, we show that the T cell receptor-beta (TCRbeta) gene, which acquires in-frame nonsense codons at high frequency during normal lymphocyte development, gives rise to an alternatively spliced transcript [ alternative messenger RNA (alt-mRNA)] that skips the offending mutations that generate such nonsense codons. This alt-mRNA is up-regulated by a transfer RNA dependent scanning mechanism that responds specifically to mutations that disrupt the reading frame. The finding that translation signals regulate the levels of alternatively spliced mRNAs generated in the nucleus may alter the current view of how gene expression is controlled in eukaryotic cells.	Univ Texas, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Wilkinson, MF (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Immunol, Box 180,1515 Holcombe Blvd, Houston, TX 77030 USA.		Li, Shulin/D-6478-2011					Aoufouchi S, 1996, CELL, V85, P415, DOI 10.1016/S0092-8674(00)81119-8; BEEMON K, COMMUNICATION; BELGRADER P, 1993, P NATL ACAD SCI USA, V90, P482, DOI 10.1073/pnas.90.2.482; Blencowe BJ, 2000, TRENDS BIOCHEM SCI, V25, P106, DOI 10.1016/S0968-0004(00)01549-8; Carter MS, 1996, EMBO J, V15, P5965, DOI 10.1002/j.1460-2075.1996.tb00983.x; CARTER MS, 1995, J BIOL CHEM, V270, P28995, DOI 10.1074/jbc.270.48.28995; CHELLY J, 1990, CELL, V63, P1239, DOI 10.1016/0092-8674(90)90419-F; CHOU HS, 1987, P NATL ACAD SCI USA, V84, P1992, DOI 10.1073/pnas.84.7.1992; Clement JQ, 2001, J BIOL CHEM, V276, P16919, DOI 10.1074/jbc.M005104200; Cooper TA, 1997, AM J HUM GENET, V61, P259, DOI 10.1086/514856; DIETZ HC, 1994, NAT GENET, V8, P183, DOI 10.1038/ng1094-183; DIETZ HC, 1993, SCIENCE, V259, P680, DOI 10.1126/science.8430317; Dostie J, 2000, EMBO J, V19, P3142, DOI 10.1093/emboj/19.12.3142; Gersappe A, 1999, MOL CELL BIOL, V19, P1640; Gersappe A, 1999, J BIOL CHEM, V274, P22452, DOI 10.1074/jbc.274.32.22452; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Iborra FJ, 2001, SCIENCE, V293, P1139, DOI 10.1126/science.1061216; KOZAK M, 1989, MOL CELL BIOL, V9, P5134, DOI 10.1128/MCB.9.11.5134; Li BH, 2002, P NATL ACAD SCI USA, V99, P5277, DOI 10.1073/pnas.082095299; Li SL, 1997, J EXP MED, V185, P985, DOI 10.1084/jem.185.6.985; Li SL, 1998, IMMUNITY, V8, P135, DOI 10.1016/S1074-7613(00)80466-5; Liu HX, 2001, NAT GENET, V27, P55, DOI 10.1038/83762; LOZANO F, 1994, EMBO J, V13, P4617, DOI 10.1002/j.1460-2075.1994.tb06783.x; Maquat LE, 1996, AM J HUM GENET, V59, P279; Mendell JT, 2001, CELL, V107, P411, DOI 10.1016/S0092-8674(01)00583-9; Monsalve M, 2000, MOL CELL, V6, P307, DOI 10.1016/S1097-2765(00)00031-9; Muhlemann O, 2001, MOL CELL, V8, P33, DOI 10.1016/S1097-2765(01)00288-X; QIAN L, 1993, J IMMUNOL, V151, P6801; Valentine CR, 1998, MUTAT RES-REV MUTAT, V411, P87, DOI 10.1016/S1383-5742(98)00010-6; Wang J, 2000, BIOTECHNIQUES, V29, P976, DOI 10.2144/00295bm09; Wang J, 2002, J BIOL CHEM, V277, P18489, DOI 10.1074/jbc.M111781200; WANG JC, UNPUB; Wilkinson MF, 2001, BIOESSAYS, V23, P775, DOI 10.1002/bies.1113; Wilkinson MF, 2002, NAT CELL BIOL, V4, pE144, DOI 10.1038/ncb0602-e144	34	61	64	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 5	2002	297	5578					108	110		10.1126/science.1069757	http://dx.doi.org/10.1126/science.1069757			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	571HB	12098701				2022-12-24	WOS:000176711000045
J	Starr, DJ; Cline, TW				Starr, DJ; Cline, TW			A host-parasite interaction rescues Drosophila oogenesis defects	NATURE			English	Article							SEX-LETHAL GENE; WOLBACHIA INFECTION; GERM-CELLS; MELANOGASTER; EXPRESSION; INCOMPATIBILITY; LOCUS; SXL	The cytoplasmically inherited bacterium Wolbachia pipientis is a widespread parasite of arthropods that manipulates the reproductive biology of its hosts, often to their detriment, in order to foster its own transmission through egg cytoplasm(1,2). Here we report that infection by Wolbachia restores fertility to Drosophila melanogaster mutant females prevented from making eggs by protein-coding lesions in Sex-lethal (Sxl), the master regulator of sex determination. Suppression of sterility by Wolbachia discriminates markedly among similar germline-specific Sxl alleles, and is not observed for mutations in other genes that produce similar 'tumorous ovary' phenotypes, including one that blocks Sxl germline expression. This allele and gene specificity indicates that suppression probably results from a specific interaction with Sxl protein, rather than from a bypass of the normal germline requirement for this developmental regulator or from an effect on Sxl expression. The Sxl-Wolbachia interaction provides a rare opportunity to explore host-parasite relationships at the molecular level in a model insect. Furthermore, demonstration that a parasite infection can counteract the deleterious effects of mutations in host genes illustrates how hosts might become dependent on parasites.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Cline, TW (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 401 Barker Hall, Berkeley, CA 94720 USA.							BOPP D, 1993, DEVELOPMENT, V118, P797; Bopp D, 1999, DEVELOPMENT, V126, P5785; Bordenstein SR, 2001, NATURE, V409, P707, DOI 10.1038/35055543; Bouchon D, 1998, P ROY SOC B-BIOL SCI, V265, P1081, DOI 10.1098/rspb.1998.0402; Bourtzis K, 1996, GENETICS, V144, P1063; BOYLE L, 1993, SCIENCE, V260, P1796, DOI 10.1126/science.8511587; CLINE TW, 1988, GENETICS, V119, P829; Cline TW, 1996, ANNU REV GENET, V30, P637, DOI 10.1146/annurev.genet.30.1.637; CLINE TW, 1979, DEV BIOL, V72, P266, DOI 10.1016/0012-1606(79)90117-9; COOK KR, 1993, THESIS U IOWA; Dedeine F, 2001, P NATL ACAD SCI USA, V98, P6247, DOI 10.1073/pnas.101304298; DINES J, 1998, ANN DROS RES C PROGR, V39, pA245; DINES JL, 2001, THESIS U CALIFORNIA; Hager JH, 1997, DEVELOPMENT, V124, P5033; Huigens ME, 2000, NATURE, V405, P178, DOI 10.1038/35012066; Hurst GDD, 2000, GENETICS, V156, P699; Knight J, 2001, NATURE, V412, P12, DOI 10.1038/35083744; Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792; OLIVER B, 1988, GENETICS, V120, P159; ONEILL SL, 1992, P NATL ACAD SCI USA, V89, P2699, DOI 10.1073/pnas.89.7.2699; Page SL, 2000, GENETICS, V155, P1757; PAULI D, 1993, DEVELOPMENT, V119, P123; PERRIMON N, 1986, GENETICS, V113, P695; SALZ HK, 1989, GENE DEV, V3, P708, DOI 10.1101/gad.3.5.708; SALZ HK, 1987, GENETICS, V117, P221; SCHUPBACH T, 1985, GENETICS, V109, P529; STEINMANNZWICKY M, 1988, EMBO J, V7, P3889, DOI 10.1002/j.1460-2075.1988.tb03275.x; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; Werren JH, 1997, INFLUENTIAL PASSENGERS, P1	29	92	102	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 4	2002	418	6893					76	79		10.1038/nature00843	http://dx.doi.org/10.1038/nature00843			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569JL	12097909				2022-12-24	WOS:000176599200041
J	Hess, C; Klimkait, T; Schlapbach, L; Del Zenero, V; Sadallah, S; Horakova, E; Balestra, G; Werder, V; Schaefer, C; Battegay, M; Schifferli, JA				Hess, C; Klimkait, T; Schlapbach, L; Del Zenero, V; Sadallah, S; Horakova, E; Balestra, G; Werder, V; Schaefer, C; Battegay, M; Schifferli, JA			Association of a pool of HIV-1 with erythrocytes in vivo: a cohort study	LANCET			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; COMPLEMENT RECEPTOR-TYPE-1 CR-1; ACTIVE ANTIRETROVIRAL THERAPY; T-CELLS; IMMUNE-COMPLEXES; INFECTION; CD35; PERSISTENCE; EXPRESSION; ANTIBODIES	Background Treatment of HIV-1-infected individuals with antiretrovirals can result in sustained suppression of plasma viral RNA at concentrations below the detection limit of available assays. However, continuing virus replication has been detected in patients with viral RNA in plasma suppressed for months to years, and many cell types are known to act as reservoirs or carriers for the virus. In vitro, erythrocytes bind HIV-1 immune complexes, so we tested for a circulating pool of HIV-1 associated with erythrocytes in people with HIV-1 infection. Methods We investigated 82 chronically HIV-1-infected individuals. Plasma, white cells, and erythrocytes were tested for HIV-1 RNA by RT-PCR. Findings Erythrocyte-associated HIV-1 RNA was detected in 80 of 82 individuals. In 23, plasma HIV-1 RNA had been undetectable (<20 copies/mL) for up to 32 months; in corresponding erythrocyte samples, there were up to 82 878 HIV-1 RNA copies per mL whole blood. HIV-1 associated with erythrocytes in vivo was shown to be infectious. Within the subgroup of patients with undetectable plasma viral load, higher numbers of HIV-1 associated with erythrocytes were correlated with a history of advanced clinical stages of HIV-1 infection (p=0.014). Interpretation A pool of HIV-1 is associated with erythrocytes even after long-term suppression of viral RNA in plasma. This finding is direct evidence for continuing virus replication or release in these individuals. Quantification of this viral pool may help to judge suppression of HIV-1 replication in individuals with undetectable plasma HIV-1 RNA.	Univ Basel Hosp, Dept Res, Immunonephrol Lab, CH-4031 Basel, Switzerland; Univ Basel Hosp, Outpatient Dept Internal Med, Basel Ctr HIV Res, CH-4031 Basel, Switzerland; Univ Basel, Inst Med Microbiol, Basel Ctr HIV Res, Basel, Switzerland; Inst Dr Viollier, Dept Mol Diagnost, Basel, Switzerland	University of Basel; University of Basel; University of Basel	Hess, C (corresponding author), Hebelstr 20, CH-4051 Basel, Switzerland.		Klimkait, Thomas/A-1057-2008; Schlapbach, Luregn J/F-7465-2017; Schlapbach, Luregn/D-8402-2014	Schlapbach, Luregn J/0000-0003-2281-2598; Potlukova, Eliska/0000-0003-4790-8860; Klimkait, Thomas/0000-0003-4945-6511				[Anonymous], 1992, MMWR MORB MORTAL WKL, V41, P1; Burton GF, 1997, IMMUNOL REV, V156, P185, DOI 10.1111/j.1600-065X.1997.tb00968.x; CHUN TW, 1995, NAT MED, V1, P1284, DOI 10.1038/nm1295-1284; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Chun TW, 1999, P NATL ACAD SCI USA, V96, P10958, DOI 10.1073/pnas.96.20.10958; Davey RT, 1999, P NATL ACAD SCI USA, V96, P15109, DOI 10.1073/pnas.96.26.15109; DAVIES KA, 1990, J IMMUNOL, V144, P4613; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Furtado MR, 1999, NEW ENGL J MED, V340, P1614, DOI 10.1056/NEJM199905273402102; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Haase AT, 1999, ANNU REV IMMUNOL, V17, P625, DOI 10.1146/annurev.immunol.17.1.625; JOUVIN MH, 1987, AIDS, V1, P89; Kacani L, 2000, J VIROL, V74, P7997, DOI 10.1128/JVI.74.17.7997-8002.2000; Klickstein LB, 1997, IMMUNITY, V7, P345, DOI 10.1016/S1074-7613(00)80356-8; Klimkait T, 1998, ARCH VIROL, V143, P2109, DOI 10.1007/s007050050447; Lach-Trifilieff E, 1999, J IMMUNOL, V162, P7549; MADI N, 1991, J IMMUNOL, V147, P495; Moir S, 2000, J EXP MED, V192, P637, DOI 10.1084/jem.192.5.637; MONTEFIORI DC, 1994, J INFECT DIS, V170, P429, DOI 10.1093/infdis/170.2.429; Morandi PA, 1998, J CLIN MICROBIOL, V36, P1534, DOI 10.1128/JCM.36.6.1534-1538.1998; Moulds JM, 1998, EXP CLIN IMMUNOGENET, V15, P291, DOI 10.1159/000019084; PASCUAL M, 1993, J IMMUNOL, V151, P397; Ramratnam B, 2000, NAT MED, V6, P82, DOI 10.1038/71577; SCHIFFERLI JA, 1986, NEW ENGL J MED, V315, P488; SCHIFFERLI JA, 1988, J IMMUNOL, V140, P899; Sharkey ME, 2000, NAT MED, V6, P76, DOI 10.1038/71569; TAUSK FA, 1986, J CLIN INVEST, V78, P977, DOI 10.1172/JCI112688; Winston JA, 2001, NEW ENGL J MED, V344, P1979, DOI 10.1056/NEJM200106283442604; Zhang LQ, 1999, NEW ENGL J MED, V340, P1605, DOI 10.1056/NEJM199905273402101; Zhou JT, 1996, VIROLOGY, V226, P13, DOI 10.1006/viro.1996.0623	30	64	67	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 29	2002	359	9325					2230	2234		10.1016/S0140-6736(02)09291-7	http://dx.doi.org/10.1016/S0140-6736(02)09291-7			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	567YJ	12103286				2022-12-24	WOS:000176514500008
J	Fukata, M; Watanabe, T; Noritake, J; Nakagawa, M; Yamaga, M; Kuroda, S; Matsuura, Y; Iwamatsu, A; Perez, F; Kaibuchi, K				Fukata, M; Watanabe, T; Noritake, J; Nakagawa, M; Yamaga, M; Kuroda, S; Matsuura, Y; Iwamatsu, A; Perez, F; Kaibuchi, K			Rac1 and Cdc42 capture microtubules through IQGAP1 and CLIP-170	CELL			English	Article							RHO-FAMILY GTPASES; CELL-CELL ADHESION; BINDING PROTEIN; ACTIN CYTOSKELETON; PLASMA-MEMBRANE; DISTAL ENDS; C-ELEGANS; DYNAMICS; POLARITY; TARGET	Linkage of microtubules to special cortical regions is essential for cell polarization. CLIP-170 binds to the growing ends of microtubules and plays pivotal roles in orientation. We have found that IQGAP1, an effector of Rac1 and Cdc42, interacts with CLIP-170. In Vero fibroblasts, IQGAP1 localizes at the polarized leading edge. Expression of carboxy-terminal fragment of 1Q-GAP1, which includes the CLIP-170 binding region, delocalizes GFP-CLIP-170 from the tips of microtubules and alters the microtubule array. Activated Rac1/Cdc42, IQGAP1, and CLIP-170 form a tripartite complex. Furthermore, expression of an IQGAP1 mutant defective in Rac1/Cdc42 binding induces multiple leading edges. These results indicate that Rac1/Cdc42 marks special cortical spots where the IQGAP1 and CLIP-170 complex is targeted, leading to a polarized microtubule array and cell polarization.	Nagoya Univ, Grad Sch Med, Dept Cell Pharmacol, Showa Ku, Aichi 4668550, Japan; Nara Inst Sci & Technol, Div Signal Transduct, Nara 6300101, Japan; Osaka Univ, Res Ctr Emerging Infect Dis, Suita, Osaka 5650871, Japan; Kirin Brewery Co Ltd, Cent Labs Key Technol, Kanagawa 2360004, Japan; Inst Curie, CNRS, UMR 144, Paris 05, France	Nagoya University; Nara Institute of Science & Technology; Osaka University; Kirin Brewery Company Limited; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite	Kaibuchi, K (corresponding author), Nagoya Univ, Grad Sch Med, Dept Cell Pharmacol, Showa Ku, 65 Tsurumai, Aichi 4668550, Japan.		Perez, Franck/A-1558-2014; Fukata, Masaki/AAZ-2476-2021	Perez, Franck/0000-0002-9129-9401; Fukata, Masaki/0000-0001-5200-9806; Watanabe, Takashi/0000-0002-9015-5246				Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Bashour AM, 1997, J CELL BIOL, V137, P1555, DOI 10.1083/jcb.137.7.1555; Brunner D, 2000, CELL, V102, P695, DOI 10.1016/S0092-8674(00)00091-X; Cook TA, 1998, J CELL BIOL, V141, P175, DOI 10.1083/jcb.141.1.175; Daub H, 2001, J BIOL CHEM, V276, P1677, DOI 10.1074/jbc.C000635200; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Fukata M, 2001, NAT REV MOL CELL BIO, V2, P887, DOI 10.1038/35103068; Fukata M, 2001, MOL CELL BIOL, V21, P2165, DOI 10.1128/MCB.21.6.2165-2183.2001; Fukata M, 1997, J BIOL CHEM, V272, P29579, DOI 10.1074/jbc.272.47.29579; Goode BL, 2000, CURR OPIN CELL BIOL, V12, P63, DOI 10.1016/S0955-0674(99)00058-7; Gotta M, 2001, CURR BIOL, V11, P482, DOI 10.1016/S0960-9822(01)00142-7; Gradin HM, 1997, MOL CELL BIOL, V17, P3459, DOI 10.1128/MCB.17.6.3459; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hart MJ, 1996, EMBO J, V15, P2997, DOI 10.1002/j.1460-2075.1996.tb00663.x; Ishizaki T, 2001, NAT CELL BIOL, V3, P8; IWAMATSU A, 1992, ELECTROPHORESIS, V13, P142, DOI 10.1002/elps.1150130129; Jensen ON, 1996, RAPID COMMUN MASS SP, V10, P1371, DOI 10.1002/(SICI)1097-0231(199608)10:11<1371::AID-RCM682>3.0.CO;2-5; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Kawasaki Y, 2000, SCIENCE, V289, P1194, DOI 10.1126/science.289.5482.1194; Kay AJ, 2001, CURR BIOL, V11, P474, DOI 10.1016/S0960-9822(01)00141-5; Kobayashi K, 1998, J BIOL CHEM, V273, P291, DOI 10.1074/jbc.273.1.291; Kroschewski R, 1999, NAT CELL BIOL, V1, P8, DOI 10.1038/8977; Kuroda S, 1996, J BIOL CHEM, V271, P23363, DOI 10.1074/jbc.271.38.23363; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; NAGAFUCHI A, 1994, J CELL BIOL, V127, P235, DOI 10.1083/jcb.127.1.235; Nathke IS, 1996, J CELL BIOL, V134, P165, DOI 10.1083/jcb.134.1.165; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Palazzo AF, 2001, CURR BIOL, V11, P1536, DOI 10.1016/S0960-9822(01)00475-4; Perez F, 1999, CELL, V96, P517, DOI 10.1016/S0092-8674(00)80656-X; PIERRE P, 1992, CELL, V70, P887, DOI 10.1016/0092-8674(92)90240-D; RICKARD JE, 1990, J CELL BIOL, V110, P1623, DOI 10.1083/jcb.110.5.1623; Rusan NM, 2001, MOL BIOL CELL, V12, P971, DOI 10.1091/mbc.12.4.971; SCHULZE E, 1987, J CELL BIOL, V105, P2167, DOI 10.1083/jcb.105.5.2167; SHISHIDO Y, 1995, J BIOL CHEM, V270, P29578, DOI 10.1074/jbc.270.49.29578; STOWERS L, 1995, P NATL ACAD SCI USA, V92, P5027, DOI 10.1073/pnas.92.11.5027; SU LK, 1995, CANCER RES, V55, P2972; TIMAUER JS, 2000, J CELL BIOL, V149, P761; VAN AL, 1997, GENE DEV, V11, P2295; Vaughan KT, 1999, J CELL SCI, V112, P1437; WEBSTER DR, 1987, P NATL ACAD SCI USA, V84, P9040, DOI 10.1073/pnas.84.24.9040; Wittmann T, 2001, J CELL SCI, V114, P3795	46	468	480	0	20	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 28	2002	109	7					873	885		10.1016/S0092-8674(02)00800-0	http://dx.doi.org/10.1016/S0092-8674(02)00800-0			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	570KJ	12110184	Bronze			2022-12-24	WOS:000176657200010
J	Allen, MR; Stainforth, DA				Allen, MR; Stainforth, DA			Towards objective probabalistic climate forecasting	NATURE			English	Editorial Material							UNCERTAINTY		Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England	University of Oxford	Allen, MR (corresponding author), Univ Oxford, Dept Phys, Clarendon Lab, Parks Rd, Oxford OX1 3PU, England.	d.stainforth1@physics.ox.ac.uk	Allen, Myles R/A-5172-2012					Allen M, 1999, NATURE, V401, P642, DOI 10.1038/44266; CUBASCH U, 2001, CLIMATE CHANGE 2001, P527; Dai A, 2001, B AM METEOROL SOC, V82, P2377, DOI 10.1175/1520-0477(2001)082<2377:ESOTFC>2.3.CO;2; Forest CE, 2002, SCIENCE, V295, P113, DOI 10.1126/science.1064419; Giles J, 2002, NATURE, V418, P476, DOI 10.1038/418476a; Hansen JA, 2001, GLOB WARM INT CTR M, P187; Lea DJ, 2000, TELLUS A, V52, P523, DOI 10.1034/j.1600-0870.2000.01137.x; MITCHELL JFB, 1995, NATURE, V376, P501, DOI 10.1038/376501a0; Palmer TN, 2000, REP PROG PHYS, V63, P71, DOI 10.1088/0034-4885/63/2/201; Palmer TN, 2002, NATURE, V415, P512, DOI 10.1038/415512a; Schneider SH, 2001, NATURE, V411, P17, DOI 10.1038/35075167; Smith LA, 2002, P NATL ACAD SCI USA, V99, P2487, DOI 10.1073/pnas.012580599; Stainforth D, 2002, COMPUT SCI ENG, V4, P82, DOI 10.1109/5992.998644; Stott PA, 2002, NATURE, V416, P723, DOI 10.1038/416723a; Wigley TML, 2001, SCIENCE, V293, P451, DOI 10.1126/science.1061604	15	3	3	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 12	2002	419	6903					228	228		10.1038/nature01092a	http://dx.doi.org/10.1038/nature01092a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592HK	12226678				2022-12-24	WOS:000177931200053
J	Srivastava, R				Srivastava, R			Beyond hope?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 11	2002	288	10					1203	1204		10.1001/jama.288.10.1203	http://dx.doi.org/10.1001/jama.288.10.1203			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592BW	12215110				2022-12-24	WOS:000177917700001
J	Baker, PJ; Harris, S; Webbon, CC				Baker, PJ; Harris, S; Webbon, CC			Ecology - Effect of British hunting ban on fox numbers	NATURE			English	Article									Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England	University of Bristol	Baker, PJ (corresponding author), Univ Bristol, Sch Biol Sci, Woodland Rd, Bristol BS8 1UG, Avon, England.	s.harris@bristol.ac.uk						ALEXANDER K, 1996, BAILYS HUNTING DIREC; BURNS L, 2000, REPORT COMMITTEE INQ; HARRIS S, 1993, SYM ZOOL S, P441; Harris S., 1995, REV BRIT MAMMALS POP; Macdonald David W., 1996, P160; PUTMAN RJ, 1984, MAMMAL REV, V14, P79, DOI 10.1111/j.1365-2907.1984.tb00341.x; Tapper S., 1999, QUESTION BALANCE GAM; 2000, BAILYS HUNTING DIREC	8	32	32	0	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 5	2002	419	6902					34	34		10.1038/419034a	http://dx.doi.org/10.1038/419034a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589YF	12214224				2022-12-24	WOS:000177788600029
J	Del Punta, K; Leinders-Zufall, T; Rodriguez, I; Jukam, D; Wysocki, CJ; Ogawa, S; Zufall, F; Mombaerts, P				Del Punta, K; Leinders-Zufall, T; Rodriguez, I; Jukam, D; Wysocki, CJ; Ogawa, S; Zufall, F; Mombaerts, P			Deficient pheromone responses in mice lacking a cluster of vomeronasal receptor genes	NATURE			English	Article							OLFACTORY SYSTEM; ORGAN; MOUSE; NEURONS; ORGANIZATION; AGGRESSION; BEHAVIORS; MAMMALS; ALPHA	The mammalian vomeronasal organ (VNO), a part of the olfactory system, detects pheromones-chemical signals that modulate social and reproductive behaviours(1,2). But the molecular receptors in the VNO that detect these chemosensory stimuli remain undefined. Candidate pheromone receptors are encoded by two distinct and complex superfamilies of genes, V1r and V2r (refs 3 and 4), which code for receptors with seven transmembrane domains. These genes are selectively expressed in sensory neurons of the VNO. However, there is at present no functional evidence for a role of these genes in pheromone responses. Here, using chromosome engineering technology(5), we delete in the germline of mice a similar to600-kilobase genomic region that contains a cluster of 16 intact V1r genes(6). These genes comprise two of the 12 described V1r gene families(7), and represent similar to12% of the V1r repertoire. The mutant mice display deficits in a subset of VNO-dependent behaviours: the expression of male sexual behaviour and maternal aggression is substantially altered. Electrophysiologically, the epithelium of the VNO of such mice does not respond detectably to specific pheromonal ligands. The behavioural impairment and chemosensory deficit support a role of V1r receptors as pheromone receptors.	Rockefeller Univ, New York, NY 10021 USA; Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA; Monell Chem Senses Ctr, Philadelphia, PA 19104 USA	Rockefeller University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Monell Chemical Senses Center	Mombaerts, P (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.		Leinders-Zufall, Trese/B-4103-2009; Leinders-Zufall, Trese/S-3664-2019; Zufall, Frank/AAE-5290-2021	Leinders-Zufall, Trese/0000-0002-0678-362X; Leinders-Zufall, Trese/0000-0002-0678-362X; Zufall, Frank/0000-0002-4383-8618; Jukam, David/0000-0003-4167-2754; rodriguez, ivan/0000-0002-6468-0565				AMOORE JE, 1991, CHEM SENSES, V3, P331; BEAN NJ, 1982, PHYSIOL BEHAV, V29, P433, DOI 10.1016/0031-9384(82)90262-1; BEAN NJ, 1982, PHYSIOL BEHAV, V28, P31, DOI 10.1016/0031-9384(82)90097-X; BEAN NJ, 1989, PHYSIOL BEHAV, V45, P875, DOI 10.1016/0031-9384(89)90209-6; Belluscio L, 1999, CELL, V97, P209, DOI 10.1016/S0092-8674(00)80731-X; CLANCY AN, 1984, J NEUROSCI, V4, P2222; Del Punta K, 2000, GENOME RES, V10, P1958, DOI 10.1101/gr.10.12.1958; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; HALPERN M, 1987, ANNU REV NEUROSCI, V10, P325, DOI 10.1146/annurev.ne.10.030187.001545; HILDEBRAND JG, 1995, P NATL ACAD SCI USA, V92, P67, DOI 10.1073/pnas.92.1.67; Holy TE, 2000, SCIENCE, V289, P1569, DOI 10.1126/science.289.5484.1569; Keverne EB, 1999, SCIENCE, V286, P716, DOI 10.1126/science.286.5440.716; Lane RP, 2002, P NATL ACAD SCI USA, V99, P291, DOI 10.1073/pnas.012608399; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; MATZUK MM, 1992, NATURE, V360, P313, DOI 10.1038/360313a0; Mombaerts P, 1999, SCIENCE, V286, P707, DOI 10.1126/science.286.5440.707; Ogawa S, 2000, P NATL ACAD SCI USA, V97, P14737, DOI 10.1073/pnas.250473597; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; Rodriguez I, 2002, NAT NEUROSCI, V5, P134, DOI 10.1038/nn795; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; Sam M, 2001, NATURE, V412, P142, DOI 10.1038/35084137; Slotnick B, 2002, J NEUROSCI, V22, P4205, DOI 10.1523/JNEUROSCI.22-10-04205.2002; Sorensen PW, 1998, CURR OPIN NEUROBIOL, V8, P458, DOI 10.1016/S0959-4388(98)80032-9; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; Takigami S, 1999, NEUROSCI LETT, V272, P115, DOI 10.1016/S0304-3940(99)00582-0; Tirindelli R, 1998, TRENDS NEUROSCI, V21, P482, DOI 10.1016/S0166-2236(98)01274-0; WYSOCKI CJ, 1991, J STEROID BIOCHEM, V39, P661, DOI 10.1016/0960-0760(91)90265-7; WYSOCKI CJ, 1982, PHYSIOL BEHAV, V29, P315, DOI 10.1016/0031-9384(82)90021-X	30	259	281	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 5	2002	419	6902					70	74		10.1038/nature00955	http://dx.doi.org/10.1038/nature00955			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589YF	12214233				2022-12-24	WOS:000177788600038
J	Deary, IJ; Whiteman, MC; Pattie, A; Starr, JM; Hayward, C; Wright, AF; Carothers, A; Whalley, LJ				Deary, IJ; Whiteman, MC; Pattie, A; Starr, JM; Hayward, C; Wright, AF; Carothers, A; Whalley, LJ			Ageing - Cognitive change and the APOE&4 allele	NATURE			English	Article							APOLIPOPROTEIN-E; OLD-AGE		Univ Edinburgh, Dept Psychol, Edinburgh EH8 9JZ, Midlothian, Scotland; Royal Victoria Hosp, Dept Geriatr Med, Edinburgh EH4 2DN, Midlothian, Scotland; Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; Univ Aberdeen, Royal Cornhill Hosp, Clin Res Ctr, Dept Mental Hlth, Aberdeen AB25 2ZH, Scotland	University of Edinburgh; University of Edinburgh; University of Aberdeen	Deary, IJ (corresponding author), Univ Edinburgh, Dept Psychol, 7 George Sq, Edinburgh EH8 9JZ, Midlothian, Scotland.		Starr, John/C-8951-2011; Whiteman, Matthew/C-6079-2009; whalley, lawrence j/E-9019-2011; Deary, Ian J/C-6297-2009; Hayward, Caroline/M-8818-2016	Whiteman, Matthew/0000-0002-6583-6779; Deary, Ian J/0000-0002-1733-263X; Hayward, Caroline/0000-0002-9405-9550				Anstey K, 2000, GERONTOLOGY, V46, P163, DOI 10.1159/000022153; Breitner JCS, 2000, NEUROLOGY, V55, P161; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; Deary IJ, 2000, INTELLIGENCE, V28, P49, DOI 10.1016/S0160-2896(99)00031-8; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; ROBERTSON FW, 1985, ARTERIOSCLEROSIS, V5, P283, DOI 10.1161/01.ATV.5.3.283; Rose G., 1992, STRATEGY PREVENTIVE; Scottish Council for Research in Education, 1933, INT SCOTT CHILDR NAT; Slooter AJC, 1998, ARCH NEUROL-CHICAGO, V55, P964, DOI 10.1001/archneur.55.7.964; *US NAT RES COUNC, 2000, AG MIND; WENHAM PR, 1991, LANCET, V337, P1158, DOI 10.1016/0140-6736(91)92823-K	11	234	242	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 29	2002	418	6901					932	932		10.1038/418932a	http://dx.doi.org/10.1038/418932a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	588AP	12198535	Bronze			2022-12-24	WOS:000177677500032
J	Garattini, S; Bertele', V				Garattini, S; Bertele', V			Efficacy, safety, and cost of new anticancer drugs	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Mario Negri Inst Pharmacol Res, Regulatory Policy Lab, I-20157 Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Garattini, S (corresponding author), Mario Negri Inst Pharmacol Res, Regulatory Policy Lab, Via Eritrea 62, I-20157 Milan, Italy.	sgarattini@marionegri.it	Bertele, Vittorio/AAA-6461-2020; Garattini, Silvio/AAA-6390-2020	Bertele, Vittorio/0000-0002-0032-7033; Garattini, Silvio/0000-0003-0647-9297				Abe O, 1998, LANCET, V352, P930; Bailar JC, 1997, NEW ENGL J MED, V336, P1569, DOI 10.1056/NEJM199705293362206; Batchelor T, 2000, LANCET, V355, P1115, DOI 10.1016/S0140-6736(00)02055-9; Berrino F, 1998, EUR J CANCER, V34, P2139, DOI 10.1016/S0959-8049(98)00334-7; Clarke M, 1998, LANCET, V351, P1451; Coleman M P, 1999, Breast Cancer Res, V1, P22, DOI 10.1186/bcr8; Findlay B P, 1998, Cancer Prev Control, V2, P140; Friedberg M, 1999, JAMA-J AM MED ASSOC, V282, P1453, DOI 10.1001/jama.282.15.1453; Garattini S, 2001, LANCET, V358, P64, DOI 10.1016/S0140-6736(00)05258-2; HORTOBAGYI GN, 1997, DRUGS S4, V54, pS1; Levi F, 2000, EUR J CANCER, V36, P1965, DOI 10.1016/S0959-8049(00)00283-5; QUINN MJ, 2001, STUDIES MED POPULATI, V66, P206; White CA, 2001, ANNU REV MED, V52, P125, DOI 10.1146/annurev.med.52.1.125	13	73	75	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 3	2002	325	7358					269	271		10.1136/bmj.325.7358.269	http://dx.doi.org/10.1136/bmj.325.7358.269			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582FL	12153927	Green Published			2022-12-24	WOS:000177339000026
J	Haskell, JP; Ritchie, ME; Olff, H				Haskell, JP; Ritchie, ME; Olff, H			Fractal geometry predicts varying body size scaling relationships for mammal and bird home ranges	NATURE			English	Article							ECOLOGY; SCALES; LAWS	Scaling laws that describe complex interactions between organisms and their environment as a function of body size offer exciting potential for synthesis in biology(1-4). Home range size, or the area used by individual organisms, is a critical ecological variable that integrates behaviour, physiology and population density and strongly depends on organism size(5-7). Here we present a new model of home range-body size scaling based on fractal resource distributions, in which resource encounter rates are a function of body size. The model predicts no universally constant scaling exponent for home range, but defines a possible range of values set by geometric limits to resource density and distribution. The model unifies apparently conflicting earlier results and explains differences in scaling exponents among herbivorous and carnivorous mammals and birds(5-18). We apply the model to predict that home range increases with habitat fragmentation, and that the home ranges of larger species should be much more sensitive to habitat fragmentation than those of smaller species.	Utah State Univ, Coll Nat Resources, Logan, UT 84322 USA; Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA; Univ Wageningen & Res Ctr, Trop Natl Conservat & Vertebrate Ecol Grp, NL-6708 PD Wageningen, Netherlands	Utah System of Higher Education; Utah State University; Syracuse University; Wageningen University & Research	Haskell, JP (corresponding author), Utah State Univ, Coll Nat Resources, Logan, UT 84322 USA.	jhaskell@cc.usu.edu	Olff, Han/A-8516-2008	Olff, Han/0000-0003-2154-3576				ARMSTRONG JT, 1965, ECOLOGY, V46, P619, DOI 10.2307/1935001; BELOVSKY GE, 1987, VIABLE POPULATIONS C; Brown James H., 1998, P71; Calder WAI., 1996, SIZE FUNCTION LIFE H; DAMUTH J, 1981, BIOL J LINN SOC, V15, P185, DOI 10.1111/j.1095-8312.1981.tb00758.x; Dunning J.B., 2007, CRC HDB AVIAN BODY M; GOMPPER ME, 1991, OECOLOGIA, V87, P343, DOI 10.1007/BF00634589; HARESTAD AS, 1979, ECOLOGY, V60, P389, DOI 10.2307/1937667; HOLLING CS, 1992, ECOL MONOGR, V62, P447, DOI 10.2307/2937313; Kelt DA, 1999, ECOLOGY, V80, P337; KOTLIAR NB, 1990, OIKOS, V59, P253, DOI 10.2307/3545542; Kunin WE, 1998, SCIENCE, V281, P1513, DOI 10.1126/science.281.5382.1513; Lawler GF, 2001, MATH RES LETT, V8, P13; Lawton JH, 1999, OIKOS, V84, P177, DOI 10.2307/3546712; LINDSTEDT SL, 1986, ECOLOGY, V67, P413, DOI 10.2307/1938584; Mandelbrot B.B, 1982, FRACTAL GEOMETRY NAT; MCNAB BK, 1963, AM NAT, V97, P133, DOI 10.1086/282264; MILNE BT, 1992, AM NAT, V139, P32, DOI 10.1086/285312; Milne BT, 1997, WILDLIFE AND LANDSCAPE ECOLOGY, P32; OLFF H, 2001, LANDSCAPE URBAN PLAN, V858, P1; Owen-Smith RN, 1992, MEGAHERBIVORES INFLU; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; POOLE A, 1996, BIRDS N AM; REISS M, 1988, TRENDS ECOL EVOL, V3, P85, DOI 10.1016/0169-5347(88)90025-0; Ritchie ME, 1999, NATURE, V400, P557, DOI 10.1038/23010; Ritchie ME, 1998, EVOL ECOL, V12, P309, DOI 10.1023/A:1006552200746; SCHOENER TW, 1968, ECOLOGY, V49, P123, DOI 10.2307/1933567; SWIHART RK, 1988, ECOLOGY, V69, P393, DOI 10.2307/1940437; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; WITTING L, 1995, J THEOR BIOL, V177, P129, DOI 10.1006/jtbi.1995.0231	30	231	238	3	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 1	2002	418	6897					527	530		10.1038/nature00840	http://dx.doi.org/10.1038/nature00840			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579EE	12152078	Green Published			2022-12-24	WOS:000177162800039
J	Dzik-Jurasz, A; Domenig, C; George, M; Wolber, J; Padhani, A; Brown, G; Doran, S				Dzik-Jurasz, A; Domenig, C; George, M; Wolber, J; Padhani, A; Brown, G; Doran, S			Diffusion MRI for prediction of response of rectal cancer to chemoradiation	LANCET			English	Article								Prediction of tumour response before onset of treatment could have considerable clinical benefit. Since the apparent diffusion coefficient (ADC) of a tumour's water content can show the extent of necrosis, we looked for a possible correlation of ADC with response to treatment. We measured mean tumour water ADC before and after chemotherapy and chemoradiation in 14 patients, with locally advanced rectal cancer, with a quantitative magnetic resonance diffusion imaging sequence. We found a strong negative correlation between mean pretreatment tumour water ADC and percentage size change of tumours after chemotherapy (r=-0.67, p=0.01) and chemoradiation (r=-0.83, p=0.001). Persistence of low ADC in responders after chemotherapy could represent loss of a nonviable fraction of the treated tumour.	Royal Marsden NHS Trust, Inst Canc Res, UK Canc Res Clin Magnet Resonance Res Grp, Sutton SM2 5PT, Surrey, England; Univ Surrey, Dept Phys, Guildford GU2 5XH, Surrey, England; Mayday Univ Hosp, Dept Surg, Thornton Heath, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Surrey; Croydon University Hospital	Dzik-Jurasz, A (corresponding author), Royal Marsden NHS Trust, Inst Canc Res, UK Canc Res Clin Magnet Resonance Res Grp, Downs Rd, Sutton SM2 5PT, Surrey, England.	andrzej@icr.ac.uk	BROWN, GINA/F-8081-2012; Woelber, Johan/AFX-4559-2022	Brown, Gina/0000-0002-2336-622X; Padhani, Anwar/0000-0002-5830-5777				Chenevert TL, 2000, JNCI-J NATL CANCER I, V92, P2029, DOI 10.1093/jnci/92.24.2029; George ML, 2001, BRIT J SURG, V88, P1628, DOI 10.1046/j.0007-1323.2001.01947.x; Lemaire L, 1999, MAGN RESON MATER PHY, V8, P20; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; Wheeler-Kingshott CA, 2000, MAGN RESON MED, V44, P737, DOI 10.1002/1522-2594(200011)44:5<737::AID-MRM12>3.0.CO;2-T	5	370	393	0	17	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 27	2002	360	9329					307	308		10.1016/S0140-6736(02)09520-X	http://dx.doi.org/10.1016/S0140-6736(02)09520-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	578DT	12147376				2022-12-24	WOS:000177102700014
J	Lomvardas, S; Thanos, D				Lomvardas, S; Thanos, D			Modifying gene expression programs by altering core promoter chromatin architecture	CELL			English	Article							INTERFERON-BETA ENHANCEOSOME; TRANSCRIPTION FACTORS; IN-VITRO; BINDING; ACETYLATION; YEAST; HYPERACETYLATION; RECRUITMENT; NUCLEOSOMES; MECHANISM	Transcriptional activation of the IFN-beta gene in response to virus infection requires the assembly of an enhanceosome, which instructs a recruitment program of chromatin modifiers/remodelers and general transcription factors to the promoter. This program culminates with sliding of a nucleosome blocking the core promoter to a downstream position, a prerequisite for transcriptional activation. We show that delivery of this nucleosome to the same downstream position to create an accessible IFN-beta core promoter prior to enhanceosome assembly results in major changes in the gene expression program with regard to the temporal pattern and the signal specificity of the transcriptional response. Thus, the identity of a gene expression program is achieved and maintained by the dynamic interplay between specific enhanceosomes and specific local chromatin structure.	Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University	Thanos, D (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA.		Thanos, Dimitris/AAE-5720-2019	Lomvardas, Stavros/0000-0002-7668-3026	NIGMS NIH HHS [GM54605] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054605] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; DAVIDSON EH, 2001, GENOME REGULATORY SY; Deckert J, 2001, MOL CELL BIOL, V21, P2726, DOI 10.1128/MCB.21.8.2726-2735.2001; Falvo JV, 2000, MOL CELL BIOL, V20, P4814, DOI 10.1128/MCB.20.13.4814-4825.2000; Hassan AH, 2001, CELL, V104, P817, DOI 10.1016/S0092-8674(01)00279-3; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Kim TK, 1998, P NATL ACAD SCI USA, V95, P12191, DOI 10.1073/pnas.95.21.12191; Kim TK, 1997, MOL CELL, V1, P119, DOI 10.1016/S1097-2765(00)80013-1; Krebs JE, 2000, CELL, V102, P587, DOI 10.1016/S0092-8674(00)00081-7; Lomvardas S, 2001, CELL, V106, P685, DOI 10.1016/S0092-8674(01)00490-1; Merika M, 1998, MOL CELL, V1, P277, DOI 10.1016/S1097-2765(00)80028-3; Merika M, 2001, CURR OPIN GENET DEV, V11, P205, DOI 10.1016/S0959-437X(00)00180-5; Munshi N, 1998, MOL CELL, V2, P457, DOI 10.1016/S1097-2765(00)80145-8; Munshi N, 2001, SCIENCE, V293, P1133, DOI 10.1126/science.293.5532.1133; Parekh BS, 1999, MOL CELL, V3, P125, DOI 10.1016/S1097-2765(00)80181-1; Pilpel Y, 2001, NAT GENET, V29, P153, DOI 10.1038/ng724; Ptashne M., 2002, GENES SIGNALS; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Roebuck KA, 1999, J INTERF CYTOK RES, V19, P429, DOI 10.1089/107999099313866; SHRADER TE, 1989, P NATL ACAD SCI USA, V86, P7418, DOI 10.1073/pnas.86.19.7418; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; STRAKA C, 1991, EMBO J, V10, P361, DOI 10.1002/j.1460-2075.1991.tb07957.x; Struhl K, 1999, CELL, V98, P1, DOI 10.1016/S0092-8674(00)80599-1; Struhl K, 2001, SCIENCE, V293, P1054, DOI 10.1126/science.1064050; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987; VanLint C, 1996, GENE EXPRESSION, V5, P245; VERDIN E, 1993, EMBO J, V12, P3249, DOI 10.1002/j.1460-2075.1993.tb05994.x; Weinmann AS, 2002, GENE DEV, V16, P235, DOI 10.1101/gad.943102; Wyrick JJ, 1999, NATURE, V402, P418, DOI 10.1038/46567; Yie JM, 1999, P NATL ACAD SCI USA, V96, P13108, DOI 10.1073/pnas.96.23.13108	35	150	153	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 26	2002	110	2					261	271		10.1016/S0092-8674(02)00822-X	http://dx.doi.org/10.1016/S0092-8674(02)00822-X			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	578EV	12150933	Bronze			2022-12-24	WOS:000177105200013
J	Zhou, ZH; Zhang, FC				Zhou, ZH; Zhang, FC			A long-tailed, seed-eating bird from the Early Cretaceous of China	NATURE			English	Article							EVOLUTION; ORIGIN	The lacustrine deposits of the Yixian and Jiufotang Formations in the Early Cretaceous Jehol Group in the western Liaoning area of northeast China are well known for preserving feathered dinosaurs, primitive birds and mammals(1-3). Here we report a large basal bird, Jeholornis prima gen. et sp. nov., from the Jiufotang Formation. This bird is distinctively different from other known birds of the Early Cretaceous period in retaining a long skeletal tail with unexpected elongated prezygopophyses and chevrons, resembling that of dromaeosaurids(4-6), providing a further link between birds and non-avian theropods(7-8). Despite its basal position in early avian evolution, the advanced features of the pectoral girdle and the carpal trochlea of the carpometacarpus of Jeholornis indicate the capability of powerful flight. The dozens of beautifully preserved ovules of unknown plant taxa in the stomach represents direct evidence for seed-eating adaptation in birds of the Mesozoic era.	Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Zhou, ZH (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, POB 643, Beijing 100044, Peoples R China.	zhonghe@yeah.net						Chiappe LM, 1999, B AM MUS NAT HIST, P3; Elzanowski A, 2001, ACTA PALAEONTOL POL, V46, P519; Forster CA, 1998, SCIENCE, V279, P1915, DOI 10.1126/science.279.5358.1915; Hopson JA, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P211; HOU LH, 1995, NATURE, V377, P616, DOI 10.1038/377616a0; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Martin LD, 1998, NATURWISSENSCHAFTEN, V85, P286, DOI 10.1007/s001140050501; MCGOWAN C, 1984, NATURE, V315, P159; Norell M, 2002, NATURE, V416, P36, DOI 10.1038/416036a; Norell MA, 2001, NATURE, V409, P181, DOI 10.1038/35051563; Norell Mark A., 1997, American Museum Novitates, V3215, P1; Novas FE, 1997, NATURE, V387, P390, DOI 10.1038/387390a0; Ostrom J. H., 1969, Bulletin of the Peabody Museum of Natural History, VNo. 30, P1; Padian K, 1998, BIOL REV, V73, P1, DOI 10.1111/j.1469-185X.1997.tb00024.x; Sanz Jose L., 1995, American Museum Novitates, V3133, P1; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; Sun G, 2001, EARLY ANGIOSPERMS TH; Wang YQ, 2001, SCIENCE, V294, P357, DOI 10.1126/science.1063830; Wellnhofer Peter, 1993, Archaeopteryx, V11, P1; Wellnhofer Peter, 1992, Natural History Museum of Los Angeles County Science Series, V36, P3; Xu X, 1999, NATURE, V401, P262, DOI 10.1038/45769; Xu X, 2000, NATURE, V408, P705, DOI 10.1038/35047056; Xu X, 2001, CAN J EARTH SCI, V38, P1739, DOI 10.1139/e01-082; Zhang FC, 2000, SCIENCE, V290, P1955, DOI 10.1126/science.290.5498.1955; Zhang FC, 2001, CHINESE SCI BULL, V46, P945, DOI 10.1007/BF02900473; Zhou ZH, 2001, CHINESE SCI BULL, V46, P1258, DOI 10.1007/BF03184320; Zhou ZH, 2002, NATURWISSENSCHAFTEN, V89, P34, DOI 10.1007/s00114-001-0276-9; Zhou ZH, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P237	28	190	226	4	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 25	2002	418	6896					405	409		10.1038/nature00930	http://dx.doi.org/10.1038/nature00930			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576MU	12140555				2022-12-24	WOS:000177009700035
J	Unnasch, TR				Unnasch, TR			River blindness	LANCET			English	Editorial Material							ONCHOCERCA-VOLVULUS; IVERMECTIN TREATMENT		Univ Alabama, Div Geog Med, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Unnasch, TR (corresponding author), Univ Alabama, Div Geog Med, Birmingham, AL 35294 USA.							CUPP EW, 1992, AM J TROP MED HYG, V47, P170, DOI 10.4269/ajtmh.1992.47.170; GREENE BM, 1992, J INFECT DIS, V166, P15, DOI 10.1093/infdis/166.1.15; Hoerauf A, 2001, LANCET, V357, P1415, DOI 10.1016/S0140-6736(00)04581-5; NEWLAND HS, 1988, BRIT J OPHTHALMOL, V72, P561, DOI 10.1136/bjo.72.8.561; Richards FO, 2001, TRENDS PARASITOL, V17, P558, DOI 10.1016/S1471-4922(01)02112-2	5	4	5	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 20	2002	360	9328					182	183		10.1016/S0140-6736(02)09498-9	http://dx.doi.org/10.1016/S0140-6736(02)09498-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	576DX	12133647				2022-12-24	WOS:000176988500002
J	Petersen-Mahrt, SK; Harris, RS; Neuberger, MS				Petersen-Mahrt, SK; Harris, RS; Neuberger, MS			AID mutates E-coli suggesting a DNA deamination mechanism for antibody diversification	NATURE			English	Article							CLASS-SWITCH RECOMBINATION; SOMATIC HYPERMUTATION; ESCHERICHIA-COLI; ENDONUCLEASE-V; MUTAGENESIS; DEFICIENCY; CONVERSION; SEQUENCES; MUTATIONS; REGION	After gene rearrangement, immunoglobulin variable genes are diversified by somatic hypermutation or gene conversion, whereas the constant region is altered by class-switch recombination. All three processes depend on activation-induced cytidine deaminase (AID)(1-7), a B-cell-specific protein that has been proposed (because of sequence homology 1) to function by RNA editing. But indications that the three gene diversification processes might be initiated by a common type of DNA lesion(8-11), together with the proposal that there is a first phase of hypermutation that targets dC/dG(12), suggested to us that AID may function directly at dC/dG pairs. Here we show that expression of AID in Escherichia coli gives a mutator phenotype that yields nucleotide transitions at dC/dG in a context-dependent manner. Mutation triggered by AID is enhanced by a deficiency of uracil-DNA glycosylase, which indicates that AID functions by deaminating dC residues in DNA. We propose that diversification of functional immunoglobulin genes is triggered by AID-mediated deamination of dC residues in the immunoglobulin locus with the outcome-that is, hypermutation phases 1 and 2, gene conversion or switch recombination-dependent on the way in which the initiating dU/dG lesion is resolved.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Neuberger, MS (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.							Arakawa H, 2002, SCIENCE, V295, P1301, DOI 10.1126/science.1067308; BETZ AG, 1994, CELL, V77, P239, DOI 10.1016/0092-8674(94)90316-6; Chen XC, 2001, P NATL ACAD SCI USA, V98, P13860, DOI 10.1073/pnas.241524898; Ehrenstein MR, 1999, EMBO J, V18, P3484, DOI 10.1093/emboj/18.12.3484; Harris RS, 2002, CURR BIOL, V12, P435, DOI 10.1016/S0960-9822(02)00717-0; He B, 2000, MUTAT RES-DNA REPAIR, V459, P109, DOI 10.1016/S0921-8777(99)00063-4; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Jin DJ, 1996, METHOD ENZYMOL, V273, P300; Lindahl T, 2000, MUTAT RES-REV MUTAT, V462, P129, DOI 10.1016/S1383-5742(00)00024-7; MAIZELS N, 1995, CELL, V83, P9, DOI 10.1016/0092-8674(95)90227-9; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; Martin A, 2002, NATURE, V415, P802, DOI 10.1038/nature714; Miller J.H., 1972, EXPT MOL GENETICS; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Navaratnam N, 1998, J MOL BIOL, V275, P695, DOI 10.1006/jmbi.1997.1506; Okazaki IM, 2002, NATURE, V416, P340, DOI 10.1038/nature727; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Rada C, 1998, IMMUNITY, V9, P135, DOI 10.1016/S1074-7613(00)80595-6; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Rogozin IB, 2001, NAT IMMUNOL, V2, P530, DOI 10.1038/88732; Sale JE, 1998, IMMUNITY, V9, P859, DOI 10.1016/S1074-7613(00)80651-2; Sale JE, 2001, NATURE, V412, P921, DOI 10.1038/35091100; Schouten KA, 1999, MUTAT RES-DNA REPAIR, V435, P245, DOI 10.1016/S0921-8777(99)00049-X; SELKER EU, 1990, ANNU REV GENET, V24, P579, DOI 10.1146/annurev.ge.24.120190.003051; SHEN JC, 1992, CELL, V71, P1073, DOI 10.1016/S0092-8674(05)80057-1; Weill JC, 1996, IMMUNOL TODAY, V17, P92, DOI 10.1016/0167-5699(96)80586-X; Wiesendanger M, 2000, J EXP MED, V191, P579, DOI 10.1084/jem.191.3.579; Zeng XM, 2001, NAT IMMUNOL, V2, P537, DOI 10.1038/88740	29	701	717	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 4	2002	418	6893					99	103		10.1038/nature00862	http://dx.doi.org/10.1038/nature00862			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569JL	12097915				2022-12-24	WOS:000176599200047
J	Thomas, WE; Trintchina, E; Forero, M; Vogel, V; Sokurenko, EV				Thomas, WE; Trintchina, E; Forero, M; Vogel, V; Sokurenko, EV			Bacterial adhesion to target cells enhanced by shear force	CELL			English	Article							STAPHYLOCOCCUS-AUREUS ADHESION; RECEPTOR-LIGAND BONDS; COLI TYPE-1 FIMBRIAE; ESCHERICHIA-COLI; MOLECULAR-DYNAMICS; FIMH ADHESIN; PROTEINS; GENES; SPECTROSCOPY; KINETICS	Surface adhesion of bacteria generally occurs in the presence of shear stress, and the lifetime of receptor bonds is expected to be shortened in the presence of external force. However, by using Escherichia coli expressing the lectin-like adhesin FimH and guinea pig erythrocytes in flow chamber experiments, we show that bacterial attachment to target cells switches from loose to firm upon a 10-fold increase in shear stress applied. Steered molecular dynamics simulations of tertiary structure of the FimH receptor binding domain and subsequent site-directed mutagenesis studies indicate that shear-enhancement of the FimH-receptor interactions involves extention of the interdomain linker chain under mechanical force. The ability of FimH to function as a force sensor provides a molecular mechanism for discrimination between surface-exposed and soluble receptor molecules.	Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; Univ Washington, Dept Phys, Seattle, WA 98195 USA; Univ Washington, Ctr Nanotechnol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Sokurenko, EV (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	evs@u.washington.edu	Vogel, Viola/O-8025-2015; MLSC, Colletion/B-3912-2013	Vogel, Viola/0000-0003-2898-7671; Forero-Shelton, Manu/0000-0002-7989-0311; Thomas, Wendy/0000-0001-8602-0819	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045820] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK053369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049063] Funding Source: NIH RePORTER; NHGRI NIH HHS [1 P50 HG02360-01] Funding Source: Medline; NIAID NIH HHS [R01 AI45820] Funding Source: Medline; NIDDK NIH HHS [P01 DK53369] Funding Source: Medline; NIGMS NIH HHS [5R01 GM49063] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAHAM SN, 1987, J BACTERIOL, V169, P5530, DOI 10.1128/jb.169.12.5530-5536.1987; Alon R, 1997, J CELL BIOL, V138, P1169, DOI 10.1083/jcb.138.5.1169; BEACHEY EH, 1981, J INFECT DIS, V143, P325, DOI 10.1093/infdis/143.3.325; BECK R, 1994, NUCLEIC ACIDS RES, V22, P886, DOI 10.1093/nar/22.5.886; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; BLOCH CA, 1992, MOL MICROBIOL, V6, P697, DOI 10.1111/j.1365-2958.1992.tb01518.x; BRINTON CC, 1965, T NEW YORK ACAD SCI, V27, P1003, DOI 10.1111/j.2164-0947.1965.tb02342.x; BROOKS DE, 1983, J GEN MICROBIOL, V129, P3661; BROOKS DE, 1983, ANN NY ACAD SCI, V416, P319, DOI 10.1111/j.1749-6632.1983.tb35196.x; BROOKS DE, 1989, INFECT IMMUN, V57, P377, DOI 10.1128/IAI.57.2.377-383.1989; Celikel R, 2000, NAT STRUCT BIOL, V7, P881; Chen SQ, 2001, P NATL ACAD SCI USA, V98, P950, DOI 10.1073/pnas.98.3.950; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; CHRISTERSSON CE, 1988, SCAND J DENT RES, V96, P91; Dickinson RB, 1997, J BIOMED MATER RES, V36, P152, DOI 10.1002/(SICI)1097-4636(199708)36:2<152::AID-JBM3>3.0.CO;2-J; DICKINSON RB, 1995, INFECT IMMUN, V63, P3143, DOI 10.1128/IAI.63.8.3143-3150.1995; Evans EB, 1999, BIOPHYS CHEM, V82, P83, DOI 10.1016/S0301-4622(99)00108-8; GIBBONS RJ, 1984, J DENT RES, V63, P378, DOI 10.1177/00220345840630030401; HANSON MS, 1988, J BACTERIOL, V170, P3350, DOI 10.1128/jb.170.8.3350-3358.1988; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Isralewitz B, 2001, CURR OPIN STRUC BIOL, V11, P224, DOI 10.1016/S0959-440X(00)00194-9; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; KLEMM P, 1987, MOL GEN GENET, V208, P439, DOI 10.1007/BF00328136; Krammer A, 2002, MATRIX BIOL, V21, P139, DOI 10.1016/S0945-053X(01)00197-4; Li ZJ, 2000, BIOTECHNOL PROGR, V16, P1086, DOI 10.1021/bp000117r; Marchese P, 1999, P NATL ACAD SCI USA, V96, P7837, DOI 10.1073/pnas.96.14.7837; Merkel R, 1999, NATURE, V397, P50, DOI 10.1038/16219; Mohamed N, 2000, BIOTECHNOL BIOENG, V68, P628, DOI 10.1002/(SICI)1097-0290(20000620)68:6<628::AID-BIT5>3.0.CO;2-D; Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x; PRATTTERPSTRA IH, 1987, J GEN MICROBIOL, V133, P3199; Schembri MA, 2000, INFECT IMMUN, V68, P2638, DOI 10.1128/IAI.68.5.2638-2646.2000; Shive MS, 1999, J BIOMED MATER RES, V46, P511, DOI 10.1002/(SICI)1097-4636(19990915)46:4<511::AID-JBM9>3.0.CO;2-M; Sokurenko EV, 1997, J BIOL CHEM, V272, P17880, DOI 10.1074/jbc.272.28.17880; SOKURENKO EV, 1995, J BACTERIOL, V177, P3680, DOI 10.1128/jb.177.13.3680-3686.1995; Sokurenko EV, 1998, P NATL ACAD SCI USA, V95, P8922, DOI 10.1073/pnas.95.15.8922; Sokurenko EV, 2001, MOL MICROBIOL, V41, P675, DOI 10.1046/j.1365-2958.2001.02545.x; SOWDHAMINI R, 1989, PROTEIN ENG, V3, P95, DOI 10.1093/protein/3.2.95; Vogel V, 2001, TRENDS BIOTECHNOL, V19, P416, DOI 10.1016/S0167-7799(01)01737-1; WANG IW, 1995, J BIOMED MATER RES, V29, P485, DOI 10.1002/jbm.820290408; Wang K, 2001, PROG BIOPHYS MOL BIO, V77, P1, DOI 10.1016/S0079-6107(01)00009-8	40	431	443	1	108	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 28	2002	109	7					913	923		10.1016/S0092-8674(02)00796-1	http://dx.doi.org/10.1016/S0092-8674(02)00796-1			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	570KJ	12110187	Bronze			2022-12-24	WOS:000176657200013
J	Fernandez-Sola, J; Nicolas, JM; Oriola, J; Sacanella, E; Estruch, R; Rubin, E; Urbano-Marquez, A				Fernandez-Sola, J; Nicolas, JM; Oriola, J; Sacanella, E; Estruch, R; Rubin, E; Urbano-Marquez, A			Angiotensin-converting enzyme gene polymorphism is associated with vulnerability to alcoholic cardiomyopathy	ANNALS OF INTERNAL MEDICINE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; IDIOPATHIC DILATED CARDIOMYOPATHY; DELETION POLYMORPHISM; ESSENTIAL-HYPERTENSION; MYOCARDIAL-INFARCTION; I/D POLYMORPHISM; BLOOD-PRESSURE; HEART-DISEASE; ACE-GENE; PERFORMANCE	Background: Chronic alcohol abuse has a dose-dependent toxic effect on the myocardium, leading to alcoholic cardiomyopathy. The fact,that only a minority of persons with chronic alcoholism have this condition suggests the possibility of a genetic vulnerability. In this context, polymorphism of the angiotensin-converting enzyme (ACE) gene has been implicated in cardiac dysfunction. Objective: To compare the ACE genotypes of alcoholic persons who have cardiomyopathy with those of comparable alcohol abusers who have normal cardiac function. Design: Case-control study over a 2-year period. Setting: An academic tertiary referral hospital in Barcelona, Spain. Patients: 30 alcoholic men with symptomatic cardiomyopathy and 27 alcoholic men with normal cardiac function. Measurements: Ethanol intake, cardiac status, left ventricular ejection fraction (LVEF), and ACE gene polymorphism. Results: The DD ACE genotype was present in 57% of alcoholic persons with an LVEF less than 0.50 and in 7% of those with normal cardiac function. Compared with persons who had an I allele, the odds ratio for development of left ventricular dysfunction in alcoholic persons with the DD genotype was 16.4. Conclusions: Vulnerability to cardiomyopathy among chronic alcohol abusers is partially genetic and is related to presence of the ACE DD genotype. This finding demonstrates genetic susceptibility to alcohol-induced myocardial damage.	Jefferson Med Coll, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA	Jefferson University	Rubin, E (corresponding author), Jefferson Med Coll, Dept Pathol Anat & Cell Biol, 1020 Locust St,Suite 279, Philadelphia, PA 19107 USA.	emanuel.rubin@mail.tju.edu	SOLA, JOAQUIM FERNANDEZ/K-3991-2019	SOLA, JOAQUIM FERNANDEZ/0000-0002-3218-0582				American Psychological Association, 1994, DIAGN STAT MAN MENT, V4th; Barley J, 1996, J HUM HYPERTENS, V10, P31; CAMBIEN F, 1992, NATURE, V359, P641, DOI 10.1038/359641a0; Candy GP, 1999, AM J CARDIOL, V83, P740, DOI 10.1016/S0002-9149(98)00981-3; Cheitlin MD, 1997, CIRCULATION, V95, P1686; Dellgren G, 1999, AM J CARDIOL, V84, P909, DOI 10.1016/S0002-9149(99)00464-6; Dostal DE, 1999, CIRC RES, V85, P643, DOI 10.1161/01.RES.85.7.643; Fernandez-Llama P, 1998, KIDNEY INT, V53, P1743, DOI 10.1046/j.1523-1755.1998.00946.x; FernandezSola J, 1997, ADDICT BIOL, V2, P9, DOI 10.1080/13556219772822; FernandezSola J, 1997, AM J CARDIOL, V80, P481, DOI 10.1016/S0002-9149(97)00399-8; FOY A, 1988, ALCOHOL CLIN EXP RES, V12, P360, DOI 10.1111/j.1530-0277.1988.tb00208.x; Gambaro G, 2000, LANCET, V355, P308, DOI 10.1016/S0140-6736(99)07202-5; GOLDMAN L, 1981, CIRCULATION, V64, P1227, DOI 10.1161/01.CIR.64.6.1227; INNIS MA, 1989, PCR PROTOCOLS GUIDE, P146; Kim HS, 2000, INT J CARDIOL, V72, P151, DOI 10.1016/S0167-5273(99)00184-9; Kohno M, 1999, AM J MED, V106, P544, DOI 10.1016/S0002-9343(99)00067-4; Ledru F, 1998, AM J CARDIOL, V82, P160, DOI 10.1016/S0002-9149(98)00304-X; LINDPAINTNER K, 1995, NEW ENGL J MED, V332, P706, DOI 10.1056/NEJM199503163321103; Lopez-Haldon J, 1999, MED CLIN-BARCELONA, V113, P161; Mondorf UF, 1998, AM J HYPERTENS, V11, P174, DOI 10.1016/S0895-7061(97)00402-0; Montgomery HE, 1998, NATURE, V393, P221, DOI 10.1038/30374; Morris BJ, 1996, CLIN EXP PHARMACOL P, V23, P1; Nakahara K, 2000, CIRCULATION, V101, P148, DOI 10.1161/01.CIR.101.2.148; NICOLAS JM, 1993, ALCOHOL ALCOHOLISM, V28, P551; Perticone F, 1999, CARDIOVASC RES, V43, P192, DOI 10.1016/S0008-6363(99)00055-3; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; RAYNOLDS MV, 1993, LANCET, V342, P1073, DOI 10.1016/0140-6736(93)92061-W; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; SCHUNKERT H, 1994, NEW ENGL J MED, V330, P1634, DOI 10.1056/NEJM199406093302302; Simko F, 1999, PHYSIOL RES, V48, P1; Staessen J A, 1997, J Cardiovasc Risk, V4, P401, DOI 10.1097/00043798-199710000-00013; URBANOMARQUEZ A, 1995, JAMA-J AM MED ASSOC, V274, P149, DOI 10.1001/jama.274.2.149; URBANOMARQUEZ A, 1989, NEW ENGL J MED, V320, P409, DOI 10.1056/NEJM198902163200701; VRIES JHM, 1999, HLTH ISSUES RELATED, P27; Williams AG, 2000, NATURE, V403, P614, DOI 10.1038/35001141; WOODROW JC, 1994, LANCET, V343, P353, DOI 10.1016/S0140-6736(94)91189-4	36	43	45	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 3	2002	137	5	1				321	326		10.7326/0003-4819-137-5_Part_1-200209030-00007	http://dx.doi.org/10.7326/0003-4819-137-5_Part_1-200209030-00007			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	591DZ	12204015				2022-12-24	WOS:000177865600003
J	Mott, JA; Wolfe, MI; Alverson, CJ; Macdonald, SC; Bailey, CR; Ball, LB; Moorman, JE; Somers, JH; Mannino, DM; Redd, SC				Mott, JA; Wolfe, MI; Alverson, CJ; Macdonald, SC; Bailey, CR; Ball, LB; Moorman, JE; Somers, JH; Mannino, DM; Redd, SC			National vehicle emissions policies and practices and declining US carbon monoxide-related mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; EXHAUST; DEATHS	Context Carbon monoxide (CO) has been reported to contribute to more than 2000 poisoning deaths per year in the United States. Objectives To evaluate the influence of national vehicle emissions policies and practices on CO-related mortality and to describe 31 years (1968-1998) of CO-related deaths in the United States. Design and Setting Longitudinal trend analysis using computerized death data from the Centers for Disease Control and Prevention, US Census Bureau population data, and annual CO emissions estimates for light-duty vehicles provided by the US Environmental Protection Agency. Main Outcome Measure All deaths in the US for which non-fire-related CO poisoning was an underlying or contributing condition, classified by intent and mechanism of death. Negative binomial regression was used to incorporate every year of data into estimated percentage changes in CO emissions and mortality rates over time. Results During 1968-1998, CO-related mortality rates in the United States declined from 20.2 deaths to 8.8 deaths per 1 million person-years (an estimated decline of 57.8%; 95% confidence interval [CI], -62.4% to -52.6%). Following the introduction of the catalytic converter to automobiles in 1975, CO emissions from automobiles decreased by an estimated 76.3% of 1975 levels (95% Cl, -82.0% to -70.4%) and unintentional motor vehicle-related CO death rates declined from 4.0 to 0.9 deaths per 1 million person-years (an estimated decline of 81.3%; 95% Cl, -84.8% to -77.0%). Rates of motor vehicle-related CO suicides declined from 10.0 to 4.9 deaths per 1 million person-years (an estimated decline of 43.3%; 95% Cl, -57.5% to -24.3%). During 1975-1996, an annual decrease of 10 g/mile of estimated CO emissions from automobiles was associated with a 21.3% decrease (95% Cl, -24.2% to -18.4%) in the annual unintentional motor vehicle-related CO death rate and a 5.9% decrease (95% CI, -10.0% to -1.8%) in the annual rate of motor vehicle-related CO suicides. Conclusions If rates of unintentional CO-related deaths had remained at pre-1975 levels, an estimated additional 11700 motor vehicle-related CO poisoning deaths might have occurred by 1998. This decline in death rates appears to be a public health benefit associated with the enforcement of standards set by the 1970 Clean Air Act.	Ctr Dis Control & Prevent, Air Pollut & Resp Hlth Branch, Natl Ctr Environm Hlth, Atlanta, GA 30333 USA; Washington State Dept Hlth, Off Epidemiol, Olympia, WA USA; US EPA, Off Transportat & Air Qual, Ann Arbor, MI USA; Ctr Dis Control & Prevent, Parasit Dis Epidemiol Branch, Natl Ctr Infect Dis, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; United States Environmental Protection Agency; Centers for Disease Control & Prevention - USA	Mott, JA (corresponding author), Ctr Dis Control & Prevent, Air Pollut & Resp Hlth Branch, Natl Ctr Environm Hlth, 1600 Clifton Rd NE,MS E-17, Atlanta, GA 30333 USA.	zud9@cdc.gov		Mannino, David/0000-0003-3646-7828				*AM AUT MAN ASS, 1985, MOT VEH FACTS FIG 19; *AM AUT MAN ASS, 1998, MOT VEH FACTS FIG 19; Amos T, 2001, PSYCHOL MED, V31, P935, DOI 10.1017/S0033291701003920; COBB N, 1991, JAMA-J AM MED ASSOC, V266, P659, DOI 10.1001/jama.266.5.659; Cummings P, 1999, JAMA-J AM MED ASSOC, V281, P2198, DOI 10.1001/jama.281.23.2198; Easley RB, 2000, SOUTH MED J, V93, P430, DOI 10.1097/00007611-200004000-00016; *FED HIGHW ADM, 1999, C P FED HIGHW ADM; HAMPSON NB, 2000, CARBON MONOXIDE TOXI, P193; Krenzelok EP, 1996, AM J EMERG MED, V14, P484, DOI 10.1016/S0735-6757(96)90159-X; Kwor R., 2000, CARBON MONOXIDE TOXI, P61; LANDERS D, 1981, WESTERN J MED, V135, P360; LESTER D, 1989, ACCIDENT ANAL PREV, V21, P191, DOI 10.1016/0001-4575(89)90086-9; MAH JC, 2002, NONFIRE CARBON MONOX; Marr LC, 1998, J AIR WASTE MANAGE, V48, P899, DOI 10.1080/10473289.1998.10463745; MATHIEUNOLF M, 2000, CARBON MONOXIDE TOXI, P291; *NAT CTR HLTH STAT, 1982, PUBL US DAT FIL DOC; National Center for Health Statistics, 1996, PUBL US DAT FIL DOC; PIRKLE JL, 1994, JAMA-J AM MED ASSOC, V272, P284, DOI 10.1001/jama.272.4.284; Raub, 2000, CARBON MONOXIDE TOXI, P83; Riveros HG, 1998, J AIR WASTE MANAGE, V48, P459, DOI 10.1080/10473289.1998.10463696; Routley VH, 1998, MED J AUSTRALIA, V168, P65, DOI 10.5694/j.1326-5377.1998.tb126713.x; SHELEF M, 1994, SCI TOTAL ENVIRON, V147, P93, DOI 10.1016/0048-9697(94)90224-0; Shepherd G, 1998, ARCH PEDIAT ADOL MED, V152, P1181; *US CONS PROD SAF, 1993, WHAT YOU SHOULD KNOW; *US EPA, 1999, 420P99015 US EPA; *US EPA, 1998, OMS12EPA400F92014 OF; *WHO, 1967, MAN INT STAT CLASS D; WHO (World Health Organization), 1977, MAN INT STAT CLASS D; 2000, MMWR MORB MORTAL WKL, V49, P105	29	107	110	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 28	2002	288	8					988	995		10.1001/jama.288.8.988	http://dx.doi.org/10.1001/jama.288.8.988			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587RM	12190369	Bronze			2022-12-24	WOS:000177656400024
J	Euler, T; Detwiler, PB; Denk, W				Euler, T; Detwiler, PB; Denk, W			Directionally selective calcium signals in dendrites of starburst amacrine cells	NATURE			English	Article							RETINAL GANGLION-CELLS; RABBIT RETINA; CHOLINERGIC NEURONS; ACETYLCHOLINE; GABA; RECEPTORS; MICROSCOPY; RELEASE; IMMUNOREACTIVITY; IDENTIFICATION	The detection of image motion is fundamental to vision. In many species, unique classes of retinal ganglion cells selectively respond to visual stimuli that move in specific directions. It is not known which retinal cell first performs the neural computations that give rise to directional selectivity in the ganglion cell. A prominent candidate has been an interneuron called the 'starburst amacrine cell'. Using two-photon optical recordings of intracellular calcium concentration, here we find that individual dendritic branches of starburst cells act as independent computation modules. Dendritic calcium signals, but not somatic membrane voltage, are directionally selective for stimuli that move centrifugally from the cell soma. This demonstrates that direction selectivity is computed locally in dendritic branches at a stage before ganglion cells.	Max Planck Inst Med Res, D-69120 Heidelberg, Germany; Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	Max Planck Society; University of Washington; University of Washington Seattle	Euler, T (corresponding author), Max Planck Inst Med Res, Jahnstr 29, D-69120 Heidelberg, Germany.		denk, winfried/I-6627-2012	Detwiler, Peter/0000-0003-3910-2023; Euler, Thomas/0000-0002-4567-6966				ARIEL M, 1982, J PHYSIOL-LONDON, V324, P161, DOI 10.1113/jphysiol.1982.sp014105; BARLOW HB, 1964, J PHYSIOL-LONDON, V173, P377, DOI 10.1113/jphysiol.1964.sp007463; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; BLOOMFIELD SA, 1992, J NEUROPHYSIOL, V68, P711, DOI 10.1152/jn.1992.68.3.711; Borg-Graham L.J., 1992, SINGLE NEURON COMPUT, P347; Borg-Graham LJ, 2001, NAT NEUROSCI, V4, P176, DOI 10.1038/84007; BORST A, 1990, P NATL ACAD SCI USA, V87, P9363, DOI 10.1073/pnas.87.23.9363; BRANDON C, 1987, BRAIN RES, V426, P119, DOI 10.1016/0006-8993(87)90431-8; BRECHA N, 1988, P NATL ACAD SCI USA, V85, P6187, DOI 10.1073/pnas.85.16.6187; Denk W, 1999, P NATL ACAD SCI USA, V96, P7035, DOI 10.1073/pnas.96.12.7035; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; EHINGER B, 1994, GLIA, V10, P40, DOI 10.1002/glia.440100106; Euler T, 2001, CURR OPIN NEUROBIOL, V11, P415, DOI 10.1016/S0959-4388(00)00228-2; FAMIGLIETTI EV, 1991, J COMP NEUROL, V309, P40, DOI 10.1002/cne.903090105; Grzywacz NM, 1997, VISUAL NEUROSCI, V14, P39, DOI 10.1017/S0952523800008749; Grzywacz NM, 1998, VISUAL NEUROSCI, V15, P1119, DOI 10.1017/S0952523898156109; He SG, 1997, NATURE, V389, P378, DOI 10.1038/38723; Keyser KT, 2000, VISUAL NEUROSCI, V17, P743, DOI 10.1017/S095252380017508X; Kittila CA, 1997, J NEUROPHYSIOL, V77, P675, DOI 10.1152/jn.1997.77.2.675; LINN DM, 1992, VISUAL NEUROSCI, V8, P97, DOI 10.1017/S0952523800009263; MASLAND RH, 1984, PROC R SOC SER B-BIO, V223, P121, DOI 10.1098/rspb.1984.0086; MASLAND RH, 1979, J CELL BIOL, V83, P159, DOI 10.1083/jcb.83.1.159; MASLAND RH, 1984, PROC R SOC SER B-BIO, V223, P79, DOI 10.1098/rspb.1984.0084; Massey SC, 1997, VISUAL NEUROSCI, V14, P939, DOI 10.1017/S0952523800011652; MILLER RF, 1983, P NATL ACAD SCI-BIOL, V80, P3069, DOI 10.1073/pnas.80.10.3069; Miller RF, 2001, J COMP NEUROL, V437, P129, DOI 10.1002/cne.1275; OMALLEY DM, 1992, J NEUROSCI, V12, P1394; PAN ZH, 1995, J NEUROSCI, V15, P2668; Peters BN, 1996, J NEUROPHYSIOL, V75, P469, DOI 10.1152/jn.1996.75.1.469; POZNANSKI RR, 1992, B MATH BIOL, V54, P905; REICHARDT W, 1961, SENS COMMUN, P377; SCHWARTZ EA, 1987, SCIENCE, V238, P350, DOI 10.1126/science.2443977; TAUCHI M, 1984, PROC R SOC SER B-BIO, V223, P101, DOI 10.1098/rspb.1984.0085; Taylor WR, 2000, SCIENCE, V289, P2347, DOI 10.1126/science.289.5488.2347; TAYLOR WR, 1995, EUR J NEUROSCI, V7, P2308, DOI 10.1111/j.1460-9568.1995.tb00652.x; TAYLOR WR, 1995, EUR J NEUROSCI, V7, P2300; Vaney D.I., 2001, MOTION VISION COMPUT; VANEY DI, 1988, BRAIN RES, V438, P369, DOI 10.1016/0006-8993(88)91366-2; VANEY DI, 1989, NEUROBIOLOGY INNER R, P157; Velte TJ, 1997, VISUAL NEUROSCI, V14, P1073, DOI 10.1017/S0952523800011780; Wassle H, 1998, VISION RES, V38, P1411, DOI 10.1016/s0042-6989(97)00300-3; WYATT HJ, 1976, SCIENCE, V191, P204, DOI 10.1126/science.1857; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6; ZHOU ZJ, 1995, J NEUROSCI, V15, P5334	45	402	408	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 22	2002	418	6900					845	852		10.1038/nature00931	http://dx.doi.org/10.1038/nature00931			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585YR	12192402				2022-12-24	WOS:000177555600030
J	Ganzini, L; Harvath, TA; Jackson, A; Goy, ER; Miller, LL; Delorit, MA				Ganzini, L; Harvath, TA; Jackson, A; Goy, ER; Miller, LL; Delorit, MA			Experiences of Oregon nurses and social workers with hospice patients who requested assistance with suicide	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TERMINALLY ILL PATIENTS; DEATH; EUTHANASIA; DESIRE; ATTITUDES	Background Oregon's 1997 Death with Dignity Act legalizes physician-assisted suicide. To date, information about patients who have requested this option has come from surveys of physicians. Although 78 percent of the 91 Oregonians who have died by assisted suicide were enrolled in hospice programs, there is little information about the experiences of hospice practitioners with these patients. Methods In 2001, we mailed a questionnaire to all hospice nurses and social workers in Oregon. Results Of 545 eligible hospice nurses and social workers, 397 (73 percent) returned the survey, including 71 percent of nurses and 78 percent of social workers. Since November 1997,179 of the respondents (45 percent) had cared for a patient who requested assistance with suicide. Hospice nurses reported on 82 patients who had received prescriptions for lethal medication. Ninety-eight percent of the nurses had discussed the request with a coworker, and 77 percent of the requests had been presented at a hospice interdisciplinary conference on patient care. A very important reason for the request was to control the circumstances of death. The least important reasons included depression, lack of social support, and fear of being a financial drain on family members. Although the patients were concerned about burdening others, only 11 percent of hospice nurses rated their family caregivers as more burdened than family caregivers for other hospice patients. Conclusions Since assisted suicide was legalized in Oregon, many hospice nurses and social workers have provided care for a patient who requested assistance with suicide. They rated desire for control as a very important reason for these requests.	Vet Affairs Med Ctr, Div Mental Hlth, Portland, OR 97207 USA; Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR USA; Oregon Hlth & Sci Univ, Sch Nursing, Portland, OR USA; Oregon Hospice Assoc, Portland, OR USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Oregon Health & Science University; Oregon Health & Science University	Ganzini, L (corresponding author), Vet Affairs Med Ctr, Div Mental Hlth, P3MHDC,POB 1034, Portland, OR 97207 USA.		Harvath, Theresa/L-1115-2019					Breitbart W, 1996, AM J PSYCHIAT, V153, P238; Breitbart W, 2000, JAMA-J AM MED ASSOC, V284, P2907, DOI 10.1001/jama.284.22.2907; BROWN JH, 1986, AM J PSYCHIAT, V143, P208; Chin AE, 1999, NEW ENGL J MED, V340, P577, DOI 10.1056/NEJM199902183400724; CHOCHINOV HM, 1995, AM J PSYCHIAT, V152, P1185; DANIEL WW, 1999, BIOSTATISTICS FDN AN; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V284, P2460, DOI 10.1001/jama.284.19.2460; Foley K, 1999, HASTINGS CENT REP, V29, P37, DOI 10.2307/3528194; Ganzini L, 2000, NEW ENGL J MED, V342, P1538; Ganzini L, 2000, NEW ENGL J MED, V342, P557, DOI 10.1056/NEJM200002243420806; Hamilton NG, 2000, HASTINGS CENT REP, V30, P4; Hedberg K, 2002, NEW ENGL J MED, V346, P450, DOI 10.1056/NEJM200202073460614; Miller FG, 1997, CAMB Q HEALTHC ETHIC, V6, P78, DOI 10.1017/S0963180100007635; Rosenfeld B, 2000, NEW ENGL J MED, V343, P151; SACHS GA, 1995, J AM GERIATR SOC, V43, P553, DOI 10.1111/j.1532-5415.1995.tb06106.x; Sullivan AD, 2000, NEW ENGL J MED, V342, P598, DOI 10.1056/NEJM200002243420822; Sullivan AD, 2001, NEW ENGL J MED, V344, P605, DOI 10.1056/NEJM200102223440811; Wilson KG, 2000, ARCH INTERN MED, V160, P2454, DOI 10.1001/archinte.160.16.2454	18	113	114	0	8	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 22	2002	347	8					582	588		10.1056/NEJMsa020562	http://dx.doi.org/10.1056/NEJMsa020562			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	587ZR	12192019				2022-12-24	WOS:000177675400008
J	Ward, DJ; MacKay, DJC				Ward, DJ; MacKay, DJC			Artificial intelligence - Fast hands-free writing by gaze direction	NATURE			English	Article									Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England	University of Cambridge	Ward, DJ (corresponding author), Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England.	mackay@nrao.cam.ac.uk						BORGES JL, 1941, LIB BABEL; CLEARY JG, 1984, IEEE T COMMUN, V32, P396, DOI 10.1109/TCOM.1984.1096090; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Teahan W. J., 1995, P NZ COMP SCI RES ST; Ward D. J., 2000, UIST. Proceedings of the 13th Annual ACM Symposium on User Interface Software and Technology, P129, DOI 10.1145/354401.354427; WITTEN IH, 1987, COMMUN ACM, V30, P520, DOI 10.1145/214762.214771	7	122	125	2	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 22	2002	418	6900					838	838		10.1038/418838a	http://dx.doi.org/10.1038/418838a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585YR	12192400	Bronze, Green Submitted			2022-12-24	WOS:000177555600028
J	Liu, W; Christenson, SD; Standage, S; Shen, B				Liu, W; Christenson, SD; Standage, S; Shen, B			Biosynthesis of the enediyne antitumor antibiotic C-1027	SCIENCE			English	Article							ADENYLATION DOMAINS; CHROMOPHORE; STREPTOMYCES; PROTEINS; PATHWAY; CODE; GENE	C-1027 is a potent antitumor agent with a previously undescribed molecular architecture and mode of action. Cloning and characterization of the 85-kilobase C-1027 biosynthesis gene cluster from Streptomyces globisporus revealed (i) an iterative type I polyketide synthase that is distinct from any bacterial polyketide synthases known to date, (ii) a general polyketide pathway for the biosynthesis of both the 9- and 10-membered enediyne antibiotics, and (iii) a convergent biosynthetic strategy for the C-1027 chromophore from four building blocks. Manipulation of genes governing C-1027 biosynthesis allowed us to produce an enediyne compound in a predicted manner.	Univ Wisconsin, Div Pharmaceut Sci, Madison, WI 53705 USA; Univ Wisconsin, Dept Chem, Madison, WI 53705 USA; Univ Calif Davis, Biochem & Mol Biol Grad Grp, Davis, CA 95616 USA; Univ Calif Davis, Dept Chem, Davis, CA 95616 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Davis; University of California System; University of California Davis	Shen, B (corresponding author), Univ Wisconsin, Div Pharmaceut Sci, Madison, WI 53705 USA.				NCI NIH HHS [CA78747] Funding Source: Medline; NIAID NIH HHS [AI51689] Funding Source: Medline; NIGMS NIH HHS [T32 GM07377] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA078747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K02AI051689] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007377] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahlert J, 2002, SCIENCE, V297, P1173, DOI 10.1126/science.1072105; BIBB MJ, 1994, MOL MICROBIOL, V14, P533, DOI 10.1111/j.1365-2958.1994.tb02187.x; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; Brukner I., 2000, CURR OPIN ONCOL ENDO, V2, P344; Cane DE, 1998, SCIENCE, V282, P63, DOI 10.1126/science.282.5386.63; Challis GL, 2000, CHEM BIOL, V7, P211, DOI 10.1016/S1074-5521(00)00091-0; Chen H, 2002, CHEM BIOL, V9, P103, DOI 10.1016/S1074-5521(02)00090-X; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; Du L, 2001, Curr Opin Drug Discov Devel, V4, P215; Funa N, 1999, NATURE, V400, P897, DOI 10.1038/23748; HENSENS OD, 1989, J AM CHEM SOC, V111, P3295, DOI 10.1021/ja00191a028; Iida K, 1996, TETRAHEDRON LETT, V37, P4997, DOI 10.1016/0040-4039(96)00993-8; Kennedy J, 1999, SCIENCE, V284, P1368, DOI 10.1126/science.284.5418.1368; Kieser T., 2000, PRACTICAL STREPTOMYC; LAM KS, 1993, J AM CHEM SOC, V115, P12340, DOI 10.1021/ja00079a014; Lee M, 1998, SCIENCE, V280, P915, DOI 10.1126/science.280.5365.915; Liu W, 2000, ANTIMICROB AGENTS CH, V44, P382, DOI 10.1128/AAC.44.2.382-392.2000; Maeda Hiroshi, 1997, NEOCARZINOSTATIN PAS, P227; Metz JG, 2001, SCIENCE, V293, P290, DOI 10.1126/science.1059593; MINAMI Y, 1993, TETRAHEDRON LETT, V34, P2633, DOI 10.1016/S0040-4039(00)77643-X; Moore BS, 2001, CHEMBIOCHEM, V2, P35, DOI 10.1002/1439-7633(20010105)2:1<35::AID-CBIC35>3.3.CO;2-T; NICOLAOU KC, 1991, ANGEW CHEM INT EDIT, V30, P1387, DOI 10.1002/anie.199113873; OTANI T, 1988, J ANTIBIOT, V41, P1580, DOI 10.7164/antibiotics.41.1580; Shen B, 2000, TOP CURR CHEM, V209, P1; Sievers EL, 1999, BLOOD, V93, P3678, DOI 10.1182/blood.V93.11.3678; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Thorson JS, 2000, CURR PHARM DESIGN, V6, P1841, DOI 10.2174/1381612003398564; TOKIWA Y, 1992, J AM CHEM SOC, V114, P4107, DOI 10.1021/ja00037a011; Xi Z., 1999, COMPREHENSIVE NATURA, V7, P553; YOSHIDA K, 1993, TETRAHEDRON LETT, V34, P2637	31	242	267	6	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 16	2002	297	5584					1170	1173		10.1126/science.1072110	http://dx.doi.org/10.1126/science.1072110			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584BP	12183628				2022-12-24	WOS:000177447600047
J	Crawford, LM				Crawford, LM			Revision of grant program	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									US FDA, Off Commissioner Food & Drugs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Crawford, LM (corresponding author), US FDA, Off Commissioner Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 14	2002	288	6					688	688		10.1001/jama.288.6.688	http://dx.doi.org/10.1001/jama.288.6.688			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	583KY	12169049				2022-12-24	WOS:000177408100006
J	Kim, DH; Sarbassov, DD; Ali, SM; King, JE; Latek, RR; Erdjument-Bromage, H; Tempst, P; Sabatini, DM				Kim, DH; Sarbassov, DD; Ali, SM; King, JE; Latek, RR; Erdjument-Bromage, H; Tempst, P; Sabatini, DM			MTOR interacts with Raptor to form a nutrient-sensitive complex that signals to the cell growth machinery	CELL			English	Article							P70 S6 KINASE; MAMMALIAN TARGET; TRANSLATION INITIATION; EIF-4E BP1; RAPAMYCIN; PROTEIN; TOR; YEAST; PHOSPHORYLATION; HOMOLOG	mTOR/RAFT1/FRAP is the target of the immunosuppressive drug rapamycin and the central component of a nutrient- and hormone-sensitive signaling pathway that regulates cell growth. We report that mTOR forms a stoichiometric complex with raptor, an evolutionarily conserved protein with at least two roles in the mTOR pathway. Raptor has a positive role in nutrient-stimulated signaling to the downstream effector S6K1, maintenance of cell size, and mTOR protein expression. The association of raptor with mTOR also negatively regulates the mTOR kinase activity. Conditions that repress the pathway, such as nutrient deprivation and mitochondrial uncoupling, stabilize the mTOR-raptor association and inhibit mTOR kinase activity. We propose that raptor is a missing component of the mTOR pathway that through its association with mTOR regulates cell size in response to nutrient levels.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Memorial Sloan Kettering Cancer Center	Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.		Sarbassov, Dos/AAS-4950-2020; Ali, Siraj/AAE-2958-2019	Tempst, Paul/0000-0002-6680-3987; Kim, Do-Hyung/0000-0002-2924-4370; Sarbassov, Dos/0000-0002-6848-1133; Erdjument-Bromage, Hediye/0000-0003-0224-3594; /0000-0002-1446-7256	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047389] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI47389] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115; BAILEY TL, 1994, ISMB, V2, P28; BERNARD PA, 1979, BIOCHIM BIOPHYS ACTA, V548, P173, DOI 10.1016/0005-2728(79)90127-0; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; CHIU MI, 1994, P NATL ACAD SCI USA, V91, P12574, DOI 10.1073/pnas.91.26.12574; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Dixon, 1998, Curr Opin Plant Biol, V1, P1, DOI 10.1016/S1369-5266(98)80118-0; Dudkin L, 2001, CLIN CANCER RES, V7, P1758; Efstratiadis A, 1998, INT J DEV BIOL, V42, P955; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Erdjument-Bromage H, 1998, J CHROMATOGR A, V826, P167, DOI 10.1016/S0021-9673(98)00705-5; Fox HL, 1998, AM J PHYSIOL-CELL PH, V274, pC206, DOI 10.1152/ajpcell.1998.274.1.C206; Geromanos S, 2000, ANAL CHEM, V72, P777, DOI 10.1021/ac991071n; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Hara K, 1997, J BIOL CHEM, V272, P26457, DOI 10.1074/jbc.272.42.26457; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hidalgo M, 2000, ONCOGENE, V19, P6680, DOI 10.1038/sj.onc.1204091; Isotani S, 1999, J BIOL CHEM, V274, P34493, DOI 10.1074/jbc.274.48.34493; Johnston LA, 2002, BIOESSAYS, V24, P54, DOI 10.1002/bies.10021; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; Kozma SC, 2002, BIOESSAYS, V24, P65, DOI 10.1002/bies.10031; KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F; Lawrence J C Jr, 2001, Prog Mol Subcell Biol, V26, P1; Lynch CJ, 2000, J CELL BIOCHEM, V77, P234, DOI 10.1002/(SICI)1097-4644(20000501)77:2<234::AID-JCB7>3.0.CO;2-I; Majumder PK, 2001, CELL GROWTH DIFFER, V12, P465; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700; Parrott LA, 1999, J BIOL CHEM, V274, P24731, DOI 10.1074/jbc.274.35.24731; Peterson RT, 2000, J BIOL CHEM, V275, P7416, DOI 10.1074/jbc.275.10.7416; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; Sabatini DM, 1999, SCIENCE, V284, P1161, DOI 10.1126/science.284.5417.1161; SABERS CJ, 1995, J BIOL CHEM, V270, P815, DOI 10.1074/jbc.270.2.815; Saunders RN, 2001, KIDNEY INT, V59, P3, DOI 10.1046/j.1523-1755.2001.00460.x; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; Shinozaki-Yabana S, 2000, MOL CELL BIOL, V20, P1234, DOI 10.1128/MCB.20.4.1234-1242.2000; Sonnhammer ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO;2-L; Sousa JE, 2001, CIRCULATION, V104, P2007, DOI 10.1161/hc4201.098056; Taha C, 1999, J MEMBRANE BIOL, V169, P1, DOI 10.1007/PL00005896; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; WOLVETANG EJ, 1994, FEBS LETT, V339, P40, DOI 10.1016/0014-5793(94)80380-3; Xu G, 2001, DIABETES, V50, P353, DOI 10.2337/diabetes.50.2.353; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000; ZHENG XF, 1995, CELL, V82, P121, DOI 10.1016/0092-8674(95)90058-6	50	2232	2312	12	189	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 26	2002	110	2					163	175		10.1016/S0092-8674(02)00808-5	http://dx.doi.org/10.1016/S0092-8674(02)00808-5			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	578EV	12150925	Bronze			2022-12-24	WOS:000177105200005
J	Kobayashi, K; Hernandez, LD; Galan, JE; Janeway, CA; Medzhitov, R; Flavell, RA				Kobayashi, K; Hernandez, LD; Galan, JE; Janeway, CA; Medzhitov, R; Flavell, RA			IRAK-M is a negative regulator of toll-like receptor signaling	CELL			English	Article							FACTOR-KAPPA-B; MONOPHOSPHORYL LIPID-A; IL-1 RECEPTOR; SALMONELLA-TYPHIMURIUM; INTERLEUKIN-1 RECEPTOR; ENDOTOXIN TOLERANCE; GENE-EXPRESSION; INNATE IMMUNITY; CUTTING EDGE; KINASE	Toll-like receptors (TLRs) detect microorganisms and protect multicellular organisms from infection. TLRs transduce their signals through MyD88 and the serine/ threonine kinase IRAK. The IRAK family consists of two active kinases, IRAK and IRAK-4, and two inactive kinases, IRAK-2 and IRAK-M. IRAK-M expression is restricted to monocytes/macrophages, whereas other IRAKs are ubiquitous. We show here that IRAK-M is induced upon TLR stimulation and negatively regulates TLR signaling. IRAK-M prevented dissociation of IRAK and IRAK-4 from MyD88 and formation of IRAK-TRAF6 complexes. IRAK-M I cells exhibited increased cytokine production upon TLR/IL-1 stimulation and bacterial challenge, and IRAK-M-/- mice showed increased inflammatory responses to bacterial infection. Endotoxin tolerance, a protection mechanism against endotoxin shock, was significantly reduced in IRAK-M-/- cells. Thus, IRAK-M regulates TLR signaling and innate immune homeostasis.	Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06510 USA; Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, New Haven, CT 06536 USA	Howard Hughes Medical Institute; Yale University; Yale University	Flavell, RA (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06510 USA.		Eckhardt, Erik/G-1567-2010	Kobayashi, Koichi/0000-0003-2930-0114				Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; BEESON PB, 1947, J EXP MED, V86, P29, DOI 10.1084/jem.86.1.29; BEUTLER B, 1985, SCIENCE, V229, P869, DOI 10.1126/science.3895437; Burns K, 2000, NAT CELL BIOL, V2, P346, DOI 10.1038/35014038; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; CELADA A, 1984, J EXP MED, V160, P55, DOI 10.1084/jem.160.1.55; Chen LM, 1996, MOL MICROBIOL, V21, P1101, DOI 10.1046/j.1365-2958.1996.471410.x; CROSS A, 1995, J CLIN INVEST, V96, P676, DOI 10.1172/JCI118110; DANNER RL, 1991, CHEST, V99, P169, DOI 10.1378/chest.99.1.169; EDEN CS, 1988, J IMMUNOL, V140, P3180; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; GALAN JE, 1989, P NATL ACAD SCI USA, V86, P6383, DOI 10.1073/pnas.86.16.6383; Goldring CE, 1998, EUR J IMMUNOL, V28, P2960, DOI 10.1002/(SICI)1521-4141(199809)28:09<2960::AID-IMMU2960>3.0.CO;2-B; GREISMAN SE, 1966, J EXP MED, V124, P983, DOI 10.1084/jem.124.5.983; Gustafson G L, 1995, Prog Clin Biol Res, V392, P567; HAGBERG L, 1984, INFECT IMMUN, V46, P839, DOI 10.1128/IAI.46.3.839-844.1984; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; HENRICSON BE, 1990, INFECT IMMUN, V58, P2429, DOI 10.1128/IAI.58.8.2429-2437.1990; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Hoshino K, 1999, J IMMUNOL, V162, P3749; Kanakaraj P, 1998, J EXP MED, V187, P2073, DOI 10.1084/jem.187.12.2073; KANIGA K, 1994, MOL MICROBIOL, V13, P555, DOI 10.1111/j.1365-2958.1994.tb00450.x; Kastenbauer S, 1999, INFECT IMMUN, V67, P1553; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Knop J, 1999, FEBS LETT, V448, P81, DOI 10.1016/S0014-5793(99)00322-1; Kobayashi K, 1999, P NATL ACAD SCI USA, V96, P1457, DOI 10.1073/pnas.96.4.1457; Kojima H, 1998, BIOCHEM BIOPH RES CO, V244, P183, DOI 10.1006/bbrc.1998.8236; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Li XX, 1999, MOL CELL BIOL, V19, P4643; Maschera B, 1999, BIOCHEM J, V339, P227, DOI 10.1042/0264-6021:3390227; MCMAHAN CJ, 1991, EMBO J, V10, P2821, DOI 10.1002/j.1460-2075.1991.tb07831.x; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Muzio M, 2000, J IMMUNOL, V164, P5998, DOI 10.4049/jimmunol.164.11.5998; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Nomura F, 2000, J IMMUNOL, V164, P3476, DOI 10.4049/jimmunol.164.7.3476; Penheiter KL, 1997, MOL MICROBIOL, V24, P697, DOI 10.1046/j.1365-2958.1997.3741745.x; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Salkowski CA, 1998, INFECT IMMUN, V66, P3569, DOI 10.1128/IAI.66.8.3569-3578.1998; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; SHAHIN RD, 1987, J IMMUNOL, V138, P3475; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Swantek JL, 2000, J IMMUNOL, V164, P4301, DOI 10.4049/jimmunol.164.8.4301; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Thomas JA, 1999, J IMMUNOL, V163, P978; van Heel DA, 2001, LANCET, V357, P1902, DOI 10.1016/S0140-6736(00)05091-1; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Wesche H, 1999, J BIOL CHEM, V274, P19403, DOI 10.1074/jbc.274.27.19403; Yamin TT, 1997, J BIOL CHEM, V272, P21540, DOI 10.1074/jbc.272.34.21540; Zhang FX, 1999, J BIOL CHEM, V274, P7611, DOI 10.1074/jbc.274.12.7611; ZIEGLERHEITBROCK HWL, 1995, J INFLAMM, V45, P13; ZIEGLERHEITBROCK HWL, 1994, J BIOL CHEM, V269, P17001	55	1089	1149	1	59	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 26	2002	110	2					191	202		10.1016/S0092-8674(02)00827-9	http://dx.doi.org/10.1016/S0092-8674(02)00827-9			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	578EV	12150927	Bronze			2022-12-24	WOS:000177105200007
J	Whistler, JL; Enquist, J; Marley, A; Fong, J; Gladher, F; Tsuruda, P; Murray, SR; von Zastro, M				Whistler, JL; Enquist, J; Marley, A; Fong, J; Gladher, F; Tsuruda, P; Murray, SR; von Zastro, M			Modulation of postendocytic sorting of G-protein coupled receptors	SCIENCE			English	Article							INDUCED DOWN-REGULATION; DELTA-OPIOID RECEPTORS; BETA(2)-ADRENERGIC RECEPTOR; BETA-2-ADRENERGIC RECEPTOR; ENDOCYTOSIS; MU; INTERNALIZATION; RESENSITIZATION; UBIQUITINATION; PROTEASOME	Recycling of the mu opioid receptor to the plasma membrane after endocytosis promotes rapid resensitization of signal transduction, whereas targeting of the delta opioid receptor (DOR) to lysosomes causes proteolytic down-regulation. We identified a protein that binds preferentially to the cytoplasmic tail of the DOR as a candidate heterotrimeric GTP-binding protein (G protein)-coupled receptor-associated sorting protein (GASP). Disruption of the DOR-GASP interaction through receptor mutation or overexpression of a dominant negative fragment of GASP inhibited receptor trafficking to lysosomes and promoted recycling. The GASP family of proteins may modulate lysosomal sorting and functional down-regulation of a variety of G protein-coupled receptors.	Univ Calif San Francisco, Dept Neurol, Ernest Gallo Clin & Res Ctr, Oakland, CA 94608 USA; Lund Univ, Program Mol Med, S-22100 Lund, Sweden; Univ Calif San Francisco, Dept Psychiat, Cell Biol Program, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; Lund University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Whistler, JL (corresponding author), Univ Calif San Francisco, Dept Neurol, Ernest Gallo Clin & Res Ctr, Oakland, CA 94608 USA.							Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Chaturvedi K, 2001, J BIOL CHEM, V276, P12345, DOI 10.1074/jbc.M008054200; Claing A, 2002, PROG NEUROBIOL, V66, P61, DOI 10.1016/S0301-0082(01)00023-5; Cong M, 2001, J BIOL CHEM, V276, P45145, DOI 10.1074/jbc.M106087200; EVANS CJ, 1992, SCIENCE, V258, P1952, DOI 10.1126/science.1335167; Finn AK, 2001, NEURON, V32, P829, DOI 10.1016/S0896-6273(01)00517-7; Gage RM, 2001, J BIOL CHEM, V276, P44712, DOI 10.1074/jbc.M107417200; Gagnon AW, 1998, J BIOL CHEM, V273, P6976, DOI 10.1074/jbc.273.12.6976; Goodman O B Jr, 1998, Adv Pharmacol, V42, P429; Heck DA, 1997, J PHARMACOL EXP THER, V282, P1219; Hicke L, 1999, TRENDS CELL BIOL, V9, P107, DOI 10.1016/S0962-8924(98)01491-3; Innamorati G, 1998, P NATL ACAD SCI USA, V95, P2222, DOI 10.1073/pnas.95.5.2222; KAUFMAN DL, 1995, J BIOL CHEM, V270, P15877, DOI 10.1074/jbc.270.26.15877; Klein U, 1997, J BIOL CHEM, V272, P19099, DOI 10.1074/jbc.272.31.19099; Koch T, 1998, J BIOL CHEM, V273, P13652, DOI 10.1074/jbc.273.22.13652; Law PY, 1999, J PHARMACOL EXP THER, V289, P607; Lefkowitz R J, 1998, Adv Pharmacol, V42, P416; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Petaja-Repo UE, 2001, J BIOL CHEM, V276, P4416, DOI 10.1074/jbc.M007151200; PETERSON MG, 1990, SCIENCE, V248, P1625, DOI 10.1126/science.2363050; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Suyama M, 1999, NUCLEIC ACIDS RES, V27, P338, DOI 10.1093/nar/27.1.338; Trejo J, 1999, J BIOL CHEM, V274, P2216, DOI 10.1074/jbc.274.4.2216; Tsao PI, 2000, J BIOL CHEM, V275, P11130, DOI 10.1074/jbc.275.15.11130; VONZASTROW M, 1992, J BIOL CHEM, V267, P3530; Whistler JL, 2001, J BIOL CHEM, V276, P34331, DOI 10.1074/jbc.M104627200; Zhang J, 1998, P NATL ACAD SCI USA, V95, P7157, DOI 10.1073/pnas.95.12.7157; ZHANG J, 1999, J REC SIG T RES, V19, P1	29	260	277	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 26	2002	297	5581					615	620		10.1126/science.1073308	http://dx.doi.org/10.1126/science.1073308			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577GY	12142540				2022-12-24	WOS:000177054200055
J	Michele, DE; Barresi, R; Kanagawa, M; Saito, F; Cohn, RD; Satz, JS; Dollar, J; Nishino, I; Kelley, RI; Somer, H; Straub, V; Mathews, KD; Moore, SA; Campbell, KP				Michele, DE; Barresi, R; Kanagawa, M; Saito, F; Cohn, RD; Satz, JS; Dollar, J; Nishino, I; Kelley, RI; Somer, H; Straub, V; Mathews, KD; Moore, SA; Campbell, KP			Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies	NATURE			English	Article							ALPHA-DYSTROGLYCAN; GLYCOPROTEIN COMPLEX; DELTA-SARCOGLYCAN; LAMININ; MEMBRANE; LOCALIZATION; MUTATIONS; RECEPTOR; BRAIN; GENE	Muscle-eye-brain disease (MEB) and Fukuyama congenital muscular dystrophy (FCMD) are congenital muscular dystrophies with associated, similar brain malformations(1,2). The FCMD gene, fukutin, shares some homology with fringe-like glycosyltransferases, and the MEB gene, POMGnT1, seems to be a new glycosyltransferase(3,4). Here we show, in both MEB and FCMD patients, that alpha-dystroglycan is expressed at the muscle membrane, but similar hypoglycosylation in the diseases directly abolishes binding activity of dystroglycan for the ligands laminin, neurexin and agrin. We show that this post-translational biochemical and functional disruption of alpha-dystroglycan is recapitulated in the muscle and central nervous system of mutant myodystrophy (myd) mice. We demonstrate that myd mice have abnormal neuronal migration in cerebral cortex, cerebellum and hippocampus, and show disruption of the basal lamina. In addition, myd mice reveal that dystroglycan targets proteins to functional sites in brain through its interactions with extracellular matrix proteins. These results suggest that at least three distinct mammalian genes function within a convergent post-translational processing pathway during the biosynthesis of dystroglycan, and that abnormal dystroglycan-ligand interactions underlie the pathogenic mechanism of muscular dystrophy with brain abnormalities.	Univ Iowa, Howard Hughes Med Inst, Dept Physiol & Biophys, Iowa City, IA 52242 USA; Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA; Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA; Albany Med Coll, Dept Pathol, Albany, NY 12208 USA; Natl Inst Neurosci, Dept Neuromuscular Res, Tokyo 1878502, Japan; Johns Hopkins Univ, Kennedy Krieger Inst, Baltimore, MD 21205 USA; Univ Helsinki Hosp, Dept Neurol, Helsinki 00029, Finland	Howard Hughes Medical Institute; University of Iowa; University of Iowa; University of Iowa; University of Iowa; Albany Medical College; National Center for Neurology & Psychiatry - Japan; Johns Hopkins University; Kennedy Krieger Institute; University of Helsinki; Helsinki University Central Hospital	Campbell, KP (corresponding author), Univ Iowa, Howard Hughes Med Inst, Dept Physiol & Biophys, Iowa City, IA 52242 USA.		Nishino, Ichizo/G-2676-2010; Barresi, Rita/AAB-9569-2022; Cohn, Ronald/AAC-5835-2021	Nishino, Ichizo/0000-0001-9452-112X; Barresi, Rita/0000-0001-7351-959X; Straub, Volker/0000-0001-9046-3540; Kanagawa, Motoi/0000-0003-0984-6398; Moore, Steven/0000-0002-6353-7900; mathews, katherine/0000-0003-4160-0435; Campbell, Kevin/0000-0003-2066-5889				Allamand V, 1997, HUM MOL GENET, V6, P747, DOI 10.1093/hmg/6.5.747; Barton LL, 2001, CLIN INFECT DIS, V33, P370, DOI 10.1086/321897; CAMPANELLI JT, 1994, CELL, V77, P663, DOI 10.1016/0092-8674(94)90051-5; Chiba A, 1997, J BIOL CHEM, V272, P2156; Dubowitz T, 2000, ANN NEUROL, V47, P143, DOI 10.1002/1531-8249(200002)47:2<143::AID-ANA2>3.0.CO;2-Y; DUBOWITZ V, 2000, ANN NEUROL, V47, P554; ENGVALL E, 1986, J CELL BIOL, V103, P2457, DOI 10.1083/jcb.103.6.2457; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; GEE SH, 1994, CELL, V77, P675, DOI 10.1016/0092-8674(94)90052-3; Grewal PK, 2001, NAT GENET, V28, P151, DOI 10.1038/88865; Haltia M, 1997, ANN NEUROL, V41, P173, DOI 10.1002/ana.410410208; Henry MD, 1998, CELL, V95, P859, DOI 10.1016/S0092-8674(00)81708-0; Henry MD, 1999, CURR OPIN CELL BIOL, V11, P602, DOI 10.1016/S0955-0674(99)00024-1; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; IBRAGHIMOVBESKROVNAYA O, 1993, HUM MOL GENET, V2, P1651, DOI 10.1093/hmg/2.10.1651; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Jung D, 1996, J BIOL CHEM, V271, P32321, DOI 10.1074/jbc.271.50.32321; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; Kunz S, 2001, J CELL BIOL, V155, P301, DOI 10.1083/jcb.200104103; LIM LE, 1995, NAT GENET, V11, P257, DOI 10.1038/ng1195-257; MATSUMURA K, 1992, NATURE, V359, P320, DOI 10.1038/359320a0; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature00838; Nigro V, 1996, NAT GENET, V14, P195, DOI 10.1038/ng1096-195; NOGUCHI S, 1995, SCIENCE, V270, P819, DOI 10.1126/science.270.5237.819; ROBERDS SL, 1994, CELL, V78, P625, DOI 10.1016/0092-8674(94)90527-4; Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003; Toda T, 2000, NEUROMUSCULAR DISORD, V10, P153, DOI 10.1016/S0960-8966(99)00109-1; Williamson RA, 1997, HUM MOL GENET, V6, P831, DOI 10.1093/hmg/6.6.831; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3	30	622	641	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 25	2002	418	6896					417	422		10.1038/nature00837	http://dx.doi.org/10.1038/nature00837			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576MU	12140558				2022-12-24	WOS:000177009700038
J	Yoshida, Y; Chiba, T; Tokunaga, F; Kawasaki, H; Iwai, K; Suzuki, T; Ito, Y; Matsuoka, K; Yoshida, M; Tanaka, K; Tai, T				Yoshida, Y; Chiba, T; Tokunaga, F; Kawasaki, H; Iwai, K; Suzuki, T; Ito, Y; Matsuoka, K; Yoshida, M; Tanaka, K; Tai, T			E3 ubiquitin ligase that recognizes sugar chains	NATURE			English	Article							HIF-ALPHA; PROTEIN; DEGRADATION; PROTEASOME; HYDROXYLATION; PRECURSOR; RECEPTOR; PATHWAY; CFTR; SCF	N-glycosylation of proteins in the endoplasmic reticulum (ER) has a central role in protein quality control(1-3). Here we report that N-glycan serves as a signal for degradation by the Skp1-Cullin1-Fbx2-Roc1 (SCFFbx2) ubiquitin ligase complex. The F-box protein Fbx2 (ref. 4) binds specifically to proteins attached to N-linked high-mannose oligosaccharides and subsequently contributes to ubiquitination of N-glycosylated proteins. Pre-integrin beta1 is a target of Fbx2; these two proteins interact in the cytosol after inhibition of the proteasome. In addition, expression of the mutant Fbx2DeltaF, which lacks the F-box domain that is essential for forming the SCF complex, appreciably blocks degradation of typical substrates of the ER-associated degradation pathway(5,6). Our results indicate that SCFFbx2 ubiquitinates N-glycosylated proteins that are translocated from the ER to the cytosol by the quality control mechanism.	Tokyo Metropolitan Inst Med Sci, Dept Tumor Immunol, Bunkyo Ku, Tokyo 1138613, Japan; Tokyo Metropolitan Inst Med Sci, Dept Mol Oncol, Bunkyo Ku, Tokyo 1138613, Japan; JST, CREST, Wako, Saitama 3320012, Japan; Osaka City Univ, Grad Sch Med, Dept Mol Cell Biol, Osaka 5458585, Japan; Yokohama City Univ, Grad Sch Integrated Sci, Kihara Inst Biol Res, Kanagawa 2440813, Japan; RIKEN, Synthet Cellular Chem Lab, Wako, Saitama 3510198, Japan; RIKEN, Chem Genet Lab, Wako, Saitama 3510198, Japan; Saitama Univ, Dept Funct Mat Sci, Saitama, Saitama 3388570, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science; Japan Science & Technology Agency (JST); Osaka Metropolitan University; Yokohama City University; RIKEN; RIKEN; Saitama University	Tai, T (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Tumor Immunol, Bunkyo Ku, Tokyo 1138613, Japan.	tanakak@rinshoken.or.jp	Matsuoka, Koji/A-9463-2008; Kawasaki, Hiroshi/C-3048-2011; Yoshida, Minoru/C-8049-2014; Ito, Yukishige/ACL-6203-2022; Ito, Yukishige/M-5119-2014; IWAI, KAZUHIRO/GSN-7385-2022; Yoshida, Yukiko/ABB-7218-2020	Matsuoka, Koji/0000-0002-8987-2715; Kawasaki, Hiroshi/0000-0002-2517-159X; Yoshida, Minoru/0000-0002-4376-5674; Ito, Yukishige/0000-0001-6251-7249; Ito, Yukishige/0000-0001-6251-7249; Yoshida, Yukiko/0000-0002-0629-0219; Tokunaga, Fuminori/0000-0003-3626-9119; Suzuki, Toshiaki/0000-0002-0650-6251; Iwai, Kazuhiro/0000-0001-5620-5951				AKIYAMA SK, 1989, J BIOL CHEM, V264, P18011; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Drickamer K, 1999, CURR OPIN STRUC BIOL, V9, P585, DOI 10.1016/S0959-440X(99)00009-3; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Erhardt JA, 1998, J BIOL CHEM, V273, P35222, DOI 10.1074/jbc.273.52.35222; HEINO J, 1989, J BIOL CHEM, V264, P380; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kawakami T, 2001, EMBO J, V20, P4003, DOI 10.1093/emboj/20.15.4003; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; KOIVISTO L, 1994, BIOCHEM J, V300, P771, DOI 10.1042/bj3000771; LENTER M, 1994, J BIOL CHEM, V269, P12263; Parodi AJ, 2000, ANNU REV BIOCHEM, V69, P69, DOI 10.1146/annurev.biochem.69.1.69; Plemper RK, 1999, TRENDS BIOCHEM SCI, V24, P266, DOI 10.1016/S0968-0004(99)01420-6; RICE KG, 1990, ANAL BIOCHEM, V184, P249, DOI 10.1016/0003-2697(90)90676-Z; TOKUNAGA F, 1995, BIOCHEMISTRY-US, V34, P1163, DOI 10.1021/bi00004a009; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4; Yu H, 1997, J BIOL CHEM, V272, P20800, DOI 10.1074/jbc.272.33.20800	24	291	303	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 25	2002	418	6896					438	442		10.1038/nature00890	http://dx.doi.org/10.1038/nature00890			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576MU	12140560				2022-12-24	WOS:000177009700043
J	Sethi, S; Lipford, G; Wagner, H; Kretzschmar, H				Sethi, S; Lipford, G; Wagner, H; Kretzschmar, H			Postexposure prophylaxis against prion disease with a stimulator of innate immunity	LANCET			English	Article							SCRAPIE	The absence of an immune response to prions-the infectious agents of scrapie, bovine spongiform encephalopathy (BSE), and Creutzfeldt-Jakob disease-might be related to the fact that these agents do not contain nucleic acids. We aimed to use CpG oligodeoxynucleotides, which have been shown to stimulate innate immunity, as a form of postexposure prophylaxis in mice. We inoculated healthy mice with brain homogenates from mice infected with the RML scrapie prion, and then injected CpG oligodeoxynucleotides. This postexposure prophylaxis with CpG oligodeoxynucleotides resulted in 38% longer survival times than treatment with saline (p<0.0001), or even longer after repeated application. The explanation for this finding remains to be elucidated, but the most likely is stimulation of TLR9-expressing cells of the innate immune system such as macrophages, monocytes, and dendritic cells. CpG oligodeoxynucleotides have not been shown to have adverse effects to human health and could therefore be considered as a therapeutic choice in postexposure prophylaxis.	Univ Munich, Inst Neuropathol, D-81377 Munich, Germany; Coley Pharmaceut, Langenfeld, Germany; Tech Univ Munich, Inst Med Mikrobiol Immunol & Hyg, D-8000 Munich, Germany	University of Munich; Coley Pharmaceutical Group; Technical University of Munich	Kretzschmar, H (corresponding author), Univ Munich, Inst Neuropathol, Marchioninistr 15, D-81377 Munich, Germany.		Sethi, Shneh/F-1796-2013					BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Lipford GB, 1998, TRENDS MICROBIOL, V6, P496, DOI 10.1016/S0966-842X(98)01408-5; Wagner H, 2002, CURR OPIN MICROBIOL, V5, P62, DOI 10.1016/S1369-5274(02)00287-4; Zimmermann S, 1998, J IMMUNOL, V160, P3627	5	110	127	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 20	2002	360	9328					229	230		10.1016/S0140-6736(02)09513-2	http://dx.doi.org/10.1016/S0140-6736(02)09513-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	576DX	12133662				2022-12-24	WOS:000176988500017
J	Lindsay, RS; Funahashi, T; Hanson, RL; Matsuzawa, Y; Tanaka, S; Tataranni, PA; Knowler, WC; Krakoff, J				Lindsay, RS; Funahashi, T; Hanson, RL; Matsuzawa, Y; Tanaka, S; Tataranni, PA; Knowler, WC; Krakoff, J			Adiponectin and development of type 2 diabetes in the Pima Indian population	LANCET			English	Article							INSULIN-RESISTANCE; OBESITY; PROTEIN	Adiponectin Is a collagen-like circulating protein secreted by adipocytes that Is proposed to mediate obesity-related resistance to Insulin. In a case-control series, we assessed the role of adiponectin in later development of type 2 diabetes In 70 patients who later developed type 2 diabetes and 70 controls, matched for body-mass index, age, and sex. Cases and controls were taken from the longitudinal study of health In the Pima Indian population. At baseline, the concentration of adiponectin was lower In cases than in controls (p=0.01) and Individuals with high concentrations of this protein were less likely to develop type 2 diabetes than those with low concentrations (incidence rate ratio 0.63 [95% CI 0.43-0.92]; p=0.02).	NIDDKD, NIH, Phoenix, AZ 85014 USA; Osaka Univ, Grad Sch Med, Dept Internal Med & Mol Sci, Osaka, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Osaka University	Lindsay, RS (corresponding author), NIDDKD, NIH, 1550 E Indian Sch Rd, Phoenix, AZ 85014 USA.		Hanson, Robert L/O-3238-2015	Hanson, Robert L/0000-0002-4252-7068; Lindsay, Robert/0000-0002-9868-5217	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK069015, Z01DK069000, ZIADK069000, ZIADK069015] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984	5	847	925	0	15	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 6	2002	360	9326					57	58		10.1016/S0140-6736(02)09335-2	http://dx.doi.org/10.1016/S0140-6736(02)09335-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	569JR	12114044				2022-12-24	WOS:000176599700014
J	Prokopenko, AA; Williams, DF; Kuzmin, MI; Karabanov, EB; Khursevich, GK; Peck, JA				Prokopenko, AA; Williams, DF; Kuzmin, MI; Karabanov, EB; Khursevich, GK; Peck, JA			Muted climate variations in continental Siberia during the mid-Pleistocene epoch	NATURE			English	Article							LAKE BAIKAL; RECORD; INSOLATION; GLACIATION; CYCLES; ORIGIN; AGE	The large difference in carbon and oxygen isotope data from the marine record between marine oxygen isotope stage 12 (MIS 12) and MIS 11, spanning the interval between about 480 and 380 kyr ago, has been interpreted as a transition between an extremely cold glacial period and an unusually warm interglacial period, with consequences for global ice volume, sea level and the global carbon cycle(1-4). The extent of the change is intriguing, because orbital forcing is predicted to have been relatively weak at that time(5). Here we analyse a continuous sediment record from Lake Baikal, Siberia, which reveals a virtually continuous interglacial diatom assemblage, a stable littoral benthic diatom assemblage and lithogenic sediments with 'interglacial' characteristics for the period from MIS 15a to MIS 11 (from about 580 to 380 kyr ago). From these data, we infer significantly weaker climate contrasts between MIS 12 and 11 than during more recent glacial-interglacial transitions in the late Pleistocene epoch (about 130 to 10 kyr ago). For the period from MIS 15a to MIS 11, we also infer an apparent lack of extensive mountain glaciation.	Univ S Carolina, Dept Geol Sci, Columbia, SC 29208 USA; Russian Acad Sci, Siberian Branch, United Inst Geol Geophys & Mineral, Novosibirsk 630090, Russia; Russian Acad Sci, Siberian Branch, Inst Geochem, Irkutsk 664033, Russia; Inst Geol Sci, Minsk 220141, BELARUS; Univ Akron, Dept Geol, Akron, OH 44325 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Russian Academy of Sciences; Sobolev Institute of Geology & Mineralogy of the Russian Academy of Sciences; Trofimuk Institute of Petroleum Geology & Geophysics; Irkutsk Science Centre of the Russian Academy of Sciences; A.P. Vinogradov Institute of Geochemistry of the Siberian Branch of the RAS; Russian Academy of Sciences; University System of Ohio; University of Akron	Prokopenko, AA (corresponding author), Univ S Carolina, Dept Geol Sci, Columbia, SC 29208 USA.	sasha@geol.sc.edu	Kuzmin, Mikhail/O-9118-2015					Antipin V, 2001, QUATERN INT, V80-1, P19, DOI 10.1016/S1040-6182(01)00016-7; *BDP MEMB, 1997, EOS AM GEOPHYS UNION, V78, P597; BERGER AL, 1999, EOS T AM GEOPHYS UN, V80, pF555; COLMAN SM, 1995, NATURE, V378, P769, DOI 10.1038/378769a0; EHLERS J, 1989, J QUATERNARY SCI, V4, P255, DOI 10.1002/jqs.3390040306; Hearty PJ, 1999, GEOLOGY, V27, P375, DOI 10.1130/0091-7613(1999)027<0375:AMMPSL>2.3.CO;2; Howard WR, 1997, NATURE, V388, P418, DOI 10.1038/41201; IMBRIE J, 1993, PALEOCEANOGRAPHY, V8, P699, DOI 10.1029/93PA02751; Karabanov EB, 1998, QUATERNARY RES, V50, P46, DOI 10.1006/qres.1998.1980; Karabanov EB, 2000, J PALEOLIMNOL, V23, P365, DOI 10.1023/A:1008188100542; Khursevich GK, 2001, QUATERN INT, V80-1, P47, DOI 10.1016/S1040-6182(01)00018-0; Kukla G, 1996, PALAEOGEOGR PALAEOCL, V120, P171, DOI 10.1016/0031-0182(95)00040-2; KUKLA G, 1991, START GLACIAL, P307; Kuzmin MI, 2000, INT J EARTH SCI, V89, P183, DOI 10.1007/s005310000090; LASKAR J, 1993, ASTRON ASTROPHYS, V270, P522; MORTLOCK RA, 1989, DEEP-SEA RES, V36, P1415, DOI 10.1016/0198-0149(89)90092-7; Oppo DW, 1990, PALEOCEANOGRAPHY, V5, P43, DOI 10.1029/PA005i001p00043; PECK JA, 1994, EARTH PLANET SC LETT, V122, P221, DOI 10.1016/0012-821X(94)90062-0; Prokopenko AA, 1999, EARTH PLANET SC LETT, V172, P239, DOI 10.1016/S0012-821X(99)00203-4; Prokopenko AA, 2001, QUATERN INT, V80-1, P37, DOI 10.1016/S1040-6182(01)00017-9; Prokopenko AA, 2001, QUATERNARY RES, V55, P123, DOI 10.1006/qres.2000.2212; RASSKAZOV SV, 2000, GEOCHRONOLOGY GEODYN; Rohling EJ, 1998, NATURE, V394, P162, DOI 10.1038/28134; RUDDIMAN WF, 1980, QUATERNARY RES, V13, P33, DOI 10.1016/0033-5894(80)90081-2; Shackleton NJ, 2000, SCIENCE, V289, P1897, DOI 10.1126/science.289.5486.1897; SHORT DA, 1991, QUATERNARY RES, V35, P157, DOI 10.1016/0033-5894(91)90064-C; Thompson R., 1986, ENV MAGNETISM, DOI 10.1007/978-94-011-8036-8; URBAN B, 1991, START GLACIAL, P37; Williams DF, 1997, SCIENCE, V278, P1114, DOI 10.1126/science.278.5340.1114	29	72	76	2	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 4	2002	418	6893					65	68		10.1038/nature00886	http://dx.doi.org/10.1038/nature00886			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569JL	12097906				2022-12-24	WOS:000176599200038
J	Davis, RL; Shrimpton, AE; Carrell, RW; Lomas, DA; Gerhard, L; Baumann, B; Lawrence, DA; Yepes, M; Kim, TS; Ghetti, B; Piccardo, P; Takao, M; Lacbawan, F; Muenke, M; Sifers, RN; Bradshaw, CB; Kent, PF; Collins, GH; Larocca, D; Holohan, PD				Davis, RL; Shrimpton, AE; Carrell, RW; Lomas, DA; Gerhard, L; Baumann, B; Lawrence, DA; Yepes, M; Kim, TS; Ghetti, B; Piccardo, P; Takao, M; Lacbawan, F; Muenke, M; Sifers, RN; Bradshaw, CB; Kent, PF; Collins, GH; Larocca, D; Holohan, PD			Association between conformational mutations in neuroserpin and onset and severity of dementia	LANCET			English	Article							SERINE-PROTEASE INHIBITOR; NEURODEGENERATIVE DISEASE; CRYSTAL-STRUCTURE; INCLUSION-BODIES; SERPINS; ALPHA(1)-ANTITRYPSIN; ENCEPHALOPATHY; ACCUMULATION; MECHANISM; MYOCLONUS	Background The aggregation of specific proteins is a common feature of the familial dementias, but whether the formation of neuronal inclusion bodies is a causative or incidental factor in the disease is not known. To clarify this issue, we investigated five families with typical neuroserpin inclusion bodies but with various neurological manifestations. Methods Five families with neurodegenerative disease and typical neuronal inclusions had biopsy or autopsy material available for further examination. Immunostaining confirmed that the inclusions were formed of neuroserpin aggregates, and the responsible mutations in neuroserpin were identified by sequencing of the neuroserpin gene (SERPINI1) in DNA from blood samples or from extraction of histology specimens. Molecular modelling techniques were used to predict the effect of the gene mutations on three-dimensional protein structure. Brain sections were stained and the topographic distribution of the neuroserpin inclusions plotted. Findings Each of the families was heterozygous for an aminoacid substitution that affected the conformational stability of neuroserpin. The least disruptive of these mutations (S49P), as predicted by molecular modelling, resulted in dementia after age 45 years, and presence of neuroserpin inclusions in only a few neurons. By contrast, the most severely disruptive mutation (G392E) resulted, at age 13 years, in progressive myoclonus epilepsy, with many inclusions present in almost all neurons. Interpretation The findings provide evidence that inclusion-body formation is in itself a sufficient cause of neurodegeneration, and that the onset and severity of the disease is associated with the rate and magnitude of neuronal protein aggregation.	Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Cambridge, England; Univ Cambridge, Dept Med, Cambridge Inst Med Res, Cambridge CB2 2QQ, England; Upstate Med Univ, Dept Pathol, Syracuse, NY USA; Univ Witten Herdecke, Inst Clin Neurosurg, Witten, Germany; Univ Magdeburg, Dept Psychiat, D-39106 Magdeburg, Germany; Amer Red Cross, Holland Lab, Dept Vasc Biol, Rockville, MD USA; Georgetown Univ, Med Ctr, Dept Neurol, Washington, DC 20007 USA; Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea; Indiana Univ, Sch Med, Div Neuropathol, Alzheimer Dis Ctr, Indianapolis, IN USA; Childrens Natl Med Ctr, Dept Med Genet, Washington, DC 20010 USA; NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Upstate Med Univ, Dept Neurol, Syracuse, NY USA; Upstate Med Univ, Dept Pharmacol, Syracuse, NY USA	University of Cambridge; University of Cambridge; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Witten Herdecke University; Otto von Guericke University; American Red Cross; Georgetown University; Yonsei University; Yonsei University Health System; Indiana University System; Indiana University-Purdue University Indianapolis; Children's National Health System; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Baylor College of Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Carrell, RW (corresponding author), Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Cambridge, England.	rwc1000@cam.ac.uk	Sifers, Richard Norman/AGQ-7262-2022; Yepes, Manuel/C-3576-2011	Lawrence, Daniel/0000-0003-3126-1935; Muenke, Maximilian/0000-0002-7719-6545	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS014426, R21NS040722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG010133] Funding Source: NIH RePORTER; NIA NIH HHS [AG10133] Funding Source: Medline; NINDS NIH HHS [NS14426, NS40722] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Belorgey D, 2002, J BIOL CHEM, V277, P17367, DOI 10.1074/jbc.M200680200; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; BENISHAY Z, 1968, ISRAEL J MED SCI, V4, P987; Bergener M, 1970, Nervenarzt, V41, P166; Bradshaw CB, 2001, ARCH NEUROL-CHICAGO, V58, P1429, DOI 10.1001/archneur.58.9.1429; Briand C, 2001, FEBS LETT, V505, P18, DOI 10.1016/S0014-5793(01)02764-8; Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; Carrell RW, 2002, NEW ENGL J MED, V346, P45, DOI 10.1056/NEJMra010772; Davis RL, 1999, AM J PATHOL, V155, P1901, DOI 10.1016/S0002-9440(10)65510-1; Davis RL, 1999, NATURE, V401, P376, DOI 10.1038/43897; GERHARD L, 1990, AKTUELLE NEUROPADIAT, P56; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; Hastings GA, 1997, J BIOL CHEM, V272, P33062, DOI 10.1074/jbc.272.52.33062; JOCHMANS K, 1994, BLOOD, V83, P146; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; LOMAS DA, 1993, J BIOL CHEM, V268, P15333; Murrell JR, 1999, J NEUROPATH EXP NEUR, V58, P1207, DOI 10.1097/00005072-199912000-00002; Osterwalder T, 1996, EMBO J, V15, P2944, DOI 10.1002/j.1460-2075.1996.tb00657.x; Rapin I, 1986, Adv Neurol, V43, P65; Ryu SE, 1996, STRUCTURE, V4, P1181, DOI 10.1016/S0969-2126(96)00126-8; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; STEIN PE, 1995, NAT STRUCT BIOL, V2, P96, DOI 10.1038/nsb0295-96; Takao M, 2000, J NEUROPATH EXP NEUR, V59, P1070, DOI 10.1093/jnen/59.12.1070; Tran PB, 1999, TRENDS NEUROSCI, V22, P194, DOI 10.1016/S0166-2236(99)01409-5; Verghese J, 2000, ARCH NEUROL-CHICAGO, V57, P389, DOI 10.1001/archneur.57.3.389; Walker LC, 2000, NEUROBIOL AGING, V21, P559, DOI 10.1016/S0197-4580(00)00160-3; WHISSTOCK J, 1996, THESIS CAMBRIDGE U C; Whisstock JC, 2000, J MOL BIOL, V296, P685, DOI 10.1006/jmbi.1999.3520; Wilson CA, 1999, J NEUROPATH EXP NEUR, V58, P787, DOI 10.1097/00005072-199908000-00001; Yazaki M, 2001, AM J PATHOL, V158, P227, DOI 10.1016/S0002-9440(10)63961-2; YERBY MS, 1986, NEUROLOGY, V36, P68, DOI 10.1212/WNL.36.1.68	33	127	130	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 29	2002	359	9325					2242	2247		10.1016/S0140-6736(02)09293-0	http://dx.doi.org/10.1016/S0140-6736(02)09293-0			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	567YJ	12103288				2022-12-24	WOS:000176514500010
J	Hall, IM; Shankaranarayana, GD; Noma, KI; Ayoub, N; Cohen, A; Grewal, SIS				Hall, IM; Shankaranarayana, GD; Noma, KI; Ayoub, N; Cohen, A; Grewal, SIS			Establishment and maintenance of a heterochromatin domain	SCIENCE			English	Article							FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; CHROMOSOME SEGREGATION; HISTONE H3; REPEATS; GENES; RNA; DNA; RECOGNITION; INHERITANCE	The higher-order assembly of chromatin imposes structural organization on the genetic information of eukaryotes and is thought to be largely determined by posttranslational modi cation of histone tails. Here, we study a 20-kilobase silent domain at the mating-type region of fission yeast as a model for heterochromatin formation. We find that, although histone H3 methylated at lysine 9 ( H3 Lys(9)) directly recruits heterochromatin protein Swi6/HP1, the critical determinant for H3 Lys(9) methylation to spread in cis and to be inherited through mitosis and meiosis is Swi6 itself. We demonstrate that a centromere-homologous repeat (cenH) present at the silent mating-type region is sufficient for heterochromatin formation at an ectopic site, and that its repressive capacity is mediated by components of the RNA interference (RNAi) machinery. Moreover, cenH and the RNAi machinery cooperate to nucleate heterochromatin assembly at the endogenous mat locus but are dispensable for its subsequent inheritance. This work defines sequential requirements for the initiation and propagation of regional heterochromatic domains.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Mol Biol, IL-91010 Jerusalem, Israel	Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; Hebrew University of Jerusalem	Grewal, SIS (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059772] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM59772] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akhtar A, 2000, NATURE, V407, P405, DOI 10.1038/35030169; ALLSHIRE RC, 1995, GENE DEV, V9, P218, DOI 10.1101/gad.9.2.218; Aravind L, 2000, P NATL ACAD SCI USA, V97, P11319, DOI 10.1073/pnas.200346997; Ayoub N, 2000, GENETICS, V156, P983; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Birchler JA, 2000, CURR OPIN GENET DEV, V10, P211, DOI 10.1016/S0959-437X(00)00065-4; Cavalli G, 2002, CURR OPIN CELL BIOL, V14, P269, DOI 10.1016/S0955-0674(02)00324-1; CHIKASHIGE Y, 1989, CELL, V57, P739, DOI 10.1016/0092-8674(89)90789-7; Cohen DE, 2002, CURR OPIN GENET DEV, V12, P219, DOI 10.1016/S0959-437X(02)00289-7; DORER DR, 1994, CELL, V77, P993, DOI 10.1016/0092-8674(94)90439-1; EKWALL K, 1994, GENETICS, V136, P53; Grewal SIS, 1998, GENETICS, V150, P563; Grewal SIS, 2002, CURR OPIN GENET DEV, V12, P178, DOI 10.1016/S0959-437X(02)00284-8; Grewal SIS, 1996, CELL, V86, P95, DOI 10.1016/S0092-8674(00)80080-X; Grewal SIS, 1997, GENETICS, V146, P1221; HAHNENBERGER KM, 1991, MOL CELL BIOL, V11, P2206, DOI 10.1128/MCB.11.4.2206; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Heard E, 2001, CELL, V107, P727, DOI 10.1016/S0092-8674(01)00598-0; Henikoff S., 2000, BIOCHIM BIOPHYS ACTA, V1470, P01; Hsieh J, 2000, ANNU REV GENET, V34, P187, DOI 10.1146/annurev.genet.34.1.187; Hutvagner G, 2002, CURR OPIN GENET DEV, V12, P225, DOI 10.1016/S0959-437X(02)00290-3; JACKSON V, 1985, BIOCHEMISTRY-US, V24, P6930, DOI 10.1021/bi00345a027; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Matzke M, 2001, SCIENCE, V293, P1080, DOI 10.1126/science.1063051; Nakagawa H, 2002, GENE DEV, V16, P1766, DOI 10.1101/gad.997702; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nakayama J, 2000, CELL, V101, P307, DOI 10.1016/S0092-8674(00)80840-5; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; NOMA K, UNPUB; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Reik W, 1998, CURR OPIN GENET DEV, V8, P154, DOI 10.1016/S0959-437X(98)80136-6; Reinhart BJ, 2002, SCIENCE, V297, P1831, DOI 10.1126/science.1077183; Selker EU, 1999, CELL, V97, P157, DOI 10.1016/S0092-8674(00)80725-4; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; THON G, 1994, GENETICS, V138, P29; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wassenegger M, 2000, PLANT MOL BIOL, V43, P203, DOI 10.1023/A:1006479327881	37	649	752	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 27	2002	297	5590					2232	2237		10.1126/science.1076466	http://dx.doi.org/10.1126/science.1076466			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597LA	12215653				2022-12-24	WOS:000178222000038
J	Pelham, RJ; Chang, F				Pelham, RJ; Chang, F			Actin dynamics in the contractile ring during cytokinesis in fission yeast	NATURE			English	Article							ARP2/3 COMPLEX; SCHIZOSACCHAROMYCES-POMBE; CLEAVAGE FURROW; CELL-DIVISION; BUDDING YEAST; GENE ENCODES; PROTEIN; CYTOSKELETON; PROFILIN; POLYMERIZATION	Cytokinesis in many eukaryotes requires a contractile ring of actin and myosin that cleaves the cell in two. Little is known about how actin filaments and other components assemble into this ring structure and generate force(1,2). Here we show that the contractile ring in the fission yeast Schizosaccharomyces pombe is an active site of actin assembly. This actin polymerization activity requires Arp3, the formin Cdc12, profilin and WASP, but not myosin II or IQGAP proteins. Both newly polymerized actin filaments and pre-existing actin cables can contribute to the initial assembly of the ring. Once formed, the ring remains a dynamic structure in which actin and other ring components continuously assemble and disassemble from the ring every minute. The rate of actin polymerization can influence the rate of cleavage. Thus, actin polymerization driven by the Arp2/3 complex and formins is a central process in cytokinesis. Our studies show that cytokinesis is a more dynamic process than previously thought and provide a perspective on the mechanism of cell division.	Columbia Univ Coll Phys & Surg, Dept Microbiol, New York, NY 10032 USA	Columbia University	Chang, F (corresponding author), Columbia Univ Coll Phys & Surg, Dept Microbiol, 701 W 168th St, New York, NY 10032 USA.				NIGMS NIH HHS [R01 GM056836] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arai R, 2002, J CELL SCI, V115, P887; Arai R, 1998, EUR J CELL BIOL, V76, P288, DOI 10.1016/S0171-9335(98)80007-1; Balasubramanian MK, 1997, METHOD ENZYMOL, V283, P494; BALASUBRAMANIAN MK, 1994, J CELL BIOL, V125, P1289, DOI 10.1083/jcb.125.6.1289; Balasubramanian MK, 1998, GENETICS, V149, P1265; CAO LG, 1990, J CELL BIOL, V110, P1089, DOI 10.1083/jcb.110.4.1089; Chang F, 1996, J CELL SCI, V109, P131; Chang F, 1997, J CELL BIOL, V137, P169, DOI 10.1083/jcb.137.1.169; Evangelista M, 2002, NAT CELL BIOL, V4, P32, DOI 10.1038/ncb718; Feierbach B, 2001, CURR OPIN MICROBIOL, V4, P713, DOI 10.1016/S1369-5274(01)00273-9; Feierbach B, 2001, CURR BIOL, V11, P1656, DOI 10.1016/S0960-9822(01)00525-5; Fukui Y, 1999, J CELL SCI, V112, P877; Goode BL, 2001, J CELL BIOL, V153, P627, DOI 10.1083/jcb.153.3.627; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Lee WL, 2000, J CELL BIOL, V151, P789, DOI 10.1083/jcb.151.4.789; LI R, 1995, J CELL BIOL, V128, P599, DOI 10.1083/jcb.128.4.599; Machesky LM, 1999, CURR OPIN CELL BIOL, V11, P117, DOI 10.1016/S0955-0674(99)80014-3; MCCOLLUM D, 1995, J CELL BIOL, V130, P651, DOI 10.1083/jcb.130.3.651; McCollum D, 1996, EMBO J, V15, P6438, DOI 10.1002/j.1460-2075.1996.tb01035.x; Morrell JL, 1999, MOL BIOL CELL, V10, P4201, DOI 10.1091/mbc.10.12.4201; Morton WM, 2000, NAT CELL BIOL, V2, P376, DOI 10.1038/35014075; Noguchi T, 2001, J CELL SCI, V114, P401; Pelham RJ, 2001, NAT CELL BIOL, V3, P235, DOI 10.1038/35060020; RAPPAPORT R, 1996, CYTOKINESIS ANIMAL C, P168; Robinson DN, 2000, TRENDS CELL BIOL, V10, P228, DOI 10.1016/S0962-8924(00)01747-5; Sagot I, 2002, NAT CELL BIOL, V4, P42, DOI 10.1038/ncb719; Sawin KE, 2002, CURR BIOL, V12, pR6, DOI 10.1016/S0960-9822(01)00637-6; Theriot JA, 2000, TRAFFIC, V1, P19, DOI 10.1034/j.1600-0854.2000.010104.x; Wasserman S, 1998, TRENDS CELL BIOL, V8, P111, DOI 10.1016/S0962-8924(97)01217-8; Winter DC, 1999, P NATL ACAD SCI USA, V96, P7288, DOI 10.1073/pnas.96.13.7288	30	257	258	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 5	2002	419	6902					82	86		10.1038/nature00999	http://dx.doi.org/10.1038/nature00999			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589YF	12214236				2022-12-24	WOS:000177788600041
J	Fyodorov, DV; Kadonaga, JT				Fyodorov, DV; Kadonaga, JT			Dynamics of ATP-dependent chromatin assembly by ACF	NATURE			English	Article							DNA HELICASE; REMODELING COMPLEXES; HISTONE OCTAMER; ISWI; TRANSCRIPTION; MECHANISMS; PROTEINS; MOTORS; CHRAC	The assembly of DNA into chromatin is a critical step in the replication and repair of the eukaryotic genome(1-8). It has been known for nearly 20 years that chromatin assembly is an ATP-dependent process(9). ATP-dependent chromatin-assembly factor (ACF) uses the energy of ATP hydrolysis for the deposition of histones into periodic nucleosome arrays, and the ISWI subunit of ACF is an ATPase that is related to helicases(10,11). Here we show that ACF becomes committed to the DNA template upon initiation of chromatin assembly. We also observed that ACF assembles nucleosomes in localized arrays, rather than randomly distributing them. By using a purified ACF-dependent system for chromatin assembly, we found that ACF hydrolyses about 2-4 molecules of ATP per base pair in the assembly of nucleosomes. This level of ATP hydrolysis is similar to that used by DNA helicases for the unwinding of DNA(12). These results suggest that a tracking mechanism exists in which ACF assembles chromatin as an ATP-driven DNA-translocating motor. Moreover, this proposed mechanism for ACF may be relevant to the function of other chromatin-remodelling factors that contain ISWI subunits.	Univ Calif San Diego, Mol Biol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Kadonaga, JT (corresponding author), Univ Calif San Diego, Mol Biol Sect, 9500 Gilman Dr, La Jolla, CA 92093 USA.							Adams CR, 1999, CURR OPIN GENET DEV, V9, P185, DOI 10.1016/S0959-437X(99)80028-8; Cairns BR, 1998, TRENDS BIOCHEM SCI, V23, P20, DOI 10.1016/S0968-0004(97)01160-2; Eberharter A, 2001, EMBO J, V20, P3781, DOI 10.1093/emboj/20.14.3781; EGGLESTON AK, 1995, J BIOL CHEM, V270, P2024, DOI 10.1074/jbc.270.5.2024; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Flaus A, 2001, CURR OPIN GENET DEV, V11, P148, DOI 10.1016/S0959-437X(00)00172-6; Fry CJ, 2001, CURR BIOL, V11, pR185, DOI 10.1016/S0960-9822(01)00090-2; Fyodorov DV, 2001, CELL, V106, P523, DOI 10.1016/S0092-8674(01)00478-0; GLIKIN GC, 1984, CELL, V37, P33, DOI 10.1016/0092-8674(84)90298-8; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Hamiche A, 1999, CELL, V97, P833, DOI 10.1016/S0092-8674(00)80796-5; Havas K, 2000, CELL, V103, P1133, DOI 10.1016/S0092-8674(00)00215-4; Ito T, 1999, GENE DEV, V13, P1529, DOI 10.1101/gad.13.12.1529; Ito T, 1997, CELL, V90, P145, DOI 10.1016/S0092-8674(00)80321-9; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; KORNBERG RD, 1995, CURR OPIN CELL BIOL, V7, P371, DOI 10.1016/0955-0674(95)80092-1; Kornberg RD, 1999, CURR OPIN GENET DEV, V9, P148, DOI 10.1016/S0959-437X(99)80022-7; Langst G, 1999, CELL, V97, P843, DOI 10.1016/S0092-8674(00)80797-7; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; Mello JA, 2001, CURR OPIN GENET DEV, V11, P136, DOI 10.1016/S0959-437X(00)00170-2; Pazin MJ, 1997, CELL, V88, P737, DOI 10.1016/S0092-8674(00)81918-2; RAMSPERGER U, 1995, EMBO J, V14, P3215, DOI 10.1002/j.1460-2075.1995.tb07324.x; STUDITSKY VM, 1995, CELL, V83, P19, DOI 10.1016/0092-8674(95)90230-9; Tsukiyama T, 1997, CURR OPIN GENET DEV, V7, P182, DOI 10.1016/S0959-437X(97)80127-X; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Verreault A, 2000, GENE DEV, V14, P1430; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Whitehouse I, 1999, NATURE, V400, P784, DOI 10.1038/23506	28	71	71	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 22	2002	418	6900					897	900		10.1038/nature00929	http://dx.doi.org/10.1038/nature00929			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585YR	12192415				2022-12-24	WOS:000177555600043
J	Honaramooz, A; Snedaker, A; Boiani, M; Scholer, H; Dobrinski, I; Schlatt, S				Honaramooz, A; Snedaker, A; Boiani, M; Scholer, H; Dobrinski, I; Schlatt, S			Sperm from neonatal mammalian testes grafted in mice	NATURE			English	Article							GERM-CELL TRANSPLANTATION; MOUSE TESTES; ESTROGEN-RECEPTOR; SPERMATOGENESIS; RAT; SPERMATOZOA; OOCYTES; HOST	Spermatogenesis is a productive and highly organized process that generates virtually unlimited numbers of sperm during adulthood. Continuous proliferation and differentiation of germ cells occur in a delicate balance with other testicular compartments, especially the supporting Sertoli cells(1). Many complex aspects of testis function in humans and large animals have remained elusive because of a lack of suitable in vitro or in vivo models. Germ cell transplantation has produced complete donor-derived spermatogenesis in rodents(2-6) but not in other mammalian species(7-9). Production of sperm in grafted tissue from immature mammalian testes and across species has not yet been accomplished. Here we report the establishment of complete spermatogenesis by grafting testis tissue from newborn mice, pigs or goats into mouse hosts. This approach maintains structural integrity and provides the accessibility that is essential for studying and manipulating the function of testes and for preserving the male germ line. Our results indicate that this approach is applicable to diverse mammalian species.	Univ Penn, Sch Vet Med, New Bolton Ctr,Male Germ Cell Biol Grp, Ctr Anim Transgenesis & Germ Cell Res, Kennett Sq, PA 19348 USA; Univ Penn, Sch Vet Med, New Bolton Ctr,Germline Dev Grp, Ctr Anim Transgenesis & Germ Cell Res, Kennett Sq, PA 19348 USA; Univ Munster, Inst Reprod Med, D-48149 Munster, Germany	University of Pennsylvania; University of Pennsylvania; University of Munster	Dobrinski, I (corresponding author), Univ Penn, Sch Vet Med, New Bolton Ctr,Male Germ Cell Biol Grp, Ctr Anim Transgenesis & Germ Cell Res, Kennett Sq, PA 19348 USA.		Boiani, Michele/M-3519-2015; Dobrinski, Ina/A-1095-2007; , HS/AAB-4434-2019	Boiani, Michele/0000-0003-2765-2781; , HS/0000-0003-2643-5136; Schlatt, Stefan/0000-0002-7571-5313				Amann R.P., 1970, TESTIS, V1, P433, DOI DOI 10.1016/B978-0-12-386601-1.50013-5; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11303, DOI 10.1073/pnas.91.24.11303; CHANDOLIA RK, 1991, ACTA ENDOCRINOL-COP, V125, P547, DOI 10.1530/acta.0.1250547; CHATOT CL, 1990, BIOL REPROD, V42, P432, DOI 10.1095/biolreprod42.3.432; Clouthier DE, 1996, NATURE, V381, P418, DOI 10.1038/381418a0; DEANESLY R, 1954, J ENDOCRINOL, V11, P201, DOI 10.1677/joe.0.0110201; Dobrinski I, 1999, BIOL REPROD, V61, P1331, DOI 10.1095/biolreprod61.5.1331; Dobrinski I, 2000, MOL REPROD DEV, V57, P270, DOI 10.1002/1098-2795(200011)57:3&lt;270::AID-MRD9&gt;3.0.CO;2-Z; Eddy EM, 1996, ENDOCRINOLOGY, V137, P4796, DOI 10.1210/en.137.11.4796; FRASER LR, 1975, BIOL REPROD, V13, P513, DOI 10.1095/biolreprod13.5.513; Goud PT, 1998, HUM REPROD, V13, P1336, DOI 10.1093/humrep/13.5.1336; Jiang FX, 1995, INT J ANDROL, V18, P326, DOI 10.1111/j.1365-2605.1995.tb00570.x; Johnson L, 1996, BIOL REPROD, V54, P948, DOI 10.1095/biolreprod54.5.948; KUOPIO T, 1989, J ANDROL, V10, P335; Lee KH, 2000, BIOL REPROD, V63, P1873, DOI 10.1095/biolreprod63.6.1873; McCarrey J, 1993, CELL MOL BIOL TESTIS, P58; Nagano M, 2001, BIOL REPROD, V64, P1409, DOI 10.1095/biolreprod64.5.1409; Ogawa T, 2000, NAT MED, V6, P29, DOI 10.1038/71496; Ogawa T, 1999, BIOL REPROD, V60, P515, DOI 10.1095/biolreprod60.2.515; Orth JM., 1993, CELL MOL BIOL TESTIS, P3; Russell LD, 1990, HISTOLOGICAL HISTOPA, P1; Schlatt S, 1999, HUM REPROD, V14, P144, DOI 10.1093/humrep/14.1.144; SCHLATT S, 2000, BR MED B, V56, P577; SWIERSTRA EE, 1968, J REPROD FERTIL, V17, P459, DOI 10.1530/jrf.0.0170459; SWIERSTRA EE, 1971, J REPROD FERTIL, V27, P91, DOI 10.1530/jrf.0.0270091; Wakayama T, 1998, J REPROD FERTIL, V112, P11, DOI 10.1530/jrf.0.1120011	27	312	351	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 15	2002	418	6899					778	781		10.1038/nature00918	http://dx.doi.org/10.1038/nature00918			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UF	12181567				2022-12-24	WOS:000177428000039
J	Michaelis, W; Seifert, R; Nauhaus, K; Treude, T; Thiel, V; Blumenberg, M; Knittel, K; Gieseke, A; Peterknecht, K; Pape, T; Boetius, A; Amann, R; Jorgensen, BB; Widdel, F; Peckmann, J; Pimenov, NV; Gulin, MB				Michaelis, W; Seifert, R; Nauhaus, K; Treude, T; Thiel, V; Blumenberg, M; Knittel, K; Gieseke, A; Peterknecht, K; Pape, T; Boetius, A; Amann, R; Jorgensen, BB; Widdel, F; Peckmann, J; Pimenov, NV; Gulin, MB			Microbial reefs in the Black Sea fueled by anaerobic oxidation of methane	SCIENCE			English	Article							SULFATE-REDUCING BACTERIA; WATER COLUMN; ARCHAEA; SEDIMENTS; COMMUNITIES; CONSORTIUM; CARBONATES; REDUCTION; DIETHERS; SEEPS	Massive microbial mats covering up to 4-meter-high carbonate buildups prosper at methane seeps in anoxic waters of the northwestern Black Sea shelf. Strong C-13 depletions indicate an incorporation of methane carbon into carbonates, bulk biomass, and specific lipids. The mats mainly consist of densely aggregated archaea ( phylogenetic ANME-1 cluster) and sulfate-reducing bacteria (Desulfosarcina/Desulfococcus group). If incubated in vitro, these mats perform anaerobic oxidation of methane coupled to sulfate reduction. Obviously, anaerobic microbial consortia can generate both carbonate precipitation and substantial biomass accumulation, which has implications for our understanding of carbon cycling during earlier periods of Earth's history.	Univ Hamburg, Inst Biogeochem & Marine Chem, D-20146 Hamburg, Germany; Max Planck Inst Marine Microbiol, D-28359 Bremen, Germany; Alfred Wegener Inst Polar & Marine Res, D-27515 Bremerhaven, Germany; Int Univ Bremen, D-28725 Bremen, Germany; Univ Gottingen, Geowissensch Zentrum, D-37077 Gottingen, Germany; Russian Acad Sci, Inst Microbiol, Moscow 117811, Russia; Natl Acad Sci Ukraine, Inst Biol So Seas, Sevastopol, Ukraine	University of Hamburg; Max Planck Society; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Jacobs University; University of Gottingen; Research Center of Biotechnology RAS; Russian Academy of Sciences; National Academy of Sciences Ukraine; Russian Academy of Sciences; AO Kovalevsky Institute of Biology of the Southern Seas of RAS (IBSS)	Michaelis, W (corresponding author), Univ Hamburg, Inst Biogeochem & Marine Chem, Bundesstr 55, D-20146 Hamburg, Germany.	michaelis@geowiss.uni-hamburg.de	Jorgensen, Bo B/C-2214-2013; Pape, Thomas/A-8138-2018; Treude, Tina/AAD-5817-2020; Boetius, Antje/D-5459-2013; Gulin, Maksim/E-1233-2016; Amann, Rudolf I/C-6534-2014	Jorgensen, Bo B/0000-0001-9398-8027; Pape, Thomas/0000-0002-6872-2144; Boetius, Antje/0000-0003-2117-4176; Gulin, Maksim/0000-0002-3644-4362; Amann, Rudolf I/0000-0002-0846-7372; Pimenov, Nikolai/0000-0001-9757-0867; Blumenberg, Martin/0000-0002-9791-8568; Peckmann, Jorn/0000-0002-8572-0060; Treude, Tina/0000-0001-6366-286X; Thiel, Volker/0000-0003-4758-2784				Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Boetius A, 2000, DEEP-SEA RES PT II, V47, P2835, DOI 10.1016/S0967-0645(00)00051-5; Boetius A., 2002, OCEAN MARGIN SYSTEMS, P457, DOI [DOI 10.1007/978-3-662-05127-6_28, 10.1007/978-3-662-05127-6_28]; Elvert M, 1999, NATURWISSENSCHAFTEN, V86, P295, DOI 10.1007/s001140050619; Elvert M, 2000, ORG GEOCHEM, V31, P1175, DOI 10.1016/S0146-6380(00)00111-X; Elvert M., 2001, NATURAL GAS HYDRATES, P115, DOI [10.1029/GM124p0115, DOI 10.1029/GM124P0115]; FRY B, 1991, DEEP SEA RES S2, V38, P1013; Hanson RS, 1996, MICROBIOL REV, V60, P439, DOI 10.1128/MMBR.60.2.439-471.1996; Hayes JM, 1994, NOBEL S, P220; Hinrichs KU, 2000, GEOCHEM GEOPHY GEOSY, V1; Hinrichs KU, 1999, NATURE, V398, P802, DOI 10.1038/19751; Hinrichs KU, 2000, ORG GEOCHEM, V31, P1685, DOI 10.1016/S0146-6380(00)00106-6; HOEHLER TM, 1994, GLOBAL BIOGEOCHEM CY, V8, P451, DOI 10.1029/94GB01800; IVANOV MV, 1991, DOKL AKAD NAUK SSSR+, V320, P1235; IVERSEN N, 1981, APPL ENVIRON MICROB, V41, P1295, DOI 10.1128/AEM.41.6.1295-1300.1981; Jahnke LL, 2001, APPL ENVIRON MICROB, V67, P5179, DOI 10.1128/AEM.67.11.5179-5189.2001; King LL, 1998, ORG GEOCHEM, V28, P677, DOI 10.1016/S0146-6380(98)00037-0; Laniece P, 1998, J NEUROSCI METH, V86, P1, DOI 10.1016/S0165-0270(98)00128-9; LIEN AY, 2002, MICROBIOLOGY, V70, P78; Mojzsis SJ, 1996, NATURE, V384, P55, DOI 10.1038/384055a0; Nauhaus K, 2002, ENVIRON MICROBIOL, V4, P296, DOI 10.1046/j.1462-2920.2002.00299.x; ORPHAN V, 2002, P NATL ACAD SCI USA; Orphan VJ, 2002, P NATL ACAD SCI USA, V99, P7663, DOI 10.1073/pnas.072210299; Orphan VJ, 2001, SCIENCE, V293, P484, DOI 10.1126/science.1061338; Orphan VJ, 2001, APPL ENVIRON MICROB, V67, P1922, DOI 10.1128/AEM.67.4.1922-1934.2001; Pancost RD, 2000, APPL ENVIRON MICROB, V66, P1126, DOI 10.1128/AEM.66.3.1126-1132.2000; Pancost RD, 2001, ORG GEOCHEM, V32, P695, DOI 10.1016/S0146-6380(01)00015-8; Peckmann J, 2001, MAR GEOL, V177, P129, DOI 10.1016/S0025-3227(01)00128-1; Pimenov NV, 1997, MICROBIOLOGY+, V66, P354; Rutters H, 2001, ARCH MICROBIOL, V176, P435, DOI 10.1007/s002030100343; SCHOPF JW, 1993, SCIENCE, V260, P640, DOI 10.1126/science.260.5108.640; Schouten S, 1997, ORG GEOCHEM, V26, P409, DOI 10.1016/S0146-6380(97)00011-9; Schramm A, 1996, APPL ENVIRON MICROB, V62, P4641, DOI 10.1128/AEM.62.12.4641-4647.1996; Seifert R, 1999, BIOGEOCHEMISTRY, V44, P73, DOI 10.1007/BF00992999; Shen YA, 2001, NATURE, V410, P77, DOI 10.1038/35065071; SINNINGHE JS, 2000, CHEM COMMUN, V2000, P1683; Snaidr J, 1997, APPL ENVIRON MICROB, V63, P2884, DOI 10.1128/AEM.63.7.2884-2896.1997; TEIXIDOR P, 1992, J CHROMATOGR, V607, P253, DOI 10.1016/0021-9673(92)87083-K; Thiel V, 2001, ORG GEOCHEM, V32, P1019, DOI 10.1016/S0146-6380(01)00075-4; Thiel V, 1999, GEOCHIM COSMOCHIM AC, V63, P3959, DOI 10.1016/S0016-7037(99)00177-5; Thiel V, 2001, MAR CHEM, V73, P97, DOI 10.1016/S0304-4203(00)00099-2; Valentine DL, 2000, ENVIRON MICROBIOL, V2, P477, DOI 10.1046/j.1462-2920.2000.00135.x	42	530	589	5	170	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 9	2002	297	5583					1013	1015		10.1126/science.1072502	http://dx.doi.org/10.1126/science.1072502			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581ZN	12169733				2022-12-24	WOS:000177325400044
J	Hynes, M; Sheik, M; Wilson, HG; Spiegel, P				Hynes, M; Sheik, M; Wilson, HG; Spiegel, P			Reproductive health indicators and outcomes among refugee and internally displaced persons in postemergency phase camps	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NUTRITIONAL-STATUS; PUBLIC-HEALTH; MORTALITY; CONFLICT; INTERVENTIONS; POPULATIONS; CHILDHOOD; GUINEA	Context Despite increasing awareness of the importance of reproductive health programs and services for refugee and internally displaced populations, there is a paucity of basic epidemiological data on reproductive health outcomes. Objectives To collect data on reproductive health outcomes among refugees and internally displaced persons in postemergency phase camps and compare these outcomes with those of host country and country-of-origin populations. To determine programmatic factors that may affect reproductive health outcomes. Design, Setting, and Participants Retrospective study of data collected from August 1998 through March 2000 of 688766 persons living in 52 postemergency phase camps in 7 countries. Reproductive health outcomes of refugee and internally displaced populations were compared with available data of reference populations within their respective host country and country of origin. Main Outcome Measures Crude birth rate (CBR), neonatal mortality rate (NNMR), maternal mortality ratio (MMR), percentage of newborns with low birth weight (LBW), and incidence of complications of unsafe or spontaneous abortions. Results Six of 11 groups had lower CBRs than their country of origin and 5 of 9 groups had lower CBRs than their host country. Four of 5 had lower NNMRs than their country of origin and 6 of 9 had lower NNMRs than the host country. Four of 6 had lower MMRs than their country of origin, and 5 of 6 had lower MMRs than their host country. Seven of 9 had lower percentages of LBWs than in the country of origin and 5 of 9 had lower percentages of LBWs than the host country. Higher CBRs were associated with more recently established camps and higher numbers of local health staff per 1000 persons; and higher percentages of LBW newborns were associated with rainy season, more recently established camps, lower numbers of community health workers per 1000 persons, and camps without supplementary feeding-programs. Conclusions Refugees and internally displaced persons inmost postemergency phase camps had better reproductive health outcomes than their respective host country and country-of-origin populations.	Ctr Dis Control & Prevent, Div Reprod Hlth, Natl Ctr Chron Dis, Atlanta, GA 30341 USA; Ctr Dis Control & Prevent, Int Emergency & Refugee Hlth Branch, Div Emergency & Environm Hlth Serv, Natl Ctr Environm Hlth, Atlanta, GA 30341 USA; Johns Hopkins Sch Publ Hlth, Ctr Refugee & Disaster Studies, Baltimore, MD USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Hynes, M (corresponding author), Ctr Dis Control & Prevent, Div Reprod Hlth, Natl Ctr Chron Dis, Mailstop K-22,2900 Woodcock Blvd, Atlanta, GA 30341 USA.	mhynes@cdc.gov	Spiegel, Paul/AAL-3238-2021	Spiegel, Paul/0000-0002-6158-6661; Hynes, Michelle/0000-0002-2204-6531				Aaby P, 1999, BRIT MED J, V319, P878, DOI 10.1136/bmj.319.7214.878; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; Banatvala N, 2000, BMJ-BRIT MED J, V321, P101, DOI 10.1136/bmj.321.7253.101; Becker S, 1998, INT J EPIDEMIOL, V27, P814, DOI 10.1093/ije/27.5.814; BOSS LP, 1987, INT J EPIDEMIOL, V16, P556, DOI 10.1093/ije/16.4.556; CANTRELLE P, 1971, POP STUD-J DEMOG, V25, P505, DOI 10.1080/00324728.1971.10405821; Ceesay SM, 1997, BMJ-BRIT MED J, V315, P786, DOI 10.1136/bmj.315.7111.786; Dorman EK, 2002, ULTRASOUND OBST GYN, V19, P165, DOI 10.1046/j.0960-7692.2001.00545.x; ELIAS CJ, 1990, AM J PUBLIC HEALTH, V80, P824, DOI 10.2105/AJPH.80.7.824; GUYATT H, 1995, T R SOC TROP MED HYG, V6, P569; Hoa DP, 1996, ANN TROP PAEDIATR, V16, P327, DOI 10.1080/02724936.1996.11747845; *MACR INT INC, 1997, TANZ DEM HLTH SURV; *MACR INT INC, 1997, MAT HLTH CAR; *MACR INT INC, 1996, UG DEM HLTH SURV 199; *MACR INT INC, 1994, ENQ DEM SANT RWAND; MAINE D, 1999, SAFE MOTHERHOOD INIT; McGinn T, 2000, INT FAM PLAN PERSPEC, V26, P174, DOI 10.2307/2648255; MCGINN T, 1998, EFFECT MAT CALORIE S; MERCER A, 1992, DISASTERS, V16, P28, DOI 10.1111/j.1467-7717.1992.tb00373.x; Palmer CA, 1999, SOC SCI MED, V49, P1689, DOI 10.1016/S0277-9536(99)00253-1; Pitt MarkM., 1998, SEASONALITY WEATHER; PRADHAN A, 1996, NEPAL FAMILY HLTH SU; Sachs L, 1997, Afr Health, V19, P24; SPIEGEL P, IN PRESS LANCET; SPIEGEL P, 2000, REFUGE, V18, P1; Spiegel PB, 2001, DISASTERS, V25, P172, DOI 10.1111/1467-7717.00169; *STEER COMM HUM RE, 1998, SPHER HUM CHART MIN; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; TOOLE MJ, 1990, JAMA-J AM MED ASSOC, V263, P3296, DOI 10.1001/jama.263.24.3296; *UN CHILDR FUND, 2000, STAT WORLDS CHILDR; *UN HIGH COMM REF, 1999, REPR HLTH REF SIT IN; *UN HIGH COMM REF, 1998, REPR HLTH REF SIT RE; UN. High Commission for Refugees, 1999, HDB EM; US Committee for Refugees, 2002, WORLD REF SURV 2002; *US STAT DIV, 2000, IND HLTH; Van Damme W, 1998, LANCET, V351, P1609, DOI 10.1016/S0140-6736(97)10348-8; Waldman R, 1999, AM J PUBLIC HEALTH, V89, P1483, DOI 10.2105/AJPH.89.10.1483; *WHO, 2000, BAS HLTH IND COUNTR; *WHO, 1998, SAF MOTH INF KIT; WHO, 2000, MAN NUTR MAJ EM, V2nd, P236; WHO UNICEF UNFPA, 1997, GUID MON AV US OBST; Wulf D, 1994, REFUGEE WOMEN REPROD	42	64	64	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 7	2002	288	5					595	603		10.1001/jama.288.5.595	http://dx.doi.org/10.1001/jama.288.5.595			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	581FJ	12150671	Bronze			2022-12-24	WOS:000177280200018
J	Kohler, E; Keysers, C; Umilta, MA; Fogassi, L; Gallese, V; Rizzolatti, G				Kohler, E; Keysers, C; Umilta, MA; Fogassi, L; Gallese, V; Rizzolatti, G			Hearing sounds, understanding actions: Action representation in mirror neurons	SCIENCE			English	Article							PREMOTOR CORTEX; PERIARCUATE NEURONS; AFFERENT PROPERTIES; MACAQUE MONKEYS; AREA; RECOGNITION; MOVEMENTS; RESPONSES; SPACE	Many object-related actions can be recognized by their sound. We found neurons in monkey premotor cortex that discharge when the animal performs a specific action and when it hears the related sound. Most of the neurons also discharge when the monkey observes the same action. These audiovisual mirror neurons code actions independently of whether these actions are performed, heard, or seen. This discovery in the monkey homolog of Broca's area might shed light on the origin of language: audiovisual mirror neurons code abstract contents - the meaning of actions - and have the auditory access typical of human language to these contents.	Univ Parma, Ist Fisiol Umana, I-43100 Parma, Italy; Univ Parma, Dipartimento Psicol, I-43100 Parma, Italy	University of Parma; University of Parma	Rizzolatti, G (corresponding author), Univ Parma, Ist Fisiol Umana, I-43100 Parma, Italy.		Keysers, Christian/H-6251-2013; Galantucci, Bruno/E-5770-2010; Gallese, Vittorio/ABD-5097-2021; FOGASSI, Leonardo/K-3541-2018	Keysers, Christian/0000-0002-2845-5467; Gallese, Vittorio/0000-0003-4815-3607; FOGASSI, Leonardo/0000-0003-3348-039X; Umilta', Maria Alessandra/0000-0003-0180-6818				BACH M, 1983, J NEUROSCI METH, V9, P9, DOI 10.1016/0165-0270(83)90103-6; BAYLIS GC, 1987, J NEUROSCI, V7, P330; BRUCE C, 1981, J NEUROPHYSIOL, V46, P369, DOI 10.1152/jn.1981.46.2.369; Cantalupo C, 2001, NATURE, V414, P505, DOI 10.1038/35107134; Fogassi L, 1996, J NEUROPHYSIOL, V76, P141, DOI 10.1152/jn.1996.76.1.141; Fogassi L, 2001, BRAIN, V124, P571, DOI 10.1093/brain/124.3.571; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; GENTILUCCI M, 1988, EXP BRAIN RES, V71, P475, DOI 10.1007/BF00248741; Graziano MSA, 1999, NATURE, V397, P428, DOI 10.1038/17115; GRAZIANO MSA, 1994, SCIENCE, V266, P1054, DOI 10.1126/science.7973661; MISTLIN AJ, 1990, EXP BRAIN RES, V82, P437; Petrides M., 1994, HDB NEUROPSYCHOLOGY, V9, P17; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; RIZZOLATTI G, 1981, BEHAV BRAIN RES, V2, P147, DOI 10.1016/0166-4328(81)90053-X; RIZZOLATTI G, 1981, BEHAV BRAIN RES, V2, P125, DOI 10.1016/0166-4328(81)90052-8; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Rizzolatti G., 1988, NEUROBIOLOGY NEOCORT, P269; Stein BE, 2001, PROG BRAIN RES, V134, P143; Umilta MA, 2001, NEURON, V31, P155, DOI 10.1016/S0896-6273(01)00337-3	20	1150	1195	4	167	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 2	2002	297	5582					846	848		10.1126/science.1070311	http://dx.doi.org/10.1126/science.1070311			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579RZ	12161656				2022-12-24	WOS:000177192800054
J	Wasch, R; Cross, FR				Wasch, R; Cross, FR			APC-dependent proteolysis of the mitotic cyclin Clb2 is essential for mitotic exit	NATURE			English	Article							ANAPHASE-PROMOTING COMPLEX; S-PHASE; SACCHAROMYCES-CEREVISIAE; MEDIATED PROTEOLYSIS; PHOSPHATASE CDC14; BUDDING YEAST; HCT1; PHOSPHORYLATION; MITOSIS; FIZZY	Cyclin degradation is central to regulation of the cell cycle. Mitotic exit was proposed to require degradation of the S phase cyclin Clb5 by the anaphase-promoting complex 1,2 activated by Cdc20 (APC(Cdc20))(3). Furthermore, Clb5 degradation was thought to be necessary for effective dephosphorylation and activation of the APC regulatory subunit Cdh1 (also known as Hct1) and the cyclin-dependent kinase inhibitor Sic1 by the phosphatase Cdc14, allowing mitotic kinase inactivation and mitotic exit(3-7). Here we show, however, that spindle disassembly and cell division occur without significant APC Cdc20-mediated Clb5 degradation, as well as in the absence of both Cdh1 and Sic1. We find instead that destruction-box-dependent degradation of the mitotic cyclin Clb2 is essential for mitotic exit. APC Cdc20 may be required for an essential early phase of Clb2 degradation, and this phase may be sufficient for most aspects of mitotic exit. Cdh1 and Sic1 may be required for further inactivation of Clb2-Cdk1, regulating cell size and the length of G1.	Rockefeller Univ, New York, NY 10021 USA	Rockefeller University	Cross, FR (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.		Waesch, Ralph/F-6282-2019					Calzada A, 2001, NATURE, V412, P355, DOI 10.1038/35085610; Cross FR, 1999, MOL CELL, V4, P11, DOI 10.1016/S1097-2765(00)80183-5; Gieffers C, 1999, P NATL ACAD SCI USA, V96, P11317, DOI 10.1073/pnas.96.20.11317; HOGAN E, 1992, P NATL ACAD SCI USA, V89, P3098, DOI 10.1073/pnas.89.7.3098; Huang JN, 2001, J CELL BIOL, V154, P85, DOI 10.1083/jcb.200102007; Jacobson MD, 2000, MOL CELL BIOL, V20, P4483, DOI 10.1128/MCB.20.13.4483-4493.2000; Jaspersen SL, 2000, CURR BIOL, V10, P615, DOI 10.1016/S0960-9822(00)00491-7; Jaspersen SL, 1999, CURR BIOL, V9, P227, DOI 10.1016/S0960-9822(99)80111-0; Juang YL, 1997, SCIENCE, V275, P1311, DOI 10.1126/science.275.5304.1311; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Lim HH, 1998, CURR BIOL, V8, P231, DOI 10.1016/S0960-9822(98)70088-0; Lorca T, 1998, EMBO J, V17, P3565, DOI 10.1093/emboj/17.13.3565; Morgan DO, 1999, NAT CELL BIOL, V1, pE47, DOI 10.1038/10039; Noton E, 2000, MOL CELL, V5, P85, DOI 10.1016/S1097-2765(00)80405-0; Oehlen LJWM, 1996, MOL CELL BIOL, V16, P2830; Pfleger CM, 2000, GENE DEV, V14, P655; Rudner AD, 2000, J CELL BIOL, V149, P1377, DOI 10.1083/jcb.149.7.1377; Schwab M, 2001, EMBO J, V20, P5165, DOI 10.1093/emboj/20.18.5165; Schwab M, 1997, CELL, V90, P683, DOI 10.1016/S0092-8674(00)80529-2; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; Shirayama M, 1999, NATURE, V402, P203, DOI 10.1038/46080; Sigrist SJ, 1997, CELL, V90, P671, DOI 10.1016/S0092-8674(00)80528-0; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Yamaguchi S, 2000, EMBO J, V19, P3968, DOI 10.1093/emboj/19.15.3968; Yeong FM, 2000, MOL CELL, V5, P501, DOI 10.1016/S1097-2765(00)80444-X; Yeong FM, 2001, MOL CELL BIOL, V21, P5071, DOI 10.1128/MCB.21.15.5071-5081.2001; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039; Zachariae W, 1998, SCIENCE, V282, P1721, DOI 10.1126/science.282.5394.1721	30	185	186	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 1	2002	418	6897					556	562		10.1038/nature00856	http://dx.doi.org/10.1038/nature00856			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579EE	12152084				2022-12-24	WOS:000177162800046
J	Benner, JS; Glynn, RJ; Mogun, H; Neumann, PJ; Weinstein, MC; Avorn, J				Benner, JS; Glynn, RJ; Mogun, H; Neumann, PJ; Weinstein, MC; Avorn, J			Long-term persistence in use of statin therapy in elderly patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; LIPID-LOWERING MEDICATIONS; CORONARY-HEART-DISEASE; ANTIHYPERTENSIVE THERAPY; DISCONTINUATION RATES; PRIMARY PREVENTION; PRAVASTATIN; EVENTS; INTERVENTIONS; COMORBIDITY	Context Knowledge of long-term persistence with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor (statin) therapy is limited because previous studies have observed patients for short periods of time, in closely monitored clinical trials, or in other unrepresentative settings. Objective To describe the patterns and predictors of long-term persistence with statin therapy in an elderly US population. Design, Setting, and Patients Retrospective cohort study including 34501 enrollees in the New Jersey Medicaid and Pharmaceutical Assistance to the Aged and Disabled programs who were 65 years of age and older, initiated statin treatment between 1990 and 1998, and who were followed up until death, disenrollment, or December 31, 1999. Main Outcome Measures Proportion of days covered (PDC) by a statin in each quarter during the first year of therapy and every 6 months thereafter; predictors of suboptimal persistence during each interval (PDC <80%) were identified using generalized linear models for repeated measures. Results The mean PDC was 79% in the first 3 months of treatment, 56% in the second quarter, and 42% after 120 months. Only 1 patient in 4 maintained a PDC of at least 80% after 5 years. The proportion of patients with a PDC less than 80% increased in a log-linear manner, comprising 40%, 61%, and 68% of the cohort after 3, 12, and 120 months, respectively. Independent predictors of poor long-term persistence included nonwhite race, lower income, older age, less cardiovascular morbidity at initiation of therapy, depression, dementia, and occurrence of coronary heart disease events after starting treatment. Patients who initiated therapy between 1996-1998 were 21% to 25% more likely to have a PDC of at least 80% than those who started in 1990. Conclusions Persistence with statin therapy in older patients declines substantially over time, with the greatest drop occurring in the first 6 months of treatment. Despite slightly better persistence among patients who began treatment in recent years, long-term use remains low. Interventions are needed early in treatment and among high-risk groups, including those who experience coronary heart disease events after initiating treatment.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Ctr Risk Anal, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Benner, JS (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Pharmacoepidemiol & Pharmacoecon, 221 Longwood Ave,Suite 341, Boston, MA 02115 USA.	jbenner@post.harvard.edu			NIA NIH HHS [AG-18935, AG-18833] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R56AG018833, R01AG018833] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		American Heart Association, 2000, 2001 HEART STROK STA; ANDRADE SE, 1995, NEW ENGL J MED, V332, P1125, DOI 10.1056/NEJM199504273321703; Avorn J, 1998, JAMA-J AM MED ASSOC, V279, P1458, DOI 10.1001/jama.279.18.1458; Brier KL, 1999, ARCH INTERN MED, V159, P569, DOI 10.1001/archinte.159.6.569; Burke LE, 1997, ANN BEHAV MED, V19, P239, DOI 10.1007/BF02892289; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Choo PW, 1999, MED CARE, V37, P846, DOI 10.1097/00005650-199909000-00002; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Eriksson M, 1998, J INTERN MED, V243, P373; Fedder DO, 2002, CIRCULATION, V105, P152, DOI 10.1161/hc0202.101971; GURWITZ JH, 1993, AM J PUBLIC HEALTH, V83, P711, DOI 10.2105/AJPH.83.5.711; Haynes RB, 1996, LANCET, V348, P383; Hiatt JG, 1999, AM J MANAG CARE, V5, P437; Hunt D, 2001, ANN INTERN MED, V134, P931, DOI 10.7326/0003-4819-134-10-200105150-00007; Insull W, 1997, J INTERN MED, V241, P317, DOI 10.1046/j.1365-2796.1997.112133000.x; Jackevicius CA, 2001, ARCH INTERN MED, V161, P183, DOI 10.1001/archinte.161.2.183; LaRosa JC, 1999, JAMA-J AM MED ASSOC, V282, P2340, DOI 10.1001/jama.282.24.2340; Lemaitre RN, 1998, ARCH INTERN MED, V158, P1761, DOI 10.1001/archinte.158.16.1761; Lewis SJ, 1998, ANN INTERN MED, V129, P681, DOI 10.7326/0003-4819-129-9-199811010-00002; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267; Majumdar SR, 1999, J GEN INTERN MED, V14, P711, DOI 10.1046/j.1525-1497.1999.02229.x; McCormick D, 1999, ARCH INTERN MED, V159, P561, DOI 10.1001/archinte.159.6.561; Miettinen TA, 1997, CIRCULATION, V96, P4211; Monane M, 1996, AM J PUBLIC HEALTH, V86, P1805, DOI 10.2105/AJPH.86.12.1805; MONANE M, 1994, ARCH INTERN MED, V154, P433, DOI 10.1001/archinte.154.4.433; Monane M, 1997, AM J HYPERTENS, V10, P697, DOI 10.1016/S0895-7061(97)00056-3; *MRC BHF HEART PRO, 2001, PREL RES; PEDERSEN TR, 1994, LANCET, V344, P1383; Redelmeier DA, 1998, NEW ENGL J MED, V338, P1516, DOI 10.1056/NEJM199805213382106; Roter DL, 1998, MED CARE, V36, P1138, DOI 10.1097/00005650-199808000-00004; Rudd P., 1994, CARDIOL REV, V2, P230; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; SAS Institute Inc., 2000, SAS VERS 8 2; Schwed A, 1999, J CLIN PHARMACOL, V39, P402, DOI 10.1177/00912709922007976; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Simons LA, 1996, MED J AUSTRALIA, V164, P208, DOI 10.5694/j.1326-5377.1996.tb94138.x; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; WANG PJ, IN PRESS J GEN INTER	40	908	923	2	38	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 24	2002	288	4					455	461		10.1001/jama.288.4.455	http://dx.doi.org/10.1001/jama.288.4.455			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	575NZ	12132975	Bronze			2022-12-24	WOS:000176955400027
J	Long, CA; Hoffman, SL				Long, CA; Hoffman, SL			Parasitology: Malaria - from infants to genomics to vaccines	SCIENCE			English	Editorial Material									NIH, Malaria Vaccine Dev Unit, Rockville, MD 20852 USA; Celera Genom, Rockville, MD 20850 USA	National Institutes of Health (NIH) - USA	Long, CA (corresponding author), NIH, Malaria Vaccine Dev Unit, Rockville, MD 20852 USA.							*WHO, 2002, REP COMM MACR HLTH W; 2002, KEYST S 3 8 MARCH 20	2	15	20	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 19	2002	297	5580					345	347		10.1126/science.1074484	http://dx.doi.org/10.1126/science.1074484			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574LV	12130768				2022-12-24	WOS:000176892600033
J	Sunda, W; Kieber, DJ; Kiene, RP; Huntsman, S				Sunda, W; Kieber, DJ; Kiene, RP; Huntsman, S			An antioxidant function for DMSP and DMS in marine algae	NATURE			English	Article							DIMETHYLSULFOXIDE DMSO; HYDROXYL RADICALS; RATE CONSTANTS; SEAWATER; SULFUR; IRON; DIMETHYLSULFONIOPROPIONATE; PHYTOPLANKTON; CONVERSION; OXYGEN	The algal osmolyte dimethylsulphoniopropionate (DMSP) and its enzymatic cleavage product dimethylsulphide (DMS) contribute significantly to the global sulphur cycle(1-3), yet their physiological functions are uncertain(4). Here we report results that, together with those in the literature(5,6), show that DMSP and its breakdown products (DMS, acrylate, dimethylsulphoxide, and methane sulphinic acid) readily scavenge hydroxyl radicals and other reactive oxygen species, and thus may serve as an antioxidant system, regulated in part by enzymatic cleavage of DMSP. In support of this hypothesis, we found that oxidative stressors, solar ultraviolet radiation(7), CO2 limitation(8), Fe limitation, high Cu2+ (ref. 9) and H2O2 substantially increased cellular DMSP and/or its lysis to DMS in marine algal cultures. Our results indicate direct links between such stressors and the dynamics of DMSP and DMS in marine phytoplankton, which probably influence the production of DMS and its release to the atmosphere. As oxidation of DMS to sulphuric acid in the atmosphere provides a major source of sulphate aerosols and cloud condensation nuclei(3), oxidative stressors-including solar radiation and Fe limitation-may be involved in complex ocean-atmosphere feedback loops that influence global climate and hydrological cycles(1,2).	NOAA, Beaufort Lab, Beaufort, NC 28516 USA; SUNY Coll Environm Sci & Forestry, Dept Chem, Syracuse, NY 13210 USA; Univ S Alabama, Dept Marine Sci, Mobile, AL 36688 USA	National Oceanic Atmospheric Admin (NOAA) - USA; State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry; University of South Alabama	Sunda, W (corresponding author), NOAA, Beaufort Lab, Beaufort, NC 28516 USA.	bill.sunda@noaa.gov						Ahner BA, 2002, MAR ECOL PROG SER, V232, P93, DOI 10.3354/meps232093; Andreae MO, 1997, SCIENCE, V276, P1052, DOI 10.1126/science.276.5315.1052; BATES TS, 1987, NATURE, V329, P319, DOI 10.1038/329319a0; BELVISO S, 1993, MAR CHEM, V44, P55, DOI 10.1016/0304-4203(93)90006-A; Butow B, 1998, J PLANKTON RES, V20, P355, DOI 10.1093/plankt/20.2.355; BUXTON GV, 1988, J PHYS CHEM REF DATA, V17, P513, DOI 10.1063/1.555805; CHARLSON RJ, 1987, NATURE, V326, P655, DOI 10.1038/326655a0; DABROWSKI K, 2001, ASCORBATE AQUATIC OR; Dacey JWH, 1998, DEEP-SEA RES PT I, V45, P2085, DOI 10.1016/S0967-0637(98)00048-X; GREENE RM, 1992, PLANT PHYSIOL, V100, P565, DOI 10.1104/pp.100.2.565; Jakob B, 1996, PLANT CELL PHYSIOL, V37, P629, DOI 10.1093/oxfordjournals.pcp.a028991; KARSTEN U, 1990, PLANT CELL ENVIRON, V13, P989, DOI 10.1111/j.1365-3040.1990.tb01991.x; Kieber DJ, 1996, J GEOPHYS RES-OCEANS, V101, P3715, DOI 10.1029/95JC03624; KIENE RP, 1994, MAR CHEM, V47, P1, DOI 10.1016/0304-4203(94)90009-4; Lee PA, 1999, J PHYCOL, V35, P8, DOI 10.1046/j.1529-8817.1999.3510008.x; LESSER MP, 1989, MAR BIOL, V102, P243, DOI 10.1007/BF00428286; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Nanninga HJ, 1996, MAR ECOL PROG SER, V136, P195, DOI 10.3354/meps136195; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Okamoto OK, 2001, ARCH ENVIRON CON TOX, V40, P18; SCADUTO RC, 1995, FREE RADICAL BIO MED, V18, P271, DOI 10.1016/0891-5849(94)E0139-A; Simo R, 2000, MAR ECOL PROG SER, V203, P1, DOI 10.3354/meps203001; Simo R, 1999, NATURE, V402, P396, DOI 10.1038/46516; Simo R, 1998, MAR ECOL PROG SER, V167, P291, DOI 10.3354/meps167291; SIMO R, 1995, MAR ECOL PROG SER, V127, P291, DOI 10.3354/meps127291; Stefels J, 2000, J SEA RES, V43, P183, DOI 10.1016/S1385-1101(00)00030-7; Stefels J, 1998, J PHYCOL, V34, P486, DOI 10.1046/j.1529-8817.1998.340486.x; Steinke M, 1996, BIOLOGICAL AND ENVIRONMENTAL CHEMISTRY OF DMSP AND RELATED SULFONIUM COMPOUNDS, P317; SUNDA WG, 1995, MAR CHEM, V50, P189, DOI 10.1016/0304-4203(95)00035-P; WILKINSON F, 1995, J PHYS CHEM REF DATA, V24, P663, DOI 10.1063/1.555965	30	790	827	13	249	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 18	2002	418	6895					317	320		10.1038/nature00851	http://dx.doi.org/10.1038/nature00851			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574BF	12124622				2022-12-24	WOS:000176868000040
J	Aboff, BM; Collier, VU; Farber, NJ; Ehrenthal, DB				Aboff, BM; Collier, VU; Farber, NJ; Ehrenthal, DB			Residents' prescription writing for nonpatients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	21st Annual Meeting of the Society-of-General-Internal-Medicine	APR 23-25, 1998	CHICAGO, IL	Soc Gen Internal Med			PHYSICIANS	Context Writing prescriptions is one of the most tangible new responsibilities that residents acquire after graduating from medical school, During their regular duties, house officers' prescription writing is carefully monitored. Little is known, however, about residents' patterns of prescription writing outside of supervision or about residents' knowledge of the ethical and legal guidelines that regulate prescription writing. Objective To study what factors influence residents' decision to write prescriptions for nonpatients. Design, Setting, and Participants Survey distributed in December 1997 to 92 internal medicine and family practice residents at a US community-based teaching hospital. Eighty percent responded. Main Outcome Measures Self-reported prescribing activities for nonpatients and for individuals in 12 hypothetical vignettes. Results Eighty-five percent of respondents reported having written prescriptions for nonpatients, Based on their responses to the vignettes, under certain circumstances, up to 95% of residents would write a prescription for an individual who is not their patient (eg, a sibling). Thirteen percent of residents believed that some ethical guidelines on prescription-writing activity existed. Only 4% of residents reported being aware of federal or state laws addressing the appropriateness of physician prescription writing for nonpatients. None of the residents were able to describe the circumstances that make prescription writing for nonpatients illegal or unethical based on legal statutes or ethical guidelines, respectively, Conclusions In a sample of community-based internal medicine and family practice residents, unsupervised prescription writing by residents for individuals who are not their patients is a common occurrence. Since residency training is a time when practice habits are established, it is important that all residents learn about the ethical, legal, and liability implications of writing prescriptions for nonpatients.	Christiana Care Hlth Syst, Dept Med, Wilmington, DE 19899 USA	Christiana Care Health System	Aboff, BM (corresponding author), Christiana Care Hlth Syst, Dept Med, 501 W 14th St, Wilmington, DE 19899 USA.	baboff@christianacare.org						AACH RD, 1992, ANN INTERN MED, V116, P245, DOI 10.7326/0003-4819-116-3-245; AJZEN I, 1977, PSYCHOL BULL, V84, P888, DOI 10.1037/0033-2909.84.5.888; *AM COLL PHYS AM S, 1999, ACP ASIM OBSERVER, V19, P1; *AM MED ASS, 1997, AMA CURR OP COUNC ET; Christie JD, 1998, JAMA-J AM MED ASSOC, V280, P1253, DOI 10.1001/jama.280.14.1253; CLARK AW, 1988, J MED EDUC, V63, P44; Desalvo KB, 2000, J INVEST MED, V48, p226A; DUSDIEKER LB, 1993, AM J DIS CHILD, V147, P146, DOI 10.1001/archpedi.1993.02160260036018; FINKEL SK, 1996, VITAL SIGNS      JUN; HOWARD ML, 1995, LEGAL MED, P265; HUGHES PH, 1991, JAMA-J AM MED ASSOC, V265, P2069, DOI 10.1001/jama.265.16.2069; LAPUMA J, 1991, NEW ENGL J MED, V325, P1290, DOI 10.1056/NEJM199110313251806; LAPUMA J, 1992, JAMA-J AM MED ASSOC, V257, P1810	13	13	13	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 17	2002	288	3					381	385		10.1001/jama.288.3.381	http://dx.doi.org/10.1001/jama.288.3.381			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	573AK	12117406	Bronze			2022-12-24	WOS:000176807000033
J	Rothenberg, KH; Terry, SF				Rothenberg, KH; Terry, SF			Human genetics: Before it's too late - Addressing fear of genetic information	SCIENCE			English	Editorial Material									Univ Maryland, Sch Law, Baltimore, MD 21201 USA; Genet Alliance, Washington, DC 20008 USA	University System of Maryland; University of Maryland Baltimore	Rothenberg, KH (corresponding author), Univ Maryland, Sch Law, Baltimore, MD 21201 USA.							ANDREWS L, 1987, MED GENETICS LEGAL F; BRIERLEY K, 1999, AM J HUM GENET, V65, P60; Collins FS, 2001, JAMA-J AM MED ASSOC, V285, P540, DOI 10.1001/jama.285.5.540; Geer K P, 2001, J Genet Couns, V10, P25, DOI 10.1023/A:1009451213035; Greely HT, 2001, U PENN LAW REV, V149, P1483, DOI 10.2307/3312966; HADLEY D, IN PRESS ARCH INTERN; KEVLES D, 1995, GENETICS USES HUMAN, P117; PROCTOR R, 1992, GENE MAPPING USING L, P61; Rothenberg K, 1997, SCIENCE, V275, P1755, DOI 10.1126/science.275.5307.1755; THOMPSON D, 2000, TIME            0703, P23; 2001, VCU NEWS        1004	11	32	32	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 12	2002	297	5579					196	197		10.1126/science.1075221	http://dx.doi.org/10.1126/science.1075221			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	571UT	12114610	Green Submitted			2022-12-24	WOS:000176738100021
J	Brown, S; Heinisch, I; Ross, E; Shaw, K; Buckley, CD; Savill, J				Brown, S; Heinisch, I; Ross, E; Shaw, K; Buckley, CD; Savill, J			Apoptosis disables CD31-mediated cell detachment from phagocytes promoting binding and engulfment	NATURE			English	Article							RECEPTOR-MEDIATED PHAGOCYTOSIS; VITRONECTIN RECEPTOR; NEUTROPHILS; MIGRATION; CLEARANCE; PECAM-1; DEATH; RECOGNITION; PLATELETS; BLOOD	Macrophage recognition and ingestion of 'self' cells undergoing apoptosis in vivo protects tissues from the toxic contents of dying cells and modulates macrophage regulation of inflammatory and immune responses(1,2). However, the complex molecular mechanisms mediating macrophage discrimination between viable and apoptotic cells are poorly understood(2,3). In particular, little is known of why viable nucleated cells are not engulfed by macrophages. To reveal active repulsion of viable cells and to seek specific capture or 'tethering' of apoptotic cells, we studied macrophage binding of viable and apoptotic leukocytes under conditions of flow. We found that homophilic ligation of CD31 (ref. 4) on viable leukocytes promoted their active, temperature-dependent detachment under low shear, whereas such CD31-mediated detachment was disabled in apoptotic leukocytes, promoting tight binding and macrophage ingestion of dying cells. Here we propose that CD31 (also known as platelet-endothelial cell adhesion molecule-1, PECAM-1) is an example of a cell-surface molecule that prevents phagocyte ingestion of closely apposed viable cells by transmitting 'detachment' signals, and which changes function on apoptosis, promoting tethering of dying cells to phagocytes.	Univ Edinburgh, MRC, Ctr Inflammat Res, Inflammat Repair Grp, Edinburgh EH8 9AG, Midlothian, Scotland; Univ Birmingham, MRC, Ctr Immune Regulat, Div Immun & Infect, Birmingham B15 2TT, W Midlands, England	University of Edinburgh; University of Birmingham	Brown, S (corresponding author), Univ Edinburgh, MRC, Ctr Inflammat Res, Inflammat Repair Grp, Edinburgh EH8 9AG, Midlothian, Scotland.		Buckley, Christopher/AAN-6378-2021; Brown, Simon/B-3006-2009	Buckley, Christopher/0000-0001-6924-6402; Ross, Ewan/0000-0001-5733-9361				Bird IN, 1999, J CELL SCI, V112, P1989; Brown SB, 2000, J BIOL CHEM, V275, P5987, DOI 10.1074/jbc.275.8.5987; Brown SB, 1997, BIOCHEM J, V323, P233, DOI 10.1042/bj3230233; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Green DR, 2001, NATURE, V412, P133, DOI 10.1038/35084313; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; MANSFIELD PJ, 1990, J CELL BIOL, V111, P3077, DOI 10.1083/jcb.111.6.3077; METZELAAR MJ, 1991, THROMB HAEMOSTASIS, V66, P700; MULLER WA, 1993, J EXP MED, V178, P449, DOI 10.1084/jem.178.2.449; Newman PJ, 1997, J CLIN INVEST, V99, P3, DOI 10.1172/JCI119129; Newton JP, 1997, J BIOL CHEM, V272, P20555, DOI 10.1074/jbc.272.33.20555; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Pumphrey NJ, 1999, FEBS LETT, V450, P77, DOI 10.1016/S0014-5793(99)00446-9; Rainger GE, 1997, CURR BIOL, V7, P316, DOI 10.1016/S0960-9822(06)00155-2; Reedquist KA, 2000, J CELL BIOL, V148, P1151, DOI 10.1083/jcb.148.6.1151; REN Y, 1995, J EXP MED, V181, P1857, DOI 10.1084/jem.181.5.1857; SAKARIASSEN KS, 1983, J LAB CLIN MED, V102, P522; SAVILL J, 1992, J CLIN INVEST, V90, P1513, DOI 10.1172/JCI116019; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; SAVILL J, 1990, NATURE, V343, P170, DOI 10.1038/343170a0; SAVILL JS, 1989, J CLIN INVEST, V83, P865, DOI 10.1172/JCI113970	21	265	288	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 11	2002	418	6894					200	203		10.1038/nature00811	http://dx.doi.org/10.1038/nature00811			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	571GV	12110892				2022-12-24	WOS:000176710400044
J	Fiaux, J; Bertelsen, EB; Horwich, AL; Wuthrich, K				Fiaux, J; Bertelsen, EB; Horwich, AL; Wuthrich, K			NMR analysis of a 900K GroEL-GroES complex	NATURE			English	Article							TRIPLE-RESONANCE EXPERIMENTS; NUCLEAR-MAGNETIC-RESONANCE; BACTERIAL CHAPERONIN GROEL; CRYSTAL-STRUCTURE; BIOLOGICAL MACROMOLECULES; POLARIZATION TRANSFER; LARGE MOLECULES; LARGE PROTEINS; TROSY; RELAXATION	Biomacromolecular structures with a relative molecular mass (M-r) of 50, 000 to 100,000 (50K-100K) have been generally considered to be inaccessible to analysis by solution NMR spectroscopy. Here we report spectra recorded from bacterial chaperonin complexes ten times this size limit (up to M-r 900K) using the techniques of transverse relaxation-optimized spectroscopy and cross-correlated relaxation-enhanced polarization transfer(1-5). These techniques prevent deterioration of the NMR spectra by the rapid transverse relaxation of the magnetization to which large, slowly tumbling molecules are otherwise subject. We tested the resolving power of these techniques by examining the isotope-labelled homoheptameric co-chaperonin GroES (M-r 72K), either free in solution or in complex with the homotetradecameric chaperonin GroEL (M-r 800K) or with the single-ring GroEL variant SR1 (M-r 400K). Most amino acids of GroES show the same resonances whether free in solution or in complex with chaperonin; however, residues 17-32 show large chemical shift changes on binding. These amino acids belong to a mobile loop region of GroES that forms contacts with GroEL(6-10). This establishes the utility of these techniques for solution NMR studies that should permit the exploration of structure, dynamics and interactions in large macromolecular complexes.	ETH Zurich, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Howard Hughes Medical Institute; Yale University; Yale University	Wuthrich, K (corresponding author), ETH Zurich, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland.			Wuthrich, Kurt/0000-0001-8739-6965				ARATA Y, 1994, METHOD ENZYMOL, V239, P440; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Brinker A, 2001, CELL, V107, P223, DOI 10.1016/S0092-8674(01)00517-7; DEMARCO A, 1976, J MAGN RESON, V24, P201, DOI 10.1016/0022-2364(76)90028-7; GOLDMAN M, 1984, J MAGN RESON, V60, P437, DOI 10.1016/0022-2364(84)90055-6; GUNTERT P, 1992, J BIOMOL NMR, V2, P619, DOI 10.1007/BF02192850; Horwich AL, 1998, METHOD ENZYMOL, V290, P141, DOI 10.1016/S0076-6879(98)90013-1; Hunt JF, 1996, NATURE, V379, P37, DOI 10.1038/379037a0; LANDRY SJ, 1993, NATURE, V364, P255, DOI 10.1038/364255a0; Landry SJ, 1996, P NATL ACAD SCI USA, V93, P11622, DOI 10.1073/pnas.93.21.11622; Mayhew M, 1996, NATURE, V379, P420, DOI 10.1038/379420a0; McEvoy MM, 1997, NAT STRUCT BIOL, V4, P9, DOI 10.1038/nsb0197-9; MORRIS GA, 1979, J AM CHEM SOC, V101, P760, DOI 10.1021/ja00497a058; Pellecchia M, 1999, NAT STRUCT BIOL, V6, P336; PERHAM RN, 1981, NATURE, V292, P474, DOI 10.1038/292474a0; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Riek R, 2000, TRENDS BIOCHEM SCI, V25, P462, DOI 10.1016/S0968-0004(00)01665-0; Riek R, 1999, P NATL ACAD SCI USA, V96, P4918, DOI 10.1073/pnas.96.9.4918; Roseman AM, 1996, CELL, V87, P241, DOI 10.1016/S0092-8674(00)81342-2; Salzmann M, 2000, J AM CHEM SOC, V122, P7543, DOI 10.1021/ja0003268; Salzmann M, 1999, J AM CHEM SOC, V121, P844, DOI 10.1021/ja9834226; Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585; Shewmaker F, 2001, J BIOL CHEM, V276, P31257, DOI 10.1074/jbc.M102765200; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; WEISSMAN JS, 1995, CELL, V83, P577, DOI 10.1016/0092-8674(95)90098-5; Wider G, 1999, CURR OPIN STRUC BIOL, V9, P594, DOI 10.1016/S0959-440X(99)00011-1; Wuthrich K., 1986, NMR PROTEINS NUCL AC; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944	30	323	340	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 11	2002	418	6894					207	211		10.1038/nature00860	http://dx.doi.org/10.1038/nature00860			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	571GV	12110894				2022-12-24	WOS:000176710400046
J	Conover, DO; Munch, SB				Conover, DO; Munch, SB			Sustaining fisheries yields over evolutionary time scales	SCIENCE			English	Article							COD GADUS-MORHUA; COUNTERGRADIENT VARIATION; DIFFERENT LATITUDES; ATLANTIC SALMON; MARINE FISHES; LIFE-HISTORY; GROWTH; HERITABILITIES; SELECTION; COLLAPSE	Fishery management plans ignore the potential for evolutionary change in harvestable biomass. We subjected populations of an exploited fish (Menidia menidia) to large, small, or random size-selective harvest of adults over four generations. Harvested biomass evolved rapidly in directions counter to the size-dependent force of fishing mortality. Large-harvested populations initially produced the highest catch but quickly evolved a lower yield than controls. Small-harvested populations did the reverse. These shifts were caused by selection of genotypes with slower or faster rates of growth. Management tools that preserve natural genetic variation are necessary for long-term sustainable yield.	SUNY Stony Brook, Marine Sci Res Ctr, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Conover, DO (corresponding author), SUNY Stony Brook, Marine Sci Res Ctr, Stony Brook, NY 11794 USA.	dconover@notes.cc.sunysb.edu						BAILEY KM, 1989, ADV MAR BIOL, V25, P1; Chen Y, 1999, FISH RES, V42, P87, DOI 10.1016/S0165-7836(99)00036-3; Conover DO, 1997, CAN J FISH AQUAT SCI, V54, P2401, DOI 10.1139/cjfas-54-10-2401; CONOVER DO, 1981, SCIENCE, V213, P577, DOI 10.1126/science.213.4507.577; CONOVER DO, 1990, OECOLOGIA, V83, P316, DOI 10.1007/BF00317554; Falconer D. S., 1981, INTRO QUANTITATIVE G; Harris PJ, 1997, FISH B-NOAA, V95, P732; Haugen TO, 2001, GENETICA, V112, P475, DOI 10.1023/A:1013315116795; Hendry AP, 2001, GENETICA, V112, P515, DOI 10.1023/A:1013367100865; HILL WG, 1972, BIOMETRICS, V28, P747, DOI 10.2307/2528760; HOUDE ED, 1989, J FISH BIOL, V35, P29, DOI 10.1111/j.1095-8649.1989.tb03043.x; Hutchings JA, 2001, J FISH BIOL, V59, P306, DOI 10.1006/jfbi.2001.1756; Hutchings JA, 2000, NATURE, V406, P882, DOI 10.1038/35022565; Imsland AK, 2001, REV FISH BIOL FISHER, V11, P71, DOI 10.1023/A:1014240430779; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jonasson J, 1997, AQUACULTURE, V154, P219, DOI 10.1016/S0044-8486(97)00059-8; Law R, 2000, ICES J MAR SCI, V57, P659, DOI 10.1006/jmsc.2000.0731; National Research Council, 2001, MAR PROT AR TOOLS SU; NICIEZA AG, 1994, CAN J ZOOL, V72, P1603, DOI 10.1139/z94-213; Palumbi SR, 2001, SCIENCE, V293, P1786, DOI 10.1126/science.293.5536.1786; Purchase CF, 2000, CAN J FISH AQUAT SCI, V57, P2223, DOI 10.1139/cjfas-57-11-2223; Quinn TP, 2001, GENETICA, V112, P493, DOI 10.1023/A:1013348024063; REZNICK DA, 1990, NATURE, V346, P357, DOI 10.1038/346357a0; RICKER WE, 1981, CAN J FISH AQUAT SCI, V38, P1636, DOI 10.1139/f81-213; Roff Derek, 2002, pi; Stergiou KI, 2002, FISH RES, V55, P1; Stokes K, 2000, MAR ECOL PROG SER, V208, P307; STOKES TK, 1993, EXPLOITATION EVOLVIN; Trexler JC, 2000, B MAR SCI, V66, P853; Weigensberg I, 1996, EVOLUTION, V50, P2149, DOI 10.1111/j.1558-5646.1996.tb03605.x	30	682	715	3	280	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 5	2002	297	5578					94	96		10.1126/science.1074085	http://dx.doi.org/10.1126/science.1074085			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	571HB	12098697				2022-12-24	WOS:000176711000040
J	Jain, M; Arvanitis, C; Chu, K; Dewey, W; Leonhardt, E; Trinh, M; Sundberg, CD; Bishop, JM; Felsher, DW				Jain, M; Arvanitis, C; Chu, K; Dewey, W; Leonhardt, E; Trinh, M; Sundberg, CD; Bishop, JM; Felsher, DW			Sustained loss of a neoplastic phenotype by brief inactivation of MYC	SCIENCE			English	Article							C-MYC; HUMAN OSTEOSARCOMA; OSTEO-SARCOMA; CELL-LINES; AMPLIFICATION; CANCER; DIFFERENTIATION; TUMORIGENESIS; ONCOGENES; GENE	Pharmacological inactivation of oncogenes is being investigated as a possible therapeutic strategy for cancer. One potential drawback is that cessation of such therapy may allow reactivation of the oncogene and tumor regrowth. We used a conditional transgenic mouse model for MYC-induced tumorigenesis to demonstrate that brief inactivation of MYC results in the sustained regression of tumors and the differentiation of osteogenic sarcoma cells into mature osteocytes. Subsequent reactivation of MYC did not restore the cells malignant properties but instead induced apoptosis. Thus, brief MYC inactivation appears to cause epigenetic changes in tumor cells that render them insensitive to MYC-induced tumorigenesis. These results raise the possibility that transient inactivation of MYC may be an effective therapy for certain cancers.	Stanford Univ, Dept Med, Div Oncol, Stanford, CA 94305 USA; Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA 94143 USA; Univ Calif San Francisco, GW Hooper Fdn, San Francisco, CA 94143 USA	Stanford University; Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Felsher, DW (corresponding author), Stanford Univ, Dept Med, Div Oncol, Stanford, CA 94305 USA.		Arvanitis, Constadina/C-5975-2013		NCI NIH HHS [R01-CA89305-01, K08-CA75967-01, R01-CA85610] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA089305, R01CA085610, K08CA075967] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AUBIN JE, 1995, BONE, V17, pS77, DOI 10.1016/8756-3282(95)00183-E; BISHOP JM, 1991, CELL, V64, P235, DOI 10.1016/0092-8674(91)90636-D; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Felsher DW, 1999, P NATL ACAD SCI USA, V96, P3940, DOI 10.1073/pnas.96.7.3940; Forrester HB, 1999, CANCER RES, V59, P931; Gamberi G, 1998, ONCOLOGY-BASEL, V55, P556, DOI 10.1159/000011912; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; GRIGORIADIS AE, 1993, J CELL BIOL, V122, P685, DOI 10.1083/jcb.122.3.685; Himelstein Bruce P., 1998, Current Opinion in Oncology, V10, P326, DOI 10.1097/00001622-199807000-00009; Huettner CS, 2000, NAT GENET, V24, P57, DOI 10.1038/71691; IKEDA S, 1989, JPN J CANCER RES, V80, P6, DOI 10.1111/j.1349-7006.1989.tb02236.x; ISFORT RJ, 1992, PROG CLIN BIOL RES, V376, P321; ISFORT RJ, 1995, MOL CARCINOGEN, V14, P170, DOI 10.1002/mc.2940140306; LADANYI M, 1993, DIAGN MOL PATHOL, V2, P163, DOI 10.1097/00019606-199303000-00024; Laird PW, 1996, ANNU REV GENET, V30, P441, DOI 10.1146/annurev.genet.30.1.441; Longhi A, 2001, ONCOL REP, V8, P131; Papagelopoulos PJ, 2000, ORTHOPEDICS, V23, P858; Pelengaris S, 1999, MOL CELL, V3, P565, DOI 10.1016/S1097-2765(00)80350-0; Philip T, 2001, BRIT J CANCER, V84, P78, DOI 10.1054/bjoc.2000.1770; Pompetti F, 1996, J CELL BIOCHEM, V63, P37; SCHMIDT J, 1988, DIFFERENTIATION, V39, P151, DOI 10.1111/j.1432-0436.1988.tb00090.x; Stock C, 2000, GENE CHROMOSOME CANC, V28, P329, DOI 10.1002/1098-2264(200007)28:3<329::AID-GCC11>3.0.CO;2-F; STURM SA, 1990, CANCER RES, V50, P4146	25	513	550	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 5	2002	297	5578					102	104		10.1126/science.1071489	http://dx.doi.org/10.1126/science.1071489			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	571HB	12098700				2022-12-24	WOS:000176711000043
J	Wagers, AJ; Sherwood, RI; Christensen, JL; Weissman, IL				Wagers, AJ; Sherwood, RI; Christensen, JL; Weissman, IL			Little evidence for developmental plasticity of adult hematopoietic stem cells	SCIENCE			English	Article							BONE-MARROW CELLS; MONOCLONAL-ANTIBODIES; IN-VIVO; MICE; ANTIGENS; MUSCLE; DIFFERENTIATE; REGENERATION; PROGENITORS; HEPATOCYTES	To rigorously test the in vivo cell fate specificity of bone marrow ( BM) hematopoietic stem cells (HSCs), we generated chimeric animals by transplantation of a single green fluorescent protein (GFP)-marked HSC into lethally irradiated nontransgenic recipients. Single HSCs robustly reconstituted peripheral blood leukocytes in these animals, but did not contribute appreciably to nonhematopoietic tissues, including brain, kidney, gut, liver, and muscle. Similarly, in GFP(+):GFP(-) parabiotic mice, we found substantial chimerism of hematopoietic but not nonhematopoietic cells. These data indicate that "transdifferentiation" of circulating HSCs and/or their progeny is an extremely rare event, if it occurs at all.	Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Wagers, AJ (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.				NCI NIH HHS [CA-86065] Funding Source: Medline; NIAID NIH HHS [5T32AI07290-16] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA086065] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Bunster E, 1933, ANAT REC, V57, P339, DOI 10.1002/ar.1090570404; Eglitis MA, 1997, P NATL ACAD SCI USA, V94, P4080, DOI 10.1073/pnas.94.8.4080; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; FLEMING WH, 1993, P NATL ACAD SCI USA, V90, P3760, DOI 10.1073/pnas.90.8.3760; GERLYNG P, 1993, CELL PROLIFERAT, V26, P557, DOI 10.1111/j.1365-2184.1993.tb00033.x; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; HAGEMANN RF, 1971, RADIAT RES, V46, P533, DOI 10.2307/3573432; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; JOHNSON P, 1997, WEIRS HDB EXPT IMMUN, V2, P1; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; LEDBETTER JA, 1979, IMMUNOL REV, V47, P63, DOI 10.1111/j.1600-065X.1979.tb00289.x; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Morrison SJ, 1997, DEVELOPMENT, V124, P1929; Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898; Orlic D, 2001, ANN NY ACAD SCI, V938, P221; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; QUASTLER H, 1956, RADIAT RES, V4, P303, DOI 10.2307/3570211; Sata M, 2002, NAT MED, V8, P403, DOI 10.1038/nm0402-403; Schwartz RE, 2002, J CLIN INVEST, V109, P1291, DOI 10.1172/JCI200215182; Shimizu K, 2001, NAT MED, V7, P738, DOI 10.1038/89121; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Theise ND, 2000, HEPATOLOGY, V31, P235, DOI 10.1002/hep.510310135; TSUBOUCHI S, 1973, RADIAT RES, V56, P345, DOI 10.2307/3573671; UCHIDA N, 1992, J EXP MED, V175, P175, DOI 10.1084/jem.175.1.175; VANEWIJK W, 1981, J IMMUNOL, V127, P2594; WAGERS AJ, UNPUB; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Wright DE, 2001, BLOOD, V97, P2278, DOI 10.1182/blood.V97.8.2278; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729	34	1141	1246	0	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 27	2002	297	5590					2256	2259		10.1126/science.1074807	http://dx.doi.org/10.1126/science.1074807			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597LA	12215650				2022-12-24	WOS:000178222000046
J	Lurbe, E; Redon, J; Kesani, A; Pascual, JM; Tacons, J; Alvarez, V; Batlle, D				Lurbe, E; Redon, J; Kesani, A; Pascual, JM; Tacons, J; Alvarez, V; Batlle, D			Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CULTURED SKIN FIBROBLASTS; ALBUMIN EXCRETION RATE; IDDM PATIENTS; NEPHROPATHY; MELLITUS; HYPERTENSION; DISEASE; PREDISPOSITION; SUSCEPTIBILITY; ADOLESCENTS	Background: Patients with type 1 diabetes mellitus and microalbuminuria often have elevated blood pressure while they are asleep, but it is not known whether the elevation develops concomitantly with microalbuminuria or precedes it. Methods: We monitored 75 adolescents and young adults who had had type 1 diabetes with normal urinary albumin excretion and blood pressure for more than five years. Ambulatory blood-pressure monitoring was used to assess blood pressure at the initial evaluation and about two years later, at which time all subjects had normal urinary albumin excretion. Subsequently, subjects were monitored for the development of microalbuminuria. Results: Microalbuminuria developed in 14 subjects, whereas the other 61 continued to have normal urinary albumin excretion. The mean (+/-SD) systolic pressure during sleep increased significantly in the subjects who ultimately had microalbuminuria (from 109.9+/-11.3 to 114.9+/-11.7 mm Hg, P=0.01) but not in the subjects with normal albumin excretion (from 106.0+/-8.8 to 106.4+/-14.8 mm Hg). The risk of progression to microalbuminuria was examined in relation to the ratio of systolic pressure during sleep to systolic pressure in the daytime. A ratio of 0.9 or lower, used to define a normal fall in nocturnal pressure, had a negative predictive value of 91 percent for the development of microalbuminuria. Moreover, the risk of microalbuminuria was 70 percent lower (95 percent confidence interval, 44 to 110 percent) in subjects with a ratio of 0.9 or less than in those with a ratio higher than 0.9 (P=0.01). Conclusions: In persons with type 1 diabetes, an increase in systolic blood pressure during sleep precedes the development of microalbuminuria. In those whose blood pressure during sleep decreases normally, the progression from normal albumin excretion to microalbuminuria appears to be less likely.	Northwestern Univ, Feinberg Sch Med, Div Nephrol & Hypertens, Chicago, IL 60611 USA; Gen Hosp, Dept Pediat, Pediat Nephrol Unit, Valencia, Spain; Univ Valencia, Valencia, Spain; Hosp Clin, Dept Med, Hypertens Clin, Valencia, Spain; Hosp Sagunto, Dept Med, Sagunto, Spain	Northwestern University; Feinberg School of Medicine; University of Valencia	Batlle, D (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Nephrol & Hypertens, 320 E Super St,10-475 Searle Bldg, Chicago, IL 60611 USA.		REDON, JOSEP/E-1719-2019; Redon, Josep/L-5997-2019	Redon, Josep/0000-0001-8777-6773; Lurbe, Empar/0000-0002-3748-5529				*2 TASK FORC BLOOD, 1987, PEDIATRICS, V79, P1; ANDERSEN AR, 1983, DIABETOLOGIA, V25, P496; Bakris GL, 2000, AM J KIDNEY DIS, V36, P646, DOI 10.1053/ajkd.2000.16225; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Caramori ML, 2000, DIABETES, V49, P1399, DOI 10.2337/diabetes.49.9.1399; CLOSE CF, 1995, BMJ-BRIT MED J, V311, P973; EARLE K, 1994, KIDNEY INT, V45, P434, DOI 10.1038/ki.1994.56; Hansen HP, 1996, KIDNEY INT, V50, P579, DOI 10.1038/ki.1996.352; KROLEWSKI AS, 1988, NEW ENGL J MED, V318, P140, DOI 10.1056/NEJM198801213180303; KROLEWSKI AS, 1995, NEW ENGL J MED, V332, P1251, DOI 10.1056/NEJM199505113321902; Lafferty AR, 2000, DIABETES CARE, V23, P533, DOI 10.2337/diacare.23.4.533; LaPointe MS, 2001, AM J KIDNEY DIS, V38, P646, DOI 10.1053/ajkd.2001.28026; Lurbe A, 1996, KIDNEY INT, V50, P1684, DOI 10.1038/ki.1996.486; LURBE A, 1993, HYPERTENSION, V21, P227, DOI 10.1161/01.HYP.21.2.227; MANCIA G, 1988, AM HEART J, V116, P1134, DOI 10.1016/0002-8703(88)90177-9; MANGILI R, 1988, NEW ENGL J MED, V318, P146, DOI 10.1056/NEJM198801213180304; MOORE WV, 1992, DIABETES, V41, P1035, DOI 10.2337/diabetes.41.9.1035; NORGAARD K, 1990, DIABETOLOGIA, V33, P407, DOI 10.1007/BF00404089; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Pecis M, 2000, DIABETES CARE, V23, P989; PICKERING TG, 1982, JAMA-J AM MED ASSOC, V247, P992, DOI 10.1001/jama.247.7.992; PICKERING TG, 1990, CIRCULATION, V81, P700, DOI 10.1161/01.CIR.81.2.700; Poulsen PL, 1997, DIABETOLOGIA, V40, P718, DOI 10.1007/s001250050739; POULSEN PL, 1994, DIABETES, V43, P1248, DOI 10.2337/diabetes.43.10.1248; Ritz E, 1999, NEW ENGL J MED, V341, P1127, DOI 10.1056/NEJM199910073411506; ROSSKOPF D, 1993, J CLIN INVEST, V92, P2553, DOI 10.1172/JCI116865; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; SOKOLOW M, 1966, CIRCULATION, V34, P279; Sowers JR, 2001, HYPERTENSION, V37, P1053, DOI 10.1161/01.HYP.37.4.1053; *SPSS, 1993, SPSS WIND REL 6 0 AD; Sturrock NDC, 2000, DIABETIC MED, V17, P360, DOI 10.1046/j.1464-5491.2000.00284.x; VERDECCHIA P, 1993, CIRCULATION, V88, P986, DOI 10.1161/01.CIR.88.3.986; VERDECCHIA P, 1990, CIRCULATION, V81, P528, DOI 10.1161/01.CIR.81.2.528; Viberti G, 1999, KIDNEY INT, V55, P2526, DOI 10.1046/j.1523-1755.1999.00507.x; VIBERTI GC, 1982, LANCET, V1, P1430; VIBERTI GC, 1987, BRIT MED J, V295, P515, DOI 10.1136/bmj.295.6597.515; Voros P, 1998, NEPHROL DIAL TRANSPL, V13, P2257, DOI 10.1093/ndt/13.9.2257	37	507	527	0	11	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 12	2002	347	11					797	805		10.1056/NEJMoa013410	http://dx.doi.org/10.1056/NEJMoa013410			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592DK	12226150				2022-12-24	WOS:000177921300004
J	Xie, Q; Guo, HS; Dallman, G; Fang, SY; Weissman, AM; Chua, NH				Xie, Q; Guo, HS; Dallman, G; Fang, SY; Weissman, AM; Chua, NH			SINAT5 promotes ubiquitin-related degradation of NAC1 to attenuate auxin signals	NATURE			English	Article							LATERAL ROOT DEVELOPMENT; ARABIDOPSIS-THALIANA; AUX/IAA PROTEINS; LIGASE; SIAH-1; PATHWAY; DOMAIN; P53; ABSENTIA; MUTATION	The plant hormone indole-3 acetic acid (IAA or auxin) controls many aspects of plant development, including the production of lateral roots(1-3). Ubiquitin-mediated proteolysis has a central role in this process. The genes AXR1 and TIR1 aid the assembly of an active SCF (Skp1/Cullin/F-box) complex that probably promotes degradation of the AUX/IAA transcriptional repressors in response to auxin(4-8). The transcription activator NAC1, a member of the NAM/CUC family of transcription factors, functions downstream of TIR1 to transduce the auxin signal for lateral root development(9). Here we show that SINAT5, an Arabidopsis homologue of the RING-finger Drosophila protein SINA, has ubiquitin protein ligase activity and can ubiquitinate NAC1. This activity is abolished by mutations in the RING motif of SINAT5. Overexpressing SINAT5 produces fewer lateral roots, whereas overexpression of a dominant-negative Cys49 --> Ser mutant of SINAT5 develops more lateral roots. These lateral root phenotypes correlate with the expression of NAC1 observed in vivo. Low expression of NAC1 in roots can be increased by treatment with a proteasome inhibitor, which indicates that SINAT5 targets NAC1 for ubiquitin-mediated proteolysis to downregulate auxin signals in plant cells.	Rockefeller Univ, Plant Mol Biol Lab, New York, NY 10021 USA; NCI, Ctr Canc Res, Regulat Prot Funct Lab, Bethesda, MD 20892 USA; Natl Univ Singapore, Temasek Life Sci Lab, Mol Cell Biol Lab, Singapore 117604, Singapore	Rockefeller University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National University of Singapore	Chua, NH (corresponding author), Rockefeller Univ, Plant Mol Biol Lab, 1230 York Ave, New York, NY 10021 USA.		Fang, Shengyun/H-3802-2011; Dallmann, Geza/E-1630-2012	Fang, Shengyun/0000-0001-7280-5463				Boehm J, 2001, EMBO J, V20, P4153, DOI 10.1093/emboj/20.15.4153; CARTHEW RW, 1990, CELL, V63, P561, DOI 10.1016/0092-8674(90)90452-K; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; del Pozo JC, 1998, SCIENCE, V280, P1760, DOI 10.1126/science.280.5370.1760; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Gray WM, 1999, GENE DEV, V13, P1678, DOI 10.1101/gad.13.13.1678; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Hu G, 1999, MOL CELL BIOL, V19, P724; Hu G, 1997, GENE DEV, V11, P2701, DOI 10.1101/gad.11.20.2701; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kost B, 1998, PLANT J, V16, P393, DOI 10.1046/j.1365-313x.1998.00304.x; Li SH, 1997, CELL, V90, P469, DOI 10.1016/S0092-8674(00)80507-3; Liu J, 2001, MOL CELL, V7, P927, DOI 10.1016/S1097-2765(01)00241-6; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; Nemani M, 1996, P NATL ACAD SCI USA, V93, P9039, DOI 10.1073/pnas.93.17.9039; Nie J, 2002, EMBO J, V21, P93, DOI 10.1093/emboj/21.1.93; Ouellet F, 2001, PLANT CELL, V13, P829, DOI 10.1105/tpc.13.4.829; Polekhina G, 2002, NAT STRUCT BIOL, V9, P68, DOI 10.1038/nsb743; Ramos JA, 2001, PLANT CELL, V13, P2349, DOI 10.1105/tpc.13.10.2349; Rogg LE, 2001, PLANT CELL, V13, P465, DOI 10.1105/tpc.13.3.465; Ruegger M, 1998, GENE DEV, V12, P198, DOI 10.1101/gad.12.2.198; Susini L, 2001, P NATL ACAD SCI USA, V98, P15067, DOI 10.1073/pnas.261571998; Tiedt R, 2001, EMBO J, V20, P4143, DOI 10.1093/emboj/20.15.4143; Xie Q, 2000, GENE DEV, V14, P3024, DOI 10.1101/gad.852200; Xie Q, 1999, PLANT MOL BIOL, V39, P647, DOI 10.1023/A:1006138221874; Zenser N, 2001, P NATL ACAD SCI USA, V98, P11795, DOI 10.1073/pnas.211312798	28	362	414	6	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 12	2002	419	6903					167	170		10.1038/nature00998	http://dx.doi.org/10.1038/nature00998			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592HK	12226665				2022-12-24	WOS:000177931200041
J	Pierce, JP; Gilpin, EA				Pierce, JP; Gilpin, EA			Impact of over-the-counter sales on effectiveness of pharmaceutical aids for smoking cessation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CALIFORNIA TOBACCO SURVEY; NICOTINE PATCH; TRANSDERMAL NICOTINE; DOUBLE-BLIND; TRIAL; POPULATION; TESTS	Context Successful smoking cessation is a major public health goal. In controlled clinical trials, nicotine replacement therapy (NRT) and the antidepressant bupropion have been shown to significantly increase cessation rates only for moderate to heavy smokers ( greater than or equal to15 cigarettes/d). Nicotine replacement therapy is heavily promoted to the general population by both the pharmaceutical industry and tobacco control advocates. Objective To examine trends in smoking cessation, pharmaceutical cessation aid use, and success in cessation in the general California population. Design, Setting, and Participants The large population-based California Tobacco Surveys of 1992, 1996, and 1999, including 5247 (71.3% response rate), 9725 (72.9% response rate), and 6412 (68.4% response rate) respondents, respectively. Main Outcome Measures Rates of cessation attempts ( greater than or equal to1 day) among smokers in the last year, use of pharmaceutical aids (mostly over-the-counter products since 1996), and cessation success. Results Between 1992 and 1999, cessation attempts among California smokers increased 61.4% (from 38.1% to 61.5%),and NRT use among quitters increased 50.5% (from 9.3% to 14.0%). A total of 17.2% of quitters used NRT, an antidepressant, or both as an aid to cessation in 1999. In 1996 and 1999, the median duration of aid use (14 days) was much less than recommended, and only about 20% of users had adjuvant one-on-one or group behavioral counseling. Use of NRT increased short-term cessation success in moderate to heavy smokers in each survey year. However, a long-term cessation advantage was only observed before NRT became widely available over-the-counter (August 1996). In 1999, no advantage for pharmaceutical aid users was observed in either the short or long term for the nearly 60% of California smokers classified as light smokers (<15 cigarettes/d). Conclusion Since becoming available over the counter, NRT appears no longer effective in increasing long-term successful cessation in California smokers.	Univ Calif San Diego, Ctr Canc, Canc Prevent & Control Program, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Pierce, JP (corresponding author), Univ Calif San Diego, Ctr Canc, Canc Prevent & Control Program, 0645, La Jolla, CA 92093 USA.	jppierce@ucsd.edu		Pierce, John/0000-0002-0075-7471				Burton S L, 2000, MMWR Morb Mortal Wkly Rep, V49, P665; Centers for Disease Control and Prevention (CDC), 1993, MMWR Morb Mortal Wkly Rep, V42, P504; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1217; Curry SJ, 1998, NEW ENGL J MED, V339, P673, DOI 10.1056/NEJM199809033391006; EFRON B, 1982, CMBS REGIONAL C SERI, V38; FIORE MC, 1990, JAMA-J AM MED ASSOC, V263, P2760, DOI 10.1001/jama.263.20.2760; Fiore MC, 2000, JAMA-J AM MED ASSOC, V283, P3244; FIORE MC, 1994, JAMA-J AM MED ASSOC, V71, P1940; FIORE MC, 2000, TREATING TOBACCO USE; GILPIN E, 1994, CANCER EPIDEM BIOMAR, V3, P613; Gilpin E, 2001, CALIFORNIA TOBACCO C; GIOVINO GA, 1993, TOBACCO CONTROL S, V2, pS3; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; HATZIANDREU EJ, 1990, J NATL CANCER I, V82, P1402, DOI 10.1093/jnci/82.17.1402; Hays JT, 1999, AM J PUBLIC HEALTH, V89, P1701, DOI 10.2105/AJPH.89.11.1701; Jorenby DE, 1999, NEW ENGL J MED, V340, P685, DOI 10.1056/NEJM199903043400903; Leischow SJ, 1999, AM J HEALTH BEHAV, V23, P61, DOI 10.5993/AJHB.23.1.7; ORLEANS CT, 1994, JAMA-J AM MED ASSOC, V271, P601, DOI 10.1001/jama.271.8.601; ORLEANS CT, 1996, TOBACCO CONTROL S, V5, pS3; Ossip-Klein D J, 1986, Health Psychol, V5 Suppl, P3, DOI 10.1037/0278-6133.5.Suppl.3; PIERCE JP, 1995, J NATL CANCER I, V87, P87, DOI 10.1093/jnci/87.2.87; Pierce JP, 1998, JAMA-J AM MED ASSOC, V280, P893, DOI 10.1001/jama.280.10.893; Pierce JP., 1998, TOBACCO CONTROL CALI; PIERCE JP, 1994, TOBACCU USE CALIFORN; RAO JNK, 1984, ANN STAT, V12, P46, DOI 10.1214/aos/1176346391; SAUL H, 1993, NEW SCI, V137, P12; Schauffler H H, 1997, Tob Control, V6 Suppl 1, pS81; SCHNEIDER NG, 1983, ADDICT BEHAV, V8, P253, DOI 10.1016/0306-4603(83)90020-5; Shaw JP, 1998, TOB CONTROL, V7, P161, DOI 10.1136/tc.7.2.161; Shiffman S, 1997, Tob Control, V6, P306; SILAGY C, 2000, COCHRANE DB SYST REV; Solberg LI, 2001, PREV MED, V33, P53, DOI 10.1006/pmed.2001.0853; Sonderskov J, 1997, AM J EPIDEMIOL, V145, P309; Stratton K., 2000, CLEARING SMOKE ASSES; *US DEP HHS, 2000, TREAT TOB US DEP; *US DEP HHS, 1989, DHHS PUBL PHS CDC; *US DEP HHS, 1990, PUBL US DEP HHS; US Department of Health and Human Services, 1980, HLTH CONS SMOK WOM R; Zhu SH, 2000, AM J PREV MED, V18, P305, DOI 10.1016/S0749-3797(00)00124-0	39	198	199	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 11	2002	288	10					1260	1264		10.1001/jama.288.10.1260	http://dx.doi.org/10.1001/jama.288.10.1260			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592BW	12215133	Bronze			2022-12-24	WOS:000177917700025
J	Rajagopalan, H; Bardelli, A; Lengauer, C; Kinzler, KW; Vogelstein, B; Velculescu, VE				Rajagopalan, H; Bardelli, A; Lengauer, C; Kinzler, KW; Vogelstein, B; Velculescu, VE			Tumorigenesis - RAF/RAS oncogenes and mismatch-repair status	NATURE			English	Article							MUTATIONS; GENE		Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Program Cellular & Mol Med, Baltimore, MD 21231 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Rajagopalan, H (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA.	velculescu@jhmi.edu	Velculescu, Victor/ABF-4846-2020; BARDELLI, Alberto/J-9721-2018	Velculescu, Victor/0000-0003-1195-438X; BARDELLI, Alberto/0000-0003-1647-5070				Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Marais R, 1997, J BIOL CHEM, V272, P4378, DOI 10.1074/jbc.272.7.4378; Markowitz S, 2000, J CLIN ONCOL, V18, p75S; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; Sparks AB, 1998, CANCER RES, V58, P1130; STORM SM, 1993, TOXICOL LETT, V67, P201, DOI 10.1016/0378-4274(93)90056-4; Thiagalingam S, 2001, P NATL ACAD SCI USA, V98, P2698, DOI 10.1073/pnas.051625398; Wang TL, 2002, P NATL ACAD SCI USA, V99, P3076, DOI 10.1073/pnas.261714699	9	1000	1055	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 29	2002	418	6901					934	934		10.1038/418934a	http://dx.doi.org/10.1038/418934a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588AP	12198537	Bronze			2022-12-24	WOS:000177677500034
J	Cumming, BG				Cumming, BG			An unexpected specialization for horizontal disparity in primate primary visual cortex	NATURE			English	Article							CORTICAL AREA V1; BINOCULAR DISPARITY; DEPTH DISCRIMINATION; STRIATE CORTEX; COMPLEX CELLS; NEURONS; MACAQUE; MECHANISMS; PERCEPTION; RESPONSES	The horizontal separation of the eyes means that objects nearer or farther than the fixation point project to different locations on the two retinae, differing principally in their horizontal coordinates (horizontal binocular disparity). Disparity-selective neurons have generally been studied with disparities applied in only one direction 1 (often horizontal), which cannot determine whether the encoding is specialized for processing disparities along the horizontal axis. It is therefore unclear if disparity selectivity represents a specialization for naturally occurring disparities. I used random dot stereograms to study disparity-selective neurons from the primary visual cortex (V1) of awake fixating monkeys. Many combinations of vertical and horizontal disparity were used, characterizing the surface of responses as a function of two-dimensional disparity. Here I report that the response surface usually showed elongation along the horizontal disparity axis, despite the isotropic stimulus. Thus these neurons modulated their firing rate over a wider range of horizontal disparity than vertical disparity. This demonstrates that disparity-selective cells are specialized for processing horizontal disparity, and that existing models(2,3) of disparity selectivity require substantial revision.	NEI, Sensorimotor Res Lab, NIH, Bethesda, MD 20982 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Cumming, BG (corresponding author), NEI, Sensorimotor Res Lab, NIH, Bethesda, MD 20982 USA.				NATIONAL EYE INSTITUTE [Z01EY000404, ZIAEY000404] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Anzai A, 1999, J NEUROPHYSIOL, V82, P909, DOI 10.1152/jn.1999.82.2.909; BARLOW HB, 1967, J PHYSIOL-LONDON, V193, P327, DOI 10.1113/jphysiol.1967.sp008360; Cumming BG, 1997, NATURE, V389, P280, DOI 10.1038/38487; Cumming BG, 2000, J NEUROSCI, V20, P4758, DOI 10.1523/JNEUROSCI.20-12-04758.2000; Cumming BG, 1999, J NEUROSCI, V19, P5602; Cumming BG, 2001, ANNU REV NEUROSCI, V24, P203, DOI 10.1146/annurev.neuro.24.1.203; DEANGELIS GC, 1991, NATURE, V352, P156, DOI 10.1038/352156a0; Howard IP, 1995, BINOCULAR VISION STE; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; JOSHUA DE, 1970, EXP BRAIN RES, V10, P389, DOI 10.1007/BF02324766; Livingstone MS, 1999, NAT NEUROSCI, V2, P825, DOI 10.1038/12199; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1148, DOI 10.1152/jn.1983.49.5.1148; MAYHEW JEW, 1982, NATURE, V297, P376, DOI 10.1038/297376a0; Nieder A, 2001, VISUAL NEUROSCI, V18, P541, DOI 10.1017/S095252380118404X; Ohzawa I, 1998, CURR OPIN NEUROBIOL, V8, P509, DOI 10.1016/S0959-4388(98)80039-1; Ohzawa I, 1997, J NEUROPHYSIOL, V77, P2879, DOI 10.1152/jn.1997.77.6.2879; OHZAWA I, 1990, SCIENCE, V249, P1037, DOI 10.1126/science.2396096; Prince SJD, 2000, J NEUROSCI, V20, P3387, DOI 10.1523/JNEUROSCI.20-09-03387.2000; Prince SJD, 2002, J NEUROPHYSIOL, V87, P209, DOI 10.1152/jn.00466.2000; VANDERHEYDT R, 1978, EXP BRAIN RES, V31, P523	20	89	91	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 8	2002	418	6898					633	636		10.1038/nature00909	http://dx.doi.org/10.1038/nature00909			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581RA	12167860				2022-12-24	WOS:000177305600041
J	Socha, JJ				Socha, JJ			Kinematics - Gliding flight in the paradise tree snake	NATURE			English	Article									Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA	University of Chicago	Socha, JJ (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57th St, Chicago, IL 60637 USA.							DALY M, 1899, BOMBAY NAT HIST J, V12, P589; EMERSON SB, 1990, EVOLUTION, V44, P1931, DOI 10.1111/j.1558-5646.1990.tb04300.x; FLOWER SS, 1899, P ZOOL SOC LOND 16 M; HEYER W R, 1970, Herpetologica, V26, P317; MCGUIRE JA, 1998, THESIS U TEXAS AUSTI; PENDLEBURY H. M., 1931, BULL RAFFLES MUS, V5, P75; Scholey K., 1986, Biona Report, V5, P187; VAUGHNARBUCKLE KH, 1959, J BOMBAY NAT HIST SO, V56, P640; Wall F., 1908, Journal of the Bombay Natural History Society, V18	9	58	59	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 8	2002	418	6898					603	604		10.1038/418603a	http://dx.doi.org/10.1038/418603a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581RA	12167849				2022-12-24	WOS:000177305600030
J	Caspi, A; McClay, J; Moffitt, TE; Mill, J; Martin, J; Craig, IW; Taylor, A; Poulton, R				Caspi, A; McClay, J; Moffitt, TE; Mill, J; Martin, J; Craig, IW; Taylor, A; Poulton, R			Role of genotype in the cycle of violence in maltreated children	SCIENCE			English	Article							MONOAMINE-OXIDASE-A; FUNCTIONAL POLYMORPHISM; AGGRESSIVE-BEHAVIOR; ANTISOCIAL-BEHAVIOR; GENE PROMOTER; ASSOCIATION; PERSONALITY; STRESS; BRAIN; RISK	We studied a large sample of male children from birth to adulthood to determine why some children who are maltreated grow up to develop antisocial behavior, whereas others do not. A functional polymorphism in the gene encoding the neurotransmitter-metabolizing enzyme monoamine oxidase A (MAOA) was found to moderate the effect of maltreatment. Maltreated children with a genotype conferring high levels of MAOA expression were less likely to develop antisocial problems. These findings may partly explain why not all victims of maltreatment grow up to victimize others, and they provide epidemiological evidence that genotypes can moderate children's sensitivity to environmental insults.	Kings Coll London, Inst Psychiat, Social Genet & Dev Psychiat Res Ctr, MRC, London SE5 8AF, England; Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA; Univ Otago, Dunedin Sch Med, Dunedin, New Zealand	University of London; King's College London; University of Wisconsin System; University of Wisconsin Madison; University of Otago	Moffitt, TE (corresponding author), Kings Coll London, Inst Psychiat, Social Genet & Dev Psychiat Res Ctr, MRC, London SE5 8AF, England.	t.moffitt@iop.kcl.ac.uk	Mill, Jonathan S/B-3276-2010; caspi, avshalom/D-5294-2011; McClay, Joseph/C-9931-2009; Kennedy, Kristen M/B-4699-2008; caspi, avshalom/AAJ-5874-2020; Craig, Ian/AAF-9167-2019; Mill, Jonathan/B-5678-2014; Moffitt, Terrie E/D-5295-2011	Mill, Jonathan S/0000-0003-1115-3224; caspi, avshalom/0000-0003-0082-4600; McClay, Joseph/0000-0002-3628-2447; Kennedy, Kristen M/0000-0001-5373-9026; caspi, avshalom/0000-0003-0082-4600; Mill, Jonathan/0000-0003-1115-3224; Moffitt, Terrie E/0000-0002-8589-6760; Craig, Ian/0000-0002-4063-1005	NIMH NIH HHS [MH45070, MH49414] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH045070, R29MH049414, R01MH049414] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AIKEN LS, 1991, MULTIPLE REGRESS TES; American Psychological Association, 1994, DIAGN STAT MAN MENT, V4th; Bennett AJ, 2002, MOL PSYCHIATR, V7, P118, DOI 10.1038/sj/mp/4000949; BERMAN ME, 1997, HDB ANTISOCIAL BEHAV; BOWTELL DDL, 1987, ANAL BIOCHEM, V162, P463, DOI 10.1016/0003-2697(87)90421-0; Bremner JD, 2001, DEV PSYCHOPATHOL, V13, P473, DOI 10.1017/S0954579401003042; BRUNNER HG, 1993, SCIENCE, V262, P578, DOI 10.1126/science.8211186; CASES O, 1995, SCIENCE, V268, P1763, DOI 10.1126/science.7792602; Cicchetti D, 2001, DEV PSYCHOPATHOL, V13, P783, DOI 10.1017/S0954579401004035; COHEN P, 1984, ARCH GEN PSYCHIAT, V41, P1178; De Bellis MD, 2001, DEV PSYCHOPATHOL, V13, P539, DOI 10.1017/S0954579401003078; Denney RM, 1999, HUM GENET, V105, P542, DOI 10.1007/s004390051143; DODGE KA, 1990, SCIENCE, V250, P1678, DOI 10.1126/science.2270481; FERGUSSON DM, 1992, J CHILD PSYCHOL PSYC, V33, P1059, DOI 10.1111/j.1469-7610.1992.tb00925.x; Francis DD, 1999, CURR OPIN NEUROBIOL, V9, P128, DOI 10.1016/S0959-4388(99)80016-6; Freeman B, 1997, BEHAV GENET, V27, P251, DOI 10.1023/A:1025614231190; Glaser D, 2000, J CHILD PSYCHOL PSYC, V41, P97, DOI 10.1111/1469-7610.00551; Grundy SM, 1999, J AM COLL CARDIOL, V34, P1348, DOI 10.1016/S0735-1097(99)00387-3; Hill AVS, 1999, BRIT MED BULL, V55, P401, DOI 10.1258/0007142991902457; Jaffee SR, 2002, ARCH GEN PSYCHIAT, V59, P215, DOI 10.1001/archpsyc.59.3.215; JEANPIERRE M, 1987, NUCLEIC ACIDS RES, V15, P9611, DOI 10.1093/nar/15.22.9611; Johnson JG, 1999, ARCH GEN PSYCHIAT, V56, P600, DOI 10.1001/archpsyc.56.7.600; Jorm AF, 2000, PSYCHIATR GENET, V10, P87, DOI 10.1097/00041444-200010020-00006; Jorm AF, 2000, SOC PSYCH PSYCH EPID, V35, P1, DOI 10.1007/s001270050001; Keiley ML, 2001, DEV PSYCHOPATHOL, V13, P891, DOI 10.1017/S0954579401004084; Kendler KS, 2001, ARCH GEN PSYCHIAT, V58, P1005, DOI 10.1001/archpsyc.58.11.1005; KRAEMER GW, 1989, NEUROPSYCHOPHARMACOL, V2, P175, DOI 10.1016/0893-133X(89)90021-3; Krueger RF, 2000, J PERS, V68, P967, DOI 10.1111/1467-6494.00123; LEVY ER, 1989, GENOMICS, V5, P368, DOI 10.1016/0888-7543(89)90072-4; Luthar SS, 2000, CHILD DEV, V71, P543, DOI 10.1111/1467-8624.00164; LYNAM D, 1993, J ABNORM PSYCHOL, V102, P187, DOI 10.1037/0021-843X.102.2.187; Manuck SB, 2000, PSYCHIAT RES, V95, P9, DOI 10.1016/S0165-1781(00)00162-1; Moffitt T. E., 2001, SEX DIFFERENCES ANTI; Moffitt TE, 2002, DEV PSYCHOPATHOL, V14, P179, DOI 10.1017/S0954579402001104; MORELL V, 1993, SCIENCE, V260, P1722, DOI 10.1126/science.8511575; MUTHEN LK, 1999, M PLUS; Parsian A, 2001, PSYCHIAT GENET, V11, P89, DOI 10.1097/00041444-200106000-00006; Pine DS, 1997, ARCH GEN PSYCHIAT, V54, P839; Pollak SD, 1997, CHILD DEV, V68, P773, DOI 10.1111/j.1467-8624.1997.tb01961.x; POULTON R, IN PRESS LANCET; RAINE A, 1994, ARCH GEN PSYCHIAT, V51, P984; ROBINS LN, 1978, PSYCHOL MED, V8, P611, DOI 10.1017/S0033291700018821; ROWE DC, 2001, BIOL CRIME; Rutter M, 2002, ANNU REV PSYCHOL, V53, P463, DOI 10.1146/annurev.psych.53.100901.135223; Rutter M., 1998, ANTISOCIAL BEHAV YOU; Sabol SZ, 1998, HUM GENET, V103, P273, DOI 10.1007/s004390050816; Samochowiec J, 1999, PSYCHIAT RES, V86, P67, DOI 10.1016/S0165-1781(99)00020-7; Satten GA, 2001, AM J HUM GENET, V68, P466, DOI 10.1086/318195; Shih JC, 1999, AM J HUM GENET, V65, P593, DOI 10.1086/302562; Shih JC, 1999, ANNU REV NEUROSCI, V22, P197, DOI 10.1146/annurev.neuro.22.1.197; Silva P., 1996, CHILD ADULT DUNEDIN; Straus MA, 1997, ARCH PEDIAT ADOL MED, V151, P761, DOI 10.1001/archpedi.1997.02170450011002; SUOMI SJ, IN PRESS HDB DEV PSY; Ward HE, 1998, PHARMACOL BIOCHEM BE, V60, P209, DOI 10.1016/S0091-3057(97)00580-7; *WHO, IN PRESS COMP QUANT; Widom C.S., 1997, HDB ANTISOCIAL BEHAV; WIDOM CS, 1989, SCIENCE, V244, P160, DOI 10.1126/science.2704995	57	2829	2923	13	682	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 2	2002	297	5582					851	854		10.1126/science.1072290	http://dx.doi.org/10.1126/science.1072290			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	579RZ	12161658				2022-12-24	WOS:000177192800056
J	Halpern, SD; Ubel, PA; Caplan, AL				Halpern, SD; Ubel, PA; Caplan, AL			Solid-organ transplantation in HIV-infected patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HUMAN-IMMUNODEFICIENCY-VIRUS; LIVER-TRANSPLANTATION; DIABETES-MELLITUS; RECIPIENTS; RETRANSPLANTATION; CYCLOSPORINE; PROGRESSION; SURVIVAL; DISEASE; SURGERY		Univ Penn, Sch Med, Philadelphia, PA 19104 USA; Vet Affairs Ann Arbor Healthcare Syst, Ann Arbor, MI 48109 USA	University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Halpern, SD (corresponding author), Univ Penn, Sch Med, Philadelphia, PA 19104 USA.							*AM COLL SURG, 1991, B AM COLL SURG, V76, P28; [Anonymous], 1988, JAMA-J AM MED ASSOC, V259, P1360; Astermark T, 1998, BRIT J HAEMATOL, V103, P10, DOI 10.1046/j.1365-2141.1998.00961.x; BAYER R, 1988, B NEW YORK ACAD MED, V64, P498; Bica I, 2001, CLIN INFECT DIS, V32, P492, DOI 10.1086/318501; BOUSCARAT F, 1994, CLIN INFECT DIS, V19, P854, DOI 10.1093/clinids/19.5.854; [Anonymous], 2001, MMWR Recomm Rep, V50, P1; CLARKE OW, 1995, ARCH INTERN MED, V155, P29, DOI 10.1001/archinte.1995.00430010033005; Corley M C, 1995, Medsurg Nurs, V4, P211; DEIN JR, 1989, ANN THORAC SURG, V48, P350, DOI 10.1016/S0003-4975(10)62855-X; DUMMER JS, 1989, TRANSPLANTATION, V47, P134, DOI 10.1097/00007890-198901000-00030; ERICE A, 1991, REV INFECT DIS, V13, P537; Forman LM, 2002, GASTROENTEROLOGY, V122, P889, DOI 10.1053/gast.2002.32418; Goldberg D, 2000, J HOSP INFECT, V44, P99, DOI 10.1053/jhin.1999.0672; Gow PJ, 2001, AIDS, V15, P291, DOI 10.1097/00002030-200101260-00029; HALEVY A, 1994, AM J MED, V96, P282, DOI 10.1016/0002-9343(94)90154-6; Halevy A, 2000, ARCH SURG-CHICAGO, V135, P51, DOI 10.1001/archsurg.135.1.51; HARIHARAN S, 1993, CLIN TRANSPLANT, V7, P235; Henderson DK, 1999, JAMA-J AM MED ASSOC, V281, P931, DOI 10.1001/jama.281.10.931; Isaacs RB, 1999, AM J KIDNEY DIS, V34, P706, DOI 10.1016/S0272-6386(99)70397-5; John PR, 2001, HEPATOLOGY, V34, P889, DOI 10.1053/jhep.2001.29134; Kaplan JE, 2000, CLIN INFECT DIS, V30, pS5, DOI 10.1086/313843; Kappes U, 2001, AM J NEPHROL, V21, P259, DOI 10.1159/000046259; KASISKE BL, 1991, NEW ENGL J MED, V324, P302, DOI 10.1056/NEJM199101313240505; Kuo PC, 2001, AM J TRANSPLANT, V1, P13, DOI 10.1034/j.1600-6143.2001.010104.x; Kuo PC, 2001, TRANSPLANTATION, V71, P1689, DOI 10.1097/00007890-200106150-00033; LEMMA M, 1992, THORAC CARDIOV SURG, V40, P279, DOI 10.1055/s-2007-1022720; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Mocroft A, 2000, LANCET, V356, P291, DOI 10.1016/S0140-6736(00)02504-6; Mullen MA, 1996, CAN MED ASSOC J, V154, P337; Nair S, 2002, LANCET, V359, P287, DOI 10.1016/S0140-6736(02)07494-9; OBrien WA, 1997, ANN INTERN MED, V126, P939, DOI 10.7326/0003-4819-126-12-199706150-00002; Ojo AO, 2000, AM J KIDNEY DIS, V36, P153, DOI 10.1053/ajkd.2000.8288; Ojo AO, 2001, J AM SOC NEPHROL, V12, P589, DOI 10.1681/ASN.V123589; *ORG TRANSPL ASS, 2001, HIV TRANSPL; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; POLI F, 1989, TRANSPLANTATION, V47, P725; Prachalias AA, 2001, TRANSPLANTATION, V72, P1684, DOI 10.1097/00007890-200111270-00020; Ragni MV, 1999, BLOOD, V93, P1113, DOI 10.1182/blood.V93.3.1113.403a38e_1113_1115; Revanur VK, 2001, CLIN TRANSPLANT, V15, P89, DOI 10.1034/j.1399-0012.2001.150202.x; RUBIN RH, 1987, TRANSPLANTATION, V44, P1, DOI 10.1097/00007890-198707000-00001; Schvarcz R, 2000, TRANSPLANTATION, V69, P2194, DOI 10.1097/00007890-200005270-00041; SCHWARZ A, 1993, TRANSPLANTATION, V55, P95, DOI 10.1097/00007890-199301000-00019; SCHWARZ A, 1987, TRANSPLANTATION, V44, P21, DOI 10.1097/00007890-198707000-00006; Sewell CA, 2001, J REPROD MED, V46, P199; SHAW BW, 1985, TRANSPLANT P, V17, P264; Sheikh AM, 1999, TRANSPLANTATION, V68, P307, DOI 10.1097/00007890-199907270-00027; SMITH S, 2002, BOSTON GLOBE    0313, pB3; Spital A, 1998, TRANSPLANTATION, V65, P1187, DOI 10.1097/00007890-199805150-00008; STRYKER J, 2001, NY TIMES        1211, pF6; TZAKIS AG, 1990, TRANSPLANTATION, V49, P354, DOI 10.1097/00007890-199002000-00025; Ubel P A, 1997, Liver Transpl Surg, V3, P343; Ubel PA, 1998, NEW ENGL J MED, V339, P1322, DOI 10.1056/NEJM199810293391811; UBEL PA, 1995, HEALTH POLICY, V34, P145, DOI 10.1016/0168-8510(95)00714-4; Ubel PA, 1996, SOC SCI MED, V42, P1049, DOI 10.1016/0277-9536(95)00216-2; UBEL PA, 1993, JAMA-J AM MED ASSOC, V270, P2469, DOI 10.1001/jama.270.20.2469; Ubel PA, 2001, LIVER TRANSPLANT, V7, P600, DOI 10.1053/jlts.2001.25361; *UN NETW ORG SHAR, 2001, POL BYL; Valente JF, 1997, CLIN TRANSPLANT, V11, P231; WHITE LJ, 1988, ANN INTERN MED, V108, P460, DOI 10.7326/0003-4819-108-3-460	60	106	107	3	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 25	2002	347	4					284	287		10.1056/NEJMsb020632	http://dx.doi.org/10.1056/NEJMsb020632			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587WB	12140307	Green Published			2022-12-24	WOS:000177665800011
J	Jackevicius, CA; Mamdami, M; Tu, JV				Jackevicius, CA; Mamdami, M; Tu, JV			Adherence with statin therapy in elderly patients with and without acute coronary syndromes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; DISCONTINUATION RATES; LOWERING MEDICATIONS; HEART-DISEASE; PRAVASTATIN; EVENTS; HYPERCHOLESTEROLEMIA; RECOMMENDATIONS; ATORVASTATIN; PREVENTION	Context Landmark clinical trials have demonstrated the survival benefits of statins, with benefits usually starting after 1 to 2 years of treatment. Research prior to these trials of older lipid-lowering agents demonstrated low levels of 1-year adherence. Objective To compare 2-year adherence following statin initiation in 3 cohorts of patients: those with recent acute coronary syndrome (ACS), those with chronic coronary artery disease (CAD), and those without coronary disease (primary prevention). Design and Setting Cohort study using linked population-based administrative data from Ontario. Patients All patients aged 66 years or older who received at least 1 statin prescription between January 1994 and December 1998 and who did not have a statin prescription in the prior year were followed up for 2 years from their first statin prescription. There were 22379 patients in the ACS, 36106 in the chronic CAD, and 85020 in the primary prevention cohorts. Main Outcome Measures Adherence to statins, defined as a statin being dispensed at least every 120 days after the index prescription for 2 years. Results Two-year adherence rates in the cohorts were only 40.1% for ACS, 36.1% for chronic CAD, and 25.4% for primary prevention. Relative to the ACS cohort, nonadherence was more likely among patients receiving statins in the chronic CAD (relative risk ERR], 1.14; 95% Cl, 1,11-1.16) and primary prevention cohorts (RR, 1,92; 95% Cl, 1.87-1.96). Conclusions Elderly patients with and without recent ACS have low rates of adherence to statins. This suggests that many patients initiating statin therapy may receive no or limited benefit from statins because of premature discontinuation.	Toronto Gen Hosp, Univ Hlth Network, Dept Pharm, Toronto, ON M5G 2C4, Canada; Toronto Gen Hosp, Univ Hlth Network, Dept Hlth Policy Management & Evolut, Toronto, ON, Canada; Toronto Gen Hosp, Univ Hlth Network, Dept Med, Toronto, ON, Canada; Toronto Gen Hosp, Univ Hlth Network, Womens Hlth Program, Toronto, ON, Canada; Univ Toronto, Inst Clin Evaluat Sci, Toronto, ON, Canada; Sunnybrook & Womens Coll, Hlth Sci Ctr, Div Gen Internal Med, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Jackevicius, CA (corresponding author), Toronto Gen Hosp, Univ Hlth Network, Dept Pharm, 200 Elizabeth St, Toronto, ON M5G 2C4, Canada.	Cynthia.Jackevicius@uhn.on.ca		Tu, Jack/0000-0003-0111-722X				ANDRADE SE, 1995, NEW ENGL J MED, V332, P1125, DOI 10.1056/NEJM199504273321703; Aronow HD, 2001, LANCET, V357, P1063, DOI 10.1016/S0140-6736(00)04257-4; Avorn J, 1998, JAMA-J AM MED ASSOC, V279, P1458, DOI 10.1001/jama.279.18.1458; Bybee KA, 2001, AM J CARDIOL, V87, P771, DOI 10.1016/S0002-9149(00)01501-0; *CTR DRUG EV RES, 2002, BAYC INF; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; ERAKER SA, 1984, ANN INTERN MED, V100, P258, DOI 10.7326/0003-4819-100-2-258; Eriksson M, 1998, J INTERN MED, V243, P373; Feely J, 1999, PHARMACOECONOMICS, V16, P175, DOI 10.2165/00019053-199916020-00006; Fodor JG, 2000, CAN MED ASSOC J, V162, P1441; GRUNDY SM, 1993, JAMA-J AM MED ASSOC, V269, P3015, DOI 10.1001/jama.269.23.3015; Heeschen C, 2002, CIRCULATION, V105, P1446, DOI 10.1161/01.CIR.0000012530.68333.C8; Hiatt JG, 1999, AM J MANAG CARE, V5, P437; *HLTH SERV UT RES, 1995, CHOL TEST TREATM AD; Insull W, 1997, J INTERN MED, V241, P317, DOI 10.1046/j.1365-2796.1997.112133000.x; Jackevicius CA, 2001, ARCH INTERN MED, V161, P183, DOI 10.1001/archinte.161.2.183; Jones P, 1998, AM J CARDIOL, V81, P582, DOI 10.1016/S0002-9149(97)00965-X; KRAVITZ RL, 1993, ARCH INTERN MED, V153, P1869, DOI 10.1001/archinte.153.16.1869; McDermott MM, 1997, ARCH INTERN MED, V157, P1921, DOI 10.1001/archinte.157.17.1921; Muhlestein JB, 2001, AM J CARDIOL, V87, P257, DOI 10.1016/S0002-9149(00)01354-0; PEDERSEN TR, 1994, LANCET, V344, P1383; Rochon PA, 2000, LANCET, V356, P639, DOI 10.1016/S0140-6736(00)02606-4; Rudd P., 1994, CARDIOL REV, V2, P230; Sackett DL, 1991, CLIN EPIDEMIOLOGY BA, V2nd; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Schwartz GG, 2001, JAMA-J AM MED ASSOC, V285, P1711, DOI 10.1001/jama.285.13.1711; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Shepherd J, 1997, EUR HEART J, V18, P1718; Simons LA, 1996, MED J AUSTRALIA, V164, P208, DOI 10.5694/j.1326-5377.1996.tb94138.x; Steiner JF, 1997, J CLIN EPIDEMIOL, V50, P105, DOI 10.1016/S0895-4356(96)00268-5; Stenestrand U, 2001, JAMA-J AM MED ASSOC, V285, P430, DOI 10.1001/jama.285.4.430; Tonkin A, 1998, NEW ENGL J MED, V339, P1349	32	810	842	0	26	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 24	2002	288	4					462	467		10.1001/jama.288.4.462	http://dx.doi.org/10.1001/jama.288.4.462			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	575NZ	12132976	Bronze			2022-12-24	WOS:000176955400028
J	Gelb, MH; Hol, WGJ				Gelb, MH; Hol, WGJ			Parasitology - Drugs to combat tropical protozoan parasites	SCIENCE			English	Editorial Material									Univ Washington, Dept Chem, Seattle, WA 98195 USA; Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Gelb, MH (corresponding author), Univ Washington, Dept Chem, Seattle, WA 98195 USA.			gelb, michael/0000-0001-7000-5219				Bahl A, 2002, NUCLEIC ACIDS RES, V30, P87, DOI 10.1093/nar/30.1.87; Croft SL, 1996, J ANTIMICROB CHEMOTH, V38, P1041, DOI 10.1093/jac/38.6.1041; Jha TK, 1999, NEW ENGL J MED, V341, P1795, DOI 10.1056/NEJM199912093412403; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; PORTILLO HA, 2001, J INFECT DIS, V183, P1653; Roos DS, 2002, PHILOS T R SOC B, V357, P35, DOI 10.1098/rstb.2001.1047; Sibley CH, 2001, TRENDS PARASITOL, V17, P582, DOI 10.1016/S1471-4922(01)02085-2; *TARG SEL STRUCT B, 2002, KEYST S 3 8 MARCH 20; Urbina JA, 2001, CURR OPIN INFECT DIS, V14, P733, DOI 10.1097/00001432-200112000-00012; Wengelnik K, 2002, SCIENCE, V295, P1311, DOI 10.1126/science.1067236	10	74	79	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 19	2002	297	5580					343	344		10.1126/science.1073126	http://dx.doi.org/10.1126/science.1073126			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574LV	12130767				2022-12-24	WOS:000176892600032
J	Mackler, JM; Drummond, JA; Loewen, CA; Robinson, IM; Reist, NE				Mackler, JM; Drummond, JA; Loewen, CA; Robinson, IM; Reist, NE			The C2BCa2+-binding motif of synaptotagmin is required for synaptic transmission in vivo	NATURE			English	Article							C2B DOMAIN; NEUROTRANSMITTER RELEASE; DROSOPHILA REVEALS; MUTANTS; EXOCYTOSIS; VESICLES; BINDING; LOCALIZATION	Synaptotagmin is a synaptic vesicle protein that is postulated to be the Ca2+ sensor for fast, evoked neurotransmitter release(1). Deleting the gene for synaptotagmin (syt(null)) strongly suppresses synaptic transmission in every species examined(2), showing that synaptotagmin is central in the synaptic vesicle cycle. The cytoplasmic region of synaptotagmin contains two C-2 domains, C(2)A and C2B. Five, highly conserved, acidic residues in both the C(2)A and C2B domains of synaptotagmin coordinate the binding of Ca2+ ions(3-5), and biochemical studies have characterized several in vitro Ca2+-dependent interactions between synaptotagmin and other nerve terminal molecules(6). But there has been no direct evidence that any of the Ca2+-binding sites within synaptotagmin are required in vivo. Here we show that mutating two of the Ca2+-binding aspartate residues in the C2B domain (D-416,N-418 in Drosophila) decreased evoked transmitter release by >95%, and decreased the apparent Ca2+ affinity of evoked transmitter release. These studies show that the Ca2+-binding motif of the C2B domain of synaptotagmin is essential for synaptic transmission.	Colorado State Univ, Dept Anat & Neurobiol, Program Mol Cellular & Integrat Neurosci, Ft Collins, CO 80523 USA; Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England	Colorado State University; University of Cambridge	Reist, NE (corresponding author), Colorado State Univ, Dept Anat & Neurobiol, Program Mol Cellular & Integrat Neurosci, Ft Collins, CO 80523 USA.			Reist, Noreen/0000-0002-1647-3166				Augustine GJ, 2001, CURR OPIN NEUROBIOL, V11, P320, DOI 10.1016/S0959-4388(00)00214-2; Bai JH, 2002, P NATL ACAD SCI USA, V99, P1665, DOI 10.1073/pnas.032541099; BOMMERT K, 1993, NATURE, V363, P163, DOI 10.1038/363163a0; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; Desai RC, 2000, J CELL BIOL, V150, P1125, DOI 10.1083/jcb.150.5.1125; DIANTONIO A, 1993, CELL, V73, P1281, DOI 10.1016/0092-8674(93)90356-U; Earles CA, 2001, J CELL BIOL, V154, P1117, DOI 10.1083/jcb.200105020; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; FUKUDA M, 1995, P NATL ACAD SCI USA, V92, P10708, DOI 10.1073/pnas.92.23.10708; Garcia RA, 2000, P NATL ACAD SCI USA, V97, P5883, DOI 10.1073/pnas.100127197; JORGENSEN EM, 1995, NATURE, V378, P196, DOI 10.1038/378196a0; Kee Y, 1996, J NEUROSCI, V16, P1975; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; Lin RC, 2000, ANNU REV CELL DEV BI, V16, P19, DOI 10.1146/annurev.cellbio.16.1.19; Littleton JT, 2001, J NEUROSCI, V21, P1421, DOI 10.1523/JNEUROSCI.21-05-01421.2001; LITTLETON JT, 1993, DEVELOPMENT, V118, P1077; Loewen CA, 2001, GENESIS, V31, P30, DOI 10.1002/gene.10002; Mackler JM, 2001, J COMP NEUROL, V436, P4, DOI 10.1002/cne.1049; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Reist NE, 1998, J NEUROSCI, V18, P7662; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; ROBINSON IM, 2002, NATURE          0707; Shao XG, 1996, SCIENCE, V273, P248, DOI 10.1126/science.273.5272.248; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Sutton RB, 1999, J CELL BIOL, V147, P589, DOI 10.1083/jcb.147.3.589; ZHANG JZ, 1994, CELL, V78, P751, DOI 10.1016/S0092-8674(94)90442-1	28	258	262	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 18	2002	418	6895					340	344		10.1038/nature00846	http://dx.doi.org/10.1038/nature00846			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574BF	12110842				2022-12-24	WOS:000176868000046
J	Carel, JC; Ecosse, E; Nicolino, M; Tauber, M; Leger, J; Cabrol, S; Bastie-Sigeac, IN; Chaussain, JL; Coste, J				Carel, JC; Ecosse, E; Nicolino, M; Tauber, M; Leger, J; Cabrol, S; Bastie-Sigeac, IN; Chaussain, JL; Coste, J			Adult height after long term treatment with recombinant growth hormone for idiopathic isolated growth hormone deficiency: observational follow up study of the French population based registry	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SHORT STATURE; FINAL HEIGHT; CHILDREN; DIAGNOSIS; VELOCITY; EXPERIENCE; CHILDHOOD; PUBERTY; THERAPY; BOYS	Objective To evaluate the efficacy of recombinant growth hormone for increasing adult height in children treated for idiopathic isolated growth hormone deficiency. Design Observational follow up study. Setting Population based registry. Participants All 2852 French children diagnosed as having isolated idiopathic growth hormone deficiency whose treatment started between 1987 and 1992 and ended before 1996. Main outcome measures Change in height between the start of treatment and adulthood; classification of patients according to whether treatment was completed as scheduled or stopped early. Results Adult height was obtained for 2165 (76%) patients. The mean dose of growth hormone at start of treatment was 0.42 IU/kg/week. Height gain was 1.1 (SD 0.9) standard deviation (SD) scores, resulting in an adult height of -1.6 (0.9) SD score (girls, 154 (5) cm; boys, 167 (6) cm). Patients who completed the treatment gained 1.0 (0.7) SD score of height in 3.6 (1.4) years. Patients with treatments stopped early gained 0.6 (0.6) SD score in 2.7 (1.4) years while receiving treatment and a further 0.4 (0.9) SD score after the end of treatment. Most of the variation in height gain was explained by regression towards the mean, patients' characteristics, and delay in starting puberty. Severe growth hormone deficiency was associated with better outcome. Each year of treatment was associated with a gain of 0.2 SD score (1.3 cm). Conclusion The effect of growth hormone is unclear in many patients treated for so called idiopathic isolated growth hormone deficiency: Most of the patients have pubertal delay and a spontaneous growth potential, which must be taken into account when measuring the effect and cost effectiveness of treatments. Growth hormone deficiency should be clearly distinguished froth pubertal delay, and criteria should restrict the definition to patients with severely and permanently altered growth hormone secretion as our results support the use of growth hormone in such patients. Long term trials are required for most patients currently treated.	Univ Paris 05, Grp Hosp Cochin St Vincent de Paul, F-75014 Paris, France; Univ Paris 05, Fac Cochin, F-75014 Paris, France; Hop Robert Debre, Dept Paediat Endocrinol, F-75019 Paris, France; Hop Robert Debre, INSERM, U561, F-75019 Paris, France; Hop Robert Debre, Dept Biostat, F-75019 Paris, France; Hop Trousseau, Paediat Endocrinol Unit, F-75571 Paris, France; Hop Debrousse, Dept Paediat Endocrinol, F-69322 Lyon, France; Hop Enfants, Dept Paediat Endocrinol, F-31026 Toulouse, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Lyon; CHU de Toulouse	Carel, JC (corresponding author), Univ Paris 05, Grp Hosp Cochin St Vincent de Paul, F-75014 Paris, France.	carel@cochin.inserm.fr	Carel, Jean-Claude/AAZ-7691-2020	Carel, Jean-Claude/0000-0002-0424-6767				August GP, 1998, PEDIATRICS, V102, P512; August GP, 1998, PEDIATRICS, V102, P517; Bayley N, 1952, J PEDIATR, V14, P432; BLAND JM, 1994, BRIT MED J, V308, P1499, DOI 10.1136/bmj.308.6942.1499; Blethen SL, 1997, J CLIN ENDOCR METAB, V82, P418, DOI 10.1210/jc.82.2.418; BOURGUIGNON JP, 1988, ENDOCR REV, V9, P467, DOI 10.1210/edrv-9-4-467; Brook CGD, 1997, BMJ-BRIT MED J, V315, P692, DOI 10.1136/bmj.315.7110.692; Brook CGD, 2000, ARCH DIS CHILD, V83, P176, DOI 10.1136/adc.83.2.176; Carel JC, 1997, J CLIN ENDOCR METAB, V82, P2117, DOI 10.1210/jc.82.7.2117; Chatelain P., 1999, GROWTH HORMONE THERA, V10, P11; COLE T, 1993, KIGS REPORT, V10, P37; *COMM L WILK PED E, 1995, J PEDIATR, V127, P857; Coste J, 1997, BRIT MED J, V315, P708, DOI 10.1136/bmj.315.7110.708; Cutfield W, 1999, ACTA PAEDIATR, V88, P72, DOI 10.1111/j.1651-2227.1999.tb14356.x; FURLANETTO RW, 1995, J PEDIATR-US, V127, P857; Greulich WW, 1959, RADIOGRAPHIC ATLAS S; Guyda HJ, 2000, PEDIATR RES, V48, P579, DOI 10.1203/00006450-200011000-00003; Guyda HJ, 1999, J CLIN ENDOCR METAB, V84, P4307, DOI 10.1210/jc.84.12.4307; Israel E, 2000, J CLIN ENDOCR METAB, V85, P3990; MARIN G, 1994, J CLIN ENDOCR METAB, V79, P537, DOI 10.1210/jc.79.2.537; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13; Price DA, 1999, GROWTH HORMONE THERA, P73; Ranke M. B., 2000, Hormone Research (Basel), V53, P47; Ranke MB, 1997, HORM RES, V48, P62, DOI 10.1159/000185487; ROSENFELD RG, 1995, J CLIN ENDOCR METAB, V80, P1532, DOI 10.1210/jc.80.5.1532; Rosenfeld RG, 1997, J CLIN ENDOCR METAB, V82, P349, DOI 10.1210/jc.82.2.349; Saggese G., 1998, Hormone Research (Basel), V50, P320; THAKRAR A, 1994, J PUBLIC HEALTH MED, V16, P200, DOI 10.1093/oxfordjournals.pubmed.a042957; Van den Broeck J, 1999, HORM RES, V51, P68, DOI 10.1159/000023317; Vance ML, 1999, NEW ENGL J MED, V341, P1206, DOI 10.1056/NEJM199910143411607; VOSS LD, 1991, ARCH DIS CHILD, V66, P833, DOI 10.1136/adc.66.7.833; Weiss NS, 1986, CLIN EPIDEMIOLOGY ST	33	95	99	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 13	2002	325	7355					70	73		10.1136/bmj.325.7355.70	http://dx.doi.org/10.1136/bmj.325.7355.70			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	575CU	12114235	Bronze, Green Published			2022-12-24	WOS:000176929400017
J	Marteau, TM; Kinmonth, AL				Marteau, TM; Kinmonth, AL			Screening for cardiovascular risk: public health imperative or matter for individual informed choice?	BRITISH MEDICAL JOURNAL			English	Article							CORONARY HEART-DISEASE	The National Screening Committee has recommended a paradigm of informed choice for participants in all screening programmes. Theresa Marteau and Ann Louise Kinmonth examine the potential consequences of applying such a policy to screening for risk of coronary heart disease in	Kings Coll London, Psychol & Genet Res Grp, London SE1 9RT, England; Univ Cambridge, Inst Publ Hlth, GP & Primary Care Res Unit, Cambridge CB2 2SR, England	University of London; King's College London; University of Cambridge	Marteau, TM (corresponding author), Kings Coll London, Psychol & Genet Res Grp, London SE1 9RT, England.	theresa.marteau@kcl.ac.uk		Marteau, Theresa/0000-0003-3025-1129	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Armitage CJ, 2001, BRIT J SOC PSYCHOL, V40, P471, DOI 10.1348/014466601164939; Austoker J, 1999, BMJ-BRIT MED J, V319, P722, DOI 10.1136/bmj.319.7212.722; Bernstein T, 1994, RADON RENTAL HOUSING; *BRIT CARD SOC BRI, 2000, BRIT MED J, V320, P795; *DEP HLTH, 2000, NAT SERV FRAM COR HE; EBRAHIM S, 2000, COCHRANE DATABASE SY; Edwards A, 2001, J HEALTH COMMUN, V6, P61, DOI 10.1080/10810730150501413; FLOOD AB, 1996, J GEN INTERN MED, V11, P341; General Medical Council, 1999, SEEK PAT CONS ETH CO; Jackson R, 2000, BMJ-BRIT MED J, V320, P709, DOI 10.1136/bmj.320.7236.709; JEPSON R, 2000, HEALTH TECHNOL ASSES, V4, P1, DOI DOI 10.3310/HTA4140; Marteau TM, 2001, BRIT MED J, V322, P526, DOI 10.1136/bmj.322.7285.526; MARTEAU TM, 2001, HLTH EXPERT, V4, P9; Misselbrook D, 2001, BRIT J GEN PRACT, V51, P276; *NAT SCREEN COMM, 2002, 2ND REP UK NAT SCREE; Petticrew M P, 2000, Health Technol Assess, V4, P1; RAFFLE AE, 1998, TRENDS UROL GYNAECOL, V3, P14; Rouse A, 2001, BRIT J GEN PRACT, V51, P834; Shaw C, 1999, SOC SCI MED, V49, P1571, DOI 10.1016/S0277-9536(99)00244-0; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Smith R, 2002, BRIT MED J, V324, P497, DOI 10.1136/bmj.324.7336.497; STOTT NCH, 1990, FAM PRACT, V7, P125, DOI 10.1093/fampra/7.2.125; Toop L, 2001, BRIT MED J, V323, P246, DOI 10.1136/bmj.323.7307.246; Witte K, 2000, HEALTH EDUC BEHAV, V27, P591, DOI 10.1177/109019810002700506	24	56	56	0	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 13	2002	325	7355					78	80		10.1136/bmj.325.7355.78	http://dx.doi.org/10.1136/bmj.325.7355.78			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	575CU	12114238	Green Published, Bronze			2022-12-24	WOS:000176929400020
J	Nasrallah, ME; Liu, P; Nasrallah, JB				Nasrallah, ME; Liu, P; Nasrallah, JB			Generation of self-incompatible Arabidopsis thaliana by transfer of two S locus genes from A-lyrata	SCIENCE			English	Article							RECEPTOR KINASE; BRASSICA; TRANSFORMATION; EVOLUTION; STIGMA	Transitions from cross-fertilizing to self-fertilizing mating systems have occurred frequently in natural and domesticated plant populations, but the underlying genetic causes are unknown. We show that gene transfer of the stigma receptor kinase SRK and its pollen-borne ligand SCR from one S-locus haplotype of the self-incompatible and cross-fertilizing Arabidopsis lyrata is sufficient to impart self-incompatibility phenotype in self-fertile Arabidopsis thaliana, which lacks functional orthologs of these genes. This successful complementation demonstrates that the signaling cascade leading to inhibition of self-related pollen was maintained in A. thaliana. Analysis of self-incompatibility will be facilitated by the tools available in this species.	Cornell Univ, Dept Plant Biol, Ithaca, NY 14853 USA	Cornell University	Nasrallah, ME (corresponding author), Cornell Univ, Dept Plant Biol, Ithaca, NY 14853 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057527] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM57527] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bi YM, 2000, MOL GEN GENET, V263, P648, DOI 10.1007/s004380051213; Charlesworth D, 2001, CURR OPIN GENET DEV, V11, P685, DOI 10.1016/S0959-437X(00)00254-9; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Frary A, 2000, SCIENCE, V289, P85, DOI 10.1126/science.289.5476.85; HODGKIN T, 1978, THEOR APPL GENET, V53, P81, DOI 10.1007/BF00274334; Kachroo A, 2001, SCIENCE, V293, P1824, DOI 10.1126/science.1062509; KHO YO, 1968, EUPHYTICA, V17, P298; Koch MA, 2000, MOL BIOL EVOL, V17, P1483, DOI 10.1093/oxfordjournals.molbev.a026248; Kusaba M, 2001, PLANT CELL, V13, P627, DOI 10.1105/tpc.13.3.627; Nasrallah JB, 2000, CURR OPIN PLANT BIOL, V3, P368, DOI 10.1016/S1369-5266(00)00098-4; NASRALLAH JB, 1994, PLANT J, V5, P373, DOI 10.1111/j.1365-313X.1994.00373.x; Schopfer CR, 1999, SCIENCE, V286, P1697, DOI 10.1126/science.286.5445.1697; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Stein JC, 1996, PLANT CELL, V8, P429, DOI 10.1105/tpc.8.3.429; Takasaki T, 2000, NATURE, V403, P913, DOI 10.1038/35002628; Takayama S, 2001, NATURE, V413, P534, DOI 10.1038/35097104; VANENGELEN FA, 1995, TRANSGENIC RES, V4, P288, DOI 10.1007/BF01969123; White S, 1998, TRENDS GENET, V14, P327, DOI 10.1016/S0168-9525(98)01524-8	18	153	168	3	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 12	2002	297	5579					247	249		10.1126/science.1072205	http://dx.doi.org/10.1126/science.1072205			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	571UT	12114625				2022-12-24	WOS:000176738100040
J	Jung, A; Maier, R; Vartanian, JP; Bocharov, G; Jung, V; Fischer, U; Meese, E; Wain-Hobson, S; Meyerhans, A				Jung, A; Maier, R; Vartanian, JP; Bocharov, G; Jung, V; Fischer, U; Meese, E; Wain-Hobson, S; Meyerhans, A			Recombination - Multiply infected spleen cells in HIV patients	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1		Univ Saarland, Dept Virol, D-66421 Homburg, Germany; Univ Saarland, Dept Human Genet, D-66421 Homburg, Germany; Inst Pasteur, Unite Retrovirol Mol, F-75724 Paris 15, France; Russian Acad Sci, Inst Numer Math, Moscow, Russia	Saarland University; Saarland University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Russian Academy of Sciences	Meyerhans, A (corresponding author), Univ Saarland, Dept Virol, D-66421 Homburg, Germany.	andreas.meyerhans@uniklinik-saarland.de	Bocharov, Gennady/T-1322-2017; Meyerhans, Andreas/D-3382-2014; Bocharov, Gennady/H-1832-2016; Maier, Reinhard/AAH-5159-2020; Meese, Eckart Ulrich/ABD-1983-2021; Meyerhans, Andreas/S-2559-2019; Bocharov, Gennady/AGA-7312-2022; Bocharov, Gennady/AAN-7508-2020; Bocharov, Gennady/GSN-1705-2022	Bocharov, Gennady/0000-0002-5049-0656; Meyerhans, Andreas/0000-0003-0620-5317; Meyerhans, Andreas/0000-0003-0620-5317; Bocharov, Gennady/0000-0002-5049-0656; Bocharov, Gennady/0000-0002-5049-0656; Bocharov, Gennady/0000-0002-5049-0656; Vartanian, Jean-Pierre/0000-0001-8079-8814				Carr JK, 1998, VIROLOGY, V247, P22, DOI 10.1006/viro.1998.9211; Gratton S, 2000, P NATL ACAD SCI USA, V97, P14566, DOI 10.1073/pnas.97.26.14566; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Hoelscher M, 2001, AIDS, V15, P1461, DOI 10.1097/00002030-200108170-00002; Jetzt AE, 2000, J VIROL, V74, P1234, DOI 10.1128/JVI.74.3.1234-1240.2000; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; McCutchan FE, 2000, AIDS, V14, pS31; ROBERTSON DL, 1995, NATURE, V374, P124, DOI 10.1038/374124b0; Schierup MH, 2000, GENETICS, V156, P879; WAINHOBSON S, 1993, NATURE, V366, P22, DOI 10.1038/366022b0; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0	11	321	330	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 11	2002	418	6894					144	144		10.1038/418144a	http://dx.doi.org/10.1038/418144a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	571GV	12110879				2022-12-24	WOS:000176710400029
J	Mikkola, I; Heavey, B; Horcher, M; Busslinger, M				Mikkola, I; Heavey, B; Horcher, M; Busslinger, M			Reversion of B cell commitment upon loss of Pax5 expression	SCIENCE			English	Article							LINEAGE COMMITMENT; BONE-MARROW; BSAP; DIFFERENTIATION; LYMPHOPOIESIS; PROGENITORS; MICE; IDENTIFICATION; PAX5/BSAP; LACKING	The transcription factor Pax5 is essential for initiating B cell lineage commitment, but its role in maintaining commitment is unknown. Using conditional Pax5 inactivation in committed pro-B cells, we demonstrate that Pax5 is required not only to initiate its B lymphoid transcription program, but also to maintain it in early B cell development. As a consequence of Pax5 inactivation, previously committed pro-B cells regained the capacity to differentiate into macrophages in vitro and to reconstitute T cell development in vivo in RAG2(-/-) mice. Hence, Pax5 expression is continuously required to maintain B cell lineage commitment, because its loss converts committed pro-B cells into hematopoietic progenitors with multilineage potential.	Res Inst Mol Pathol, Vienna Bioctr, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Busslinger, M (corresponding author), Res Inst Mol Pathol, Vienna Bioctr, Dr Bohr Gasse 7, A-1030 Vienna, Austria.		Busslinger, Meinrad J./J-1249-2016	Busslinger, Meinrad J./0000-0002-9111-9351; Mikkola, Ingvild/0000-0001-6442-7626				ADAMS B, 1992, GENE DEV, V6, P1589, DOI 10.1101/gad.6.9.1589; BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; Bjorck P, 1998, J IMMUNOL, V161, P5795; Busslinger M, 2000, CURR OPIN IMMUNOL, V12, P151, DOI 10.1016/S0952-7915(99)00065-5; Deftos ML, 1998, IMMUNITY, V9, P777, DOI 10.1016/S1074-7613(00)80643-3; Fischer A, 1997, ANNU REV IMMUNOL, V15, P93, DOI 10.1146/annurev.immunol.15.1.93; Horcher M, 2001, IMMUNITY, V14, P779, DOI 10.1016/S1074-7613(01)00153-4; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; LeBien TW, 2000, BLOOD, V96, P9, DOI 10.1182/blood.V96.1.9; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Manabe N, 2001, J IMMUNOL, V167, P2625, DOI 10.4049/jimmunol.167.5.2625; MIKKOLA I, UNPUB; Montecino-Rodriguez E, 2001, NAT IMMUNOL, V2, P83, DOI 10.1038/83210; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; Nutt SL, 1997, GENE DEV, V11, P476, DOI 10.1101/gad.11.4.476; Nutt SL, 1998, EMBO J, V17, P2319, DOI 10.1093/emboj/17.8.2319; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Nutt SL, 1999, NAT GENET, V21, P390, DOI 10.1038/7720; Nutt SL, 1999, COLD SPRING HARB SYM, V64, P51, DOI 10.1101/sqb.1999.64.51; Rinkenberger JL, 1996, IMMUNITY, V5, P377, DOI 10.1016/S1074-7613(00)80263-0; Rolink AG, 1999, NATURE, V401, P603, DOI 10.1038/44164; Schwenk F, 1998, NUCLEIC ACIDS RES, V26, P1427, DOI 10.1093/nar/26.6.1427; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Sigvardsson M, 1997, IMMUNITY, V7, P25, DOI 10.1016/S1074-7613(00)80507-5; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5	25	219	232	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 5	2002	297	5578					110	113		10.1126/science.1067518	http://dx.doi.org/10.1126/science.1067518			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	571HB	12098702				2022-12-24	WOS:000176711000046
J	Pandha, HS; Kirby, RS				Pandha, HS; Kirby, RS			PC-SPES: phytotherapy for prostate cancer	LANCET			English	Editorial Material							CHINESE HERBAL PREPARATION; IN-VITRO; ETHANOLIC EXTRACTS; CELLS; SUPPLEMENT; EXPRESSION; APOPTOSIS; THERAPY; TRIAL		St George Hosp, Sch Med, Dept Oncol, London SW17 0RE, England; St George Hosp, Sch Med, Dept Urol, London SW17 0RE, England	St Georges University London; St Georges University London	Pandha, HS (corresponding author), St George Hosp, Sch Med, Dept Oncol, London SW17 0RE, England.							Carraro JC, 1996, PROSTATE, V29, P231, DOI 10.1002/(SICI)1097-0045(199610)29:4&lt;231::AID-PROS4&gt;3.0.CO;2-E; Chen S, 2001, UROLOGY, V58, P28, DOI 10.1016/S0090-4295(01)01239-0; De la Taille A, 2000, J UROLOGY, V164, P1229, DOI 10.1097/00005392-200010000-00021; Di Silverio F, 1993, Minerva Urol Nefrol, V45, P143; DiPaola RS, 1998, NEW ENGL J MED, V339, P785, DOI 10.1056/NEJM199809173391201; Duda RB, 1996, ANN SURG ONCOL, V3, P515, DOI 10.1007/BF02306082; Halicka HD, 1997, INT J ONCOL, V11, P437; Hsieh TC, 1998, INT J ONCOL, V13, P1199; Hsieh TC, 1997, BIOCHEM MOL BIOL INT, V42, P535; IKEZOE T, 2002, ANN M AM ASS CANC RE; Kubota T, 2000, PROSTATE, V42, P163; Pfeifer BL, 2000, BJU INT, V85, P481, DOI 10.1046/j.1464-410x.2000.00476.x; Small EJ, 2000, J CLIN ONCOL, V18, P3595, DOI 10.1200/JCO.2000.18.21.3595; Small EJ, 1997, J CLIN ONCOL, V15, P382, DOI 10.1200/JCO.1997.15.1.382; Smith DC, 1998, UROLOGY, V52, P257, DOI 10.1016/S0090-4295(98)00173-3; SOVAK M, 2002, ANN M AM ASS CANC RE; Tiwari RK, 1999, INT J ONCOL, V14, P713; Wang SY, 1997, INT J CANCER, V70, P699, DOI 10.1002/(SICI)1097-0215(19970317)70:6&lt;699::AID-IJC12&gt;3.0.CO;2-5; Weinrobe MC, 2001, NEW ENGL J MED, V345, P1213, DOI 10.1056/NEJM200110183451616; Zhu BT, 1997, CANCER RES, V57, P2419	20	10	11	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 29	2002	359	9325					2213	2215		10.1016/S0140-6736(02)09313-3	http://dx.doi.org/10.1016/S0140-6736(02)09313-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	567YJ	12103281				2022-12-24	WOS:000176514500003
J	Gil, D; Schamel, WWA; Montoya, M; Sanchez-Madrid, F; Alarcon, B				Gil, D; Schamel, WWA; Montoya, M; Sanchez-Madrid, F; Alarcon, B			Recruitment of Nck by CD3 epsilon reveals a Ligand-Induced conformational change essential for T cell receptor signaling and synapse formation	CELL			English	Article							ANTIGEN RECEPTOR; ACTIVATION; TRANSDUCTION; CHAIN; PHOSPHORYLATION; INHIBITOR; SELECTION; REGION; ZETA; CD4	How membrane receptors initiate signal transduction upon ligand binding is a matter of intense scrutiny. The T cell receptor complex (TCR-CD3) is composed of TCRalpha/beta ligand binding subunits bound to the CD3 subunits responsible for signal transduction. Although it has long been speculated that TCR-CD3 may undergo a conformational change, confirmation is still lacking. We present strong evidence that ligand engagement of TCR-CD3 induces a conformational change that exposes a proline-rich sequence in CD3epsilon and results in recruitment of the adaptor protein Nck. This occurs earlier than and independently of tyrosine kinase activation. Finally, by interfering with Nck-CD3epsilon association in vivo, we demonstrate that TCR-CD3 recruitment of Nck is critical for maturation of the immune synapse and for T cell activation.	Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain; Univ Autonoma Madrid, Hosp Princesa, Serv Inmunol, Madrid 28006, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid; Hospital de La Princesa	Alarcon, B (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain.	balarcon@cbm.uam.es	Sanchez-Madrid, Francisco/M-7889-2016; Alarcon, Balbino/N-9648-2016; Montoya, María/N-1558-2014	Sanchez-Madrid, Francisco/0000-0001-5303-0762; Alarcon, Balbino/0000-0001-7820-1070; Montoya, María/0000-0001-8878-7028				Aivazian D, 2000, NAT STRUCT BIOL, V7, P1023; ALARCON B, 1991, EMBO J, V10, P903, DOI 10.1002/j.1460-2075.1991.tb08023.x; ARONHEIM A, 2000, METH MOL B, V177, P319; Boniface JJ, 1998, IMMUNITY, V9, P459, DOI 10.1016/S1074-7613(00)80629-9; Borroto A, 1998, J BIOL CHEM, V273, P12807, DOI 10.1074/jbc.273.21.12807; Borroto A, 1999, J IMMUNOL, V163, P25; Borroto A, 1997, BIOPOLYMERS, V42, P75; Borroto A, 2000, EUR J IMMUNOL, V30, P3403, DOI 10.1002/1521-4141(2000012)30:12<3403::AID-IMMU3403>3.0.CO;2-H; Buday L, 1999, BBA-REV BIOMEMBRANES, V1422, P187, DOI 10.1016/S0304-4157(99)00005-2; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Cochran JR, 2000, IMMUNITY, V12, P241, DOI 10.1016/S1074-7613(00)80177-6; Cochran JR, 2001, TRENDS BIOCHEM SCI, V26, P304, DOI 10.1016/S0968-0004(01)01815-1; Delon J, 1998, EUR J IMMUNOL, V28, P716, DOI 10.1002/(SICI)1521-4141(199802)28:02<716::AID-IMMU716>3.0.CO;2-E; DIANZANI U, 1992, J IMMUNOL, V148, P678; Ding YH, 1999, IMMUNITY, V11, P45, DOI 10.1016/S1074-7613(00)80080-1; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Fernandez-Miguel G, 1999, P NATL ACAD SCI USA, V96, P1547, DOI 10.1073/pnas.96.4.1547; Gil D, 2001, J BIOL CHEM, V276, P11174, DOI 10.1074/jbc.M010114200; Gobel TWF, 2000, CURR TOP MICROBIOL, V248, P303; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; JACOBS RR, 1997, INT J OCCUP ENV HL S, V3, P3; JANEWAY CA, 1995, IMMUNOL TODAY, V16, P223, DOI 10.1016/0167-5699(95)80163-4; Jiang GQ, 1999, CURR BIOL, V9, pR568, DOI 10.1016/S0960-9822(99)80357-1; Jose ES, 1998, EUR J IMMUNOL, V28, P12; KAYE J, 1992, J IMMUNOL, V148, P3342; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; Laczko I, 1998, BIOCHEM BIOPH RES CO, V242, P474, DOI 10.1006/bbrc.1997.7989; Lin J, 2001, J CELL SCI, V114, P243; MALLABIABARRENA A, 1992, NATURE, V357, P593, DOI 10.1038/357593a0; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Montoya MC, 2002, NAT IMMUNOL, V3, P159, DOI 10.1038/ni753; Niedergang F, 1997, J IMMUNOL, V159, P1703; Ottemann KM, 1999, SCIENCE, V285, P1751, DOI 10.1126/science.285.5434.1751; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; Reth M, 2001, TRENDS IMMUNOL, V22, P356, DOI 10.1016/S1471-4906(01)01964-0; Schamel WWA, 2000, IMMUNITY, V13, P5, DOI 10.1016/S1074-7613(00)00003-0; SECRIST JP, 1993, J BIOL CHEM, V268, P5886; Sun ZYJ, 2001, CELL, V105, P913, DOI 10.1016/S0092-8674(01)00395-6; Villalba M, 2000, IMMUNITY, V12, P151, DOI 10.1016/S1074-7613(00)80168-5; Weiss A, 1998, CELL, V94, P277, DOI 10.1016/S0092-8674(00)81469-5; Yablonski D, 1998, EMBO J, V17, P5647, DOI 10.1093/emboj/17.19.5647; YOON ST, 1994, IMMUNITY, V1, P563	42	341	359	3	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 28	2002	109	7					901	912		10.1016/S0092-8674(02)00799-7	http://dx.doi.org/10.1016/S0092-8674(02)00799-7			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	570KJ	12110186	Bronze			2022-12-24	WOS:000176657200012
J	Spence, D				Spence, D			Interpreting the evidence	BRITISH MEDICAL JOURNAL			English	Review									Maryhill Hlth Ctr, Glasgow G20 9DR, Lanark, Scotland		Spence, D (corresponding author), Maryhill Hlth Ctr, Glasgow G20 9DR, Lanark, Scotland.							COLLINS R, 1995, LANCET, V345, P669; Evans AT, 2002, LANCET, V359, P1648, DOI 10.1016/S0140-6736(02)08597-5; HILTON E, 1992, ANN INTERN MED, V116, P353, DOI 10.7326/0003-4819-116-5-353; Horton R, 1999, BRIT MED J, V319, P865, DOI 10.1136/bmj.319.7214.865	4	2	2	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 14	2002	325	7364					587	587		10.1136/bmj.325.7364.587	http://dx.doi.org/10.1136/bmj.325.7364.587			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	595JJ	12228138	Green Published			2022-12-24	WOS:000178105200025
J	Miake, J; Marban, E; Nuss, HB				Miake, J; Marban, E; Nuss, HB			Gene therapy - Biological pacemaker created by gene transfer	NATURE			English	Article							CHANNELS; MYOCYTES; NODE		Johns Hopkins Univ, Sch Med, Inst Mol Cardiobiol, Baltimore, MD 21205 USA	Johns Hopkins University	Miake, J (corresponding author), Univ Maryland, Sch Med, Dept Med, Div Cardiol,Cardiol Res Grp, Baltimore, MD 21201 USA.		Marban, Eduardo/GWC-8514-2022; Miake, Junichiro/AAD-3643-2020	Miake, Junichiro/0000-0001-7781-3649				Brooks C., 1972, SINOATRIAL PACEMAKER; BROWN HF, 1984, PROC R SOC SER B-BIO, V222, P329, DOI 10.1098/rspb.1984.0067; CAMPBELL DL, 1988, J PHYSIOL-LONDON, V403, P239, DOI 10.1113/jphysiol.1988.sp017248; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; HIRANO Y, 1988, J PHYSIOL-LONDON, V395, P455, DOI 10.1113/jphysiol.1988.sp016929; IMOTO Y, 1987, AM J PHYSIOL, V252, P325; IRISAWA H, 1993, PHYSIOL REV, V73, P197, DOI 10.1152/physrev.1993.73.1.197; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; Kusumoto FM, 1996, NEW ENGL J MED, V334, P89, DOI 10.1056/NEJM199601113340206; Rodriguez-Contreras A, 2002, J PHYSIOL-LONDON, V538, P729, DOI 10.1113/jphysiol.2001.013312; Santoro B, 1999, ANN NY ACAD SCI, V868, P741, DOI 10.1111/j.1749-6632.1999.tb11353.x; Slesinger PA, 1996, NEURON, V16, P321, DOI 10.1016/S0896-6273(00)80050-1; WOBUS AM, 1995, ANN NY ACAD SCI, V752, P460, DOI 10.1111/j.1749-6632.1995.tb17456.x	13	305	351	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 12	2002	419	6903					132	133		10.1038/419132b	http://dx.doi.org/10.1038/419132b			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592HK	12226654				2022-12-24	WOS:000177931200031
J	Doray, B; Ghosh, P; Griffith, J; Geuze, HJ; Kornfeld, S				Doray, B; Ghosh, P; Griffith, J; Geuze, HJ; Kornfeld, S			Cooperation of GGAs and AP-1 in packaging MPRs at the trans-Golgi network	SCIENCE			English	Article							MANNOSE 6-PHOSPHATE RECEPTORS; CYTOPLASMIC DOMAIN; ADAPTER COMPLEX; GAMMA-ADAPTIN; BINDING-SITES; VHS DOMAINS; PROTEINS; CLATHRIN; FAMILY; INTERACT	The Golgi-localized, gamma-ear-containing, adenosine diphosphate ribosylation factor-binding proteins (GGAs) are multidomain proteins that bind mannose 6-phosphate receptors (MPRs) in the Golgi and have an essential role in lysosomal enzyme sorting. Here the GGAs and the coat protein adaptor protein-1 (AP-1) were shown to colocalize in clathrin-coated buds of the trans-Golgi networks of mouse L cells and human HeLa cells. Binding studies revealed a direct interaction between the hinge domains of the GGAs and the gamma-ear domain of AP-1. Further, AP-1 contained bound casein kinase-2 that phosphorylated GGA1 and GGA3, thereby causing autoinhibition. This could induce the directed transfer of the MPRs from GGAs to AP-1. MPRs that are defective in binding to GGAs are poorly incorporated into AP-1-containing clathrin-coated vesicles. Thus, the GGAs and AP-1 interact to package MPRs into AP-1-containing coated vesicles.	Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; Univ Utrecht, Inst Biomembranes, NL-3584 CX Utrecht, Netherlands; Univ Utrecht, Univ Med Ctr, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands	Washington University (WUSTL); Utrecht University; Utrecht University; Utrecht University Medical Center	Kornfeld, S (corresponding author), Washington Univ, Sch Med, Dept Internal Med, 660 S Euclid Ave, St Louis, MO 63110 USA.			Doray, Balraj/0000-0003-3347-5013	NATIONAL CANCER INSTITUTE [R01CA008759] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA-08759] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Benmerah A, 1998, J CELL BIOL, V140, P1055, DOI 10.1083/jcb.140.5.1055; Black MW, 2000, J CELL BIOL, V151, P587, DOI 10.1083/jcb.151.3.587; Chen HJ, 1997, J BIOL CHEM, V272, P7003, DOI 10.1074/jbc.272.11.7003; Dell'Angelica EC, 2000, J CELL BIOL, V149, P81, DOI 10.1083/jcb.149.1.81; Doray B, 2002, P NATL ACAD SCI USA, V99, P8072, DOI 10.1073/pnas.082235699; Doray B, 2001, MOL BIOL CELL, V12, P1925, DOI 10.1091/mbc.12.7.1925; GEUZE HJ, 1981, J CELL BIOL, V89, P653, DOI 10.1083/jcb.89.3.653; Hao WH, 1999, J BIOL CHEM, V274, P22785, DOI 10.1074/jbc.274.32.22785; Hirst J, 2000, J CELL BIOL, V149, P67, DOI 10.1083/jcb.149.1.67; Honing S, 1997, J BIOL CHEM, V272, P19884, DOI 10.1074/jbc.272.32.19884; KLUMPERMAN J, 1993, J CELL BIOL, V121, P997, DOI 10.1083/jcb.121.5.997; KORNFELD S, 1992, ANNU REV BIOCHEM, V61, P307, DOI 10.1146/annurev.bi.61.070192.001515; Laporte SA, 2000, J BIOL CHEM, V275, P23120, DOI 10.1074/jbc.M002581200; MERESSE S, 1990, J BIOL CHEM, V265, P18833; Mishra SK, 2001, J BIOL CHEM, V276, P46230, DOI 10.1074/jbc.M108177200; MISHRA SK, IN PRESS EMBO J; Misra S, 2002, NATURE, V415, P933, DOI 10.1038/415933a; Puertollano R, 2001, SCIENCE, V292, P1712, DOI 10.1126/science.1060750; Puertollano R, 2001, CELL, V105, P93, DOI 10.1016/S0092-8674(01)00299-9; RAPOSO G, 1997, WEIRS HDB EXPT IMMUN; Shiba T, 2002, NATURE, V415, P937, DOI 10.1038/415937a; Takatsu H, 2001, J BIOL CHEM, V276, P28541, DOI 10.1074/jbc.C100218200; Wan L, 1998, CELL, V94, P205, DOI 10.1016/S0092-8674(00)81420-8; WANG LH, 1995, J BIOL CHEM, V270, P10079, DOI 10.1074/jbc.270.17.10079; Zhu YX, 2001, SCIENCE, V292, P1716, DOI 10.1126/science.1060896; Zhu YX, 1998, MOL BIOL CELL, V9, P1323, DOI 10.1091/mbc.9.6.1323	26	195	199	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 6	2002	297	5587					1700	1703		10.1126/science.1075327	http://dx.doi.org/10.1126/science.1075327			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590JE	12215646				2022-12-24	WOS:000177819100049
J	Mann, ME				Mann, ME			The value of multiple proxies	SCIENCE			English	Editorial Material							TREE-RING CHRONOLOGIES; NORTH-ATLANTIC; CLIMATE-CHANGE; TEMPERATURE; RECONSTRUCTION		Univ Virginia, Dept Environm Sci, Charlottesville, VA 22903 USA	University of Virginia	Mann, ME (corresponding author), Univ Virginia, Dept Environm Sci, Clark Hall, Charlottesville, VA 22903 USA.	mann@virginia.edu	Mann, Michael E/B-8472-2017	Mann, Michael E/0000-0003-3067-296X				BAUER E, IN PRESS KIHZ PROJEC; Briffa KR, 2002, SCIENCE, V295, P2227, DOI 10.1126/science.1069486; Briffa KR, 1998, NATURE, V393, P450, DOI 10.1038/30943; Brovkin V, 1999, GLOBAL ECOL BIOGEOGR, V8, P509, DOI 10.1046/j.1365-2699.1999.00169.x; Cook ER, 2002, J CLIMATE, V15, P1754, DOI 10.1175/1520-0442(2002)015<1754:AWVMRO>2.0.CO;2; Crowley TJ, 2000, SCIENCE, V289, P270, DOI 10.1126/science.289.5477.270; Crowley TJ, 2000, AMBIO, V29, P51, DOI 10.1579/0044-7447-29.1.51; Esper J, 2002, SCIENCE, V295, P2250, DOI 10.1126/science.1066208; Evans MN, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2000PA000590; Folland CK, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P99; GERBER S, IN PRESS CLIM DYN; Jones PD, 1998, HOLOCENE, V8, P455, DOI 10.1191/095968398667194956; Jones PD, 1999, REV GEOPHYS, V37, P173, DOI 10.1029/1999RG900002; Kirchner I, 1999, J GEOPHYS RES-ATMOS, V104, P19039, DOI 10.1029/1999JD900213; Luterbacher J, 2002, CLIM DYNAM, V18, P545, DOI 10.1007/s00382-001-0196-6; Mann ME, 2002, SCIENCE, V296, P848, DOI 10.1126/science.296.5569.848; Mann ME, 1998, NATURE, V392, P779, DOI 10.1038/33859; Mann ME, 1999, GEOPHYS RES LETT, V26, P759, DOI 10.1029/1999GL900070; RUTHERFORD S, IN PRESS J CLIMATE; Shindell DT, 2001, SCIENCE, V294, P2149, DOI 10.1126/science.1064363	20	121	127	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2002	297	5586					1481	1482		10.1126/science.1074318	http://dx.doi.org/10.1126/science.1074318			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588JA	12202805				2022-12-24	WOS:000177697300031
J	Hole, DG; Whittingham, MJ; Bradbury, RB; Anderson, GQA; Lee, PLM; Wilson, JD; Krebs, JR				Hole, DG; Whittingham, MJ; Bradbury, RB; Anderson, GQA; Lee, PLM; Wilson, JD; Krebs, JR			Widespread local house-sparrow extinctions - Agricultural intensification is blamed for the plummeting populations of these birds.	NATURE			English	Article									Univ Oxford, Farmland Bird Grp, Edward Grey Inst Field Ornithol, Oxford OX1 3PS, England; Royal Soc Protect Birds, Sandy SG19 2DL, Beds, England; Dunedin House, Edinburgh EH4 3TP, Midlothian, Scotland; Univ Coll Swansea, Sch Biol Sci, Swansea SA2 8PP, W Glam, Wales	University of Oxford; Royal Society for Protection of Birds; Swansea University	Hole, DG (corresponding author), Univ Oxford, Farmland Bird Grp, Edward Grey Inst Field Ornithol, S Parks Rd, Oxford OX1 3PS, England.		Whittingham, Mark/C-4958-2008; Lee, Patricia/N-4157-2013; Hole, David/Q-1692-2019; Wilson, Jeremy/A-6842-2016	Lee, Patricia/0000-0002-8489-9206; Wilson, Jeremy/0000-0001-7485-5878; Bradbury, Richard/0000-0002-1245-2763				Chamberlain DE, 2000, J APPL ECOL, V37, P771, DOI 10.1046/j.1365-2664.2000.00548.x; Cornuet JM, 1996, GENETICS, V144, P2001; Crochet PA, 2000, MOL ECOL, V9, P1463, DOI 10.1046/j.1365-294x.2000.01026.x; GREGORY RD, 2001, STATE UKS BIRDS 2000; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Krebs JR, 1999, NATURE, V400, P611, DOI 10.1038/23127; Robinson RA, 2002, J APPL ECOL, V39, P157, DOI 10.1046/j.1365-2664.2002.00695.x; SUMMERSMITH JD, 1988, SPARROWS; WERNHAM CV, IN PRESS MIGRATION A	9	118	127	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 29	2002	418	6901					931	932		10.1038/418931a	http://dx.doi.org/10.1038/418931a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588AP	12198534				2022-12-24	WOS:000177677500031
J	Lassus, P; Opitz-Araya, X; Lazebnik, Y				Lassus, P; Opitz-Araya, X; Lazebnik, Y			Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization	SCIENCE			English	Article							ONCOGENE-DEPENDENT APOPTOSIS; CELL-DEATH; MAMMALIAN-CELLS; BCL-2; GENE; ACTIVATION; ENCODES; APAF-1; NEDD2; MICE	A current view is that cytotoxic stress, such as DNA damage, induces apoptosis by regulating the permeability of mitochondria. Mitochondria sequester several proteins that, if released, kill by activating caspases, the proteases that disassemble the cell. Cytokines activate caspases in a different way, by assembling receptor complexes that activate caspases directly; in this case, the subsequent mitochondrial permeabilization accelerates cell disassembly by amplifying caspase activity. We found that cytotoxic stress causes activation of caspase-2, and that this caspase is required for the permeabilization of mitochondria. Therefore, we argue that cytokine-induced and stress-induced apoptosis act through conceptually similar pathways in which mitochondria are amplifiers of caspase activity rather than initiators of caspase activation.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Lazebnik, Y (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.			Lassus, Patrice/0000-0002-2785-7843	NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER; NCI NIH HHS [CA-13106-31] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; Bossy Wetzel E, 1998, EMBO J, V17, P37; Duelli DM, 2000, NAT CELL BIOL, V2, P859, DOI 10.1038/35041112; Ekert PG, 1999, CELL DEATH DIFFER, V6, P1081, DOI 10.1038/sj.cdd.4400594; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Evan G, 1998, SCIENCE, V281, P1317, DOI 10.1126/science.281.5381.1317; Fearnhead HO, 1998, P NATL ACAD SCI USA, V95, P13664, DOI 10.1073/pnas.95.23.13664; Gerlai R, 2001, BEHAV BRAIN RES, V125, P13, DOI 10.1016/S0166-4328(01)00282-0; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; Hannon GJ, 1999, SCIENCE, V283, P1129, DOI 10.1126/science.283.5405.1129; Hausmann G, 2000, J CELL BIOL, V149, P623, DOI 10.1083/jcb.149.3.623; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Herr I, 2001, BLOOD, V98, P2603, DOI 10.1182/blood.V98.9.2603; Honarpour N, 2000, DEV BIOL, V218, P248, DOI 10.1006/dbio.1999.9585; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; KUMAR S, 1994, GENE DEV, V8, P1613, DOI 10.1101/gad.8.14.1613; KUMAR S, 1995, FEBS LETT, V368, P69, DOI 10.1016/0014-5793(95)00602-6; LASSUS P, UNPUB; Li HL, 1997, J BIOL CHEM, V272, P21010, DOI 10.1074/jbc.272.34.21010; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; Paroni G, 2002, J BIOL CHEM, V277, P15147, DOI 10.1074/jbc.M112338200; Rodriguez J, 1999, GENE DEV, V13, P3179, DOI 10.1101/gad.13.24.3179; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Troy CM, 2000, J NEUROSCI, V20, P1386; WANG L, 1994, CELL, V78, P739, DOI 10.1016/S0092-8674(94)90422-7; Wang XD, 2001, GENE DEV, V15, P2922; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Zheng TS, 2000, NAT MED, V6, P1241, DOI 10.1038/81343	31	618	641	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 23	2002	297	5585					1352	1354		10.1126/science.1074721	http://dx.doi.org/10.1126/science.1074721			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FL	12193789				2022-12-24	WOS:000177573900049
J	Crawford, LM				Crawford, LM			Limited approval for Lotronex	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									US FDA, Off Commissioner Food & Drugs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Crawford, LM (corresponding author), US FDA, Off Commissioner Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 14	2002	288	6					688	688		10.1001/jama.288.6.688	http://dx.doi.org/10.1001/jama.288.6.688			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	583KY	12169049				2022-12-24	WOS:000177408100005
J	Achard, F; Eva, HD; Stibig, HJ; Mayaux, P; Gallego, J; Richards, T; Malingreau, JP				Achard, F; Eva, HD; Stibig, HJ; Mayaux, P; Gallego, J; Richards, T; Malingreau, JP			Determination of deforestation rates of the world's humid tropical forests	SCIENCE			English	Article							SATELLITE IMAGERY; CARBON; COVER; ECOSYSTEMS; EMISSIONS; AMAZON	A recently completed research program (TREES) employing the global imaging capabilities of Earth-observing satellites provides updated information on the status of the world's humid tropical forest cover. Between 1990 and 1997, 5.8 +/- 1.4 million hectares of humid tropical forest were lost each year, with a further 2.3 +/- 0.7 million hectares of forest visibly degraded. These figures indicate that the global net rate of change in forest cover for the humid tropics is 23% lower than the generally accepted rate. This result affects the calculation of carbon fluxes in the global budget and means that the terrestrial sink is smaller than previously inferred.	Joint Res Ctr, Global Vegetat Monitoring Unit, I-21020 Ispra, Italy; Joint Res Ctr, Land Use Land Cover Unit, I-21020 Ispra, Italy; Conservat Technol Ltd, Tarnwell BS18 4EA, Somerset, England; European Commiss, Joint Res Ctr, Sci Strategy Directorate, B-1049 Brussels, Belgium	European Commission Joint Research Centre; EC JRC ISPRA Site; European Commission Joint Research Centre; EC JRC ISPRA Site; European Commission Joint Research Centre	Achard, F (corresponding author), Joint Res Ctr, Global Vegetat Monitoring Unit, TP 440, I-21020 Ispra, Italy.		Wrbka, Thomas/A-5699-2010; EVA, Hugh D/F-8412-2011	Wrbka, Thomas/0000-0002-1451-9108; 				Achard F, 1995, REMOTE SENS ENVIRON, V54, P198, DOI 10.1016/0034-4257(95)00153-0; Achard F., 1998, IDENTIFICATION DEFOR; [Anonymous], EOS; Brown S, 1997, ESTIMATING BIOMASS B; Cochran W. G., 1977, SAMPLING TECHNIQUES; CZAPLEWSKI RI, 2002, SAMPLING ESTIMATING; DEVILLE JC, 1992, J AM STAT ASSOC, V87, P376, DOI 10.2307/2290268; EVA HD, 1999, VEGETATION MAP S AME; *FAO, 1993, FOR RES ASS 1990 TRO; *FAO, 2001, STAT WORLDS FOR 2001; *FAO, 2001, GLOB FOR RES ASS 200; Fearnside PM, 1997, CLIMATIC CHANGE, V35, P321, DOI 10.1023/A:1005336724350; Geist HJ, 2001, LUCC REP SER, P136; Harcourt C. S., 1996, CONSERVATION ATLAS T; Houghton RA, 2000, NATURE, V403, P301, DOI 10.1038/35002062; *I NAC PESQ ESP I, 1997, DEF 1995 1997 AM; MATTHEWS E, 2001, UNDERSTANDING FRA 20; Mayaux P, 1999, J BIOGEOGR, V26, P353, DOI 10.1046/j.1365-2699.1999.00270.x; Mayaux P, 1997, REMOTE SENS ENVIRON, V59, P29, DOI 10.1016/S0034-4257(96)00077-6; Mayaux P, 1998, ENVIRON CONSERV, V25, P37, DOI 10.1017/S0376892998000083; Richards T, 2000, INT J REMOTE SENS, V21, P1473, DOI 10.1080/014311600210272; Schimel DS, 2001, NATURE, V414, P169, DOI 10.1038/35102500; SCHOLES RJ, 1993, SCIENCE, V294, P1012; Siegert F, 2001, NATURE, V414, P437, DOI 10.1038/35106547; SKOLE D, 1993, SCIENCE, V260, P1905, DOI 10.1126/science.260.5116.1905; Stibig HJ, 2001, INT J REMOTE SENS, V22, P503, DOI 10.1080/01431160010013531; Watson RT, 2000, LAND USE LAND USE CH; Zhang Q, 2001, AMBIO, V30, P351, DOI 10.1639/0044-7447(2001)030[0351:CEASPO]2.0.CO;2	28	1258	1338	9	548	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 9	2002	297	5583					999	1002		10.1126/science.1070656	http://dx.doi.org/10.1126/science.1070656			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581ZN	12169731				2022-12-24	WOS:000177325400041
J	Dawson, E; Abecasis, GR; Bumpstead, S; Chen, Y; Hunt, S; Beare, DM; Pabial, J; Dibling, T; Tinsley, E; Kirby, S; Carter, D; Papaspyridonos, M; Livingstone, S; Ganske, R; Lohmmussaar, E; Zernant, J; Tonisson, N; Remm, M; Magi, R; Puurand, T; Vilo, J; Kurg, A; Rice, K; Deloukas, P; Mott, R; Metspalu, A; Bentley, DR; Cardon, LR; Dunham, I				Dawson, E; Abecasis, GR; Bumpstead, S; Chen, Y; Hunt, S; Beare, DM; Pabial, J; Dibling, T; Tinsley, E; Kirby, S; Carter, D; Papaspyridonos, M; Livingstone, S; Ganske, R; Lohmmussaar, E; Zernant, J; Tonisson, N; Remm, M; Magi, R; Puurand, T; Vilo, J; Kurg, A; Rice, K; Deloukas, P; Mott, R; Metspalu, A; Bentley, DR; Cardon, LR; Dunham, I			A first-generation linkage disequilibrium map of human chromosome 22	NATURE			English	Article							MEIOTIC RECOMBINATION; SEQUENCE; FINLAND; REGION; SCAN	DNA sequence variants in specific genes or regions of the human genome are responsible for a variety of phenotypes such as disease risk or variable drug response(1). These variants can be investigated directly, or through their non-random associations with neighbouring markers (called linkage disequilibrium (LD))(2-8). Here we report measurement of LD along the complete sequence of human chromosome 22. Duplicate genotyping and analysis of 1,504 markers in Centre d'Etude du Polymorphisme Humain (CEPH) reference families at a median spacing of 15 kilobases (kb) reveals a highly variable pattern of LD along the chromosome, in which extensive regions of nearly complete LD up to 804 kb in length are interspersed with regions of little or no detectable LD. The LD patterns are replicated in a panel of unrelated UK Caucasians. There is a strong correlation between high LD and low recombination frequency in the extant genetic map, suggesting that historical and contemporary recombination rates are similar. This study demonstrates the feasibility of developing genome-wide maps of LD.	Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; Third Wave Technol Inc, Madison, WI 53719 USA; Univ Tartu, IMCB, EE-51010 Tartu, Estonia; Univ Tartu, Estonian Bioctr, EE-51010 Tartu, Estonia; Asper Ltd, EE-51014 Tartu, Estonia; European Bioinformat Inst, Cambridge CB10 1SD, England	Wellcome Trust Sanger Institute; University of Oxford; Wellcome Centre for Human Genetics; University of Michigan System; University of Michigan; University of Tartu; Estonian Biocentre; University of Tartu; European Molecular Biology Laboratory (EMBL)	Dunham, I (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	lon.cardon@well.ox.ac.uk; id1@sanger.ac.uk	Tonisson, Neeme/H-2783-2015; Kurg, Ants/J-2616-2015; Org, Elin/AAJ-9631-2021; Vilo, Jaak/A-7183-2008; Vilo, Jaak/AAK-2228-2020; Kurg, Ants/AAM-1292-2020; Mägi, Reedik/AAJ-9679-2021; Abecasis, Goncalo R/B-7840-2010; Remm, Maido/L-9072-2019; Deloukas, Panos/B-2922-2013	Vilo, Jaak/0000-0001-5604-4107; Vilo, Jaak/0000-0001-5604-4107; Kurg, Ants/0000-0002-0829-1987; Remm, Maido/0000-0003-3966-8422; Deloukas, Panos/0000-0001-9251-070X; Hunt, Sarah/0000-0002-8350-1235; Abecasis, Goncalo/0000-0003-1509-1825; Mott, Richard/0000-0002-1022-9330; Carter, Emma/0000-0002-0825-2793; Org, Elin/0000-0001-8688-9717; Magi, Reedik/0000-0002-2964-6011; Dunham, Ian/0000-0003-2525-5598				Abecasis GR, 2001, AM J HUM GENET, V68, P191, DOI 10.1086/316944; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Dawson E, 2001, GENOME RES, V11, P170, DOI 10.1101/gr.156901; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Eaves IA, 2000, NAT GENET, V25, P320; Eisenbarth I, 2001, HUM MOL GENET, V10, P2833, DOI 10.1093/hmg/10.24.2833; Ghosh S, 2000, AM J HUM GENET, V67, P1174, DOI 10.1016/S0002-9297(07)62948-6; Huttley GA, 1999, GENETICS, V152, P1711; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; KARLIN S, 1990, P NATL ACAD SCI USA, V87, P2264, DOI 10.1073/pnas.87.6.2264; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Kurg A, 2000, GENET TEST, V4, P1, DOI 10.1089/109065700316408; Mein CA, 2000, GENOME RES, V10, P330, DOI 10.1101/gr.10.3.330; Mullikin JC, 2000, NATURE, V407, P516, DOI 10.1038/35035089; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Payseur BA, 2000, GENETICS, V156, P1285; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; PULVER AE, 1994, AM J MED GENET, V54, P36, DOI 10.1002/ajmg.1320540108; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Taillon-Miller P, 2000, NAT GENET, V25, P324, DOI 10.1038/77100; THOMPSON EA, 1988, AM J HUM GENET, V42, P113; Weir B., 1996, GENETIC DATA ANAL; WEIR BS, 1979, HEREDITY, V42, P105, DOI 10.1038/hdy.1979.10; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; Yu A, 2001, NATURE, V409, P951, DOI 10.1038/35057185	30	293	331	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 1	2002	418	6897					544	548		10.1038/nature00864	http://dx.doi.org/10.1038/nature00864			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579EE	12110843	Bronze, Green Published			2022-12-24	WOS:000177162800043
J	Hara, K; Maruki, Y; Long, XM; Yoshino, K; Oshiro, N; Hidayat, S; Tokunaga, C; Avruch, J; Yonezawa, K				Hara, K; Maruki, Y; Long, XM; Yoshino, K; Oshiro, N; Hidayat, S; Tokunaga, C; Avruch, J; Yonezawa, K			Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action	CELL			English	Article							P70 S6 KINASE; MESSENGER-RNA TRANSLATION; MAMMALIAN TARGET; AMINO-ACID; PHAS-I; EIF-4E BP1; WD-REPEAT; YEAST TOR; PROTEIN; PHOSPHORYLATION	mTOR controls cell growth, in part by regulating p70 S6 kinase alpha (p70alpha) and eukaryotic initiation factor 4E binding protein 1 (4EBP1). Raptor is a 150 kDa mTOR binding protein that also binds 4EBP1 and p70alpha. The binding of raptor to mTOR is necessary for the mTOR-catalyzed phosphorylation of 4EBP1 in vitro, and it strongly enhances the mTOR kinase activity toward p70alpha. Rapamycin or amino acid withdrawal increases, whereas insulin strongly inhibits, the recovery of 4EBP1 and raptor on 7-methyl-GTP Sepharose. Partial inhibition of raptor expression by RNA interference (RNAi) reduces mTOR-catalyzed 4EBP1 phosphorylation in vitro. RNAi of C. elegans raptor yields an array of phenotypes that closely resemble those produced by inactivation of Ce-TOR. Thus, raptor is an essential scaffold for the mTOR-catalyzed phosphorylation of 4EBP1 and mediates TOR action in vivo.	Kobe Univ, Biosignal Res Ctr, Kobe, Hyogo 6578501, Japan; Harvard Univ, Sch Med, Dept Med, Massachusetts Gen Hosp,Dept Mol Biol, Boston, MA 02114 USA	Kobe University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Hara, K (corresponding author), Kobe Univ, Biosignal Res Ctr, Kobe, Hyogo 6578501, Japan.	harak@kobe-u.ac.jp; yonezawa@kobe-u.ac.jp	Long, Samuel/AAR-8118-2021	Long, Samuel/0000-0001-7559-3232	NCI NIH HHS [R01 CA73818B 06] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA073818] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alessi DR, 1997, CURR BIOL, V7, P776, DOI 10.1016/S0960-9822(06)00336-8; Alessi DR, 1998, CURR BIOL, V8, P69, DOI 10.1016/S0960-9822(98)70037-5; Avruch J, 2001, Prog Mol Subcell Biol, V26, P115; Barbe E., 1996, MEDITERR POLIT, V1, P25; Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x; BRENNER S, 1974, GENETICS, V77, P71; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Chen J, 1998, BIOCHEM BIOPH RES CO, V247, P827, DOI 10.1006/bbrc.1998.8792; CHIU MI, 1994, P NATL ACAD SCI USA, V91, P12574, DOI 10.1073/pnas.91.26.12574; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; DiComo CJ, 1996, GENE DEV, V10, P1904, DOI 10.1101/gad.10.15.1904; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fox HL, 1998, AM J PHYSIOL-CELL PH, V274, pC206, DOI 10.1152/ajpcell.1998.274.1.C206; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Gingras AC, 2001, GENE DEV, V15, P2852; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Gout I, 1998, J BIOL CHEM, V273, P30061, DOI 10.1074/jbc.273.46.30061; Hara K, 1997, J BIOL CHEM, V272, P26457, DOI 10.1074/jbc.272.42.26457; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Isotani S, 1999, J BIOL CHEM, V274, P34493, DOI 10.1074/jbc.274.48.34493; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; KEITH CT, 1995, SCIENCE, V270, P50, DOI 10.1126/science.270.5233.50; Koh H, 1999, ONCOGENE, V18, P5115, DOI 10.1038/sj.onc.1202895; KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F; Lawrence JC, 1997, TRENDS BIOCHEM SCI, V22, P345, DOI 10.1016/S0968-0004(97)01101-8; Lee-Fruman KK, 1999, ONCOGENE, V18, P5108, DOI 10.1038/sj.onc.1202894; LONG X, 2002, IN PRESS CURR BIOL, V12; Minami T, 2001, GENES CELLS, V6, P1003, DOI 10.1046/j.1365-2443.2001.00479.x; Mothe-Satney I, 2000, J BIOL CHEM, V275, P33836, DOI 10.1074/jbc.M006005200; Murata K, 1997, P NATL ACAD SCI USA, V94, P10624, DOI 10.1073/pnas.94.20.10624; Nanahoshi M, 1999, FEBS LETT, V446, P108, DOI 10.1016/S0014-5793(99)00189-1; Nishiuma T, 1998, BIOCHEM BIOPH RES CO, V252, P440, DOI 10.1006/bbrc.1998.9671; Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700; Patti ME, 1998, J CLIN INVEST, V101, P1519, DOI 10.1172/JCI1326; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; PRICE DJ, 1992, SCIENCE, V257, P973, DOI 10.1126/science.1380182; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; SABERS CJ, 1995, J BIOL CHEM, V270, P815, DOI 10.1074/jbc.270.2.815; Saitoh M, 1998, BIOCHEM BIOPH RES CO, V253, P470, DOI 10.1006/bbrc.1998.9784; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Schmidt A, 1998, EMBO J, V17, P6924, DOI 10.1093/emboj/17.23.6924; Shigemitsu K, 1999, J BIOL CHEM, V274, P1058, DOI 10.1074/jbc.274.2.1058; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; Shinozaki-Yabana S, 2000, MOL CELL BIOL, V20, P1234, DOI 10.1128/MCB.20.4.1234-1242.2000; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Sonenberg N, 1996, TRANSLATIONAL CONTRO, P245; Takahashi T, 2000, GENES CELLS, V5, P765, DOI 10.1046/j.1365-2443.2000.00365.x; Tang H, 2001, MOL CELL BIOL, V21, P8671, DOI 10.1128/MCB.21.24.8671-8683.2001; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Wang XM, 1998, BIOCHEM J, V334, P261, DOI 10.1042/bj3340261; Weisman R, 2001, J BIOL CHEM, V276, P7027, DOI 10.1074/jbc.M010446200; Xu G, 1998, J BIOL CHEM, V273, P28178, DOI 10.1074/jbc.273.43.28178; ZAKIAN VA, 1995, CELL, V82, P685, DOI 10.1016/0092-8674(95)90463-8; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000	57	1365	1437	4	121	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 26	2002	110	2					177	189		10.1016/S0092-8674(02)00833-4	http://dx.doi.org/10.1016/S0092-8674(02)00833-4			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	578EV	12150926	Bronze			2022-12-24	WOS:000177105200006
J	Bull, JJ; Parrish, CR				Bull, JJ; Parrish, CR			Microbiology: A binding contract for anthrax	SCIENCE			English	Editorial Material									Univ Texas, Sect Integrat Biol, Austin, TX 78712 USA; Univ Texas, Inst Mol & Cellular Biol, Austin, TX 78712 USA; Cornell Univ, Coll Vet Med, James A Baker Inst, Ithaca, NY 14853 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Cornell University	Bull, JJ (corresponding author), Univ Texas, Sect Integrat Biol, Austin, TX 78712 USA.							Enserink M, 2002, SCIENCE, V295, P777; Enserink M, 2002, SCIENCE, V296, P639; Maynard JA, 2002, NAT BIOTECHNOL, V20, P597, DOI 10.1038/nbt0602-597	3	6	11	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 12	2002	297	5579					201	202		10.1126/science.1074590	http://dx.doi.org/10.1126/science.1074590			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	571UT	12114612				2022-12-24	WOS:000176738100025
J	Robinson, GE				Robinson, GE			Development: Sociogenomics takes flight	SCIENCE			English	Editorial Material							EVOLUTION; BEHAVIOR; BRAIN		Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; Univ Illinois, Program Neurosci, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Robinson, GE (corresponding author), Univ Illinois, Dept Entomol, 320 Morrill Hall, Urbana, IL 61801 USA.	generobi@uiuc.edu						Abouheif E, 2002, SCIENCE, V297, P249, DOI 10.1126/science.1071468; Ben-Shahar Y, 2002, SCIENCE, V296, P741, DOI 10.1126/science.1069911; Carroll S. B., 2001, DNA DIVERSITY MOL GE; Evans JD, 2001, GENOME BIOL, V2; Fernald RD, 2002, NOVART FDN SYMP, V244, P169; FOUNTAIN H, 2002, NY TIMES WEEK R 0421, P5; Giraud T, 2002, P NATL ACAD SCI USA, V99, P6075, DOI 10.1073/pnas.092694199; Holldobler B., 1990, pi; Holldobler B, 1994, JOURNEY ANTS; Julian GE, 2002, P NATL ACAD SCI USA, V99, P8157, DOI 10.1073/pnas.112222099; Krieger MJB, 2002, SCIENCE, V295, P328, DOI 10.1126/science.1065247; Kucharski R, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-research0007; Nijhout H.F., 1994, INSECT HORMONES; Page RE, 2002, GENETICS, V160, P375; Robinson GE, 1997, BIOESSAYS, V19, P1099, DOI 10.1002/bies.950191209; Robinson GE, 1999, TRENDS ECOL EVOL, V14, P202, DOI 10.1016/S0169-5347(98)01536-5; Volny VP, 2002, P NATL ACAD SCI USA, V99, P6108, DOI 10.1073/pnas.092066699; Whitfield CW, 2002, GENOME RES, V12, P555, DOI 10.1101/gr.5302; Wilson E.O., 1975, P1	19	22	25	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 12	2002	297	5579					204	205		10.1126/science.1074493	http://dx.doi.org/10.1126/science.1074493			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	571UT	12114614				2022-12-24	WOS:000176738100027
J	Kjaer, SK; van den Brule, AJC; Paull, G; Svare, EI; Sherman, ME; Thomsen, BL; Suntum, M; Bock, JE; Poll, PA; Meijer, CJLM				Kjaer, SK; van den Brule, AJC; Paull, G; Svare, EI; Sherman, ME; Thomsen, BL; Suntum, M; Bock, JE; Poll, PA; Meijer, CJLM			Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study	BRITISH MEDICAL JOURNAL			English	Article							NATURAL-HISTORY; RAPID DETECTION; CANCER; INFECTION; DNA	Objectives To investigate the role of human papillomavirus (HPV) in the development of cervical neoplasia in women with no previous cervical cytological abnormalities; whether the presence of virus DNA predicts development of squamous intraepithelial lesion; and whether the risk of incident squamous intraepithelial lesions differs with repeated detection of the same HPV type versus repeated detection of different types. Design Population based prospective cohort study. Setting General population in Copenhagen, Denmark. Participants 10 758 Women aged 20-29 years followed up for development of cervical cytological abnormalities; 370 incident cases were detected (40 with atypical squamous cells of undetermined significance, 165 with low grade squamous intraepithelial lesions, 165 With high grade squamous intraepithelial lesions). Main outcome measures Results of cervical smear tests and cervical swabs at enrolment and at the second examination about two years later. Results Compared with women who were negative for human papillomavirus at enrolment, those with positive results had a significantly increased risk at follow up of having atypical cells (odds ratio 3.2, 95% confidence interval 1.3 to 7.9), low grade lesions (7.5, 4.8 to 11.7), or high grade lesions (25.8, 15.3 to 43.6). Similarly, women who were positive for HPV at the second examination had a strongly increased risk of low (34.3, 17.6 to 67.0) and high grade lesions (60.7, 25.5 to 144.0). For high grade lesions the risk was strongly increased if the same virus type was present at both examinations (813.0, 168.2 to 3229.2). Conclusions Infection with human papillomavirus precedes the development of low and high grade squamous intraepithelial lesions. For high grade lesions the risk is greatest in women positive for the same type of HPV on repeated testing.	Danish Canc Soc, DK-2100 Copenhagen, Denmark; Vrije Univ Amsterdam, Univ Hosp, Dept Pathol, Sect Mol Pathol, Amsterdam, Netherlands; Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; Rigshosp, Dept Gynecol, DK-2100 Copenhagen, Denmark; Nylobing Falster Hosp, Dept Pathol, Falster, Denmark	Danish Cancer Society; Vrije Universiteit Amsterdam; Emory University; Johns Hopkins University; Johns Hopkins Medicine; Rigshospitalet; University of Copenhagen	Kjaer, SK (corresponding author), Danish Canc Soc, DK-2100 Copenhagen, Denmark.			Kjaer, Susanne/0000-0002-8347-1398	NATIONAL CANCER INSTITUTE [R01CA047812] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA047812, R01 CA47812] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Einstein MH, 2001, PAPILLOMAVIRUS REP, V12, P119; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; Jacobs MV, 1997, J CLIN MICROBIOL, V35, P791, DOI 10.1128/JCM.35.3.791-795.1997; Kjaer SK, 1996, INT J CANCER, V65, P601, DOI 10.1002/(SICI)1097-0215(19960301)65:5<601::AID-IJC8>3.0.CO;2-6; Liaw KL, 1999, J NATL CANCER I, V91, P954, DOI 10.1093/jnci/91.11.954; LUFF RD, 1992, HUM PATHOL, V23, P719, DOI 10.1016/0046-8177(92)90338-4; Meijer CJLM, 2000, CAN MED ASSOC J, V163, P535; Munk C, 1998, ACTA OBSTET GYN SCAN, V77, P917, DOI 10.1034/j.1600-0412.1998.770908.x; Rozendaal L, 1996, INT J CANCER, V68, P766, DOI 10.1002/(SICI)1097-0215(19961211)68:6<766::AID-IJC13>3.0.CO;2-Z; VANDENBRULE AJC, 1990, J CLIN MICROBIOL, V28, P2739, DOI 10.1128/JCM.28.12.2739-2743.1990; Wallin KL, 1999, NEW ENGL J MED, V341, P1633, DOI 10.1056/NEJM199911253412201; *WHO, 1995, IARC MON EV CARC RIS, P64; Woodman CBJ, 2001, LANCET, V357, P1831, DOI 10.1016/S0140-6736(00)04956-4	13	321	350	0	13	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 14	2002	325	7364					572	576		10.1136/bmj.325.7364.572	http://dx.doi.org/10.1136/bmj.325.7364.572			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	595JJ	12228133	Green Published, Bronze			2022-12-24	WOS:000178105200017
J	Trewick, SC; Henshaw, TF; Hausinger, RP; Lindahl, T; Sedgwick, B				Trewick, SC; Henshaw, TF; Hausinger, RP; Lindahl, T; Sedgwick, B			Oxidative demethylation by Escherichia coli AlkB directly reverts DNA base damage	NATURE			English	Article							ALPHA-KETOGLUTARATE; ADAPTIVE RESPONSE; ALKYLATING-AGENTS; REPAIR; PROTEIN; GENE; SENSITIVITY; EXPRESSION; HOMOLOG; IRON	Methylating agents generate cytotoxic and mutagenic DNA damage. Cells use 3-methyladenine-DNA glycosylases to excise some methylated bases from DNA, and suicidal O-6-methyl-guanine- DNA methyltransferases to transfer alkyl groups from other lesions onto a cysteine residue(1,2). Here we report that the highly conserved AlkB protein repairs DNA alkylation damage by means of an unprecedented mechanism. AlkB has no detectable nuclease, DNA glycosylase or methyltransferase activity; however, Escherichia coli alkB mutants are defective in processing methylation damage generated in single-stranded DNA(3-5). Theoretical protein fold recognition had suggested that AlkB resembles the Fe(II)- and alpha-ketoglutarate-dependent dioxygenases (6), which use iron-oxo intermediates to oxidize chemically inert compounds(7,8). We show here that purified AlkB repairs the cytotoxic lesions 1-methyladenine and 3-methylcytosine in single- and double-stranded DNA in a reaction that is dependent on oxygen, alpha-ketoglutarate and Fe( II). The AlkB enzyme couples oxidative decarboxylation of alpha-ketoglutarate to the hydroxylation of these methylated bases in DNA, resulting in direct reversion to the unmodified base and the release of formaldehyde.	Canc Res UK London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England; Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA; Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Cancer Research UK; Michigan State University; Michigan State University	Sedgwick, B (corresponding author), Canc Res UK London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England.			Hausinger, Robert/0000-0002-3643-2054	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045686] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK045686] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1223, DOI 10.1093/nar/27.5.1223; ARAVIND L, 2001, GENOME BIOL, V2; BODELL WJ, 1979, BIOCHEMISTRY-US, V18, P2860, DOI 10.1021/bi00580a029; CHEN BRJ, 1994, J BACTERIOL, V176, P6255, DOI 10.1128/jb.176.20.6255-6261.1994; Colombi D, 1997, J BACTERIOL, V179, P3139, DOI 10.1128/jb.179.10.3139-3145.1997; DEJONG L, 1982, BIOCHIM BIOPHYS ACTA, V704, P326, DOI 10.1016/0167-4838(82)90162-5; Dinglay S, 2000, GENE DEV, V14, P2097; HECK HD, 1982, BIOMED MASS SPECTROM, V9, P347; Hegg EL, 1999, BIOCHEMISTRY-US, V38, P16714, DOI 10.1021/bi991796l; KATAOKA H, 1983, J BACTERIOL, V153, P1301, DOI 10.1128/JB.153.3.1301-1307.1983; KONDO H, 1986, J BIOL CHEM, V261, P5772; LINDAHL T, 1988, ANNU REV BIOCHEM, V57, P133, DOI 10.1146/annurev.bi.57.070188.001025; Lizcano JM, 2000, ANAL BIOCHEM, V286, P75, DOI 10.1006/abio.2000.4782; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; MYLLYLA R, 1984, J BIOL CHEM, V259, P5403; Pavel EG, 1998, J AM CHEM SOC, V120, P743, DOI 10.1021/ja972408a; Prescott AG, 2000, NAT PROD REP, V17, P367, DOI 10.1039/a902197c; REBECK GW, 1991, J BACTERIOL, V173, P2068, DOI 10.1128/jb.173.6.2068-2076.1991; Ryle MJ, 2002, CURR OPIN CHEM BIOL, V6, P193, DOI 10.1016/S1367-5931(02)00302-2; Ryle MJ, 1999, BIOCHEMISTRY-US, V38, P15278, DOI 10.1021/bi9912746; SEEBERG E, 1999, BASE EXCISION REPAIR, P151; Singer B., 1983, MOL BIOL MUTAGENS CA, P45; Smith SS, 2000, J MOL BIOL, V302, P1, DOI 10.1006/jmbi.2000.4046; THORNBURG LD, 1993, BIOCHEMISTRY-US, V32, P14023, DOI 10.1021/bi00213a036; VAUGHAN P, 1991, CARCINOGENESIS, V12, P263, DOI 10.1093/carcin/12.2.263; Wei YF, 1996, NUCLEIC ACIDS RES, V24, P931, DOI 10.1093/nar/24.5.931	26	605	633	4	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 12	2002	419	6903					174	178		10.1038/nature00908	http://dx.doi.org/10.1038/nature00908			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592HK	12226667				2022-12-24	WOS:000177931200043
J	Holowka, S; Petitto, LA				Holowka, S; Petitto, LA			Left hemisphere cerebral specialization for babies while babbling	SCIENCE			English	Article							LANGUAGE		McGill Univ, Dept Psychol, Montreal, PQ H3A 1B1, Canada; Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA; Dartmouth Coll, Dept Educ, Hanover, NH 03755 USA	McGill University; Dartmouth College; Dartmouth College	Petitto, LA (corresponding author), McGill Univ, Dept Psychol, 1205 Dr Penfield Ave, Montreal, PQ H3A 1B1, Canada.							BOROD JC, 1988, NEUROPSYCHOLOGIA, V26, P759, DOI 10.1016/0028-3932(88)90013-9; GAZZANIGA MS, 1983, ANN NEUROL, V13, P536, DOI 10.1002/ana.410130511; GRAVES R, 1990, INT J PSYCHOL, V25, P179, DOI 10.1080/00207599008247856; Locke JL, 2000, SCIENCE, V288, P449, DOI 10.1126/science.288.5465.449; MacNeilage PF, 2000, SCIENCE, V288, P527, DOI 10.1126/science.288.5465.527; Petitto LA, 2001, NATURE, V413, P35, DOI 10.1038/35092613; Pinker S, 1992, ADAPTED MIND EVOLUTI, P451	7	94	94	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 30	2002	297	5586					1515	1515		10.1126/science.1074941	http://dx.doi.org/10.1126/science.1074941			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588JA	12202820				2022-12-24	WOS:000177697300046
J	Boes, M; Cerny, J; Massol, R; Op den Brouw, M; Kirchhausen, T; Chen, JZ; Ploegh, HL				Boes, M; Cerny, J; Massol, R; Op den Brouw, M; Kirchhausen, T; Chen, JZ; Ploegh, HL			T-cell engagement of dendritic cells rapidly rearranges MHC class II transport	NATURE			English	Article							ANTIGEN PRESENTATION; INVARIANT CHAIN; EXPRESSION; MICE; ACTIVATION; DEGRADATION; MOLECULES; COMPLEXES; GENES	Assembly of major histocompatibility complex (MHC) molecules, which present antigen in the form of short peptides to T lymphocytes, occurs in the endoplasmic reticulum; once assembled, these molecules travel from the endoplasmic reticulum to their final destination. MHC class II molecules follow a route that takes them by means of the endocytic pathway, where they acquire peptide, to the cell surface(1). The transport of MHC class II molecules in 'professional' antigen-presenting cells (APCs) is subject to tight control and responds to inflammatory stimuli such as lipopolysaccharide. To study class II transport in live APCs, we replaced the mouse MHC class II gene with a version that codes for a class II molecule tagged with enhanced green fluorescent protein (EGFP). The resulting mice are immunologically indistinguishable from wild type. In bone-marrow-derived dendritic cells, we observed class II molecules in late endocytic structures with transport patterns similar to those in Langerhans cells observed in situ. We show that tubular endosomes extend intracellularly and polarize towards the interacting T cell, but only when antigen-laden dendritic cells encounter T cells of the appropriate specificity. We propose that such tubulation serves to facilitate the ensuing T-cell response.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; MIT, Ctr Canc Res, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Charles Univ, Fac Sci, Prague, Van Cerny, Czech Republic	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Charles University Prague	Ploegh, HL (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 200 Longwood Ave, Boston, MA 02115 USA.		Cerny, Jan/C-1887-2012	Cerny, Jan/0000-0002-5624-2215; Boes, Marianne/0000-0003-2590-1692				Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; COSGROVE D, 1991, CELL, V66, P1051, DOI 10.1016/0092-8674(91)90448-8; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; Gunzer M, 2000, IMMUNITY, V13, P323, DOI 10.1016/S1074-7613(00)00032-7; HUGO P, 1992, NATURE, V360, P679, DOI 10.1038/360679a0; Kleijmeer M, 2001, J CELL BIOL, V155, P53, DOI 10.1083/jcb.200103071; Lanzavecchia A, 2001, CELL, V106, P263, DOI 10.1016/S0092-8674(01)00455-X; MALISSEN B, 1983, NATURE, V305, P440, DOI 10.1038/305440a0; Maric M, 2001, SCIENCE, V294, P1361, DOI 10.1126/science.1065500; MATHIS DJ, 1983, P NATL ACAD SCI-BIOL, V80, P273, DOI 10.1073/pnas.80.1.273; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; ROWDEN G, 1981, CRC CR REV IMMUNOL, V3, P95; SCHOLL PR, 1994, IMMUNOL TODAY, V15, P418, DOI 10.1016/0167-5699(94)90271-2; Turley SJ, 2000, SCIENCE, V288, P522, DOI 10.1126/science.288.5465.522; Underhill DM, 1999, J EXP MED, V190, P1909, DOI 10.1084/jem.190.12.1909; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; Villadangos JA, 1999, IMMUNOL REV, V172, P109, DOI 10.1111/j.1600-065X.1999.tb01360.x; Villadangos JA, 1997, J EXP MED, V186, P549, DOI 10.1084/jem.186.4.549; Villadangos JA, 2001, IMMUNITY, V14, P739, DOI 10.1016/S1074-7613(01)00148-0; Wubbolts R, 1996, J CELL BIOL, V135, P611, DOI 10.1083/jcb.135.3.611	22	322	348	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 29	2002	418	6901					983	988		10.1038/nature01004	http://dx.doi.org/10.1038/nature01004			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588AP	12198548				2022-12-24	WOS:000177677500046
J	Doligez, B; Danchin, E; Clobert, J				Doligez, B; Danchin, E; Clobert, J			Public information and breeding habitat selection in a wild bird population	SCIENCE			English	Article							CONSPECIFIC REPRODUCTIVE SUCCESS; FLYCATCHER FICEDULA-ALBICOLLIS; PHALACROCORAX-CARBO SINENSIS; IDEAL FREE DISTRIBUTION; COLLARED FLYCATCHER; GREAT CORMORANT; TITS; COLONIALITY; RECRUITMENT; SURVIVAL	According to the public information hypothesis, some animal species may monitor the current reproductive success of conspecifics to assess local habitat quality and to choose their own subsequent breeding site. To test this hypothesis experimentally, we manipulated two components of public information, the mean number of offspring raised locally ( quantity) and their condition ( quality), in the collared flycatcher Ficedula albicollis. Immigration rate decreased with local offspring quantity but did not depend on local offspring quality, suggesting that immigrants are deprived of information regarding local quality. Conversely, emigration rate increased both when local offspring quantity or quality decreased, suggesting that residents can use both components of public information.	Univ Paris 06, Ecol Lab, CNRS, UMR 7625, F-75252 Paris 05, France; Uppsala Univ, Dept Anim Ecol, Ctr Evolutionary Biol, S-75236 Uppsala, Sweden	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Uppsala University	Doligez, B (corresponding author), Univ Bern, Inst Zool, Dept Evolutionary Ecol, Baltzerstr 6, CH-3012 Bern, Switzerland.		Danchin, Etienne/AAB-2091-2021; Danchin, Etienne/A-2299-2009; Doligez, Blandine/ABB-5977-2020	Danchin, Etienne/0000-0002-5013-9612; Doligez, Blandine/0000-0003-3015-5022				Boulinier T, 1996, J AVIAN BIOL, V27, P252, DOI 10.2307/3677230; Boulinier T, 1997, EVOL ECOL, V11, P505, DOI 10.1007/s10682-997-1507-0; Boulinier T, 2002, J APPL STAT, V29, P509, DOI 10.1080/02664760120108566; Brown CR, 2000, J ANIM ECOL, V69, P133, DOI 10.1046/j.1365-2656.2000.00382.x; Caro T, 1999, TRENDS ECOL EVOL, V14, P366, DOI 10.1016/S0169-5347(99)01663-8; Clobert J, 1995, J APPL STAT, V22, P989, DOI 10.1080/02664769524757; Colbert J, 2001, DISPERSAL; Danchin E, 1998, ECOLOGY, V79, P2415, DOI 10.2307/176832; Danchin E, 1997, TRENDS ECOL EVOL, V12, P342, DOI 10.1016/S0169-5347(97)01124-5; Danchin E, 2000, SCIENCE, V287, P804; Danchin Etienne, 2001, P243; Doligez B, 1999, J ANIM ECOL, V68, P1193, DOI 10.1046/j.1365-2656.1999.00362.x; DOLIGEZ B, UNPUB; Frederiksen M, 2001, P ROY SOC B-BIOL SCI, V268, P1519, DOI 10.1098/rspb.2001.1701; Giraldeau Luc-Alain, 1997, P42; GRAY RD, 1994, ANIM BEHAV, V47, P469, DOI 10.1006/anbe.1994.1064; GUSTAFSSON L, 1988, NATURE, V335, P813, DOI 10.1038/335813a0; Gustafsson L., 1989, P75; Houston AI, 1998, ANIM BEHAV, V56, P243, DOI 10.1006/anbe.1998.0773; Johnstone RA, 1999, BEHAV ECOL SOCIOBIOL, V45, P277, DOI 10.1007/s002650050562; Lahti K, 1998, BEHAV ECOL, V9, P122, DOI 10.1093/beheco/9.2.122; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; LINDEN M, 1992, ECOLOGY, V73, P336, DOI 10.2307/1938745; Naef-Daenzer B, 2001, J ANIM ECOL, V70, P730, DOI 10.1046/j.0021-8790.2001.00533.x; PART T, 1994, ANIM BEHAV, V48, P401, DOI 10.1006/anbe.1994.1254; PART T, 1989, J ANIM ECOL, V58, P305, DOI 10.2307/5002; Pettifor RA, 2001, J ANIM ECOL, V70, P62, DOI 10.1046/j.1365-2656.2001.00465.x; Reed J. Michael, 1999, Current Ornithology, V15, P189; Schjorring S, 1999, ANIM BEHAV, V57, P647, DOI 10.1006/anbe.1998.0993; SLAGSVOLD T, 1990, POPULATION BIOL PASS, P441; Sutherland WJ, 1998, ANIM BEHAV, V56, P801, DOI 10.1006/anbe.1998.0896; VALONE TJ, 1993, ANIM BEHAV, V45, P721, DOI 10.1006/anbe.1993.1086	32	372	380	1	155	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 16	2002	297	5584					1168	1170		10.1126/science.1072838	http://dx.doi.org/10.1126/science.1072838			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584BP	12183627				2022-12-24	WOS:000177447600046
J	Fairbrother, WG; Yeh, RF; Sharp, PA; Burge, CB				Fairbrother, WG; Yeh, RF; Sharp, PA; Burge, CB			Predictive identification of exonic splicing enhancers in human genes	SCIENCE			English	Article							PRE-MESSENGER-RNA; T ALTERNATIVE EXON; SR-PROTEINS; SITE SELECTION; SEQUENCES; BINDING; MUTATIONS; RECOGNITION; ELEMENTS; INVITRO	Specific short oligonucleotide sequences that enhance pre-mRNA splicing when present in exons, termed exonic splicing enhancers (ESEs), play important roles in constitutive and alternative splicing. A computational method, RESCUE-ESE, was developed that predicts which sequences have ESE activity by statistical analysis of exon-intron and splice site composition. When large data sets of human gene sequences were used, this method identified 10 predicted ESE motifs. Representatives of all 10 motifs were found to display enhancer activity in vivo, whereas point mutants of these sequences exhibited sharply reduced activity. The motifs identified enable prediction of the splicing phenotypes of exonic mutations in human genes.	MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Ctr Canc Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Burge, CB (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.		Burge, Christopher B./AAH-2177-2020	Fairbrother, William/0000-0002-6312-5615	NHGRI NIH HHS [1 R01 HG02439-01] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002439] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; BLACK DL, 1991, GENE DEV, V5, P389, DOI 10.1101/gad.5.3.389; BLACK DL, 1995, RNA, V1, P763; Blencowe BJ, 2000, TRENDS BIOCHEM SCI, V25, P106, DOI 10.1016/S0968-0004(00)01549-8; Bourgeois CF, 1999, MOL CELL BIOL, V19, P7347; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cavaloc Y, 1999, RNA, V5, P468, DOI 10.1017/S1355838299981967; COOPER TA, 1992, J BIOL CHEM, V267, P5330; Coulter LR, 1997, MOL CELL BIOL, V17, P2143, DOI 10.1128/MCB.17.4.2143; DIRKSEN WP, 1994, J BIOL CHEM, V269, P6431; DOMINSKI Z, 1992, MOL CELL BIOL, V12, P2108, DOI 10.1128/MCB.12.5.2108; DOMINSKI Z, 1991, MOL CELL BIOL, V11, P6075, DOI 10.1128/MCB.11.12.6075; FU XD, 1991, GENE DEV, V5, P211, DOI 10.1101/gad.5.2.211; Gersappe A, 1999, MOL CELL BIOL, V19, P1640; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; HELFMAN DM, 1988, GENE DEV, V2, P1627, DOI 10.1101/gad.2.12a.1627; Kanopka A, 1996, NATURE, V381, P535, DOI 10.1038/381535a0; KATZ RA, 1990, MOL CELL BIOL, V10, P696, DOI 10.1128/MCB.10.2.696; LAVIGUEUR A, 1993, GENE DEV, V7, P2405, DOI 10.1101/gad.7.12a.2405; Lim LP, 2001, P NATL ACAD SCI USA, V98, P11193, DOI 10.1073/pnas.201407298; Liu HX, 2001, NAT GENET, V27, P55, DOI 10.1038/83762; Liu HX, 2000, MOL CELL BIOL, V20, P1063, DOI 10.1128/MCB.20.3.1063-1071.2000; Liu HX, 1998, GENE DEV, V12, P1998, DOI 10.1101/gad.12.13.1998; MARDON HJ, 1987, NUCLEIC ACIDS RES, V15, P7725, DOI 10.1093/nar/15.19.7725; McNally LM, 1998, MOL CELL BIOL, V18, P3103, DOI 10.1128/MCB.18.6.3103; NELSON KK, 1988, GENE DEV, V2, P319, DOI 10.1101/gad.2.3.319; RAMCHATESINGH J, 1995, MOL CELL BIOL, V15, P4898; REED R, 1986, CELL, V46, P681, DOI 10.1016/0092-8674(86)90343-0; Schaal TD, 1999, MOL CELL BIOL, V19, P1705; Schaal TD, 1999, MOL CELL BIOL, V19, P261; Selvakumar M, 1999, RNA, V5, P378, DOI 10.1017/S1355838299981050; Staffa A, 1997, J BIOL CHEM, V272, P33394, DOI 10.1074/jbc.272.52.33394; STEINGRIMSDOTTIR H, 1992, NUCLEIC ACIDS RES, V20, P1201, DOI 10.1093/nar/20.6.1201; Stickeler E, 2001, EMBO J, V20, P3821, DOI 10.1093/emboj/20.14.3821; SUN Q, 1993, GENE DEV, V7, P2598, DOI 10.1101/gad.7.12b.2598; TACKE R, 1995, EMBO J, V14, P3540, DOI 10.1002/j.1460-2075.1995.tb07360.x; Tacke R, 1997, P NATL ACAD SCI USA, V94, P1148, DOI 10.1073/pnas.94.4.1148; Tacke R, 1998, CELL, V93, P139, DOI 10.1016/S0092-8674(00)81153-8; TANAKA K, 1994, MOL CELL BIOL, V14, P1347, DOI 10.1128/MCB.14.2.1347; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TIAN HC, 1995, MOL CELL BIOL, V15, P6291; Tu M, 2000, MUTAT RES-GENOMICS, V432, P15, DOI 10.1016/S1383-5726(99)00011-4; Valentine CR, 1998, MUTAT RES-REV MUTAT, V411, P87, DOI 10.1016/S1383-5742(98)00010-6; WATAKABE A, 1993, GENE DEV, V7, P407, DOI 10.1101/gad.7.3.407; XU RS, 1993, MOL CELL BIOL, V13, P3660, DOI 10.1128/MCB.13.6.3660	45	824	861	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 9	2002	297	5583					1007	1013		10.1126/science.1073774	http://dx.doi.org/10.1126/science.1073774			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581ZN	12114529				2022-12-24	WOS:000177325400043
J	Wu, LC; Tuot, DS; Lyons, DS; Garcia, KC; Davis, MM				Wu, LC; Tuot, DS; Lyons, DS; Garcia, KC; Davis, MM			Two-step binding mechanism for T-cell receptor recognition of peptide-MHC	NATURE			English	Article							ANTIGEN RECOGNITION; HOT-SPOT; LIGANDS; COMPLEX; REQUIREMENTS; REACTIVITY; REPERTOIRE; INTERFACE; RESIDUES; ENERGY	T cells probe a diverse milieu of peptides presented by molecules of the major histocompatibility complex (MHC) by using the T-cell receptor (TCR) to scan these ligands with high sensitivity and specificity(1). Here we describe a physical basis for this scanning process by studying the residues involved in both the initial association and the stable binding of TCR to peptide-MHC, using the well-characterized TCR and peptide-MHC pair of 2B4 and MCC-IEk (moth cytochrome c, residues 88-103)(2). We show that MHC contacts dictate the initial association, guiding TCR docking in a way that is mainly independent of the peptide. Subsequently, MCC-IEk peptide contacts dominate stabilization, imparting specificity and influencing T-cell activation by modulating the duration of binding. This functional subdivision of the peptide-MHC ligand suggests that a two-step process for TCR recognition facilitates the efficient scanning of diverse peptide-MHC complexes on the surface of cells and also makes TCRs inherently crossreactive towards different peptides bound by the same MHC.	Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University	Davis, MM (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, B221 Beckman Ctr, Stanford, CA 94305 USA.			Davis, Mark/0000-0001-6868-657X				Baker BM, 2001, J EXP MED, V193, P551, DOI 10.1084/jem.193.5.551; Baker BM, 1999, COLD SPRING HARB SYM, V64, P235, DOI 10.1101/sqb.1999.64.235; BEVAN MJ, 1977, NATURE, V269, P417, DOI 10.1038/269417a0; Boniface JJ, 1999, P NATL ACAD SCI USA, V96, P11446, DOI 10.1073/pnas.96.20.11446; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Davis SJ, 1998, P NATL ACAD SCI USA, V95, P5490, DOI 10.1073/pnas.95.10.5490; Degano M, 2000, IMMUNITY, V12, P251, DOI 10.1016/S1074-7613(00)80178-8; EHRICH EW, 1993, J EXP MED, V178, P713, DOI 10.1084/jem.178.2.713; Fersht AR, 1997, CURR OPIN STRUC BIOL, V7, P3, DOI 10.1016/S0959-440X(97)80002-4; Fremont DH, 2002, J EXP MED, V195, P1043, DOI 10.1084/jem.20011971; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Germain RN, 1999, ANNU REV IMMUNOL, V17, P467, DOI 10.1146/annurev.immunol.17.1.467; Hare BJ, 1999, NAT STRUCT BIOL, V6, P574; Hennecke J, 2002, J EXP MED, V195, P571, DOI 10.1084/jem.20011194; Kersh GJ, 1998, IMMUNITY, V9, P817, DOI 10.1016/S1074-7613(00)80647-0; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lee PUY, 2000, J EXP MED, V191, P1355, DOI 10.1084/jem.191.8.1355; Luz JG, 2002, J EXP MED, V195, P1175, DOI 10.1084/jem.20011644; Manning TC, 1998, IMMUNITY, V8, P413, DOI 10.1016/S1074-7613(00)80547-6; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; REAY PA, 1994, J IMMUNOL, V152, P3946; Reiser JB, 2002, IMMUNITY, V16, P345, DOI 10.1016/S1074-7613(02)00288-1; Rudolph MG, 2002, CURR OPIN IMMUNOL, V14, P52, DOI 10.1016/S0952-7915(01)00298-9; Savage PA, 2001, IMMUNITY, V14, P243, DOI 10.1016/S1074-7613(01)00106-6; Schreiber G, 1996, NAT STRUCT BIOL, V3, P427, DOI 10.1038/nsb0596-427; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; Willcox BE, 1999, IMMUNITY, V10, P357, DOI 10.1016/S1074-7613(00)80035-7; Zerrahn J, 1997, CELL, V88, P627, DOI 10.1016/S0092-8674(00)81905-4; ZINKERNAGEL RM, 1978, J EXP MED, V147, P882, DOI 10.1084/jem.147.3.882	30	224	229	2	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 1	2002	418	6897					552	556		10.1038/nature00920	http://dx.doi.org/10.1038/nature00920			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579EE	12152083				2022-12-24	WOS:000177162800045
J	Mitchell, J; Hussaini, H; McGovern, D; Farrow, R; Maskell, G; Dalton, H				Mitchell, J; Hussaini, H; McGovern, D; Farrow, R; Maskell, G; Dalton, H			Quality improvement report - The "jaundice hotline" for the rapid assessment of patients with jaundice	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Problem Patients with jaundice require rapid diagnosis and treatment, yet such patients are often subject to delay. Design An open referral, rapid access jaundice dinic was established by reorganisation of existing services and without the need for significant extra resources. Background and setting A large general hospital in a largely rural and geographically isolated area, Key measures for improvement Waiting times for, referral, consultation, diagnosis, and treatment, length of stay in hospital, and general practitioners' and patients' satisfaction with the service. Strategies for change Referrals were made through a 24 hour telephone answering machine and fax line. Initial assessment of patients was Carried out by junior staff as part of their working week. Dedicated ultrasonography appointments were made available. Effects of change Of 107 patients seen in the first year of the service, 62 had biliary obstruction. The mean time between referral and consultation was 2.5 days. Patients who went on to endoscopic retrograde cholangiopancreatography waited 5,7 clays on average. The mean length of stay in hospital in the 69 patients who were admitted was 6.1 days, compared with 11,5 days in 1996, as shown by audit data, Nearly all the 36 general practices (95%) and the 30 consecutive patients (97%) that were surveyed rated the service as above average or excellent. Lessons learnt An open referral, rapid access service for patients with jaundice can shorten time to diagnosis and treatment mid length of stay in hospital. These improvements can occur through die reorganisation of existing services and with minimal extra cost.	Royal Cornwall Hosp, Gastrointestinal Unit, Truro, NS TR1 3LJ, Canada		Mitchell, J (corresponding author), Kings Coll Hosp London, Inst Liver Studies, Denmark Hill, London SE5 9RS, England.	jonmitch@clara.net						*CORN ISL SCILL HL, 1998, BID HLTH ACT ZON STA; *DEP HLTH, 1998, POL FRAM COMM CANC S; Mitchell J, 2001, CLIN RADIOL, V56, P64, DOI 10.1053/crad.2000.0637; Sherlock, 1997, DIS LIVER BILIARY SY, V30, P61	4	18	19	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 27	2002	325	7357					213	215		10.1136/bmj.325.7357.213	http://dx.doi.org/10.1136/bmj.325.7357.213			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	580PX	12142314	Green Published			2022-12-24	WOS:000177243900027
J	Kjaer, SK				Kjaer, S. K.			Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study (vol 325, pg 572, 2002)	BMJ-BRITISH MEDICAL JOURNAL			English	Correction														Kjaer, Susanne/0000-0002-8347-1398	NATIONAL CANCER INSTITUTE [R01CA047812] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA047812, R01 CA47812] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Kjaer SK, 2016, BMJ-BRIT MED J, V353, DOI [10.1136/bmj.325.7364.572, 10.1136/bmj.i2820]	1	321	350	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 18	2016	353									10.1136/bmj.i2820	http://dx.doi.org/10.1136/bmj.i2820			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6GC	12228133	Green Published, Bronze			2022-12-24	WOS:000376447600012
J	Patterson, GH; Lippincott-Schwartz, J				Patterson, GH; Lippincott-Schwartz, J			A photoactivatable GFP for selective photolabeling of proteins and cells	SCIENCE			English	Article							GREEN-FLUORESCENT PROTEIN; LYSOSOMAL MEMBRANE; STRUCTURAL BASIS; LIVING CELLS; MUTATIONS; GLYCOPROTEINS; EXCITATION; DYNAMICS; MUTANTS	We report a photoactivatable variant of the Aequorea victoria green fluorescent protein (GFP) that, after intense irradiation with 413-nanometer light, increases fluorescence 100 times when excited by 488-nanometer light and remains stable for days under aerobic conditions. These characteristics offer a new tool for exploring intracellular protein dynamics by tracking photoactivated molecules that are the only visible GFPs in the cell. Here, we use the photoactivatable GFP both as a free protein to measure protein diffusion across the nuclear envelope and as a chimera with a lysosomal membrane protein to demonstrate rapid interlysosomal membrane exchange.	NICHHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Lippincott-Schwartz, J (corresponding author), NICHHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA.	jlippin@helix.nih.gov	Patterson, George/ABI-4751-2020		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001609] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001609] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Brejc K, 1997, P NATL ACAD SCI USA, V94, P2306, DOI 10.1073/pnas.94.6.2306; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; DENG YP, 1988, P NATL ACAD SCI USA, V85, P3860, DOI 10.1073/pnas.85.11.3860; EHRIG T, 1995, FEBS LETT, V367, P163, DOI 10.1016/0014-5793(95)00557-P; Elowitz MB, 1997, CURR BIOL, V7, P809, DOI 10.1016/S0960-9822(06)00342-3; FERRIS AL, 1987, J CELL BIOL, V105, P2703, DOI 10.1083/jcb.105.6.2703; Haupts U, 1998, P NATL ACAD SCI USA, V95, P13573, DOI 10.1073/pnas.95.23.13573; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; HOWE CL, 1988, P NATL ACAD SCI USA, V85, P7577, DOI 10.1073/pnas.85.20.7577; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; LEWIS V, 1985, J CELL BIOL, V100, P1839, DOI 10.1083/jcb.100.6.1839; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Marchant JS, 2001, NAT BIOTECHNOL, V19, P645, DOI 10.1038/90249; Palm GJ, 1997, NAT STRUCT BIOL, V4, P361, DOI 10.1038/nsb0597-361; Patterson GH, 1997, BIOPHYS J, V73, P2782, DOI 10.1016/S0006-3495(97)78307-3; Piston DW, 1999, METHOD CELL BIOL, V58, P31; Politz JC, 1999, TRENDS CELL BIOL, V9, P284, DOI 10.1016/S0962-8924(99)01585-8; Prendergast FG, 1999, METHOD CELL BIOL, V58, P1; Sawin KE, 1997, CURR BIOL, V7, pR606, DOI 10.1016/S0960-9822(06)00313-7; Siemering KR, 1996, CURR BIOL, V6, P1653, DOI 10.1016/S0960-9822(02)70789-6; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; van Thor JJ, 2002, NAT STRUCT BIOL, V9, P37, DOI 10.1038/nsb739; WARD WW, 1982, BIOCHEMISTRY-US, V21, P4535, DOI 10.1021/bi00262a003; Yang TT, 1996, NUCLEIC ACIDS RES, V24, P4592, DOI 10.1093/nar/24.22.4592; Yokoe E, 1996, NAT BIOTECHNOL, V14, P1252, DOI 10.1038/nbt1096-1252	25	1185	1237	13	256	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2002	297	5588					1873	1877		10.1126/science.1074952	http://dx.doi.org/10.1126/science.1074952			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592UJ	12228718				2022-12-24	WOS:000177955000045
J	Falnes, PO; Johansen, RF; Seeberg, E				Falnes, PO; Johansen, RF; Seeberg, E			AlkB-mediated oxidative demethylation reverses DNA damage in Escherichia coli	NATURE			English	Article							ADAPTIVE RESPONSE; ALKYLATING-AGENTS; GLYCOSYLASE; INDUCTION; ADDUCTS; BEARING; REPAIR; CELLS	The bacterial AlkB protein is known to be involved in cellular recovery from alkylation damage; however, the function of this protein remains unknown. AlkB homologues have been identified in several organisms, including humans, and a recent sequence alignment study has suggested that these proteins may belong to a superfamily of 2-oxoglutarate-dependent and iron-dependent oxygenases (2OG-Fe(II)-oxygenases)(1). Here we show that AlkB from Escherichia coli is indeed a 2-oxoglutarate-dependent and iron-dependent DNA repair enzyme that releases replication blocks in alkylated DNA by a mechanism involving oxidative demethylation of 1-methyladenine residues. This mechanism represents a new pathway for DNA repair and the third type of DNA damage reversal mechanism so far discovered.	Univ Oslo, Natl Hosp, Ctr Mol Biol & Neurosci, N-0027 Oslo, Norway; Univ Oslo, Natl Hosp, Inst Med Microbiol, N-0027 Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway	Falnes, PO (corresponding author), Univ Oslo, Natl Hosp, Ctr Mol Biol & Neurosci, N-0027 Oslo, Norway.		Falnes, Pål Ø./AAA-4581-2020	Falnes, Pal/0000-0001-8114-6025				*AM PHARM BIOT, 1997, GST GEN FUS SYST US; ARAVIND L, 2001, GENOME BIOL, V2; BJELLAND S, 1993, NUCLEIC ACIDS RES, V21, P2045, DOI 10.1093/nar/21.9.2045; CHEN BRJ, 1994, J BACTERIOL, V176, P6255, DOI 10.1128/jb.176.20.6255-6261.1994; CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172; Dinglay S, 2000, GENE DEV, V14, P2097; EVENSEN G, 1982, NATURE, V296, P773, DOI 10.1038/296773a0; Hofer T, 1998, CHEM RES TOXICOL, V11, P882, DOI 10.1021/tx980041x; KARRAN P, 1982, NATURE, V296, P770, DOI 10.1038/296770a0; KARRAN P, 1979, NATURE, V280, P76, DOI 10.1038/280076a0; KATAOKA H, 1983, J BACTERIOL, V153, P1301, DOI 10.1128/JB.153.3.1301-1307.1983; NASH T, 1953, BIOCHEM J, V55, P416, DOI 10.1042/bj0550416; PALEJWALA VA, 1991, BIOCHEMISTRY-US, V30, P8736, DOI 10.1021/bi00100a004; Parkinson A, 1996, TOXICOLOGY BASIC SCI, P113; Pegg AE, 2000, MUTAT RES-REV MUTAT, V462, P83, DOI 10.1016/S1383-5742(00)00017-X; RAPOPORT R, 1994, ANAL BIOCHEM, V218, P309, DOI 10.1006/abio.1994.1183; Singer B., 1983, MOL BIOL MUTAGENS CA; Wang G, 1997, BIOCHEMISTRY-US, V36, P9486, DOI 10.1021/bi970650o; Wei YF, 1996, NUCLEIC ACIDS RES, V24, P931, DOI 10.1093/nar/24.5.931	19	477	495	1	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 12	2002	419	6903					178	182		10.1038/nature01048	http://dx.doi.org/10.1038/nature01048			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592HK	12226668				2022-12-24	WOS:000177931200044
J	Malik, I; Berger, A				Malik, I; Berger, A			Science commentary: Coronary angioplasty and stenting	BRITISH MEDICAL JOURNAL			English	Editorial Material							DISEASE		St Marys Hosp, Waller Dept Cardiol, London W2 1NY, England	Imperial College London	Malik, I (corresponding author), St Marys Hosp, Waller Dept Cardiol, Praed St, London W2 1NY, England.							Alderman EL, 2000, J AM COLL CARDIOL, V35, P1122; Bhatt DL, 2000, J AM COLL CARDIOL, V35, P922, DOI 10.1016/S0735-1097(99)00650-6; George CJ, 1998, AM J CARDIOL, V81, P860, DOI 10.1016/S0002-9149(98)00004-6; LINCOFF AM, 1999, J AM COLL CARDIOL, V133, pA45; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Serruys PW, 2001, NEW ENGL J MED, V344, P1117, DOI 10.1056/NEJM200104123441502; SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801; *SOS INV, 2001, STENT SURG SOS TRIAL	8	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 7	2002	325	7363					519	520		10.1136/bmj.325.7363.519	http://dx.doi.org/10.1136/bmj.325.7363.519			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	593NJ	12217991	Bronze, Green Published			2022-12-24	WOS:000177997800017
J	Bochkov, VN; Kadl, A; Huber, J; Gruber, F; Binder, BR; Leitinger, N				Bochkov, VN; Kadl, A; Huber, J; Gruber, F; Binder, BR; Leitinger, N			Protective role of phospholipid oxidation products in endotoxin-induced tissue damage	NATURE			English	Article							LIPOPOLYSACCHARIDE-BINDING PROTEIN; SOLUBLE CD14; LIPID-A; OXIDIZED PHOSPHOLIPIDS; LPS; CELLS; INFLAMMATION; LIPOPROTEINS; ANTAGONIST; MONOCYTES	Lipopolysaccharide (LPS), an outer-membrane component of Gram-negative bacteria, interacts with LPS-binding protein and CD14, which present LPS to toll-like receptor 4 (refs 1, 2), which activates inflammatory gene expression through nuclear factor kappaB (NFkappaB) and mitogen-activated protein-kinase signalling(3,4). Antibacterial defence involves activation of neutrophils that generate reactive oxygen species capable of killing bacteria(5); therefore host lipid peroxidation occurs, initiated by enzymes such as NADPH oxidase and myeloperoxidase(6). Oxidized phospholipids are pro-inflammatory agonists promoting chronic inflammation in atherosclerosis(7); however, recent data suggest that they can inhibit expression of inflammatory adhesion molecules(8). Here we show that oxidized phospholipids inhibit LPS-induced but not tumour-necrosis factor-alpha-induced or interleukin-1beta-induced NFkappaB-mediated upregulation of inflammatory genes, by blocking the interaction of LPS with LPS-binding protein and CD14. Moreover, in LPS-injected mice, oxidized phospholipids inhibited inflammation and protected mice from lethal endotoxin shock. Thus, in severe Gram-negative bacterial infection, endogenously formed oxidized phospholipids may function as a negative feedback to blunt innate immune responses. Furthermore, identified chemical structures capable of inhibiting the effects of endotoxins such as LPS could be used for the development of new drugs for treatment of sepsis.	Univ Vienna, Dept Vasc Biol & Thrombosis Res, A-1090 Vienna, Austria; BMT Res, A-1235 Vienna, Austria	University of Vienna	Leitinger, N (corresponding author), Univ Vienna, Dept Vasc Biol & Thrombosis Res, Schwarzspanierstr 17, A-1090 Vienna, Austria.	norbert.leitinger@univie.ac.at	Kadl, Alexandra/AAV-3395-2021	Gruber, Florian/0000-0003-1094-5641				Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Beutler B, 2000, CURR OPIN IMMUNOL, V12, P20, DOI 10.1016/S0952-7915(99)00046-1; Bochkov VN, 2002, BLOOD, V99, P199, DOI 10.1182/blood.V99.1.199; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; CHRIST WJ, 1995, SCIENCE, V268, P80, DOI 10.1126/science.7701344; Cunningham MD, 1996, INFECT IMMUN, V64, P3601, DOI 10.1128/IAI.64.9.3601-3608.1996; Elass-Rochard E, 1998, INFECT IMMUN, V66, P486, DOI 10.1128/IAI.66.2.486-491.1998; EMANCIPATOR K, 1992, INFECT IMMUN, V60, P596, DOI 10.1128/IAI.60.2.596-601.1992; FREY EA, 1992, J EXP MED, V176, P1665, DOI 10.1084/jem.176.6.1665; GOLENBOCK DT, 1991, J BIOL CHEM, V266, P19490; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; Kitchens RL, 2001, J CLIN INVEST, V108, P485, DOI 10.1172/JCI200113139; Lawrence T, 2001, NAT MED, V7, P1291, DOI 10.1038/nm1201-1291; Leitinger N, 1999, P NATL ACAD SCI USA, V96, P12010, DOI 10.1073/pnas.96.21.12010; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; RUSTICI A, 1993, SCIENCE, V259, P361, DOI 10.1126/science.8420003; Scott MG, 2000, J IMMUNOL, V164, P549, DOI 10.4049/jimmunol.164.2.549; Su GL, 1995, CRIT REV IMMUNOL, V15, P201, DOI 10.1615/CritRevImmunol.v15.i3-4.10; Sugiyama T, 2001, J IMMUNOL, V166, P826, DOI 10.4049/jimmunol.166.2.826; Tanamoto K, 2000, J IMMUNOL, V164, P3149, DOI 10.4049/jimmunol.164.6.3149; Watson AD, 1997, J BIOL CHEM, V272, P13597, DOI 10.1074/jbc.272.21.13597; Wurfel MM, 1997, J IMMUNOL, V158, P3925; Yu B, 1997, J CLIN INVEST, V99, P315, DOI 10.1172/JCI119160; Zhang RL, 2002, BLOOD, V99, P1802, DOI 10.1182/blood.V99.5.1802.h8001802_1802_1810	26	302	322	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 5	2002	419	6902					77	81		10.1038/nature01023	http://dx.doi.org/10.1038/nature01023			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589YF	12214235				2022-12-24	WOS:000177788600040
J	Li, HB; Linke, WA; Oberhauser, AF; Carrion-Vazquez, M; Kerkviliet, JG; Lu, H; Marszalek, PE; Fernandez, JM				Li, HB; Linke, WA; Oberhauser, AF; Carrion-Vazquez, M; Kerkviliet, JG; Lu, H; Marszalek, PE; Fernandez, JM			Reverse engineering of the giant muscle protein titin	NATURE			English	Article							ATOMIC-FORCE MICROSCOPY; SINGLE MOLECULES; CONFORMATIONS; ELASTICITY; DNA	Through the study of single molecules it has become possible to explain the function of many of the complex molecular assemblies found in cells(1-5). The protein titin provides muscle with its passive elasticity. Each titin molecule extends over half a sarcomere, and its extensibility has been studied both in situ(6-10) and at the level of single molecules(11-14). These studies suggested that titin is not a simple entropic spring but has a complex structure-dependent elasticity. Here we use protein engineering and single-molecule atomic force microscopy(15) to examine the mechanical components that form the elastic region of human cardiac titin(16,17). We show that when these mechanical elements are combined, they explain the macroscopic behaviour of titin in intact muscle(6). Our studies show the functional reconstitution of a protein from the sum of its parts.	Mayo Clin & Mayo Fdn, Dept Physiol & Biophys, Rochester, MN 55905 USA; Heidelberg Univ, Inst Physiol & Pathophysiol, D-69120 Heidelberg, Germany; Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA	Mayo Clinic; Ruprecht Karls University Heidelberg; Donald Danforth Plant Science Center	Fernandez, JM (corresponding author), Mayo Clin & Mayo Fdn, Dept Physiol & Biophys, Rochester, MN 55905 USA.	jfernandez@columbia.edu	Linke, Wolfgang A/E-8662-2012; Li, Hongbin/G-2949-2012; Carrion-Vazquez, Mariano/Y-3741-2018	Li, Hongbin/0000-0001-7813-1332; Lu, Hui/0000-0001-8347-0830; Carrion-Vazquez, Mariano/0000-0001-7319-406X; Linke, Wolfgang/0000-0003-0801-3773				ALLEN DG, 1985, J MOL CELL CARDIOL, V17, P821, DOI 10.1016/S0022-2828(85)80097-3; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Best RB, 2001, BIOPHYS J, V81, P2344, DOI 10.1016/S0006-3495(01)75881-X; BUECHE F, 1962, PHYSICAL PROPERTIES, P37; Bustamante C, 2000, CURR OPIN STRUC BIOL, V10, P279, DOI 10.1016/S0959-440X(00)00085-3; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; Fisher TE, 2000, NAT STRUCT BIOL, V7, P719; Freiburg A, 2000, CIRC RES, V86, P1114; Gregorio CC, 1999, CURR OPIN CELL BIOL, V11, P18, DOI 10.1016/S0955-0674(99)80003-9; HIGUCHI H, 1993, BIOPHYS J, V65, P1906, DOI 10.1016/S0006-3495(93)81261-X; Kellermayer MSZ, 1997, SCIENCE, V276, P1112, DOI 10.1126/science.276.5315.1112; LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293; Li HB, 2000, P NATL ACAD SCI USA, V97, P6527, DOI 10.1073/pnas.120048697; Li HB, 2001, P NATL ACAD SCI USA, V98, P10682, DOI 10.1073/pnas.191189098; Linke WA, 1999, J CELL BIOL, V146, P631, DOI 10.1083/jcb.146.3.631; Linke WA, 1996, J MOL BIOL, V261, P62, DOI 10.1006/jmbi.1996.0441; Lu H, 1999, PROTEINS, V35, P453, DOI 10.1002/(SICI)1097-0134(19990601)35:4<453::AID-PROT9>3.3.CO;2-D; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; Marszalek PE, 1999, NATURE, V402, P100, DOI 10.1038/47083; Maruyama K, 1997, FASEB J, V11, P341, DOI 10.1096/fasebj.11.5.9141500; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Scott KA, 2002, J MOL BIOL, V315, P819, DOI 10.1006/jmbi.2001.5260; SIGWORTH FJ, 1980, NATURE, V287, P447, DOI 10.1038/287447a0; Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581; TRINKAUS E, 1980, J HUM EVOL, V9, P377, DOI 10.1016/0047-2484(80)90049-4; Trombitas K, 1999, BIOPHYS J, V77, P3189, DOI 10.1016/S0006-3495(99)77149-3; Tskhovrebova L, 1997, NATURE, V387, P308, DOI 10.1038/387308a0; Tskhovrebova L, 1997, J MOL BIOL, V265, P100, DOI 10.1006/jmbi.1996.0717; Wang K, 1996, ADV BIOPHYS, V33, P123	30	404	411	2	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 29	2002	418	6901					998	1002		10.1038/nature00938	http://dx.doi.org/10.1038/nature00938			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588AP	12198551				2022-12-24	WOS:000177677500049
J	Wang, XQ; McLachlan, J; Zamore, PD; Hall, TMT				Wang, XQ; McLachlan, J; Zamore, PD; Hall, TMT			Modular recognition of RNA by a human pumilio-homology domain	CELL			English	Article							HUNCHBACK MESSENGER-RNA; SPERM-OOCYTE SWITCH; CAENORHABDITIS-ELEGANS; MOLECULAR REPLACEMENT; DROSOPHILA EMBRYOS; BINDING PROTEIN; NANOS; REGULATOR; SEQUENCE; PROGRAM	Puf proteins are developmental regulators that control mRNA stability and translation by binding sequences in the 3' untranslated regions of their target mRNAs. We have determined the structure of the RNA binding domain of the human Puf protein, Pumilio 1 , bound to a high-affinity RNA ligand. The RNA binds the concave surface of the molecule, where each of the protein's eight repeats makes contacts with a different RNA base via three amino acid side chains at conserved positions. We have mutated these three side chains in one repeat, thereby altering the sequence specificity of Pumilio 1. Thus, the high affinity and specificity of the PUM-HD for RNA is achieved using multiple copies of a simple repeated motif.	NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; Univ Massachusetts, Sch Med, Dept Biochem & Mol Biol, Worcester, MA 01655 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Massachusetts System; University of Massachusetts Worcester	Hall, TMT (corresponding author), NIEHS, Struct Biol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.		Zamore, Phillip D/A-8941-2013; Hall, Traci/F-5849-2019	Hall, Traci/0000-0001-6166-3009; Zamore, Phillip/0000-0002-4505-9618				AHRINGER J, 1991, NATURE, V349, P346, DOI 10.1038/349346a0; Asaoka-Taguchi M, 1999, NAT CELL BIOL, V1, P431, DOI 10.1038/15666; BARKER DD, 1992, GENE DEV, V6, P2312, DOI 10.1101/gad.6.12a.2312; Bateman A, 1999, NUCLEIC ACIDS RES, V27, P260, DOI 10.1093/nar/27.1.260; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Crittenden SL, 2002, NATURE, V417, P660, DOI 10.1038/nature754; Edwards TA, 2001, CELL, V105, P281, DOI 10.1016/S0092-8674(01)00318-X; Forbes A, 1998, DEVELOPMENT, V125, P679; Gamberi C, 2002, DEVELOPMENT, V129, P2699; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kraemer B, 1999, CURR BIOL, V9, P1009, DOI 10.1016/S0960-9822(99)80449-7; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEHMANN R, 1987, NATURE, V329, P167, DOI 10.1038/329167a0; Lin HF, 1997, DEVELOPMENT, V124, P2463; MACDONALD PM, 1992, DEVELOPMENT, V114, P221; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MURATA Y, 1995, CELL, V80, P747, DOI 10.1016/0092-8674(95)90353-4; Nakahata S, 2001, J BIOL CHEM, V276, P20945, DOI 10.1074/jbc.M010528200; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Olivas W, 2000, EMBO J, V19, P6602, DOI 10.1093/emboj/19.23.6602; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sonoda J, 1999, GENE DEV, V13, P2704, DOI 10.1101/gad.13.20.2704; Sonoda J, 2001, GENE DEV, V15, P762, DOI 10.1101/gad.870801; Souza GM, 1999, DEVELOPMENT, V126, P3263; Tadauchi T, 2001, EMBO J, V20, P552, DOI 10.1093/emboj/20.3.552; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wang XQ, 2001, MOL CELL, V7, P855, DOI 10.1016/S1097-2765(01)00229-5; Wharton RP, 1998, MOL CELL, V1, P863, DOI 10.1016/S1097-2765(00)80085-4; White EK, 2001, RNA, V7, P1855; Zamore PD, 1999, BIOCHEMISTRY-US, V38, P596, DOI 10.1021/bi982264s; Zamore PD, 1997, RNA, V3, P1421; Zhang BL, 1997, NATURE, V390, P477, DOI 10.1038/37297	35	389	413	1	40	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 23	2002	110	4					501	512		10.1016/S0092-8674(02)00873-5	http://dx.doi.org/10.1016/S0092-8674(02)00873-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	587QJ	12202039	Bronze			2022-12-24	WOS:000177653200011
J	Zhu, JJ; Qin, Y; Zhao, MM; Van Aelst, L; Malinow, R				Zhu, JJ; Qin, Y; Zhao, MM; Van Aelst, L; Malinow, R			Ras and Rap control AMPA receptor trafficking during synaptic plasticity	CELL			English	Article							LONG-TERM DEPRESSION; PROTEIN-KINASE CASCADE; GLUTAMATE RECEPTORS; MAP KINASE; HIPPOCAMPAL-NEURONS; SIGNALING PATHWAY; STRUCTURAL BASIS; ACTIVATION; MECHANISMS; TRANSMISSION	Recent studies show that AMPA receptor (-R) trafficking is important in synaptic plasticity. However, the signaling controlling this trafficking is poorly understood. Small GTPases have diverse neuronal functions and their perturbation is responsible for several mental disorders. Here, we examine the small GTPases Ras and Rap in the postsynaptic signaling underlying synaptic plasticity. We show that Ras relays the NMDA-R and CaMKII signaling that drives synaptic delivery of AMPA-Rs during long-term potentiation. In contrast, Rap mediates NMDA-R-dependent removal of synaptic AMPA-Rs that occurs during long-term depression. Ras and Rap exert their effects on AMPA-Rs that contain different subunit composition. Thus, Ras and Rap, whose activity can be controlled by postsynaptic enzymes, serve as independent regulators for potentiating and depressing central synapses.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Univ Virginia, Sch Med, Dept Pharmacol, Charlottesville, VA 22908 USA	Cold Spring Harbor Laboratory; University of Virginia	Malinow, R (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	malinow@cshl.org						Antonarakis SE, 1998, NAT GENET, V19, P106, DOI 10.1038/450; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bolshakov VY, 2000, NAT NEUROSCI, V3, P1107, DOI 10.1038/80624; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; Boussiotis VA, 1997, SCIENCE, V278, P124, DOI 10.1126/science.278.5335.124; Brambilla R, 1997, NATURE, V390, P281, DOI 10.1038/36849; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Chelly J, 2001, NAT REV GENET, V2, P669, DOI 10.1038/35088558; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; Comings DE, 1996, PSYCHIAT RES, V63, P25, DOI 10.1016/0165-1781(96)02829-6; COOK SJ, 1993, EMBO J, V12, P3475, DOI 10.1002/j.1460-2075.1993.tb06022.x; Costa RM, 2002, NATURE, V415, P526, DOI 10.1038/nature711; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; DUDEK SM, 1993, J NEUROSCI, V13, P2910; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; Feig LA, 1999, NAT CELL BIOL, V1, pE25, DOI 10.1038/10018; Grewal SS, 2000, J BIOL CHEM, V275, P3722, DOI 10.1074/jbc.275.5.3722; Gutmann DH, 1999, ARCH NEUROL-CHICAGO, V56, P1322, DOI 10.1001/archneur.56.11.1322; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Kawasaki H, 1998, P NATL ACAD SCI USA, V95, P13278, DOI 10.1073/pnas.95.22.13278; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; KIM S, 1990, MOL CELL BIOL, V10, P2645, DOI 10.1128/MCB.10.6.2645; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; KOHLER M, 1994, J BIOL CHEM, V269, P17367; Lee JC, 1999, PHARMACOL THERAPEUT, V82, P389, DOI 10.1016/S0163-7258(99)00008-X; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Lisman J, 1997, SCIENCE, V276, P2001, DOI 10.1126/science.276.5321.2001; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; M'Rabet L, 1998, BLOOD, V92, P2133, DOI 10.1182/blood.V92.6.2133.418k19_2133_2140; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; MALY FE, 1994, J BIOL CHEM, V269, P18743; Mochizuki N, 1999, NATURE, V400, P891, DOI 10.1038/23738; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Noel J, 1999, NEURON, V23, P365, DOI 10.1016/S0896-6273(00)80786-2; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Sawada Y, 2001, J CELL SCI, V114, P1221; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; Sheng M, 2001, CELL, V105, P825, DOI 10.1016/S0092-8674(01)00406-8; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Silva AJ, 1997, NAT GENET, V15, P281, DOI 10.1038/ng0397-281; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tonini R, 1999, EUR J NEUROSCI, V11, P959, DOI 10.1046/j.1460-9568.1999.00504.x; VAN AL, 1993, P NATL ACAD SCI USA, V90, P6213; WHITE MA, 1995, CELL, V80, P533, DOI 10.1016/0092-8674(95)90507-3; Whitmarsh AJ, 1997, MOL CELL BIOL, V17, P2360, DOI 10.1128/MCB.17.5.2360; Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Ye B, 2000, NEURON, V26, P603, DOI 10.1016/S0896-6273(00)81198-8; Yoshimura Y, 2000, MOL BRAIN RES, V81, P118, DOI 10.1016/S0169-328X(00)00170-4; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614; Zwartkruis FJT, 1999, EXP CELL RES, V253, P157, DOI 10.1006/excr.1999.4695	70	594	622	1	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 23	2002	110	4					443	455		10.1016/S0092-8674(02)00897-8	http://dx.doi.org/10.1016/S0092-8674(02)00897-8			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	587QJ	12202034	Bronze			2022-12-24	WOS:000177653200006
J	Deane, GB; Stokes, MD				Deane, GB; Stokes, MD			Scale dependence of bubble creation mechanisms in breaking waves	NATURE			English	Article							AIR ENTRAINMENT; SIZE DISTRIBUTIONS; DISSIPATION; GENERATION; AMBIENT; CLOUDS	Breaking ocean waves entrain air bubbles that enhance air-sea gas flux, produce aerosols, generate ambient noise and scavenge biological surfactants. The size distribution of the entrained bubbles is the most important factor in controlling these processes, but little is known about bubble properties and formation mechanisms inside whitecaps. We have measured bubble size distributions inside breaking waves in the laboratory and in the open ocean, and provide a quantitative description of bubble formation mechanisms in the laboratory. We find two distinct mechanisms controlling the size distribution, depending on bubble size. For bubbles larger than about 1 mm, turbulent fragmentation determines bubble size distribution, resulting in a bubble density proportional to the bubble radius to the power of -10/3. Smaller bubbles are created by jet and drop impact on the wave face, with a -3/2 power-law scaling. The length scale separating these processes is the scale where turbulent fragmentation ceases, also known as the Hinze scale. Our results will have important implications for the study of air-sea gas transfer.	Univ Calif San Diego, Scripps Inst Oceanog, Marine Phys Lab, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography	Deane, GB (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Marine Phys Lab, La Jolla, CA 92093 USA.	grant@mpl.ucsd.edu	Deane, Grant/B-1967-2010					BALDY S, 1993, J GEOPHYS RES-OCEANS, V98, P18277, DOI 10.1029/93JC01627; BEZZABOTNOV VS, 1986, IZV AS USSR ATMOS OC, V22, P922; BONETTO F, 1993, INT J MULTIPHAS FLOW, V19, P281, DOI 10.1016/0301-9322(93)90003-D; BONMARIN P, 1989, J FLUID MECH, V209, P405, DOI 10.1017/S0022112089003162; CLAY PH, 1940, P ROY ACAD SCI AMST, V43, P979; de Leeuw G, 2002, GEOPH MONOG SERIES, V127, P271; Deane GB, 1997, J ACOUST SOC AM, V102, P2671, DOI 10.1121/1.420321; Deane GB, 1999, J PHYS OCEANOGR, V29, P1393, DOI 10.1175/1520-0485(1999)029<1393:AEPABS>2.0.CO;2; Fan L.S., 1990, BUTTER WORTH HEINEMA; FARMER D, 1995, J PHYS OCEANOGR, V25, P1426, DOI 10.1175/1520-0485(1995)025<1426:POBCOB>2.0.CO;2; FARMER DM, 1993, NATURE, V361, P620, DOI 10.1038/361620a0; Garrett C, 2000, J PHYS OCEANOGR, V30, P2163, DOI 10.1175/1520-0485(2000)030<2163:TCBBSS>2.0.CO;2; HINZE JO, 1955, AICHE J, V1, P289, DOI 10.1002/aic.690010303; HWANG PA, 1990, J PHYS OCEANOGR, V20, P19, DOI 10.1175/1520-0485(1990)020<0019:ABPBBW>2.0.CO;2; KOGA M, 1982, TELLUS, V34, P481, DOI 10.1111/j.2153-3490.1982.tb01836.x; KOLMOGOROV AN, 1949, DOKL AKAD NAUK SSSR+, V66, P825; LAMARRE E, 1991, NATURE, V351, P469, DOI 10.1038/351469a0; Leighton T.G., 1994, ACOUSTIC BUBBLE, DOI DOI 10.1121/1.410082; LEWIS DA, 1982, T I CHEM ENG-LOND, V60, P283; Loewen MR, 1996, J GEOPHYS RES-OCEANS, V101, P20759, DOI 10.1029/96JC01919; LOEWEN MR, 1994, J ACOUST SOC AM, V95, P1329, DOI 10.1121/1.408573; LOEWEN MR, 1991, J FLUID MECH, V224, P601, DOI 10.1017/S0022112091001891; LOEWEN MR, 1995, 3 INT S AIR WAT GAS, P337; LONGUETHIGGINS MS, 1992, P ROY SOC LOND A MAT, V439, P611, DOI 10.1098/rspa.1992.0171; Martinez-Bazan C, 1999, J FLUID MECH, V401, P157, DOI 10.1017/S0022112099006680; MEDWIN H, 1989, J GEOPHYS RES-OCEANS, V94, P12751, DOI 10.1029/JC094iC09p12751; Melville WK, 1996, ANNU REV FLUID MECH, V28, P279, DOI 10.1146/annurev.fl.28.010196.001431; Minnaert M, 1933, PHILOS MAG, V16, P235; MONAHAN EC, 1990, IEEE J OCEANIC ENG, V15, P340, DOI 10.1109/48.103530; PUMPHREY HC, 1990, J FLUID MECH, V220, P539, DOI 10.1017/S0022112090003378; Stokes D, 2002, GEOPH MONOG SERIES, V127, P279; Stokes MD, 1999, IEEE J OCEANIC ENG, V24, P300, DOI 10.1109/48.775292; THORPE SA, 1984, J FLUID MECH, V142, P151, DOI 10.1017/S0022112084001038; THORPE SA, 1992, Q J ROY METEOR SOC, V118, P1, DOI 10.1002/qj.49711850302; THORPE SA, 1992, J PHYS OCEANOGR, V22, P382, DOI 10.1175/1520-0485(1992)022<0382:SFATSD>2.0.CO;2; VANDESANDE E, 1976, CHEM ENG SCI, V31, P219, DOI 10.1016/0009-2509(76)85060-9; WALLACE DWR, 1992, NATURE, V356, P694, DOI 10.1038/356694a0	37	382	393	9	125	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 22	2002	418	6900					839	844		10.1038/nature00967	http://dx.doi.org/10.1038/nature00967			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585YR	12192401				2022-12-24	WOS:000177555600029
J	Bhalla, US; Ram, PT; Iyengar, R				Bhalla, US; Ram, PT; Iyengar, R			MAP kinase phosphatase as a locus of flexibility in a mitogen-activated protein kinase signaling network	SCIENCE			English	Article							PHOSPHORYLATION; RAF-1; GENE; ACID; 2A	Intracellular signaling networks receive and process information to control cellular machines. The mitogen-activated protein kinase (MAPK) 1,2/protein kinase C (PKC) system is one such network that regulates many cellular machines, including the cell cycle machinery and autocrine/paracrine factor synthesizing machinery. We used a combination of computational analysis and experiments in mouse NIH-3T3 fibroblasts to understand the design principles of this controller network. We find that the growth factor stimulated signaling network containing MAPK 1,2/PKC can operate with one (monostable) or two (bistable) stable states. At low concentrations of MAPK phosphatase, the system exhibits bistable behavior, such that brief stimulus results in sustained MAPK activation. The MAPK-induced increase in the amounts of MAPK phosphatase eliminates the prolonged response capability and moves the network to a monostable state, in which it behaves as a proportional response system responding acutely to stimulus. Thus, the MAPK 1,2/PKC controller network is flexibly designed, and MAPK phosphatase may be critical for this flexible response.	Natl Ctr Biol Sci, Bangalore 560065, Karnataka, India; Mt Sinai Sch Med, Dept Pharmacol & Biol Chem, New York, NY 10029 USA	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Icahn School of Medicine at Mount Sinai	Bhalla, US (corresponding author), Natl Ctr Biol Sci, Bangalore 560065, Karnataka, India.			Ram, Prahlad/0000-0003-4739-3166	NCI NIH HHS [CA-79134, CA-81050] Funding Source: Medline; NIGMS NIH HHS [GM-54508] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA081050, F32CA079134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054508] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALESSI DR, 1995, CURR BIOL, V5, P283, DOI 10.1016/S0960-9822(95)00059-5; Baharians Z, 1998, J BIOL CHEM, V273, P19019, DOI 10.1074/jbc.273.30.19019; Bhalla US, 2001, CHAOS, V11, P221, DOI 10.1063/1.1350440; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; BHALLA US, 1998, BOOK GENESIS EXPLORI, pCH10; Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; BRAY D, 1995, NATURE, V376, P307, DOI 10.1038/376307a0; Brondello JM, 1999, SCIENCE, V286, P2514, DOI 10.1126/science.286.5449.2514; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; DENT P, 1995, SCIENCE, V268, P1902, DOI 10.1126/science.7604263; Dorfman K, 1996, ONCOGENE, V13, P925; GOMEZ N, 1991, NATURE, V353, P170, DOI 10.1038/353170a0; Hemesath TJ, 1998, NATURE, V391, P298, DOI 10.1038/34681; Jordan JD, 2000, CELL, V103, P193, DOI 10.1016/S0092-8674(00)00112-4; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; NEMENOFF RA, 1993, J BIOL CHEM, V268, P1960; NISHIBE S, 1990, SCIENCE, V250, P1253, DOI 10.1126/science.1700866; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; SHEARMAN MS, 1989, FEBS LETT, V243, P177, DOI 10.1016/0014-5793(89)80125-5; SHINOMURA T, 1991, P NATL ACAD SCI USA, V88, P5149, DOI 10.1073/pnas.88.12.5149; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; Weng GZ, 1999, SCIENCE, V284, P92, DOI 10.1126/science.284.5411.92; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O	24	483	496	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 9	2002	297	5583					1018	1023		10.1126/science.1068873	http://dx.doi.org/10.1126/science.1068873			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581ZN	12169734				2022-12-24	WOS:000177325400046
J	Nykypanchuk, D; Strey, HH; Hoagland, DA				Nykypanchuk, D; Strey, HH; Hoagland, DA			Brownian motion of DNA confined within a two-dimensional array	SCIENCE			English	Article							POLYMER-CHAIN; DIFFUSION; ELECTROPHORESIS; MACROMOLECULES; REPTATION; DYNAMICS; GELS; MEMBRANES; MOLECULES; VOIDS	Linear DNA molecules are visualized while undergoing Brownian motion inside media patterned with molecular-sized spatial constraints. The media, prepared by colloidal templating, trap the macromolecules within a two-dimensional array of spherical cavities interconnected by circular holes. Across a broad DNA size range, diffusion does not proceed by the familiar mechanisms of reptation or sieving. Rather, because of their inherent flexibility, DNA molecules strongly localize in cavities and only sporadically jump through holes. Jumping closely follows Poisson statistics. By reducing DNA's configurational freedom, the holes act as molecular weight dependent entropic barriers. Sterically constrained macromolecular diffusion underlies many separation methods and assumes an important role in intracellular and extracellular transport.	Univ Massachusetts, Dept Polymer Sci & Engn, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Strey, HH (corresponding author), Univ Massachusetts, Dept Polymer Sci & Engn, Amherst, MA 01003 USA.	strey@mail.pse.umass.edu; dah@neurotica.pse.umass.edu	Strey, Helmut/B-5456-2009	Strey, Helmut/0000-0002-6554-5322				Akerman B, 1996, PHYS REV E, V54, P6685, DOI 10.1103/PhysRevE.54.6685; Chou CF, 1999, P NATL ACAD SCI USA, V96, P13762, DOI 10.1073/pnas.96.24.13762; DEGENNES PG, 1971, J CHEM PHYS, V55, P572, DOI 10.1063/1.1675789; DEGENNES PG, 1979, SCALING CONCEPTS PO, P193; DOI M, 1978, J CHEM SOC FARAD T 2, V74, P1789, DOI 10.1039/f29787401789; Einstein A, 1908, Z ELKTROCHEM ANGEW P, V14, P235, DOI 10.1002/bbpc.19080141703; Einstein A, 1905, ANN PHYS-BERLIN, V17, P549, DOI 10.1002/andp.19053220806; GUILLOT G, 1985, MACROMOLECULES, V18, P2531, DOI 10.1021/ma00154a030; Han J, 1999, PHYS REV LETT, V83, P1688, DOI 10.1103/PhysRevLett.83.1688; HAUS JW, 1987, PHYS REP, V150, P263, DOI 10.1016/0370-1573(87)90005-6; HOUSEAL TW, 1989, BIOPHYS J, V56, P507, DOI 10.1016/S0006-3495(89)82697-9; Jiang P, 1999, J AM CHEM SOC, V121, P11630, DOI 10.1021/ja9903476; KAS J, 1994, NATURE, V368, P226, DOI 10.1038/368226a0; Liu L, 1999, NATURE, V397, P141, DOI 10.1038/16426; LODGE TP, 1990, ADV CHEM PHYS, V79, P1; Masaro L, 1999, PROG POLYM SCI, V24, P731, DOI 10.1016/S0079-6700(99)00016-7; MATSUMOTO M, 1992, J POLYM SCI POL PHYS, V30, P779, DOI 10.1002/polb.1992.090300716; Meistermann L, 2000, PHYS REV E, V62, P4014, DOI 10.1103/PhysRevE.62.4014; MUTHUKUMAR M, 1989, MACROMOLECULES, V22, P1941, DOI 10.1021/ma00194a071; MUTHUKUMAR M, 1989, MACROMOLECULES, V22, P1937, DOI 10.1021/ma00194a070; OGSTON AG, 1958, T FARADAY SOC, V54, P1754, DOI 10.1039/tf9585401754; Park SH, 1998, CHEM MATER, V10, P1745, DOI 10.1021/cm9801993; PERKINS TT, 1994, SCIENCE, V264, P819, DOI 10.1126/science.8171335; Slater GW, 1996, METHOD ENZYMOL, V270, P272; SMISEK DL, 1990, SCIENCE, V248, P1221, DOI 10.1126/science.2349481; Smith DE, 1996, MACROMOLECULES, V29, P1372, DOI 10.1021/ma951455p; Turner SWP, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.128103; Velikov KP, 2002, SCIENCE, V296, P106, DOI 10.1126/science.1067141; VOLKMUTH WD, 1992, NATURE, V358, P600, DOI 10.1038/358600a0; ZIMM BH, 1993, MACROMOLECULES, V26, P226, DOI 10.1021/ma00053a035	30	120	126	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 9	2002	297	5583					987	990		10.1126/science.1073277	http://dx.doi.org/10.1126/science.1073277			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581ZN	12169727				2022-12-24	WOS:000177325400037
J	Okkenhaug, K; Bilancio, A; Farjot, G; Priddle, H; Sancho, S; Peskett, E; Pearce, W; Meek, SE; Salpekar, A; Waterfield, MD; Smith, AJH; Vanhaesebroeck, B				Okkenhaug, K; Bilancio, A; Farjot, G; Priddle, H; Sancho, S; Peskett, E; Pearce, W; Meek, SE; Salpekar, A; Waterfield, MD; Smith, AJH; Vanhaesebroeck, B			Impaired B and T cell antigen receptor signaling in p110 delta PI 3-kinase mutant mice	SCIENCE			English	Article							PHOSPHOINOSITIDE 3-KINASE P85-ALPHA; P110 DELTA; SUBUNIT; THYMOCYTES; LEUKOCYTES; DELETION; IMMUNITY; KINASES; ABSENCE	Class IA phosphoinositide 3-kinases (PI3Ks) are a family of p85/p110 heterodimeric lipid kinases that generate second messenger signals downstream of tyrosine kinases, thereby controlling cell metabolism, growth, proliferation, differentiation, motility, and survival. Mammals express three class IA catalytic subunits: p110alpha, p110beta, and p110delta. It is unclear to what extent these p110 isoforms have overlapping or distinct biological roles. Mice expressing a catalytically inactive form of p110delta (p110delta(D910A)) were generated by gene targeting. Antigen receptor signaling in B and T cells was impaired and immune responses in vivo were attenuated in p110delta mutant mice. They also developed inflammatory bowel disease. These results reveal a selective role for p110delta in immunity.	Ludwig Inst Canc Res, London W1W 7BS, England; Univ Edinburgh, Ctr Genome Res, Gene Targeting Lab, Edinburgh EH9 3JQ, Midlothian, Scotland; Frimorfo, CH-1705 Fribourg, Switzerland; UCL, Dept Biochem & Mol Biol, London WC1E 6BT, England	Ludwig Institute for Cancer Research; University of Edinburgh; University of London; University College London	Vanhaesebroeck, B (corresponding author), Ludwig Inst Canc Res, 91 Riding House St, London W1W 7BS, England.	bartvanh@ludwig.ucl.ac.uk	Okkenhaug, Klaus/H-3154-2019; Okkenhaug, Klaus/D-5149-2012	Okkenhaug, Klaus/0000-0002-9432-4051; Okkenhaug, Klaus/0000-0002-9432-4051; Pearce, Wayne/0000-0001-5407-4767; Peskett, Emma/0000-0002-0978-5401; BILANCIO, Antonio/0000-0002-5118-3359				Bi L, 1999, J BIOL CHEM, V274, P10963, DOI 10.1074/jbc.274.16.10963; Chantry D, 1997, J BIOL CHEM, V272, P19236, DOI 10.1074/jbc.272.31.19236; Cho JH, 2000, HUM MOL GENET, V9, P1425, DOI 10.1093/hmg/9.9.1425; Duckworth BC, 1997, J BIOL CHEM, V272, P27665, DOI 10.1074/jbc.272.44.27665; Ebert PJR, 2000, J IMMUNOL, V165, P5435, DOI 10.4049/jimmunol.165.10.5435; Fruman DA, 2002, SEMIN IMMUNOL, V14, P7, DOI 10.1006/smim.2001.0337; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; Lu-Kuo JM, 2000, J BIOL CHEM, V275, P6022, DOI 10.1074/jbc.275.8.6022; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Okkenhaug K, 2001, NAT IMMUNOL, V2, P325, DOI 10.1038/86327; OKKENHAUG K, 2001, SCI STKE; Sasaki T, 2002, J BIOCHEM, V131, P495, DOI 10.1093/oxfordjournals.jbchem.a003126; Scharenberg AM, 1998, CELL, V94, P5, DOI 10.1016/S0092-8674(00)81214-3; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Seki N, 1997, DNA Res, V4, P355, DOI 10.1093/dnares/4.5.355; Sprent J, 2002, ANNU REV IMMUNOL, V20, P551, DOI 10.1146/annurev.immunol.20.100101.151926; Suzuki A, 2001, IMMUNITY, V14, P523, DOI 10.1016/S1074-7613(01)00134-0; Suzuki H, 1999, SCIENCE, V283, P390, DOI 10.1126/science.283.5400.390; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Vanhaesebroeck B, 1999, NAT CELL BIOL, V1, P69, DOI 10.1038/9045; Vanhaesebroeck B, 1997, P NATL ACAD SCI USA, V94, P4330, DOI 10.1073/pnas.94.9.4330; Vanhaesebroeck B, 1999, EMBO J, V18, P1292, DOI 10.1093/emboj/18.5.1292; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680	25	767	855	2	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 9	2002	297	5583					1031	1034						5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581ZN	12130661				2022-12-24	WOS:000177325400049
J	Kato, Y; Habas, R; Katsuyama, Y; Naar, AM; He, X				Kato, Y; Habas, R; Katsuyama, Y; Naar, AM; He, X			A component of the ARC/mediator complex required for TGF beta/Nodal signalling	NATURE			English	Article							TRANSCRIPTIONAL REGULATION; DROSOPHILA HOMOLOGS; MEDIATOR COMPLEX; COFACTOR COMPLEX; BETA SIGNALS; COACTIVATOR; PROTEIN; INDUCTION; SMADS; GENE	The transforming growth factor beta (TGFbeta) family of cytokines, including Nodal, Activin and bone morphogenetic protein (BMP), have essential roles in development and tumorigenesis(1,2). TGFbeta molecules activate the Smad family of signal transducers, which form complexes with specific DNA-binding proteins to regulate gene expression(1,2). Two discrete Smad-dependent signalling pathways have been identified: TGFbeta, Activin and Nodal signal via the Smad2 (or Smad3)-Smad4 complex, whereas BMP signals via the Smad1-Smad4 complex(1,2). How distinct Smad complexes regulate specific gene expression is not fully understood. Here we show that ARC105, a component of the activator-recruited co-factor (ARC)(3) complex or the metazoan Mediator complex, is essential for TGFbeta/Activin/Nodal/Smad2/3 signal transduction. Expression of ARC105 stimulates Activin/Nodal/Smad2 signalling in Xenopus laevis embryos, inducing axis duplication and mesendoderm differentiation, and enhances TGFbeta response in human cells. Depletion of ARC105 inhibits TGFbeta/Activin/Nodal/Smad2/3 signalling and Xenopus axis formation, but not BMP/Smad1 signalling. ARC105 protein binds to Smad2/3-Smad4 in response to TGFbeta and is recruited to Activin/Nodal-responsive promoters in chromatin in a Smad2-dependent fashion. Thus ARC105 is a specific and key ARC/Mediator component linking TGFbeta/Activin/Nodal/Smad2/3 signalling to transcriptional activation.	Harvard Univ, Sch Med, Childrens Hosp, Dept Neurol,Div Neurosci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Canc Ctr,Dept Cell Biol, Charlestown, MA 02129 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Massachusetts General Hospital	He, X (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, Dept Neurol,Div Neurosci, Boston, MA 02115 USA.							Abraham S, 2000, GENE, V255, P389, DOI 10.1016/S0378-1119(00)00292-4; Bai RY, 2002, NAT CELL BIOL, V4, P181, DOI 10.1038/ncb753; Berti L, 2001, GENOMICS, V74, P320, DOI 10.1006/geno.2001.6566; Boube M, 2000, GENE DEV, V14, P2906, DOI 10.1101/gad.17900; Boyer TG, 1999, NATURE, V399, P276, DOI 10.1038/20466; Candia AF, 1997, DEVELOPMENT, V124, P4467; CHEN WH, 1989, COMPUT MECH, V4, P1; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fondell JD, 1996, P NATL ACAD SCI USA, V93, P8329, DOI 10.1073/pnas.93.16.8329; Gu W, 1999, MOL CELL, V3, P97, DOI 10.1016/S1097-2765(00)80178-1; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; HEMMATIBRIVANLOU A, 1992, NATURE, V359, P609, DOI 10.1038/359609a0; Hsu DR, 1998, MOL CELL, V1, P673, DOI 10.1016/S1097-2765(00)80067-2; Jiang YW, 1998, P NATL ACAD SCI USA, V95, P8538, DOI 10.1073/pnas.95.15.8538; Kato Y, 1999, J NEUROSCI, V19, P9364; Malik S, 2000, MOL CELL, V5, P753, DOI 10.1016/S1097-2765(00)80254-3; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Naar AM, 1999, NATURE, V398, P828, DOI 10.1038/19789; Naar AM, 2001, ANNU REV BIOCHEM, V70, P475, DOI 10.1146/annurev.biochem.70.1.475; Rachez C, 1999, NATURE, V398, P824, DOI 10.1038/19783; Rachez C, 2001, CURR OPIN CELL BIOL, V13, P274, DOI 10.1016/S0955-0674(00)00209-X; Ryu SJ, 1999, NATURE, V397, P446, DOI 10.1038/17141; Sachs LM, 2000, P NATL ACAD SCI USA, V97, P13138, DOI 10.1073/pnas.260141297; Shimizu K, 2001, MOL CELL BIOL, V21, P3901, DOI 10.1128/MCB.21.12.3901-3912.2001; SINGH N, 1995, GENE DEV, V9, P2251, DOI 10.1101/gad.9.18.2251; Stroschein SL, 1999, SCIENCE, V286, P771, DOI 10.1126/science.286.5440.771; Treisman JE, 2001, DEVELOPMENT, V128, P603; Whitman M, 1998, GENE DEV, V12, P2445, DOI 10.1101/gad.12.16.2445; Yeo CY, 1999, J BIOL CHEM, V274, P26584, DOI 10.1074/jbc.274.37.26584; Zhang H, 2000, GENE DEV, V14, P2161, DOI 10.1101/gad.814700	30	128	140	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 8	2002	418	6898					641	646		10.1038/nature00969	http://dx.doi.org/10.1038/nature00969			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581RA	12167862				2022-12-24	WOS:000177305600043
J	Mayou, R; Farmer, A				Mayou, R; Farmer, A			ABC of psychological medicine - Functional somatic symptoms and syndromes	BRITISH MEDICAL JOURNAL			English	Review									Univ Oxford, Warneford Hosp, Oxford OX1 2JD, England; Univ Oxford, Dept Publ Hlth & Primary Care, Oxford OX1 2JD, England	University of Oxford; University of Oxford	Mayou, R (corresponding author), Univ Oxford, Warneford Hosp, Oxford OX1 2JD, England.							Clark DM, 1998, BRIT J PSYCHIAT, V173, P218, DOI 10.1192/bjp.173.3.218; Kisely S, 1997, PSYCHOL MED, V27, P1011, DOI 10.1017/S0033291797005485; KROENKE K, 1989, AM J MED, V86, P262, DOI 10.1016/0002-9343(89)90293-3; Mayou R, 1995, TREATMENT FUNCTIONAL; Wessely S, 1999, LANCET, V354, P936, DOI 10.1016/S0140-6736(98)08320-2	5	106	106	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 3	2002	325	7358					265	268		10.1136/bmj.325.7358.265	http://dx.doi.org/10.1136/bmj.325.7358.265			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582FL	12153926	Green Published			2022-12-24	WOS:000177339000025
J	Bachman, ES; Dhillon, H; Zhang, CY; Cinti, S; Bianco, AC; Kobilka, BK; Lowell, BB				Bachman, ES; Dhillon, H; Zhang, CY; Cinti, S; Bianco, AC; Kobilka, BK; Lowell, BB			beta AR signaling required for diet-induced thermogenesis and obesity resistance	SCIENCE			English	Article							BROWN ADIPOSE-TISSUE; TYPE-2 IODOTHYRONINE DEIODINASE; MICE LACKING; ADAPTIVE THERMOGENESIS; NEONATAL SYMPATHECTOMY; UNCOUPLING PROTEIN; BODY-COMPOSITION; SUSCEPTIBILITY; NORADRENALINE; DISRUPTION	Excessive caloric intake is thought to be sensed by the brain, which then activates thermogenesis as a means of preventing obesity. The sympathetic nervous system, through beta-adrenergic receptor (betaAR) action on target tissues, is likely the efferent arm of this homeostatic mechanism. To test this hypothesis, we created mice that lack the three known betaARs (beta-less mice). beta-less mice on a Chow diet had a reduced metabolic rate and were slightly obese. On a high-fat diet, beta-less mice, in contrast to wild-type mice, developed massive obesity that was due entirely to a failure of diet-induced thermogenesis. These findings establish that betaARs are necessary for diet-induced thermogenesis and that this efferent pathway plays a critical role in the body's defense against diet-induced obesity.	Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; Univ Ancona, Fac Med, Inst Normal Human Morphol, I-60020 Ancona, Italy; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Thyroid Div, Boston, MA 02215 USA; Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Howard Hughes Med Inst, Stanford, CA 94305 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Marche Polytechnic University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Stanford University	Lowell, BB (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol, 99 Brookline Ave, Boston, MA 02215 USA.		Bianco, Antonio C/A-4965-2008; Bianco, Antonio/AAK-6336-2020	Bianco, Antonio C/0000-0001-7737-6813; Bianco, Antonio/0000-0001-7737-6813; CINTI, Saverio/0000-0003-0362-5017; Kobilka, Brian/0000-0001-5958-3990				BACHMAN ES, UNPUB; Bronnikov G, 1999, ENDOCRINOLOGY, V140, P4185, DOI 10.1210/en.140.9.4185; CARRVALHO SD, 1996, ENDOCRINOLOGY, V137, P5519; Cinti S, 1997, ENDOCRINOLOGY, V138, P797, DOI 10.1210/en.138.2.797; Collins S, 2001, RECENT PROG HORM RES, V56, P309, DOI 10.1210/rp.56.1.309; Curcio C, 2001, J BIOL CHEM, V276, P30183, DOI 10.1074/jbc.C100325200; de Jesus LA, 2001, J CLIN INVEST, V108, P1379, DOI 10.1172/JCI200113803; DESAUTELS M, 1991, CAN J PHYSIOL PHARM, V69, P1868, DOI 10.1139/y91-276; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Golozoubova V, 2001, FASEB J, V15, P2048, DOI 10.1096/fj.00-0536fje; Hamann A, 1996, ENDOCRINOLOGY, V137, P21, DOI 10.1210/en.137.1.21; HIMMSHAGEN J, 1990, FASEB J, V4, P2890, DOI 10.1096/fasebj.4.11.2199286; LANDSBERG L, 1984, AM J PHYSIOL, V247, pE181, DOI 10.1152/ajpendo.1984.247.2.E181; LEVIN BE, 1984, AM J PHYSIOL, V247, pR979, DOI 10.1152/ajpregu.1984.247.6.R979; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Revelli JP, 1997, J CLIN INVEST, V100, P1098, DOI 10.1172/JCI119620; Rohrer DK, 1999, J BIOL CHEM, V274, P16701, DOI 10.1074/jbc.274.24.16701; ROTHWELL NJ, 1979, NATURE, V281, P31, DOI 10.1038/281031a0; ROTHWELL NJ, 1984, J PHYSIOL-LONDON, V355, P457, DOI 10.1113/jphysiol.1984.sp015431; Schoeller DA, 2001, AM J CLIN NUTR, V73, P511; SUSULIC VS, 1995, J BIOL CHEM, V270, P29483, DOI 10.1074/jbc.270.49.29483; Thomas SA, 1997, NATURE, V387, P94, DOI 10.1038/387094a0; TORDOFF MG, 1985, PHYSIOL BEHAV, V35, P455, DOI 10.1016/0031-9384(85)90323-3; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6	25	587	603	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 2	2002	297	5582					843	845		10.1126/science.1073160	http://dx.doi.org/10.1126/science.1073160			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579RZ	12161655				2022-12-24	WOS:000177192800053
J	Schillinger, D; Grumbach, K; Piette, J; Wang, F; Osmond, D; Daher, C; Palacios, J; Sullivan, GD; Bindman, AB				Schillinger, D; Grumbach, K; Piette, J; Wang, F; Osmond, D; Daher, C; Palacios, J; Sullivan, GD; Bindman, AB			Association of health literacy with diabetes outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NON-HISPANIC WHITES; MEXICAN-AMERICANS; GLYCEMIC CONTROL; CARE; KNOWLEDGE; RETINOPATHY; SKILLS; DEPRESSION; MANAGEMENT; ADHERENCE	Context Health literacy is a measure of patients' ability to read, comprehend, and act on medical instructions. Poor health literacy is common among racial and ethnic minorities, elderly persons, and patients with chronic conditions, particularly in public-sector settings. Little is known about the extent to which health literacy affects clinical health outcomes. Objectives To examine the association between health literacy and diabetes outcomes among patients with type 2 diabetes. Design, Setting, and Participants Cross-sectional observational study of 408 English- and Spanish-speaking patients who were older than 30 years and had type 2 diabetes identified from the clinical database of 2 primary care clinics of a University-affiliated public hospital in San Francisco, Calif. Participants were enrolled and completed questionnaires between June and December 2000. We assessed patients' health literacy by using the short-form Test of Functional Health Literacy in Adults (s-TOFHLA) in English or Spanish Main Outcome Measures Most recent hemoglobin A(1c) (HbA(1c)) level. Patients were classified as having tight glycemic control if their HbA(1c) was in the lowest quartile and poor control if it was in the highest quartile. We also measured the presence of self-reported diabetes complications. Results After adjusting for patients' sociodemographic characteristics, depressive symptoms, social support, treatment regimen, and years with diabetes, for each 1-point decrement in s-TOFHLA score, the HbA(1c), value increased by 0.02 (P=.02). Patients with inadequate health literacy were less likely than patients with adequate health literacy to achieve tight glycemic control (HbA(1c) less than or equal to 7.2%; adjusted odds ratio [OR], 0.57; 95% confidence interval [CI], 0.32-1.00; P=.05) and were more likely to have poor glycemic control (HbA(1c) greater than or equal to9.5%; adjusted OR, 2.03; 95% Cl, 1.11-3.73; P=.02) and to report having retinopathy (adjusted OR, 2.33; 95% Cl, 1.19-4.57; P=.01). Conclusions Among primary care patients with type 2 diabetes, inadequate health literacy is independently associated with worse glycemic control and higher rates of retinopathy. Inadequate health literacy may contribute to the disproportionate burden of diabetes-related problems among disadvantaged populations. Efforts should focus on developing and evaluating interventions to improve diabetes outcomes among patients with inadequate health literacy.	Univ Calif San Francisco, San Francisco Gen Hosp, Primary Care Res Ctr, Dept Med, San Francisco, CA 94110 USA; Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA; VA Ann Arbor Hlth Care Syst, Ctr Practice Management & Outcomes Res, Ann Arbor, MI USA; Univ Michigan, Sch Med, Ann Arbor, MI USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan	Schillinger, D (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Primary Care Res Ctr, Dept Med, San Francisco, CA 94110 USA.		Grumbach, Kevin/L-9222-2016		AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [P01HS010856] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000084] Funding Source: NIH RePORTER; AHRQ HHS [P01HS/10856] Funding Source: Medline; NCRR NIH HHS [M01-RR00084-30] Funding Source: Medline; PHS HHS [DII 99187-1] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Anderson RM, 2000, DIABETES EDUCATOR, V26, P597, DOI 10.1177/014572170002600405; ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; Baker DW, 1998, J GEN INTERN MED, V13, P791, DOI 10.1046/j.1525-1497.1998.00242.x; Baker DW, 1999, PATIENT EDUC COUNS, V38, P33, DOI 10.1016/S0738-3991(98)00116-5; Baker DW, 1997, AM J PUBLIC HEALTH, V87, P1027, DOI 10.2105/AJPH.87.6.1027; BILD DE, 1989, DIABETES CARE, V12, P24, DOI 10.2337/diacare.12.1.24; Burton P, 1998, STAT MED, V17, P1261, DOI 10.1002/(SICI)1097-0258(19980615)17:11<1261::AID-SIM846>3.0.CO;2-Z; *CDCP, 2000, NAT DIAB FACT SHEET; Centers for Disease Control and Prevention, 2001, MMWR MORB MORTAL WKL, V50, P1; COWIE CC, 1989, NEW ENGL J MED, V321, P1074, DOI 10.1056/NEJM198910193211603; COWIE CC, 1995, PUBLICATION, P85; Doak CC, 1998, CA-CANCER J CLIN, V48, P151, DOI 10.3322/canjclin.48.3.151; Doak CC, 1996, TEACHING PATIENTS LO; El-Kebbi IM, 2001, ARCH INTERN MED, V161, P1295, DOI 10.1001/archinte.161.10.1295; Elasy TA, 2001, PATIENT EDUC COUNS, V43, P121, DOI 10.1016/S0738-3991(00)00150-6; Fisher L, 1998, DIABETES EDUCATOR, V24, P599, DOI 10.1177/014572179802400504; Fitzgerald JT, 1996, EVAL HEALTH PROF, V19, P208, DOI 10.1177/016327879601900205; FLEGAL KM, 1991, DIABETES CARE, V14, P628, DOI 10.2337/diacare.14.7.628; Fleming BB, 2001, DIABETES CARE, V24, P1815, DOI 10.2337/diacare.24.10.1815; Gazmararian JA, 1999, JAMA-J AM MED ASSOC, V281, P545, DOI 10.1001/jama.281.6.545; Glasgow RE, 1997, DIABETES CARE, V20, P556, DOI 10.2337/diacare.20.4.556; Gunning Robert, 1968, TECHNIQUE CLEAR WRIT; Hadden W C, 1987, Vital Health Stat 11, P1; HAFFNER SM, 1988, DIABETES, V37, P878, DOI 10.2337/diabetes.37.7.878; Harris MI, 1998, DIABETES CARE, V21, P1230, DOI 10.2337/diacare.21.8.1230; Harris MI, 2000, DIABETES CARE, V23, P754, DOI 10.2337/diacare.23.6.754; HARRIS MI, 1995, PUBLICATION; Kalichman SC, 1999, J GEN INTERN MED, V14, P267, DOI 10.1046/j.1525-1497.1999.00334.x; Kalichman SC, 2000, AM J PREV MED, V18, P325, DOI 10.1016/S0749-3797(00)00121-5; Kalichman SC, 2000, J ACQ IMMUN DEF SYND, V25, P337, DOI 10.1097/00126334-200012010-00007; KLEIN R, 1994, ARCH OPHTHALMOL-CHIC, V112, P1217, DOI 10.1001/archopht.1994.01090210105023; Lavery LA, 1996, DIABETES CARE, V19, P48, DOI 10.2337/diacare.19.1.48; LEAHY JL, 2000, MED MANAGEMENT DIABE; Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934; Mayeaux EJ, 1996, AM FAM PHYSICIAN, V53, P205; McCulloch DK, 2000, DIS MANAG, V3, P75; *MI DIAB RES TRAIN, 2002, SURV INSTR; PARKER RM, 1995, J GEN INTERN MED, V10, P537, DOI 10.1007/BF02640361; Parker RM, 1999, JAMA-J AM MED ASSOC, V281, P552; Schillinger D, 2001, DIS MANAGE, V4, P103; SCHILLINGER D, IN PRESS ARCH INTERN; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Taylor WL, 1953, JOURNALISM QUART, V30, P415, DOI 10.1177/107769905303000401; TULL ES, 1995, PUB NIH, P613; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; U.S. Department of Health and Human Services, 2002, HLTH PEOPL 2010; *US DEP HHS, 2001, HLTH PEOPL 2010 UND; Von Korff M, 1997, ANN INTERN MED, V127, P1097, DOI 10.7326/0003-4819-127-12-199712150-00008; Wagner EH, 2001, JAMA-J AM MED ASSOC, V285, P182, DOI 10.1001/jama.285.2.182; Weiss B D, 1992, J Am Board Fam Pract, V5, P257; Williams M, 1995, ACAD EMERG MED, V2, P386; WILLIAMS MV, 1995, JAMA-J AM MED ASSOC, V274, P1677; Williams MV, 1998, CHEST, V114, P1008, DOI 10.1378/chest.114.4.1008; Williams MV, 1998, ARCH INTERN MED, V158, P166, DOI 10.1001/archinte.158.2.166	54	1137	1157	4	143	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 24	2002	288	4					475	482		10.1001/jama.288.4.475	http://dx.doi.org/10.1001/jama.288.4.475			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	575NZ	12132978	Bronze			2022-12-24	WOS:000176955400030
J	Zitter, JN; Mazonson, PD; Miller, DP; Hulley, SB; Balmes, JR				Zitter, JN; Mazonson, PD; Miller, DP; Hulley, SB; Balmes, JR			Aircraft cabin air recirculation and symptoms of the common cold	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LONG AIRPLANE FLIGHT; MYCOBACTERIUM-TUBERCULOSIS; TRANSMISSION; RISK	Context In recent years, new commercial aircraft have been designed to recirculate approximately 50% of the cabin air to increase fuel efficiency. Some older aircraft use only fresh air. Whether air recirculation increases the transmission of infectious disease is unknown; some studies have demonstrated higher rates of the common cold among persons working in buildings that recirculate air. Objective To evaluate the role of air recirculation as a predictor of postflight upper respiratory tract infections (URIs). Design, Setting, and Participants A natural experiment conducted among 1100 passengers departing the San Francisco Bay area in California and traveling to Denver, Colo, during January through early April 1999, and who completed a questionnaire in the boarding area and a follow-up telephone interview 5 to 7 days later. Forty-seven percent traveled aboard airplanes using 100% fresh air for ventilation, and 53% traveled aboard aircraft that recirculated cabin air. Main Outcome Measure Incidence of reporting new URI symptoms within 1 week of the flight. Results Passengers on airplanes that did and did not recirculate air had similar rates of postflight respiratory symptoms. The rates of reporting a cold were 19% vs 21% (P=34); a runny nose and a cold, 10% vs 11%, (P=70); and an aggregation of 8 URI symptoms 3% in both groups (P>.99). Results were similar after statistical adjustment for potential confounders. Conclusion We found no evidence that aircraft cabin air recirculation increases the risk for URI symptoms in passengers traveling aboard commercial jets.	Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Lewin Grp, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Zitter, JN (corresponding author), Univ Calif San Francisco, Dept Med, Box 0843, San Francisco, CA 94143 USA.	nutik@itsa.ucsf.edu	Balmes, John/L-6281-2019	Miller, Dave/0000-0003-2947-152X	NHLBI NIH HHS [HL07185] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 1995, MMWR-MORBID MORTAL W, V44, P137; BRUNDAGE JF, 1988, JAMA-J AM MED ASSOC, V259, P2108, DOI 10.1001/jama.259.14.2108; DRIVER CR, 1994, JAMA-J AM MED ASSOC, V272, P1031, DOI 10.1001/jama.272.13.1031; HALFPENNY P, 1990, FLIGHT ATT OCC HLTH; HENDLEY JO, 1988, EPIDEMIOL REV, V10, P242, DOI 10.1093/oxfordjournals.epirev.a036024; HIGGINS M, 2000, WALL STREET J   0609; Hueston WJ, 1998, J FAM PRACTICE, V46, P487; JAAKKOLA JJK, 1995, EUR J EPIDEMIOL, V11, P213, DOI 10.1007/BF01719490; JACKSON GG, 1958, ARCH INTERN MED, V101, P267, DOI 10.1001/archinte.1958.00260140099015; Kenyon TA, 1996, NEW ENGL J MED, V334, P933, DOI 10.1056/NEJM199604113341501; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267; Lina B, 1996, J CLIN MICROBIOL, V34, P3007, DOI 10.1128/JCM.34.12.3007-3011.1996; MARINI RA, 2000, FREQUENT FLYER   MAR, P20; MOSER MR, 1979, AM J EPIDEMIOL, V110, P1; NEEDELMAN WM, 1997, PALL CORP SEPT 5 POR; ODONNELL A, 1991, ASHRAE J, V33, P42; REID DD, 1953, LANCET, V265, P1303; Tracy MJ, 1996, NEW ENGL J MED, V335, P675; 1994, CONSUMER REPORTS AUG, P501	19	52	53	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 24	2002	288	4					483	486		10.1001/jama.288.4.483	http://dx.doi.org/10.1001/jama.288.4.483			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	575NZ	12132979	Bronze			2022-12-24	WOS:000176955400031
J	Gorbunova, YV; Spitzer, NC				Gorbunova, YV; Spitzer, NC			Dynamic interactions of cyclic AMP transients and spontaneous Ca2+ spikes	NATURE			English	Article							APLYSIA SENSORY NEURONS; GENE-EXPRESSION; CALCIUM OSCILLATIONS; PROTEIN-KINASE; ADENYLYL CYCLASES; IN-SITU; CAMP; ACTIVATION; RECEPTOR; CELLS	Transient increases of intracellular Ca2+ drive many cellular processes, ranging from membrane channel kinetics to transcriptional regulation(1-5), and links of Ca2+ to other second messengers should activate signalling networks(6-11). However, real-time kinetic interactions have been difficult to investigate. Here we report observations of spontaneous increases in concentration of cyclic AMP (cAMP) in embryonic spinal neurons, and their dynamic interactions with Ca2+ oscillations. Blocking the production of these cAMP transients decreases the intrinsic frequency of spontaneous Ca2+ spikes, whereas inducing cAMP increases causes spike frequency to increase. Transients of cAMP in turn are absent when Ca2+ spikes are blocked, and are generated only in response to specific patterns of stimulated spikes that mimic endogenous Ca2+ kinetics. We present a mathematical model of Ca2+-cAMP reciprocity that generates the slow cAMP oscillations and reproduces the dynamics of Ca2+-cAMP interactions observed experimentally. The model predicts that this module of coupled second messengers is tuned to optimize production of cAMP transients, and that simultaneous stimulation of Ca2+ and cAMP systems produces distinct temporal patterns of oscillations of both messengers. Our findings may prove useful in the investigation of the regulation of gene expression by second-messenger transients.	Univ Calif San Diego, Neurobiol Sect, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Mol Genet, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Spitzer, NC (corresponding author), Univ Calif San Diego, Neurobiol Sect, La Jolla, CA 92093 USA.			Spitzer, Nicholas/0000-0002-3523-1103				BACSKAI BJ, 1993, SCIENCE, V260, P222, DOI 10.1126/science.7682336; Beck F, 2001, P ROY SOC B-BIOL SCI, V268, P1307, DOI 10.1098/rspb.2001.1655; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BERRIDGE MJ, 1988, FASEB J, V2, P3074, DOI 10.1096/fasebj.2.15.2847949; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Carey MB, 1999, DEV BIOL, V215, P298, DOI 10.1006/dbio.1999.9433; COOPER DMF, 1995, NATURE, V374, P421, DOI 10.1038/374421a0; CUTHBERTSON KSR, 1985, NATURE, V316, P541, DOI 10.1038/316541a0; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; ELIOT LS, 1989, P NATL ACAD SCI USA, V86, P9564, DOI 10.1073/pnas.86.23.9564; FEWTRELL C, 1993, ANNU REV PHYSIOL, V55, P427, DOI 10.1146/annurev.ph.55.030193.002235; Fields RD, 1997, J NEUROSCI, V17, P7252; Goldbeter A, 2000, Novartis Found Symp, V227, P19; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; Haisenleder DJ, 1997, ENDOCRINOLOGY, V138, P5227, DOI 10.1210/en.138.12.5227; HAISENLEDER DJ, 1992, ENDOCRINOLOGY, V131, P3027, DOI 10.1210/en.131.6.3027; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Haug LS, 1999, J BIOL CHEM, V274, P7467, DOI 10.1074/jbc.274.11.7467; Islam MS, 1998, P NATL ACAD SCI USA, V95, P6145, DOI 10.1073/pnas.95.11.6145; KAANG BK, 1993, NEURON, V10, P427, DOI 10.1016/0896-6273(93)90331-K; KLINE D, 1992, DEV BIOL, V149, P80, DOI 10.1016/0012-1606(92)90265-I; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Mons N, 1998, LIFE SCI, V62, P1647, DOI 10.1016/S0024-3205(98)00122-2; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; RASMUSSEN H, 1981, CALCIUM CAMP SYNARCH; SETTE C, 1994, J BIOL CHEM, V269, P18271; TANG YH, 1995, P NATL ACAD SCI USA, V92, P7869, DOI 10.1073/pnas.92.17.7869; Villalobos C, 1998, MOL ENDOCRINOL, V12, P87, DOI 10.1210/mend.12.1.0055; WAYMAN GA, 1995, J BIOL CHEM, V270, P24108, DOI 10.1074/jbc.270.41.24108; WOODS NM, 1986, NATURE, V319, P600, DOI 10.1038/319600a0	30	142	145	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 4	2002	418	6893					93	96		10.1038/nature00835	http://dx.doi.org/10.1038/nature00835			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569JL	12097913				2022-12-24	WOS:000176599200045
J	Reinhart, BJ; Bartel, DP				Reinhart, BJ; Bartel, DP			Small RNAs correspond to centromere heterochromatic repeats	SCIENCE			English	Article							METHYLATION		MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Reinhart, BJ (corresponding author), MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	dbartel@wi.mit.edu						Ayoub N, 2000, GENETICS, V156, P983; BAUM M, 1994, MOL BIOL CELL, V5, P747, DOI 10.1091/mbc.5.7.747; Hutvagner G, 2002, CURR OPIN GENET DEV, V12, P225, DOI 10.1016/S0959-437X(02)00290-3; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; NAKASEKO Y, 1986, EMBO J, V5, P1011, DOI 10.1002/j.1460-2075.1986.tb04316.x; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973	10	390	474	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2002	297	5588					1831	1831		10.1126/science.1077183	http://dx.doi.org/10.1126/science.1077183			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592UJ	12193644				2022-12-24	WOS:000177955000033
J	Yang, HJ; Jeffrey, PD; Miller, J; Kinnucan, E; Sun, YT; Thoma, NH; Zheng, N; Chen, PL; Lee, WH; Pavletich, NP				Yang, HJ; Jeffrey, PD; Miller, J; Kinnucan, E; Sun, YT; Thoma, NH; Zheng, N; Chen, PL; Lee, WH; Pavletich, NP			BRCA2 function in DNA binding and recombination from a BRCA2-DSS1-ssDNA structure	SCIENCE			English	Article							SINGLE-STRANDED-DNA; REPLICATION PROTEIN-A; HUMAN RAD51 PROTEIN; HOMOLOGY-DIRECTED REPAIR; CRYSTAL-STRUCTURE; CANCER SUSCEPTIBILITY; ESCHERICHIA-COLI; RADIATION HYPERSENSITIVITY; SACCHAROMYCES-CEREVISIAE; COMPLEX-FORMATION	Mutations in the BRCA2 (breast cancer susceptibility gene 2) tumor suppressor lead to chromosomal instability due to defects in the repair of double-strand DNA breaks (DSBs) by homologous recombination, but BRCA2's role in this process has been unclear. Here, we present the 3.1 angstrom crystal structure of a similar to90- kilodalton BRCA2 domain bound to DSS1, which reveals three oligonucleotide-binding ( OB) folds and a helix-turn-helix (HTH) motif. We also (i) demonstrate that this BRCA2 domain binds single-stranded DNA, (ii) present its 3.5 angstrom structure bound to oligo(dT)(9), (iii) provide data that implicate the HTH motif in dsDNA binding, and (iv) show that BRCA2 stimulates RAD51-mediated recombination in vitro. These findings establish that BRCA2 functions directly in homologous recombination and provide a structural and biochemical basis for understanding the loss of recombination-mediated DSB repair in BRCA2-associated cancers.	Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, New York, NY 10021 USA; Cornell Univ, Dept Pharmacol, Sloan Kettering Div, Joan & Sanford I Weill Grad Sch Med Sci, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA; Univ Texas, Dept Mol Med, Ctr Hlth, San Antonio, TX 78245 USA; Univ Texas, Inst Biotechnol, Ctr Hlth, San Antonio, TX 78245 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; University of Texas System; University of Texas System	Pavletich, NP (corresponding author), Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, 1275 York Ave, New York, NY 10021 USA.	nikola@xray2.mskcc.org		Sun, Yutong/0000-0002-9368-2957; Miller, Julie/0000-0002-1288-593X; Chen, Phang-Lang/0000-0002-0357-9017; Jeffrey, Philip/0000-0002-4351-5341				Aasland R, 1996, TRENDS BIOCHEM SCI, V21, P87, DOI 10.1016/S0968-0004(96)30009-1; Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bastin-Shanower SA, 2001, J BIOL CHEM, V276, P36446, DOI 10.1074/jbc.M104386200; Baumann P, 1997, EMBO J, V16, P5198, DOI 10.1093/emboj/16.17.5198; Baumann P, 1996, CELL, V87, P757, DOI 10.1016/S0092-8674(00)81394-X; Baumann P, 1998, TRENDS BIOCHEM SCI, V23, P247, DOI 10.1016/S0968-0004(98)01232-8; Benson FE, 1998, NATURE, V391, P401, DOI 10.1038/34937; BENSON FE, 1994, EMBO J, V13, P5764, DOI 10.1002/j.1460-2075.1994.tb06914.x; BLACKWELL LJ, 1994, MOL CELL BIOL, V14, P3993, DOI 10.1128/MCB.14.6.3993; Bochkarev A, 1997, NATURE, V385, P176, DOI 10.1038/385176a0; Bochkarev A, 1999, EMBO J, V18, P4498, DOI 10.1093/emboj/18.16.4498; Bochkareva E, 2001, EMBO J, V20, P612, DOI 10.1093/emboj/20.3.612; Bochkareva E, 2002, EMBO J, V21, P1855, DOI 10.1093/emboj/21.7.1855; Bochkareva E, 1998, J BIOL CHEM, V273, P3932, DOI 10.1074/jbc.273.7.3932; Bork P, 1996, NAT GENET, V13, P22, DOI 10.1038/ng0596-22; Breast Canc Linkage Consortium, 1999, JNCI-J NATL CANCER I, V91, P1310; Brill SJ, 1998, MOL CELL BIOL, V18, P7225, DOI 10.1128/MCB.18.12.7225; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen CF, 1999, J BIOL CHEM, V274, P32931, DOI 10.1074/jbc.274.46.32931; Chen JJ, 1998, MOL CELL, V2, P317, DOI 10.1016/S1097-2765(00)80276-2; Chen JJ, 1999, CANCER RES, V59, p1752S; Chen PL, 1998, P NATL ACAD SCI USA, V95, P5287, DOI 10.1073/pnas.95.9.5287; CHOU CH, 1992, J EXP MED, V175, P1677, DOI 10.1084/jem.175.6.1677; Connor F, 1997, NAT GENET, V17, P423, DOI 10.1038/ng1297-423; Crackower MA, 1996, HUM MOL GENET, V5, P571, DOI 10.1093/hmg/5.5.571; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; FENG JA, 1994, SCIENCE, V263, P348, DOI 10.1126/science.8278807; FOLMER RHA, 1995, EMBO J, V14, P4132, DOI 10.1002/j.1460-2075.1995.tb00087.x; Gasior SL, 2001, P NATL ACAD SCI USA, V98, P8411, DOI 10.1073/pnas.121046198; Golub EI, 1998, NUCLEIC ACIDS RES, V26, P5388, DOI 10.1093/nar/26.23.5388; Hays SL, 1998, MOL CELL BIOL, V18, P4400, DOI 10.1128/MCB.18.7.4400; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; HOLM L, 1991, J MOL BIOL, V218, P183, DOI 10.1016/0022-2836(91)90883-8; Horvath MP, 1998, CELL, V95, P963, DOI 10.1016/S0092-8674(00)81720-1; HOWARDFLANDERS P, 1984, NATURE, V309, P215, DOI 10.1038/309215a0; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Hubbard TJP, 1997, NUCLEIC ACIDS RES, V25, P236, DOI 10.1093/nar/25.1.236; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kanaar R, 1998, NATURE, V391, P335, DOI 10.1038/34790; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; KISSINGER CR, 1990, CELL, V63, P579, DOI 10.1016/0092-8674(90)90453-L; Kraakman-van der Zwet M, 2002, MOL CELL BIOL, V22, P669, DOI 10.1128/MCB.22.2.669-679.2002; Lim DS, 1996, MOL CELL BIOL, V16, P7133; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.biochem.63.1.527; LOLL PJ, 1988, J BIOL CHEM, V263, P18190; Ludwig T, 1997, GENE DEV, V11, P1226, DOI 10.1101/gad.11.10.1226; Marston NJ, 1999, MOL CELL BIOL, V19, P4633; Mer G, 2000, CELL, V103, P449, DOI 10.1016/S0092-8674(00)00136-7; Mizuta R, 1997, P NATL ACAD SCI USA, V94, P6927, DOI 10.1073/pnas.94.13.6927; Morimatsu M, 1998, CANCER RES, V58, P3441; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; MURZIN AG, 1993, EMBO J, V12, P861, DOI 10.1002/j.1460-2075.1993.tb05726.x; Nathanson KN, 2001, NAT MED, V7, P552, DOI 10.1038/87876; Nayal M, 1999, PROTEIN SCI, V8, P676; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; OGATA K, 1994, CELL, V79, P639, DOI 10.1016/0092-8674(94)90549-5; OGAWA T, 1993, SCIENCE, V259, P1896, DOI 10.1126/science.8456314; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park MS, 1996, J BIOL CHEM, V271, P18996, DOI 10.1074/jbc.271.31.18996; Patel KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0; Pfuetzner RA, 1997, J BIOL CHEM, V272, P430; Pierce AJ, 2001, TRENDS CELL BIOL, V11, pS52, DOI 10.1016/S0962-8924(01)02149-3; Raghunathan S, 2000, NAT STRUCT BIOL, V7, P648, DOI 10.1038/77943; Rijkers T, 1998, MOL CELL BIOL, V18, P6423, DOI 10.1128/MCB.18.11.6423; RUFF M, 1991, SCIENCE, V252, P1682, DOI 10.1126/science.2047877; Scully R, 2000, NATURE, V408, P429, DOI 10.1038/35044000; SHAMOO Y, 1995, NATURE, V376, P362, DOI 10.1038/376362a0; Sharan SK, 1997, NATURE, V386, P804, DOI 10.1038/386804a0; Sheldrick GM, 2001, NATO SCI SER I LIFE, V325, P72; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Shinohara A, 1998, NATURE, V391, P404, DOI 10.1038/34943; Sigurdsson S, 2001, GENE DEV, V15, P3308, DOI 10.1101/gad.935501; Sigurdsson S, 2001, J BIOL CHEM, V276, P8798, DOI 10.1074/jbc.M010011200; Singleton MR, 2001, CELL, V107, P79, DOI 10.1016/S0092-8674(01)00501-3; Stark JM, 2002, J BIOL CHEM, V277, P20185, DOI 10.1074/jbc.M112132200; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; Suck D, 1997, NAT STRUCT BIOL, V4, P161, DOI 10.1038/nsb0397-161; Sugiyama T, 1997, J BIOL CHEM, V272, P7940, DOI 10.1074/jbc.272.12.7940; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; Sung P, 1997, GENE DEV, V11, P1111, DOI 10.1101/gad.11.9.1111; SUNG P, 1995, CELL, V82, P453, DOI 10.1016/0092-8674(95)90434-4; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Suzuki A, 1997, GENE DEV, V11, P1242, DOI 10.1101/gad.11.10.1242; Szabo C, 2000, HUM MUTAT, V16, P123, DOI 10.1002/1098-1004(200008)16:2<123::AID-HUMU4>3.0.CO;2-Y; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; Tsuzuki T, 1996, P NATL ACAD SCI USA, V93, P6236, DOI 10.1073/pnas.93.13.6236; TUCKER PA, 1994, EMBO J, V13, P2994, DOI 10.1002/j.1460-2075.1994.tb06598.x; Tutt A, 1999, CURR BIOL, V9, P1107, DOI 10.1016/S0960-9822(99)80479-5; Tutt A, 2001, EMBO J, V20, P4704, DOI 10.1093/emboj/20.17.4704; Tutt ANJ, 2002, EMBO REP, V3, P255, DOI 10.1093/embo-reports/kvf037; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Warren M, 2002, HUM MOL GENET, V11, P841, DOI 10.1093/hmg/11.7.841; Webster G, 1997, FEBS LETT, V411, P313, DOI 10.1016/S0014-5793(97)00747-3; WEST SC, 1992, ANNU REV BIOCHEM, V61, P603, DOI 10.1146/annurev.bi.61.070192.003131; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Wong AKC, 1997, J BIOL CHEM, V272, P31941, DOI 10.1074/jbc.272.51.31941; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Xia F, 2001, P NATL ACAD SCI USA, V98, P8644, DOI 10.1073/pnas.151253498; Yang H., UNPUB; YANG W, 1995, CELL, V82, P193, DOI 10.1016/0092-8674(95)90307-0; Yu VPCC, 2000, GENE DEV, V14, P1400; Yuan SSF, 1999, CANCER RES, V59, P3547	106	526	542	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2002	297	5588					1837	1848		10.1126/science.297.5588.1837	http://dx.doi.org/10.1126/science.297.5588.1837			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592UJ	12228710				2022-12-24	WOS:000177955000035
J	Black, C; Kaye, JA; Jick, H				Black, C; Kaye, JA; Jick, H			Relation of childhood gastrointestinal disorders to autism: nested case-control study using data from the UK General Practice Research Database	BRITISH MEDICAL JOURNAL			English	Article							INFLAMMATORY BOWEL-DISEASE; MEASLES VACCINATION; RISK; USERS	Objectives To assess whether children with autism are more likely to have a history of gastrointestinal disorders than children without autism. Design Nested case-control study. Setting UK General Practice Research Database. Subjects Children born after 1 January 1988 and registered with the General Practice Research Database within 6 months of birth. Outcome measures Chronic inflammation of the gastrointestinal tract, coeliac disease, food intolerance, and recurrent gastrointestinal symptoms recorded by the general practitioner. Results 9 of 96 (9%) children with a diagnosis of autism (cases) and 41 of 449 (9%) children without autism (matched controls) had a history of gastrointestinal disorders before the index date (the date of first recorded diagnosis of autism in the cases and the same date for controls). The estimated odds ratio for a history of gastrointestinal disorders among children with autism compared with children without autism was 1.0 (95% confidence interval 0.5 to 2.2). Conclusions No evidence was found that children with autism were more likely than children without autism to have had defined gastrointestinal disorders at any time before their diagnosis of autism.	Boston Univ, Boston Collaborat Drug Surveillance Program, Boston, MA 02421 USA	Boston University	Black, C (corresponding author), Boston Univ, Boston Collaborat Drug Surveillance Program, Boston, MA 02421 USA.		Black, Corri/A-7924-2012	Jick, Hershel/0000-0003-4270-5992; Kaye, James A./0000-0002-9357-4227				Dales L, 2001, JAMA-J AM MED ASSOC, V285, P1183, DOI 10.1001/jama.285.9.1183; Derby L, 2000, J ALLERGY CLIN IMMUN, V105, P912, DOI 10.1067/mai.2000.106044; Feeney M, 1997, LANCET, V350, P764, DOI 10.1016/S0140-6736(97)03192-9; Fombonne E, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.4.e58; Gasse C, 2000, PHARMACOTHERAPY, V20, P629, DOI 10.1592/phco.20.7.629.35174; JICK H, 1991, BRIT MED J, V302, P766, DOI 10.1136/bmj.302.6779.766; Jick H, 1997, LANCET, V349, P525, DOI 10.1016/S0140-6736(97)80084-0; Jick H, 2001, BRIT J CLIN PHARMACO, V52, P451, DOI 10.1046/j.0306-5251.2001.?aid?.x; Jick H., 1992, PHARMACOEPIDEM DR S, V1, P347, DOI DOI 10.1002/PDS.2630010607; Jick SS, 1997, PHARMACOTHERAPY, V17, P561; Kaye JA, 2001, BRIT MED J, V322, P460, DOI 10.1136/bmj.322.7284.460; Myers MW, 2000, BRIT J CLIN PHARMACO, V49, P604, DOI 10.1046/j.1365-2125.2000.00208.x; Perry J, 1978, OXMIS PROBLEM CODES; Taylor B, 2002, BRIT MED J, V324, P393, DOI 10.1136/bmj.324.7334.393; THOMPSON NP, 1995, LANCET, V345, P1071, DOI 10.1016/S0140-6736(95)90816-1; Vasilakis-Scaramozza C, 2001, LANCET, V358, P1427, DOI 10.1016/S0140-6736(01)06522-9; Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0; Wing L, 1997, LANCET, V350, P1761, DOI 10.1016/S0140-6736(97)09218-0; Yang CC, 2002, BRIT J CLIN PHARMACO, V53, P101, DOI 10.1046/j.0306-5251.2001.01523.x	19	154	156	0	14	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 24	2002	325	7361					419	421		10.1136/bmj.325.7361.419	http://dx.doi.org/10.1136/bmj.325.7361.419			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	588RY	12193358	Green Published			2022-12-24	WOS:000177715500020
J	Geffeney, S; Brodie, ED; Ruben, PC; Brodie, ED				Geffeney, S; Brodie, ED; Ruben, PC; Brodie, ED			Mechanisms of adaptation in a predator-prey arms race: TTX-resistant sodium channels	SCIENCE			English	Article							SNAKE SKELETAL-MUSCLE; DANGEROUS PREY; NA+ CHANNEL; EVOLUTIONARY RESPONSE; GARTER SNAKES; TETRODOTOXIN; POPULATIONS; SAXITOXIN; TOXICITY; PERFORMANCE	Populations of the garter snake Thamnophis sirtalis have evolved geographically variable resistance to tetrodotoxin ( TTX) in a coevolutionary arms race with their toxic prey, newts of the genus Taricha. Here, we identify a physiological mechanism, the expression of TTX-resistant sodium channels in skeletal muscle, responsible for adaptive diversification in whole-animal resistance. Both individual and population differences in the ability of skeletal muscle fibers to function in the presence of TTX correlate closely with whole-animal measures of TTX resistance. Demonstration of individual variation in an essential physiological function responsible for the adaptive differences among populations is a step toward linking the selective consequences of coevolutionary interactions to geographic and phylogenetic patterns of diversity.	Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; Utah State Univ, Dept Biol, Logan, UT 84322 USA	Indiana University System; Indiana University Bloomington; Utah System of Higher Education; Utah State University	Brodie, ED (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.		Brodie, Edmund D/B-2335-2013	Geffeney, Shana/0000-0003-0504-2077				ARNOLD SJ, 1983, AM ZOOL, V23, P347, DOI 10.1093/icb/23.2.347; BEAM KG, 1985, NATURE, V313, P588, DOI 10.1038/313588a0; Brodie ED, 1999, EVOLUTION, V53, P626, DOI 10.1111/j.1558-5646.1999.tb03798.x; BRODIE ED, 1990, EVOLUTION, V44, P651, DOI 10.1111/j.1558-5646.1990.tb05945.x; BRODIE ED, 1991, EVOLUTION, V45, P221, DOI 10.1111/j.1558-5646.1991.tb05280.x; Brodie ED, 1999, BIOSCIENCE, V49, P557, DOI 10.2307/1313476; BRODIE ED, 1968, COPEIA, P307; BRODIE ED, 1974, COPEIA, P506; BRODIE ED, IN PRESS EVOLUTION; CADE BS, 1999, USER MANUAL BLOSSOM; CALDWELL JH, 1988, J PHYSIOL-LONDON, V401, P145, DOI 10.1113/jphysiol.1988.sp017155; CALDWELL JH, 1986, J GEN PHYSIOL, V87, P907, DOI 10.1085/jgp.87.6.907; GARLAND T, 1990, EXPERIENTIA, V46, P530, DOI 10.1007/BF01954257; GARLAND T, 1994, ANNU REV PHYSIOL, V56, P579, DOI 10.1146/annurev.ph.56.030194.003051; GARLAND T, 1991, ANNU REV ECOL SYST, V22, P193, DOI 10.1146/annurev.es.22.110191.001205; Goldin AL, 2001, ANNU REV PHYSIOL, V63, P871, DOI 10.1146/annurev.physiol.63.1.871; Hanifin CT, 1999, J CHEM ECOL, V25, P2161, DOI 10.1023/A:1021049125805; JANZEN FJ, IN PRESS MOL ECOL; KAO CY, 1967, TOXICON, V5, P24; KIDOKORO Y, 1974, J COMP PHYSIOL, V89, P59, DOI 10.1007/BF00696163; LIPKIND GM, 1994, BIOPHYS J, V66, P1, DOI 10.1016/S0006-3495(94)80746-5; Mielke P. W., 2001, PERMUTATION METHODS; MOSHER HS, 1964, SCIENCE, V144, P1100, DOI 10.1126/science.144.3622.1100; NARAHASH.T, 1967, SCIENCE, V156, P976, DOI 10.1126/science.156.3777.976; Nuismer SL, 1999, P ROY SOC B-BIOL SCI, V266, P605, DOI 10.1098/rspb.1999.0679; Penzotti JL, 1998, BIOPHYS J, V75, P2647, DOI 10.1016/S0006-3495(98)77710-0; Ridenhour BJ, 1999, COPEIA, P531; ROBERTS WM, 1987, J PHYSIOL-LONDON, V388, P213, DOI 10.1113/jphysiol.1987.sp016611; TERLAU H, 1991, FEBS LETT, V293, P93, DOI 10.1016/0014-5793(91)81159-6; Thompson J. N., 1994, COEVOLUTIONARY PROCE, DOI 10.7208/chicago/9780226797670.001.0001; Thompson JN, 1999, AM NAT, V153, pS92, DOI 10.1086/303214; Westfall P.H., 1999, MULTIPLE COMPARISONS; WOOD SJ, 1995, J PHYSIOL-LONDON, V486, P401, DOI 10.1113/jphysiol.1995.sp020821; Yotsu-Yamashita M, 2000, BIOCHEM BIOPH RES CO, V267, P403, DOI 10.1006/bbrc.1999.1974	34	129	134	0	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 23	2002	297	5585					1336	1339		10.1126/science.1074310	http://dx.doi.org/10.1126/science.1074310			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FL	12193784				2022-12-24	WOS:000177573900044
J	Pool, MR; Stumm, J; Fulga, TA; Sinning, I; Dobberstein, B				Pool, MR; Stumm, J; Fulga, TA; Sinning, I; Dobberstein, B			Distinct modes of signal recognition particle interaction with the ribosome	SCIENCE			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; PROTEIN TRANSLOCATION; SEQUENCE RECOGNITION; NASCENT PREPROLACTIN; MICROSOMAL MEMBRANE; ELONGATION ARREST; CHAIN COMPLEXES; 80S RIBOSOME; BINDING; SRP	Signal recognition particle (SRP), together with its receptor (SR), mediates the targeting of ribosome-nascent chain complexes to the endoplasmic reticulum. Using protein cross-linking, we detected distinct modes in the binding of SRP to the ribosome. During signal peptide recognition, SRP54 is positioned at the exit site close to ribosomal proteins L23a and L35. When SRP54 contacts SR, SRP54 is rearranged such that it is no longer close to L23a. This repositioning may allow the translocon to dock with the ribosome, leading to insertion of the signal peptide into the translocation channel.	Heidelberg Univ, Zentrum Mol Biol, D-69120 Heidelberg, Germany; European Mol Biol Lab, Struct Biol Programme, D-69117 Heidelberg, Germany	Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL)	Pool, MR (corresponding author), Heidelberg Univ, Zentrum Mol Biol, D-69120 Heidelberg, Germany.	mrp@zmbh.uni-heidelberg.de	Pool, Martin R./AAB-9181-2021; Sinning, Irmgard/A-2982-2010	Pool, Martin R./0000-0003-3071-1535; Fulga, Tudor/0000-0002-1056-0082				Bacher G, 1996, NATURE, V381, P248, DOI 10.1038/381248a0; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; Beckmann R, 1997, SCIENCE, V278, P2123, DOI 10.1126/science.278.5346.2123; BERNSTEIN HD, 1989, NATURE, V340, P482, DOI 10.1038/340482a0; CONNOLLY T, 1989, CELL, V57, P599, DOI 10.1016/0092-8674(89)90129-3; Fulga TA, 2001, EMBO J, V20, P2338, DOI 10.1093/emboj/20.9.2338; GILMORE R, 1982, J CELL BIOL, V95, P463, DOI 10.1083/jcb.95.2.463; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; Harlow E, 1988, ANTIBODIES LAB MANUA; HAUSER S, 1995, EMBO J, V14, P5485, DOI 10.1002/j.1460-2075.1995.tb00235.x; HIGH S, 1993, J CELL BIOL, V121, P743, DOI 10.1083/jcb.121.4.743; Johnson AE, 1999, ANNU REV CELL DEV BI, V15, P799, DOI 10.1146/annurev.cellbio.15.1.799; JUNGNICKEL B, 1995, CELL, V82, P261, DOI 10.1016/0092-8674(95)90313-5; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; KRIEG UC, 1986, P NATL ACAD SCI USA, V83, P8604, DOI 10.1073/pnas.83.22.8604; KURZCHALIA TV, 1986, NATURE, V320, P634, DOI 10.1038/320634a0; Lu Y, 2001, EMBO J, V20, P6724, DOI 10.1093/emboj/20.23.6724; LUIRINK J, 1992, NATURE, V359, P741, DOI 10.1038/359741a0; Martoglio B, 1997, EMBO J, V16, P6636, DOI 10.1093/emboj/16.22.6636; MARTOGLIO B, 1997, CELL BIOL LAB HDB, P265; Mason N, 2000, EMBO J, V19, P4164, DOI 10.1093/emboj/19.15.4164; Menetret JF, 2000, MOL CELL, V6, P1219, DOI 10.1016/S1097-2765(00)00118-0; MILLER JD, 1995, J CELL BIOL, V128, P273, DOI 10.1083/jcb.128.3.273; Neuhof A, 1998, MOL BIOL CELL, V9, P103, DOI 10.1091/mbc.9.1.103; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; OGG SC, 1995, CELL, V81, P1075, DOI 10.1016/S0092-8674(05)80012-1; Rapiejko PJ, 1997, CELL, V89, P703, DOI 10.1016/S0092-8674(00)80253-6; Rapoport TA, 1996, ANNU REV BIOCHEM, V65, P271; ROMISCH K, 1989, NATURE, V340, P478, DOI 10.1038/340478a0; ROMISCH K, 1990, J CELL BIOL, V111, P1793, DOI 10.1083/jcb.111.5.1793; SIEGEL V, 1985, J CELL BIOL, V100, P1913, DOI 10.1083/jcb.100.6.1913; Song WQ, 2000, CELL, V100, P333, DOI 10.1016/S0092-8674(00)80669-8; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; WALLECZEK J, 1989, J BIOL CHEM, V264, P4231; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511	36	160	162	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2002	297	5585					1345	1348		10.1126/science.1072366	http://dx.doi.org/10.1126/science.1072366			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FL	12193787				2022-12-24	WOS:000177573900047
J	Bouarab, K; Melton, R; Peart, J; Baulcombe, D; Osbourn, A				Bouarab, K; Melton, R; Peart, J; Baulcombe, D; Osbourn, A			A saponin-detoxifying enzyme mediates suppression of plant defences	NATURE			English	Article							ALLENE OXIDE SYNTHASE; ALPHA-TOMATINE; SEPTORIA-LYCOPERSICI; DISEASE RESISTANCE; GENE; BETA(2)-TOMATINASE; PURIFICATION; DEGRADATION; SENSITIVITY; EXPRESSION	Plant disease resistance can be conferred by constitutive features such as structural barriers or preformed antimicrobial secondary metabolites. Additional defence mechanisms are activated in response to pathogen attack and include localized cell death (the hypersensitive response)(1,2). Pathogens use different strategies to counter constitutive and induced plant defences, including degradation of preformed antimicrobial compounds(3) and the production of molecules that suppress induced plant defences(4-6). Here we present evidence for a two-component process in which a fungal pathogen subverts the preformed antimicrobial compounds of its host and uses them to interfere with induced defence responses. Antimicrobial saponins are first hydrolysed by a fungal saponin-detoxifying enzyme. The degradation product of this hydrolysis then suppresses induced defence responses by interfering with fundamental signal transduction processes leading to disease resistance.	John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Osbourn, A (corresponding author), John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England.	annie.osbourn@sainsbury-laboratory.ac.uk		Baulcombe, David/0000-0003-0780-6878; MELTON, RACHEL/0000-0002-8439-8153				ARNESON PA, 1968, PLANT PHYSIOL, V43, P683, DOI 10.1104/pp.43.5.683; ARNESON PA, 1967, PHYTOPATHOLOGY, V57, P1358; ARNESON PA, 1968, PHYTOPATHOLOGY, V58, P536; Austin MJ, 2002, SCIENCE, V295, P2077, DOI 10.1126/science.1067747; Azevedo C, 2002, SCIENCE, V295, P2073, DOI 10.1126/science.1067554; Baulcombe DC, 1999, CURR OPIN PLANT BIOL, V2, P109, DOI 10.1016/S1369-5266(99)80022-3; Doke N, 1998, DEV PLANT PATHOL, V13, P331; DURBIN RD, 1969, BIOCHIM BIOPHYS ACTA, V191, P176, DOI 10.1016/0005-2744(69)90331-3; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Froehlich JE, 2001, PLANT PHYSIOL, V125, P306, DOI 10.1104/pp.125.1.306; GRUNWELLER S, 1990, PHYTOCHEMISTRY, V29, P2485, DOI 10.1016/0031-9422(90)85171-B; HAMMONDKOSACK K, 2001, BIOCH MOL BIOL PLANT, P1102; Heath MC, 2000, PLANT MOL BIOL, V44, P321, DOI 10.1023/A:1026592509060; MARTIN GB, 1993, SCIENCE, V262, P1432, DOI 10.1126/science.7902614; Martin-Hernandez AM, 2000, MOL PLANT MICROBE IN, V13, P1301, DOI 10.1094/MPMI.2000.13.12.1301; Morrissey JP, 1999, MICROBIOL MOL BIOL R, V63, P708, DOI 10.1128/MMBR.63.3.708-724.1999; Osbourn A, 1995, MOL PLANT MICROBE IN, V8, P971, DOI 10.1094/MPMI-8-0971; PEART J, 2002, P NATL ACAD SCI 0715, DOI DOI 10.1073/PNAS.152330599; RODDICK JG, 1974, PHYTOCHEMISTRY, V13, P9, DOI 10.1016/S0031-9422(00)91261-5; ROMMENS CMT, 1995, PLANT CELL, V7, P1537, DOI 10.1105/tpc.7.10.1537; Sandrock RW, 1995, MOL PLANT MICROBE IN, V8, P960, DOI 10.1094/MPMI-8-0960; Sandrock RW, 1998, PHYTOPATHOLOGY, V88, P137, DOI 10.1094/PHYTO.1998.88.2.137; Sandrock RW, 2001, PHYSIOL MOL PLANT P, V58, P159, DOI 10.1006/pmpp.2001.0324; Scofield SR, 1996, SCIENCE, V274, P2063, DOI 10.1126/science.274.5295.2063; Shiraishi T, 1998, DEV PLANT PATHOL, V13, P343; SINGH S, 1974, PHYTOCHEMISTRY, V13, P2020, DOI 10.1016/0031-9422(74)85157-5; Tronchet M, 2001, PLANT J, V27, P115, DOI 10.1046/j.1365-313x.2001.01072.x; Voinnet O, 1997, NATURE, V389, P553, DOI 10.1038/39215; Yoshioka K, 2001, PLANT J, V26, P447, DOI 10.1046/j.1365-313X.2001.2641039.x; Ziegler J, 2001, PHYTOCHEMISTRY, V58, P729, DOI 10.1016/S0031-9422(01)00284-9	30	179	194	0	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 22	2002	418	6900					889	892		10.1038/nature00950	http://dx.doi.org/10.1038/nature00950			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585YR	12192413				2022-12-24	WOS:000177555600041
J	Schneider, ME; Belyantseva, IA; Azevedo, RB; Kachar, B				Schneider, ME; Belyantseva, IA; Azevedo, RB; Kachar, B			Structural cell biology: Rapid renewal of auditory hair bundles - The recovery time after noise-induced hearing loss is in step with a molecular treadmill.	NATURE			English	Article							STEREOCILIA; RECEPTORS; COCHLEA		Natl Inst Deafness & Other Commun Disorders, Sect Struct Cell Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Schneider, ME (corresponding author), Natl Inst Deafness & Other Commun Disorders, Sect Struct Cell Biol, NIH, Bethesda, MD 20892 USA.		Azevedo, Ricardo/D-6273-2012	Azevedo, Ricardo/0000-0002-2137-9588	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000002] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Dumont RA, 2001, J NEUROSCI, V21, P5066, DOI 10.1523/JNEUROSCI.21-14-05066.2001; He DZZ, 2001, HEARING RES, V162, P113, DOI 10.1016/S0378-5955(01)00376-8; Hofer D, 1997, J CELL SCI, V110, P765; KALTENBACH JA, 1994, J COMP NEUROL, V350, P187, DOI 10.1002/cne.903500204; MILLER JS, 1989, MOL CRYST LIQ CRYST, V176, P1; Nguyen-Legros J, 2000, INT REV CYTOL, V196, P245; Pickles JO, 1996, HEARING RES, V101, P45, DOI 10.1016/S0378-5955(96)00129-3; Sobkowicz HM, 1997, INT J DEV NEUROSCI, V15, P463, DOI 10.1016/S0736-5748(96)00104-9; TILNEY LG, 1992, ANNU REV CELL BIOL, V8, P257, DOI 10.1146/annurev.cb.08.110192.001353; Zine A, 1996, BRAIN RES, V721, P49, DOI 10.1016/0006-8993(96)00147-3	10	145	156	2	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 22	2002	418	6900					837	838		10.1038/418837a	http://dx.doi.org/10.1038/418837a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585YR	12192399				2022-12-24	WOS:000177555600027
J	Apperley, JF; Gardembas, M; Melo, JV; Russell-Jones, R; Bain, BJ; Baxter, J; Chase, A; Chessells, JM; Colombat, M; Dearden, CE; Dimitrijevic, S; Mahon, FX; Marin, D; Nikolova, Z; Olavarria, E; Silberman, S; Schultheis, B; Cross, NCP; Goldman, JM				Apperley, JF; Gardembas, M; Melo, JV; Russell-Jones, R; Bain, BJ; Baxter, J; Chase, A; Chessells, JM; Colombat, M; Dearden, CE; Dimitrijevic, S; Mahon, FX; Marin, D; Nikolova, Z; Olavarria, E; Silberman, S; Schultheis, B; Cross, NCP; Goldman, JM			Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TYROSINE KINASE INHIBITOR; CHRONIC MYELOMONOCYTIC LEUKEMIA; PROTEASE-ACTIVATED LIGAND; CHRONIC MYELOID-LEUKEMIA; BCR-ABL; FUSION; CELLS; GENE; MICE; TEL	Background A small proportion of patients with chronic myeloproliferative diseases have constitutive activation of the gene for platelet-derived growth factor receptor beta (PDGFRB), which encodes a receptor tyrosine kinase. The gene is located on chromosome 5q33, and the activation is usually caused by a t(5;12)(q33;p13) translocation associated with an ETV6-PDGFRB fusion gene. The tyrosine kinase inhibitor imatinib mesylate specifically inhibits ABL, PDGFR, and KIT kinases and has impressive clinical efficacy in BCR-ABL-positive chronic myeloid leukemia. Methods We treated four patients who had chronic myeloproliferative diseases and chromosomal translocations involving 5q33 with imatinib mesylate (400 mg daily). Three of the four patients presented with leukocytosis and eosinophilia; their leukemia cells carried the ETV6-PDGFRB fusion gene. The fourth patient had leukocytosis, eosinophilia, and a t(5;12) translocation involving PDGFRB and an unknown partner gene; he also had extensive raised, ulcerated skin lesions that had been present for a long time. Results In all four patients, a normal blood count was achieved within four weeks after treatment began. In the patient with skin disease, the lesions began to resolve shortly after treatment began. The t(5;12) translocation was undetectable by 12 weeks in three patients and by 36 weeks in the fourth patient. In the three patients with the ETV6-PDGFRB fusion gene, the transcript level decreased, and in one patient, it became undetectable by 36 weeks. All responses were durable at 9 to 12 months of follow-up. Conclusions Imatinib mesylate induces durable responses in patients with chronic myeloproliferative diseases associated with activation of PDGFRB.	Ctr Hosp Univ Angers, Dept Hematol, Angers, France; St Thomas Hosp, Skin Tumour Unit, St Johns Inst Dermatol, London, England; Salisbury Dist Hosp, Wessex Reg Genet Lab, Salisbury, Wilts, England; Great Ormond St Hosp Children, Dept Haematol, London WC1N 3JH, England; Ctr Hosp Univ Bordeaux, Dept Hematol, Pessac, France; Univ London St Georges Hosp, Dept Haematol, London SW17 0RE, England; Novartis Oncol, Basel, Switzerland; Univ London Imperial Coll Sci Technol & Med, Dept Haematol, Fac Med, London, England	Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Salisbury District Hospital; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; CHU Bordeaux; St Georges University London; Novartis; Imperial College London	Apperley, JF (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Haematol, Fac Med, Hammersmith Hosp, Du Cane Rd, London W12 0NN, England.		Cross, Nicholas/B-4817-2009; Schultheis, Beate/M-5889-2017	Cross, Nicholas/0000-0001-5481-2555; Baxter, Elizabeth Joanna/0000-0002-5946-5238; Chase, Andrew/0000-0001-6617-9953				Bergsten E, 2001, NAT CELL BIOL, V3, P512, DOI 10.1038/35074588; Buchdunger E, 2000, J PHARMACOL EXP THER, V295, P139; Carroll M, 1997, BLOOD, V90, P4947, DOI 10.1182/blood.V90.12.4947.4947_4947_4952; CLAESSONWELSH L, 1994, J BIOL CHEM, V269, P32023; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Druker BJ, 2001, NEW ENGL J MED, V345, P232; Gleich GJ, 2002, LANCET, V359, P1577, DOI 10.1016/S0140-6736(02)08505-7; GOLUB TR, 1994, CELL, V77, P307, DOI 10.1016/0092-8674(94)90322-0; Heldin CH, 1998, BIOCHIM BIOPHYS ACTA, V1378, P79; Irusta PM, 1998, EMBO J, V17, P6912, DOI 10.1093/emboj/17.23.6912; JANI K, 1994, BRIT J HAEMATOL, V87, P57, DOI 10.1111/j.1365-2141.1994.tb04870.x; Joensuu H, 2001, NEW ENGL J MED, V344, P1052, DOI 10.1056/NEJM200104053441404; KEENE P, 1987, BRIT J HAEMATOL, V67, P25, DOI 10.1111/j.1365-2141.1987.tb02291.x; Kulkarni S, 2000, CANCER RES, V60, P3592; LaRochelle WJ, 2001, NAT CELL BIOL, V3, P517, DOI 10.1038/35074593; Li XR, 2000, NAT CELL BIOL, V2, P302, DOI 10.1038/35010579; Magnusson MK, 2001, BLOOD, V98, P2518, DOI 10.1182/blood.V98.8.2518; Magnusson MK, 2001, BLOOD, V98, p631A; Reilly JT, 2002, BRIT J HAEMATOL, V116, P744, DOI 10.1046/j.0007-1048.2001.03294.x; Rioux JD, 1998, AM J HUM GENET, V63, P1086, DOI 10.1086/302053; Ritchie KA, 1999, LEUKEMIA, V13, P1790, DOI 10.1038/sj.leu.2401494; Ross TS, 1998, BLOOD, V91, P4419, DOI 10.1182/blood.V91.12.4419.412k43_4419_4426; Steer EJ, 2002, ACTA HAEMATOL-BASEL, V107, P113, DOI 10.1159/000046641; Tomasson MH, 1999, BLOOD, V93, P1707, DOI 10.1182/blood.V93.5.1707.405k24_1707_1714; Tomasson MH, 2000, J CLIN INVEST, V105, P423, DOI 10.1172/JCI8902	27	501	524	1	10	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 15	2002	347	7					481	487		10.1056/NEJMoa020150	http://dx.doi.org/10.1056/NEJMoa020150			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587ZM	12181402				2022-12-24	WOS:000177674400004
J	Campbell, G				Campbell, G			Distalization of the Drosophila leg by graded EGF-receptor activity	NATURE			English	Article							HOMEOBOX GENES; WINGLESS; PROTEIN; ROLES; KINASE; AXIS; EYE; SPECIFICATION; ARISTALESS; ACTIVATION	Arthropods and higher vertebrates both possess appendages, but these are morphologically distinct and the molecular mechanisms regulating patterning along their proximodistal axis (base to tip) are thought to be quite different. In Drosophila, gene expression along this axis is thought to be controlled primarily by a combination of transforming growth factor-beta (TGF-beta) and Wnt signalling from sources of ligands, Decapentaplegic (Dpp) and Wingless (Wg), in dorsal and ventral stripes, respectively(1-3). In vertebrates, however, proximodistal patterning is regulated by receptor tyrosine kinase (RTK) activity from a source of ligands, fibroblast growth factors (FGFs), at the tip of the limb bud(4). Here I revise our understanding of limb development in flies and show that the distal region is actually patterned by a distal-to-proximal gradient of RTK activity, established by a source of epidermal growth factor (EGF)-related ligands at the presumptive tip. This similarity between proximodistal patterning in vertebrates and flies supports previous suggestions(5,6) of an evolutionary relationship between appendages/body-wall outgrowths in animals.	Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Campbell, G (corresponding author), Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA.			Campbell, Gerard/0000-0002-7631-4394				Bang AG, 2000, GENE DEV, V14, P177; Brook WJ, 1996, SCIENCE, V273, P1373, DOI 10.1126/science.273.5280.1373; Campbell G, 1998, DEVELOPMENT, V125, P4483; CAMPBELL G, 1993, CELL, V74, P1113, DOI 10.1016/0092-8674(93)90732-6; CAMPBELL G, 1995, DEVELOPMENT, V121, P619; Casares F, 2001, SCIENCE, V293, P1477, DOI 10.1126/science.1062542; Casci T, 1999, CELL, V96, P655, DOI 10.1016/S0092-8674(00)80576-0; CLIFFORD RJ, 1989, GENETICS, V123, P771; Couso JP, 1998, INT J DEV BIOL, V42, P345; DIAZBENJUMEA FJ, 1994, NATURE, V372, P175, DOI 10.1038/372175a0; Halfar K, 2001, DEVELOPMENT, V128, P1687; Irvine KD, 1999, CURR OPIN GENET DEV, V9, P434, DOI 10.1016/S0959-437X(99)80066-5; Kojima T, 2000, DEVELOPMENT, V127, P769; Kramer S, 1999, DEVELOPMENT, V126, P2515; Kumar JP, 1998, DEVELOPMENT, V125, P3875; Lecuit T, 1997, NATURE, V388, P139, DOI 10.1038/40563; MARDON G, 1994, DEVELOPMENT, V120, P3473; Martin GR, 1998, GENE DEV, V12, P1571, DOI 10.1101/gad.12.11.1571; NELLEN D, 1994, CELL, V78, P225, DOI 10.1016/0092-8674(94)90293-3; Panganiban G, 1997, P NATL ACAD SCI USA, V94, P5162, DOI 10.1073/pnas.94.10.5162; PENTON A, 1994, CELL, V78, P239, DOI 10.1016/0092-8674(94)90294-1; Queenan AM, 1997, DEVELOPMENT, V124, P3871; Schweitzer R, 1997, TRENDS GENET, V13, P191, DOI 10.1016/S0168-9525(97)01091-3; Shubin N, 1997, NATURE, V388, P639, DOI 10.1038/41710; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; Wasserman JD, 2000, GENE DEV, V14, P1651; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110	27	109	110	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 15	2002	418	6899					781	785		10.1038/nature00971	http://dx.doi.org/10.1038/nature00971			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UF	12181568				2022-12-24	WOS:000177428000040
J	Crawford, LM				Crawford, LM			Xenotransplantation advisory	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									US FDA, Off Commissioner Food & Drugs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Crawford, LM (corresponding author), US FDA, Off Commissioner Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 14	2002	288	6					688	688		10.1001/jama.288.6.688	http://dx.doi.org/10.1001/jama.288.6.688			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	583KY	12169049				2022-12-24	WOS:000177408100004
J	Gabellini, D; Green, MR; Tupler, R				Gabellini, D; Green, MR; Tupler, R			Inappropriate gene activation in FSHD: A repressor complex binds a chromosomal repeat deleted in dystrophic muscle	CELL			English	Article							FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY; TRANSCRIPTION FACTOR YY1; MINISATELLITE LOCUS; DNA REARRANGEMENTS; 4Q35; IDENTIFICATION; EXPRESSION; PROTEIN; REGION; ASSOCIATION	Facioscapulolhumeral muscular dystrophy (FSHD), a common myopathy, is an autosomal dominant disease of unknown molecular mechanism. Almost all FSHD patients carry deletions of an integral number of tandem 3.3 kilobase repeats, termed D4Z4, located on chromosome 4q35. Here, we find that in FSHD muscle, 4q35 genes located upstream of D4Z4 are inappropriately overexpressed. We show that an element within D4Z4 specifically binds a multiprotein complex consisting of YY1, a known transcriptional repressor, HMGB2, an architectural protein, and nucleolin. We demonstrate that this multiprotein complex binds D4Z4 in vitro and in vivo and mediates transcriptional repression of 4q35 genes. Based upon these results, we propose that deletion of D4Z4 leads to the inappropriate transcriptional derepression of 4q35 genes resulting in disease.	Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Gene Funct & Express,Program Mol Med, Worcester, MA 01605 USA; Univ Pavia, I-27100 Pavia, Italy	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Pavia	Tupler, R (corresponding author), Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Gene Funct & Express,Program Mol Med, Worcester, MA 01605 USA.		Tupler, Rossella/C-9500-2015; Gabellini, Davide/I-4551-2018	Tupler, Rossella/0000-0002-3797-1789; Gabellini, Davide/0000-0002-3811-4121	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS043973] Funding Source: NIH RePORTER; NINDS NIH HHS [R21 NS43973] Funding Source: Medline; Telethon [GP0284Y01] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Telethon(Fondazione Telethon)		AUSUBEL FM, 2001, CURRENT PROTOCOLS MO; Bauer MKA, 1999, J CELL BIOL, V147, P1493, DOI 10.1083/jcb.147.7.1493; BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284; BLAIR IP, 2002, IN PRESS MOL PSYCHIA; Boyd KE, 1998, P NATL ACAD SCI USA, V95, P13887, DOI 10.1073/pnas.95.23.13887; Chung JH, 1997, P NATL ACAD SCI USA, V94, P575, DOI 10.1073/pnas.94.2.575; Clark LN, 1996, CHROMOSOMA, V105, P180, DOI 10.1007/BF02509499; Dorner R, 2000, HERZ, V25, P176, DOI 10.1007/s000590050004; Dunger DB, 1998, NAT GENET, V19, P98, DOI 10.1038/ng0598-98; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fisher J, 1997, NEUROMUSCULAR DISORD, V7, P55, DOI 10.1016/S0960-8966(96)00400-2; Gabriels J, 1999, GENE, V236, P25, DOI 10.1016/S0378-1119(99)00267-X; GOTO K, 1995, NEUROMUSCULAR DISORD, V5, P201, DOI 10.1016/0960-8966(94)00055-E; Hanakahi LA, 1997, P NATL ACAD SCI USA, V94, P3605, DOI 10.1073/pnas.94.8.3605; HEWITT JE, 1994, HUM MOL GENET, V3, P1287, DOI 10.1093/hmg/3.8.1287; Hsu YD, 1997, J NEUROL SCI, V149, P73, DOI 10.1016/S0022-510X(97)05394-X; Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782; KENNEDY GC, 1995, NAT GENET, V9, P293, DOI 10.1038/ng0395-293; KRONTIRIS TG, 1993, NEW ENGL J MED, V329, P517, DOI 10.1056/NEJM199308193290801; Lehming N, 1998, P NATL ACAD SCI USA, V95, P7322, DOI 10.1073/pnas.95.13.7322; Lunt P W, 1998, Neuromuscul Disord, V8, P126, DOI 10.1016/S0960-8966(98)00012-1; LUNT PW, 1995, HUM MOL GENET, V4, P951, DOI 10.1093/hmg/4.5.951; Lustig AJ, 1998, CURR OPIN GENET DEV, V8, P233, DOI 10.1016/S0959-437X(98)80146-9; LYLE R, 1995, GENOMICS, V28, P389, DOI 10.1006/geno.1995.1166; Morcos PA, 2001, GENESIS, V30, P94, DOI 10.1002/gene.1039; Napoli L, 2001, NEUROLOGY, V57, P2295, DOI 10.1212/WNL.57.12.2295; ORLANDO V, 1993, CELL, V75, P1187, DOI 10.1016/0092-8674(93)90328-N; Padberg GW, 1982, THESIS LEIDEN U LEID; Pryde FE, 1999, EMBO J, V18, P2538, DOI 10.1093/emboj/18.9.2538; RENAULD H, 1993, GENE DEV, V7, P1133, DOI 10.1101/gad.7.7a.1133; Ricci E, 1999, ANN NEUROL, V45, P751, DOI 10.1002/1531-8249(199906)45:6<751::AID-ANA9>3.0.CO;2-M; Sandri M, 2001, J NEUROPATH EXP NEUR, V60, P302, DOI 10.1093/jnen/60.3.302; SARFARAZI M, 1992, AM J HUM GENET, V51, P396; Schulz M, 2001, BIOCHEM BIOPH RES CO, V280, P476, DOI 10.1006/bbrc.2000.4141; Tawil R, 1996, ANN NEUROL, V39, P744, DOI 10.1002/ana.410390610; Tews DS, 1997, NEUROPATH APPL NEURO, V23, P331, DOI 10.1046/j.1365-2990.1997.5998059.x; Thomas JO, 2001, TRENDS BIOCHEM SCI, V26, P167, DOI 10.1016/S0968-0004(01)01801-1; Thomas MJ, 1999, GENE, V236, P197, DOI 10.1016/S0378-1119(99)00261-9; Tupler R, 1999, P NATL ACAD SCI USA, V96, P12650, DOI 10.1073/pnas.96.22.12650; Tupler R, 1996, J MED GENET, V33, P366, DOI 10.1136/jmg.33.5.366; van Geel M, 1999, GENOMICS, V61, P55, DOI 10.1006/geno.1999.5942; van Geel M, 2000, CYTOGENET CELL GENET, V88, P316, DOI 10.1159/000015518; vanDeutekom JCT, 1996, HUM MOL GENET, V5, P581, DOI 10.1093/hmg/5.5.581; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26; Winokur ST, 1994, CHROMOSOME RES, V2, P225, DOI 10.1007/BF01553323; Xie JP, 1998, J CELL BIOCHEM, V70, P489, DOI 10.1002/(SICI)1097-4644(19980915)70:4<489::AID-JCB6>3.0.CO;2-F; YANT SR, 1995, NUCLEIC ACIDS RES, V23, P4353, DOI 10.1093/nar/23.21.4353; Ying GG, 2000, J BIOL CHEM, V275, P4152, DOI 10.1074/jbc.275.6.4152; ZATZ M, 1995, AM J HUM GENET, V56, P99	49	297	308	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 9	2002	110	3					339	348		10.1016/S0092-8674(02)00826-7	http://dx.doi.org/10.1016/S0092-8674(02)00826-7			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	583MN	12176321	Bronze			2022-12-24	WOS:000177411800010
J	Munekage, Y; Hojo, M; Meurer, J; Endo, T; Tasaka, M; Shikanai, T				Munekage, Y; Hojo, M; Meurer, J; Endo, T; Tasaka, M; Shikanai, T			PGR5 is involved in cyclic electron flow around photosystem I and is essential for photoprotection in Arabidopsis	CELL			English	Article							NDHB GENE; PHOTOACOUSTIC MEASUREMENTS; CHLOROPHYLL-FLUORESCENCE; DEHYDROGENASE COMPLEX; NAD(P)H DEHYDROGENASE; INTACT CHLOROPLASTS; NADH-DEHYDROGENASE; TRANSPORT; TOBACCO; ENERGY	During photosynthesis, plants must control the utilization of light energy in order to avoid photoinhibition. We isolated an Arabidopsis mutant, pgr5 (proton gradient regulation), in which downregulation of photosystem 11 photochemistry in response to intense light was impaired. PGR5 encodes a novel thylakoid membrane protein that is involved in the transfer of electrons from ferredoxin to plastoquinone. This alternative electron transfer pathway, whose molecular identity has long been unclear, is known to function in vivo in cyclic electron flow around photosystern 1. We propose that the PGR5 pathway contributes to the generation of a DeltapH that induces thermal dissipation when Calvin cycle activity is reduced. Under these conditions, the PGR5 pathway also functions to limit the overreduction of the acceptor side of photosystem 1, thus preventing photosystern I photoinhibition.	Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan; Univ Munich, Inst Bot, D-80638 Munich, Germany; Kyoto Univ, Grad Sch Biostudies, Sakyou Ku, Kyoto 6068502, Japan	Nara Institute of Science & Technology; University of Munich; Kyoto University	Shikanai, T (corresponding author), Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan.	shikanai@bs.aist-nara.ac.jp	Shikanai, Toshiharu/AAK-9112-2020; Meurer, Jörg/F-8479-2010	Meurer, Jörg/0000-0003-2973-9514				ARNON DI, 1975, P NATL ACAD SCI USA, V72, P4961, DOI 10.1073/pnas.72.12.4961; ARNON DI, 1954, NATURE, V174, P394, DOI 10.1038/174394a0; ARNON DI, 1959, NATURE, V184, P10; ARNON DI, 1967, NATURE, V214, P562, DOI 10.1038/214562a0; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; ASADA K, 1993, PLANT CELL PHYSIOL, V34, P39; BELL CJ, 1994, GENOMICS, V19, P137, DOI 10.1006/geno.1994.1023; BENDALL DS, 1995, BBA-BIOENERGETICS, V1229, P23, DOI 10.1016/0005-2728(94)00195-B; Burrows PA, 1998, EMBO J, V17, P868, DOI 10.1093/emboj/17.4.868; Cornic G, 2000, PLANTA, V210, P468, DOI 10.1007/PL00008154; Endo T, 1999, FEBS LETT, V457, P5, DOI 10.1016/S0014-5793(99)00989-8; Endo T, 1998, PLANT CELL PHYSIOL, V39, P1226, DOI 10.1093/oxfordjournals.pcp.a029324; Felder S, 2001, PLANT CELL, V13, P2127, DOI 10.1105/tpc.13.9.2127; Finazzi G, 2002, EMBO REP, V3, P280, DOI 10.1093/embo-reports/kvf047; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Golbeck J., 1991, CURR TOP BIOENERG, P83; HEBER U, 1992, PLANT PHYSIOL, V100, P1621, DOI 10.1104/pp.100.4.1621; HEBER U, 1978, PLANTA, V143, P41, DOI 10.1007/BF00389050; HERBERT SK, 1990, PLANT PHYSIOL, V94, P926, DOI 10.1104/pp.94.3.926; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; Horvath EM, 2000, PLANT PHYSIOL, V123, P1337, DOI 10.1104/pp.123.4.1337; Joet T, 2001, PLANT PHYSIOL, V125, P1919, DOI 10.1104/pp.125.4.1919; Kofer W, 1998, MOL GEN GENET, V258, P166, DOI 10.1007/s004380050719; KONIECZNY A, 1993, PLANT J, V4, P403, DOI 10.1046/j.1365-313X.1993.04020403.x; Kozaki A, 1996, NATURE, V384, P557, DOI 10.1038/384557a0; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; MAKINO A, 2002, IN PRESS PLANT CELL; MATSUBAYASHI T, 1987, MOL GEN GENET, V210, P385, DOI 10.1007/BF00327187; Meurer J, 1996, PLANTA, V198, P385, DOI 10.1007/BF00620055; MI HL, 1995, PLANT CELL PHYSIOL, V36, P661; MILLS JD, 1978, BIOCHIM BIOPHYS ACTA, V504, P298, DOI 10.1016/0005-2728(78)90178-0; MILLS JD, 1979, BIOCHIM BIOPHYS ACTA, V547, P127, DOI 10.1016/0005-2728(79)90101-4; MIYAKE C, 1994, PLANT CELL PHYSIOL, V35, P539, DOI 10.1093/oxfordjournals.pcp.a078628; MOSS DA, 1984, BIOCHIM BIOPHYS ACTA, V767, P389, DOI 10.1016/0005-2728(84)90036-7; Munekage Y, 2001, PLANT J, V28, P351, DOI 10.1046/j.1365-313X.2001.01178.x; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Peltier G, 2002, ANNU REV PLANT BIOL, V53, P523, DOI 10.1146/annurev.arplant.53.100301.135242; RAVENEL J, 1994, PLANTA, V193, P251; SCHREIBER U, 1988, Z NATURFORSCH C, V43, P686; Shikanai T, 1998, P NATL ACAD SCI USA, V95, P9705, DOI 10.1073/pnas.95.16.9705; Shikanai T, 1999, PLANT CELL PHYSIOL, V40, P1134, DOI 10.1093/oxfordjournals.pcp.a029498; Sonoike K, 1996, PLANT CELL PHYSIOL, V37, P239, DOI 10.1093/oxfordjournals.pcp.a028938; SONOIKE K, 1994, PLANTA, V194, P287, DOI 10.1007/BF01101690; TAGAWA K, 1963, P NATL ACAD SCI USA, V49, P567, DOI 10.1073/pnas.49.4.567; Zhang HM, 2001, J BIOL CHEM, V276, P38159	47	722	756	6	147	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 9	2002	110	3					361	371		10.1016/S0092-8674(02)00867-X	http://dx.doi.org/10.1016/S0092-8674(02)00867-X			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	583MN	12176323	Bronze			2022-12-24	WOS:000177411800012
J	Addiscott, T; Brookes, P				Addiscott, T; Brookes, P			Nitrogen cycle - What governs nitrogen loss from forest soils?	NATURE			English	Article									Rothamsted Expt, Harpenden AL5 2JQ, Herts, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Addiscott, T (corresponding author), Rothamsted Expt, Harpenden AL5 2JQ, Herts, England.	tom.addiscott@bbsrc.ac.uk						ANDERSON O. E., 1960, SOIL SCI SOC AMER PROC, V24, P286; CLARKSON DT, 1979, PLANT PHYSIOL, V64, P557, DOI 10.1104/pp.64.4.557; HERBERT BE, 1995, CARBON FORMS AND FUNCTIONS IN FOREST SOILS, P63; PEARCE F, 2002, NEW SCI, P11; Perakis SS, 2002, NATURE, V415, P416, DOI 10.1038/415416a; Persson J, 2001, ECOL LETT, V4, P434, DOI 10.1046/j.1461-0248.2001.00260.x; TYLER K. B., 1959, SOIL SCI, V87, P123, DOI 10.1097/00010694-195903000-00001; van Breemen N, 2002, NATURE, V415, P381, DOI 10.1038/415381a; Williams LE, 2001, ANNU REV PLANT PHYS, V52, P659, DOI 10.1146/annurev.arplant.52.1.659	9	1	1	4	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 8	2002	418	6898					604	604		10.1038/418604a	http://dx.doi.org/10.1038/418604a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581RA	12167851	Green Published			2022-12-24	WOS:000177305600031
J	He, QY; Cheng, P; Yang, YH; Wang, LX; Gardner, KH; Liu, Y				He, QY; Cheng, P; Yang, YH; Wang, LX; Gardner, KH; Liu, Y			White collar-1, a DNA binding transcription factor and a light sensor	SCIENCE			English	Article							SIGNAL-TRANSDUCTION; NEUROSPORA-CRASSA; CIRCADIAN CLOCK; ESCHERICHIA-COLI; PAS PROTEIN; PHOTORECEPTOR; DOMAIN; ARABIDOPSIS; FREQUENCY; PHOSPHORYLATION	Blue light regulates many physiological processes in fungi, but their photoreceptors are not known. In Neurospora crassa, all light responses depend on the Per-Arnt-Sim (PAS) domain-containing transcription factor white collar-1 (wc-1). By removing the WC-1 light, oxygen, or voltage domain, a specialized PAS domain that binds flavin mononucleotide in plant phototropins, we show that light responses are abolished, including light entrainment of the circadian clock. However, the WC-1-mediated dark activation of frq remains normal in this mutant, and the circadian clock can be entrained by temperature. Furthermore, we demonstrate that the purified Neurospora WC-1-WC-2 protein complex is associated with stoichiometric amounts of the chromophore flavin-adenine dinucleotide. Together, these observations suggest that WC-1 is the blue-light photoreceptor for the circadian clock and other light responses in Neurospora.	Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Liu, Y (corresponding author), Univ Texas, SW Med Ctr, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.		He, qiyang/GQA-4070-2022; Yang, Yuhong/A-6033-2013; Gardner, Kevin H./K-7802-2012; Gardner, Kevin/K-5493-2019; He, qiyang/AAT-5826-2021	Gardner, Kevin H./0000-0002-8671-2556; he, qiyang/0000-0003-3694-6036				ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; Ballario P, 1996, EMBO J, V15, P1650, DOI 10.1002/j.1460-2075.1996.tb00510.x; Bibikov SI, 2000, P NATL ACAD SCI USA, V97, P5830, DOI 10.1073/pnas.100118697; Briggs WR, 1999, ANNU REV CELL DEV BI, V15, P33, DOI 10.1146/annurev.cellbio.15.1.33; Cheng P, 2002, MOL CELL BIOL, V22, P517, DOI 10.1128/MCB.22.2.517-524.2002; Cheng P, 2001, P NATL ACAD SCI USA, V98, P7408, DOI 10.1073/pnas.121170298; Cheng P, 2001, EMBO J, V20, P101, DOI 10.1093/emboj/20.1.101; Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; Christie JM, 1998, SCIENCE, V282, P1698, DOI 10.1126/science.282.5394.1698; Collett MA, 2002, GENETICS, V160, P149; Crosson S, 2001, P NATL ACAD SCI USA, V98, P2995, DOI 10.1073/pnas.051520298; CROSTHWAITE SK, 1995, CELL, V81, P1003, DOI 10.1016/S0092-8674(05)80005-4; Crosthwaite SK, 1997, SCIENCE, V276, P763, DOI 10.1126/science.276.5313.763; Denault DL, 2001, EMBO J, V20, P109, DOI 10.1093/emboj/20.1.109; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; FAEDER EJ, 1973, ANAL BIOCHEM, V53, P332, DOI 10.1016/0003-2697(73)90442-9; Froehlich AC, 2002, SCIENCE, V297, P815, DOI 10.1126/science.1073681; Garceau NY, 1997, CELL, V89, P469, DOI 10.1016/S0092-8674(00)80227-5; HE Q, UNPUB; Heintzen C, 2001, CELL, V104, P453, DOI 10.1016/S0092-8674(01)00232-X; HUENNEKENS FM, 1957, METHOD ENZYMOL, V3, P950, DOI 10.1016/S0076-6879(57)03484-9; Iseki M, 2002, NATURE, V415, P1047, DOI 10.1038/4151047a; LAKINTHOMAS PL, 1990, CRIT REV MICROBIOL, V17, P365, DOI 10.3109/10408419009114762; Linden H, 1997, EMBO J, V16, P98, DOI 10.1093/emboj/16.1.98; Liu Y, 1998, SCIENCE, V281, P825, DOI 10.1126/science.281.5378.825; Nelson DC, 2000, CELL, V101, P331, DOI 10.1016/S0092-8674(00)80842-9; Repik A, 2000, MOL MICROBIOL, V36, P806, DOI 10.1046/j.1365-2958.2000.01910.x; Salomon M, 2000, BIOCHEMISTRY-US, V39, P9401, DOI 10.1021/bi000585+; Sancar A, 2000, ANNU REV BIOCHEM, V69, P31, DOI 10.1146/annurev.biochem.69.1.31; Schwerdtfeger C, 2000, EUR J BIOCHEM, V267, P414, DOI 10.1046/j.1432-1327.2000.01016.x; SELKER EU, 1990, ANNU REV GENET, V24, P579, DOI 10.1146/annurev.ge.24.120190.003051; Somers DE, 2000, CELL, V101, P319, DOI 10.1016/S0092-8674(00)80841-7; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Talora C, 1999, EMBO J, V18, P4961, DOI 10.1093/emboj/18.18.4961	34	332	351	3	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 2	2002	297	5582					840	843		10.1126/science.1072795	http://dx.doi.org/10.1126/science.1072795			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579RZ	12098705				2022-12-24	WOS:000177192800052
J	Schultz, PG; Lerner, RA				Schultz, PG; Lerner, RA			Antibody catalysis: Completing the circle	NATURE			English	Article									Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA	Scripps Research Institute	Schultz, PG (corresponding author), Scripps Res Inst, Dept Chem, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.							Haldane JBS, 1930, ENZYMES; SCHULTZ P, IN PRESS ANGEW CHEM	2	19	20	2	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 1	2002	418	6897					485	485		10.1038/418485a	http://dx.doi.org/10.1038/418485a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579EE	12152057	Bronze			2022-12-24	WOS:000177162800019
J	Andre, F; Schartz, NEC; Movassagh, M; Flament, C; Pautier, P; Morice, P; Pomel, C; Lhomme, C; Escudier, B; Le Chevalier, T; Tursz, T; Amigorena, S; Raposo, G; Angevin, E; Zitvogel, L				Andre, F; Schartz, NEC; Movassagh, M; Flament, C; Pautier, P; Morice, P; Pomel, C; Lhomme, C; Escudier, B; Le Chevalier, T; Tursz, T; Amigorena, S; Raposo, G; Angevin, E; Zitvogel, L			Malignant effusions and immunogenic tumour-derived exosomes	LANCET			English	Article							AUTOLOGOUS DENDRITIC CELLS; CYTOTOXIC T-LYMPHOCYTES; HEAT-SHOCK-PROTEIN; INFILTRATING LYMPHOCYTES; OVARIAN-CANCER; ADOPTIVE IMMUNOTHERAPY; ANTIGEN; VACCINATION; INDUCTION; CARCINOMA	Background Exosomes derived from tumours are small vesicles released in vitro by tumour cell lines in culture supernatants. To assess the role of these exosomes in vivo, we examined malignant effusions for their presence. We also investigated whether these exosomes could induce production of tumour-specific T cells when pulsed with dendritic cells. Methods We isolated exosomes by ultracentrifugation on sucrose and D2O gradients of 11 malignant effusions. We characterised exosomes with Western blot analyses, immunoelectron microscopy, and in-vitro stimulations of autologous T lymphocytes. Findings Malignant effusions accumulate high numbers of membrane vesicles that have a mean diameter of 80 nm (SD 30). These vesicles have antigen-presenting molecules (MHC class-I heat-shock proteins), tetraspanins (CD81), and tumour antigens (Her2/Neu, Mart1, TRP, gp100). These criteria, including their morphological characteristics, indicate the similarities between these vesicles and exosomes. Exosomes from patients with melanoma deliver Mart1 tumour antigens to dendritic cells derived from monocytes (MD-DCs) for cross presentation to clones of cytotoxic T lymphocytes specific to Mart1. In seven of nine patients with cancer, lymphocytes specific to the tumour could be efficiently expanded from peripheral blood cells by pulsing autologous MD-DCs with autologous ascitis exosomes. In one patient tested, we successfully expanded a restricted T-cell repertoire, which could not be recovered carcinomatosis nodules. Interpretation Exosomes derived from tumours accumulate in ascites from patients with cancer. Ascitis exosomes are a natural and new source of tumour-rejection antigens, opening up new avenues for immunisation against cancers.	Inst Gustave Roussy, Dept Biol Clin, Unite Immunol, F-94805 Villejuif, France; Inst Gustave Roussy, Dept Med Oncol, Villejuif, France; Inst Gustave Roussy, Dept Surg Oncol, Villejuif, France; Hop St Louis, INSERM, U520, Paris, France; Inst Curie, CNRS, UMR 144, F-75231 Paris, France	UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite	Zitvogel, L (corresponding author), Inst Gustave Roussy, Dept Biol Clin, Unite Immunol, 39 Rue Camille Desmoulins, F-94805 Villejuif, France.		ANDRE, Fabrice/AAL-2683-2020; Morice, Philippe/ABC-3179-2021; Pomel, Christophe/E-6833-2013	ANDRE, Fabrice/0000-0001-5795-8357; Pomel, Christophe/0000-0003-3903-7321; ANGEVIN, Eric/0000-0001-6249-7209; Amigorena, Sebastian/0000-0001-8583-8416; ZITVOGEL, laurence/0000-0003-1596-0998; Morice, Philippe/0000-0003-0579-9993				Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; AOKI Y, 1991, CANCER RES, V51, P1934; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Denzer K, 2000, J IMMUNOL, V165, P1259, DOI 10.4049/jimmunol.165.3.1259; Dufour E, 1997, J IMMUNOL, V158, P3787; Farace F, 1997, INT J CANCER, V71, P972, DOI 10.1002/(SICI)1097-0215(19970611)71:6<972::AID-IJC11>3.3.CO;2-8; FREEDMAN RS, 1994, J IMMUNOTHER, V16, P198, DOI 10.1097/00002371-199410000-00004; Gong JL, 2000, J IMMUNOL, V165, P1705, DOI 10.4049/jimmunol.165.3.1705; Henry F, 1999, CANCER RES, V59, P3329; HSU D, 2002, P AM ASSOC CANC RES, V21, pA3362; Hsu FJ, 1996, NAT MED, V2, P52, DOI 10.1038/nm0196-52; Kugler A, 2000, NAT MED, V6, P332, DOI 10.1038/73193; Murphy GP, 1999, PROSTATE, V39, P54, DOI 10.1002/(SICI)1097-0045(19990401)39:1<54::AID-PROS9>3.0.CO;2-U; Nair SK, 2000, NAT MED, V6, P1011, DOI 10.1038/79519; Nestle FO, 1998, NAT MED, V4, P328, DOI 10.1038/nm0398-328; PEOPLES GE, 1993, J IMMUNOL, V151, P5472; PEOPLES GE, 1994, J IMMUNOL, V152, P4993; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Regnault A, 1999, J EXP MED, V189, P371, DOI 10.1084/jem.189.2.371; Santin AD, 2000, AM J OBSTET GYNECOL, V183, P601, DOI 10.1067/mob.2000.107097; Santin AD, 2000, OBSTET GYNECOL, V96, P422, DOI 10.1016/S0029-7844(00)00916-9; Singh-Jasuja H, 2000, J EXP MED, V191, P1965, DOI 10.1084/jem.191.11.1965; Soda H, 1999, J SURG ONCOL, V72, P211, DOI 10.1002/(SICI)1096-9098(199912)72:4<211::AID-JSO6>3.3.CO;2-1; Srivastava PK, 1997, METHODS, V12, P165, DOI 10.1006/meth.1997.0464; STEIS RG, 1990, J CLIN ONCOL, V8, P1618, DOI 10.1200/JCO.1990.8.10.1618; Thery C, 1999, J CELL BIOL, V147, P599, DOI 10.1083/jcb.147.3.599; VANPEL A, 1983, J EXP MED, V157, P1992, DOI 10.1084/jem.157.6.1992; Vermorken JB, 1999, LANCET, V353, P345, DOI 10.1016/S0140-6736(98)07186-4; Wolfe K, 2000, NAT REV GENET, V1, P7, DOI 10.1038/35049607; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594	30	707	769	2	67	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 27	2002	360	9329					295	305		10.1016/S0140-6736(02)09552-1	http://dx.doi.org/10.1016/S0140-6736(02)09552-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	578DT	12147373				2022-12-24	WOS:000177102700011
J	Chenn, A; Walsh, CA				Chenn, A; Walsh, CA			Regulation of cerebral cortical size by control of cell cycle exit in neural precursors	SCIENCE			English	Article							BETA-CATENIN; MICE LACKING; EXPRESSION; BRAIN; MORPHOGENESIS; HYPERPLASIA; EVOLUTION; EXPANSION; DELETION; POLARITY	Transgenic mice expressing a stabilized beta-catenin in neural precursors develop enlarged brains with increased cerebral cortical surface area and folds resembling sulci and gyri of higher mammals. Brains from transgenic animals have enlarged lateral ventricles lined with neuroepithelial precursor cells, reflecting an expansion of the precursor population. Compared with wild-type precursors, a greater proportion of transgenic precursors reenter the cell cycle after mitosis. These results show that beta-catenin can function in the decision of precursors to proliferate or differentiate during mammalian neuronal development and suggest that beta-catenin can regulate cerebral cortical size by controlling the generation of neural precursor cells.	Beth Israel Deaconess Med Ctr, Dept Neurol, Div Neurogenet, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital	Walsh, CA (corresponding author), Beth Israel Deaconess Med Ctr, Dept Neurol, Div Neurogenet, Boston, MA 02115 USA.	cwalsh@caregroup.harvard.edu		Walsh, Christopher/0000-0002-0156-2238	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032457] Funding Source: NIH RePORTER; NINDS NIH HHS [R01NS32457] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson SA, 2001, DEVELOPMENT, V128, P353; Barth AIM, 1997, J CELL BIOL, V136, P693, DOI 10.1083/jcb.136.3.693; Barton RA, 2000, NATURE, V405, P1055, DOI 10.1038/35016580; Berger UV, 2001, J COMP NEUROL, V433, P101, DOI 10.1002/cne.1128; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Brault V, 2001, DEVELOPMENT, V128, P1253; BULFONE A, 1995, NEURON, V15, P63, DOI 10.1016/0896-6273(95)90065-9; Butz S, 1995, CELL ADHES COMMUN, V3, P337, DOI 10.3109/15419069509081018; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; Cho EA, 1998, MECH DEVELOP, V77, P9; Clark DA, 2001, NATURE, V411, P189, DOI 10.1038/35075564; Clevers H, 1997, TRENDS GENET, V13, P485, DOI 10.1016/S0168-9525(97)01305-X; Cox RT, 1996, J CELL BIOL, V134, P133, DOI 10.1083/jcb.134.1.133; DISALVO CV, 1995, CELL PROLIFERAT, V28, P511, DOI 10.1111/j.1365-2184.1995.tb00089.x; ELIAS H, 1969, SCIENCE, V166, P111, DOI 10.1126/science.166.3901.111; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; FINLAY BL, 1995, SCIENCE, V268, P1578, DOI 10.1126/science.7777856; Galceran J, 2000, DEVELOPMENT, V127, P469; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; HAUG H, 1987, AM J ANAT, V180, P126, DOI 10.1002/aja.1001800203; Huang HT, 2000, AM J PATHOL, V156, P433, DOI 10.1016/S0002-9440(10)64747-5; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Kuan CY, 2000, TRENDS NEUROSCI, V23, P291, DOI 10.1016/S0166-2236(00)01581-2; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Lee SMK, 2000, DEVELOPMENT, V127, P457; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Moon RT, 1997, TRENDS GENET, V13, P157, DOI 10.1016/S0168-9525(97)01093-7; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; MURPHY TH, 1989, NEURON, V2, P1547, DOI 10.1016/0896-6273(89)90043-3; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; OOSTERWEGEL M, 1993, DEVELOPMENT, V118, P439; PARR BA, 1993, DEVELOPMENT, V119, P247; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1995, TRENDS NEUROSCI, V18, P383, DOI 10.1016/0166-2236(95)93934-P; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Takahashi T, 1996, J NEUROSCI, V16, P6183; van de Water S, 2001, DEVELOPMENT, V128, P3877; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; Yaworsky PJ, 1999, DEV BIOL, V205, P309, DOI 10.1006/dbio.1998.9035	43	1105	1159	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 19	2002	297	5580					365	369		10.1126/science.1074192	http://dx.doi.org/10.1126/science.1074192			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574LV	12130776				2022-12-24	WOS:000176892600041
J	Cohen, P; Miyazaki, M; Socci, ND; Hagge-Greenberg, A; Liedtke, W; Soukas, AA; Sharma, R; Hudgins, LC; Ntambi, JM; Friedman, JM				Cohen, P; Miyazaki, M; Socci, ND; Hagge-Greenberg, A; Liedtke, W; Soukas, AA; Sharma, R; Hudgins, LC; Ntambi, JM; Friedman, JM			Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss	SCIENCE			English	Article							FATTY-ACID OXIDATION; GENE-EXPRESSION; OBESE GENE; OB PROTEIN; MICE; MOUSE; BIOSYNTHESIS; CHOLESTEROL; DEFICIENCY; METABOLISM	Leptin elicits a metabolic response that cannot be explained by its anorectic effects alone. To examine the mechanism underlying leptin's metabolic actions, we used transcription pro ling to identify leptin-regulated genes in ob/ob liver. Leptin was found to specifically repress RNA levels and enzymatic activity of hepatic stearoyl-CoA desaturase-1 (SCD-1), which catalyzes the biosynthesis of monounsaturated fatty acids. Mice lacking SCD-1 were lean and hypermetabolic. ob/ob mice with mutations in SCD-1 were significantly less obese than ob/ob controls and had markedly increased energy expenditure. ob/ob mice with mutations in SCD-1 had histologically normal livers with significantly reduced triglyceride storage and VLDL ( very low density lipoprotein) production. These findings suggest that down-regulation of SCD-1 is an important component of leptin's metabolic actions.	Rockefeller Univ, Mol Genet Lab, New York, NY 10021 USA; Rockefeller Univ, Ctr Studies Phys & Biol, New York, NY 10021 USA; Rockefeller Univ, Rogosin Inst, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA	Rockefeller University; Rockefeller University; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Friedman, JM (corresponding author), Rockefeller Univ, Mol Genet Lab, 1230 York Ave, New York, NY 10021 USA.		Liedtke, Wolfgang/GNH-1878-2022; Liedtke, Wolfgang B/G-4633-2011		NIDDK NIH HHS [R01-DK41096] Funding Source: Medline; NIGMS NIH HHS [GM07739] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041096] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; ASILMAZ E, UNPUB; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; Cohen P, 2001, J CLIN INVEST, V108, P1113, DOI 10.1172/JCI200113914; Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204; Ferrante AW, 2001, DIABETES, V50, P2268, DOI 10.2337/diabetes.50.10.2268; Friedman JM, 2000, NATURE, V404, P632, DOI 10.1038/35007504; GATES AH, 1965, SCIENCE, V148, P1471, DOI 10.1126/science.148.3676.1471; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Kamohara S, 1997, NATURE, V389, P374, DOI 10.1038/38717; Levin N, 1996, P NATL ACAD SCI USA, V93, P1726, DOI 10.1073/pnas.93.4.1726; Liang CP, 2001, J BIOL CHEM, V276, P49066, DOI 10.1074/jbc.M107250200; LUNZER MA, 1977, J BIOL CHEM, V252, P5483; MCGARRY JD, 1977, J CLIN INVEST, V60, P265, DOI 10.1172/JCI108764; Merkel M, 1998, J CLIN INVEST, V102, P893, DOI 10.1172/JCI2912; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Miyazaki M, 2001, J NUTR, V131, P2260, DOI 10.1093/jn/131.9.2260; Miyazaki M, 2000, J BIOL CHEM, V275, P30132, DOI 10.1074/jbc.M005488200; NTAMBI JM, 1988, J BIOL CHEM, V263, P17291; Ntambi JM, 1999, J LIPID RES, V40, P1549; Oral EA, 2002, NEW ENGL J MED, V346, P570, DOI 10.1056/NEJMoa012437; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Shimomura I, 1999, NATURE, V401, P73, DOI 10.1038/43448; Soukas A, 2000, GENE DEV, V14, P963; VOLPE JJ, 1976, PHYSIOL REV, V56, P339, DOI 10.1152/physrev.1976.56.2.339; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zheng Y, 1999, NAT GENET, V23, P268, DOI 10.1038/15446	27	603	653	1	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 12	2002	297	5579					240	243		10.1126/science.1071527	http://dx.doi.org/10.1126/science.1071527			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	571UT	12114623				2022-12-24	WOS:000176738100038
J	Naoumova, RP; Betteridge, DJ				Naoumova, RP; Betteridge, DJ			A new drug target for treatment of dyslipidaemia associated with type 2 diabetes and the metabolic syndrome?	LANCET			English	Editorial Material									Middlesex Hosp, Royal Free & Univ Coll Med Sch, Dept Med, London W1N 8AA, England; Hammersmith Hosp, MRC, Clin Sci Ctr, London, England	University of London; University College London; Imperial College London	Betteridge, DJ (corresponding author), Middlesex Hosp, Royal Free & Univ Coll Med Sch, Dept Med, London W1N 8AA, England.	j.betteridge@ucl.ac.uk						Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Conklin D, 1999, GENOMICS, V62, P477, DOI 10.1006/geno.1999.6041; Ginsberg HN, 2000, J CLIN INVEST, V106, P453, DOI 10.1172/JCI10762; Koishi R, 2002, NAT GENET, V30, P151, DOI 10.1038/ng814; Krssak M, 1999, DIABETOLOGIA, V42, P113, DOI 10.1007/s001250051123; MCGARRY JD, 1992, SCIENCE, V258, P766, DOI 10.1126/science.1439783; Moller DE, 2001, NATURE, V414, P821, DOI 10.1038/414821a; Ruderman NB, 1999, AM J PHYSIOL-ENDOC M, V276, pE1, DOI 10.1152/ajpendo.1999.276.1.E1; UNGER RH, 1995, DIABETES, V44, P863, DOI 10.2337/diabetes.44.8.863	9	11	21	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 29	2002	359	9325					2215	2216		10.1016/S0140-6736(02)09315-7	http://dx.doi.org/10.1016/S0140-6736(02)09315-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	567YJ	12103282				2022-12-24	WOS:000176514500004
J	Crawford, LM				Crawford, LM			Nominations for device panels	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commissioner Food & Drugs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Crawford, LM (corresponding author), US FDA, Off Commissioner Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 11	2002	288	10					1225	1225		10.1001/jama.288.10.1225	http://dx.doi.org/10.1001/jama.288.10.1225			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592BW	12215114				2022-12-24	WOS:000177917700008
J	Crawford, LM				Crawford, LM			Needlestick injury data needed	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commissioner Food & Drugs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Crawford, LM (corresponding author), US FDA, Off Commissioner Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 11	2002	288	10					1225	1225		10.1001/jama.288.10.1225	http://dx.doi.org/10.1001/jama.288.10.1225			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592BW	12215114				2022-12-24	WOS:000177917700006
J	O'Leary, DR; Nasci, RS; Campbell, GL; Marfin, AA				O'Leary, DR; Nasci, RS; Campbell, GL; Marfin, AA		CDC	West Nile virus activity - United States, 2001 (Reprinted from MMWR, vol 51, pg 497-501, 2002)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint							NEW-YORK; MOSQUITOS; INFECTION; HORSES; BIRDS		CDC, Div Vector Borne Infect Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	O'Leary, DR (corresponding author), CDC, Div Vector Borne Infect Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA.							Bunning ML, 2002, EMERG INFECT DIS, V8, P380; *CDC, 2001, UPD EP EP W NIL VIR; *HLTH CAN, 2002, W NIL VIR SURV 2002; Komar N, 2001, ANN NY ACAD SCI, V951, P58; Kulasekera VL, 2001, EMERG INFECT DIS, V7, P722, DOI 10.3201/eid0704.010421; Marfin AA, 2001, EMERG INFECT DIS, V7, P730; Nasci RS, 2001, EMERG INFECT DIS, V7, P626; O'Leary DR, 2002, JAMA-J AM MED ASSOC, V288, P158; Rappole JH, 2000, EMERG INFECT DIS, V6, P319, DOI 10.3201/eid0604.000401; Sardelis MR, 2001, EMERG INFECT DIS, V7, P1018, DOI 10.3201/eid0706.010617; Turell MJ, 2001, J MED ENTOMOL, V38, P130, DOI 10.1603/0022-2585-38.2.130	11	57	64	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 10	2002	288	2					158	160						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	571HC	12113262				2022-12-24	WOS:000176711100010
